FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Cassell, AM
   Li, J
   Nguyen-Vu, TB
   Koehne, JE
   Chen, H
   Andrews, R
   Meyyappan, M
AF Cassell, Alan M.
   Li, Jun
   Nguyen-Vu, Thuy-Duong Barbara
   Koehne, Jessica E.
   Chen, Hua
   Andrews, Russell
   Meyyappan, M.
TI Vertically Aligned Carbon Nanofibers: Interconnecting Solid State
   Electronics with Biosystems
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Nanoneuroscience - Nanoeuroprotection and
   Nanoeurotoxicity
CY AUG 20-26, 2007
CL Killithea, GREECE
DE Neural Interface; Carbon Nanofiber; Vertically Aligned; Polypyrrole;
   Nucleic Acid Detection; Electrochemical Methods; Neurotransmitter;
   Dopamine; Implantable Electrode; PC12 Cells; Biocompatibility
ID NANOTUBE NANOELECTRODE ARRAYS; CONDUCTING-POLYMER; NUCLEIC-ACIDS; DNA
   ANALYSIS; ELECTROCHEMISTRY; ELECTROCATALYSIS; FABRICATION; BIOSENSORS;
   RELEASE; FIELD
AB Vertically aligned carbon nanofibers (VACNFs) are grown directly on prefabricated electronic circuits with nanoscale precision. Utilizing the free-standing nanofiber array geometry, we have demonstrated the detection of nucleic acids to construct an ultrasensitive electrochemical sensor. Extending this technology towards in vivo applications, we have modified the free-standing VACNF arrays in order to achieve a multifunctional three dimensional (3-D) matrix that interpenetrates the neuronal network of PC12 cells. We found that PC12 cells cultured on the nanofiber arrays can form an extended neural network upon proper chemical and biochemical modification. The soft 3-D nanofiber array architecture provides a novel platform to fine-tune the topographical, mechanical, chemical, and electrical cues at sub-cellular scales. This biomaterial platform can be used for both fundamental studies of nanomaterial-cell interactions and the development of multifunctional, chronically stable implantable devices. The application of these devices and potential utility as a multifunctional platform for neurophysiology and biochemical studies will be discussed.
C1 [Cassell, Alan M.; Nguyen-Vu, Thuy-Duong Barbara; Koehne, Jessica E.; Chen, Hua; Andrews, Russell; Meyyappan, M.] Univ Calif Santa Cruz, UARC, NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.
   [Li, Jun] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA.
RP Cassell, AM (reprint author), Univ Calif Santa Cruz, UARC, NASA, Ames Res Ctr, M-S 229-1, Moffett Field, CA 94035 USA.
RI Li, Jun/H-7771-2013
OI Li, Jun/0000-0002-3689-8946; Nguyen-Vu, T.D. Barbara/0000-0002-4708-1982
FU NINDS NIH HHS [5 R21 NS047721]
CR Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   Armistead PM, 2000, ANAL CHEM, V72, P3764, DOI 10.1021/ac000051e
   Boczkowski J, 2007, NANOMEDICINE-UK, V2, P407, DOI 10.2217/17435889.2.4.407
   Boon EM, 2000, NAT BIOTECHNOL, V18, P1096, DOI 10.1038/80301
   Cai WB, 2007, SMALL, V3, P1840, DOI 10.1002/smll.200700351
   Campbell JK, 1999, J AM CHEM SOC, V121, P3779, DOI 10.1021/ja990001v
   Chen J. H., 2002, SYNTHETIC MET, V125, P289
   Cruden BA, 2003, J APPL PHYS, V94, P4070, DOI 10.1063/1.1601293
   CUI X, 2003, BIOMATERIALS, V24, P177
   Dresselhaus M. S., 1996, SCI FULLERENES CARBO
   EBBESEN TW, 1997, CARBON NANOTUBES PRE
   FAN FRF, 1995, SCIENCE, V267, P871, DOI 10.1126/science.267.5199.871
   Heaton RJ, 2001, P NATL ACAD SCI USA, V98, P3701, DOI 10.1073/pnas.071623998
   Heller MJ, 1996, IEEE ENG MED BIOL, V15, P100, DOI 10.1109/51.486725
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kim HM, 2004, CURR APPL PHYS, V4, P577, DOI 10.1016/j.cap.2004.01.022
   Koehne J, 2004, J MATER CHEM, V14, P676, DOI 10.1039/b311728f
   Koehne J, 2003, NANOTECHNOLOGY, V14, P1239, DOI 10.1088/0957-4484/14/12/001
   Koehne JE, 2004, CLIN CHEM, V50, P1886, DOI 10.1373/clinchem.2004.036285
   Lang F, 2000, CELL PHYSIOL BIOCHEM, V10, P417, DOI 10.1159/000016367
   Li J, 2003, NANO LETT, V3, P597, DOI 10.1021/nl0340677
   Li J, 2003, APPL PHYS LETT, V82, P2491, DOI 10.1063/1.1566791
   Li J, 2002, APPL PHYS LETT, V81, P910, DOI 10.1063/1.1496494
   Lin YH, 2004, NANO LETT, V4, P191, DOI 10.1021/nl0347233
   McCreery R.L., 1991, ELECTROANALYTICAL CH, V17, P221
   Meyyappan M., 2004, CARBON NANOTUBES SCI
   Musameh M, 2002, ELECTROCHEM COMMUN, V4, P743, DOI 10.1016/S1388-2481(02)00451-4
   Nguyen CV, 2002, NANO LETT, V2, P1079, DOI 10.1021/nl025689f
   Nguyen-Vu TDB, 2007, IEEE T BIO-MED ENG, V54, P1121, DOI 10.1109/TBME.2007.891169
   Nguyen-Vu TDB, 2006, SMALL, V2, P89, DOI 10.1002/smll.200500175
   NIMNI ME, 1988, BIOCHEMISTRY-US, V1, P143
   NIMNI ME, 1988, BIOCH BIOMECHANICS, V2, P50
   Nugent JM, 2001, NANO LETT, V1, P87, DOI 10.1021/nl005521z
   Patolsky F, 2006, NANOMEDICINE-UK, V1, P51, DOI 10.2217/17435889.1.1.51
   PENNER RM, 1990, SCIENCE, V250, P1118, DOI 10.1126/science.250.4984.1118
   POPOVICH ND, 2002, INTERFACE, V11, P30
   Saito R, 1998, PHYS PROPERTIES CARB
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Sistare MF, 1999, J PHYS CHEM B, V103, P10718, DOI 10.1021/jp992940f
   Tomanek D., 2000, SCI APPL NANOTUBES
   Umek RM, 2001, J MOL DIAGN, V3, P74, DOI 10.1016/S1525-1578(10)60655-1
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   Wang J, 2003, J AM CHEM SOC, V125, P2408, DOI 10.1021/ja028951v
   WIGHTMAN RM, 1981, ANAL CHEM, V53, P1125
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
NR 47
TC 7
Z9 7
U1 0
U2 14
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD AUG
PY 2009
VL 9
IS 8
BP 5038
EP 5046
DI 10.1166/jnn.2009.GR06
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 470QO
UT WOS:000267994100069
PM 19928183
DA 2018-10-19
ER

PT J
AU Stan, GE
AF Stan, G. E.
TI Adherent functional graded hydroxylapatite coatings produced by
   sputtering deposition techniques
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Biomaterial; coatings; hydroxylapatite; sputtering techniques;
   functional graded material; adherence
ID HYDROXYAPATITE COATINGS; IMMERSION BEHAVIOR; IMPLANTS; TITANIUM;
   BIOCERAMICS; INTERFACE; ALLOYS; FILMS
AB The aim of this paper was to study the influence of crystallization heat treatments up to 750 degrees C, upon the integrity and structure of hydroxylapatite thin films. Two different types of hydroxylapatite coatings were investigated: abrupt structures prepared by magnetron sputtering and respectively functional graded structures deposited by a co-sputtering technique. A clear dependence was noticed between adherence values and annealing temperature and was correlated with the SEM, XRD and FTIR results. X-ray diffraction and FTIR measurements showed that the hydroxylapatite coatings annealed at 400 degrees C were less crystalline, similar to biological apatites. Over 550 degrees C, the apatite coatings obtained were well crystallized and preferentially oriented on (002) HA crystal plane. The adherence of HA coating increased with annealing the temperature up to 550 degrees C due to diffusion phenomena. At 550 degrees C the adhesion test results indicated better adhesion values in case of functional graded structures (> 85 MPa) in comparison with abrupt ones (similar to 70 MPa). At 750 degrees C an adherence decreasing occurred for both types of structures. This is mainly due to the effect of a significant thermal stress owed to the mismatch of the thermal expansion coefficients between the crystallized HA and Ti substrate. The presence of rutile lines in XRD spectrum suggests an increasing of the diffusion phenomena and a strong substrate oxidation at the HAM interface with annealing temperature.
C1 Natl Inst Mat Phys, Bucharest 077125, Romania.
RP Stan, GE (reprint author), Natl Inst Mat Phys, POB MG-7, Bucharest 077125, Romania.
EM George_stan@infim.ro
RI Stan, George/B-5690-2011
OI Stan, George/0000-0003-0289-8988
FU  [PN09-450103];  [PNII 71110/2007]
FX The financial support of PN09-450103 and PNII 71110/2007 research
   programs is acknowledged.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Chen MF, 2007, SURF COAT TECH, V201, P5688, DOI 10.1016/j.surfcoat.2006.07.057
   Cheng K, 2005, SURF COAT TECH, V198, P242, DOI 10.1016/j.surfcoat.2004.10.024
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   Ding SJ, 2003, BIOMATERIALS, V24, P4233, DOI 10.1016/S0142-9612(03)00315-6
   Ding SJ, 1999, J BIOMED MATER RES, V47, P551, DOI 10.1002/(SICI)1097-4636(19991215)47:4<551::AID-JBM12>3.0.CO;2-C
   DUCHEYNE P, 1987, J BIOMED MATER RES-A, V21, P219
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   Ergun C, 2004, ACTA MATER, V52, P4767, DOI 10.1016/j.actamat.2004.06.032
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   Guillemot F, 2005, EXPERT REV MED DEVIC, V2, P741, DOI 10.1586/17434440.2.6.741
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Inagaki M, 2003, SURF COAT TECH, V173, P1, DOI 10.1016/S0257-8972(03)00513-9
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mercioniu I, 2007, J OPTOELECTRON ADV M, V9, P2535
   Nelea V, 2007, J MATER SCI-MATER M, V18, P2347, DOI 10.1007/s10856-007-3135-1
   Park E, 1998, MATER LETT, V36, P38, DOI 10.1016/S0167-577X(97)00287-5
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Sam Z, 2006, SURF COAT TECH, V200, P6350, DOI 10.1016/j.surfcoat.2005.11.033
   SIMA LE, 2008, ROM J BIOCHEM, V45, P122
   Socrates G., 2007, INFRARED RAMAN CHARA
   Stan GE, 2009, APPL SURF SCI, V255, P9132, DOI 10.1016/j.apsusc.2009.06.117
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tschernitschek H, 2005, QUINTESSENCE INT, V36, P523
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Ueda R, 2000, J CERAM SOC JPN, V108, P865, DOI 10.2109/jcersj.108.1261_865
   Verestiuc L, 2004, J CRYST GROWTH, V264, P483, DOI 10.1016/j.jcrysgro.2004.01.015
   Wang CX, 2001, BIOMATERIALS, V22, P1619, DOI 10.1016/S0142-9612(00)00319-7
   Wang CX, 2001, NUCL INSTRUM METH B, V179, P364, DOI 10.1016/S0168-583X(01)00585-7
   Wasa K, 2003, THIN FILM MAT TECHNO
NR 34
TC 20
Z9 20
U1 1
U2 5
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD AUG
PY 2009
VL 11
IS 8
BP 1132
EP 1138
PG 7
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 493GR
UT WOS:000269724200015
DA 2018-10-19
ER

PT J
AU Rivera, JA
   Fetter, G
   Banos, L
   Guzman, J
   Bosch, P
AF Rivera, J. A.
   Fetter, G.
   Banos, L.
   Guzman, J.
   Bosch, P.
TI New hydroxyapatite-hydrotalcite composites I. synthesis
SO JOURNAL OF POROUS MATERIALS
LA English
DT Article
DE Hydrotalcite; Hydroxyapatite; Composite; Microwave irradiation;
   Biomaterial; Catalyst; Bone
ID LAYERED DOUBLE HYDROXIDES; MICROWAVE; CATALYSTS; FLUORAPATITE
AB The synthesis and characterization of original materials, composed by hydrotalcite and hydroxyapatite, is discussed. All the syntheses were carried out in presence of microwave irradiation during the crystallization step. The interactions between the two compounds depend on the synthesis procedure. If hydroxyapatite is incorporated to hydrotalcite, the first compound is encapsulated by hydrotalcite. Instead, if hydroxyapatite is first prepared, the resulting solid is essentially a hydrotalcite with interlayered hydroxyapatite. When the composite material is synthesized by a simultaneous coprecipitation, the small clusters of hydroxyapatite and hydrotalcite are homogeneously dispersed. Consequently, the specific surface area and the particle size vary.
C1 [Rivera, J. A.; Fetter, G.] Univ Autonoma Puebla, Fac Ciencias Quim, Puebla 72570, Mexico.
   [Banos, L.; Guzman, J.; Bosch, P.] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico.
RP Fetter, G (reprint author), Univ Autonoma Puebla, Fac Ciencias Quim, Blvd 18 Sur & Av San Claudio, Puebla 72570, Mexico.
EM geolarfetter@yahoo.com.mx
FU CONACYT
FX The authors gratefully acknowledge the financial support of CONACYT.
CR Benito P, 2006, J SOLID STATE CHEM, V179, P3784, DOI 10.1016/j.jssc.2006.08.010
   Bergada O, 2007, MICROPOR MESOPOR MAT, V101, P363, DOI 10.1016/j.micromeso.2006.11.033
   Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K
   Climent MJ, 2004, J CATAL, V225, P316, DOI 10.1016/j.jcat.2004.04.027
   DRIESSENS FCM, 2000, BIOMINERALS, P41
   Du LC, 2007, POLYM COMPOSITE, V28, P131, DOI 10.1002/pc.20279
   Elazarifi N, 2004, CATAL TODAY, V98, P161, DOI 10.1016/j.cattod.2004.07.030
   Fetter G, 2001, J POROUS MAT, V8, P227, DOI 10.1023/A:1012292807651
   Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z
   Katsuki H, 1999, J AM CERAM SOC, V82, P2257
   Komarneni S, 1996, J MATER RES, V11, P1866, DOI 10.1557/JMR.1996.0236
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Lopez T, 1997, MATER LETT, V31, P311, DOI 10.1016/S0167-577X(96)00296-0
   Milev AS, 2004, LANGMUIR, V20, P1888, DOI 10.1021/la0355601
   Mori K, 2003, J AM CHEM SOC, V125, P11460, DOI 10.1021/ja0302533
   Olanrewaju J, 2000, MATER LETT, V45, P307, DOI 10.1016/S0167-577X(00)00123-3
   Paredes SP, 2006, J MATER SCI, V41, P3377, DOI 10.1007/s10853-005-5347-4
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   Prinetto F, 2000, CATAL TODAY, V55, P103, DOI 10.1016/S0920-5861(99)00230-8
   Rivera JA, 2007, APPL CATAL A-GEN, V316, P207, DOI 10.1016/j.apcata.2006.09.031
   Rivera JA, 2006, MICROPOR MESOPOR MAT, V89, P306, DOI 10.1016/j.micromeso.2005.10.041
   Rives V, 1999, COORDIN CHEM REV, V181, P61, DOI 10.1016/S0010-8545(98)00216-1
   Simon P, 2005, J MATER CHEM, V15, P4992, DOI 10.1039/b504977f
   Smahi A, 2003, APPL CATAL A-GEN, V250, P151, DOI 10.1016/S0926-860X(03)00254-0
   Tichit D, 2002, J MATER CHEM, V12, P3832, DOI 10.1039/b203376n
   Uota M, 2005, LANGMUIR, V21, P4724, DOI 10.1021/la050029m
   Wang SL, 2000, AM MINERAL, V85, P739, DOI 10.2138/am-2000-5-612
   Wang YF, 2006, J COLLOID INTERF SCI, V301, P19, DOI 10.1016/j.jcis.2006.04.061
   Zapata B, 2001, INT J INORG MATER, V3, P23, DOI 10.1016/S1466-6049(00)00097-0
NR 30
TC 8
Z9 10
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-2224
J9 J POROUS MAT
JI J. Porous Mat.
PD AUG
PY 2009
VL 16
IS 4
BP 401
EP 408
DI 10.1007/s10934-008-9227-6
PG 8
WC Chemistry, Applied; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 464DZ
UT WOS:000267486700005
DA 2018-10-19
ER

PT J
AU Brown, EM
AF Brown, Eleanor M.
TI COLLAGEN - A NATURAL SCAFFOLD FOR BIOLOGY AND ENGINEERING
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
CT 105th Annual Meeting of the American-Leather-Chemists-Association
CY JUN 18-21, 2009
CL Wheeling, WV
SP Amer Leather Chem Assoc
ID 3-DIMENSIONAL-ENERGY MINIMIZED MODELS; MOLECULAR-DYNAMICS SIMULATIONS; I
   COLLAGEN; CROSS-LINKING; TRIPLE-HELIX; TERMINAL TELOPEPTIDES;
   THERMAL-STABILITY; NEUTRAL SALTS; C-TELOPEPTIDE; HIDE POWDER
AB Collagen, the most abundant protein in mammals, constitutes a quarter of the animal's total weight. The unique structure of fibrous collagens, a long triple helix that further associates into fibers, provides an insoluble scaffold that gives strength and form to the skin, tendons, bones, cornea and teeth. The ready availability, to meat eaters, of animal skins that Would putrefy, if left untreated, led to man's earliest venture into biomaterials engineering and resulted In the production Of leather. Through empirical methods, a number of tanning agents with a variety of properties were identified. The methods for production of leather evolved over several centuries as art and engineering with little understanding of the underlying science. Scientific advances of the twentieth century, including increasing use of collagen in medical biomaterial research, began to provide a basis for understanding the relationship between collagen structure and function in both biology and technology.
   During the past 20 years, leather researchers at ERRC have used experimental and theoretical approaches to investigate several methods for stabilizing collagen structure. This research, which includes studies of mineral and vegetable tannages, enzyme-catalyzed and aldehyde-based covalent crosslinks, electrostatic and hydrophobic interactions, will be reviewed. Insight gained from these studies and those of other leather and biomaterials scientists will be evaluated as steps toward a still elusive, comprehensive mechanism for stabilization of collagen in leather and other biomaterials.
C1 ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.
RP Brown, EM (reprint author), ARS, USDA, Eastern Reg Res Ctr, 600 E Mermaid Lane, Wyndmoor, PA 19038 USA.
EM eleanor.brown@ars.usda.gov
CR BAILEY AJ, 1992, J SOC LEATH TECH CH, V76, P111
   BAILEY DG, 1981, J AM LEATHER CHEM AS, V76, P204
   BORASKY R, 1952, J AM LEATHER CHEM AS, V47, P312
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Bronco S, 2006, J PHYS CHEM B, V110, P13227, DOI 10.1021/jp061776a
   Bronco S, 2004, J PHYS CHEM B, V108, P10101, DOI 10.1021/jp049172z
   Brown EM, 2008, J AM LEATHER CHEM AS, V103, P290
   Brown EM, 2005, J AM LEATHER CHEM AS, V100, P401
   Brown EM, 2004, J AM LEATHER CHEM AS, V99, P376
   Brown EM, 2003, J AM LEATHER CHEM AS, V98, P408
   Brown EM, 1999, J AM LEATHER CHEM AS, V94, P59
   BROWN EM, 1993, J AM LEATHER CHEM AS, V88, P2
   Brown EM, 1997, J AM LEATHER CHEM AS, V92, P225
   Brown EM, 2000, J PROTEIN CHEM, V19, P85, DOI 10.1023/A:1007074314686
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Bulo RE, 2007, MACROMOL BIOSCI, V7, P234, DOI 10.1002/mabi.200600208
   Buttar D, 1997, J AM LEATHER CHEM AS, V92, P185
   Cappelli C, 2005, CHIRALITY, V17, P577, DOI 10.1002/chir.20210
   Castaneda L, 2008, BIOMACROMOLECULES, V9, P3383, DOI 10.1021/bm800793z
   CHEN JM, 1991, J AM LEATHER CHEM AS, V86, P475
   CHEN JM, 1991, J AM LEATHER CHEM AS, V86, P487
   CHEN JM, 1991, J PROTEIN CHEM, V10, P535, DOI 10.1007/BF01025482
   CHU CC, 2001, POLYM BIOMATERIALS, pCH19
   Covington A.D., 2003, P 27 C INT UN LEATH, P148
   De Simone A, 2008, BIOCHEM BIOPH RES CO, V372, P121, DOI 10.1016/j.bbrc.2008.04.190
   Ding K, 2007, J AM LEATHER CHEM AS, V102, P164
   Ding K, 2006, J AM LEATHER CHEM AS, V101, P362
   EIKENBERRY EF, 1980, J MOL BIOL, V144, P397, DOI 10.1016/0022-2836(80)90098-4
   FEAIRHELLER SH, 1991, J AM LEATHER CHEM AS, V86, P171
   FEAIRHELLER SH, 1979, P 16 C INT UN LEATH, P79
   Fennen J, 1998, J SOC LEATH TECH CH, V82, P5
   FILACHION EM, 1961, J AM LEATHER CHEM AS, V56, P200
   FILACHIONE EM, 1959, JALCA, V54, P668
   Furuichi K, 2006, CHEM MATER, V18, P229, DOI 10.1021/cm052213z
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   George A, 1999, P INDIAN AS-CHEM SCI, V111, P121
   GUSTAVSON KH, 1949, ADV PROTEIN CHEM, V5, P354
   HAPPICH ML, 1971, J AM LEATHER CHEM AS, V66, P364
   Harlan J W, 1977, Adv Exp Med Biol, V86A, P425
   HENSHILWOOD CS, 2001, J HUM EVOL, V41, P678
   HULMES DJS, 1981, P NATL ACAD SCI-BIOL, V78, P3567, DOI 10.1073/pnas.78.6.3567
   HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1
   KADLER K, 1994, PROTEIN PROFILES, V1, P535
   King G, 1996, PROTEIN ENG, V9, P43, DOI 10.1093/protein/9.1.43
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   Lastowka A, 2005, J AM LEATHER CHEM AS, V100, P196
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Loo RW, 2008, LANGMUIR, V24, P13276, DOI 10.1021/la803041v
   Maffia Gennaro J., 2003, United States Patent, Patent No. 6660829
   Maffia GJ, 2004, J AM LEATHER CHEM AS, V99, P164
   Malone JP, 2004, BIOCHEMISTRY-US, V43, P15358, DOI 10.1021/bi048304b
   Malone JP, 2004, PROTEINS, V54, P206, DOI 10.1002/prot.10526
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MILLER MH, 1980, MACROMOLECULES, V13, P910, DOI 10.1021/ma60076a028
   Mogilner IG, 2002, J MOL GRAPH MODEL, V21, P209, DOI 10.1016/S1093-3263(02)00145-6
   Monti S, 2005, J PHYS CHEM B, V109, P11389, DOI 10.1021/jp0440941
   Monti S, 2007, J PHYS CHEM C, V111, P6086, DOI 10.1021/jp070266t
   NA GC, 1986, BIOCHEMISTRY-US, V25, P958, DOI 10.1021/bi00353a003
   NA GC, 1989, BIOCHEMISTRY-US, V28, P7161, DOI 10.1021/bi00444a005
   NAGHSKI J, 1967, LEATHER MANUF, V84, P40
   NUTTING GC, 1948, J AM LEATHER CHEM AS, V43, P96
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   OTTER A, 1988, BIOCHEMISTRY-US, V27, P3560, DOI 10.1021/bi00410a006
   Qi PX, 2002, J AM LEATHER CHEM AS, V97, P235
   QUIMBY D, 1975, J AM LEATHER CHEM AS, V70, P510
   Ramachandran G. N., 1967, TREATIES COLLAGEN
   Ramasami T, 2001, J AM LEATHER CHEM AS, V96, P290
   SCHOLNICK F, 1992, J AM LEATHER CHEM AS, V87, P333
   Siggel L, 2006, J AM LEATHER CHEM AS, V101, P179
   Siggel L, 2007, J AM LEATHER CHEM AS, V102, P333
   Sistiabudi R, 2007, J PHYS CHEM C, V111, P11676, DOI 10.1021/jp072757j
   SMITH JW, 1968, NATURE, V219, P157, DOI 10.1038/219157a0
   Stuart K, 2009, BIOMACROMOLECULES, V10, P25, DOI 10.1021/bm800888u
   Sun M, 2008, LANGMUIR, V24, P5418, DOI 10.1021/la703292h
   SUSI H, 1971, J AM LEATHER CHEM AS, V66, P508
   Takenouchi K., 1981, J SOC LEATHER TECHN, V75, P190
   TAYLOR MM, 1989, J AM LEATHER CHEM AS, V84, P71
   TAYLOR MM, 1986, J AM LEATHER CHEM AS, V81, P43
   TAYLOR MM, 1991, J AM LEATHER CHEM AS, V86, P199
   Terao K, 2008, MACROMOLECULES, V41, P7203, DOI 10.1021/ma800790w
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   VANDERREST M, 1991, FASEB J, V5, P2814
   VIOLA SJ, 1966, JALCA, V61, P661
   WILSON JA, 1928, JALCA, V24, P157
   WILSON JA, 1943, J AM LEATHER CHEM AS, V38, P20
   WILSON JA, 1919, JALCA, V14, P450
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   Zhong SP, 2007, MAT SCI ENG C-BIO S, V27, P262, DOI 10.1016/j.msec.2006.05.010
   1974, TANNING EXTRACT PROD, pCH1
NR 89
TC 6
Z9 7
U1 1
U2 12
PU AMER LEATHER CHEMISTS ASSOC
PI LUBBOCK
PA TEXAS TECH UNIV, BOX 45300, LUBBOCK, TX 79409-5300 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD AUG
PY 2009
VL 104
IS 8
BP 275
EP 285
PG 11
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA 479ZH
UT WOS:000268700500003
DA 2018-10-19
ER

PT J
AU Trommer, RM
   Santos, LA
   Bergmann, CP
AF Trommer, R. M.
   Santos, L. A.
   Bergmann, C. P.
TI Nanostructured hydroxyapatite powders produced by a flame-based
   technique
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Calcium phosphate; Hydroxyapatite; Powder; Flame
ID CALCIUM-PHOSPHATE CERAMICS; PARTICLE FORMATION; COATINGS; APATITE; FILMS
AB In this work we reported the production of hydroxyapatite (RA) powder, one of the most studied calcium phosphates in the bioceramics field, using a cost-effective apparatus, composed by three major components: the atomization device, the pilot and main flames and finally the powder collector system. Calcium acetate and ammonium phosphate, diluted in ethanol and water, were used as salts in the precursor solution. The Ca/P molar ratio in the precursor solution was 1.65, equivalent to biological hydroxyapatite. After its production and collection, HA powder was calcined at 600 degrees C for 2 h. X-ray diffraction analysis pointed to the formation of crystalline hydroxyapatite powders. Carbonate was identified in the powders by Fourier-transform infrared (FTIR) spectroscopy. Scanning electronic microscopy (SEM) showed that the powders were composed of spherical primary particles and secondary aggregates, with the morphology unchanged after calcination. By transmission electronic microscopy (TEM), it was observed that the crystallite size of the primary particles was 24.8 +/- 5.8 nm. for the calcined powder. The specific surface area was 15.03 +/- 6.4 and 26.50 +/- 7.6 m(2)/g, for the as-synthetized and calcined powder respectively. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Trommer, R. M.; Bergmann, C. P.] Ceram Mat Lab, BR-90035190 Porto Alegre, RS, Brazil.
   [Santos, L. A.] Biomat Lab, BR-91501970 Porto Alegre, RS, Brazil.
RP Trommer, RM (reprint author), Ceram Mat Lab, Av Osvaldo Aranha 99-705, BR-90035190 Porto Alegre, RS, Brazil.
EM rafael_trommer@yahoo.com.br
RI Trommer, Rafael/D-4156-2015; Biofabris, Inct/I-2418-2013; Perez
   Bergmann, Carlos/F-2225-2010
OI Trommer, Rafael/0000-0002-1599-0583; Perez Bergmann,
   Carlos/0000-0002-8951-8943
FU Brazilian Agency CNPq - Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico
FX The authors gratefully acknowledge the financial support of the
   Brazilian Agency CNPq - Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico. In addition, the CME - Centro de Microscopia Eletronica
   of Federal University of Rio Grande do Sul - is hereby acknowledged for
   kindly helping in the electron microscopy procedures.
CR Adanez J, 1999, FUEL, V78, P583, DOI 10.1016/S0016-2361(98)00186-0
   Andrade AL, 2006, QUIM NOVA, V29, P100, DOI 10.1590/S0100-40422006000100019
   AOKI IH, 1991, SCI MED APPL HYDROXY
   Balamurugan A, 2006, MATER LETT, V60, P2288, DOI 10.1016/j.matlet.2005.12.126
   Balamurugan A, 2006, CERAM-SILIKATY, V50, P27
   Cho JS, 2008, J ALLOY COMPD, V464, P282, DOI 10.1016/j.jallcom.2007.09.092
   Edelstein A, 1996, NANOMATERIALS SYNTHE
   GAYDON AG, 1953, FLAMES THEIR STRUCTU
   HAMMARI E, 2007, MATER CHEM PHYS, V104, P448
   Han YC, 2004, MATER RES BULL, V39, P25, DOI 10.1016/j.materresbull.2003.09.022
   Hench L. L., 1993, ADV SERIES CERAMICS
   Jalota S, 2005, J AM CERAM SOC, V88, P3353, DOI 10.1111/j.1551-2916.2005.00623.x
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   KWEH SWK, 1999, J MATER PROCESS TECH, V89, P373
   Leeuwenburgh SCG, 2006, BIOMATERIALS, V27, P3368, DOI 10.1016/j.biomaterials.2006.01.052
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Loher S, 2005, CHEM MATER, V17, P36, DOI 10.1021/cm048776c
   Mukherjee ST, 2008, J ALLOY COMPD, V466, P493, DOI 10.1016/j.jallcom.2007.11.070
   Pratsinis SE, 1998, PROG ENERG COMBUST, V24, P197, DOI 10.1016/S0360-1285(97)00028-2
   Pratsinis SE, 1996, POWDER TECHNOL, V88, P267, DOI 10.1016/S0032-5910(96)03130-0
   Qiu CF, 2008, CERAM INT, V34, P1747, DOI 10.1016/j.ceramint.2007.06.001
   RAJABIZAMANI AH, 2008, MAT SCI ENG B-SOLID, P1326
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Rigo E. C. S., 2007, REV DENT PRESS PERIO, V1, P39
   Roth P, 2007, P COMBUST INST, V31, P1773, DOI 10.1016/j.proci.2006.08.118
   Santos ML, 2005, ECLET QUIM, V30, P29
   Solla EL, 2005, APPL SURF SCI, V248, P360, DOI 10.1016/j.apsusc.2005.03.053
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Trommer RM, 2007, SURF COAT TECH, V201, P9587, DOI 10.1016/j.surfcoat.2007.04.028
   ULRICH GD, 1971, COMBUST SCI TECHNOL, V4, P47, DOI 10.1080/00102207108952471
NR 30
TC 23
Z9 25
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2009
VL 29
IS 6
BP 1770
EP 1775
DI 10.1016/j.msec.2009.02.006
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 485RA
UT WOS:000269140200002
DA 2018-10-19
ER

PT J
AU An, J
   Wang, DS
   Luo, QZ
   Yuan, XY
AF An, Jing
   Wang, Desong
   Luo, Qingzhi
   Yuan, Xiaoyan
TI Antimicrobial active silver nanoparticles and silver/polystyrene
   core-shell nanoparticles prepared in room-temperature ionic liquid
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silver nanoparticles; Polystyrene; Core-shell nanoparticles; Ionic
   liquid; Antimicrobial activity
ID FERRITE COMPOSITE NANOPARTICLES; BIOMATERIAL SYSTEM; PHOTOCATALYTIC
   SHELL; ESCHERICHIA-COLI; MAGNETIC CORE; POLYMERIZATION; PARTICLES;
   COPPER; GOLD; FILM
AB Uniform silver nanoparticles and silver/polystyrene core-shell nanoparticles were successfully synthesized in a room temperature ionic liquid, 1-n-butyl-3-methylimidazolium tetra fluoroborate ([BMIM]center dot BF(4)). [BMIM]center dot BF(4) plays a protective role to prevent the nanoparticles from aggregation during the preparation process. Transmission electron micrographs confirm that both silver nanoparticles and core-shell nanoparticles are regular spheres with the sizes in the range of 5-15 nm and 15-25 nm, respectively. The X-ray diffraction analysis reveals the face-centered cubic geometry of silver nanoparticles. The as-prepared nanoparticles were also characterized by Fourier transform infrared spectroscopy, Raman spectroscopy, UV-vis diffuse reflectance spectroscopy and X-ray photoelectron spectroscopy. In addition, antimicrobial activities against E. coli and S. aureus were studied and the results show that both silver nanoparticles and core-shell nanoparticles possess excellent antimicrobial activities. The antimicrobial mechanism of the as-prepared nanoparticles was discussed. Crown Copyright (C) 2009 Published by Elsevier B.V. All rights reserved.
C1 [An, Jing; Wang, Desong; Luo, Qingzhi] Hebei Univ Sci & Technol, Sch Sci, Hebei 050018, Shijiazhuang, Peoples R China.
   [An, Jing; Yuan, Xiaoyan] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Wang, DS (reprint author), Hebei Univ Sci & Technol, Sch Sci, Hebei 050018, Shijiazhuang, Peoples R China.
EM dswang06@126.com
RI Desong, Wang/J-9105-2013; Dom, Rekha/B-7113-2012
FU Nature Science Foundation of Hebei Province [E2008000699]
FX The authors are grateful for the support of this research by the Nature
   Science Foundation of Hebei Province (Grant no. E2008000699).
CR Dellinger TM, 2004, CHEM MATER, V16, P2201, DOI 10.1021/cm0349194
   Dong AG, 2002, CHEM COMMUN, P350, DOI 10.1039/b110164c
   Dupont J, 2004, ANGEW CHEM INT EDIT, V43, P5296, DOI 10.1002/anie.200460431
   Dyson PJ, 2002, APPL ORGANOMET CHEM, V16, P495, DOI 10.1002/aoc.337
   ELHAGAHMED MO, 2006, J ORGANOMET CHEM, V691, P1055
   Gogoi SK, 2006, LANGMUIR, V22, P9322, DOI 10.1021/la060661v
   HAO E, 2002, J AM CHEM SOC, V124, P1518
   He ST, 2001, LANGMUIR, V17, P1571, DOI 10.1021/la001239w
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Liang GD, 2007, MAT SCI ENG B-SOLID, V142, P55, DOI 10.1016/j.mseb.2007.06.028
   Liu P, 2006, COLLOID SURFACE A, V291, P155, DOI 10.1016/j.colsurfa.2006.05.007
   Liu WJ, 2006, J SOLID STATE CHEM, V179, P1253, DOI 10.1016/j.jssc.2006.01.042
   Maillard M, 2003, J PHYS CHEM B, V107, P2466, DOI 10.1021/jp022357q
   Mallick K, 2006, MAT SCI ENG C-BIO S, V26, P87, DOI 10.1016/j.msec.2005.06.004
   Manna A, 2001, LANGMUIR, V17, P6000, DOI 10.1021/la010389j
   Nakashima T, 2003, J AM CHEM SOC, V125, P6386, DOI 10.1021/ja034954b
   Olivier-Bourbigou H, 2002, J MOL CATAL A-CHEM, V182, P419, DOI 10.1016/S1381-1169(01)00465-4
   Paulo A. Z., 1996, POLYHEDRON, V15, P1217
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   SANPUI P, 2008, INT J FOOD MICROBIOL, V31, P142
   Scheeren CW, 2006, J PHYS CHEM B, V110, P13011, DOI 10.1021/jp0623037
   Scheeren CW, 2003, INORG CHEM, V42, P4738, DOI 10.1021/ic034453r
   Sondi I, 2003, J COLLOID INTERF SCI, V260, P75, DOI 10.1016/S0021-9797(02)00205-9
   Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Swatloski RP, 2002, GREEN CHEM, V4, P81, DOI 10.1039/b108905f
   Torres FJ, 2007, J PHYS CHEM B, V111, P6327, DOI 10.1021/jp072257q
   Vigneshwaran N, 2006, CARBOHYD RES, V341, P2012, DOI 10.1016/j.carres.2006.04.042
   Wang DB, 2005, MATER LETT, V59, P1760, DOI 10.1016/j.matlet.2005.01.061
   Whitehead JA, 2007, HYDROMETALLURGY, V88, P109, DOI 10.1016/j.hydromet.2007.03.009
   Xu W, 2003, J PHYS CHEM B, V107, P6170, DOI 10.1021/jp0275894
   XUA JZ, 2004, MAT SCI ENG C-BIO S, V24, P833
   Yoon KY, 2007, SCI TOTAL ENVIRON, V373, P572, DOI 10.1016/j.scitotenv.2006.11.007
   Yoon M, 2005, MATER CHEM PHYS, V91, P104, DOI 10.1016/j.matchemphys.2004.10.059
   Zhang K, 2005, MATER LETT, V59, P3682, DOI 10.1016/j.matlet.2005.06.063
   Zhang Y, 2008, ENVIRON SCI TECHNOL, V42, P1724, DOI 10.1021/es0713983
   Zhang ZQ, 2000, J PHYS CHEM B, V104, P1176, DOI 10.1021/jp991569t
NR 41
TC 32
Z9 32
U1 0
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2009
VL 29
IS 6
BP 1984
EP 1989
DI 10.1016/j.msec.2009.03.015
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 485RA
UT WOS:000269140200036
DA 2018-10-19
ER

PT J
AU Ernstberger, T
   Buchhorn, G
   Heidrich, G
AF Ernstberger, Thorsten
   Buchhorn, Gottfried
   Heidrich, Gabert
TI Artifacts in spine magnetic resonance imaging due to different
   intervertebral test spacers: an in vitro evaluation of magnesium versus
   titanium and carbon-fiber-reinforced polymers as biomaterials
SO NEURORADIOLOGY
LA English
DT Article
DE Magnesium alloys; Innovative biomaterials; Interbody test implants; MRI
   artifacting
ID INTERBODY FUSION; PEDICLE SCREWS; LUMBAR SPINE; IMPLANT; CAGES; MRI;
   INSTRUMENTATION; PARAMETERS; QUALITY; ALLOYS
AB Introduction Intervertebral spacers are made of different materials, which can affect the postfusion magnetic imaging (MRI) scans. Susceptibility artifacts especially for metallic implants can decrease the image quality. This study aimed to determine whether magnesium as a lightweight and biocompatible metal is suitable as a biomaterial for spinal implants based on its MRI artifacting behavior.
   Materials and methods To compare artifacting behaviors, we implanted into one porcine cadaveric spine different test spacers made of magnesium, titanium, and carbon-fiber-reinforced polymers (CFRP). All test spacers were scanned using two T1-TSE MRI sequences. The artifact dimensions were traced on all scans and statistically analyzed.
   Results The total artifact volume and median artifact area of the titanium spacers were statistically significantly larger than magnesium spacers (p<0.001), while magnesium and CFRP spacers produced almost identical artifacting behaviors (p>0.05).
   Conclusion Our results suggest that spinal implants made with magnesium alloys will behave more like CFRP devices in MRI scans. Given its osseoconductive potential as a metal, implant alloys made with magnesium would combine the advantages to the two principal spacer materials currently used but without their limitations, at least in terms of MRI artifacting.
C1 [Ernstberger, Thorsten] Klinikum Bad Bramstedt, Ctr Spinal Surg, D-24576 Bad Bramstedt, Germany.
   [Buchhorn, Gottfried] Univ Gottingen, Dept Orthoped Surg, Biomat Lab, D-37075 Gottingen, Germany.
   [Heidrich, Gabert] Univ Gottingen, Dept Diagnost Radiol, D-37075 Gottingen, Germany.
RP Ernstberger, T (reprint author), Klinikum Bad Bramstedt, Ctr Spinal Surg, Oskar Alexander Str 26, D-24576 Bad Bramstedt, Germany.
EM ernstberger@klinikumbb.de
CR BRANTIGAN JW, 1993, SPINE, V18, P2106, DOI 10.1097/00007632-199310001-00030
   DEBATIN JF, 1992, INVEST RADIOL, V27, P198, DOI 10.1097/00004424-199203000-00003
   Diedrich O, 2001, ZBL NEUROCHIR, V62, P106, DOI 10.1055/s-2001-21796
   ERNSTBERGER T, 2006, EUR SPINE J, V7, P1
   Ernstberger T, 2007, SPINE J, V7, P353, DOI 10.1016/j.spinee.2006.03.016
   Ernstberger T, 2007, NEURORADIOLOGY, V49, P103, DOI 10.1007/s00234-006-0161-5
   Henk C B, 1999, Top Magn Reson Imaging, V10, P247, DOI 10.1097/00002142-199908000-00006
   Kuklo TR, 2006, J SPINAL DISORD TECH, V19, P376, DOI 10.1097/01.bsd.0000203945.03922.f6
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Malik AS, 2001, ACTA RADIOL, V42, P291, DOI 10.1034/j.1600-0455.2001.042002291.x
   McAfee PC, 2005, SPINE, V30, pS60, DOI 10.1097/01.brs.0000155578.62680.dd
   Ortiz O, 1996, NEUROSURGERY, V38, P741, DOI 10.1227/00006123-199604000-00022
   Petersilge CA, 1996, AM J ROENTGENOL, V166, P1213, DOI 10.2214/ajr.166.5.8615272
   RAUZZINO MJ, 1999, NEUROSURG FOCUS, V15, pE7
   Rudisch A, 1998, SPINE, V23, P692, DOI 10.1097/00007632-199803150-00009
   RUPP R, 1993, SPINE, V18, P379
   Schreiner U, 2000, Z ORTHOP GRENZGEB, V138, P540, DOI 10.1055/s-2000-9598
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Thomsen M, 2001, ORTHOPADE, V30, P540, DOI 10.1007/s001320170063
   Troitskii VV, 1944, KHIRURGIIA, V8, P41
   Trouillier Hans, 2006, Acta Orthop Belg, V72, P460
   VACCARO AR, 1994, SPINE, V19, P1237, DOI 10.1097/00007632-199405310-00008
   Van Goethem JWM, 2002, NEURORADIOLOGY, V44, P723, DOI 10.1007/s00234-002-0790-2
   Waldman ID, 2005, AM J MED GENET B, V138B, P144
   Wang JC, 1997, J SPINAL DISORD, V10, P27
   Wang JC, 1998, SPINE, V23, P1684, DOI 10.1097/00007632-199808010-00014
   Znamenskii MS, 1945, KHIRURGIIA, V12, P60
NR 27
TC 18
Z9 18
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-3940
J9 NEURORADIOLOGY
JI Neuroradiology
PD AUG
PY 2009
VL 51
IS 8
BP 525
EP 529
DI 10.1007/s00234-009-0537-4
PG 5
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 484AB
UT WOS:000269013900004
PM 19468722
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Mohammadi, H
   Boughner, D
   Millon, LE
   Wan, WK
AF Mohammadi, H.
   Boughner, D.
   Millon, L. E.
   Wan, W. K.
TI Design and simulation of a poly(vinyl alcohol)-bacterial cellulose
   nanocomposite mechanical aortic heart valve prosthesis
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE finite element method; mechanical heart valves; poly(vinyl alcohol);
   bacterial cellulose; soft tissue; anisotropy; non-linearity
ID STRESS-ANALYSIS; LEAFLET; CAVITATION; MODEL
AB In this study, a polymeric aortic heart valve made of poly(vinyl alcohol) (PVA)-bacterial cellulose (BC) nanocomposite is simulated and designed using a hyperelastic non-linear anisotropic material model. A novel nanocomposite biomaterial combination of 15 wt % PVA and 0.5 wt % BC is developed in this study. The mechanical properties of the synthesized PVA-BC are similar to those of the porcine heart valve in both the principal directions. To design the geometry of the leaflets an advance surfacing technique is employed. A Galerkin-based non-linear finite element method is applied to analyse the mechanical behaviour of the leaflet in the closing and opening phases under physiological conditions. The model used in this study can be implemented in mechanical models for any soft tissues such as articular cartilage, tendon, and ligament.
C1 [Mohammadi, H.; Boughner, D.; Millon, L. E.; Wan, W. K.] Univ Western Ontario, Fac Engn, Dept Biomed Engn, London, ON N6A 5B9, Canada.
   [Boughner, D.] London Hlth Sci Ctr, London, ON, Canada.
   [Wan, W. K.] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Mohammadi, H (reprint author), Univ Western Ontario, Fac Engn, Dept Biomed Engn, London, ON N6A 5B9, Canada.
EM hmohamm3@uwo.ca
RI Boughner, Derek/G-3282-2011
FU Canadian Institutes of Health Research
FX The authors thank the Integrated Manufacturing Technology Institute and
   the Virtual Environment Technology Centre for providing technical
   supports and facilities to achieve this project. The authors also thank
   the Canadian Institutes of Health Research for funding this project.
CR Beck A, 2001, J HEART VALVE DIS, V10, P1
   BURRIESCI G, 1999, J BIOMECH, V10, P707
   De Hart J, 2004, J BIOMECH, V37, P303, DOI 10.1016/S0021-9290(03)00293-8
   GERALD F, 1993, CURVES SURFACES COMP
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   Grande-Allen KJ, 2001, IEEE T BIO-MED ENG, V48, P647, DOI 10.1109/10.923783
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   He ZM, 2001, J HEART VALVE DIS, V10, P666
   JIANG H, 2003, J MED ENG PHYS, V24, P267
   KEISER R, 2004, P VIS MOD VIS VMV 04, P315
   Kim H, 2006, J BIOMECH ENG-T ASME, V128, P717, DOI 10.1115/1.2244578
   KNIERBEIN B, 1992, J BIOMED ENG, V14, P275, DOI 10.1016/0141-5425(92)90001-2
   KRUCINSKI S, 1993, J BIOMECH, V26, P929, DOI 10.1016/0021-9290(93)90055-J
   LEAT ME, 1994, MED ENG PHYS, V16, P470, DOI 10.1016/1350-4533(94)90071-X
   Li J, 2001, J BIOMECH, V34, P1279, DOI 10.1016/S0021-9290(01)00092-6
   Luo XY, 2003, J BIOMECH ENG-T ASME, V125, P735, DOI 10.1115/1.1614821
   Mackay TG, 1996, BIOMATERIALS, V17, P1857, DOI 10.1016/0142-9612(95)00242-1
   MERCER JL, 1973, J THORAC CARDIOV SUR, V65, P511
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Mohammadi H, 2006, MED ENG PHYS, V28, P122, DOI 10.1016/j.medengphy.2005.03.013
   Mohammadi H, 2008, P I MECH ENG H, V222, P1115, DOI 10.1243/09544119JEIM432
   NISTAL F, 1990, J THORAC CARDIOVASC, V99, P1047
   Patterson EA, 1996, J MED ENG TECHNOL, V20, P95, DOI 10.3109/03091909609008387
   ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9
   Sripathi VC, 2004, ANN THORAC SURG, V77, P844, DOI 10.1016/S0003-4975(03)01518-2
   *U W ONT HEART VAL, 1997, WHAT DOES REAL HEART
   WIJSMULLER EG, 1990, INT J ARTIF ORGANS, V13, P503
   Yoganathan A P, 1994, J Heart Valve Dis, V3, P571
NR 29
TC 26
Z9 27
U1 2
U2 20
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD AUG
PY 2009
VL 223
IS H6
BP 697
EP 711
DI 10.1243/09544119JEIM493
PG 15
WC Engineering, Biomedical
SC Engineering
GA 491JG
UT WOS:000269574100006
PM 19743636
DA 2018-10-19
ER

PT J
AU Choe, HC
   Saji, VS
   Ko, YM
AF Choe, Han-Cheol
   Saji, Viswanathan S.
   Ko, Yeong-Mu
TI Mechanical properties and corrosion resistance of low rigidity
   quaternary titanium alloy for biomedical applications
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE Ti-35Nb-5Ta-7Zr; biomaterial; mechanical properties; corrosion
ID IN-VITRO; TA
AB Electrochemical corrosion of Ti-35Nb-5Ta-7Zr alloy fabricated by arc melting and heat treatment process was studied in 0.9% NaCl at (37 +/- 1) degrees C. Phase and microstructure of the fabricated alloy were investigated using X-ray diffractometer and scanning electron microscope. Mechanical properties such as yield strength and elastic modulus of the alloy were determined by tensile test. Potentiodynamic polarization technique and impedance spectroscopy were employed to study the corrosion behavior. The results of the study were compared with those obtained for Ti-6Al-4V commercial alloy. The result of the study supports feasibility of Ti-35Nb-5Ta-7Zr alloy for implant applications.
C1 [Choe, Han-Cheol; Saji, Viswanathan S.; Ko, Yeong-Mu] Chosun Univ, Dept Dent Mat, Coll Dent, Kwangju 501759, South Korea.
RP Choe, HC (reprint author), Chosun Univ, Dept Dent Mat, Coll Dent, Kwangju 501759, South Korea.
EM hcchoe@chosun.ac.kr
RI Viswanathan S., Saji/H-8533-2015
OI Viswanathan S., Saji/0000-0003-1724-0011
CR *ASTM, 2000, 3 ASTM
   Balazic Matej, 2007, International Journal of Nano and Biomaterials, V1, P3, DOI 10.1504/IJNBM.2007.016517
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Jatsy M., 1993, J APPL BIOMATER, V4, P273
   Karthega M, 2007, ACTA BIOMATER, V3, P1019, DOI 10.1016/j.actbio.2007.02.009
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Okazaki Y, 2001, CURR OPIN SOLID ST M, V5, P45, DOI 10.1016/S1359-0286(00)00025-5
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Qazi JI, 2004, JOM-US, V56, P49, DOI 10.1007/s11837-004-0253-9
   Raman V, 2006, ELECTROCHEM COMMUN, V8, P1309, DOI 10.1016/j.elecom.2006.06.004
   Rosa S, 2001, BRAZ J CHEM ENG, V18, P47, DOI 10.1590/S0104-66322001000100005
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P370, DOI 10.1016/j.msec.2005.04.003
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
NR 17
TC 9
Z9 10
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD AUG
PY 2009
VL 19
IS 4
BP 862
EP 865
DI 10.1016/S1003-6326(08)60365-9
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 485CV
UT WOS:000269099300016
DA 2018-10-19
ER

PT J
AU Ranjan, A
   Webster, TJ
AF Ranjan, Ashwini
   Webster, Thomas J.
TI Increased endothelial cell adhesion and elongation on micron-patterned
   nano-rough poly(dimethylsiloxane) films
SO NANOTECHNOLOGY
LA English
DT Article
ID SILICONE SURFACES; POLY(LACTIC-CO-GLYCOLIC ACID); TITANIUM SURFACES;
   FOCAL CONTACT; FEATURES; BEHAVIOR; SPECIFICITY; TOPOGRAPHY; MECHANISMS;
   STRESS
AB The success of synthetic vascular grafts is largely determined by their ability to promote vital endothelial cell functions such as adhesion, alignment, proliferation, and extracellular matrix (ECM) deposition. Developing such biomaterials requires the design and fabrication of materials that mimic select properties of native extracellular matrices. Furthermore, cells of the native endothelium have elongated and aligned morphology in the direction of blood flow, yet few materials promote this type of morphology initially, but rather rely on blood flow to orient endothelial cells. Therefore, the objective of this in vitro study was to design a biomaterial that mimics the conditions of the micro-and nano-environment of vascular intima tissue suitable for endothelial cell adhesion and elongation to improve the efficacy of small synthetic vascular grafts. Towards this end, patterned poly(dimethylsiloxane) (PDMS) films consisting of periodic arrays of nano-grooves (500 nm), with spacings ranging from 22 to 80 mu m, and alternating nano-and micron roughness were fabricated using a novel electron beam physical vapor deposition method followed by polymer casting. By varying pattern spacing, the area of micron-and nano-rough surface was controlled. In vitro rat aortic endothelial cell adhesion and elongation studies indicated that endothelial cell function was enhanced on patterned PDMS surfaces with the widest spacing and greatest surface area of nano-roughness, as compared to more narrow pattern spacings and non-patterned PDMS surfaces. Specifically, endothelial cells adherent on PDMS patterned films of the widest spacing (greatest nano-rough area) displayed almost twice as much elongation as cells on non-patterned surfaces. For these reasons, the present study highlighted design criteria (the use of micron patterns of nano-features on PDMS) that may contribute to the intelligent design of new-generation vascular grafts.
C1 [Ranjan, Ashwini; Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
   [Webster, Thomas J.] Brown Univ, Dept Orthopaed, Providence, RI 02912 USA.
RP Webster, TJ (reprint author), Brown Univ, Div Engn, Providence, RI 02912 USA.
EM Thomas_Webster@brown.edu
FU National Institutes of Health [1R21AG027521]
FX The authors would like to thank the National Institutes of Health (Grant
   No. 1R21AG027521) for funding, Dr Robbert Creton and Mr Geoffrey
   Williams for help with fluorescence microscopy, Dr Michael Jibitsky at
   the Microelectronics Facility, and Dr Anthony McCormick at the Electron
   Microscope Facility of Brown University.
CR ABBOTT WM, 1993, J VASC SURG, V17, P746, DOI 10.1016/0741-5214(93)90120-B
   BARRON V, 2006, J MATER SCI, V18, P1973
   Boateng SY, 2003, AM J PHYSIOL-CELL PH, V285, P171
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   CHU CFL, 1999, BIOCHIM BIOPHYS ACTA, V3, P479
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   DAVIES PF, 1993, CIRC RES, V72, P239, DOI 10.1161/01.RES.72.2.239
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jiang XY, 2002, LANGMUIR, V18, P3273, DOI 10.1021/la011668+
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   MACKAY J, 2005, ATLAS HEART DIS STRO
   Mathur AB, 2003, J BIOMED MATER RES A, V66A, P729, DOI 10.1002/jbm.a.10581
   Meyle J, 1993, J Biomater Appl, V7, P362, DOI 10.1177/088532829300700404
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Molitor P, 2001, INT J ADHES ADHES, V21, P129, DOI 10.1016/S0143-7496(00)00044-0
   Moretti M, 2004, J MATER SCI-MATER M, V15, P1159, DOI 10.1023/B:JMSM.0000046400.18607.72
   NEREM RM, 1981, J BIOMECH ENG-T ASME, V103, P172, DOI 10.1115/1.3138275
   NOLLERT MU, 1991, BIOTECHNOL BIOENG, V38, P588, DOI 10.1002/bit.260380605
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van Kooten TG, 1999, TISSUE ENG, V5, P223
   Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
NR 29
TC 36
Z9 36
U1 2
U2 35
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD JUL 29
PY 2009
VL 20
IS 30
AR 305102
DI 10.1088/0957-4484/20/30/305102
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 468LW
UT WOS:000267821000002
PM 19581692
DA 2018-10-19
ER

PT J
AU Skopinska-Wisniewska, J
   Sionkowska, A
   Kaminska, A
   Kaznica, A
   Jachimiak, R
   Drewa, T
AF Skopinska-Wisniewska, J.
   Sionkowska, A.
   Kaminska, A.
   Kaznica, A.
   Jachimiak, R.
   Drewa, T.
TI Surface characterization of collagen/elastin based biomaterials for
   tissue regeneration
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Collagen; Elastin; Surface modification; UV-irradiation
ID COLLAGEN/PVP BLENDED FILMS; EXTRACELLULAR-MATRIX; CROSS-LINKING;
   IN-VITRO; ULTRAVIOLET-IRRADIATION; RECONSTITUTED COLLAGEN; DERMAL
   SUBSTITUTE; PROTEIN RELEASE; UV-RADIATION; CELL-CULTURE
AB Collagen and elastin are the main proteins of extracellular matrix. Collagen plays a crucial role in tensile strength of tissues, whereas elastin provides resilience to many organs. Both biopolymers are readily available and biocompatible. These properties point out that collagen and elastin are good components of materials for many potential medical applications. The surface properties of biomaterials play an important role in biomedicine as the majority of biological reactions occur on the surface of implanted materials. One of the methods of surface modi. cation is UV-irradiation. The exposition of the biomaterial on ultraviolet light can alterate surface properties of the materials, their chemical stability, swelling properties and mechanical properties as well.
   The aim of our work was to study the surface properties and biocompatibility of new collagen/elastin based biomaterials and consideration of the influence of ultraviolet light on these properties.
   The surface properties of collagen/elastin based biomaterials modified by UV-irradiation were studied using the technique of atomic force microscopy (AFM) and contact angle measurements. On the basis of the results the surface free energy and its polar component was calculated using Owens-Wendt method. To assess the biological performance of films based on collagen, elastin and their blends, the response of 3T3 cell was investigated.
   It was found that the surface of collagen/elastin film is enriched in less polar component-collagen. Exposition on UV light increases polarity of collagen/elastin based films, due to photooxidation process. The AFM images have shown that topography and roughness of the materials had been also affected by UV-irradiation. The changes in surface properties influence on interaction between the material's surface and cells. The investigation of 3T3 cells grown on films based on collagen, elastin and their blends, leads to the conclusion that higher content of elastin in biomaterial promotes the cell adhesion and their viability on the surface. Also the suitable dose of UV light (1, 2 h) improves the biocompatibility of the materials. (C) 2009 Elsevier B. V. All rights reserved.
C1 [Skopinska-Wisniewska, J.; Sionkowska, A.; Kaminska, A.] Nicholas Copernicus Univ, Fac Chem, PL-87100 Torun, Poland.
   [Kaznica, A.; Jachimiak, R.; Drewa, T.] Nicholas Copernicus Univ, Coll Med, PL-85092 Bydgoszcz, Poland.
RP Skopinska-Wisniewska, J (reprint author), Nicholas Copernicus Univ, Fac Chem, Gagarin 7, PL-87100 Torun, Poland.
EM joanna@chem.uni.torun.pl
RI Skopinska-Wisniewska, Joanna/O-6445-2015; Sionkowska, Alina/I-5599-2014
FU Ministry of Science (MNII, Poland) [N507 3495325]
FX Financial support from the Ministry of Science (MNII, Poland) Grant no.
   N N507 3495325 is gratefully acknowledged.
CR Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Bellingham CM, 2004, CURR OPIN SOLID ST M, V8, P135, DOI 10.1016/j.cossms.2004.01.007
   BELLINGHAM CM, 2002, ELASTOMERIC PROTEINS, P39
   Besseau L, 2002, BIOMATERIALS, V23, P27, DOI 10.1016/S0142-9612(01)00075-8
   BONZON N, 1995, BIOMATERIALS, V16, P881, DOI 10.1016/0142-9612(95)94151-A
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   BUTTAFOCO L, 2005, J BIOMED MATER RES B, P357
   Cao H, 2008, J MATER SCI-MATER M, V19, P567, DOI [10.1007/s10856-007-3281-5, 10.1007/S10856-007-3281-5]
   Chan BP, 2008, ACTA BIOMATER, V4, P1627, DOI 10.1016/j.actbio.2008.06.007
   Cunha MR, 2008, J MATER SCI-MATER M, V19, P1341, DOI 10.1007/s10856-006-0105-y
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2005, BIOMATERIALS, V26, P81, DOI 10.1016/j.biomaterials.2004.02.011
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Dutoya S, 1998, BIOMATERIALS, V19, P147, DOI 10.1016/S0142-9612(97)00214-7
   Enever PAJ, 2002, J SURG RES, V105, P160, DOI 10.1006/jsre.2002.6372
   Engbers-Buijtenhuijs P, 2006, BIOMATERIALS, V27, P2390, DOI 10.1016/j.biomaterials.2005.10.016
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   GREGORY KW, 2000, Patent No. 6110212
   Gunasekaran Subramanian, 1995, P1267
   Habermehl J, 2005, MACROMOL BIOSCI, V5, P821, DOI 10.1002/mabi.200500102
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hiles M, 2006, INT UROGYNECOL J, V17, pS39, DOI 10.1007/s00192-006-0104-z
   Hsu FY, 2005, J MATER SCI-MATER M, V16, P341, DOI 10.1007/s10856-005-0633-x
   Jarman-Smith M, 2004, BIOCHEM ENG J, V20, P217, DOI 10.1016/j.bej.2003.09.016
   Jiang B, 2006, BIOMATERIALS, V27, P15, DOI 10.1016/j.biomaterials.2005.05.091
   Kaminska A, 1996, J PHOTOCH PHOTOBIO A, V96, P123, DOI 10.1016/1010-6030(95)04278-4
   Klein B, 2001, J MATER SCI-MATER M, V12, P419, DOI 10.1023/A:1011249020155
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lefebvre F, 1996, BIOMATERIALS, V17, P1813, DOI 10.1016/0142-9612(95)00346-0
   Li B, 2002, J MUSCLE RES CELL M, V23, P561, DOI 10.1023/A:1023474909980
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   OBITABOT ET, 2000, Patent No. 6046160
   Ohan MP, 2002, J BIOMED MATER RES, V60, P384, DOI 10.1002/jbm.10111
   Park J., 2007, BIOMATERIALS INTRO
   Park J. B., 2003, BIOMATERIALS PRINCIP
   RABAUD M, 1993, Patent No. 5223420
   Rajan N, 2008, BIOTECHNOL PROGR, V24, P884, DOI 10.1002/btpr.3
   ROTHSTEIN A, 2004, Patent No. 6765086
   Sai P, 2000, BURNS, V26, P54
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Silver Frederick H., 1995, P1245
   SIMONESCU DT, 2006, BIOMATERIALS, V27, P702
   Sionkowska A, 2006, APPL SURF SCI, V253, P1970, DOI 10.1016/j.apsusc.2006.03.048
   Sionkowska A, 2004, SURF SCI, V566, P608, DOI 10.1016/j.susc.2004.05.114
   Sionkowska A, 2000, POLYM DEGRAD STABIL, V67, P79, DOI 10.1016/S0141-3910(99)00084-1
   Sionkowska A, 2007, J PHOTOCH PHOTOBIO B, V86, P186, DOI 10.1016/j.jphotobiol.2006.09.004
   Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V85, P79, DOI 10.1016/j.jphotobiol.2006.05.005
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   SOSKEL NT, 1987, METHOD ENZYMOL, V144, P196
   Vardaxis NJ, 1996, BIOMATERIALS, V17, P1489, DOI 10.1016/0142-9612(96)89773-0
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Yao CC, 2007, J MATER SCI-MATER M, V18, P1969, DOI 10.1007/s10856-007-3093-7
   Yunoki S, 2007, J MATER SCI-MATER M, V18, P2179, DOI 10.1007/s10856-007-3011-z
NR 62
TC 29
Z9 29
U1 1
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUL 15
PY 2009
VL 255
IS 19
BP 8286
EP 8292
DI 10.1016/j.apsusc.2009.05.127
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 466VZ
UT WOS:000267692900018
DA 2018-10-19
ER

PT J
AU Chiba, A
   Lee, SH
   Matsumoto, H
   Nakamura, M
AF Chiba, Akihiko
   Lee, Sang-Hak
   Matsumoto, Hiroaki
   Nakamura, Mitsuru
TI Construction of processing map for biomedical Co-28Cr-6Mo-0.16N alloy by
   studying its hot deformation behavior using compression tests
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Co-Cr-Mo alloy; Biomaterial; Hot deformation; Processing map
ID CO-CR-MO; IMPLANT ALLOY; SUPERALLOY
AB The high-temperature deformation behavior of Co-28Cr-6Mo-0.16N alloy was investigated by carrying out compression tests for determination of the optimum hot-forging conditions; the tests were carried out in the temperature range of 1000-1200 degrees C and strain rates ranging from 0.01 to 50 s(-1) with a height reduction of 50%. The optimum hot-working conditions were decided from the processing map based on the dynamic materials model (DMM). Dynamic recrystallization (DRX) occurred over the entire temperature and strain rate range. However, uniformly sized grains were formed for strain rates higher than 10 s(-1), which is considered the optimum hot-working condition. The characteristic microstructures predicted from the processing map agreed well with the results of microstructural observations. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Chiba, Akihiko; Matsumoto, Hiroaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Lee, Sang-Hak] Iwate Ind Promot Ctr, Morioka, Iwate 0200852, Japan.
   [Nakamura, Mitsuru] Iwate Univ, Fac Engn, Dept Die Mold & Casting Engn, Morioka, Iwate 0208551, Japan.
RP Chiba, A (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
EM a.chiba@imr.tohoku.ac.jp
RI Chiba, Akihiko/D-1326-2011
FU Ministry of Education, Science and Culture of Japan
FX This research was supported by Cooperation of Innovative Technology and
   Advanced Research in Evolutional Area from the Ministry of Education,
   Science and Culture of Japan.
CR CHAUDHURY PK, 1993, ATLAS FORMABILITY HA, V188, P63
   Chiba A, 1999, PHILOS MAG A, V79, P1533, DOI 10.1080/01418619908210378
   Cong Dahn N., 1984, Acta Metallurgica, V32, P1317
   DIETER GE, 1976, MECH METALLURGY, P138
   DOBBS HS, 1983, J MATER SCI, V18, P391, DOI 10.1007/BF00560627
   Garcia ADJS, 1999, METALL MATER TRANS A, V30, P1177, DOI 10.1007/s11661-999-0267-6
   Hsu HC, 2003, J MATER PROCESS TECH, V138, P231, DOI 10.1016/S0924-0136(03)00077-3
   Kartika I, 2009, METALL MATER TRANS A, V40A, P1457, DOI 10.1007/s11661-009-9829-x
   Lin HY, 2004, BIOMATERIALS, V25, P1233, DOI 10.1016/j.biomaterials.2003.08.016
   Medyanik SN, 2007, J MECH PHYS SOLIDS, V55, P1439, DOI 10.1016/j.jmps.2006.12.006
   Monajati H, 2005, METALL MATER TRANS A, V36A, P895, DOI 10.1007/s11661-005-0284-z
   OH SI, 1992, METALL TRANS A, V23, P963, DOI 10.1007/BF02675571
   Prasad YVRK, 2003, J MATER ENG PERFORM, V12, P638, DOI 10.1361/105994903322692420
   PRASAD YVRK, 1984, METALL TRANS A, V15, P1883, DOI 10.1007/BF02664902
   RAJ R, 1981, METALL TRANS A, V12, P1089, DOI 10.1007/BF02643490
   Ramanathan S, 2006, MAT SCI ENG A-STRUCT, V441, P321, DOI 10.1016/j.msea.2006.08.044
   Rodriguez P., 1984, Bulletin of Materials Science, V6, P653, DOI 10.1007/BF02743993
   SalinasRodriguez A, 1996, J BIOMED MATER RES, V31, P409, DOI 10.1002/(SICI)1097-4636(199607)31:3<409::AID-JBM16>3.0.CO;2-D
   Shettlemore MG, 2001, BIOMATERIALS, V22, P2215, DOI 10.1016/S0142-9612(00)00410-5
   Ziegler H, 1965, PROGR SOLID MECH, V4, P91
NR 20
TC 40
Z9 40
U1 2
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUL 15
PY 2009
VL 513-14
BP 286
EP 293
DI 10.1016/j.msea.2009.02.044
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 452YP
UT WOS:000266577400040
DA 2018-10-19
ER

PT J
AU Zou, YQ
   Rossi, NAA
   Kizhakkedathu, JN
   Brooks, DE
AF Zou, Yuquan
   Rossi, Nicholas A. A.
   Kizhakkedathu, Jayachandran N.
   Brooks, Donald E.
TI Barrier Capacity of Hydrophilic Polymer Brushes To Prevent Hydrophobic
   Interactions: Effect of Graft Density and Hydrophilicity
SO MACROMOLECULES
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; ATOMIC-FORCE MICROSCOPY; HUMAN
   SERUM-ALBUMIN; PROTEIN ADSORPTION; MOLECULAR-WEIGHT; CELL-ADHESION;
   BLOOD-PLASMA; SINGLE-MOLECULE; CHAIN-LENGTH; SURFACE
AB The performance of biomaterials in contact with biological systems can be greatly affected by hydrophobic interactions at the interface between the biomaterial surface and surrounding biomolecules. Polymer brushes can function as a protective layer, preventing such interfacial hydrophobic interactions. In this paper, a systematic study of the barrier properties of a hydrophilic polymer brush is made by investigating the influence of graft density and its chemical nature (hydrophilicity/hydrophobicity) on hydrophobic interactions with the surface. To achieve this, it series of novel thermoresponsive poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide (PDMDOMA) polymer brushes were grown from silicon wafers via surface-initiated atom transfer radical polymerization. Without changing graft density or degree of polymerization, the hydrophilicity of the PDMDOMA brushes was manipulated by partial or complete hydrolysis or the pendent dioxolane moieties. A lower critical solution temperature (LCST) was observed at 22-24 degrees C, below which the PDMDOMA brush was Found to be in a hydrated state (amphiphilic), while at temperatures above the LCST, the PDMDOMA brush formed a collapsed. more hydrophobic structure. A physical method was developed to analyze the ability of these brushes to act as a barrier against hydrophobic interactions based on AFM force-distance measurements. The adhesive forces between the Si(3)N(4) tip and the silicon wafer surface upon (a) modification with ATRP initiator, (b) grafting of PDMDOMA brushes, and (c) partial and complete hydrolysis of PDMDOMA were investigated. Hydrophobic interactions decreased after each modification, while graft density and the degree of hydrolysis increased the barrier function of the surface layer. In particular, when graft density was above 0.22 chains/nm(2), the barrier capacity completely counteracted the hydrophobic interactions, as evidenced from the disappearance of the adhesive force in AFM measurements. Further Studies revealed that the barrier property its assessed by AFM correlated well with the wettability of the surfaces.
C1 [Zou, Yuquan; Rossi, Nicholas A. A.; Kizhakkedathu, Jayachandran N.; Brooks, Donald E.] Univ British Columbia, Ctr Blood Res, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada.
   [Brooks, Donald E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada.
RP Kizhakkedathu, JN (reprint author), Univ British Columbia, Ctr Blood Res, Dept Pathol & Lab Med, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.
EM jay@pathology.ubc.ca; don.brooks@ubc.ca
OI Brooks, Donald/0000-0002-7946-4320
FU Canadian Institutes of Health Research (CIHR); Canadian Blood Services
   (CBS); Canada Foundation for Innovation (CFI); Natural Sciences and
   Engineering Council,; Michael Smith Foundation for Health Research
   (MSFHR); Canada Foundation for Innovation; Michael Smith Foundation for
   Health Research
FX Financial support front Canadian Institutes of Health Research (CIHR),
   Canadian Blood Services (CBS), Canada Foundation for Innovation (CFI),
   the Natural Sciences and Engineering Council, and the Michael Smith
   Foundation for Health Research (MSFHR) is gratefully acknowledged.
   Theauthors thank the LMB Macromolecular Hub at the UBC Centel- for Blood
   Research for the use of their research facilities. These facilities are
   supported in part by grants from the Canada Foundation for Innovation
   and the Michael Smith Foundation for Health Research. J.N.K. is the
   recipient of CBS/Cll-lR new investigator award in transfusion science.
CR Alarcon CDH, 2005, J MATER CHEM, V15, P2089, DOI 10.1039/b419142k
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   Arieh B. N., 1980, HYDROPHOBIC INTERACT
   Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y
   Bhat RR, 2005, ADV MATER, V17, P2802, DOI 10.1002/adma.200500858
   Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162
   Coelho MAN, 2003, LANGMUIR, V19, P7544, DOI 10.1021/la034445n
   Cuenot S, 2006, MACROMOLECULES, V39, P8428, DOI 10.1021/ma060824m
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Dimitrov I, 2007, PROG POLYM SCI, V32, P1275, DOI 10.1016/j.progpolymsci.2007.07.001
   DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C
   Geisler M, 2008, LANGMUIR, V24, P1350, DOI 10.1021/la702341j
   Goodman D, 2004, LANGMUIR, V20, P6238, DOI 10.1021/la030692y
   Goodman D, 2004, LANGMUIR, V20, P3297, DOI 10.1021/la036164l
   Goodman D, 2004, LANGMUIR, V20, P2333, DOI 10.1021/la035843t
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v
   Inglis W, 2001, LANGMUIR, V17, P7402, DOI 10.1021/la010511e
   Ishida N, 2006, J COLLOID INTERF SCI, V297, P513, DOI 10.1016/j.jcis.2005.10.068
   Jisr RM, 2005, ANGEW CHEM INT EDIT, V44, P782, DOI 10.1002/anie.200461645
   Jones DM, 2002, ADV MATER, V14, P1130, DOI 10.1002/1521-4095(20020816)14:16<1130::AID-ADMA1130>3.0.CO;2-7
   Kainthan RK, 2008, BIOMATERIALS, V29, P1693, DOI 10.1016/j.biomaterials.2007.11.030
   Kizhakkedathu JN, 2009, LANGMUIR, V25, P3794, DOI 10.1021/la803690q
   KOOTEN TGV, 2004, BIOMATERIALS, V25, P1735
   Krishnan A, 2006, BIOMATERIALS, V27, P3187, DOI 10.1016/j.biomaterials.2005.12.032
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Lamba NMK, 2000, BIOMATERIALS, V21, P89, DOI 10.1016/S0142-9612(99)00145-3
   Lappegard KT, 2005, ANN THORAC SURG, V79, P917, DOI 10.1016/j.athoracsur.2004.08.015
   Luzinov I, 2004, PROG POLYM SCI, V29, P635, DOI 10.1016/j.progpolymsci.2004.03.001
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Matyjaszewski K, 1999, MACROMOLECULES, V32, P8716, DOI 10.1021/ma991146p
   Mei Y, 2005, LANGMUIR, V21, P12309, DOI 10.1021/la050668x
   Meyer EE, 2006, P NATL ACAD SCI USA, V103, P15739, DOI 10.1073/pnas.0606422103
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533
   Plunkett KN, 2006, LANGMUIR, V22, P4259, DOI 10.1021/la0531502
   REID DS, 1969, NATURE, V224, P1293, DOI 10.1038/2241293b0
   Singh N, 2007, BIOMATERIALS, V28, P763, DOI 10.1016/j.biomaterials.2006.09.036
   Sonnenberg L, 2007, LANGMUIR, V23, P6660, DOI 10.1021/la063682y
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Videm V, 2004, BIOMATERIALS, V25, P43, DOI 10.1016/S0142-9612(03)00470-8
   Wang DA, 2002, BIOCONJUGATE CHEM, V13, P792, DOI 10.1021/bc0255079
   Wang MJ, 2006, POLYMER, V47, P2548, DOI 10.1016/j.polymer.2005.12.086
   WARE JA, 1991, BLOOD, V78, P1713
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu T, 2003, MACROMOLECULES, V36, P2448, DOI 10.1021/ma0257189
   Yamamoto S, 2000, MACROMOLECULES, V33, P5608, DOI 10.1021/ma991988o
   Yamamoto S, 2000, MACROMOLECULES, V33, P5995, DOI 10.1021/ma000225u
   Yeh PYJ, 2008, LANGMUIR, V24, P4907, DOI 10.1021/la702867t
   Zou YQ, 2008, MACROMOLECULES, V41, P5393, DOI 10.1021/ma8006703
   Zou YQ, 2009, MACROMOLECULES, V42, P3258, DOI 10.1021/ma8025699
NR 57
TC 41
Z9 41
U1 0
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUL 14
PY 2009
VL 42
IS 13
BP 4817
EP 4828
DI 10.1021/ma901055t
PG 12
WC Polymer Science
SC Polymer Science
GA 472NJ
UT WOS:000268138500067
DA 2018-10-19
ER

PT J
AU Bartlett, L
   Nowak, M
   Ho, YH
AF Bartlett, Lynne
   Nowak, Madeleine
   Ho, Yik-Hong
TI Impact of fecal incontinence on quality of life
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Quality of life; Fecal incontinence; Rural health; Colorectal cancer;
   Urogynecology
ID INJECTABLE SILICONE BIOMATERIAL; ANAL INCONTINENCE;
   URINARY-INCONTINENCE; RISK-FACTORS; J-POUCH; PREVALENCE; EPIDEMIOLOGY;
   CONSTIPATION; DYSFUNCTION; SPHINCTER
AB AIM: To explore the impact of fecal incontinence (FI) on quality of life (QOL) of patients attending urogynecology and colorectal clinics (CCs).
   METHODS: Cross-sectional study of 154 patients (27 male) with FI, who attended the clinics at a regional hospital in North Queensland, Australia in 2003 and 2004, and completed the Fecal Incontinence Quality of Life Scale (FIQL: 1 = very affected; 4 = not affected).
   RESULTS: More than 22% of patients had their QOL affected severely by FI. Patients reported that they had not previously been asked about FI by a medical practitioner nor did they voluntarily disclose its presence. The median FIQL scores for all participants were: lifestyle = 3.24; coping = 2.23; depression = 2.42; and embarrassment = 2.33. Increasing frequency of soiling had a negative effect on all four FIQL scales (P < 0.001) as did the quantity of soiling (P < 0.01). Female CC patients had poorer FIQL scores than urogynecology clinic patients for lifestyle (P = 0.015), coping (P = 0.004) and embarrassment (P = 0.009), but not depression (P = 0.062), despite having experienced FI for a shorter period.
   CONCLUSION: Failure to seek treatment for FI degrades the quality of patients' lives over time. FI assessment tools should incorporate the quantity of fecal loss. (C) 2009 The WJG Press and Baishideng. All rights reserved.
C1 [Bartlett, Lynne] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Fecal Incontinence Res Grp, N Queensland Ctr Canc Res, Townsville, Qld 4811, Australia.
   [Ho, Yik-Hong] James Cook Univ, Sch Med & Dent, N Queensland Ctr Canc Res, Townsville, Qld 4811, Australia.
RP Bartlett, L (reprint author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Fecal Incontinence Res Grp, N Queensland Ctr Canc Res, Townsville, Qld 4811, Australia.
EM lynne.bartlett@jcu.edu.au
FU James Cook University Program [2003]; Cancer Council Queensland
FX Supported by A James Cook University Program Grant (2003) and A Cancer
   Council Queensland scholarship
CR Avery KNL, 2007, J UROLOGY, V177, P39, DOI 10.1016/j.juro.2006.08.075
   Bartlett L, 2007, Tech Coloproctol, V11, P251, DOI 10.1007/s10151-007-0360-z
   Baxter NN, 2003, DIS COLON RECTUM, V46, P1591, DOI 10.1097/013DCR.0000098906.61097.1C
   Bharucha AE, 2004, ALIMENT PHARM THERAP, V20, P355, DOI 10.1111/j.1365-2036.2004.02028.x
   Bordeianou L, 2008, COLORECTAL DIS, V10, P273, DOI 10.1111/j.1463-1318.2007.01288.x
   Boreham MK, 2005, AM J OBSTET GYNECOL, V192, P1637, DOI 10.1016/j.ajog.2004.11.030
   Colquhoun P, 2006, WORLD J SURG, V30, P1925, DOI 10.1007/s00268-006-0531-5
   Colquhoun PHD, 2004, DIS COLON RECTUM, V47, P538, DOI 10.1007/s10350-003-0074-x
   Damon H, 2004, GASTROEN CLIN BIOL, V28, P16, DOI 10.1016/S0399-8320(04)94835-X
   Deutekom M, 2005, COLORECTAL DIS, V7, P263, DOI 10.1111/j.1463-1318.2005.00772.x
   Deutekom M, 2005, SCAND J GASTROENTERO, V40, P552, DOI 10.1080/00365520510012172
   DROSSMAN DA, 1986, DIGEST DIS SCI, V31, P1221, DOI 10.1007/BF01296523
   Edwards NI, 2001, AGE AGEING, V30, P503, DOI 10.1093/ageing/30.6.503
   ENCK P, 1991, INT J COLORECTAL DIS, V6, P143, DOI 10.1007/BF00341234
   FUJITA S, 1992, DIS COLON RECTUM, V35, P1030, DOI 10.1007/BF02252992
   Ho Yik-Hong, 2005, Aust J Rural Health, V13, P28, DOI 10.1111/j.1440-1854.2004.00642.x
   Johanson JF, 1996, AM J GASTROENTEROL, V91, P33
   Kalantar JS, 2002, MED J AUSTRALIA, V176, P54
   Lam TCF, 1999, COLORECTAL DIS, V1, P197
   Landefeld CS, 2008, ANN INTERN MED, V148, P449, DOI 10.7326/0003-4819-148-6-200803180-00210
   LEIGH RJ, 1982, LANCET, V1, P1349
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Miner PB, 2004, GASTROENTEROLOGY, V126, pS8, DOI 10.1053/j.gastro.2003.10.056
   Park JG, 2005, WORLD J GASTROENTERO, V11, P2570, DOI 10.3748/wjg.v11.i17.2570
   Pla-Marti V, 2007, COLORECTAL DIS, V9, P90, DOI 10.1111/j.1463-1318.2006.01128.x
   *QUEENSL HLTH, TOWNSV HOSP
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P16, DOI DOI 10.1007/BF02237236]
   Rockwood T, 2008, DIS COLON RECTUM, V51, P1434, DOI 10.1007/s10350-008-9280-x
   Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823
   Rullier E, 2004, GASTROEN CLIN BIOL, V28, P562, DOI 10.1016/S0399-8320(04)95012-9
   Stevens TK, 2003, CLEV CLIN J MED, V70, P441, DOI 10.3949/ccjm.70.5.441
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Whitehead WE, 2005, GASTROENTEROLOGY, V129, P6, DOI 10.1053/j.gastro.2005.05.043
   WHITEHEAD WE, 2009, GASTROENTEROLOGY
NR 36
TC 44
Z9 45
U1 0
U2 1
PU W J G PRESS
PI BEIJING
PA APT 1066, YISHOU GARDEN, NO 58, NORTH LANGXINZHUANG RD, PO BOX 2345,
   BEIJING 100023, PEOPLES R CHINA
SN 1007-9327
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD JUL 14
PY 2009
VL 15
IS 26
BP 3276
EP 3282
DI 10.3748/wjg.15.3276
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 471AE
UT WOS:000268023100011
PM 19598304
OA Green Published
DA 2018-10-19
ER

PT J
AU Krebs, MD
   Jeon, O
   Alsberg, E
AF Krebs, Melissa D.
   Jeon, Oju
   Alsberg, Eben
TI Localized and Sustained Delivery of Silencing RNA from Macroscopic
   Biopolymer Hydrogels
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID IN-VIVO; DNA DELIVERY; SIRNA; INTERFERENCE; THERAPY; CANCER
AB The ability to silence the expression of specific genes at a particular location of the body would provide a powerful new therapeutic too[ for treatment of diseases such as cancer or for use in regenerative medicine. RNA interference (RNAi) is a gene silencing mechanism where specific mRNA molecules that are complementary to short interfering RNA (siRNA) are degraded, thus inhibiting gene expression at the post-transcriptional level. However, the use of siRNA has not yet realized its full clinical potential due to degradation in vivo, the difficulty retaining siRNA at the site of interest, and the relatively short-term effect it has on rapidly dividing cells. In this work a new paradigm is presented that will allow for the localized delivery of siRNA that is controlled and sustained over time, thus allowing cells at the site of interest to be directly exposed to a gradual release of bioactive siRNA. To accomplish this, three different types of macroscopic, degradable biomaterial hydrogel. scaffolds were employed: calcium crosslinked alginate, photocrosslinked alginate, and collagen. Differing rates of release from these hydrogels were achieved, and the ability of the released siRNA to knock down the expression of GFP in cells that constitutively express this protein was shown. Furthermore, the ability to encapsulate cells within these materials and achieve sustained gene silencing of these incorporated cells was demonstrated. These biopolymer hydrogels are injectable and, therefore, can be delivered in a minimally invasive manner, and they can serve as delivery vehicles for both siRNA and transplanted cell populations.
C1 [Krebs, Melissa D.; Jeon, Oju; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
RI Jeon, Oju/K-7227-2018; Krebs, Melissa/L-4878-2015
OI Jeon, Oju/0000-0003-3972-9272; Krebs, Melissa/0000-0002-5170-7116;
   Alsberg, Eben/0000-0002-3487-4625
FU National Brain Tumor Foundation; Ohio Department of Development
   [08-081]; Ellison Medical Foundation; National Science Foundation
FX The authors thank Kathleen Sutter for technical assistance and
   gratefully acknowledge funding support for this work from the National
   Brain Tumor Foundation (E.A.), Biomedical Research and Technology
   Transfer Grant 08-081 from the Ohio Department of Development (E.A.),
   the Ellison Medical Foundation (E.A.), and a National Science Foundation
   Graduate Research Fellowship (M.D.K.).
CR Aigner A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71659
   Bi J. X., 2002, Journal of Biotechnology, V93, P231, DOI 10.1016/S0168-1656(01)00400-X
   Chen YC, 2008, EXPERT OPIN DRUG DEL, V5, P1301, DOI 10.1517/17425240802568505 
   De Fougerolles AR, 2008, HUM GENE THER, V19, P125, DOI 10.1089/hum.2008.928
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Dykxhoorn DM, 2006, GENE THER, V13, P541, DOI 10.1038/sj.gt.3302703
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Gao ZY, 2006, PLAST RECONSTR SURG, V118, P1328, DOI 10.1097/01.prs.0000239537.77870.2c
   Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021
   Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27
   Pardridge WM, 2004, EXPERT OPIN BIOL TH, V4, P1103, DOI 10.1517/14712598.4.7.1103
   Rutz S, 2004, ARTHRITIS RES THER, V6, P78, DOI 10.1086/ar1168
   Ryther RCC, 2005, GENE THER, V12, P5, DOI 10.1038/sj.gt.3302356
   Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101
NR 17
TC 103
Z9 104
U1 0
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUL 8
PY 2009
VL 131
IS 26
BP 9204
EP +
DI 10.1021/ja9037615
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 466AT
UT WOS:000267633300033
PM 19530653
DA 2018-10-19
ER

PT J
AU Rusu, MC
   Ichim, IC
   Popa, M
   Rusu, D
   Rusu, M
AF Rusu, Marius Ciprian
   Ichim, Ionut Cameliu
   Popa, Marcel
   Rusu, Daniela
   Rusu, Mihai
TI Radiopaque acrylic bone cement with bromine-containing acrylic monomer.
   II
SO E-POLYMERS
LA English
DT Article
ID WATER-ABSORPTION CHARACTERISTICS; IODINE-CONTAINING MONOMERS;
   BARIUM-SULFATE; P/L RATIO; METHACRYLATE; POLYMETHYLMETHACRYLATE;
   POLYMERIZATION; FORMULATIONS; BIOMATERIAL; SHRINKAGE
AB Bromine-containing methacrylate, 2-(2-bromoisobutyryloxy) ethyl methacrylate (BIEM), had been used in the formulation of acrylic radiopaque cements. The effect of this monomer incorporated into the liquid phase of acrylic bone cement (ABC), on the curing parameters, thermal properties, water absorption, density, compression tests and radiopacity was studied. A decrease of maximum temperature and an increase of the setting time were observed with the addition of the bromine-containing monomer in the radiolucent cement composition. Adding BIEM in radiolucent ABCs composition results in the decrease of glass transition temperature and increase in its thermal stability. The ABCs modified with bromine-containing comonomer are characterized by polymerization shrinkage lower than the radiolucent cement. Addition of bromine-containing comonomer in radiolucent ABC composition determines the increase of compressive strength. The ABCs modified with bromine-containing comonomer proved to be radiopaque.
C1 [Rusu, Marius Ciprian; Ichim, Ionut Cameliu; Popa, Marcel; Rusu, Mihai] Gh Asachi Tech Univ Iasi, Dept Nat & Synthet Polymers, Fac Chem Engn, Iasi 700050, Romania.
   [Rusu, Daniela] Ecole Mines Douai, Polymer & Composites Technol & Mech Engn Dept, F-59508 Douai, France.
RP Rusu, M (reprint author), Gh Asachi Tech Univ Iasi, Dept Nat & Synthet Polymers, Fac Chem Engn, D Mangeron St,71A, Iasi 700050, Romania.
EM mrusu@ch.tuiasi.ro
RI RUSU, Mihai/C-2257-2008; RUSU, Daniela/A-6918-2008
OI RUSU, Mihai/0000-0002-4143-6818; RUSU, Daniela/0000-0001-6475-6841
CR Aldenhoff YBJ, 2002, BIOMATERIALS, V23, P881, DOI 10.1016/S0142-9612(01)00197-1
   ALLEN PEM, 1992, EUR POLYM J, V28, P347, DOI 10.1016/0014-3057(92)90252-W
   Artola A, 2003, BIOMATERIALS, V24, P4071, DOI 10.1016/S0142-9612(03)00298-9
   BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   BERRIEJ A, 1968, WATER POLYM
   BOWEN RL, 1982, J DENT RES, V61, P654, DOI 10.1177/00220345820610050701
   BRADEN M, 1984, BIOMATERIALS, V5, P369, DOI 10.1016/0142-9612(84)90038-3
   Breusch SJ, 2003, ORTHOPADE, V32, P41, DOI 10.1007/s00132-002-0411-0
   CEVANTESUC JM, 2005, J BIOMATERIALS, V26, P4063
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Charnley J., 1970, ACRYLIC CEMENT ORTHO
   Coleman MM, 1991, SPECIFIC INTERACTION
   Crank J., 1956, MATH DIFFUSION
   DAVY KWM, 1997, POLYM INT, V43, P142
   DEB S, 1995, BIOMATERIALS, V16, P1095, DOI 10.1016/0142-9612(95)98906-U
   Deb S, 1999, J BIOMED MATER RES, V48, P719, DOI 10.1002/(SICI)1097-4636(1999)48:5<719::AID-JBM18>3.0.CO;2-H
   DiMaio FR, 2002, ORTHOPEDICS, V25, P1399
   Ginebra MP, 2002, BIOMATERIALS, V23, P1873, DOI 10.1016/S0142-9612(01)00314-3
   HASS SS, 1975, J BONE JOINT SURG AM, V57, P380
   Ichim IC, 2007, E-POLYMERS
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   JEFFERISS CD, 1975, J BONE JOINT SURG BR, V57, P511
   KRAUSE WR, 1988, ENCY MED DEVICES INS, V1, P491
   KUHN KD, 2000, BONE CEMENTS, P245
   KUSY RP, 1978, J BIOMED MATER RES, V12, P271, DOI 10.1002/jbm.820120304
   LABELLA R, 1992, BIOMATERIALS, V13, P937, DOI 10.1016/0142-9612(92)90117-7
   LANTENSCHLAGER EP, 1974, J BIOMED MAT RES S, V5, P185
   Larraz E, 2005, BIOMACROMOLECULES, V6, P2058, DOI 10.1021/bm050055z
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2005, J BIOMED MATER RES B, V73B, P77, DOI 10.1002/jbm.b.30176
   LEWIS G, 2000, 2000 ANN BOOK ASTM S, P55
   LEWIS G, 1992, ISO58331992
   LOSHACK S, 1953, J AM CHEM ASS, V75, P544
   MANERO JM, 2004, J ENG MED, V218, P3
   MEYER PR, 1973, J BONE JOINT SURG AM, VA 55, P149, DOI 10.2106/00004623-197355010-00015
   Molino LN, 1996, J BIOMED MATER RES, V31, P131, DOI 10.1002/(SICI)1097-4636(199605)31:1<131::AID-JBM14>3.0.CO;2-Q
   MOLNAR EJ, 1968, J DENT RES, V47, P665, DOI 10.1177/00220345680470042701
   Nicholas MKD, 2007, J MATER SCI-MATER M, V18, P1407, DOI 10.1007/s10856-007-0125-2
   NIZIHOU A, 1998, POWDER TECHNOL, V99, P60
   PARK JB, 1992, BIOMATERIALS INTRO, P154
   Pascual B, 1999, J BIOMED MATER RES, V48, P447, DOI 10.1002/(SICI)1097-4636(1999)48:4<447::AID-JBM8>3.0.CO;2-I
   Pascual B, 1999, BIOMATERIALS, V20, P465, DOI 10.1016/S0142-9612(98)00192-6
   Pascual B, 1999, BIOMATERIALS, V20, P453, DOI 10.1016/S0142-9612(98)00191-4
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   RAVELL PA, 1998, J BIOMATERIALS, V19, P1579
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   ROSE E E, 1958, J Am Dent Assoc, V56, P375
   Rusu MC, 2008, J MATER SCI-MATER M, V19, P2609, DOI 10.1007/s10856-007-3357-2
   Rusu MC, 2006, MATER PLAST, V43, P215
   Silikas N, 2005, BIOMATERIALS, V26, P197, DOI 10.1016/j.biomaterials.2004.02.028
   THANNER J, 1995, ACTA ORTHOP SCAND, V66, P207, DOI 10.3109/17453679508995525
   Vazquez B, 2002, J BIOMED MATER RES, V63, P88, DOI 10.1002/jbm.10092
   Vazquez B, 1999, BIOMATERIALS, V20, P2047, DOI 10.1016/S0142-9612(99)00108-8
   Ward IM, 1993, INTRO MECH PROPERTIE
   Yang JM, 1997, BIOMATERIALS, V18, P1293, DOI 10.1016/S0142-9612(97)00060-4
NR 55
TC 0
Z9 0
U1 0
U2 5
PU EUROPEAN POLYMER FEDERATION
PI STRASBOURG
PA 1, QUAI LEZAY-MARNESIA, F067000 STRASBOURG, FRANCE
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD JUL 7
PY 2009
AR 086
PG 15
WC Polymer Science
SC Polymer Science
GA 467AJ
UT WOS:000267707800001
DA 2018-10-19
ER

PT J
AU Servoli, E
   Maniglio, D
   Aguilar, MR
   Motta, A
   Vazquez, B
   Roman, JS
   Migliaresi, C
AF Servoli, Eva
   Maniglio, Devid
   Aguilar, Maria Rosa
   Motta, Antonella
   Vazquez, Blanca
   Roman, Julio San
   Migliaresi, Claudio
TI Comparative Methods for the Evaluation of Protein Adsorption
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE adsorption; atomic force microscopy (AFM); biological applications of
   polymers; proteins; surfaces
ID SURFACE-PLASMON RESONANCE; ATOMIC-FORCE MICROSCOPY; SELF-ASSEMBLED
   MONOLAYERS; SILK FIBROIN; MOLECULAR-WEIGHT; BIOMATERIALS; SPECTROSCOPY;
   RECOGNITION; BINDING; FILMS
AB AFM, Immunogold labeling and SPR have been successfully applied to the analysis of protein adsorption on fibroin substrates, chosen as a paradigmatic biomaterial. The process was evaluated both under static and dynamic conditions, also considering the effect of protein competition. AFM via antibody-modified tips provided maps of protein adsorption and information on protein-protein interactions. Double labeling Immunogold imaged protein distribution upon competitive adsorption. SPR described the dynamics of the process, offering also quantitative data both from individual and two-component protein solutions. The integration of these analytical techniques and the critical evaluation of the results can provide a detailed description of protein adsorption.
C1 [Servoli, Eva; Maniglio, Devid; Motta, Antonella; Migliaresi, Claudio] Univ Trent, Dept Mat Engn & Ind Technol, I-38100 Trento, Italy.
   [Servoli, Eva; Maniglio, Devid; Motta, Antonella; Migliaresi, Claudio] Univ Trent, INSTM Res Unit, I-38100 Trento, Italy.
   [Aguilar, Maria Rosa; Vazquez, Blanca; Roman, Julio San] CSIC, Inst Polymer Sci & Technol, E-28006 Madrid, Spain.
RP Servoli, E (reprint author), Univ Trent, Dept Mat Engn & Ind Technol, Via Mesiano 77, I-38100 Trento, Italy.
EM servolie@ing.unitn.it
RI Maniglio, Devid/C-4187-2014; Aguilar, Maria Rosa/C-2593-2014
OI Maniglio, Devid/0000-0002-1653-861X; Aguilar, Maria
   Rosa/0000-0001-7395-5754; Motta, Antonella/0000-0003-4893-6863; Vazquez,
   Blanca/0000-0001-5539-8026
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Aguilar MR, 2004, MACROMOL BIOSCI, V4, P631, DOI 10.1002/mabi.200400039
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Bowen WR, 2000, BIOTECHNOL LETT, V22, P893, DOI 10.1023/A:1005604028444
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chowdhury PB, 1998, COLLOID SURFACE A, V143, P53, DOI 10.1016/S0927-7757(98)00408-7
   Flores SM, 2006, SURF SCI, V600, P2847, DOI 10.1016/j.susc.2006.04.047
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C
   KARLSSON R, 1995, ANAL BIOCHEM, V228, P274, DOI 10.1006/abio.1995.1350
   Lechuga LM, 2000, QUIM ANAL, V19, P54
   MCCLARY KB, 2000, J BIOMED MATER RES, V50, P42
   MOSS J, 1996, CURR DIAGN PATHOL, V3, P211
   Motta A, 2002, J BIOACT COMPAT POL, V17, P23, DOI 10.1106/088391102023195
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   Pernodet N, 2003, J BIOMED MATER RES A, V64A, P684, DOI 10.1002/jbm.a.10394
   PUTNAM FW, 1984, PLASMA PROTEINS, V4, P25608
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Santin M, 2002, J BIOACT COMPAT POL, V17, P195, DOI 10.1106/0883911`02026326
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Servoli E, 2008, MACROMOL BIOSCI, V8, P1126, DOI 10.1002/mabi.200800110
   Sigal GB, 1997, LANGMUIR, V13, P2749, DOI 10.1021/la961024f
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   Willemsen OH, 2000, BIOPHYS J, V79, P3267, DOI 10.1016/S0006-3495(00)76559-3
NR 34
TC 4
Z9 4
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUL 7
PY 2009
VL 9
IS 7
BP 661
EP 670
DI 10.1002/mabi.200800301
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 470GH
UT WOS:000267962700005
PM 19226562
DA 2018-10-19
ER

PT J
AU Marquez, SP
   Martinez, VS
   Ambrose, WM
   Wang, J
   Gantxegui, NG
   Schein, O
   Elisseeff, J
AF Ponce Marquez, Sara
   Saez Martinez, Virginia
   Ambrose, Winnette McIntosh
   Wang, Jennie
   Garagorri Gantxegui, Nerea
   Schein, Oliver
   Elisseeff, Jennifer
TI Decellularization of bovine corneas for tissue engineering applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cornea; Biomaterial; Decellularized; Tissue engineering; Collagen
ID HUMAN AMNIOTIC MEMBRANE; OCULAR SURFACE RECONSTRUCTION; ENDOTHELIAL-CELL
   ADHERENCE; EPITHELIAL-CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; STEM-CELLS;
   ADHESION; COLLAGENASE; HYDROGELS
AB Scaffolds derived from processed tissues offer viable alternatives to synthetic polymers as biological scaffolds for regenerative medicine. Tissue-derived scaffolds provide an extracellular matrix (ECM) as the starting material for wound healing and the functional reconstruction of tissues, offering a potentially valuable approach for the replacement of damaged or missing tissues. Additionally, acellular tissue may provide a natural microenvironment for host-cell migration and the induction of stem cell differentiation to contribute to tissue regeneration. There are a number of processing methods that aim to stabilize and provide an immunologically inert tissue scaffold. Furthermore, these tissue-processing methods can often be applied to xenogenic transplants because the essential components of the ECM are often maintained between species. In this study, we applied several tissue-processing protocols to the cornea in order to obtain a decellularized cornea matrix that maintained the clarity and mechanical properties of the native tissue. Histology, mechanical testing and electron microscopy techniques were used to assess the cell extraction process and the organization of the remaining ECM. In vitro cell seeding experiments confirmed the processed corneas' biocompatibility. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ponce Marquez, Sara; Saez Martinez, Virginia; Ambrose, Winnette McIntosh; Wang, Jennie; Elisseeff, Jennifer] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
   [Ponce Marquez, Sara; Saez Martinez, Virginia; Garagorri Gantxegui, Nerea] Inasmet Tecnalia, Hlth Unit, Donostia San Sebastian, Spain.
   [Schein, Oliver] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21287 USA.
RP Elisseeff, J (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Clark Hall 106,3400 N Charles St, Baltimore, MD 21218 USA.
EM jhe@jhu.edu
FU Inaki Goenaga Scholarships for Technological Centers; Basque Government;
   Johns Hopkins University; Inasmet Foundation
FX The authors thank the Inaki Goenaga Scholarships for Technological
   Centers, the ETORTEK Program of the Basque Government, the Department of
   Biomedical Engineering of the Johns Hopkins University and Inasmet
   Foundation, for their financial and technical support.
CR Aucoin L, 2002, J BIOMAT SCI-POLYM E, V13, P447, DOI 10.1163/156856202320253956
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Berman, 1975, Int Ophthalmol Clin, V15, P49, DOI 10.1097/00004397-197501540-00006
   Berryhill BL, 2001, INVEST OPHTH VIS SCI, V42, P1201
   Bhrany AD, 2006, TISSUE ENG, V12, P319, DOI 10.1089/ten.2006.12.319
   Chipev CC, 2000, CELL DEATH DIFFER, V7, P166, DOI 10.1038/sj.cdd.4400605
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Flynn L, 2006, J BIOMED MATER RES A, V79A, P359, DOI 10.1002/jbm.a.30762
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   Garagorri N, 2008, ACTA BIOMATER, V4, P1139, DOI 10.1016/j.actbio.2008.05.007
   GNADINGE.MC, 1969, AM J OPHTHALMOL, V68, P478
   Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a
   Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003
   HAN S, 1992, ANAL BIOCHEM, V201, P336, DOI 10.1016/0003-2697(92)90348-B
   HARPER E, 1970, BIOCHEM BIOPH RES CO, V41, P482, DOI 10.1016/0006-291X(70)90531-0
   Hayashi S, 2002, J MORPHOL, V254, P247, DOI 10.1002/jmor.10030
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Higa K, 2005, CORNEA, V24, P206, DOI 10.1097/01.ico.0000133999.45262.83
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Imoto Y, 2003, JPN J OPHTHALMOL, V47, P444, DOI 10.1016/S0021-5155(03)00135-7
   Jacob JT, 2005, J BIOMED MATER RES B, V72B, P198, DOI 10.1002/jbm.b.30131
   Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110
   Keelan JA, 2000, PLACENTA, V21, P38, DOI 10.1053/plac.1999.0451
   KIGASAWA K, 1995, JPN J OPHTHALMOL, V39, P35
   KIM JC, 1995, CORNEA, V14, P473
   Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506
   Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012
   MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259
   MCCULLEY JP, 1970, ARCH OPHTHALMOL-CHIC, V84, P516
   McFetridge PS, 2004, ASAIO J, V50, P591, DOI 10.1097/01.MAT.0000144365.22025.9B
   McFetridge PS, 2004, J BIOMED MATER RES A, V70A, P224, DOI 10.1002/jbm.a.30060
   Merrett K, 2001, J BIOMAT SCI-POLYM E, V12, P647, DOI 10.1163/156856201316883467
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Witcher J, 2001, B WORLD HEALTH ORGAN, V79, P214
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yoshida S, 2005, INVEST OPHTH VIS SCI, V46, P1653, DOI 10.1167/iovs.04-1405
NR 42
TC 53
Z9 54
U1 3
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 1839
EP 1847
DI 10.1016/j.actbio.2009.02.011
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900001
PM 19286434
DA 2018-10-19
ER

PT J
AU Ailenberg, M
   Sefton, MV
AF Ailenberg, Menachem
   Sefton, Michael V.
TI Effect of a matrix metalloproteinase sequestering biomaterial on Caco-2
   epithelial cell barrier integrity in vitro
SO ACTA BIOMATERIALIA
LA English
DT Article
DE MI Theramer (TM) biomaterial beads; Matrix metalloproteinases;
   Epithelial barrier; Actin cytoskeleton
ID INFLAMMATORY-BOWEL-DISEASE; CANCER-THERAPY; SERTOLI-CELLS; INHIBITOR;
   COLLAGENASE; GELATINASE; ACTIVATION; COLITIS
AB A novel matrix metalloproteinase sequestering biomaterial (MI Theramer (TM) beads) restored the epithelial barrier in a double chamber in vitro test system after disruption by Cytochalasin D and the secretion of the metalloproteinase MMP-2. MI beads are chemically modified (hydroxamated) poly(methacrylic acid-co-methyl methacrylate). We are exploring the utility of this material in inflammatory bowel disease (IBD), in which one manifestation is a compromised intestinal epithelial barrier. In a first step towards this goal we incubated MI beads (or polymethyl methacrylate control beads) with Caco-2 epithelial cells and mesenchymal 3T3 fibroblasts on two sides of a Matrigel (R)-coated filter and used Cytochalasin D (Cyto D) to activate MMP-2 (secreted by the 3T3 cells), disrupt actin filaments of Caco-2 cells and render the epithelial barrier leaky, as measured by dextran fluorescein equilibration. Addition of MI beads to Cyto D-treated cells inhibited active MMP-2 and prevented equilibration of dextran fluorescein. This study is the first step in showing a potential benefit to local (as opposed to systemic) inhibition of metalloproteinases in IBD or other intestinal inflammatory diseases. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ailenberg, Menachem; Sefton, Michael V.] Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
EM michael.sefton@utoronto.ca
FU Natural Sciences and Engineering Research Council; Ontario Research and
   Development Challenge Fund (ORDCF)
FX We acknowledge the financial support of the Natural Sciences and
   Engineering Research Council and the Ontario Research and Development
   Challenge Fund (ORDCF), the latter through the Advanced Regenerative
   Tissue Engineering Centre at Sunnybrook Health Science Centre and the
   University of Toronto. Some of the ORDCF funding was matched to support
   provided by Rimon Therapeutics Limited among other Ontario based
   companies. MVS is Chief Scientific Officer of Rimon Therapeutics and has
   a financial interest in that company.
CR AILENBERG M, 1988, ENDOCRINOLOGY, V122, P2613, DOI 10.1210/endo-122-6-2613
   Ailenberg M, 1996, BIOCHEM J, V313, P879, DOI 10.1042/bj3130879
   AILENBERG M, 1989, ENDOCRINOLOGY, V124, P1399, DOI 10.1210/endo-124-3-1399
   AILENBERG M, 1991, BIOCHEM J, V279, P75, DOI 10.1042/bj2790075
   AILENBERG M, 1994, J AM SOC NEPHROL, V4, P1760
   AILENBERG M, 2002, BIOCHIM BIOPHYS ACTA, P1
   Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100
   Di Sebastiano P, 2001, DIGESTION, V63, P234, DOI 10.1159/000051895
   INFANTEDUARTE C, 2000, CELL MICROBIOL, V2, P11
   LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C
   McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9
   Medina C, 2001, SCAND J GASTROENTERO, V36, P1314
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   Naito Y, 2004, INFLAMM RES, V53, P462, DOI 10.1007/s00011-004-1281-1
   Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821
   Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043
   OVERALL CM, 1990, J BIOL CHEM, V265, P21141
   Pantoja LG, 2000, INFECT IMMUN, V68, P6478, DOI 10.1128/IAI.68.11.6478-6481.2000
   Renkiewicz R, 2003, ARTHRITIS RHEUM, V48, P1742, DOI 10.1002/art.11030
   Skarja GA, 2009, BIOMATERIALS, V30, P1890, DOI 10.1016/j.biomaterials.2008.12.040
   Sykes AP, 1999, ALIMENT PHARM THERAP, V13, P1535
   Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047
   Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005
   Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387
NR 24
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 1898
EP 1904
DI 10.1016/j.actbio.2009.02.028
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900007
PM 19307161
DA 2018-10-19
ER

PT J
AU Chang, KY
   Cheng, LW
   Ho, GH
   Huang, YP
   Lee, YD
AF Chang, Kuo-Yung
   Cheng, Li-Wei
   Ho, Guan-Huei
   Huang, Yun-Peng
   Lee, Yu-Der
TI Fabrication and characterization of poly(gamma-glutamic
   acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for
   cartilage tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Articular cartilage; Poly(gamma-glutamic acid); Chondroitin sulfate;
   Poly(epsilon-caprolactone)
ID IN-VITRO; POLY(L-GLUTAMIC ACID); BIOLOGICAL GLUE; DRUG-DELIVERY;
   PORE-SIZE; DEGRADATION; CELL; POLYCAPROLACTONE; CHONDROCYTES; COMPOSITES
AB The development of blended biomacromolecule and polyester scaffolds can potentially be used in many tissue engineering applications. This study was to develop a poly(gamma-glutamic acid)-graft-chondroitin sulfate-blend-poly(epsilon-caprolactone) (gamma-PGA-g-CS/PCL) composite biomaterial as a scaffold for cartilage tissue engineering. Chondroitin sulfate (CS) was grafted to gamma-PGA, forming a gamma-PGA-g-CS copolymer with 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide (EDC) system. The gamma-PGA-g-CS copolymers were then blended with PCL to yield a porous gamma-PGA-g-CS/PCL scaffold by salt leaching. These blended scaffolds were characterized by (1)H NMR, ESCA, water-binding capacity, mechanical test, degradation rate and CS assay. The results showed that with gamma-PGA-g-CS as a component, the water-binding capacity and the degradation rate of the scaffolds would substantially increase. During a 4 week period of culture, the mechanical stability of gamma-PGA-g-CS/PCL scaffolds was raised gradually and chondrocytes were induced to function normally in vitro. Furthermore, a larger amount of secreted GAGS was present in the gamma-PGA-g-CS/PCL matrices than in the control (PCL), as revealed by Alcian blue staining of the histochemical sections. Thus, gamma-PGA-g-CS/PCL matrices exhibit excellent biodegradation and biocompatibility for chondrocytes and have potential in tissue engineering as temporary substitutes for articular cartilage regeneration. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Chang, Kuo-Yung; Cheng, Li-Wei; Lee, Yu-Der] Natl Tsing Hua Univ 101, Dept Chem Engn, Hsinchu 300, Taiwan.
   [Ho, Guan-Huei; Huang, Yun-Peng] Vedan Enterprise Corp, Taichung 433, Taiwan.
RP Lee, YD (reprint author), Natl Tsing Hua Univ 101, Dept Chem Engn, Sect 2,Kuang Fu Rd, Hsinchu 300, Taiwan.
EM ydlee@che.nthu.edu.tw
FU Ministry of Economic Affairs of the Republic of China, Taiwan
   [95-EC-17-A-17-S1-0009]
FX The authors thank the Ministry of Economic Affairs of the Republic of
   China, Taiwan, for financially supporting this research under Contract
   No. 95-EC-17-A-17-S1-0009 of the Technology Development Program.
CR AYAD S, 1994, EXTRACELLULAR MATRIX
   Bei JZ, 1997, POLYM ADVAN TECHNOL, V8, P693, DOI 10.1002/(SICI)1099-1581(199711)8:11<693::AID-PAT702>3.0.CO;2-B
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   Chen C, 2005, EUR POLYM J, V41, P958, DOI 10.1016/j.eurpolymj.2004.12.002
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   Humphreys TR, 1996, DERMATOL SURG, V22, P693, DOI 10.1111/j.1524-4725.1996.tb00619.x
   INGBER D, 1993, PHYS FORCES MAMMALIA, V2
   Ishizeki K, 2000, TISSUE CELL, V32, P207, DOI 10.1054/tice.2000.0106
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   Kavlock KD, 2007, ACTA BIOMATER, V3, P475, DOI 10.1016/j.actbio.2007.02.001
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Kuberka M, 2002, INT J ARTIF ORGANS, V25, P67
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   KUBOTA H, 1993, J POLYM SCI POL CHEM, V31, P2877, DOI 10.1002/pola.1993.080311127
   Kunioka M, 1998, POLYM DEGRAD STABIL, V59, P33, DOI 10.1016/S0141-3910(97)00181-X
   Lazzeri L, 2006, J MATER SCI-MATER M, V17, P1211, DOI 10.1007/s10856-006-0594-8
   Lee CT, 2006, BIOMACROMOLECULES, V7, P2200, DOI 10.1021/bm060451x
   Lee CT, 2006, J MATER SCI-MATER M, V17, P1411, DOI 10.1007/s10856-006-0617-5
   Li C, 2000, CLIN CANCER RES, V6, P2829
   Li LH, 2004, J APPL POLYM SCI, V91, P274, DOI 10.1002/app.12954
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Liang HF, 2006, BIOMATERIALS, V27, P2051, DOI 10.1016/j.biomaterials.2005.10.027
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mucci A, 2000, CARBOHYD POLYM, V41, P37, DOI 10.1016/S0144-8617(99)00075-2
   Multani AS, 1997, ANTICANCER RES, V17, P4269
   Murakami S, 2006, BIOMACROMOLECULES, V7, P2122, DOI 10.1021/bm0600264
   Mustin C., 1993, APPL SURF SCI, V68, P147
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Olabarrieta I, 2001, POLYMER, V42, P4401, DOI 10.1016/S0032-3861(00)00680-7
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1996, BIOMATERIALS, V17, P1387, DOI 10.1016/0142-9612(96)87279-6
   Otani Y, 1998, BIOMATERIALS, V19, P2167, DOI 10.1016/S0142-9612(98)00123-9
   Otani Y, 1998, BIOMATERIALS, V19, P2091, DOI 10.1016/S0142-9612(98)00121-5
   Pena J, 2006, J BIOMED MATER RES A, V76A, P788, DOI 10.1002/jbm.a.30547
   PENKOVA K, 1996, J BIOCHEM BIOPH METH, V32, P33
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Richard A, 2001, CRIT REV BIOTECHNOL, V21, P219, DOI 10.1080/07388550108984171
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Wu CS, 2005, POLYMER, V46, P147, DOI 10.1016/j.polymer.2004.11.013
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Xiong XB, 2007, BIOMACROMOLECULES, V8, P874, DOI 10.1021/bm060967g
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 52
TC 58
Z9 68
U1 3
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 1937
EP 1947
DI 10.1016/j.actbio.2009.02.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900012
PM 19282262
DA 2018-10-19
ER

PT J
AU Park, KM
   Lee, SY
   Joung, YK
   Na, JS
   Lee, MC
   Park, KD
AF Park, Kyung Min
   Lee, Sang Young
   Joung, Yoon Ki
   Na, Jae Sik
   Lee, Myung Chul
   Park, Ki Dong
TI Thermosensitive chitosan-Pluronic hydrogel as an injectable cell
   delivery carrier for cartilage regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tissue engineering; Chitosan; Injectable hydrogel; Thermosensitive;
   Cartilage regeneration
ID TISSUE-ENGINEERED CARTILAGE; IN-VITRO; ARTICULAR-CARTILAGE;
   EXTRACELLULAR-MATRIX; CHONDROCYTE; BIOMATERIALS; PROLIFERATION; GELS;
   TRANSPLANTATION; PHENOTYPE
AB Injectable hydrogels have been studied for potential applications for articular cartilage regeneration. In this study, a thermosensitive chitosan-Pluronic (CP) hydrogel was designed as an injectable cell delivery carrier for cartilage regeneration. The CP conjugate was synthesized by grafting Pluronic onto chitosan using EDC/NHS chemistry. The sol-gel phase transition and mechanical properties of the CP hydrogel were examined by rheological experiments. The CP solution underwent a sol-gel transition around 25 degrees C at which the storage modulus (G) approaches 10(4) Pa, highlighting the potential of this material as an injectable scaffold for cartilage regeneration. The CP hydrogel was formed rapidly by increasing the temperature. The morphology of the dried CP hydrogel was observed by scanning electron microscopy. In vitro cell culture was performed using bovine chondrocytes. The proliferation of bovine chondrocytes and the amount of synthesized glycosaminoglycan increased for 28 days. These results suggested that the CP hydrogel has potential as an injectable cell delivery carrier for cartilage regeneration and could serve as a new biomaterial for tissue engineering. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Park, Kyung Min; Joung, Yoon Ki; Park, Ki Dong] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   [Lee, Sang Young; Lee, Myung Chul] Seoul Natl Univ, Dept Orthoped Surg, Coll Med, Seoul 110744, South Korea.
   [Na, Jae Sik] Kwangwoon Univ, Dept Chem Engn, Seoul 139701, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, 5 Wonchun Dong, Suwon 443749, South Korea.
EM kdp@ajou.ac.kr
RI Lee, Myung Chul/J-2779-2012
OI joung, yoon ki/0000-0001-8661-481X
FU Ministry of Health and Welfare, Republic of Korea
   [02-PJ3-PG6-EVII-0002]; Ministry of Science and Technology, Republic of
   Korea [13020214]
FX This study was supported by a grant from the Korea Health 21 R&D
   Project, Ministry of Health and Welfare, Republic of Korea
   (02-PJ3-PG6-EVII-0002) and the Nano-Biotechnology Project (Regenomics),
   Ministry of Science and Technology, Republic of Korea (13020214).
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   Barnewitz D, 2006, BIOMATERIALS, V27, P2882, DOI 10.1016/j.biomaterials.2006.01.008
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Chaipinyo K, 2004, J ORTHOPAED RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001
   Chen GP, 2006, MAT SCI ENG C-BIO S, V26, P124, DOI 10.1016/j.msec.2005.08.042
   Chung HJ, 2005, MACROMOL SYMP, V224, P275, DOI 10.1002/masy.200550624
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   DePALMA ANTHONY F., 1966, CLIN ORTHOP RELATED RES, V48, P229
   Donati I, 2005, BIOMATERIALS, V26, P987, DOI 10.1016/j.biomaterials.2004.04.015
   Gerard C, 2005, J MATER SCI-MATER M, V16, P541, DOI 10.1007/s10856-005-0530-3
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Hong PD, 1998, POLYMER, V39, P5809, DOI 10.1016/S0032-3861(98)00031-7
   Hong Y, 2007, ACTA BIOMATER, V3, P23, DOI 10.1016/j.actbio.2006.06.007
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Ibusuki S, 2003, TISSUE ENG, V9, P371, DOI 10.1089/107632703764664846
   Jia XQ, 2004, MACROMOLECULES, V37, P3239, DOI 10.1021/ma035970w
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Kim SH, 2000, J BIOMED MATER RES, V53, P258, DOI 10.1002/(SICI)1097-4636(2000)53:3<258::AID-JBM11>3.3.CO;2-F
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   Martinez-Ruvalcaba A, 2007, CARBOHYD POLYM, V67, P586, DOI 10.1016/j.carbpol.2006.06.033
   Messner K, 1996, ACTA ORTHOP SCAND, V67, P165, DOI 10.3109/17453679608994664
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Nisbet DR, 2006, BIOPHYS CHEM, V121, P14, DOI 10.1016/j.bpc.2005.12.005
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park KM, 2008, COLLOID SURFACE B, V63, P1, DOI 10.1016/j.colsurfb.2007.10.024
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sobajima Satoshi, 2005, Spine J, V5, P14, DOI 10.1016/j.spinee.2004.05.251
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Ting V, 1998, ANN PLAS SURG, V40, P413, DOI 10.1097/00000637-199804000-00016
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   Wu H, 2008, ACTA BIOMATER, V4, P76, DOI 10.1016/j.actbio.2007.06.010
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
NR 40
TC 178
Z9 188
U1 16
U2 124
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 1956
EP 1965
DI 10.1016/j.actbio.2009.01.040
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900014
PM 19261553
DA 2018-10-19
ER

PT J
AU Serrano, MC
   Pagani, R
   Vallet-Regi, M
   Pena, J
   Comas, JV
   Portoles, MT
AF Serrano, Maria-Concepcion
   Pagani, Raffaella
   Vallet-Regi, Maria
   Pena, Juan
   Comas, Juan-Valentin
   Portoles, Maria-Teresa
TI Nitric oxide production by endothelial cells derived from blood
   progenitors cultured on NaOH-treated polycaprolactone films: A
   biofunctionality study
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Endothelial progenitor cell; Poly(epsilon-caprolactone); Nitric oxide;
   Reactive oxygen species; Intracellular calcium
ID POLY(EPSILON-CAPROLACTONE) FILMS; OXIDATIVE STRESS; IN-VITRO;
   PLATELET-ADHESION; IDENTIFICATION; DIFFERENTIATION; REGENERATION;
   FIBROBLASTS; MEMBRANE; SCAFFOLD
AB Poly(epsilon-caprolactone) (PCL) is a biodegradable polyester whose biocompatibility has been widely demonstrated both in vivo and in vitro. In the last few years, our group has confirmed that NaOH-treated PCL films can serve as a suitable biomaterial for vascular tissue engineering by supporting the culture of primary vascular cells and, more recently, endothelial-like EC2 cells derived from endothelial progenitor cells (EPC). In the present study, NO production in basal conditions and after stimulation with different agents has been evaluated and related to the reactive oxygen species (ROS) content and the intracellular calcium levels on EC2 cells cultured on NaOH-treated PCL films. The results obtained demonstrate that EC2 seeded on NaOH-treated PCL films enhance the basal NO levels and show a faster, more intense response to physiological stimuli such as VEGF, bradykinin and thrombin than vein endothelial cells (ECv). This result could be indicative of a better capacity of EC2 cells to maintain their endothelial functionality when seeded on polymers. On the other hand, the culture of both EC2 and ECv cells on NaOH-treated PCL films induces a significant increase in both ROS content and intracellular calcium that is balanced out through the stimulation of NO production in these cells. In conclusion, these results demonstrate the ability of NaOH-treated PCL films to support endothelial cell production of nitric oxide and reinforce the idea of considering the endothelial-like EC2 cells derived from blood progenitors as an adequate source of endothelial cells to functionalize vascular grafts. Furthermore, NaOH-treated PCL films could be considered as a promising cellular NO production-inducing biomaterial for vascular tissue engineering applications. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Serrano, Maria-Concepcion; Pagani, Raffaella; Portoles, Maria-Teresa] Univ Complutense, Dept Biochem & Mol Biol 1, Fac Chem, E-28040 Madrid, Spain.
   [Vallet-Regi, Maria; Pena, Juan] Univ Complutense, Dept Inorgan & Bioinorgan Chem, Fac Pharm, E-28040 Madrid, Spain.
   [Vallet-Regi, Maria; Pena, Juan] Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain.
   [Comas, Juan-Valentin] Hosp Univ 12 Octubre, Pediat Heart Inst, Madrid, Spain.
RP Portoles, MT (reprint author), Univ Complutense, Dept Biochem & Mol Biol 1, Fac Chem, Ciudad Univ S-N, E-28040 Madrid, Spain.
EM portoles@quim.ucm.es
RI Vallet-Regi, Maria/M-3378-2014; pena, juan/E-5913-2018; Serrano, Maria
   Concepcion/D-7442-2014; Portoles, Maria Teresa/U-1678-2017
OI Vallet-Regi, Maria/0000-0002-6104-4889; pena, juan/0000-0002-5992-908X;
   Serrano, Maria Concepcion/0000-0002-5010-644X; Portoles, Maria
   Teresa/0000-0002-9681-0184
FU Fundacion MMA; Comunidad de Madrid [S-0505/MAT/0324]
FX This study was supported by research grants from Fundacion MMA
   (2004-033) and from Comunidad de Madrid (S-0505/MAT/0324). The authors
   wish to express their thanks to Dr. G.A. Ameer for scientific assistance
   and the staff from the Electronic Microscopy and Flow Cytometry Center
   (CAI, UCM, Spain) and the Flow Cytometry Service (CNIC, Carlos III
   Institute, Spain) for the assistance with the confocal microscopy and
   flow cytometry studies.
CR Allen J, 2008, TISSUE ENG PT A, V14, P183, DOI 10.1089/ten.a.2007.0265
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Berges A, 2003, ACTA CARDIOL, V58, P119, DOI 10.2143/AC.58.2.2005264
   Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje
   Ciccolini F, 2001, MOL CELL NEUROSCI, V17, P895, DOI 10.1006/mcne.2001.0980
   DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3
   Edlund U, 2008, BIOMACROMOLECULES, V9, P901, DOI 10.1021/bm701267u
   FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193
   Hristov M, 2003, TRENDS CARDIOVAS MED, V13, P201, DOI 10.1016/S1050-1738(03)00077-X
   Mo X, 2006, INT J ARTIF ORGANS, V29, P790
   MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5
   Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2
   Ng KW, 2007, J BIOMAT SCI-POLYM E, V18, P925, DOI 10.1163/156856207781367693
   Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   RUBANYI GM, 1988, ANN NY ACAD SCI, V522, P226
   Rubbo H, 1995, Biochem Soc Symp, V61, P33
   Sanchez FA, 2006, AM J PHYSIOL-HEART C, V291, pH1058, DOI 10.1152/ajpheart.00370.2006
   Serrano MC, 2006, BIOMATERIALS, V27, P4706, DOI 10.1016/j.biomaterials.2006.05.007
   Serrano MC, 2008, J BIOMED MATER RES A, V87A, P964, DOI 10.1002/jbm.a.31728
   Serrano MC, 2005, BIOMATERIALS, V26, P5827, DOI 10.1016/j.biomaterials.2005.02.039
   Serrano MC, 2005, MACROMOL BIOSCI, V5, P415, DOI 10.1002/mabi.200400214
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI [10.1007/s10787-007-0013-x, 10.1007/s10787-007-0013-2]
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Udall J N, 1987, Adv Exp Med Biol, V216A, P821
   Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Wu YD, 2007, J BIOMED MATER RES A, V81A, P956, DOI 10.1002/jbm.a.31105
   WYATT AW, 2004, BIOCH SOC S, V71, P143
   Yamamoto H, 2008, ANN HEMATOL, V87, P87, DOI 10.1007/s00277-007-0381-8
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Yamashita JK, 2007, TRENDS CARDIOVAS MED, V17, P59, DOI 10.1016/j.tcm.2007.01.001
NR 37
TC 20
Z9 20
U1 3
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 2045
EP 2053
DI 10.1016/j.actbio.2009.02.034
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900022
PM 19332384
DA 2018-10-19
ER

PT J
AU Saji, VS
   Choe, HC
   Brantley, WA
AF Saji, Viswanathan S.
   Choe, Han Cheol
   Brantley, William A.
TI An electrochemical study on self-ordered nanoporous and nanotubular
   oxide on Ti-35Nb-5Ta-7Zr alloy for biomedical applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanotubes; Anodization; Ti-35Nb-5Ta-7Zr; Biomaterial; Corrosion
ID ANODIC-OXIDATION; TIO2 NANOTUBES; TITANIUM-ALLOYS; TA6V ALLOY;
   ELECTROLYTES; ANODIZATION; ARRAYS; LAYERS; ORGANIZATION; GROWTH
AB Highly ordered nanoporous and nanotubular oxide layers were developed on low-rigidity beta Ti-35Nb-5Ta-7Zr alloy by controlled DC anodization in electrolyte containing 1 M H(3)PO(4) and 0.5 wt.% NaF at room temperature. The as-formed and crystallized nanotubes were characterized by electron microscopy, energy-dispersive X-ray spectrometry and X-ray diffraction. The electrochemical passivation behavior of the nanoporous and nanotubular oxide surfaces were investigated in Ringer's solution at 37 +/- 1 degrees C employing a potentiodynamic polarization technique and impedance spectroscopy. The diameters of the as-formed nanotubes were in the range of 30-80 nm. The nanotubular surface exhibited passivation behavior similar to that of the nanoporous surface. However, the corrosion current density was considerably higher for the nanotubular alloy. The surface after nanotube formation seemed to favor an immediate and effective passivation. Electrochemical impedance spectra were simulated by equivalent circuits and the results were discussed with regard to biomedical applications. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Saji, Viswanathan S.; Choe, Han Cheol] Chosun Univ, Dept Dent Mat, Sch Dent, Kwangju 501759, South Korea.
   [Saji, Viswanathan S.; Choe, Han Cheol] Chosun Univ, Res Ctr Nanointerface Activat Biomat, Sch Dent, Kwangju 501759, South Korea.
   [Brantley, William A.] Ohio State Univ, Coll Dent, Columbus, OH 43210 USA.
RP Choe, HC (reprint author), Chosun Univ, Dept Dent Mat, Sch Dent, Kwangju 501759, South Korea.
EM hcchoe@chosun.ac.kr
RI Viswanathan S., Saji/H-8533-2015
OI Viswanathan S., Saji/0000-0003-1724-0011
CR *ASTM, 2000, R58350 UNS ASTM
   Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   CHOE HC, 2008, P NSTI NAN BOST, V1, P454
   Feng XJ, 2007, ELECTROCHEM COMMUN, V9, P2403, DOI 10.1016/j.elecom.2007.07.007
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Ivasishin OM, 2005, MAT SCI ENG A-STRUCT, V405, P296, DOI 10.1016/j.msea.2005.06.027
   Jakubowicz J, 2008, ELECTROCHEM COMMUN, V10, P735, DOI 10.1016/j.elecom.2008.02.027
   Kubota S, 2004, J MATER SCI-MATER M, V15, P1031, DOI 10.1023/B:JMSM.0000042689.78768.77
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Macak JM, 2007, ELECTROCHEM COMMUN, V9, P1783, DOI 10.1016/j.elecom.2007.04.002
   Macak JM, 2005, J BIOMED MATER RES A, V75A, P928, DOI 10.1002/jbm.a.30501
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Munoz AG, 2007, J SOLID STATE ELECTR, V11, P1077, DOI 10.1007/s10008-006-0241-9
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Okazaki Y, 2001, CURR OPIN SOLID ST M, V5, P45, DOI 10.1016/S1359-0286(00)00025-5
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Richert L, 2008, ADV MATER, V20, P1488, DOI 10.1002/adma.200701428
   Saji VS, 2007, CURR SCI INDIA, V92, P51
   Sieber I, 2005, ELECTROCHEM COMMUN, V7, P97, DOI 10.1016/j.elecom.2004.11.012
   Sieber IV, 2005, J ELECTROCHEM SOC, V152, pC639, DOI 10.1149/1.1997153
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   Tsuchiya H, 2004, ELECTROCHEM COMMUN, V6, P1131, DOI 10.1016/j.elecom.2004.09.003
   Tsuchiya H, 2006, ELECTROCHIM ACTA, V52, P94, DOI 10.1016/j.electacta.2006.03.087
   Varghese OK, 2003, SENSOR ACTUAT B-CHEM, V93, P338, DOI 10.1016/S0925-4005(03)00222-3
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Yasuda K, 2007, J ELECTROCHEM SOC, V154, pC472, DOI 10.1149/1.2749091
   Yasuda K, 2007, ADV MATER, V19, P1757, DOI 10.1002/adma.200601912
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 34
TC 66
Z9 66
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2009
VL 5
IS 6
BP 2303
EP 2310
DI 10.1016/j.actbio.2009.02.017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461XS
UT WOS:000267307900049
PM 19289307
DA 2018-10-19
ER

PT J
AU Higgins, DM
   Basaraba, RJ
   Hohnbaum, AC
   Lee, EJ
   Grainger, DW
   Gonzalez-Juarrero, M
AF Higgins, David M.
   Basaraba, Randall J.
   Hohnbaum, April C.
   Lee, Eric J.
   Grainger, David W.
   Gonzalez-Juarrero, Mercedes
TI Localized Immunosuppressive Environment in the Foreign Body Response to
   Implanted Biomaterials
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID GROWTH-FACTOR-BETA; GIANT-CELL FORMATION; IN-VIVO; ADHERENT MACROPHAGES;
   SURFACE-CHEMISTRY; DENDRITIC CELLS; CYTOKINE; TISSUE; ACTIVATION;
   EXPRESSION
AB The implantation of synthetic biomaterials initiates the foreign body response (FBR), which is characterized by macrophage infiltration, foreign body giant cell formation, and fibrotic encapsulation of the implant. The FBR is orchestrated by a complex network of immune modulators, including diverse cell types, soluble mediators, and unique cell surface interactions. The specific tissue locations, expression patterns, and spatial distribution of these immune modulators around the site of implantation are not clear. This study describes a model for studying the FBR in vivo and specifically evaluates the spatial relationship of immune modulators. We modified a biomaterials implantation in vivo model that allowed for cross-sectional in situ analysis of the FBR. Immunohistochemical techniques were used to determine the localization of soluble mediators, ie, interleukin (11)4, IL-13, IL-10, IL-6, transforming growth factor-beta, tumor necrosis factor-alpha, interferon-gamma, and MCP-1; specific cell types, ie, macrophages, neutrophils, fibroblasts, and lymphocytes; and cell surface markers, ie, F4/80, CD11b, CD11c, and Ly-6C, at early, middle, and late stages of the FBR in subcutaneous implant sites. The cytokines IL-4, IL-13, IL-10, and transforming growth factor-beta were localized to implant-adherent cells that included macrophages and foreign body giant cells. A better understanding of the FBR in vivo will allow the development of novel strategies to enhance biomaterial implant design to achieve better performance and safety of biomedical devices at the site of implant. (Am J Pathol 2009, 175:161-170; DOI: 10.2353/ajpath.2009.080962)
C1 [Higgins, David M.; Basaraba, Randall J.; Hohnbaum, April C.; Lee, Eric J.; Gonzalez-Juarrero, Mercedes] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Grainger, David W.] Univ Utah, Hlth Sci Ctr, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT USA.
RP Gonzalez-Juarrero, M (reprint author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM malba@mail.colostate.edu
FU National Institutes of Health [R01 EB000894]
FX Supported by National Institutes of Health grant R01 EB000894.
CR Abbondanzo SL, 1999, MODERN PATHOL, V12, P706
   AlSaffar N, 1997, J MATER SCI-MATER M, V8, P641, DOI 10.1023/A:1018575504518
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 2000, BIOMATERIALS FACTORS, P89
   ANDERSON JM, 2007, SEMIN IMMUNOL, P86
   ATHANASOU NA, 1990, J CLIN PATHOL, V43, P997, DOI 10.1136/jcp.43.12.997
   BORDER WA, 1994, NEW ENGL J MED, V331, P1286
   Brandt E, 2000, J LEUKOCYTE BIOL, V68, P125
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Calvo P, 1997, BIOMATERIALS, V18, P1305, DOI 10.1016/S0142-9612(97)00061-6
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DOUSSIS IA, 1992, J CLIN PATHOL, V45, P398, DOI 10.1136/jcp.45.5.398
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   GORDON S, 1974, J EXP MED, V139, P1228, DOI 10.1084/jem.139.5.1228
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Higgins DM, 2008, J IMMUNOL, V180, P4892, DOI 10.4049/jimmunol.180.7.4892
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407
   Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770
   Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806
   Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231
   Konittinen YT, 2006, INT J PERIODONT REST, V26, P135
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113
   Li AG, 2007, J BIOMED MATER RES A, V82A, P498, DOI 10.1002/jbm.a.31168
   Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737
   Lim SM, 2008, J BIOMAT SCI-POLYM E, V19, P453, DOI 10.1163/156856208783719482
   Luttikhuizen DT, 2007, J TISSUE ENG REGEN M, V1, P398, DOI 10.1002/term.50
   Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P869, DOI 10.1001/jama.283.7.869
   MIRESLUIS AR, 1998, INTERLEUKIN 4 CYTOKI, P51
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Ochoa MT, 2008, J INVEST DERMATOL, V128, P2225, DOI 10.1038/jid.2008.56
   Pan H, 2008, BIOMATERIALS, V29, P1583, DOI 10.1016/j.biomaterials.2007.12.005
   Rodriguez A, 2008, J BIOMED MATER RES A, V85A, P556, DOI 10.1002/jbm.a.31562
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rollins BJ, 1997, BLOOD, V90, P909
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Scheidbach H, 2004, SURG ENDOSC, V18, P211, DOI 10.1007/s00464-003-8113-1
   Wang X, 2008, CYTOKINE, V43, P15, DOI 10.1016/j.cyto.2008.04.009
   Ward WK, 2008, J BIOMAT SCI-POLYM E, V19, P1065, DOI 10.1163/156856208784909408
   Woerly G, 2002, J LEUKOCYTE BIOL, V72, P769
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yuan HT, 2003, AM J PATHOL, V163, P2289, DOI 10.1016/S0002-9440(10)63586-9
NR 54
TC 73
Z9 75
U1 2
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JUL
PY 2009
VL 175
IS 1
BP 161
EP 170
DI 10.2353/ajpath.2009.080962
PG 10
WC Pathology
SC Pathology
GA 464MG
UT WOS:000267508600015
PM 19528351
OA Green Published
DA 2018-10-19
ER

PT J
AU Kim, K
   Dean, D
   Mikos, AG
   Fisher, JP
AF Kim, Kyobum
   Dean, David
   Mikos, Antonios G.
   Fisher, John P.
TI Effect of Initial Cell Seeding Density on Early Osteogenic Signal
   Expression of Rat Bone Marrow Stromal Cells Cultured on Cross-Linked
   Poly(propylene fumarate) Disks
SO BIOMACROMOLECULES
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; TITANIUM FIBER MESH; IN-VITRO; GROWTH-FACTOR;
   OSTEOBLASTIC DIFFERENTIATION; MORPHOGENETIC PROTEINS; SCAFFOLD
   FABRICATION; EXTRACELLULAR-MATRIX; TISSUE FORMATION; BMP-2
AB The intercellular signaling mechanisms among a transplanted cell population are largely determined by the cell population itself as well as the Surrounding environment. Changes in cell-to-cell paracrine signaling distance can be obtained by altering cell density, and signal expression of growth factors can be enhanced by auto/paracrine signal transduction. To examine these relationships, we investigated the effect of cell seeding density on viability, proliferation, differentiation, and the endogenous osteogenic signal expression among rat bone marrow stromal cells (BMSCs) cultured on a 2D disk. Rat BMSCs were isolated from rats and then Cultured for 8 days on biodegradable poly(propylene fumarate) disks with three different seeding densities (0.06, 0.15, and 0.30 million cells/disk). At days 1, 4, and 8, viability by live/dead fluorescent staining, DNA amount, osteogenic differentiation by alkaline phosphatase and osteocalcin mRNA expression, calcium deposition, and osteogenic growth factor mRNA expression were assayed. Osteogenic signal expression was evaluated using quantitative reverse transcriptase-polymerase chain reaction, and signals of interest include bone morphogenetic protein-2, transforming growth factor-beta(1), fibroblast growth factor-2, and platelet-derived growth factor-A. The results from this study demonstrate that rat BMSCs were viable over 8 days without being affected by cell density and that both cell proliferation rate and early osteogenic differentiation were stimulated by lower cell seeding density. Most importantly, this study has demonstrated for the first time that the temporal gene expression profiles of endogenous growth factors can be controlled by altering the initial cell seeding density on poly(propylene fumarate) disks. Therefore, our results suggest that changes in the paracrine signal distance by altering cell seeding density may be a useful strategy to optimize the cell-biomaterial construct microenvironments to enhance the osteogenic signal expression.
C1 [Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Kim, Kyobum] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Dean, David] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA.
   [Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Kim, Kyobum/D-3485-2011; Dean, David/F-9605-2017; Fisher,
   John/F-8078-2012
OI Dean, David/0000-0002-1217-3764; 
FU National Institutes of Health [R01-DE013740]; National Science
   Foundation [CBET 0448684]
FX This work was supported by the National Institutes of Health
   (R01-DE013740) and the National Science Foundation (CBET 0448684):
CR Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Banoub RW, 1996, CANCER LETT, V108, P35, DOI 10.1016/S0304-3835(96)04367-4
   Bitar M, 2008, BIOMACROMOLECULES, V9, P129, DOI 10.1021/bm701112w
   CANALIS E, 1989, J CELL PHYSIOL, V140, P530, DOI 10.1002/jcp.1041400319
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Goldstein AS, 2001, TISSUE ENG, V7, P817, DOI 10.1089/107632701753337753
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Horch RA, 2004, BIOMACROMOLECULES, V5, P1990, DOI 10.1021/bm049768s
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kruyt M, 2008, TISSUE ENG PT A, V14, P1283, DOI 10.1089/ten.tea.2008.1505
   Lee JW, 2007, MICROELECTRON ENG, V84, P1702, DOI 10.1016/j.mee.2007.01.267
   Lee KW, 2008, BIOMATERIALS, V29, P2839, DOI 10.1016/j.biomaterials.2008.03.030
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lieb E, 2004, TISSUE ENG, V10, P1414, DOI 10.1089/1076327042500201
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Peter SJ, 1998, J CELL BIOCHEM, V71, P55, DOI 10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shanti RM, 2007, J ORAL MAXIL SURG, V65, P1640, DOI 10.1016/j.joms.2007.04.008
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Toh YC, 2005, BIOMATERIALS, V26, P4149, DOI 10.1016/j.biomaterials.2004.10.033
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   van der Zande M, 2008, J BIOMED MATER RES A, V86A, P788, DOI 10.1002/jbm.a.31645
   Vehof JWM, 2001, TISSUE ENG, V7, P373, DOI 10.1089/10763270152436436
   Zhou YF, 2006, J BIOMED MATER RES A, V78A, P183, DOI 10.1002/jbm.a.30685
NR 45
TC 85
Z9 89
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2009
VL 10
IS 7
BP 1810
EP 1817
DI 10.1021/bm900240k
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 472NR
UT WOS:000268139300019
PM 19469498
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Tang, H
   Xu, ZF
   Qin, X
   Wu, B
   Wu, LH
   Zhao, XW
   Li, YL
AF Tang, Hua
   Xu, Zhifei
   Qin, Xiong
   Wu, Bin
   Wu, Lihui
   Zhao, XueWei
   Li, Yulin
TI Chest wall reconstruction in a canine model using polydioxanone mesh,
   demineralized bone matrix and bone marrow stromal cells
SO BIOMATERIALS
LA English
DT Article
DE Chest wall; Tissue engineering; PDO; DBM; BMSCs; Canine model
ID BETA-TRICALCIUM PHOSPHATE; POLY-L-LACTIDE; TISSUE-RESPONSE; IN-VITRO;
   REPAIR; SCAFFOLD; GRAFT; FLAP; RESECTION; STRENGTH
AB Extensive chest wall defect reconstruction remains a challenging problem for surgeons. In the past several years, little progress has been made in this area. in this study, a biodegradable polydioxanone (PDO) mesh and demineralized bone matrix (DBM) seeded with osteogenically induced bone marrow stromal cells (BMSCs) were used to reconstruct a 6 cm x 5.5 cm chest wall defect. Four experimental groups were evaluated (n=6 per group): polydioxanone (PDO) mesh/DBMs/BMSCs group, polydioxanone (PDO) mesh/DBMs group, polydioxanone (PDO) mesh group, and a blank group (no materials) in a canine model. All the animals survived except those in the blank group. In all groups receiving biomaterial implants, the polydioxanone (PDO) mesh completely degraded at 24 weeks and was replaced by fibrous tissue with thickness close to that of the normal intercostal tissue (P > 0.05). In the polydioxanone (PDO) mesh/DBMs/BMSCs group, new bone formation and bone-union were observed by radiographic and histological examination. More importantly, the reconstructed rib could maintain its original radian and achieve satisfactory biomechanics close to normal ribs in terms of bending stress (P > 0.05). However, in the other two groups, fibrous tissue was observed in the defect and junctions, and the reconstructed ribs were easily distorted under an outer force. Based on these results, a surgical approach utilizing biodegradable polydioxanone (PDO) mesh in combination with DBMs and BMSCs could repair the chest wall defect not only in function but also in structure. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Tang, Hua; Xu, Zhifei; Qin, Xiong; Wu, Bin; Wu, Lihui; Zhao, XueWei] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac & Cardiovasc Surg, Shanghai 200003, Peoples R China.
   [Li, Yulin] Donghua Univ, Shanghai, Peoples R China.
RP Xu, ZF (reprint author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac & Cardiovasc Surg, 415 Fengyang Rd, Shanghai 200003, Peoples R China.
EM xu_zhi_fei@yahoo.com.cn
FU National Science foundation of China (NSFC) [30571847]; Shanghai Science
   and Technology Development Foundation [08ZRI404900]
FX This work was funded by National Science foundation of China (NSFC)
   (30571847) and Shanghai Science and Technology Development Foundation
   (08ZRI404900).
CR Akhavani MA, 2007, PLAST RECONSTR SURG, V119, P761, DOI 10.1097/01.prs.0000254925.42803.32
   Arnold PG, 1996, PLAST RECONSTR SURG, V98, P804, DOI 10.1097/00006534-199610000-00008
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Deschamps C, 1999, J THORAC CARDIOV SUR, V117, P588, DOI 10.1016/S0022-5223(99)70339-9
   Garreta E, 2007, BIOMOL ENG, V24, P75, DOI 10.1016/j.bioeng.2006.05.017
   Geiger F, 2007, BONE, V41, P516, DOI 10.1016/j.bone.2007.06.018
   HIDALGO DA, 1993, ANN PLAS SURG, V30, P375, DOI 10.1097/00000637-199304000-00017
   Horio H, 2005, SURG TODAY, V35, P73, DOI 10.1007/s00595-004-2868-4
   Hoshino M, 2007, PLAST RECONSTR SURG, V119, P1431, DOI 10.1097/01.prs.0000256319.89619.c8
   Isik AF, 2007, ACTA CHIR BELG, V107, P313, DOI 10.1080/00015458.2007.11680063
   Jonsson P, 1998, Sarcoma, V2, P143, DOI 10.1080/13577149877894
   Klinge U, 2001, BIOMATERIALS, V22, P1415, DOI 10.1016/S0142-9612(00)00299-4
   Kontio R, 2005, INT J ORAL MAX SURG, V34, P766, DOI 10.1016/j.ijom.2005.04.027
   KROLL SS, 1993, ANN PLAS SURG, V31, P303, DOI 10.1097/00000637-199310000-00003
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   Lee Kenneth J H, 2005, Spine J, V5, p217S, DOI 10.1016/j.spinee.2005.02.006
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   Lin H, 2008, BIOMATERIALS, V29, P1189, DOI 10.1016/j.biomaterials.2007.11.032
   Lindsey RW, 2006, J ORTHOP RES, V24, P1438, DOI 10.1002/jor.20154
   LINDSEY RW, 1993, CHN ORTHOP RELAT RES, V291, P303
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mansour KA, 2002, ANN THORAC SURG, V73, P1720, DOI 10.1016/S0003-4975(02)03527-0
   MATSUI T, 1994, J THORAC CARDIOV SUR, V108, P162
   Matsusaki M, 2007, BIOMATERIALS, V28, P2729, DOI 10.1016/j.biomaterials.2007.02.015
   MCCORMACK PM, 1989, SURG CLIN N AM, V69, P965
   MURAGLIA A, 1998, BONE, V22, P131
   Novoa Nuria, 2005, Interact Cardiovasc Thorac Surg, V4, P250, DOI 10.1510/icvts.2004.103432
   Ohno K, 1998, ANN THORAC SURG, V66, P1805, DOI 10.1016/S0003-4975(98)00922-9
   PUMA F, 1992, ANN THORAC SURG, V53, P408, DOI 10.1016/0003-4975(92)90259-7
   Qin X, 2008, EUR J CARDIO-THORAC, V34, P870, DOI 10.1016/j.ejcts.2008.06.038
   Rathinam S, 2004, EUR J CARDIO-THORAC, V26, P197, DOI 10.1016/j.ejcts.2004.03.022
   RUDOLPHY VJ, 1991, ANN THORAC SURG, V52, P821, DOI 10.1016/0003-4975(91)91218-K
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   van Geel AN, 1998, EUR J SURG, V164, P305
   Weyant MJ, 2006, ANN THORAC SURG, V81, P279, DOI 10.1016/j.athoracsur.2005.07.001
   WHITAKER LA, 1979, PLAST RECONSTR SURG, V64, P198, DOI 10.1097/00006534-197908000-00011
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
NR 41
TC 14
Z9 17
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2009
VL 30
IS 19
BP 3224
EP 3233
DI 10.1016/j.biomaterials.2009.02.007
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 454GS
UT WOS:000266671000002
PM 19233465
DA 2018-10-19
ER

PT J
AU Grellier, M
   Granja, PL
   Fricain, JC
   Bidarra, SJ
   Renard, M
   Bareille, R
   Bourget, C
   Amedee, J
   Barbosa, MA
AF Grellier, Maritie
   Granja, Pedro L.
   Fricain, Jean-Christophe
   Bidarra, Silvia J.
   Renard, Martine
   Bareille, Reine
   Bourget, Chantal
   Amedee, Joelle
   Barbosa, Mario A.
TI The effect of the co-immobilization of human osteoprogenitors and
   endothelial cells within alginate microspheres on mineralization in a
   bone defect
SO BIOMATERIALS
LA English
DT Article
DE Osteoprogenitors; Endothelial cells; Co-culture; Alginate; Cell
   immobilization; Vascular endothelial growth factor (VEGF)
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTORS; STROMAL CELLS; IN-VITRO;
   DIFFERENTIATION; ANGIOGENESIS; SCAFFOLDS; HYDROGELS; VEGF; BIOMATERIALS
AB Bone regeneration seems to be dependant on cell communication between osteogenic and endothelial cells arising from surrounding blood vessels. This study aims to determine whether endothelial cells can regulate the osteogenic potential of osteoprogenitor cells in vitro and in vivo, in a long bone defect, when co-immobilized in alginate microspheres. Alginate is a natural polymer widely used as a biomaterial for cell encapsulation. Human osteoprogenitors (HOP) from bone marrow mesenchymal stem cells were immobilized alone or together with human umbilical vein endothelial cells (HUVEC) inside irradiated, oxidized and RGD-grafted alginate microspheres. Immobilized cells were cultured in dynamic conditions and cell metabolic activity increased during three weeks. The gene expression of alkaline phosphatase and osteocalcin, both specific markers of the osteoblastic phenotype, and mineralization deposits were upregulated in co-immobilized HOPs and HUVECs, comparing to the immobilization of monocultures. VEGF secretion was also increased when HOPs were co-immobilized with HUVECs. Microspheres containing co-cultures were further implanted in a bone defect and bone formation was analysed by mu CT and histology at 3 and 6 weeks post-implantation. Mineralization was observed inside and around the implanted microspheres containing the immobilized cells. However, when HOPs were co-immobilized with HUVECs, mineralization significantly increased. These findings demonstrate that co-immobilization of osteogenic and endothelial cells within RGD-grafted alginate microspheres provides a promising strategy for bone tissue engineering. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Grellier, Maritie; Fricain, Jean-Christophe; Bareille, Reine; Bourget, Chantal; Amedee, Joelle] INSERM, U577, Bordeaux, France.
   [Grellier, Maritie; Fricain, Jean-Christophe; Bareille, Reine; Bourget, Chantal; Amedee, Joelle] Univ Bordeaux 2, UMR S577, F-33076 Bordeaux, France.
   [Grellier, Maritie; Granja, Pedro L.; Bidarra, Silvia J.; Barbosa, Mario A.] INEB, Div Biomat, P-4150180 Oporto, Portugal.
   [Renard, Martine] Hop Xavier Arnozan, PTIB, Ctr Invest Clin Innovat Technol Biomat, INSERM,CHU Bordeaux,CIT802 Biomat, F-33600 Pessac, France.
   [Barbosa, Mario A.] Univ Porto, Fac Engn, Dept Mat & Met Engn, P-4100 Oporto, Portugal.
RP Grellier, M (reprint author), INSERM, U577, Bordeaux, France.
EM maritie.grellier@inserm.fr
RI Barbosa, Mario/F-5964-2011; Bidarra, Silvia/J-8421-2013; VILAMITJANA
   AMEDEE, Joelle/F-3369-2013; Granja, Pedro/B-1685-2008
OI Barbosa, Mario/0000-0003-3568-7482; Granja, Pedro/0000-0003-2761-4929;
   Bidarra, Silvia/0000-0002-1515-9597
FU French Ministry "de l'Enseignement Superieur et de la Recherche";
   Portuguese Foundation for Science and Technology
   [POCI/SAU-BMA/55556/2004]
FX This work was supported by grants from INSERM ANR PNano, "Agence de
   Biomedecine", the French Ministry "de l'Enseignement Superieur et de la
   Recherche" and from the Portuguese Foundation for Science and Technology
   (FCT; POCI/SAU-BMA/55556/2004). The authors thank Isabel Carvalho and
   Meriem Lamghari for their technical help and David Mooney for helpful
   discussions.
CR Abbah SA, 2006, BIOCHEM BIOPH RES CO, V347, P185, DOI 10.1016/j.bbrc.2006.06.072
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Barrias CC, 2005, J BIOMED MATER RES A, V74A, P545, DOI 10.1002/jbm.a.30348
   Bjerre L, 2008, BIOMATERIALS, V29, P2616, DOI 10.1016/j.biomaterials.2008.03.003
   BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P2384, DOI 10.1097/00006534-200206000-00033
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Cheng C, 2007, BIOCHEM BIOPH RES CO, V358, P342, DOI 10.1016/j.bbrc.2007.04.147
   CLARKIN CE, 2007, J CELL PHYSL
   Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Kaigler D, 2006, J DENT RES, V85, P633, DOI 10.1177/154405910608500710
   Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Leal D, 2008, CARBOHYD RES, V343, P308, DOI 10.1016/j.carres.2007.10.016
   LU HH, 2008, J BIOMED MAT RES A
   Lubiatowski P, 2006, TRANSPLANT P, V38, P320, DOI 10.1016/j.transproceed.2005.12.012
   Mann V., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P408
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   STIEHLER M, 2008, J BIOMED MAT RES A
   Sun HC, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-41
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231
   Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609
NR 34
TC 124
Z9 129
U1 2
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2009
VL 30
IS 19
BP 3271
EP 3278
DI 10.1016/j.biomaterials.2009.02.033
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 454GS
UT WOS:000266671000007
PM 19299013
DA 2018-10-19
ER

PT J
AU Chen, YC
   Lee, DC
   Hsiao, CY
   Chung, YF
   Chen, HC
   Thomas, JP
   Pong, WF
   Tai, NH
   Lin, IN
   Chiu, IM
AF Chen, Ying-Chieh
   Lee, Don-Ching
   Hsiao, Chao-Yang
   Chung, Yu-Fen
   Chen, Huang-Chin
   Thomas, Joseph P.
   Pong, Way-Faung
   Tai, Nyan-Hwa
   Lin, I-Nan
   Chiu, Ing-Ming
TI The effect of ultra-nanocrystalline diamond films on the proliferation
   and differentiation of neural stem cells
SO BIOMATERIALS
LA English
DT Article
DE Neural stem cells; Neural differentiation; Ultra-nanocrystalline
   diamond; ECM
ID THIN-FILMS; IN-VITRO; ULTRANANOCRYSTALLINE DIAMOND; STEM/PROGENITOR
   CELLS; SURFACE MODIFICATION; BIOCOMPATIBILITY; GROWTH; NEUROGENESIS;
   REPLACEMENT; EXPRESSION
AB The interaction of ultra-nanocrystalline diamond (UNCD) with neural stem cells (NSCs) has been studied along with its surface modification in order to improve its function as a biomaterial. Hydrogen- and oxygen-terminated UNCD films were compared with standard grade polystyrene in terms of their impact on the growth, expansion and differentiation of NSCs. When NSCs were cultured on these substrates in low serum and without any differentiating factors, hydrogen-terminated UNCD films spontaneously induced cell proliferation and neuronal differentiation. Oxygen-terminated UNCD films were also shown to further improve neural differentiation, with a preference to differentiate into oligodendrocytes. Hence, controlling the surface properties of UNCD could manipulate the differentiation of NSCs for different biomedical applications. These observations raise the potential for the use of UNCD as a biomaterial for central nervous system transplantation and tissue engineering. (c) 2009 Elsevier Ltd. All rights reserved.
C1 [Chen, Ying-Chieh; Thomas, Joseph P.; Tai, Nyan-Hwa] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan.
   [Chen, Ying-Chieh; Lee, Don-Ching; Hsiao, Chao-Yang; Chung, Yu-Fen; Chiu, Ing-Ming] Natl Hlth Res Inst, Inst Cellular & Syst Med, Jhunan 35053, Miaoli, Taiwan.
   [Chen, Huang-Chin; Pong, Way-Faung; Lin, I-Nan] Tamkang Univ, Dept Phys, Tamsui 251, Taiwan.
   [Chiu, Ing-Ming] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.
RP Tai, NH (reprint author), Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan.
EM nhtai@mx.nthu.edu.tw; ingming@nhri.org.tw
RI Chiu, Ing-Ming/B-1534-2008
OI Thomas, Joseph P/0000-0001-6455-908X
FU National Science Council, Taiwan [NSC-95-2221-E-007-062MY3]
FX The authors are grateful to the National Science Council, Taiwan for the
   support of this research under NSC-95-2221-E-007-062MY3.
CR Amaral M, 2008, J BIOMED MATER RES A, V87A, P91, DOI 10.1002/jbm.a.31742
   Ariano P, 2005, DIAM RELAT MATER, V14, P669, DOI 10.1016/j.diamond.2004.11.021
   Armstrong RJE, 2000, CELL TRANSPLANT, V9, P139, DOI 10.1177/096368970000900202
   Arunkumar AI, 2002, PROTEIN SCI, V11, P1050, DOI 10.1110/ps.2270102
   Auciello O, 2004, J PHYS-CONDENS MAT, V16, pR539, DOI 10.1088/0953-8984/16/16/R02
   Bithell A, 2005, CLIN SCI, V108, P13, DOI 10.1042/CS20040276
   Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131
   Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256
   Chen RS, 2009, BIOMATERIALS, V30, P541, DOI 10.1016/j.biomaterials.2008.09.054
   Chen YC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838303
   Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015
   Chiu IM, 2000, ONCOGENE, V19, P6229, DOI 10.1038/sj.onc.1204021
   Christoph E. N., 2007, J PHYS D, V40, P6443
   Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558
   Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   Flaumenhaft R, 1991, CURR OPIN CELL BIOL, V3, P817, DOI 10.1016/0955-0674(91)90055-4
   Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5
   Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211
   Hamers RJ, 2005, DIAM RELAT MATER, V14, P661, DOI 10.1016/j.diamond.2004.09.018
   Hartl A, 2004, NAT MATER, V3, P736, DOI 10.1038/nmat1204
   Hsu YC, 2009, DEV DYNAM, V238, P302, DOI 10.1002/dvdy.21753
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005
   Keblinski P, 1998, MRS BULL, V23, P36, DOI 10.1557/S0883769400029353
   Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036
   Kristensen BW, 2001, BRAIN RES, V896, P1, DOI 10.1016/S0006-8993(00)03304-7
   Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025
   LECHLEITNER T, 2008, BIOMATERIALS, V29, P2433
   Lee YC, 2008, DIAM RELAT MATER, V17, P446, DOI 10.1016/j.diamond.2007.08.025
   Lee YC, 2005, DIAM RELAT MATER, V14, P296, DOI 10.1016/j.diamond.2004.10.015
   MATTHEW JD, 2004, BIOMATERIALS, V25, P5415
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010
   Pollard SM, 2006, CEREB CORTEX S1, V16, pi112
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758
   Ruiz A, 2008, BIOMATERIALS, V29, P4766, DOI 10.1016/j.biomaterials.2008.08.017
   Schwahn HN, 2001, GRAEF ARCH CLIN EXP, V239, P961, DOI 10.1007/s004170100368
   Song SJ, 2007, J CELL BIOCHEM, V100, P402, DOI 10.1002/jcb.21068
   Specht CG, 2004, BIOMATERIALS, V25, P4073, DOI 10.1016/j.biomaterials.2003.11.006
   Steinmuller-Nethl D, 2006, BIOMATERIALS, V27, P4547, DOI 10.1016/j.biomaterials.2006.04.036
   WILLIAM CC, 2008, BIOMATERIALS, V29, P3461
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xiao XC, 2006, J BIOMED MATER RES B, V77B, P273, DOI 10.1002/jbm.b.30448
   Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779
   Zurn AD, 1996, J NEUROSCI RES, V44, P133, DOI 10.1002/(SICI)1097-4547(19960415)44:2<133::AID-JNR5>3.0.CO;2-E
NR 47
TC 53
Z9 53
U1 3
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2009
VL 30
IS 20
BP 3428
EP 3435
DI 10.1016/j.biomaterials.2009.03.058
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 455FR
UT WOS:000266744100008
PM 19406465
DA 2018-10-19
ER

PT J
AU Lee, JY
   Choo, JE
   Choi, YS
   Suh, JS
   Lee, SJ
   Chung, CP
   Park, YJ
AF Lee, Jue-Yeon
   Choo, Jung-Eun
   Choi, Young-Suk
   Suh, Jin-Sook
   Lee, Seung-Jin
   Chung, Chong-Pyoung
   Park, Yoon-Jeong
TI Osteoblastic differentiation of human bone marrow stromal cells in
   self-assembled BMP-2 receptor-binding peptide-amphiphiles
SO BIOMATERIALS
LA English
DT Article
DE Osteopromotive domain (OPD); BMP-2; Peptide-amphiphiles; Nanofibers;
   Scaffold; Osteoblastic differentiation
ID MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; IN-VITRO;
   EXTRACELLULAR-MATRIX; OSTEOGENIC DIFFERENTIATION; MOLECULAR
   ARCHITECTURE; BIOMATERIAL SCAFFOLDS; VERSATILE SCAFFOLD;
   CONTROLLED-RELEASE; CRYSTAL-STRUCTURE
AB Self-assembled nanostructures consisting of BMP receptor-binding peptides, termed osteopromotive domains (OPDs), and hydrophobic alkyl chains were fabricated with the aim of developing three-dimensional scaffolding materials for osteoblastic differentiation. OPD peptide was identified from BMP-2 and had an affinity for BMP receptors thereby inducing differentiation of human bone marrow stromal cells into osteoblastic cells. The peptide-hydrophobic alkyl chain amphiphiles were designed to mimic nanofibrous extracellular structures and to add osteogenic ligands to enhance osteoblastic cell function. The OPD peptide-amphiphiles (OPDAs) that end with the alkylation of the N-terminus of the OPD peptide were synthesized by standard solid phase chemistry. The self-assembly was triggered by mixing OPDA solution with calcium ions. Observation using scanning electron microscopy (SEM) revealed the formation of nanofibrous structures with extremely high aspect ratios and high surface areas. The FT-IR and circular dichroism (CD) spectro photometry demonstrated that self-assembled nanofibers have a beta-sheet structure. The activation of Smad, an osteoblastic differentiation marker. was obtained in the cell culture gel of self-assembled OPDA; therefore, the intracellular signal transduction for osteogenesis was performed like an OPD peptide. Cell survival was supported in the OPDA gel for 10 days, and osteoblastic differentiation of human bone marrow stromal cells (hBMSCs) was evident as demonstrated by calcein staining and ALP activity measurement. These results revealed that self-assembled OPDA maintained osteogenic activity by the surface-exposed OPD peptide. Taken together, the self-assembled OPDA nanofibrous gel can be utilized as a cell culture scaffold in bone regeneration. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Lee, Jue-Yeon; Choo, Jung-Eun; Choi, Young-Suk; Suh, Jin-Sook; Park, Yoon-Jeong] Seoul Natl Univ, Sch Dent, Dept Craniomaxillofacial Reconstruct Sci, Seoul 110749, South Korea.
   [Lee, Jue-Yeon; Choo, Jung-Eun; Choi, Young-Suk; Suh, Jin-Sook; Chung, Chong-Pyoung; Park, Yoon-Jeong] Seoul Natl Univ, Sch Dent, IBEC, Seoul, South Korea.
   [Lee, Jue-Yeon; Chung, Chong-Pyoung; Park, Yoon-Jeong] NIBEC, Res Ctr, Seoul, South Korea.
   [Lee, Seung-Jin] Ewha Womans Univ, Coll Pharm, Dept Pharm, Seoul, South Korea.
   [Chung, Chong-Pyoung] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul, South Korea.
RP Park, YJ (reprint author), Seoul Natl Univ, Sch Dent, Dept Craniomaxillofacial Reconstruct Sci, 28-22 Yongon Dong, Seoul 110749, South Korea.
EM parkyj@snu.ac.kr
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Bull SR, 2005, BIOCONJUGATE CHEM, V16, P1343, DOI 10.1021/bc050153h
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007
   Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Iba K, 2004, J BONE MINER METAB, V22, P594, DOI 10.1007/s00774-004-0528-9
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Kihara T, 2004, BIOCHEM BIOPH RES CO, V316, P943, DOI 10.1016/j.bbrc.2004.02.134
   Kim H, 2005, BIOCHEM BIOPH RES CO, V332, P1053, DOI 10.1016/j.bbrc.2005.05.051
   Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   Kubelka J, 2001, J AM CHEM SOC, V123, P12048, DOI 10.1021/ja0116627
   Lee JY, 2007, J BIOMED MATER RES A, V83A, P970, DOI 10.1002/jbm.a.31351
   Lee JY, 2007, BIOMATERIALS, V28, P4257, DOI 10.1016/j.biomaterials.2007.05.040
   Lee JY, 2009, BIOTECHNOL APPL BIOC, V52, P69, DOI 10.1042/BA20070169
   Lee YM, 2003, J PERIODONTOL, V74, P865, DOI 10.1902/jop.2003.74.6.865
   Lou J, 2000, BIOCHEM BIOPH RES CO, V268, P757, DOI 10.1006/bbrc.2000.2210
   Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Park JB, 2007, J PERIODONTOL, V78, P2150, DOI 10.1902/jop.2007.070108
   Park JB, 2007, J PERIODONTOL, V78, P157, DOI 10.1902/jop.2007.060200
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Seol YJ, 2006, J BIOMED MATER RES A, V77A, P599, DOI 10.1002/jbm.a.30639
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Wada R, 2006, BBA-GEN SUBJECTS, V1760, P841, DOI 10.1016/j.bbagen.2005.12.025
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 48
TC 43
Z9 45
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2009
VL 30
IS 21
BP 3532
EP 3541
DI 10.1016/j.biomaterials.2009.03.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 458HR
UT WOS:000267007300004
PM 19345406
DA 2018-10-19
ER

PT J
AU Bernstein, P
   Dong, M
   Corbeil, D
   Gelinsky, M
   Gunther, KP
   Fickert, S
AF Bernstein, Peter
   Dong, Meng
   Corbeil, Denis
   Gelinsky, Michael
   Guenther, Klaus-Peter
   Fickert, Stefan
TI Pellet Culture Elicits Superior Chondrogenic Redifferentiation than
   Alginate-Based Systems
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE cartilage tissue engineering; alginate; chitosan; fibrin; pellet
ID HUMAN ARTICULAR CHONDROCYTES; GENE-EXPRESSION; STEM-CELLS; CARTILAGE
   FORMATION; SOX9 EXPRESSION; IN-VITRO; DIFFERENTIATION; COLLAGEN;
   MICROMASS; REPAIR
AB Although pellet culture and encapsulation of chondrocytes into gel-like biomaterials have lead to major advances in cartilage tissue engineering, a quantitative comparative characterization of cellular differentiation behavior during those cultivation procedures has not yet been performed. Our study therefore aimed at answering the following question: is the redifferentiation pathway of chondrocytes altered by slight changes in the type of alginate biomaterial (pure alginate, alginate-fibrin, alginate-chitosan) and how do the cells behave in comparison to biomaterial-free (pellet) three-dimensional culturing? Monolayer-expanded chondrocytes from healthy adult porcine knee joints were cultivated in alginate, alginate-chitosan, alginate-fibrin beads and as pellets up to 4 weeks. Quantitative PCR and Immunohistology were used to assess chondrogenic markers. Alginate-fibrin-encapsulated chondrocytes behaved almost like monolayer chondrocytes. Alginate- and alginate-chitosan encapsulation lead to a low chondrogenic marker gene expression. Although all 3D-cultured chondrocytes showed a considerable amount of Sox9 expression, only pellet cultivation lead to a sufficient Collagen II expression. This puts the usage of alginate-cultivated cartilage tissue engineering constructs under question. Fibrin addition is not beneficial for chondrogenic differentiation. Sox9 and Collagen H behave differently, depending upon the surrounding 3D-environment. (C) 2009 American Institute of Chemical Engineers Biotechnol. Prog., 25: 1146-1152, 2009
C1 [Bernstein, Peter; Dong, Meng; Guenther, Klaus-Peter] Tech Univ Dresden, Dept Orthopaed Surg, Univ Hosp Carl Gustav Carus Dresden, Fac Med, D-01307 Dresden, Germany.
   [Dong, Meng; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs, D-01307 Dresden, Germany.
   [Gelinsky, Michael] Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, D-01069 Dresden, Germany.
   [Fickert, Stefan] Univ Heidelberg, Dept Orthopaed Surg, Fac Clin Med Mannheim, D-68167 Mannheim, Germany.
RP Bernstein, P (reprint author), Tech Univ Dresden, Dept Orthopaed Surg, Univ Hosp Carl Gustav Carus Dresden, Fac Med, D-01307 Dresden, Germany.
EM peter.bernstein@uniklinikum-dresden.de
RI Gelinsky, Michael/A-9680-2012; Corbeil, Denis/A-6519-2010
OI Gelinsky, Michael/0000-0001-9075-5121; Corbeil,
   Denis/0000-0003-1181-3659
CR Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0
   Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Almqvist KF, 2001, ANN RHEUM DIS, V60, P781, DOI 10.1136/ard.60.8.781
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Banu N, 2007, J BIOMED MATER RES A, V80A, P257, DOI 10.1002/jbm.a.30931
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bi WM, 1999, NAT GENET, V22, P85
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Bradham DM, 1998, CLIN ORTHOP RELAT R, P239
   Chadjichristos C, 2002, J BIOL CHEM, V277, P43903, DOI 10.1074/jbc.M206111200
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Heywood HK, 2004, TISSUE ENG, V10, P1467, DOI 10.1089/ten.2004.10.1467
   Hoemann CD, 2002, ANAL BIOCHEM, V300, P1, DOI 10.1006/abio.2001.5436
   HOYLAND JA, 1991, BONE MINER, V15, P151, DOI 10.1016/0169-6009(91)90005-K
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hu JC, 2005, BIOMATERIALS, V26, P2001, DOI 10.1016/j.biomaterials.2004.06.008
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   Kelly DJ, 2007, J MATER SCI-MATER M, V18, P273, DOI 10.1007/s10856-006-0689-2
   Kulyk WM, 2000, EXP CELL RES, V255, P327, DOI 10.1006/excr.1999.4784
   Kypriotou M, 2003, DNA CELL BIOL, V22, P119, DOI 10.1089/104454903321515922
   Lefebvre V., 2001, OSTEOARTHR CARTILAGE, V9, P69
   LI Z, 2005, J BIOMED MATER RES A, V75, P458
   Mandl EW, 2004, TISSUE ENG, V10, P109, DOI 10.1089/107632704322791754
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   Park SH, 2005, ARTIF ORGANS, V29, P838, DOI 10.1111/j.1525-1594.2005.00137.x
   Perka C, 2000, J BIOMED MATER RES, V49, P305, DOI 10.1002/(SICI)1097-4636(20000305)49:3<305::AID-JBM2>3.3.CO;2-0
   Rahman MS, 2001, TISSUE ENG, V7, P781, DOI 10.1089/107632701753337726
   Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002
   Robinson D, 2001, CELL TRANSPLANT, V10, P203
   ROZEN S, 2000, BIOINFORMATICS METHO, P365, DOI DOI 10.1385/1-59259-192-2:365
   Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738
   Shum Lillian, 2003, Birth Defects Research, V69, P102, DOI 10.1002/bdrc.10012
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004
   Tare RS, 2005, BIOCHEM BIOPH RES CO, V333, P609, DOI 10.1016/j.bbrc.2005.05.117
   Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200
   Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200
   Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200
NR 49
TC 29
Z9 30
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD JUL-AUG
PY 2009
VL 25
IS 4
BP 1146
EP 1152
DI 10.1002/btpr.186
PG 7
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 489EO
UT WOS:000269403000030
PM 19572391
DA 2018-10-19
ER

PT J
AU Caplan, MR
   Shah, MM
AF Caplan, Michael R.
   Shah, Miti M.
TI Translating Biomaterial Properties to Intracellular Signaling
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Biocompatible materials; Integrins; Signal transduction; Systems biology
   Mathematical model; Principal component analysis; Bayesian analysis;
   Chemical models
ID EPIDERMAL-GROWTH-FACTOR; STEM-CELL FATE; EXTRACELLULAR-MATRIX;
   ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; MOLECULAR-BASIS; INTEGRINS;
   NETWORKS; ADHESION; SURFACE
AB Bioactive materials present important micro-environmental cues that induce specific intracellular signaling responses which ultimately determine cell behavior. For example, vascular endothelial cells on a normal vessel wall resist inflammation and thrombosis, but the same cells seeded on an artificial vascular graft or stent do not. What makes these cells behave so differently when they are adhered to different materials? Intracellular signaling from integrins and other cell-surface receptors is an important part of the answer, but these signaling responses constitute a highly-branched, interconnected network of molecules. In order to perform rational design of biomaterials, one must understand how altering the properties of the material (micro-environment) causes changes in cell behavior, and this in turn requires understanding the complex signaling response. Systems biology and mathematical modeling aid analysis of the connectivity of this network. This review summarizes applicable systems biology and mathematical modeling techniques including ordinary differential equations-based models, principal component analysis, and Bayesian networks. Next covered is biomaterials research which studies the intracellular signaling responses generated by variation of biomaterial properties. Finally, the review details ways in which modeling has been or could be applied to better understand the link between biomaterial properties and intracellular signaling.
C1 [Caplan, Michael R.; Shah, Miti M.] Arizona State Univ, Harrington Dept Bioengn, Ctr Intervent Biomat, Tempe, AZ 85287 USA.
RP Caplan, MR (reprint author), Arizona State Univ, Harrington Dept Bioengn, Ctr Intervent Biomat, POB 879709, Tempe, AZ 85287 USA.
EM Michael.Caplan@asu.edu
FU NIH [R21 EB004386]; Arizona Biomedical Research Commission [0916];
   National Institute of Dental and Craniofacial Research [K22 DE014846]
FX This study was supported by the NIH (R21 EB004386), the Arizona
   Biomedical Research Commission (# 0916), and a Career Development and
   Faculty Transition Award to M. R. C. from the National Institute of
   Dental and Craniofacial Research (K22 DE014846).
CR Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Alford SK, 2009, J BIOMED MATER RES A, V88A, P205, DOI 10.1002/jbm.a.31885
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8
   Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162
   COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110
   *EIG INC, PLS TOOLB MAN
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998
   Janes KA, 2006, CURR OPIN CHEM BIOL, V10, P73, DOI 10.1016/j.cbpa.2005.12.016
   Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598
   Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/cmb.2004.11.544
   Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041
   JENKINS DD, 2005, NANOSCALE TECHNOLOGY
   JOLLIFFE IT, 2002, SPRINGER SERIES STAT
   Jones JL, 1999, J CLIN PATHOL-MOL PA, V52, P208
   Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443
   Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169
   KLEIN S, 1993, MOL BIOL CELL, V4, P973
   Lauffenburger D. A., 1993, RECEPTORS MODELS BIN, P365
   Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t
   Maheshwari G, 1999, BIOPHYS J, V76, P2814, DOI 10.1016/S0006-3495(99)77435-7
   Marnmoto A, 2008, CURR OPIN HEMATOL, V15, P228, DOI 10.1097/MOH.0b013e3282fa7445
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y
   PLATT MO, J CELL PHYS IN PRESS
   Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101
   Reyes CD, 2008, J CELL PHYSIOL, V217, P450, DOI 10.1002/jcp.21512
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Rotundo RF, 2002, AM J PHYSIOL-LUNG C, V282, pL316, DOI 10.1152/ajplung.00145.2000
   Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0
   Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071
   Takahashi N, 1999, CIRC RES, V84, P1194, DOI 10.1161/01.RES.84.10.1194
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   TRUSKEY GA, 2004, TRANSPORT PHENOMENAI
   Wacker BK, 2006, BIOMACROMOLECULES, V7, P1335, DOI 10.1021/bm050948r
   Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056
   Yeh CH, 1999, EXP CELL RES, V251, P57, DOI 10.1006/excr.1999.4560
NR 51
TC 15
Z9 15
U1 0
U2 11
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PD JUL
PY 2009
VL 54
IS 1-3
BP 1
EP 10
DI 10.1007/s12013-009-9048-5
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 459LI
UT WOS:000267103400001
PM 19390790
DA 2018-10-19
ER

PT J
AU Yang, F
   Mei, Y
   Langer, R
   Anderson, DG
AF Yang, Fan
   Mei, Ying
   Langer, Robert
   Anderson, Daniel G.
TI High Throughput Optimization of Stem Cell Microenvironments
SO COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
LA English
DT Article
ID GENE DELIVERY; SMALL MOLECULES; CATIONIC POLYMERS; ADIPOSE-TISSUE;
   BIOMATERIALS; MICROARRAYS; LIBRARY; DIFFERENTIATION; THERAPY; CANCER
AB Stem cells have great potential as cell sources for regenerative medicine due to both their self-renewal and multi-lineage differentiation capacity. Despite advances in the field of stem cell biology, major challenges remain before stem cells can be widely used for therapeutic purposes. One challenge is to develop reproducible methods to control stem cell growth and differentiation. The niche in which stem cells reside is a complex, multi-factorial environment. In contrast to using cells alone, biomaterials can provide initial structural support, and allow cells to adhere, proliferate and differentiate in a three-dimensional environment. Researchers have incorporated signals into the biomaterials that can promote desired cell functions in a spatially and temporally controlled manner. Despite progress in biomaterial design and methods to modulate cellular behavior, many of the complex signal networks that regulate cell-material interactions remain unclear. Due to the vast numbers of material properties to be explored and the complexity of cell-surface interactions, it is often difficult to optimize stem cell microenvironments using conventional, iterative approaches. To address these challenges, high throughput screening of combinatorial libraries has emerged as a novel approach to achieve rapid screening with reduced materials and costs. In this review, we discuss recent research in the area of high throughput approaches for characterization and optimization of cellular interactions with their microenvironments. In contrast to conventional approaches, screening combinatorial libraries can result in the discovery of unexpected material solutions to these complex problems.
C1 [Yang, Fan; Mei, Ying; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Langer, Robert; Anderson, Daniel G.] MIT, Ctr Canc Res, Cambridge, MA 02139 USA.
RP Yang, F (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM fyang4@mit.edu
FU NIAMS NIH HHS [F32 AR056567, F32 AR056567-01]
CR Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Bailey SN, 2004, P NATL ACAD SCI USA, V101, P16144, DOI 10.1073/pnas.0404425101
   Bailey SN, 2006, NAT METHODS, V3, P117, DOI 10.1038/NMETH848
   Bhat RR, 2005, ADV MATER, V17, P2802, DOI 10.1002/adma.200500858
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009
   BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828
   Chen MH, 2007, EXPERT REV MOL DIAGN, V7, P281, DOI 10.1586/14737159.7.3.281
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen SB, 2004, J AM CHEM SOC, V126, P410, DOI 10.1021/ja037390k
   Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100
   Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713
   Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gallant ND, 2007, ADV MATER, V19, P965, DOI 10.1002/adma.200602221
   Green JJ, 2006, BIOCONJUGATE CHEM, V17, P1162, DOI 10.1021/bc0600968
   Harris BP, 2006, LANGMUIR, V22, P4467, DOI 10.1021/la053417x
   Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj/gt/3301719
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacBeath G, 2000, SCIENCE, V289, P1760
   Matsumoto T, 2006, ADV BIOCHEM ENG BIOT, V102, P113, DOI 10.1007/b137207
   Mei Y, 2006, J BIOMED MATER RES A, V79A, P974, DOI 10.1002/jbm.a.30883
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Metallo CM, 2007, BIOTECHNOL PROGR, V23, P18, DOI 10.1021/bp060350a
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Peng WD, 2007, PROSTATE, V67, P855, DOI 10.1002/pros.20576
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924
   Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076
   Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Wagner E, 2004, BIOMED PHARMACOTHER, V58, P152, DOI 10.1016/j.biopha.2004.01.003
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
   Zugates GT, 2007, MOL THER, V15, P1306, DOI 10.1038/sj.mt.6300132
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 56
TC 27
Z9 27
U1 0
U2 9
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1386-2073
J9 COMB CHEM HIGH T SCR
JI Comb. Chem. High Throughput Screen
PD JUL
PY 2009
VL 12
IS 6
BP 554
EP 561
DI 10.2174/138620709788681916
PG 8
WC Biochemical Research Methods; Chemistry, Applied; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA 474BC
UT WOS:000268256200003
PM 19601753
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Su, J
   Meredith, JC
AF Su, Jing
   Meredith, J. Carson
TI Local Histogram Analysis: Detecting Cell-Microstructure Interactions on
   Combinatorial Biomaterial Libraries
SO COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; POLYMER SURFACES; SUBSTRATE MICROTOPOGRAPHY;
   GEOMETRIC CONTROL; DIFFERENTIATION; PROLIFERATION; TOPOGRAPHY; ADHESION;
   DESIGN; GROWTH
AB Increasingly, combinatorial libraries are used to screen large numbers of complex chemically- and physically-patterned polymers against cell response. There is a strong need to extract meaningful relationships between cell function and material surface features from these experiments. A novel high-throughput cell-material screening strategy, based upon local cell-feature analysis (LCFA) was applied to screen osteoblast proliferation behavior on combinatorial libraries of phase-separated PLGA and PCL. Traditional factor importance analysis, which uses summary statistical inference to identify significant variables, indicated that one controlling material surface feature was PCL diameter. However, the summary statistic analysis was unable to uncover more subtle relationships. The LCFA method, based on histograms of distances between cells and microstructures, was able to identify non-linear, discrete relationships between proliferation, PCL diameter, and cell-PCL distance. LCFA provides an advantage in that a distribution function is not assumed, but rather is developed from the data. Using these results, we propose a model for classifying the material-microstructure interactions, in which small PCL islands far from the cell nucleus act as holders for attachment and large islands close to cells act to shape the cell.
C1 [Meredith, J. Carson] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
   [Su, Jing] Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
RP Meredith, JC (reprint author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
EM Carson.Meredith@chbe.gatech.edu
RI Yu, Chengfei/A-2538-2012; Su, Jing/B-3171-2013; Meredith,
   Carson/B-3323-2009
OI Meredith, Carson/0000-0003-2519-5003; Su, Jing/0000-0003-4917-6173
FU NIH [R21 RR17425-01, 1R21 HK072039-01]
FX The authors gratefully acknowledge helpful guidance from Professor
   Andres Garcia and financial support from NIH ( NCRR# R21 RR17425-01 and
   NHLBI# 1R21 HK072039-01).
CR Akinc A, 2003, J AM CHEM SOC, V125, P5316, DOI 10.1021/ja034429c
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Boltau M, 1998, NATURE, V391, P877
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chicurel ME, 1998, NATURE, V392, P730
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dean DD, 2002, J BONE MINER RES, V17, pS399
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   HUANG S, 1998, MOL BIOL CELL, V9
   IOST A, 2003, THERMEC 2003 1, V426, P3031
   Kennedy SW, 2002, ABSTR PAP AM CHEM S, V224, pU237
   Kholodovych V, 2004, POLYMER, V45, P7367, DOI 10.1016/j.polymer.2004.09.002
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Lohmann CH, 2002, J BIOMED MATER RES, V62, P204, DOI 10.1002/jbm.10290
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Ranucci CS, 1999, TISSUE ENG, V5, P407, DOI 10.1089/ten.1999.5.407
   Raz P, 2004, J BIOMED MATER RES A, V71A, P217, DOI 10.1002/jbm.a.30134
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   Smith JR, 2004, J CHEM INF COMP SCI, V44, P1088, DOI 10.1021/ci0499774
   SU J, 2009, BMC BIOINFORMA UNPUB
   SU J, 2006, COMBINATORIAL METHOD
   Sung FJ, 2005, BIOMATERIALS, V26, P4557, DOI 10.1016/j.biomaterials.2004.11.034
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Wang L, 2005, J BONE MINER RES, V20, pS363
   Washburn NR, 2004, ABSTR PAP AM CHEM S, V227, pU557
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
NR 45
TC 4
Z9 4
U1 0
U2 3
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1386-2073
J9 COMB CHEM HIGH T SCR
JI Comb. Chem. High Throughput Screen
PD JUL
PY 2009
VL 12
IS 6
BP 626
EP 633
DI 10.2174/138620709788681880
PG 8
WC Biochemical Research Methods; Chemistry, Applied; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA 474BC
UT WOS:000268256200010
PM 19601760
DA 2018-10-19
ER

PT J
AU Santhi, T
   Manonmani, S
   Ravi, S
AF Santhi, T.
   Manonmani, S.
   Ravi, S.
TI Uptake of Cationic Dyes from Aqueous Solution by Biosorption onto
   Granular Muntingia calabura
SO E-JOURNAL OF CHEMISTRY
LA English
DT Article
DE Muntingia calabura; Biosorption; Methylene blue; Methylene red;
   Malachite green
ID ORANGE PEEL; METAL-IONS; ADSORPTION; REMOVAL; EQUILIBRIUM; ADSORBENT;
   SORPTION
AB A new, low cost, locally available biomaterial was tested for its ability to remove cationic dyes from aqueous solution. A granule prepared from a mixture of leafs, fruits and twigs of Muntingia calabura had been utilized as a sorbent for uptake of three cationic dyes, methylene blue (MB), methylene red (MR) and malachite green (MG). The effects of various experimental parameters (e.g., contact time, dye concentration, adsorbent dose and pH) were investigated and optimal experimental conditions were ascertained. Above the value of initial pH 6, three dyes studied could be removed effectively. The isothermal data fitted the Langmuir and Freundlich isotherm models for all three dyes sorption. The biosorption processes followed the pseudo-first order rate kinetics. The results in this study indicated that Muntingia calabura was an attractive candidate for removing cationic dyes from the dye wastewater.
C1 [Santhi, T.] Karpagam Univ, Dept Chem, Coimbatore 641021, Tamil Nadu, India.
   [Manonmani, S.] PSG Coll Arts & Sci, Dept Chem, Coimbatore 641014, Tamil Nadu, India.
RP Santhi, T (reprint author), Karpagam Univ, Dept Chem, Coimbatore 641021, Tamil Nadu, India.
EM ravisubban@rediffmail.com
CR Arami M, 2005, J COLLOID INTERF SCI, V288, P371, DOI 10.1016/j.jcis.2005.03.020
   Brown P, 2000, ADV ENVIRON RES, V4, P19, DOI 10.1016/S1093-0191(00)00004-6
   Dhakal RP, 2005, SEP PURIF TECHNOL, V42, P219, DOI 10.1016/j.seppur.2004.07.016
   Ghimire K. N., 2001, CHITIN CHITOSAN RES, V7, P61
   Gong RM, 2007, BIORESOURCE TECHNOL, V98, P1319, DOI 10.1016/j.biortech.2006.04.034
   Husseien M, 2007, J APPL SCI RES, V3, P1352
   Kumar KV, 2007, DYES PIGMENTS, V74, P595, DOI 10.1016/j.dyepig.2006.03.026
   Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027
   Kweon DK, 2001, CARBOHYD POLYM, V46, P171, DOI 10.1016/S0144-8617(00)00300-3
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Senthilkumaar S, 2005, J COLLOID INTERF SCI, V284, P78, DOI 10.1016/j.jcis.2004.09.027
   Singh KK, 2006, BIORESOURCE TECHNOL, V97, P2124, DOI 10.1016/j.biortech.2005.09.016
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009
   Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001
NR 15
TC 9
Z9 9
U1 0
U2 1
PU WWW PUBL PTE
PI TAMIL NADU
PA KHADAR BLDG, NEAR SHIFA HOSP, ADIRAMPATTINAM, TAMIL NADU, 614 701, INDIA
SN 0973-4945
J9 E-J CHEM
JI E-J. Chem.
PD JUL-SEP
PY 2009
VL 6
IS 3
BP 737
EP 742
DI 10.1155/2009/927406
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 468BD
UT WOS:000267787400019
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Swanson, BO
   Anderson, SP
   DiGiovine, C
   Ross, RN
   Dorsey, JP
AF Swanson, Brook O.
   Anderson, Stuart P.
   DiGiovine, Caitlin
   Ross, Rachel N.
   Dorsey, John P.
TI The evolution of complex biomaterial performance: The case of spider
   silk
SO INTEGRATIVE AND COMPARATIVE BIOLOGY
LA English
DT Article; Proceedings Paper
CT SICB Meeting 2009
CY JAN 03-07, 2009
CL Boston, MA
ID ORB-WEAVING SPIDERS; CLAVIPES DRAGLINE SILK; FIBROIN GENE FAMILY;
   MECHANICAL-PROPERTIES; CAPTURE-SILK; TENSILE PROPERTIES; PROTEINS; WEB;
   ARANEAE; SPUN
AB Spider silk is a high-performance biomaterial with exceptional mechanical properties and over half a century of research into its mechanics, structure, and biology. Recent research demonstrates that it is a highly variable class of materials that differs across species and individuals in complex and interesting ways. Here, we review recent literature on mechanical variation and evolution in spider silk. We then present new data on material properties of silk from nine species of spiders in the Mesothelae and Mygalomorphae, the two basal clades of spiders. Silk from spiders in the Araneomorphae (true spiders where most previous research on silk has focused) is significantly stronger and therefore much tougher than the silk produced by spiders in the basal groups. These data support the hypothesis that the success and diversity seen in araneomorph spiders is associated with the evolution of this high-performance fiber. This comparative approach shows promise as a way to understand complex, high-performance biomaterials.
C1 [Swanson, Brook O.; Anderson, Stuart P.; DiGiovine, Caitlin; Ross, Rachel N.; Dorsey, John P.] Gonzaga Univ, Dept Biol, Spokane, WA 99203 USA.
RP Swanson, BO (reprint author), Gonzaga Univ, Dept Biol, Spokane, WA 99203 USA.
EM swansonb@gonzaga.edu
CR Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Beckwitt R, 1998, INSECT BIOCHEM MOLEC, V28, P121, DOI 10.1016/S0965-1748(97)00083-0
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x
   Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001
   Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327
   Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x
   Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x
   Bond JE, 1998, EVOLUTION, V52, P403, DOI 10.1111/j.1558-5646.1998.tb01641.x
   Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487
   Coddington J. A., 2004, ASSEMBLING TREE LIFE
   CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025
   CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x
   Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292
   DENNY M, 1976, J EXP BIOL, V65, P483
   Dicko C, 2004, BIOMACROMOLECULES, V5, P2105, DOI 10.1021/bm034486y
   FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325
   FOELIX RF, 1996, BIOL SPIDERS
   Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102
   Garland T, 1999, AM ZOOL, V39, P374
   GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051
   Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745
   GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503
   GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464
   Garrido MA, 2002, POLYMER, V43, P1537, DOI 10.1016/S0032-3861(01)00713-3
   Garrido MA, 2002, POLYMER, V43, P4495, DOI 10.1016/S0032-3861(02)00254-9
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Glisovic A, 2007, APPL PHYS A-MATER, V87, P63, DOI 10.1007/s00339-006-3849-9
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Knight DP, 2002, PHILOS T R SOC B, V357, P155, DOI 10.1098/rstb.2001.1030
   KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Opell BD, 2000, BIOL J LINN SOC, V70, P107, DOI 10.1006/bijl.1999.0390
   Opell BD, 2001, EVOL ECOL RES, V3, P567
   Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3
   Perez-Riguero J, 2001, J APPL POLYM SCI, V82, P2245, DOI 10.1002/app.2072
   Platnick N. I., 1991, AM MUS NOVIT, V3016, P1
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1
   Selden PA, 1996, NATURE, V379, P498, DOI 10.1038/379498b0
   Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Swanson BO, 2006, EVOLUTION, V60, P2539
   Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u
   TIAN MZ, 2004, BIOMACROMOLECULES, V5, P675
   Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221
   Wainwright S. A., 1976, MECH DESIGN ORGANISM
   WORK RW, 1978, T AM MICROSC SOC, V97, P180, DOI 10.2307/3225590
   WORK RW, 1977, T AM MICROSC SOC, V96, P170, DOI 10.2307/3226094
   WORK RW, 1987, J ARACHNOL, V15, P65
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang Y, 2005, ADV MATER, V17, P84, DOI 10.1002/adma.200400344
   Zemlin JC, 1968, 6929CM US ARM NAT LA
NR 68
TC 24
Z9 25
U1 0
U2 16
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1540-7063
J9 INTEGR COMP BIOL
JI Integr. Comp. Biol.
PD JUL
PY 2009
VL 49
IS 1
BP 21
EP 31
DI 10.1093/icb/icp013
PG 11
WC Zoology
SC Zoology
GA 465QO
UT WOS:000267602100004
PM 21669843
OA Bronze
DA 2018-10-19
ER

PT J
AU Wang, XQ
   Yao, X
   Zhu, ZA
   Tang, TT
   Dai, KR
   Sadovskaya, I
   Flahaut, S
   Jabbouri, S
AF Wang, Xiaoqing
   Yao, Xiao
   Zhu, Zhen'an
   Tang, Tingting
   Dai, Kerong
   Sadovskaya, Irina
   Flahaut, Sigrid
   Jabbouri, Said
TI Effect of berberine on Staphylococcus epidermidis biofilm formation
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Berberine; Staphylococcus epidermidis; Biofilm; Confocal laser scanning
   microscopy; Scanning electron microscopy
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CANDIDA-ALBICANS; MULTIDRUG PUMP;
   IN-VITRO; INFECTION; AUREUS; AGENTS; CATHETERS; DISEASE; MODEL
AB Staphylococcus epidermidis is one of the main causes of medical device-related infections owing to its adhesion and biofilm-forming abilities on biomaterial surfaces. Berberine is an isoquinoline-type alkaloid isolated from Coptidis rhizoma (huang lian in Chinese) and other herbs with many activities against various disorders. Although the inhibitory effects of berberine on planktonic bacteria have been investigated in a few studies, the capacity of berberine to inhibit biofilm formation has not been reported to date. In this study, we observed that berberine is bacteriostatic for S. epidermidis and that sub-minimal inhibitory concentrations of berberine blocked the formation of S. epidermidis biofilm. Using viability assays and berberine uptake testing, berberine at a concentration of 15-30 mu g/mL was shown to inhibit bacterial metabolism. Data from this study also indicated that modest concentrations of berberine (30-45 mu g/mL) were sufficient to exhibit an antibacterial effect and to inhibit biofilm formation significantly, as shown by the tissue culture plate (TCP) method, confocal laser scanning microscopy and scanning electron microscopy for both S. epidermidis ATCC 35984 and a clinical isolate strain SE243. Although the mechanisms of bacterial killing and inhibition of biofilm formation are not fully understood, data from this investigation indicated a potential application for berberine as an adjuvant therapeutic agent for the prevention of biofilm-related infections. (C) 2008 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
C1 [Wang, Xiaoqing; Zhu, Zhen'an; Tang, Tingting; Dai, Kerong] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthopaed Surg, Shanghai 200011, Peoples R China.
   [Yao, Xiao] Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China.
   [Sadovskaya, Irina; Flahaut, Sigrid; Jabbouri, Said] Univ Littoral Cote dOpale, Lab Rech Biomat & Biotechnol, F-32327 Boulogne Sur Mer, France.
RP Zhu, ZA (reprint author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthopaed Surg, Shanghai 200011, Peoples R China.
EM zhuzhenan2006@hotmail.com
RI Tang, Tingting/B-1361-2013; Jabbouri, Said/N-6672-2014
OI Tang, Tingting/0000-0002-1670-7452; Jabbouri, Said/0000-0003-1354-494X;
   yan, wei/0000-0001-5575-7017
FU National Natural Science Foundation of China [30700852]; National High
   Technology Research and Development Program of China [2006AA02A137]
FX This work was supported by a grant from the National Natural Science
   Foundation of China (No. 30700852) and a grant from the National High
   Technology Research and Development Program of China (No. 2006AA02A137).
   The study sponsors were not involved in the study design, in the
   collection, analysis and interpretation of data, in writing of the
   manuscript, or in the decision to submit the manuscript for publication.
CR Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344
   Ando E, 2004, ACTA MED OKAYAMA, V58, P207
   Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043
   Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438
   Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665.4684.2004
   Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006
   Camara M, 2002, LANCET INFECT DIS, V2, P667, DOI 10.1016/S1473-3099(02)00447-4
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Farooq M, 1999, J SURG RES, V87, P57, DOI 10.1006/jsre.1999.5729
   Flemming H.-C., 2000, BIOFILMS RECENT ADV, P19
   Francois P, 2003, FEMS IMMUNOL MED MIC, V35, P135, DOI 10.1016/S0928-8244(02)00463-7
   Gilbert P, 1997, Adv Dent Res, V11, P160
   Hayashi K, 2007, BIOORG MED CHEM LETT, V17, P1562, DOI 10.1016/j.bmcl.2006.12.085
   Hsieh PC, 1998, P NATL ACAD SCI USA, V95, P6602, DOI 10.1073/pnas.95.12.6602
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   INMAN RD, 1984, AM J MED, V77, P47, DOI 10.1016/0002-9343(84)90434-0
   Iwasa K, 2001, J NAT PROD, V64, P896, DOI 10.1021/np000554f
   JENNINGS BR, 1983, BIOPHYS STRUCT MECH, V10, P71, DOI 10.1007/BF00535543
   Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002
   Lewis K, 2001, J MOL MICROB BIOTECH, V3, P247
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448
   Musumeci R, 2003, INT J ANTIMICROB AG, V22, P48, DOI 10.1016/S0924-8579(03)00085-2
   Park KD, 2006, BIOORG MED CHEM LETT, V16, P3913, DOI 10.1016/j.bmcl.2006.05.033
   Park KS, 1999, J ANTIMICROB CHEMOTH, V43, P667, DOI 10.1093/jac/43.5.667
   Peck KR, 2003, CHEMOTHERAPY, V49, P189, DOI 10.1159/000071143
   Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837
   RAAD II, 1992, CLIN INFECT DIS, V15, P197, DOI 10.1093/clinids/15.2.197
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Rupp ME, 1994, CLIN INFECT DIS, V19, P244
   Severina II, 2001, IUBMB LIFE, V52, P321, DOI 10.1080/152165401317291183
   Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597
   Wikler M. A., 2006, M7A7 CLSI
   Yi ZB, 2007, J PHARMACEUT BIOMED, V44, P301, DOI 10.1016/j.jpba.2007.02.018
   Yu HH, 2005, J MED FOOD, V8, P454, DOI 10.1089/jmf.2005.8.454
   Yu Y, 2007, BIOORG MED CHEM LETT, V17, P1855, DOI 10.1016/j.bmcl.2007.01.032
   Zeng XH, 2003, AM J CARDIOL, V92, P173, DOI 10.1016/S0002-9149(03)00533-2
   Zhu Cai-lian, 2006, Shanghai Kou Qiang Yi Xue, V15, P434
NR 40
TC 72
Z9 76
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD JUL
PY 2009
VL 34
IS 1
BP 60
EP 66
DI 10.1016/j.ijantimicag.2008.10.033
PG 7
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 458KZ
UT WOS:000267020800010
PM 19157797
DA 2018-10-19
ER

PT J
AU Reinis, A
   Kroica, J
   Berzina-Cimdina, L
   Vetra, J
   Kuznecova, V
   Stunda, A
   Jakovlevs, D
   Rostoka, D
AF Reinis, A.
   Kroica, J.
   Berzina-Cimdina, L.
   Vetra, J.
   Kuznecova, V.
   Stunda, A.
   Jakovlevs, D.
   Rostoka, D.
TI Staphylococcus epidermidis and Pseudomonas aeruginosa adhesion and
   colonisation intensity on a biomaterial with various crystallisation
   degrees and modified surfaces in an in vitro study
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Meeting Abstract
CT 26th International Congress of Chemotherapy and Infection
CY JUN 18-21, 2009
CL Toronto, CANADA
C1 [Reinis, A.; Kroica, J.; Vetra, J.; Kuznecova, V.; Rostoka, D.] Riga Stradins Univ, Riga, Latvia.
   [Berzina-Cimdina, L.] Riga Tech Univ, Riga, Latvia.
NR 0
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD JUL
PY 2009
VL 34
MA O62
BP S22
EP S22
DI 10.1016/S0924-8579(09)70209-2
PG 1
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 470DR
UT WOS:000267955200063
DA 2018-10-19
ER

PT J
AU Velard, F
   Laurent-Maquin, D
   Guillaume, C
   Bouthors, S
   Jallot, E
   Nedelec, JM
   Belaaouaj, A
   Laquerriere, P
AF Velard, F.
   Laurent-Maquin, D.
   Guillaume, C.
   Bouthors, S.
   Jallot, E.
   Nedelec, J. M.
   Belaaouaj, A.
   Laquerriere, P.
TI ZINC DOPED HYDROXYAPATITE AS IMMUNOMODULATORY BIOMATERIAL
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 [Velard, F.; Laurent-Maquin, D.; Guillaume, C.; Bouthors, S.] INSERM, UMRS926, Reims, France.
   [Jallot, E.] CNRS, UMR6533, Aubiere, France.
   [Nedelec, J. M.] CNRS, UMR6002, Aubiere, France.
   [Belaaouaj, A.] URCA EA4303, Reims, France.
   [Laquerriere, P.] CNRS, UMR7178, Strasbourg, France.
RI NEDELEC, jean-marie/A-6920-2008; Laquerriere, Patrice/P-1025-2016;
   Bentaher, Abderrazzak/F-6531-2018; Bentaher, Abderrazzaq/M-4424-2017
OI NEDELEC, jean-marie/0000-0002-8243-6849; Laquerriere,
   Patrice/0000-0001-7637-9094; 
NR 0
TC 4
Z9 4
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2009
VL 32
IS 7
BP 457
EP 458
PG 2
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 485KY
UT WOS:000269121300257
DA 2018-10-19
ER

PT J
AU Niemiec-Cyganek, A
   Baranska, A
   Nozynski, J
   Pawlus-Lachecka, L
   Wilczek, P
   Wszolek, J
   Kudrjavtseva, JA
   Barbarash, LS
AF Niemiec-Cyganek, A.
   Baranska, A.
   Nozynski, J.
   Pawlus-Lachecka, L.
   Wilczek, P.
   Wszolek, J.
   Kudrjavtseva, J. A.
   Barbarash, L. S.
TI CHEMICAL-FIXED ACELLULAR PORCINE TISSUE AS BIOMATERIAL FOR TISSUE
   ENGINEERING
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 [Niemiec-Cyganek, A.; Baranska, A.; Nozynski, J.; Pawlus-Lachecka, L.; Wilczek, P.; Wszolek, J.] Fdn Cardiac Surg Dev, Zabrze, Poland.
RI Kudryavtseva, Yuliya/H-8434-2017
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2009
VL 32
IS 7
BP 459
EP 459
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 485KY
UT WOS:000269121300265
DA 2018-10-19
ER

PT J
AU Madhumathi, K
   Shalumon, KT
   Rani, VVD
   Tamura, H
   Furuike, T
   Selvamurugan, N
   Nair, SV
   Jayakumar, R
AF Madhumathi, K.
   Shalumon, K. T.
   Rani, V. V. Divya
   Tamura, H.
   Furuike, T.
   Selvamurugan, N.
   Nair, S. V.
   Jayakumar, R.
TI Wet chemical synthesis of chitosan hydrogel-hydroxyapatite composite
   membranes for tissue engineering applications
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan hydrogel membranes; Composite membranes; Tissue engineering;
   Hydroxyapatite; Biomaterials
ID ALTERNATE SOAKING PROCESS; BONE-FORMATION; SCAFFOLDS; CHITIN;
   DEPOSITION; RELEASE; CALCIUM; BIOMATERIALS; BIOACTIVITY; COATINGS
AB Chitosan, a deacetylated derivative of chitin is a commonly studied biomaterial for tissue-engineering applications due to its biocompatibility, biodegradability, low toxicity, antibacterial activity, wound healing ability and haemostatic properties. However, chitosan has poor mechanical strength due to which its applications in orthopedics are limited. Hydroxyapatite (HAp) is a natural inorganic component of bone and teeth and has mechanical strength and osteoconductive property. In this work, HAp was deposited on the surface of chitosan hydrogel membranes by a wet chemical synthesis method by alternatively soaking the membranes in CaCl(2) (pH 7.4) and Na(2)HPO(4) solutions for different time intervals. These chitosan hydrogel-HAp membranes were characterized using SEM, AFM, EDS, FT-IR and XRD analyses. MTT assay was done to evaluate the biocompatibility of these membranes using MG-63 osteosarcoma cells. The biocompatibility studies suggest that chitosan hydrogel-HAp composite membranes can be useful for tissue-engineering applications. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Madhumathi, K.; Shalumon, K. T.; Rani, V. V. Divya; Selvamurugan, N.; Nair, S. V.; Jayakumar, R.] Amrita Viswa Vidyapeetham Univ, Amrita Inst Med Sci & Res Ctr, Amrita Ctr Nanosci, Kochi 682026, India.
   [Tamura, H.; Furuike, T.] Kansai Univ, Fac Chem Mat & Bioengn, Osaka 5648680, Japan.
   [Tamura, H.; Furuike, T.] Kansai Univ, High Technol Res Ctr, Osaka 5648680, Japan.
RP Jayakumar, R (reprint author), Amrita Viswa Vidyapeetham Univ, Amrita Inst Med Sci & Res Ctr, Amrita Ctr Nanosci, Kochi 682026, India.
EM rjayakumar@aims.amrita.edu
FU Department of Science and Technology, Government of India
FX This work was supported by the Department of Science and Technology,
   Government of India, under the Nanoscience and Nanotechnology Initiative
   program monitored by Dr. C. N. R. Rao.
CR AMARAL F, 2006, J BIOMED SCI POLYM E, V16, P1575
   ANDREW CA, 1998, J BIOMED MATER RES, V41, P5451
   ARAI K, 1968, B TOKAI REGIONAL FIS, V56, P89
   Beppu MM, 2003, MAT SCI ENG C-BIO S, V23, P651, DOI 10.1016/j.msec.2003.08.002
   Bigi A, 1998, BIOMATERIALS, V19, P739, DOI 10.1016/S0142-9612(97)00194-4
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Cleries L, 2000, J BIOMED MATER RES, V49, P43, DOI 10.1002/(SICI)1097-4636(200001)49:1<43::AID-JBM6>3.0.CO;2-G
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Guibal E, 2005, PROG POLYM SCI, V30, P71, DOI 10.1016/j.progpolymsci.2004.12.001
   JARCHO M, 1977, J BIOENG, V1, P79
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Jayakumar R, 2009, INT J BIOL MACROMOL, V44, P107, DOI 10.1016/j.ijbiomac.2008.10.010
   Jayakumar R., 2006, ASIAN CHITIN J, V2, P91
   Jin HH, 2008, MATER LETT, V62, P1630, DOI 10.1016/j.matlet.2007.09.043
   Jonathan ZK, 1999, J APPL POLYM SCI, V72, P1721
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Li JJ, 2008, MATER LETT, V62, P3220, DOI 10.1016/j.matlet.2008.02.072
   Madhumathi K, 2009, INT J BIOL MACROMOL, V44, P1, DOI 10.1016/j.ijbiomac.2008.09.013
   Maeda Y, 2008, INT J BIOL MACROMOL, V42, P463, DOI 10.1016/j.ijbiomac.2008.03.002
   Malette W.G., 1986, CHITIN NATURE TECHNO, P435
   Manara S, 2008, INORG CHIM ACTA, V361, P1634, DOI 10.1016/j.ica.2007.03.044
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711
   THEINHAN WW, ACTA BIOMAT IN PRESS
   Valagao Amadeu do Serro Ana Paula, 2000, Journal of Biomedical Materials Research, V49, P345, DOI 10.1002/(SICI)1097-4636(20000305)49:3<345::AID-JBM7>3.0.CO;2-R
   Viala S, 1998, ANN CHIM-SCI MAT, V23, P69, DOI 10.1016/S0151-9107(98)80025-1
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.3.CO;2-6
   Yang BC, 1999, J BIOMED MATER RES, V47, P213, DOI 10.1002/(SICI)1097-4636(199911)47:2<213::AID-JBM11>3.0.CO;2-C
   Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
NR 39
TC 85
Z9 96
U1 2
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUL 1
PY 2009
VL 45
IS 1
BP 12
EP 15
DI 10.1016/j.ijbiomac.2009.03.011
PG 4
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 456EY
UT WOS:000266825500003
PM 19447253
DA 2018-10-19
ER

PT J
AU Miyamoto, K
   Atarashi, M
   Kadozono, H
   Shibata, M
   Koyama, Y
   Okai, M
   Inakuma, A
   Kitazono, E
   Kaneko, H
   Takebayashi, T
   Horiuchi, T
AF Miyamoto, Keiichi
   Atarashi, Masaki
   Kadozono, Hideki
   Shibata, Masakazu
   Koyama, Yoshihiro
   Okai, Masanori
   Inakuma, Akinobu
   Kitazono, Eiichi
   Kaneko, Hiroaki
   Takebayashi, Takafumi
   Horiuchi, Takashi
TI Creation of cross-linked electrospun isotypic-elastin fibers controlled
   cell-differentiation with new cross-linker
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Tissue engineering; Elastin; Vascular smooth muscle cells;
   Differentiation; Electrospinning
ID HUMAN TROPOELASTIN; COLLAGEN; RECEPTOR; ATHEROSCLEROSIS; COACERVATION;
   BIOMATERIAL; MATRICES; TISSUES
AB Effective application of elastin materials for vascular grafts in tissue engineering requires these materials to retain the elastic and biological properties of native elastin. To clarify the influence of soluble elastin isotypes on vascular smooth muscle cells (VSMCs), soluble elastin was prepared from insoluble elastin by hydrolysis with oxalic acid. Its fractions were separated and classified into three isotypes. Elastin retaining 2.25 mol% of cross-linked structures exhibited significant differentiation of VSMCs, which adhered to the elastin with contraction phenotypes similar to that of native elastin, causing proliferation to cease. This trend was more strongly demonstrated in cotton-like elastin fibers with a new cross-linker. The results suggest that elastin isotypes could be applied as new effective biomaterials for suppressing intimal hyperplasia in vascular grafts. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Miyamoto, Keiichi; Atarashi, Masaki; Kadozono, Hideki; Shibata, Masakazu; Koyama, Yoshihiro; Okai, Masanori; Inakuma, Akinobu; Takebayashi, Takafumi; Horiuchi, Takashi] Mie Univ, Grad Sch Engn, Div Chem Mat, Tsu, Mie 5148507, Japan.
   [Kitazono, Eiichi; Kaneko, Hiroaki] Teijin Ltd, TEIJIN Technol Innovat Ctr, Tokyo 1918512, Japan.
RP Miyamoto, K (reprint author), Mie Univ, Grad Sch Engn, Div Chem Mat, 1577 Kurima Machiya Cho, Tsu, Mie 5148507, Japan.
EM miyamoto@chem.mie-u.ac.jp
FU Ministry of Education, Science, Sports and Culture of Japan [16390359]
FX Part of this study was supported by a Grant-in-Aid for Basic Scientific
   Research (B) No. 16390359 of the Ministry of Education, Science, Sports
   and Culture of Japan.
CR Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200
   ELENE PM, 2001, CARDIOVASC RES, V52, P372
   FRANZBLAU C, 1981, CELL BIOL EXTRACELLU, P65
   INDIK Z, 1987, P NATL ACAD SCI USA, V84, P5680, DOI 10.1073/pnas.84.16.5680
   JACOB MP, 1985, METHODS CONNECTIVE T, V4, P921
   Kaibara K, 1996, BIOPOLYMERS, V39, P189, DOI 10.1002/(SICI)1097-0282(199608)39:2<189::AID-BIP7>3.0.CO;2-L
   Kaibara K, 2000, BIOPOLYMERS, V53, P369, DOI 10.1002/(SICI)1097-0282(20000415)53:5<369::AID-BIP2>3.3.CO;2-X
   KIMBERLY TC, 2003, BIOMACROMOLECULES, V4, P572
   KOERT PD, 2000, ANAT REC, V258, P1
   LAURA P, 2006, TISSUE CELL, V38, P111
   Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Maeda I, 2007, J PEPT SCI, V13, P263, DOI 10.1002/psc.845
   Martino M, 2001, BIOPOLYMERS, V59, P29, DOI 10.1002/1097-0282(200107)59:1<29::AID-BIP1003>3.0.CO;2-F
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Miyamoto K, 2001, PROTEIN PEPTIDE LETT, V8, P231, DOI 10.2174/0929866013409481
   NATHALIE FW, 2001, CELL MOTIL CYTOSKEL, V49, P130
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011
   PARTRIDGE SM, 1964, BIOCHEM J, V93, P30
   Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   RUCKER RB, 1982, METHOD ENZYMOL, V82, P650
   SATYAJIT KK, 2003, DEVELOPMENT, V130, P411
   SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445
   Spofford CM, 2003, J BIOMECH, V36, P645, DOI 10.1016/S0021-9290(02)00442-6
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Toonkool P, 2001, J BIOL CHEM, V276, P28042, DOI 10.1074/jbc.M103391200
   Tranquillo RT, 2002, ANN NY ACAD SCI, V961, P251, DOI 10.1111/j.1749-6632.2002.tb03094.x
   Umeda H, 2001, J BIOL CHEM, V276, P12579, DOI 10.1074/jbc.M009744200
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   XIAOYI W, 2005, BIOMACROMOLECULES, V6, P3037
   YAMAGUCHI Y, 1987, J CHROMATOGR-BIOMED, V422, P53, DOI 10.1016/0378-4347(87)80439-5
NR 40
TC 21
Z9 24
U1 1
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUL 1
PY 2009
VL 45
IS 1
BP 33
EP 41
DI 10.1016/j.ijbiomac.2009.03.014
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 456EY
UT WOS:000266825500007
PM 19447257
DA 2018-10-19
ER

PT J
AU Kumirska, J
   Weinhold, MX
   Steudte, S
   Thoming, J
   Brzozowski, K
   Stepnowski, P
AF Kumirska, Jolanta
   Weinhold, Mirko X.
   Steudte, Stephanie
   Thoeming, Jorg
   Brzozowski, Krzysztof
   Stepnowski, Piotr
TI Determination of the pattern of acetylation of chitosan samples:
   Comparison of evaluation methods and some validation parameters
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan; Pattern of acetylation; NMR spectroscopy; Some validation
   parameters
ID DEACETYLATED CHITINS CHITOSANS; FIELD NMR-SPECTROSCOPY; DERIVATIVES;
   CHEMISTRY; BLOCK
AB Chitosan is a linear copolymer consisting of glucosamine and N-acetylglucosamine units. its specific biological features make it a very attractive biomaterial for diverse applications in both pharmaceutics and medicine. The pattern of acetylation of chitosan samples (P(A)) can strongly influence their biomedical activities. So far, three methods of determining the P(A) value of chitosan samples, based on NMR spectroscopy, have been developed. Chitosans with a degree of acetylation (F(A)) from 0.02 to 0.48 were used to compare these methods. The most suitable and specific method of P(A) determination was (13)C NMR based on the intensities of carbon C-5 signals. Some validation parameters-specificity, sensitivity, precision (repeatability and reproducibility)-were established. The intra- and inter-day precision of this method depended on the degree of acetylation of the chitosan samples. It was found to be specific, sensitive, repeatable and reproducible. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Kumirska, Jolanta; Brzozowski, Krzysztof; Stepnowski, Piotr] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland.
   [Weinhold, Mirko X.; Steudte, Stephanie; Thoeming, Jorg] Univ Bremen, UFT Ctr Environm Res & Sustainable Technol, D-28359 Bremen, Germany.
RP Kumirska, J (reprint author), Univ Gdansk, Fac Chem, Sobieskiego 18-19, PL-80952 Gdansk, Poland.
EM kumirska@chem.univ.gda.pl
RI Thoming, Jorg/N-7067-2014; Steudte, Stephanie/A-2811-2013
OI Thoming, Jorg/0000-0002-5374-114X; Stepnowski,
   Piotr/0000-0001-5022-6962; Kumirska, Jolanta/0000-0003-1211-1114;
   Brzozowski, Krzysztof/0000-0001-8693-1452
FU Polish Ministry of Research and Higher Education [BW/8000-5-0123-8,
   DS/8200-4-0085-9]
FX The authors express their gratitude for the financial support provided
   by the Polish Ministry of Research and Higher Education under grants
   BW/8000-5-0123-8 and DS/8200-4-0085-9.
CR AIBA S, 1991, INT J BIOL MACROMOL, V13, P40, DOI 10.1016/0141-8130(91)90008-I
   AIBA S, 1992, INT J BIOL MACROMOL, V14, P225, DOI 10.1016/S0141-8130(05)80032-7
   Berth G, 1998, CARBOHYD POLYM, V36, P205, DOI 10.1016/S0144-8617(98)00029-0
   BOVEY P, 1996, NMR POLYM
   Chopra S, 2006, J PHARM PHARMACOL, V58, P1021, DOI 10.1211/jpp.58.8.0002
   Cobas JC, 2003, CONCEPT MAGN RESON A, V19A, P80, DOI 10.1002/cmr.a.10089
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   Kato Yoshinori, 2003, Current Pharmaceutical Biotechnology, V4, P303, DOI 10.2174/1389201033489748
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumirska J, 2009, J PHARMACEUT BIOMED, V50, P587, DOI 10.1016/j.jpba.2008.09.048
   KURITA K, 1977, MAKROMOL CHEM, V178, P3197
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Mao SR, 2004, INT J PHARM, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019
   MIREAU A, 1996, PRACTICAL GUIDE UNDE
   Muzzarelli RAA, 1996, CARBOHYD POLYM, V29, P309, DOI 10.1016/S0144-8617(96)00033-1
   Niekraszewicz A, 2005, FIBRES TEXT EAST EUR, V13, P16
   No HK, 2000, REV ENVIRON CONTAM T, V163, P1
   Ottoy MH, 1996, CARBOHYD POLYM, V29, P17
   Peniche C, 2003, MACROMOL BIOSCI, V3, P511, DOI 10.1002/mabi.200300019
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Shahidi F, 2005, ADV FOOD NUTR RES, V49, P93, DOI 10.1016/S1043-4526(05)49003-8
   Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473
   VARUM KM, 1991, CARBOHYD RES, V217, P19, DOI 10.1016/0008-6215(91)84113-S
   VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2
   WEINHOLD MX, 2007, J ADV CHITIN SCI, V10, P66
NR 26
TC 5
Z9 5
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUL 1
PY 2009
VL 45
IS 1
BP 56
EP 60
DI 10.1016/j.ijbiomac.2009.04.002
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 456EY
UT WOS:000266825500010
DA 2018-10-19
ER

PT J
AU Maccauro, G
   Bianchino, G
   Sangiorgi, S
   Magnani, G
   Marotta, D
   Manicone, PF
   Raffaelli, L
   Iommetti, PR
   Stewart, A
   Cittadini, A
   Sgambato, A
AF Maccauro, G.
   Bianchino, G.
   Sangiorgi, S.
   Magnani, G.
   Marotta, D.
   Manicone, P. F.
   Raffaelli, L.
   Iommetti, P. Rossi
   Stewart, A.
   Cittadini, A.
   Sgambato, A.
TI DEVELOPMENT OF A NEW ZIRCONIA-TOUGHENED ALUMINA: PROMISING MECHANICAL
   PROPERTIES AND ABSENCE OF IN VITRO CARCINOGENICITY
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE ceramics; carcinogenicity; biocompatibility
ID DNA-DAMAGE; ARTHROPLASTY; FRACTURE; CELLS; HEAD
AB High purity alumina as well as zirconia ceramics have been widely used as orthopaedic implant biomaterials and dental devices displaying optimal, but sometimes exclusive, mechanical properties. In order to combine the advantages of alumina and zirconia ceramic materials different types of composites have been developed in which either zirconia is dispersed in an alumina matrix or vice versa. Orthopaedic and dental implant biomaterials are expected to be in contact with living tissues for a long period of time and their long term toxicity must. be carefully evaluated. In this study we report the development of a high performance chromia-doped Zirconia Toughened Alumina (ZTA) material which displays promising mechanical properties in terms of hardness, strength and fracture toughness that make it suitable for prosthesis even for small joints. The long-term biocompatibility of this material was also evaluated, mainly in terms of DNA damage, mutagenicity and cancerogenetic potential in mammalian cells. The results obtained suggest that this new ZTA material does not display any long-term carcinogenic effect and it is suitable for biomedical applications from a cancerogenetic point of view. In conclusion, we report the development of a new chromia-doped ZTA material with interesting properties both from a mechanical and a biocompatibility point of view which warrant further studies on its suitability as a candidate biomaterial for orthopaedic implants and dental devices.
C1 [Manicone, P. F.; Raffaelli, L.; Iommetti, P. Rossi] Univ Cattolica Sacro Cuore, Inst Clin Dent, I-00168 Rome, Italy.
   [Maccauro, G.; Marotta, D.] Univ Cattolica Sacro Cuore, Dept Orthopaed & Traumatol, I-00168 Rome, Italy.
   [Bianchino, G.; Cittadini, A.; Sgambato, A.] Univ Cattolica Sacro Cuore, Inst Gen Pathol, I-00168 Rome, Italy.
   [Bianchino, G.; Cittadini, A.; Sgambato, A.] Univ Cattolica Sacro Cuore, Canc Res Ctr, I-00168 Rome, Italy.
   [Bianchino, G.; Cittadini, A.; Sgambato, A.] Canc Referral Ctr Basilicata CROB IRCCS, Potenza, Italy.
   [Sangiorgi, S.; Magnani, G.; Stewart, A.] Faenza Res Ctr, ENEA, Faenza, Italy.
RP Raffaelli, L (reprint author), Univ Cattolica Sacro Cuore, Inst Clin Dent, Largo A Gemelli 8, I-00168 Rome, Italy.
EM lraffaelli@rm.unicatt.it
OI Sgambato, Alessandro/0000-0002-9487-4563; Manicone, Paolo
   Francesco/0000-0003-0283-2903; MACCAURO, Giulio/0000-0002-7359-268X
FU EU [GRD1-199-10585]
FX This work was supported by the EU project GRD1-199-10585 "HYPERCER".
CR Burger W., 1997, KERAM Z, V49, P1067
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   GRISS P, 1973, J BIOMED MATER RES, V7, P453, DOI 10.1002/jbm.820070328
   HE C, 1993, WEAR, V162, P314, DOI 10.1016/0043-1648(93)90514-M
   LANDOLPH JR, 1979, P NATL ACAD SCI USA, V76, P930, DOI 10.1073/pnas.76.2.930
   Maccauro G, 2004, J BONE JOINT SURG BR, V86B, P1192, DOI 10.1302/0301-620X.86B8.15012
   Manicone P F, 2007, Int J Immunopathol Pharmacol, V20, P9
   Piconi C, 2006, J MATER SCI-MATER M, V17, P289, DOI 10.1007/s10856-006-7316-0
   Piconi C, 2005, KEY ENG MAT, V284-286, P979, DOI 10.4028/www.scientific.net/KEM.284-286.979
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   REZNIKOFF CA, 1973, CANCER RES, V33, P3239
   RYU RKN, 1987, CLIN ORTHOP RELAT R, P207
   Satoh Y, 1990, BIOCERAMICS, V3, P101
   Sgambato A, 2001, MUTAT RES-GEN TOX EN, V496, P171, DOI 10.1016/S1383-5718(01)00232-7
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Takami Y, 1997, J BIOMED MATER RES, V36, P381, DOI 10.1002/(SICI)1097-4636(19970905)36:3<381::AID-JBM12>3.0.CO;2-H
   WILLIAMS DF, 1992, BIOMATERIALS TISSUE, P525
NR 19
TC 20
Z9 20
U1 0
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JUL-SEP
PY 2009
VL 22
IS 3
BP 773
EP 779
DI 10.1177/039463200902200323
PG 7
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA 510WV
UT WOS:000271125100023
PM 19822094
OA Bronze
DA 2018-10-19
ER

PT J
AU Lopattananon, N
   Songkaew, S
   Thongruang, W
   Seadan, M
AF Lopattananon, N.
   Songkaew, S.
   Thongruang, W.
   Seadan, M.
TI Sustainable Biocomposites from Rice Flour and Sisal Fiber: Effect of
   Fiber Loading, Length and Alkali Treatment
SO INTERNATIONAL POLYMER PROCESSING
LA English
DT Article
ID PINEAPPLE LEAF FIBER; REINFORCED POLYPROPYLENE COMPOSITES;
   MECHANICAL-PROPERTIES; THERMOPLASTIC STARCH; EPOXY COMPOSITES; NATURAL
   FIBERS; POLYESTER COMPOSITES; PLASTICIZED STARCH; RUBBER COMPOSITES;
   WATER-ABSORPTION
AB Rice flour was modified with water and glycerol in singles-crew extruder to obtain bioplastic of low manufacturing cost. Sisal fibers were used as reinforcing fillers to enhance rice flour-bored bioplastic properties. The effects of short sisal fiber content (5 to 20 wt.%), length (0.2 to 6 mm) and alkali treatment (5 % w/v NaOH) on the moisture content, tensile properties, impact properties, dynamic mechanical properties and morphology of the biocomposites were studied. The results showed that incorporation of the sisal fibers with a fixed fiber length into the bioplastics improved moisture resistance, tensile strength, impact strength and storage modulus, and that the improvement level increased with increasing sisal fiber content. The optimum reinforcement was achieved at 20 wt.% of fiber loading and 4 mm long fibers. The tensile strength of the biocomposite was about 4 times more than that of the neat rice flour-based bioplastic. The use of 5 % NaOH aqueous solution further improved the moisture resistance and mechanical properties of the biocomposites, mainly resulting from better interfacial adhesion between the sisal fiber and rice flour matrix. Furthermore, the performance of the rice flour-based bioplastics synergistically combined with the sisal fibers suggests that they have great potential in development of environmentally friendly/sustainable biomaterial products from renewable resources.
C1 [Lopattananon, N.; Songkaew, S.] Prince Songkla Univ, Fac Sci & Technol, Dept Rubber Technol & Polymer Sci, Pattani 94000, Thailand.
   [Thongruang, W.] Prince Songkla Univ, Fac Engn, Dept Mech Engn, Hat Yai, Thailand.
   [Seadan, M.] Silpakorn Univ, Fac Sci, Dept Phys, Nakhon Prathom, Thailand.
RP Lopattananon, N (reprint author), Prince Songkla Univ, Fac Sci & Technol, Dept Rubber Technol & Polymer Sci, Pattani 94000, Thailand.
EM lnatinee@bunga.pn.psu.ac.th
FU National Science and Technology Development Agency (NSTDA); Ministry of
   Science and Technology (Thailand) [F 31-315-18-01]; Graduate School.
   Prince of Songkla University, Thailand
FX The authors gratefully acknowledge the financial Support from the
   National Science and Technology Development Agency (NSTDA). Ministry of
   Science and Technology (Thailand) for the research grant to contract
   number F 31-315-18-01 and the special scholarship granted by Graduate
   School. Prince of Songkla University, Thailand to Ms Suweeraya Songkeau.
CR Alvarez VA, 2004, J APPL POLYM SCI, V91, P4007, DOI 10.1002/app.13561
   Alvarez VA, 2006, COMPOS PART A-APPL S, V37, P1672, DOI 10.1016/j.compositesa.2005.10.005
   Averous L, 2001, POLYMER, V42, P6565, DOI 10.1016/S0032-3861(01)00125-2
   Averous L, 2004, CARBOHYD POLYM, V56, P111, DOI 10.1016/j.carbpol.2003.11.015
   Averous L, 2000, POLYMER, V41, P4157, DOI 10.1016/S0032-3861(99)00636-9
   Cardoso MB, 2007, CARBOHYD POLYM, V70, P160, DOI 10.1016/j.carbpol.2007.03.014
   COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302
   Curvelo AAS, 2001, CARBOHYD POLYM, V45, P183, DOI 10.1016/S0144-8617(00)00314-3
   Devi LU, 1997, J APPL POLYM SCI, V64, P1739
   Dufresne A, 1998, MACROMOLECULES, V31, P2693, DOI 10.1021/ma971532b
   FUJII T, 1975, J JPN SOC COMP MAT, V1, P35
   Funke U, 1998, POLYM DEGRAD STABIL, V59, P293, DOI 10.1016/S0141-3910(97)00163-8
   Gaspar M, 2005, POLYM DEGRAD STABIL, V90, P563, DOI 10.1016/j.polymdegradstab.2005.03.012
   JOSEPH K, 1993, J APPL POLYM SCI, V47, P1731, DOI 10.1002/app.1993.070471003
   Joseph PV, 1999, COMPOS SCI TECHNOL, V59, P1625, DOI 10.1016/S0266-3538(99)00024-X
   Joseph PV, 2003, COMPOS PART A-APPL S, V34, P253, DOI 10.1016/S1359-835X(02)00185-9
   Liu WJ, 2005, POLYMER, V46, P2710, DOI 10.1016/j.polymer.2005.01.027
   Lopattananon N, 2008, J APPL POLYM SCI, V110, P433, DOI 10.1002/app.28496
   Lopattananon N, 2006, J APPL POLYM SCI, V102, P1974, DOI 10.1002/app.24584
   Lourdin D, 1997, J APPL POLYM SCI, V63, P1047, DOI 10.1002/(SICI)1097-4628(19970222)63:8<1047::AID-APP11>3.0.CO;2-3
   Ma XF, 2005, CARBOHYD POLYM, V62, P19, DOI 10.1016/j.carbpol.2005.07.015
   Mali S, 2005, CARBOHYD POLYM, V60, P283, DOI 10.1016/j.carbpol.2005.01.003
   Martins MA, 2004, J APPL POLYM SCI, V91, P670, DOI 10.1002/app.13210
   Martins MA, 2003, J APPL POLYM SCI, V89, P2507, DOI 10.1002/app.12285
   Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916
   Mohanty AK, 2001, COMPOS INTERFACE, V8, P313, DOI 10.1163/156855401753255422
   MUKHERJEE PS, 1984, J MATER SCI, V19, P3925, DOI 10.1007/BF00980755
   Mukhopadhyay S, 2008, POLYM DEGRAD STABIL, V93, P2048, DOI 10.1016/j.polymdegradstab.2008.02.018
   Oksman K, 2002, J APPL POLYM SCI, V84, P2358, DOI 10.1002/app.10475
   Rodriguez-Gonzalez FJ, 2004, CARBOHYD POLYM, V58, P139, DOI 10.1016/j.carbpol.2004.06.002
   Rong MZ, 2001, COMPOS SCI TECHNOL, V61, P1437, DOI 10.1016/S0266-3538(01)00046-X
   Sarazin P, 2008, POLYMER, V49, P599, DOI 10.1016/j.polymer.2007.11.029
   Sreekumar PA, 2007, COMPOS SCI TECHNOL, V67, P453, DOI 10.1016/j.compscitech.2006.08.025
   Towo AN, 2008, COMPOS SCI TECHNOL, V68, P925, DOI 10.1016/j.compscitech.2007.08.022
   Wollerdorfer M, 1998, IND CROP PROD, V8, P105, DOI 10.1016/S0926-6690(97)10015-2
   Zarate CN, 2003, J APPL POLYM SCI, V89, P2714, DOI 10.1002/app.12404
   ZELEZNAK KJ, 1987, CEREAL CHEM, V64, P121
NR 37
TC 3
Z9 3
U1 1
U2 12
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0930-777X
J9 INT POLYM PROC
JI Int. Polym. Process.
PD JUL
PY 2009
VL 24
IS 3
BP 272
EP 279
DI 10.3139/217.2258
PG 8
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 479VM
UT WOS:000268689500008
DA 2018-10-19
ER

PT J
AU Yeh, LK
   Chen, YH
   Chiu, CS
   Hu, FR
   Young, TH
   Wang, IJ
AF Yeh, Lung-Kun
   Chen, Yi-Hsin
   Chiu, Chih-Sheng
   Hu, Fung-Rong
   Young, Tai-Horng
   Wang, I-Jong
TI The phenotype of bovine corneal epithelial cells on chitosan membrane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan; amniotic membrane; corneal epithelial cells
ID STEVENS-JOHNSON-SYNDROME; HUMAN AMNIOTIC MEMBRANE; SURFACE
   RECONSTRUCTION; CELLULAR GROWTH; OCULAR SURFACE; STEM-CELLS;
   TRANSPLANTATION; PROLIFERATION; ADHESION; HYPOPYON
AB Corneal wound healing is one of the major issues in ocular surface reconstruction and ocular surface diseases. Amniotic membrane (AM) transplantation is an excellent treatment modality to promote corneal wound healing and treat corneal diseases. It is interesting and valuable to search for another synthetic and biocompatible for the study of mechanism of AM and the treatment of ocular surface disorders. Chitosan, the second-most abundant polymer in nature, has many biological advantages such as biocompatibility, biodegradability, hemostatic activity, and wound-healing property to be used as biomedical applications. The purpose of this project is to evaluate the phenotype of cultured corneal epithelial cells in vitro on synthetic chitosan membrane (CM). We cultivated bovine corneal epithelial cells on CM and AM, and then evaluated their phenotypes. The viability of the respective cell cultures was invetigated using the 3-[4,5-dimethylrhiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay. The cytotoxicity of CM and AM to corneal epithelial cells Was evaluated by lactate dehydrogenase (LDH) assay. The morphology of cultivated corneal epithelial cells on CM and AM was observed by scanning electron microscopy. Additionally, immunocytochemical stainings were used to confirm the phenotype of corneal epithelial cells. In MTT and LDH assays we found that the CM Can support the growth of cultured corneal epithelial cells in good condition with minimal toxicity. The SEM and immunohistocytochemistry, showed that the phenotype of corneal epithelial cells is compatible with that of AM. We conclude that the CM has the potential to be a suitable biomaterial for treating ocular surface disorders. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A:18-26, 2009
C1 [Hu, Fung-Rong; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
   [Yeh, Lung-Kun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan.
   [Yeh, Lung-Kun] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei 10764, Taiwan.
   [Chen, Yi-Hsin; Young, Tai-Horng] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan.
   [Chiu, Chih-Sheng; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Chiu, Chih-Sheng; Young, Tai-Horng] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan.
RP Wang, IJ (reprint author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
EM ljong@ms8.hinet.net
OI HU, FUNG-RONG/0000-0002-2102-5317; Wang, I-Jong/0000-0002-3045-0614
FU Taiwan NSC [923112B002004, 933112B002031, 943112B002007, 932314B002090,
   942314B002043, 94WHK0500128]
FX Taiwan NSC; contract grant numbers: 923112B002004, 933112B002031,
   943112B002007, 932314B002090, 942314B002043, 94WHK0500128
CR Anderson JM, 1993, CURR OPIN CELL BIOL, V5, P772, DOI 10.1016/0955-0674(93)90024-K
   AZAD AK, 2004, J BIOMED MATER RES B, V69, pB216
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363
   Evans MDM, 1997, EXP CELL RES, V233, P88, DOI 10.1006/excr.1997.3523
   Evans MDM, 2003, J BIOMED MATER RES A, V64A, P357, DOI 10.1002/jbm.a.10341
   Gabler B, 2000, OPHTHALMOLOGY, V107, P1344, DOI 10.1016/S0161-6420(00)00167-6
   George A, 2002, BIOMATERIALS, V23, P1369, DOI 10.1016/S0142-9612(01)00257-5
   GERDES J, 1984, J IMMUNOL, V133, P1710
   Honavar SG, 2000, OPHTHALMOLOGY, V107, P975, DOI 10.1016/S0161-6420(00)00026-9
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506
   KOJI K, 1993, ADV CHITIN CHITOSAN, P9
   Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   LIU CY, 1994, J BIOL CHEM, V269, P24627
   MARKEY ML, 1989, CHITIN CHITOSAN, P713
   Messmer EM, 2001, OPHTHALMOLOGY, V108, P1714, DOI 10.1016/S0161-6420(01)00734-5
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MUZZARELLI R, 1994, IN VIVO BIOCH SIGNIF, P179
   MUZZARELLI RA, 1999, BIOCH HISTOLOGY CLIN
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   Shimazaki J, 1998, BRIT J OPHTHALMOL, V82, P235, DOI 10.1136/bjo.82.3.235
   STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755
   Sweeney DF, 2003, INVEST OPHTH VIS SCI, V44, P3301, DOI 10.1167/iovs.02-0561
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
NR 31
TC 20
Z9 21
U1 1
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 18
EP 26
DI 10.1002/jbm.a.32077
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700002
PM 18481792
DA 2018-10-19
ER

PT J
AU Dettin, M
   Bagno, A
   Gambaretto, R
   Iucci, G
   Conconi, MT
   Tuccitto, N
   Menti, AM
   Grandi, C
   Di Bello, C
   Licciardello, A
   Polzonetti, G
AF Dettin, Monica
   Bagno, Andrea
   Gambaretto, Roberta
   Iucci, Giovanna
   Conconi, Maria Teresa
   Tuccitto, Nunzio
   Menti, Anna Michela
   Grandi, Claudio
   Di Bello, Carlo
   Licciardello, Antonino
   Polzonetti, Giovanni
TI Covalent surface modification of titanium oxide with different adhesive
   peptides: Surface characterization and osteoblast-like cell adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomimetic surface; biomaterial; peptide; cell adhesion; surface
   characterization
ID CHEMICAL-MODIFICATION; IN-VITRO; ATTACHMENT; RGD; BIOMATERIALS; FILM
AB A fundamental goal in the field of implantology is the design of innovative devices suitable foil promoting, implant-to-tissue integration. This result can be achieved by means of surface modifications aimed at optimizing tissue regeneration. In the framework of oral and orthopedic implantology, surface modifications concern both the optimization of titanium/titanium alloy surface roughness and the attachment of biochemical factors able to guide cellular adhesion and/or growth. This article focuses on the covalent attachment of two different adhesive peptides to rough titanium disks. The capability of biomimetic surfaces to increase osteoblast adhesion and the specificity of their biological activity due to the presence of cell adhesion signal-motif have also been investigated. In addition, surface analyses by profilometry, X-ray photoelectron spectroscopy, and time of flight-secondary ion mass spectrometry have been carried out to investigate the effects and modifications induced by grafting procedures. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 35-45, 2009
C1 [Dettin, Monica; Bagno, Andrea; Gambaretto, Roberta; Di Bello, Carlo] Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy.
   [Iucci, Giovanna; Polzonetti, Giovanni] Univ Roma Tre, Dept Phys, I-00146 Rome, Italy.
   [Conconi, Maria Teresa; Menti, Anna Michela; Grandi, Claudio] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy.
   [Tuccitto, Nunzio; Licciardello, Antonino] Univ Catania, Dept Chem Sci, I-95125 Catania, Italy.
RP Dettin, M (reprint author), Univ Padua, Dept Chem Proc Engn, Via Marzolo 9, I-35131 Padua, Italy.
EM monica.dettin@unipd.it
RI Licciardello, Antonino/A-6614-2011
OI Licciardello, Antonino/0000-0001-5146-8971; Bagno,
   Andrea/0000-0002-4296-3601; Tuccitto, Nunzio/0000-0003-4129-0406
CR Bagno A, 2004, BIOMATERIALS, V25, P2437, DOI 10.1016/j.biomaterials.2003.09.018
   BRIGGS D, 1990, PRACTICAL SURFACE AN, V1
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   Dettin M, 1998, J PEPT SCI, V4, P436, DOI 10.1002/(SICI)1099-1387(199811)4:7<436::AID-PSC163>3.0.CO;2-C
   Dettin M, 2006, TISSUE ENG, V12, P3509, DOI 10.1089/ten.2006.12.3509
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Koo LY, 2002, J CELL SCI, V115, P1423
   LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J
   LUNA LG, 1968, MANUAL HISTOLOGIC ST, P174
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Moulder J. F., 1996, HDB XRAY PHOTOELECTR
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   SCHMIDT M, 1991, FRESEN J ANAL CHEM, V341, P412, DOI 10.1007/BF00321947
   Seah M. P., 1979, Surface and Interface Analysis, V1, P2, DOI 10.1002/sia.740010103
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Yokose S, 1996, ENDOCRINOLOGY, V137, P469, DOI 10.1210/en.137.2.469
NR 27
TC 29
Z9 29
U1 0
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 35
EP 45
DI 10.1002/jbm.a.32064
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700004
PM 18481788
DA 2018-10-19
ER

PT J
AU Walpole, AR
   Xia, ZD
   Wilson, CW
   Triffitt, JT
   Wilshaw, PR
AF Walpole, Andrew R.
   Xia, Zhidao
   Wilson, Crispian W.
   Triffitt, James T.
   Wilshaw, Peter R.
TI A novel nano-porous alumina biomaterial with potential for loading with
   bioactive materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE anodic aluminium oxide (AAO); titanium; nano-porous; osteoblastic cells
ID NANOPHASE CERAMICS; HYDROXYAPATITE COATINGS; OSTEOBLAST ADHESION; ANODIC
   ALUMINA; IN-VITRO; ARTHROPLASTY; FABRICATION; INTERFACE; MEMBRANES;
   STRENGTHS
AB Nano-porous alumina, with the potential for being loaded with bioactive materials, has been proposed as a novel material for coating implants. In this study, the shear strength of the interface between such nano-porous anodic aluminium oxide (AAO) coatings and titanium substrates, their biocompatibility, and their potential for pore loading have been investigated. An interface shear strength in excess of 29 MPa was obtained which is comparable with that of conventional plasma sprayed hydroxyapatite implant coatings. The viability and differentiation of MG63 osteoblastic cells co-cultured on the coating was found to be broadly comparable to that of similar cells co-cultured on conventional bioinort implant materials such as titanium and fully dense alumina. Extensive pore loading with silica nano-particles of different sizes and in different combinations was demonstrated throughout the thickness of AAO layers 1 mu m and 60 mu m thick. This work has demonstrated, that with suitable choice of pore filling materials, this novel coating might simultaneously combat infection, encourage bone regeneration, and secure fixation of the implant to bone. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 46-54, 2009
C1 [Walpole, Andrew R.; Wilson, Crispian W.; Wilshaw, Peter R.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England.
   [Xia, Zhidao; Triffitt, James T.] Univ Oxford, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford OX1 3PH, England.
RP Wilshaw, PR (reprint author), Univ Oxford, Dept Mat, Parks Rd, Oxford OX1 3PH, England.
EM peter.wilshaw@materials.ox.ac.uk
OI Xia, Zhidao/0000-0002-2047-7282; Wilshaw, Peter R/0000-0002-3864-6064
CR Aubin Jane E., 1996, P51
   BAUN WL, 1980, J MATER SCI, V15, P2749, DOI 10.1007/BF00550542
   Briggs EP, 2004, J MATER SCI-MATER M, V15, P1021, DOI 10.1023/B:JMSM.0000042688.33507.12
   BRUNSKI JB, 1991, BONE-BIOMATERIAL INTERFACE, P391
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Choong C, 2004, FOOD BIOPROD PROCESS, V82, P117, DOI 10.1205/0960308041614864
   Ding SJ, 2001, BIOMATERIALS, V22, P833, DOI 10.1016/S0142-9612(00)00247-7
   Dumbleton J, 2004, J BONE JOINT SURG AM, V86A, P2526, DOI 10.2106/00004623-200411000-00028
   ELDRIDGE JDJ, 2000, INTERFACES TOTAL HIP, P71
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   Fischer H, 2005, BIOMATERIALS, V26, P6151, DOI 10.1016/j.biomaterials.2005.04.038
   FURNEAUX RC, 1989, NATURE, V337, P147, DOI 10.1038/337147a0
   Green DJ, 1998, INTRO MECH PROPERTIE
   GRISS P, 1975, J BIOMED MATER RES, V9, P177, DOI 10.1002/jbm.820090421
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   Gu YW, 2004, BIOMATERIALS, V25, P3177, DOI 10.1016/j.biomaterials.2003.09.101
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   JARCHO M, 1977, J BIOENG, V1, P79
   Kamada K, 2004, ELECTROCHEM SOLID ST, V7, pB25, DOI 10.1149/1.1758932
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Li Y, 2000, J VAC SCI TECHNOL B, V18, P994, DOI 10.1116/1.591314
   Munz D., 1999, CERAMICS MECH PROPER
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Oh IK, 2005, J MATER SCI-MATER M, V16, P635, DOI 10.1007/s10856-005-2534-4
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   OSULLIVAN JP, 1970, PROC R SOC LON SER-A, V317, P511, DOI 10.1098/rspa.1970.0129
   Park JB, 1992, BIOMATERIALS INTRO
   Phung LH, 2004, MACROMOL SYMP, V210, P349, DOI 10.1002/masy.200450639
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Ridgeway S, 2005, J BONE JOINT SURG BR, V87B, P844, DOI 10.1302/0301-620X.87B6.15121
   Shackelford JF, 1999, MATER SCI FORUM, V293, P99, DOI 10.4028/www.scientific.net/MSF.293.99
   SHIRKHANZADEH M, 1994, MATER LETT, V18, P211, DOI 10.1016/0167-577X(94)90233-X
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Tonino AJ, 2003, ACTA ORTHOP SCAND, V74, P365, DOI 10.1080/00016470310014328
   Walpole AR, 2003, MATERIALWISS WERKST, V34, P1064, DOI 10.1002/mawe.200300707
   Webster T.J., 1998, BIOCERAMICS, P273
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WILSON CW, 2005, IMPROVED BONE IMPL 2
NR 46
TC 28
Z9 29
U1 1
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 46
EP 54
DI 10.1002/jbm.a.32067
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700005
PM 18481790
DA 2018-10-19
ER

PT J
AU Filova, E
   Brynda, E
   Riedel, T
   Bacakova, L
   Chlupac, J
   Lisa, V
   Houska, M
   Dyr, JE
AF Filova, Elena
   Brynda, Eduard
   Riedel, Tomas
   Bacakova, Lucie
   Chlupac, Jaroslav
   Lisa, Vera
   Houska, Milan
   Dyr, Jan E.
TI Vascular endothelial cells on two- and three-dimensional fibrin
   assemblies for biomaterial coatings
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE artificial fibrin networks; surface modification; nanostructure;
   endothelial cells; von Willebrand factor
ID GROWTH-FACTOR; ANGIOGENESIS; LOCALIZATION; SCAFFOLD; MATRIX; GEL
AB Various techniques for coating synthetic surfaces with fibrin structures were tested for seeding bovine pulmonary artery endothelial cells (EC). Two-dimensional fibrin (Fb) structures (2D 17b) were obtained by successively repeating adsorption of fibrinogen) (Fbg), incubating the surface with thrombin (Thr) solution, and inhibiting surface attached Thr. Three-dimensional fibrin networks immobilized at the surface (3D Fb) were formed by catalytic action of surface-attached thrombin on an ambient Fbg solution. Ultra-thin 3D Fbs were obtained if thrombin inhibitors antithrombin III and heparin were added into an Fbg solution. The formation of surface fibrin structures was observed in situ using surface plasmon resonance. The morphology of the structures was studied by transmission and phology scanning electron microscopy. A polylactide fibrous scaffold was modified with a surface fibrin film without filling the inner pores with a bulk gel. The growth of EC seeded on a polystyrene surface coated with the Fb films was evaluated by the number and and morphology of the adhering ECs and the concentration of beta-actin, vinculin, alpha((sic))-intergrin, and and von Willebrand factor (vWF). The best initial cell spreading after 1 day was observed on 2D Fb and ultra-thin 3D Fb. The highest concentration of vWF, a marker Of EC differentiation, was observed after 3 days on thick 3D Fbs. The highest EC population densities after 7 days were observed on 2D Fb and thick 3D Fb. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 55-69, 2009
C1 [Filova, Elena; Bacakova, Lucie; Chlupac, Jaroslav; Lisa, Vera] Acad Sci Czech Republic, Inst Physiol, Dept Growth & Differentiat Cell Populat, CR-14220 Prague 4, Czech Republic.
   [Filova, Elena; Bacakova, Lucie; Chlupac, Jaroslav] Cardiovasc Res Ctr, Prague 14220 4, Czech Republic.
   [Brynda, Eduard; Riedel, Tomas; Houska, Milan] Acad Sci Czech Republic, Inst Macromol Chem, CR-16206 Prague 6, Czech Republic.
   [Riedel, Tomas; Dyr, Jan E.] Inst Hematol & Blood Transfus, Prague 12800 2, Czech Republic.
RP Filova, E (reprint author), Acad Sci Czech Republic, Inst Physiol, Dept Growth & Differentiat Cell Populat, Videnska 1083, CR-14220 Prague 4, Czech Republic.
EM filova@biomed.cas.cz
RI Riedel, Tomas/H-6777-2014; Bacakova, Lucie/C-2664-2012; Houska,
   Milan/H-6809-2014; Dyr, Jan/G-5580-2017; Brynda, Eduard/H-6818-2014;
   Filova, Elena/C-2209-2012
OI Riedel, Tomas/0000-0002-2971-6956; Bacakova, Lucie/0000-0002-1818-9484;
   Houska, Milan/0000-0001-6668-8870; Dyr, Jan/0000-0002-7970-5868;
   Chlupac, Jaroslav/0000-0003-1482-6105
CR Bense CA, 1999, J BIOMED MATER RES, V46, P305, DOI 10.1002/(SICI)1097-4636(19990905)46:3<305::AID-JBM1>3.0.CO;2-A
   BRYNDA E, 1986, J COLLOID INTERF SCI, V113, P164, DOI 10.1016/0021-9797(86)90216-X
   Cardon A, 2000, ANN VASC SURG, V14, P543, DOI 10.1007/s100169910102
   CHEN YP, 1995, BLOOD, V86, P2606
   CHLUPAC J, 2006, ENG BIOMATER, V9, P10
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   COLMAN RW, 2005, HEMOSTASIS THROMBOSI
   Di Cera E, 2003, CHEST, V124, P11, DOI [10.1378/chest.124.3_suppl.11S, DOI 10.1378/CHEST.124.3_SUPPL.11S]
   Dyr JE, 1998, SENSOR ACTUAT B-CHEM, V51, P268, DOI 10.1016/S0925-4005(98)00204-4
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Hokugo A, 2006, BIOMATERIALS, V27, P61, DOI 10.1016/j.biomaterials.2005.05.030
   Jackson MR, 2001, AM J SURG, V182, P1
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x
   MOLA A, 2005, BIOMATERIALS, V26, P3113
   RIEDEL T, 2004, 43 MICR POL BIOM BIO, pPC46
   RUBENS FD, 1993, THROMB HAEMOSTASIS, V69, P130
   Sahni A, 2000, BLOOD, V96, P3772
   Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Tsurupa G, 2001, ANN NY ACAD SCI, V936, P328
   Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647
   WEISEL JW, 1986, J ULTRA MOL STRUCT R, V96, P176, DOI 10.1016/0889-1605(86)90019-4
   WOLBERG AS, 2007, BLOOD REV, V21, P132
   Xue L, 2002, SURGERY, V132, P259, DOI 10.1067/msy.2002.125720
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 28
TC 22
Z9 22
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 55
EP 69
DI 10.1002/jbm.a.32065
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700006
PM 18481789
DA 2018-10-19
ER

PT J
AU Rodriguez, A
   MacEwan, SR
   Meyerson, H
   Kirk, JT
   Anderson, JM
AF Rodriguez, Analiz
   MacEwan, Sarah R.
   Meyerson, Howard
   Kirk, James T.
   Anderson, James M.
TI The foreign body reaction in T-cell-deficient mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE foreign body response; IL-4; IL-13; T lymphocyte; biomaterials
ID IN-VIVO BIOCOMPATIBILITY; MAST-CELLS; SURFACE-CHEMISTRY; MACROPHAGE
   FUSION; GIANT-CELLS; INTERLEUKIN-4; BIOMATERIALS; CYTOKINE; LYMPHOKINE;
   ACTIVATION
AB The role(s) of T lymphocytes in the foreign body response has not been thoroughly elucidated. Lymphocytes are known to augment macrophage adhesion and fusion in vitro. Furthermore, T lymphocytes are a possible source of the cytokine, IL-4 and IL-13, which induce macrophage fusion. In this study, we used BALB/c mice and BALB/c (nu/nu) nude mice to investigate foreign body giant cell (FBGC) formation in T-cell-deficient setting. Mice were implanted with Elasthane 80A (PEU), silicone rubber (SR), or poly(ethylene terephthalate) (PET) for 7, 14, or 21 days using the cage implant system. Exudate cells and IL-4 and IL-13 levels in exudate supernatants were analyzed by flow cytometry and a multiplex immunoassay, respectively, at Days 7, 14, and 21. Macrophage adhesion and fusion on material surfaces were analyzed using optical microscopy. T-cell-deficient mice had lower total leukocyte concentration at the biomaterial implant site at all time points. Adherent cell density was comparable between normal and T-cell-deficient mice except in the PEU group at Day 21. However, percent fusion, average nuclei per FBGC, and FBGC morphology were comparable between normal and T-cell-deficient mice. IL-4 was not detected in any sample, but IL-13 levels were also comparable between normal and T-cell-deficient mice indicating Th2-polarized T-cells are not the sole source of this cytokine. We have shown that there, are pathways that do not require thymus-matured T lymphocytes, which lead to a normal foreign body response to biomaterials in a murine model. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 106-113, 2009
C1 [Rodriguez, Analiz; Meyerson, Howard; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [MacEwan, Sarah R.; Kirk, James T.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), 2103 Cornell Rd,Wolstein Res Bldg 5104, Cleveland, OH 44106 USA.
EM jma6@case.edu
OI MacEwan, Sarah/0000-0002-4365-6232
FU NIBIB NIH HHS [R56 EB000282, R01 EB000282, EB-000282]; NIGMS NIH HHS
   [T32 GM007250, T32-GM07250]
CR Al-Saffar N, 1998, J MATER SCI-MATER M, V9, P849, DOI 10.1023/A:1008952329788
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063
   Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   MACEWAN MR, 2005, 30 ANN M SOC BIOM ME
   McNally AK, 1996, AM J PATHOL, V149, P975
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Metwali A, 2002, EUR J IMMUNOL, V32, P1242, DOI 10.1002/1521-4141(200205)32:5<1242::AID-IMMU1242>3.0.CO;2-7
   Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x
   Miosge L, 2007, CURR OPIN IMMUNOL, V19, P194, DOI 10.1016/j.coi.2007.02.008
   MORENO JL, 2007, J LEUKOC BIOL
   Nasser S, 2007, ORTHOPEDICS, V30, P89
   PAUL WE, 1991, BLOOD, V77, P1859
   RODRIGUEZ A, 2007, J BIOMED MATER RES A, V852, P556
   Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x
   Shelburne CP, 2001, IMMUNOL REV, V179, P82, DOI 10.1034/j.1600-065X.2001.790109.x
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
NR 30
TC 27
Z9 27
U1 2
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 106
EP 113
DI 10.1002/jbm.a.32050
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700010
PM 18491378
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Orefice, R
   Hench, L
   Brennan, A
AF Orefice, Rodrigo
   Hench, Larry
   Brennan, Anthony
TI Evaluation of the interactions between collagen and the surface of a
   bioactive glass during in vitro test
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bioactive glasses; collagen; adsorption; afm
ID ATOMIC-FORCE MICROSCOPY; ADHESION FORCES; AFM; QUANTIFICATION; SILICA;
   CELL; POLYSTYRENE
AB Interactions between biomaterials and the body environment usually determine the lifetime and performance of biomedical devices used as implants. Among a variety of different types of interactions that occur whenever bio-materials are implanted into the body, adsorption of biomacromolcules onto the surface of biomaterials can guide other relevant processes such as cell attachment, cell differentiation, cell proliferation, tissue growth and biomaterials degradation. In this work, fundamental mechanisms associated with the interactions between collagen and the surface of biomaterials were studied by using Atomic Force Microscopy (AFM). The ultimate goal of this work is to isolate and simulate phenomena occurring at the molecular level, when biological entities are brought in contact with biomaterials. These results can then be used to design and test new biomedical devices. This Manuscript reports the evaluation of interaction between collagen and the surface of bioactive glasses. These bioactive glasses are known to bond to soft and hard tissues through the formation of a hydroxy-carbonate-apatite layer. Collagen was grafted onto AFM cantilevers. AFM force-displacement curves were obtained using these modified tips against the surface of a bioactive glass at different stages of an in vitro test performed in a stimulated body fluid. The results showed that the structure of the bioactive glass surface affects the adsorption of collagen on the biomaterial. The magnitude of the adhesion force measured is highly dependent on the deposition of a hydroxyl-carbonate-apatite at the surface of the glass. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 114-120, 2009
C1 [Orefice, Rodrigo] Univ Fed Minas Gerais, Dept Met & Mat Sci, BR-30160030 Belo Horizonte, MG, Brazil.
   [Hench, Larry] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Brennan, Anthony] Univ Florida, Dept Mat Sci & Eng & Biomed Engn, Gainesville, FL 32611 USA.
RP Orefice, R (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Sci, R Espirito Santo 35-206, BR-30160030 Belo Horizonte, MG, Brazil.
EM rorefice@demet.ufmg.br
RI Orefice, Rodrigo/N-8055-2018
OI Orefice, Rodrigo/0000-0002-6046-4056
CR ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   Curran MD, 1999, J NON-CRYST SOLIDS, V249, P62, DOI 10.1016/S0022-3093(99)00237-9
   DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024
   Dupont-Gillain CC, 2003, SURF SCI, V539, P145, DOI 10.1016/S0039-6028(03)00779-9
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2000, CURR ORTHOPAED, V14, P7, DOI 10.1054/cuor.1999.0074
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hyonchol K, 2002, COLLOID SURFACE B, V25, P33, DOI 10.1016/S0927-7765(01)00299-5
   Kim H, 2003, ULTRAMICROSCOPY, V97, P359, DOI 10.1016/S0304-3991(03)00061-5
   LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628
   Lu SQ, 2006, POLYMER, V47, P2539, DOI 10.1016/j.polymer.2005.11.095
   Lubarsky GV, 2004, SURF SCI, V558, P135, DOI 10.1016/j.susc.2004.03.054
   MOSBACH K, 1976, METHOD ENZYMOL, P44
   MOY VT, 1994, SCIENCE, V266, P297
   Orefice RL, 2006, MACROMOL MATER ENG, V291, P377, DOI 10.1002/mame.200500322
   Orefice R, 2007, J BIOMED MATER RES A, V80A, P565, DOI 10.1002/jbm.a.30948
   Park JB, 1992, BIOMATERIALS INTRO
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003
   Ratner B.D., 2004, BIOMATERIALS SCI
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Sokolov I, 2006, J COLLOID INTERF SCI, V300, P475, DOI 10.1016/j.jcis.2006.04.023
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
NR 26
TC 13
Z9 14
U1 1
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 114
EP 120
DI 10.1002/jbm.a.32080
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700011
PM 18491395
DA 2018-10-19
ER

PT J
AU Inanc, B
   Arslan, YE
   Seker, S
   Elcin, AE
   Elcin, YM
AF Inanc, Buelend
   Arslan, Y. Emre
   Seker, Suekran
   Elcin, A. Eser
   Elcin, Y. Murat
TI Periodontal ligament cellular structures engineered with electrospun
   poly(DL-lactide-co-glycolide) nanofibrous membrane scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PLGA nanofibers; cell sheets; electrospinning; human periodontal
   ligament cells; tissue engineering
ID MESENCHYMAL STEM-CELLS; IN-VITRO; TISSUE; FIBROBLASTS; REGENERATION;
   MODEL
AB Periodontal tissue engineering is expected to overcome the limitations associated with the existing regenerative techniques tor the treatment of periodontal defects involving alveolar bone, cementum, and periodontal ligament. Cell-based tissue engineering approaches involve the utilization of in vitro expanded cells with regenerative capacity and their delivery to the appropriate sites via biomaterial scaffolds. The aim of this study was to establish living periodontal ligament cell-containing structures on electrospun poly(DL-lactic-co-glycolic acid) (PLGA) nanofiber membrane scaffolds, assess their viability and characteristics, and engineer multilayered structures amenable to easy handling. Human periodontal ligament (hPDL) cells were expanded in explant culture and then characterized morphologically and immunohistochemically. PLGA nanofiber membranes were prepared by the electrospinning process; mechanical tensile properties were determined, surface topography, nanofiber size, and porosity status were investigated with SEM. Cells were seeded on the membranes at similar to 50,000 cell/cm(2) and cultured for 21 days either in expansion or in osteogenic induction medium. Cell adhesion and viability were demonstrated using SEM and MTT, respectively, and osteogenic differentiation was determined with IHC and immunohistomorphometric evaluation of osteopontin, osteocalcin, and bone sialoprotein marker expression. At days 3, 6, 9, and 12 additional cell membrane layers were deposited on the existing ones and multilayered hybrid structures were established. Results indicate the feasibility of periodontal ligament cell-containing, tissue-like structures engineering with PDL cells and electrospun nanofiber PLGA scaffolds supporting cell adhesion, viability and osteogenic differentiation properties of cells in hybrid structures amenable to macroscopic handling. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 186-19-5, 2009
C1 [Inanc, Buelend; Arslan, Y. Emre; Seker, Suekran; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Fac Sci, Tissue Engn & Biomat Lab, TR-06100 Ankara, Turkey.
   [Inanc, Buelend; Arslan, Y. Emre; Seker, Suekran; Elcin, A. Eser; Elcin, Y. Murat] Inst Biotechnol, TR-06100 Ankara, Turkey.
   [Elcin, A. Eser] Gazi Univ, Div Biol Educ, GEF, TR-06100 Ankara, Turkey.
RP Elcin, YM (reprint author), Ankara Univ, Fac Sci, Tissue Engn & Biomat Lab, TR-06100 Ankara, Turkey.
EM elcin@science.ankara.edu.tr
RI ARSLAN, Yavuz Emre/M-2907-2016
OI ARSLAN, Yavuz Emre/0000-0003-3445-1814; Elcin, Yasar
   Murat/0000-0003-1037-0825
CR AGRAWAL SM, 2001, J BIOMED MATER RES, V55, P145
   Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003
   Benatti BB, 2007, J BIOSCI BIOENG, V103, P1, DOI 10.1263/jbb.103.1
   ELEIN YM, 2003, TISSUE ENG STEM CELL
   Engelmayr GC, 2006, J BIOMECH ENG-T ASME, V128, P610, DOI 10.1115/1.2205371
   Fisher RJ, 2007, ADV BIOCHEM ENG BIOT, V103, P1, DOI 10.1007/10_018
   Grzesik WJ, 2002, CRIT REV ORAL BIOL M, V13, P474, DOI 10.1177/154411130201300605
   Hasegawa M, 2005, TISSUE ENG, V11, P469, DOI 10.1089/ten.2005.11.469
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Inanc B, 2006, TISSUE ENG, V12, P257, DOI 10.1089/ten.2006.12.257
   Inanc B, 2007, J BIOMED MATER RES A, V82A, P917, DOI 10.1002/jbm.a.31213
   Kao Richard T, 2005, J Calif Dent Assoc, V33, P205
   Kramer PR, 2004, J DENT RES, V83, P27, DOI 10.1177/154405910408300106
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   LI WJ, 2006, TISSUE CELL ORGAN EN, V9, P135
   LIU X, 2005, J BIOMED MATER RES A, V71, P84
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nakahara Taka, 2006, Dent Clin North Am, V50, P265, DOI 10.1016/j.cden.2005.11.004
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Sawa Y, 2000, TISSUE CELL, V32, P163, DOI 10.1054/tice.2000.0100
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yang YQ, 2006, FRONT BIOSCI, V11, P776, DOI 10.2741/1835
NR 25
TC 49
Z9 53
U1 2
U2 30
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 186
EP 195
DI 10.1002/jbm.a.32066
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700018
PM 18491392
DA 2018-10-19
ER

PT J
AU Perrotti, V
   Nicholls, BM
   Horton, MA
   Piattelli, A
AF Perrotti, Vittoria
   Nicholls, Brian M.
   Horton, Michael A.
   Piattelli, Adriano
TI Human osteoclast formation and activity on a xenogenous bone mineral
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone substitute materials; confocal microscopy; ELISA; osteoclasts;
   resorption
ID CALCIUM-PHOSPHATE CERAMICS; BOVINE BONE; IN-VITRO; SYNTHETIC
   HYDROXYAPATITE; SUBSTITUTE BIOMATERIALS; VITRONECTIN RECEPTOR;
   HISTOLOGIC-FINDINGS; SEALING ZONE; RESORPTION; INTERFACE
AB To date, the majority of studies on bone substitute materials have investigated their regenerative properties; however, little is known about their resorption processes, forasmuch as it is believed that the ideal biomaterial for bone regeneration must be completely resorbable. This study is aimed at defining, the in vitro resorption potential of human osteoclasts (OCLs) on a xenogenous bone mineral (XBM). Peripheral blood mortonuclear cells from healthy volunteers were used to generate OCLs in vitro in the presence of macrophage colony stimulating factor and receptor activator of NF-kappa B ligand on bovine bone slices and XBM. By using morphologic and biochemical methods, we observed that OCL formation occurred on XBM and these cells were positive for the major OCL marker. Regarding OCL activity, resorption pits were detected on XBM by reflection and confocal microscopy. However, biochemical analysis revealed that collagen degradation at day 14 and was significantly lower in XBM supernatants when compared to bovine bone, suggesting that XBM underwent a much slower resorption over time. These findings demonstrate that OCLs are generated on, attach to, and resorb XBM through more slowly than native bone, and suggest that cultured human OCLs could be used as a model for comparing resorption rates of bone substitute materials. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 238-246, 2009
C1 [Perrotti, Vittoria; Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Perrotti, Vittoria; Nicholls, Brian M.; Horton, Michael A.] UCL, London Ctr Nanotechnol, London, England.
   [Perrotti, Vittoria; Nicholls, Brian M.; Horton, Michael A.] UCL, Ctr Nanomed, London, England.
RP Piattelli, A (reprint author), Via Vestini 13, I-66100 Chieti, Italy.
EM apiattelli@unich.it
FU Wellcome Trust
CR Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   DEBRUIJN JD, 1994, J BIOMED MATER RES, V28, P105, DOI 10.1002/jbm.820280114
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   GROSS UM, 1990, BIOMATERIALS, V11, P83
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawahara H, 2004, J MATER SCI-MATER M, V15, P1297, DOI 10.1007/s10856-004-5738-0
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Lader CS, 2001, BRIT J HAEMATOL, V112, P430, DOI 10.1046/j.1365-2141.2001.02437.x
   LAKKAKORPI PT, 1991, J CELL BIOL, V115, P1179, DOI 10.1083/jcb.115.4.1179
   LAKKAKORPI PT, 1993, J CELL SCI, V104, P663
   Lane JM, 1998, AAOS INSTR COURS LEC, V47, P525
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Massey HM, 1999, BRIT J HAEMATOL, V106, P167
   Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586
   Nakamura I, 1999, J CELL SCI, V112, P3985
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Swiontkowski M, 1999, LANCET S1, V353, pS128
   TAKESHITA N, 1992, J ELECTRON MICROSC, V41, P141
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Vance GS, 2004, INT J ORAL MAX IMPL, V19, P491
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
NR 35
TC 27
Z9 27
U1 1
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 238
EP 246
DI 10.1002/jbm.a.32079
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700023
PM 18496862
DA 2018-10-19
ER

PT J
AU Sarkar, D
   Yailg, JC
   Sen Gupta, A
   Lopina, ST
AF Sarkar, Debanjan
   Yailg, Jui-Chen
   Sen Gupta, Anirban
   Lopina, Stephanie T.
TI Synthesis and characterization of L-tyrosine based polyurethanes for
   biomaterial applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE amino acid; L-tyrosine; polyurethanes; biomaterial; tissue engineering
ID ELASTOMERS; POLYCARBONATES; COPOLYMERS; POLYARYLATES; DESIGN; FILMS
AB The use of amino acid based polymers for biomaterial applications enhance biocompatibility and ensure biodegradability. Two polyurethanes based on L-tyrosine based diphenolic dipeptide, desaminotyrosyl tyrosine hexyl ester as chain extender are synthesized with polyethylene glycol (PEG) and polycaprolactone diol (PCL) as soft segment and hexamethylene diisocyanate as diisocyanate. The chemical structure and molecular characteristics of the polymers were studied by H-1 NMR, FTIR, and gel permeation chromatography. Results of DSC and TGA analysis were used for examining the thermal behavior of the polyurethanes. In addition, DSC results were used to analyze the morphology of the polymers, which shows characteristic microphase behavior of the polyurethanes. The tensile properties of the polyurethanes are primarily controlled by the soft segment and are higher in PCL based polymers. Contact angle, water vapor permeation, release of model drug, and water absorption characteristics of the polymers were studied and analyzed in terms of structure of the polyurethanes. In vitro degradation studies show that PEG based polyurethane is more degradable than PCL based polyurethane. The difference in the soft segment structure offers significant variation in the properties of the polyurethanes. These polyurethanes show the potential for use in a variety of biomaterial applications including tissue engineering. (C) 2008 Wiley Periodical, Inc. J Biomed Mater Res 90A: 263-271, 2009.
C1 [Sarkar, Debanjan; Yailg, Jui-Chen; Sen Gupta, Anirban; Lopina, Stephanie T.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
RP Lopina, ST (reprint author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
EM lopina@uakron.edu
RI Sarkar, Debanjan/C-6093-2017
OI Sarkar, Debanjan/0000-0002-6666-3152
CR Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   ANDERSON JM, 1985, BIOCOMPATIBILITY TIS, P67
   Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   HESKETH TR, 1980, POLYM ENG SCI, V20, P190, DOI 10.1002/pen.760200304
   Hu Y, 2001, J APPL POLYM SCI, V81, P1624, DOI 10.1002/app.1593.abs
   KEMNITZER J, 1997, HDB BIODEGRADABLE PO, P251
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1991, POLYM DRUG DRUG DEVI, P155
   Kohn J., 1984, POLYM MAT SCI ENG, P817
   Lelah M. D., 1986, POLYURETHANES MED
   LI C, 1989, MACROMOLECULES, V22, P2029, DOI 10.1021/ma00195a001
   PANCHENE JP, 2000, PRINCIPLES TISSUE EN, P263
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Shen E, 2001, BIOMATERIALS, V22, P201, DOI 10.1016/S0142-9612(00)00175-7
   SIEGMANN A, 1987, POLYM ENG SCI, V27, P1187, DOI 10.1002/pen.760271512
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Wang SH, 2003, MACROMOL SYMP, V197, P255, DOI 10.1002/masy.200350723
NR 22
TC 52
Z9 53
U1 3
U2 40
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 263
EP 271
DI 10.1002/jbm.a.32095
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700026
PM 18496869
DA 2018-10-19
ER

PT J
AU Jarrell, JD
   Dolly, B
   Morgan, JR
AF Jarrell, John D.
   Dolly, Brandon
   Morgan, Jeffrey R.
TI Controlled release of vanadium from titanium oxide coatings for improved
   integration of soft tissue implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE metal ion release; titanium oxide; fibroblast; bioactivity; sol-gel
   techniques
ID STAINLESS-STEEL; VANADATE; ORGANIZATION; FIBROBLASTS; INTERFACE;
   APOPTOSIS; STRENGTH; INSULIN; RATS
AB This study evaluates the potential of titanium oxide coatings for short-term delivery of vanadium for improved wound healing around implants. Titanium and vanadium oxides are bioactive agents that elicit different bioresponses in cells, ranging from implant integration and reduction of inflammation to modulation of cell proliferation and morphology. These oxides were combined in biomaterial coatings using metal-organic precursors and rapidly screened in cell-culture microplates to establish how vanadium-loading influences cell proliferation and morphology. Twenty-eight-day elution studies indicated that there was a controlled release of vanadium from stable titanium oxide matrices. Elution profiles were mathematically modeled for vanadium loading of 20-1.25% up to a period of 28 days. Scanning electron microscopy and energy dispersive spectroscopy of the coatings indicated that the vanadium was present as a nanoscale dispersion and not segregated micron-scale islands. The study confirmed that the observed bioresponse of cells was modulated by the soluble release of vanadium into the surrounding medium. Controlled release of vandium from titania coating may be used to influence soft-tissue integration of implants by modulating cell proliferation, attachment, inflammation, and wound healing dynainics. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 272-281, 2009
C1 [Jarrell, John D.; Dolly, Brandon; Morgan, Jeffrey R.] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.
RP Jarrell, JD (reprint author), Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.
EM msa_ri@verizon.net
OI Jarrell, John/0000-0001-8179-9456; Morgan, Jeffrey/0000-0002-7546-3443
CR BJURSTEN LM, 1991, INT WORKSH OSS SKEL, P25
   Brand RM, 1997, INT J PHARM, V146, P115, DOI 10.1016/S0378-5173(96)04781-3
   BRAND RM, 2000, AAPS PHARMSCI, V2, pF35
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   Chen J, 2006, KNEE SURG SPORT TR A, V14, P750, DOI 10.1007/s00167-006-0043-8
   Cortizo AM, 1997, BIOMETALS, V10, P127, DOI 10.1023/A:1018335324447
   EFFAH EAB, 1995, J BIOMED MATER RES, V29, P73, DOI 10.1002/jbm.820290111
   Ehrlich HP, 2001, PLAST RECONSTR SURG, V107, P471, DOI 10.1097/00006534-200102000-00024
   Ehrlich HP, 1999, ARCH SURG-CHICAGO, V134, P494, DOI 10.1001/archsurg.134.5.494
   Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61
   Garcia-Vicente S, 2007, DIABETES, V56, P486, DOI 10.2337/db06-0269
   Guo Zijian, 1999, Angew Chem Int Ed Engl, V38, P1512, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1512::AID-ANIE1512>3.0.CO;2-Y
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Huang CS, 2000, J BIOL CHEM, V275, P32516, DOI 10.1074/jbc.M005366200
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1554
   JARRELL JD, 2007, ORTHOPAEDIC RES SOC, V32, P1590
   Jarrell JD, 2007, J BIOMED MATER RES A, V83A, P853, DOI 10.1002/jbm.a.31446
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   Mackay DJD, 2003, WOUND REPAIR REGEN, V11, P204, DOI 10.1046/j.1524-475X.2003.11309.x
   Moyer KE, 2003, EXP MOL PATHOL, V75, P80, DOI 10.1016/S0014-4800(03)00031-5
   Overgaard L, 1998, J BONE JOINT SURG BR, V80B, P888, DOI 10.1302/0301-620X.80B5.8101
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   SHECHTER Y, 1999, DIABETES, V39, P1
   Srivastava AK, 2000, MOL CELL BIOCHEM, V206, P177, DOI 10.1023/A:1007075204494
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   Suzuki R, 2003, J BIOMED MATER RES A, V66A, P396, DOI 10.1002/jbm.a.10001
   SUZUKI R, 2000, CLIN ORTOP REL RES, V372, P280
   Takada Y, 2004, J PHARMACOL EXP THER, V311, P1249, DOI 10.1124/jpet.104.070839
   Thompson KH, 2006, J INORG BIOCHEM, V100, P1925, DOI 10.1016/j.jinorgbio.2006.08.016
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   ZIEGLER G, 2006, Patent No. 0161256
NR 36
TC 13
Z9 13
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 272
EP 281
DI 10.1002/jbm.a.32093
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700027
PM 18496866
DA 2018-10-19
ER

PT J
AU Zhao, XB
   Courtney, JM
AF Zhao, Xiaobin
   Courtney, James M.
TI Novel "anchor modification" of polymeric biomaterial surfaces by the
   utilization of cyclodextrin inclusion complex supramolecules
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE plasticized poly (vinyl chloride); surface modification; protein
   adsorption; cyclodextrins; cyclodextrin inclusion complex;
   supramolecules
ID ALPHA-CYCLODEXTRIN; COPOLYMERS; CHLORIDE; OXIDE
AB In this article, a novel approach for the surface modification of polymeric biomaterials by the utilization of supramolecules was studied. The supramolecules selected were cyclodextrin inclusion complexes (CICs). The biomaterial selected for surface modification was plasticized poly (vinyl chloride) (PVC-P). Results indicate that when the CICs were blended into PVC-P, they tend to migrate and "anchor" on the surface to achieve a remarkable protein-resistant surface, with improved blood compatibility. In comparison with a physical mixture of cyclodextrins and a "guest" molecule, such as poly(ethylene oxide) (PEO)-poly(propylene oxide) (PPO)-PEO and PPO-PEO-PPO for PVC-P modification, CICs modified PVC-P are more consistent in processing and achieve reproducible surface characteristics. Based on this study, a novel "anchor modification" was proposed regarding CICs modified surface. This "anchor modification" is likely to reduce plasticizer extraction from PVC-P and also can be utilized for the modification of polymers other than PVC-P. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 282-291, 2009
C1 [Zhao, Xiaobin; Courtney, James M.] Univ Strathclyde, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland.
RP Zhao, XB (reprint author), Univ Strathclyde, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland.
EM xiaobin.zhao@strath.ac.uk
CR Courtney JM, 1999, PERFUSION-UK, V14, P263, DOI 10.1177/026765919901400405
   Gaitano GG, 1997, J PHYS CHEM B, V101, P710, DOI 10.1021/jp961996w
   Harada A, 1997, CARBOHYD POLYM, V34, P183, DOI 10.1016/S0144-8617(97)00023-4
   HARADA A, 1990, MACROMOLECULES, V23, P2821, DOI 10.1021/ma00212a039
   HARADA A, 1990, J CHEM SOC CHEM COMM, P1321
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Lakshmi S, 1998, ARTIF ORGANS, V22, P222, DOI 10.1046/j.1525-1594.1998.06124.x
   Lemos-Senna E, 1998, INT J PHARM, V170, P119, DOI 10.1016/S0378-5173(98)00147-1
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Li JT, 1996, ADV CHEM SER, V248, P61
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   TOPCHIEVA IN, 1994, VYSOKOMOL SOEDIN, V36, P271
   TOPCHIEVA IN, 1993, VYSOKOMOL SOEDIN A, V35, P395
   Zhao XB, 2003, J MATER SCI-MATER M, V14, P905, DOI 10.1023/A:1025690828200
   Zhao X, 2008, J MATER SCI-MATER M, V19, P713, DOI 10.1007/s10856-007-3191-6
   Zhao XB, 2007, J BIOMED MATER RES A, V80A, P539, DOI 10.1002/jbm.a.30925
NR 16
TC 4
Z9 4
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 282
EP 291
DI 10.1002/jbm.a.32020
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700028
PM 18508336
DA 2018-10-19
ER

PT J
AU Munoz-Pinto, DJ
   Bulick, AS
   Hahn, MS
AF Munoz-Pinto, Dany J.
   Bulick, Allen S.
   Hahn, Mariah S.
TI Uncoupled investigation of scaffold modulus and mesh size on smooth
   muscle cell behavior
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyethylene glycol hydrogels; cell-biomaterial interactions; modulus;
   mesh size; rational scaffold design
ID POLY(ETHYLENE GLYCOL) HYDROGELS; DIAMETER VASCULAR GRAFTS; MESENCHYMAL
   STEM-CELLS; GENE-EXPRESSION; CHONDROCYTE METABOLISM; ENDOTHELIAL-CELLS;
   DIFFERENTIATION; NETWORKS; PROTEIN; RHOA
AB Although scaffold material properties are known to critically impact cell behavior, it has proven difficult to correlate specific cell responses to isolated scaffold parameters, inhibiting rational design of scaffold material properties. The aim of this study was to validate a systematic approach for evaluating the influence of initial scaffold modulus and mesh size on cell extracellular matrix (ECM) deposition and phenotype. Poly(ethylene glycol) diacrylate (PEGDA) hydrogels were selected for this study because of their tunable material properties. Following screening of six distinct PEGDA hydrogels, three formulations were identified which permitted uncoupled investigation of scaffold mesh size and modulus within the target incremental modulus range of similar to 100-300 kPa. Smooth muscle cells (SMCs) Were encapsulated within these three formulations, and cell ECM deposition and phenotype were evaluated following 21 days of culture. Although elastin content appeared to be correlated with scaffold mesh size mid modulus to a similar degree, levels of collagen and serum response factor (SRF), a key regulator of SMC phenotype, were more strongly correlated with mesh size. To gain insight into the cell signaling underlying these observed correlations, variations in cell metabolic state and in RhoA signaling were semi-quantitatively evaluated. Both RhoA activity, which is largely modulated by scaffold mechanics in 2D, and cell metabolic activity were highly correlated with hydrogel mesh size. These results indicate that the effects of scaffold mechanics on RhoA activity in 3D may be distinct from those in 2D and underscore the need for uncoupled investigation of scaffold parameters on cell behavior. Furthermore, the present data suggest that RhoA signaling and cell metabolic regulation may be closely linked. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 303-316, 2009
C1 [Munoz-Pinto, Dany J.; Bulick, Allen S.; Hahn, Mariah S.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.
   [Hahn, Mariah S.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
RP Hahn, MS (reprint author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.
EM mhahn@tamu.edu
RI Hahn, Mariah/G-3998-2014
OI Hahn, Mariah/0000-0001-8794-129X
CR Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746
   Bryant SJ, 2005, ACTA BIOMATER, V1, P243, DOI 10.1016/j.actbio.2004.11.003
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   BURKEL WE, 1989, MED PROG TECHNOL, V14, P165
   Calo LA, 2007, J HYPERTENS, V25, P259, DOI 10.1097/HJH.0b013e328010d4d2
   CANAL T, 1989, J BIOMED MATER RES, V23, P1183, DOI 10.1002/jbm.820231007
   Carson JA, 2003, BBA-GENE STRUCT EXPR, V1628, P133, DOI 10.1016/S0167-4781(03)00122-2
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GOODRICH RP, 1992, P NATL ACAD SCI USA, V89, P967, DOI 10.1073/pnas.89.3.967
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   Hahn MS, 2007, ANN BIOMED ENG, V35, P190, DOI 10.1007/s10439-006-9099-3
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hahn MS, 2006, BIOMATERIALS, V27, P1104, DOI 10.1016/j.biomaterials.2005.07.022
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   KEMPEZINSKI R, 2000, VASCULAR SURG
   Kibbe MR, 2000, J VASC SURG, V31, P1214, DOI 10.1067/mva.2000.105006
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598
   Koh WG, 2003, ANAL CHEM, V75, P5783, DOI 10.1021/ac034773s
   Lee HJ, 2007, ONCOGENE, V26, P173, DOI 10.1038/sj.onc.1209774
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Lu X, 2004, AM J PHYSIOL-HEART C, V287, pH1663, DOI 10.1152/ajpheart.00226.2004
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Metters AT, 2000, J PHYS CHEM B, V104, P7043, DOI 10.1021/jp000523t
   Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814
   MIANO M, 2007, AM J PHYSIOL-CELL PH, V292, pC70
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Ren XD, 2000, METHOD ENZYMOL, V325, P264
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5
   Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004
   Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510
   Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382
   Watkins AW, 2005, MACROMOLECULES, V38, P1326, DOI 10.1021/ma0475232
   Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287
   Weirich J, 2001, CELL CALCIUM, V29, P359, DOI 10.1054/ceca.2001.0198
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Won JS, 2003, J NEUROSCI, V23, P7470
   Zhang ZQ, 2000, J BIOL CHEM, V275, P40042, DOI 10.1074/jbc.M007505200
   Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X
NR 56
TC 31
Z9 31
U1 2
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2009
VL 90A
IS 1
BP 303
EP 316
DI 10.1002/jbm.a.32492
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 453YL
UT WOS:000266648700030
PM 19402139
DA 2018-10-19
ER

PT J
AU Aboushwareb, T
   Eberli, D
   Ward, C
   Broda, C
   Holcomb, J
   Atala, A
   Van Dyke, M
AF Aboushwareb, Tamer
   Eberli, Daniel
   Ward, Catherine
   Broda, Christopher
   Holcomb, John
   Atala, Anthony
   Van Dyke, Mark
TI A Keratin Biomaterial Gel Hemostat Derived from Human Hair: Evaluation
   in a Rabbit Model of Lethal Liver Injury
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE keratin; hemostasis; hemostat; liver injury; hemorrhage
ID GROIN INJURY; VENOUS HEMORRHAGE; HEPATIC-INJURY; ANIMAL-MODEL;
   BLOOD-LOSS; SWINE; DRESSINGS; WOOL; SURVIVAL; BANDAGE
AB Effective hemostatic dressings that are compatible with tissues are needed. Keratins are a class of biomaterials that can be derived by extraction of proteins from human hair. We have recently discovered that keratin biomaterials have hemostatic characteristics and hypothesize that a keratin hydrogel having the ability to absorb fluid and bind cells may be an effective hemostat. The goal of this study was to test a keratin hydrogel and evaluate it compared to current hemostats. Thirty-two New Zealand white rabbits received a lethal liver injury. Eight animals each were assigned to negative control, QuickClotu (R), HemCon (R) bandage, and keratin treatment groups. Vital stats and other data were recorded during surgery and all surviving animals were sacrificed after 72 h. Histology was conducted on all surviving animals. Twenty-four-hour survival rates were 0%, 62.5%, 62.5%, anti 75% for the negative control, QuickClot, HemCon, and keratin groups, respectively. Other outcomes included blood loss, mean arterial pressure, heart rate, shock index, and liver histology. All of the hemostats were statistically better than the negative control group at late operative time points. The keratin group consistently performed as well as, or better than, the commercial hemostats. Histology showed an interesting healing response at the hemostat-liver interface in the keratin group. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Apt Biomater 90B: 45-54, 2009
C1 [Aboushwareb, Tamer; Eberli, Daniel; Ward, Catherine; Broda, Christopher; Atala, Anthony; Van Dyke, Mark] Wake Forest Univ, Wake Forest Inst Regenerat Med, Sch Med, Winston Salem, NC 27157 USA.
   [Holcomb, John] USA, Inst Surg Res, Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA.
RP Van Dyke, M (reprint author), Wake Forest Univ, Wake Forest Inst Regenerat Med, Sch Med, Winston Salem, NC 27157 USA.
EM mavandyk@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160
CR Ahuja N, 2006, J TRAUMA, V61, P1312, DOI 10.1097/01.ta.0000240597.42420.8f
   Alam HB, 2004, J TRAUMA, V56, P974, DOI 10.1097/01.TA.0000127763.90890.31
   Alam HB, 2003, J TRAUMA, V54, P1077, DOI 10.1097/01.TA.0000068258.99048.70
   Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   BENNETT HPJ, 1986, J CHROMATOGR, V359, P221, DOI 10.1016/0021-9673(86)80076-0
   Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029
   Carson JL, 2002, TRANSFUS MED REV, V16, P187, DOI 10.1053/tmrv.2002.33461
   Connolly RJ, 2004, J TRAUMA, V57, pS26, DOI 10.1097/01.TA.0000136746.97192.B2
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   de Queiroz AAA, 2003, J BIOMED MATER RES A, V64A, P147, DOI 10.1002/jbm.a.10265
   Fujii T, 2008, J MATER SCI-MATER M, V19, P2335, DOI 10.1007/s10856-007-3341-x
   Goddard DR, 1934, J BIOL CHEM, V106, P605
   ITO H, 1982, KOBUNSHI RONBUNSHU, V39, P249, DOI 10.1295/koron.39.249
   Kheirabadi BS, 2005, J TRAUMA, V59, P25, DOI 10.1097/01.TA.0000171458.72037.EE
   King DR, 2004, J TRAUMA, V57, P756, DOI 10.1097/01.TA.0000147501.64610.AF
   Martinowitz U, 2001, J TRAUMA, V50, P721, DOI 10.1097/00005373-200104000-00021
   MIES HH, 1987, J CHROMATOGR, V405, P365, DOI 10.1016/S0021-9673(01)81778-7
   Neel S, 1991, MED SUPPORT US ARMY
   Neuffer MC, 2004, MIL MED, V169, P716, DOI 10.7205/MILMED.169.9.716
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Peake JB, 2005, NEW ENGL J MED, V352, P219, DOI 10.1056/NEJMp048312
   Pusateri AE, 2004, J TRAUMA, V57, P555, DOI 10.1097/01.TA.0000136155.97758.CD
   Pusateri AE, 2003, J TRAUMA, V55, P518, DOI 10.1097/01.TA.0000075336.92129.27
   Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/01.TA.0000032512.04647.C6
   Regel G, 1997, Acta Anaesthesiol Scand Suppl, V110, P71
   Robinson Kathy, 2004, J Emerg Nurs, V30, P160, DOI 10.1016/j.jen.2004.01.004
   Rothwell SW, 2003, THROMB RES, V108, P335
   Schreiber MA, 2002, J TRAUMA, V53, P252, DOI 10.1097/01.TA.0000022087.35916.9F
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   SIMMONDS DH, 1958, TEXT RES J, V28, P314
   Sondeen JL, 2003, J TRAUMA, V54, P280, DOI 10.1097/01.TA.0000037431.19185.B4
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   Turner AS, 2002, J BIOMED MATER RES, V63, P37, DOI 10.1002/jbm.10081
   Vournakis JN, 2003, J SURG RES, V113, P1, DOI 10.1016/S0022-4804(03)00161-6
   Zimmerman L. M., 1993, GREAT IDEAS HIST SUR
NR 36
TC 63
Z9 64
U1 5
U2 51
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2009
VL 90B
IS 1
BP 45
EP 54
DI 10.1002/jbm.b.31251
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461UU
UT WOS:000267298500006
PM 18988274
DA 2018-10-19
ER

PT J
AU Heiss, C
   Kraus, R
   Peters, F
   Henn, W
   Schnabelrauch, M
   Berg, A
   Pautzsch, T
   Weisser, J
   Schnettler, R
AF Heiss, C.
   Kraus, R.
   Peters, F.
   Henn, W.
   Schnabelrauch, M.
   Berg, A.
   Pautzsch, T.
   Weisser, J.
   Schnettler, R.
TI Development of a Bioresorbable Self-Hardening Bone Adhesive Based on a
   Composite Consisting of Polylactide Methacrylates and beta-Tricalcium
   Phosphate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adhesion; bone regeneration; calcium phosphate; composite; polylactic
   acid
ID ALKYLENE BIS(DILACTOYL)-METHACRYLATE; IN-VIVO; SCREW AUGMENTATION;
   APATITE
AB In this work, a novel bioresorbable bone adhesive based on radically polymerizable polylactide with methacrylate endgroups known from polymethylmethacrylate (PMMA) cements and varying amounts of bioresorbable/biodegradable lactide moieties was developed. The swelling and degradation properties as well as the hardening time, viscosity, and adhesion properties (tension and shear resistance) were subsequently measured in vitro and optimized. For a broad use in surgery the handling properties, the shelf life and the storage temperature are important issues. The finally developed material consists of three substances that have to be mixed to start the reaction: a highly viscous mixture of oligomers and two beta-tricalcium phosphate (beta-TCP, Cerasorl (R)) powders with the radical starter and the promoter. The material has a processing time of 2 min and is completely cured after another minute. The tension and shear resistance of the material is 3.1-13.9 MPa that will decrease by storing the substance in a humid atmosphere. Degradation experiments showed a mass loss of 20-35% during the first 5 weeks. Tests with MC3T3-E1 cells showed an increase of the alkaline phosphatase activity over a period of 14 days. The mechanical and handling properties and the in vitro data are showing a promising biomaterial for bone regeneration. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 90B: 55-66, 2009
C1 [Heiss, C.; Kraus, R.; Schnettler, R.] Univ Hosp Giessen Marburg, Dept Trauma Surg, Lab Expt Trauma Surg, D-35385 Giessen, Germany.
   [Peters, F.; Henn, W.] Curasan AG, D-63801 Kleinostheim, Bavaria, Germany.
   [Schnabelrauch, M.; Berg, A.; Pautzsch, T.; Weisser, J.] INNOVENT Technol Entwicklung eV, D-07745 Jena, Germany.
RP Heiss, C (reprint author), Univ Hosp Giessen Marburg, Dept Trauma Surg, Lab Expt Trauma Surg, D-35385 Giessen, Germany.
EM christian.heiss@chiru.med.uni-giessen.de
FU German Ministry of Economy and Employment [KA 01432011-11-5]
FX Contract grant sponsor: German Ministry of Economy and Employment;
   Contract grant number: KA 01432011-11-5
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRANDEIS E, 1993, J MATER SCI-MATER M, V4, P543, DOI 10.1007/BF00125591
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   GIEBEL G, 1981, BIOMED TECH, V26, P35, DOI 10.1515/bmte.1981.26.3.35
   Grossterlinden L, 2006, BIOMATERIALS, V27, P3379, DOI 10.1016/j.biomaterials.2006.01.051
   Heiss C, 2005, BIOMATERIALS, V26, P1389, DOI 10.1016/j.biomaterials.2004.04.048
   Heiss C, 2004, BIOMED TECH, V49, P163, DOI 10.1515/BMT.2004.031
   Heiss C, 2006, EUR J TRAUMA, V32, P141
   *ICDD, 2005, 55898 ICDD
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P701, DOI 10.1002/jbm.10024
   Ignatius AA, 2005, J BIOMED MATER RES B, V75B, P128, DOI 10.1002/jbm.b.30274
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   Kim BS, 2000, BIOMATERIALS, V21, P259, DOI 10.1016/S0142-9612(99)00174-X
   Kuhn K. D., 2000, BONE CEMENTS
   LEEMANN RA, 1961, SCHWEIZ MED WSCHR, V91, P908
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   Peters F, 2004, MATERIALWISS WERKST, V35, P203, DOI 10.1022/mawe.200400735
   RIETZ K A, 1964, Acta Chir Scand, V128, P387
   VENKATA MN, 2004, BIOMATERIALS, V25, P3283
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
NR 20
TC 7
Z9 7
U1 1
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2009
VL 90B
IS 1
BP 55
EP 66
DI 10.1002/jbm.b.31252
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 461UU
UT WOS:000267298500007
PM 18985775
DA 2018-10-19
ER

PT J
AU Tseng, SJ
   Lee, YH
   Chen, ZH
   Lin, HH
   Lin, CY
   Tang, SC
AF Tseng, S-ja
   Lee, Ying-Hui
   Chen, Zhi-Hao
   Lin, Hui-Hao
   Lin, Chih-Yung
   Tang, Shiue-Cheng
TI Integration of optical clearing and optical sectioning microscopy for
   three-dimensional imaging of natural biomaterial scaffolds in thin
   sections
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE confocal microscopy; collagen; chitosan; cellulose; three-dimensional
   (3-D) microscopy
ID DROSOPHILA MUSHROOM BODY; BOVINE SERUM-ALBUMIN; TISSUE; CHITOSAN;
   TOMOGRAPHY; CELLULOSE; DELIVERY; COLLAGEN; BINDING; AGENTS
AB The intrinsic turbidity of scaffolds formed by natural biomaterials such as collagen fibers prevents high-resolution light microscopy in depth. In this research, we have developed a new method of using light microscopy for penetrative three-dimensional (3-D) visualization of scaffolds formed by collagen, chitosan, or cellulose. First, we applied an optical-clearing solution, FocusClear, to permeate and reduce the turbidity of the scaffolds. The improved photon penetration allowed fluorophores for efficient excitation and emission in the FocusClear solution. Confocal microscopy was applied to achieve cellular-level resolution up to 350 mu m for both the fibroblast/collagen and the osteoblast/chitosan constructs and micrometer-level resolution up to 40 mu m for the cellulose membrane. The depth of imaging of the cellulose membrane was further improved to 80 mu m using two-photon microscopy. Significantly, these voxel-based confocal/two-photon micrographs allowed postrecording image processing via Amira projection algorithms for 3-D visualization and analysis of the scanned region. Although this optical method remains limited in viewing block scaffolds in thin sections, our approach provides a non-invasive way to microscopically examine the scaffold structure, which would be a valuable tool to studying biomaterials and their interactions with the molecule/cell of interest within the scaffold in an integrated fashion. (C) 2009 Society of Photo-Optical Instrumentation Engineers. [DOI: 10.1117/1.3158998]
C1 [Tseng, S-ja; Lee, Ying-Hui; Chen, Zhi-Hao; Tang, Shiue-Cheng] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
   [Lin, Hui-Hao; Lin, Chih-Yung] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.
   [Lin, Hui-Hao; Lin, Chih-Yung] Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu 30013, Taiwan.
RP Tang, SC (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
EM sctang@che.nthu.edu.tw
RI Tseng, S.-Ja/F-9414-2012
OI Tseng, S.-Ja/0000-0002-1299-7202
FU National Science Council, Taiwan [NSC 96-3112-B-007-005, NSC
   97-2221-E-007-041-MY2]; National Tsing Hua University, Taiwan
FX This work was supported in part by grants from the National Science
   Council, Taiwan (NSC 96-3112-B-007-005 and NSC 97-2221-E-007-041-MY2)
   and the Research Development Program, National Tsing Hua University,
   Taiwan. We thank Dr. Ann-Shyn Chiang and Dr. Hsiu-Ming Chang at NTHU for
   supporting the imaging techniques.
CR Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815
   Cunha-Reis C, 2007, J MATER SCI-MATER M, V18, P195, DOI 10.1007/s10856-006-0681-x
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Ferrando M, 2005, J MEMBRANE SCI, V250, P283, DOI 10.1016/j.memsci.2004.10.043
   Gareau DS, 2004, J BIOMED OPT, V9, P254, DOI 10.1117/1.1645798
   Genina EA, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2899149
   Ghosn MG, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907699
   Harrington BJ, 2003, LAB MED, V34, P361, DOI 10.1309/EPH2TDT8335GH0R3
   Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818
   Jiang JY, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2899153
   LaComb R, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907207
   Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817
   Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006
   Liu YC, 2003, METHODS, V30, P86, DOI 10.1016/S1046-2023(03)00010-0
   Mao ZZ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2892684
   MOULTON K, 2005, J BIOMED OPT, V11
   MURATA M, 1993, BIOSCI BIOTECH BIOCH, V57, P43, DOI 10.1271/bbb.57.43
   Oldham M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907968
   Oldham M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2709858
   Sakhalkar HS, 2007, PHYS MED BIOL, V52, P2035, DOI 10.1088/0031-9155/52/8/001
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P2665, DOI 10.1021/bm7006983
   Schulmerich MV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2892687
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Tseng SJ, 2007, BIOCONJUGATE CHEM, V18, P1383, DOI 10.1021/bc060382j
   van Reis R, 2007, J MEMBRANE SCI, V297, P16, DOI 10.1016/j.memsci.2007.02.045
   Vargas G, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907327
   Veerman C, 2003, INT J BIOL MACROMOL, V31, P139, DOI 10.1016/S0141-8130(02)00074-0
   Vogel G, 2008, SCIENCE, V322, P176, DOI 10.1126/science.322.5899.176
   Wang RKK, 2001, J OPT SOC AM B, V18, P948, DOI 10.1364/JOSAB.18.000948
   Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008
   Wang ZH, 2008, J MEMBRANE SCI, V310, P141, DOI 10.1016/j.memsci.2007.10.048
   Wickramasinghe SR, 2006, J MEMBRANE SCI, V281, P609, DOI 10.1016/j.memsci.2006.04.032
   Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005
   Yeh AT, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2166381
NR 37
TC 13
Z9 13
U1 0
U2 5
PU SPIE-SOC PHOTOPTICAL INSTRUMENTATION ENGINEERS
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD JUL-AUG
PY 2009
VL 14
IS 4
AR 044004
DI 10.1117/1.3158998
PG 9
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 503MV
UT WOS:000270540100011
PM 19725716
DA 2018-10-19
ER

PT J
AU Makaya, K
   Terada, S
   Ohgo, K
   Asakura, T
AF Makaya, Kumiko
   Terada, Shinichi
   Ohgo, Kosuke
   Asakura, Tetsuo
TI Comparative study of silk fibroin porous scaffolds derived from
   salt/water and sucrose/hexafluoroisopropanol in cartilage formation
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Biomaterial; Tissue engineering; Bombyx mori; Silk fibroin; Cartilage;
   Scaffold
ID IN-VITRO; BOMBYX-MORI; AURICULAR RECONSTRUCTION; FIBROBLAST CELLS;
   GROWTH; FILMS; ATTACHMENT; FIBERS; CHONDROCYTES; DEGRADATION
AB The purpose of this study is to create a new silk fibroin scaffold with sufficient three-dimensional morphology and porous structure for cartilage formation. We have applied sucrose particles sized around 300 to 500 pm as porogens compared to equal-sized salt particles. After the porogen was leached out with water, scaffolds were prepared with fibroin derived from sucrose/hexafluoroisopropanol (Su/H) or salt/water (Sa/W) based composites. A compression test indicated that the Sa/W fibroin was much harder than the Su/H fibroin, but a protease enzyme digested the Sa/W fibroin more quickly than Su/H fibroin. Rabbit ear chondrocytes were seeded onto the scaffolds for 4-8 week in vitro culture and histological analyses were performed. The distribution of cartilage formation in Safranin O staining was more homogenous in Su/H fibroin than that of Sa/W fibroin. The overall amount of cartilage was significantly better in the Su/H fibroin than that in the Sa/W fibroin. However, the inner structure of pore wall in the Sa/W fibroin was rough and microporous with cartilage matrix deposition, while that in the Su/H fibroin was thin and homogenous. Since mature cartilage gradually regenerates to fill the porous space, slowly degradable Su/H fibroin should be a better candidate for cartilage formation. (C) 2009, The Society for Biotechnology, Japan. All rights reserved.
C1 [Makaya, Kumiko; Ohgo, Kosuke; Asakura, Tetsuo] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan.
   [Terada, Shinichi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Chiba 2768524, Japan.
RP Asakura, T (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan.
EM asakura@cc.tuat.ac.jp
RI Asakura, Tetsuo/B-9970-2013
FU Scientific Research [18105007]
FX T. A. acknowledges partial support from Grants-in-Aid for Scientific
   Research (S) (No. 18105007), Japan.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Asakura T. K., 1994, ENCY AGR SCI
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   DAL PI, 2003, TISSUE ENG, V9, P1113
   Drummy LF, 2005, BIOMACROMOLECULES, V6, P3328, DOI 10.1021/bm0503524
   Habiballah JA, 2000, SAUDI MED J, V21, P1173
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x
   Luan XY, 2006, BIOMED MATER, V1, P181, DOI 10.1088/1748-6041/1/4/001
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MIN L, 2008, J BIOMED MATER RES A, V87, P1010
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Romo Thomas 3rd, 2006, Facial Plast Surg Clin North Am, V14, P129, DOI 10.1016/j.fsc.2006.01.006
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   Taddei P, 2006, BIOMACROMOLECULES, V7, P259, DOI 10.1021/bm0506290
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Terada S, 2005, ANN PLAS SURG, V55, P196, DOI 10.1097/01.sap.0000164388.33965.4e
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Zhao CH, 2003, BIOPOLYMERS, V69, P253, DOI 10.1002/bip.10350
NR 31
TC 67
Z9 74
U1 1
U2 36
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JUL
PY 2009
VL 108
IS 1
BP 68
EP 75
DI 10.1016/j.jbiosc.2009.02.015
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 487LD
UT WOS:000269274800014
PM 19577196
DA 2018-10-19
ER

PT J
AU Jeong, Y
   Joo, MK
   Bahk, KH
   Choi, YY
   Kim, HT
   Kim, WK
   Lee, HJ
   Sohn, YS
   Jeong, B
AF Jeong, Yuri
   Joo, Min Kyung
   Bahk, Kyung Hyun
   Choi, Yun Young
   Kim, Ho-Tae
   Kim, Won-Ki
   Lee, Hwa Jeong
   Sohn, Youn Soo
   Jeong, Byeongmoon
TI Enzymatically degradable temperature-sensitive polypeptide as a new
   in-situ gelling biomaterial
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Sol-gel transition; Polypeptide; Enzymatic degradability; Polymer;
   Hydrogel
ID COPOLYMER AQUEOUS-SOLUTIONS; BOVINE BETA-LACTOGLOBULIN; HYBRID
   BLOCK-COPOLYMERS; REVERSIBLE HYDROGELS; PHASE-TRANSITION; DRUG-DELIVERY;
   PEPTIDE; GELATION; PEG; SEQUENCES
AB We are reporting a poly (ethylene glycol) -block-poly(alanine-co-phenyl alanine) (PEG-PAF) aqueous solution that undergoes sol-to-gel transition as the temperature increases. The sol-to-gel transition was observed at as low a concentration as 3.0-7.0 wt%. Micellar aggregation accompanying small conformational changes of the peptide from random coils to beta-sheets is suggested as the sol-to-gel transition mechanism of the PEG-PAF aqueous solution. The PEG-PAF is stable in phosphate buffered saline, however, it degraded in the subcutaneous layer of rats. In vitro study showed that proteolytic enzymes such as cathepsin B, cathepsin C, and elastase that are present in the subcutaneous layer of the mammalian tissue might be responsible for the degradation of the polymer in rats. As a feasibility study of this material, a single shot of an aqueous insulin formulation (13.8 mg insulin/kg) showed a hypoglycemic effect over 18 days in rats. The current functional polypeptide may be very promising as an in-situ gelling system for tissue engineering, cell/stem cell therapy, and drug delivery. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Jeong, Yuri; Joo, Min Kyung; Bahk, Kyung Hyun; Choi, Yun Young; Sohn, Youn Soo; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul 120750, South Korea.
   [Kim, Ho-Tae] Kumoh Natl Inst Technol, Dept Appl Chem, Yangho Dong 730701, Gumi, South Korea.
   [Kim, Won-Ki] Korea Univ, Dept Neurosci, Seoul, South Korea.
   [Lee, Hwa Jeong] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem & Nano Sci, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
FU Korea Research Foundation [KRF-2008-313-C00590]; Korea government (MEST)
   [R11-2005-008-00000-00, R01-2007-000-20141-0]; Seoul Science Fellowship
FX This work was supported by the Korea Research Foundation (Grant number
   KRF-2008-313-C00590), Korea Science and Engineering Foundation grant
   (KOSEF) funded by the Korea government (MEST) (Grant:
   R11-2005-008-00000-00 and R01-2007-000-20141-0). YJ and MKJ equally
   contributed to the paper. MKJ was supported by the Seoul Science
   Fellowship.
CR Booth C, 2000, MACROMOL RAPID COMM, V21, P501, DOI 10.1002/1521-3927(20000601)21:9<501::AID-MARC501>3.0.CO;2-R
   Braga PC, 2006, PHARMACOLOGY, V77, P130, DOI 10.1159/000093790
   Charman SA, 2000, J PHARM SCI, V89, P168, DOI 10.1002/(SICI)1520-6017(200002)89:2<168::AID-JPS4>3.0.CO;2-Q
   Cheng V, 2007, J APPL POLYM SCI, V106, P1201, DOI 10.1002/app.26760
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Gezimati J, 1996, J AGR FOOD CHEM, V44, P804, DOI 10.1021/jf950445k
   Hamley IW, 2008, ADV MATER, V20, P4394, DOI 10.1002/adma.200800266
   Hamley IW, 2005, BIOMACROMOLECULES, V6, P1310, DOI 10.1021/bm049286g
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hong YH, 2007, J AGR FOOD CHEM, V55, P5653, DOI 10.1021/jf070564n
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong B, 2003, J PHYS CHEM B, V107, P10032, DOI 10.1021/jp027339n
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2001, CHEM COMMUN, P1516, DOI 10.1039/b102819g
   Jeong Y, 2007, ADV MATER, V19, P3947, DOI 10.1002/adma.200700149
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kim SY, 2007, MACROMOLECULES, V40, P5519, DOI 10.1021/ma070190z
   Klok HA, 2002, ANGEW CHEM INT EDIT, V41, P1509, DOI 10.1002/1521-3773(20020503)41:9<1509::AID-ANIE1509>3.0.CO;2-K
   Klok HA, 2000, MACROMOLECULES, V33, P7819, DOI 10.1021/ma0009606
   Kopecek J, 2003, EUR J PHARM SCI, V20, P1, DOI 10.1016/S0928-0987(03)00164-7
   Lao UL, 2007, BIOMACROMOLECULES, V8, P3736, DOI 10.1021/bm700662n
   Lim YB, 2007, ANGEW CHEM INT EDIT, V46, P3475, DOI 10.1002/anie.200604576
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   MCSWINEY M, 1994, FOOD HYDROCOLLOID, V8, P441, DOI 10.1016/S0268-005X(09)80087-8
   Morihara Y, 2005, J POLYM SCI POL CHEM, V43, P6048, DOI 10.1002/pola.21097
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Sarvestani AS, 2007, BIOMACROMOLECULES, V8, P406, DOI 10.1021/bm060648p
   Soyez H, 1996, ADV DRUG DELIVER REV, V21, P81, DOI 10.1016/S0169-409X(96)00400-0
   Takeuchi Y, 2006, J POLYM SCI POL CHEM, V44, P671, DOI 10.1002/pola.21189
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Yamaoka T, 2003, BIOMACROMOLECULES, V4, P1680, DOI 10.1021/bm0341201
   Yang H, 2006, LANGMUIR, V22, P8553, DOI 10.1021/la061238p
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
NR 43
TC 89
Z9 92
U1 4
U2 72
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUL 1
PY 2009
VL 137
IS 1
BP 25
EP 30
DI 10.1016/j.jconrel.2009.03.008
PG 6
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 465XY
UT WOS:000267624900006
PM 19306901
DA 2018-10-19
ER

PT J
AU Agnarsson, I
   Dhinojwala, A
   Sahni, V
   Blackledge, TA
AF Agnarsson, Ingi
   Dhinojwala, Ali
   Sahni, Vasav
   Blackledge, Todd A.
TI Spider silk as a novel high performance biomimetic muscle driven by
   humidity
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE supercontraction; major ampullate silk; biomaterial; Nephila clavipes
ID MECHANICAL-PROPERTIES; ARTIFICIAL MUSCLES; DRAGLINE SILK;
   SUPERCONTRACTION; SEQUENCE; FIBERS; WATER
AB The abrupt halt of a bumble bee's flight when it impacts the almost invisible threads of an orb web provides an elegant example of the amazing strength and toughness of spider silk. Spiders depend upon these properties for survival, yet the impressive performance of silk is not limited solely to tensile mechanics. Here, we show that silk also exhibits powerful cyclic contractions, allowing it to act as a high performance mimic of biological muscles. These contractions are actuated by changes in humidity alone and repeatedly generate work 50 times greater than the equivalent mass of human muscle. Although we demonstrate that this response is general and occurs weakly in diverse hydrophilic materials, the high modulus of spider silk is such that it generates exceptional force. Furthermore, because this effect already operates at the level of single silk fibers, only 5 mu m in diameter, it can easily be scaled across the entire size range at which biological muscles operate. By contrast, the most successful synthetic muscles developed so far are driven by electric voltage, such that they cannot scale easily across large ranges in cross-sectional areas. The potential applicability of silk muscles is further enhanced by our finding that silkworm fibers also exhibit cyclic contraction because they are already available in commercial quantities. The simplicity of using wet or dry air to drive the biomimetic silk muscle fibers and the incredible power generated by silk offer unique possibilities in designing lightweight and compact actuators for robots and micro-machines, new sensors, and green energy production.
C1 [Agnarsson, Ingi; Blackledge, Todd A.] Univ Akron, Integrated Biosci Program, Dept Biol, Akron, OH 44325 USA.
   [Dhinojwala, Ali; Sahni, Vasav] Univ Akron, Integrated Biosci Program, Dept Polymer Sci, Akron, OH 44325 USA.
   [Agnarsson, Ingi] Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA.
RP Blackledge, TA (reprint author), Univ Akron, Integrated Biosci Program, Dept Biol, Akron, OH 44325 USA.
EM blackledge@uakron.edu
FU National Science Foundation [DBI-0521261, IOS-0745379, DEB-0516038,
   DMR-0512156]; Slovenian Research Agency research fellowship
   [Z1-9799-0618-07]; Integrated Bioscience Program at University of Akron
FX We thank Linden Higgins and Claire Ritschoff for supplying spiders.
   Cecilia Boutry and Victoria Sain assisted with collection of data for
   non-spider silk fibers. Cheryl Hayashi, Alan Gent, John Gosline, Hans
   Thewissen, and an anonymous reviewer provided helpful comments on early
   drafts of the manuscript. This work was supported by National Science
   Foundation awards DBI-0521261 (T.A.B.), IOS-0745379 (T.A.B.),
   DEB-0516038 (T.A.B.) and DMR-0512156 (A.D.). Additional funding was
   provided by a Slovenian Research Agency research fellowship ARRS
   Z1-9799-0618-07 (I.A.), and from the Integrated Bioscience Program at
   University of Akron.
CR Bar-Cohen Y, 2003, IND ROBOT, V30, P331, DOI 10.1108/01439910310479702
   Bar-Cohen Y, 2004, ELECTROACTIVE POLYM
   Bar-Cohen Y, 2007, SMART MATER STRUCT, V16, pS195
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Bell FI, 2002, NATURE, V416, P37, DOI 10.1038/416037a
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x
   Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944
   Dawson J, 1997, NATURE, V390, P668
   Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guinea GV, 2003, POLYMER, V44, P5785, DOI 10.1016/S0032-3861(03)00625-6
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Jelinski LW, 1999, INT J BIOL MACROMOL, V24, P197, DOI 10.1016/S0141-8130(98)00085-3
   KORNBLUH R, 1998, P IEEE INT C ROB AUT, V3, P2147
   Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   Schafer A, 2008, EUR BIOPHYS J BIOPHY, V37, P197, DOI [10.1007/s00249-007-0216-5, 10.1007/S00249-007-0216-5]
   Shahinpoor M, 1998, SMART MATER STRUCT, V7, pR15, DOI 10.1088/0964-1726/7/6/001
   Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584
   STAUFFER SL, 1994, J ARACHNOL, V22, P5
   Swanson BO, 2006, EVOLUTION, V60, P2539
   TANAKA T, 1980, PHYS REV LETT, V45, P1636, DOI 10.1103/PhysRevLett.45.1636
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   VADLAMUDI S, 1995, THESIS U WYOMING
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wheeler TD, 2008, NATURE, V455, P208, DOI 10.1038/nature07226
   WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003
NR 31
TC 55
Z9 58
U1 0
U2 44
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
J9 J EXP BIOL
JI J. Exp. Biol.
PD JUL 1
PY 2009
VL 212
IS 13
BP 1989
EP 1993
DI 10.1242/jeb.028282
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 457QY
UT WOS:000266948400011
PM 19525423
OA Bronze
DA 2018-10-19
ER

PT J
AU Al-Kahtani, AA
   Sherigara, BS
AF Al-Kahtani, Ahmed A.
   Sherigara, B. S.
TI Controlled release of theophylline through semi-interpenetrating network
   microspheres of chitosan-(dextran-g-acrylamide)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DEGRADABLE DEXTRAN HYDROGELS; CONTROLLED DRUG-DELIVERY; CHITOSAN
   MICROSPHERES; IN-VITRO; MICROCAPSULES; COPOLYMER; MATRIX; BIOMATERIAL;
   SYSTEMS; BLOOD
AB Semi-interpenetrating network microspheres of chitosan-(dextran-g-acrylamide) were prepared by emulsion-crosslinking method using glutaraldehyde (GA) as a crosslinking agent. Graft copolymerization of dextran with acrylamide (Dx-g-AAm) was carried out by aqueous free-radical polymerization using ceric ammonium nitrate (CAN) as initiator. The grafting efficiency was found to be 92%. Theophylline (TH), antiasthmatic drug, was successfully encapsulated into semi-INP microspheres by varying the ratio of Dx-g-AAm and amount of GA. The laser light scattering technique shows that the particles size increased with increasing amount of graft copolymer and decrease with increasing amount of GA. The % encapsulation efficiency was found to vary between 50 and 78. MPs were characterized by FTIR spectroscopy and differential scanning calorimetry (DSC) techniques to confirm the graft copolymer, formation of semi-IPN structure of MPs and molecular distribution of the drug molecules in the polymer matrix. In vitro release studies of TH from these matrices have been investigated at Ph 1.2 and 7.4 media and the slow release were extended up to 18 h at 37 degrees C. The release rates were fitted to an empirical equation to estimate the diffusion exponent n, which indicated that the release from the MPs follows non-Fickian type.
C1 [Al-Kahtani, Ahmed A.; Sherigara, B. S.] Kuvempu Univ, Dept Ind Chem, Sch Chem Sci, Shankaraghatta 577451, Karnataka, India.
RP Sherigara, BS (reprint author), Kuvempu Univ, Dept Ind Chem, Sch Chem Sci, Shankaraghatta 577451, Karnataka, India.
EM sherigarabs@yahoo.com
CR Aiedeh K, 2001, EUR J PHARM SCI, V13, P159, DOI 10.1016/S0928-0987(00)00217-7
   ARTURSSON P, 1984, J PHARM SCI, V73, P1506
   BENITA S, 1982, J PHARM SCI, V71, P205, DOI 10.1002/jps.2600710217
   CASU B, 1990, MACROMOLECOLE SCI TE, P5
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   EDMAN P, 1980, J PHARM SCI, V69, P839
   EPPLEY BL, 1994, AESTHET PLAST SURG, V18, P413, DOI 10.1007/BF00451350
   Finnerty JP, 1996, EUR RESPIR J, V9, P1672, DOI 10.1183/09031936.96.09081672
   Franssen O, 1999, J CONTROL RELEASE, V60, P211, DOI 10.1016/S0168-3659(99)00074-7
   GEERT JB, 2000, ORGANIC SYNTHESIS CA, P56
   He P, 1999, J MICROENCAPSUL, V16, P343
   KALSI PS, 2004, SPECTROSCOPY ORGANIC, P90
   KAMATH KR, 1995, POLYM GELS NETW, V3, P243, DOI 10.1016/0966-7822(95)00005-6
   Kang DW, 1999, J APPL POLYM SCI, V73, P469, DOI 10.1002/(SICI)1097-4628(19990725)73:4<469::AID-APP2>3.3.CO;2-9
   Knaul JZ, 1999, J APPL POLYM SCI, V72, P1721, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1721::AID-APP8>3.0.CO;2-V
   Kweon DK, 1999, J APPL POLYM SCI, V74, P458, DOI 10.1002/(SICI)1097-4628(19991010)74:2<458::AID-APP29>3.0.CO;2-6
   LAFONT J, 1994, CELL MATER, V4, P219
   LANGER R, 1993, ACCOUNTS CHEM RES, V26, P537, DOI 10.1021/ar00034a004
   LEVY MC, 1990, INT J PHARM, V62, P27, DOI 10.1016/0378-5173(90)90028-3
   LIN SY, 1987, J PHARM SCI, V76, P219, DOI 10.1002/jps.2600760307
   Liu YH, 2002, J MACROMOL SCI PURE, V39, P129, DOI 10.1081/MA-120006523
   MAROYAMA K, 1989, J CONTROL RELEASE, V10, P177
   MELLSTRAND T, 1980, EUR J RESP DIS S, V109, P54
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   MINO G, 1958, J POLYM SCI, V31, P242, DOI 10.1002/pol.1958.1203112248
   MOHAMMAD J, 2005, IRAN POLYM J, V14, P132
   MOTYCKA S, 1985, J PHARM SCI, V74, P643, DOI 10.1002/jps.2600740612
   PENG T, 1994, J POLYM SCI POL CHEM, V32, P591, DOI 10.1002/pola.1994.080320322
   Peppas NA, 1996, MACROMOLECULES, V29, P8798, DOI 10.1021/ma9613392
   PROUCHAYRET F, 1992, BIOMAT ARTIF CELL IM, V20, P319, DOI 10.3109/10731199209119649
   Remunan-Lopez C, 1998, EUR J PHARM BIOPHARM, V45, P49, DOI 10.1016/S0939-6411(97)00122-7
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   SANNAN T, 1978, POLYMER, V19, P458, DOI 10.1016/0032-3861(78)90256-2
   Sato M, 2000, J Orthop Sci, V5, P256, DOI 10.1007/s007760050161
   Shepherd R, 1997, GLYCOCONJUGATE J, V14, P535, DOI 10.1023/A:1018524207224
   Sperling L.H., 1981, INTERPENETRATING POL
   Stubbe BG, 2003, BIOMACROMOLECULES, V4, P691, DOI 10.1021/bm020129w
   Tarquasy A.C., 1974, CONTROLLED RELEASE B, V47, P15
   TEFFT J, 1993, J CONTROL RELEASE, V27, P27, DOI 10.1016/0168-3659(93)90054-9
   THANOO BC, 1992, J PHARM PHARMACOL, V44, P283, DOI 10.1111/j.2042-7158.1992.tb03607.x
   Tohda Y, 1998, INT J IMMUNOPHARMACO, V20, P173, DOI 10.1016/S0192-0561(98)00026-5
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
NR 42
TC 12
Z9 12
U1 1
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2009
VL 20
IS 7
BP 1437
EP 1445
DI 10.1007/s10856-009-3704-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472BD
UT WOS:000268103200006
PM 19252971
DA 2018-10-19
ER

PT J
AU He, QR
   Zhang, TY
   Yang, YM
   Ding, F
AF He, Qianru
   Zhang, Tianyi
   Yang, Yumin
   Ding, Fei
TI In vitro biocompatibility of chitosan-based materials to primary culture
   of hippocampal neurons
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NERVE-CELL AFFINITY; SYNAPTIC VESICLES; POLARITY; GAP-43; SYNAPTOPHYSIN;
   REGENERATION; MEMBRANES; SCAFFOLD; FIBERS; GROWTH
AB The natural biomaterial chitosan has been widely used as a promising nerve guidance conduit material for peripheral nerve repair. This study aimed to investigate in vitro biocompatibility of chitosan to primarily cultured hippocampal neurons, one type of central nervous system (CNS) cells. The substrate made up of chitosan fibers or membranes was found to support the survival and growth of the attached hippocampal neurons by using light and electron microscopy as well as immunocytochemistry for neurofilament 200, growth-associated protein-43, microtubule-associated protein 2, beta-tubulin III and synaptophysin. MTT assay indicated that the cell viability of hippocampal neurons in chitosan fiber or membrane extract was not significantly different from that in hydroxyapatite extract or plain neuronal medium, but significantly higher than that in organotin extract after culture for different times. Western analysis revealed that no significant difference in the protein level of growth-associated protein-43 and beta-tubulin III was detected between hippocampal neurons cultured in chitosan extract and in plain neuronal culture medium. The results collectively demonstrate that chitosan is biocompatible to primary culture of hippocampal neurons without cytotoxic effects on cell phenotype and functions, raising a potential possibility of using chitosan for CNS therapy.
C1 [He, Qianru; Zhang, Tianyi; Yang, Yumin; Ding, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu Prov, Peoples R China.
RP Ding, F (reprint author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226001, Jiangsu Prov, Peoples R China.
EM shengdd@public.nt.js.cn
FU Hi-Tech Research and Development Program of China [2006AA02A128];
   National Natural Science Foundation of China [30670667, 30870811]
FX This study was supported by Hi-Tech Research and Development Program of
   China (863 Program, Grant No. 2006AA02A128), National Natural Science
   Foundation of China ( Grant No. 30670667 and 30870811). We wish to thank
   Professor Jie Liu for assistance in manuscript preparation.
CR Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2
   Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200
   Chakravarthy B, 2008, BIOCHEM BIOPH RES CO, V371, P679, DOI 10.1016/j.bbrc.2008.04.119
   Cheng MY, 2004, J BIOMATER APPL, V19, P59, DOI 10.1177/0885328204043450
   Cheng MY, 2003, J BIOMAT SCI-POLYM E, V14, P1155, DOI 10.1163/156856203769231628
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Gingras M, 2003, BIOMATERIALS, V24, P1653, DOI 10.1016/S0142-9612(02)00572-0
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0
   Hu Y, 2002, BIOMATERIALS, V23, P3193, DOI 10.1016/S0142-9612(02)00071-6
   Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x
   JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137
   Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033
   Lee SH, 2004, J APPL POLYM SCI, V92, P2054, DOI 10.1002/app.20160
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511
   Popovic N, 2006, INT J PHARM, V314, P120, DOI 10.1016/j.ijpharm.2005.09.040
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   RIGATO F, 2005, BIOVALLEY MONOGRAPHS, P82
   Shafit-Zagardo B, 1998, MOL NEUROBIOL, V16, P149, DOI 10.1007/BF02740642
   Shen ZL, 2001, MICROSURG, V21, P6, DOI 10.1002/1098-2752(2001)21:1<6::AID-MICR1001>3.0.CO;2-6
   Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7
   THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x
   Wan Y, 2005, J MATER SCI-MATER M, V16, P1017, DOI 10.1007/s10856-005-4756-x
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9
   Yang YM, 2007, J MATER SCI-MATER M, V18, P2117, DOI 10.1007/s10856-007-3013-x
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhu AP, 2002, J BIOMAT SCI-POLYM E, V13, P501, DOI 10.1163/15685620260178364
NR 32
TC 22
Z9 29
U1 1
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2009
VL 20
IS 7
BP 1457
EP 1466
DI 10.1007/s10856-009-3702-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472BD
UT WOS:000268103200008
PM 19301107
DA 2018-10-19
ER

PT J
AU Tian, M
   Chen, F
   Song, W
   Song, YC
   Chen, YW
   Wan, CX
   Yu, XX
   Zhang, XH
AF Tian, Meng
   Chen, Feng
   Song, Wei
   Song, Yancheng
   Chen, Yuanwei
   Wan, Changxiu
   Yu, Xixun
   Zhang, Xiaohua
TI In vivo study of porous strontium-doped calcium polyphosphate scaffolds
   for bone substitute applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PHOSPHATE CERAMICS; CELL REPLICATION; CEMENT; RANELATE; MINERALIZATION;
   VITRO; RATS; RESORPTION; GROWTH
AB The purpose of this study was to investigate in vivo biocompatibility and osteogenesis as well as degradability of the porous strontium-doped calcium polyphosphate (SCPP) scaffolds as a biomaterial for bone substitute applications. The evaluation was performed on a rabbit model over a period of 16 weeks by histology combined with image analysis, X-ray microradiography and immunohistochemistry methods. The histological and X-ray microradiographic results showed that the SCPP scaffold exhibited good biocompatibility and extensive osteoconductivity with host bone. Moreover, a significant more bone formation was observed in the SCPP group compared with that in the CPP group, especially at the initial stage after implantation. New bone volumes (NBVs) of the SCPP group determined at week 4, 8 and 16 were 14, 27 and 45%, respectively. Accordingly, NBVs of the CPP group were 10, 19 and 40%. Immunohistochemical results revealed that both the expression of collagen type I and bone morphogenetic proteins in the SCPP group were higher than that in the CPP group, which might be associated with the release of strontium ions during the implantation. In addition, during 16 weeks implantation the SCPP scaffold exhibited similar degradability with the CPP scaffold in vivo. Both scaffolds showed the greatest degradation rate for the first 4 weeks, and then the degradation rate gradually decreased. The results presented in this study demonstrated that SCPP scaffold can be considered as a biocompatible material, making it attractive for bone substitute application purposes.
C1 [Tian, Meng; Chen, Feng; Song, Wei; Chen, Yuanwei; Wan, Changxiu; Yu, Xixun; Zhang, Xiaohua] Sichuan Univ, Dept Biomed Polymers & Artificial Organs, Coll Polymer Sci & Engn, Chengdu 610065, Sichuan, Peoples R China.
   [Song, Yancheng] Sichuan Univ, Dept Orthopaed, W China Hosp, Chengdu 610041, Sichuan, Peoples R China.
RP Wan, CX (reprint author), Sichuan Univ, Dept Biomed Polymers & Artificial Organs, Coll Polymer Sci & Engn, Chengdu 610065, Sichuan, Peoples R China.
EM wanchangxiu@163.com
RI Song, Wei/B-3084-2013
FU National Science Foundation of China [30870614, 50472091]
FX This work is supported by the National Science Foundation of China (
   Project No. 30870614 and 50472091). The authors would like to thank Ms.
   Suilin Liu and Mr. Zhu Li, researchers at the Analytical & Testing
   Center of Sichuan University, for valuable suggestion and specimen
   characterization.
CR Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Caverzasio J, 2008, BONE, V42, P1131, DOI 10.1016/j.bone.2008.02.010
   Chen YW, 2008, J MATER SCI-MATER M, V19, P2655, DOI 10.1007/s10856-007-3350-9
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   GRYNPAS MD, 1990, BONE, V11, P313, DOI 10.1016/8756-3282(90)90086-E
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032
   Hott M, 2003, BONE, V33, P115, DOI 10.1016/S8756-3282(03)00115-7
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.0.CO;2-R
   Marie PJ, 2007, BONE, V40, pS5, DOI 10.1016/j.bone.2007.02.003
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   MOROHASHI T, 1994, JPN J PHARMACOL, V64, P155, DOI 10.1254/jjp.64.155
   Ni GX, 2006, BIOMATERIALS, V27, P5127, DOI 10.1016/j.biomaterials.2006.05.030
   Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   Sous M, 1998, BIOMATERIALS, V19, P2147, DOI 10.1016/S0142-9612(98)00118-5
   Thorwarth M, 2005, BIOMATERIALS, V26, P2575, DOI 10.1016/j.biomaterials.2004.07.041
   Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x
   Wong CT, 2004, J BIOMED MATER RES A, V70A, P428, DOI 10.1002/jbm.a.30097
   Wong CT, 2004, J BIOMED MATER RES A, V68A, P513, DOI 10.1002/jbm.a.20089
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 27
TC 51
Z9 56
U1 1
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2009
VL 20
IS 7
BP 1505
EP 1512
DI 10.1007/s10856-009-3713-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472BD
UT WOS:000268103200013
PM 19267259
DA 2018-10-19
ER

PT J
AU Cerri, F
   Lopez, ID
   Triolo, D
   Salvatore, L
   Del Carro, U
   Mortini, P
   Comi, G
   Sannino, A
   Quattrini, A
AF Cerri, F.
   Lopez, I. D.
   Triolo, D.
   Salvatore, L.
   Del Carro, U.
   Mortini, P.
   Comi, G.
   Sannino, A.
   Quattrini, A.
TI BIOMATERIAL TO PROMOTE NERVE REGENERATION: TOWARDS CLINICAL TRIALS
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 04-08, 2009
CL Wurzburg, GERMANY
SP Peripheral Nerve Soc
C1 [Cerri, F.; Lopez, I. D.; Triolo, D.; Del Carro, U.; Comi, G.; Quattrini, A.] Ist Sci San Raffaele, INSPE, I-20132 Milan, Italy.
   [Cerri, F.; Lopez, I. D.; Triolo, D.; Del Carro, U.; Comi, G.; Quattrini, A.] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy.
   [Salvatore, L.; Sannino, A.] Univ Lecce, Dept Engn Innovat, I-73100 Lecce, Italy.
   [Mortini, P.] Ist Sci San Raffaele, Dept Neurosurg, I-20132 Milan, Italy.
RI SALVATORE, LUCA/N-8222-2015
OI SALVATORE, LUCA/0000-0001-6747-2473
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1085-9489
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD JUL
PY 2009
VL 14
BP 31
EP 31
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 490TE
UT WOS:000269527000071
DA 2018-10-19
ER

PT J
AU Tigli, RS
   Ghosh, S
   Laha, MM
   Shevde, NK
   Daheron, L
   Gimble, J
   Gumusderelioglu, M
   Kaplan, DL
AF Tigli, R. Seda
   Ghosh, Sourabh
   Laha, Michael M.
   Shevde, Nirupama K.
   Daheron, Laurence
   Gimble, Jeffrey
   Gumusderelioglu, Menemse
   Kaplan, David L.
TI Comparative chondrogenesis of human cell sources in 3D scaffolds
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE chondrocytes; stem cells; silk; chitosan; chrondrogenesis; scaffold
ID MESENCHYMAL STEM-CELLS; HUMAN ARTICULAR CHONDROCYTES; BONE-MARROW;
   ADIPOSE-TISSUE; IN-VITRO; STROMAL CELLS; SILK SCAFFOLDS; NEOCARTILAGE
   FORMATION; CHITOSAN SCAFFOLDS; CARTILAGE DEFECTS
AB Cartilage tissue can be engineered by starting from a diversity of cell sources, including stem-cell based and primary cell-based platforms. Selecting an appropriate cell source for the process of cartilage tissue engineering or repair is critical and challenging, due to the variety of cell options available. in this study, cellular responses of isolated human chondrocytes, human embryonic stem cells and mesenchymal stem cells (MSCs) derived from three sources, human embryonic stem cells, bone marrow and adipose tissue, were assessed for chondrogenic potential in 3D culture. All cell sources were characterized by FACS analysis to compare expression of some surface markers. The cells were differentiated in two different biomaterial matrices, silk and chitosan scaffolds, in the presence and absence of bone morphogenetic protein 6 (BMP6), along with the standard chondrogenic differentiating factors. Embryonic stem cells-derived MSCs showed unique characteristics, with preserved chondrogenic phenotype in both scaffolds with regard to chondrogenesis, as determined by real time RT-PCR, histological and microscopical analyses. After 4 weeks of cultivation, embryonic stem cells-derived MSCs were promising for chondrogenesis, particularly in the silk scaffolds with BMP6. The results suggest that cell source differences are important to consider with regard to chondrogenic outcomes, and among the variables addressed here the human embryonic stem cells-derived MSCs were the preferred cell source. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Tigli, R. Seda; Ghosh, Sourabh; Laha, Michael M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Tigli, R. Seda; Gumusderelioglu, Menemse] Hacettepe Univ, Dept Chem Engn, TR-06800 Beytepe, Turkey.
   [Shevde, Nirupama K.] WiCell Res Inst, Madison, WI 53707 USA.
   [Daheron, Laurence] Massachusetts Gen Hosp, Ctr Regenerat Med & Technol, Boston, MA 02114 USA.
   [Gimble, Jeffrey] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI Ghosh, Sourabh/D-2942-2011
FU Turkish National Research Council (TuBiTAK); NIH [P41]
FX R. Seda Tigh acknowledges a grant provided by the Turkish National
   Research Council (TuBiTAK). We thank the NIH P41 Tissue Engineering
   Resource Center for support of the studies.
CR Afizah H, 2007, TISSUE ENG, V13, P659, DOI 10.1089/ten.2006.0118
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Deschaseaux F, 2003, BRIT J HAEMATOL, V122, P506, DOI 10.1046/j.1365-2141.2003.04469.x
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006
   Francioli SE, 2007, TISSUE ENG, V13, P1227, DOI 10.1089/ten.2006.0342
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Guo CA, 2007, J BIOSCI BIOENG, V103, P547, DOI 10.1263/jbb.103.547
   Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Homicz MR, 2002, OTOLARYNG HEAD NECK, V127, P398, DOI 10.1067/mhn.2002.129730
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Im GI, 2005, CURR APPL PHYS, V5, P438, DOI 10.1016/j.cap.2005.01.006
   Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   Jin XB, 2007, ACTA PHARMACOL SIN, V28, P663, DOI 10.1111/j.1745-7254.2007.00553.x
   Jukes JM, 2008, TISSUE ENG PT A, V14, P135, DOI 10.1089/ten.a.2006.0397
   Kameda T, 2000, DEV GROWTH DIFFER, V42, P229
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karp JM, 2006, STEM CELLS, V24, P835, DOI 10.1634/stemcells.2005-0383
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508
   Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lohmander L Stefan, 2003, Novartis Found Symp, V249, P2
   Malafaya PB, 2006, J MATER SCI-MATER M, V17, P675, DOI 10.1007/s10856-006-9231-9
   MALLEINGERIN F, 1990, DIFFERENTIATION, V43, P204, DOI 10.1111/j.1432-0436.1990.tb00447.x
   Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325
   Park J, 2006, J GENE MED, V8, P112, DOI 10.1002/jgm.826
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Sottile V, 2002, BONE, V30, P699, DOI 10.1016/S8756-3282(02)00674-9
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200
   Thomson JA, 1998, SCIENCE, V282, P1827
   Tigli RS, 2007, J MATER SCI-MATER M, V18, P1665, DOI [10.1007/s10856-007-3066, 10.1007/s10856-007-3066-x]
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Velema J, 2006, ADV BIOCHEM ENG BIOT, V102, P187, DOI 10.1007/10_013
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   WOBUS AM, 1984, EXP CELL RES, V152, P212, DOI 10.1016/0014-4827(84)90246-5
   Wu M, 2006, BRIT J DERMATOL, V155, P282, DOI 10.1111/j.1365-2133.2006.07357.x
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
   Zhao J, 2004, J APPL POLYM SCI, V91, P1676, DOI 10.1002/app.13323
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 63
TC 75
Z9 79
U1 1
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUL
PY 2009
VL 3
IS 5
BP 348
EP 360
DI 10.1002/term.169
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 473SA
UT WOS:000268228000003
PM 19382119
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gotz, C
   Handge, UA
   Altstadt, V
   Piatek, M
   El Fray, M
AF Goetz, C.
   Handge, U. A.
   Altstaedt, V.
   Piatek, M.
   El Fray, M.
TI Influence of E-Beam Irradiation on Poly(aliphatic/aromatic-ester)
   Multiblock Copolymers Used as Biomaterials
SO KGK-KAUTSCHUK GUMMI KUNSTSTOFFE
LA English
DT Article
DE Thermoplastic elastomers; E-beam irradiation; Hysteresis measurement;
   Biomaterials
ID SEGMENTED POLY(URETHANEUREAS); FATIGUE BEHAVIOR; COMPONENTS
AB The use of polymers became more relevant in medical applications for the versatility in processing and enhanced material properties of polymers. In order to be suitable as a biomaterial, it is of medical importance that these polymers are biocompatible and do not elicit negative responses from the body after implantation. Furthermore during the course of usage under load-bearing conditions, these biomaterials must sustain dynamical loadings and must not degrade or fracture, which can cause inflammatory responses of the host body.
C1 [Altstaedt, V.] Univ Bayreuth, Dept Polymer Engn, Fac Engn Sci, D-95447 Bayreuth, Germany.
RP Altstadt, V (reprint author), Univ Bayreuth, Dept Polymer Engn, Fac Engn Sci, Univ Str 30, D-95447 Bayreuth, Germany.
EM altstaedt@uni-bayreuth.de
RI Altstaedt, Volker/J-3869-2014; Piatek-Hnat, Marta/O-1288-2018; El Fray,
   Miroslawa/J-4128-2016
OI Piatek-Hnat, Marta/0000-0002-7731-2323; 
FU Deutsche Forschungsgemeinschaft; Polish Ministry of Science and Higher
   Education [AI 474/12-1, DWM/18/POL/2005]
FX The authors are grateful to the Deutsche Forschungsgemeinschaft and
   Polish Ministry of Science and Higher Education for financial support
   (DFG-Project AI 474/12-1 and DWM/18/POL/2005).
CR ASTM International, 2006, D41206A ASTM INT
   *DIN ISO, 2005, 53504 DIN ISO
   El Fray M, 2000, J MATER SCI-MATER M, V11, P757
   El Fray M, 2003, POLYMER, V44, P4635, DOI 10.1016/S0032-3861(03)00417-8
   El Fray M, 2003, NANOSTRUCTURED ELAST, P1
   ELFRAY M, 2003, SCI PAPERS I ORGANIC, V52, P481
   FAKIROW S, 2005, HDB CONDENSATION THE
   GOTZ C, 2008, POL PROC SOC 24 ANN
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TAKAHARA A, 1985, J BIOMED MATER RES, V19, P13, DOI 10.1002/jbm.820190104
NR 10
TC 0
Z9 0
U1 0
U2 0
PU DR ALFRED HUTHIG VERLAG GMBH
PI HEIDELBERG
PA POSTFACH 10 28 69, D-69018 HEIDELBERG, GERMANY
SN 0948-3276
J9 KGK-KAUT GUMMI KUNST
JI KGK-Kautsch. Gummi Kunstst.
PD JUL-AUG
PY 2009
VL 62
IS 7-8
BP 396
EP 398
PG 3
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 486GV
UT WOS:000269185200007
DA 2018-10-19
ER

PT J
AU Lauto, A
AF Lauto, Antonio
TI Integration of Extracellular Matrix With Chitosan Adhesive Film for
   Sutureless Tissue Fixation
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE scaffold; tissue engineering; biomaterial; laser; adhesive; glue
ID SMALL-INTESTINAL SUBMUCOSA; IN-VIVO; HYPOSPADIAS REPAIR; NERVE REPAIR;
   LASER; VITRO; IDENTIFICATION; FIBRONECTIN; EFFICACY; CLOSURE
AB Background and Objectives: Extracellular matrices (ECMs) are currently applied in reconstructive surgery to enhance wound healing and tissue remodelling. Sutures and staples are usually employed to stabilize ECM on tissue although they may damage the matrix structure. In this investigation, a novel biocompatible bandage was developed to fix ECM on tissue without sutures.
   Study Design/Materials and Methods: An adhesive film, based on chitosan, was integrated with small intestine submucosa (SIS) in a single bandage strip. This bandage was bonded to sheep small intestine upon laser irradiation of the chitosan film (P = 0.12 W, Fluence = 46 +/- 1 J/cm(2)) to assess tissue adhesion strength. Thermocouples were used to estimate temperatures under SIS during laser irradiation. Bandage strips were also mechanically tested to evaluate their tensile strength before and after irradiation.
   Results and Conclusions: The bandage successfully bonded to intestine achieving a shear stress of 9.6 +/- 1.6 kPa (n = 15). During laser irradiation, the temperature increased modestly to 31 +/- 2 degrees C (n = 14) beneath the ECM portion of the bandage. The bandage withstood a tensile strength of 3,122 +/- 780 and 3,384 +/- 791 kPa, before and after laser irradiation respectively (n = 10, P = 0.47, t-test). The SIS-chitosan bandage bonded effectively to tissue without sutures and preserved the ECM structure avoiding irreversible thermal denaturation of imbedded bioactive proteins. Lasers Surg. Med. 41:366-371, 2009. (C) 2009 Wiley-Liss, Inc.
C1 [Lauto, Antonio] Univ Western Sydney, Sch Biomed & Hlth Sci, Nanoscale Org & Dynam Grp, Sydney, NSW 1797, Australia.
RP Lauto, A (reprint author), Univ Western Sydney, Sch Biomed & Hlth Sci, Locked Bag 1797, Penrith, NSW, Australia.
EM a.lauto@uws.edu.au
FU University of Western Sydney; ARC Discovery [DP077253]
FX The author thanks Dr. Bin Clarke for her kind advice and help. This work
   was partly sponsored by the SBHS School grant of the University of
   Western Sydney and the ARC Discovery grant # DP077253.
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028
   Bhattacharya A, 2003, PHYSIOL MEAS, V24, P769, DOI 10.1088/0967-3334/24/3/312
   Brown P D, 1990, Growth Factors, V3, P35, DOI 10.3109/08977199009037500
   Colvert JR, 2002, J UROLOGY, V168, P1872, DOI 10.1097/01.ju.0000027285.05828.e6
   Dornish M, 2001, ANN NY ACAD SCI, V944, P388
   Fine Arthur P, 2006, JSLS, V10, P461
   Franklin M E Jr, 2002, Hernia, V6, P171
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   INGHAM KC, 1984, J BIOL CHEM, V259, P1901
   Kajitani M, 2000, ASAIO J, V46, P409, DOI 10.1097/00002480-200007000-00007
   Katkhouda Namir, 2004, Surg Technol Int, V12, P120
   Kirsch AJ, 1996, UROLOGY, V48, P616, DOI 10.1016/S0090-4295(96)00243-9
   Kirsch AJ, 2001, J UROLOGY, V165, P574, DOI 10.1097/00005392-200102000-00073
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lamsa T, 2008, PANCREAS, V36, P261, DOI 10.1097/MPA.0b013e31816714a2
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 2005, LASER SURG MED, V36, P193, DOI 10.1002/lsm.20145
   Lauto A, 1997, LASER SURG MED, V21, P134, DOI 10.1002/(SICI)1096-9101(1997)21:2<134::AID-LSM4>3.0.CO;2-R
   Lauto A, 2008, PHOTOMED LASER SURG, V26, P227, DOI 10.1089/pho.2007.2131
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Menabuoni L, 2007, J CATARACT REFR SURG, V33, P1608, DOI 10.1016/j.jcrs.2007.04.013
   Menovsky T, 2001, J NEUROSURG, V95, P694, DOI 10.3171/jns.2001.95.4.0694
   O'Connor L, 2006, DIS COLON RECTUM, V49, P1569, DOI 10.1007/s10350-006-0695-y
   Ponce ML, 1999, CIRC RES, V84, P688, DOI 10.1161/01.RES.84.6.688
   Poppas DP, 1996, LASER SURG MED, V19, P360
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Topart P, 2005, SURG ENDOSC, V19, P724, DOI 10.1007/s00464-004-8812-2
   VANDERREST M, 1991, FASEB J, V5, P2814
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Yang YM, 2007, J MATER SCI-MATER M, V18, P2117, DOI 10.1007/s10856-007-3013-x
NR 35
TC 6
Z9 6
U1 2
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PD JUL
PY 2009
VL 41
IS 5
BP 366
EP 371
DI 10.1002/lsm.20774
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 464RS
UT WOS:000267524400006
PM 19533766
DA 2018-10-19
ER

PT J
AU Choi, WS
   Bae, JW
   Joung, YK
   Park, KD
   Lee, MH
   Park, JC
   Kwon, IK
AF Choi, Won Sup
   Bae, Jin Woo
   Joung, Yoon Ki
   Park, Ki Dong
   Lee, Mi Hee
   Park, Jong-Chul
   Kwon, Il Keun
TI Fabrication of Endothelial Cell-Specific Polyurethane Surfaces
   co-Immobilized with GRGDS and YIGSR Peptides
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE polyurethane; GRGDS; YIGSR; endothelial cells; endothelialization
ID BLOOD COMPATIBILITY; RGD PEPTIDE; ADHESION; GROWTH; LAMININ; GRAFT;
   ATTACHMENT; SCAFFOLDS; POLYMERS; PEO
AB Polyurethane (PU) is widely used as a cardiovascular biomaterial due to its good mechanical properties and hemocompatibility, but it is not adhesive to endothelial cells (ECs). Cell adhesive peptides, GRGDS and YIGSR, were found to promote adhesion and spreading of ECs and showed a synergistic effect when both of them were used. In this study, a surface modification was designed to fabricate an EC-active PU surface capable of promoting endothelialization using the peptides and poly(ethylene glycol) (PEG) spacer, The modified PU surfaces were characterized in vitro. The density of the grafted PEG on the PU surface was measured by acid-base back titration to the terminal-free isocyanate groups. The successful immobilization of peptides was confirmed by amino acid analysis, following hydrolysis, and contact angle measurement. The uniform distribution of peptides on the surface was observed by scanning electron microscopy (SEM) and atomic force microscopy (AFM). To evaluate the EC adhesive property, cell viability test using human umbilical vein EC (HUVEC) was investigated in vitro and enhanced endothelialization was characterized by the introduction of cell adhesive peptides, GRGDS and YIGSR, and PEG spacer. Therefore, GRGDS and YIGSR co-immobilized PU surfaces can be applied to an EC-specific vascular graft with long-term patency by endothelialization.
C1 [Choi, Won Sup; Bae, Jin Woo; Joung, Yoon Ki; Park, Ki Dong] Ajou Univ, Dept Mol Sci & Technol, Seoul 443749, South Korea.
   [Lee, Mi Hee; Park, Jong-Chul] Yonsei Univ, Dept Med Engn, Brain Korea Project Med Sci 21, Coll Med, Seoul 120749, South Korea.
   [Kwon, Il Keun] Kyung Hee Univ, Grad Sch Dent, Dept Oral Biol, Seoul 130701, South Korea.
   [Kwon, Il Keun] Kyung Hee Univ, Grad Sch Dent, Inst Oral Biol, Seoul 130701, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, Seoul 443749, South Korea.
EM kdp@ajou.ac.kr
OI joung, yoon ki/0000-0001-8661-481X
CR Bae MS, 2007, MACROMOL RES, V15, P469, DOI 10.1007/BF03218816
   Cha DI, 2006, MACROMOL RES, V14, P331, DOI 10.1007/BF03219090
   CLEMENT B, 1990, J CELL BIOL, V110, P185, DOI 10.1083/jcb.110.1.185
   DEE KC, 1994, MATER RES SOC SYMP P, V331, P115
   Doi K, 1997, J BIOMED MATER RES, V34, P361, DOI 10.1002/(SICI)1097-4636(19970305)34:3<361::AID-JBM11>3.0.CO;2-J
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   Ernsting MJ, 2005, BIOMATERIALS, V26, P6536, DOI 10.1016/j.biomaterials.2005.04.047
   Fields C, 2002, J BIOMATER APPL, V17, P45, DOI 10.1106/088532802027861
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   IWAMOTO Y, 1988, J CELL PHYSIOL, V134, P287, DOI 10.1002/jcp.1041340216
   Jun HW, 2004, J BIOMAT SCI-POLYM E, V15, P73, DOI 10.1163/156856204322752246
   JUN YJ, MACROMOL RE IN PRESS
   Jung CM, 2007, MACROMOL RES, V15, P682, DOI 10.1007/BF03218950
   Kim YH, 2003, BIOMATERIALS, V24, P2213, DOI 10.1016/S0142-9612(03)00023-1
   Kwon OH, 1999, J APPL POLYM SCI, V71, P631, DOI 10.1002/(SICI)1097-4628(19990124)71:4<631::AID-APP15>3.0.CO;2-G
   Labat-Robert J, 2003, PATHOL BIOL, V51, P563, DOI 10.1016/j.patbio.2003.09.006
   Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee K, 2005, MACROMOL RES, V13, P441, DOI 10.1007/BF03218478
   Lee SJ, 2007, MACROMOL RES, V15, P348, DOI 10.1007/BF03218798
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Malinda KM, 1996, INT J BIOCHEM CELL B, V28, P957, DOI 10.1016/1357-2725(96)00042-8
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Park HD, 2006, MACROMOL RES, V14, P73, DOI 10.1007/BF03219071
   Park JS, 2007, MACROMOL RES, V15, P424, DOI 10.1007/BF03218809
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   Park KM, 2008, MACROMOL RES, V16, P517, DOI 10.1007/BF03218553
   Raghu AV, 2008, MACROMOL RES, V16, P194, DOI 10.1007/BF03218852
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sagnella SM, 2004, BIOMATERIALS, V25, P1249, DOI 10.1016/S0142-9612(03)00634-3
   Tan CY, 2008, MACROMOL RES, V16, P481, DOI 10.1007/BF03218548
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L
   Yang HS, 2007, MACROMOL RES, V15, P256, DOI 10.1007/BF03218784
   Yoo HJ, 2008, MACROMOL RES, V16, P596, DOI 10.1007/BF03218566
   Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014
   Yun JK, 2007, MACROMOL RES, V15, P22, DOI 10.1007/BF03218748
NR 42
TC 12
Z9 13
U1 1
U2 24
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD JUL
PY 2009
VL 17
IS 7
BP 458
EP 463
DI 10.1007/BF03218892
PG 6
WC Polymer Science
SC Polymer Science
GA 479FB
UT WOS:000268644000002
DA 2018-10-19
ER

PT J
AU Clifton, LA
   Neylon, C
   Terry, AE
   Dicko, IC
   Diddens, IA
AF Clifton, L. A.
   Neylon, C.
   Terry, A. E.
   Dicko, I. C.
   Diddens, I. A.
TI Characterizing biomaterial complexity
SO MATERIALS TODAY
LA English
DT Article
ID HYDRATION-WATER DYNAMICS; 2ND TARGET STATION; NEUTRON-SCATTERING;
   STRUCTURAL-CHARACTERIZATION; PROTEIN; REFLECTION; SURFACTANT; INTERFACES
AB Biomaterials research will always require a range of techniques to examine structure and function on a range of length scales and in a range of settings. Neutron scattering provides a unique way of disentangling the molecular and structural complexity of biomaterials through study of the constituent components. We examine how the technique has been used to study surface immobilized proteins and lipid films, floating lipid bilayers as mimics of in vitro planar membranes, and formation of fibres from solution by insects and spiders.
C1 [Clifton, L. A.; Neylon, C.; Terry, A. E.] Rutherford Appleton Lab, Sci & Technol Facil Council, ISIS Pulsed Neutron & Muon Source, Didcot OX11 0QX, Oxon, England.
   [Dicko, I. C.] Lund Univ, Dept Pure & Appl Biochem, S-22100 Lund, Sweden.
   [Diddens, I. A.] Dept Zool, Oxford OX1 3PS, England.
RP Clifton, LA (reprint author), Rutherford Appleton Lab, Sci & Technol Facil Council, ISIS Pulsed Neutron & Muon Source, Harwell Sci & Innovat Campus, Didcot OX11 0QX, Oxon, England.
EM cameron.neylon@stfc.ac.uk
RI Greving, Imke/N-9335-2014
OI Neylon, Cameron/0000-0002-0068-716X
CR Almogren A, 2009, MOL IMMUNOL, V46, P1534, DOI 10.1016/j.molimm.2008.12.022
   Asakura T, 1997, MACROMOLECULES, V30, P2429, DOI 10.1021/ma9616726
   Bennington SM, 2009, NUCL INSTRUM METH A, V600, P32, DOI 10.1016/j.nima.2008.11.102
   Botti A, 2006, PHYSICA B, V385-86, P1070, DOI 10.1016/j.physb.2006.05.342
   DENNY MW, 1980, SOC EXP BIOL S, V34, P245
   DICKO C, 2006, FIBROUS PROTEINS, P17
   Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840
   Hamley IW, 2008, CHEM-EUR J, V14, P11369, DOI 10.1002/chem.200800817
   Holland C, 2008, WOODHEAD PUBL TEXT, P74, DOI 10.1533/9781845695088.1.74
   Hughes AV, 2008, LANGMUIR, V24, P1989, DOI 10.1021/la702050b
   Hughes AV, 2002, PHYS CHEM CHEM PHYS, V4, P2371, DOI 10.1039/b200409g
   Krysmann MJ, 2008, LANGMUIR, V24, P8158, DOI 10.1021/la800942n
   Le Brun AP, 2008, EUR BIOPHYS J BIOPHY, V37, P639, DOI [10.1007/s00249-008-0291-2, 10.1007/S00249-008-0291-2]
   LUA JR, 1998, J CHEM SOC FARADAY T, V94
   MAJKRZAK CF, 1999, PHYSICA B, V268, P168
   Malardier-Jugroot C, 2008, PHYS CHEM CHEM PHYS, V10, P4903, DOI 10.1039/b806995f
   Nagarkar RP, 2008, J AM CHEM SOC, V130, P4466, DOI 10.1021/ja710295t
   NEYLON C, 2008, EUROPEAN BIOPHYSICS, P531
   Pereira P, 2008, COLLOID SURFACE B, V64, P1, DOI 10.1016/j.colsurfb.2007.12.015
   Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009
   Plomp J, 2007, THIN SOLID FILMS, V515, P5732, DOI 10.1016/j.tsf.2006.12.129
   Pozzo DC, 2009, LANGMUIR, V25, P1558, DOI 10.1021/la8039994
   ROGERS SE, 2009, J COLLOID INTERF SCI, V330, P5
   Shah DS, 2007, BIOCHEM SOC T, V35, P522, DOI 10.1042/BST0350522
   Shen HH, 2009, LANGMUIR, V25, P4211, DOI 10.1021/la802913x
   Stuhrmann HB, 2008, ACTA CRYSTALLOGR A, V64, P181, DOI 10.1107/S0108767307046569
   Teixeira SCM, 2008, CHEM PHYS, V345, P133, DOI 10.1016/j.chemphys.2008.02.030
   Telling MTF, 2008, J PHYS CHEM B, V112, P10873, DOI 10.1021/jp801779x
   Thomas RK, 2004, ANNU REV PHYS CHEM, V55, P391, DOI 10.1146/annurev.physchem.54.011002.103830
   Tucker I, 2009, LANGMUIR, V25, P4934, DOI 10.1021/la804116d
   Voets IK, 2006, ANGEW CHEM INT EDIT, V45, P6673, DOI 10.1002/anie.200601000
   VOLLRATH F, 2001, NATURE, V410, P8
   VOLLRATH F, 2006, APPL PHYS A
   Whitten AE, 2007, J MOL BIOL, V368, P407, DOI 10.1016/j.jmb.2007.01.064
   Wood K, 2007, P NATL ACAD SCI USA, V104, P18049, DOI 10.1073/pnas.0706566104
NR 35
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD JUL-AUG
PY 2009
VL 12
IS 7-8
BP 86
EP 91
DI 10.1016/S1369-7021(09)70234-2
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 486YV
UT WOS:000269237900040
OA Other Gold
DA 2018-10-19
ER

PT J
AU Wu, CH
   Bernard, SM
   Andersen, GL
   Chen, W
AF Wu, Cindy H.
   Bernard, Stephanie M.
   Andersen, Gary L.
   Chen, Wilfred
TI Developing microbe-plant interactions for applications in plant-growth
   promotion and disease control, production of useful compounds,
   remediation and carbon sequestration
SO MICROBIAL BIOTECHNOLOGY
LA English
DT Review
AB Interactions between plants and microbes are an integral part of our terrestrial ecosystem. Microbe-plant interactions are being applied in many areas. In this review, we present recent reports of applications in the areas of plant-growth promotion, biocontrol, bioactive compound and biomaterial production, remediation and carbon sequestration. Challenges, limitations and future outlook for each field are discussed.
C1 [Wu, Cindy H.; Bernard, Stephanie M.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA.
   [Chen, Wilfred] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.
RP Wu, CH (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.
EM chwu@lbl.gov
RI Andersen, Gary/G-2792-2015; Chen, Wilfred/H-4335-2013
OI Andersen, Gary/0000-0002-1618-9827; Swarbreck, Stephanie
   M./0000-0001-8355-7354
FU U.S. Department of Energy [DE-AC02-05CH11231]; U.S. Department of Energy
   (DOE), Office of Science, Biological and Environmental Research
FX In memoriam of Bo Bodvarsson, LBL Earth Sciences Division Director, 2001
   to 2006. We are grateful to Janet Jansson and two anonymous reviewers
   for critically reviewing this manuscript. We thank Walter Denn for
   drawing the plant figure. We would like to acknowledge funding support
   from the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.
   S.M.B. acknowledges support from the U.S. Department of Energy (DOE),
   Office of Science, Biological and Environmental Research, Program for
   Ecosystem Research.
CR ANDERSON TA, 1993, ENVIRON SCI TECHNOL, V27, P2630, DOI 10.1021/es00049a001
   Arkhipova TN, 2007, PLANT SOIL, V292, P305, DOI 10.1007/s11104-007-9233-5
   ARKHIPOVA TN, 2005, PLANT DIS, V87, P4
   Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0
   Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960
   Bauer WD, 2004, CURR OPIN PLANT BIOL, V7, P429, DOI 10.1016/j.pbi.2004.05.008
   Bazot S, 2006, SOIL BIOL BIOCHEM, V38, P729, DOI 10.1016/j.soilbio.2005.06.023
   Boddey RM, 2003, PLANT SOIL, V252, P139, DOI 10.1023/A:1024152126541
   Boltner D, 2008, MICROB BIOTECHNOL, V1, P87, DOI 10.1111/j.1751-7915.2007.00004.x
   Boiero L, 2007, APPL MICROBIOL BIOT, V74, P874, DOI 10.1007/s00253-006-0731-9
   BRAZIL GM, 1995, APPL ENVIRON MICROB, V61, P1946
   Bremer E, 2008, SOIL SCI SOC AM J, V72, P970, DOI 10.2136/sssaj2007.0327
   CAMPBELL N, 1995, BIOLOGY, P502
   Catalan AI, 2007, ENZYME MICROB TECH, V40, P1352, DOI 10.1016/j.enzmictec.2006.10.008
   Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005
   de Carcer DA, 2007, APPL ENVIRON MICROB, V73, P6224, DOI 10.1128/AEM.01254-07
   de Carcer DA, 2007, ISME J, V1, P215, DOI 10.1038/ismej.2007.27
   Degenhardt J, 2005, MOL GENET GENOMICS, V273, P326, DOI 10.1007/s00438-005-1136-7
   Del Giudice L, 2008, ENVIRON MICROBIOL, V10, P2824, DOI 10.1111/j.1462-2920.2008.01703.x
   Dong YH, 2004, APPL ENVIRON MICROB, V70, P954, DOI 10.1128/AEM.70.2.954-960.2004
   Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x
   Drissner D, 2007, EUR J SOIL SCI, V58, P260, DOI 10.1111/j.1365-2389.2006.00838.x
   Elmer PAG, 2006, PLANT PATHOL, V55, P155, DOI 10.1111/j.1365-3059.2006.01348.x
   Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833
   FILLION M, 2008, MICROB BIOTECHNOL, V1, P463
   Gao MS, 2003, MOL PLANT MICROBE IN, V16, P827, DOI 10.1094/MPMI.2003.16.9.827
   Gau AE, 2002, ENVIRON MICROBIOL, V4, P744, DOI 10.1046/j.1462-2920.2002.00359.x
   Georgiev MI, 2007, APPL MICROBIOL BIOT, V74, P1175, DOI 10.1007/s00253-007-0856-5
   Gerhardt KE, 2009, PLANT SCI, V176, P20, DOI 10.1016/j.plantsci.2008.09.014
   Guillon S, 2006, TRENDS BIOTECHNOL, V24, P403, DOI 10.1016/j.tibtech.2006.07.002
   Heath KD, 2008, NEW PHYTOL, V180, P268, DOI 10.1111/j.1469-8137.2008.02633.x
   Heinemeyer A, 2007, GLOBAL CHANGE BIOL, V13, P1786, DOI 10.1111/j.1365-2486.2007.01383.x
   Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619
   Ingram LJ, 2008, SOIL SCI SOC AM J, V72, P939, DOI 10.2136/sssaj2007.0038
   Iniguez AL, 2004, MOL PLANT MICROBE IN, V17, P1078, DOI 10.1094/MPMI.2004.17.10.1078
   James EK, 2002, MOL PLANT MICROBE IN, V15, P894, DOI 10.1094/MPMI.2002.15.9.894
   Kamaludeen SPB, 2008, INDIAN J MICROBIOL, V48, P80, DOI 10.1007/s12088-008-0008-3
   Kanamori N, 2006, P NATL ACAD SCI USA, V103, P359, DOI 10.1073/pnas.0508883103
   Khan MS, 2009, ENVIRON CHEM LETT, V7, P1, DOI 10.1007/s10311-008-0155-0
   Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714
   Kurkcuoglu S, 2007, J EXP BOT, V58, P733, DOI 10.1093/jxb/erl249
   Kuffner M, 2008, PLANT SOIL, V304, P35, DOI 10.1007/s11104-007-9517-9
   Kumar R, 2006, CURR SCI INDIA, V91, P885
   Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P425, DOI 10.1016/j.soilbio.2005.08.020
   Leake JR, 2006, APPL SOIL ECOL, V33, P152, DOI 10.1016/j.apsoil.2006.03.001
   Lee W, 2006, BIOTECHNOL BIOENG, V95, P399, DOI 10.1002/bit.20950
   Leigh MB, 2006, APPL ENVIRON MICROB, V72, P2331, DOI 10.1128/AEM.72.4.2331-2342.2006
   Li PJ, 2009, ENVIRON MONIT ASSESS, V149, P275, DOI 10.1007/s10661-008-0201-1
   Liu L, 2007, ENVIRON MICROBIOL, V9, P465, DOI 10.1111/j.1462-2920.2006.01163.x
   Mark GL, 2006, FEMS MICROBIOL ECOL, V56, P167, DOI 10.1111/j.1574-6941.2006.00056.x
   Marra R, 2006, CURR GENET, V50, P307, DOI 10.1007/s00294-006-0091-0
   Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599
   Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009
   Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025
   Molina L, 2000, SOIL BIOL BIOCHEM, V32, P315, DOI 10.1016/S0038-0717(99)00156-X
   Moore FP, 2006, SYST APPL MICROBIOL, V29, P539, DOI 10.1016/j.syapm.2005.11.012
   Narasimhan K, 2003, PLANT PHYSIOL, V132, P146, DOI 10.1104/pp.102.016295
   Newman KL, 2008, MOL PLANT MICROBE IN, V21, P326, DOI 10.1094/MPMI-21-3-0326
   Niklaus PA, 2006, GLOBAL CHANGE BIOL, V12, P1909, DOI 10.1111/j.1365-2486.2006.01215.x
   Norby RJ, 1998, NATURE, V396, P17, DOI 10.1038/23812
   Olson PE, 2003, ENVIRON SCI TECHNOL, V37, P638, DOI 10.1021/es026099m
   Park K, 2008, J MICROBIOL BIOTECHN, V18, P1095
   Partida-Martinez LP, 2007, APPL ENVIRON MICROB, V73, P793, DOI 10.1128/AEM.01784-06
   Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997
   Patten CL, 2002, CAN J MICROBIOL, V48, P635, DOI 10.1139/W02-053
   Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x
   Preininger E, 2001, IN VITRO CELL DEV-PL, V37, P139
   Pritchard SG, 2008, GLOBAL CHANGE BIOL, V14, P1252, DOI 10.1111/j.1365-2486.2008.01567.x
   Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y
   Ryan RP, 2007, LETT APPL MICROBIOL, V45, P668, DOI 10.1111/j.1472-765X.2007.02248.x
   Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x
   Salvi S, 2005, TRENDS PLANT SCI, V10, P297, DOI 10.1016/j.tplants.2005.04.008
   Saravanan VS, 2008, MICROB ECOL, V55, P130, DOI 10.1007/s00248-007-9258-6
   Scherlach K, 2006, J AM CHEM SOC, V128, P11529, DOI 10.1021/ja062953o
   Scott RA, 2006, MOL PLANT MICROBE IN, V19, P227, DOI 10.1094/MPMI-19-0227
   Shaharoona B, 2007, J MICROBIOL BIOTECHN, V17, P1300
   Sindhoj E, 2006, AGR ECOSYST ENVIRON, V114, P360, DOI 10.1016/j.agee.2005.11.011
   Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008
   Singh P, 2004, ENVIRON MICROBIOL, V6, P1149, DOI 10.1111/j.1462-2920.2004.00622.x
   SORENSEN J, 2007, MODERN SOIL MICROBIO, P211
   Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x
   Srivastava S, 2007, CRIT REV BIOTECHNOL, V27, P29, DOI 10.1080/07388550601173918
   Stougaard J, 2001, CURR OPIN PLANT BIOL, V4, P328, DOI 10.1016/S1369-5266(00)00181-3
   Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005
   Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07
   Van Dillewijn P, 2007, ENVIRON SCI TECHNOL, V41, P1378, DOI 10.1021/es062165z
   Verburg PSJ, 2004, GLOBAL CHANGE BIOL, V10, P498, DOI 10.1111/j.1529-8817.2003.00744.x
   Villacieros M, 2005, APPL ENVIRON MICROB, V71, P2687, DOI 10.1128/AEM.71.5.2687-2694.2005
   Watt M, 2006, ENVIRON MICROBIOL, V8, P871, DOI 10.1111/j.1462-2920.2005.00973.x
   Whipps J.M., 2007, MODERN SOIL MICROBIO, P479
   Whipps JM, 2004, CAN J BOT, V82, P1198, DOI [10.1139/b04-082, 10.1139/B04-082]
   Wu CH, 2006, APPL ENVIRON MICROB, V72, P1129, DOI 10.1128/AEM.72.2.1129-1134.2006
   Wu CH, 2008, APPL MICROBIOL BIOT, V79, P511, DOI 10.1007/s00253-008-1438-x
   Wu JY, 2007, APPL MICROBIOL BIOT, V77, P543, DOI 10.1007/s00253-007-1192-5
   You M, 2005, APPL ENVIRON MICROB, V71, P8183, DOI 10.1128/AEM.71.12.8183-8190.2005
   Zhang LH, 2003, TRENDS PLANT SCI, V8, P238, DOI 10.1016/S1360-1385(03)00063-3
NR 96
TC 37
Z9 39
U1 1
U2 16
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1751-7907
J9 MICROB BIOTECHNOL
JI Microb. Biotechnol.
PD JUL
PY 2009
VL 2
IS 4
SI SI
BP 428
EP 440
DI 10.1111/j.1751-7915.2009.00109.x
PG 13
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA V16YD
UT WOS:000207904000006
PM 21255275
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Wiesenfeld, D
AF Wiesenfeld, D.
TI Tissue engineering and biomaterial in craniofacial reconstruction
SO ORAL ONCOLOGY
LA English
DT Meeting Abstract
CT 2nd World Congress of the International-Academy-of-Oral-Oncology
CY JUL 08-11, 2009
CL Toronto, CANADA
SP Int Acad Oral Oncol
C1 [Wiesenfeld, D.] Royal Melbourne Hosp, Melbourne, Vic, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1368-8375
J9 ORAL ONCOL
JI Oral Oncol.
PD JUL
PY 2009
BP 15
EP 15
DI 10.1016/j.oos.2009.06.035
PG 1
WC Oncology; Dentistry, Oral Surgery & Medicine
SC Oncology; Dentistry, Oral Surgery & Medicine
GA 509KJ
UT WOS:000271015100020
DA 2018-10-19
ER

PT J
AU Byun, EB
   Sung, NY
   Kwon, SK
   Song, BS
   Kim, JH
   Choi, JI
   Hwang, HJ
   Byun, MW
   Lee, JW
AF Byun, Eui-Baek
   Sung, Nak-Yun
   Kwon, Sun-Kyu
   Song, Beom-Seok
   Kim, Jae-Hun
   Choi, Jong-il
   Hwang, Han-Joon
   Byun, Myung-Woo
   Lee, Ju-Woon
TI In vitro and in vivo studies on the cytotoxicity of irradiated silk
   fibroin against mouse melanoma tumor cell
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 15th International Meeting on Radiation Processing (IMRP 2008)
CY SEP 21-25, 2008
CL London, ENGLAND
SP Int Irradiat Assoc
DE Fibroin; Gamma irradiation; Cytotoxicity; Anti-tumor activity
ID BREAST-CANCER; RADIATION; PROTEINS; SKIN
AB The physicochemical properties of proteins can be altered by irradiation. But, it is rarely that the researches on the functional properties of irradiated proteins have been reported. Fibroin is a fibrous protein derived from silkworm Bombyx mori and has been suggested as a biomaterial for biomedical application. Therefore, fibroin was selected as a model protein and was examined with the irradiation effects on the cytotoxicity of fibroin on tumor cell. The cytotoxicity of fibroin against mouse melanoma cell (B16BL6) showed a significant increase dependent upon the increase of irradiation dose. And also, the splenocyte proliferation activities of fibroin were increased by gamma irradiation. In addition, the oral administration of irradiated fibroin significantly increased the inhibition rate of tumor growth in tumor-bearing mouse model. The reason might be due to the change of protein structure by gamma irradiation and is being studied. From these result, it could be concluded that the irradiated fibroin might be a potential candidate as a valuable product in food and medical industry. (C) 2009 Published by Elsevier Ltd.
C1 [Byun, Eui-Baek; Sung, Nak-Yun; Kwon, Sun-Kyu; Song, Beom-Seok; Kim, Jae-Hun; Choi, Jong-il; Byun, Myung-Woo; Lee, Ju-Woon] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Team Radiat Food Sci & Biotechnol, Jeongeup 580185, South Korea.
   [Kwon, Sun-Kyu; Hwang, Han-Joon] Korea Univ, Grad Sch Food & Biotechnol, Jochiwon 339800, South Korea.
   [Byun, Eui-Baek] Kyushu Univ, Grad Sch, Fac Agr, Div Bioresources & Biosci, Fukuoka 8128581, Japan.
RP Lee, JW (reprint author), Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Team Radiat Food Sci & Biotechnol, Jeongeup 580185, South Korea.
EM sjwlee@kaeri.re.kr
CR Ahmed M., 2007, BIOCHEM BIOPH RES CO, V352, P317
   An BJ, 2005, AM J CHINESE MED, V33, P535, DOI 10.1142/S0192415X0500317X
   BRUCE P, 2003, BIORNATERIALS, V24, P3079
   Byun M.W., 1994, RADIOISOTOPE NEWS, V9, P32
   Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006
   Cheema SK, 2007, INT J PHARMACEUT, V341, P221, DOI 10.1016/j.ijpharm.2007.03.043
   GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006
   HONGWEI R, 2006, CELL IMMUNOL, V244, P50
   KANG HJ, 2007, J MED FOOD, V9, P313
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   KUME T, 1995, RADIAT PHYS CHEM, V46, P225, DOI 10.1016/0969-806X(95)00017-R
   Lee N. Y., 2006, J FOOD SCI, V71, P269
   LIXIA H, 2007, J ETHNOPHARMACOL, V111, P227
   Luo J, 1993, 2 INT SILK C CHIN, P73
   MARIA TV, 2000, RADIOTHER ONCOL, V54, P261
   Qian JH, 1997, BIOSENS BIOELECTRON, V12, P1213, DOI 10.1016/S0956-5663(97)00056-0
   Seo JH, 2007, INT IMMUNOPHARMACOL, V7, P464, DOI 10.1016/j.intimp.2006.11.012
   STEVENS CO, 1967, J BIOL CHEM, V242, P1821
   Zhaorigetu S, 2003, J PHOTOCH PHOTOBIO B, V71, P11, DOI 10.1016/S1011-1344(03)00092-7
NR 19
TC 10
Z9 11
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUL-AUG
PY 2009
VL 78
IS 7-8
BP 429
EP 431
DI 10.1016/j.radphyschem.2009.03.021
PG 3
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 476EU
UT WOS:000268422100003
DA 2018-10-19
ER

PT J
AU Huang, NF
   Lam, A
   Fang, QZ
   Sievers, RE
   Li, S
   Lee, RJ
AF Huang, Ngan F.
   Lam, Amy
   Fang, Qizhi
   Sievers, Richard E.
   Li, Song
   Lee, Randall J.
TI Bone marrow-derived mesenchymal stem cells in fibrin augment
   angiogenesis in the chronically infarcted myocardium
SO REGENERATIVE MEDICINE
LA English
DT Article
DE angiogenesis; cardiac tissue engineering; extracellular matrix; fibrin;
   mesenchymal stem cell; myocardial infarction
ID SKELETAL MYOBLAST TRANSPLANTATION; ENDOTHELIAL GROWTH-FACTOR;
   ISCHEMIC-MYOCARDIUM; CARDIAC-FUNCTION; IN-VITRO; HEART; ADULT; REPAIR;
   DELIVERY; MATRIX
AB Aims: Current efforts to treat myocardial infarction include the delivery of cells and matrix scaffolds. Bone marrow-derived mesenchymal stem cells (BM-MSCs) are multipotent stem cells that secrete angiogenic growth factors, and fibrin has been shown to be a biomaterial that provides structural support to cells and tissues. The objective of this study was to characterize the attachment and viability of BM-MSCs in fibrin in vitro, and then to assess the efficacy of treatment with BM-MSCs in fibrin for promoting neovascularization in the chronically infarcted myocardium. Materials & methods: BM-MSCs were cultured in fibrin and assessed for cell attachment and viability by using immunofluorescence staining for actin filaments and Live/Dead (R) viability assays, respectively. To determine the efficacy of BM-MSCs in fibrin in vivo, chronically infarcted rat hearts were treated with either cells, cells in fibrin, fibrin or saline (n = 9). After 5 weeks, the infarct scar tissues were assessed for neovascularization. Results: BM-MSCs exhibited robust cell attachment and viability when cultured in fibrin in vitro. Furthermore, when injected together into the infarcted tissue, BM-MSCs in fibrin could enhance neovasculature formation by increasing capillary density, in comparison to treatment by cells or fibrin separately. Concomitant to significant improvement in capillary density was an increase in the levels of VEGF in the infarct scar. Conclusion: This study demonstrates the angiogenic potential of the combined delivery of BM-MSCs and fibrin, and highlights the advantage of stem cell-matrix approaches for myocardial repair.
C1 [Fang, Qizhi; Sievers, Richard E.; Lee, Randall J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Huang, Ngan F.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.
   [Huang, Ngan F.; Lam, Amy; Li, Song] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Fang, Qizhi; Sievers, Richard E.; Lee, Randall J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.
RP Lee, RJ (reprint author), Univ Calif San Francisco, Dept Med, MU E Tower,Box 1354,500 Parnassus Ave, San Francisco, CA 94143 USA.
EM randall.lee@ucsf.edu
OI Huang, Ngan/0000-0003-2298-6790
FU NHLBI NIH HHS [R01 HL083900-03, R01 HL083900, HL083900, R01 HL078534-04,
   HL078534, R01 HL078534]
CR Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a
   Beeres SLMA, 2005, J AM COLL CARDIOL, V46, P1943, DOI 10.1016/j.jacc.2005.07.055
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Chekanov V, 2003, PACE, V26, P496, DOI 10.1046/j.1460-9592.2003.00080.x
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Grinnemo KH, 2006, ANN MED, V38, P144, DOI 10.1080/07853890500422982
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   HUANG NF, 2006, NAT PROTOC, V1, P1598
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Kofidis T, 2005, CIRCULATION, V112, P1173
   Kutschka I, 2006, CIRCULATION, V114, P1167
   Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3
   Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008
   Matsumoto R, 2005, ARTERIOSCL THROM VAS, V25, P1168, DOI 10.1161/01.ATV.0000165696.25680.ce
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070
   NAGAYA N, 2004, AM J PHYSIOL-HEART C, V287, P2670
   Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Reinecke H, 2004, CIRC RES, V94, pE56, DOI 10.1161/01.RES.0000125294.04612.81
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ruger BM, 2008, DIFFERENTIATION, V76, P772, DOI 10.1111/j.1432-0436.2007.00259.x
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600
   Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8
   SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423
   Strauer BE, 2005, J AM COLL CARDIOL, V46, P1651, DOI 10.1016/j.jacc.2005.01.069
   Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Wang CC, 2008, CARDIOVASC RES, V77, P515, DOI 10.1093/cvr/cvm46
   Wang XH, 2006, AM J PHYSIOL-HEART C, V290, pH1393, DOI 10.1152/ajpheart.00871.2005
   Zacharowski K, 2006, J MOL MED, V84, P469, DOI 10.1007/s00109-006-0051-7
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 50
TC 45
Z9 50
U1 0
U2 7
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD JUL
PY 2009
VL 4
IS 4
BP 527
EP 538
DI 10.2217/RME.09.32
PG 12
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 472HY
UT WOS:000268122400010
PM 19580402
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Albu, MG
   Ghica, MV
   Giurginca, M
   Trandafir, V
   Popa, L
   Cotrut, C
AF Albu, Madalina Georgiana
   Ghica, Mihaela Violeta
   Giurginca, Maria
   Trandafir, Viorica
   Popa, Lacramioara
   Cotrut, Cosmin
TI Spectral Characteristics and Antioxidant Properties of Tannic Acid
   Immobilized on Collagen Drug-Delivery Systems
SO REVISTA DE CHIMIE
LA English
DT Article
DE collagen; tannic acid; biomaterials; antioxidant activity; kinetic
   release
ID RELEASE
AB Tannic acid, a biologic active polyphenol, performs antiviral, antibacterial and antioxidant activity. At the same time, collagen as a natural polymer is widely used in medicine as biomaterial scaffold for tissue regeneration of different types of connective tissue. The aim of this study is to obtain some composite biomaterials with antioxidant activity based on collagen-tannic acid which can be used both as topical formulations and as bioactive dressing for skin wounds. Biomaterials like hydrogels and matrices from collagen gels and tannic acid are obtained by different techniques of conditioning or drying. The antioxidant activity of collagen-tannic acid hydrogels is investigated by chemiluminescence technique (CL) and fluorescence spectroscopy (SF). The chemical-structural characterization of collagen-tannic acid matrices is investigated by UV-VIS-NIR and FT-IR-ATR spectroscopy. The in vitro kinetic release both for collagen hydrogels and matrices proves that these biomaterials can act as bioactive systems for controlled release of tannic acid.
C1 [Albu, Madalina Georgiana; Trandafir, Viorica] INCDTP Leather & Footwear Res Inst, Bucharest 031215, Romania.
   [Ghica, Mihaela Violeta; Popa, Lacramioara] Univ Med & Pharm, Fac Pharm, Bucharest 020956, Romania.
   [Giurginca, Maria] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 010737, Romania.
   [Cotrut, Cosmin] Univ Politehn Bucuresti, Bucharest 060032, Romania.
RP Albu, MG (reprint author), INCDTP Leather & Footwear Res Inst, 93 Ion Minulescu St, Bucharest 031215, Romania.
EM albu_mada@yahoo.com
RI Cotrut, Mihai Cosmin/G-4505-2011; POPA, LACRAMIOARA/A-8822-2013; ghica,
   mihaela violeta/B-7356-2011
OI Cotrut, Mihai Cosmin/0000-0002-8991-7485; POPA,
   LACRAMIOARA/0000-0002-3139-9865; Albu, Madalina
   Georgiana/0000-0001-9960-2244
CR ALBU MG, IN PRESS
   ALEXA C, 1963, MATERII PRIME SI AUX
   Andrade RG, 2005, ARCH BIOCHEM BIOPHYS, V437, P1, DOI 10.1016/j.abb.2005.02.016
   Andrews ME, 2003, COLLOID POLYM SCI, V281, P766, DOI 10.1007/s00396-002-0843-4
   Avram M., 1966, SPECTROSCOPIA IR APL
   BADILESCU I, 1981, LEGATURI HIDROGEN
   Balaban A. T., 1983, APLICATII ALE METODE
   DERRICK M, 1991, EVALUATION STATE DEG, P10
   FALCON J, 2000, Patent No. 6063770
   GHICA VM, 2005, PHARMACIA BULGARIA, V52, P147
   Isenburg JC, 2005, BIOMATERIALS, V26, P1237, DOI 10.1016/j.biomaterials.2004.04.034
   Meghea A, 2003, REV CHIM-BUCHAREST, V54, P885
   MIYATA T, 1981, Patent No. 56122317
   Nerurkar J, 2005, EUR J PHARM BIOPHARM, V61, P56, DOI 10.1016/j.ejpb.2005.03.003
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   RITGER PL, 1987, J CONTROL RELEASE, V5, P337
   TRANDAFIR V, 2007, BIOPRODUSE PE BAZA C, P277
   Trombino S, 2008, MACROMOL BIOSCI, V8, P86, DOI 10.1002/mabi.200700110
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
NR 19
TC 39
Z9 39
U1 1
U2 15
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD JUL
PY 2009
VL 60
IS 7
BP 666
EP 672
PG 7
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 484ZG
UT WOS:000269089200005
DA 2018-10-19
ER

PT J
AU Maluf, F
   Hondo, F
   Halwan, B
   de Lima, MS
   Giordano-Nappi, JH
   Sakai, P
AF Maluf-Filho, Fauze
   Hondo, Fabio
   Halwan, Bhawna
   de Lima, Marcelo Simas
   Giordano-Nappi, Jose Humberto
   Sakai, Paulo
TI Endoscopic treatment of Roux-en-Y gastric bypass-related gastrocutaneous
   fistulas using a novel biomaterial
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE Bariatric operation; Clinical trial; Complication; Gastrointestinal
   endoscopy; Technical endoscopy
ID SMALL-INTESTINAL SUBMUCOSA; FIBRIN SEALANT; MANAGEMENT; SURGERY; REPAIR;
   OBESITY; LEAKS
AB Background Roux-en-Y gastric bypass (RYGB) is amongst the commonest surgical intervention for weight loss in obese patients. Gastrocutaneous fistula, which usually occurs along the vertical staple line of the pouch, is amongst its most alarming complications. Medical management comprised of wound drainage, nutritional support, acid suppression, and antibiotics may be ineffective in as many as a third of patients with this complication. We present outcomes after endoscopic application of SurgiSIS (R), which is a novel biomaterial for the treatment of this complication.
   Design A case series of 25 patients.
   Methods Twenty-five patients who had failed conservative medical management of gastrocutaneous fistula after RYGB underwent endoscopic application of SurgiSIS (R)-an acellular fibrogenic matrix biomaterial to help fistula healing.
   Main outcome measures Fistula closure as assessed by upper gastrointestinal imaging and endoscopic examination. Results In patients who had failed medical management lasting 4-25 (median, 7) weeks, closure of the fistulous tract was successful after one application in six patients (30%), two applications in 11 patients (55%), and three applications in three patients (15%). There were no procedure-related complications.
   Conclusions Endoscopic application of SurgiSIS (R)-an acellular fibrogenic matrix-is safe and effective for the treatment of gastrocutaneous fistula after RYGB.
C1 [Maluf-Filho, Fauze; Hondo, Fabio; de Lima, Marcelo Simas; Giordano-Nappi, Jose Humberto; Sakai, Paulo] Univ Sao Paulo, Sch Med, Gastrointestinal Endoscopy Unit, Hosp Clin, Sao Paulo, Brazil.
   [Halwan, Bhawna] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA.
RP Maluf, F (reprint author), Univ Sao Paulo, Sch Med, Gastrointestinal Endoscopy Unit, Hosp Clin, Sao Paulo, Brazil.
EM fauze.maluf@terra.com.br
RI Maluf-Filho, Fauze/D-5062-2013
OI Maluf-Filho, Fauze/0000-0001-8875-420X
CR Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603
   Alpert SA, 2005, J UROLOGY, V174, P1687, DOI 10.1097/01.ju.0000176621.99922.35
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Ballesta C, 2008, OBES SURG, V18, P623, DOI 10.1007/s11695-007-9297-6
   Capella RF, 1991, OBES SURG, V1, P389
   Cellier C, 1996, GASTROINTEST ENDOSC, V44, P731, DOI 10.1016/S0016-5107(96)70062-7
   Dunn CJ, 1999, DRUGS, V58, P863, DOI 10.2165/00003495-199958050-00010
   Familiari P, 2003, DIGEST LIVER DIS, V35, P907, DOI 10.1016/j.dld.2003.05.001
   FOBI M A L, 1989, Journal of Obesity and Weight Regulation, V8, P99
   Fobi MAL, 1998, WORLD J SURG, V22, P925, DOI 10.1007/s002689900496
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   Maluf F, 2002, GASTROINTEST ENDOSC, V55, pAB108
   MALUF F, 2004, GASTROINTEST ENDOSC, V59, pP151
   Merrifield BF, 2006, GASTROINTEST ENDOSC, V63, P710, DOI 10.1016/j.gie.2005.11.018
   Murr MM, 1999, J GASTROINTEST SURG, V3, P607, DOI 10.1016/S1091-255X(99)80082-1
   Papavramidis ST, 2004, GASTROINTEST ENDOSC, V59, P296, DOI 10.1016/S0016-5107(03)02545-8
   Papavramidis ST, 2001, OBES SURG, V11, P766, DOI 10.1381/09608920160558759
   Rabago LR, 2002, ENDOSCOPY, V34, P632, DOI 10.1055/s-2002-33237
   Shand A, 1997, GASTROINTEST ENDOSC, V46, P357, DOI 10.1016/S0016-5107(97)70125-1
   Thurairajah P, 2004, ENDOSCOPY, V36, P834, DOI 10.1055/s-2004-825835
NR 21
TC 20
Z9 20
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD JUL
PY 2009
VL 23
IS 7
BP 1541
EP 1545
DI 10.1007/s00464-009-0440-4
PG 5
WC Surgery
SC Surgery
GA 458BB
UT WOS:000266984400021
PM 19296165
DA 2018-10-19
ER

PT J
AU Yang, CW
   Lui, TS
   Chen, LH
AF Yang, Chung-Wei
   Lui, Truan-Sheng
   Chen, Li-Hui
TI Hydrothermal crystallization effect on the improvement of erosion
   resistance and reliability of plasma-sprayed hydroxyapatite coatings
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Technological Advanced of Thin Films and
   Surface Coating
CY JUL 14-16, 2008
CL Singapore Management Univ, Singapore, SINGAPORE
SP IEEE
HO Singapore Management Univ
DE Biomaterial; Hydrothermal treatment; Bonding strength; Erosion; Weibull
   model; Failures
ID BONDING STRENGTH; HEAT-TREATMENT; CERAMIC COATINGS; HA COATINGS;
   IN-VITRO; BONE; MICROSTRUCTURE; TITANIUM; MODULUS; IMPLANT
AB The aim of present study is to investigate the crystallization effect of air and hydrothermal heat treatments on the erosion resistance, failure behaviors and reliability of plasma-sprayed HA coatings (HACs). Experimental results show that just 150 degrees C is required to see a significant increase in crystallinity and phase purity for hydrothermally-treated HACs compared with the high-temperature (600 degrees C) air heat treatment. The significantly improved bonding strength of hydrothermally-treated HACs can be recognized for the self-healing effect that resulted from the hydrothermal crystallization. Results of erosion test indicated that the erosion resistance decreases with increasing erosion impact angle. The maximum erosion rate occurred at 90 degrees impact angle for all the as-sprayed and heat-treated HACs. The erosion resistance of plasma-sprayed HACs is significantly improved through the crystallization of a coating after heat treatments. Furthermore, it should be worth noting that the erosion resistance for hydrothermally-treated HACs is much better than as-sprayed and air heat-treated HACs at any impact angle. The statistical analysis of Weibull model shows that plasma-sprayed coatings are generally reliable materials with a wear-out failure model (with a Weibull modulus m>3) of increasing failure rate (IFR). The knowledge of the minimum strength and failure behavior will be very helpful for understanding the HA coating reliability for further biological applications. Crown Copyright (C) 2009 Published by Elsevier B.V. All rights reserved.
C1 [Yang, Chung-Wei; Lui, Truan-Sheng; Chen, Li-Hui] Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 70101, Taiwan.
RP Lui, TS (reprint author), Natl Cheng Kung Univ, Dept Mat Sci & Engn, 1 Univ Rd, Tainan 70101, Taiwan.
EM Rei@mse.ncku.edu.tw; z7408020@email.ncku.edu.tw; chenlh@mail.ncku.edu.tw
CR BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   BAUER TW, 1994, CLIN ORTHOP RELAT R, V298, P11
   BESHISH GK, 1993, J THERM SPRAY TECHN, V2, P35
   Burrow MF, 2004, BIOMATERIALS, V25, P5031, DOI 10.1016/j.biomaterials.2004.01.060
   Chen JY, 1997, J BIOMED MATER RES, V34, P15, DOI 10.1002/(SICI)1097-4636(199701)34:1<15::AID-JBM3>3.0.CO;2-Q
   Coathup MJ, 2005, BIOMATERIALS, V26, P4161, DOI 10.1016/j.biomaterials.2004.10.020
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   FAUCHER B, 1988, J MATER SCI LETT, V7, P1199, DOI 10.1007/BF00722337
   Fu YQ, 1999, WEAR, V230, P98, DOI 10.1016/S0043-1648(98)00340-8
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   Gross KA, 2002, J BIOMED MATER RES, V63, P106, DOI 10.1002/jbm.10090
   Hardy D. C. R., 1999, EUR J ORTHOP SURG TR, V9, P75
   Kim HJ, 1999, THIN SOLID FILMS, V342, P201, DOI 10.1016/S0040-6090(98)01491-6
   KITSUGI T, 1988, CLIN ORTHOP RELAT R, V234, P280
   Kweh SWK, 2000, BIOMATERIALS, V21, P1223, DOI 10.1016/S0142-9612(99)00275-6
   Li CJ, 1997, J MATER SCI, V32, P997, DOI 10.1023/A:1018574221589
   Li H, 2002, BIOMATERIALS, V23, P2105, DOI 10.1016/S0142-9612(01)00326-X
   Lima RS, 2003, J THERM SPRAY TECHN, V12, P240, DOI 10.1361/105996303770348357
   LINTNER F, 1994, J BONE JOINT SURG BR, V76B, P824
   Liou JW, 1997, WEAR, V211, P169, DOI 10.1016/S0043-1648(97)00105-1
   LIOU JW, 1995, J MATER SCI, V30, P258, DOI 10.1007/BF00352159
   Morks ME, 2008, J MECH BEHAV BIOMED, V1, P105, DOI 10.1016/j.jmbbm.2007.04.003
   OGISO M, 1981, J DENT RES, V60, P419
   OONISHI H, 1989, J BONE JOINT SURG BR, V71, P213
   Roth R. S., 1983, PHASE DIAGRAMS CERAM, V5, P321
   Tong WD, 1997, J BIOMED MATER RES, V36, P242, DOI 10.1002/(SICI)1097-4636(199708)36:2<242::AID-JBM13>3.0.CO;2-I
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Yang CY, 2007, J BIOMED MATER RES A, V83A, P263, DOI 10.1002/jbm.a.31246
   Yang CW, 2008, J EUR CERAM SOC, V28, P2151, DOI 10.1016/j.jeurceramsoc.2008.02.015
   Yang CW, 2007, MATER TRANS, V48, P211, DOI 10.2320/matertrans.48.211
   Yang CW, 2005, MATER TRANS, V46, P709, DOI 10.2320/matertrans.46.709
   YANG CY, 1995, J MATER SCI-MATER M, V6, P258, DOI 10.1007/BF00120268
NR 33
TC 10
Z9 10
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD JUL 1
PY 2009
VL 517
IS 17
BP 5380
EP 5385
DI 10.1016/j.tsf.2009.03.006
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 460YW
UT WOS:000267230300147
DA 2018-10-19
ER

PT J
AU Wu, ZM
   Zhang, XG
   Zheng, C
   Li, CX
   Zhang, SM
   Dong, RN
   Yu, DM
AF Wu, Z. M.
   Zhang, X. G.
   Zheng, C.
   Li, C. X.
   Zhang, S. M.
   Dong, R. N.
   Yu, D. M.
TI Disulfide-crosslinked chitosan hydrogel for cell viability and
   controlled protein release
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Chitosan hydrogel; Disulfide bond; Cell growth; Controlled protein
   release; Biomaterial
ID DENATURED THIOLATED COLLAGEN; DRUG-DELIVERY; ANTIMICROBIAL AGENT;
   BETA-LACTOGLOBULIN; THERMAL-ANALYSIS; DEGRADATION; DERIVATIVES; FILMS;
   GELS; BIONANOTECHNOLOGY
AB Synthetic hydrogel mimics of the extracellular matrix (ECM) were prepared by cross-linking a thiol-modified chitosan (CS). CS was chemically modified using N-acetyl-L-Cysteine (NAC). To minimize interference with biological function, the degree of substitution of thiol groups was kept below 50%. Solution of thiolated CS was prepared in pH 7.4 phosphate buffered saline (PBS) and crosslinked by disulfide bond formation in air. The gelation mainly depended on the content of thiol groups on thiolated CS, concentration of thiolated CS and the molecular weight of CS. Thermogravimetric analysis showed the thermal stabilities of CSS-S hydrogels. Results from SEM observation showed a porous 3D hydrogel structure with pores ranging from 5 to 30 mu m. In vitro release showed that insulin and BSA release could be controlled by choosing the composition, loading and disulfide bond contents. In vitro cell compatibility of the hydrogels on NIH 3T3 cells was evaluated, indicating that the hydrogels were biocompatible and the cells could migrate into the hydrogels. Moreover, cells were viable and preserved 3D cell morphology inside the hydrogels. These results demonstrate that disulfide-crosslinked CS hydrogels, a new type of macroporous, biocompatible, synthetic polymers, are promising applications in tissue engineering, drug delivery, and cell culture. (C) 2009 Published by Elsevier B.V.
C1 [Wu, Z. M.; Zhang, S. M.; Dong, R. N.; Yu, D. M.] Tianjin Med Univ, Key Lab Hormones & Dev, Minist Hlth, Metab Dis Hosp, Tianjin 300070, Peoples R China.
   [Zhang, X. G.; Zheng, C.; Li, C. X.] Nankai Univ, Inst Polymer Chem, Minist Educ, Key Lab Funct Polymer Mat, Tianjin 300071, Peoples R China.
RP Yu, DM (reprint author), Tianjin Med Univ, Key Lab Hormones & Dev, Minist Hlth, Metab Dis Hosp, Tianjin 300070, Peoples R China.
EM yudemin@tijmu.edu.cn
FU Chinese Postdoctoral Science Foundation [20070410766]; Tianjin Health
   Bureau Scientific Research Found [07kz47]
FX Financial support from Chinese Postdoctoral Science Foundation
   (20070410766) and Tianjin Health Bureau Scientific Research Found
   (07kz47) are gratefully acknowledged.
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   de Campos AM, 2004, PHARM RES, V21, P803, DOI 10.1023/B:PHAM.0000026432.75781.cb
   Desbrieres J, 1996, INT J BIOL MACROMOL, V19, P21, DOI 10.1016/0141-8130(96)01095-1
   DRAGET KI, 1992, BIOMATERIALS, V13, P635, DOI 10.1016/0142-9612(92)90032-J
   Faergemand M, 1998, J AGR FOOD CHEM, V46, P884, DOI 10.1021/jf970733b
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Giunchedi P, 2002, EUR J PHARM BIOPHARM, V53, P233, DOI 10.1016/S0939-6411(01)00237-5
   GORBACH VI, 1994, CARBOHYD RES, V260, P73, DOI 10.1016/0008-6215(94)80023-5
   Gosal WS, 2004, BIOMACROMOLECULES, V5, P2420, DOI 10.1021/bm049660c
   Gosal WS, 2002, LANGMUIR, V18, P7174, DOI 10.1021/la025531a
   Hiemstra C, 2007, J CONTROL RELEASE, V122, P71, DOI 10.1016/j.jconrel.2007.06.011
   HIRANO S, 1990, CARBOHYD RES, V201, P145, DOI 10.1016/0008-6215(90)84231-I
   Hisano N, 1998, J BIOMED MATER RES, V40, P115, DOI 10.1002/(SICI)1097-4636(199804)40:1<115::AID-JBM13>3.0.CO;2-N
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Krauland AH, 2005, DRUG DEV IND PHARM, V31, P885, DOI 10.1080/03639040590405002791985
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2004, BIOMATERIALS, V25, P2461, DOI 10.1016/j.biomaterials.2003.09.030
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Mi FL, 2000, CARBOHYD POLYM, V41, P389, DOI 10.1016/S0144-8617(99)00104-6
   MOORE RH, 1980, REGUL PEPTIDES, V1, P77, DOI 10.1016/0167-0115(80)90012-9
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Neto CGT, 2005, CARBOHYD POLYM, V62, P97, DOI 10.1016/j.carbpol.2005.02.022
   Nicolas FL, 1997, BIOMATERIALS, V18, P807, DOI 10.1016/S0142-9612(97)00002-1
   Nicolas FL, 1997, BIOMATERIALS, V18, P815, DOI 10.1016/S0142-9612(97)00003-3
   NIETO JM, 1991, THERMOCHIM ACTA, V176, P63, DOI 10.1016/0040-6031(91)80260-P
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Plunkett KN, 2003, MACROMOLECULES, V36, P3960, DOI 10.1021/ma025874f
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Read RC, 2005, VACCINE, V23, P4367, DOI 10.1016/j.vaccine.2005.04.021
   Rinaudo M, 1999, POLYMER, V40, P7029, DOI 10.1016/S0032-3861(99)00056-7
   ROBERTS GAF, 1989, MAKROMOL CHEM, V190, P951
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Santovena A, 2004, BIOMATERIALS, V25, P925, DOI 10.1016/S0142-9612(03)00592-1
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   THANNHAUSER TW, 1987, METHOD ENZYMOL, V143, P115
   Vachoud L, 1997, CARBOHYD RES, V302, P169, DOI 10.1016/S0008-6215(97)00126-2
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   van der Lubben IM, 2001, BIOMATERIALS, V22, P687, DOI 10.1016/S0142-9612(00)00231-3
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Wang XH, 2005, POLYM BULL, V55, P105, DOI 10.1007/s00289-005-0414-1
   Wang X, 2009, J BIOMED MATER RES B, V88B, P150, DOI 10.1002/jbm.b.31161
   Yamauchi K, 2001, BIOMATERIALS, V22, P855, DOI 10.1016/S0142-9612(00)00249-0
NR 48
TC 57
Z9 57
U1 9
U2 93
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD JUN 28
PY 2009
VL 37
IS 3-4
BP 198
EP 206
DI 10.1016/j.ejps.2009.01.010
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 464BK
UT WOS:000267479500002
PM 19491006
DA 2018-10-19
ER

PT J
AU Wang, ZY
   Song, J
   Zhang, DS
AF Wang, Zi-Yu
   Song, Jian
   Zhang, Dong-Sheng
TI Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid
   hyperthermia selectively target liver cancer cells
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Liver cancer; Magnetic fluid hyperthermia; Nanoparticle; As2O3
ID ARSENIC TRIOXIDE; NANOPARTICLES; CARCINOMA; MODEL; THERMOTHERAPY;
   APOPTOSIS
AB AIM: To study the methods of preparing the magnetic nano-microspheres of Fe2O3 and As2O3/Fe2O3 complexes and their therapeutic effects with magnetic fluid hyperthermia (MFH).
   METHODS: Nanospheres were prepared by chemical co-precipitation and their shape and diameter were observed. Hemolysis, micronucleus, cell viability, and LD50 along with other in vivo tests were performed to evaluate the Fe2O3 microsphere biocompatibility. The inhibition ratio of tumors after Fe2O3 and As2O3/Fe2O3 injections combined with induced hyperthermia in xenograft human hepatocarcinoma was calculated.
   RESULTS: Fe2O3 and As2O3/Fe2O3 particles were round with an average diameter of 20 nm and 100 nm as observed under transmission electron microscope. Upon exposure to an alternating magnetic field (AMF), the temperature of the suspension of magnetic particles increased to 41-51 degrees C, depending on different particle concentrations, and remained stable thereafter. Nanosized Fe2O3 microspheres are a new kind of biomaterial without cytotoxic effects. The LD50 of both Fe2O3 and As2O3/Fe2O3 in mice was higher than 5 g/kg. One to four weeks after Fe2O3 and As2O3/Fe2O3 complex injections into healthy pig livers, no significant differences were found in serum AST, ALT, BUN and Cr levels among the pigs of all groups (P > 0.05), and no obvious pathological alterations were observed. After exposure to alternating magnetic fields, the inhibition ratio of the tumors was significantly different from controls in the Fe2O3 and As2O3/Fe2O3 groups (68.74% and 82.79%, respectively; P < 0.01). Tumors of mice in treatment groups showed obvious necrosis, while normal tissues adjoining the tumor and internal organs did not.
   CONCLUSION: Fe2O3 and As2O3/Fe2O3 complexes exerted radiofrequency-induced hyperthermia and drug toxicity on tumors without any liver or kidney damage. Therefore, nanospheres are ideal carriers for tumor-targeted therapy. (c) 2009 The WJG Press and Baishideng. All rights reserved.
C1 [Song, Jian; Zhang, Dong-Sheng] Southeast Univ, Sch Basic Med Sci, Nanjing 210009, Jiangsu, Peoples R China.
   [Wang, Zi-Yu] Southeast Univ, Sch Clin Med, Nanjing 210009, Peoples R China.
   [Wang, Zi-Yu] Nanjing Univ Tradit Chinese Med, Sch Basic Med Sci, Nanjing 210046, Jiangsu, Peoples R China.
RP Zhang, DS (reprint author), Southeast Univ, Sch Basic Med Sci, Nanjing 210009, Jiangsu, Peoples R China.
EM b7712900@jlonline.com
CR Chow SKY, 2004, J CELL BIOCHEM, V93, P173, DOI 10.1002/jcb.20102
   DONG JT, 1994, MUTAT RES, V315, P11, DOI 10.1016/0921-8777(94)90022-1
   Fuic A, 1999, Arh Hig Rada Toksikol, V50, P299
   Gneveckow U, 2004, MED PHYS, V31, P1444, DOI 10.1118/1.1748629
   HARMAND MF, 1995, J BIOMAT SCI-POLYM E, V6, P809, DOI 10.1163/156856295X00193
   Jiang XH, 2001, INT J CANCER, V91, P173, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1039>3.0.CO;2-D
   Johannsen M, 2006, PROSTATE, V66, P97, DOI 10.1002/pros.20324
   Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Li Ling-Hao, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P1335
   Luo LQ, 2006, INT J CANCER, V118, P1823, DOI 10.1002/ijc.21557
   Miller WH, 2002, CANCER RES, V62, P3893
   Moroz P, 2002, INT J HYPERTHER, V18, P129, DOI 10.1080/02656730110095609
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445
   Wust P, 2006, INT J HYPERTHER, V22, P673, DOI 10.1080/02656730601106037
   Yan SY, 2005, J NANOSCI NANOTECHNO, V5, P1185, DOI 10.1166/jnn.2005.219
   Yang X, 2001, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V18, P123
   Zhang YY, 2008, WORLD J GASTROENTERO, V14, P1641, DOI 10.3748/wjg.14.1641
   Zhao XY, 2008, BASIC CLIN PHARMACOL, V102, P419, DOI 10.1111/j.1742-7843.2007.00150.x
NR 20
TC 33
Z9 43
U1 0
U2 24
PU BAISHIDENG PUBL GRP CO LTD
PI WANCHAI
PA ROOM 1701, 17-F, HENAN BUILDING, NO. 90, JAFFE RD, WANCHAI, HONG KONG
   100025, PEOPLES R CHINA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD JUN 28
PY 2009
VL 15
IS 24
BP 2995
EP 3002
DI 10.3748/wjg.15.2995
PG 8
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 464HN
UT WOS:000267496100006
PM 19554652
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Deng, ML
   Yu, DF
   Hou, YB
   Wang, YL
AF Deng, Manli
   Yu, Defeng
   Hou, Yanbo
   Wang, Yilin
TI Self-assembly of Peptide-Amphiphile C-12-A beta(11-17) into Nanofibrils
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID SURFACTANT-LIKE PEPTIDES; BETA-SHEET ASSEMBLAGE; SOLID-STATE NMR;
   BIOLOGICAL-MATERIALS; POLYMORPHISM; DERIVATIVES; FIBRILS; BINDING; FORM
AB A peptide-amphiphile (C-12-A beta(11-17)) was constructed with a key fragment of amyloid beta-peptide (A beta(11-17)) attached to dodecanoic acid through an amide bond. The self-assembly behavior of C-12-A beta(11-17) in aqueous solution is studied at 25 degrees C and at pH 3.0 and 10.0. A beta(11-17) cannot form ordered self-assemblies. But C-12-A beta(11-17) exhibits a very strong ability to form ordered nanofibrils, and the specific fine structure of the nanofibrils can be modulated simply by adjusting the concentration or pH. The critical micelle concentration of C-12-A beta(11-17) was determined as 0.063 and 0.11 mM at pH 3.0 and 10.0, respectively, indicating a stronger assembling ability of C-12-A beta(11-17) at acidic pH. In 0.47 mM C-12-A beta(11-17) solution at pH 3.0, rodlike fibrils with a diameter of similar to 5 nm and varying length of hundreds of nanometers are observed. When the C-12-A beta(11-17) concentration increases to 1.87 mM at pH 3.0, the above rodlike fibrils pack in parallel and form tapelike fibrils through lateral association. In 1.87 mM C-12-A beta(11-17) solution at pH.10.0, twisted fibrils with regular periodicity of similar to 200 nm are formed by the twisting of similar to 20 nm wide and similar to 11 nm thick nanoribbons. The hydrophobic moiety is necessary in fibril formation, whereas the beta-sheet secondary structure of the peptide moiety plays an essential role in the twisting morphology. This work helps to understand the possible mechanism in amyloid fibrillogenesis and provides an approach to inscribe biological signals in self-assemblies with potential application in biomaterial fabrication.
C1 [Deng, Manli; Yu, Defeng; Hou, Yanbo; Wang, Yilin] Chinese Acad Sci, Inst Chem, Key Lab Colloid & Interface Sci, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.
RP Wang, YL (reprint author), Chinese Acad Sci, Inst Chem, Key Lab Colloid & Interface Sci, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.
EM yilinwang@iccas.ac.cn
FU National Natural Science Foundation of China; National Basic Research
   Program of China [20633010, 20056221300]
FX We are grateful for financial support from the National Natural Science
   Foundation of China and National Basic Research Program of China (Grants
   20633010,20056221300). We gratefully acknowledge the Institute of
   Biophysics of the Chinese Academy of Sciences for access to the
   transmission electron microscope (FEI Tecnai 20).
CR Adams DJ, 2007, LANGMUIR, V23, P12729, DOI 10.1021/la7011183
   Aggeli A, 1997, J MATER CHEM, V7, P1135, DOI 10.1039/a701088e
   Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330
   Baumann MK, 2008, LANGMUIR, V24, P7645, DOI 10.1021/la801605b
   Behanna HA, 2005, J AM CHEM SOC, V127, P1193, DOI 10.1021/ja044863u
   Cao MW, 2007, J PHYS CHEM B, V111, P13436, DOI 10.1021/jp075271b
   Clippingdale AB, 2001, J PEPT SCI, V7, P227
   Danielsson J, 2004, BIOCHEMISTRY-US, V43, P6261, DOI 10.1021/bi036254p
   Dexter AF, 2008, IND ENG CHEM RES, V47, P6391, DOI 10.1021/ie800127f
   Dexter AF, 2007, J PHYS CHEM C, V111, P10484, DOI 10.1021/jp071554s
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   Dzwolak W, 2005, BIOCHEMISTRY-US, V44, P8948, DOI 10.1021/bi050281t
   Ganesh S, 2003, BIOPOLYMERS, V70, P346, DOI 10.1002/bip.10493
   Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Janek K, 2001, BIOCHEMISTRY-US, V40, P5457, DOI 10.1021/bi002005e
   Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007
   Lu K, 2003, J AM CHEM SOC, V125, P6391, DOI 10.1021/ja0341642
   Madine J, 2008, J AM CHEM SOC, V130, P14990, DOI 10.1021/ja802483d
   Marcinowski KJ, 1998, J AM CHEM SOC, V120, P11082, DOI 10.1021/ja9738687
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Nilsson G, 1998, EUR J BIOCHEM, V255, P116, DOI 10.1046/j.1432-1327.1998.2550116.x
   Oda R, 2008, J AM CHEM SOC, V130, P14705, DOI 10.1021/ja8048964
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   Radovan D, 2008, BIOCHEMISTRY-US, V47, P6352, DOI 10.1021/bi800503j
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stendahl JC, 2006, ADV FUNCT MATER, V16, P499, DOI 10.1002/adfm.200500161
   Uversky VN, 2006, J PROTEOME RES, V5, P2505, DOI 10.1021/pr0603349
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+
   Wang J Y., 2002, BIOCHEMISTRY
   Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899
   WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003
   Yamada N, 1998, J AM CHEM SOC, V120, P12192, DOI 10.1021/ja981363q
   Yamada N, 2003, ANGEW CHEM INT EDIT, V42, P5496, DOI 10.1002/anie.200352185
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 42
TC 36
Z9 37
U1 1
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JUN 25
PY 2009
VL 113
IS 25
BP 8539
EP 8544
DI 10.1021/jp904289y
PG 6
WC Chemistry, Physical
SC Chemistry
GA 460RU
UT WOS:000267205600020
PM 19534562
DA 2018-10-19
ER

PT J
AU Fako, VE
   Furgeson, DY
AF Fako, Valerie E.
   Furgeson, Darin Y.
TI Zebrafish as a correlative and predictive model for assessing
   biomaterial nanotoxicity
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Nanotechnology; Nanopharmaceuticals; Nanoparticles; Dendrimers;
   Fullerenes; Carbon nanotubes; Metal oxide nanoparticles; Copper
   nanoparticles
ID WALLED CARBON NANOTUBES; TARGETED DRUG-DELIVERY; DANIO-RERIO EMBRYOS;
   IN-VIVO; MANUFACTURED NANOMATERIALS; BIOMEDICAL APPLICATIONS;
   DEVELOPMENTAL TOXICITY; GOLD NANOPARTICLES; PULMONARY TOXICITY;
   LIPID-PEROXIDATION
AB The lack of correlative and predictive models to assess acute and chronic toxicities limits the rapid preclinical development of new therapeutics. This barrier is due in part to the exponential growth of nanotechnology and nanotherapeutics, coupled with the lack of rigorous and robust screening assays and putative standards. It is a fairly simple and cost-effective process to initially screen the toxicity of a nanomaterial by using in vitro cell cultures; unfortunately it is nearly impossible to imitate a complimentary in vivo system. Small mammalian models are the most common method used to assess possible toxicities and biodistribution of nanomaterials in humans. Alternatively, Dania rerio, commonly known as zebrafish, are proving to be a quick, cheap, and facile model to conservatively assess toxicity of nanomaterials. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Furgeson, Darin Y.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Dept Bioengn, Salt Lake City, UT 84108 USA.
   [Fako, Valerie E.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.
RP Furgeson, DY (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Dept Bioengn, 421 Wakara Way 318, Salt Lake City, UT 84108 USA.
EM darin.furgeson@utah.edu
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   BARILAN O, 2009, SMALL IN PRESS, DOI DOI 10.1002/SMLL.200801716
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b
   Bogdanovic G, 2004, TOXICOL IN VITRO, V18, P629, DOI 10.1016/j.tiv.2004.02.010
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Bulte JWM, 1998, INVEST RADIOL, V33, P841, DOI 10.1097/00004424-199811000-00008
   Chen Z, 2006, TOXICOL LETT, V163, P109, DOI 10.1016/j.toxlet.2005.10.003
   Cheng JP, 2007, ENVIRON TOXICOL CHEM, V26, P708, DOI 10.1897/06-272R.1
   Cho M, 2004, WATER RES, V38, P1069, DOI 10.1016/j.watres.2003.10.029
   Cioffi N, 2005, ANAL BIOANAL CHEM, V382, P1912, DOI 10.1007/s00216-005-3334-x
   Curtis John, 2006, Toxicol Rev, V25, P245, DOI 10.2165/00139709-200625040-00005
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   De la Zerda A, 2007, NAT NANOTECHNOL, V2, P745, DOI 10.1038/nnano.2007.399
   DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P286, DOI 10.1067/mcp.2001.115132
   DiMasi Joseph A., 2007, MANAG DECIS EC, V28, P469, DOI DOI 10.1002/MDE.1360
   Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223
   Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X
   Dugan LL, 1996, NEUROBIOL DIS, V3, P129, DOI 10.1006/nbdi.1996.0013
   Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019
   Eustis S, 2006, CHEM SOC REV, V35, P209, DOI 10.1039/b514191e
   Firkowska I, 2006, LANGMUIR, V22, P5427, DOI 10.1021/la053067e
   *FREED GROUP, 2007, NAN HLTH CAR 2011
   Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X
   Gharbi N, 2005, NANO LETT, V5, P2578, DOI 10.1021/nl051866b
   Griffitt RJ, 2007, ENVIRON SCI TECHNOL, V41, P8178, DOI 10.1021/es071235e
   Grosell M, 2007, AQUAT TOXICOL, V84, P162, DOI 10.1016/j.aquatox.2007.03.026
   Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Heiden TCK, 2007, TOXICOL APPL PHARM, V225, P70, DOI 10.1016/j.taap.2007.07.009
   Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110
   Hirsch A., 2005, FULLERENES CHEM REAC
   Hong S, 2007, CHEM BIOL, V14, P107, DOI 10.1016/j.chembiol.2006.11.015
   Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Isakovic A, 2006, TOXICOL SCI, V91, P173, DOI 10.1093/toxsci/kfj127
   Jafvert CT, 2008, ENVIRON SCI TECHNOL, V42, P5945, DOI 10.1021/es702809a
   Jensen AW, 1996, BIOORGAN MED CHEM, V4, P767, DOI 10.1016/0968-0896(96)00081-8
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Kim Y, 1998, CURR OPIN CHEM BIOL, V2, P733, DOI 10.1016/S1367-5931(98)80111-7
   Kobayashi H, 2001, MAGNET RESON MED, V46, P781, DOI 10.1002/mrm.1257.abs
   Kolhe P, 2006, BIOMATERIALS, V27, P660, DOI 10.1016/j.biomaterials.2005.06.007
   Kukowska-Latallo JF, 2005, CANCER RES, V65, P5317, DOI 10.1158/0008-5472.CAN-04-3921
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326
   Liopo AV, 2006, J NANOSCI NANOTECHNO, V6, P1365, DOI 10.1166/jnn.2006.155
   Loutfy RO, 2002, PERSPECTIVES FULLERE
   Luesebrink H, 2005, J NANOSCI NANOTECHNO, V5, P864, DOI 10.1166/jnn.2005.129
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   *LUX RES, 2006, NAN REP INV OV MARK
   Lyons MS, 1998, DEV DYNAM, V212, P133, DOI 10.1002/(SICI)1097-0177(199805)212:1<133::AID-AJA12>3.3.CO;2-3
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Malarkey EB, 2007, NEURODEGENER DIS, V4, P292, DOI 10.1159/000101885
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007
   Mei F, 2007, BIOMACROMOLECULES, V8, P3729, DOI 10.1021/bm7006295
   Mori T, 2006, TOXICOLOGY, V225, P48, DOI 10.1016/j.tox.2006.05.001
   Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008
   Myc A, 2007, BIOMACROMOLECULES, V8, P13, DOI 10.1021/bm060815l
   *NAT SCI TECHN COU, 2005, NAT NAN IN RES DEV S
   Natarajan A, 2008, CANCER BIOTHER RADIO, V23, P82, DOI 10.1089/cbr.2007.0410
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Panchapakesan B, 2007, SURG ONCOL CLIN N AM, V16, P293, DOI 10.1016/j.soc.2007.03.002
   Parng C, 2005, CURR OPIN DRUG DISC, V8, P100
   Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542
   Patri AK, 2005, ADV DRUG DELIVER REV, V57, P2203, DOI 10.1016/j.addr.2005.09.014
   Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965
   Pyati UJ, 2007, SEMIN CANCER BIOL, V17, P154, DOI 10.1016/j.semcancer.2006.11.007
   Rawson DM, 2000, AQUAC RES, V31, P325, DOI 10.1046/j.1365-2109.2000.00401.x
   Rincon AG, 2004, APPL CATAL B-ENVIRON, V49, P99, DOI 10.1016/j.apcatb.2003.11.013
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   Robichaud CO, 2005, ENVIRON SCI TECHNOL, V39, P8985, DOI 10.1021/es0506509
   Rosen H, 2005, NAT REV DRUG DISCOV, V4, P381, DOI 10.1038/nrd1721
   Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218
   Rubinstein AL, 2006, EXPERT OPIN DRUG MET, V2, P231, DOI 10.1517/17425255.2.2.231
   RUSSELL RW, 1991, NEUROSCI BIOBEHAV R, V15, P7, DOI 10.1016/S0149-7634(05)80085-5
   Sadler Kristen, 2002, J Biotechnol, V90, P195
   Sawai J, 1996, J CHEM ENG JPN, V29, P251, DOI 10.1252/jcej.29.251
   Sayes CM, 2007, NANO LETT, V7, P2399, DOI 10.1021/nl0710710
   Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027
   Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011
   Sayes CM, 2004, NANO LETT, V4, P1881, DOI 10.1021/nl0489586
   Schroder U, 1996, BRAIN RES, V710, P121, DOI 10.1016/0006-8993(95)01375-X
   Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711
   Service RF, 2004, SCIENCE, V304, P1732, DOI 10.1126/science.304.5678.1732
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   SPETZLER JC, 1995, INT J PEPT PROT RES, V45, P78
   Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230309774
   Staples M, 2006, PHARM RES, V23, P847, DOI 10.1007/s11095-006-9906-4
   Sun EY, 2006, BIOCONJUGATE CHEM, V17, P109, DOI 10.1021/bc050290e
   Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   Teraoka Hiroki, 2003, Congenital Anomalies, V43, P123, DOI 10.1111/j.1741-4520.2003.tb01036.x
   Tomalia DA, 2007, BIOCHEM SOC T, V35, P61, DOI 10.1042/BST0350061
   *TUFTS CTR STUD DR, 1995, PHARM RES MAN AM BAS
   Usenko CY, 2008, TOXICOL APPL PHARM, V229, P44, DOI 10.1016/j.taap.2007.12.030
   Wang IC, 1999, J MED CHEM, V42, P4614, DOI 10.1021/jm990144s
   Warheit DB, 2006, TOXICOL SCI, V91, P227, DOI 10.1093/toxsci/kfj140
   WEI C, 1994, ENVIRON SCI TECHNOL, V28, P934, DOI 10.1021/es00054a027
   Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159
   Westerfield M, 1997, SEMIN CELL DEV BIOL, V8, P477, DOI 10.1006/scdb.1997.0173
   Westerfield M, 2000, ZEBRAFISH BOOK GUIDE
   Yamakoshi Y, 2003, J AM CHEM SOC, V125, P12803, DOI 10.1021/ja0355574
   Yamamoto A, 2004, J BIOMED MATER RES A, V68A, P244, DOI 10.1002/jbm.a.20020
   Yang H, 2007, INT J NANOMED, V2, P89, DOI 10.2147/nano.2007.2.1.89
   YANG W, 2008, EUR J MED CHEM
   Zabirnyk O, 2007, AUTOPHAGY, V3, P278, DOI 10.4161/auto.3916
   Zhu XS, 2008, J ENVIRON SCI HEAL A, V43, P278, DOI 10.1080/10934520701792779
   Zhu XS, 2007, ENVIRON TOXICOL CHEM, V26, P976, DOI 10.1897/06-583.1
   Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606
   2005, NANO WORLD 150 NANOD
   2007, DISPOSABLE INSULIN N
NR 121
TC 126
Z9 129
U1 2
U2 68
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JUN 21
PY 2009
VL 61
IS 6
BP 478
EP 486
DI 10.1016/j.addr.2009.03.008
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 464AN
UT WOS:000267476600007
PM 19389433
DA 2018-10-19
ER

PT J
AU Parker, ST
   Domachuk, P
   Amsden, J
   Bressner, J
   Lewis, JA
   Kaplan, DL
   Omenetto, FG
AF Parker, Sara T.
   Domachuk, Peter
   Amsden, Jason
   Bressner, Jason
   Lewis, Jennifer A.
   Kaplan, David L.
   Omenetto, Fiorenzo G.
TI Biocompatible Silk Printed Optical Waveguides
SO ADVANCED MATERIALS
LA English
DT Article
ID COHERENCE TOMOGRAPHY; BIOMATERIAL COATINGS; FIBROIN FILMS; DEVICES;
   TECHNOLOGY; ROBUST
AB Biocompatible silk optical waveguides are fabricated by direct-write assembly and demonstrated to guide light in both straight and curved architectures. These waveguides can easily be doped or functionalized with bioactive molecules, and are promising materials for biophotonic devices.
C1 [Domachuk, Peter; Amsden, Jason; Bressner, Jason; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Domachuk, Peter; Amsden, Jason; Bressner, Jason; Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys, Medford, MA 02155 USA.
   [Kaplan, David L.] Tufts Univ, Dept Chem Engn, Medford, MA 02155 USA.
   [Parker, Sara T.; Lewis, Jennifer A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   [Parker, Sara T.; Lewis, Jennifer A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.
RP Omenetto, FG (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM fiorenzo.omenetto@tufts.edu
RI Amsden, Jaosn/B-3701-2011
FU National Science Foundation Graduate Research Fellowship; Defense
   Advanced Research Projects Agency; Air Force Office of Scientific
   Research; US Department of Energy [DE-FG02-07ER46471]
FX This work was partly funded by a National Science Foundation Graduate
   Research Fellowship (STP), the Defense Advanced Research Projects Agency
   (FGO), the Air Force Office of Scientific Research (DLK), and by the US
   Department of Energy under grant DE-FG02-07ER46471 (STP, JAL).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Contag CH, 2002, J MAGN RESON IMAGING, V16, P378, DOI 10.1002/jmri.10178
   Duoss EB, 2007, ADV MATER, V19, P3485, DOI 10.1002/adma.200701372
   Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892
   Fujimoto JG, 2000, NEOPLASIA, V2, P9, DOI 10.1038/sj.neo.7900071
   Ghosh S., 2008, ADV FUNCT MATER, V18, P1
   Gratson GM, 2004, NATURE, V428, P386, DOI 10.1038/428386a
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840
   Ma H, 2002, ADV MATER, V14, P1339, DOI 10.1002/1521-4095(20021002)14:19<1339::AID-ADMA1339>3.0.CO;2-O
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   PETERSON JI, 1984, SCIENCE, V224, P123, DOI 10.1126/science.6422554
   Smay JE, 2002, ADV MATER, V14, P1279, DOI 10.1002/1521-4095(20020916)14:18<1279::AID-ADMA1279>3.0.CO;2-A
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   West JL, 2003, ANNU REV BIOMED ENG, V5, P285, DOI 10.1146/annurev.bioeng.5.011303.120723
NR 24
TC 136
Z9 140
U1 6
U2 99
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JUN 19
PY 2009
VL 21
IS 23
BP 2411
EP +
DI 10.1002/adma.200801580
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 465GN
UT WOS:000267570800009
DA 2018-10-19
ER

PT J
AU McCann, L
   Ingham, E
   Jin, Z
   Fisher, J
AF McCann, L.
   Ingham, E.
   Jin, Z.
   Fisher, J.
TI An investigation of the effect of conformity of knee hemiarthroplasty
   designs on contact stress, friction and degeneration of articular
   cartilage: A tribological study
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Knee hemiarthroplasty; Contact stress; Friction; Wear; Articular
   cartilage
ID MCKEEVER METALLIC HEMIARTHROPLASTY; INNOVATIVE CHONDROPLASTY MATERIALS;
   ARTHRITIS; MENISCI; WEAR
AB Hemiarthroplasty is a potentially attractive alternative to knee replacement for young, active patients, as it allows preservation of more bone stock for potential revisions. However, there has been limited success with hemiarthroplasty or spacers to date. The wear and degradation of the biomaterial-cartilage interface is of paramount importance in the design and success of hemiarthroplasties. A comprehensive understanding of the tribological performance of hemiarthroplasty implants in the natural joint is required. The objective of this study was to investigate the tribological response of bovine medial compartmental knees, both natural and hemiarthroplasty replaced, under physiological loads and motion. The conformity of these metallic hemi arthroplasties was varied (conforming plates with radius of 50 mm and radius of 100 mm and a flat plate design), in order to examine the effects of conformity and contact stress, on the friction, friction shear stress and cartilage degeneration. With decreasing conformity of hemiarthroplasty bearings, an increase in contact stress was found, which resulted in elevated friction, elevated friction shear stress and increased cartilage degeneration. A strong correlation was found between contact stress and wear and between friction shear stress and wear. This new and unique in vitro tribological simulation has shown the direct elevation of friction, surface fibrillation and biomechanical wear of cartilage, upon replacing the tibia with a hemiarthroplasty, particularly when using low conformity hemiarthroplasty designs. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [McCann, L.; Ingham, E.; Jin, Z.; Fisher, J.] Univ Leeds, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
RP McCann, L (reprint author), Univ Leeds, Inst Med & Biol Engn, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.
EM menlmc@leeds.ac.uk
FU Engineering and Physical Sciences Research Council [EP/F040792/1]
CR AMSTUTZ HC, 1994, J BONE JOINT SURG BR, V76B, P423
   Bailie AG, 2008, J BONE JOINT SURG BR, V90B, P446, DOI 10.1302/0301-620X.90B4.20319
   DARCY J, 1976, J BONE JOINT SURG BR, V58, P279
   EMERSON RH, 1985, J BONE JOINT SURG AM, V67A, P208, DOI 10.2106/00004623-198567020-00005
   Freeman ME, 2000, WEAR, V241, P129, DOI 10.1016/S0043-1648(00)00387-2
   Hallock RH, 2003, CLIN ORTHOP RELAT R, P154, DOI 10.1097/01.blo.0000093031.56370.90
   Katta J, 2007, P I MECH ENG J-J ENG, V221, P175, DOI 10.1243/13506501JET240
   KATTA J, 2008, WORLD C BIOM AMST
   KETTELKAMP DB, 1972, J BONE JOINT SURG AM, VA 54, P349, DOI 10.2106/00004623-197254020-00013
   KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003
   McCann L, 2008, TRIBOL INT, V41, P1126, DOI 10.1016/j.triboint.2008.03.012
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Northwood E, 2007, P I MECH ENG H, V221, P263, DOI 10.1243/09544119JEIM178
   Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008
   SCOTT RD, 1985, J BONE JOINT SURG AM, V67A, P203, DOI 10.2106/00004623-198567020-00004
   SEEDHOM BB, 1974, J BONE JOINT SURG BR, VB 56, P381
   SIMON WH, 1970, ARTHRITIS RHEUM, V13, P244, DOI 10.1002/art.1780130305
   Sisto DJ, 2005, J BONE JOINT SURG AM, V87A, P1706, DOI 10.2106/JBJS.D.02339
   Springer BD, 2006, J BONE JOINT SURG AM, V88A, P366, DOI 10.2106/JBJS.E.00123
   WALKER PS, 1975, CLIN ORTHOP RELAT R, P184
NR 20
TC 19
Z9 21
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
J9 J BIOMECH
JI J. Biomech.
PD JUN 19
PY 2009
VL 42
IS 9
BP 1326
EP 1331
DI 10.1016/j.jbiomech.2009.03.028
PG 6
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 468JT
UT WOS:000267814600024
PM 19380137
DA 2018-10-19
ER

PT J
AU Zhang, YF
   Shi, B
   Li, CZ
   Wang, YN
   Chen, Y
   Zhang, W
   Luo, T
   Cheng, XR
AF Zhang, Yufeng
   Shi, Bin
   Li, Chengzhang
   Wang, Yining
   Chen, Yun
   Zhang, Wei
   Luo, Tao
   Cheng, Xiangrong
TI The synergetic bone-forming effects of combinations of growth factors
   expressed by adenovirus vectors on chitosan/collagen scaffolds
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Bone morphogenetic protein; Platelet-derived growth factor; Bone;
   Adenovirus vector; Tissue engineering
ID PERIODONTAL-LIGAMENT CELLS; GUIDED TISSUE REGENERATION; DENTAL IMPLANT
   DEFECTS; IN-VITRO; CONTROLLED-RELEASE; FACTOR-BB; TITANIUM IMPLANTS;
   HYDROGEL COMPLEX; GENE-THERAPY; RHPDGF-BB
AB Supporting and enhancing the regeneration and stability of alveolar bone at dental implant sites is necessary to improve implant integration and stability. In this study chitosan/collagen scaffolds combined with adenoviruses expressing either bone morphogenetic protein 7 (BMP-7), platelet-derived growth factor B (PDGF-B), or a combination of both BMP-7 and PDGF-B, were prepared by a freeze-drying method. The cytotoxicity of the resulting biomaterials, and their potential effects on cell proliferation and differentiation towards an osteoblast phenotype, were studied in an initial in vitro study using human periodontal ligament cells (HPLCs). These in vitro results indicate that the scaffold materials are not cytotoxic, and moreover that scaffolds expressing PDGF-B show a higher proliferation rate, while scaffolds expressing BMP-7 show a stronger differentiation towards the osteoblast phenotype. In a subsequent in vivo study, scaffolds were implanted into surgically induced defects on both sides of the dog mandible. Bone formation, which was evaluated histomorphometrically at 4 and 8 weeks and after sacrificing the animals at 12 weeks. revealed a significant increase in bone formation in scaffolds expressing only BMP-7 and also the combined growth factors, with the highest increase occurring for the scaffold expressing both BMP-7 and PDGF-B. This study demonstrates the promising potential of biomaterial expression of combinations of growth factors such as BMP-7 and PDGF-B for bone regeneration in tissue engineering applications. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Zhang, Yufeng; Shi, Bin; Li, Chengzhang; Wang, Yining; Zhang, Wei; Luo, Tao; Cheng, Xiangrong] Wuhan Univ, Sch Stomatol, Minist Educ Key Lab Oral Biomed Engn, Wuhan 430079, Peoples R China.
   [Chen, Yun] Wuhan Univ, Sch Med, Hubei Key Lab Allergy & Immune Related Dis, Wuhan 430072, Peoples R China.
   [Chen, Yun] Wuhan Univ, Sch Med, Med Res Ctr, Wuhan 430072, Peoples R China.
RP Cheng, XR (reprint author), Wuhan Univ, Sch Stomatol, Minist Educ Key Lab Oral Biomed Engn, Wuhan 430079, Peoples R China.
EM xiangrongcheng@hotmail.com
RI chen, yun/C-8105-2014
OI chen, yun/0000-0002-5984-7455
FU National Natural Science Foundation of China [30700948, 30772445]
FX This work was supported by the National Natural Science Foundation of
   China (30700948,30772445).
CR Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005
   Becker J, 2006, CLIN ORAL INVEST, V10, P217, DOI 10.1007/s00784-006-0049-0
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663
   BUSER D, 1999, PERIODONTOLOGY, P151
   Cassiede P, 1996, J BONE MINER RES, V11, P1264
   CENTRELLA M, 1991, J CELL PHYSIOL, V147, P420, DOI 10.1002/jcp.1041470306
   Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   Cooke JW, 2006, TISSUE ENG, V12, P1441, DOI 10.1089/ten.2006.12.1441
   Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005
   Gu DL, 2004, MOL THER, V9, P699, DOI 10.1016/j.ymthe.2004.02.018
   HANNINK M, 1989, BIOCHIM BIOPHYS ACTA, V989, P1, DOI 10.1016/0304-419X(89)90031-0
   Hayashi K, 2007, DENT MATER J, V26, P170, DOI 10.4012/dmj.26.170
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   JOSEPHS SF, 1984, SCIENCE, V225, P636, DOI 10.1126/science.6740330
   Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257
   Liu Y, 2007, BIOMATERIALS, V28, P2677, DOI 10.1016/j.biomaterials.2007.02.003
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mehrara BJ, 1999, J BONE MINER RES, V14, P1290, DOI 10.1359/jbmr.1999.14.8.1290
   Meraw SJ, 2000, J PERIODONTOL, V71, P8, DOI 10.1902/jop.2000.71.1.8
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Ojima Y, 2003, ORAL DIS, V9, P144, DOI 10.1034/j.1601-0825.2003.02906.x
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rundle CH, 2003, BONE, V32, P591, DOI 10.1016/S8756-3282(03)00096-6
   RUTHERFORD RB, 1993, J CLIN PERIODONTOL, V20, P537, DOI 10.1111/j.1600-051X.1993.tb00403.x
   Ryu WH, 2007, J CONTROL RELEASE, V124, P98, DOI 10.1016/j.jconrel.2007.08.024
   Sarment DP, 2006, J CLIN PERIODONTOL, V33, P135, DOI 10.1111/j.1600.051X.2005.00870.x
   Sculean A, 2001, J CLIN PERIODONTOL, V28, P397, DOI 10.1034/j.1600-051x.2001.028005397.x
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   SOMERMAN MJ, 1990, ARCH ORAL BIOL, V35, P241, DOI 10.1016/0003-9969(90)90062-F
   Stefani C M, 2000, Implant Dent, V9, P126, DOI 10.1097/00008505-200009020-00004
   Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4
   Taba M Jr, 2005, Orthod Craniofac Res, V8, P292
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   Zhang YF, 2007, BIOMATERIALS, V28, P4635, DOI 10.1016/j.biomaterials.2007.07.009
NR 42
TC 43
Z9 46
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUN 19
PY 2009
VL 136
IS 3
BP 172
EP 178
DI 10.1016/j.jconrel.2009.02.016
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 465DE
UT WOS:000267561200002
PM 19250951
DA 2018-10-19
ER

PT J
AU Wang, YB
   Zheng, YF
AF Wang, Y. B.
   Zheng, Y. F.
TI Corrosion behaviour and biocompatibility evaluation of low modulus
   Ti-16Nb shape memory alloy as potential biomaterial
SO MATERIALS LETTERS
LA English
DT Article
DE Electrochemical measurements; TiNb alloys; XPS; Metals and alloys;
   Corrosion and oxidation; Cytotoxicity
ID ELECTROCHEMICAL CHARACTERIZATION; BIOMEDICAL APPLICATIONS;
   MICROSTRUCTURE
AB With CP Ti sample as control, the electrochemical measurements were used to investigate the corrosion resistance of low modulus Ti16Nb shape memory alloy in Hank's solution with pH value 7.4. The OCP curves show that the passive film on the Ti16Nb alloy surface is quite stable. The tafel plots and anodic polarization curves prove that the Ti16Nb alloy has excellent anti-corrosion properties in Hank's solution, which is even better than that of CP Ti. The XPS analysis reveals that the composition of the oxide film on Ti16Nb alloy is mainly TiO(2) and Nb(2)O(5). The indirect cytotoxicity results prove that Ti16Nb alloy has an excellent biocompatibility as CP Ti with high proliferation rate approaching that of the negative control group. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Zheng, Y. F.] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010; Wang, Yanbo/E-8046-2010
OI Zheng, Yufeng/0000-0002-7402-9979; Wang, Yanbo/0000-0002-3184-4201
FU National Natural Science Foundation of China [30770580]; National Basic
   Research Program of China (973 Program) [2007CB936103]
FX This work was supported by the National Natural Science Foundation of
   China (No. 30770580) and National Basic Research Program of China (973
   Program) with Grant No. 2007CB936103.
CR Cai Z, 2005, ACTA BIOMATER, V1, P353, DOI 10.1016/j.actbio.2005.02.006
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   Wang YB, 2008, MATER LETT, V62, P269, DOI 10.1016/j.matlet.2007.05.038
   Wen CE, 2006, MAT SCI ENG C-BIO S, V26, P1439, DOI 10.1016/j.msec.2005.08.006
   Xu LJ, 2008, J ALLOY COMPD, V453, P320, DOI 10.1016/j.jallcom.2006.11.144
NR 8
TC 30
Z9 32
U1 1
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUN 15
PY 2009
VL 63
IS 15
BP 1293
EP 1295
DI 10.1016/j.matlet.2009.02.062
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 443JT
UT WOS:000265906700020
DA 2018-10-19
ER

PT J
AU Ledet, EH
   Jeshuran, W
   Glennon, JC
   Shaffrey, C
   De Deyne, P
   Belden, C
   Kallakury, B
   Carl, AL
AF Ledet, Eric H.
   Jeshuran, Winston
   Glennon, Joseph C.
   Shaffrey, Christopher
   De Deyne, Patrick
   Belden, Cliff
   Kallakury, Bhaskar
   Carl, Allen L.
TI Small Intestinal Submucosa for Anular Defect Closure Long-term Response
   in an In Vivo Sheep Model
SO SPINE
LA English
DT Article
DE small intestinal submucosa; SIS; anulotomy; discectomy; lumbar spine;
   sheep
ID LUMBAR DISC HERNIATION; EXTRACELLULAR-MATRIX; INTERVERTEBRAL DISC;
   COLLATERAL LIGAMENT; REPAIR; RECONSTRUCTION; BIOMATERIAL; DISKECTOMY;
   SCAFFOLDS; SURGERY
AB Study Design. After undergoing anulotomy, lumbar intervertebral discs from sheep were treated with small intestinal submucosa (SIS) and assessed functionally at 24 weeks after surgery.
   Objective. To determine the efficacy of an SIS-based patch and plug scaffold to facilitate anular defect closure and anular functional recovery after anulotomy and partial discectomy.
   Summary of Background Data. The incidence of reherniation following discectomy remains high and mechanical means of anular closure have met with limited success. SIS is a naturally occurring collagen-based material, which acts as a resorbable scaffold in vivo that promotes soft tissue regeneration.
   Methods. Twelve sheep underwent retroperitoneal exposure of the lumbar spine. Three levels were assigned to either: no additional procedure, box anulotomy alone, or box anulotomy followed by placement of an SIS "patch and plug" anchored by titanium bone screws. At 26 weeks after surgery, 18 motion segments underwent pressure-volume testing to assess the competency of the anulus. High resolution MRI images were taken of the remaining 18 segments. Undecalcified histology was conducted on all specimens.
   Results. Radiographs, MRI images, and histology indicate that there was an exuberant tissue response at SIS-treated levels. New tissue formation in SIS-treated specimens was integrated well with the native anulus, but did not resemble the organization of native anulus. The extent of anular closure was substantial enough to allow the disc a functional recovery to a mean 66% of its capacity to develop internal pressure. MRI images indicate that SIS-treated levels did not maintain signal intensity comparable to exposure-only (intact) levels, but SIS-treated discs were statistically significantly higher than anulotomy-only levels.
   Conclusion. SIS-treated discs were better able to maintain hydration and resulted in a functional recovery relative to anulotomy alone levels. The SIS patch and plug reduced the cascade of functional degeneration that an intervertebral disc undergoes following anulotomy.
C1 [Ledet, Eric H.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Jeshuran, Winston; Carl, Allen L.] Albany Med Coll, Div Orthopaed Surg, Albany, NY 12208 USA.
   [Glennon, Joseph C.] Capital Dist Vet Surg Associates, Pattersonville, NY USA.
   [Shaffrey, Christopher] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA.
   [Belden, Cliff] Albany Med Coll, Dept Radiol, Albany, NY 12208 USA.
   [De Deyne, Patrick] DePuty Biol, Raynham, MA USA.
   [Kallakury, Bhaskar] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA.
RP Ledet, EH (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, JEC 7044,110 8th St, Troy, NY 12180 USA.
EM ledete@rpi.edu
RI Glennon, Jeffrey/D-2379-2013
FU DePuy Biologics
FX Supported by an institutional grant from DePuy Biologics.
CR Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Allori AC, 2008, TISSUE ENG PART B-RE, V14, P259, DOI 10.1089/ten.teb.2008.0082
   Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS244
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   BAJARES G, 2007, P 23 ANN M AANS CNS
   Bertone AL, 2008, J BIOMED MATER RES A, V84A, P219, DOI 10.1002/jbm.a.31432
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   COOK J, 2000, P 46 ANN M ORTH RES, P607
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Fritsch EW, 1996, SPINE, V21, P626, DOI 10.1097/00007632-199603010-00017
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   GORENSEK M, 2006, SPINE J S1, V6, P161
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Jonsson B, 1996, SPINE, V21, P500, DOI 10.1097/00007632-199602150-00017
   Keramaris NC, 2008, INJURY S2, V39, P45
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Ledet Eric H, 2002, Spine J, V2, P188, DOI 10.1016/S1529-9430(02)00182-1
   Liang R, 2006, J ORTHOP RES, V24, P811, DOI 10.1002/jor.20080
   Liatsikos EN, 2001, J UROLOGY, V165, P1719, DOI 10.1016/S0022-5347(05)66401-4
   Loupasis GA, 1999, SPINE, V24, P2313, DOI 10.1097/00007632-199911150-00005
   Owen TJ, 1997, J SURG RES, V71, P179, DOI 10.1006/jsre.1997.5148
   Padua R, 1999, EUR SPINE J, V8, P70, DOI 10.1007/s005860050129
   PANJABI M, 1988, SPINE, V13, P913, DOI 10.1097/00007632-198808000-00008
   Takechi M, 2008, J MATER SCI-MATER M, V19, P2949, DOI 10.1007/s10856-008-3416-3
   Takeshima T, 2000, SPINE, V25, P450, DOI 10.1097/00007632-200002150-00010
   Ueno T, 2007, J GASTROINTEST SURG, V11, P918, DOI 10.1007/s11605-007-0171-6
   Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071
   Zhang LF, 2007, ACTA OTO-LARYNGOL, V127, P631, DOI 10.1080/00016480600987750
NR 32
TC 23
Z9 25
U1 1
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD JUN 15
PY 2009
VL 34
IS 14
BP 1457
EP 1463
DI 10.1097/BRS.0b013e3181a48554
PG 7
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 459OM
UT WOS:000267112700005
PM 19525836
DA 2018-10-19
ER

PT J
AU Shikha, D
   Jha, U
   Sinha, SK
   Barhai, PK
   Nair, KGM
   Dash, S
   Tyagi, A
   Kalavathy, S
   Kothari, DC
AF Shikha, Deep
   Jha, Usha
   Sinha, S. K.
   Barhai, P. K.
   Nair, K. G. M.
   Dash, S.
   Tyagi, A. K.
   Kalavathy, S.
   Kothari, D. C.
TI Microstructure and biocompatibility investigation of biomaterial alumina
   after 30 keV and 60 keV nitrogen ion implantation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 15th International Conference on Surface Modification of Materials by
   Ion Beams
CY SEP 30-OCT 05, 2007
CL Univ Mumbai, Mumbai, INDIA
SP Mat Res Soc India, Bhabha Atom Res Ctr, Tata Inst Fundamental Res
HO Univ Mumbai
DE Alumina; Biocompatibility; Nanohardness; Surface roughness; Compound
   formation
ID FILMS
AB Polycrystalline alumina is widely used as biomaterial. It is being used as hip joints, tooth roots etc. Commercially available polycrystalline alumina samples were implanted with 30 keV and 60 keV energy N(+) ions at different ion doses ranging from 5 x 10(15) ions/cm(2) to 5 x 10(17) ions/cm(2). Change in surface structure is studied using optical microscope. Compound formation at the surface of alumina is confirmed with GXRD. The change in nanohardness at different energies and different ion doses is studied. Improvement in corrosion resistance in Ringer solution is observed implying improvement in biocompatibility of alumina after nitrogen ion implantation. The thrombogenicity of unimplanted and implanted alumina was evaluated using whole blood kinetic clotting time method. Wettability test was carried to judge cell-material adhesion by measuring the contact angle. A comparison of the change in properties after 30 keV and 60 keV nitrogen ion implantation is described in the paper. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Sinha, S. K.; Barhai, P. K.] BIT Mesra, Dept Appl Phys, Ranchi 835215, Jharkhand, India.
   [Shikha, Deep; Jha, Usha] BIT Mesra, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
   [Nair, K. G. M.; Dash, S.; Tyagi, A. K.; Kalavathy, S.] Indira Gandhi Ctr Atom Res, Div Mat Sci, Kalpakkam 603102, Tamil Nadu, India.
   [Kothari, D. C.] Univ Bombay, Dept Phys, Bombay 400098, Maharashtra, India.
RP Sinha, SK (reprint author), BIT Mesra, Dept Appl Phys, Ranchi 835215, Jharkhand, India.
EM sksinha@bitmesra.ac.in
RI Jha, Usha/L-9583-2017
OI Jha, Usha/0000-0001-9033-6517; Kothari, Dushyant/0000-0003-0448-4164
CR Azevedo AF, 2005, SURF COAT TECH, V194, P271, DOI 10.1016/j.surfcoat.2004.10.007
   BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1
   Delgado-Alvarado C, 2006, ACTA BIOMATER, V2, P701, DOI 10.1016/j.actbio.2006.05.012
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   Heimke G., 1986, HDB BIOMATERIALS EVO
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Hulbert S. F., 1993, INTRO BIOCERAMICS
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   Liu ZS, 2006, MATER CHEM PHYS, V99, P75, DOI 10.1016/j.matchemphys.2005.09.088
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Wang MC, 2001, J MATER SCI, V36, P3283, DOI 10.1023/A:1017907024197
NR 13
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 15
PY 2009
VL 203
IS 17-18
BP 2541
EP 2545
DI 10.1016/j.surfcoat.2009.02.071
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 454KY
UT WOS:000266682000045
DA 2018-10-19
ER

PT J
AU Ge, SR
   Wang, SB
   Huang, XL
AF Ge, Shirong
   Wang, Shibo
   Huang, Xiaolong
TI Increasing the wear resistance of UHMWPE acetabular cups by adding
   natural biocompatible particles
SO WEAR
LA English
DT Article; Proceedings Paper
CT 17th International Conference on Wear of Materials
CY APR 19-23, 2009
CL Las Vegas, NV
DE UHMWPE; Natural coral; Reinforcement; Acetabular cups; Wear resistance;
   Biomaterials
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL JOINT REPLACEMENTS; CROSS-LINKING;
   COMPOSITES; FRICTION; CORAL; BEHAVIOR
AB Ultra-high molecular weight polyethylene (UHMWPE) is a kind of biomaterial applied as the acetabular cup in artificial hip joints. However, wear debris generation of UHMWPE materials after their replacements in human body has been proved to induce aseptic loosening and osteolysis, which is the main cause of long-term failure of total hip joints composed of UHMWPE and hard femoral balls. in this paper, natural coral (NC) particles in the size within 50 mu m were applied as reinforcement fillers into UHMWPE to increase the wear resistance of UHMWPE composites as artificial acetabular cups. The micro-hardness and scratch resistance of UHMWPE/NC composites were studied. A hip joint wear simulator was operated to investigate the wear behavior of UHMWPE/NC composites against CoCrMo balls, the wear tests were lubricated by 25% bovine serum solutions. The wear mass loss and wear debris distribution through one million test cycles were examined in the paper. It is shown that the adding of NC particles in UHMWPE resulted in the enhancement of micro-hardness and scratching resistance of the UHMWPE/NC composites. The micro-hardness of UHMWPE/NC composites increased with natural coral contents in the linear relationship. The scratch coefficients of UHMWPE/NC composites increased in contents range of 10 wt% NC particles, the scratch depth decreased with the increasing NC contents. The wear resistance of UHMWPE/NC composites increased with the increasing contents of natural coral particles. It was found that the relation of wear mass loss of UHMWPE acetabular cup to the micro-hardness followed a negative power law. The wear mechanism of UHMWPE/NC composites was mainly controlled by adhesive wear. The NC contents in UHMWPE changed the severity of adhesive wear. The investigation of UHMWPE wear debris revealed that adding of NC particles in UHMWPE resulted in variations of size distribution of UHMWPE wear debris. Because micro-hardness of natural coral materials was much lower compared to CoCrMo alloy, few metal debris from CoCrMo ball were captured in the filter paper. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Ge, Shirong; Wang, Shibo; Huang, Xiaolong] China Univ Mining & Technol, Sch Mechtron Engn, Xuzhou 221116, Jiangsu, Peoples R China.
   [Ge, Shirong] China Univ Mining & Technol, Inst Tribol & Reliabil, Xuzhou 221116, Jiangsu, Peoples R China.
RP Ge, SR (reprint author), China Univ Mining & Technol, Sch Mechtron Engn, Xuzhou 221116, Jiangsu, Peoples R China.
EM gesr@cumt.edu.cn
CR Bhushan B, 2002, INTRO TRIBOLOGY, P332
   CHRISTIAN J, 2007, WEAR, V263, P1072
   Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042
   FISHER J, 1994, WEAR, V175, P219, DOI 10.1016/0043-1648(94)90185-6
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203
   Muratoglu OK, 2001, J ARTHROPLASTY, V16, P149, DOI 10.1054/arth.2001.20540
   WANG A, 1995, WEAR, V181, P241, DOI 10.1016/0043-1648(95)90030-6
   Wang A, 1998, TRIBOL INT, V31, P17, DOI 10.1016/S0301-679X(98)00005-X
   Wang Q, 2007, P I MECH ENG J-J ENG, V221, P307, DOI 10.1243/13506501JET232
   Xie XL, 2003, BIOMATERIALS, V24, P1889, DOI 10.1016/S0142-9612(02)00610-5
   Xiong DS, 2005, MATER LETT, V59, P175, DOI 10.1016/j.matlet.2004.09.011
   Xiong DS, 2001, WEAR, V250, P242, DOI 10.1016/S0043-1648(01)00647-0
   Zhou JS, 2005, J APPL POLYM SCI, V96, P2336, DOI 10.1002/app.21534
NR 16
TC 51
Z9 55
U1 0
U2 47
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD JUN 15
PY 2009
VL 267
IS 5-8
BP 770
EP 776
DI 10.1016/j.wear.2009.01.057
PG 7
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 465JX
UT WOS:000267580700013
DA 2018-10-19
ER

PT J
AU Osada, K
   Christie, RJ
   Kataoka, K
AF Osada, Kensuke
   Christie, R. James
   Kataoka, Kazunori
TI Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block
   copolymer for drug and gene delivery
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE nanomedicine; drug delivery systems; polymeric micelle; non-viral gene
   delivery; block copolymer; cancer therapy
ID POLYION COMPLEX MICELLES; PEGYLATED POLYPLEX MICELLES; INCORPORATING
   PLASMID DNA; CROSS-LINKED CORE; IN-VIVO; ANTITUMOR-ACTIVITY; SOLID
   TUMORS; SUPRAMOLECULAR NANOCARRIER; PHOTODYNAMIC THERAPY;
   POLY(BETA-BENZYL L-ASPARTATE)
AB Dramatic advances in biological research have revealed the mechanisms underlying many diseases at the molecular level. However, conventional techniques may be inadequate for direct application of this new knowledge to medical treatments. Nanobiotechnology, which integrates biology with the rapidly growing field of nanotechnology, has great potential to overcome many technical problems and lead to the development of effective therapies. The use of nanobiotechnology in drug delivery systems (DDS) is attractive for advanced treatment of conditions such as cancer and genetic diseases. In this review paper for a special issue on biomaterial research in Japan, we discuss the development of DDS based on polymeric micelles mainly in our group for anti-cancer drug and gene delivery, and also address our challenges associated with developing polymeric micelles as super-functionalized nanodevices with intelligent performance.
C1 [Osada, Kensuke; Christie, R. James; Kataoka, Kazunori] Univ Tokyo, Dept Mat Engn, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Kataoka, Kazunori] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Bunkyo Ku, Tokyo 1138656, Japan.
   [Osada, Kensuke; Kataoka, Kazunori] Univ Tokyo, Ctr Nanobio Integrat, Bunkyo Ku, Tokyo 1138656, Japan.
RP Kataoka, K (reprint author), Univ Tokyo, Dept Mat Engn, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM kataoka@bmw.t.u-tokyo.ac.jp
RI Kataoka, Kazunori/K-7108-2012; Osada, Kensuke/V-3322-2017
OI Kataoka, Kazunori/0000-0002-8591-413X; Osada,
   Kensuke/0000-0001-9557-6851
CR Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104
   Akagi D, 2007, GENE THER, V14, P1029, DOI 10.1038/dj.gt.3302945
   ARNIDA N, 2006, J CONTROL RELEASE, V115, P208, DOI DOI 10.1016/J.JCONREL.2006.07.014
   BADER H, 1984, ANGEW MAKROMOL CHEM, V123, P457, DOI 10.1002/apmc.1984.051230121
   Bae Y, 2005, MOL BIOSYST, V1, P242, DOI 10.1039/b500266d
   Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653
   Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166
   Bae YS, 2003, J CONTROL RELEASE, V91, P237
   Bogdanov A, 1997, J DRUG TARGET, V4, P321, DOI 10.3109/10611869708995848
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751
   Cabral H, 2005, J CONTROL RELEASE, V101, P223, DOI 10.1016/j.jconrel.2004.08.022
   Cabral H, 2007, J CONTROL RELEASE, V121, P146, DOI 10.1016/j.jconrel.2007.05.024
   Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669
   Christie RJ, 2003, ADV DRUG DELIVER REV, V55, P421, DOI 10.1016/S0169-409X(02)00229-6
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Fukushima S, 2005, J AM CHEM SOC, V127, P2810, DOI 10.1021/ja0440506
   Gebhart CL, 2001, J CONTROL RELEASE, V73, P401, DOI 10.1016/S0168-3659(01)00357-1
   Gianasi E, 1999, EUR J CANCER, V35, P994, DOI 10.1016/S0959-8049(99)00030-1
   Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Haag R, 2004, ANGEW CHEM INT EDIT, V43, P278, DOI 10.1002/anie.200301694
   Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547
   Hamaguchi T, 2007, BRIT J CANCER, V97, P170, DOI 10.1038/sj.bjc.6603855
   Hamaguchi T, 2005, BRIT J CANCER, V92, P1240, DOI 10.1038/sj.bjc.6602479
   Han M, 2007, J CONTROL RELEASE, V121, P38, DOI 10.1016/j.jconrel.2007.05.012
   Harada A, 1999, SCIENCE, V283, P65, DOI 10.1126/science.283.5398.65
   HARADA A, 1995, MACROMOLECULES, V28, P5294, DOI 10.1021/ma00119a019
   Harada-Shiba M, 2002, GENE THER, V9, P407, DOI 10.1038/sj.gt/3301665
   Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200
   Ideta R, 2005, NANO LETT, V5, P2426, DOI 10.1021/nl051679d
   Imai Y, 2007, J ATHEROSCLER THROMB, V14, P65, DOI 10.5551/jat.14.65
   Itaka K, 2004, J AM CHEM SOC, V126, P13612, DOI 10.1021/ja047174r
   Itaka K, 2003, BIOMATERIALS, V24, P4495, DOI 10.1016/S0142-9612(03)00347-8
   Itaka K, 2007, MOL THER, V15, P1655, DOI 10.1038/sj.mt.6300218
   Jang WD, 2005, ANGEW CHEM INT EDIT, V44, P419, DOI 10.1002/anie.200461603
   Jang WD, 2007, SUPRAMOL CHEM, V19, P309, DOI 10.1080/10610270701324089
   Jang WD, 2006, J CONTROL RELEASE, V113, P73, DOI 10.1016/j.jconrel.2006.03.009
   Jaturanpinyo M, 2004, BIOCONJUGATE CHEM, V15, P344, DOI 10.1021/bc034149m
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jeong YI, 2005, INT J PHARM, V296, P151, DOI 10.1016/j.ijpharm.2005.02.027
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   Kabanov AV, 1996, MACROMOLECULES, V29, P6797, DOI 10.1021/ma960120k
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P223, DOI 10.1016/S0169-409X(02)00018-2
   Kakizawa Y, 1999, J AM CHEM SOC, V121, P11247, DOI 10.1021/ja993057y
   Kakizawa Y, 2006, J CONTROL RELEASE, V111, P368, DOI 10.1016/j.jconrel.2006.01.004
   Kanayama N, 2006, CHEMMEDCHEM, V1, P439, DOI 10.1002/cmdc.200600008
   Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104
   Kataoka K, 1998, MACROMOLECULES, V31, P6071, DOI 10.1021/ma971838i
   KATAOKA K, 1993, J CONTROL RELEASE, V24, P119
   Kataoka K, 1996, MACROMOLECULES, V29, P8556, DOI 10.1021/ma961217+
   Kataoka K, 1999, MACROMOLECULES, V32, P6892, DOI 10.1021/ma990973n
   Katayose S, 1998, J PHARM SCI, V87, P160, DOI 10.1021/js970304s
   Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306
   Kawamura A, 2007, BIOCONJUGATE CHEM, V18, P1555, DOI 10.1021/bc070029t
   Kawano T, 2004, MOL THER, V9, pS315
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   KIDANI Y, 1978, J MED CHEM, V21, P1315, DOI 10.1021/jm00210a029
   KIDANI Y, 1977, Journal of Clinical Hematology and Oncology, V7, P197
   Kim WJ, 2005, J CONTROL RELEASE, V106, P224, DOI 10.1016/j.jconrel.2005.04.016
   Kim WJ, 2006, J CONTROL RELEASE, V114, P381, DOI 10.1016/j.jconrel.2006.05.029
   Kogure K, 2008, ADV DRUG DELIVER REV, V60, P559, DOI 10.1016/j.addr.2007.10.007
   Koizumi F, 2006, CANCER RES, V66, P10048, DOI 10.1158/0008-5472.CAN-06-1605
   Kumagai M, 2007, COLLOID SURFACE B, V56, P174, DOI 10.1016/j.colsurfb.2006.12.019
   KWON G, 1994, J CONTROL RELEASE, V29, P17, DOI 10.1016/0168-3659(94)90118-X
   KWON G, 1993, LANGMUIR, V9, P945, DOI 10.1021/la00028a012
   Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Lehrman S, 1999, NATURE, V401, P517, DOI 10.1038/43977
   Mann A, 2008, J CONTROL RELEASE, V125, P252, DOI 10.1016/j.jconrel.2007.10.019
   Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244
   Masago K, 2007, BIOMATERIALS, V28, P5169, DOI 10.1016/j.biomaterials.2007.07.019
   Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960
   Matsumoto S, 2009, BIOMACROMOLECULES, V10, P119, DOI 10.1021/bm800985e
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Matsumura Y, 2008, ADV DRUG DELIVER REV, V60, P899, DOI 10.1016/j.addr.2007.11.010
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Miyata K, 2005, J CONTROL RELEASE, V109, P15, DOI 10.1016/j.jconrel.2005.09.043
   Miyata K, 2004, J AM CHEM SOC, V126, P2355, DOI 10.1021/ja0379666
   Nagasaki Y, 2001, BIOMACROMOLECULES, V2, P1067, DOI 10.1021/bm015574q
   Nah JW, 2002, J CONTROL RELEASE, V78, P273, DOI 10.1016/S0168-3659(01)00499-0
   Nakanishi M, 2007, REACT FUNCT POLYM, V67, P1361, DOI 10.1016/j.reactfunetpolym.2007.08.009
   Nasongkla N, 2004, ANGEW CHEM INT EDIT, V43, P6323, DOI 10.1002/anie.200460800
   Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923
   Nishiyama N, 2001, PHARMACEUT RES, V18, P1035, DOI 10.1023/A:1010908916184
   Nishiyama N, 2005, NAT MATER, V4, P934, DOI 10.1038/nmat1524
   Nishiyama N, 2003, CANCER RES, V63, P8977
   Nishiyama N, 1999, LANGMUIR, V15, P377, DOI 10.1021/la980572l
   Nishiyama N, 2007, NEW J CHEM, V31, P1074, DOI 10.1039/b616050f
   Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006
   Nishiyama N, 2006, J DRUG TARGET, V14, P413, DOI 10.1080/10611860600834508
   Oba M, 2007, BIOCONJUGATE CHEM, V18, P1415, DOI 10.1021/bc0700133
   Osada K, 2005, ANGEW CHEM INT EDIT, V44, P3544, DOI 10.1002/anie.200500201
   Osada K, 2006, ADV POLYM SCI, V202, P113, DOI 10.1007/12_084
   Otsuka H, 2001, CURR OPIN COLLOID IN, V6, P3, DOI 10.1016/S1359-0294(00)00082-0
   Oupicky D, 2000, J CONTROL RELEASE, V65, P149, DOI 10.1016/S0168-3659(99)00249-7
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6
   ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0
   Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140
   SCHMIDT JA, 1986, CELL, V46, P41, DOI 10.1016/0092-8674(86)90858-5
   SOROKIN LM, 1989, CANCER RES, V49, P1941
   Sumitomo M, 2008, CANCER RES, V68, P1631, DOI 10.1158/0008-5472.CAN-07-6532
   Sutton D, 2007, PHARM RES-DORDR, V24, P1029, DOI 10.1007/s11095-006-9223-y
   Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0
   Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P6039, DOI 10.1073/pnas.0931428100
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   Uchino H, 2005, BRIT J CANCER, V93, P678, DOI 10.1038/sj.bjc.6602772
   Wagner E., 2006, POLYM THERAPEUTICS 1, VI, P135, DOI DOI 10.1007/12_023
   Wakebayashi D, 2004, J CONTROL RELEASE, V95, P653, DOI 10.1016/j.jconrel.2004.01.003
   WEITMAN SD, 1992, CANCER RES, V52, P3396
   Wermuth J, 1997, J AM CHEM SOC, V119, P1328, DOI 10.1021/ja961908l
   Wickham TJ, 2003, NAT MED, V9, P135, DOI 10.1038/nm0103-135
   WU GY, 1988, J BIOL CHEM, V263, P14621
   Yamamoto Y, 1999, COLLOID SURFACE B, V16, P135, DOI 10.1016/S0927-7765(99)00065-X
   Yasugi K, 1999, MACROMOLECULES, V32, P8024, DOI 10.1021/ma991066l
   YOKOYAMA M, 1989, MAKROMOL CHEM, V190, P2041
   YOKOYAMA M, 1993, PHARMACEUT RES, V10, P895, DOI 10.1023/A:1018921513605
   YOKOYAMA M, 1987, MAKROMOL CHEM-RAPID, V8, P431
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
   YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269
   Yokoyama M, 1996, J CONTROL RELEASE, V39, P351, DOI 10.1016/0168-3659(95)00165-4
   Yokoyama M, 1999, J DRUG TARGET, V7, P171, DOI 10.3109/10611869909085500
   Yoo HS, 2004, J CONTROL RELEASE, V96, P273, DOI 10.1016/j.jconrel.2004.02.003
   Yuan XF, 2005, POLYMER, V46, P7749, DOI 10.1016/j.polymer.2005.02.121
   Zhang CX, 2003, CURR OPIN CHEM BIOL, V7, P481, DOI 10.1016/S1367-5931(03)00081-4
NR 129
TC 142
Z9 145
U1 2
U2 88
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JUN 6
PY 2009
VL 6
BP S325
EP S339
DI 10.1098/rsif.2008.0547.focus
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 438AU
UT WOS:000265529100006
PM 19364722
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Tabata, Y
AF Tabata, Yasuhiko
TI Biomaterial technology for tissue engineering applications
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE biomaterials; drug delivery system; biosignalling molecules; tissue
   engineering; tissue regeneration
ID MESENCHYMAL STEM-CELLS; FIBROBLAST-GROWTH-FACTOR; BIODEGRADABLE GELATIN
   HYDROGEL; PLATELET-RICH PLASMA; IN-VIVO RELEASE; PROTEIN RELEASE;
   DRUG-DELIVERY; MYOCARDIAL-INFARCTION; REGENERATIVE MEDICINE; CATIONIZED
   GELATIN
AB Tissue engineering is a newly emerging biomedical technology and methodology to assist and accelerate the regeneration and repairing of defective and damaged tissues based on the natural healing potentials of patients themselves. For the new therapeutic strategy, it is indispensable to provide cells with a local environment that enhances and regulates their proliferation and differentiation for cell-based tissue regeneration. Biomaterial technology plays an important role in the creation of this cell environment. For example, the biomaterial scaffolds and the drug delivery system (DDS) of biosignalling molecules have been investigated to enhance the proliferation and differentiation of cell potential for tissue regeneration. In addition, the scaffold and DDS technologies contribute to develop the basic research of stem cell biology and medicine as well as obtain a large number of cells with a high quality for cell transplantation therapy. A technology to genetically engineer cells for their functional manipulation is also useful for cell research and therapy. Several examples of tissue engineering applications with the cell scaffold and DDS of growth factors and genes are introduced to emphasize the significance of biomaterial technology in new therapeutic and research fields.
C1 Kyoto Univ, Dept Biomat, Field Tissue Engn, Inst Frontier Med Sci,Sakyo Ku, Kyoto 6068507, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Dept Biomat, Field Tissue Engn, Inst Frontier Med Sci,Sakyo Ku, 53 Kawara Cho Shogoin, Kyoto 6068507, Japan.
EM yasuhiko@frontier.kyoto-u.ac.jp
CR Andrianov AK, 1998, ADV DRUG DELIVER REV, V31, P185, DOI 10.1016/S0169-409X(97)00122-1
   Aoyama T, 2003, TISSUE ENG, V9, P1289, DOI 10.1089/10763270360728206
   Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005
   Bach AD, 2003, CLIN PLAST SURG, V30, P589, DOI 10.1016/S0094-1298(03)00077-4
   Balamurugan AN, 2003, PANCREAS, V26, P279, DOI 10.1097/00006676-200304000-00012
   Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Ehashi T, 2006, J BIOMED MATER RES A, V77A, P90, DOI 10.1002/jbm.a.30631
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FALQUI L, 1991, TRANSPLANTATION, V51, P1322
   Fernyhough ME, 2008, BIOCHEM BIOPH RES CO, V368, P455, DOI 10.1016/j.bbrc.2008.01.113
   Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Hiraoka Y, 2003, TISSUE ENG, V9, P1101, DOI 10.1089/10763270360728017
   Hokugo A, 2005, TISSUE ENG, V11, P1224, DOI 10.1089/ten.2005.11.1224
   Holtorf HL, 2006, ADV EXP MED BIOL, V585, P225
   Hsu YC, 2007, CELL TRANSPLANT, V16, P133
   Hubbel JA, 2004, CURR OPIN BIOTECH, V15, P381, DOI 10.1016/j.copbio.2004.08.015
   Ichioka S, 2005, BRIT J PLAST SURG, V58, P1124, DOI 10.1016/j.bjps.2005.04.054
   Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193
   Iwai K, 2006, LARYNGOSCOPE, V116, P529, DOI 10.1097/01.mlg.0000200791.77819.eb
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Jo JI, 2008, EUR J PHARM BIOPHARM, V68, P90, DOI 10.1016/j.ejpb.2007.04.021
   Jo JI, 2007, TISSUE ENG, V13, P313, DOI 10.1089/ten.2006.0133
   Kawakami O, 2005, NEUROSURGERY, V56, P1075, DOI 10.1227/01.NEU.0000158195.10959.43
   Kobayashi Naoya, 2003, J Artif Organs, V6, P236, DOI 10.1007/s10047-003-0235-7
   Kornblum HI, 2007, STROKE, V38, P810, DOI 10.1161/01.STR.0000255757.12198.0f
   Korsgren O, 1996, TRANSPLANTATION, V61, P772, DOI 10.1097/00007890-199603150-00017
   Kumagai Norio, 2002, Methods Mol Biol, V188, P185
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Kuroyanagi Y, 2001, ARTIF ORGANS, V25, P180, DOI 10.1046/j.1525-1594.2001.025003180.x
   Kushibiki T, 2006, J CONTROL RELEASE, V110, P610, DOI 10.1016/j.jconrel.2005.11.007
   Kushibiki T, 2004, GENE THER, V11, P1205, DOI 10.1038/sj.gt.3302285
   Kushibiki T, 2003, J CONTROL RELEASE, V90, P207, DOI 10.1016/S0168-3659(03)00197-4
   Kushibiki Toshihiro, 2004, Current Drug Delivery, V1, P153, DOI 10.2174/1567201043479948
   Lai Y, 2008, ADV DRUG DELIVER REV, V60, P146, DOI 10.1016/j.addr.2007.08.039
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leo AJ, 2006, CELLS TISSUES ORGANS, V183, P112, DOI 10.1159/000095985
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marui A, 2005, J VASC SURG, V41, P82, DOI 10.1016/j.jvs.2004.10.029
   Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181
   Mironov V, 2008, TRENDS BIOTECHNOL, V26, P338, DOI 10.1016/j.tibtech.2008.03.001
   Mountford JC, 2008, TRANSFUSION MED, V18, P1, DOI 10.1111/j.1365-3148.2007.00807.x
   Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042
   Nagane K, 2009, TISSUE ENG PT A, V15, P1655, DOI 10.1089/ten.tea.2008.0453
   Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015
   Nakajima Hiroyuki, 2004, J Artif Organs, V7, P58
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   Oe S, 2003, J CONTROL RELEASE, V88, P193, DOI 10.1016/S0168-3659(02)00463-7
   Ogawa K, 2001, CELL TRANSPLANT, V10, P723
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Okazaki A, 2007, TISSUE ENG, V13, P245, DOI 10.1089/ten.2006.0185
   Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1
   Picinich SC, 2007, EXPERT OPIN BIOL TH, V7, P965, DOI 10.1517/14712598.7.7.965
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Saito A, 2003, J AM SOC NEPHROL, V14, P2025, DOI 10.1097/01.ASN.0000078804.98322.4A
   Sakakibara Y, 2002, J THORAC CARDIOV SUR, V124, P50, DOI 10.1067/mtc.2002.121293
   Salgado Antonio J, 2006, Curr Stem Cell Res Ther, V1, P345
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Shanti RM, 2007, J ORAL MAXIL SURG, V65, P1640, DOI 10.1016/j.joms.2007.04.008
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Silva EA, 2004, CURR TOP DEV BIOL, V64, P181, DOI 10.1016/S0070-2153(04)64008-7
   Soto-Gutierrez A, 2006, NAT BIOTECHNOL, V24, P1412, DOI 10.1038/nbt1257
   Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
   Tabata Y, 2005, METH MOL B, V300, P81
   Tabata Y, 2005, DRUG DISCOV TODAY, V10, P1639, DOI 10.1016/S1359-6446(05)03639-1
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P891, DOI 10.1163/156856200744084
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   TABATA Y, 2003, TISSUE ENG RELEASE T
   TABATA Y, 2003, TISSUE ENG, V15, pS5, DOI DOI 10.1089/1076327030696941
   Tabata Y, 2007, MATER SCI FORUM, V561-565, P1467, DOI 10.4028/www.scientific.net/MSF.561-565.1467
   Tabata Y, 2008, REPROD BIOMED ONLINE, V16, P70, DOI 10.1016/S1472-6483(10)60558-5
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052
   Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215
   Tambara K, 2005, CIRCULATION, V112, pI129, DOI 10.1161/CIRCULATIONAHA.104.526293
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Tsuji-Saso Y, 2007, SCAND J PLAST RECONS, V41, P228, DOI 10.1080/02844310701384041
   Van Tomme SR, 2007, EXPERT REV MED DEVIC, V4, P147, DOI 10.1586/17434440.4.2.147
   YAMAMOTO M, 2007, INFLAMM REGEN, V27, P102, DOI DOI 10.2492/INFLAMMREGEN.27.102
   Yamamoto M, 2006, ADV DRUG DELIVER REV, V58, P535, DOI 10.1016/j.addr.2006.03.003
   Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012
   Yamashita Y, 2002, SURGERY, V131, pS334, DOI 10.1067/msy.2002.120118
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 96
TC 145
Z9 150
U1 6
U2 56
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JUN 6
PY 2009
VL 6
SU 3
BP S311
EP S324
DI 10.1098/rsif.2008.0448.focus
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 438AU
UT WOS:000265529100005
PM 19324684
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Sarig-Nadir, O
   Livnat, N
   Zajdman, R
   Shoham, S
   Seliktar, D
AF Sarig-Nadir, Offra
   Livnat, Noga
   Zajdman, Ruthy
   Shoham, Shy
   Seliktar, Dror
TI Laser Photoablation of Guidance Microchannels into Hydrogels Directs
   Cell Growth in Three Dimensions
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID SCAFFOLDS; FABRICATION; THRESHOLDS; FIBRINOGEN; MIGRATION; OUTGROWTH;
   PATTERNS; SURFACES; CULTURE; TISSUES
AB Recent years have seen rapid progress in the engineering and application of biomaterials with controlled biological, physical, and chemical properties, and the,development of associated methods for micropatterning of three-dimensional tissue-engineering scaffolds. A remaining challenge is the development of robust, flexible methods that can be used to create physical guidance structures in cell-seeded scaffolds independently of environmental constraints, Here we demonstrate that focal photoablation caused by pulsed lasers can generate guidance structures in transparent hydrogels, with feature control down to the micron scale. These photopatterned microchannels guide the directional growth of neurites from dorsal root ganglia. We characterize the effect of laser properties and biomaterial properties on microchannel formation in PEGylated fibrinogen hydrogels, and the effect of photoablation on neural outgrowth. This strategy could lead to the development of a new generation of guidance channels for treating nerve injuries, and the engineering of structured three-dimensional neuronal or nonneuronal networks.
C1 [Sarig-Nadir, Offra; Zajdman, Ruthy; Shoham, Shy; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, Haifa, Israel.
   [Livnat, Noga] Technion Israel Inst Technol, Norman Seiden Multidisciplinary Program Nanosci &, Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567; Shoham, Shy/0000-0003-0376-3495
FU Russell Berrie Nanotechnology Institute; Israel Science Foundation
   [1140/04, 1248/06]; Lorry I. Lokey Interdisciplinar Center for Life
   Science and Engineering
FX The authors gratefully acknowledge the financial support of the Russell
   Berrie Nanotechnology Institute, the Israel Science Foundation (1140/04
   and 1248/06). and the Lorry I. Lokey Interdisciplinar Center for Life
   Science and Engineering.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Arcaute K, 2006, ANN BIOMED ENG, V34, P1429, DOI 10.1007/s10439-006-9156-y
   Bellamy N, 2006, SCAND J RHEUMATOL, V35, P35
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   Brayfield CA, 2008, ACTA BIOMATER, V4, P244, DOI 10.1016/j.actbio.2007.10.004
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Edelman DB, 2005, EXP NEUROL, V192, P1, DOI 10.1016/j.expneurol.2004.10
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fernandes R, 2003, LANGMUIR, V19, P4058, DOI 10.1021/la027052h
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002
   Hutchison JB, 2005, CHEM MATER, V17, P4789, DOI 10.1021/cm0504541
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   KENNEDY PK, 1995, IEEE J QUANTUM ELECT, V31, P2250, DOI 10.1109/3.477754
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   Noack J, 1999, IEEE J QUANTUM ELECT, V35, P1156, DOI 10.1109/3.777215
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Potter S M, 2001, Prog Brain Res, V130, P49
   Sarig-Nadir O, 2008, TISSUE ENG PT A, V14, P401, DOI 10.1089/tea.2007.0029
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038//NMETH793
   Suh KY, 2004, BIOMATERIALS, V25, P557, DOI 10.1016/S0142-9612(03)00543-X
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yuste R., 2005, IMAGING NEUROSCIENCE
NR 34
TC 49
Z9 50
U1 0
U2 25
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JUN 3
PY 2009
VL 96
IS 11
BP 4743
EP 4752
DI 10.1016/j.bpj.2009.03.019
PG 10
WC Biophysics
SC Biophysics
GA 453ZC
UT WOS:000266650400039
PM 19486697
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Subbiahdoss, G
   Kuijer, R
   Grijpma, DW
   van der Mei, HC
   Busscher, HJ
AF Subbiahdoss, Guruprakash
   Kuijer, Roel
   Grijpma, Dirk W.
   van der Mei, Henny C.
   Busscher, Henk J.
TI Microbial biofilm growth vs. tissue integration: "The race for the
   surface" experimentally studied
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Race for the surface; Biofilm; Tissue integration; Biomaterial
ID JOINT REPLACEMENT; ADHESION; INFECTION; TITANIUM; PEPTIDE; CELLS; FLOW
AB Biomaterial-associated infections constitute a major clinical problem. Unfortunately, microorganisms are frequently introduced onto an implant surface during surgery and start the race for the surface before tissue integration can occur. So far, no method has been forwarded to study biofilm formation and tissue integration simultaneously. The aim of this study is to describe an in vitro method to investigate this "race for the surface". First, a suitable growth medium was prepared that allowed both bacterial and tissue growth in a parallel plate flow chamber. Staphylococci were deposited on the glass bottom plate of the flow chamber in different surface densities, after which U2OS osteosarcoma cells were seeded. U2OS cells did not grow in the absence of flow, possibly due to poisoning by bacterial endotoxins, but under flow both staphylococci and U2OS cells grew. The number of adhering cells and area per spread cell were determined after 48 h in relation to the initial number of bacteria present. Both the number and spread area per cell decreased with increasing density of adhering staphylococci. This demonstrates that the outcome of the race for the surface between bacteria and tissue cells is dependent on the number of bacteria present prior to cell seeding. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Subbiahdoss, Guruprakash; Kuijer, Roel; Grijpma, Dirk W.; van der Mei, Henny C.; Busscher, Henk J.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   [Subbiahdoss, Guruprakash; Kuijer, Roel; Grijpma, Dirk W.; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, NL-9700 AD Groningen, Netherlands.
   [Grijpma, Dirk W.] Univ Twente, Inst Biomed Technol, Fac Sci & Technol, Dept Polymer Chem & Biomat, NL-7500 AE Enschede, Netherlands.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, POB 196, NL-9700 AD Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944; Subbiahdoss,
   Guruprakash/0000-0002-6684-7322
CR AHLBERG A, 1978, CLIN ORTHOP RELAT R, P69
   Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006
   CALHOUN JH, 1994, ORTHOPEDICS, V17, P453
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dexter SJ, 2001, J BIOMED MATER RES, V56, P222, DOI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Fundeanu I, 2008, COLLOID SURFACE B, V64, P297, DOI 10.1016/j.colsurfb.2008.02.005
   Gristina A G, 1990, Infect Dis Clin North Am, V4, P391
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   Gristina A G, 1994, Semin Arthroplasty, V5, P160
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Klein-Nulend J, 2005, PATHOL BIOL, V53, P576, DOI 10.1016/j.patbio.2004.12.005
   LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5
   Lussi JW, 2006, BIOMATERIALS, V27, P2534, DOI 10.1016/j.biomaterials.2005.11.027
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   MOHR VD, 1995, J TRAUMA, V38, P648, DOI 10.1097/00005373-199504000-00033
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Trampuz Andrej, 2005, Curr Opin Investig Drugs, V6, P185
NR 24
TC 120
Z9 122
U1 4
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2009
VL 5
IS 5
BP 1399
EP 1404
DI 10.1016/j.actbio.2008.12.011
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 451YM
UT WOS:000266506800002
PM 19158003
DA 2018-10-19
ER

PT J
AU Aggarwal, D
   Matthew, HWT
AF Aggarwal, Dinesh
   Matthew, Howard W. T.
TI Branched chitosans II: Effects of branching on degradation, protein
   adsorption and cell growth properties
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Branched chitosan films; Biodegradation; Protein adsorption; Cell
   proliferation; Branched polymers
ID MOLECULAR-WEIGHT MANIPULATION; MECHANICAL-PROPERTIES; NITROUS-ACID;
   IN-VITRO; SCAFFOLDS; FILMS; DEPOLYMERIZATION; POLYSACCHARIDES;
   DEACETYLATION; ANGIOGENESIS
AB The demand for biodegradable implant materials has fueled interest in chitosan as a biomaterial. In previous work, branched chitosans were synthesized and structurally characterized. In this study the biological properties of branched chitosans were explored. Branched chitosans were synthesized by grafting low molecular weight chitosan chains (1.6, 16 and 80 kDa) to high molecular weight (600 kDa) linear chitosans via reductive amination. Films of the branched materials were evaluated with regard to: lysozyme-mediated degradation; protein adsorption; cell adhesion and proliferation. Branched chitosan with a 1.6 kDa branch length exhibited higher degradation rates than either linear or higher branch length materials. Branched chitosans also exhibited reduced adsorption of bovine serum albumin that was more pronounced with thicker films. Branched chitosans supported proliferation of rat endothelial cells, but growth rates were significantly lower than on linear chitosan. The results of this study demonstrate that control of many aspects of chitosan's physical and biological properties can be achieved by changes in molecular architecture. (c) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Aggarwal, Dinesh; Matthew, Howard W. T.] Wayne State Univ, Detroit, MI 48202 USA.
RP Matthew, HWT (reprint author), Wayne State Univ, 5050 Anthony Wayne Dr, Detroit, MI 48202 USA.
EM hmatthew@wayne.edu
OI Matthew, Howard/0000-0001-6033-9258
CR Aggarwal D, 2007, J BIOMED MATER RES A, V82A, P201, DOI 10.1002/jbm.a.31133
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Alexeev VL, 2000, POLYM ENG SCI, V40, P1211, DOI 10.1002/pen.11248
   ALLAN GG, 1995, CARBOHYD RES, V277, P273, DOI 10.1016/0008-6215(95)00208-B
   ALLAN GG, 1995, CARBOHYD RES, V277, P257, DOI 10.1016/0008-6215(95)00207-A
   AZAD AK, 2002, ADV CHITIN SCI, V5, P620
   Baran ET, 2005, BIODEGRADABLE SYSTEMS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P325
   Channasanon S, 2007, J COLLOID INTERF SCI, V316, P331, DOI 10.1016/j.jcis.2007.07.071
   Chen SF, 2006, LANGMUIR, V22, P8186, DOI 10.1021/la061012m
   Childs MA, 2001, BIOMACROMOLECULES, V2, P526, DOI 10.1021/bm0100054
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Denkbas EB, 2004, J BIOMATER APPL, V18, P291, DOI 10.1177/0885328204041510
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Fujita M, 2007, WOUND REPAIR REGEN, V15, P58, DOI 10.1111/j.1524-475X.2006.00185.x
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Gustafson SB, 2007, PREHOSP EMERG CARE, V11, P172, DOI 10.1080/10903120701205893
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   HWANG KT, 2002, ADV CHITIN SCI, V5, P216
   Ishihara Masayuki, 2006, Current Drug Delivery, V3, P351, DOI 10.2174/156720106778559047
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Jiang T, 2005, MATER RES SOC SYMP P, V845, P187
   Kawamoto N, 1998, J BIOMAT SCI-POLYM E, V9, P543, DOI 10.1163/156856298X00037
   Knill CJ, 2004, CARBOHYD POLYM, V55, P65, DOI 10.1016/j.carbpol.2003.08.004
   Kurita K, 1998, MACROMOLECULES, V31, P4764, DOI 10.1021/ma980272a
   Kurita K, 2003, BIOMACROMOLECULES, V4, P1264, DOI 10.1021/bm034074p
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   Shalaby SW, 2004, ADV POL BIO, P77
   Tanaka H, 1996, J BIOMAT SCI-POLYM E, V8, P211
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Tasaka F, 2001, MACROMOLECULES, V34, P5494, DOI 10.1021/ma010067m
   Tsaih ML, 2003, J APPL POLYM SCI, V90, P3526, DOI 10.1002/app.13027
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   YALPANI M, 1984, MACROMOLECULES, V17, P272, DOI 10.1021/ma00133a003
   YALPANI M, 1985, NEW DEV IND POLYSACC, P295
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
   Zhu AP, 2006, COLLOID SURFACE B, V50, P120, DOI 10.1016/j.colsurfb.2006.04.021
NR 39
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2009
VL 5
IS 5
BP 1575
EP 1581
DI 10.1016/j.actbio.2009.01.003
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 451YM
UT WOS:000266506800019
PM 19231304
DA 2018-10-19
ER

PT J
AU Velard, F
   Laurent-Maquin, D
   Guillaume, C
   Bouthors, S
   Jallot, E
   Nedelec, JM
   Belaaouaj, A
   Laquerriere, P
AF Velard, Frederic
   Laurent-Maquin, Dominique
   Guillaume, Christine
   Bouthors, Sylvie
   Jallot, Edouard
   Nedelec, Jean-Marie
   Belaaouaj, Abderrazzaq
   Laquerriere, Patrice
TI Polymorphonuclear neutrophil response to hydroxyapatite particles,
   implication in acute inflammatory reaction
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Inflammation; Hydroxyapatite; Neutrophil; Cytokines
ID MONOCYTES IN-VITRO; SURFACE-AREA; CYTOKINE; OSTEOBLASTS; CHEMOKINE;
   ACTIVATION; MACROPHAGE; EXPRESSION; CELLS; STEM
AB Hydroxyapatite (HA) is widely used as a bone substitute or coating biomaterial in bone diseases or prosthesis metal parts. The release of HA particles induces an inflammatory response and, if uncontrolled, could result in implant loss. Among the hallmarks of such inflammatory response is early recruitment of the polymorphonuclear cells (PMNs). The purpose of this work is to investigate the response of PMNs following exposure to HA in terms of secreted mediators. Our study shows that HA particles increase the release of pro-inflammatory mediators such as interleukin-1 alpha, as well as chemotactic factors such as interleukin-8, macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta. HA also induces an increase in matrix metalloproteinase 9 expression. Taken together, our data demonstrate for the first time that HA is capable of activating PMNs, a phenomenon that could potentially contribute to the onset of implant-associated inflammation. (c) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Jallot, Edouard] Univ Clermont Ferrand, Lab Phys Corpusculaire Clermont Ferrand, CNRS, IN2P3,UMR 6533, F-63177 Aubiere, France.
   [Velard, Frederic; Laurent-Maquin, Dominique; Guillaume, Christine; Bouthors, Sylvie; Laquerriere, Patrice] URCA, IFR 53, CHU Reims, INSERM,UMRS 926, F-51095 Reims, France.
   [Nedelec, Jean-Marie] Univ Clermont Ferrand, CNRS, UMR 6002, Lab Mat Inorgan, F-63177 Aubiere, France.
   [Belaaouaj, Abderrazzaq] URCA, IFR 53, CHU Reims, INSERM,Avenir Program,EA 4303, F-51092 Reims, France.
   [Laquerriere, Patrice] Equipe IMABIO, IPHC, CNRS, UMR 7178, F-67037 Strasbourg 02, France.
RP Velard, F (reprint author), URCA, IFR 53, CHU Reims, INSERM,UMRS 926, 1 Ave Marechal Juin, F-51095 Reims, France.
EM frederic.velard@etudiant.univ-reims.fr
RI NEDELEC, jean-marie/A-6920-2008; Laquerriere, Patrice/P-1025-2016;
   Bentaher, Abderrazzak/F-6531-2018; Bentaher, Abderrazzaq/M-4424-2017
OI NEDELEC, jean-marie/0000-0002-8243-6849; Laquerriere,
   Patrice/0000-0001-7637-9094; VELARD, Frederic/0000-0002-4826-2160
FU INSERM
FX This work was supported by INSERM, Avenir program and Region
   CHAMPAGNE-ARDENNE.
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z
   Bloebaum RD, 1997, CLIN ORTHOP RELAT R, P109
   Burt HM, 1997, DIGEST DIS SCI, V42, P1283, DOI 10.1023/A:1018870511257
   Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612
   Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196
   Cheung HS, 1997, OSTEOARTHR CARTILAGE, V5, P145, DOI 10.1016/S1063-4584(97)80009-X
   Dinarello CA, 1996, BLOOD, V87, P2095
   Fritz EA, 2006, J BIOMED MATER RES A, V77A, P192, DOI 10.1002/jbm.a.30609
   Grandjean-Laquerrier A, 2006, BIOMATERIALS, V27, P3195, DOI 10.1016/j.biomaterial.2006.01.024
   Grandjean-Laquerriere A, 2005, BIOMATERIALS, V26, P2361, DOI 10.1016/j.biomaterials.2004.07.036
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200
   Jallot E, 2005, COLLOID SURFACE B, V42, P205, DOI 10.1016/j.colsurfb.2005.03.001
   Laquerriere P, 2004, BIOMATERIALS, V25, P2515, DOI 10.1016/j.biomaterials.2003.09.034
   Liao S, 2006, J BIOMED MATER RES A, V76A, P820, DOI 10.1002/jbm.a.30582
   Lisignoli G, 1999, J RHEUMATOL, V26, P791
   Lisignoli G, 2002, CYTOKINE, V20, P231, DOI 10.1006/cyto.2002.2006
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   Meng ZH, 1997, J RHEUMATOL, V24, P2385
   Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X
   NAGASE M, 1994, FEBS LETT, V349, P13, DOI 10.1016/0014-5793(94)00626-1
   PATEL JD, 2006, J BIOMED MATER RES A, V80, P381
   Penolazzi L, 2008, CELL BIOL INT, V32, P320, DOI 10.1016/j.cellbi.2007.08.030
   PRYSTOWSKY JB, 1995, DIGEST DIS SCI, V40, P412, DOI 10.1007/BF02065430
   Reichel CA, 2008, J LEUKOCYTE BIOL, V83, P864, DOI 10.1189/jlb.1007666
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Wagner JG, 2000, PHARMACOL REV, V52, P349
NR 28
TC 25
Z9 26
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2009
VL 5
IS 5
BP 1708
EP 1715
DI 10.1016/j.actbio.2009.01.008
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 451YM
UT WOS:000266506800034
PM 19231306
DA 2018-10-19
ER

PT J
AU Dinda, GP
   Shin, J
   Mazumder, J
AF Dinda, G. P.
   Shin, J.
   Mazumder, J.
TI Pulsed laser deposition of hydroxyapatite thin films on Ti-6Al-4V:
   Effect of heat treatment on structure and properties
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hydroxyapatite; Pulsed laser deposition; Coatings; Ti-6Al-4V;
   Biocompatibility
ID CALCIUM-PHOSPHATE COATINGS; HYDROXYLAPATITE; ABLATION; DISSOLUTION;
   TITANIUM; IMPLANTS
AB Hydroxyapatite (HA) is an attractive biomaterial that has been widely used as a coating for dental and orthopedic metal implants. In this work, HA coatings were deposited on Ti-6Al-4V substrates by laser ablation of HA targets with a KrF excimer laser. Deposition was performed at ambient temperature under different working pressures that varied from 10(-4) to 10(-1) torr of oxygen. The as-deposited films were amorphous. They were annealed at 290-310 degrees C in ambient air in order to restore the crystalline structure of HA. The coatings morphology, composition and structure were investigated by scanning electron microscopy, atomic force microscopy, energy-dispersive X-ray spectroscopy and X-ray diffraction techniques. Mechanical and adhesive properties were examined using nanoindentation and scratch tests, respectively. The stability of the HA coatings was tested under simulated physiological conditions. This study reveals that the combination of pulsed laser deposition and post-deposition annealing at 300 degrees C have the potential to produce pure, adherent, crystalline HA coatings, which show no dissolution in a simulated body fluid. (c) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Dinda, G. P.; Shin, J.; Mazumder, J.] Univ Michigan, Ctr Laser Aided Intelligent Mfg, Ann Arbor, MI 48109 USA.
RP Dinda, GP (reprint author), Univ Michigan, Ctr Laser Aided Intelligent Mfg, 2216 GGB,2350 Hayward St, Ann Arbor, MI 48109 USA.
EM dinda@umich.edu
FU Army Tank Command RD
FX This work was supported by Army Tank Command R&D group via Allion
   corporation. Todd Richman was the program manager.
CR BAERI P, 1992, APPL SURF SCI, V54, P210, DOI 10.1016/0169-4332(92)90046-Z
   BARTHELL HL, 1989, MATER RES SOC S P, V110, P709
   Blind O, 2005, DENT MATER, V21, P1017, DOI 10.1016/j.dental.2004.12.003
   BREME J, 1995, BIOMATERIALS, V16, P239, DOI 10.1016/0142-9612(95)92123-N
   Cleries L, 1998, BIOMATERIALS, V19, P1483, DOI 10.1016/S0142-9612(98)00063-5
   COOK SD, 1986, J DENT RES, V65, P222
   COTELL CM, 1992, J APPL BIOMATER, V3, P87, DOI 10.1002/jab.770030204
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   DASARATHY H, 1993, J BIOMED MATER RES, V27, P477, DOI 10.1002/jbm.820270408
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DEPUTTER C, 1983, J PROSTHET DENT, V49, P87, DOI 10.1016/0022-3913(83)90246-9
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   Fernandez-Pradas JM, 1998, THIN SOLID FILMS, V317, P393, DOI 10.1016/S0040-6090(97)00629-9
   Garcia F, 1998, J BIOMED MATER RES, V43, P69, DOI 10.1002/(SICI)1097-4636(199821)43:1<69::AID-JBM8>3.0.CO;2-K
   Hontsu S, 1997, THIN SOLID FILMS, V295, P214, DOI 10.1016/S0040-6090(96)09146-8
   Johnson S, 2006, MAT SCI ENG C-BIO S, V26, P1312, DOI 10.1016/j.msec.2005.08.023
   Katto M, 2002, APPL SURF SCI, V197, P768, DOI 10.1016/S0169-4332(02)00411-7
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   MONMA H, 1993, J CERAM SOC JPN, V101, P718
   OGUCHI H, 1992, BIOMATERIALS, V13, P471, DOI 10.1016/0142-9612(92)90169-O
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
NR 24
TC 55
Z9 57
U1 0
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2009
VL 5
IS 5
BP 1821
EP 1830
DI 10.1016/j.actbio.2009.01.027
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 451YM
UT WOS:000266506800046
PM 19269271
DA 2018-10-19
ER

PT J
AU Kai, H
   Wang, XL
   Madhukar, KS
   Qin, L
   Yan, YN
   Zhang, RJ
   Wang, XH
AF Kai, He
   Wang, Xinluan
   Madhukar, Kumta Shekhar
   Qin, Ling
   Yan, Yongnian
   Zhang, Renji
   Wang, Xiaohong
TI Fabrication of a two-level tumor bone repair biomaterial based on a
   rapid prototyping technique
SO BIOFABRICATION
LA English
DT Article
ID POLYURETHANE-COLLAGEN CONDUIT; CALCIUM-PHOSPHATE CEMENTS; NERVE
   REGENERATION; BIOARTIFICIAL LIVERS; CONSTRUCT; CHITOSAN; HYDROGEL;
   CHITIN; SYSTEM; GUIDE
AB After the removal of the giant cell tumor (GCT) of bone, it is necessary to fill the defects with adequate biomaterials. A new functional bone repair material with both stimulating osteoblast growth and inhibiting osteoclast activity has been developed with phosphorylated chitosan (P-chitosan) and disodium (1 -> 4)-2-deoxy-2-sulfoamino-beta-D-glucopyranuronan (S-chitosan) as the additives of poly(lactic acid-co-glycolic acid) (PLGA)/calcium phosphate (TCP) scaffolds based on a double-nozzle low-temperature deposition manufacturing technique. A computer-assisted design model was used and the optimal fabrication parameters were determined through the manipulation of a pure PLGA/TCP system. The microscopic structures, water absorbability and mechanical properties of the samples with different P-chitosan and S-chitosan concentrations were characterized correspondingly. The results suggested that this unique composite porous scaffold material is a potential candidate for the repair of large bone defects after a surgical removal of GCT.
C1 [Wang, Xinluan; Madhukar, Kumta Shekhar; Qin, Ling] Chinese Univ Hong Kong, Dept Orthoaped & Traumatol, Shatin, NT, Peoples R China.
   [Kai, He; Yan, Yongnian; Zhang, Renji; Wang, Xiaohong] Tsinghua Univ, Minist Educ, Key Lab Adv Mat Proc Technol, Beijing 100084, Peoples R China.
   [Kai, He; Yan, Yongnian; Zhang, Renji; Wang, Xiaohong] Tsinghua Univ, Inst Life Sci & Med, Beijing 100084, Peoples R China.
   [Kai, He; Yan, Yongnian; Zhang, Renji; Wang, Xiaohong] Tsinghua Univ, Ctr Organ Mfg, Dept Mech Engn, Beijing 100084, Peoples R China.
RP Madhukar, KS (reprint author), Chinese Univ Hong Kong, Dept Orthoaped & Traumatol, Shatin, NT, Peoples R China.
EM kumta@cuhk.edu.hk; qin@ort.cuhk.edu.hk; wangxiaohong@tsinghua.edu.cn
RI Qin, Ling/J-9047-2018
OI Qin, Ling/0000-0001-6173-6167
CR Cui TK, 2009, J BIOACT COMPAT POL, V24, P5, DOI 10.1177/0883911509102349
   Cui TK, 2009, TISSUE ENG PART C-ME, V15, P1, DOI 10.1089/ten.tec.2008.0354
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   Draghi L, 2005, J MATER SCI-MATER M, V16, P1093, DOI 10.1007/s10856-005-4711-x
   Gupta A, 2007, J BIOACT COMPAT POL, V22, P265, DOI 10.1177/0883911507078268
   HORTON D, 1973, CARBOHYD RES, V29, P173, DOI 10.1016/S0008-6215(00)82081-9
   HUANG JY, 1993, IEEE T IND ELECTRON, V40, P2
   Li SJ, 2009, J BIOACT COMPAT POL, V24, P84, DOI 10.1177/0883911509103357
   Li SJ, 2009, J BIOACT COMPAT POL, V24, P249, DOI 10.1177/0883911509104094
   NISHI N, 1986, INT J BIOL MACROMOL, V8, P311, DOI 10.1016/0141-8130(86)90046-2
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   Wang XH, 2003, J BIOACT COMPAT POL, V18, P259, DOI 10.1177/088391103036042
   Wang XH, 2003, J BIOACT COMPAT POL, V18, P45, DOI 10.1177/088391103032798
   Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0
   Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010
   Wang XH, 2009, J BIOACT COMPAT POL, V24, P109, DOI 10.1177/0883911508101183
   XIONG Z, 2002, THESIS TSINGHUA U CH
   Xu W, 2008, J BIOACT COMPAT POL, V23, P409, DOI 10.1177/0883911508095517
   Xu W, 2008, J BIOACT COMPAT POL, V23, P103, DOI 10.1177/0883911507088271
   Xu W, 2007, J BIOACT COMPAT POL, V22, P363, DOI 10.1177/0883911507079451
   Yan YN, 2005, BIOMATERIALS, V26, P5864, DOI 10.1016/j.biomaterials.2005.02.027
   Yan YN, 2005, J BIOACT COMPAT POL, V20, P259, DOI 10.1177/0883911505053658
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 23
TC 15
Z9 18
U1 1
U2 29
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2009
VL 1
IS 2
AR 025003
DI 10.1088/1758-5082/1/2/025003
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 601RV
UT WOS:000278082400005
PM 20811103
DA 2018-10-19
ER

PT J
AU Hsiang, CY
   Chen, YS
   Ho, TY
AF Hsiang, Chien-Yun
   Chen, Yueh-Sheng
   Ho, Tin-Yun
TI Nuclear factor-kappa B bioluminescence imaging-guided transcriptomic
   analysis for the assessment of host-biomaterial interaction in vivo
SO BIOMATERIALS
LA English
DT Article
DE Bioluminescence imaging; Transcriptomic analysis; Nuclear factor-kappa
   B; Genipin-cross-linked gelatin conduit
ID GENE-EXPRESSION PROFILES; ACTIVATED-RECEPTOR-GAMMA; 3T3-L1 ADIPOCYTES;
   CONNECTIVITY MAP; DNA MICROARRAY; GLUCOSE-UPTAKE; CELLS; RESISTANCE;
   INSIGHTS; GENIPIN
AB Establishment of a comprehensive platform for the assessment of host-biomaterial interaction in vivo is an important issue. Nuclear factor-kappa B (NF-kappa B) is an inducible transcription factor that is activated by numerous stimuli. Therefore, NF-kappa B-dependent luminescent signal in transgenic mice carrying the luciferase genes was used as the guide to monitor the biomaterials-affected organs, and transcriptomic analysis was further applied to evaluate the complex host responses in affected organs in this study. In vivo imaging showed that genipin-cross-linked gelatin conduit (GGC) implantation evoked the strong NF-kappa B activity at 6 h in the implanted region, and transcriptomic analysis showed that the expressions of interleukin-6 (IL-6), IL-24, and IL-1 family were up-regulated. A strong luminescent signal was observed in spleen on 14 cl, suggesting that GGC implantation might elicit the biological events in spleen. Transcriptomic analysis of spleen showed that 13 Kyoto Encyclopedia of Genes and Genomes pathways belonging to cell cycles, immune responses, and metabolism were significantly altered by GGC implants. Connectivity Map analysis suggested that the gene signatures of GGC were similar to those of compounds that affect lipid or glucose metabolism. GeneSetTest analysis further showed that host responses to GGC implants might be related to diseases states, especially the metabolic and cardiovascular diseases. In conclusion, our data provided a concept of molecular imaging-guided transcriptomic platform for the evaluation and the prediction of host-biomaterial interaction in vivo. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med Sci, Mol Biol Lab, Taichung 40402, Taiwan.
   [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung 40402, Taiwan.
   [Chen, Yueh-Sheng] China Med Univ, Grad Inst Chinese Med Sci, Biomat Lab, Taichung 40402, Taiwan.
   [Ho, Tin-Yun] China Med Univ Hosp, Dept Nucl Med, Taichung 40447, Taiwan.
RP Ho, TY (reprint author), China Med Univ, Grad Inst Chinese Med Sci, Mol Biol Lab, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.
EM cyhsiang@mail.cmu.edu.tw
RI Ho, Tin-Yun/O-3889-2015; Hsiang, Chien-Yun/O-3853-2015
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431
   Chen CC, 2008, J ETHNOPHARMACOL, V118, P46, DOI 10.1016/j.jep.2008.03.001
   Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Cheng WY, 2008, AM J CHINESE MED, V36, P783, DOI 10.1142/S0192415X08006235
   Cheng WY, 2007, PHARMACOL RES, V56, P474, DOI 10.1016/j.phrs.2007.09.009
   Collison M, 2000, DIABETOLOGIA, V43, P1374, DOI 10.1007/s001250051541
   Delaleu N, 2004, PERIODONTOL 2000, V35, P42, DOI 10.1111/j.0906-6713.2004.003569.x
   DIEHL AK, 1985, DIABETES CARE, V8, P219, DOI 10.2337/diacare.8.3.219
   Dieudonne MN, 2004, AM J PHYSIOL-CELL PH, V286, pC655, DOI 10.1152/ajpcell.00321.2003
   Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Gunther EC, 2003, P NATL ACAD SCI USA, V100, P9608, DOI 10.1073/pnas.1632587100
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660
   Kanehisa M, 1997, TRENDS BIOCHEM SCI, V22, P442, DOI 10.1016/S0968-0004(97)01130-4
   Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621
   Klapperich CM, 2004, BIOMATERIALS, V25, P5631, DOI 10.1016/j.biomaterials.2004.01.025
   Kojima N, 2008, CLIN ORAL IMPLAN RES, V19, P173, DOI 10.1111/j.1600-0501.2007.01432.x
   Lagace DC, 2004, ENDOCRINOLOGY, V145, P5493, DOI 10.1210/en.2004-0877
   Lagace DC, 2004, J BIOL CHEM, V279, P18851, DOI 10.1074/jbc.M312795200
   Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011
   Mater MK, 1998, J LIPID RES, V39, P1327
   Nugent C, 2001, J BIOL CHEM, V276, P9149, DOI 10.1074/jbc.M009817200
   Riedel RF, 2008, MOL CANCER THER, V7, P3141, DOI 10.1158/1535-7163.MCT-08-0642
   Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439
   Seifert M, 2005, TRENDS GENET, V21, P553, DOI 10.1016/j.tig.2005.07.011
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Smyth G.K., 2005, BIOINFORMATICS COMPU, P397, DOI DOI 10.1007/0-387-29362-0_23
   Suzuki Y, 2001, PLANTA MED, V67, P807, DOI 10.1055/s-2001-18842
   Wang M, 2005, IMMUNOLOGY, V114, P166, DOI 10.1111/j.1365-2567.2005.02094.x
   Wen Y, 2008, J CELL BIOCHEM, V105, P404, DOI 10.1002/jcb.21838
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010
NR 42
TC 25
Z9 25
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2009
VL 30
IS 17
BP 3042
EP 3049
DI 10.1016/j.biomaterials.2009.02.016
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 447MJ
UT WOS:000266194900002
PM 19250667
DA 2018-10-19
ER

PT J
AU Bettinger, CJ
   Bruggeman, PP
   Misra, A
   Borenstein, JT
   Langer, R
AF Bettinger, Christopher J.
   Bruggeman, Post P.
   Misra, Asish
   Borenstein, Jeffrey T.
   Langer, Robert
TI Biocompatibility of biodegradable semiconducting melanin films for nerve
   tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Electroactive polymer; Biocompatibility; Nerve tissue engineering
ID ELECTRICALLY CONDUCTING POLYMER; BIOMEDICAL APPLICATIONS; POLYPYRROLE;
   STIMULATION; DEGRADATION
AB The advancement of tissue engineering is contingent upon the development and implementation of advanced biomaterials. Conductive polymers have demonstrated potential for use as a medium for electrical stimulation, which has shown to be beneficial in many regenerative medicine strategies including neural and cardiac tissue engineering. Melanins are naturally occurring pigments that have previously been shown to exhibit unique electrical properties. This study evaluates the potential use of melanin films as a semiconducting material for tissue engineering applications. Melanin thin films were produced by solution processing and the physical properties were characterized. Films were molecularly smooth with a roughness (R(ms)) of 0.341 nm and a conductivity of 7.00 +/- 1.10 x 10(-5) S cm(-1) in the hydrated state. In vitro biocompatibility was evaluated by Schwann cell attachment and growth as well as neurite extension in PC12 cells. In vivo histology was evaluated by examining the biomaterial-tissue response of melanin implants placed in close proximity to peripheral nerve tissue. Melanin thin films enhanced Schwann cell growth and neurite extension compared to collagen films in vitro. Melanin films induced an inflammation response that was comparable to silicone implants in vivo. Furthermore, melanin implants were significantly resorbed after 8 weeks. These results suggest that solution-processed melanin thin films have the potential for use as a biodegradable semiconducting biomaterial for use in tissue engineering applications. (C) 2009 Published by Elsevier Ltd.
C1 [Borenstein, Jeffrey T.] Charles Stark Draper Lab Inc, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   [Bettinger, Christopher J.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
   [Bruggeman, Post P.] Erasmus Univ, Erasmus Med Ctr, Dept Plast & Reconstruct Surg, NL-3015 GE Rotterdam, Netherlands.
   [Misra, Asish; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Borenstein, JT (reprint author), Charles Stark Draper Lab Inc, Ctr Biomed Engn, 555 Technol Sq, Cambridge, MA 02139 USA.
EM jborenstein@draper.com; rlanger@mit.edu
RI Bettinger, Christopher/A-3895-2009
FU NIBIB NIH HHS [P41 EB002520, P41 EB002520-01A1]; NIDCR NIH HHS [R01
   DE013023, R01-DE-013023-06]; NHLBI NIH HHS [1R01HL076485-01A2, R01
   HL076485]
CR BAKKER D, 1988, J BIOMED MATER RES, V22, P423, DOI 10.1002/jbm.820220506
   Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.0.CO;2-M
   Blinova NV, 2008, POLYM INT, V57, P66, DOI 10.1002/pi.2312
   Borovansky J, 2003, PIGM CELL RES, V16, P280, DOI 10.1034/j.1600-0749.2003.00040.x
   Bothma JP, 2008, ADV MATER, V20, P3539, DOI 10.1002/adma.200703141
   George PM, 2006, ADV MATER, V18, P577, DOI 10.1002/adma.200501242
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   GIACOMANTONIO C, 2005, CHARGE TRANSPORT MEL
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Heijke GCM, 2001, MICROSURG, V21, P306, DOI 10.1002/micr.1057
   Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jirsova K, 1997, J NEUROSCI METH, V78, P133, DOI 10.1016/S0165-0270(97)00146-5
   Mandemakers W, 2000, EMBO J, V19, P2992, DOI 10.1093/emboj/19.12.2992
   MCGINNESS J, 1974, SCIENCE, V183, P853, DOI 10.1126/science.183.4127.853
   NAPOLITANO A, 1995, TETRAHEDRON, V51, P5913, DOI 10.1016/0040-4020(95)00259-B
   *NIH, 1985, PRINC LAB AN CAR
   PEDROTTY DM, 2005, AM J PHYSIOL-HEART C, V288, P1620
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Suh KY, 2001, ADV MATER, V13, P1386, DOI 10.1002/1521-4095(200109)13:18<1386::AID-ADMA1386>3.0.CO;2-X
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Zelikin AN, 2002, ANGEW CHEM INT EDIT, V41, P141, DOI 10.1002/1521-3773(20020104)41:1<141::AID-ANIE141>3.0.CO;2-V
NR 24
TC 141
Z9 145
U1 10
U2 132
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2009
VL 30
IS 17
BP 3050
EP 3057
DI 10.1016/j.biomaterials.2009.02.018
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 447MJ
UT WOS:000266194900003
PM 19286252
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Meinel, AJ
   Kubow, KE
   Klotzsch, E
   Garcia-Fuentes, M
   Smith, ML
   Vogel, V
   Merkle, HP
   Meinel, L
AF Meinel, Anne J.
   Kubow, Kristopher E.
   Klotzsch, Enrico
   Garcia-Fuentes, Marcos
   Smith, Michael L.
   Vogel, Viola
   Merkle, Hans P.
   Meinel, Lorenz
TI Optimization strategies for electrospun silk fibroin tissue engineering
   scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Silk fibroin; Electrospinning; Topography; Mechanical properties;
   Adsorption; Fibronectin
ID MESENCHYMAL STEM-CELLS; RESONANCE ENERGY-TRANSFER; BOMBYX-MORI SILK;
   IN-VITRO; OSTEOGENIC DIFFERENTIATION; FIBRONECTIN CONFORMATION;
   MECHANICAL-PROPERTIES; NANOFIBER ALIGNMENT; STRUCTURAL-CHANGES; INTEGRIN
   BINDING
AB As a contribution to the functionality of scaffolds in tissue engineering, here we report on advanced scaffold design through introduction and evaluation of topographical, mechanical and chemical cues. For scaffolding, we used silk fibroin (SF), a well-established biomaterial. Biomimetic alignment of fibers was achieved as a function of the rotational speed of the cylindrical target during electrospinning of a SF solution blended with polyethylene oxide. Seeding fibrous SF scaffolds with human mesenchymal stem cells (hMSCs) demonstrated that fiber alignment could guide hMSC morphology and orientation demonstrating the impact of scaffold topography on the engineering of oriented tissues. Beyond currently established methodologies to measure bulk properties, we assessed the mechanical properties of the fibers by conducting extension at breakage experiments on the level of single fibers. Chemical modification of the scaffolds was tested using donor/acceptor fluorophore labeled fibronectin. Fluorescence resonance energy transfer imaging allowed to assess the conformation of fibronectin when adsorbed on the SF scaffolds, and demonstrated an intermediate extension level of its subunits. Biological assays based on hMSCs showed enhanced cellular adhesion and spreading as a result of fibronectin adsorbed on the scaffolds. Our studies demonstrate the versatility of SF as a biomaterial to engineer modified fibrous scaffolds and underscore the use of biofunctionally relevant analytical assays to optimize fibrous biomaterial scaffolds. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Meinel, Anne J.; Garcia-Fuentes, Marcos; Merkle, Hans P.; Meinel, Lorenz] ETH, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.
   [Kubow, Kristopher E.; Klotzsch, Enrico; Smith, Michael L.; Vogel, Viola] ETH, Lab Biol Oriented Mat, CH-8093 Zurich, Switzerland.
RP Meinel, L (reprint author), ETH, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, HCI J 390-1,Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
EM lorenz.meinel@pharma.ethz.ch
RI Klotzsch, Enrico/J-8831-2012; Merkle, Hans/A-4381-2014; Garcia-Fuentes,
   Marcos/B-4218-2012; Meinel, Lorenz/D-9997-2015; Vogel, Viola/O-8025-2015
OI Klotzsch, Enrico/0000-0002-7577-9042; Garcia-Fuentes,
   Marcos/0000-0002-6393-6469; Meinel, Lorenz/0000-0002-7549-7627; Vogel,
   Viola/0000-0003-2898-7671
FU NEI NIH HHS [PN2 EY016586]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215
   BONDAR B, 2007, BIOMATERIALS    1015
   Casper CL, 2004, MACROMOLECULES, V37, P573, DOI 10.1021/ma0351975
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   DALBY MJ, 2005, EUR CELLS MATER, V9, P8
   DeLisser H M, 1993, Curr Top Microbiol Immunol, V184, P37
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069
   He W, 2006, TISSUE ENG, V12, P2457, DOI 10.1089/ten.2006.12.2457
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Karakecili AG, 2007, J BIOSCI BIOENG, V104, P69, DOI 10.1263/jbb.104.69
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KLOTZSCH E, FIBRONECTIN FO UNPUB
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   LI WJ, 2006, J BIOMECH       1020
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Mit-uppatham C, 2004, MACROMOL CHEM PHYSIC, V205, P2327, DOI 10.1002/macp.200400225
   MITA K, 1994, J MOL EVOL, V38, P583
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nair L S, 2006, TISSUE CELL ORGAN EN, V9, P1
   Negrin RS, 2000, BIOL BLOOD MARROW TR, V6, P262, DOI 10.1016/S1083-8791(00)70008-5
   Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Shao ZZ, 2003, MACROMOLECULES, V36, P1157, DOI 10.1021/ma0214660
   Smith M.L., 2007, PLOS BIOL, V5, pe268
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   SUN Y, 2007, BIOMED MATER, pS16
   Toh YC, 2006, NANO TODAY, V1, P34, DOI 10.1016/S1748-0132(06)70078-0
   Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   WANG Y, 2006, BIOMATERIALS    0804
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 72
TC 128
Z9 130
U1 4
U2 77
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2009
VL 30
IS 17
BP 3058
EP 3067
DI 10.1016/j.biomaterials.2009.01.054
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 447MJ
UT WOS:000266194900004
PM 19233463
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Chou, SY
   Cheng, CM
   Leduc, PR
AF Chou, Szu-Yuan
   Cheng, Chao-Min
   LeDuc, Philip R.
TI Composite polymer systems with control of local substrate elasticity and
   their effect on cytoskeletal and morphological characteristics of
   adherent cells
SO BIOMATERIALS
LA English
DT Article
DE Cell-material interactions; Elasticity; Extracellular matrix;
   Fibroblasts; Poly(dimethylsiloxane); Cytoskeleton
ID CONTACT GUIDANCE; ADHESION PEPTIDE; SURFACES; FORCES; MIGRATION;
   TENSION; STATE
AB At the interface between extracellular substrates and biological materials, substrate elasticity strongly influences cell morphology and function. The associated biological ramifications comprise a diversity of critical responses including apoptosis, differentiation, and motility, which can affect medical devices such as stents. The interactions of the extracellular environment with the substrate are also affected by local properties wherein cells sense and respond to different physical inputs. To investigate the effects of having localized elasticity control of substrate microenvironments on cell response, we have developed a method to control material interface interactions with cells by dictating local substrate elasticity. This system is created by generating a composite material system with alternating, linear regions of polymers that have distinct stiffness characteristics. This approach was used to examine cytoskeletal and morphological changes in NIH 3T3 fibroblasts with emphasis on both local and global properties. noting that cells sense and respond to distinct material elasticities. Isolated cells sense and respond to these local differences in substrate elasticity by extending processes along the interface. Also, cells grown on softer elastic regions at higher densities (in contact with each other) have a higher projected area than isolated cells. Furthermore, when using chemical agents such as cytochalasin-D to disrupt the actin cytoskeleton, there is a significant increase in projected area for cells cultured on softer elastic regions This method has the potential to promote understanding of biomaterial-affected responses in a diversity of areas including morphogenesis, mechanotransduction, stents, and stem cell differentiation. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [LeDuc, Philip R.] Carnegie Mellon Univ, Dept Mech & Biomed Engn, Pittsburgh, PA 15213 USA.
   Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.
RP Leduc, PR (reprint author), Carnegie Mellon Univ, Dept Mech & Biomed Engn, 420 Scaife Hall,5000 Forbes Ave, Pittsburgh, PA 15213 USA.
EM prl@andrew.cmu.edu
RI LeDuc, Philip/M-1103-2014
OI LeDuc, Philip/0000-0001-6397-2905
FU National Science Foundation; Office of Naval Research; Beckman Young
   Investigators Program; PhD Research Scholarship from Taiwan; Carnegie
   Mellon University, USA
FX This work was supported in part by the National Science Foundation, the
   Office of Naval Research, and the Beckman Young Investigators Program
   (P.R.L). S.-Z.C. was supported in part by a PhD Research Scholarship
   from Taiwan. C.-M. C. was supported in part by a PhD Research
   Scholarship from Taiwan, and the Dowd-ICES Scholarship from Carnegie
   Mellon University, USA.
CR Armani D., 1999, RECONFIGURABLE FLUID
   Aucoin L, 2002, J BIOMAT SCI-POLYM E, V13, P447, DOI 10.1163/156856202320253956
   Autumn K, 2006, AM SCI, V94, P124, DOI 10.1511/2006.58.987
   Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X
   BERNAL R, 2007, PHYS REV LETT, V99
   Boateng SY, 2003, AM J PHYSIOL-CELL PH, V285, pC171, DOI 10.1152/ajpcell.00013.2003
   BRANDLEY BK, 1989, DEV BIOL, V135, P74, DOI 10.1016/0012-1606(89)90159-0
   BROWN XQO, 2004, BIOMATERIALS, V26, P7
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Kubicek JD, 2004, LANGMUIR, V20, P11552, DOI 10.1021/la0487646
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leduc PR, 2007, ADV MATER, V19, P3761, DOI 10.1002/adma.200701286
   LeDuc PR, 2006, ANN BIOMED ENG, V34, P102, DOI 10.1007/s10439-005-9008-1
   Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   NAKATSUJI N, 1984, NATURE, V307, P453, DOI 10.1038/307453a0
   Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122
   Patel N, 1998, FASEB J, V12, P1447
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104
   Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X
   Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6
   TURNER DC, 1983, DEV BIOL, V95, P497, DOI 10.1016/0012-1606(83)90052-0
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
NR 30
TC 63
Z9 64
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2009
VL 30
IS 18
BP 3136
EP 3142
DI 10.1016/j.biomaterials.2009.02.037
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 446UZ
UT WOS:000266148200002
PM 19299009
DA 2018-10-19
ER

PT J
AU Zhang, QS
   Yan, YH
   Li, SP
   Feng, T
AF Zhang, Qing-Song
   Yan, Yu-Hua
   Li, Shi-Pu
   Feng, Tao
TI Synthesis of a novel biodegradable and electroactive polyphosphazene for
   biomedical application
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; ANILINE PENTAMER; IN-VITRO;
   POLYANILINE; POLYLACTIDE; NANOPARTICLES; COMPOSITE; COPOLYMER; POLYMER
AB To prepare one electroactive and biodegradable biomaterial for biomedical application, a new synthetic strategy was developed to synthesize a novel electrically conductive biodegradable polyphosphazene polymer containing parent aniline pentamer (PAP) and glycine ethyl ester (GEE) as side chains by a nucleophilic substitution reaction. The electrical conductivity of the polymer is similar to 2 x 10(-5) S cm(-1) in the semiconducting region upon preliminarily protonic-doped experiment. The degradation and RSC96 Schwann cells experiments in vitro prove that the polymer is biodegradable and beneficial to the cell adhesion and proliferation. The as-synthesized polymer also shows good solubility in common organic solvent and good film-forming properties. This new type of polymer has potential applications as scaffolds for neuronal and cardiovascular tissue engineering or other biomedical devices that require electroactivity.
C1 [Zhang, Qing-Song; Yan, Yu-Hua; Li, Shi-Pu; Feng, Tao] Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
RP Zhang, QS (reprint author), Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
EM zhangqingsong@whut.edu.cn
FU State Basic Research Foundation of China [2005CB623905]
FX This work was supported by the State Basic Research Foundation of China
   ( Grant NO. 2005CB623905).
CR ALLCOCK HR, 1975, MACROMOLECULES, V8, P36, DOI 10.1021/ma60043a008
   ALLCOCK HR, 1993, MACROMOLECULES, V26, P764, DOI 10.1021/ma00056a031
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   Allcock HR, 1998, MACROMOLECULES, V31, P5206, DOI 10.1021/ma971072m
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   Bidez PR, 2006, J BIOMAT SCI-POLYM E, V17, P199, DOI 10.1163/156856206774879180
   Bunge RP, 1994, J NEUROL S1, V241, P19
   Chao DM, 2006, J POLYM SCI POL CHEM, V44, P477, DOI 10.1002/pola.21158
   Cheng D, 2005, THIN SOLID FILMS, V477, P19, DOI 10.1016/j.tsf.2004.08.105
   Dispenza C, 2006, J NON-CRYST SOLIDS, V352, P3835, DOI 10.1016/j.jnoncrysol.2006.06.017
   Gao JB, 2004, ADV FUNCT MATER, V14, P537, DOI 10.1002/adfm.200305087
   Gurunathan K, 1999, MATER CHEM PHYS, V61, P173, DOI 10.1016/S0254-0584(99)00081-4
   Hu J, 2008, BIOMACROMOLECULES, V9, P2637, DOI 10.1021/bm800705t
   Huang LH, 2008, BIOMACROMOLECULES, V9, P850, DOI 10.1021/bm7011828
   Huang LH, 2007, BIOMATERIALS, V28, P1741, DOI 10.1016/j.biomaterials.2006.12.007
   Kamalesh S, 2000, J BIOMED MATER RES, V52, P467, DOI 10.1002/1097-4636(20001205)52:3<467::AID-JBM4>3.3.CO;2-Y
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Kumbar SG, 2006, J INORG ORGANOMET P, V16, P365, DOI 10.1007/s10904-006-9071-6
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Liu SW, 2005, MATER LETT, V59, P3715, DOI 10.1016/j.matlet.2005.06.044
   MACDIARMID AG, 1985, MOL CRYST LIQ CRYST, V121, P173, DOI 10.1080/00268948508074857
   Mattioli-Belmonte M, 2003, INT J ARTIF ORGANS, V26, P1077
   Niple JC, 2004, BIOELECTROMAGNETICS, V25, P369, DOI 10.1002/bem.20000
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Shi GX, 2004, BIOMATERIALS, V25, P2477, DOI 10.1016/j.biomaterials.2003.09.032
   TANG JS, 1988, SYNTHETIC MET, V24, P231, DOI 10.1016/0379-6779(88)90261-5
   Tiitu M, 2002, MACROMOLECULES, V35, P5212, DOI 10.1021/ma011943z
   Wan Y, 2005, J MEMBRANE SCI, V246, P193, DOI 10.1016/j.memsci.2004.07.032
   Wang CH, 1999, SYNTHETIC MET, V102, P1313, DOI 10.1016/S0379-6779(98)01006-6
   Wei Y, 1996, TETRAHEDRON LETT, V37, P731, DOI 10.1016/0040-4039(95)02300-3
   Wei Y, 1997, SYNTHETIC MET, V84, P289, DOI 10.1016/S0379-6779(97)80756-4
NR 33
TC 22
Z9 22
U1 2
U2 37
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2009
VL 4
IS 3
AR 035008
DI 10.1088/1748-6041/4/3/035008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 470QE
UT WOS:000267992100014
PM 19468157
DA 2018-10-19
ER

PT J
AU Kittiworrawatt, S
   Devahastin, S
AF Kittiworrawatt, Sommart
   Devahastin, Sakamon
TI Improvement of a mathematical model for low-pressure superheated steam
   drying of a biomaterial
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Boundary condition; Drying; Mass transfer; Mathematical modeling; Steam
   condensation; Transport processes
ID CONDENSATION; DEFORMATION; KINETICS
AB Although there currently are a number of works reporting experimental study of low-pressure superheated steam drying (LPSSD), which has proved to be an attractive alternative to drying heat-sensitive biomaterials, there are a very few works reporting the development of a mathematical model to predict the evolutions of product moisture content and temperature during LPSSD. Moreover, the predictions of those few developed models are still not satisfactory because, most of the time, the models do not include the effect of initial steam condensation; the use of mass transfer boundary condition is, in some cases, also not quite realistic. The aim of the present study was thus to develop a more realistic liquid diffusion based model to simulate the transport of heat and mass within a product undergoing LPSSD. The effect of initial steam condensation, in terms of film condensation, was included and a more realistic mass transfer boundary condition, in terms of the vapor pressure gradient and the physical condition at the drying surface, was applied in the newly developed model. The effect of the product shrinkage was also included directly in the model. The predictability of the model was tested against the available experimental data. The model with initial steam condensation was found to be able to predict the center temperature and average moisture content of the product undergoing LPSSD very well. However, at higher temperatures and lower pressures the product core temperature was still under predicted. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Kittiworrawatt, Sommart; Devahastin, Sakamon] King Mongkuts Univ Technol Thonburi, Dept Food Engn, Fac Engn, Bangkok 10140, Thailand.
RP Devahastin, S (reprint author), King Mongkuts Univ Technol Thonburi, Dept Food Engn, Fac Engn, 126 Pracha Tid Rd, Bangkok 10140, Thailand.
EM sakamon.dev@kmutt.ac.th
OI Devahastin, Sakamon/0000-0001-9582-1554
FU Commission on Higher Education, Thailand; International Foundation for
   Science (IFS), Sweden
FX The authors express their sincere appreciation to the Commission on
   Higher Education, Thailand and the International Foundation for Science
   (IFS), Sweden for supporting the study financially.
CR Chen Z, 2000, FUEL, V79, P961, DOI 10.1016/S0016-2361(99)00217-3
   Devahastin S, 2004, DRY TECHNOL, V22, P1845, DOI [10.1081/DRT-200032818, 10.1081/LDRT-200032818]
   HICKMAN KCD, 1954, IND ENG CHEM, V46, P1442, DOI 10.1021/ie50535a038
   Holman J. P., 2001, HEAT TRANSFER
   Iyota H, 2001, DRY TECHNOL, V19, P1425, DOI 10.1081/DRT-100105298
   Keenan JH, 1936, THERMODYNAMIC PROPER
   MAA JR, 1970, IND ENG CHEM FUND, V9, P283, DOI 10.1021/i160034a015
   MAA JR, 1969, IND ENG CHEM FUND, V8, P564, DOI 10.1021/i160031a032
   Mayachiew P, 2008, DRY TECHNOL, V26, P176, DOI 10.1080/07373930701831309
   Methakhup S, 2005, LWT-FOOD SCI TECHNOL, V38, P579, DOI 10.1016/j.lwt.2004.08.012
   Mujumdar A. S., 2000, MUJUMDARS PRACTICAL, P115
   MULET A, 1994, J FOOD ENG, V22, P329, DOI 10.1016/0260-8774(94)90038-8
   Niamnuy C, 2008, CHEM ENG SCI, V63, P5503, DOI 10.1016/j.ces.2008.07.031
   Nimmol C, 2007, J FOOD ENG, V81, P624, DOI 10.1016/j.jfoodeng.2006.12.022
   PANYAWONG S, 2004, THESIS MONGKUTS U TE
   Panyawong S, 2007, J FOOD ENG, V78, P151, DOI 10.1016/j.jfoodeng.2005.09.012
   Siebel E, 1982, ICE REFRIG, V2, P256
   Suvarnakuta P, 2005, IND ENG CHEM RES, V44, P1934, DOI 10.1021/ie049675r
   Suvarnakuta P, 2007, CHEM ENG PROCESS, V46, P675, DOI 10.1016/j.cep.2006.09.002
   SWEAT VE, 1974, J FOOD SCI, V39, P1080, DOI 10.1111/j.1365-2621.1974.tb07323.x
   Taechapairoj C, 2003, J FOOD ENG, V58, P67, DOI 10.1016/S0260-8774(02)00335-7
NR 21
TC 17
Z9 20
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 1
PY 2009
VL 64
IS 11
BP 2644
EP 2650
DI 10.1016/j.ces.2009.02.036
PG 7
WC Engineering, Chemical
SC Engineering
GA 452IV
UT WOS:000266534600011
DA 2018-10-19
ER

PT J
AU Kwon, JH
   Wuethrich, T
   Mayer, P
   Escher, BI
AF Kwon, Jung-Hwan
   Wuethrich, Thomas
   Mayer, Philipp
   Escher, Beate I.
TI Development of a dynamic delivery method for in vitro bioassays
SO CHEMOSPHERE
LA English
DT Article
DE Passive dosing; Polycyclic aromatic hydrocarbons (PAHs); Membrane
   vesicles; Nanoparticles; Poly(dimethylsiloxane) (PDMS); Aqueous boundary
   layer
ID POLYCYCLIC AROMATIC-HYDROCARBONS; DETERMINE PARTITION-COEFFICIENTS;
   SOLID-PHASE MICROEXTRACTION; HYDROPHOBIC CHEMICALS; TOXICITY TESTS;
   PROTEIN; POLY(DIMETHYLSILOXANE); WATER; CHROMATOPHORES; CLASSIFICATION
AB Measuring the biological activity of hydrophobic chemicals using in vitro assays is challenging because their aqueous solubility is low and the high density of bio-suspensions strongly decreases the bioavailability of hydrophobic pollutants. Dynamic dosing by partitioning from a stable polymer has a potential to overcome these limitations. Poly(dimethylsiloxane) (PDMS) was chosen due to its documented bio-compatibility and excellent partitioning properties. PDMS sheets were loaded with five polycyclic aromatic hydrocarbons (PAHs) and then immersed in model bio-suspensions composed of membrane vesicles ("chromatophores", composed of 30% lipids and 70% proteins) isolated from the photosynthetic bacterium Rhodobacter sphaeroides or phospholipid bilayer vesicles (liposomes) composed of palmitoyloleoyl phosphatidylcholine (POPC), Method development included the determination of partition coefficients between chromatophores or liposomes and water, desorption rate constants from PDMS to bio-suspensions, and diffusion resistances in both PDMS and bio-suspensions. The release of the PAHs from the PDMS into the bio-suspensions was measured and modeled as a combination of diffusion in pure water and diffusion in a completely mixed solvent composed of water and bio-suspensions. The mass transfer resistance for the release was lower in the PDMS than in the tested solutions, which demonstrates that PDMS can efficiently deliver PAHs even to dense biosuspensions. The contribution of aqueous diffusion to the mass transfer decreased with increasing hydrophobicity of the PAHs indicating that hydrophobic chemicals are efficiently transported with suspended biomaterial. The passive dosing system is versatile and offers a number of applications. Promising are tests with instantaneous response, where the time-dependent effect can be translated to concentration-effect curves but the system is also applicable for assuring constant dosing for longer-term testing. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Kwon, Jung-Hwan] Ajou Univ, Dept Environm Engn, Suwon 443749, South Korea.
   [Kwon, Jung-Hwan; Wuethrich, Thomas; Escher, Beate I.] Swiss Fed Inst Aquat Sci & Technol Eawag, Dept Environm Toxicol Utox, CH-8600 Dubendorf, Switzerland.
   [Mayer, Philipp] Aarhus Univ, Natl Environm Res Inst, DK-4000 Roskilde, Denmark.
   [Escher, Beate I.] Univ Queensland, Natl Res Ctr Environm Toxicol EnTox, Brisbane, Qld 4108, Australia.
RP Kwon, JH (reprint author), Ajou Univ, Dept Environm Engn, Suwon 443749, South Korea.
EM jhkwon@ajou.ac.kr
RI Escher, Beate/C-7992-2009; Mayer, Philipp/D-8474-2011
OI Escher, Beate/0000-0002-5304-706X; Mayer, Philipp/0000-0001-5138-7506;
   Kwon, Jung-Hwan/0000-0002-6341-7562
FU Conservation of Clean Air and Water in Europe (CONCAWE); Ajou University
   [20081100]
FX This research was supported by Conservation of Clean Air and Water in
   Europe (CONCAWE). JHK also acknowledges a start-up research grant
   (20081100) from Ajou University. We thank Nynke Kramer for reviewing the
   manuscript.
CR Ai J, 1997, ANAL CHEM, V69, P1230, DOI 10.1021/ac9609541
   Bendels S, 2006, PHARM RES, V23, P2525, DOI 10.1007/s11095-006-9137-8
   BIRRELL GB, 1978, BIOCHEMISTRY-US, V17, P3768, DOI 10.1021/bi00611a015
   Brown RS, 2001, ENVIRON SCI TECHNOL, V35, P4097, DOI 10.1021/es010708t
   CASADIO R, 1988, EUR BIOPHYS J BIOPHY, V16, P243
   Cocera M, 2001, CHEM PHYS LIPIDS, V109, P29, DOI 10.1016/S0009-3084(00)00212-7
   Debruyn AMH, 2007, ENVIRON TOXICOL CHEM, V26, P1803, DOI 10.1897/07-016R.1
   Escher BI, 1997, ENVIRON TOXICOL CHEM, V16, P405, DOI 10.1897/1551-5028(1997)016<0405:ANMFSQ>2.3.CO;2
   Fadnavis NW, 2005, ARCH BIOCHEM BIOPHYS, V433, P454, DOI 10.1016/j.abb.2004.10.005
   Gulden M, 2005, AQUAT TOXICOL, V72, P327, DOI 10.1016/j.aquatox.2005.02.002
   Heringa MB, 2004, ENVIRON SCI TECHNOL, V38, P6263, DOI 10.1021/es049285w
   Heringa MB, 2003, CHEM RES TOXICOL, V16, P1662
   Hestermann EV, 2000, TOXICOL SCI, V53, P316, DOI 10.1093/toxsci/53.2.316
   Jahnke A, 2008, CHEMOSPHERE, V73, P1575, DOI 10.1016/j.chemosphere.2008.09.017
   Jain M. K., 1988, INTRO BIOL MEMBRANES
   Jonker MTO, 2007, ENVIRON SCI TECHNOL, V41, P7363, DOI 10.1021/es0709977
   Kaiser SM, 2006, ENVIRON SCI TECHNOL, V40, P1784, DOI 10.1021/es051908y
   Kanda K, 2007, J VISUAL-JAPAN, V10, P207, DOI 10.1007/BF03181832
   Kramer NI, 2007, ANAL CHEM, V79, P6941, DOI 10.1021/ac070574n
   Kwon JH, 2007, ANAL CHEM, V79, P6816, DOI 10.1021/ac0710073
   Kwon JH, 2007, ENVIRON SCI TECHNOL, V41, P4011, DOI 10.1021/es0618200
   LEVICH VG, 1962, PHYSIOCOCHEMICAL HYD
   Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3
   Mayer P, 2005, ENVIRON SCI TECHNOL, V39, P6123, DOI 10.1021/es050556s
   Mayer P, 1999, ENVIRON SCI TECHNOL, V33, P2284, DOI 10.1021/es9808898
   Mayer P, 2008, ENVIRON SCI TECHNOL, V42, P7516, DOI 10.1021/es801689y
   Mayer P, 2007, ENVIRON SCI TECHNOL, V41, P6148, DOI 10.1021/es070495t
   Rusina TP, 2007, CHEMOSPHERE, V68, P1344, DOI 10.1016/j.chemosphere.2007.01.025
   Salaun P, 2004, ANAL CHEM, V76, P31, DOI 10.1021/ac034264q
   Sangster Research Laboratories, LOGKOW DAT EV OCT WA
   Schirmer K, 1997, TOXICOL IN VITRO, V11, P107, DOI 10.1016/S0887-2333(97)00002-7
   Schirmer K, 2008, AQUAT TOXICOL, V90, P128, DOI 10.1016/j.aquatox.2008.08.005
   SCHLAUTMAN MA, 1993, ENVIRON SCI TECHNOL, V27, P961, DOI 10.1021/es00042a020
   Schreiber R, 2008, ENVIRON TOXICOL CHEM, V27, P1676, DOI [10.1897/07-504.1, 10.1897/07-504]
   Schreiber U, 2007, BIOSENS BIOELECTRON, V22, P2554, DOI 10.1016/j.bios.2006.10.018
   Schwarzenbach R. P., 2003, ENV ORGANIC CHEM
   ter Laak TL, 2008, ANAL CHEM, V80, P3859, DOI 10.1021/ac800258j
   Ter Laak TL, 2005, ENVIRON SCI TECHNOL, V39, P3736, DOI 10.1021/es048406p
NR 38
TC 42
Z9 45
U1 0
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
J9 CHEMOSPHERE
JI Chemosphere
PD JUN
PY 2009
VL 76
IS 1
BP 83
EP 90
DI 10.1016/j.chemosphere.2009.02.023
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 457AP
UT WOS:000266897200013
PM 19324392
DA 2018-10-19
ER

PT J
AU Kanayama, K
   Kitago, M
   Shiraki, M
   Doi, Y
   Shibutani, T
AF Kanayama, Keiichi
   Kitago, Mitsunobu
   Shiraki, Masafumi
   Doi, Yutaka
   Shibutani, Toshiaki
TI Induction of new bone by basic FGF-loaded porous carbonate apatite
   implants in femur defects in rats
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE basic FGF; bone augmentation; carbonate apatite; carrier material
ID FIBROBLAST-GROWTH-FACTOR; CALCIUM PHOSPHATES; BETA; REGENERATION;
   STIMULATION; BIOMATERIAL; CELLS
AB The aim of the present study was to investigate whether porous carbonate apatite (CA) containing basic FGF (bFGF) enhances bone augmentation as compared with porous CA alone.
   Thirty-six disc-shaped porous CA implants were inserted into femur defects in 36 Wister rats. Porous CA containing 0, 5, or 50 ng of bFGF was placed in the defect. Bone augmentation was evaluated radiographically using micro-CT and histologically by conventional staining at 2 and 12 weeks.
   At 2 weeks postoperatively, new bone was evident in the defect sites with porous CA containing either 5 or 50 ng of bFGF. The area of regenerated bone, however, was significantly higher with porous CA containing 5 ng of bFGF than with porous CA containing 50 ng. At 12 weeks postoperatively, no differences in new bone formation were seen between porous CA containing 5 and 50 ng bFGF. Porous CA containing bFGF, however, markedly increased the amount of bone newly formed as compared with porous CA without bFGF. Regardless of the implantation period, TRAP-positive cells were visible around the material, indicating that osteoclast-like cells were resorbing porous CA. In accordance with the evidence, bioresorption of the material increased over time: 6.3-7.8% at 2 weeks to 9.1-11.5% at 12 weeks.
   Porous CA is useful as a growth factor carrier and scaffold for bone augmentation.
   To cite this article:Keiichi K, Mitsunobu K, Masafumi S, Yutaka D, Toshiaki S. Induction of new bone by bFGF-loaded porous carbonate apatite implants in femur defects in rats. Clin. Oral Impl. Res. 20, 2009; 560-565.doi: 10.1111/j.1600-0501.2008.01676.x.
C1 [Kanayama, Keiichi; Kitago, Mitsunobu; Shiraki, Masafumi; Shibutani, Toshiaki] Asahi Univ, Sch Dent, Dept Periodontol, Div Oral Infect & Hlth Sci, Gifu 5010296, Japan.
   [Doi, Yutaka] Asahi Univ, Sch Dent, Dept Dent Mat Sci, Div Oral Funct Sci & Rehabil, Gifu 5010296, Japan.
RP Kanayama, K (reprint author), Asahi Univ, Sch Dent, Dept Periodontol, Div Oral Infect & Hlth Sci, 1851 Hozumi Mizuho, Gifu 5010296, Japan.
EM k-k1@dent.asahi-u.ac.jp
FU Japan Society for the Promotion of Science [16390570, 19390503]
FX This work was supported in part by Grants-in-Aid for Scientific Research
   from the Japan Society for the Promotion of Science (B) (Y.D., Nos.
   16390570 and 19390503).
CR ASPENBERG P, 1991, ACTA ORTHOP SCAND, V62, P481, DOI 10.3109/17453679108996650
   Barralet J, 2000, J BIOMED MATER RES, V49, P176, DOI 10.1002/(SICI)1097-4636(200002)49:2<176::AID-JBM4>3.3.CO;2-#
   Chikazu D, 2001, J BONE MINER RES, V16, P2074, DOI 10.1359/jbmr.2001.16.11.2074
   DOI Y, 1993, J DENT RES, V72, P1279, DOI 10.1177/00220345930720090401
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0
   Doi Yutaka, 1997, Cells and Materials, V7, P111
   ELLIOS LG, 1998, J BIOMEDICAL MAT RES, V22, P137
   GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539
   GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98, DOI 10.1210/endo-123-1-98
   Hasegawa M, 2003, J BONE JOINT SURG BR, V85B, P142, DOI 10.1302/0301-620X.85B1.13414
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   Kimoto T, 1998, J DENT RES, V77, P1965, DOI 10.1177/00220345980770120301
   Kogaya Y, 2006, DENT MATER J, V25, P487, DOI 10.4012/dmj.25.487
   LeGeros RZ, 1991, MONOGRAPHS ORAL SCI, V15, P82
   Murakami S, 1999, J PERIODONTAL RES, V34, P425, DOI 10.1111/j.1600-0765.1999.tb02277.x
   Nagayama M, 2006, DENT MATER J, V25, P219, DOI 10.4012/dmj.25.219
   Nakamura T, 1998, J BONE MINER RES, V13, P942, DOI 10.1359/jbmr.1998.13.6.942
   Nakasa T, 2005, J BIOMED MATER RES A, V75A, P350, DOI 10.1002/jbm.a..30435
   REINHARD S, 2003, BIOMATERIALS, V24, P4603
   RODAN SB, 1989, CONNECT TISSUE RES, V20, P283, DOI 10.3109/03008208909023898
   Takayama S, 2001, J DENT RES, V80, P2075, DOI 10.1177/00220345010800121001
   Tamura K, 2007, J PERIODONTOL, V78, P315, DOI 10.1902/jop.2007.060228
   Tang Gongyou, 2001, High Technology Letters (English Language Edition), V7, P16
NR 24
TC 7
Z9 9
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2009
VL 20
IS 6
BP 560
EP 565
DI 10.1111/j.1600-0501.2008.01676.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 446GR
UT WOS:000266110600005
PM 19515035
DA 2018-10-19
ER

PT J
AU Liu, RX
   Fraylich, M
   Saunders, BR
AF Liu, Ruixue
   Fraylich, Michael
   Saunders, Brian R.
TI Thermoresponsive copolymers: from fundamental studies to applications
SO COLLOID AND POLYMER SCIENCE
LA English
DT Review
DE Thermoresponsive copolymer; NIPAm; LCST; Thermogelation
ID POLY N-ISOPROPYLACRYLAMIDE; THERMALLY CONTROLLED ASSOCIATION; TRANSFER
   RADICAL POLYMERIZATION; CRITICAL SOLUTION TEMPERATURES; GENE
   TRANSFECTION EFFICIENCY; RESPONSIVE GRAFT-COPOLYMERS; ANGLE
   NEUTRON-SCATTERING; VOLUME PHASE-TRANSITION; CROSS-LINKING POLYMER;
   AQUEOUS-SOLUTION
AB Thermoresponsive copolymers have attracted considerable interest in both the polymer and biomaterial literature. They show interesting fundamental behaviour (thermally triggered contraction and aggregation) as well as potentially useful properties (reversible gelation). Biocompatible thermoresponsive copolymers are being developed for application in drug delivery and regenerative medicine. This review focuses on the fundamental aspects of thermally triggered conformational changes with an emphasis on copolymer design. Also, the ability to use these copolymers to produce thermoresponsive colloidal dispersions is discussed. Recent examples from within our group and elsewhere are considered in order to illustrate structure-property relationships. The review focuses on copolymers involving N-isopropylacrylamide. However, non-acrylamide thermoresponsive copolymers are also considered in detail. Emerging areas that appear likely to be actively pursued in the future are also discussed.
C1 [Liu, Ruixue; Fraylich, Michael; Saunders, Brian R.] Univ Manchester, Polymer Sci & Technol Grp, Sch Mat, Manchester M1 7HS, Lancs, England.
   [Liu, Ruixue] Zhengzhou Univ Light Ind, Sch Mat & Chem Engn, Zhengzhou 450002, Peoples R China.
RP Saunders, BR (reprint author), Univ Manchester, Polymer Sci & Technol Grp, Sch Mat, Grosvenor St, Manchester M1 7HS, Lancs, England.
EM brian.saunders@manchester.ac.uk
FU EPSRC; Engineering and Physical Sciences Research Council [EP/E001319/1,
   EP/E02078X/1]
FX The authors gratefully acknowledge the EPSRC for funding the work
   performed on thermoresponsive copolymers
CR Alava C, 2006, J COLLOID INTERF SCI, V293, P93, DOI 10.1016/j.jcis.2005.06.027
   Alava C, 2004, LANGMUIR, V20, P3107, DOI 10.1021/la0363711
   Anastase-Ravion S, 2001, J CHROMATOGR B, V761, P247, DOI 10.1016/S0378-4347(01)00336-X
   Aoshima S, 2008, ADV POLYM SCI, V210, P169, DOI 10.1007/12_2007_120
   Aubrecht KB, 2005, J POLYM SCI POL CHEM, V43, P5156, DOI 10.1002/pola.21007
   Baltes T, 1999, J POLYM SCI POL CHEM, V37, P2977, DOI 10.1002/(SICI)1099-0518(19990801)37:15<2977::AID-POLA31>3.0.CO;2-I
   Barker IC, 2003, MACROMOLECULES, V36, P7765, DOI 10.1021/ma034250m
   Berlinova IV, 2001, POLYMER, V42, P5963, DOI 10.1016/S0032-3861(01)00080-5
   Bokias G, 2000, MACROMOLECULES, V33, P2929, DOI 10.1021/ma991409f
   Bulmus V, 2001, J CONTROL RELEASE, V76, P265, DOI 10.1016/S0168-3659(01)00433-3
   Cao Y, 2007, MACROMOLECULES, V40, P6481, DOI 10.1021/ma0628230
   Cao ZQ, 2005, POLYMER, V46, P5268, DOI 10.1016/j.polymer.2005.04.050
   Chang C, 2008, J POLYM SCI POL CHEM, V46, P3048, DOI 10.1002/pola.22645
   CHEN GH, 1995, MACROMOL RAPID COMM, V16, P175, DOI 10.1002/marc.1995.030160304
   CHEN GH, 1995, MACROMOL CHEM PHYS, V196, P1251, DOI 10.1002/macp.1995.021960424
   Cheng H, 2008, BIOCONJUGATE CHEM, V19, P1368, DOI 10.1021/bc700478s
   Chiefari J, 1998, MACROMOLECULES, V31, P5559, DOI 10.1021/ma9804951
   CHIU TT, 1986, ADV CHEM SER, V213, P425
   CHO CS, 1994, MACROMOL RAPID COMM, V15, P727, DOI 10.1002/marc.1994.030150911
   Choi C, 2006, POLYMER, V47, P4571, DOI 10.1016/j.polymer.2006.05.011
   Chourdakis N, 2004, J APPL POLYM SCI, V92, P3466, DOI 10.1002/app.20326
   Chung JE, 1999, J CONTROL RELEASE, V62, P115, DOI 10.1016/S0168-3659(99)00029-2
   David G, 2003, EUR POLYM J, V39, P1209, DOI 10.1016/S0014-3057(02)00369-5
   Deshmukh MV, 2000, POLYMER, V41, P7951, DOI 10.1016/S0032-3861(00)00174-9
   Diab C, 2004, MACROMOLECULES, V37, P2556, DOI 10.1021/ma0358733
   Dilgimen AS, 2001, BIOMATERIALS, V22, P2383, DOI 10.1016/S0142-9612(00)00425-7
   Dincer S, 2006, J POLYM RES, V13, P121, DOI 10.1007/s10965-005-9014-x
   Dincer S, 2002, MACROMOL CHEM PHYSIC, V203, P1460, DOI 10.1002/1521-3935(200207)203:10/11<1460::AID-MACP1460>3.0.CO;2-O
   Djokpe E, 2001, MACROMOL CHEM PHYSIC, V202, P750, DOI 10.1002/1521-3935(20010301)202:5<750::AID-MACP750>3.0.CO;2-8
   Durand A, 1999, POLYMER, V40, P4941, DOI 10.1016/S0032-3861(98)00698-3
   Durand A, 2000, POLYMER, V41, P545, DOI 10.1016/S0032-3861(99)00212-8
   Durand A, 2000, MACROMOL CHEM PHYSIC, V201, P858, DOI 10.1002/(SICI)1521-3935(20000501)201:8<858::AID-MACP858>3.3.CO;2-Y
   Eeckman F, 2004, EUR POLYM J, V40, P873, DOI 10.1016/j.eurpolymj.2003.11.010
   Fraylich M, 2008, LANGMUIR, V24, P7761, DOI 10.1021/la800869u
   FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   GREEN MS, 1946, J CHEM PHYS, V14, P80, DOI 10.1063/1.1724109
   Han HD, 2006, J PHARM SCI-US, V95, P1909, DOI 10.1002/jps.20646
   He CL, 2008, MACROMOL RAPID COMM, V29, P490, DOI 10.1002/marc.200700721
   He CL, 2008, J POLYM SCI POL CHEM, V46, P4140, DOI 10.1002/pola.22760
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   Higgins J., 1996, POLYM NEUTRON SCATTE
   Hinrichs WLJ, 1999, J CONTROL RELEASE, V60, P249, DOI 10.1016/S0168-3659(99)00075-9
   HIROTSU S, 1988, J CHEM PHYS, V88, P427, DOI 10.1063/1.454619
   Hourdet D, 1998, MACROMOLECULES, V31, P5323, DOI 10.1021/ma980220l
   Hourdet D, 2005, MACROMOLECULES, V38, P8512, DOI 10.1021/ma050786r
   Hourdet D, 1997, POLYMER, V38, P2535, DOI 10.1016/S0032-3861(96)00808-7
   Huber S, 2008, COLLOID POLYM SCI, V286, P1653, DOI 10.1007/s00396-008-1942-7
   Huber S, 2008, COLLOID POLYM SCI, V286, P395, DOI 10.1007/s00396-007-1781-y
   Jones JA, 2005, J POLYM SCI POL CHEM, V43, P6095, DOI 10.1002/pola.21099
   Kalaycioglu E, 2003, LANGMUIR, V19, P9538, DOI 10.1021/la027042g
   Keerl M, 2008, MACROMOLECULES, V41, P6830, DOI 10.1021/ma800785w
   Keerl M, 2007, COLLOID POLYM SCI, V285, P471, DOI 10.1007/s00396-006-1605-5
   Koh AYC, 2005, LANGMUIR, V21, P6734, DOI 10.1021/la050600h
   Koh AYC, 2003, PHYS CHEM CHEM PHYS, V5, P2417, DOI 10.1039/b211294a
   Kohori F, 1998, J CONTROL RELEASE, V55, P87, DOI 10.1016/S0168-3659(98)00023-6
   Kohori F, 1999, COLLOID SURFACE B, V16, P195, DOI 10.1016/S0927-7765(99)00070-3
   Konak C, 2002, LANGMUIR, V18, P8217, DOI 10.1021/la020357b
   Konak C, 2000, MACROMOLECULES, V33, P5318, DOI 10.1021/ma000500c
   KONDO A, 1994, BIOTECHNOL BIOENG, V44, P1, DOI 10.1002/bit.260440102
   Kotsuchibashi Y, 2008, J POLYM SCI POL CHEM, V46, P6142, DOI 10.1002/pola.22925
   Koyama M, 2008, J PHYS CHEM B, V112, P10854, DOI 10.1021/jp800759w
   LAlloret F, 1997, REV I FR PETROL, V52, P117, DOI 10.2516/ogst:1997009
   LAlloret F, 1995, COLLOID POLYM SCI, V273, P1163, DOI 10.1007/BF00653085
   Laukkanen A, 2004, MACROMOLECULES, V37, P2268, DOI 10.1021/ma035124l
   Lee KK, 1998, POLYM BULL, V40, P455, DOI 10.1007/s002890050276
   Li CM, 2005, BIOMACROMOLECULES, V6, P994, DOI 10.1021/bm049331k
   Li SH, 2008, J POLYM SCI POL PHYS, V46, P2355, DOI 10.1002/polb.21567
   Liu HY, 1999, POLYMER, V40, P6985, DOI 10.1016/S0032-3861(98)00858-1
   Liu L, 2008, J POLYM SCI POL CHEM, V46, P3294, DOI 10.1002/pola.22669
   Liu R, 2008, LANGMUIR, V24, P7099, DOI 10.1021/la8002756
   Liu R, 2009, POLYMER, V50, P1456, DOI 10.1016/j.polymer.2009.01.035
   Liu R, 2009, LANGMUIR, V25, P490, DOI 10.1021/la802941h
   LIU R, 2009, SOFT MATTER UNPUB
   Liu SQ, 2007, BIOMATERIALS, V28, P1423, DOI 10.1016/j.biomaterials.2006.11.013
   Liu SQ, 2005, BIOMATERIALS, V26, P5064, DOI 10.1016/j.biomaterials.2005.01.030
   Liu SQ, 2003, BIOMACROMOLECULES, V4, P1784, DOI 10.1021/bm034189t
   Liu SY, 2001, J AM CHEM SOC, V123, P9910, DOI 10.1021/ja011206i
   Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n
   Maeda T, 2006, J COLLOID INTERF SCI, V302, P467, DOI 10.1016/j.jcis.2006.06.047
   Mao ZW, 2007, BIOMATERIALS, V28, P4488, DOI 10.1016/j.biomaterials.2007.06.033
   Marcucci F, 2004, DRUG DISCOV TODAY, V9, P219, DOI 10.1016/S1359-6446(03)02988-X
   Masci G, 2008, J POLYM SCI POL CHEM, V46, P4830, DOI 10.1002/pola.22816
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   MCDONALD TO, 2009, SOFT MATTER IN PRESS
   Nedelcheva AN, 2005, POLYMER, V46, P2059, DOI 10.1016/j.polymer.2005.01.014
   Ohya Shoji, 2004, J Artif Organs, V7, P181
   Oupicky D, 2003, MACROMOLECULES, V36, P6863, DOI 10.1021/ma034039a
   Persson J, 2000, BIOSEPARATION, V9, P105, DOI 10.1023/A:1008167603733
   Petit L, 2007, LANGMUIR, V23, P147, DOI 10.1021/la061466j
   Qin SH, 2006, ADV MATER, V18, P2905, DOI 10.1002/adma.200601019
   Saunders BR, 2009, ADV COLLOID INTERFAC, V147-48, P251, DOI 10.1016/j.cis.2008.08.008
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   SCHILD HG, 1991, MACROMOLECULES, V24, P948, DOI 10.1021/ma00004a022
   SCHILD HG, 1990, J PHYS CHEM-US, V94, P4352, DOI 10.1021/j100373a088
   Schwerdt A, 2008, HUM GENE THER, V19, P1283, DOI [10.1089/hum.2008.064, 10.1089/hgt.2008.064]
   Seetapan N, 2006, RHEOL ACTA, V45, P1011, DOI 10.1007/s00397-005-0055-1
   Shen ZY, 2006, COLLOID POLYM SCI, V284, P1001, DOI 10.1007/s00396-005-1442-y
   Sweta M., 2006, CURR PHARM DESIGN, V12, P4785
   Takeda N, 2004, J CONTROL RELEASE, V95, P343, DOI 10.1016/j.jconrel.2003.12.001
   TANII H, 1991, TOXICOL LETT, V58, P209
   Turk M, 2004, J CONTROL RELEASE, V96, P325, DOI 10.1016/j.jconrel.2004.01.013
   Twaites BR, 2004, J CONTROL RELEASE, V97, P551, DOI 10.1016/j.jconrel.2004.03.032
   Uguzdogan E, 2005, EUR POLYM J, V41, P2142, DOI 10.1016/j.eurpolymj.2005.04.007
   UYAMA H, 1992, CHEM LETT, P1643, DOI 10.1246/cl.1992.1643
   Vasile C, 2004, POLYM INT, V53, P1176, DOI 10.1002/pi.1529
   Verbrugghe S, 2003, MACROMOL CHEM PHYSIC, V204, P1217, DOI 10.1002/macp.200390098
   Verdonck B, 2003, MACROMOL CHEM PHYSIC, V204, P2090, DOI 10.1002/macp.200350069
   Vieira NAB, 2005, COLLOID SURFACE A, V262, P251, DOI 10.1016/j.colsurfa.2005.05.006
   Wang LQ, 2002, REACT FUNCT POLYM, V53, P19, DOI 10.1016/S1381-5148(02)00126-8
   WANG W, 2009, ADV MAT IN PRESS
   Wei H, 2006, BIOMATERIALS, V27, P2028, DOI 10.1016/j.biomaterials.2005.09.028
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   WINTER HH, 1987, POLYM ENG SCI, V27, P1698, DOI 10.1002/pen.760272209
   Xu YL, 2007, POLYMER, V48, P1711, DOI 10.1016/j.polymer.2007.01.022
   Yamazaki A, 1998, MACROMOLECULES, V31, P109
   Yang M, 2007, J BIOMED MATER RES A, V81A, P847, DOI 10.1002/jbm.a.31129
   Yin X, 2006, BIOMACROMOLECULES, V7, P1381, DOI 10.1021/bm0507812
   Yuk SH, 1997, MACROMOLECULES, V30, P6856, DOI 10.1021/ma970725w
   Zhang J, 1999, J POLYM SCI POL CHEM, V37, P2137, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2137::AID-POLA29>3.0.CO;2-Q
   Zhang JX, 2004, MACROMOL RAPID COMM, V25, P1563, DOI 10.1002/marc.200400180
   Zhang YJ, 2005, J AM CHEM SOC, V127, P14505, DOI 10.1021/ja0546424
NR 122
TC 299
Z9 302
U1 29
U2 436
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0303-402X
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD JUN
PY 2009
VL 287
IS 6
BP 627
EP 643
DI 10.1007/s00396-009-2028-x
PG 17
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 448KD
UT WOS:000266260600001
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Agnihotri, A
   Soman, P
   Siedlecki, CA
AF Agnihotri, Aashiish
   Soman, Pranav
   Siedlecki, Christopher A.
TI AFM measurements of interactions between the platelet integrin receptor
   GPIIbIIIa and fibrinogen
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Fibrinogen; Platelet membrane integrin; Atomic force microscopy (AFM);
   Binding force measurements; Blood-material interactions
ID ATOMIC-FORCE MICROSCOPY; GLYCOPROTEIN-IIB-IIIA; LIGAND-BINDING; ADSORBED
   FIBRINOGEN; SURFACE WETTABILITY; PLASMA-PROTEINS; ADHESION; TIME;
   RECOGNITION; ADSORPTION
AB Binding of receptor proteins on circulating platelets to fibrinogen adsorbed on a biomaterial surface is a critical event in the blood-material interactions and surface-induced thrombogenesis. In this work, the interactions between purified platelet membrane integrin GPIIbIIIa (alpha IIb beta(3)) and fibrinogen on model hydrophilic and hydrophobic surfaces were characterized by measuring ligand-receptor debonding forces by atomic force microscopy (AFM). Force profiles between AFM probes functionalized with platelet integrins and fibrinogen on these substrates showed multiple rupture events over large distances on both surfaces. On the hydrophobic surface, the rupture length range was 20-200 nm, whereas on the hydrophilic surface, the rupture length range was 20-400 nm. Rupture events in the force curves were found to arise from non-specific protein-protein interactions. mechanical denaturation of fibrinogen domains, as well as the specific ligand-receptor interactions between integrins and fibrinogen. Analysis of the distributions of the debonding forces was used to estimate the strength of single integrin-fibrinogen pair at different loading rates. For loading rates of 10-60 nN/s, the debonding strength of a single integrin-fibrinogen pair was found to be in the range of 50-80 pN and was independent of the underlying substrate. Results Suggest that once the active platelet binding epitope in fibrinogen becomes exposed by surface adsorption, binding of the platelet membrane integrin receptor will be similar regardless of the material surface properties. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Siedlecki, Christopher A.] Penn State Univ, Milton S Hershey Med Ctr, Inst Biomed Engn, Dept Surg,Coll Med, Hershey, PA 17033 USA.
   [Agnihotri, Aashiish; Soman, Pranav; Siedlecki, Christopher A.] Penn State Univ, Dept Bioengn, Inst Biomed Engn, Coll Med, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Milton S Hershey Med Ctr, Inst Biomed Engn, Dept Surg,Coll Med, H151,500 Univ Dr, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
FU National Science Foundation [DMR-0804873]; Biomedical Engineering
   Institute at the Pennsylvania State University College of Medicine;
   Materials Research Institute at the Pennsylvania State University
FX The authors would like to acknowledge financial support from the
   National Science Foundation (DMR-0804873), the Biomedical Engineering
   Institute at the Pennsylvania State University College of Medicine, and
   the Materials Research Institute at the Pennsylvania State University.
   We would also like to thank Dr. Lichong Xu for valuable technical
   discussions.
CR Agnihotri A, 2005, ULTRAMICROSCOPY, V102, P257, DOI 10.1016/j.ultramic.2004.10.006
   Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   BRASH JL, 1994, PROTEINS INTERFACES, V2
   BRASS LF, 1985, J BIOL CHEM, V260, P7875
   BUSTAMANTE C, 1994, SCIENCE, V265, P1600
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   Chowdhury PB, 1998, COLLOID SURFACE A, V143, P53, DOI 10.1016/S0927-7757(98)00408-7
   DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0
   DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922
   DSOUZA SE, 1990, J BIOL CHEM, V265, P3440
   FARRELL DH, 1994, J BIOL CHEM, V269, P226
   Goldsmith HL, 2000, BIOPHYS J, V78, P1195, DOI 10.1016/S0006-3495(00)76677-X
   Hantgan R. R., 2001, HEMOSTASIS THROMBOSI, P203
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P403, DOI 10.1002/jbm.820150311
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451
   Kokkoli E, 2004, LANGMUIR, V20, P2397, DOI 10.1021/la035597l
   Lee I, 2003, ULTRAMICROSCOPY, V97, P341, DOI 10.1016/S0304-3991(03)00059-7
   Lee I, 2001, SURF SCI, V491, P433, DOI 10.1016/S0039-6028(01)01309-7
   Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827
   Litvinov R, 2004, FASEB J, V18, pC69
   Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999
   Malmsten M, 1998, J COLLOID INTERF SCI, V207, P186, DOI 10.1006/jcis.1998.5763
   MARCHANT RE, 1992, J COLLOID INTERF SCI, V148, P261, DOI 10.1016/0021-9797(92)90135-9
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Plow E. F., 2001, HEMOSTASIS THROMBOSI, P479
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   PRIVALOV PL, 1982, J MOL BIOL, V159, P665, DOI 10.1016/0022-2836(82)90107-3
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rooney MM, 1996, J BIOL CHEM, V271, P8553, DOI 10.1074/jbc.271.15.8553
   SANTORO SA, 1987, CELL, V48, P867, DOI 10.1016/0092-8674(87)90083-3
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   Sethuraman A, 2005, BIOPHYS J, V88, P1322, DOI 10.1529/biophysj.104.051797
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318
   Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922
   SIEDLECKI CA, 1994, J BIOMED MATER RES, V28, P971, DOI 10.1002/jbm.820280902
   Soman P, 2008, LANGMUIR, V24, P8801, DOI 10.1021/la801227e
   STANISLAWSKI L, 1995, J BIOMED MATER RES, V29, P315, DOI 10.1002/jbm.820290306
   Takagi J, 2002, CELL, V110, P511
   Tsai WB, 2003, J BIOMED MATER RES A, V67A, P1255, DOI 10.1002/jbm.a.20024
   Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 48
TC 28
Z9 28
U1 2
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUN 1
PY 2009
VL 71
IS 1
BP 138
EP 147
DI 10.1016/j.colsurfb.2009.01.019
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 445BC
UT WOS:000266023600022
PM 19250806
DA 2018-10-19
ER

PT J
AU Toussaint, E
   Eisendrath, P
   Kwan, V
   Dugardeyn, S
   Deviere, J
   Le Moine, O
AF Toussaint, E.
   Eisendrath, P.
   Kwan, V.
   Dugardeyn, S.
   Deviere, J.
   Le Moine, O.
TI Endoscopic treatment of postoperative enterocutaneous fistulas after
   bariatric surgery with the use of a fistula plug: report of five cases
SO ENDOSCOPY
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; TERM-FOLLOW-UP; FIBRIN GLUE; LEAKS;
   EFFICACY; CLOSURE; REPAIR
AB Anastomotic leaks frequently occur after bariatric surgery and their management includes different options. The present study describes the management of enterocutaneous fistulas in patients in whom surgical or endoscopic treatments have failed, by insertion of a biomaterial (Surgisis fistula plug) to facilitate healing of the gastrocutaneous fistula. Five patients with leaks after bariatric surgery were treated. All patients had undergone previous failed surgical or endoscopic attempt(s) at closure. Our technique entailed insertion of the Surgisis fistula plug into the fistula tract by a "rendezvous" procedure, via both per-cutaneous and endoscopic routes. The data were collected retrospectively. Initially, two patients were treated by fistula plug alone and three received fistula plug plus a self-expanding stent. In two patients, cutaneous fistula outflow ceased within a few days. The other three patients required one additional endoscopic procedure. At the end we observed healed leaks in four of the five patients (80%). The median follow-up duration was 18 months. In conclusion, the combined therapy consisting of fistula plug implantation with optional stenting helps closure in these difficult refractory cases of gastrocutaneous fistula.
C1 [Toussaint, E.; Eisendrath, P.; Kwan, V.; Dugardeyn, S.; Deviere, J.; Le Moine, O.] Univ Libre Bruxelles, Erasme Hosp, Dept Gastroenterol Hepatopancreatol & Digest Onco, B-1070 Brussels, Belgium.
RP Toussaint, E (reprint author), Univ Libre Bruxelles, Erasme Hosp, Dept Gastroenterol Hepatopancreatol & Digest Onco, 808 Route Lennik, B-1070 Brussels, Belgium.
EM emmanuel.toussaint@bordet.be
CR Alpert SA, 2005, J UROLOGY, V174, P1687, DOI 10.1097/01.ju.0000176621.99922.35
   Alpert SA, 2005, J UROL 2, V174, P1689
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Champagne BJ, 2006, DIS COLON RECTUM, V49, P1817, DOI 10.1007/s10350-006-0755-3
   COLQUITT J, 2005, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003641.PUB2]
   Eisendrath P, 2007, ENDOSCOPY, V39, P625, DOI 10.1055/s-2007-966533
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Gonzalez R, 2007, J AM COLL SURGEONS, V204, P47, DOI 10.1016/j.jamcollsurg.2006.09.023
   Johnson EK, 2006, DIS COLON RECTUM, V49, P371, DOI 10.1007/s10350-005-0288-1
   Pross M, 2000, GASTROINTEST ENDOSC, V51, P73, DOI 10.1016/S0016-5107(00)70391-9
   Truong S, 2004, SURG ENDOSC, V18, P1105, DOI 10.1007/s00464-003-8286-7
NR 11
TC 31
Z9 32
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0013-726X
J9 ENDOSCOPY
JI Endoscopy
PD JUN
PY 2009
VL 41
IS 6
BP 560
EP 563
DI 10.1055/s-0029-1214606
PG 4
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 464GO
UT WOS:000267493600017
PM 19533563
DA 2018-10-19
ER

PT J
AU Alonso-Sande, M
   Teijeiro-Osorio, D
   Remunan-Lopez, C
   Alonso, MJ
AF Alonso-Sande, M.
   Teijeiro-Osorio, D.
   Remunan-Lopez, C.
   Alonso, M. J.
TI Glucomannan, a promising polysaccharide for biopharmaceutical purposes
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Workshop on Biological Barriers and
   Nanomedicine - Advanced Drug Delivery and Predictive non-vivo Testing
   Technologies
CY FEB 20-29, 2008
CL Sarrland Univ, Sarrbrucken, GERMANY
HO Sarrland Univ
DE Glucomannan; Polysaccharides; Gelation; Colloidal systems;
   Nanoparticles; Nanocomplexes; Drug delivery
ID CARBOXYMETHYL KONJAC GLUCOMANNAN; CHAIN FATTY-ACIDS; CONTROLLED
   METABOLIC TRIAL; SARCOMA-180 SOLID TUMOR; ANIMAL FEEDING TRIAL;
   BETA-D-MANNANASE; DRUG-DELIVERY; CHITOSAN NANOPARTICLES; BLEND FILMS;
   ACETOBACTER-XYLINUM
AB Over the last few decades, polysaccharides have gained increasing attention in the biomedical and drug delivery fields. Among them, glucomannan (GM), has become a particularly attractive polymer. In this paper, we review the physicochemical and biological properties which are decisive for the exploitation of GM as a biomaterial. These properties include the structural organization, molecular weight, solubility, viscosity, gelling properties and degradation behavior. Moreover, herein we analyze the possibilities of combining GM with other hydrophilic polymers, as well as the preparation of semisynthetic derivatives of GM, which may be of interest in the pharmaceutical context. Finally, we discuss the specific applications of GM in the drug delivery field. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Alonso, M. J.] Univ Santiago de Compostela, Dept Pharm & Pharmaceut Technol, Fac Pharm, Santiago De Compostela 15782, Spain.
RP Alonso, MJ (reprint author), Univ Santiago de Compostela, Dept Pharm & Pharmaceut Technol, Fac Pharm, Santiago De Compostela 15782, Spain.
EM ffmjalon@usc.es
RI Alonso-Sande, Maria/F-3131-2010
OI Alonso, Maria Jose/0000-0001-7187-9567
CR Ademark P, 1999, J BIOTECHNOL, V75, P281, DOI 10.1016/S0168-1656(99)00172-8
   Ademark P, 1998, J BIOTECHNOL, V63, P199, DOI 10.1016/S0168-1656(98)00086-8
   Agoub AA, 2007, CARBOHYD POLYM, V69, P713, DOI 10.1016/j.carbpol.2007.02.014
   AKINO T, 1988, AGR BIOL CHEM TOKYO, V52, P773
   ALONSO MJ, 2004, ACS SYM SER, V879, P283
   Alonso-Sande M, 2006, MACROMOLECULES, V39, P4152, DOI 10.1021/ma060230j
   ALONSOSANDE M, 2005, P 32 M CONTR REL SOC
   ALONSOSANDE M, 2006, P 33 M CONTR REL SOC
   Alvarez-Mancenido F, 2008, INT J PHARM, V349, P11, DOI 10.1016/j.ijphariii.2007.07.015
   Alvarez-Mancenido F, 2006, INT J PHARM, V316, P37, DOI 10.1016/j.ijpharm.2006.02.029
   ARAKI T, 1983, J FAC AGR KYUSHU U, V27, P89
   Bertram U, 2006, EUR J PHARM SCI, V27, P62, DOI 10.1016/j.ejps.2005.08.005
   BOUVENG HO, 1963, ACTA CHEM SCAND, V17, P1796, DOI 10.3891/acta.chem.scand.17-1796
   BUCHALA AJ, 1974, PHYTOCHEMISTRY, V13, P163, DOI 10.1016/S0031-9422(00)91286-X
   Case SE, 1992, GUMS STABILIZERS FOO, P489
   Challa R., 2005, AAPS PHARMSCITECH, V6, P329, DOI DOI 10.1208/PT060243.PMID:16353992
   Chen LG, 2005, POLYMER, V46, P6274, DOI 10.1016/j.polymer.2005.05.041
   Cheng LH, 2002, FOOD RES INT, V35, P829, DOI 10.1016/S0963-9969(02)00086-8
   CHIURA H, 1982, AGR BIOL CHEM TOKYO, V46, P1733
   Chorvatovicova D, 1999, MUTAT RES-GEN TOX EN, V444, P117, DOI 10.1016/S1383-5718(99)00102-3
   CIVAS A, 1984, BIOCHEM J, V219, P857, DOI 10.1042/bj2190857
   COUSO RO, 1987, J GEN MICROBIOL, V133, P2123
   CSABA N, 2006, 5 WORLD M PHARM BIOP
   CUI Z, 2003, DRUG DEV IND PHARM, V6, P689
   Cuna M, 2006, J NANOSCI NANOTECHNO, V6, P2887, DOI 10.1166/jnn.2006.435
   Dave V, 1997, J ENVIRON POLYM DEGR, V5, P237
   DAWSON AM, 1964, P SOC EXP BIOL MED, V117, P97
   De la Fuente JM, 2006, BBA-GEN SUBJECTS, V1760, P636, DOI 10.1016/j.bbagen.2005.12.001
   de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001
   Dekker R F, 1976, Adv Carbohydr Chem Biochem, V32, P277
   DELAFUENTE BM, 2006, P 33 M CONTR REL SOC
   Dey P. M., 1978, ADV CARBOHYD CHEM BI, V35, P341
   DOI K, 1983, Tohoku Journal of Experimental Medicine, V141, P677
   Doi K., 1982, INT C SER, V549, P306
   Du J, 2005, J BIOMED MATER RES B, V72B, P299, DOI 10.1002/jbm.b.30156
   Du J, 2004, MACROMOL RAPID COMM, V25, P954, DOI 10.1002/marc.200300314
   DU J, 2005, BIOPOLYMERS, V18, P1
   EMI S, 1972, AGR BIOL CHEM TOKYO, V36, P991, DOI 10.1080/00021369.1972.10860352
   ERIKSSON KE, 1968, ACTA CHEM SCAND, V22, P1924, DOI 10.3891/acta.chem.scand.22-1924
   *FMC EUR NV, 1995, TECHN SCI DOSS
   Franz G., 1973, PHYTOCHEMISTRY, V10, P2369
   FUJII S, 1980, CARBOHYD RES, V83, P389, DOI 10.1016/S0008-6215(00)84553-X
   Gao SJ, 2004, COLLOID SURFACE B, V38, P241, DOI 10.1016/j.colsurfb.2004.02.026
   González Canga A., 2004, Nutr. Hosp., V19, P45
   GRANT S, 1990, POLYM COMMUN, V31, P267
   Guang Y., 1998, J MEMBRANE SCI, V139, P47
   Guebitz G. M., 1996, Bioresource Technology, V58, P127, DOI 10.1016/S0960-8524(96)00093-4
   HANSSON JA, 1970, HOLZFORSCHUNG, V24, P54, DOI 10.1515/hfsg.1970.24.2.54
   HUANG C-Y, 1990, Biomedical and Environmental Sciences, V3, P123
   Huang L, 2002, BIOMACROMOLECULES, V3, P1296, DOI 10.1021/bm0255995
   ISHIHARA M, 1980, MOZUKAI GAKKAISHI, V12, P811
   Ishrud O., 2001, AGR FOOD CHEM, V8, P3772
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   JANSSON PE, 1993, CARBOHYD RES, V245, P303, DOI 10.1016/0008-6215(93)80079-T
   KATO K, 1970, AGR BIOL CHEM TOKYO, V34, P532, DOI 10.1080/00021369.1970.10859645
   Kenne L., 1975, CARBOHYD RES, V1, P69
   KISHIDA N, 1978, AGR BIOL CHEM TOKYO, V42, P1645, DOI 10.1080/00021369.1978.10863226
   KISHIDA N, 1979, AGR BIOL CHEM TOKYO, V11, P2391
   Kobayashi S, 2002, FOOD HYDROCOLLOID, V16, P289, DOI 10.1016/S0268-005X(01)00101-1
   Kohyama K, 1997, JARQ-JPN AGR RES Q, V31, P301
   KOHYAMA K, 1993, FOOD HYDROCOLLOID, V7, P213, DOI 10.1016/S0268-005X(09)80173-2
   KONISHI F, 1984, JPN J EXP MED, V54, P139
   Koroskenyi B, 2001, BIOMACROMOLECULES, V2, P824, DOI 10.1021/bm010014c
   KUSAKABE I, 1988, AGR BIOL CHEM TOKYO, V2, P519
   Li B, 2006, CARBOHYD POLYM, V65, P488, DOI 10.1016/j.carbpol.2006.02.006
   Liu CH, 2004, J APPL POLYM SCI, V93, P1868, DOI 10.1002/app.20646
   Liu ZL, 2004, J POLYM SCI POL CHEM, V42, P4370, DOI 10.1002/pola.20272
   Lu YS, 2003, POLYMER, V44, P6689, DOI 10.1016/S0032-3861(03)00594-9
   Lu YS, 2002, IND ENG CHEM RES, V41, P1234, DOI 10.1021/ie001117z
   MAEDA M, 1980, AGR BIOL CHEM TOKYO, V44, P245, DOI 10.1080/00021369.1980.10863939
   MAEKAJI K, 1978, AGR BIOL CHEM TOKYO, V42, P177, DOI 10.1080/00021369.1978.10862945
   MATSUMURA S, 1991, MAKROMOL CHEM-RAPID, V12, P89
   Matsuura Y, 1998, J NUTR SCI VITAMINOL, V44, P423
   MCCARTHY MF, 2002, MED HYPOTHESES, V6, P487
   MCCLEARY BV, 1983, CARBOHYD RES, V119, P191, DOI 10.1016/0008-6215(83)84056-7
   MCCLEARY BV, 1991, ACS S SER, V460, pCH34
   Miyoshi E, 1998, POLYM GELS NETW, V6, P273, DOI 10.1016/S0966-7822(98)00019-7
   Nakajima N, 1997, BIOSCI BIOTECH BIOCH, V61, P1739, DOI 10.1271/bbb.61.1739
   NAKANO M, 1979, J BIOMED MATER RES, V13, P811, DOI 10.1002/jbm.820130511
   Nishinari K, 2000, DEV FOOD SCI, V41, P309
   NOZAWA Y, 1969, J CHROMATOGR, V45, P244, DOI 10.1016/S0021-9673(01)86206-3
   ODA YJ, 1993, J FERMENT BIOENG, V76, P14, DOI 10.1016/0922-338X(93)90045-A
   OHYA Y, 1994, CARBOHYD POLYM, V25, P123, DOI 10.1016/0144-8617(94)90148-1
   OJINNAKA C, 1994, GUMS STABILISERS FOO, V7, P15
   OJINNAKA C, 1998, CARBOHYD RES, V305, P101
   Ozu E. M., 1993, PHYS CHEM FOOD PROCE, V2, P487
   Paradossi G, 2002, BIOMACROMOLECULES, V3, P498, DOI 10.1021/bm010163v
   Peng Shu-Sheng, 1995, Biomedical and Environmental Sciences, V8, P80
   REESE ET, 1965, CAN J MICROBIOL, V11, P167, DOI 10.1139/m65-023
   Rhodes DI, 2002, J CEREAL SCI, V36, P83, DOI 10.1006/jcrs.2001.0450
   Ridout MJ, 1998, CARBOHYD RES, V309, P375, DOI 10.1016/S0008-6215(98)00149-9
   RUPPIN H, 1980, GASTROENTEROLOGY, V78, P1500
   SAITO Y, 1987, Human Nutrition Food Sciences and Nutrition, V41F, P63
   Schatz C, 2004, LANGMUIR, V20, P7766, DOI 10.1021/la049460m
   SHATWELL K P, 1991, Carbohydrate Polymers, V14, P131
   SHIMAHARA H, 1975, AGR BIOL CHEM TOKYO, V39, P293, DOI 10.1080/00021369.1975.10861604
   SHIMIZU K, 1983, AGR BIOL CHEM TOKYO, V47, P949, DOI 10.1080/00021369.1983.10865759
   SIRCAR AK, 1967, J APPL POLYM SCI, V9, P1683
   STAHL PD, 1978, P NATL ACAD SCI USA, V75, P1399, DOI 10.1073/pnas.75.3.1399
   Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9
   SUGIYAMA N, 1973, AGR BIOL CHEM TOKYO, V1, P9
   SUZUKI S, 1971, GANN, V62, P343
   SUZUKI S, 1969, GANN, V60, P273
   TAKADA M, 1984, BIOCHIM BIOPHYS ACTA, V802, P237, DOI 10.1016/0304-4165(84)90167-3
   TAKAHASHI R, 1984, AGR BIOL CHEM TOKYO, V48, P2943, DOI 10.1080/00021369.1984.10866626
   Takechi K, 1999, SEN-I GAKKAISHI, V55, P315, DOI 10.2115/fiber.55.7_315
   TAKO M, 1992, BIOSCI BIOTECH BIOCH, V56, P1188, DOI 10.1271/bbb.56.1188
   TAMARU Y, 1995, APPL ENVIRON MICROB, V61, P4454
   TEIJEIROOSORIO D, PREPARATION CH UNPUB
   Tenkanen M, 1998, BIOTECHNOL APPL BIOC, V27, P19, DOI 10.1111/j.1470-8744.1998.tb01370.x
   Tian BS, 1998, J APPL POLYM SCI, V67, P1035, DOI 10.1002/(SICI)1097-4628(19980207)67:6<1035::AID-APP10>3.3.CO;2-3
   TIMELL TE, 1964, ADV CARBOHYD CHEM, V19, P247
   TOMIZAWA H, 1993, PHARMACEUT RES, V10, P549, DOI 10.1023/A:1018945902276
   Viikari L., 1993, V9, P131
   VIIKARI L, 1994, FEMS MICROBIOL REV, V13, P335, DOI 10.1111/j.1574-6976.1994.tb00053.x
   Vuksan V, 1999, DIABETES CARE, V22, P913, DOI 10.2337/diacare.22.6.913
   Vuksan V, 2000, DIABETES CARE, V23, P9, DOI 10.2337/diacare.23.1.9
   Wang K, 2002, INT J PHARM, V244, P117, DOI 10.1016/S0378-5173(02)00324-1
   Williams PA, 1991, FOOD HYDROCOLLOID, V4, P489, DOI 10.1016/S0268-005X(09)80199-9
   WILLIAMS PA, 1993, MACROMOLECULES, V26, P5441, DOI 10.1021/ma00072a023
   WILLIAMS PA, 1991, SPECIAL PUBLICATION, V82, P339
   Xiao CB, 2002, J APPL POLYM SCI, V84, P2554, DOI 10.1002/app.10582
   XIAO SC, 2000, J APPL POLYM SCI, V3, P617
   XIAO SC, 2000, J APPL POLYM SCI, V4, P509
   YAMAURA I, 1990, AGR BIOL CHEM TOKYO, V54, P2425, DOI 10.1080/00021369.1990.10870308
   YAMAZAKI N, 1976, HOLZFORSCHUNG, V4, P101
   Ye X, 2006, CARBOHYD POLYM, V64, P532, DOI 10.1016/j.carbpol.2005.11.005
   YONGSHANG L, 2002, IND ENG CHEM RES, V5, P1234
   Yu HQ, 2006, J APPL POLYM SCI, V100, P1561, DOI 10.1002/app.23634
   Zhang Mao-Yu, 1995, Biomedical and Environmental Sciences, V8, P74
   Zhang YQ, 2005, CARBOHYD POLYM, V60, P27, DOI 10.1016/j.carbpol.2004.11.003
   Zheng Hua, 2002, Wuhan University Journal of Natural Sciences, V7, P107
   ZHOU G, 2007, J BIOMED MAT RES A, V13
NR 133
TC 86
Z9 93
U1 3
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0939-6411
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD JUN
PY 2009
VL 72
IS 2
BP 453
EP 462
DI 10.1016/j.ejpb.2008.02.005
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 458FO
UT WOS:000267000800022
PM 18511246
DA 2018-10-19
ER

PT J
AU Smith, AE
   Prasad, HS
   Rohrer, MD
AF Smith, Astley E.
   Prasad, Hari S.
   Rohrer, Michael D.
TI Bone Regeneration With Autologous Biomaterial; Rapid Induction of Vital
   New Bone in Maxillary Sinus Floor by Platelet Concentrate Alone at 23x
   Baseline (PRP23x): A Case Report
SO IMPLANT DENTISTRY
LA English
DT Article
DE platelet concentrate; strategic pooling; triple spin; osteogenic;
   osteoinductive; chondrogenic; nondecalcified histology
ID ANORGANIC BOVINE BONE; RICH PLASMA; GROWTH-FACTORS; AUGMENTATION;
   ENHANCEMENT; ACTIVATION; SURGERY; MARKER; GEL
AB To date, most clinicians and researchers have been using platelet concentrate within the range of 4X to 8X baseline. In this case report a new procedure involving strategic pooling and triple spin was developed and used to concentrate platelets to 23X baseline. The concentrate alone was infused into morselized resorbable collagen sponge, activated with calcium chloride and autologous thrombin, then placed as an autologous graft into the left sinus floor of a healthy 80-year-old. woman. The floor of the sinus had similar to 2 mm of bony height. A computed tomography scan taken after 5 months showed that new bone was formed and it was as dense as native bone around the surgical site. From the computed tomography scan bone density analysis using Hounsfield Units revealed that the bone formed was D(3) bone (518.3 +/- 224.9 Hounsfield Units) and it was as dense as native bone on the axial, coronal and sagittal slices. Histomorphometric analysis of 2 bone core biopsies taken after 6 months showed that I core had 34% bone of which 98% was vital new bone and the other core had 39% bone of. which 100% was vital new bone. The height of the bone formed in the sinus floor was 12 mm. It was also characterized by good trabecular pattern and connectivity. The quality of the bone generated was such that 2 endosseous implants were placed and torqued to 30 N cm after the cores were removed. (Implant Dent 2009;18:210-219)
C1 [Smith, Astley E.] Ctr Autografting & Implantol, Metro Vancouver, BC V3L 3C2, Canada.
   [Prasad, Hari S.; Rohrer, Michael D.] Univ Minnesota, Sch Dent, Hard Tissue Res Lab, Minneapolis, MN 55455 USA.
RP Smith, AE (reprint author), Ctr Autografting & Implantol, Royal City Ctr Mall Main Floor,108-610 6th St, Metro Vancouver, BC V3L 3C2, Canada.
EM belmontdentalcentre@telus.net
CR ALDER SC, 2002, FACIAL PLAST SURG CL, V10, P129
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   Caplan AI, 2000, CLIN ORTHOP RELAT R, pS67
   CARLSON NE, 2002, J AM DENT ASSOC, V133, P1386
   Degidi M, 2007, IMPLANT DENT, V16, P317, DOI 10.1097/ID.0b013e3180de4c5f
   DEVINE DV, 1993, ARTERIOSCLER THROMB, V13, P857, DOI 10.1161/01.ATV.13.6.857
   Froum SJ, 2006, INT J PERIODONT REST, V26, P543
   Gonshor A, 2002, INT J PERIODONT REST, V22, P547
   Haynesworth SE, 2002, 48 M ORTH RES SOC DA
   John Vanchit, 2003, J Indiana Dent Assoc, V82, P8
   Landesberg R, 2000, J ORAL MAXIL SURG, V58, P297, DOI 10.1016/S0278-2391(00)90058-2
   LAZADA JL, 2001, J ORAL IMPLANTOL, V27, P38
   Levin E, 2000, THROMB HAEMOSTASIS, V83, P54
   LEVIN E, 1997, THROMB HAEMOSTASIS, V77, P32
   Man D, 2001, PLAST RECONSTR SURG, V107, P229, DOI 10.1097/00006534-200101000-00037
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   MARX RE, 2000, BONE ENG, P447
   MARX RE, 2005, DENT CRANIOFACIAL AP, P31
   REED GL, 2002, PLATELETS, P181
   Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170
   Sanchez AR, 2003, INT J ORAL MAX IMPL, V18, P93
   SMITH AE, 2006, ORAL HLTH, P6
   SMITH AE, 2006, ORAL HLTH, P79
   Sonnleitner D, 2000, INT J ORAL MAX IMPL, V15, P879
   Stanworth SJ, 1999, CLIN LAB HAEMATOL, V21, P113, DOI 10.1046/j.1365-2257.1999.00200.x
   Tozum Tolga Fikret, 2003, J Can Dent Assoc, V69, P664
   Zimmermann R, 2001, TRANSFUSION, V41, P1217, DOI 10.1046/j.1537-2995.2001.41101217.x
NR 28
TC 7
Z9 7
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD JUN
PY 2009
VL 18
IS 3
BP 210
EP 215
DI 10.1097/ID.0b013e318198d3f9
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 457BG
UT WOS:000266899300004
PM 19509531
DA 2018-10-19
ER

PT J
AU Simonpieri, A
   Del Corso, M
   Sammartino, G
   Ehrenfest, DMD
AF Simonpieri, Alain
   Del Corso, Marco
   Sammartino, Gilberto
   Ehrenfest, David M. Dohan
TI The Relevance of Choukroun's Platelet-Rich Fibrin and Metronidazole
   During Complex Maxillary Rehabilitations Using Bone Allograft. Part II:
   Implant Surgery, Prosthodontics, and Survival
SO IMPLANT DENTISTRY
LA English
DT Article
DE fibrin; freeze-dried bone allograft; implant; platelet concentrate;
   platelet-rich fibrin; platelet-rich plasma
ID CONSENSUS CONFERENCE; SINUS GRAFT; SURFACE; OSSEOINTEGRATION;
   EXTRACTION; PLACEMENT; ACADEMY; PLASMA; CELLS; LIFT
AB Extensive bone grafting remains a delicate procedure, due to the slow and difficult integration of the grafted material into the physiological architecture. The recent use of platelet concentrates at. Ins to improve this process of integration by accelerating bone and mucosal healing. Choukroun's platelet-rich fibrin (PRF) is a healing biomaterial that concentrates in a single autologous fibrin membrane, most platelets, leukocytes, and cytokines from a 10-mL blood harvest, without artificial biochemical modification (no anticoagulant, no bovine thrombin). In this second pail, we describe the implant and prosthetic phases of a complex maxillary rehabilitation, after preimplant bone grafting using allograft, Choukroun's PRF membranes, and metronidazole. Twenty patients were treated using this new technique and followed up among 2.1 years (1-5 years). Finally, 184 dental implants were placed, including 54 classical screw implants (31, Palm Beach Gardens, FL) and 130 implants with microthreaded collar (46 from AstraT ech, Molndal, Sweden; 84 from IntraLock Boca Raton, FL). No implant or graft was lost in this case series, confirming the validity of this reconstructive protocol. However, the number of implants used per maxillary rehabilitation was always higher with simple screw implants than. with microthreaded implants, the latter presenting a stronger initial implant stability. Finally, during complex implant rehabilitations, PRF membranes are particularly helpful for periosteum healing and maturation. The thick peri-implant gingiva is related to several healing phases on a PRF membrane layer and could explain the low marginal bone loss observed in this series. Microthreaded collar and platform switching concept even improved this result. Multiple healing on PRF membranes seems a new opportunity to improve the final esthetic result. (Implant Dent 2009;18:220-229)
C1 [Ehrenfest, David M. Dohan] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, S-41390 Gothenburg, Sweden.
   [Del Corso, Marco] Univ Turin, Dept Periodontol, Turin, Italy.
   [Sammartino, Gilberto; Ehrenfest, David M. Dohan] Univ Naples Federico II, Dept Odontostomatol & Maxillofacial Sci, Naples, Italy.
   [Ehrenfest, David M. Dohan] AP HP, Fdn Res LoB5, Paris, France.
RP Ehrenfest, DMD (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Med Regatan 8B, S-41390 Gothenburg, Sweden.
EM drdohand@hotmail.com
RI Dohan Ehrenfest, David/C-8866-2012
OI Del Corso, Marco/0000-0002-2882-8139
CR Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P147, DOI 10.1111/j.1600-0501.2006.01309.x
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J., 2001, IMPLANTODONTIE, V42, P55
   Choukroun J, 2008, IMPLANT DENT, V17, P257, DOI 10.1097/ID.0b013e318181349a
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Diss A, 2008, ORAL SURG ORAL MED O, V105, P572, DOI 10.1016/j.tripleo.2007.08.021
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P587, DOI 10.1016/j.tripleo.2007.03.016
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Geurs NC, 2001, INT J PERIODONT REST, V21, P517
   Holmquist P, 2008, CLIN IMPLANT DENT R, V10, P86, DOI 10.1111/j.1708-8208.2007.00063.x
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Kawase T, 2003, J PERIODONTOL, V74, P858, DOI 10.1902/jop.2003.74.6.858
   Lazzara RJ, 2006, INT J PERIODONT REST, V26, P9
   Lindeboom JAH, 2007, CLIN ORAL IMPLAN RES, V18, P133, DOI 10.1111/j.1600-0501.2006.01288.x
   Minichetti John C, 2004, J Oral Implantol, V30, P74, DOI 10.1563/0.693.1
   Misch CE, 2008, IMPLANT DENT, V17, P5, DOI 10.1097/ID.0b013e3181676059
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P279, DOI 10.1034/j.1600-0501.2001.012003279.x
   Shulman LB, 1998, INT J ORAL MAX IMPL, V13, P5
   Sul YT, 2006, INT J PROSTHODONT, V19, P319
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Weng D, 2003, CLIN ORAL IMPLAN RES, V14, P703, DOI 10.1046/j.0905-7161.2003.00955.x
NR 25
TC 43
Z9 48
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD JUN
PY 2009
VL 18
IS 3
BP 220
EP 224
DI 10.1097/ID.0b013e31819b5e3f
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 457BG
UT WOS:000266899300005
PM 19509532
DA 2018-10-19
ER

PT J
AU Xie, KL
   Hou, AQ
   Zhang, YL
AF Xie, Kongliang
   Hou, Aiqin
   Zhang, Yanli
TI Color analysis of the nano-structured dyed cellulose materials
   containing inorganic particles
SO INTERNATIONAL JOURNAL OF NONLINEAR SCIENCES AND NUMERICAL SIMULATION
LA English
DT Article
DE composite; nano-particle; color; synthesis; dyeing, biomaterial
ID ELECTROSPUN NANOFIBERS; TRIAZINE DERIVATIVES; BIOMATERIALS; COTTON
AB The nano-structured cellulose containing inorganic particles (SiO(2)) was prepared by the sol-gel process. The color data of the nanocomposite was analyzed by the colorimetric data of CIELAB. The results show that compared with the dyed fabric without the nano-particles, the color yield of three color samples (Red, Yellow, Blue) containing nano-structured inorganic particles (SiO(2)) is enhanced. The color shade of samples containing inorganic particles becomes dark. The color difference of all samples containing nano-structured inorganic particles is observed, and the change of color shade is more significant with the increase of the concentration of nano-particles in the cellulose.
C1 [Xie, Kongliang; Zhang, Yanli] Donghua Univ, Modern Text Inst, Shanghai 200051, Peoples R China.
   [Hou, Aiqin] Donghua Univ, Natl Engn Res Ctr Dyeing & Finishing Text, Shanghai 200051, Peoples R China.
RP Xie, KL (reprint author), Donghua Univ, Modern Text Inst, Shanghai 200051, Peoples R China.
EM klxie@dhu.edu.cn
CR Addamo M, 2008, THIN SOLID FILMS, V516, P3802, DOI 10.1016/j.tsf.2007.06.139
   FU BX, 2001, MOL POLYM, V42, P599
   He JH, 2007, POLYM INT, V56, P1323, DOI 10.1002/pi.2370
   He JH, 2007, CHAOS SOLITON FRACT, V33, P26, DOI 10.1016/j.chaos.2006.09.023
   Hou AQ, 2008, CARBOHYD POLYM, V74, P934, DOI 10.1016/j.carbpol.2008.05.011
   Hou AQ, 2009, CARBOHYD POLYM, V75, P328, DOI 10.1016/j.carbpol.2008.07.032
   Kulpinski P, 2005, J APPL POLYM SCI, V98, P1793, DOI 10.1002/app.22279
   LOU M, 2003, COLOR TECHNOL, V119, P297
   LOVA R, 2008, COLOR TECHNOL, V124, P86
   Mughal MJ, 2008, COLOR TECHNOL, V124, P62, DOI 10.1111/j.1478-4408.2007.00122.x
   Okada A, 2006, MACROMOL MATER ENG, V291, P1449, DOI 10.1002/mame.200600260
   Samuneva B, 2008, J NON-CRYST SOLIDS, V354, P733, DOI 10.1016/j.jnoncrysol.2007.07.094
   Xie KL, 2006, INT J NONLINEAR SCI, V7, P117
   Xie KL, 2008, J DISPER SCI TECHNOL, V29, P1385, DOI 10.1080/01932690802313105
   Xie KL, 2008, CARBOHYD POLYM, V72, P646, DOI 10.1016/j.carbpol.2007.10.005
   Xie KL, 2008, J DISPER SCI TECHNOL, V29, P436, DOI 10.1080/01932690701718834
   Xu L, 2007, INT J NONLINEAR SCI, V8, P199
   Yeh JT, 2007, MATER LETT, V61, P1292, DOI 10.1016/j.matlet.2006.07.016
NR 18
TC 11
Z9 11
U1 1
U2 4
PU FREUND PUBLISHING HOUSE LTD
PI TEL AVIV
PA PO BOX 35010, TEL AVIV 61350, ISRAEL
SN 1565-1339
J9 INT J NONLIN SCI NUM
JI Int. J. Nonlinear Sci. Numer. Simul.
PD JUN
PY 2009
VL 10
IS 6
BP 759
EP 765
PG 7
WC Engineering, Multidisciplinary; Mathematics, Applied; Mechanics;
   Physics, Mathematical
SC Engineering; Mathematics; Mechanics; Physics
GA 483MH
UT WOS:000268970400008
DA 2018-10-19
ER

PT J
AU Fatimi, A
AF Fatimi, A.
TI Rheological behavior of biomaterials for osteoarticular and dental
   tissue engineering: Synthetic extracellular matrix and calcium phosphate
   suspensions
SO IRBM
LA English
DT Article
DE Biomaterial; Hydrogel; Rheology; Hydroxypropylmethylcellulose; Bipahsic
   calcium phosphate ceramic; Suspension
AB Injectable biomaterials are a particular field of biomaterials used for noninvasive surgical techniques (e.g. percutaneous surgery). The fundamental characteristic of this type of biomaterials is their rheological properties during implantation. In this context, the subject of this research work was to evaluate the rheological properties of two injectable biomaterials used in osteoarticular and dental tissue engineering: (i) a synthetic extracellular matrix and (ii) an injectable calcium phosphate suspension. The rheological properties of silated hydroxypropylmethylcellulose hydrogel were studied. It is shown that although silanization reduces the hydrodynamic volume in dilute solution, it does not affect significantly the theological behavior of the concentrated solutions. In dilute solution, intrinsic viscosity of different HPMC-Si solutions before steam sterilization indicated that macromolecular chains occupied larger hydrodynamic volume compared to the sterilized HPMC-Si solutions. For the sterilized HPMC-Si concentrated solutions, the limiting viscosities decreased when the pH increased. This change, remarked in dilute and concentrated domain has been attributed to the formation of both intra- and intermolecular associations during the phase separation process of HPMC-Si during steam sterilization. The formation of HPMC-Si hydrogels from injectable aqueous solution was studied after neutralization. The study of the gelation process revealed the dependence of the final concentration of HPMC-Si hydrogel, pH and temperature on cross-linking kinetics and viscoelastic properties. An injectable calcium phosphate ceramic suspension was studied. This "ready-to-use" injectable bone substitute is consisting of an aqueous HPMC solution as matrix and calcium phosphate particles as fillers. The rheological characterization revealed the macromolecular behavior of the HPMC. The investigations of settling kinetics showed the dependence of the particle size and the HPMC concentration on the settling velocity and sediment compactness before and after sterilization. The rheological properties and injectability of this suspension were also studied. The suspensions showed a strongly increased viscosity as compared to the HPMC solution. The theological proprieties of suspensions depend on the composition. A simple device has been used to characterize extrusion of the paste using a disposable syringe fitted with a needle. The injectability modeling was realized. A theoretical approach based on the capillary flow of non newtonian fluids was used to predict the necessary pressure for injection, on the basis of rheological properties and extrusion conditions. The theoretical estimation of the extrusion pressure showed a wall slip in the suspensions, so that the injection pressure is less than anticipated. The influence of wall slip leads, however, to a constant proportionality factor between theory and injection experiments. (C) 2008 Elsevier Masson SAS. All rights reserved.
C1 Univ Nantes, INSERM, U791, Lab Ingn Osteoarticulaire & Dent, F-44042 Nantes, France.
RP Fatimi, A (reprint author), Univ Nantes, INSERM, U791, Lab Ingn Osteoarticulaire & Dent, 1 Pl Alexis Ricordeau, F-44042 Nantes, France.
EM ahmed.fatimi@univ-nantes.fr
NR 0
TC 4
Z9 5
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1959-0318
J9 IRBM
JI IRBM
PD JUN
PY 2009
VL 30
IS 3
BP 139
EP 140
DI 10.1016/j.irbm.2008.11.001
PG 2
WC Engineering, Biomedical
SC Engineering
GA 469WX
UT WOS:000267932900007
DA 2018-10-19
ER

PT J
AU Li, QL
   Huang, N
   Chen, JL
   Wan, GJ
   Zhao, AS
   Chen, JY
   Wang, J
   Yang, P
   Leng, YX
AF Li, Quan-Li
   Huang, Nan
   Chen, Jialong
   Wan, Guojiang
   Zhao, Ansa
   Chen, Junying
   Wang, Jin
   Yang, Ping
   Leng, Yongxiang
TI Anticoagulant surface modification of titanium via layer-by-layer
   assembly of collagen and sulfated chitosan multilayers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium; surface modification; self-assembly; collagen; sulfated
   chitosan; hemocompatibility
ID PLATELET-ADHESION; WHOLE-BLOOD; ACTIVATION; BIOMATERIAL; ADSORPTION;
   TIO2; CELL
AB Extracellular matrix (ECM)-like biomimetic surface modification of cardiovascular implants is a promising method for improving hemocompatibility. In the present work, collagen (Col) and sulfated chitosan (SCS) multilayers were coated on pure titanium using a layer-by-layer (LBL) self-assembly technique. The Col-SCS multilayer growth was carried out by first depositing a single layer of positively charged poly-L-lysine (PLL) on the NaOH-treated titanium substrate (negatively charged surface), followed by alternate deposition of negatively charged SCS and positively charged Col, and terminated by an Outermost layer of SCS. Platelet adhesion in vitro, partial activated thromboplastin time (APTT) and prothrombin time (PT) assays were used to evaluate the hemocompatibility of the Col-SCS multilayer coated titanium. The multilayer processed surfaces displayed reduced platelet adhesion and activation, and prolonged clotting time of APTT and PT compared with untreated titanium. Thus, the approach described here may provide a basis for the preparation of modified titanium surfaces for application in cardiovascular implants. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 575-584, 2009
C1 [Li, Quan-Li; Huang, Nan; Chen, Jialong; Wan, Guojiang; Zhao, Ansa; Chen, Junying; Wang, Jin; Yang, Ping; Leng, Yongxiang] SW Jiaotong Univ, Educ Minist China, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Educ Minist China, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM nhuang@263.net
RI Leng, Yongxiang/G-5488-2010; Chen, Jialong/E-4388-2015
OI Chen, Jialong/0000-0002-5323-1801; Leng, Y.X./0000-0001-6823-1233
FU Key Basic Research Program of China [2005CB623904]; NSFC [20603027,
   30318006]; China Postdoctoral Science Foundation [20060401019]; The
   National High Technology Research and Development Program of China
   [2006AA02A139]
FX Contract grant sponsor: Key Basic Research Program of China; contract
   grant number: 2005CB623904 Contract grant sponsor: NSFC; contract grant
   numbers: 20603027,30318006 Contract grant sponsor: China Postdoctoral
   Science Foundation; contract grant number: 20060401019 Contract grant
   sponsor: The National High Technology Research and Development Program
   of China; contract grant number: 2006AA02A139
CR AMIJI MM, 1995, BIOMATERIALS, V16, P593, DOI 10.1016/0142-9612(95)93856-9
   Amiji MM, 1998, COLLOID SURFACE B, V10, P263, DOI 10.1016/S0927-7765(98)00005-8
   AMZAZADE A, 1997, CARBOHYD POLYM, V34, P113
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   BEENA MS, 1995, ARTIF CELL BLOOD SUB, V23, P175, DOI 10.3109/10731199509117937
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Breme F, 2000, THIN SOLID FILMS, V377, P755, DOI 10.1016/S0040-6090(00)01329-8
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dumitriu S, 1998, ADV DRUG DELIVER REV, V31, P223, DOI 10.1016/S0169-409X(97)00120-8
   Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3
   Fasman G. D, 1976, HDB BIOCH MOL BIOL P, V2
   Grant GGS, 2001, BIOMED MICRODEVICES, V3, P301, DOI 10.1023/A:1012456714628
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hughes-Wassell Diana T., 1996, Biomaterials, V17, P859
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   Li Cheng, 2004, Hemodial Int, V8, P360, DOI 10.1111/j.1492-7535.2004.80412.x
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   MARK AR, 2001, THESIS CASE W RESERV
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P3, DOI 10.1016/0142-9612(91)90123-R
   Otto M, 2004, J MATER SCI-MATER M, V15, P35, DOI 10.1023/B:JMSM.0000010095.19693.67
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   Ruiz-Taylor LA, 2001, P NATL ACAD SCI USA, V98, P852, DOI 10.1073/pnas.98.3.852
   SAGNELLA SM, 2003, THESIS CASE W RESERV
   Salditt T., 2002, REV MOL BIOTECHNOL, V90, P55
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P1003, DOI 10.1002/jbm.820260804
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Takemoto S, 2001, J SOL-GEL SCI TECHN, V21, P97, DOI 10.1023/A:1011269802356
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   VONGCHAN P, 2002, CARBOHYD RES, V337, P1233
NR 39
TC 32
Z9 33
U1 4
U2 36
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2009
VL 89A
IS 3
BP 575
EP 584
DI 10.1002/jbm.a.31999
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 443FJ
UT WOS:000265895300003
PM 18435411
DA 2018-10-19
ER

PT J
AU Schopper, C
   Moser, D
   Spassova-Tzekova, E
   Russmueller, G
   Goriwoda, W
   Lagogiannis, G
   Ewers, R
   Redl, H
AF Schopper, Christian
   Moser, Doris
   Spassova-Tzekova, Else
   Russmueller, Guenter
   Goriwoda, Walter
   Lagogiannis, Georgios
   Ewers, Rolf
   Redl, Heinz
TI Mineral apposition rates provide significant information on long-term
   effects in BMP-induced bone regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone regeneration; calcium phosphate; fluorescence; growth factors;
   histomorphometry
ID BIPHASIC CALCIUM-PHOSPHATE; RECOMBINANT HUMAN BONE; PLATELET-RICH
   PLASMA; MORPHOGENETIC PROTEIN-2; TISSUE; OSTEOGENESIS; OSTEOPOROSIS;
   DEFECTS; RHBMP-2
AB In this study, a CaP biomaterial was used as a carrier for rhBMP-2. Biomaterials were investigated in calvarial and femoral defects using a rabbit animal model, with unloaded biomaterials serving as control. Fluorochrome labels were administered at days 14 and 70. Specimens were retrieved after 12 weeks for histological analysis. When area fractions were assessed by conventional histomorphometry, no significant effect of rhBMP-2 on the amounts of regenerated bone and residual biomaterial were seen by 12 weeks. After mineral appositional rate (MAR) measurement using double labels, calculation yielded significantly higher MARs for defects at both implantation sites, when compared with surrounding bone, whether or not biomaterials were loaded with rhBMP-2. Analyzing the effect of rhBMP-2, both defect sites showed significantly higher MARs in the rhBMP-2 group. MARs of bone surrounding the defects had also been elevated significantly by rhBMP-2 at calvarial and femoral implantation sites. It is concluded that MAR measurement is suitable to identify long-term effects of rhBMP-2 on bone formation at a time when conventional histomorphometry using fractional area determination is inadequate. Also, by MAR assessment, effects of rhBMP-2 on surrounding bone can be documented. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 679-686, 2009
C1 [Schopper, Christian; Moser, Doris; Russmueller, Guenter; Goriwoda, Walter; Lagogiannis, Georgios; Ewers, Rolf] Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, Vienna, Austria.
   [Spassova-Tzekova, Else] AlgOss Biotechnol GmbH, Vienna, Austria.
   [Redl, Heinz] AUVA Res Ctr Traumatol, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.
RP Schopper, C (reprint author), Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, Vienna, Austria.
EM christian.schopper@meduniwien.ac.at
FU EU [CRAFT-1999-70428]
FX Contract grant sponsor: EU; contract grant number: CRAFT-1999-70428
CR Arlot M E, 1990, Osteoporos Int, V1, P41, DOI 10.1007/BF01880415
   DACULSI G, 1990, J BIOMED MATER RES, V24, P391
   DONATH K, 1982, J ORAL PATHOL, V11, P198
   ERIKSEN EF, 1990, J BONE MINER RES, V5, P311, DOI 10.1002/jbmr.5650050402
   ERIKSEN EF, 1994, BONE HISTOMORPHOMETR
   FOLDES J, 1990, J BONE MINER RES, V5, P1063
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Fujita R, 2003, J ORAL MAXIL SURG, V61, P1045, DOI 10.1016/S0278-2391(03)00317-3
   HASHIMOTOUOSHIMA M, 1995, INT J PERIODONT REST, V15, P205
   Hauge E, 1999, BONE, V25, P389, DOI 10.1016/S8756-3282(99)00194-5
   Jung RE, 2005, CLIN ORAL IMPLAN RES, V16, P676, DOI 10.1111/j.1600-0501.2005.01183.x
   KIMMEL DB, 1990, BONE MINER, V11, P217, DOI 10.1016/0169-6009(90)90061-J
   MELSEN F, 1978, CALC TISS RES, V26, P99, DOI 10.1007/BF02013242
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Phillips Frank M, 2006, Spine J, V6, P500, DOI 10.1016/j.spinee.2006.01.014
   RENGACHARY SS, 2002, NEUROSURG FOCUS, V13, P1
   Roldan JC, 2004, BONE, V34, P80, DOI 10.1016/j.bone.2003.09.011
   Schopper C, 2008, J BIOMED MATER RES A, V85A, P954, DOI 10.1002/jbm.a.31525
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   SEEHERMAN H, 2002, SPINE, V27, P16
   Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006
   Springer ING, 2005, BONE, V37, P563, DOI 10.1016/j.bone.2005.05.010
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P469, DOI 10.1054/ijom.2000.0008
   Zheng LW, 2006, BRIT J ORAL MAX SURG, V44, P487, DOI 10.1016/j.bjoms.2005.09.005
NR 25
TC 4
Z9 4
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2009
VL 89A
IS 3
BP 679
EP 686
DI 10.1002/jbm.a.32012
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 443FJ
UT WOS:000265895300013
PM 18442117
DA 2018-10-19
ER

PT J
AU Meek, MF
   Jansen, K
AF Meek, Marcel F.
   Jansen, Koen
TI Two years after in vivo implantation of
   poly(DL-lactide-epsilon-caprolactone) nerve guides: Has the material
   finally resorbed?
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(DL-lactide-epsilon-caprolactone) nerve guide; Neurolac; long-term
   nerve regeneration; collagen III/IV distribution; foreign body reaction
ID SCIATIC-NERVE; RECONSTRUCTION; CONDUITS; REPAIR; GRAFTS
AB Long-term nerve guide studies on nerve regeneration in vivo are scarce. Previously, we showed that small fragments of biomaterial could still be found on the edge of the epineurium of the regenerated nerve after implantation Of poly(DL-lactide-epsilon-caprolactone) [poly(DLLA-epsilon-CL), Neurolac (R)] nerve guides. As these nerve guides are assumed to fully resorb, we studied the 2-year degradation and possible long-term foreign body reaction against the nerve guides after implantation in the sciatic nerve of the rat. In addition, the distribution of both collagen type III and W, and nerve regeneration through the nerve guides were studied and compared with the non-operated control side. The results demonstrate that nerve regeneration took place through the poly(DLLA-epsilon-CL) nerve guides. After 2 years of implantation, biomaterial could not be found macroscopically. Biomaterial fragments in company of multinucleated giant cells and macrophages were found along the regenerated nerve tissue. Collagen III and IV were both found around the epineurium and perineurium in the regenerated nerve, the organization of these layers resembled that of the contra-lateral non-operated nerve. Although sufficient nerve regeneration was obtained after long-term implantation in the rat sciatic nerve, biomaterial fragments and foreign body reactions against these fragments, even after 24 months of implantation, could still be found. The poly(DLLA-epsilon-CL), Neurolac nerve guides do resorb, however, not complete up to 2 years of implantation. It is not known whether the remaining biomaterial fragments and foreign body reactions may cause granulomas or other complications after longer implantation periods. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 734-738, 2009
C1 [Jansen, Koen] Hutchinson Technol Inc, Hutchinson, MN 55350 USA.
   [Meek, Marcel F.] Bernhoven Hosp, Dept Plast Reconstruct Hand & Aesthet Surg, NL-5460 DA Veghel, Netherlands.
RP Jansen, K (reprint author), Hutchinson Technol Inc, 40 W Highland Pk Dr, Hutchinson, MN 55350 USA.
EM koenjansen66@gmail.com
CR CARR MM, 1992, ANN PLAS SURG, V28, P538
   den Dunnen WFA, 2000, J BIOMED MATER RES, V51, P575, DOI 10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.3.CO;2-Q
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Jansen K, 2006, J BIOMED MATER RES A, V77A, P436, DOI 10.1002/jbm.a.30719
   Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004
   Lombardi T, 2004, J ORAL PATHOL MED, V33, P115, DOI 10.1111/j.1600-0714.2004.00194.x
   Meek MF, 2008, ANN PLAS SURG, V60, P110, DOI 10.1097/SAP.0b013e31804d441c
   Meek M F, 2003, Ned Tijdschr Geneeskd, V147, P717
   Meek MF, 2007, BIO-MED MATER ENG, V17, P329
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Meek MF, 2006, J RECONSTR MICROSURG, V22, P149, DOI 10.1055/s-2006-939959
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   Pogrel MA, 2001, J ORAL MAXIL SURG, V59, P985, DOI 10.1053/joms.2001.25821
   Poveda Rafael, 2006, Med Oral Patol Oral Cir Bucal, V11, pE1
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
NR 17
TC 18
Z9 19
U1 0
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2009
VL 89A
IS 3
BP 734
EP 738
DI 10.1002/jbm.a.32024
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 443FJ
UT WOS:000265895300019
PM 18464254
DA 2018-10-19
ER

PT J
AU Qiu, YZ
   Zhang, N
   Kang, Q
   An, YH
   Wen, XJ
AF Qiu, Yongzhi
   Zhang, Ning
   Kang, Qian
   An, Yuehuei
   Wen, Xuejun
TI Chemically modified light-curable chitosans with enhanced potential for
   bone tissue repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE light curable; chitosan; osteoconductivity; bone tissue engineering
ID POLYMERIC SCAFFOLDS; CARTILAGE; CHITIN; DERIVATIVES; POLYSACCHARIDE;
   REGENERATION; BIOMATERIAL
AB Light curable polymers are showing great potential in overcoming some of the current obstacles in bone repair. With stereolithography, they can be fabricated into scaffolds with desired topography for repairing bone defects in irregular shapes. In this study, we developed a series of light curable chitosans, which have photocurability and good solubility in organic solvent. Through adjusting the feeding ratio of the raw components, the content of photocurable groups in the backbone of chitosan can be controlled. The light curable chitosans were characterized through FTIR-ATR and (1)H NMR, which also confirmed their controllable photocurability. NIH 3T3 fibroblasts were co-cultured with the photocured samples for 7 days and the results indicated that these photocured chitosans are cyto-compatible. Scaffolds with interconnected pores, fabricated using salt leaching and photocuring and seeded with fetal bovine osteoblasts, were implanted subcutaneously in the backs of athymic rat. Histological study on the implants at 6 weeks showed that the photocured chitosans have good osteoconductivity. The results indicated the light curable chitosans have good biocompatibility and osteoconductivity. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 772-779, 2009
C1 [Qiu, Yongzhi; Zhang, Ning; Wen, Xuejun] Clemson Univ, Dept Bioengn, Clemson MUSC Bioengn Program, Charleston, SC 29425 USA.
   [Zhang, Ning; Wen, Xuejun] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA.
   [Kang, Qian; An, Yuehuei; Wen, Xuejun] Med Univ S Carolina, Dept Orthoped Surg, Charleston, SC 29425 USA.
RP Wen, XJ (reprint author), Clemson Univ, Dept Bioengn, Clemson MUSC Bioengn Program, Charleston, SC 29425 USA.
EM xjwen@clemson.edu
FU AO Foundation; National Institutes of Health; National Center for
   Research Resources [C06 RR018823]
FX Contract grant sponsor: AO Foundation Contract grant sponsors: National
   Institutes of Health, National Center for Research Resources; contract
   grant number: C06 RR018823
CR Badawy MEI, 2004, BIOMACROMOLECULES, V5, P589, DOI 10.1021/bm0344295
   BORAH G, 1992, ADVANCES IN CHITIN AND CHITOSAN, P47
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Cowan CM, 2005, CURR TOP DEV BIOL, V66, P239, DOI 10.1016/S0070-2153(05)66008-5
   Decker C, 1996, PROG POLYM SCI, V21, P593, DOI 10.1016/0079-6700(95)00027-5
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   Holland TA, 2006, ADV BIOCHEM ENG BIOT, V102, P161, DOI 10.1007/b137205
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Mattioli-Belmonte M, 1999, CARBOHYD POLYM, V40, P23, DOI 10.1016/S0144-8617(99)00028-4
   MATTIOLIBELMONTE M, 1995, J BIOACT COMPAT POL, V10, P249, DOI 10.1177/088391159501000304
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   MUZZARELLI R, 1992, J BIOACT COMPAT POL, V7, P130, DOI 10.1177/088391159200700202
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4745, DOI 10.1021/ma00017a003
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rodrigues MR, 2005, J CARBOHYD CHEM, V24, P41, DOI 10.1081/CAR-200049412
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Shi DH, 2005, CHINESE MED J-PEKING, V118, P1436
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thein-Han WW, 2007, J BIOMED MATER RES B, V80B, P92, DOI 10.1002/jbm.b.30573
   Tsai BH, 2006, J APPL POLYM SCI, V100, P1794, DOI 10.1002/app.23074
   Wang AJ, 2006, J BIOMED MATER RES A, V79A, P36, DOI 10.1002/jbm.a.30683
   Wu YS, 2004, J POLYM SCI POL PHYS, V42, P4107, DOI 10.1002/polb.20263
   Yan JH, 2006, ARTIF CELL BLOOD SUB, V34, P27, DOI [10.1080/10731190500430024, 10.1080/107311090500430024]
   Yoksan R, 2003, BIOPOLYMERS, V69, P386, DOI 10.1002/bip.10400
   Yoksan R, 2001, BIOMACROMOLECULES, V2, P1038, DOI 10.1021/bm0155569
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
NR 37
TC 12
Z9 14
U1 1
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2009
VL 89A
IS 3
BP 772
EP 779
DI 10.1002/jbm.a.32017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 443FJ
UT WOS:000265895300023
PM 18465814
DA 2018-10-19
ER

PT J
AU Yim, EKF
   Sefton, MV
AF Yim, Evelyn K. F.
   Sefton, Michael V.
TI Amidine surface modification of poly(acrylonitrile-co-vinyl chloride)
   reduces platelet adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE amidine; platelet adhesion; complement; surface modification
ID COMPLEMENT COMPONENT C1Q; PROCOAGULANT ACTIVITY; ARTIFICIAL SURFACES;
   ARACHIDONIC-ACID; 1ST COMPONENT; WHOLE-BLOOD; P-SELECTIN; ACTIVATION;
   INHIBITION; PROTEINS
AB The surface nitrile groups of solvent-cast polyacrylonitrile-co-vinyl chloride (PAN-VC) films were converted into amidine groups through a two-step process analogous to Pinner's method of 1877. The amidine groups were hypothesized to reduce platelet adhesion and activation through the inhibition of the classical complement pathway, as was noted for benzamidine and pentamidine in earlier studies. A slightly higher nitrogen content was detected on the amidine-surface modified (ASM) samples by X-ray photoelectron spectroscopy relative to the solvent-treated and unmodified controls. Reaction with pentafluoroaldehyde resulted in increased fluorine and decreased nitrogen contents (relative), consistent with the formation of a Schiff base with the primary nitrogen of the amidine on ASM PAN-VC surface. The corresponding yield was 17.2% based on nitrile groups and 9.6% based on all repeating units of the base polymer. Despite this low degree of amidine modification, platelet adhesion was similar to 40% lower on the amidine-modified film compared to the solvent-treated and unmodified controls. The scanning electron micrographs also showed less activation in the adherent platelets. A small reduction in C1s binding was also noted on the amidine-modified surface. Taken together, these results support the notion that amidine modification may be a useful approach to improve the nonthrombogenicity of a biomaterial. However, much effort is required to improve the degree of surface modification and to provide unequivocal evidence linking amidines to the improved thrombogenicity. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 780-790, 2009
C1 [Sefton, Michael V.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
EM michael.sefton@utoronto.ca
OI Yim, Evelyn/0000-0001-9812-1801
FU US National Institutes of Health [HL24020]; Ontario Graduate Scholarship
   in Science and Technology (OGSST); Ontario Ministry of Training,
   Colleges; Universities and NSERC Postgraduate Scholarships (PGS);
   Natural Sciences and Engineering Research Council (NSERC) of Canada
FX Contract grant sponsor: US National Institutes of Health; contract grant
   number: HL24020. E.K.F. Yim was a recipient of the Ontario Graduate
   Scholarship in Science and Technology (OGSST) awarded by the Ontario
   Ministry of Training, Colleges and Universities and NSERC Postgraduate
   Scholarships (PGS) awarded by Natural Sciences and Engineering Research
   Council (NSERC) of Canada.
CR AEBISCHER P, 1991, BIOMATERIALS, V12, P50, DOI 10.1016/0142-9612(91)90132-T
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   ANDREWS JM, 1978, J MED CHEM, V21, P1202, DOI 10.1021/jm00210a006
   ARLAUD GJ, 1989, BEHRING I MITT, V84, P56
   AU AT, 1999, THESIS U TORONTO TOR
   BEAMSON G, 1992, SCI ESCA DATABASE
   BING DH, 1970, J IMMUNOL, V105, P1289
   COOPER FC, 1953, J CHEM SOC, P255, DOI 10.1039/jr9530000255
   COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5
   ENDRESEN GKM, 1985, THROMB HAEMOSTASIS, V53, P360
   EVERHART DS, 1981, ANAL CHEM, V53, P665, DOI 10.1021/ac00227a022
   GAUTIER JA, 1975, CHEM AMIDINES IMIDAT, P283
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Gemmell CH, 2001, J BIOMAT SCI-POLYM E, V12, P933, DOI 10.1163/156856201753113114
   Gemmell CH, 1998, J LAB CLIN MED, V131, P84, DOI 10.1016/S0022-2143(98)90081-6
   GEMMELL CH, 2004, BIOMATERIALS SCI, P456
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gouzy MF, 2004, BIOMATERIALS, V25, P3493, DOI 10.1016/j.biomaterials.2003.10.091
   GROUT R, 1991, BIOL REACTIONS PHARM, P255
   HAFELINGER G, 1975, CHEM AMIDINES IMIDAT, P1
   HANSCH GM, 1985, J IMMUNOL, V135, P1320
   HAUPTMANN J, 1977, BIOCHEM PHARMACOL, V26, P325, DOI 10.1016/0006-2952(77)90185-X
   Hughes M, 2000, BLOOD, V96, P188
   IP WF, 1991, J BIOMED MATER RES, V25, P875, DOI 10.1002/jbm.820250707
   Murakami Y, 2005, J BIOMAT SCI-POLYM E, V16, P685, DOI 10.1163/1568562053992469
   ODA M, 1990, JPN J PHARMACOL, V52, P23, DOI 10.1254/jjp.52.23
   PEERSCHKE EIB, 1994, SEMIN HEMATOL, V31, P320
   Peerschke EIB, 1998, IMMUNOBIOLOGY, V199, P239, DOI 10.1016/S0171-2985(98)80030-2
   PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579
   Pinner A., 1892, IMIDOATHER IHRE DERI
   POLLEY MJ, 1981, J EXP MED, V153, P257, DOI 10.1084/jem.153.2.257
   REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019
   RONIZO AR, 1941, ORGANIC SYNTHESIS CO, P5
   Salchert K, 2005, ACTA BIOMATER, V1, P441, DOI 10.1016/j.actbio.2005.04.001
   SCHMAIER AH, 1985, J CLIN INVEST, V75, P242, DOI 10.1172/JCI111680
   SIMS PJ, 1986, BLOOD, V68, P556
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   SIMS PJ, 1988, J BIOL CHEM, V263, P18205
   SWARTZ WE, 1974, J ELECTRON SPECTROSC, V4, P351, DOI 10.1016/0368-2048(74)80066-6
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Wallace EM, 1997, MOL MED, V3, P385, DOI 10.1007/BF03401685
   WAUTIER JL, 1973, HAEMOSTASIS, V2, P281
   WAUTIER JL, 1981, THROMB HAEMOSTASIS, V45, P247
   WIEDMER T, 1986, BLOOD, V68, P875
NR 44
TC 6
Z9 6
U1 2
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2009
VL 89A
IS 3
BP 780
EP 790
DI 10.1002/jbm.a.32022
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 443FJ
UT WOS:000265895300024
PM 18465816
DA 2018-10-19
ER

PT J
AU Zhu, CH
   Fan, DD
   Duan, ZZ
   Xue, WJ
   Shang, LA
   Chen, FL
   Luo, YE
AF Zhu, Chenhui
   Fan, Daidi
   Duan, Zhiguang
   Xue, Wenjiao
   Shang, Longan
   Chen, Fulin
   Luo, Yane
TI Initial investigation of novel human-like collagen/chitosan scaffold for
   vascular tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE human-like collagen; chitosan; scaffold; tissue engineering;
   biocompatibility
ID HUMAN-LIKE COLLAGEN; RECOMBINANT ESCHERICHIA-COLI; SMOOTH-MUSCLE-CELLS;
   BOVINE PERICARDIUM; EXTRACELLULAR-MATRIX; CROSS-LINKING; GROWTH-FACTOR;
   AORTIC-WALL; HYDROXYAPATITE; ANGIOGENESIS
AB With the increasing occurrence of vascular diseases and poor long-term patency rates of current small diameter vascular grafts, it becomes urgent to pursuit biomaterial as scaffold to mimic blood vessel morphologically and mechanically. In this study, novel human-like collagen (HLC, produced by recombinant E. coli)/chitosan tubular scaffolds were fabricated by cross-linking and freeze-drying process. The scaffolds were characterized by scanning electron microscope (SEM), X-ray photoelectron spectroscopy (XPS), and tensile test, respectively. Human venous fibroblasts were expanded and seeded onto the scaffolds in the density of 1 x 10(5) cells/cm(2). After a 15-day culture under static conditions, the cell-polymer constructs were observed using SEM, confocal laser scanning microscopy (CLSM), histological examination, and biochemical assays for cell proliferation and extracellular matrix production (collagen and glycosaminoglycans). Furthermore, the scaffolds were implanted into rabbits' livers to evaluate their biocompatibility. The results indicated that HLC/chitosan tubular scaffolds (1) exhibited interconnected porous structure; (2) achieved the desirable levels of pliability (elastic Lip to 30% strain) and stress of 300 +/- 1.6 kPa; (3) were capable of enhancing cell adhesion and proliferation and ECM secretion; (4) showed superior biocompatibility. This study suggested the feasibility of HLC/chitosan composite as a promising candidate scaffold for blood vessel tissue engineering. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 829-840, 2009
C1 [Zhu, Chenhui; Fan, Daidi; Shang, Longan] NW Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Xian 710069, Shaanxi, Peoples R China.
   [Zhu, Chenhui; Fan, Daidi; Xue, Wenjiao; Luo, Yane] NW Univ Xian, Dept Chem Engn, Xian 710069, Shaanxi, Peoples R China.
   [Duan, Zhiguang; Chen, Fulin] NW Univ Xian, Fac Life Sci, Xian 710069, Shaanxi, Peoples R China.
RP Fan, DD (reprint author), NW Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Taibai N Rd 229, Xian 710069, Shaanxi, Peoples R China.
EM fandaidi@nwu.edu.cn
RI Fan, daidi/J-1128-2017; Shang, Longan/C-5416-2008
OI Shang, Longan/0000-0002-5350-1189; xue, wenjiao/0000-0002-8867-1575
FU National High Technology Research and Development Program of China
   [2006AA02Z246]
FX Contract grant sponsor: National High Technology Research and
   Development Program of China; contract grant number: 2006AA02Z246
CR Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Butcher JT, 2006, BIOMATERIALS, V27, P5252, DOI 10.1016/j.biomaterials.2006.05.040
   DAHM M, 1990, J THORAC CARDIOV SUR, V99, P1082
   Elcin YM, 1996, ARTIF CELL BLOOD SUB, V24, P257, DOI 10.3109/10731199609117438
   [范代娣 Fan Daidi], 2002, [化工学报, Journal of Chemical Industry and Engineering (China)], V53, P752
   Fan DD, 2005, BIOTECHNOL LETT, V27, P865, DOI 10.1007/s10529-005-6720-8
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   HARKNESS RD, 1961, BIOL REV, V36, P399, DOI 10.1111/j.1469-185X.1961.tb01596.x
   Hua XF, 2006, CHINESE J CHEM ENG, V14, P242, DOI 10.1016/S1004-9541(06)60065-7
   Human P, 2002, BIOMATERIALS, V23, P2099, DOI 10.1016/S0142-9612(01)00302-7
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   LEE JM, 1991, ARTIF ORGANS, V15, P303
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MARANTO AR, 1988, CIRC RES, V63, P844, DOI 10.1161/01.RES.63.4.844
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P597
   SANTOS PM, 1991, OTOLARYNG HEAD NECK, V105, P12, DOI 10.1177/019459989110500103
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Tu R, 1991, ASAIO Trans, V37, pM470
   Usami Y, 1998, J BIOMED MATER RES, V42, P517
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Wang Y, 2006, MAT SCI ENG C-BIO S, V26, P635, DOI 10.1016/j.msec.2005.07.019
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 32
TC 80
Z9 88
U1 2
U2 38
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2009
VL 89A
IS 3
BP 829
EP 840
DI 10.1002/jbm.a.32256
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 443FJ
UT WOS:000265895300028
PM 19165794
DA 2018-10-19
ER

PT J
AU Klein, KM
   Ostrowicki, G
   Gewirtz, AT
   Sitaraman, SK
AF Klein, Kevin M.
   Ostrowicki, Gregory
   Gewirtz, Andrew T.
   Sitaraman, Suresh K.
TI Fabrication and Bioconjugation of Micro- and Nanoscale Structures
   Intended for Cancer-Specific Antigen Detection
SO JOURNAL OF ELECTRONIC PACKAGING
LA English
DT Article
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 05-10, 2006
CL Chicago, IL
SP ASME
DE biochemistry; bioMEMS; cancer; chromium; clean rooms; electron beam
   lithography; gold; metallic thin films; microfabrication;
   nanobiotechnology; nanofabrication; nanolithography; photolithography;
   proteins; silicon; sputter deposition; tumours
AB Cleanroom processes can be used for fabricating microscale and nanoscale structures, and such structures, when bioconjugated, can be used for detecting low levels of cancer-specific circulating antigens. The concentration of such circulating antigens in human serum continues to increase with cancer progression, and therefore, detection of cancer at very early stages of the disease can be facilitated by monitoring small increases in circulating antigen concentration. Therefore, fabrication and bioconjugation are the first steps in the development of bio-assays for cancer detection. In this work, microscale and nanoscale Au/Cr thin film structures have been fabricated on Si substrate using dc sputtering and electron-beam (e-beam) evaporation in combination with photo and e-beam lithography. Using the fabricated device material stack (Au/Cr/Si), we have assessed the binding affinity of Au, Cr, and Si with Protein G, and antibodies for prostate specific antigen and cancer antigen 125, an ovarian cancer-associated antigen. Based on our experiments, we see that the thin gold layer of the Au/Cr/Si samples provides increased biomaterial binding affinity, and the chromium layer has a similar, if not less, binding affinity compared with the silicon chip alone. Thus, this work demonstrates that the fabricated material stack provides an appropriate platform for antigen detection.
C1 [Klein, Kevin M.; Ostrowicki, Gregory; Sitaraman, Suresh K.] Georgia Inst Technol, George W Woodruff Packaging Sch Mech Engn, Comp Aided Simulat Reliabil Lab, Atlanta, GA 30332 USA.
   [Gewirtz, Andrew T.] Emory Univ, Sch Med, Atlanta, GA 30322 USA.
RP Klein, KM (reprint author), Georgia Inst Technol, George W Woodruff Packaging Sch Mech Engn, Comp Aided Simulat Reliabil Lab, Atlanta, GA 30332 USA.
EM suresh.sitaraman@me.gatech.edu
CR Bhiladvala RB, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036307
   CHEN GY, 1995, J APPL PHYS, V77, P3618, DOI 10.1063/1.359562
   Davis ZJ, 2000, J VAC SCI TECHNOL B, V18, P612, DOI 10.1116/1.591247
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316
   Hansen KM, 2001, ANAL CHEM, V73, P1567, DOI 10.1021/ac0012748
   Ilic B, 2004, J APPL PHYS, V95, P3694, DOI 10.1063/1.1650542
   Li SQ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2174092
   MADOU MJ, 2002, FUNDAMENTALS MICROFA, P543
   Raiteri R, 1999, SENSOR ACTUAT B-CHEM, V61, P213
   Vancura C, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2108130
   Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856
   Wu GH, 2001, P NATL ACAD SCI USA, V98, P1560, DOI 10.1073/pnas.031362498
NR 13
TC 0
Z9 0
U1 0
U2 10
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1043-7398
J9 J ELECTRON PACKAGING
JI J. Electron. Packag.
PD JUN
PY 2009
VL 131
IS 2
AR 021014
DI 10.1115/1.3103937
PG 6
WC Engineering, Electrical & Electronic; Engineering, Mechanical
SC Engineering
GA 439HT
UT WOS:000265618900014
DA 2018-10-19
ER

PT J
AU Pan, YS
   Xiong, DS
AF Pan, Yusong
   Xiong, Dangsheng
TI Study on compressive mechanical properties of nanohydroxyapatite
   reinforced poly(vinyl alcohol) gel composites as biomaterial
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ARTIFICIAL ARTICULAR-CARTILAGE; PVA-HYDROGEL
AB Nanohydroxyapatite reinforced poly(vinyl alcohol) (nano-HA/PVA) gel composites has been proposed as a promising biomaterial to replace diseased or damaged articular cartilage. In this paper, nano-HA/PVA gel composites were prepared by in situ synthesis nano-HA particles in PVA solution and accompanied with freeze/thaw method. The influence of nano-HA content, PVA concentration and freeze/thaw cycle times on the compressive mechanical behavior of nano-HA/PVA gel composites were evaluated using mechanical test equipment. The results showed that the compressive mechanical behavior of nano-HA/PVA gel composites was similar to that of natural articular cartilage, which held special viscoelastic characteristics. Both the compressive strength and modulus of the composites improved correspondingly with the rise of freeze/thaw cycle times and PVA concentration. The compressive strength and modulus of nano-HA/PVA gel composites firstly increased and then presented decreasing trend with the rise of nano-HA content. Furthermore, the compressive modulus of the composites improved exponentially with the rise of compressive strain ratio.
C1 [Pan, Yusong] Anhui Univ Sci & Technol, Dept Mat Sci & Engn, Huainan 232001, Peoples R China.
   [Xiong, Dangsheng] Nanjing Univ Sci & Technol, Dept Mat Sci & Engn, Nanjing 210094, Peoples R China.
RP Pan, YS (reprint author), Anhui Univ Sci & Technol, Dept Mat Sci & Engn, Huainan 232001, Peoples R China.
EM yusongpan@163.com
RI xiong, dangsheng/B-1823-2015
OI xiong, dangsheng/0000-0003-3210-3728
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   Huang H. Y., 1997, CLIN NEUROL NEUROSUR, V99, P20
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   Muta H, 2001, J MOL STRUC-THEOCHEM, V536, P219, DOI 10.1016/S0166-1280(00)00632-1
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   PAN YS, 2007, MAT SCI, V42, P5129
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Rosa R., 2004, MACROMOLECULES, V37, P1921
   Rosa R., 2004, MACROMOLECULES, V37, P9510
   Srinath G, 2005, J MATER SCI, V40, P2897, DOI 10.1007/s10853-005-2439-0
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Xu FL, 2004, J MATER SCI, V39, P5669, DOI 10.1023/B:JMSC.0000040074.64787.b3
   Zheng YD, 2005, CHEM J CHINESE U, V26, P1735
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 18
TC 35
Z9 39
U1 2
U2 28
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2009
VL 20
IS 6
BP 1291
EP 1297
DI 10.1007/s10856-008-3679-8
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 442ZY
UT WOS:000265881200011
PM 19132507
DA 2018-10-19
ER

PT J
AU Coleman, NJ
AF Coleman, Nichola J.
TI Aspects of the in vitro bioactivity and antimicrobial properties of Ag+-
   and Zn2+-exchanged 11 A... tobermorites
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NEWSPRINT RECYCLING RESIDUE; HUMAN OSTEOBLASTS; BONE-FORMATION;
   ION-EXCHANGE; ZINC; HYDROXYAPATITE; KINETICS; SILVER; PHOSPHATE; GLASSES
AB 11 A... tobermorite, Ca5Si6O16(OH)(2) center dot A 4H(2)O, is a layer lattice ion exchange mineral whose potential as a carrier for Ag+ and Zn2+ ions in antimicrobial, bioactive formulations has not yet been explored. In view of this, the in vitro bioactivity of Ag+- and Zn2+-exchanged 11 A... tobermorites and their bactericidal action against S. aureus and P. aeruginosa are reported. The in vitro bioactivity of the synthetic unsubstituted tobermorite phase was confirmed by the formation of bone-like hydroxycarbonate apatite (HCA) on its surface within 48 h of contact with simulated body fluid. The substitution of labile Ag+ ions into the tobermorite lattice delayed the onset of HCA-formation to 72 h; whereas, the Zn2+-substituted phase failed to elicit an HCA-layer within 14 days. Both Ag+- and Zn2+-exchanged tobermorite phases were found to exhibit marked antimicrobial action against S. aureus and P. aeruginosa, two common pathogens in biomaterial-centred infections.
C1 Univ Greenwich, Sch Sci, Chatham ME4 4TB, Kent, England.
RP Coleman, NJ (reprint author), Univ Greenwich, Sch Sci, Chatham ME4 4TB, Kent, England.
EM nj_coleman@yahoo.co.uk
RI Coleman, Nichola/D-1847-2009
OI Coleman, Nichola/0000-0002-3484-977X
FU Royal Society of Chemistry; Royal Society
FX The author acknowledges, with gratitude, financial support for this
   research from the Royal Society of Chemistry and from The Royal Society.
CR Ahmed I, 2006, J BIOMED MATER RES A, V79A, P618, DOI 10.1002/jbm.a.30808
   Aina V, 2007, CHEM-BIOL INTERACT, V167, P207, DOI 10.1016/j.cbi.2007.03.002
   Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   BELLANTONE M, 2001, KEY ENG MATER, V195, P597
   Bonferoni MC, 2007, APPL CLAY SCI, V36, P95, DOI 10.1016/j.clay.2006.04.014
   Bright KR, 2002, J HOSP INFECT, V52, P307, DOI 10.1053/jhin.2002.1317
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Coleman NJ, 2006, WASTE MANAGE, V26, P260, DOI 10.1016/j.wasman.2005.01.019
   Coleman NJ, 2005, MATER RES BULL, V40, P2000, DOI 10.1016/j.materresbull.2005.05.006
   Coleman NJ, 2003, MATER RES BULL, V38, P485, DOI 10.1016/S0025-5408(02)01056-5
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Halle T, 2008, CORROS SCI, V50, P713, DOI 10.1016/j.corsci.2007.08.012
   HAMID SA, 1981, Z KRISTALLOGR, V154, P189, DOI 10.1524/zkri.1981.154.3-4.189
   Huang HT, 2008, COMPOS SCI TECHNOL, V68, P2948, DOI 10.1016/j.compscitech.2007.10.003
   Ito A, 2005, CURR APPL PHYS, V5, P402, DOI 10.1016/j.cap.2004.10.006
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   KALOUSEK GL, 1957, J AM CERAM SOC, V40, P74, DOI 10.1111/j.1151-2916.1957.tb12579.x
   Kanzaki N, 2001, J PHYS CHEM B, V105, P1991, DOI 10.1021/jp003295b
   Kanzaki N, 2000, J PHYS CHEM B, V104, P4189, DOI 10.1021/jp9939726
   Kirkpatrick RJ, 1997, ADV CEM BASED MATER, V5, P93, DOI 10.1016/S1065-7355(97)00001-1
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2005, MAT SCI ENG C-BIO S, V25, P97, DOI 10.1016/j.msec.2005.01.002
   KOMARNENI S, 1983, SCIENCE, V221, P647, DOI 10.1126/science.221.4611.647
   KOMARNENI S, 1986, CEMENT CONCRETE RES, V16, P47, DOI 10.1016/0008-8846(86)90067-0
   Lansdown Alan B G, 2006, Curr Probl Dermatol, V33, P17
   Lin KL, 2007, ACTA BIOMATER, V3, P271, DOI 10.1016/j.actbio.2006.11.003
   Merlino S, 2001, EUR J MINERAL, V13, P577, DOI 10.1127/0935-1221/2001/0013-0577
   MIYAKE M, 1989, MATER RES BULL, V24, P311, DOI 10.1016/0025-5408(89)90217-1
   Mostafa NY, 2009, J ALLOY COMPD, V467, P332, DOI 10.1016/j.jallcom.2007.11.130
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Quintavalla S, 2002, MEAT SCI, V62, P373, DOI 10.1016/S0309-1740(02)00121-3
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Shaw S, 2000, CHEM GEOL, V167, P141, DOI 10.1016/S0009-2541(99)00206-5
   Top A, 2004, APPL CLAY SCI, V27, P13, DOI 10.1016/j.clay.2003.12.002
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
NR 37
TC 15
Z9 15
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2009
VL 20
IS 6
BP 1347
EP 1355
DI 10.1007/s10856-009-3698-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 442ZY
UT WOS:000265881200018
PM 19214715
DA 2018-10-19
ER

PT J
AU Gomes, PJ
   Silva, VMTM
   Quadros, PA
   Dias, MM
   Lopes, JCB
AF Gomes, Paulo J.
   Silva, Viviana M. T. M.
   Quadros, Paulo A.
   Dias, Madalena M.
   Lopes, Jose C. B.
TI A Highly Reproducible Continuous Process for Hydroxyapatite
   Nanoparticles Synthesis
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Hydroxyapatite; Nanoparticles; Micromixing; NETmix (R); NanoXIM
ID BIOMEDICAL APPLICATIONS; STOICHIOMETRIC HYDROXYAPATITE; IN-VIVO;
   DELIVERY; PRECIPITATION; TEMPERATURE
AB This work presents a continuous process for producing hydroxyapatite nanoparticles (NanoXIM) in a network reactor, NETmix (R), fed by a calcium solution, a phosphorus solution and an alkaline solution. Hydroxyapatite is considered a biomaterial, used as: food additives and nutritional supplements; bone graft for bone replacement, growth and repair; biocements and coating of metallic implant. Some of the most recent applications include their use in cosmetics, toothpaste and in esthetical treatments for diminishing wrinkles by stimulating conjunctive tissue formation. The proposed process enables the micromixing control, which is essential to form nanometric structures, but it is also a determining factor in the crystals purity, crystallinity and morphology. The reactants distribution scheme at the inlet of the reactor and along the reactor, performed continuously or varying in time, is also a crucial factor to programme the properties of reactant media along the reactor, such as the pH, the supersaturation degree, the Ca/P molar ratio, and the temperature. The calcium phosphate nanoparticles suspension that exits the reactor is submitted to further aging, separation, drying, sintering and milling processes.
C1 [Gomes, Paulo J.; Silva, Viviana M. T. M.; Quadros, Paulo A.; Lopes, Jose C. B.] Engn Fluidos SA, Fluidinova, P-4470605 Moreira Da Maia, Portugal.
   [Gomes, Paulo J.; Dias, Madalena M.; Lopes, Jose C. B.] Univ Porto, Fac Engn, Dept Chem Engn, Lab Separat & React Engn, P-4200465 Oporto, Portugal.
RP Lopes, JCB (reprint author), Engn Fluidos SA, Fluidinova, TecMaia Rua Engn Frederico Ulrich 2650, P-4470605 Moreira Da Maia, Portugal.
RI Lopes, Jose Carlos/B-6880-2013; Dias, Madalena/B-6377-2013
OI Lopes, Jose Carlos/0000-0001-6127-6340; Quadros,
   Paulo/0000-0002-7207-1110; Dias, Madalena/0000-0003-1208-1496
CR AHN ES, 2005, Patent No. 2005031704
   Balcik C, 2007, ACTA BIOMATER, V3, P985, DOI 10.1016/j.actbio.2007.04.004
   BISHOP A, 2005, P 8 POL ADV TECHN IN
   Chow LC, 2004, J RES NATL INST STAN, V109, P543, DOI 10.6028/jres.109.041
   Chow LC, 2001, J RES NATL INST STAN, V106, P1029, DOI 10.6028/jres.106.053
   Conn J. F., 1982, United States Patent, Patent No. [4,324,772, 4324772]
   Conz Marcio Baltazar, 2005, J. Appl. Oral Sci., V13, P136, DOI 10.1590/S1678-77572005000200008
   Gomez-Morales J, 2001, CRYST RES TECHNOL, V36, P1065, DOI 10.1002/1521-4079(200110)36:8/10<1065::AID-CRAT1065>3.0.CO;2-G
   Gomez-Morales J, 2001, CRYST RES TECHNOL, V36, P15, DOI 10.1002/1521-4079(200101)36:1<15::AID-CRAT15>3.3.CO;2-5
   Greish YE, 2003, J BIOMED MATER RES B, V67B, P632, DOI 10.1002/jbm.b.10056
   Kumar R, 2004, LANGMUIR, V20, P5196, DOI 10.1021/la049304f
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O, P110
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   LOPES JCB, 2005, Patent No. 2005077508
   LUO P, 1999, Patent No. 5858318
   Nair MB, 2008, ACTA BIOMATER, V4, P173, DOI 10.1016/j.actbio.2007.07.004
   Ozeki K, 2005, J MATER SCI, V40, P2837, DOI 10.1007/s10853-005-0420-6
   Palazzo B, 2007, ADV FUNCT MATER, V17, P2180, DOI 10.1002/adfm.200600361
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Paul W, 2002, J BIOMED MATER RES, V61, P660, DOI 10.1002/jbm.10213
   Paul W, 1999, J MATER SCI-MATER M, V10, P383, DOI 10.1023/A:1008918412198
   RAMAKINGAM M, 2005, Patent No. 2005226939
   REN J, 2005, Patent No. 1587195
   RUDIN VN, 2002, Patent No. 0202461
   Schindler OS, 2007, KNEE, V14, P458, DOI 10.1016/j.knee.2007.07.001
   SINHA M, 2002, 10 FOR C MOL NAN MAR
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wen CE, 2007, ACTA BIOMATER, V3, P403, DOI 10.1016/j.actbio.2006.10.004
   Yang D, 2005, CERAM INT, V31, P1021, DOI 10.1016/j.ceramint.2004.10.016
   YING JY, 2000, Patent No. 6013591
NR 31
TC 9
Z9 9
U1 0
U2 14
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN
PY 2009
VL 9
IS 6
BP 3387
EP 3395
DI 10.1166/jnn.2009.NS06
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 441TX
UT WOS:000265794500006
PM 19504858
DA 2018-10-19
ER

PT J
AU Shirosaki, Y
   Botelho, CM
   Lopes, MA
   Santos, JD
AF Shirosaki, Yuki
   Botelho, Claudia M.
   Lopes, Maria A.
   Santos, Jose D.
TI Synthesis and Characterization of Chitosan-Silicate Hydrogel as
   Resorbable Vehicle for Bonelike (R) Bone Graft
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Synthetic Bone Graft; Injectable System; Vehicle; Bonelike (R);
   Chitosan-Silicate Hybrid; Hydrogel
ID CELLS; COMPOSITE; GROWTH; DYNAMICS; DELIVERY; RELEASE; FILMS
AB The use of bone grafts is required to restore skeletal integrity and enhance bone healing of large defects in several areas of regenerative medicine, such as: orthopedic and maxillofacial procedures. Some of these bone grafts can be resorbed in a time controlled way, in order to allow the correct process of natural re-construction of the involved bone tissue to occur. The Bonelike (R) graft is a bone substitute that mimics the inorganic composition of bone; this biomaterial was developed and characterized over the last decade. In a granular form, Bonelike (R) has proved its highly bioactive behavior in medical applications, such as; maxillofacial and orthopedics surgery. The clinical applications in maxillary bone defects indicated a good bone bonding between new formed bone and the Bonelike (R) granules. The purpose of this study was to develop a new injectable system for the application of Bonelike (R) using a resorbable vehicle which may be used in minimal invasive surgery. A new hydrogel derived from chitosan and gamma-glycidoxypropyltrimethoxysilane (GPTMS) was synthesized and characterized. The mixture derived from chitosan and GPTMS existed in sol state at room temperature and formed a hydrogel at 37 degrees C. The degradability of the hydrogel could be controlled by the concentration of chitosan and GPTMS, and the presence the presence of Bonelike (R) did not affect its degradability. The pH changes caused by the degradation of this hydrogel were small, so it is not expected to cause any deleterious effect in vivo conditions.
C1 [Santos, Jose D.] Univ Porto, Fac Engn, Seccao Mat, DEMM, P-4200465 Oporto, Portugal.
   INEB, Lab Biomat, P-4150180 Oporto, Portugal.
RP Santos, JD (reprint author), Univ Porto, Fac Engn, Seccao Mat, DEMM, Rua Dr Roberto Frias, P-4200465 Oporto, Portugal.
RI Lopes, Maria A./P-4442-2014; SHIROSAKI, Yuki/B-2601-2011; Lopes,
   Cristina/A-4241-2010; Botelho, Claudia/K-7523-2012
OI Lopes, Maria A./0000-0003-4105-8148; Botelho,
   Claudia/0000-0001-8221-419X; Santos, Jose Domingos/0000-0002-6871-9850
FU FCT-Fundacao para a Ciencia c a Tecnologia [SFRH/BPD/20492/2004,
   SFRH/BPD/20987/2004]
FX The authors express their grateful thanks to the FCT-Fundacao para a
   Ciencia c a Tecnologia for their support in this project through a grant
   SFRH/BPD/20492/2004 and grant SFRH/BPD/20987/2004.
CR BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Chandy TSP, 1990, ARTIF CELLS ARTIF OR, V18, P1, DOI DOI 10.3109/10731199009117286
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   de Groot K, 1983, CERAMICS CALCIUM PHO, P100
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DOMARD A, 1983, INT J BIOL MACROMOL, V5, P49, DOI 10.1016/0141-8130(83)90078-8
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   FERRAZ MP, 2001, KEY ENG MATER, V192, P449
   Gutierres M, 2006, J ORTHOP RES, V24, P953, DOI 10.1002/jor.20117
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HUO Q, 2004, J MATER CHEM, V14, P1915
   Jha LJ, 1996, J BIOMED MATER RES, V31, P481, DOI 10.1002/(SICI)1097-4636(199608)31:4<481::AID-JBM7>3.0.CO;2-H
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   LOPEZ PL, 2001, EMBO REP, V1, P1
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Nayak S, 2003, LANGMUIR, V19, P7374, DOI 10.1021/la034390p
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   POHL ER, 1986, SURFACES INTERFACES
   Santos JD, 1996, J MATER SCI-MATER M, V7, P181, DOI 10.1007/BF00121258
   Santos JD, 1999, European. Patent, Patent No. [0068164, WO 0068164]
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   Strnad Z, 2000, INT J ORAL MAX IMPL, V15, P483
   Suzuki T, 1999, J BIOSCI BIOENG, V88, P194, DOI 10.1016/S1389-1723(99)80201-1
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   TRECANT M, 1996, J MATER SCI-MATER M, V7, P2227
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   Xiao CB, 2000, J APPL POLYM SCI, V76, P509, DOI 10.1002/(SICI)1097-4628(20000425)76:4<509::AID-APP8>3.0.CO;2-2
   Yamaguchi I, 2003, BIOMATERIALS, V24, P2031, DOI 10.1016/S0142-9612(02)00633-6
   Zhang XZ, 2002, BIOMATERIALS, V23, P1313, DOI 10.1016/S0142-9612(01)00249-6
NR 35
TC 13
Z9 13
U1 0
U2 12
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN
PY 2009
VL 9
IS 6
BP 3714
EP 3719
DI 10.1166/jnn.2009.NS56
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 441TX
UT WOS:000265794500056
PM 19504908
DA 2018-10-19
ER

PT J
AU Grellier, M
   Bareille, R
   Bourget, C
   Amedee, J
AF Grellier, Maritie
   Bareille, Reine
   Bourget, Chantal
   Amedee, Joelle
TI Responsiveness of human bone marrow stromal cells to shear stress
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE human bone marrow stromal cells; shear stress; osteoblasts; p38; ERK1/2;
   Connexin43
ID PULSATILE FLUID-FLOW; GAP-JUNCTION COMMUNICATION; MESENCHYMAL
   STEM-CELLS; ENDOTHELIAL-CELLS; MECHANICAL STRAIN; OSTEOBLASTIC CELLS;
   MAP KINASE; DIFFERENTIATION; OSTEOCYTES; PROLIFERATION
AB We examined the hypothesis that human mesenchymal stem cells detect physiological mechanical signals. Human bone marrow stromal cells (HBMSCs) were exposed to fluid shear stress of 12 dynes/cm(2) and analysed for their ability to express osteoblast-specific markers and associated signalling pathways. HBMSCs showed a significant increase in alkaline phosphatase (ALP) gene expression and a marked decrease in type I collagen, while no effect on Cbfa1/Runx2 was detected. This regulation is related to p38 and ERK1/2 activation, although the use of specific inhibitors to these two MAP kinases suggests that ALP mRNA induction is especially dependent on p38 activity, while type I collagen downregulation is ERK1/2-dependent. interestingly, the expression of connexin43, which is involved in cell-to-cell communication of osteoblastic cells through gap junction formation, and its distribution through the cells, were modified by fluid flow (FF). HBMSCs are sensitive to shear stress and it appears essential to take their responsiveness into consideration before associating these regenerative cells with a bioactive biomaterial in a new bone tissue-engineering strategy. Copyright (c) 2009 John Wiley & Sons, Ltd.
C1 [Grellier, Maritie] Univ Victor Segalen Bordeaux 2, INSERM, U577, UMR S577, F-33076 Bordeaux, France.
RP Grellier, M (reprint author), Univ Victor Segalen Bordeaux 2, INSERM, U577, UMR S577, 146 Rue Leo Saignat,Case 45, F-33076 Bordeaux, France.
EM maritie.grellier@inserm.fr
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013
FU INSERM; ANR PNANO 'Nanobonefiller'
FX This work was supported by grants from INSERM and ANR PNANO
   'Nanobonefiller'. The authors thank Richard Daculsi for his helpful
   input.
CR Alford AI, 2003, BONE, V33, P64, DOI 10.1016/S8756-3282(03)00167-4
   Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009
   Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018
   Burger EH, 1999, FASEB J, V13, pS101
   Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912
   Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200
   Daculsi R, 2008, J BIOMECH, V41, P2781, DOI 10.1016/j.jbiomech.2008.06.003
   Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581
   FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812
   Friedl G, 2007, OSTEOARTHR CARTILAGE, V15, P1293, DOI 10.1016/j.joca.2007.04.002
   Gramsch B, 2001, EXP CELL RES, V264, P397, DOI 10.1006/excr.2000.5145
   Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Hillsley MV, 1997, CALCIFIED TISSUE INT, V60, P48, DOI 10.1007/s002239900185
   Jackson RA, 2006, J CELL PHYSIOL, V209, P894, DOI 10.1002/jcp.20779
   Jagodzinski M, 2004, Eur Cell Mater, V7, P35
   Jiang GL, 2002, AM J PHYSIOL-ENDOC M, V283, pE383, DOI 10.1152/ajpendo.00547.2001
   Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1
   Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068
   Li YJ, 2004, J ORTHOP RES, V22, P1283, DOI 10.1016/j.orthes.2004.04.002
   McGarry JG, 2005, BIOCHEM BIOPH RES CO, V330, P341, DOI 10.1016/j.bbrc.2005.02.175
   Mehrotra M, 2006, BIOCHEM BIOPH RES CO, V341, P1225, DOI 10.1016/j.bbrc.2006.01.084
   Myers KA, 2007, BIOCHEM BIOPH RES CO, V364, P214, DOI 10.1016/j.bbrc.2007.09.109
   Nauman EA, 2001, J APPL PHYSIOL, V90, P1849
   PONIK S, 2002, MECH PROPERTIES EXTR
   Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005
   Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721
   Scaglione S, 2008, J BIOMED MATER RES A, V86A, P411, DOI 10.1002/jbm.a.31607
   Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6
   Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y
   Tanaka SM, 2005, CALCIFIED TISSUE INT, V76, P261, DOI 10.1007/s00223-004-0238-2
   Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005
   Thi MM, 2003, AM J PHYSIOL-CELL PH, V284, pC389, DOI 10.1152/ajpcell.00052.2002
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200
NR 37
TC 59
Z9 63
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2009
VL 3
IS 4
BP 302
EP 309
DI 10.1002/term.166
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 473RY
UT WOS:000268227800007
PM 19283726
DA 2018-10-19
ER

PT J
AU Mansur, HS
   Costa, ED
   Mansur, AAP
   Barbosa-Stancioli, EF
AF Mansur, Herman S.
   Costa, Ezequiel de S., Jr.
   Mansur, Alexandra A. P.
   Barbosa-Stancioli, Edel Figueiredo
TI Cytocompatibility evaluation in cell-culture systems of chemically
   crosslinked chitosan/PVA hydrogels
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Cytocompatibility; Cell culture; Biomaterial; Hydrogel; Poly(vinyl
   alcohol); Chemical crosslinking
ID ALUMINA SCAFFOLDS; FTIR SPECTROSCOPY; ALCOHOL; GAMMA; GLUTARALDEHYDE;
   BIOMATERIALS; MACROPHAGES; LINKING; CHITIN
AB In the present study we report the preparation, characterization and cytocompatibility of novel polymeric systems based on blends of chitosan and poly(vinyl alcohol) (PVA) and chemically crosslinked by glutaraldehyde for biomedical applications. The structure of the hydrogels was characterized through Fourier Transform Infrared spectroscopy (FTIR) and their swelling behavior was investigated as preliminary in vitro test. Bioactivity, cytotoxicity and cell viability were assessed via MTT assay with 2 cell cultures and cell spreading-adhesion analysis. Moreover, the cell viability and potential biocompatibility were assessed by the secretion of nitric oxide by activated macrophages with gamma interferon (IFN-gamma) cytokine and lipopolysaccharide (LPS). It was found that by increasing the chitosan to PVA ratio the swelling behavior was significantly altered. In addition, all tested hydrogels have clearly presented adequate cell viability, non-toxicity and suitable properties which can be tailored for prospective use in tissue engineering. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Mansur, Herman S.; Costa, Ezequiel de S., Jr.; Mansur, Alexandra A. P.] Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-30160030 Belo Horizonte, MG, Brazil.
   [Barbosa-Stancioli, Edel Figueiredo] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, BR-30160030 Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Rua Espirito Santo 35-206, BR-30160030 Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br
OI Mansur, Herman/0000-0002-3032-495X; Mansur,
   Alexandra/0000-0003-1526-2508
FU FAPEMIG-PPM/CAPES
FX The authors acknowledge FAPEMIG-PPM/CAPES for financial support on this
   work. Authors also thank Mr. Mateus Laguardia and DDS Sandhra Carvalho
   for conducting MTT laboratory protocols.
CR Berner MD, 2005, IMMUNOL LETT, V98, P115, DOI 10.1016/j.imlet.2004.10.020
   Bose S, 2002, J MATER SCI-MATER M, V13, P23, DOI 10.1023/A:1013622216071
   Bruch-Gerharz D, 1998, ARCH DERMATOL RES, V290, P643, DOI 10.1007/s004030050367
   Costa ED, 2009, J MATER SCI-MATER M, V20, P553, DOI 10.1007/s10856-008-3627-7
   Costa HS, 2008, J MATER SCI, V43, P510, DOI 10.1007/s10853-007-1849-6
   Costa HS, 2008, J MATER SCI, V43, P494, DOI 10.1007/s10853-007-1875-4
   Don TM, 2006, CARBOHYD POLYM, V63, P331, DOI 10.1016/j.carbpol.2005.08.023
   DUNN GA, 1995, J CELL SCI, V108, P1239
   Hannah S, 2005, BIOMATERIALS, V26, P5492, DOI DOI 10.1016/J.BIOMATERIALS.2005.01.043
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Liu YL, 2004, POLYMER, V45, P6831, DOI 10.1016/j.polymer.2004.08.006
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103
   Muzzarelli C, 2002, J INORG BIOCHEM, V92, P89, DOI 10.1016/S0162-0134(02)00486-5
   Shelma R., 2008, TRENDS BIOMATER ARTI, V22, P107
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Subramanian A, 2006, CARBOHYD POLYM, V66, P321, DOI 10.1016/j.carbpol.2006.03.022
   Wang DA, 2004, ADV FUNCT MATER, V14, P1152, DOI 10.1002/adfm.200305018
   Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461
   YAMAOKA T, 1995, J PHARM PHARMACOL, V47, P479, DOI 10.1111/j.2042-7158.1995.tb05835.x
   Yeo YJ, 2005, J BIOMED MATER RES B, V72B, P86, DOI 10.1002/jbm.b.30121
NR 25
TC 65
Z9 66
U1 2
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JUN 1
PY 2009
VL 29
IS 5
BP 1574
EP 1583
DI 10.1016/j.msec.2008.12.012
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 458LV
UT WOS:000267025900012
DA 2018-10-19
ER

PT J
AU Henkelman, S
   Rakhorst, G
   Blanton, J
   van Oeveren, W
AF Henkelman, Sandra
   Rakhorst, Gerhard
   Blanton, John
   van Oeveren, Willem
TI Standardization of incubation conditions for hemolysis testing of
   biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Hemolysis; Biomaterial; Biocompatibility; Cryopreservation; Test method
ID STIMULATION; HEMOGLOBIN; POLYMERS; SURFACES; PLASMA; IONS
AB Hemolysis testing is the most common method to determine the hemocompatibility properties of biomaterials. There is however no consensus on the procedures of hemolysis testing due to insufficient comparative studies on the quality of the red blood cells used and the experimental conditions of testing. In this study we determined the effects of a number of incubation variables on the sensitivity and reproducibility of the hemolysis test using positively as well as negatively responding biomaterials and compared these results to those obtained according to the American Society for Testing and Materials (ASTM) standard. The ASTM standard method recommends hemolysis testing with highly diluted rabbit blood that is static incubated for 3 h. in this study we found that 24 h incubation of a biomaterial sample at 37 degrees C in slightly diluted human blood or with washed red blood cells was the most sensitive hemolysis test. Moreover usage of cryopreserved human RBC in the hemolysis test seemed to be a good alternative for fresh RBC since cryopreserved and fresh human RBC gave similar results in the hemolysis test. Hemolysis testing by exposing diluted rabbit erythrocytes to biomaterials as according to the ASTM method or by exposing biomaterials extract in saline to washed human red blood cells gave a different outcome and appeared not to be representative for clinical applications. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Henkelman, Sandra; Rakhorst, Gerhard; van Oeveren, Willem] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
RP van Oeveren, W (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, POB 196, NL-9700 AD Groningen, Netherlands.
EM w.van.oeveren@med.rug.nl
FU Goodfellow for supplying characterized test samples, Supachill
   Technologies Inc, Australia
FX We gratefully acknowledge Goodfellow for supplying characterized test
   samples, Supachill Technologies Inc, Australia for generously providing
CR American Society for Testing of Materials, 2000, F75600 ASTM
   DILLINGHAM EO, 1975, J BIOMED MATER RES, V9, P569, DOI 10.1002/jbm.820090605
   FERNANDES A, 1988, FREE RADICAL RES COM, V4, P291, DOI 10.3109/10715768809066894
   GIDALEVITZ D, 1998, INT J LEGAL MED, V111, P22
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   HARBOE M, 1959, SCAND J CLIN LAB INV, V11, P66, DOI 10.3109/00365515909060410
   International Organization for Standardization (ISO), 2002, 10993 ISO
   Kempe DS, 2005, AM J PHYSIOL-CELL PH, V288, pC396, DOI 10.1152/ajpcell.00115.2004
   Malinauskas RA, 1997, ARTIF ORGANS, V21, P1255
   Niemoeller OM, 2006, TOXICOL APPL PHARM, V217, P168, DOI 10.1016/j.taap.2006.09.001
   SEVASTIANOV VI, 1983, ARTIF ORGANS, V7, P126, DOI 10.1111/j.1525-1594.1983.tb04171.x
   Streller U, 2003, J BIOMED MATER RES B, V66B, P379, DOI 10.1002/jbm.b.10016
   Valeri CR, 2004, TRANSFUSION, V44, P990, DOI 10.1111/j.1537-2995.2004.04001.x
NR 13
TC 40
Z9 42
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JUN 1
PY 2009
VL 29
IS 5
BP 1650
EP 1654
DI 10.1016/j.msec.2009.01.002
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 458LV
UT WOS:000267025900024
DA 2018-10-19
ER

PT J
AU Onoki, T
   Higashi, T
   Wang, XM
   Zhu, SL
   Sugiyama, N
   Hoshikawa, Y
   Akao, M
   Matsushita, N
   Nakahira, A
   Yasuda, E
   Yoshimura, M
   Inoue, A
AF Onoki, Takamasa
   Higashi, Taisuke
   Wang, Xinmin
   Zhu, Shengli
   Sugiyama, Naota
   Hoshikawa, Yasuto
   Akao, Masaru
   Matsushita, Nobuhiro
   Nakahira, Atsushi
   Yasuda, Eiichi
   Yoshimura, Masahiro
   Inoue, Akihisa
TI Interface Structure between Ti-Based Bulk Metallic Glasses and
   Hydroxyapatite Ceramics Jointed by Hydrothermal Techniques
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT IUMRS International Conference in Asia
CY DEC 10-12, 2008
CL Nagoya, JAPAN
SP IUMRS
DE biomaterials; hydrothermal; electrochemical; ceramics coatings
ID TITANIUM; BEHAVIOR
AB The authors successfully formed a bond between bioactive hydroxyapatite (HA) ceramics and titanium (Ti)-based bulk metallic glasses (Ti40Zr10Cu36Pd14: BMG) through a growing integrated layer (GIL) to develop a new type of biomaterial. The GILs were formed on the BMG surfaces by hydrothermal-electrochemical (HE) techniques. The BMG substrates were treated in a 5 mol/L NaOH solution at 90 degrees C for 600, 2400 and 7200 seconds while a constant electric current of 50 mA/mm(2) was maintained between the electrodes. Then the BMG disks with the GIL and a powder mixture of calcium phosphate di-hydrate (CaHPO4 center dot 2H(2)O) and calcium hydroxide (Ca(OH)(2)) were simultaneously treated with an autoclave for hydrothermal hot-pressing (HHP) (150 degrees C, 40 MPa, 7.2 ks). Direct bonding between the HA ceramics and the BMG disks could be achieved through the above processing method. Scanning electron microscopy observations was conducted around the interface between BMG and HA. The bonding model of the bonding BMG and HA was suggested. The bonding was achieved through the amorphous nano-meshed layer consumption during the HHP processing. Sufficient thickness of GIL derived from hydrothermal-electrochemical treatment for over 2.4 ks is needed for the bonding. [doi:10.2320/matertrans.ME200815]
C1 [Onoki, Takamasa; Higashi, Taisuke; Nakahira, Atsushi] Osaka Prefecture Univ, Grad Sch Engn, Dept Mat Sci, Sakai, Osaka 5998531, Japan.
   [Sugiyama, Naota; Hoshikawa, Yasuto; Akao, Masaru; Matsushita, Nobuhiro; Yasuda, Eiichi; Yoshimura, Masahiro] Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan.
   [Wang, Xinmin; Zhu, Shengli; Yoshimura, Masahiro; Inoue, Akihisa] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Onoki, T (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Mat Sci, Sakai, Osaka 5998531, Japan.
EM onoki@mtr.osakafu-u.ac.jp
RI Zhu, Shengli/D-5281-2009; Yoshimura, Masahiro/H-5938-2011; zhu,
   shengli/A-8818-2011; Inoue, Akihisa/E-5271-2015; Matsushita,
   Nobuhiro/F-9416-2014
OI Zhu, Shengli/0000-0002-0190-2626; Yoshimura,
   Masahiro/0000-0003-1810-0301; 
CR Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051
   Bavykin DV, 2006, ADV MATER, V18, P2807, DOI 10.1002/adma.200502696
   GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Li BY, 2000, INTERMETALLICS, V8, P643, DOI 10.1016/S0966-9795(99)00140-5
   Onoki T, 2005, SCRIPTA MATER, V52, P767, DOI 10.1016/j.scriptamat.2004.12.011
   Onoki T, 2008, MAT SCI ENG C-BIO S, V28, P207, DOI 10.1016/j.msec.2006.12.002
   Onoki T, 2008, J CERAM SOC JPN, V116, P115, DOI 10.2109/jcersj2.116.115
   Onoki T, 2006, SURF COAT TECH, V200, P6801, DOI 10.1016/j.surfcoat.2005.10.016
   Onoki T, 2009, MATER SCI ENG B-ADV, V161, P27, DOI 10.1016/j.mseb.2008.11.011
   Yoshimura M, 2008, MATER SCI ENG B-ADV, V148, P2, DOI 10.1016/j.mseb.2007.09.080
   Zhu SL, 2007, MAT SCI ENG A-STRUCT, V459, P233, DOI 10.1016/j.msea.2007.01.044
NR 13
TC 2
Z9 2
U1 1
U2 11
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUN
PY 2009
VL 50
IS 6
SI SI
BP 1308
EP 1312
DI 10.2320/matertrans.ME200815
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 478VE
UT WOS:000268615800018
OA Bronze
DA 2018-10-19
ER

PT J
AU da Silva, EE
   Della Colleta, HHM
   Ferlauto, AS
   Moreira, RL
   Resende, RR
   Oliveira, S
   Kitten, GT
   Lacerda, RG
   Ladeira, LO
AF da Silva, Edelma E.
   Della Colleta, Heloisa H. M.
   Ferlauto, Andre S.
   Moreira, Roberto L.
   Resende, Rodrigo R.
   Oliveira, Sergio
   Kitten, Gregory T.
   Lacerda, Rodrigo G.
   Ladeira, Luiz O.
TI Nanostructured 3-D Collagen/Nanotube Biocomposites for Future Bone
   Regeneration Scaffolds
SO NANO RESEARCH
LA English
DT Article
DE Biomaterials; carbon nanotubes; collagen; tissue engineering;
   biocompatibility
ID WALLED CARBON NANOTUBES; FLOW-INDEPENDENT VISCOELASTICITY;
   SURFACE-CHEMISTRY; DRUG-DELIVERY; COLLAGEN; COMPOSITES;
   FUNCTIONALIZATION; HYDROXYAPATITE; NANOTECHNOLOGY; BIOMATERIALS
AB The field of bionanotechnology has been rapidly growing during the last few years and we can now envision a controllable integration between biological and artificial matter, where new biomimetic structures with a wide range of chemical and physical properties will promote the development of a novel generation of medical devices. In this work we describe a collagen/carbon nanotube composite which has the potential to be used as a scaffold for tissue regeneration. Because this biocomposite incorporates the advantageous properties of both collagen and carbon nanotubes, it has most of the characteristics that an ideal biomaterial requires in order to be used as an osteoinductive agent. This biocomposite is bioresorbable and biodegradable and has the desired mechanical rigidity while maintaining a three-dimensional(3-D) nanostructured surface. Tuned stability and swelling were achieved under fluid environments by varying the amount of carbon nanotubes (CNTs) incorporated into the composite. These variations can dictate the degree of interaction between fibroblastic cells and the biomaterials. Proof-of-concept was shown by performing an in vitro induced mineralization of hydroxylapatite crystals under physiological conditions. Furthermore, the ability to attach biofunctional groups to the CNT walls can open a new road for tissue regeneration since the combination of CNTs with specific growth factors or cellular ligands can create an environment capable of signaling and influencing specific cell functions. Our observations suggest that collagen/carbon nanotube biocomposites will have important uses in a wide range of biotechnological areas.
C1 [da Silva, Edelma E.; Ferlauto, Andre S.; Moreira, Roberto L.; Resende, Rodrigo R.; Oliveira, Sergio; Lacerda, Rodrigo G.; Ladeira, Luiz O.] Univ Fed Minas Gerais, Dept Fis, Lab Nanomat, BR-30123970 Belo Horizonte, MG, Brazil.
   [Della Colleta, Heloisa H. M.; Kitten, Gregory T.] Univ Fed Minas Gerais, Dept Morfol, BR-30123970 Belo Horizonte, MG, Brazil.
RP Lacerda, RG (reprint author), Univ Fed Minas Gerais, Dept Fis, Lab Nanomat, Av Antonio Carlos 6627, BR-30123970 Belo Horizonte, MG, Brazil.
EM rlacerda@fisica.ufmg.br
RI Nbiofar, Inct/J-9539-2013; Lacerda, Rodrigo/N-2176-2014; FERLAUTO,
   ANDRE/C-1209-2013; Moreira, Roberto/B-8568-2013
OI FERLAUTO, ANDRE/0000-0003-3056-7289; Moreira,
   Roberto/0000-0001-6820-0269; Kitten, Gregory/0000-0002-4044-9932; Eleto
   da Silva, Edelma/0000-0002-1498-9134
FU Fapemig; Pronex; Instituto do Milenio/CNPq-MCT; Rede Nano; Instituto
   Nacional de Ciencia e Tecnologia de Nanomateriais de Carbono
FX This work was supported by Fapemig, Pronex, Instituto do
   Milenio/CNPq-MCT, Rede Nano and Instituto Nacional de Ciencia e
   Tecnologia de Nanomateriais de Carbono. R.G.L, A.S.F., R.L.M, S.O.,
   G.T.K., and L.O.L., R.R.R, are CNPq fellows. H.H.M.D.C. is a CAPES
   fellow.
CR Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340
   Bhattacharyya S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209187
   Bianco A, 2003, ADV MATER, V15, P1765, DOI 10.1002/adma.200301646
   Breuer O, 2004, POLYM COMPOSITE, V25, P630, DOI 10.1002/pc.20058
   Cao Y, 2007, J NANOSCI NANOTECHNO, V7, P447, DOI 10.1166/jnn.2007.137
   Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634
   Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038
   Crouzier T, 2008, LANGMUIR, V24, P13173, DOI 10.1021/la801999n
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Endo M, 2005, CHIM OGGI, V23, P16
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fyhrie DP, 2003, J BIOMECH ENG-T ASME, V125, P578, DOI 10.1115/1.1610019
   Georgakilas V, 2002, CHEM COMMUN, P3050, DOI 10.1039/b209843a
   Greco R. S., 2004, NANOSCALE TECHNOLOGY
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Huang CY, 2001, J BIOMECH ENG-T ASME, V123, P410, DOI 10.1115/1.1392316
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kolosnjaj J, 2007, ADV EXP MED BIOL, V620, P181
   Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   Pasquali M, 2004, NAT MATER, V3, P509, DOI 10.1038/nmat1188
   Pastorin G, 2006, CHEM COMMUN, P1182, DOI 10.1039/b516309a
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Raja PMV, 2007, TOXICOL LETT, V169, P51, DOI 10.1016/j.toxlet.2006.12.003
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Sato M, 2004, EXPERT REV MED DEVIC, V1, P105, DOI 10.1586/17434440.1.1.105
   Shim M, 2002, NANO LETT, V2, P285, DOI 10.1021/nl015692j
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   SYLVESTER MF, 1989, THROMB RES, V55, P135, DOI 10.1016/0049-3848(89)90463-5
   Tasis D, 2003, CHEM-EUR J, V9, P4001, DOI 10.1002/chem.200304800
   Taton TA, 2001, NATURE, V412, P491, DOI 10.1038/35087687
   Terrones M, 1997, NATURE, V388, P52, DOI 10.1038/40369
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Trigueiro JPC, 2007, J NANOSCI NANOTECHNO, V7, P3477, DOI 10.1166/jnn.2007.831
   Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670
   Veld PJ, 2008, BIOPHYS J, V95, P33, DOI 10.1529/biophysj.107.120659
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006/1211
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wahl DA, 2007, J MATER SCI-MATER M, V18, P201, DOI 10.1007/s10856-006-0682-9
   Yunoki S, 2007, J NANOSCI NANOTECHNO, V7, P818, DOI 10.1166/jnn.2007.504
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
NR 55
TC 28
Z9 27
U1 2
U2 29
PU TSINGHUA UNIV PRESS
PI BEIJING
PA TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA
SN 1998-0124
J9 NANO RES
JI Nano Res.
PD JUN
PY 2009
VL 2
IS 6
BP 462
EP 473
DI 10.1007/s12274-009-9042-7
PG 12
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 548DI
UT WOS:000273939400003
OA Bronze
DA 2018-10-19
ER

PT J
AU Ewald, A
   Ihde, S
AF Ewald, Andrea
   Ihde, Stefan
TI Salt impregnation of implant materials
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND
   ENDODONTOLOGY
LA English
DT Article
ID ANTIBIOTIC-PROPHYLAXIS; TITANIUM SURFACE; ANTIBACTERIAL; BIOMATERIAL;
   SILVER; BIOCOMPATIBILITY; CONTAMINATION; PREVENTION; INFECTION; DEVICES
AB Implant infection and peri-implantitis are recurrent and serious complications in implantology. Antibiotic treatment of infected implants in bone is complicated because of limited vascularization of the surrounding tissue on the one hand, and biofilm formation on the implant surface on the other. Therefore, contamination of the implant surface has to be prevented. For this purpose we developed a method of coating Ti6Al4V samples with NaCl in order to reduce the water activity on the sample surface. The resulting NaCl-coated surfaces showed good biocompatibility with osteoblastlike cells and resulted in a significant reduction of bacterial strains. The presented surface modification is hence a promising method to reduce bacterially induced implant failure. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 790-795)
C1 [Ewald, Andrea] Univ Wurzburg, Dept Funct Mat Med & Dent, Sch Dent, D-97070 Wurzburg, Germany.
   [Ihde, Stefan] Gommiswald Dent Clin, Gommiswald, Switzerland.
RP Ewald, A (reprint author), Univ Wurzburg, Dept Funct Mat Med & Dent, Sch Dent, Pleicherwall 2, D-97070 Wurzburg, Germany.
EM andrea.ewald@fmz.uni-wuerzburg.de
RI Ewald, Andrea/G-1457-2012
CR ANTOLIN AB, 2007, MED ORAL PATOL ORAL, V12, pE323
   Aumsuwan N, 2008, BIOMACROMOLECULES, V9, P1712, DOI 10.1021/bm800176t
   Bechert T, 1999, INFECTION, V27, pS24, DOI 10.1007/BF02561613
   Blom AW, 1998, J HOSP INFECT, V40, P79, DOI 10.1016/S0195-6701(98)90029-9
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   Decraene V, 2008, J GEN APPL MICROBIOL, V54, P195, DOI 10.2323/jgam.54.195
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gynther GW, 1998, ORAL SURG ORAL MED O, V85, P509, DOI 10.1016/S1079-2104(98)90281-5
   Imberty A, 2008, CHEM-EUR J, V14, P7490, DOI 10.1002/chem.200800700
   Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5
   Macia-Vicente JG, 2008, FEMS MICROBIOL ECOL, V64, P90, DOI 10.1111/j.1574-6941.2007.00443.x
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Parvizi J, 2004, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000150116.65231.45
   Projan SJ, 2007, CURR OPIN MICROBIOL, V10, P441, DOI 10.1016/j.mib.2007.08.007
   Rice LB, 2006, BIOCHEM PHARMACOL, V71, P991, DOI 10.1016/j.bcp.2005.09.018
   Russell A D, 1994, Prog Med Chem, V31, P351
   Schwartz AB, 2007, J DENT, V35, P881, DOI 10.1016/j.jdent.2007.08.003
   SILVER S, 2003, FEMS MICROBIOL REV
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705
   Tasman AJ, 2000, LARYNGO RHINO OTOL, V79, P30
   WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221
   Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.14219/jada.archive.2007.0262
NR 27
TC 3
Z9 3
U1 0
U2 5
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1079-2104
EI 1528-395X
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD JUN
PY 2009
VL 107
IS 6
BP 790
EP 795
DI 10.1016/j.tripleo.2008.12.028
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 448QY
UT WOS:000266278300009
PM 19272816
DA 2018-10-19
ER

PT J
AU Oliveira, LCC
   Jorge, JMN
   Yussuf, S
   Habr-Gama, A
   Kiss, D
   Cecconello, I
AF Oliveira, Lucia C. C.
   Neves Jorge, Jose Marcio
   Yussuf, Sonia
   Habr-Gama, Angelita
   Kiss, Desiderio
   Cecconello, Ivan
TI Anal Incontinence Improvement After Silicone Injection May Be Related to
   Restoration of Sphincter Asymmetry
SO SURGICAL INNOVATION
LA English
DT Article
DE silicone; fecal incontinence; asymmetry index; manometry
ID FECAL INCONTINENCE; BIOMATERIAL; DYSFUNCTION; MANAGEMENT
AB Background. This study aimed to evaluate manometric parameters that may explain improvement in anal incontinence using a silicone bulking agent. Methods. Incontinent patients having internal sphincter defects were prospectively selected and injected with a silicone bulking agent. Manometry and endoanal ultrasound were performed before and 3 months after injections. Twenty continent healthy volunteers were used only for manometric comparison. Results. Thirty-five patients (28 females; mean age 60.3 years) and 20 controls entered this study. Patients had lower resting and squeeze pressures compared with controls (P<.05). Length of the high-pressure zone increased from 1 to 1.7 cm postinjection (P=.002). Asymmetry index showed a significant change postinjection (P<.001). Conclusion. Despite considerable clinical improvement, no significant increase in manometric pressures was noted posttreatment. There was significant improvement in both high-pressure zone and asymmetry index, and these findings may explain the mechanism of action of the bulking agent injected.
C1 [Oliveira, Lucia C. C.; Cecconello, Ivan] Policlin Geral Rio de Janeiro, Dept Anorectal Physiol & Coloproctol, Rio De Janeiro, Brazil.
   [Neves Jorge, Jose Marcio; Yussuf, Sonia; Habr-Gama, Angelita; Kiss, Desiderio] Univ Sao Paulo, Dept Surg, Sao Paulo, Brazil.
RP Oliveira, LCC (reprint author), Rua Visc Piraja 414-812, BR-22410002 Rio De Janeiro, Brazil.
EM dralucia@uninet.com.br
RI Cecconello, Ivan/A-3918-2013
OI Cecconello, Ivan/0000-0002-3535-4170
CR BROWN NR, 2007, COCHRANE DB SYST REV
   Cheetham MJ, 2001, GASTROENTEROL CLIN N, V30, P115, DOI 10.1016/S0889-8553(05)70170-9
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   JORGE JMN, 1993, SOUTH MED J, V86, P924, DOI 10.1097/00007611-199308000-00016
   Jorge JMN, 2000, INT J COLORECTAL DIS, V15, P303, DOI 10.1007/s003840000249
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   LAW PJ, 1991, BRIT J SURG, V78, P312, DOI 10.1002/bjs.1800780315
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Mavrantonis C, 1998, J CLIN GASTROENTEROL, V27, P108, DOI 10.1097/00004836-199809000-00003
   OLIVEIRA L, 1999, FUNDAMENTALS ANORECT, P115
   Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   WILLIAMS N, 1995, DIS COLON RECTUM, V38, P1275, DOI 10.1007/BF02049152
NR 18
TC 7
Z9 8
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1553-3506
J9 SURG INNOV
JI Surg. Innov.
PD JUN
PY 2009
VL 16
IS 2
BP 155
EP 161
DI 10.1177/1553350609338374
PG 7
WC Surgery
SC Surgery
GA 479EQ
UT WOS:000268642900011
PM 19546122
DA 2018-10-19
ER

PT J
AU Kim, HH
   Kim, MR
   Kim, SJ
AF Kim, Hyun-Hee
   Kim, Myung-Rae
   Kim, Sun-Jong
TI Comparison of Gene-Expression of MC3T3-E1 Osteoblast Cell Cultured on
   Resorbable Blast Medium, Sandblasted with Hydroxyapatite Surface and
   Machined Surface
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Osteoblastic cell; machined surface; RBM; DNA microarray technique
ID TITANIUM SURFACES; REMOVAL TORQUE; IMPLANTS; ATTACHMENT; GROWTH
AB The purpose of this study was to clarify the behavior of the osteoblastic cell(MC3T3-E1 osteoblastic cell line) induces by RBM(resorbable blasting media)surface treated implantto isolate specific genes that promote the titanium-bone integration by using DNA microarray technique. The Ti disks used for the cell culture were fabricated from grade 4 commercially pure Ti. The disk samples were classified into 2 groups, MS Group: Machined surface, used as control. RBM Group: The experimental groups were composed of cells Cultured on RBM. MTT test assay(Sigma, USA) were used for examining the proliferation of cells. After 24 hours of adhesion, the cell density on anodized titanium surface appeared to be higher than machined titanium surface, but there was no significant difference in cell viability between the MS and RBM(P > 0.05). From the results of this Study, microarray assay revealed that osteoinductive molecules appeared more prominent oil the RBM surface, whereas the adhesion molecules on the biomaterial were higher on the machined surface than RBM Surface, which will affect the phenotype of the plated cells depending on the surface morphology.
C1 [Kim, Hyun-Hee; Kim, Myung-Rae; Kim, Sun-Jong] Ewha Womans Univ, Grad Sch Clin Dent, Dept Implant Dent, Seoul 158050, South Korea.
   [Kim, Sun-Jong] Korea Univ, Inst Clin Dent Res, Seoul 152703, South Korea.
RP Kim, SJ (reprint author), Ewha Womans Univ, Grad Sch Clin Dent, Dept Implant Dent, 911-1 Mok Dong, Seoul 158050, South Korea.
EM sjsj7777@hanmail.net
CR Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   CARLSSON L, 1986, ACTA ORTHOP SCAND, V57, P289
   Cho SA, 2003, BIOMATERIALS, V24, P3611, DOI 10.1016/S0142-9612(03)00218-7
   FEIGHAN JE, 1995, J BONE JOINT SURG AM, V77, P1380, DOI 10.2106/00004623-199509000-00015
   GOTFREDSEN K, 1995, J BIOMED MATER RES, V29, P1223, DOI 10.1002/jbm.820291009
   JANG YJ, 2009, TISSUE ENG REGEN MED, V6, P142
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Khang G, 2007, TISSUE ENG REGEN MED, V4, P441
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Niimi A, 1997, CLIN ORAL IMPLAN RES, V8, P286, DOI 10.1034/j.1600-0501.1997.080406.x
   Piattelli Maurizio, 2002, J Oral Implantol, V28, P2, DOI 10.1563/1548-1336(2002)028<0002:BRTMAR>2.3.CO;2
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V69B, P46, DOI 10.1002/jbm.b.20021
   YUN YP, 2009, TISSUE ENG REGEN MED, V6, P36
NR 18
TC 1
Z9 1
U1 0
U2 2
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JEONJU
PA CHONBUK NATIONAL UNIV, DEPT POLYMER-NANO SCIENCE & TECH, 664-14,
   DUCKJIN, JEONJU, 561-756, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD JUN
PY 2009
VL 6
IS 4-11
BP 533
EP 539
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 460YY
UT WOS:000267230500019
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Mechanical Tensile Stress and SIS Membrane Stimulate Differentiation of
   Rabbit Costal Chondrocytes into Fibrotic Cartilage
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Rabbit vertebral disc; anulus fibrosus; bioreactor; costal chondrocyte
ID SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS; INTERVERTEBRAL DISC;
   TISSUE; STRAIN; CHONDROGENESIS; REGENERATION; RAT
AB Intervertebral disc is comprised of two distinct region named anulus fibrosus and nucleus pulposus. Anulus fibrosus(AF) is composed of fibrous cartilage that bears a tension and give flexibility to the vertebrate. For regeneration of intervertebral disc tissue, it must include engineering of these two specialized tissues, but differentiation of in vitro cultured chondrocytes into fibrous cartilage like AF is not well established yet than hyaline cartilage. In this study, we established the differentiating condition into fibrous cartilage using dedifferentiated rabbit costal chondrocytes(CCs) oil biomaterials through mechanical and biochemical stimulation. To apply the mechanical stress, dedifferentiated CCs as a cell source were seeded on small intestine submucosa(SIS) membrane as biomaterial. To apply tensile stress into CCs, custom-made bioreactor was used. In mechanical tensile stress applied culture of 20% elongation and 5 Hz frequency, the proliferation rate of CCs on SIS membrane were increased 9.64% and 4.64% after 24 hr and 72 hr. After applying mechanical tensile stress, cell alignment was in parallel with the direction of tension. In reverse transcriptase polymerase chain reaction analysis, expression of type I collagen was up regulated by mechanical stimulation. Based on these results, the differentiation of CCs to fibrotic cartilage like anulus fibrosus can be achieved by applying mechanical stimulation oil SIS membrane.
FU Korean Ministry of Health, Welfare and Family Affairs
FX This work was supported by the Musculoskeletal Bioorgan Center Project
   of Korean Ministry of Health, Welfare and Family Affairs given to Dr.
   Youngsook Son.
CR ALCHOU SB, 2008, J BIOMED MAT A 0911
   Archer CW, 2006, BIORHEOLOGY, V43, P355
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Cao L, 2007, J ANAT, V211, P444, DOI 10.1111/j.1469-7580.2007.00784.x
   Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Fox DB, 2004, TISSUE ENG, V10, P129, DOI 10.1089/107632704322791772
   Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008
   Gupta V, 2008, ACTA BIOMATER, V4, P88, DOI 10.1016/j.actbio.2007.08.009
   HAUNG CY, 2004, STEM CELLS, V22, P323
   HUANG L, 2008, MOL BIOL REP    1011
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415
   Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb
   Lee J, 2007, BIOTECHNOL APPL BIOC, V48, P149, DOI 10.1042/BA20060233
   LIUA B, 2008, BIOPHYS J, V94, P1497
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   Richardson SM, 2007, HISTOL HISTOPATHOL, V22, P1033, DOI 10.14670/HH-22.1033
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005
   Sebastine I M, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P3648
   Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418
   Zeichen J, 2000, AM J SPORT MED, V28, P888, DOI 10.1177/03635465000280061901
   Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JC134174
NR 26
TC 0
Z9 0
U1 0
U2 2
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JEONJU
PA CHONBUK NATIONAL UNIV, DEPT POLYMER-NANO SCIENCE & TECH, 664-14,
   DUCKJIN, JEONJU, 561-756, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD JUN
PY 2009
VL 6
IS 4-11
SI SI
BP 893
EP 898
PG 6
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 460YY
UT WOS:000267230500068
DA 2018-10-19
ER

PT J
AU Stevens, KR
   Pabon, L
   Muskheli, V
   Murry, CE
AF Stevens, Kelly R.
   Pabon, Lil
   Muskheli, Veronica
   Murry, Charles E.
TI Scaffold-Free Human Cardiac Tissue Patch Created from Embryonic Stem
   Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ENGINEERED HEART-TISSUE; INFARCTED RAT HEARTS; MYOCARDIAL TISSUE;
   CARDIOMYOCYTES; MUSCLE; TRANSPLANTATION; GRAFTS; CONSTRUCT; SURVIVAL;
   PROLIFERATION
AB Progress in cardiac tissue engineering has been limited by (1) unfavorable cell and host responses to biomaterial scaffolds, (2) lack of suitable human cardiomyocyte sources, and (3) lack of fabrication techniques for scalable production of engineered tissue constructs. Here we report a novel and scalable method to generate scaffold-free human cardiac tissue patches. Human embryonic stem cells were differentiated to cardiomyocytes using activin A and BMP4 and placed into suspension on a rotating orbital shaker. Cells aggregated to form macroscopic disc-shaped patches of beating tissue after 2 days. Patch diameter was directly proportional to input cell number (approximately 11 mm with 12 million cells), and patches were 300-600 mm thick. Cardiomyocytes were concentrated around the patch edges and exhibited increased purity and maturation with time, comprising approximately 80% of total cells after 11 days. Noncardiac cell elements, primarily epithelium, were present at day 2 but were diminished markedly at later time points. Cardiomyocyte proliferation occurred throughout the patches at day 2 but declined by day 8. Patches exhibited automaticity and synchronous calcium transients, indicating electromechanical coupling. These novel scaffold-free human myocardial patches address critical challenges related to human cell sourcing and tissue fabrication that previously inhibited progress in cardiac tissue engineering.
C1 [Stevens, Kelly R.; Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Stevens, Kelly R.; Pabon, Lil; Muskheli, Veronica; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.
   [Stevens, Kelly R.; Pabon, Lil; Muskheli, Veronica; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.
   [Pabon, Lil; Muskheli, Veronica; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
RP Murry, CE (reprint author), 815 Mercer St,Room 453, Seattle, WA 98109 USA.
EM murry@u.washington.edu
FU NIH [R24HL64387, P01 HL03174, R01 HL084642]; NIGMS [P01GM081619];
   Bioengineering Cardiovascular Training Grant
FX The authors thank James Fugate, Kira Bendixen, Nina Tan, Ron Seifert,
   and Mark Saiget for their technical assistance as well as Jonathan
   Golob, Sharon Paige, Marilyn Nourse, Nate Tulloch, Tomo Osugi, and
   Kareen Kreutziger for assistance with quantitative RT-PCR and confocal
   microscopy. This work was supported by grants NIH R24HL64387, P01
   HL03174, R01 HL084642, and NIGMS P01GM081619. K. R. S. was supported by
   the Bioengineering Cardiovascular Training Grant.
CR [Anonymous], 2006, HEART DIS STROK STAT
   Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A
   Cao Y, 1997, PLAST RECONSTR SURG, V100, P303
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carrier RL, 2002, BIOTECHNOL BIOENG, V78, P617, DOI 10.1002/bit.10245
   Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011
   Eschenhagen T, 1997, FASEB J, V11, P683
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Hayashi M, 2004, CELL TRANSPLANT, V13, P639, DOI 10.3727/000000004783983558
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kutschka I., 2006, CIRCULATION S, V114, pI
   Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Li RK, 1999, CIRCULATION, V100, P63
   McDevitt TC, 2005, J MOL CELL CARDIOL, V39, P865, DOI 10.1016/j.yjmcc.2005.09.007
   MOSCONA A, 1952, J ANAT, V86, P287
   MOSCONA AA, 1959, SCI AM, V200, P132, DOI 10.1038/scientificamerican0559-132
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Naito H., 2006, CIRCULATION, V114, pI72
   Pouzet B, 2001, ANN THORAC SURG, V71, P844, DOI 10.1016/S0003-4975(00)01785-9
   POUZET B, 2001, ANN THORAC SURG, V71, P850
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Shimizu T, 2002, J BIOMED MATER RES, V60, P110, DOI 10.1002/jbm.1284
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   SNIR M, 2003, AM J PHYSIOL-HEART C, V285, P2355
   Stevens KR, 2007, HUM GENE THER, V18, P401, DOI 10.1089/hum.2006.161
   Suzuki K, 2004, CIRCULATION S1, V110, DOI DOI 10.1161/01.CIR.0000138388.55416.06
   Tambara K, 2003, CIRCULATION, V108, P259, DOI 10.1161/01.cir.0000087430.17543.b8
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001
   WEIER HUG, 1991, CHROMOSOMA, V100, P371, DOI 10.1007/BF00337515
   Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91
   Xu CH, 2006, STEM CELLS DEV, V15, P631, DOI 10.1089/scd.2006.15.631
   Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2
   Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
   ZIMMERMANN WH, 2002, CIRCULATION, V106, P151
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
NR 49
TC 95
Z9 97
U1 1
U2 13
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUN
PY 2009
VL 15
IS 6
BP 1211
EP 1222
DI 10.1089/ten.tea.2008.0151
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 449QH
UT WOS:000266344600002
PM 19063661
OA Green Published, Green Accepted
DA 2018-10-19
ER

PT J
AU Fassina, L
   Saino, E
   Sbarra, MS
   Visai, L
   De Angelis, MGC
   Mazzini, G
   Benazzo, F
   Magenes, G
AF Fassina, Lorenzo
   Saino, Enrica
   Sbarra, Maria Sonia
   Visai, Livia
   De Angelis, Maria Gabriella Cusella
   Mazzini, Giuliano
   Benazzo, Francesco
   Magenes, Giovanni
TI Ultrasonic and Electromagnetic Enhancement of a Culture of Human SAOS-2
   Osteoblasts Seeded onto a Titanium Plasma-Spray Surface
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID ECTOPIC BONE-FORMATION; MARROW STROMAL CELLS; POLYURETHANE POROUS
   SCAFFOLD; CALCIFIED MATRIX PRODUCTION; FIBER MESH; PERFUSION BIOREACTOR;
   CALCIUM-PHOSPHATE; OSTEOGENIC CELLS; DIFFERENTIATION; BIOMATERIALS
AB Several studies suggest that the surface coating of titanium could play an important role in bone tissue engineering. In the present study, we have followed a particular biomimetic strategy where ultrasonically or electromagnetically stimulated SAOS-2 human osteoblasts proliferated and built their extracellular matrix on a titanium plasma-spray surface. In comparison with control conditions, the ultrasonic stimulation (average power, 149 mW; frequency, 1.5 MHz) and the electromagnetic stimulation (magnetic field intensity, 2 mT; frequency, 75 Hz) caused higher cell proliferation, and increased surface coating with decorin, osteocalcin, osteopontin, and type I collagen together with higher incorporation of calcium and phosphorus inside the extracellular matrix. The immunofluorescence related to the preceding bone matrix proteins showed their colocalization in the cell-rich areas. The use of the two physical stimulations aimed at obtaining the coating of the rough titanium plasma-spray surface in terms of cell colonization and deposition of extracellular matrix. The superficially cultured biomaterial could be theoretically used, in clinical applications, as an implant for bone repair.
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, Pavia, Italy.
   [Fassina, Lorenzo; Saino, Enrica; Sbarra, Maria Sonia; Visai, Livia; De Angelis, Maria Gabriella Cusella; Mazzini, Giuliano; Benazzo, Francesco; Magenes, Giovanni] Univ Pavia, CIT, I-27100 Pavia, Italy.
   [Saino, Enrica; Sbarra, Maria Sonia; Visai, Livia] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
   [De Angelis, Maria Gabriella Cusella] Univ Pavia, Dipartimento Med Sperimentale, I-27100 Pavia, Italy.
   [Mazzini, Giuliano] Univ Pavia, Dipartimento Biol Anim, IGM CNR Istochim & Citometria, I-27100 Pavia, Italy.
   [Benazzo, Francesco] Univ Pavia, Dipartimento SMEC, IRCCS San Matteo, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, Via Ferrata 1, Pavia, Italy.
EM lorenzo.fassina@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632; Cusella De Angelis, Maria
   Gabriella/0000-0003-2642-3346
FU Fondazione Cariplo [2004.1424/10.8485, 2006.0581/10.8485]; Italian
   Ministry of Education, University and Research [RBIP06FH7J]
FX The authors thank Prof. L. W. Fisher, Dr. S. Setti, Dr. R. Cadossi, Dr.
   A. Facchini, Mr. D. Picenoni, and Mr. A. Mortara for support. The FAST
   ultrasound generator and the Biostim SPT pulse generator were gifts from
   Igea (Carpi, Italy). This work was supported by Fondazione Cariplo
   Grants (2004.1424/10.8485 and 2006.0581/10.8485) to F. B.; by PRIN Grant
   (2006) from Italian Ministry of Education, University and Research, to
   L. V.; and by FIRB Grant (RBIP06FH7J) from Italian Ministry of
   Education, University and Research, to M. G. C. De A.
CR Aaron RK, 1996, J ORTHOPAED RES, V14, P582, DOI 10.1002/jor.1100140412
   Anderson HC, 2002, J BONE MINER METAB, V20, P73, DOI 10.1007/s007740200010
   ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P129
   ANDERSON HC, 1992, BONE MINER, V16, P49, DOI 10.1016/0169-6009(92)90821-T
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CANE V, 1993, J ORTHOPAED RES, V11, P664, DOI 10.1002/jor.1100110508
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Diniz P, 2002, BIOELECTROMAGNETICS, V23, P398, DOI 10.1002/bem.10032
   Duan YR, 2004, J MATER SCI-MATER M, V15, P1205, DOI 10.1007/s10856-004-5673-0
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004
   Holland NB, 1998, NATURE, V392, P799
   Holtorf HL, 2005, BIOMATERIALS, V26, P6208, DOI 10.1016/j.biomaterials.2005.04.006
   Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P138, DOI 10.2106/JBJS.G.01218
   KIM YH, 1993, J BONE JOINT SURG BR, V75, P6
   Krout A, 2005, J BIOMED MATER RES A, V73A, P377, DOI 10.1002/jbm.a.30310
   Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017
   Lohmann CH, 2003, J ORTHOP RES, V21, P326, DOI 10.1016/S0736-0266(02)00137-7
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Reher P, 2002, BONE, V31, P236, DOI 10.1016/S8756-3282(02)00789-5
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   Vehof JWM, 2001, PLAST RECONSTR SURG, V108, P434, DOI 10.1097/00006534-200108000-00024
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
   WANG SJ, 1994, J ORTHOP RES, V12, P40, DOI 10.1002/jor.1100120106
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
NR 50
TC 19
Z9 20
U1 0
U2 9
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JUN
PY 2009
VL 15
IS 2
BP 233
EP 242
DI 10.1089/ten.tec.2008.0398
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 455OW
UT WOS:000266773700012
PM 19119923
DA 2018-10-19
ER

PT J
AU Lacroix, D
   Planell, JA
   Prendergast, PJ
AF Lacroix, Damien
   Planell, Josep A.
   Prendergast, Patrick J.
TI Computer-aided design and finite-element modelling of biomaterial
   scaffolds for bone tissue engineering
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Review
DE biomechanics; tissue engineering; biomaterials; finite-element modelling
ID MICRO-CT; IN-VIVO; MECHANO-REGULATION; BIOPHYSICAL STIMULI;
   DIFFERENTIATION; REGENERATION; TOMOGRAPHY; STRESS; CELLS; BIOREACTOR
AB Scaffold biomaterials for tissue engineering can be produced in many different ways depending on the applications and the materials used. Most research into new biomaterials is based on an experimental trial-and-error approach that limits the possibility of making many variations to a single material and studying its interaction with its surroundings. Instead, computer simulation applied to tissue engineering can offer a more exhaustive approach to test and screen out biomaterials. In this paper, a review of the current approach in biomaterials designed through computer-aided design (CAD) and through finite-element modelling is given. First we review the approach used in tissue engineering in the development of scaffolds and the interactions existing between biomaterials, cells and mechanical stimuli. Then, scaffold fabrication through CAD is presented and characterization of existing scaffolds through computed images is reviewed. Several case studies of finite-element studies in tissue engineering show the usefulness of computer simulations in determining the mechanical environment of cells when seeded into a scaffold and the proper design of the geometry and stiffness of the scaffold. This creates a need for more advanced studies that include aspects of mechanobiology in tissue engineering in order to be able to predict over time the growth and differentiation of tissues within scaffolds. Finally, current perspectives indicate that more efforts need to be put into the development of such advanced studies, with the removal of technical limitations such as computer power and the inclusion of more accurate biological and genetic processes into the developed algorithms.
C1 [Lacroix, Damien; Planell, Josep A.] Inst Bioengn Catalonia, Barcelona 08028, Spain.
   [Planell, Josep A.] Tech Univ Catalonia, Dept Mat Sci, Barcelona 08034, Spain.
   [Prendergast, Patrick J.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Dublin 2, Ireland.
RP Lacroix, D (reprint author), Inst Bioengn Catalonia, Barcelona 08028, Spain.
EM dlacroix@ibec.pcb.ub.es
RI Lacroix, Damien/G-3230-2010
OI Lacroix, Damien/0000-0002-5482-6006
FU European Commission [NMP3-CT-2005-013912]; Spanish Ministry of Science
   and Education
FX The authors acknowledge funding from the European Commission (6FP
   SmartCaP project, NMP3-CT-2005-013912) and the Spanish Ministry of
   Science and Education. The following postgraduate students have
   contributed to parts of this work: Damien Byrne, Stephan Midderhoff and
   Clara Sandino.
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   Bellomo N, 2008, MATH MOD METH APPL S, V18, P593, DOI 10.1142/S0218202508002796
   Boccaccio A, 2008, MED BIOL ENG COMPUT, V46, P283, DOI 10.1007/s11517-007-0247-1
   Boger A, 2008, J BIOMED MATER RES B, V86B, P474, DOI 10.1002/jbm.b.31044
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Charles-Harris M, 2008, J MATER SCI-MATER M, V19, P1503, DOI 10.1007/s10856-008-3390-9
   Charles-Harris M, 2007, BIOMATERIALS, V28, P4429, DOI 10.1016/j.biomaterials.2007.06.029
   CHECA C, 2008, ANN BIOMED ENG, V37, P129
   Cioffi M, 2006, BIOTECHNOL BIOENG, V93, P500, DOI 10.1002/bit.20740
   Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5
   Cohen IR, 2007, J R SOC INTERFACE, V4, P175, DOI 10.1098/rsif.2006.0173
   Coveney PV, 2005, J R SOC INTERFACE, V2, P267, DOI 10.1098/rsif.2005.0045
   Cristofolini L, 2008, PHILOS T R SOC A, V366, P3319, DOI 10.1098/rsta.2008.0077
   *D MD, 2001, TISS ENG TECHN MARK
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Geris L, 2008, J THEOR BIOL, V251, P137, DOI 10.1016/j.jtbi.2007.11.008
   Geris L, 2008, J BIOMECH, V41, P145, DOI 10.1016/j.jbiomech.2007.07.008
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holtorf HL, 2006, ADV EXP MED BIOL, V585, P225
   Huiskes R, 1997, J MATER SCI-MATER M, V8, P785, DOI 10.1023/A:1018520914512
   Hutchmacher D.W., 2007, J CELL MOL MED, V11, P654, DOI DOI 10.1111/J.1582-4934.2007.00078.X
   Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037
   Isaksson H, 2007, J BIOMECH, V40, P2002, DOI 10.1016/j.jbiomech.2006.09.028
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   Kalyanaraman B, 2007, TISSUE ENG, V13, P983, DOI 10.1089/ten.2006.0338
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kelly DJ, 2006, TISSUE ENG, V12, P2509, DOI 10.1089/ten.2006.12.2509
   Kelly P, 1964, INT J ENG SCI, V2, P129
   Kerckhoffs Roy C P, 2008, Heart Fail Clin, V4, P371, DOI 10.1016/j.hfc.2008.02.009
   Kirkpatrick CJ, 2007, BIOMATERIALS, V28, P5193, DOI 10.1016/j.biomaterials.2007.08.012
   Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449
   Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6
   Lacroix D, 2006, BIOMATERIALS, V27, P5326, DOI 10.1016/j.biomaterials.2006.06.009
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   MAQUET P, 1980, BIOMECHANICS LOCOMOT, P375
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Miura J, 2009, DENT MATER, V25, P67, DOI 10.1016/j.dental.2008.04.015
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Muller Ralph, 2006, Curr Osteoporos Rep, V4, P80, DOI 10.1007/s11914-006-0007-4
   Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881
   PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401
   Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331
   Perez MA, 2007, J BIOMECH, V40, P2244, DOI 10.1016/j.jbiomech.2006.10.020
   Porter BD, 2007, BIOMATERIALS, V28, P2525, DOI 10.1016/j.biomaterials.2007.01.013
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   RICHARDSON JB, 1992, CLIN BIOMECH, V7, P75, DOI 10.1016/0268-0033(92)90018-Y
   Sandino C, 2008, J BIOMECH, V41, P1005, DOI 10.1016/j.jbiomech.2007.12.011
   Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043
   Sanz-Herrera JA, 2009, ACTA BIOMATER, V5, P219, DOI 10.1016/j.actbio.2008.06.021
   Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008
   Smith MH, 2007, INT J MED ROBOT COMP, V3, P207, DOI 10.1002/rcs.143
   Southern J, 2008, PROG BIOPHYS MOL BIO, V96, P60, DOI 10.1016/j.pbiomolbio.2007.07.019
   Stoneham AM, 2003, NAT MATER, V2, P77, DOI 10.1038/nmat804
   Sumanasinghe RD, 2006, TISSUE ENG, V12, P3459, DOI 10.1089/ten.2006.12.3459
   Sun W, 2002, COMPUT METH PROG BIO, V67, P85, DOI 10.1016/S0169-2607(01)00116-X
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P49, DOI 10.1042/BA20030109
   Swider P, 2007, J BIOMECH, V40, P2112, DOI 10.1016/j.jbiomech.2006.10.002
   Van Cleynenbreugel T, 2002, J MATER SCI-MATER M, V13, P1245, DOI 10.1023/A:1021183230549
   Van Cleynenbreugel T, 2006, MED BIOL ENG COMPUT, V44, P517, DOI 10.1007/s11517-006-0071-z
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
   Viceconti M, 2004, J BIOMECH, V37, P1597, DOI 10.1016/j.biomech.2003.12.030
   Voor MJ, 2008, J BIOMECH, V41, P186, DOI 10.1016/j.jbiomech.2007.06.028
   Weinberg EJ, 2008, J BIOMECH, V41, P3482, DOI 10.1016/j.jbiomech.2008.08.006
   Wikswo JP, 2006, IEE PROC-NANOBIOTECH, V153, P81, DOI 10.1049/ip-nbt:20050045
   Xie YZ, 2006, TISSUE ENG, V12, P3535, DOI 10.1089/ten.2006.12.3535
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 81
TC 48
Z9 49
U1 2
U2 18
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD MAY 28
PY 2009
VL 367
IS 1895
BP 1993
EP 2009
DI 10.1098/rsta.2009.0024
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 434NU
UT WOS:000265282200010
PM 19380322
OA Bronze
DA 2018-10-19
ER

PT J
AU Dubey, DK
   Tomar, V
AF Dubey, Devendra K.
   Tomar, Vikas
TI The effect of tensile and compressive loading on the hierarchical
   strength of idealized tropocollagen-hydroxyapatite biomaterials as a
   function of the chemical environment
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; HUMAN TRABECULAR BONE;
   MECHANICAL-PROPERTIES; COLLAGEN FIBRILS; BIOLOGICAL-MATERIALS; YOUNGS
   MODULUS; TRIPLE-HELIX; NANOSTRUCTURE; STABILITY; PROTEINS
AB Hard biomaterials such as bone, dentin and nacre have primarily a polypeptide phase (e.g. tropocollagen (TC)) and a mineral phase (e.g. hydroxyapatite (HAP) or aragonite) arranged in a staggered manner. It has been observed that the mechanical behaviour of such materials changes with the chemical environment and the direction of applied loading. In the presented investigation, explicit three-dimensional molecular dynamics (MD) simulations based analyses are performed on idealized TC-HAP composite biomaterial systems to understand the effects of tensile and compressive loadings in three different chemical environments: (1) unsolvated, (2) solvated with water and (3) calcinated and solvated with water. The MD analyses are performed on two interfacial supercells corresponding to the lowest structural level (level n) of TC-HAP interactions and on two other supercells with HAP supercells arranged in a staggered manner (level n + 1) in a TC matrix. The supercells at level n + 1 are formed by arranging level n interfacial supercells in a staggered manner. Analyses show that at level n, the presence of water molecules results in greater stability of TC molecules and TC-HAP interfaces during mechanical deformation. In addition, water also acts as a lubricant between adjacent TC molecules. Under the application of shear stress dominated loading, water molecules act to strengthen the TC-HAP interfacial strength in a manner similar to the action of glue. An overall effect of the observed mechanisms is that, in a staggered arrangement, tensile strength increases in the presence of water and calcinated water environments. On the other hand, corresponding compressive strength decreases under similar circumstances. Fundamentally, supercells with primarily normal load transfer at the TC-HAP interfaces are stronger in tensile shear loading. On the other hand, supercells with primarily tangential or shear load transfer at the TC-HAP interfaces are stronger in compressive shear loading. A combination of changes in chemical environment from vacuum to calcinated water and changes in interfacial configurations in a staggered arrangement could be chosen to make the TC-HAP material stronger under applied deformation.
C1 [Dubey, Devendra K.; Tomar, Vikas] Univ Notre Dame, Notre Dame, IN 46556 USA.
RP Tomar, V (reprint author), Univ Notre Dame, Notre Dame, IN 46556 USA.
EM vikas.tomar@nd.edu
CR ANDERSON D, 2005, THESIS U TORONTO, P4105
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   Berryman JG, 2005, J MECH PHYS SOLIDS, V53, P2141, DOI 10.1016/j.jmps.2005.05.004
   BHOWMIK R, 2007, MAT RES SOC S P, V975, P4105
   Bhowmik R, 2007, MAT SCI ENG C-BIO S, V27, P352, DOI 10.1016/j.msec.2006.05.048
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   Broedling NC, 2008, J MECH PHYS SOLIDS, V56, P1086, DOI 10.1016/j.jmps.2007.06.006
   Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001
   Buehler MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295102
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Chen JH, 2006, J PHYS-CONDENS MAT, V18, pS1049, DOI 10.1088/0953-8984/18/25/S11
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   Ghosh P, 2007, BIOMACROMOLECULES, V8, P851, DOI 10.1021/bm060942h
   Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b
   Handgraaf JW, 2006, PROTEINS, V64, P711, DOI 10.1002/prot.21019
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Hein JI, 2005, PHILOS T ROY SOC A, V363, P1987, DOI 10.1098/rsta.2005.1624
   Hodge A. J., 1963, ASPECTS PROTEIN STRU, P289
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Huang C C, 1998, Pac Symp Biocomput, P349
   Israelowitz M, 2005, PROTEIN ENG DES SEL, V18, P329, DOI 10.1093/protein/gzi037
   Jager I, 2000, BIOPHYS J, V79, P1737
   Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j
   Ji BH, 2008, J BIOMECH, V41, P259, DOI 10.1016/j.jbiomech.2007.09.022
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   Lorenzo AC, 2005, J BIOMECH, V38, P1527, DOI 10.1016/j.jbiomech.2004.07.011
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Makarov V, 2002, ACCOUNTS CHEM RES, V35, P376, DOI 10.1021/ar0100273
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   MOW VC, 2005, BASIC ORTHOPAEDIC BI, P4105
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Ponder J. W., 2003, PROTEIN SIMULATIONS, P27
   POSNER A S, 1975, Seminars in Arthritis and Rheumatism, V4, P267, DOI 10.1016/0049-0172(75)90013-X
   Radmer RJ, 2006, BIOPHYS J, V90, P578, DOI 10.1529/biophysj.105.065276
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Simone A. D., 2008, BIOCHEM BIOPH RES CO, V372, P121
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Thurner PJ, 2007, ENG FRACT MECH, V74, P1928, DOI 10.1016/j.engfracmech.2006.05.024
   Tomar V, 2007, J MECH PHYS SOLIDS, V55, P1053, DOI 10.1016/j.jmps.2006.10.005
   Voth GA, 2006, ACCOUNTS CHEM RES, V39, P143, DOI 10.1021/ar0402098
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1983, INT J BIOL MACROMOL, V5, P325, DOI 10.1016/0141-8130(83)90055-7
   Wenk HR, 1999, BONE, V24, P361, DOI 10.1016/S8756-3282(98)00192-6
   Zhang DJ, 2007, ANN BIOMED ENG, V35, P1216, DOI 10.1007/s10439-007-9296-8
NR 58
TC 12
Z9 12
U1 2
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD MAY 20
PY 2009
VL 21
IS 20
AR 205103
DI 10.1088/0953-8984/21/20/205103
PG 13
WC Physics, Condensed Matter
SC Physics
GA 436MQ
UT WOS:000265418600018
PM 21825522
DA 2018-10-19
ER

PT J
AU Berglin, M
   Pinori, E
   Sellborn, A
   Andersson, M
   Hulander, M
   Elwing, H
AF Berglin, Mattias
   Pinori, Emillano
   Sellborn, Anders
   Andersson, Marcus
   Hulander, Mats
   Elwing, Hans
TI Fibrinogen Adsorption and Conformational Change on Model Polymers: Novel
   Aspects of Mutual Molecular Rearrangement
SO LANGMUIR
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; SELF-ASSEMBLED MONOLAYERS; IMMUNE
   COMPLEMENT ACTIVATION; SURFACE-PLASMON RESONANCE; ATOMIC-FORCE
   MICROSCOPY; GLYCOPROTEIN-IIB-IIIA; PROTEIN ADSORPTION; VISCOELASTIC
   PROPERTIES; INFLAMMATORY RESPONSES; BIOMATERIAL SURFACES
AB By combining quartz crystal microbalance with dissipation monitoring (QCM-D) and surface plasmon resonance (SPR), the organic mass, water content, and corresponding protein film structure of Fibrinogen adsorbed to acrylic polymeric substrates with varying polymer chain flexibility was investigated. Albumin and immunoglobulin G were included as reference proteins. For Fibrinogen, the QCM-D model resulted in decreased adsorbed mass with increased polymer chain flexibility. This stands in contrast to the SPR model, in which the adsorbed mass increased with increased polymer chain flexibility. As the QCM-D model includes the hydrodynamically coupled water, we propose that on the nonflexible polymer significant protein conformational change with water incorporation in the protein film takes place. Fibrinogen maintained a more native conformation on the flexible polymer, probably due to polymer chain rearrangement rather than protein conformational change. In comparison with immunoglobulin G and albumin, polymer chain flexibility had only minor impact on adsorbed mass and protein structure. Understanding the adsorption and corresponding conformational change of a protein together with the mutual rearrangement of the polymer chain upon adsorption not only has implications in biomaterial science but could also increase the efficacy of molecular imprinted polymers (MIPs).
C1 [Berglin, Mattias; Pinori, Emillano; Andersson, Marcus; Hulander, Mats; Elwing, Hans] Univ Gothenburg, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
   [Sellborn, Anders] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Surg, SE-41345 Gothenburg, Sweden.
RP Berglin, M (reprint author), Univ Gothenburg, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
EM Mattias.berglin@cmb.gu.se
OI Pinori, Emiliano/0000-0002-8945-9904
CR Andersson M, 2008, J BIOMED MATER RES A, V84A, P652, DOI 10.1002/jbm.a.31389
   Andersson M, 2007, J MATER SCI-MATER M, V18, P283, DOI 10.1007/s10856-006-0690-9
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Baty AM, 1996, J COLLOID INTERF SCI, V177, P307, DOI 10.1006/jcis.1996.0036
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Choi KH, 2002, APPL PHYS LETT, V81, P1335, DOI 10.1063/1.1500777
   Choukourov A, 2007, SURF SCI, V601, P3948, DOI 10.1016/j.susc.2007.04.155
   Clarke ML, 2006, LANGMUIR, V22, P8627, DOI 10.1021/la0607656
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Ishizaki T, 2007, SURF SCI, V601, P3861, DOI 10.1016/j.susc.2007.04.096
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Li J, 2005, BIOSENS BIOELECTRON, V20, P1333, DOI 10.1016/j.bios.2004.05.004
   LIN YS, 1992, BIOMATERIALS, V13, P497
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Luck M, 1998, J BIOMED MATER RES, V39, P478
   Macakova L, 2007, LANGMUIR, V23, P12436, DOI 10.1021/la7014308
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   Maste MCL, 1997, J COLLOID INTERF SCI, V196, P224, DOI 10.1006/jcis.1997.5205
   Mayes AG, 1997, TRAC-TREND ANAL CHEM, V16, P321, DOI 10.1016/S0165-9936(97)00037-X
   McHale G, 2004, J APPL PHYS, V95, P373, DOI 10.1063/1.1630373
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   SAURBREY G, 1959, Z PHYS, V155, P206
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   SAVAGE B, 1992, J BIOL CHEM, V267, P11300
   Scott EA, 2007, BIOMATERIALS, V28, P3904, DOI 10.1016/j.biomaterials.2007.05.022
   Sellborn A, 2005, MOL IMMUNOL, V42, P569, DOI 10.1016/j.molimm.2004.09.015
   Shi HQ, 1999, NATURE, V398, P593
   SHIBA E, 1991, AM J PHYSIOL, V260, pC965
   Sit PS, 2001, SURF SCI, V491, P421, DOI 10.1016/S0039-6028(01)01308-5
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tzoneva R, 2002, J BIOMAT SCI-POLYM E, V13, P1033, DOI 10.1163/156856202760319171
   UGAROVA TP, 1993, J BIOL CHEM, V268, P21080
   Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Weber N, 2007, LANGMUIR, V23, P3298, DOI 10.1021/la060500r
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wilson WD, 2002, SCIENCE, V295, P2103, DOI 10.1126/science.295.5562.2103
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Wulf M, 2000, J APPL POLYM SCI, V77, P2493, DOI 10.1002/1097-4628(20000912)77:11<2493::AID-APP19>3.0.CO;2-H
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   Yang Q, 2007, ANAL CHIM ACTA, V597, P58, DOI 10.1016/j.aca.2007.06.025
   Ye L, 2008, CHEM MATER, V20, P859, DOI 10.1021/cm703190w
   Zhou C, 2004, LANGMUIR, V20, P5870, DOI 10.1021/la036251d
NR 58
TC 46
Z9 48
U1 0
U2 49
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 19
PY 2009
VL 25
IS 10
BP 5602
EP 5608
DI 10.1021/la803686m
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 445WA
UT WOS:000266081000028
PM 19366199
DA 2018-10-19
ER

PT J
AU Tao, N
   Cheng, J
   Wei, L
   Yue, JC
AF Tao, Ning
   Cheng, Jie
   Wei, Ling
   Yue, Jiachang
TI Self-Assembly of F0F1-ATPase Motors and Ghost
SO LANGMUIR
LA English
DT Article
ID ATP SYNTHASE; PEPTIDES; DELIVERY; PROTEINS; VESICLES
AB F0F1-ATPase motors have unique mechanical properties, making them attractive building blocks in the field of nanotechnology. However, their organization into well-defined structures with practical functions remains a critical challenge. Here, we describe a self-assembling complex formed by F0F1-ATPase and a ghost which is ordered. Formation of the complex includes two steps: the molecular motors first self-assemble into filaments and then attach to the ghost. The ghost and attached Filaments then aggregate into large self-assembled complexes. Oil illumination, these complexes disassemble because of the rotation force of the molecular motors. The complexes are macroscopic, having a diameter greater than 1 mm. Such complexes of a flexible biomaterial (ghost) self-assembled with a dynamic biomaterial (F0F1-ATPase molecular motor) have several advantages, including flexibility, stability, and ability to be controlled by light, and Could be used as controllable rotational molecular machines.
C1 [Tao, Ning; Cheng, Jie; Yue, Jiachang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
   [Cheng, Jie] Chinese Acad Sci, Grad Sch, Beijing 100101, Peoples R China.
   [Wei, Ling] S China Normal Univ, Coll Life Sci, Guangzhou 510631, Guangdong, Peoples R China.
RP Yue, JC (reprint author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
EM yuejc@sun5.ibp.ac.cn
FU National Basic Research 973 Program [2007CB935901]; National Natural
   Science Foundation of China [30800289, 20873176]; Chinese Postdoctoral
   Research Award [20070420075]
FX We thank Prof. Lin Kechun (Medical Science Center, Peking University)
   for critical reading of this manuscript. This work was supported by the
   National Basic Research 973 Program (No. 2007CB935901), National Natural
   Science Foundation of China (No. 30800289; 20873176), and Chinese
   Postdoctoral Research Award (20070420075).
CR Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717
   Carrico IS, 2009, NAT NANOTECHNOL, V4, P14, DOI 10.1038/nnano.2008.389
   Feniouk BA, 2002, BIOPHYS J, V82, P1115, DOI 10.1016/S0006-3495(02)75470-2
   Hamidi M, 2003, DRUG DELIV, V10, P9, DOI 10.1080/10717540390169520
   Jin YG, 2008, INT J PHARM, V350, P330, DOI 10.1016/j.ijpharm.2007.08.037
   Liu XL, 2006, BIOCHEM BIOPH RES CO, V347, P752, DOI 10.1016/j.bbrc.2006.06.160
   Magnani M, 2002, GENE THER, V9, P749, DOI 10.1038/sj.gt.3301758
   MEHRDAD H, 2007, J CONTROL RELEASE, V118, P145
   Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166
   MONTEMAGNO CD, 1999, NANOTECHNOLOGY, V10, P3
   NOJI H, 1997, NATURE, V386, P6622
   Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Rossi Luiga, 2005, Expert Opin Drug Deliv, V2, P311, DOI 10.1517/17425247.2.2.311
   Schreiber F, 2000, PROG SURF SCI, V65, P151, DOI 10.1016/S0079-6816(00)00024-1
   Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555
   STECK TL, 1970, SCIENCE, V168, P255, DOI 10.1126/science.168.3928.255
   SU T, 2005, BIOCHEM BIOPH RES CO, V350, P1013
   van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570
   VERTESSY BG, 1989, BIOPHYS J, V55, P255, DOI 10.1016/S0006-3495(89)82800-0
   Wu J, 2005, CHINESE J CHEM, V23, P330
   Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451
   Zhang YH, 2005, BIOCHEM BIOPH RES CO, V331, P370, DOI 10.1016/j.bbrc.2005.03.172
NR 23
TC 6
Z9 6
U1 1
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 19
PY 2009
VL 25
IS 10
BP 5747
EP 5752
DI 10.1021/la804083f
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 445WA
UT WOS:000266081000047
PM 19374455
DA 2018-10-19
ER

PT J
AU Szili, EJ
   Kumar, S
   Smart, RSC
   Voelcker, NH
AF Szili, Endre J.
   Kumar, Sunil
   Smart, Roger St. C.
   Voelcker, Nicolas H.
TI Generation of a stable surface concentration of amino groups on silica
   coated onto titanium substrates by the plasma enhanced chemical vapour
   deposition method
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE 3-Aminopropyl triethoxysilane; Plasma enhanced chemical vapour
   deposition; Silica; Titanium
ID TRINITROBENZENESULFONIC ACID; CELL-ADHESION; IMMOBILIZATION; ATTACHMENT;
   PEPTIDES; PROTEINS; ALLOY; XPS
AB This report describes the amino functionalisation of the surface of plasma enhanced chemically vapour deposited silica films (PECVD-SiO(2)), which were coated onto titanium substrates. Amino groups were linked to PECVD-SiO(2) via 3-aminpropyl triethoxysilane (APTES). We showed that the APTES functionalised PECVD-SiO(2) surfaces contained a high packing density of amino groups (67-92 NH(2) groups per nm(2)), indicative of a multilayered and highly cross-linked APTES film. 65-66% of the original surface concentration of APTES was retained on the PECVD-SiO(2) surface after incubation under physiological conditions, indicating that APTES films are relatively stable on PECVD-SiO(2) in these environments. The stability of the amino groups obtained on PECVD-SiO(2) in this study is much higher compared to other hydroxyl-bearing materials, such as titanium. Therefore, PECVD-SiO(2) films may find use as functional biomaterial coatings and as intermediate adhesion layers in silanisation processes. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Kumar, Sunil] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   [Szili, Endre J.; Voelcker, Nicolas H.] Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Bedford Pk, SA 5042, Australia.
   [Szili, Endre J.] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
   [Smart, Roger St. C.] Univ S Australia, Appl Ctr Struct & Synchrotron Studies, Mawson Lakes, SA 5095, Australia.
RP Kumar, S (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM sunil.kumar@unisa.edu.au; nico.voelcker@flinders.edu.au
RI Smart, Roger/D-1786-2009; Voelcker, Nicolas/D-6199-2012
OI Voelcker, Nicolas/0000-0002-1536-7804
FU TGR Biosciences; Australian Research Council
FX This work was supported by TGR Biosciences and the Australian Research
   Council.
CR ABBOTT JR, 2001, J CRANIOFAC SURG, V8, P17
   ARAI K, 1993, J POLYM SCI POL CHEM, V31, P249, DOI 10.1002/pola.1993.080310129
   Arora PS, 1996, SURF INTERFACE ANAL, V24, P539, DOI 10.1002/(SICI)1096-9918(19960916)24:9<539::AID-SIA162>3.0.CO;2-5
   Black J, 2006, BIOL PERFORMANCE MAT
   BROWN HH, 1968, CLIN CHEM, V14, P967
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Dubruel P, 2006, SURF SCI, V600, P2562, DOI 10.1016/j.susc.2006.04.021
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Giordano C, 2004, J Appl Biomater Biomech, V2, P35
   Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   Heiney PA, 2000, LANGMUIR, V16, P2651, DOI 10.1021/1a990557w
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   LYUBCHENKO Y, 1993, P NATL ACAD SCI USA, V90, P2137, DOI 10.1073/pnas.90.6.2137
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Neel E.A.A., 2007, BIOMATERIALS, V28, P2967
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   PALMER DW, 1969, CLIN CHEM, V15, P891
   Pham MT, 2000, J MATER SCI-MATER M, V11, P383, DOI 10.1023/A:1008938125348
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   PULEO DA, 1995, J BIOMED MATER RES, V29, P951, DOI 10.1002/jbm.820290806
   Sandrini E, 2005, J BIOMED MATER RES B, V73B, P392, DOI 10.1002/jbm.b.30241
   SARANTONIS EG, 1986, ANAL BIOCHEM, V155, P129, DOI 10.1016/0003-2697(86)90237-X
   SPADARO AC, 1979, ANAL BIOCHEM, V96, P317, DOI 10.1016/0003-2697(79)90587-6
   Steveson M, 1998, SURF INTERFACE ANAL, V26, P1027, DOI 10.1002/(SICI)1096-9918(199812)26:13<1027::AID-SIA452>3.0.CO;2-9
   Szili EJ, 2008, SURF SCI, V602, P2402, DOI 10.1016/j.susc.2008.05.027
   Teghil R, 2002, J MATER SCI LETT, V21, P379, DOI 10.1023/A:1014903117057
   Wang ZH, 2004, J IMMUNOL METHODS, V285, P237, DOI 10.1016/j.jim.2003.12.002
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Zhang HL, 2006, COLLOID SURFACE A, V291, P128, DOI 10.1016/j.colsurfa.2006.07.057
NR 34
TC 14
Z9 14
U1 3
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 15
PY 2009
VL 255
IS 15
BP 6846
EP 6850
DI 10.1016/j.apsusc.2009.02.092
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 443JP
UT WOS:000265906300018
DA 2018-10-19
ER

PT J
AU Li, F
   Dong, PJ
   Zhuang, QF
AF Li, Feng
   Dong, Ping-Jun
   Zhuang, Qian-Fen
TI Novel column-based protein refolding strategy using dye-ligand affinity
   chromatography based on macroporous biomaterial
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article
DE Column-based; Protein refolding; Dye-ligand affinity chromatography;
   Porous biomaterial
ID BOVINE LIVER CATALASE; SOL-GEL PROCESS; ESCHERICHIA-COLI; PURIFICATION;
   CHITOSAN; ADSORPTION; MEMBRANES; GAMMA
AB A novel column-based chromatographic protein refolding strategy was developed using dye-ligand affinity chromatography (DLAC) based on macroporous biomaterial. Chitosan-silica (CS-silica) biomaterial with macroporous surface was used as the supporting matrix for the preparation of the DLAC material. The dye-ligand Cibacron Blue F3GA (CBF) was selected as affinity handle and could be covalently immobilized to form dye-ligand affinity adsorbent (CBF-CS-silica) using the reactivity of NH(2) on CS-silica biomaterial. After the model protein catalase was denatured with 6 mol/L urea, the denaturant could be rapidly removed and catalase could be successfully refolded as facilitated by the adsorption of CBF-CS-silica. The urea denaturation process and the elute condition for the chromatographic refolding were optimized by measuring tryptophan fluorescence and activity of catalase. The refolding performance of the proposed DLAC was compared with dilution refolding. The protein concentration during the proposed chromatographic refolding increased by a factor of 20 without reducing the yield achieved as compared to dilution refolding. The column-based protein refolding strategy based on dye-ligand affinity chromatography with porous biomaterial being matrix possessed potential in chromatographic refolding of protein. (C) 2009 Published by Elsevier B.V.
C1 [Li, Feng; Dong, Ping-Jun; Zhuang, Qian-Fen] Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Minist Educ, Key Lab Ecochem Engn, Qingdao 266042, Peoples R China.
RP Li, F (reprint author), Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Minist Educ, Key Lab Ecochem Engn, Qingdao 266042, Peoples R China.
EM lifeng@qust.edu.cn
FU National Natural Science Foundation of China [20775039, 20775038]; Open
   Foundation of State Key Laboratory of Electroanalytical Chemistry
   [20080x]
FX This research was supported by the National Natural Science Foundation
   of China (nos. 20775039 and 20775038), the Open Foundation of State Key
   Laboratory of Electroanalytical Chemistry (20080x).
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Garcia-Diego C, 2008, CHEM ENG J, V143, P337, DOI 10.1016/j.cej.2008.06.022
   Guan YX, 2006, J CHROMATOGR A, V1107, P192, DOI 10.1016/j.chroma.2005.12.090
   Gusarova V, 2007, J CHROMATOGR A, V1176, P157, DOI 10.1016/j.chroma.2007.10.090
   Hugo A., 1987, METHOD ENZYMOL, V105, P121
   Hutchinson MH, 2006, J CHROMATOGR A, V1128, P125, DOI 10.1016/j.chroma.2006.06.050
   LI F, 2006, J CHROMATOGR A, V1134, P45
   Li F, 2008, TALANTA, V74, P1247, DOI 10.1016/j.talanta.2007.08.032
   Li F, 2007, ANAL CHIM ACTA, V585, P211, DOI 10.1016/j.aca.2006.12.047
   Li F, 2009, TALANTA, V77, P1304, DOI 10.1016/j.talanta.2008.09.004
   Liu YL, 2004, POLYMER, V45, P6831, DOI 10.1016/j.polymer.2004.08.006
   Liu YL, 2005, J MEMBRANE SCI, V251, P233, DOI 10.1016/j.memsci.2004.12.003
   Nian R, 2008, J CHROMATOGR A, V1214, P47, DOI 10.1016/j.chroma.2008.10.076
   Prajapati S, 1998, EUR J BIOCHEM, V255, P178, DOI 10.1046/j.1432-1327.1998.2550178.x
   Prakash K, 2002, PROTEIN SCI, V11, P46, DOI 10.1101/ps.20102
   Roque ACA, 2007, J CHROMATOGR A, V1160, P44, DOI 10.1016/j.chroma.2007.05.109
   SAMEJIMA T, 1963, J BIOL CHEM, V238, P3256
   Shentu JL, 2005, INT J BIOL MACROMOL, V37, P42, DOI 10.1016/j.ijbiomac.2005.08.004
   Tan HD, 2007, PROTEIN EXPRES PURIF, V56, P40, DOI 10.1016/j.pep.2007.07.006
   Wang CZ, 2007, BIOMED CHROMATOGR, V21, P1291, DOI 10.1002/bmc.890
   Wu FY, 2006, J CHROMATOGR A, V1134, P45, DOI 10.1016/j.chroma.2006.07.087
NR 21
TC 6
Z9 7
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD MAY 15
PY 2009
VL 1216
IS 20
BP 4383
EP 4387
DI 10.1016/j.chroma.2009.02.069
PG 5
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 444BW
UT WOS:000265956100010
PM 19344905
DA 2018-10-19
ER

PT J
AU Mandal, BB
   Mann, JK
   Kundu, SC
AF Mandal, Biman B.
   Mann, Jasdeep K.
   Kundu, S. C.
TI Silk fibroin/gelatin multilayered films as a model system for controlled
   drug release
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Silk fibroin; Gelatin; Multilayered films; Drug delivery; Controlled
   release
ID TRANSFORM INFRARED-SPECTROSCOPY; TISSUE ENGINEERING APPLICATIONS;
   BIOMATERIAL COATINGS; IN-VITRO; FIBROIN PROTEIN; BLEND FILMS;
   THIN-FILMS; GELATIN; DELIVERY; MICROCAPSULES
AB Multilayer films based on silk fibroin protein and gelatin was fabricated in aqueous solution for controlled drug release. The gradual build up of layer was investigated by UV-vis spectroscopy and was further analyzed through attenuated total reflectance-Fourier transform infrared spectroscopy. Scanning electron microscopy confirmed the presence of distinct layers within the multilayer system. Intervening dehydrating step by methanol treatment was used to control the structure and stability of the self-assembled silk fibroin/gelatin multilayer films. The films were tested for in vitro release using three different molecular weight model compounds namely trypan blue (961 Da), FITC-inulin (3.9 kDa) and FITC-BSA (66 kDa). The release profile of compounds revealed dependence on multilayer film degradation for sustained release. The release kinetics was further evaluated as a function of gelatin and buildup of layers suggesting their possible role in restricting initial burst leading to sustained compound release. WIT and confocal microscopy were used to assess cellular viability and biocompatibility of fabricated films using fibroblast cells. The results highlight the versatile and tunable properties of fibroin/gelatin multilayer films making them exciting candidates for the controlled release of a wide spectrum of bioactive molecules. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Mandal, Biman B.; Mann, Jasdeep K.; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
FU Department of Biotechnology [BT/PR6035/MED/14/733/2005]; Indo-Australia
   Biotechnology [BT/PR9552/ICD/16/755/2006]; Council of Scientific
   Industrial Research (for fellowship to BBM), Govt. of India; Indo-US
   Science and Technology Forum, New Delhi
FX Department of Biotechnology (BT/PR6035/MED/14/733/2005) and its
   Bioinformatics facility, Indo-Australia Biotechnology Fund
   (BT/PR9552/ICD/16/755/2006), Council of Scientific Industrial Research
   (for fellowship to BBM), Govt. of India, and Indo-US Science and
   Technology Forum, New Delhi supported our project financially.
CR Acharya C, 2008, BIOMATERIALS, V29, P4665, DOI 10.1016/j.biomaterials.2008.08.033
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   CHAKFE N, 1993, POLYM POLYM COMPOS, V1, P229
   Dai ZF, 2004, CHEM-EUR J, V10, P6369, DOI 10.1002/chem.200400579
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dong ZF, 2006, J MEMBRANE SCI, V280, P37, DOI 10.1016/j.memsci.2006.01.002
   DRAVE JP, 1998, BIOMATERIALS, V19, P1677
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   Fukunaka Y, 2002, J CONTROL RELEASE, V80, P333, DOI 10.1016/S0168-3659(02)00026-3
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   Gil ES, 2007, MAT SCI ENG C-BIO S, V27, P426, DOI 10.1016/j.msec.2006.05.017
   Guyot M, 1996, INT J PHARM, V144, P209, DOI 10.1016/S0378-5173(96)04757-6
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Huang YH, 2007, CARBOHYD POLYM, V69, P774, DOI 10.1016/j.carbpol.2007.02.016
   Jensen AW, 2004, MACROMOLECULES, V37, P4196, DOI 10.1021/ma035321k
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Johnston APR, 2006, CURR OPIN COLLOID IN, V11, P203, DOI 10.1016/j.cocis.2006.05.001
   Kotov NA, 1999, NANOSTRUCT MATER, V12, P789, DOI 10.1016/S0965-9773(99)00237-8
   LAMBERT WJ, 1995, J CONTROL RELEASE, V33, P189, DOI 10.1016/0168-3659(94)00083-7
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liang ZP, 2004, PROG CHEM, V16, P485
   Liao W, 2004, ACTA PHYS-CHIM SIN, V20, P405, DOI 10.3866/PKU.WHXB20040415
   Lojou Elisabeth, 2004, Langmuir, V20, P748, DOI 10.1021/la030286w
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Pargaonkar N, 2005, PHARM RES, V22, P826, DOI 10.1007/s11095-005-2600-0
   Peyratout CS, 2004, ANGEW CHEM INT EDIT, V43, P3762, DOI 10.1002/anie.200300568
   Qian F, 2001, J BIOMED MATER RES, V55, P512, DOI 10.1002/1097-4636(20010615)55:4<512::AID-JBM1044>3.3.CO;2-E
   Qiu XP, 2001, LANGMUIR, V17, P5375, DOI 10.1021/la010201w
   Quinn JF, 2004, LANGMUIR, V20, P20, DOI 10.1021/la0360310
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Serizawa T, 2002, MACROMOLECULES, V35, P8656, DOI 10.1021/ma012153s
   SERIZAWA T, 1999, J POLYM SCI A, V36, P801
   Shao JZ, 2005, J APPL POLYM SCI, V96, P1999, DOI 10.1002/app.21346
   Shimazaki Y, 1997, LANGMUIR, V13, P1385, DOI 10.1021/la9609579
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P751, DOI 10.1163/156856299X00621
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   [王映红 Wang Yinghong], 2003, [功能高分子学报, Journal of Functional Polymer], V16, P36
   Wood KC, 2005, LANGMUIR, V21, P1603, DOI 10.1021/la0476480
   Xiao CB, 2001, J MACROMOL SCI PURE, V38, P317, DOI 10.1081/MA-100103352
   Yan XD, 2005, ANAL CHEM, V77, P6197, DOI 10.1021/ac050801q
   Ye SQ, 2005, J CONTROL RELEASE, V106, P319, DOI 10.1016/j.jconrel.2005.05.006
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   Zhao T., 2002, J ANAL SCI, V48, P100
NR 65
TC 50
Z9 51
U1 3
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD MAY 12
PY 2009
VL 37
IS 2
BP 160
EP 171
DI 10.1016/j.ejps.2009.02.005
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 435JX
UT WOS:000265341300012
PM 19429423
DA 2018-10-19
ER

PT J
AU Niemeyer, TC
   Grandini, CR
   Pinto, LMC
   Angelo, ACD
   Schneider, SG
AF Niemeyer, T. C.
   Grandini, C. R.
   Pinto, L. M. C.
   Angelo, A. C. D.
   Schneider, S. G.
TI Corrosion behavior of Ti-13Nb-13Zr alloy used as a biomaterial
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Metals and alloys; Gas-solid reactions; Corrosion; Oxidation
ID FREE TITANIUM-ALLOYS; BIOMEDICAL APPLICATIONS; RESISTANCE;
   MICROSTRUCTURE; STRENGTH; ELEMENTS; MODULUS
AB Titanium alloys were developed as an alternative to stainless steels and have been extensively used as biomaterials ever since. One of these alloys is Ti-13Nb-13Zr (TNZ), a near-beta phase alloy containing elements with excellent biocompatibility. The main advantage of the TNZ alloy, compared to other titanium alloys, such as Ti-6Al-4V and Ti-6Al-7Nb, widely used as biomaterials, is its low elasticity modulus, closer to that of bone, and the absence of aluminum and vanadium, which have been reported to cause long-term adverse effects. In this paper, the corrosion and electrochemical behavior of TNZ alloy (as cast and after oxygen charge) was studied in a PBS solution. The results showed that, with the oxygen load, there is a significant reduction of the anodic current in almost the whole potential spam explored in this work, meaning that the corrosion rate decreases when the doping is performed. (C) 2008 Elsevier BY. All rights reserved.
C1 [Niemeyer, T. C.; Grandini, C. R.] UNESP, Grp Relaxacoes Anelast, BR-17033360 Bauru, SP, Brazil.
   [Pinto, L. M. C.; Angelo, A. C. D.] UNESP, Grp Eletrocatalise & Reacoes Superficiais, BR-17033360 Bauru, SP, Brazil.
   [Schneider, S. G.] USP, Escola Engn Lorena, BR-12601810 Lorena, SP, Brazil.
RP Grandini, CR (reprint author), UNESP, Grp Relaxacoes Anelast, BR-17033360 Bauru, SP, Brazil.
EM betog@fc.unesp.br
RI Grandini, Carlos Roberto/A-3790-2008; Moreira de Campos Pinto,
   Leandro/L-8673-2014; Schneider, Sandra/E-6087-2015; Angelo,
   Antonio/A-9004-2008; Niemeyer, Terlize/A-7995-2013
OI Grandini, Carlos Roberto/0000-0002-3336-309X; Moreira de Campos Pinto,
   Leandro/0000-0002-6035-8827; Angelo, Antonio/0000-0002-7980-185X;
   Niemeyer, Terlize/0000-0002-8887-8226
FU Capes; CNPq; FAPESP
FX The authors wish to thank the following Brazilian agencies for their
   financial support: Capes, CNPq and FAPESP.
CR [Anonymous], 1999, JOINT COMM POWD DIFF
   Cai Z, 2003, BIOMATERIALS, V24, P213, DOI 10.1016/S0142-9612(02)00293-4
   Davidson J.A., 1992, US Patent, Patent No. [4.169.597, 4169597]
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Lopez MF, 2003, ELECTROCHIM ACTA, V48, P1395, DOI 10.1016/S0013-4686(03)00006-9
   Metikos Hukovic M., 2003, BIOMATERIALS, V24, P3765
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P2068, DOI 10.1016/j.electacta.2005.07.015
   Qi XH, 2005, ELECTROCHEM COMMUN, V7, P227, DOI 10.1016/j.elecom.2005.01.001
   RODRIGUES JA, 1994, GASES METAIS LIGAS
   Schweitzer P. A., 2006, FUNDAMENTALS METALLI
   Silva HM, 2004, MAT SCI ENG C-BIO S, V24, P679, DOI 10.1016/j.msec.2004.08.051
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Steinemann S., 1980, EVALUATION BIOMATERI
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
NR 19
TC 43
Z9 44
U1 1
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD MAY 12
PY 2009
VL 476
IS 1-2
BP 172
EP 175
DI 10.1016/j.jallcom.2008.09.026
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 446JM
UT WOS:000266117900039
DA 2018-10-19
ER

PT J
AU Hansen, RD
   Krath, BN
   Frederiksen, K
   Tjonneland, A
   Overvadd, K
   Roswall, N
   Loft, S
   Dragsted, LO
   Vogel, U
   Raaschou-Nielsen, O
AF Hansen, Rikke Dalgaard
   Krath, Britta Naimi
   Frederiksen, Kirsten
   Tjonneland, Anne
   Overvadd, Kim
   Roswall, Nina
   Loft, Steffen
   Dragsted, Lars Ove
   Vogel, Ulla
   Raaschou-Nielsen, Ole
TI GPX1 Pro(198)Leu polymorphism, erythrocyte GPX activity, interaction
   with alcohol consumption and smoking, and risk of colorectal cancer
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE Colorectal cancer; GPX1; OGG1; Gene-environment interaction; Enzyme
   activity; Oxidative stress
ID GLUTATHIONE-PEROXIDASE ACTIVITY; BREAST-CANCER; BLOOD SELENIUM; NO
   ASSOCIATION; COLON-CANCER; PRO198LEU POLYMORPHISM; SER326CYS
   POLYMORPHISM; LIPID-PEROXIDATION; PROSPECTIVE COHORT; OXIDATIVE STRESS
AB GPX1 encoding the enzyme glutathione peroxiclase 1 (GPX1) and hOGG1 encoding the 8-oxoguanine glycosylase 1 (OGG1) may counteract oxidative stress and resulting DNA damage associated with lifestyle-related exposures. We examined whether the polymorphisms GPX1 Pro(198)Leu and OGG1 Ser(326)CyS or low erythrocyte GPX enzyme activity in pre-diagnostic blood samples are associated with colorectal cancer risk, and assessed possible interactions between the polymorphisms or enzyme activity and various lifestyle factors in relation to colorectal cancer risk. Additionally, we studied whether the GPX1 Pro(198)Leu polymorphism and several lifestyle factors predict GPX activity in erythrocytes. The present study was nested within the prospective "Diet, Cancer and Health" study of 57,053 Danes including 375 colorectal cancer cases and a comparison group of 779 individuals matched on gender. Biomaterial was sampled and information on lifestyle factors was obtained from questionnaires filled in at enrolment in 1993-1997. GPX1 Pro(198)Leu, hOGG1 Ser(326)Cys and erythrocyte GPX enzyme activity were not associated with risk of colorectal cancer. We observed a higher risk associated with alcohol consumption and smoking among homozygous GPX1 (198)Leu carriers, with incidence rate ratios for colorectal cancer of 1.45 (95% CI: 1.17-1.81, P = 0.02) per 10 g alcohol intake per day and 2.56 (95% CI: 0.99-6.61, P = 0.02) among ever smokers compared with never smokers at enrolment. Erythrocyte GPX activity was influenced by the GPX1 Pro(198)Leu genotype, gender, smoking intensity. and intake of fruits and vegetables. Our results indicate that lifestyle-related oxidative stress may be a risk factor for colorectal cancer among subjects with a lowered defence. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Hansen, Rikke Dalgaard; Frederiksen, Kirsten; Tjonneland, Anne; Roswall, Nina; Raaschou-Nielsen, Ole] Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark.
   [Hansen, Rikke Dalgaard; Vogel, Ulla] Natl Res Ctr Working Environm, DK-2100 Copenhagen, Denmark.
   [Krath, Britta Naimi; Dragsted, Lars Ove] Univ Copenhagen, Dept Human Nutr, Fac Life Sci, DK-1870 Frederiksberg, Denmark.
   [Overvadd, Kim] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-9100 Aalborg, Denmark.
   [Loft, Steffen] Univ Copenhagen, Inst Publ Hlth, Dept Occupat & Lifestyle Hlth, DK-1014 Copenhagen K, Denmark.
   [Vogel, Ulla] Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark.
   [Vogel, Ulla] Univ Roskilde, Inst Sci Syst & Models, DK-4000 Roskilde, Denmark.
RP Hansen, RD (reprint author), Danish Canc Soc, Inst Canc Epidemiol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
EM Rikkehan@cancer.dk
RI Vogel, Ulla/I-5048-2012; Dragsted, Lars/N-3384-2014
OI Vogel, Ulla/0000-0001-6807-1524; Dragsted, Lars/0000-0003-0609-6317;
   Tjonneland, Anne/0000-0003-4385-2097; Loft, Steffen/0000-0001-9552-8518
FU Danish Research Council [2052-03-0016]; Danish Graduate School in Public
   Health Science; Faculty of Medicine at University of Copenhagen
FX We thank Anne-Karin Jensen and Lourdes M. Pedersen for excellent
   technical assistance. And our thanks goes to the students Sana Ebdah and
   Xu Jin from Roskilde University, Denmark, who genotyped the GPX1 5'UTR
   polymorphism. This study was supported by Danish Research Council (Grant
   number 2052-03-0016) and a scholarship from the Danish Graduate School
   in Public Health Science and from the Faculty of Medicine at University
   of Copenhagen.
CR Abiaka C, 2002, J CLIN LAB ANAL, V16, P167, DOI 10.1002/jcla.10037
   Aburatani H, 1997, CANCER RES, V57, P2151
   Andersen HR, 1997, CLIN CHEM, V43, P562
   Baliga MS, 2007, BIOL TRACE ELEM RES, V115, P227, DOI 10.1007/BF02685998
   Baliga MS, 2008, MOL NUTR FOOD RES, V52, P1300, DOI 10.1002/mnfr.200800020
   BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444
   Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X
   Beevi SS, 2007, CLIN CHIM ACTA, V375, P119, DOI 10.1016/j.cca.2006.06.028
   Belsten JL, 1995, EUR J CLIN NUTR, V49, P921
   CHADA S, 1989, BLOOD, V74, P2535
   Cox DG, 2004, CANCER EPIDEM BIOMAR, V13, P1821
   DIANZANI MU, 1985, ALCOHOL ALCOHOLISM, V20, P161
   Dragsted LO, 2004, AM J CLIN NUTR, V79, P1060
   Drew JE, 2005, FEBS LETT, V579, P6135, DOI 10.1016/j.febslet.2005.09.085
   GALLO V, 2008, VALIDATION BIOMARKER
   Goodman JE, 2006, INT J CANCER, V118, P1790, DOI 10.1002/ijc.21523
   GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005
   Hansen R, 2005, CANCER LETT, V229, P85, DOI 10.1016/j.canlet.2005.04.019
   Hu YJ, 2003, CANCER RES, V63, P3347
   KESHAVARZIAN A, 1992, NUTR CANCER, V17, P243, DOI 10.1080/01635589209514193
   Kim JI, 2003, WORLD J GASTROENTERO, V9, P956
   Kondo S, 2000, CLIN CANCER RES, V6, P1394
   LAURITSEN J, 1997, DAN MED B, V44, P535
   Lee DH, 2006, CANCER RES, V66, P9845, DOI 10.1158/0008-5472.CAN-06-0732
   Lloyd DR, 1997, CHEM RES TOXICOL, V10, P393, DOI 10.1021/tx960158q
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363
   MOSCOW JA, 1992, J BIOL CHEM, V267, P5949
   NEVE J, 1995, J TRACE ELEM MED BIO, V9, P65, DOI 10.1016/S0946-672X(11)80013-1
   OTAMIRI T, 1989, CANCER, V64, P422, DOI 10.1002/1097-0142(19890715)64:2<422::AID-CNCR2820640214>3.0.CO;2-2
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Raaschou-Nielsen O, 2007, CANCER LETT, V247, P293, DOI 10.1016/j.canlet.2006.05.006
   Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010
   Ratnasinghe D, 2000, CANCER RES, V60, P6381
   Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267
   ROBINSON MF, 1979, AM J CLIN NUTR, V32, P1477
   RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016
   SAEDI MS, 1988, BIOCHEM BIOPH RES CO, V153, P855, DOI 10.1016/S0006-291X(88)81174-4
   SCHUMACHER JN, 1977, J AGR FOOD CHEM, V25, P310, DOI 10.1021/jf60210a003
   Seitz HK, 2005, DIGEST DIS, V23, P297, DOI 10.1159/000090177
   Skrzydlewska E, 2005, WORLD J GASTROENTERO, V11, P403, DOI 10.3748/wjg.v11.i3.403
   Tas F, 2005, MED ONCOL, V22, P11, DOI 10.1385/MO:22:1:011
   Tjonneland A, 1999, AM J CLIN NUTR, V69, P49
   Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986
   Vogel U, 2004, CANCER EPIDEM BIOMAR, V13, P1412
   Vogel U, 2003, CANCER EPIDEM BIOMAR, V12, P170
   WHANGER PD, 1988, FASEB J, V2, P2996
   Yildiz L, 2002, CLIN CHEM LAB MED, V40, P612, DOI 10.1515/CCLM.2002.106
NR 48
TC 58
Z9 59
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0027-5107
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD MAY 12
PY 2009
VL 664
IS 1-2
BP 13
EP 19
DI 10.1016/j.mrfmmm.2009.01.009
PG 7
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 449XM
UT WOS:000266364100003
PM 19428376
DA 2018-10-19
ER

PT J
AU Fathi, MH
   Zahrani, EM
AF Fathi, M. H.
   Zahrani, E. Mohammadi
TI Fabrication and characterization of fluoridated hydroxyapatite
   nanopowders via mechanical alloying
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Ceramics; Nanostructured materials; Mechanical alloying; X-ray
   diffraction
ID SUBSTITUTED HYDROXYAPATITE; FLUORAPATITE; FLUORINE; SUBSTRATE;
   COMPOSITES; STABILITY; PHOSPHATE; CERAMICS; COATINGS; BEHAVIOR
AB The aim of this work was preparation and characterization of fluoridated hydroxyapatite (FHA) nanopowders with different degrees of fluoridation via mechanical alloying (MA) method. FHA nanopowders; with a chemical composition of Ca-10(PO4)(6)OH2-xFx (where x values were selected equal to 0.0, 0.5, 1.0. 1.5, and 2.0) were synthesized using a mixture of appropriate amounts of calcium hydroxide, phosphorous pentoxide, and calcium fluoride powders by 6 h of mechanical alloying at 300 rpm, using eight balls with a diameter of 20 mm, and the ball-to-powder weight ratio equal to 35:1. X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), Fourier transform infrared (FTIR) spectroscopy, and ICP-OES analysis techniques were utilized in order to evaluate phase composition, agglomerates size distribution, morphology and particle size, functional groups, and purity of synthesized FHA nanopowders. The FTIR result combined with the X-ray diffraction indicated that single phase of homogeneous FHA with the carbonate peaks in the FTIR spectrum could be prepared after 6 h MA. TEM photomicrograph revealed that obtained powder after 6 h of MA was composed of FHA nanoparticles (35-65 nm). The results of ICP-OES analysis illustrated that synthesized nanopowder could fulfill the requirement of ASTM F1185-88 to be used as a biomaterial. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Fathi, M. H.; Zahrani, E. Mohammadi] Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
RP Zahrani, EM (reprint author), Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
EM emohamadizahrani@gmail.com
RI Mohammadi Zahrani, Ehsan/G-6037-2011
OI Mohammadi Zahrani, Ehsan/0000-0001-7562-3569
FU Isfahan University of Technology
FX The authors are grateful to Isfahan University of Technology for
   supporting of this research.
CR Arami H, 2009, J ALLOY COMPD, V469, P391, DOI 10.1016/j.jallcom.2008.01.116
   *ASTM, 1988, ASTM F, V1185, P415
   Chen YM, 2005, BIOMATERIALS, V26, P1205, DOI 10.1016/j.biomaterials.2004.04.027
   Cheng K, 2006, J SOL-GEL SCI TECHN, V38, P13, DOI 10.1007/s10971-005-5630-5
   Cheng K, 2005, BIOMATERIALS, V26, P6288, DOI 10.1016/j.biomaterials.2005.03.041
   Cheng K, 2003, MATER RES BULL, V38, P89, DOI 10.1016/S0025-5408(02)00985-6
   Cho JS, 2008, J ALLOY COMPD, V464, P282, DOI 10.1016/j.jallcom.2007.09.092
   Fathi MH, 2007, MATER LETT, V61, P3978, DOI 10.1016/j.matlet.2007.01.028
   Feki H. E., 1999, J ALLOY COMPD, V287, P114
   HENCH LL, 1998, INTRO BIOCERAMICS
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim HW, 2004, BIOMATERIALS, V25, P2919, DOI 10.1016/j.biomaterials.2003.09.074
   Kim HW, 2003, J MATER SCI-MATER M, V14, P899, DOI 10.1023/A:1025638811361
   Kurmaev EZ, 2002, J MATER SCI-MATER M, V13, P33, DOI 10.1023/A:1013626316980
   Lafon JP, 2008, J EUR CERAM SOC, V28, P139, DOI 10.1016/j.jeurceramsoc.2007.06.009
   Murugan R, 2005, J CRYST GROWTH, V274, P209, DOI 10.1016/j.jcrysgro.2004.09.069
   Oh SH, 2008, J ALLOY COMPD, V452, P389, DOI 10.1016/j.jallcom.2006.10.153
   Okazaki M, 1998, BIOMATERIALS, V19, P611, DOI 10.1016/S0142-9612(97)00151-8
   Qu H, 2005, J MATER SCI-MATER M, V16, P129, DOI 10.1007/s10856-005-5943-5
   REY C, 1995, BONE, V16, P583, DOI 10.1016/8756-3282(95)00101-I
   Rodriguez-Lorenzo LM, 2003, BIOMATERIALS, V24, P3777, DOI 10.1016/S0142-9612(03)00259-X
   Sakasegawa H, 2008, J ALLOY COMPD, V452, P2, DOI 10.1016/j.jallcom.2007.01.177
   Sheu HH, 2009, J ALLOY COMPD, V469, P483, DOI 10.1016/j.jallcom.2008.02.019
   Shi H, 2008, J ALLOY COMPD, V455, P207, DOI 10.1016/j.jallcom.2007.01.079
   Shih WJ, 2007, J ALLOY COMPD, V434, P693, DOI 10.1016/j.jallcom.2006.08.225
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Taylor MG, 2001, PHYS CHEM CHEM PHYS, V3, P1514, DOI 10.1039/b005666i
   Wang JH, 2008, J ALLOY COMPD, V456, P139, DOI 10.1016/j.jallcom.2007.02.027
   Wei M, 2003, J MATER SCI-MATER M, V14, P311, DOI 10.1023/A:1022975730730
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
   Yoon BH, 2005, BIOMATERIALS, V26, P2957, DOI 10.1016/j.biomaterials.2004.07.062
   Zhang HG, 2005, MATER RES BULL, V40, P1326, DOI 10.1016/j.materresbull.2005.04.005
   Zhu RH, 2008, J ALLOY COMPD, V457, P555, DOI 10.1016/j.jallcom.2007.03.081
NR 34
TC 48
Z9 49
U1 2
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD MAY 5
PY 2009
VL 475
IS 1-2
BP 408
EP 414
DI 10.1016/j.jallcom.2008.07.058
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 443LO
UT WOS:000265911700089
DA 2018-10-19
ER

PT J
AU Hu, WW
   Lang, MW
   Krebsbach, PH
AF Hu, Wei-Wen
   Lang, Michael W.
   Krebsbach, Paul H.
TI Digoxigenin modification of adenovirus to spatially control gene
   delivery from chitosan surfaces
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Antibody; Tissue engineering; Adenovirus; Digoxigenin; Gene delivery
ID GROWTH-FACTOR DELIVERY; ANTIBODY-TETHERED ADENOVIRUS; BONE REGENERATION;
   VECTOR DELIVERY; POLYMER SCAFFOLDS; THERAPY; IMMOBILIZATION;
   ANGIOGENESIS; HYDROGELS; PROTEINS
AB To spatially control the delivery of multiple viral vectors from biomaterial scaffolds, digoxigenin (DIG) was conjugated to adenoviral capsid proteins as an antigenic determinant for antibody immobilization. The infectivity, toxicity, specificity and immobilization stability of DIG-modified adenovirus were examined to investigate the feasibility and effectiveness of this viral surface modification. Anti-DIG antibody conjugated on chitosan surfaces was able to immobilize DIG-modified adenovirus and could be stably bound on the material for at least two weeks, yet the modification was mild enough that viral infectivity was maintained. To immobilize two different adenoviruses, wax masking was applied to conjugate anti-DIG and anti-adenovirus antibodies in two discrete regions of a chitosan film. The distribution of these two viral vectors expressing different reporter genes was examined after cell culture. Fluorescent protein expression from transduced cells illustrated that the infection distribution could be controlled: one gene was delivered to the entire region of the biomaterial, and another was only delivered to defined regions. Compared to three other cardiac glycosides, ATPase inhibition was undetectable when DIG was conjugated on the adenovirus, suggesting that the method may be safe for in vivo application. This dual viral vector delivery system should be capable of generating distinct interfaces between cell signaling viruses to control tissue regeneration from a range of different biomaterials. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Hu, Wei-Wen; Lang, Michael W.; Krebsbach, Paul H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   [Hu, Wei-Wen; Krebsbach, Paul H.] Univ Michigan, Sch Biomed Engn, Ann Arbor, MI 48109 USA.
RP Krebsbach, PH (reprint author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, 1011 N Univ Ave,K1030, Ann Arbor, MI 48109 USA.
EM paulk@umich.edu
FU National Institutes of Health [RO1 DE018890]
FX The research was supported by a grant from the National Institutes of
   Health grant RO1 DE018890 (PHK).
CR Abrahams JM, 2002, STROKE, V33, P1376, DOI 10.1161/01.STR.0000014327.03964.C0
   Alden TD, 2000, J CRANIOFAC SURG, V11, P24, DOI 10.1097/00001665-200011010-00005
   Ashinoff RL, 2004, ANN PLAS SURG, V52, P585, DOI 10.1097/01.sap.0000123.23.28874.1e
   Bengali Z, 2005, MRS BULL, V30, P659, DOI 10.1557/mrs2005.193
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   CHAN ELP, 1992, CLIN BIOCHEM, V25, P15, DOI 10.1016/0009-9120(92)80040-N
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Fishbein I, 2006, P NATL ACAD SCI USA, V103, P159, DOI 10.1073/pnas.0502945102
   Fishbein I, 2005, J CONTROL RELEASE, V109, P37, DOI 10.1016/j.jconrel.2005.09.031
   Gifford SC, 2006, TRANSFUSION, V46, P578, DOI 10.1111/j.1537-2995.2006.00776.x
   Grossman PM, 2002, CATHETER CARDIO INTE, V55, P392, DOI 10.1002/ccd.10136
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hobson DA, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-4
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Hu WW, 2008, J GENE MED, V10, P1102, DOI 10.1002/jgm.1233
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Lindsey WH, 2001, LARYNGOSCOPE, V111, P1128, DOI 10.1097/00005537-200107000-00003
   Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Peng HR, 2005, MOL THER, V12, P239, DOI 10.1016/j.ymthe.2005.02.027
   Qiang BP, 2004, J CONTROL RELEASE, V98, P447, DOI 10.1016/j.conrel.2004.05.017
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   SMITH TW, 1973, NEW ENGL J MED, V289, P945, DOI 10.1056/NEJM197311012891805
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   SOLDIN SJ, 1986, CLIN CHEM, V32, P5
   Spalazzi JP, 2008, J BIOMED MATER RES A, V86A, P1, DOI 10.1002/jbm.a.32073
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tepper OM, 2002, PLAST RECONSTR SURG, V109, P716, DOI 10.1097/00006534-200202000-00047
   Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015
   Yao F, 2000, WOUND REPAIR REGEN, V8, P443, DOI 10.1046/j.1524-475x.2000.00443.x
   Zhang YF, 2007, BIOMATERIALS, V28, P4635, DOI 10.1016/j.biomaterials.2007.07.009
NR 39
TC 10
Z9 10
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAY 5
PY 2009
VL 135
IS 3
BP 250
EP 258
DI 10.1016/j.jconrel.2009.01.020
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 440LQ
UT WOS:000265702200010
PM 19331850
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Li, JJ
   Dou, Y
   Yang, J
   Yin, YJ
   Zhang, H
   Yao, FL
   Wang, HB
   Yao, KD
AF Li, Junjie
   Dou, Yan
   Yang, Jun
   Yin, Yuji
   Zhang, Hong
   Yao, Fanglian
   Wang, Haibin
   Yao, Kangde
TI Surface characterization and biocompatibility of micro- and
   nano-hydroxyapatite / chitosan-gelatin network films
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Surface characterization; Nano-hydroxyapatite; Micro-hydroxyapatite;
   Biocompatibility; Topography; Mesenchymal stem cells
ID MESENCHYMAL STEM-CELLS; IN-VITRO EVALUATION; OSTEOBLAST ADHESION;
   CALCIUM-PHOSPHATE; HISTOLOGICAL-EVALUATION; NITI ALLOY; DIFFERENTIATION;
   PROLIFERATION; SCAFFOLDS; RGD
AB Hydroxyapatite (HA)/polymer composites have been widely used in bone tissue engineering due to theirchemical similarity to natural bone. And the surface characters of the composites are crucial to influence their biological properties. Here, nano-hydroxyapatite/chitosan-gelatin (nHCG) films were prepared via biomineralization of chitosan-gelatin (CG) network films in Ca(NO(3))(2)-Na(3)PO(4) Tris buffer solution at alkaline condition. And the micro-hydroxyapatite/chitosan-gelatin (mHCG) films were formed through immersing the CG network films into the HA crystal (with average size 5 mu m) suspensions. The Surface chemical characteristics of nHCG and mHCG were evaluated by Fourier transformed infrared (ATR-FTIR) and X-ray photoelectron spectroscopy (XPS). Surface topographies of the samples were observed by atomic force microscopy (AFM) and scanning electron microscope (SEM). Results suggest that the ion/polar interactions are the main drive forces for nHCG formation via biornineralization. And the hydrogen bonds between COOH, OH. -NH(2) of CG films and OH groups of HA crystals take the important role in the formation process of mHCG. A comparative study of mesenchymal stem cells (MSCs) behaviors on the nHCG and mHCG Surface layer was carried out. Both nHCG and mHCG have excellent biocompatibility, moreover, the MSCs on nHCG present higher osteogenic differentiation activity than on mHCG. The nHCG is a potential biomaterial in bone tissue engineering. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Li, Junjie; Zhang, Hong; Yao, Fanglian] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
   [Li, Junjie; Yin, Yuji; Yao, Kangde] Tianjin Univ, Res Inst Polymer Mat, Tianjin 300072, Peoples R China.
   [Dou, Yan; Wang, Haibin] Shanxi Med Univ, Taiyuan 030001, Peoples R China.
   [Yang, Jun] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China.
RP Yao, FL (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
EM yaofanglian@tju.edu.cn; ripm@tju.edu.cn
RI Li, Junjie/B-7068-2012
OI Li, Junjie/0000-0003-2152-6952
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004419900074
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Chen F, 2007, J BIOMED MATER RES B, V82B, P183, DOI 10.1002/jbm.b.30720
   Cheng XM, 2009, MAT SCI ENG C-BIO S, V29, P29, DOI 10.1016/j.msec.2008.05.008
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Chesnutt BM, 2007, J BIOMED MATER RES A, V82A, P343, DOI 10.1002/jbm.a.31070
   Cui ZD, 2008, MAT SCI ENG C-BIO S, V28, P1117, DOI 10.1016/j.msec.2007.05.006
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Driessens FCM, 2002, BIOMATERIALS, V23, P4011, DOI 10.1016/S0142-9612(02)00151-5
   Evans ND, 2006, MATER TODAY, V9, P26, DOI 10.1016/S1369-7021(06)71740-0
   Lee HJ, 2007, EUR POLYM J, V43, P1602, DOI 10.1016/j.eurpolymj.2007.02.030
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Li CY, 2007, MAT SCI ENG C-BIO S, V27, P122, DOI 10.1016/j.msec.2006.03.004
   Li JJ, 2008, MATER LETT, V62, P3220, DOI 10.1016/j.matlet.2008.02.072
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Liao S, 2007, ACTA BIOMATER, V3, P669, DOI [10.1016/j.actbio.2007.03.007, 10.1016/j.aetbio.2007.03.007]
   Liu HF, 2005, J BIOMATER APPL, V19, P303, DOI 10.1177/0885328205048590
   Ma S, 2005, J Oral Implantol, V31, P61, DOI 10.1563/0-742.1
   Masanori K., 2004, COMPOS SCI TECHNOL, V64, P819
   Minguell JJ, 2001, EXP BIOL MED, V226, P507
   Miyamoto Y, 1998, BIOMATERIALS, V19, P707, DOI 10.1016/S0142-9612(97)00186-5
   Monkawa A, 2006, MATER LETT, V60, P3647, DOI 10.1016/j.matlet.2006.03.076
   Murugan R, 2005, CRYST GROWTH DES, V5, P111, DOI 10.1021/cg034227s
   Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069
   Papageorgiou I, 2007, BIOMATERIALS, V28, P2946, DOI 10.1016/j.biomaterials.2007.02.034
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Santis D., 1996, J MATER SCI-MATER M, V7, P21
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   Serizawa T, 2001, J BIOMAT SCI-POLYM E, V12, P1293, DOI 10.1163/156856202753419231
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Tanaka T, 2007, MAT SCI ENG C-BIO S, V27, P817, DOI 10.1016/j.msec.2006.09.019
   Weissenbock M, 2006, CELLS TISSUES ORGANS, V182, P79, DOI 10.1159/000093062
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yin YJ, 2000, J APPL POLYM SCI, V77, P2929
   Zahor D, 2007, MAT SCI ENG C-BIO S, V27, P117, DOI 10.1016/j.msec.2006.03.005
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 42
TC 74
Z9 78
U1 2
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY 5
PY 2009
VL 29
IS 4
BP 1207
EP 1215
DI 10.1016/j.msec.2008.09.038
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 485QX
UT WOS:000269139900025
DA 2018-10-19
ER

PT J
AU Oh, WC
   Jung, AR
   Ko, WB
AF Oh, Won-Chun
   Jung, Ah-Reum
   Ko, Weon-Bae
TI Characterization and relative photonic efficiencies of a new
   nanocarbon/TiO2 composite photocatalyst designed for organic dye
   decomposition and bactericidal activity
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Nanocarbon; Titanium (IV) n-butoxide; Organic dye; Bactericidal effect
ID ANATASE-TYPE TIO2; CARBON NANOTUBES; BIOMATERIAL SYSTEM; ACTIVATED
   CARBON; SURFACE; NANOPARTICLES; DERIVATIVES; ACID
AB Two kinds of nanocarbon/TiO2 composite photocatalysts were synthesized using an MCPBA oxidation method, employing MWCNT (multi-wall carbon nanotubes) and C-60 as nanocarbon sources and TNB (titanium (IV) n-butoxide) as a titanium dioxide source. From the XRD patterns of the composites, structural variations revealed the C-60/TiO2 composite having a mixture of anatase and rutile forms, with the MWCNT/TiO2 composite presenting only the anatase phase. Elemental analysis indicated a predominance of carbon and Ti metal peaks over any other element. From the SEM results, the TiO2 particles were dispersed regularly on the fullerene surface with large clusters bearing irregular agglomerate dispersions. However, the MWCNT/TiO2 showed homogenous distributions with only individual MWCNT, covered with TiO2 and without any jam-like aggregates between the two. According to the photocatalytic results. the relationship of the -In (c/c(0)) of the solution products of the organic dye, methylene blue (MB), as a function of time under UV irradiation, showed linearity properties with first-order kinetics and an excellent photodegradation effect. From the measured bactericidal effects, the inhibition zone was defined by the halo method with the curves of E. coli inactivation denoting effectiveness of the nanocarbon/TiO2 composites in the sunlight. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Oh, Won-Chun; Jung, Ah-Reum] Hanseo Univ, Dept Adv Mat Sci & Engn, Chungnam 356706, South Korea.
   [Ko, Weon-Bae] Sahmyook Univ, Dept Chem, Seoul 139742, South Korea.
RP Oh, WC (reprint author), Hanseo Univ, Dept Adv Mat Sci & Engn, Chungnam 356706, South Korea.
EM wc_oh@hanseo.ac.kr
CR Akiyama T, 2000, COLLOID SURFACE A, V169, P137, DOI 10.1016/S0927-7757(00)00426-X
   Berman E., 1980, TOXIC METALS THEIR A, P116
   Cao G., 2004, NANOSTRUCTURES NANOM, P344
   Chen ML, 2007, J CERAM PROCESS RES, V8, P119
   Dang H, 2002, J AM CHEM SOC, V124, P136, DOI 10.1021/ja016189b
   DARGON G, 1993, J PHYS CHEM-US, V97, P12651
   Drees M, 2002, APPL PHYS LETT, V81, P4607, DOI 10.1063/1.1522830
   DRESSELHAUS MS, 1996, SCI FULLERENE CARBON, P587
   HARRIES GD, 1987, WATER RES, V21, P689
   Hernadi K, 2003, ACTA MATER, V51, P1447, DOI 10.1016/S1359-6454(02)00539-6
   Inagaki M, 2003, CARBON, V41, P2619, DOI 10.1016/S0008-6223(03)00340-3
   Jitianu A, 2004, CARBON, V42, P1147, DOI 10.1016/j.carbon.2003.12.041
   Kaneko M., 1999, PHOTOCATALYSIS SCI T, P124
   KANMAT PV, 1997, J PHYS CHEM B, V101, P4422
   Kikuchi Y, 1997, J PHOTOCH PHOTOBIO A, V106, P51, DOI 10.1016/S1010-6030(97)00038-5
   Langa F, 2002, J MATER CHEM, V12, P2130, DOI 10.1039/b203112b
   Maldonado-Hodar FJ, 2000, APPL CATAL A-GEN, V203, P151, DOI 10.1016/S0926-860X(00)00480-4
   OCONNELL MJ, 2006, CARBON NANOTUBES PRO, P213
   Oh W. C., 2007, CARBON SCI, V8, P6
   Oh W. C., 2006, ANAL SCI TECHNOLOGY, V19, P376
   Oh W.C., 2006, B KOREAN CHEM SOC, V27, P1423
   Oh W.C., 2007, CARBON SCI, V8, P108
   Oh W.C., 2006, CARBON SCI, V7, P259
   Oh WC, 2004, B KOR CHEM SOC, V25, P639
   Oh WC, 2003, CARBON, V41, P1737, DOI 10.1016/S0008-6223(03)00119-2
   OH WC, 2007, ANAL SCI TECHNOL, V20, P124
   OH WC, 2007, P INT C CARB CARBON, P284
   OH WC, 2006, ANAL SCI TECHNOL, V19, P460
   Oh WC, 2007, ANAL SCI TECHNOL, V20, P279
   OLLIS DF, 1993, PHOTCATALYTIC PURIFI, P265
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rincon AG, 2001, J PHOTOCH PHOTOBIO A, V139, P233, DOI 10.1016/S1010-6030(01)00374-4
   Robert D, 2000, APPL SURF SCI, V167, P51, DOI 10.1016/S0169-4332(00)00496-7
   Seeger T, 2001, CHEM PHYS LETT, V339, P41, DOI 10.1016/S0009-2614(01)00256-1
   Sun BY, 2002, ELECTROCHIM ACTA, V47, P3545, DOI 10.1016/S0013-4686(02)00355-9
   Sun J., 2004, CARBON, V42, P885
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tsumura T, 2002, J MATER CHEM, V12, P1391, DOI 10.1039/b201942f
   Wang WD, 2005, J MOL CATAL A-CHEM, V235, P194, DOI 10.1016/j.molcata.2005.02.027
   Wang WD, 2008, MATER RES BULL, V43, P958, DOI 10.1016/j.materresbull.2007.04.032
   Yu KF, 2005, MATER LETT, V59, P3563, DOI 10.1016/j.matlet.2005.06.028
   Yu Y, 2005, APPL CATAL A-GEN, V289, P186, DOI 10.1016/j.apcata.2005.04.057
NR 42
TC 64
Z9 68
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY 5
PY 2009
VL 29
IS 4
BP 1338
EP 1347
DI 10.1016/j.msec.2008.10.034
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 485QX
UT WOS:000269139900047
DA 2018-10-19
ER

PT J
AU Donato, TAG
   de Almeida, LH
   Nogueira, RA
   Niemeyer, TC
   Grandini, CR
   Caram, R
   Schneider, SG
   Santos, AR
AF Donato, Tatiani A. G.
   de Almeida, Luciano H.
   Nogueira, Renata A.
   Niemeyer, Terlize C.
   Grandini, Carlos R.
   Caram, Rubens
   Schneider, Sandra G.
   Santos, Arnaldo R., Jr.
TI Cytotoxicity study of some Ti alloys used as biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Biocompatibility; Ti alloys; Cytotoxicity; Cell culture
ID TITANIUM-ALLOYS; VERO CELLS; MECHANICAL-PROPERTIES; PLASMA IMMERSION;
   BEHAVIOR; IRRADIATION; COMPOSITES; WEAR
AB An implanted material is considered biocompatible, if adverse and uncontrollable reactions don't exist in the biological system. in this sense, biocompatibility tests made in the constituent materials are very important so that the implants have Success. The in vitro cytotoxicity tests represent the initial phase of the process, and Could be considered as a pre-selection of those materials. in vitro techniques using cell culture have become widely used in the evaluation of biomaterial cytotoxicity, which has contributed to their standardization and the substitution of in vivo tests. This paper shows a study of the in vitro cytotoxicity of two Ti based alloys, Ti-13Nb-13Zr and Ti-35Nb-7Zr-5Ta, in the as-received condition and after heat treated. The results show that the alloys presented no cytotoxic effects in the studied conditions. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Donato, Tatiani A. G.; de Almeida, Luciano H.; Nogueira, Renata A.; Niemeyer, Terlize C.; Grandini, Carlos R.] UNESP, Grp Relaxacoes Anelast, BR-17033360 Bauru, SP, Brazil.
   [Caram, Rubens] Univ Estadual Campinas, Dept Mat Engn, BR-13083970 Campinas, SP, Brazil.
   [Schneider, Sandra G.] USP, Escola Engn Lorena, BR-12600970 Lorena, SP, Brazil.
   [Santos, Arnaldo R., Jr.] Univ Fed Abc, Ctr Ciencias Nat & Humanas, BR-09090400 Santo Andre, SP, Brazil.
RP Grandini, CR (reprint author), UNESP, Grp Relaxacoes Anelast, BR-17033360 Bauru, SP, Brazil.
EM betog@fc.unesp.br
RI Niemeyer, Terlize/A-7995-2013; Schneider, Sandra/E-6087-2015; Biofabris,
   Inct/I-2418-2013; Grandini, Carlos Roberto/A-3790-2008; Caram,
   Rubens/C-2068-2012; Santos, Jr, Arnaldo/I-4813-2012
OI Niemeyer, Terlize/0000-0002-8887-8226; Grandini, Carlos
   Roberto/0000-0002-3336-309X; Caram, Rubens/0000-0001-6996-5116; 
FU Capes; CNPq; FAPESP
FX The authors wish to thank the Brazilian agencies Capes, CNPq and FAPESP
   for their financial support.
CR [Anonymous], 1992, 109935E ISO
   Arisu HD, 2006, LASER MED SCI, V21, P175, DOI 10.1007/s10103-006-0398-6
   ATALA A, 2002, METHODS TISSUE ENG
   Black J., 1992, BIOL PERFORMANCE MAT
   Cheng WW, 2003, MATER LETT, V57, P2591, DOI 10.1016/S0167-577X(02)01316-2
   Ciapetti G, 1996, BIOMATERIALS, V17, P1259, DOI 10.1016/0142-9612(96)88670-4
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Fast J.D., 1976, GASES METALS
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Gorsse S, 2003, ACTA MATER, V51, P2427, DOI 10.1016/S1359-6454(02)00510-4
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   KENNY MT, 1975, J BIOL STAND, V3, P291, DOI 10.1016/0092-1157(75)90033-5
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   KIRKPATRICK CJ, 1992, REGULATORY AFFAIRS, V4, P13
   Lee E, 1997, ECON IND DEMOCRACY, V18, P35, DOI 10.1177/0143831X97181002
   Liu YC, 2003, MATER LETT, V57, P2262, DOI 10.1016/S0167-577X(02)01207-7
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lucchesi C, 2008, J MATER SCI-MATER M, V19, P635, DOI 10.1007/s10856-007-0169-3
   MATSUDA T, 1987, BIOMATERIALS, V8, P257
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Oh JC, 2003, MAT SCI ENG A-STRUCT, V351, P98, DOI 10.1016/S0921-5093(02)00821-3
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Santos AR, 2004, ARTIF ORGANS, V28, P381, DOI 10.1111/j.1525-1594.2004.47199.x
   SCHLIEPHAKE H, 1993, INT J ORAL MAX SURG, V22, P20, DOI 10.1016/S0901-5027(05)80350-9
   Steinemann S., 1980, EVALUATION BIOMATERI
   Uzumaki ET, 2006, THIN SOLID FILMS, V515, P293, DOI 10.1016/j.tsf.2005.12.081
   Uzumaki ET, 2006, KEY ENG MAT, V309-311, P367, DOI 10.4028/www.scientific.net/KEM.309-311.367
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wu TI, 2003, MATER CHEM PHYS, V80, P150, DOI 10.1016/S0254-0584(02)00453-4
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
NR 31
TC 28
Z9 28
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY 5
PY 2009
VL 29
IS 4
BP 1365
EP 1369
DI 10.1016/j.msec.2008.10.021
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 485QX
UT WOS:000269139900052
DA 2018-10-19
ER

PT J
AU Borisenko, KB
   Zhao, Q
   Abel, EW
AF Borisenko, K. B.
   Zhao, Q.
   Abel, E. W.
TI Computational design of electrostatic potential to maximise or minimise
   adhesion to surfaces
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Computer simulation; Electrostatic interactions; Free energy difference;
   Adsorption; Biomaterial surfaces
ID DENSITY; ADSORPTION; ENERGY; LAYERS
AB The free energy of adsorption based on electrostatic interactions only has been optimised for glycine on a (111) diamond surface in continuum water to show maximum adhesion or maximum repulsion by adjusting the partial point charge distribution in the diamond surface model. It has been found that the free energy of adhesion is readily maximised by means of increasing the polarity of the electrostatic surface potential in a distinctive dipolar pattern. The maximum adhesion obtained in the present calculations was - 21.02 +/- 0.49 kJ mol(-1). The surface with the maximum repulsion. which would be of particular interest for designing novel surfaces with low protein adsorption, had a mostly uniform, slightly positive, surface electrostatic potential with a specific irregular pattern. The maximum free energy of repulsion achieved in the present simulations was 0.08 +/- 0.01 kJ mol(-1). These values suggest that most real surfaces are more likely to be overall attractive due to electrostatic interactions of the partial surface charges, and that the overall energy of repulsion, although theoretically possible, is likely to be small. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Borisenko, K. B.; Zhao, Q.; Abel, E. W.] Univ Dundee, Sch Engn & Phys Sci, Dundee DD1 4HN, Scotland.
RP Abel, EW (reprint author), Univ Dundee, Sch Engn & Phys Sci, Dundee DD1 4HN, Scotland.
EM e.w.abel@dundee.ac.uk
OI Borisenko, Konstantin/0000-0002-2368-4500
FU Department of Health, UK
FX We thank the Department of Health, UK for financial support.
CR BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Borisenko KB, 2008, J BIOMED MATER RES A, V86A, P1113, DOI 10.1002/jbm.a.31700
   Erol M, 2006, LANGMUIR, V22, P11329, DOI 10.1021/la061790e
   Frisch M. J., 2004, GAUSSIAN 03 REVISION
   Grant ML, 2001, J PHYS CHEM B, V105, P2858, DOI 10.1021/jp0039823
   Kangas E, 1999, PHYS REV E, V59, P5958, DOI 10.1103/PhysRevE.59.5958
   Kangas E, 2000, J CHEM PHYS, V112, P9120, DOI 10.1063/1.481522
   KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   MARSAGLIA G, 1972, ANN MATH STAT, V43, P645, DOI 10.1214/aoms/1177692644
   MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980
   Parbhu A, 2006, FOOD BIOPROD PROCESS, V84, P274, DOI 10.1205/fbp06025
   Ramaekers R, 2004, J CHEM PHYS, V120, P4182, DOI 10.1063/1.1643735
   Suci PA, 2005, LANGMUIR, V21, P8686, DOI 10.1021/la050217c
   Valle-Delgado JJ, 2006, LANGMUIR, V22, P5108, DOI 10.1021/la053011k
NR 16
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY 5
PY 2009
VL 29
IS 4
BP 1458
EP 1462
DI 10.1016/j.msec.2008.11.018
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 485QX
UT WOS:000269139900066
DA 2018-10-19
ER

PT J
AU Hulander, M
   Hong, J
   Andersson, M
   Gerven, F
   Ohrlander, M
   Tengvall, P
   Elwing, H
AF Hulander, Mats
   Hong, Jaan
   Andersson, Marcus
   Gerven, Frida
   Ohrlander, Mattias
   Tengvall, Pentti
   Elwing, Hans
TI Blood Interactions with Noble Metals: Coagulation and Immune Complement
   Activation
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE silver; palladium; gold; titanium; immune complement; protein
   adsorption; coagulation; platelets; nanostructure; QCM-D
ID COATED URINARY CATHETERS; IN-VITRO MODEL; PROTEIN ADSORPTION;
   CONFORMATIONAL-CHANGES; SURFACE WETTABILITY; PLATELET-ADHESION; ADSORBED
   FIBRINOGEN; ARTIFICIAL SURFACES; TITANIUM-OXIDE; WHOLE-BLOOD
AB Noble metals are interesting biomaterials for a number of reasons, e.g., their chemical inertness and relative mechanical softness, silver's long known antimicrobial properties, and the low allergenic response shown by gold. Although important for the final outcome of biomaterials, little is reported about early events between pure noble metals and blood. In this article, we used whole blood in the "slide chamber model" to study the activation of the immune complement activation, generation of thrombin/antithrombin (TAT) complexes, and platelet depletion from blood upon contact with silver (Ag), palladium (Pd), gold (Au), titanium (Ti), and Bactiguard, a commercial nanostructured biomaterial coating comprised of Ag, Pd, and Au. The results show the highest TAT generation and platelet depletion on Ti and Au and lower on Pd, Ag, and the Bactiguard coating. The immune complement factor 3 fragment (C3a) was generated by the surfaces in the following order: Ag > Au > Pd > Bactiguard > Ti. Quartz crystal microbalance adsorption studies with human fibrinogen displayed the highest deposition to Ag and the lowest onto the Bactiguard coating. The adsorbed amounts of fibrinogen did not correlate with thrombogenicity in terms of TAT formation and platelet surface accumulation in blood. The combined results suggest, hence, that noble metal chemistry has a different impact on the protein adsorption properties and general blood compatibility. The low thrombogenic response by the Bactiguard coating cannot be explained by any of the single noble metal properties but is likely a successful combination of the nanostructure, nanogalvanic effects, or combinatory chemical and physical materials properties.
C1 [Hulander, Mats; Andersson, Marcus; Gerven, Frida; Elwing, Hans] Gothenburg Univ, Dept Cell & Mol Biol Interface Biophys, S-41390 Gothenburg, Sweden.
   [Hong, Jaan] Uppsala Univ, Div Clin Immunol, SE-75105 Uppsala, Sweden.
   [Ohrlander, Mattias] Bactiguard AB, S-10242 Stockholm, Sweden.
   [Tengvall, Pentti] Gothenburg Univ, Sahlgrenska Acad, Dept Biomat Sci, S-41390 Gothenburg, Sweden.
RP Hulander, M (reprint author), Gothenburg Univ, Dept Cell & Mol Biol Interface Biophys, Med Regatan 9E, S-41390 Gothenburg, Sweden.
EM mats.hulander@cmb.gu.se
FU Bactiguard AB
FX The authors acknowledge Bactiguard AB for financing this research
   project and Helen Karlholm and Billy Sodervall at Bactiguard AB for
   laboratory support. We also thank Bo Thuner at Linkoping University for
   his expertise in the PVD of metals.
CR Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Chang QY, 2007, LANGMUIR, V23, P11197, DOI 10.1021/la701006r
   Chiang WC, 2008, ELECTROCHIM ACTA, V54, P108, DOI 10.1016/j.electacta.2008.02.112
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Harter C, 2002, CANCER, V94, P245, DOI 10.1002/cncr.10199
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   Holmberg M, 2008, J MATER SCI-MATER M, V19, P2179, DOI 10.1007/s10856-007-3318-9
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hornez JC, 2002, BIOMOL ENG, V19, P103, DOI 10.1016/S1389-0344(02)00017-5
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jarvis RA, 2005, J BIOMED MATER RES A, V75A, P41, DOI 10.1002/jbm.a.30404
   Johne J, 2006, BIOL CHEM, V387, P173, DOI 10.1515/BC.2006.023
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Karchmer TB, 2000, ARCH INTERN MED, V160, P3294, DOI 10.1001/archinte.160.21.3294
   Locci P, 2000, J BIOMED MATER RES, V51, P561, DOI 10.1002/1097-4636(20000915)51:4<561::AID-JBM3>3.0.CO;2-H
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   Merchant B, 1998, BIOLOGICALS, V26, P49, DOI 10.1006/biol.1997.0123
   Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83
   Podolnikova NP, 2003, J BIOL CHEM, V278, P32251, DOI 10.1074/jbc.M300410200
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Saint S, 1998, AM J MED, V105, P236, DOI 10.1016/S0002-9343(98)00240-X
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7
   Song W, 2007, CHINESE SCI BULL, V52, P3169, DOI 10.1007/s11434-007-0504-6
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Turner N, 2004, CELL BIOL INT, V28, P541, DOI 10.1016/j.cellbi.2004.04.009
   Ugarova TP, 2001, ANN NY ACAD SCI, V936, P368
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Weber N, 2005, J BIOMED MATER RES A, V72A, P420, DOI 10.1002/jbm.a.30272
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
NR 55
TC 24
Z9 24
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY
PY 2009
VL 1
IS 5
BP 1053
EP 1062
DI 10.1021/am900028e
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 479NB
UT WOS:000268665200012
PM 20355891
DA 2018-10-19
ER

PT J
AU Allison, DD
   Braun, KR
   Wight, TN
   Grande-Allen, KJ
AF Allison, D. D.
   Braun, K. R.
   Wight, T. N.
   Grande-Allen, K. J.
TI Differential effects of exogenous and endogenous hyaluronan on
   contraction and strength of collagen gels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hyaluronan synthases; Ultimate tensile strength; Collagen gel
   contraction; Smooth muscle cells; Hyaluronan oligosaccharides
ID SMOOTH-MUSCLE-CELLS; MATRIX SYNTHESIS; OVEREXPRESSION; SYNTHASES;
   PROMOTES; OLIGOSACCHARIDES; PROLIFERATION; MORPHOGENESIS; ANGIOGENESIS;
   FIBROBLASTS
AB The addition of exogenous hyaluronan to biomaterial scaffolds has been an important area of investigation for many decades. The ability to manipulate endogenous production of hyaluronan via the hyaluronan synthases has offered another mechanism to study the effect of hyaluronan. While the literature suggests that exogenously added hyaluronan and endogenously produced hyaluronan will have varying impacts on extracellular matrix organization and function, no studies have directly shown this phenomenon. In this investigation, we demonstrate that the addition of exogenous high molecular weight (similar to 1 MDa) hyaluronan and hyaluronan oligosaccharides have a distinct impact on both contraction and strength of smooth muscle cell-seeded collagen gels when compared to the effects of hyaluronan that is endogenously produced by the hyaluronan synthases. More specifically, the addition of exogenous high molecular weight hyaluronan resulted in more compact collagen gels with a higher ultimate tensile strength, whereas the endogenous overproduction of hyaluronan resulted in the opposite effect. We suggest that the addition of exogenous HA to collagen gels represents a model for the therapeutic administration of HA, whereas the addition of excess HA to a tissue via the endogenous overexpression of has represents a model for the pathological accumulation of HA. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Allison, D. D.; Grande-Allen, K. J.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
   [Braun, K. R.; Wight, T. N.] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA.
RP Grande-Allen, KJ (reprint author), Rice Univ, Dept Bioengn, 6100 Main St,MS 142, Houston, TX 77005 USA.
EM grande@rice.edu
RI Grande-Allen, Kathryn/P-4042-2014
OI Grande-Allen, Kathryn/0000-0003-1533-3767
CR Allison DD, 2008, BIOMATERIALS, V29, P2969, DOI 10.1016/j.biomaterials.2008.04.005
   Allison DD, 2007, BIOMATERIALS, V28, P5509, DOI 10.1016/j.biomaterials.2007.08.037
   Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Barber JE, 2001, J HEART VALVE DIS, V10, P320
   Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272
   Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b
   Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200
   Coleman PJ, 2002, BBA-GEN SUBJECTS, V1571, P173, DOI 10.1016/S0304-4165(02)00213-1
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619
   Gupta V, 2006, CARDIOVASC RES, V72, P375, DOI 10.1016/j.cardiores.2006.08.017
   HUA Q, 1993, J CELL SCI, V106, P365
   HUANGLEE LLH, 1994, J BIOMED MATER RES, V28, P123, DOI 10.1002/jbm.820280116
   Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799
   Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875
   Joddar B, 2006, BIOMATERIALS, V27, P2994, DOI 10.1016/j.biomaterials.2006.01.020
   KINSELLA MG, 2001, CURRENT METHODS MOL, P576
   Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320
   Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LAURENT TC, 1992, FASEB J, V6, P2397
   Mehra TD, 2006, J INVEST DERMATOL, V126, P2202, DOI 10.1038/sj.jid.5700380
   Montesano R, 1996, LAB INVEST, V75, P249
   Nishida Y, 2005, EXP CELL RES, V307, P194, DOI 10.1016/j.yexcr.2005.03.026
   Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x
   ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511
   SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Spicer AP, 1997, J BIOL CHEM, V272, P8957
   Stuhlmeier KM, 2006, WIEN MED WOCHENSCHR, V156, P563, DOI 10.1007/s10354-006-0351-0
   Sussmann M, 2004, CIRC RES, V94, P592, DOI 10.1161/01.RES.0000119169.87429.A0
   Tang T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2363
   Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Toole BP, 2000, J CLIN INVEST, V106, P335, DOI 10.1172/JCI10706
   Travis JA, 2001, CIRC RES, V88, P77, DOI 10.1161/01.RES.88.1.77
   Wilkinson TS, 2006, J CELL PHYSIOL, V206, P378, DOI 10.1002/jcp.20468
   Xin XJ, 2004, J BIOMAT SCI-POLYM E, V15, P1223, DOI 10.1163/1568562041753025
NR 38
TC 10
Z9 14
U1 2
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2009
VL 5
IS 4
BP 1019
EP 1026
DI 10.1016/j.actbio.2008.11.013
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 444YQ
UT WOS:000266017200007
PM 19109082
DA 2018-10-19
ER

PT J
AU Hu, YJ
   Wei, X
   Zhao, W
   Liu, YS
   Chen, GQ
AF Hu, Ya-Jun
   Wei, Xing
   Zhao, Wei
   Liu, Yuan-Sheng
   Chen, Guo-Qiang
TI Biocompatibility of
   poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate)with
   bone marrow mesenchymal stem cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biocompatibility; PHA; PHBHHx; PLA; Tissue engineering
ID ARTICULAR-CARTILAGE CHONDROCYTES; UMBILICAL-CORD BLOOD; MICROBIAL
   POLYHYDROXYALKANOATES; AEROMONAS-HYDROPHILA; IN-VITRO; BACTERIAL
   POLYHYDROXYALKANOATES; SURFACE-ROUGHNESS; STROMAL CELLS;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); PROLIFERATION
AB As a new member of the polyhydroxyalkanoate (PHA) family, poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) (PHBVHHx) was produced by recombinant Aeromonas hydrophila 4AK4. PHBVHHx showed a rougher surface and had higher hydrophobicity than the well-studied polymers poly(L-lactic acid) (PLA) and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx). Human bone marrow mesenchymal stem cells (MSCs) adhered better on PHBVHHx film than on tissue culture plates (TCPs), PLA film and PHBHHx film. The cell number on the PHBVHHx film was 115% higher than that on the TCPs, 66% higher than on the PHBHHx film and 263% higher than on the PLA film (p<0.01). PHBVHHx also supported the osteogenic differentiation of MSCs. Previous studies have shown that all PHA polymers tested were either poorer than or equal to TCPs for supporting cell growth. PHBVHHx is the only PHA polymer to significantly increase cell numbers compared with TCPs. These data demonstrate that PHBVHHx could be a promising biomaterial for bone tissue engineering. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hu, Ya-Jun; Wei, Xing; Zhao, Wei; Chen, Guo-Qiang] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
   [Liu, Yuan-Sheng] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou 515041, Guangdong, Peoples R China.
RP Wei, X (reprint author), Shantou Univ, Multidisciplinary Res Ctr, 243 Daxue Rd, Shantou 515063, Guangdong, Peoples R China.
EM wei70@hotmail.com; chengq@stu.cdu.cn
FU Li Ka Shing Foundation; State High Tech Project [2006AA02Z 242]
FX The authors are grateful to the Li Ka Shing Foundation and State High
   Tech Project 863 Grant No. 2006AA02Z 242 for providing financial support
   to this work. We also thank members of Polymer Group and Rongcong Luo in
   MRC for technical help.
CR Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413
   Chang YJ, 2006, STEM CELLS, V24, P679, DOI 10.1634/stemcells.2004-0308
   Chen C, 2006, BIOMATERIALS, V27, P4804, DOI 10.1016/j.biomaterials.2006.04039
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   Dias JML, 2006, MACROMOL BIOSCI, V6, P885, DOI 10.1002/mabi.200600112
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   FERNANDEZCASTILLO R, 1986, APPL ENVIRON MICROB, V51, P214
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Lu XY, 2005, FEMS MICROBIOL LETT, V243, P149, DOI 10.1016/j.femsle.2004.11.051
   Meng W, 2007, J BIOMAT SCI-POLYM E, V18, P81, DOI 10.1163/156856207779146114
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Qiu YZ, 2004, MACROMOL BIOSCI, V4, P255, DOI 10.1002/mabi.200300090
   Qu XH, 2006, BIOMATERIALS, V27, P2944, DOI 10.1016/j.biomaterials.2006.01.013
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9
   TAN G, 2002, J POLYM SCI POL LETT, V40, P649
   Tsuge T, 2004, MACROMOL BIOSCI, V4, P238, DOI 10.1002/mabi.200300077
   Wang YW, 2005, BIOMACROMOLECULES, V6, P566, DOI 10.1021/bm049342d
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Xu J, 2002, POLYMER, V43, P6893, DOI 10.1016/S0032-3861(02)00615-8
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Zanchetta P, 2001, COLLOID SURFACE B, V22, P301, DOI 10.1016/S0927-7765(01)00200-4
   Zhao W, 2007, PROCESS BIOCHEM, V42, P1342, DOI 10.1016/j.procbio.2007.07.006
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
NR 43
TC 36
Z9 37
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2009
VL 5
IS 4
BP 1115
EP 1125
DI 10.1016/j.actbio.2008.09.021
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 444YQ
UT WOS:000266017200017
PM 18976972
DA 2018-10-19
ER

PT J
AU Zhu, XD
   Fan, HS
   Xiao, YM
   Li, DX
   Zhang, HJ
   Luxbacher, T
   Zhang, XD
AF Zhu, X. D.
   Fan, H. S.
   Xiao, Y. M.
   Li, D. X.
   Zhang, H. J.
   Luxbacher, T.
   Zhang, X. D.
TI Effect of surface structure on protein adsorption to biphasic
   calcium-phosphate ceramics in vitro and in vivo
SO ACTA BIOMATERIALIA
LA English
DT Article
DE BCPs; Surface structure; Protein adsorption; TGF-beta 1
ID BONE MORPHOGENETIC PROTEIN-2; BOVINE SERUM-ALBUMIN;
   LIQUID-CHROMATOGRAPHY; HYDROXYAPATITE; BIOMATERIALS; PARTICLES; TISSUE;
   OSTEOGENESIS; INTERFACES; EXCHANGE
AB Protein adsorption affects the function of cells and determines the bioactivity of biomaterial implants. Surface structure and properties of materials determine the behavior of protein adsorption. In the present study, two biphasic calcium-phosphate ceramics (BCPs) with different surface structures were fabricated by pressing and H2O2 foaming methods. Their surface characteristics were analyzed and the in vitro and in vivo protein adsorption on them was investigated. Porous BCP showed higher ability to adsorb proteins, and transforming growth factor-beta 1 (TGF-beta 1) adsorption notably increased with increasing in vivo implantation time. The strong affinity of BCP to TGF-beta 1 might provide important information for exploring the mechanism of the osteoinduction of calcium phosphates. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhu, X. D.; Fan, H. S.; Xiao, Y. M.; Zhang, H. J.; Zhang, X. D.] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Li, D. X.] Sichuan Acad Chinese Med Sci, Inst Pharmacol & Toxicol, Chengdu, Peoples R China.
   [Luxbacher, T.] Anton Paar GmbH, Colloid Sci Dept, Graz, Austria.
RP Zhu, XD (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM zxd7303@163.com
RI Zhang, Huijie/N-9869-2014
OI Luxbacher, Thomas/0000-0002-5472-8203; , Jay/0000-0001-9676-4264
FU National Basic Research Program of China [G2005cb623901]; National
   Natural Foundation of China [50802060]
FX This work has been financially supported by National Basic Research
   Program of China (Contract Grant No. G2005cb623901) and National Natural
   Foundation of China (Contract Grant No. 50802060).
CR Andrade J.D., 1985, SURFACE INTERFACIAL, P1
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Dee K.C., 2002, INTRO TISSUE BIOMATE, P37
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Ikeuchi M, 2002, J BIOMED MATER RES, V60, P61, DOI 10.1002/jbm.1281
   Kandori K, 2004, J COLLOID INTERF SCI, V273, P406, DOI 10.1016/j.jcis.2004.01.069
   KANDORI K, 1995, COLLOID SURFACE B, V5, P81, DOI 10.1016/0927-7765(95)98210-E
   Kandori K, 2005, CALCIFIED TISSUE INT, V76, P194, DOI 10.1007/s00223-004-0102-4
   KAWASAKI T, 1990, J CHROMATOGR, V515, P125, DOI 10.1016/S0021-9673(01)89307-9
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Krajewski A, 1998, BIOMATERIALS, V19, P637, DOI 10.1016/S0142-9612(97)00153-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Nawata M, 2005, ARTHRITIS RHEUM-US, V52, P155, DOI 10.1002/art.20713
   Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X
   NORDE W, 1995, CELL MATER, V5, P97
   Ohta K, 2001, J BIOMED MATER RES, V55, P409, DOI 10.1002/1097-4636(20010605)55:3<409::AID-JBM1030>3.0.CO;2-Z
   Oreffo ROC, 1999, J MATER SCI-MATER M, V10, P607, DOI 10.1023/A:1008931607002
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Sharpe JR, 1997, BIOMATERIALS, V18, P471, DOI 10.1016/S0142-9612(96)00157-3
   Suh CW, 2004, J BIOTECHNOL, V112, P267, DOI 10.1016/j.jbiotec.2004.05.005
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   Villarreal D R, 1998, J Oral Implantol, V24, P67, DOI 10.1563/1548-1336(1998)024<0067:PAAORT>2.3.CO;2
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WINTER M, 1981, BIOMATERIALS, V2, P159, DOI 10.1016/0142-9612(81)90043-0
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   ZHANG X, 2000, 6 WORLD BIOM C HAW M
   Zhang XD, 1991, BIOCERAMICS HUMAN BO, P408
   Zhu XD, 2007, J MATER SCI-MATER M, V18, P2243, DOI 10.1007/s10856-006-0057-2
   Zhu XD, 2007, J BIOMED MATER RES B, V82B, P65, DOI 10.1002/jbm.b.30706
NR 37
TC 57
Z9 59
U1 6
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2009
VL 5
IS 4
BP 1311
EP 1318
DI 10.1016/j.actbio.2008.11.024
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 444YQ
UT WOS:000266017200036
PM 19121984
DA 2018-10-19
ER

PT J
AU Janssen, LM
   van Osch, GJVM
   Li, JP
   Kops, N
   de Groot, K
   Von den Hoff, JWV
   Feenstra, L
   Hardillo, JAU
AF Janssen, Luuk M.
   van Osch, Gerjo J. V. M.
   Li, Jia Ping
   Kops, Nicole
   de Groot, Klaas
   Von den Hoff, Johannes W.
   Feenstra, Louw
   Hardillo, Jose A. U.
TI Tracheal Reconstruction Mucosal Survival on Porous Titanium
SO ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
LA English
DT Article
ID TISSUE-ENGINEERED TRACHEA; LARYNGOTRACHEAL RECONSTRUCTION; SUBGLOTTIC
   STENOSIS; COMPOSITE TISSUE; CARTILAGE; REPLACEMENT; MODEL; RATS
AB Objective: To investigate whether porous titanium can provide a better support for revascularization of a mucosal graft ideal for tracheal reconstruction. In patients with laryngotracheal stenosis or tumor, the mucosa with supporting structures can be damaged, resulting in a defect that has to be reconstructed. Autologous tissues like cartilage and mucosa have been used for reconstruction. The main problem has been incomplete mucosal reepithelialization.
   Design: In the first experiment, porous titanium or ear cartilage was combined with mucosa and implanted subcutaneously in athymic mice for different periods of time. In the second experiment, using rabbits, surgically created defects were reconstructed with porous titanium and mucosa on a pedicled fascia flap using a 2-stage procedure. The implants were analyzed with emphasis on angiogenesis and mucosal survival.
   Subjects: Male New Zealand white rabbits and nude athymic mice (BALB-c nu/nu).
   Results: Normal mucosa having a submucosal layer with vital cells was noted on top of the titanium. Multiple blood vessels were observed extending from the muscle layer through the titanium. Cytokeratin expression was detected in the suprabasal and basal layers of the mucosal epithelium. In contrast, the mucosa on cartilage showed no vital cells and no cytokeratin expression. In the rabbit experiment, all animals survived the reconstruction. The titanium was well integrated to the adjacent tracheal cartilage and surrounding tissues, supporting a fully vital mucosa.
   Conclusions: Porous titanium is an inert biomaterial that provides support and allows easy revascularization of a mucosal graft. Titanium, in combination with viable autologous tissues, is a good alternative for tracheal reconstruction. Arch Otolaryngol Head Neck Surg. 2009; 135(5): 472-478
C1 [Janssen, Luuk M.; van Osch, Gerjo J. V. M.; Feenstra, Louw; Hardillo, Jose A. U.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Otorhinolaryngol, NL-3000 CA Rotterdam, Netherlands.
   [van Osch, Gerjo J. V. M.; Kops, Nicole] Univ Med Ctr Rotterdam, Erasmus MC, Dept Orthoped, NL-3000 CA Rotterdam, Netherlands.
   [Li, Jia Ping; de Groot, Klaas] Univ Twente, Inst Biomed Technol, Bilthoven, Netherlands.
   [Li, Jia Ping] PoroGen, Enschede, Netherlands.
   [Von den Hoff, Johannes W.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Orthodont & Oral Biol, Nijmegen, Netherlands.
RP Hardillo, JAU (reprint author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Otorhinolaryngol, Room HS 601,POB 2040, NL-3000 CA Rotterdam, Netherlands.
EM j.hardillo@erasmusmc.nl
RI Von den Hoff, Johannes/L-8762-2015
CR Aidonis A, 2002, EUR ARCH OTO-RHINO-L, V259, P404, DOI 10.1007/s00405-002-0483-9
   COTTON RT, 1991, LARYNGOSCOPE, V101, P1, DOI 10.1288/00005537-199112000-00001
   Delaere PR, 2003, ANN OTO RHINOL LARYN, V112, P807, DOI 10.1177/000348940311200911
   Delaere PR, 2001, ANN OTO RHINOL LARYN, V110, P849, DOI 10.1177/000348940111000909
   Duynstee MLG, 2002, INT J PEDIATR OTORHI, V62, P1, DOI 10.1016/S0165-5876(01)00545-6
   Foschi D, 2001, EUR SURG RES, V33, P16, DOI 10.1159/000049687
   Glatz F, 2003, ARCH OTOLARYNGOL, V129, P201, DOI 10.1001/archotol.129.2.201
   Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6
   Grimmer JF, 2004, ARCH OTOLARYNGOL, V130, P1191, DOI 10.1001/archotol.130.10.1191
   Hashem FK, 2001, J OTOLARYNGOL, V30, P334, DOI 10.2310/7070.2001.19382
   Herberhold C, 1999, LARYNGO RHINO OTOL, V78, P54, DOI 10.1055/s-2007-996830
   HIERCK BP, 1994, J HISTOCHEM CYTOCHEM, V42, P1499, DOI 10.1177/42.11.7930532
   HIRANO M, 1989, ANN OTO RHINOL LARYN, V98, P713, DOI 10.1177/000348948909800910
   Klein AM, 2005, LARYNGOSCOPE, V115, P583, DOI 10.1097/01.mlg.0000161342.77386.8b
   Kojima K, 2003, FASEB J, V17, P823, DOI 10.1096/fj.02-0462com
   Li JP, 2005, J BIOMED MATER RES A, V73A, P223, DOI 10.1002/jbm.a.30278
   Monnier P, 1998, ANN OTO RHINOL LARYN, V107, P961, DOI 10.1177/000348949810701111
   Nakajima H, 1996, Dent Mater J, V15, P77
   Olias J, 2005, LARYNGOSCOPE, V115, P159, DOI 10.1097/01.mlg.0000150688
   Ophof R, 2002, BIOMATERIALS, V23, P3741, DOI 10.1016/S0142-9612(02)00108-4
   Romanos GE, 1998, J BIOMED MATER RES, V39, P462, DOI 10.1002/(SICI)1097-4636(19980305)39:3<462::AID-JBM17>3.0.CO;2-C
   Schultz P, 2002, ANN THORAC SURG, V73, P1747, DOI 10.1016/S0003-4975(02)03569-5
   Shinohara H, 2004, ANN PLAS SURG, V53, P278, DOI 10.1097/01.sap.0000106432.58239.fe
   Tan Q, 2006, EUR J CARDIO-THORAC, V30, P782, DOI 10.1016/j.ejcts.2006.08.023
   TRIGLIA JM, 1993, ARCH OTOLARYNGOL, V119, P87
NR 25
TC 9
Z9 14
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610-0946 USA
SN 0886-4470
J9 ARCH OTOLARYNGOL
JI Arch. Otolaryngol. Head Neck Surg.
PD MAY
PY 2009
VL 135
IS 5
BP 472
EP 478
DI 10.1001/archoto.2009.29
PG 7
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 447QT
UT WOS:000266207600010
PM 19451469
OA Bronze
DA 2018-10-19
ER

PT J
AU Lau, KHA
   Bang, J
   Hawker, CJ
   Kim, DH
   Knoll, W
AF Lau, K. H. Aaron
   Bang, Joona
   Hawker, Craig J.
   Kim, Dong Ha
   Knoll, Wolfgang
TI Modulation of Protein-Surface Interactions on Nanopatterned Polymer
   Films
SO BIOMACROMOLECULES
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; THIN-FILMS; MONOCLONAL-ANTIBODY; COPOLYMER
   TEMPLATES; DIBLOCK COPOLYMERS; BLOCK-COPOLYMERS; ADSORPTION; NANOARRAYS;
   ORIENTATION; ACTIVATION
AB The introduction of nanoscale features brings with it a high density of surface interface boundaries and effectively introduces an additional boundary material that exhibits properties different from the surrounding surfaces. We systematically varied the feature size of self-assembled polystyrene-block-poly(methyl methacrylate) copolymer nanopatterns from 13 to 200 am and demonstrated that the basic property of protein adsorption on a nanopatterned surface can be modulated by the length density of surface interfaces present. Protein adsorption on the nanopatterns could be described by a modified adsorption affinity along the surface interface with an effective width on the length-scale of individual proteins. Due to the intrinsic high density of surface interfaces in many polymeric thin film nanopatterns and structures, the interaction of proteins with such interfaces may be of particular relevance to cell-surface studies and to biomaterial and biosensor applications involving nanoscale features.
C1 [Kim, Dong Ha] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   Korea Univ, Dept Chem & Biol Engn, Seoul 136701, South Korea.
   Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA.
   Ewha Womans Univ, Dept Chem & Nano Sci, Seoul 120750, South Korea.
RP Kim, DH (reprint author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM dhkim@ewha.ac.kr; knoll@mpip-mainz.mpg.de
RI Lau, King Hang Aaron/D-2061-2010; Bang, Joona/F-6589-2013; Hawker,
   Craig/G-4971-2011; Kim, Dong Ha/B-3778-2008; Kim, Dong Ha/E-7868-2017
OI Lau, King Hang Aaron/0000-0003-3676-9228; Bang,
   Joona/0000-0002-2301-6190; Hawker, Craig/0000-0001-9951-851X; Kim, Dong
   Ha/0000-0003-0444-0479; 
FU Korea Science and Engineering Foundation (KOSEF); Korea government
   (MEST) [R11-2005-008-00000-0, R01-2008-000-11712-0]; Seoul Research and
   Business Development Program [10816]
FX This work was supported by the Korea Science and Engineering Foundation
   (KOSEF) grant funded by the Korea government (MEST; No.
   R11-2005-008-00000-0; R01-2008-000-11712-0) and by the Seoul Research
   and Business Development Program (10816). We are indebted to J. T.
   Goldbach for the synthesis of the block copolymers with symmetric
   composition.
CR Agheli H, 2006, NANO LETT, V6, P1165, DOI 10.1021/nl060403i
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Ayhan F, 2003, J BIOMAT SCI-POLYM E, V14, P1427, DOI 10.1163/156856203322599752
   Buck E, 2001, MACROMOLECULES, V34, P2172, DOI 10.1021/ma001288f
   Denis FA, 2005, SMALL, V1, P984, DOI 10.1002/smll.200500116
   Douillard R, 2003, CURR OPIN COLLOID IN, V8, P380, DOI 10.1016/S1359-0294(03)00097-9
   Engel E, 2008, TRENDS BIOTECHNOL, V26, P39, DOI 10.1016/j.tibtech.2007.10.005
   Fasolka MJ, 2001, ANN REV MATER RES, V31, P323, DOI 10.1146/annurev.matsci.31.1.323
   Green BT, 2001, SOUTHERN MED J, V94, P81
   Gunari N, 2008, LANGMUIR, V24, P5197, DOI 10.1021/la7034054
   Hamley IW, 2003, NANOTECHNOLOGY, V14, pR39, DOI 10.1088/0957-4484/14/10/201
   HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0
   HASEGAWA M, 1992, LANGMUIR, V8, P1582, DOI 10.1021/la00042a015
   Kim DH, 2005, ADV MATER, V17, P2442, DOI 10.1002/adma.200500170
   Kim HC, 2001, J POLYM SCI POL PHYS, V39, P663, DOI 10.1002/1099-0488(20010315)39:6<663::AID-POLB1040>3.0.CO;2-K
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   Knoner G, 2006, BIOPHYS J, V91, P3085, DOI 10.1529/biophysj.105.076125
   Kumaki J, 2003, J AM CHEM SOC, V125, P4907, DOI 10.1021/ja0290429
   Kumar N, 2005, LANGMUIR, V21, P6652, DOI 10.1021/la050331v
   Kumar N, 2008, LANGMUIR, V24, P2688, DOI 10.1021/la7022456
   Kumar N, 2007, J PHYS CHEM B, V111, P4581, DOI 10.1021/jp068509p
   Lau KHA, 2008, ADV FUNCT MATER, V18, P3148, DOI 10.1002/adfm.200800487
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lee KB, 2004, NANO LETT, V4, P1869, DOI 10.1021/nl049002y
   Li L, 2006, J PHYS CHEM B, V110, P16763, DOI 10.1021/jp062442o
   Lynch M, 2004, PROTEOMICS, V4, P1695, DOI 10.1002/pmic.200300701
   Matsen MW, 2002, J PHYS-CONDENS MAT, V14, pR21, DOI 10.1088/0953-8984/14/2/201
   Morin C, 2004, J ELECTRON SPECTROSC, V137, P785, DOI 10.1016/j.elspec.2004.02.158
   Mrksich M, 2002, CURR OPIN CHEM BIOL, V6, P794, DOI 10.1016/S1367-5931(02)00362-9
   Neto C, 2007, PHYS CHEM CHEM PHYS, V9, P149, DOI 10.1039/b614085h
   Pallandre A, 2005, J AM CHEM SOC, V127, P4320, DOI 10.1021/ja043656r
   Parajuli O, 2007, J PHYS CHEM B, V111, P14022, DOI 10.1021/jp075909j
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Pratt W. K., 2001, DIGITAL IMAGE PROCES
   Raether H., 1988, SURFACE PLASMONS SMO, V111
   Raffaini G, 2007, MACROMOL BIOSCI, V7, P552, DOI 10.1002/mabi.200600278
   Rasband W, 1997, IMAGEJ
   Riedel M, 2001, BIOMATERIALS, V22, P2307, DOI 10.1016/S0142-9612(01)00011-4
   Ryu DY, 2005, SCIENCE, V308, P236, DOI 10.1126/science.1106604
   Schrader D., 1999, POLYM HDB, P91
   Senaratne W, 2006, J AM CHEM SOC, V128, P5594, DOI 10.1021/ja058701p
   Sonka M, 2007, IMAGE PROCESSING ANA
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sutherland DS, 2001, MACROMOL BIOSCI, V1, P270, DOI 10.1002/1616-5195(20010801)1:6<270::AID-MABI270>3.3.CO;2-V
   Talbot J, 2000, COLLOID SURFACE A, V165, P287, DOI 10.1016/S0927-7757(99)00409-4
   Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072
   Wunderlich W., 1999, POLYM HDB, P87
   Xu H, 2006, LANGMUIR, V22, P6313, DOI 10.1021/la0532454
NR 48
TC 25
Z9 25
U1 0
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2009
VL 10
IS 5
BP 1061
EP 1066
DI 10.1021/bm801158x
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 443ML
UT WOS:000265914200006
PM 19301909
DA 2018-10-19
ER

PT J
AU Davis, NE
   Karfeld-Sulzer, LS
   Ding, S
   Barron, AE
AF Davis, Nicolynn E.
   Karfeld-Sulzer, Lindsay S.
   Ding, Sheng
   Barron, Annelise E.
TI Synthesis and Characterization of a New Class of Cationic Protein
   Polymers for Multivalent Display and Biomaterial Applications
SO BIOMACROMOLECULES
LA English
DT Article
ID ELASTIN-LIKE POLYPEPTIDES; CROSS-LINKING; BIOLOGICAL APPLICATIONS; GENE
   DELIVERY; THERAPEUTICS; DENDRIMERS; HYDROGELS; PEPTIDE;
   TRANSGLUTAMINASES; PEPTOIDS
AB Monodisperse protein polymers engineered by biosynthetic techniques are well suited to serve as a basis for creating comb-like polymer architectures for biomaterial applications. We have developed a new class of linear, cationic, random-coil protein polymers designed to act as scaffolds for multivalent display. These polymers contain evenly spaced lysine residues that allow for chemical or enzymatic conjugation of pendant functional groups. Circular dichroism spectroscopy and turbidity experiments have confirmed that these proteins have a random coil structure and are soluble up to at least 65 degrees C. Cell viability assays suggest these constructs are nontoxic in solution up to a concentration of 100 mu M. We have successfully attached a small bioactive peptide, a peptoid-peptide hybrid, a poly(ethylene glycol) polymer, and a fluorophore to the protein polymers by chemical or enzymatic coupling, demonstrating their suitability to serve as multivalent scaffolds in solutions or as gels.
C1 [Davis, Nicolynn E.; Karfeld-Sulzer, Lindsay S.; Ding, Sheng; Barron, Annelise E.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
RP Barron, AE (reprint author), Stanford Univ, Dept Bioengn, 318 Campus Dr,W300B James H Clark Ctr, Stanford, CA 94305 USA.
EM aebarron@stanford.edu
RI Barron, Annelise/B-7639-2009
FU NIH/NIBIB [1 R01 EB003806]
FX We thankfully acknowledge the use of instruments in the Keck Biophysics
   Facility at Northwestern University
   (http://www.biochem.northwestern.edu/Keck/keckmain.html), the
   Northwestern University Analytical Services Laboratory, and Northwestern
   University Institute for Bionanotechnology in Medicine. We thank
   Jennifer Rea for the NIH 3T3 cells and Russell Haynes and Nate Brown for
   assistance with peptide and peptoid synthesis. This work was funded by
   NIH/NIBIB Grant 1 R01 EB003806.
CR Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903
   Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820
   Borman S, 1998, CHEM ENG NEWS, V76, P56, DOI 10.1021/cen-v076n018.p056
   Cloninger MJ, 2002, CURR OPIN CHEM BIOL, V6, P742, DOI 10.1016/S1367-5931(02)00400-3
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   CREEL HS, 1991, MACROMOLECULES, V24, P1213, DOI 10.1021/ma00005a040
   Crespo L, 2005, CHEM REV, V105, P1663, DOI 10.1021/cr030449l
   Crommelin DJA, 2003, J LIPOSOME RES, V13, P33, DOI 10.1081/LPR-120017488
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Farmer RS, 2006, MACROMOLECULES, V39, P162, DOI 10.1021/ma051534t
   Godwin A, 2001, ANGEW CHEM INT EDIT, V40, P594, DOI 10.1002/1521-3773(20010202)40:3<594::AID-ANIE594>3.0.CO;2-P
   GREENBERG CS, 1991, FASEB J, V5, P3071
   Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234
   Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Henaut A., 1996, ESCHERICHIA COLI SAL, V2, P2047
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b
   Kanai M, 1997, J AM CHEM SOC, V119, P9931, DOI 10.1021/ja972089n
   Karfeld LS, 2007, BIOCONJUGATE CHEM, V18, P1697, DOI 10.1021/bc700149uCCC:$37.00
   Kiessling LL, 2000, CURR OPIN CHEM BIOL, V4, P696, DOI 10.1016/S1367-5931(00)00153-8
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Liu S, 2008, MACROMOLECULES, V41, P764, DOI 10.1021/ma702128a
   LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602
   MAEDA H, 1992, BIOCONJUGATE CHEM, V3, P351, DOI 10.1021/bc00017a001
   MAMMEN M, 1995, J MED CHEM, V38, P4179, DOI 10.1021/jm00021a007
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   MILLER SM, 1995, DRUG DEVELOP RES, V35, P20, DOI 10.1002/ddr.430350105
   MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P453, DOI 10.1002/rcm.1290090514
   Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Polizzotti BD, 2007, MACROMOLECULES, V40, P7103, DOI 10.1021/ma070725o
   Putnam D, 2001, P NATL ACAD SCI USA, V98, P1200, DOI 10.1073/pnas.031577698
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Roman GT, 2006, ELECTROPHORESIS, V27, P2933, DOI 10.1002/elps.200500795
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   SEYMOUR LW, 1987, J BIOMED MATER RES, V21, P1341, DOI 10.1002/jbm.820211106
   SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   van Baal I, 2005, ANGEW CHEM INT EDIT, V44, P5052, DOI 10.1002/anie.200500635
   Wang Y, 2005, J AM CHEM SOC, V127, P16392, DOI 10.1021/ja055102+
   Wolfert MA, 1999, BIOCONJUGATE CHEM, V10, P993, DOI 10.1021/bc990025r
   Won JI, 2005, ELECTROPHORESIS, V26, P2138, DOI 10.1002/elps.200410042
   Won JI, 2004, BIOMACROMOLECULES, V5, P618, DOI 10.1021/bm034442p
   Won JI, 2002, MACROMOLECULES, V35, P8281, DOI 10.1021/ma020892i
   Yu SJM, 1997, NATURE, V389, P167
   Zhuravel MA, 2004, J AM CHEM SOC, V126, P9882, DOI 10.1021/ja046965q
   ZUCKERMANN RN, 1992, J AM CHEM SOC, V114, P10646, DOI 10.1021/ja00052a076
NR 55
TC 20
Z9 20
U1 0
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2009
VL 10
IS 5
BP 1125
EP 1134
DI 10.1021/bm801348g
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 443ML
UT WOS:000265914200014
PM 19361214
OA Green Accepted
DA 2018-10-19
ER

PT J
AU George, PA
   Donose, BC
   Cooper-White, JJ
AF George, Peter A.
   Donose, Bogdan C.
   Cooper-White, Justin J.
TI Self-assembling polystyrene-block-poly(ethylene oxide) copolymer surface
   coatings: Resistance to protein and cell adhesion
SO BIOMATERIALS
LA English
DT Article
DE Protein adsorption; Biocompatibility; Self-assembly; Surface
   modification; Block copolymer
ID PEO TRIBLOCK COPOLYMERS; ADSORPTION; BIOMATERIALS; DENSITY; LAYERS;
   FILMS
AB In this paper we report a method for biomaterial surface modification that utilizes the self-assembly of block copolymers of poly(styrene-block-ethylene oxide) (PS-PEO) to generate micro-phase separated surfaces with varying density PEO domains. These PS-PEO self-assembled surfaces showed a significant reduction in protein adsorption compared to control polystyrene surfaces. The adhesion of NIH-3T3 fibroblast cells was shown to be significantly affected by the surface coverage of PEO nano-domains formed by copolymer self-assembly. These nano-domains, when presented at high number density (almost 1000 domains per square micron), were shown to completely prevent cellular attachment, even though small amounts of protein were able to bind to the surface. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
C1 [George, Peter A.; Cooper-White, Justin J.] Univ Queensland, Sch Engn, Brisbane, Qld 4072, Australia.
   [George, Peter A.; Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Donose, Bogdan C.] Univ Queensland, Australian Natl Fabricat Facil QLD Node, Brisbane, Qld 4072, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Sch Engn, Bld 75,Cnr Cooper & Coll Rds, Brisbane, Qld 4072, Australia.
EM j.cooperwhite@uq.edu.au
RI Donose, Bogdan/C-5657-2009; Cooper-White, Justin/B-2567-2010
OI Donose, Bogdan/0000-0003-1935-9489; Cooper-White,
   Justin/0000-0002-1920-8229
FU University of Queensland
FX The authors would like to acknowledge the financial support provided by
   the University of Queensland External Support Enabling Grant. This work
   was performed in part at the Queensland node of the Australian National
   Fabrication Facility, a company established under the National
   Collaborative Research Infrastructure Strategy to provide nano and
   microfabrication facilities for Australia's researchers. We would also
   like to thank Dr. Barry Wood for his assistance with XPS analysis.
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   Cha T, 2004, PROTEOMICS, V4, P1965, DOI 10.1002/pmic.200300747
   Emoto K, 1998, LANGMUIR, V14, P2722, DOI 10.1021/la971010p
   Garric X, 2008, J MATER SCI-MATER M, V19, P1645, DOI 10.1007/s10856-007-3232-1
   GEORGE P, EUROPEAN PO IN PRESS
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   Ismail AE, 2007, LANGMUIR, V23, P8508, DOI 10.1021/la700829r
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Lee JH, 2005, BIOMATERIALS, V26, P671, DOI 10.1016/j.biomaterials.2004.03.009
   Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   NIE HY, 1995, 3 INT C NAN SCAL SCI, P1163
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2007, POLYM INT, V56, P1183, DOI 10.1002/pi.2319
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Szulgit G, 2002, J INVEST DERMATOL, V118, P409, DOI 10.1046/j.0022-202x.2001.01680.x
   Unsworth LD, 2006, J COLLOID INTERF SCI, V296, P520, DOI 10.1016/j.jcis.2005.09.056
NR 22
TC 67
Z9 67
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2009
VL 30
IS 13
BP 2449
EP 2456
DI 10.1016/j.biomaterials.2009.01.012
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 426EQ
UT WOS:000264691200004
PM 19201020
DA 2018-10-19
ER

PT J
AU Engberg, AE
   Sandholm, K
   Bexborn, F
   Persson, J
   Nilsson, B
   Lindahl, G
   Ekdahl, KN
AF Engberg, Anna E.
   Sandholm, Kerstin
   Bexborn, Fredrik
   Persson, Jenny
   Nilsson, Bo
   Lindahl, Gunnar
   Ekdahl, Kristina N.
TI Inhibition of complement activation on a model biomaterial surface by
   streptococcal M protein-derived peptides
SO BIOMATERIALS
LA English
DT Article
DE Blood compatibility; Complement; C4b-binding protein (C4BP); In vitro
   test; Regulator of complement activation (RCA); Streptococcal M proteins
ID HUMAN C4B-BINDING PROTEIN; FACTOR-H; ALTERNATIVE PATHWAY; POLYMER
   SURFACE; BINDING; COMPONENT; PYOGENES; SYSTEM; BLOOD; C4BP
AB The aim of this study was to evaluate a new approach to inhibit complement activation triggered by biomaterial surfaces in contact with blood. In order to inhibit complement activation initiated by the classical pathway (CP), we used streptococcal M protein-derived peptides that specifically bind human C4BP, an inhibitor of the CP. The peptides were used to coat polystyrene microtiter wells which served as a model biomaterial. The ability of coated peptides to bind C4BP and to attenuate complement activation via the CP (monitored as generation of fluid-phase C3a and binding of fragments of C3 and C4 to the surface) was investigated using diluted normal human serum, where complement activation by the AP is minimal, as well as serum from a patient lacking alternative pathway activation. Complement activation (all parameters) was significantly decreased in serum incubated in well surfaces coated with peptides. Total inhibition of complement activation was obtained at peptide coating concentrations as low as 1-5 mu g/mL. Successful use of Streptococcus-derived peptides shows that it is feasible to control complement activation at a model biomaterial surface by capturing autologous complement regulatory molecules from plasma. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Engberg, Anna E.; Sandholm, Kerstin; Bexborn, Fredrik; Ekdahl, Kristina N.] Univ Kalmar, Sch Pure & Appl Nat Sci, Kalmar 39182, Sweden.
   [Persson, Jenny; Lindahl, Gunnar] Lund Univ, Dept Lab Med, Lund, Sweden.
   [Nilsson, Bo; Ekdahl, Kristina N.] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden.
RP Ekdahl, KN (reprint author), Univ Kalmar, Sch Pure & Appl Nat Sci, Kalmar 39182, Sweden.
EM kristina.nilsson_ekdahl@klinimm.uu.se
RI Persson, Jenny/H-1796-2012; Nilsson Ekdahl, Kristina/B-5301-2012;
   Nilsson, Bo/B-3102-2012
OI Persson, Jenny/0000-0002-1075-4346; Nilsson, Bo/0000-0003-0057-2730
FU National Institutes of Health [EB003968]; Swedish Research Council
   [2006-5595, 06X-09490]; A.O. Sward and U. Eklunds Foundation; The trusts
   of Kock and Osterlund, Lund University Hospital; Faculty of Natural
   Sciences & Engineering, University of Kalmar, Sweden
FX We are grateful to Dr. Graciela EIgue for analysis of the anti-MP
   antibodies and Dr. Deborah McClellan for editorial assistance. We
   acknowledge support from the National Institutes of Health (#EB003968),
   the Swedish Research Council (2006-5595 and 06X-09490), the A.O. Sward
   and U. Eklunds Foundation, The trusts of Kock and Osterlund, Lund
   University Hospital, and the Faculty of Natural Sciences & Engineering,
   University of Kalmar, Sweden.
CR Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847
   Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Andre I, 2006, BIOCHEMISTRY-US, V45, P4559, DOI 10.1021/bi052455c
   Benesch J, 2002, BIOMATERIALS, V23, P2561, DOI 10.1016/S0142-9612(01)00391-X
   Blom AM, 2000, J IMMUNOL, V164, P5328, DOI 10.4049/jimmunol.164.10.5328
   Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543
   Dunlop LR, 2003, MICROBES INFECT, V5, P1049, DOI 10.1016/S1286-4579(03)00194-1
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   FRITHZ E, 1989, MOL MICROBIOL, V3, P1111, DOI 10.1111/j.1365-2958.1989.tb00261.x
   Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x
   Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x
   Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x
   HED J, 1984, IMMUNOL LETT, V8, P295, DOI 10.1016/0165-2478(84)90013-0
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Lindahl G, 2000, CURR OPIN IMMUNOL, V12, P44, DOI 10.1016/S0952-7915(99)00049-7
   Morfeldt E, 2001, J IMMUNOL, V167, P3870, DOI 10.4049/jimmunol.167.7.3870
   Murakami Y, 2005, J BIOMAT SCI-POLYM E, V16, P381, DOI 10.1163/1568562053654095
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   NILSSON UR, 1992, ARTHRITIS RHEUM, V35, P580, DOI 10.1002/art.1780350516
   NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L
   Persson J, 2005, J IMMUNOL METHODS, V297, P83, DOI 10.1016/j.jim.2004.11.024
   Persson J, 2006, PLOS PATHOG, V2, P442, DOI 10.1371/journal.ppat.0020047
   Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600
   STENBERG L, 1994, J BIOL CHEM, V269, P13458
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Tengvall P, 1996, BIOMATERIALS, V17, P1001, DOI 10.1016/0142-9612(96)84675-8
   THERN A, 1995, J IMMUNOL, V154, P375
NR 30
TC 16
Z9 17
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2009
VL 30
IS 13
BP 2653
EP 2659
DI 10.1016/j.biomaterials.2009.01.001
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 426EQ
UT WOS:000264691200026
PM 19171378
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Jeon, O
   Bouhadir, KH
   Mansour, JM
   Alsberg, E
AF Jeon, Oju
   Bouhadir, Kamal H.
   Mansour, Joseph M.
   Alsberg, Eben
TI Photocrosslinked alginate hydrogels with tunable biodegradation rates
   and mechanical properties
SO BIOMATERIALS
LA English
DT Article
DE Alginate; Biodegradable; Biomaterial; Hydrogel; Photopolymerization;
   Tissue engineering
ID TISSUE ENGINEERING APPLICATIONS; CONTROLLED SCAFFOLD DEGRADATION;
   SYNTHETIC EXTRACELLULAR-MATRIX; IN-VIVO BONE; DRUG-DELIVERY; CELLS;
   BIOMATERIALS; CARTILAGE; DIFFERENTIATION; CHONDROCYTES
AB Photocrosslinked and biodegradable alginate hydrogels were engineered for biomedical applications. Photocrosslinkable alginate macromers were prepared by reacting sodium alginate and 2-aminoethyl methacrylate in the presence of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride and N-hydroxysuccinimide. Methacrylated alginates were photocrosslinked using ultraviolet light with 0.05% photoinitiator. The swelling behavior, elastic moduli, and degradation fates of photocrosslinked alginate hydrogels were quantified and could be controlled by varying the degree of alginate methacrylation. The methacrylated alginate macromer and photocrosslinked alginate hydrogels exhibited low cytotoxicity when cultured with primary bovine chondrocytes. in addition, chondrocytes encapsulated in these hydrogels remained viable anti metabolically active as demonstrated by Live/Dead cell staining and MTS assay. These photocrosslinked alginate hydrogels, with tailorable mechanical properties and degradation Fates, may find great utility as therapeutic materials in regenerative medicine and bioactive factor delivery. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Jeon, Oju; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Mansour, Joseph M.; Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
   [Mansour, Joseph M.] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA.
   [Bouhadir, Kamal H.] Amer Univ Beirut, Dept Chem, Beirut, Lebanon.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
RI Jeon, Oju/K-7227-2018
OI Jeon, Oju/0000-0003-3972-9272; Alsberg, Eben/0000-0002-3487-4625
FU Biomedical Research and Technology Transfer [05-065]; Ohio Department of
   Development; Ellison Medical Foundation
FX The authors gratefully acknowledge funding support from Biomedical
   Research and Technology Transfer Grant 05-065 from the Ohio Department
   of Development (EA) and a New Scholar in Aging Award from the Ellison
   Medical Foundation (EA), and thank Loran D. Solorio for supplying the
   chondrocytes.
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   BIRNBAUM S, 1981, BIOTECHNOL LETT, V3, P393, DOI 10.1007/BF01134097
   Cheng N, 2008, TISSUE ENG PT A, V14, P1, DOI 10.1089/ten.a.2007.0131
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   Dadsetan M, 2007, BIOMACROMOLECULES, V8, P1702, DOI 10.1021/bm070052h
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dusseault J, 2005, BIOMATERIALS, V26, P1515, DOI 10.1016/j.biomaterials.2004.05.013
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Fisher JP, 2001, ANN REV MATER RES, V31, P171, DOI 10.1146/annurev.matsci.31.1.171
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Hsiong SX, 2008, J BIOMED MATER RES A, V87A, P282, DOI 10.1002/jbm.a.31521
   Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Ito T, 2007, BIOMATERIALS, V28, P3418, DOI 10.1016/j.biomaterials.2007.04.017
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Kong HJ, 2003, CELL TRANSPLANT, V12, P779, DOI 10.3727/000000003108747253
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Paige K.T., 1995, PLAST RECONSTR SURG, V96, P1399
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Petrini P, 2003, J MATER SCI-MATER M, V14, P683, DOI 10.1023/A:1024955531173
   Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014
   Ravi N, 2006, POLYMER, V47, P4203, DOI 10.1016/j.polymer.2006.02.029
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Wei HL, 2005, EUR POLYM J, V41, P948, DOI 10.1016/j.eurpolymj.2004.11.041
   Yasuda A, 2006, TISSUE ENG, V12, P1237, DOI 10.1089/ten.2006.12.1237
NR 49
TC 240
Z9 248
U1 27
U2 245
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2009
VL 30
IS 14
BP 2724
EP 2734
DI 10.1016/j.biomaterials.2009.01.034
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 429XR
UT WOS:000264953900008
PM 19201462
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Low, SP
   Voelcker, NH
   Canham, LT
   Williams, KA
AF Low, Suet P.
   Voelcker, Nicolas H.
   Canham, Leigh T.
   Williams, Keryn A.
TI The biocompatibility of porous silicon in tissues of the eye
SO BIOMATERIALS
LA English
DT Article
DE Silicon; Cornea; Ophthalmology; Bioprosthesis; Biodegradation
ID EPITHELIAL STEM-CELLS; EX-VIVO EXPANSION; OCULAR SURFACE; AMNIOTIC
   MEMBRANE; DRUG-DELIVERY; TRANSPLANTATION; RECONSTRUCTION; FABRICATION;
   SUBSTRATE
AB In this report, we explore the biocompatibility of thermally-oxidised, aminosilanised porous silicon membranes and their potential to support human ocular cells in vitro and in vivo, in the rat eye. A colorimetric assay for silicic acid showed that membranes with pore sizes of 40-60 nm slowly dissolved, but the material could be maintained in tissue culture medium in vitro for at least two weeks without visible degradation. When implanted under the rat conjunctiva, the material did not erode the underlying or overlying tissue. The implant underwent slow dissolution, but remained visible at the operating microscope for over 8 weeks. End-stage histology indicated the presence of a thin fibrous capsule surrounding the implant, but little evidence of any local accumulation of acute inflammatory cells or vascularization. Human lens epithelial cells and primary human corneal explants adhered to the porous silicon membranes, where they remained viable and underwent division. Primary corneal epithelial cells supported on membranes were labelled with a cell tracker dye and implanted under the rat conjunctiva. Seven days later, labelled cells had moved from the membrane into the ocular tissue spaces. A porous silicon membrane may have value as a biomaterial that can support the delivery of cells to the ocular surface and improve existing therapeutic options in patients with corneal epithelial stem cell dysfunction and ocular surface disease. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Williams, Keryn A.] Flinders Univ S Australia, Flinders Med Ctr, Dept Ophthalmol, Bedford Pk, SA 5042, Australia.
   [Low, Suet P.; Voelcker, Nicolas H.] Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Adelaide, SA 5001, Australia.
   [Canham, Leigh T.] pSi Med Ltd, Malvern WR14 3SZ, Worcs, England.
RP Williams, KA (reprint author), Flinders Univ S Australia, Flinders Med Ctr, Dept Ophthalmol, Bedford Pk, SA 5042, Australia.
EM keryn.williams@flinders.edu.au
RI Voelcker, Nicolas/D-6199-2012
OI Voelcker, Nicolas/0000-0002-1536-7804
FU Australian Research Council; National Health & Medical Research Council
   of Australia; Ophthalmic Research Institute of Australia; Flinders
   Medical Centre Research Foundation
FX This work was supported by funding from the Australian Research Council,
   the National Health & Medical Research Council of Australia, the
   Ophthalmic Research Institute of Australia and the Flinders Medical
   Centre Research Foundation. The authors gratefully acknowledge the
   technical expertise of Kirsty Marshall and the expert opinion of Dr.
   Sonja Klebe, a pathologist. Some porous silicon materials were made
   available by pSi Medica Ltd., Malvern, Worcester, UK.
CR Ang LPK, 2006, INVEST OPHTH VIS SCI, V47, P105, DOI 10.1167/iovs.05-0512
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Baharvand H, 2007, MOL VIS, V13, P1711
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Chin V, 2001, ADV MATER, V13, P1877, DOI 10.1002/1521-4095(200112)13:24<1877::AID-ADMA1877>3.0.CO;2-4
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]
   Dancil KPS, 1999, J AM CHEM SOC, V121, P7925, DOI 10.1021/ja991421n
   Daniels JT, 2006, REGEN MED, V1, P715, DOI 10.2217/17460751.1.5.715
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Foell H., 2002, MAT SCI ENG R, VR39, P93, DOI DOI 10.1016/S0927-796X(02)00090-6
   Galal A, 2007, CORNEA, V26, P473, DOI 10.1097/ICO.0b013e318033bd0f
   Hayashida Y, 2005, INVEST OPHTH VIS SCI, V46, P1632, DOI 10.1167/iovs.04-0813
   Higa K, 2008, CORNEA, V27, pS41, DOI 10.1097/ICO.0b013e31817f358e
   Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664
   Janshoff A, 1998, J AM CHEM SOC, V120, P12108, DOI 10.1021/ja9826237
   Khung YL, 2006, BIOTECHNOL PROGR, V22, P1388, DOI 10.1021/bp060115s
   Kimura H, 2001, OPHTHALMOLOGICA, V215, P143, DOI 10.1159/000050849
   Lee Gyun Min, 2000, In Vitro Cellular and Developmental Biology Animal, V36, P4
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   MOLLER F, 1995, THIN SOLID FILMS, V255, P16, DOI 10.1016/0040-6090(94)05623-L
   Moxon KA, 2007, J BIOMAT SCI-POLYM E, V18, P1263, DOI 10.1163/156856207782177882
   Reffitt DM, 1999, J INORG BIOCHEM, V76, P141, DOI 10.1016/S0162-0134(99)00126-9
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Shortt AJ, 2008, OPHTHALMOLOGY, V115, P1989, DOI 10.1016/j.ophtha.2008.04.039
   Shortt AJ, 2007, SURV OPHTHALMOL, V52, P483, DOI 10.1016/j.survophthal.2007.06.013
   Steinem C, 2004, TETRAHEDRON, V60, P11259, DOI 10.1016/j.tet.2004.06.130
   Stewart MP, 2000, ADV MATER, V12, P859, DOI 10.1002/1521-4095(200006)12:12<859::AID-ADMA859>3.0.CO;2-0
   SWEETMAN MJ, 2008, P SPIE, V6799
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   VOELCKER NH, 2008, CHEMBIOCHEM, V21, P1776
   Whitehead MA, 2008, TISSUE ENG PT A, V14, P195, DOI 10.1089/ten.a.2006.0370
   Worsfold O, 2006, LANGMUIR, V22, P7078, DOI 10.1021/la060121y
   Zhu X, 2006, ANN ACAD MED SINGAP, V35, P210
NR 33
TC 191
Z9 191
U1 1
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2009
VL 30
IS 15
BP 2873
EP 2880
DI 10.1016/j.biomaterials.2009.02.008
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435FA
UT WOS:000265328100003
PM 19251317
DA 2018-10-19
ER

PT J
AU Yang, CY
   Song, BB
   Ao, Y
   Nowak, AP
   Abelowitz, RB
   Korsak, RA
   Havton, LA
   Deming, TJ
   Sofroniew, MV
AF Yang, Chu-Ya
   Song, Bingbing
   Ao, Yan
   Nowak, Andrew P.
   Abelowitz, Ryan B.
   Korsak, Rose A.
   Havton, Leif A.
   Deming, Timothy J.
   Sofroniew, Michael V.
TI Biocompatibility of amphiphilic diblock copolypeptide hydrogels in the
   central nervous system
SO BIOMATERIALS
LA English
DT Article
DE Scaffolds; Brain; Spinal cord; Biocompatibility; Drug delivery;
   Hydrogels
ID SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; POLYPEPTIDE HYDROGELS; BLOCK
   COPOLYPEPTIDES; IN-VIVO; DELIVERY; REPAIR; CELLS; SCAFFOLDS; NEURONS
AB Amphiphilic diblock copolypeptide hydrogels (DCHs) are synthetic materials whose properties can be varied readily and predictably by altering copolymer chain length or composition and which are of potential interest for biomaterial applications. We tested the biocompatibility in the central nervous system (CNS) of DCH composed of lysine, homoarginine or glutamate in combination with leucine. A range of DCH formulations with theological properties similar to brain tissue were injected into mouse forebrain and examined after 1-8 weeks using light microscopy, immunohistochemistry and electron microscopy. DCH deposits elicited no more gliosis, inflammation, or toxicity to neurons, myelin or axons than did injections of physiological saline. The size, rigidity, and density of DCH deposits could be varied subtly by altering DCH composition and concentration. For any given DCH formulation, increased concentration correlated with increased gel strength in vitro and increased deposit size in vivo. DCHs of lysine and leucine (K(m)L(n)) were selected for detailed analyses because these formed deposits with desirable physical properties and since lysine is routinely used as a substrate for neural cell cultures. Deposits of unmodified K(180)L(20) exhibited time-dependent in-growth of blood vessels and of certain glial cells, and limited in-growth of nerve fibers. These findings show that DCHs are injectable, re-assemble in vivo to form 3-dimensional deposits, exhibit little or no detectable toxicity in the CNS, integrate well with brain tissue and represent a new class of synthetic biomaterials with potential for applications as depots or scaffolds in the CNS. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Song, Bingbing; Ao, Yan; Abelowitz, Ryan B.; Korsak, Rose A.; Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.
   [Yang, Chu-Ya; Nowak, Andrew P.; Deming, Timothy J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
   [Havton, Leif A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.
RP Sofroniew, MV (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, 10833 Conte Ave, Los Angeles, CA 90095 USA.
EM sofroniew@mednet.ucla.edu
RI Deming, Timothy/I-5411-2013
OI Deming, Timothy/0000-0002-0594-5025
FU Adelson Medical Research Foundation
FX This study was supported by the Adelson Medical Research Foundation
   (Adelson Program in Neural Rehabilitation and Repair). We thank Dr. A.
   Katapodis, Novartis Insitute, Basel, Switzerland, for the
   anti-poly-lysine antibody, Prof. T.G. Mason and Dr. J.N. Wilking for
   rheology assistance, and Ms. B. Sjostrand for ultrastructural
   assistance.
CR Beardsley RL, 2002, ANAL CHEM, V74, P1884, DOI 10.1021/ac015613o
   Bocchiaro CM, 2004, P NATL ACAD SCI USA, V101, P4292, DOI 10.1073/pnas.0305712101
   Breedveld V, 2004, MACROMOLECULES, V37, P3943, DOI 10.1021/ma049885f
   Deming TJ, 2005, SOFT MATTER, V1, P28, DOI 10.1039/b500307e
   Deming TJ, 2002, ADV DRUG DELIVER REV, V54, P1145, DOI 10.1016/S0169-409X(02)00062-5
   Deming TJ, 1999, MACROMOLECULES, V32, P4500, DOI 10.1021/ma9902899
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Havton LA, 2005, J NEUROSCI METH, V149, P101, DOI 10.1016/j.jjneumath.2005.03.014
   Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holowka EP, 2007, NAT MATER, V6, P52, DOI 10.1038/nmat1794
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   HUSEK P, 1991, J CHROMATOGR, V552, P289, DOI 10.1016/S0021-9673(01)95945-X
   Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Katopodis AG, 2002, J CLIN INVEST, V110, P1869, DOI 10.1172/JCI200216526
   Kimmel J. R., 1967, METHOD ENZYMOL, V11, P584, DOI DOI 10.1016/S0076-6879(67)11072-0
   KLEIN HF, 1975, CHEM BER-RECL, V108, P944, DOI 10.1002/cber.19751080327
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2
   Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586
   Nowak AP, 2003, J AM CHEM SOC, V125, P15666, DOI 10.1021/ja0381050
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Peters A, 1991, FINE STRUCTURE NERVO
   Pochan DJ, 2002, MACROMOLECULES, V35, P5358, DOI 10.1021/ma025526d
   Sanjana NE, 2004, J NEUROSCI METH, V136, P151, DOI 10.1016/j.jneumeth.2004.01.011
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   SVENDSEN CN, 1994, J NEUROSCI, V14, P75
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 43
TC 85
Z9 87
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2009
VL 30
IS 15
BP 2881
EP 2898
DI 10.1016/j.biomaterials.2009.01.056
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435FA
UT WOS:000265328100004
PM 19251318
DA 2018-10-19
ER

PT J
AU Jeon, DJ
   Yeom, SH
AF Jeon, Dong Jin
   Yeom, Sung Ho
TI Recycling wasted biomaterial, crab shells, as an adsorbent for the
   removal of high concentration of phosphate
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Phosphate; Removal; Crab shell; Recycling; Adsorbent
ID FLY-ASH; AQUEOUS-SOLUTIONS; BIOSORPTION; ADSORPTION
AB In this study, crab shells were recycled as an adsorbent for the removal of phosphate. The effects of shell particle size, temperature, pH and phosphate concentration on phosphate removal were investigated. Shell particles less than 1000 mu m in diameter removed more than 85% of 500 mg/L phosphate in 24 h while particles 3350 mu m in diameter exhibited only 50% removal efficiency. Temperature showed negligible effect on phosphate removal in the range of 15-45 degrees C. Although removal efficiency was highest at pH 2.0, the efficiency remained 50-60% at pH of 4.0-10.0. The maximum removal capacity was calculated as 108.9 mg/g through Langmuir isotherm plotting, which was 17.0 and 4.7 times higher than those of coal fly ash and scallop shells, respectively. Although calcium carbonate played an active role in the removal of phosphate, both proteins composing 12.5% of crab shells and cellulose-like backbone of the crab shells also played an important role in phosphate removal. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Jeon, Dong Jin; Yeom, Sung Ho] Kangnung Natl Univ, Dept Environm & Appl Chem Engn, Kangnung 212702, Gangwondo, South Korea.
RP Yeom, SH (reprint author), Kangnung Natl Univ, Dept Environm & Appl Chem Engn, Kangnung 212702, Gangwondo, South Korea.
EM shyeom@kangnung.ac.kr
FU Ministry of Konwledge Economy (MKE), Korea [RTI05-01-02]
FX This work was supported by grant No. RTI05-01-02 from the Regional
   Technology Innovation Program of the Ministry of Konwledge Economy
   (MKE), Korea. The authors are grateful for the support. The authors also
   thank Hyeok Man Kwon, Sang Hart Shim and Jung Hee Eum for their
   technical assistance.
CR ANDREW DE, 1995, STANDARD METHODS EXA, P106
   Cheung KC, 2000, CHEMOSPHERE, V41, P243, DOI 10.1016/S0045-6535(99)00417-8
   Choi SS, 2005, J IND ENG CHEM, V11, P638
   Dahiya S, 2008, BIORESOURCE TECHNOL, V99, P179, DOI 10.1016/j.biortech.2006.11.011
   Entsar S. A., 2008, BIORESOURCE TECHNOL, V99, P1359
   Hu J, 2004, WATER SCI TECHNOL, V50, P139
   Karaca S, 2004, J COLLOID INTERF SCI, V277, P257, DOI 10.1016/j.jcis.2004.04.042
   Lu SG, 2009, J HAZARD MATER, V161, P95, DOI 10.1016/j.jhazmat.2008.02.123
   Ozacar M, 2003, CHEMOSPHERE, V51, P321, DOI 10.1016/S0045-6535(02)00847-0
   PENGTHAMKEERATI P, 2008, FUEL, V84, P2469
   Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001
   YEOM SH, 2009, J IND ENG CHEM, V15
   Yildiz E, 2004, SEP PURIF TECHNOL, V35, P241, DOI 10.1016/S1383-5866(03)00145-X
NR 13
TC 38
Z9 43
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD MAY
PY 2009
VL 100
IS 9
BP 2646
EP 2649
DI 10.1016/j.biortech.2008.11.035
PG 4
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 416YK
UT WOS:000264041200030
PM 19144514
DA 2018-10-19
ER

PT J
AU Hilmy, N
   Manjas, M
   Ferdiansyah
   Abbas, B
   Pedraza, JM
AF Hilmy, Nazly
   Manjas, Menkher
   Ferdiansyah
   Abbas, Basril
   Pedraza, Jorge Morales
TI The impact of the International Atomic Energy Agency (IAEA) program on
   radiation and tissue banking in Indonesia
SO CELL AND TISSUE BANKING
LA English
DT Article
DE IAEA; Tissue banking; Allografts; Xenogarft; Indonesia
AB In 1986, the National Nuclear Energy Agency (Batan) in Jakarta started the research and development for the setting up of a tissue bank (Batan Research Tissue Bank/BRTB) by preserving fresh amnion or fetal membranes by lyophilisation and then sterilising by gamma irradiation. During the period of 1990 and 2000, three more tissue banks were set up, i.e., Biomaterial Centre in Surabaya, Jamil Tissue Bank in Padang, and Sitanala Tissue Bank in Tangerang. In 1994, BRTB produced bone allografts. The banks established under the IAEA program concentrated its work on the production of amnion, bone and soft tissues allografts, as well as bone xenografts. These tissues (allografts and xenografts) were sterilised using gamma irradiation (about 90%) and the rest were sterilized by ETO and those products have been used in the treatment of patients at more than 50 hospitals in Indonesia. In 2004, those tissue banks produced 8,500 grafts and 5,000 of them were amnion grafts for eye treatment and wound dressing. All of those grafts were used for patients as well as for research. In 2006, the production increased to 9,000 grafts. Although the capacity of those banks can produce more grafts, we are facing problems on getting raw materials from suitable donors. To fulfill the demand of bone grafts we also produced bone xenografts. The impact of the IAEA program in tissue banking activities in Indonesia can be summarised as follows: to support the national program on importing substitutes for medical devices. The price of imported tissues are between US$ 50 and US$ 6,000 per graft. Local tissue bank can produce tissues with the same quality with the price for about 10-30% of the imported tissues.
C1 [Hilmy, Nazly; Abbas, Basril] Batan Res Tissue Bank, Jakarta, Indonesia.
   [Manjas, Menkher] Dr M Jamil Hosp, Tissue Bank, Padang, Indonesia.
   [Ferdiansyah] Dr Sutomo Hosp, Ctr Biomat, Surabaya, Indonesia.
   [Pedraza, Jorge Morales] IAEA, A-1030 Vienna, Austria.
RP Hilmy, N (reprint author), Batan Res Tissue Bank, Jakarta, Indonesia.
EM nazly@batan.go.id; jmorales_47@yahoo.com
CR FERDIANSYAH, 2006, TISSUE BANKING, P317
   Hilmy N, 2007, RADIAT PHYS CHEM, V76, P1751, DOI 10.1016/j.radphyschem.2007.03.014
   HILMY N, 2006, RAD TISSUE BANKING, P133
   MANJAS M, 2006, TISSUE BANKING, P329
NR 4
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD MAY
PY 2009
VL 10
IS 2
BP 103
EP 107
DI 10.1007/s10561-008-9088-x
PG 5
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA 431RK
UT WOS:000265080600004
PM 18651245
DA 2018-10-19
ER

PT J
AU Kang, YK
   Yim, CJ
   Pedraza, JM
AF Kang, Yong-Koo
   Yim, Chang-Joon
   Pedraza, Jorge Morales
TI The impact of the International Atomic Energy Agency (IAEA) program on
   radiation and tissue banking in Korea
SO CELL AND TISSUE BANKING
LA English
DT Article
DE IAEA tissue banking program; Tissue banks; National Training Center
   (NTC)
AB In 1971, first bone bank was established at the Department of Orthopaedic Surgery in Catholic University of Korea. The first clinical case was reported at the Journal of Korean Orthopaedic Association in 1973. Subsequently, more than 60 surgical bone banks were established in the university and teaching hospitals throughout country. In 1990, the Korea Biomaterial Research Institute (KBRI) organised the IAEA/RCA training course on tissue banking. In this course students from 17 countries participated. In 1994 the first collaboration for cadaver tissue recovery was performed. It is important to single out that the various religious groups in Korea have favourable attitudes towards tissue donation, which contributes to the success of the tissue banking programs in the country. The demands of allograft were getting increased in the Korean medical and dental society. Currently, 62 hospital based bone banks, 5 processing tissue banks, 1 regional tissue bank and more than 30 tissue distributors are working in Korea. Based on the U.S.A. usage of more than 1,000,000 grafts per year, 100,000-200,000 grafts will be needed in Korea. Those findings indicate a greatly increased need for training of tissue bank operators. The Korean society will need at least 20-30 tissue bank operators for training in every year. The National Training Centre (NTC) for tissue bank operators and medical personal using the IAEA Curriculum in the Korean languages was established in 2003. From 2004 to 2006, NTC have been trained 40 tissue bank operators. They have produced at least 10,000 tissues per year. These figures indicate a cost saving of US$ 10 million. Within 5 years, NTC will train 100 tissue bank operators. These individuals and their respective banks will provide an increasing number of high quality grafts to the communities they serve at a cost far less than if they were acquired from abroad.
C1 [Kang, Yong-Koo] Catholic Univ Korea, St Vincents Hosp, Dept Orthoped Surg, Suwon, South Korea.
   [Yim, Chang-Joon] ENE Dent Clin, Seoul, South Korea.
RP Kang, YK (reprint author), Catholic Univ Korea, St Vincents Hosp, Dept Orthoped Surg, Suwon, South Korea.
EM ykang@vincent.cuk.ac.kr; jmorales_47@yahoo.com
CR KANG YK, 2001, J KOREAN MED ASS, V44
   KANG YK, 2006, J KOREAN ORTHOP ASS, V41
   KANG YK, 2006, 15 INT C EATB VARN B
   *KFDA, 2007, CURR STAT NAT WID PR
   MOON MS, 1973, J KOREAN ORTHOP ASS, V8
   NATHER A, TRAINING TISSUE BANK
   YIM CJ, 2002, 9 INT C ISS BANK APA
NR 7
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD MAY
PY 2009
VL 10
IS 2
BP 109
EP 113
DI 10.1007/s10561-008-9083-2
PG 5
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA 431RK
UT WOS:000265080600005
PM 18841494
DA 2018-10-19
ER

PT J
AU Vajaradul, Y
   Pedraza, JM
AF Vajaradul, Yongyudh
   Pedraza, Jorge Morales
TI The impact of the International Atomic Energy Agency (IAEA) program on
   radiation and tissue banking in Thailand
SO CELL AND TISSUE BANKING
LA English
DT Article
DE Thailand; IAEA; Tissue banking; Tissue banks
AB Tissue banking started in Thailand in 1979. Five years after this, the Bangkok Biomaterial Centre (BBC) was established in the Faculty of Medicine, Siriraj Hospital, with the support of the IAEA program. The objective of the Centre was to provide sterile bones and tissues for clinical use. Through the passage of time, the Bangkok Biomaterial Centre has gained confidence from the end user and by 2007 has processed 33,872 allografts from 491 deceased donors and 4,035 live donors were used in medical treatment in 3,596 patients in more than 79 different hospitals. More than 305 surgeons from Thailand used the tissue produced in the BBC. At the beginning of its work the BBC concentrate its activities on the production of the following tissues: freeze dried bone, freeze dried dura mater and freeze dried fascia lata. All of these tissues were sterilised using ethylene oxide gas until the end of year 1984. Since 1985 the BBC sterilise tissue using ionising radiation. The BBC is now producing deep-frozen; bone tendon, cartilage, trachea and soft tissue; freeze-dried; bone, fascia lata, dura mater, amniotic membrane, bone hydroxyapatite, bone tablet and fresh preserved amniotic membrane.
C1 [Vajaradul, Yongyudh] Mahidol Univ, Bangkok Biomat Ctr, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand.
   [Vajaradul, Yongyudh] TATB, Bangkok, Thailand.
RP Vajaradul, Y (reprint author), Mahidol Univ, Bangkok Biomat Ctr, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand.
EM siyvj@mahidol.ac.th; jmorales_47@yahoo.com
CR PEDRAZA JM, 2006, INT J BANKING ENG TR, V4
   PEDRAZA JM, 2002, IAEA ADV TECHN COMM, P179
   VAJARADUL Y, 2002, 11 INT C TISS BANK E
NR 3
TC 4
Z9 4
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD MAY
PY 2009
VL 10
IS 2
BP 125
EP 132
DI 10.1007/s10561-008-9087-y
PG 8
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA 431RK
UT WOS:000265080600008
PM 18663602
DA 2018-10-19
ER

PT J
AU Kar, S
   Chen, XD
   Adhikari, BP
   Lin, SXQ
AF Kar, S.
   Chen, X. D.
   Adhikari, B. P.
   Lin, S. X. Q.
TI The impact of various drying kinetics models on the prediction of sample
   temperature-time and moisture content-time profiles during moisture
   removal from stratum corneum
SO CHEMICAL ENGINEERING RESEARCH & DESIGN
LA English
DT Article
DE Drying; Thin layer; Biomaterial; Effective liquid diffusivity;
   Optimisation; Porcine skin; Stratum corneum
ID WATER DIFFUSION; MASS-TRANSFER; POROUS-MEDIA; HUMAN SKIN; TRANSITIONS;
   EVAPORATION; PERMEATION; BEHAVIOR; HEAT
AB An attempt has been made here to model the moisture transport kinetics across porcine stratum corneum. Samples of porcine skin were dissected in the form of 'thin layers' (i.e. stratum corneum) of dimensions of 11.3 x 11.3 mm (70-200 mu m thick). These layers were dried in a laboratory convection air dryer at 37 degrees C (normal human body temperature). The changes in weights of the samples were noted. The weight loss data was then converted in terms of moisture content (dry basis) and were monitored over time. Thereafter they were fitted against an empirical equation notably the Page model (Model 1) and the solution generated by the Fickian diffusion equation (Model 2). The current paper demonstrates the effectiveness of these two models in prediction of the sample temperature during drying. Furthermore, it also demonstrates the variation in spatial distribution of moisture content within the skin sample when moisture content and temperature dependency are introduced in the diffusivity. Such findings are important especially when developing skin multi-compartment physiologically based pharmacokinetic (PBPK) models to assess transdermal permeation of various hydrophilic penetrants. (C) 2008 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Kar, S.; Chen, X. D.; Lin, S. X. Q.] Monash Univ, Dept Chem Engn, Biotechnol & Food Engn Grp, Clayton, Vic 3800, Australia.
   [Chen, X. D.] Univ Auckland, Dept Chem Engn, Auckland 1, New Zealand.
   [Adhikari, B. P.] Univ Ballarat, Sch Sci & Engn, Ballarat, Vic 3353, Australia.
RP Chen, XD (reprint author), Monash Univ, Dept Chem Engn, Biotechnol & Food Engn Grp, Clayton Campus, Clayton, Vic 3800, Australia.
EM dong.chen@eng.monash.edu.au
RI Adhikari, Benu/K-6192-2017; Kar, Saptarshi/H-5166-2014
OI Adhikari, Benu/0000-0002-7571-7968; Kar, Saptarshi/0000-0002-3788-372X;
   Chen, xiao dong/0000-0002-0150-0491
CR Adhikari B, 2002, J FOOD ENG, V54, P157, DOI 10.1016/S0260-8774(01)00203-5
   Akpinar EK, 2005, INT J FOOD SCI TECH, V40, P273, DOI 10.1111/j.1365-2621.2004.00886.x
   ASHWORTH JC, 1972, CHEM ENG SCI, V27, P1797, DOI 10.1016/0009-2509(72)85041-3
   Baini R, 2008, J FOOD ENG, V85, P201, DOI 10.1016/j.jfoodeng.2007.06.035
   BLANK IH, 1984, J INVEST DERMATOL, V82, P188, DOI 10.1111/1523-1747.ep12259835
   Chen X. D., 2007, HDB FOOD BIOPROCESS, P179
   Chen XD, 2005, DRY TECHNOL, V23, P83, DOI 10.1081/DRT-200047667
   Chen XD, 2002, INT J HEAT MASS TRAN, V45, P4369, DOI 10.1016/S0017-9310(02)00139-4
   Choi Y., 1986, FOOD ENG PROCESS APP, V1, P93
   COUMANS WJ, 1987, THESIS TU EINDHOVEN
   Crank J, 1976, MATH DIFFUSION
   Datta AK, 2007, J FOOD ENG, V80, P80, DOI 10.1016/j.jfoodeng.2006.05.013
   Doymaz I, 2005, J FOOD ENG, V69, P161, DOI 10.1016/j.jfoodeng.2004.08.009
   GAY CL, 1994, J INVEST DERMATOL, V103, P233, DOI 10.1111/1523-1747.ep12393214
   GOLDEN GM, 1986, J INVEST DERMATOL, V86, P255, DOI 10.1111/1523-1747.ep12285373
   Incropera F. P., 2000, FUNDAMENTALS HEAT MA
   KAR S, 2008, THESIS MONASH U CLAY
   KAR S, 2004, T IMECHE E, V218, P213
   Kasting GB, 2003, J PHARM SCI-US, V92, P2326, DOI 10.1002/jps.10483
   Keey R.B., 1972, DRYING LOOSE PARTICU
   Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470
   Lin SY, 1996, SPECTROCHIM ACTA A, V52, P1671, DOI 10.1016/0584-8539(96)01722-9
   LIRON Z, 1994, J PHARM SCI, V83, P692, DOI 10.1002/jps.2600830520
   Lopez A, 2000, DRY TECHNOL, V18, P995, DOI 10.1080/07373930008917749
   MICHAELS AS, 1975, AICHE J, V21, P985, DOI 10.1002/aic.690210522
   Nedler JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308
   PAGE GE, 1949, THESIS PURDUE U W LA
   PAKOWSKI Z, 2006, HDB IND DRYING
   Pakowski Z, 2006, DRY TECHNOL, V24, P1075, DOI 10.1080/07373930600778130
   Pezzutti A, 1997, J FOOD ENG, V31, P113, DOI 10.1016/S0260-8774(96)00021-0
   Pieper J, 2003, CHEM PHYS, V292, P465, DOI 10.1016/S0301-0104(03)00269-6
   POTTS RO, 1991, J INVEST DERMATOL, V96, P495, DOI 10.1111/1523-1747.ep12470197
   RADERER M, 2000, THESIS TU MUNICH GER
   Rahman M.S., 2000, FOOD PROPERTIES HDB
   SCHEUPLEIN RJ, 1965, J INVEST DERMATOL, V45, P334, DOI 10.1038/jid.1965.140
   SCHOEBER WJA, 1976, THESIS TU EINDHOVEN
   Simal S, 1998, J FOOD ENG, V37, P423, DOI 10.1016/S0260-8774(98)00095-8
   STANISH MA, 1986, AICHE J, V32, P1301, DOI 10.1002/aic.690320808
   STOCKDALE M, 1978, J SOC COSMET CHEM, V29, P625
   Sutar PP, 2007, DRY TECHNOL, V25, P1695, DOI 10.1080/07373930701590947
   Tanojo H, 1997, PHARMACEUT RES, V14, P42, DOI 10.1023/A:1012099216060
   TONG CH, 1990, BIOTECHNOL PROGR, V6, P67, DOI 10.1021/bp00001a011
   Treybal RE, 1980, MASS TRANSFER OPERAT
   Vijayaraj B, 2007, INT J ENERG RES, V31, P422, DOI 10.1002/er.1237
   Yaws C.L., 1999, CHEM PROPERTIES HDB
   Zhang J, 2004, DRY TECHNOL, V22, P1983, DOI [10.1081/DRT-200032740, 10.1081/LDRT-200032740]
NR 46
TC 15
Z9 16
U1 0
U2 5
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0263-8762
J9 CHEM ENG RES DES
JI Chem. Eng. Res. Des.
PD MAY
PY 2009
VL 87
IS 5A
BP 739
EP 755
DI 10.1016/j.cherd.2008.10.009
PG 17
WC Engineering, Chemical
SC Engineering
GA 446TX
UT WOS:000266145200009
DA 2018-10-19
ER

PT J
AU Lur'e, MA
   Shmidt, FK
AF Lur'e, M. A.
   Shmidt, F. K.
TI Carbon and sulfur isotopes as geochemical keys to the origin of
   petroleum
SO CHEMISTRY AND TECHNOLOGY OF FUELS AND OILS
LA English
DT Article
AB A possible abiogenic origin for oil structures is indicated by the carbon and sulfur isotope ratios in crude oil, oil components, and other natural systems. Oils are enriched in the (34)S isotope as the sulfur content decreases, which provides indirect evidence for an increase in the contribution of biomaterial to oil as the sizes of oil pools decrease.
C1 [Lur'e, M. A.; Shmidt, F. K.] Irkutsk State Univ, Inst Oil & Coal Chem Synth, Irkutsk 664003, Russia.
RP Lur'e, MA (reprint author), Irkutsk State Univ, Inst Oil & Coal Chem Synth, Irkutsk 664003, Russia.
CR Barenbaum A. A., 2004, DOKL AKAD NAUK, V399, P802
   BARKER C, 1984, AAPG BULL, V68, P108
   BOBROV VN, 1985, P 2 ALL UN C OUTG EA, P88
   BOGACHEVA MP, 1969, P 9 ALL UN S STABL I, V1, P66
   Cruse AM, 2006, GEOCHIM COSMOCHIM AC, V70, P2073, DOI 10.1016/j.gca.2006.01.015
   Dai J, 2007, J PETROL GEOL, V30, P275, DOI 10.1111/j.1747-5457.2007.00275.x
   Faure G., 1989, PRINCIPLES ISOTOPE G
   GALIMOV EM, 1973, STUDIES ORGANIC MATT
   Goncharov I. V., 1987, GEOCHEMISTRY W SIBER
   KRAYUSHKIN VA, 2001, P INT C FOR DIAM BAS, P120
   KUKLINSKII AY, 1982, P 9 ALL UN S STABL I, P256
   Lur'e M. A., 2007, KHTTM, P3
   LURE MA, 2003, KHIM TEKH TOPL MASEL, P3
   LURE MA, 2004, ROSS KHIM ZH, V48, P135
   LURE MA, 2008, OTECHESTVENNAYA GEOL, P10
   PIROGOV SY, 2006, NATURAL GAS METHANE
   RUDENKO AP, 2006, ORIGINS HYDROCARBON, P68
   SHUMYANSKII VA, 1982, P 9 ALL UN STABL IS, V1, P62
   Syngaevskii E. D., 2007, LITOLOGIYA POLEZ ISK, P468
   TROFIMOV VA, 2005, GEOL NEFTI GAZA, P51
   VINOGRADOV VI, 2007, LITOLOGIYA POLEZ ISK, P3
NR 21
TC 1
Z9 2
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-3092
J9 CHEM TECH FUELS OIL+
JI Chem. Tech. Fuels Oils
PD MAY
PY 2009
VL 45
IS 3
BP 189
EP 192
DI 10.1007/s10553-009-0116-8
PG 4
WC Energy & Fuels; Engineering, Chemical; Engineering, Petroleum
SC Energy & Fuels; Engineering
GA 476YM
UT WOS:000268482700008
DA 2018-10-19
ER

PT J
AU Li, L
   Lin, ZB
   Yang, X
   Wan, ZZ
   Cui, SX
AF Li Lu
   Lin ZhangBi
   Yang Xiao
   Wan ZhenZhen
   Cui ShuXun
TI A novel cellulose hydrogel prepared from its ionic liquid solution
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE cellulose; hydrogel; ionic liquid
ID DISSOLUTION
AB A novel cellulose hydrogel is prepared by regenerating cellulose from its ionic liquid solution. The transparency cellulose hydrogel presents a good chemical stability and an acceptable mechanical property. This non-toxic cellulose hydrogel should be biocompatible and may be useful in the future as a biomaterial.
C1 [Li Lu; Lin ZhangBi; Yang Xiao; Wan ZhenZhen; Cui ShuXun] Sichuan Univ, State Key Lab Polymer Mat Engn, Polymer Res Inst, Chengdu 610065, Peoples R China.
RP Cui, SX (reprint author), Sichuan Univ, State Key Lab Polymer Mat Engn, Polymer Res Inst, Chengdu 610065, Peoples R China.
EM cuisx@scu.edu.cn
RI Cui, Shuxun/G-3599-2010
OI Cui, Shuxun/0000-0002-7713-7377
FU National Natural Science Foundation of China [20604017]; Ministry of
   Education of China
FX Supported by the National Natural Science Foundation of China (Grant No.
   20604017) and Scientific Research Foundation for the Returned Overseas
   Chinese Scholars, Ministry of Education of China
CR Gavillon R, 2007, BIOMACROMOLECULES, V8, P424, DOI 10.1021/bm060376q
   Heinze T, 2005, MACROMOL BIOSCI, V5, P520, DOI 10.1002/mabi.200500039
   Kim CW, 2006, POLYMER, V47, P5097, DOI 10.1016/j.polymer.2006.05.033
   Kim DB, 2002, J APPL POLYM SCI, V83, P981, DOI 10.1002/app.2278
   Liu LY, 2006, CHINESE SCI BULL, V51, P2432, DOI 10.1007/s11434-006-2134-9
   Schurz J, 1999, PROG POLYM SCI, V24, P481, DOI 10.1016/S0079-6700(99)00011-8
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   Turner MB, 2005, BIOMACROMOLECULES, V6, P2497, DOI 10.1021/bm050199d
   Wu J, 2004, BIOMACROMOLECULES, V5, P266, DOI 10.1021/bm034398d
   Zhang H, 2005, MACROMOLECULES, V38, P8272, DOI 10.1021/ma0505676
   Zhu SD, 2006, GREEN CHEM, V8, P325, DOI 10.1039/b601395c
NR 12
TC 30
Z9 33
U1 8
U2 49
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD MAY
PY 2009
VL 54
IS 9
BP 1622
EP 1625
DI 10.1007/s11434-009-0207-2
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 445VC
UT WOS:000266078600022
DA 2018-10-19
ER

PT J
AU Araujo, MG
   Lindhe, J
AF Araujo, Mauricio G.
   Lindhe, Jan
TI Ridge preservation with the use of Bio-Oss (R) collagen: A 6-month study
   in the dog
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; extraction socket; grafting; ridge preservation
ID FRESH EXTRACTION SOCKETS; ANORGANIC BOVINE BONE; FREEZE-DRIED BONE;
   BETA-TRICALCIUM PHOSPHATE; TOOTH EXTRACTION; IMPLANT PLACEMENT; TISSUE
   FORMATION; REGENERATION; DEFECTS; RESORPTION
AB Background: In previous short-term studies, it was observed that while the placement of biomaterial in alveolar sockets may promote bone formation and ridge preservation, the graft may in fact also delay healing.
   Aim: The objective of the present experiment was to evaluate the more long-term effect on hard tissue formation and the amount of ridge augmentation that can occur by the placement of a xenogeneic graft in extraction sockets of dogs.
   Material and methods: Five beagle dogs were used. The third mandibular premolars were hemi-sected. The distal roots were carefully removed. A graft consisting of Bio-Oss (R) collagen was placed in one socket while the contra-lateral site was left without grafting. After 6 months of healing, the dogs were euthanized and biopsies were sampled. From each experimental site, four ground sections-two from the mesial root and two from the healed socket-were prepared, stained and examined under a microscope.
   Results: The placement of Bio-Oss (R) collagen in the fresh extraction socket served as a scaffold for tissue modeling but did not enhance new bone formation. In comparison with the non-grafted sites, the dimension of the alveolar process as well as the profile of the ridge was better preserved inBio-Oss (R)-grafted sites.
   Conclusion: The placement of a biomaterial in an extraction socket may modify modeling and counteract marginal ridge contraction that occurs following tooth removal.
C1 [Araujo, Mauricio G.] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [Lindhe, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Gothenburg, Sweden.
RP Araujo, MG (reprint author), Rua Silva Jardim,15 Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
CR AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Botticelli D, 2006, CLIN ORAL IMPLAN RES, V17, P351, DOI 10.1111/j.1600-0501.2006.01270.x
   BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donath K., 1988, PRAPARATOR, V34, P197
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Froum Stuart, 2004, Implant Dent, V13, P153
   Guarnieri R, 2004, J PERIODONTOL, V75, P902, DOI 10.1902/jop.2004.75.6.902
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Iezzi G, 2008, J PERIODONTOL, V79, P192, DOI 10.1902/jop.2008.070105 
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Jensen SS, 2005, INT J ORAL MAX IMPL, V20, P703
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1
   Sandor GKB, 2003, DENT TRAUMATOL, V19, P221, DOI 10.1034/j.1600-9657.2003.00164.x
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Tal H, 1999, CLIN ORAL IMPLAN RES, V10, P289, DOI 10.1034/j.1600-0501.1999.100405.x
   TRAINI T, 2008, J PERIODONTOL, V79, P955
   Vance GS, 2004, INT J ORAL MAX IMPL, V19, P491
   Vasilic Nikola, 2003, J Okla Dent Assoc, V93, P33
NR 42
TC 150
Z9 156
U1 3
U2 26
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2009
VL 20
IS 5
BP 433
EP 440
DI 10.1111/j.1600-0501.2009.01705.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 432PH
UT WOS:000265145700001
PM 19522974
DA 2018-10-19
ER

PT J
AU Lee, SW
   Kim, SY
   Lee, MH
   Lee, KW
   Leesungbok, R
   Oh, N
AF Lee, Suk-Won
   Kim, Su-Yeon
   Lee, Myung-Hyun
   Lee, Keun-Woo
   Leesungbok, Richard
   Oh, Namsik
TI Influence of etched microgrooves of uniform dimension on in vitro
   responses of human gingival fibroblasts
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE acid etching; cell adhesion; cell proliferation; microgrooves; titanium
   substrata
ID DEFINED BIOMATERIAL SURFACES; CONNECTIVE-TISSUE RESPONSES; TITANIUM
   SUBSTRATA; CELL BEHAVIOR; MICROMACHINED GROOVES; QUANTITATIVE-ANALYSIS;
   GROWTH; RAT; PROLIFERATION; ORIENTATION
AB Objective: The purpose of this study was to investigate the influence of titanium (Ti) substrata with etched surface microgrooves on in vitro responses of human gingival fibroblasts.
   Material and methods: Commercially pure Ti discs with surface microgrooves 15, 30, and 60 mm in width were fabricated using photolithography. Microgrooves 15 mm in widths were designed to be 3.5 mu m in depth, whereas microgrooves 30 and 60 mm in width varied between 5 and 10 mu m in depth. The entire surface of the microgrooved Ti substrata was further acid etched and used as the five experimental groups in this study (E15/3.5, E30/5, E30/10, E60/5, and E60/10), whereas the smooth and acid-etched Ti discs were both used as the control (NE0 and E0). Human gingival fibroblasts were cultured on all groups of substrata on successive timelines. Fibroblast adhesion and morphology was analyzed using confocal laser scanning microscopy (CLSM). Cell adhesion and proliferation were analyzed and compared using crystal violet staining and sulforhodamine B protein staining assays, respectively.
   Results: In CLSM, the cells in E30/10 and E60/10 were observed to be able to readily descend into and form focal adhesions inside the microgrooves, whereas the cells in E15/3.5 were mostly found on the ridge tops. Cell adhesion was significantly increased in E60/10 compared with that in NE0 or E0 at 4-h incubation. Cell proliferation was significantly increased in E60/10 and E15/3.5 compared with NE0 or E0 after 72 and 96 h of culture.
   Conclusion: This study indicates that Ti substrata with etched microgrooves 60 mm in width and 10 mm in depth significantly enhance human gingival fibroblast adhesion and proliferation.
C1 [Oh, Namsik] Inha Univ, Coll Med, Dept Dent, Div Prosthodont & Implantol, Inchon 400711, South Korea.
   [Lee, Suk-Won; Leesungbok, Richard] Kyung Hee Univ, EW Neo Med Ctr, Dent Hosp, Dept Biomat & Prosthodont, Seoul, South Korea.
   [Kim, Su-Yeon] Catholic Univ Korea, Coll Med, Cathol Hemopoiet Stem Cell Bank, Seoul, South Korea.
   [Lee, Myung-Hyun] Inst Ceram Engn & Technol, Reliabil Assessment & Mat Evaluat Ctr, Seoul, South Korea.
   [Lee, Keun-Woo] Yonsei Univ, Coll Dent, Dept Prosthodont, Seoul 120749, South Korea.
RP Oh, N (reprint author), Inha Univ, Coll Med, Dept Dent, Div Prosthodont & Implantol, 7-206 Sinhung Dong 3Ga, Inchon 400711, South Korea.
EM onsdo@inha.ac.kr
FU Basic Research Program of the Korea Science & Engineering Foundation
   [R012005-000-10989-0]
FX We would like to thank MEMSware Inc. for fabricating the Ti discs used
   in this study. This work was supported by the grant No.
   R012005-000-10989-0 from the Basic Research Program of the Korea Science
   & Engineering Foundation.
CR Bottaro DP, 2002, ANN NY ACAD SCI, V961, P143, DOI 10.1111/j.1749-6632.2002.tb03068.x
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1992, J BIOMED MATER RES, V26, P493, DOI 10.1002/jbm.820260407
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Grinnell F, 2003, MOL BIOL CELL, V14, P384, DOI 10.1091/mbc.E02-08-0493
   Hamilton DW, 2006, CALCIFIED TISSUE INT, V78, P314, DOI 10.1007/s00223-005-0238-x
   Jansen J A, 1999, Adv Dent Res, V13, P57
   Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P56, DOI 10.1111/j.1600-0501.2008.01597.x
   Listgarten MA, 1991, CLIN ORAL IMPLAN RES, V2, P1, DOI 10.1034/j.1600-0501.1991.020101.x
   Oakley C, 1997, EXP CELL RES, V234, P413, DOI 10.1006/excr.1997.3625
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Sun F, 2004, TISSUE ENG, V10, P267, DOI 10.1089/107632704322791907
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 2000, J BIOMED MATER RES, V51, P529, DOI 10.1002/1097-4636(20000905)51:3<529::AID-JBM30>3.0.CO;2-R
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 25
TC 23
Z9 24
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2009
VL 20
IS 5
BP 458
EP 466
DI 10.1111/j.1600-0501.2008.01671.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 432PH
UT WOS:000265145700004
PM 19250242
DA 2018-10-19
ER

PT J
AU Tjandra, JJ
   Chan, MKY
   Yeh, HCH
AF Tjandra, J. J.
   Chan, M. K. Y.
   Yeh, H. C. H.
TI Injectable silicone biomaterial (PTQ(TM)) is more effective than
   carbon-coated beads (Durasphere (R)) in treating passive faecal
   incontinence - a randomized trial
SO COLORECTAL DISEASE
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons
CY JUN 02-06, 2007
CL St Louis, MO
SP Amer Soc Colon & Rectal Surg
DE Silicone; Durasphere; anal sphincter; faecal incontinence; quality of
   life
ID INTERNAL ANAL-SPHINCTER; URINARY-INCONTINENCE; AUTOLOGOUS FAT;
   INJECTION; MANAGEMENT
AB Both injectable silicone biomaterial (PTQ(TM)) and pyrolytic carbon-coated beads (Durasphere (R)) have been shown to be effective in treating passive faecal incontinence due to internal sphincter dysfunction. This is a randomized study to evaluate their relative safety and efficacy.
   Forty patients (mean age 59.5 years vs 58.9 years) were randomized to have inter-sphincteric injection of PTQ(TM) or submucosal injection of Durasphere (R). Patients were assessed with anorectal physiology, endoanal ultrasound, a validated incontinence score and quality of life questionnaires.
   In the Durasphere (R) group, complications included rectal pain (5%), erosion through rectal mucosa (10%), and type III hypersensitivity reaction (5%). No complications occurred in the PTQ(TM) group. Compared with PTQ(TM), Durasphere((R)) group has a more rapid action, with improved continence at 2 weeks after injection. In both groups, faecal continence significantly improved 6 weeks after injection, and continued to improve significantly up to 6 months in both groups (P < 0.0001). At 6 weeks, 6 and 12 months after injection, significantly more PTQ(TM) patients achieved greater than 50% improvement in Wexner's continence score than Durasphere((R)) patients (respectively, P = 0.01; P < 0.0001; P = 0.001). There was a significant improvement in faecal incontinence quality of life scale and the 12-month physical health scale of Short Form-12 health survey in the PTQ(TM) group but not in the Durasphere((R)) group.
   In patients with internal sphincter dysfunction, injectable silicone biomaterial was safer and more effective than Durasphere (R)(.).
C1 [Tjandra, J. J.; Chan, M. K. Y.; Yeh, H. C. H.] Univ Melbourne, Dept Colorectal Surg, Epworth Hosp, Melbourne, Vic, Australia.
RP Chan, MKY (reprint author), Caritas Med Ctr, Dept Surg, 111 Wing Hong St, Kowloon, Hong Kong, Peoples R China.
EM mirchan@hotmail.com
CR Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   *CARB MED TECHN IN, DUR FI
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   Kumar D, 1998, BRIT J SURG, V85, P978
   Lowry A C, 2001, Colorectal Dis, V3, P272, DOI 10.1046/j.1463-1318.2001.00269.x
   Madjar S, 2006, J UROLOGY, V175, P1408, DOI 10.1016/S0022-5347(05)00679-8
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   OOI BS, 2000, COLORECTAL DIS, V2, P220
   Pannek J, 2001, J UROLOGY, V166, P1350, DOI 10.1016/S0022-5347(05)65767-9
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   TAN JJ, 2006, DIS COLON RECTUM, V49, P761
   Tjandra JJ, 2006, DIS COLON RECTUM, V49, P730
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   TJANDRA JJ, 1993, DIS COLON RECTUM, V36, P689, DOI 10.1007/BF02238597
   TJANDRA JJ, 1994, AUST NZ J SURG, V64, P322, DOI 10.1111/j.1445-2197.1994.tb02219.x
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   van der Hagen SJ, 2007, BRIT J SURG, V94, P222, DOI 10.1002/bjs.5463
   Ware J. E., 1995, SF 12 SCORE SF 12 PH
   Weiss EG, 2002, DIS COLON RECTUM, V45, pA46
NR 25
TC 37
Z9 38
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1462-8910
J9 COLORECTAL DIS
JI Colorectal Dis.
PD MAY
PY 2009
VL 11
IS 4
BP 382
EP 389
DI 10.1111/j.1463-1318.2008.01634.x
PG 8
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 431OC
UT WOS:000265070100009
PM 18637935
OA Bronze
DA 2018-10-19
ER

PT J
AU Marimuthu, M
   Kim, S
AF Marimuthu, Mohana
   Kim, Sanghyo
TI Survey of the State of the Art in Biomaterials, Cells, Genes and
   Proteins Integrated into Micro- and Nanoscaffolds for Tissue
   Regeneration
SO CURRENT NANOSCIENCE
LA English
DT Review
DE Biomaterial; micro- and nanoscaffold; growth factor; cell; gene; tissue
   regeneration
ID FIBROBLAST-GROWTH-FACTOR; CALCIUM-PHOSPHATE CEMENT; SPINAL-CORD-INJURY;
   BONE INDUCTIVE PROPERTIES; ELASTIN-LIKE POLYPEPTIDE; COLLAGEN-GAG
   SCAFFOLDS; MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; DRUG-DELIVERY;
   ENGINEERING APPLICATIONS
AB Over the past few years, nanoscience and nanotechnology has emerged as a new exciting field in which studies on micro- and nanoscaffolding for tissue regeneration have become a focus exclusively. Micro- and Nanocomposite materials that can provide the appropriate matrix environment, integrate the desirable biological cues, as well as provide for the controlled, sequential delivery of multiple growth factors for different stages of the tissue repair process would help fulfill the promise of regenerative medicine. Also the development of relevant scaffold design using suitable biomaterials and incorporation of appropriate biomolecules and the selection of cell types plays a vital role in tissue repair. The present paper intends to illustrate the progress that has been achieved in the important field of scaffolding nanoscience includes primary view on biomaterials such as natural-origin and synthetic polymers, and inorganic biomaterials that might be potentially useful as carrier systems for active biomolecules (growth factors/genes) or as cell carriers for tissue regeneration. We also attempted to discuss the distinctive proteins or growth factors and cells which have been selectively studied for bone, cartilage, neural, skin, vascular and dental regeneration, with the aim of stimulating a broader interest in developing tissue regenerative nanoscience and nanotechnology.
C1 [Marimuthu, Mohana; Kim, Sanghyo] Kyungwon Univ, Dept Bionanotechnol, Songnam 461701, Gyeonggi Do, South Korea.
RP Kim, S (reprint author), Kyungwon Univ, Dept Bionanotechnol, San 65, Songnam 461701, Gyeonggi Do, South Korea.
EM samkim@kyungwon.ac.kr
FU Gyeonggi Regional Research Centre (GRRC) Program, Republic of Korea
   [2008-0176]
FX This work was supported by the grant (Grant No: 2008-0176) from Gyeonggi
   Regional Research Centre (GRRC) Program, Republic of Korea.
CR Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556
   Andreopoulos FM, 2006, BIOMATERIALS, V27, P2468, DOI 10.1016/j.biomaterials.2005.11.019
   ANJANA J, 2006, BIOMATERIALS, V27, P497
   Arigita C, 1999, PHARMACEUT RES, V16, P1534, DOI 10.1023/A:1015096302720
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   BARQUINERO J, 2004, GENE THER, V1, pS3
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Bloch K, 2005, J BIOMED MATER RES A, V75A, P802, DOI 10.1002/jbm.a.30466
   Bonzani IC, 2007, BIOMATERIALS, V28, P423, DOI 10.1016/j.biomaterials.2006.08.026
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   BUCALA R, 1994, MOL MED, V1, P71
   Burger C, 2007, COLLOID SURFACE B, V56, P134, DOI 10.1016/j.colsurfb.2006.09.023
   CENTRELLA M, 1986, ENDOCRINOLOGY, V119, P2306, DOI 10.1210/endo-119-5-2306
   Charwat S, 2008, EXP HEMATOL, V36, P672, DOI 10.1016/j.exphem.2008.01.005
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen HC, 2009, BIOMATERIALS, V30, P674, DOI 10.1016/j.biomaterials.2008.10.017
   CHENGTIE W, 2006, J BIOMED MATER RES B, V78, P47
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Chia SL, 2006, TISSUE ENG, V12, P1945, DOI 10.1089/ten.2006.12.1945
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Clapper JD, 2007, POLYMER, V48, P6554, DOI 10.1016/j.polymer.2007.08.023
   Cooke JW, 2006, TISSUE ENG, V12, P1441, DOI 10.1089/ten.2006.12.1441
   Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   DAQING H, 2008, MED HYPOTHESES, V71, P374
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   de Wolf HK, 2007, INT J PHARM, V331, P167, DOI 10.1016/j.ijpharm.2006.10.029
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DiMuzio P, 2007, J VASC SURG, V45, p99A, DOI 10.1016/j.jvs.2007.02.046
   Domb A, 2007, ADV DRUG DELIVER REV, V59, P185, DOI 10.1016/j.addr.2007.05.001
   Domingues ZR, 2004, BIOMATERIALS, V25, P327, DOI 10.1016/S0142-9612(03)00524-6
   Duarte ARC, 2009, EUR POLYM J, V45, P141, DOI 10.1016/j.eurpolymj.2008.10.004
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   FABIANA Q, 2008, INT J PHARMACEUT, V364, P281
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Ferruti P, 2005, MACROMOL BIOSCI, V5, P613, DOI 10.1002/mabi.200500020
   Garcia C, 2004, J NON-CRYST SOLIDS, V348, P218, DOI 10.1016/j.jnoncrysol.2004.08.172
   Ghosh S, 2008, MAT SCI ENG C-BIO S, V28, P80, DOI 10.1016/j.msec.2006.12.012
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Goodman GR, 2001, BONE, V28, P583, DOI 10.1016/S8756-3282(01)00428-8
   Goraltchouk A, 2006, J CONTROL RELEASE, V110, P400, DOI 10.1016/j.jconrel.2005.10.019
   Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107
   Grill R, 1997, J NEUROSCI, V17, P5560
   Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001
   Guicheux J, 1998, J BIOMED MATER RES, V40, P560, DOI 10.1002/(SICI)1097-4636(19980615)40:4<560::AID-JBM7>3.0.CO;2-D
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Haile Y, 2007, BIOMATERIALS, V28, P1163, DOI 10.1016/j.biomaterials.2006.10.030
   Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009
   Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   HENNING S, 2008, BIOMATERIALS, V29, P103
   Heywood HK, 2006, TISSUE ENG, V12, P3487, DOI 10.1089/ten.2006.12.3487
   Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028
   HOCKIN HKX, 2008, DENT MATER, V24, P1212
   Holmbom J, 2002, BONE, V30, p5S
   Hou R, 2007, J BIOMED MATER RES A, V80A, P85, DOI 10.1002/jbm.a.30840
   Huang S, 2009, MAT SCI ENG C-BIO S, V29, P1351, DOI 10.1016/j.msec.2008.10.036
   Ishii T, 2001, BBA-BIOMEMBRANES, V1514, P51, DOI 10.1016/S0005-2736(01)00362-5
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030
   Jiang WG, 1998, INT J MOL MED, V2, P203
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   JUTHAMAS R, 2006, J METALS MAT MINERAL, V16, P31
   Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015
   Katsube K, 2005, J ORTHOP RES, V23, P469, DOI 10.1016/j.orthres.2004.08.013
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kimakhe S, 1999, J BIOMED MATER RES, V47, P18, DOI 10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   KIYOSHI O, 2009, MAT RES B, V44, P298
   Kleinheinz J, 2005, J ORAL MAXIL SURG, V63, P1310, DOI 10.1016/j.joms.2005.05.303
   Ko HF, 2007, MAT SCI ENG C-BIO S, V27, P479, DOI 10.1016/j.msec.2006.05.045
   Kofron MD, 2006, ADV DRUG DELIVER REV, V58, P555, DOI 10.1016/j.addr.2006.03.008
   Kroese-Deutman HC, 2005, BIOMATERIALS, V26, P1131, DOI 10.1016/j.biomaterials.2004.04.021
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Kundu B, 1999, PEPTIDES, V20, P523, DOI 10.1016/S0196-9781(99)00034-0
   KUNIKO H, 2007, J CONTROL RELEASE, V118, P169
   Kushibiki T, 2005, J CONTROL RELEASE, V105, P318, DOI 10.1016/j.jconrel.2005.02.030
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   LAPORTE LD, BIOMATERIALS, DOI DOI 10.1016/J.BIOMATERIALS.2008.12.051
   Lei YG, 2009, BIOMATERIALS, V30, P254, DOI 10.1016/j.biomaterials.2008.09.027
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li X, 2007, CHEM MATER, V19, P4322, DOI 10.1021/cm0708564
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Lim YB, 2000, J AM CHEM SOC, V122, P6524, DOI 10.1021/ja001033h
   Link DP, 2007, TISSUE ENG, V13, P493, DOI 10.1089/ten.2006.0015
   Liu Y, 2005, COLLOID SURFACE B, V43, P216, DOI 10.1016/j.colsurfb.2005.04.011
   Liu Y, 2007, CELL BIOL INT, V31, P985, DOI 10.1016/j.cellbi.2007.03.009
   Lode A, 2007, J BIOMED MATER RES A, V81A, P474, DOI 10.1002/jbm.a.31024
   Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA
   Luten J, 2008, EUR J PHARM SCI, V33, P241, DOI 10.1016/j.ejps.2007.12.003
   Maheshwari A, 2002, GENE THER, V9, P1075, DOI 10.1038/sj.gt.3301766
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malafaya PB, 2006, J MATER SCI-MATER M, V17, P371, DOI 10.1007/s10856-006-8240-z
   Malafaya PB, 2002, CURR OPIN SOLID ST M, V6, P297, DOI 10.1016/S1359-0286(02)00077-3
   Malafaya PB, 2002, CURR OPIN SOLID ST M, V6, P283, DOI 10.1016/S1359-0286(02)00075-X
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Martins AM, 2008, ACTA BIOMATER, V4, P1637, DOI 10.1016/j.actbio.2008.06.004
   MAY PX, 2007, BIOMATERIALS, V28, P4889
   Meinel L, 2003, BONE, V33, P660, DOI 10.1016/S8756-3282(03)00207-2
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   Moioli EK, 2007, ADV DRUG DELIVER REV, V59, P308, DOI 10.1016/j.addr.2007.03.019
   Morisada T, 2006, ENDOTHELIUM-J ENDOTH, V13, P71, DOI 10.1080/10623320600697989
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Mumper RJ, 1996, PHARMACEUT RES, V13, P701, DOI 10.1023/A:1016039330870
   Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   NIHOUANNEN DL, 2006, BIOMATERIALS, V27, P2716
   Nishinari K, 2003, CURR OPIN COLLOID IN, V8, P396, DOI 10.1016/S1359-0294(03)00099-2
   NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Ohya Y, 2004, J BIOMAT SCI-POLYM E, V15, P111, DOI 10.1163/156856204322752264
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Pek YS, 2009, BIOMATERIALS, V30, P822, DOI 10.1016/j.biomaterials.2008.10.053
   Petersen H, 2002, BIOCONJUGATE CHEM, V13, P845, DOI 10.1021/bc025529v
   Phan T. T., 2005, Cell and Tissue Banking, V6, P91, DOI 10.1007/s10561-004-3904-8
   Pun SH, 2004, BIOCONJUGATE CHEM, V15, P831, DOI 10.1021/bc049891g
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Rashid ST, 2004, EUR J VASC ENDOVASC, V27, P608, DOI 10.1016/j.ejvs.2004.01.020
   Ren L, 2006, SOL ST PHEN, V111, P13, DOI 10.4028/www.scientific.net/SSP.111.13
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   RITA CDA, J SUPERCRIT, DOI DOI 10.1016/J.SUPFLU.2008.12.008
   Rives CB, 2009, BIOMATERIALS, V30, P394, DOI 10.1016/j.biomaterials.2008.09.013
   RODRIGUEZ FJ, 2004, DRUG DISCOV TODAY DI, V1, P177, DOI DOI 10.1016/J.DDMOD.2004.09.008
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Salgado AJ, 2007, J BIOMED MATER RES A, V80A, P983, DOI 10.1002/jbm.a.30946
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Saraf A, 2006, ADV DRUG DELIVER REV, V58, P592, DOI 10.1016/j.addr.2006.03.005
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   Scuderi N, 2008, BIOMATERIALS, V29, P1620, DOI 10.1016/j.biomaterials.2007.12.024
   Seeherman H, 2006, J BONE JOINT SURG AM, V88A, P144, DOI 10.2106/JBJS.D.02453
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Sethumadhavan S, 2007, EUR J PHARMACOL, V572, P69
   Shah NM, 2006, BIOMACROMOLECULES, V7, P3171, DOI 10.1021/bm060339z
   Shen HC, 2004, BONE, V34, P982, DOI 10.1016/j.bone.2004.01.028
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shi L, 2003, GENE THER, V10, P1179, DOI 10.1038/sj.gt.3301970
   Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8
   SIYU N, 2006, J BIOMED MATER RES A, V76, P196
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Soriano I, 2000, J CONTROL RELEASE, V68, P121, DOI 10.1016/S0168-3659(00)00251-0
   Stallmann HP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-18
   Stallmann HP, 2003, J ANTIMICROB CHEMOTH, V52, P853, DOI 10.1093/jac/dkg443
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   Sterodimas A, 2009, J PLAST RECONSTR AES, V62, P447, DOI 10.1016/j.bjps.2008.11.046
   Stevens MM, 2004, J ORTHOPAED RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021
   Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004
   Sundaram J, 2008, ACTA BIOMATER, V4, P932, DOI 10.1016/j.actbio.2008.01.019
   Swierczewska M, 2008, ACTA BIOMATER, V4, P827, DOI 10.1016/j.actbio.2007.11.004
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Tsuruma A, 2008, COLLOID SURFACE A, V313, P536, DOI 10.1016/j.colsurfa.2007.05.079
   Tuominen T, 2000, INT ORTHOP, V24, P289, DOI 10.1007/s002640000164
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Vergara C, 2004, BRAIN RES REV, V47, P161, DOI 10.1016/j.brainresrev.2004.07.010
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   Wang J, 2001, J AM CHEM SOC, V123, P9480, DOI 10.1021/ja016062m
   Wang J, 2004, INT J PHARMACEUT, V279, P115, DOI 10.1016/j.ijpharm.2004.04.014
   Wang M, 2007, EUR POLYM J, V43, P4683, DOI 10.1016/j.eurpolymj.2007.08.012
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Williams RL, 2005, J MATER SCI-MATER M, V16, P1087, DOI 10.1007/s10856-005-4710-y
   Wu CT, 2007, J MATER SCI-MATER M, V18, P857, DOI [10.1007/s10856-006-0083-0, 10.1007/S10856-006-0083-0]
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Wu CT, 2004, MATER LETT, V58, P2415, DOI 10.1016/j.matlet.2004.02.039
   Wu XP, 2006, MICROVASC RES, V71, P12, DOI 10.1016/j.mvr.2005.11.004
   Xu HHK, 2008, DENT MATER, V24, P1212, DOI 10.1016/j.dental.2008.02.001
   Xu XL, 2005, J BIOMED MATER RES B, V75B, P289, DOI 10.1002/jbm.b.30299
   Yang F, 2008, CHEM ENG J, V137, P154, DOI 10.1016/j.cej.2007.07.076
   YI HS, 2008, ACTA BIOMATER, V4, P477
   Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   YOWA SZ, BIOMATERIALS, DOI DOI 10.1016/J.BIOMATERIALS.2008.11.003
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   YUFANG Z, 2008, MICROPOR MESOPOR MAT, V112, P494
   Yun HS, 2007, CHEM COMMUN, P2139, DOI 10.1039/b702103h
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   ZARANA SP, 2008, ACTA BIOMATER, V4, P1126
   ZARANA SP, 2008, BONE, V43, P931
   Zeugolis DI, 2008, ACTA BIOMATER, V4, P1646, DOI 10.1016/j.actbio.2008.05.015
   Zhang FM, 2008, J EUR CERAM SOC, V28, P539, DOI 10.1016/j.jeurceramsoc.2007.07.012
   Zhang G, 2007, ADV DRUG DELIVER REV, V59, P360, DOI 10.1016/j.addr.2007.03.018
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   Zhang YF, 2007, BIOMATERIALS, V28, P1515, DOI 10.1016/j.biomaterials.2006.11.040
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
   Zhu YB, 2005, J BIOMED MATER RES B, V75B, P193, DOI 10.1002/jbm.b.30305
   Zhu YF, 2005, NANOTECHNOLOGY, V16, P2633, DOI 10.1088/0957-4484/16/11/027
   Zhu YF, 2007, MICROPOR MESOPOR MAT, V103, P243, DOI 10.1016/j.micromeso.2007.02.012
   Ziegler J, 2002, J BIOMED MATER RES, V59, P422, DOI 10.1002/jbm.1258
NR 211
TC 7
Z9 7
U1 1
U2 31
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4137
EI 1875-6786
J9 CURR NANOSCI
JI Curr. Nanosci.
PD MAY
PY 2009
VL 5
IS 2
BP 189
EP 203
DI 10.2174/157341309788185389
PG 15
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA 440JU
UT WOS:000265697400009
DA 2018-10-19
ER

PT J
AU Chekan, NM
   Beliauski, NM
   Akulich, VV
   Pozdniak, LV
   Sergeeva, EK
   Chernov, AN
   Kazbanov, VV
   Kulchitsky, VA
AF Chekan, N. M.
   Beliauski, N. M.
   Akulich, V. V.
   Pozdniak, L. V.
   Sergeeva, E. K.
   Chernov, A. N.
   Kazbanov, V. V.
   Kulchitsky, V. A.
TI Biological activity of silver-doped DLC films
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 19th European Conference on Diamond, Diamond-Like Materials, Carbon
   Nanotubes, Nitrides and Silicon Garbide
CY SEP 07-11, 2008
CL Sitges, SPAIN
DE Diamond-like carbon; Silver doping; Arc deposition; Biomaterial
ID DIAMOND-LIKE-CARBON; VACUUM-ARC DEPOSITION; AMORPHOUS-CARBON; HARD
   CARBON; THIN-FILMS; COATINGS; ADHESION; BEHAVIOR; SURFACE; CELLS
AB The technique of combined DC metal arc and carbon pulsed arc was used to deposit thin solid films containing up to 6.5 at.% of silver. The microstructure and antibacterial properties of silver-doped diamondlike carbon (DLC) films have been investigated. Silver nanoparticle of flat disk shape located inside of an amorphous carbon matrix revealed excellent antibacterial properties concerning Staphylococcus aureus bacteria. Titanium substrates with DLC films doped with silver have an inhibiting effect on growth of some tumors, in particular, on rat neoplastic C6 glioma. This result is new and opens further possibility for application of DLC:Ag composite in medicine. (C) 2009 Published by Elsevier B.V.
C1 [Chekan, N. M.; Beliauski, N. M.; Akulich, V. V.; Sergeeva, E. K.] NAS Belarus, Phys Tech Inst, Minsk 220141, Byelarus.
   [Pozdniak, L. V.; Chernov, A. N.; Kazbanov, V. V.; Kulchitsky, V. A.] NAS Belarus, Inst Physiol, Minsk 220072, Byelarus.
RP Chekan, NM (reprint author), NAS Belarus, Phys Tech Inst, 1-3 Kuprevich St, Minsk 220141, Byelarus.
EM pec@bas-net.by
CR Babonneau D, 2000, J APPL PHYS, V87, P3432, DOI 10.1063/1.372363
   Davis CA, 1995, SURF COAT TECH, V76, P316
   Ferrari AC, 2002, DIAM RELAT MATER, V11, P1053, DOI 10.1016/S0925-9635(01)00730-0
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Guo CT, 2007, APPL SURF SCI, V253, P9191, DOI 10.1016/j.apsusc.2007.05.045
   Hauert R, 2003, DIAM RELAT MATER, V12, P171, DOI 10.1016/S0925-9635(03)00019-0
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Kelly S, 2008, BIOMATERIALS, V29, P2573, DOI 10.1016/j.biomaterials.2008.03.001
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Lifshitz Y, 2003, DIAM RELAT MATER, V12, P130, DOI 10.1016/S0925-9635(03)00014-1
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079
   McKenzie DR, 1996, REP PROG PHYS, V59, P1611, DOI 10.1088/0034-4885/59/12/002
   Merel P, 1998, APPL SURF SCI, V136, P105, DOI 10.1016/S0169-4332(98)00319-5
   Morrison ML, 2006, DIAM RELAT MATER, V15, P138, DOI 10.1016/j.diamond.2005.08.031
   OSTROVSKAYA LY, 2003, VACUUM, V68, P219
   Reinoso M, 2007, APPL SURF SCI, V254, P181, DOI 10.1016/j.apsusc.2007.07.020
   TOCHITSKY EI, 1991, SURF COAT TECH, V47, P292, DOI 10.1016/0257-8972(91)90294-7
   Vandevelde TCS, 1999, SURF COAT TECH, V113, P80, DOI 10.1016/S0257-8972(98)00831-7
NR 20
TC 25
Z9 26
U1 0
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD MAY-AUG
PY 2009
VL 18
IS 5-8
BP 1006
EP 1009
DI 10.1016/j.diamond.2009.02.024
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 467KG
UT WOS:000267737000069
DA 2018-10-19
ER

PT J
AU Wippermann, J
   Schumann, D
   Klemm, D
   Kosmehl, H
   Satehi-Gelani, S
   Wahlers, T
AF Wippermann, J.
   Schumann, D.
   Klemm, D.
   Kosmehl, H.
   Satehi-Gelani, S.
   Wahlers, T.
TI Preliminary Results of Small Arterial Substitute Performed with a New
   Cylindrical Biomaterial Composed of Bacterial Cellulose
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Article
DE Bacterial cellulose; Cylindrical biomaterial; Small arterial substitutes
ID CELLS; VIVO
AB Objective: Tissue-engineered blood vessels (TEBVs) represent an innovative approach for overcoming reconstructive problems associated with extended vascular diseases by providing small-calibre vascular grafts. This study aimed to evaluate a novel biomaterial of bacterially synthesised cellulose (BC) as a potential scaffold for TEBV.
   Methods: Highly crystalline cellulose was produced by a bacterium (Acetobacter xylinum) using glucose as a source of carbon. Using a patented process, hollow-shaped segments of BC werecreated with a length of 10 mm, an inner diameter of 3.0-3.7 mm and a wall thickness of 0.6-1.0 mm. These grafts were used to replace the carotid arteries of eight pigs, and after a follow-up period of 3 months, the grafts were removed and analysed, both macro-and microscopically.
   Results: Seven grafts (87.5%) remained patent, whereas one graft was found to be occluded. Scanning electron microscopic examination revealed rapid re-cellularisation by recipient endothelial cells. Light microscopic examination showed a three-layered wall structure of the BC segments, with cellulose still being present in the media.
   Conclusion: These data indicate that the innovative BC-engineering technique results in the production of stable vascular conduits, which exhibit attractive properties for their use in future TEBV programmes for vascular surgery. (C) 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Wippermann, J.; Satehi-Gelani, S.; Wahlers, T.] Univ Hosp Cologne, Dept Cardiothorac Surg, D-50937 Cologne, Germany.
   [Schumann, D.; Klemm, D.] Univ Jena & Polymer Jena, Inst Organ Chem, Jena, Germany.
   [Kosmehl, H.] Helios Clin Erfurt, Inst Pathol, Erfurt, Germany.
RP Wippermann, J (reprint author), Univ Hosp Cologne, Dept Cardiothorac Surg, Kerpener Str 62, D-50937 Cologne, Germany.
EM jens.wippermann@uk-koeln.de
CR *AM HEART ASS, 2002, CIRCULATION, V16, P388
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   Hoerstrup S.P., 2006, CIRCULATION, V114, P1159
   KAUBE HR, 2006, J THORAC CARDIOVASC, V120, P134
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JW, 2001, APPL ENVIRON MICROB, V67, P3970, DOI 10.1128/AEM.67.9.3970-3975.2001
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
NR 14
TC 79
Z9 85
U1 2
U2 25
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1078-5884
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD MAY
PY 2009
VL 37
IS 5
BP 592
EP 596
DI 10.1016/j.ejvs.2009.01.007
PG 5
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 446RQ
UT WOS:000266139200016
PM 19231251
OA Bronze
DA 2018-10-19
ER

PT J
AU Att, W
   Yamada, M
   Ogawa, T
AF Att, Wael
   Yamada, Masahiro
   Ogawa, Takahiro
TI Effect of Titanium Surface Characteristics on the Behavior and Function
   of Oral Fibroblasts
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE acid etching; collagen; fibroblasts; machined; surface topography;
   titanium
ID DEFINED BIOMATERIAL SURFACES; CONNECTIVE-TISSUE RESPONSES; IN-VITRO;
   MINERALIZED TISSUE; TOPOGRAPHICAL CONTROL; PERCUTANEOUS DEVICES;
   HISTOMETRIC ANALYSIS; DIFFERENT DIMENSIONS; IMPLANT MATERIALS; CELL
   BEHAVIOR
AB Purpose: The purpose of this study was to evaluate the effect of different titanium surface characteristics on the behavior and function of oral fibroblasts as well as the deposition pattern of collagen within the extracellular matrix. Materials and Methods: Titanium surfaces created by machining, acid etching with sulfuric acid (AE1), or acid etching with hydrofluoric acid (AE2) were analyzed using scanning electron microscopy (SEM) and energy-dispersive x-ray spectroscopy. Rat oral fibroblasts were cultured on different surfaces. Cell spread and morphology of extracellular matrix were evaluated using SEM. Attachment and proliferation of cells were examined by comparing the numbers of attached to detached cells and cell count, respectively. Gene expression was analyzed via reverse transcriptase polymerase chain reaction. Collagen production and deposition were examined via a Sirius red-based stain assay and confocal laser scanning microscopy. Results: The machined surface showed a flat profile with isotropic grooves, the AE1 surface showed a uniformly microscale roughened surface, and the AE2 surface had a grooved profile with intermediate surface roughness. The AE2 surface contained fluoride atoms (2.45% +/- 0.44% as F/Ti atomic ratio). Cell attachment was significantly weaker on the machined surface than on the AE1 and AE2 surfaces, whereas no differences were observed between the AE1 and AE2 surfaces. The cell counts on the machined and AE2 surfaces were higher, with a parallel orientation, whereas the cell count was lower and randomly distributed on the AE1 surface, The expression level of fibroblastic genes was similar among surfaces for all time points tested. Collagen production was highest on the machined surface, followed by AE2 and AE1 surfaces. Collagen deposition displayed a parallel pattern on the machined surface, while it was multidirectional on the AE1 and AE2 surfaces. Conclusion: The surface characteristics of titanium affect attachment, spread, and proliferative activity of oral fibroblasts as well as the deposition pattern of collagen in vitro. INT J ORAL MAXILLOFAC IMPLANTS 2009;24:419-431
C1 [Att, Wael; Yamada, Masahiro; Ogawa, Takahiro] Univ Calif Los Angeles, Sch Dent, Biomat & Hosp Dent, Div Adv Prosthodont,Weintraub Ctr Reconstruct Bio, Los Angeles, CA 90095 USA.
   [Att, Wael] Univ Freiburg, Sch Dent, Dept Prosthodont, Freiburg, Germany.
RP Att, W (reprint author), Univ Calif Los Angeles, Sch Dent, Biomat & Hosp Dent, Div Adv Prosthodont,Jane & Jerry Weintraub Ctr Re, 10833 Conte Ave B3-081 CHS,Box 951668, Los Angeles, CA 90095 USA.
EM wael.att@uniklinik-freiburg.de
OI Yamada, Masahiro/0000-0002-6316-7866
CR Abrahamsson I, 2002, J CLIN PERIODONTOL, V29, P448, DOI 10.1034/j.1600-051X.2002.290510.x
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1992, J PERIODONTOL, V63, P225, DOI 10.1902/jop.1992.63.3.225
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1992, J BIOMED MATER RES, V26, P493, DOI 10.1002/jbm.820260407
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Cochran DL, 1997, J PERIODONTOL, V68, P186, DOI 10.1902/jop.1997.68.2.186
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Esposito M, 2000, Clin Implant Dent Relat Res, V2, P18, DOI 10.1111/j.1708-8208.2000.tb00103.x
   Esposito M, 1999, INT J ORAL MAX IMPL, V14, P798
   Glauser R, 2005, CLIN IMPLANT DENT R, V7, pS44, DOI 10.1111/j.1708-8208.2005.tb00074.x
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032
   Kim H, 2006, INT J ORAL MAX IMPL, V21, P354
   Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9
   Kivirikko KI, 1998, MATRIX BIOL, V16, P355, DOI 10.1016/S0945-053X(98)90008-7
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Listgarten MA, 1991, CLIN ORAL IMPLAN RES, V2, P1, DOI 10.1034/j.1600-0501.1991.020101.x
   MCCULLOCH CAG, 1991, J PERIODONTAL RES, V26, P144, DOI 10.1111/j.1600-0765.1991.tb01638.x
   Nakamura HK, 2007, J DENT RES, V86, P147, DOI 10.1177/154405910708600208
   Ogawa T, 2000, J DENT RES, V79, P1857, DOI 10.1177/00220345000790110701
   Phipps RP, 1997, J PERIODONTAL RES, V32, P159, DOI 10.1111/j.1600-0765.1997.tb01398.x
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Richards R. G., 1996, Injury, V27, pSC38
   Romeo E, 2004, Minerva Stomatol, V53, P215
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   Saruwatari L, 2005, J BONE MINER RES, V20, P2002, DOI 10.1359/JBMR-050703
   SCHLEGEL D, 1978, INT J ORAL MAXILLOF, V7, P569, DOI 10.1016/S0300-9785(78)80075-1
   SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Sukotjo C, 2003, J BIOL CHEM, V278, P51527, DOI 10.1074/jbc.M309616200
   Sukotjo C, 2002, J DENT RES, V81, P229, DOI 10.1177/154405910208100402
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Takeuchi K, 2005, J BIOMED MATER RES A, V72A, P296, DOI 10.1002/jbm.a.30227
   Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447
   Ungersbock A., 1994, Bio-Medical Materials and Engineering, V4, P317
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   VONRECUM AF, 1981, CRC CR REV BIOM ENG, V5, P37
   Vuorela A, 1999, MATRIX BIOL, V18, P519, DOI 10.1016/S0945-053X(99)00040-2
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Wieland M, 2002, J BIOMED MATER RES, V60, P434, DOI 10.1002/jbm.10059
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 60
TC 13
Z9 13
U1 0
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAY-JUN
PY 2009
VL 24
IS 3
BP 419
EP 431
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 464GU
UT WOS:000267494200005
PM 19587863
DA 2018-10-19
ER

PT J
AU Sergent, F
   Desilles, N
   Lacoume, Y
   Bunel, C
   Marie, JP
   Marpeau, L
AF Sergent, Fabrice
   Desilles, Nicolas
   Lacoume, Yann
   Bunel, Claude
   Marie, Jean-Paul
   Marpeau, Loic
TI Experimental biomechanical evaluation of polypropylene prostheses used
   in pelvic organ prolapse surgery
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Elasticity; Linear force at the rupture; Polypropylene; Prolapse;
   Prosthesis; Retraction
ID IN-VIVO; HERNIA MODEL; RAT MODEL; REPAIR; MESH; WEIGHT; MULTICENTER;
   IMPACT; LIGHT
AB Although polypropylene (PP) is the most common biomaterial used to repair genital prolapse via vaginal route, its mechanical properties however remain obscure.
   An abdominal hernia rabbit model was used to evaluate retraction, solidity, and elasticity of the principal types of PP prostheses currently available, i.e., three large pore size monofilament prostheses, one heavy weight (HWPP), a second low weight (LWPP), and a third coated with atelocollagen (CPP). A small pore size multifilament PP (MPP) implant was also tested.
   In comparison with HWPP (12%), LWPP (15%), and MPP (30%), CPP had less retraction (8% of the original size). Unlike pore size, weight prosthesis is not an influencing factor for retraction. Atelocollagen coating reduced retraction. HWPP and MPP were the most solid prostheses. MPP supported the greatest elastic force.
   When the biomechanical parameters were comparatively assessed, HWPP was considered to have the most advantageous properties for prolapse surgery.
C1 [Sergent, Fabrice] Univ Rouen, Hosp Charles Nicolle, Dept Obstet & Gynecol, F-76031 Rouen, France.
   [Sergent, Fabrice; Marpeau, Loic] CHU Hop Rouen, Clin Gynecol & Obstet, F-76031 Rouen, France.
   [Sergent, Fabrice; Desilles, Nicolas; Bunel, Claude] CNRS FRE 3101, INSA ROUEN, F-76131 Mont St Aignan, France.
   [Sergent, Fabrice; Lacoume, Yann; Marie, Jean-Paul] UPRES EA 3830, GRHV, Fac Med Pharm Rouen, Chirurg Expt Lab, F-76183 Rouen 1, France.
RP Sergent, F (reprint author), Univ Rouen, Hosp Charles Nicolle, Dept Obstet & Gynecol, Pavillon Femme Mere Enfant,1 Rue Germont, F-76031 Rouen, France.
EM Fabrice.Sergent@chu-rouen.fr
FU Covidien Co. (Trevoux, France)
FX The authors are most grateful to Richard Medeiros, Rouen University
   Hospital Medical Editor, for editing the manuscript. The authors are
   also grateful for the gift of polypropylene prostheses from Covidien Co.
   (Trevoux, France).
CR Abdel-Fattah M, 2008, BJOG-INT J OBSTET GY, V115, P22, DOI 10.1111/j.1471-0528.2007.01558.x
   Alponat A, 1997, AM SURGEON, V63, P818
   Altman D, 2006, OBSTET GYNECOL, V107, P59, DOI 10.1097/01.AOG.0000192547.58102.ab
   Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   Arnaud J P, 2003, Hernia, V7, P85, DOI 10.1007/s10029-003-0116-2
   CLAERHOUT F, 2003, NEUROUROL URODYNAM, V5, P516
   Cobb WS, 2006, J SURG RES, V136, P1, DOI 10.1016/j.jss.2006.05.022
   Cobb WS, 2005, J SURG RES, V129, P231, DOI 10.1016/j.jss.2005.06.015
   de Tayrac R, 2007, INT UROGYNECOL J, V18, P251, DOI 10.1007/s00192-006-0135-5
   Debodinance P, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P577
   Deffieux X, 2007, INT UROGYNECOL J, V18, P73, DOI 10.1007/s0192-005-0041-2
   Higgs P, 2005, AUST NZ J OBSTET GYN, V45, P430, DOI 10.1111/j.1479-828X.2005.00459.x
   Klinge U, 1998, EUR J SURG, V164, P965
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Klosterhalfen B, 1998, BIOMATERIALS, V19, P2235, DOI 10.1016/S0142-9612(98)00115-X
   Konstantinovic ML, 2007, INT UROGYNECOL J, V18, P619, DOI 10.1007/s00192-006-0202-y
   Maher C, 2007, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004014.PUB3, 10. 1002/ 14651858. CD004014. pub3]
   Mathe ML, 2007, GYNECOL OBSTET FERTI, V35, P398, DOI 10.1016/j.gyobfe.2007.02.024
   Nygaard IE, 2004, OBSTET GYNECOL, V104, P805, DOI 10.1097/01.AOG.0000139514.90897.07
   O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833
   Pariente JL, 2005, PROG UROL, V15, P1106
   Scheidbach H, 2004, SURG ENDOSC, V18, P211, DOI 10.1007/s00464-003-8113-1
   Sergent F, 2007, J Gynecol Obstet Biol Reprod (Paris), V36, P459
   Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0
   Wheeler TL, 2006, AM J OBSTET GYNECOL, V194, P1486, DOI 10.1016/j.ajog.2006.01.075
NR 25
TC 7
Z9 8
U1 0
U2 3
PU SPRINGER LONDON LTD
PI ARTINGTON
PA ASHBOURNE HOUSE, THE GUILDWAY, OLD PORTSMOUTH ROAD, ARTINGTON GU3 1LP,
   GUILDFORD, ENGLAND
SN 0937-3462
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD MAY
PY 2009
VL 20
IS 5
BP 597
EP 604
DI 10.1007/s00192-009-0825-x
PG 8
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA 426JA
UT WOS:000264702600018
PM 19221679
DA 2018-10-19
ER

PT J
AU Mendoza-Novelo, B
   Cauich-Rodriguez, JV
AF Mendoza-Novelo, Birzabith
   Cauich-Rodriguez, Juan V.
TI The effect of surfactants, crosslinking agents and L-cysteine on the
   stabilization and mechanical properties of bovine pericardium
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
DE Bovine pericardium; Crosslinking; Cysteine
ID IMPROVED HEMOCOMPATIBILITY; HEART-VALVES; NITRIC-OXIDE; GLUTARALDEHYDE;
   XENOGRAFT; POLYMERS; TISSUES
AB Aim: Bovine pericardium (BP) is a collagenous tissue commonly used in cardiovascular applications. However, it suffers from thrombus formation and calcification, the latter generally being related to cell debris and the use of glutaraldehyde (GA). With this in mind, BP was decellularized, crosslinked and grafted with L-cysteine in order to improve its stabilization and mechanical properties.
   Methods: BP was decellularized with ionic and non-ionic surfactants such as sodium dodecyl sulfate (SDS), cetyl trimethyl ammonium chloride (CTMA) or t-octyl phenoxy polyethoxy ethanol (Triton X-100). It was then crosslinked with 1-(3-dimethyl amino propyl)-3-ethyl carbodiimide hydrochloride (EDAC) or GA. Finally, residual aldehyde groups on GA only or EDAC-GA crosslinked pericardium were left to react with L-cysteine (Cys).
   Results: It was found that the treatment with GA led to a biomaterial with a lower amino-group content than the treatment with EDAC (15 vs. 50 mu mol/g). The increase in denaturation temperature from 71.2 +/- 0.5 to 86.3 +/- 0.8 degrees C confirmed that GA was a more effective crosslinking agent than EDAC. In a similar manner, crosslinking with GA increased the percentage of deformation while decreasing their tensile strength.
   Conclusion: The amount of grafted Cys varied from 3 to 9 mu mol/g thiol-groups and depended on the concentration of this amino acid and method of crosslinking, but did not modify its physicochemical and mechanical properties. (Journal of Applied Biomaterials & Biomechanics 2009; 7: 123-31)
C1 [Mendoza-Novelo, Birzabith; Cauich-Rodriguez, Juan V.] Ctr Invest Cient Yucatan, Merida, Yucatan, Mexico.
RP Cauich-Rodriguez, JV (reprint author), Ctr Invest Cient Yucatan, AC Colonia Chuburna Hidalgo, Merida, Yucatan, Mexico.
EM jvcr@cicy.mx
RI Mendoza-Novelo, Birzabith/M-8588-2016
OI Mendoza-Novelo, Birzabith/0000-0001-6604-395X
FU CONACYT (Mexico) [SEP-2003CO243175]
FX This work was supported by CONACYT (Mexico) grant SEP-2003CO243175 and a
   scholarship for B. Mendoza-Novelo. We thank Rossana Vargas-Coronado for
   her assistance in the SEM and microanalysis work. The authors also want
   to thank the referees' suggestions to improve this paper.
CR COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Drochioiu G., 2001, ROUM BIOTECHNOL LETT, V6, P155
   Duan XB, 2002, BIOMATERIALS, V23, P1197, DOI 10.1016/S0142-9612(01)00234-4
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Gappa-Fahlenkamp H, 2005, BIOMATERIALS, V26, P3479, DOI 10.1016/j.biomaterials.2004.09.028
   HABBEB AFS, 1972, METHOD ENZYMOL, V25, P457
   Jee KS, 2003, BIOMATERIALS, V24, P3409, DOI 10.1016/S0142-9612(03)00204-7
   Jorge-Herrero E, 2005, J Appl Biomater Biomech, V3, P67
   JORGEHERRERO E, 2005, P 19 EUR C BIOM SEPT, pP4
   Langdon SE, 1999, BIOMATERIALS, V20, P137, DOI 10.1016/S0142-9612(98)00142-2
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   Lee WK, 2000, BIOMATERIALS, V21, P2323, DOI 10.1016/S0142-9612(00)00159-9
   MENDOZANOVELO B, 2006, THESIS CICY MEXICO
   Paez JMG, 2000, J MATER SCI-MATER M, V11, P459, DOI 10.1023/A:1008996210734
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SHEEHAN JC, 1957, J AM CHEM SOC, V79, P4528, DOI 10.1021/ja01573a075
   Stacchino C, 1998, J HEART VALVE DIS, V7, P190
   WHIPPLE EB, 1974, J ORG CHEM, V39, P1666, DOI 10.1021/jo00925a015
   Zilla P, 2008, BIOMATERIALS, V29, P385, DOI 10.1016/j.biomaterials.2007.09.033
NR 20
TC 11
Z9 11
U1 0
U2 3
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
EI 1724-6024
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD MAY-AUG
PY 2009
VL 7
IS 2
BP 123
EP 131
PG 9
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 485HG
UT WOS:000269111200007
PM 20799173
DA 2018-10-19
ER

PT J
AU Liu, L
   Xiong, Z
   Zhang, RJ
   Jin, L
   Yan, YN
AF Liu, Li
   Xiong, Zhuo
   Zhang, Renji
   Jin, Le
   Yan, Yongnian
TI A Novel Osteochondral Scaffold Fabricated via Multi-nozzle
   Low-temperature Deposition Manufacturing
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE tissue engineering; rapid prototyping; osteochondral; separate
   interface; low-temperature deposition; bone-like tissue; cartilage-like
   tissue
ID CALCIUM-PHOSPHATE CERAMICS; POLYCAPROLACTONE SCAFFOLDS; OSTEOINDUCTIVE
   BIOMATERIAL; MECHANICAL-PROPERTIES; BONE; CELLS; DEGRADATION; HYDROGEL;
   CARRIER; REPAIR
AB A functional-region/separate-interface/single-cell-type of tissue engineering pathway was evaluated to regenerate osteochondral defects that are deep in the marrow cavity. A gradient osteochondral scaffold fabricated via a rapid prototyping technology, called multi-nozzle low-temperature deposition manufacturing, was composed of three parts with different materials and pore-structures, respectively, for bone, cartilage and a separate interface between them. The separate interface was composed of micro-pores, that were less than 5 mm and with low porosity, to reduce or to avoid the destruction of the micro-environment in vivo by preventing blood and cells and reducing the amount of oxygen and nutrients moving from the marrow cavity to the articulate marrow. The preliminary results after 6 weeks of implantation into 4 mm diameter osteochondral defects in the knee joints of rabbits showed that the defects with the scaffold/cells composition had bone-like or cartilage-like tissue filling the defects with smooth surface, while the defects with nothing (blank) showed only fibrous tissue.
C1 [Liu, Li; Xiong, Zhuo; Zhang, Renji; Jin, Le; Yan, Yongnian] Tsinghua Univ, Dept Mech Engn, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China.
RP Xiong, Z (reprint author), Tsinghua Univ, Dept Mech Engn, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China.
EM xiongzhuo99@mails.tsinghua.edu.cn
FU Hi-tech Research and Development Program of China [715-009-0160];
   National Natural Science Foundation of China [50675108]
FX The authors would like to thank the Hi-tech Research and Development
   Program of China under grant number 715-009-0160 and the National
   Natural Science Foundation of China under grant number 50675108 for
   supporting this work.
CR Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Jiao YP, 2007, J BIOACT COMPAT POL, V22, P492, DOI 10.1177/0883911507082161
   Koc A, 2008, J BIOACT COMPAT POL, V23, P244, DOI 10.1177/0883911508091828
   Kokubo S, 2008, J BIOACT COMPAT POL, V23, P348, DOI 10.1177/0883911508092791
   Kyriakidou K, 2008, J BIOACT COMPAT POL, V23, P227, DOI 10.1177/0883911508091905
   Lee SJ, 2002, J BIOMAT SCI-POLYM E, V13, P197, DOI 10.1163/156856202317414375
   LIU L, 2008, J BIOMEDI B IN PRESS
   Liu L, 2007, J BIOMED MATER RES A, V82A, P618, DOI 10.1002/bjm.a.31177
   Miranda P, 2006, ACTA BIOMATER, V2, P457, DOI 10.1016/j.actbio.2006.02.004
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Qu SX, 2002, J MATER SCI LETT, V21, P153, DOI 10.1023/A:1014201416677
   Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Tan KH, 2005, P I MECH ENG H, V219, P183, DOI 10.1243/095441105X9345
   Tong JC, 2007, J BIOACT COMPAT POL, V22, P232, DOI 10.1177/0883911507076460
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
   Xu W, 2007, J BIOACT COMPAT POL, V22, P363, DOI 10.1177/0883911507079451
   Yan YN, 2005, J BIOACT COMPAT POL, V20, P259, DOI 10.1177/0883911505053658
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
   Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025
NR 26
TC 18
Z9 22
U1 0
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2009
VL 24
BP 18
EP 30
DI 10.1177/0883911509102347
PG 13
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 446XW
UT WOS:000266156000002
DA 2018-10-19
ER

PT J
AU Lu, H
   Chen, WJ
   Xing, Y
   Ying, DJ
   Jiang, B
AF Lu, Hai
   Chen, Wei-Jun
   Xing, Yan
   Ying, Da-Jun
   Jiang, Bo
TI Design and Preparation of an Electrospun Biomaterial Surgical Patch
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Electrospun collagen; surgical patch; biomechanics; electrospun surgical
   patches; biocompatible electrospun patches; bioengineering; tissue
   engineering
ID NANOFIBERS
AB A biomaterial patch of electrospun collagen type fibers was designed and produced by electrospinning seven different concentrations (8%-20% w/v) of collagen solutions. The tensile strength, yield strength, and elastic modulus of the electrospun collagen fibrous patches were found to be suitable for clinical transplantation. No significant differences versus fresh porcine pericardium as controls were observed. The SEM images of the groups showed that the patches were smooth with uniform interwoven and porous morphology. The fibrous patches were biocompatible and did not elicit local or systemic toxic effects when implanted in vivo. These electrospun collagen fibrous patches have significant potential as surgical biomaterial patches.
C1 [Lu, Hai; Chen, Wei-Jun; Xing, Yan; Ying, Da-Jun] Third Mil Med Univ, Dept Anat, Key Lab Biomech & Tissue Engn, Chongqing 400038, Peoples R China.
   [Jiang, Bo] Sichuan Univ, Natl Inst Biomat Engn, Chengdu 610064, Peoples R China.
RP Ying, DJ (reprint author), Third Mil Med Univ, Dept Anat, Key Lab Biomech & Tissue Engn, Chongqing 400038, Peoples R China.
EM ydj96@yahoo.com.cn
FU Natural Science Foundation in China [30672535, 30472027]
FX This work was supported by the Natural Science Foundation in China (No.
   30672535, 30472027).
CR Choi JS, 2007, J BIOACT COMPAT POL, V22, P508, DOI 10.1177/0883911507081101
   Khil MS, 2004, POLYMER, V45, P295, DOI 10.1016/j.polymer.2003.09.049
   LI WJ, 2002, J BIOMED MATER RES, V60, P13
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Piras AM, 2008, J BIOACT COMPAT POL, V23, P423, DOI 10.1177/0883911508093357
   Spasova M, 2007, J BIOACT COMPAT POL, V22, P62, DOI 10.1177/0883911506073570
   WEISENBERGER MC, 2002, J NANOSCI NANOTECHNO, V3, P35
   XU CY, 2004, BIOMATERIALS, V25, P77
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Zhao DM, 2007, J BIOACT COMPAT POL, V22, P379, DOI 10.1177/0883911507079802
NR 10
TC 8
Z9 8
U1 1
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2009
VL 24
BP 158
EP 168
DI 10.1177/0883911509103559
PG 11
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 446XW
UT WOS:000266156000013
DA 2018-10-19
ER

PT J
AU Wei, YT
   Sun, XD
   Xia, X
   Cui, FZ
   He, Y
   Liu, BF
   Xu, QY
AF Wei, Yue-Teng
   Sun, Xiao-Dan
   Xia, Xue
   Cui, Fu-Zhai
   He, Yu
   Liu, Bing-Fang
   Xu, Qun-Yuan
TI Hyaluronic Acid Hydrogel Modified with Nogo-66 Receptor Antibody and
   Poly(L-Lysine) Enhancement of Adherence and Survival of Primary
   Hippocampal Neurons
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE hyaluronic acid; hydrogel; antiNgR; poly(L-lysine); cell attachment;
   tissue engineering; biomaterial; bioengineering; central nervous system
   injuries; repairing CNS injuries; modified hyaluronic acid hydrogels
ID SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; IN-VITRO; AXONAL
   REGENERATION; POLYETHYLENE-GLYCOL; NERVE REGENERATION; DELIVERY-SYSTEM;
   CULTURE; RAT; ATTACHMENT
AB Hyaluronic acid (HA) hydrogel was modified with poly(L-lysine) (PLL) and Nogo-66 Receptor antibody (antiNgR) to enhance the repair of central nervous system (CNS) injuries. The immobilization of PLL was characterized by X-ray photoelectron spectroscopy (XPS) and the immobilization of antiNgR was studied by immunofluorescence. The cytocompatibility of this modified hydrogel was analyzed by culturing primary hippocampal neurons. The quantity and morphology of the neurons were influenced by different modifications; the primary hippocampal neurons cultured with modified HA hydrogel exhibited multipolar and bipolar morphology were compared with unmodified hydrogel cultures. The number of neurons obtained by culturing with HA hydrogel modified with both PLL and antiNgR was almost twice the number of neurons cultured with HA modified with only PLL or antiNgR. This phenomenon was attributed to the collaborative effect of PLL and antiNgR on the neurons. The characteristics of this new hydrogel system, including pore structure, water absorption, hydrolysis degradation did not change much when compared with the hydrogel modified with PLL or antiNgR, respectively. It is expected that this modified HA hydrogel has potential as a CNS tissue engineering material.
C1 [Wei, Yue-Teng; Sun, Xiao-Dan; Xia, Xue; Cui, Fu-Zhai] Tsinghua Univ, Adv Mat Lab, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   [He, Yu; Liu, Bing-Fang; Xu, Qun-Yuan] Capital Med Univ, Beijing Inst Neurosci, Beijing Ctr Neural Regenerat & Repairing, Key Lab Neurodegenerat Dis,Minist Educ, Beijing 100069, Peoples R China.
RP Cui, FZ (reprint author), Tsinghua Univ, Adv Mat Lab, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM cuifz@mail.tsinghua.edu.cn
RI Wei, Yueteng/B-4653-2012; liu, bingfang/J-9615-2013
FU National Natural Science Foundation of China [50573044, 30670656];
   National Basic Research Program of China [2005CB623905, 2007CB947704];
   National Natural Science Foundation of Beijing [705001]; Beijing
   Scientific Committee [20005187040311]; Foundation of Analysis and
   Testing in Tsinghua University
FX Yue-Teng Wei and Yu He contributed equally to this work. This work was
   supported by National Natural Science Foundation of China (Grant No.
   50573044, 30670656), National Basic Research Program of China (Grant No.
   2005CB623905, 2007CB947704), National Natural Science Foundation of
   Beijing (Grant No. 705001), Beijing Scientific Committee (Grant No.
   20005187040311) and Foundation of Analysis and Testing in Tsinghua
   University.
CR Baptiste D, 2007, J NEUROTRAUM, V24, P1285
   Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3
   Brittis PA, 2001, NEURON, V30, P11, DOI 10.1016/S0896-6273(01)00258-6
   Cai J, 2007, J BIOMED MATER RES A, V83A, P512, DOI 10.1002/jbm.a.31296
   CARBONETTO S, 1983, J NEUROSCI, V3, P2324
   Evans MS, 1998, J NEUROSCI METH, V79, P37, DOI 10.1016/S0165-0270(97)00159-3
   GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hadlock T, 1999, LARYNGOSCOPE, V109, P1412, DOI 10.1097/00005537-199909000-00010
   Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hu M, 2000, TISSUE ENG, V6, P585, DOI 10.1089/10763270050199532
   Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   Oerther S, 2000, BIOPOLYMERS, V54, P273, DOI 10.1002/1097-0282(20001005)54:4<273::AID-BIP40>3.3.CO;2-9
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   SECKEL BR, 1995, J NEUROSCI RES, V40, P318, DOI 10.1002/jnr.490400305
   Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
   YONG VW, 1988, DEV NEUROSCI-BASEL, V10, P222, DOI 10.1159/000111972
   Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025
NR 25
TC 15
Z9 15
U1 2
U2 24
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2009
VL 24
IS 3
BP 205
EP 219
DI 10.1177/0883911509102266
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 443OF
UT WOS:000265918900001
DA 2018-10-19
ER

PT J
AU Salgado, AJ
   Sousa, RA
   Fraga, JS
   Pego, JM
   Silva, BA
   Malva, JO
   Neves, NM
   Reis, RL
   Sousa, N
AF Salgado, A. J.
   Sousa, R. A.
   Fraga, J. S.
   Pego, J. M.
   Silva, B. A.
   Malva, J. O.
   Neves, N. M.
   Reis, R. L.
   Sousa, N.
TI Effects of Starch/Polycaprolactone-based Blends for Spinal Cord Injury
   Regeneration in Neurons/Glial Cells Viability and Proliferation
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE biodegrable polymers; starch-poly(epsilon-caprolactone) blends;
   cytotoxicity; neurons; glial; spinal cord injury; tissue engineering
ID STARCH-BASED SCAFFOLDS; TISSUE-ENGINEERING APPLICATIONS; AXON
   REGENERATION; GUIDANCE CHANNELS; NERVOUS-SYSTEM; IN-VIVO;
   DIFFERENTIATION; GROWTH; MIGRATION; RECOVERY
AB Spinal cord injury (SCI) leads to drastic alterations on the quality of life of afflicted individuals. With the advent of Tissue Engineering and Regenerative Medicine where approaches combining biomaterials, cells and growth factors are used, one can envisage novel strategies that can adequately tackle this problem. The objective of this study was to evaluate a blend of starch with poly(epsilon-caprolactone) (SPCL) aimed to be used for the development of scaffolds spinal cord injury (SCI) repair. SPCL linear parallel filaments were deposited on polystyrene coverslips and assays were carried out using primary cultures of hippocampal neurons and glial cells. Light and fluorescence microscopy observations revealed that both cell populations were not negatively affected by the SPCL-based biomaterial. MTS and total protein quantification indicated that both cell viability and proliferation rates were similar to controls. Both neurons and astrocytes occasionally contacted the surface of SPCL filaments through their dendrites and cytoplasmatic processes, respectively, while microglial cells were unable to do so. Using single cell [Ca(2+)](i) imaging, hippocampal neurons were observed growing within the patterned channels and were functional as assessed by the response to a 30mM KCl stimulus. The present data demonstrated that SPCL-based blends are potentially suitable for the development of scaffolds in SCI regenerative medicine.
C1 [Salgado, A. J.; Fraga, J. S.; Pego, J. M.; Sousa, N.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal.
   [Sousa, R. A.; Neves, N. M.; Reis, R. L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Taipas, Guimaraes, Portugal.
   [Sousa, R. A.; Neves, N. M.; Reis, R. L.] PT Associated Lab, IBB, P-471057 Braga, Portugal.
   [Silva, B. A.; Malva, J. O.] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004504 Coimbra, Portugal.
   [Malva, J. O.] Univ Coimbra, Fac Med, Inst Biochem, P-3004504 Coimbra, Portugal.
RP Sousa, N (reprint author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal.
EM njcsousa@ecsaude.uminho.pt
RI Reis, Rui L./A-8938-2008; Fraga, Joana/K-3509-2013; Sousa,
   Nuno/N-9137-2017; Salgado, Antonio/J-4129-2013; Pego, Jose
   Miguel/C-2795-2009; Neves, Nuno/B-4685-2008; Sousa, Nuno/C-2782-2009;
   Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Fraga, Joana/0000-0003-3234-0600;
   Sousa, Nuno/0000-0002-8755-5126; Salgado, Antonio/0000-0003-3806-9823;
   Pego, Jose Miguel/0000-0002-9497-6543; Neves, Nuno/0000-0003-3041-0687;
   Group, 3Bs/0000-0002-5195-3456; Malva, Joao/0000-0002-5438-4447; Sousa,
   Rui/0000-0003-0362-7418
FU Portuguese Foundation for Science and Technology; POCTI and/or FEDER
   programs;  [SFRH/BPD/17595/2004]
FX Portuguese Foundation for Science and Technology through funds from
   POCTI and/or FEDER programs (Funding to ICVS, 3B's Research Group and
   post doctoral fellowship to A.J. Salgado-SFRH/BPD/17595/2004).
CR BERKOWITZ M, 1992, EC CONSEQUENCES TRAU
   CORY AH, 1991, CANCER COMMUN, V3, P207
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   FIBOUZI M, 2006, NEUROSCI LETT, V10, P66
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054
   Lu J, 2005, DEVELOPMENT, V132, P3231, DOI 10.1242/dev.01893
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Marques AP, 2005, MACROMOL BIOSCI, V5, P775, DOI 10.1002/mabi.200500010
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Pastrana E, 2006, J NEUROSCI, V26, P5347, DOI 10.1523/JNEUROSCI.1111-06.2006
   Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8
   Reis R., 2001, ENCY MAT SCI TECHNOL, P8810
   Salgado AJ, 2007, J BIOMED MATER RES A, V80A, P983, DOI 10.1002/jbm.a.30946
   Salgado AJ, 2004, NATO SCI SER II MATH, V171, P205
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Salih V, 2000, J MATER SCI-MATER M, V11, P615, DOI 10.1023/A:1008901612674
   Samadikuchaksaraei A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-15
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002
   Silva AP, 2001, J NEUROSCI RES, V65, P378, DOI 10.1002/jnr.1164
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
NR 34
TC 12
Z9 12
U1 0
U2 15
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2009
VL 24
IS 3
BP 235
EP 248
DI 10.1177/0883911509104081
PG 14
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 443OF
UT WOS:000265918900003
DA 2018-10-19
ER

PT J
AU Beloti, MM
   De Oliveira, PT
   De Carvalho, PSP
   Rosa, AL
AF Beloti, Marcio Mateus
   De Oliveira, Paulo Tambasco
   Perri De Carvalho, Paulo Sergio
   Rosa, Adalberto Luiz
TI Seeding Osteoblastic Cells into a Macroporous Biodegradable CaP/PLGA
   Scaffold by a Centrifugal Force
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE scaffold; cell seeding; centrifugal force; osteoblast; bone tissue
   engineering
ID TISSUE ENGINEERED BONE; MARROW STROMAL CELLS; STEM-CELLS; IN-VITRO;
   ALGINATE SCAFFOLDS; CULTURE; PHOSPHATE; BIOMATERIALS; DENSITY;
   BIOCOMPATIBILITY
AB This study aims to construct a hybrid biomaterial by seeding osteoblastic cells into a CaP/PLGA scaffold by a centrifugal force. Constructs are evaluated with respect to potential application in bone tissue engineering. Cells adher, spread, and form a layer of tissue lining the scaffold and are capable of migrating, proliferating, and producing mineralized matrix. We have demonstrated that the centrifugal force is highly efficient for constructing a hybrid biomaterial, which acts similarly to bone explants in a cell culture environment. In this way, these constructs could mimic an autogenous bone graft in clinical circumstances. Such a strategy may be useful for bone tissue engineering.
C1 [Beloti, Marcio Mateus; De Oliveira, Paulo Tambasco; Perri De Carvalho, Paulo Sergio; Rosa, Adalberto Luiz] Univ Sao Paulo, Sao Paulo, Brazil.
RP Rosa, AL (reprint author), Univ Sao Paulo, Sao Paulo, Brazil.
EM adalrosa@forp.usp.br
RI de Carvalho, Paulo Sergio/H-4279-2012; Tambasco de Oliveira,
   Paulo/F-9749-2010; Beloti, Marcio/E-7473-2012; Rosa,
   Adalberto/A-6314-2008
OI Tambasco de Oliveira, Paulo/0000-0002-6662-0486; Beloti,
   Marcio/0000-0003-0149-7189; Rosa, Adalberto/0000-0002-6495-2778
CR Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027
   Anselme K, 1999, BONE, V25, P51
   Beloti MM, 2006, J BIOMED MATER RES A, V79A, P282, DOI 10.1002/jbm.a.30801
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Burg KJL, 2000, J BIOMED MATER RES, V51, P642, DOI 10.1002/1097-4636(20000915)51:4<642::AID-JBM12>3.0.CO;2-L
   Casabona F, 1998, PLAST RECONSTR SURG, V101, P577, DOI 10.1097/00006534-199803000-00003
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Godbey WT, 2004, BIOMATERIALS, V25, P2799, DOI 10.1016/j.biomaterials.2003.09.056
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   HOFFMAN RM, 1993, STEM CELLS, V11, P105, DOI 10.1002/stem.5530110205
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Krupnick AS, 2002, TISSUE ENG, V8, P145, DOI 10.1089/107632702753503135
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Mao X, 2005, TISSUE CELL, V37, P349, DOI 10.1016/j.tice.2005.05.003
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Sabolinski ML, 1996, BIOMATERIALS, V17, P311, DOI 10.1016/0142-9612(96)85569-4
   Schultz O, 2000, ARTHRITIS RES, V2, P433, DOI 10.1186/ar123
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Yang TH, 2001, J BIOMED MATER RES, V55, P379, DOI 10.1002/1097-4636(20010605)55:3<379::AID-JBM1026>3.0.CO;2-Z
NR 39
TC 9
Z9 9
U1 0
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2009
VL 23
IS 6
BP 481
EP 495
DI 10.1177/0885328208094082
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 441DU
UT WOS:000265750300001
PM 18801891
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Claramunt, R
   Herrero, EJ
   Millan, I
   Tolmos, JR
   Alvarez, L
   Cordon, A
   Rocha, A
   Sanz, P
   Ayuso, B
   Ros, A
AF Paez, J. M. Garcia
   Claramunt, R.
   Herrero, E. Jorge
   Millan, I.
   Tolmos, J. R.
   Alvarez, L.
   Cordon, A.
   Rocha, A.
   Sanz, P.
   Ayuso, B.
   Ros, A.
TI Energy consumption as a predictor test of the durability of a biological
   tissue employed in cardiac bioprosthesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bioprosthesis; fatigue; heart valve; mechanical properties
ID COLLAGEN FIBER ARCHITECTURE; HEART-VALVES; BOVINE PERICARDIUM; CALF
   PERICARDIUM; SELECTION SITES; AORTIC VALVES; CALCIFICATION;
   CONSTRUCTION; REOPERATION; STRESS
AB The mechanical behavior of the young bull pericardium in a fatigue test has been studied. This material is a similar tissue to those used in valve leaflet construction for a cardiac bioprosthesis. The consumed energy on each test was evaluated and afterwards used as a predictor of the biomaterial strength. Two-hundred and nine samples were tested to cyclical fatigue. The cut-off point to determine the sample quality was whether or not they resisted at least 4500 cycles. Only 22 samples withstood over that point (10.52%). The samples were classified according to their fatigue behavior in excellent, undefined and unsuitable. By using as a reference the consumed energy in the first 25 cycles, we could distinguish correctly (between 93.2 and 96.1%) the unsuitable material and most of the excellent (between 78.1 and 95.2%). From the rejected material 77% was really detachable and from the accepted, only 50% was excellent, with an equal methodology. The receiver operating characteristics curve was employed to establish decision levels when selecting samples, being 0.85 the best area (theoretical maximum value of 1). It is concluded that the energy wasted is a good predictor of the strength of the tissue. More than 90% of the unsuitable material and 50%, of the excellent material (5% of all the material) is detected with this method. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 336-344, 2009
C1 [Paez, J. M. Garcia; Alvarez, L.] Clin Puerta Hierro, Med Interna Serv, Madrid 28035, Spain.
   [Claramunt, R.; Tolmos, J. R.; Cordon, A.; Ros, A.] Univ Politecn Madrid, ETS Ingn Ind, Dept Mecan Estruct & Construcc Ind, E-28006 Madrid, Spain.
   [Herrero, E. Jorge; Rocha, A.; Sanz, P.] Clin Puerta Hierro, Serv Cirugia Expt, Madrid 28035, Spain.
   [Millan, I.; Ayuso, B.] Clin Puerta Hierro, Serv Bioestadist, Madrid 28035, Spain.
RP Paez, JMG (reprint author), Clin Puerta Hierro, Med Interna Serv, C San Martin de Porres 4, Madrid 28035, Spain.
EM jmgpaez@telefonica.net
FU Comunidad de Madrid [GR/MAT/0429/2004]
FX Contract grant sponsor: Comunidad de Madrid; contract grant number:
   GR/MAT/0429/2004
CR Bernacca GM, 2002, J BIOMED MATER RES, V61, P138, DOI 10.1002/jbm.10149
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   DEURRIBARRI IL, 1998, CAD ATEN PRIMARIA, V5, P239
   GLOWER DD, 1994, J THORAC CARDIOV SUR, V107, P381
   GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709
   GUERRA F, 1990, J THORAC CARDIOV SUR, V99, P838
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   IGUAL A, 2004, CIR CARDIOV, V11, P97
   Jennings LM, 2002, ANN THORAC SURG, V74, P63, DOI 10.1016/S0003-4975(02)03617-2
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   KHANNA RA, 2000, T 6 WORLD BIOM C HAW
   Lewin MB, 2005, CIRCULATION, V111, P832, DOI 10.1161/01.CIR.0000157137.59691.0B
   Mausner J, 1985, EPIDEMIOLOGY INTRO T, P214
   Paez JMG, 2000, J BIOMATER APPL, V15, P47
   Paez JMG, 2006, J BIOMED MATER RES A, V77A, P839, DOI 10.1002/jbm.a.30650
   Paez JMG, 2001, J MATER SCI-MATER M, V12, P425, DOI 10.1023/A:1011201104225
   Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   SCHOEN FJ, 2001, CARDIOVASCULAR PATHO
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vesely I, 2003, CARDIOVASC PATHOL, V12, P277, DOI 10.1016/S1054-8807(03)00075-9
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   Wells SM, 2005, BIOMATERIALS, V26, P2611, DOI 10.1016/j.biomaterials.2004.06.046
NR 30
TC 2
Z9 2
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2009
VL 89A
IS 2
BP 336
EP 344
DI 10.1002/jbm.a.31970
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 428LR
UT WOS:000264850200006
PM 18431770
DA 2018-10-19
ER

PT J
AU Chang, DT
   Colton, E
   Anderson, JM
AF Chang, David T.
   Colton, Erica
   Anderson, James M.
TI Paracrine and juxtacrine lymphocyte enhancement of adherent macrophage
   and foreign body giant cell activation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; foreign body reaction; lymphocytes; macrophages;
   activation
ID TNF-ALPHA; T-CELL; CYTOKINE PRODUCTION; ADHESION; MONOCYTES; POLYMERS;
   CONTACT; SURFACE
AB Lymphocytes have been shown to be involved in modulating monocyte and macrophage behavior in the foreign body reaction. Lymphocyte effects on biomaterial-adherent macrophage and foreign body giant cell (FBGC) behavior were further investigated by culturing monocytes alone or together with lymphocytes, either in direct co-cultures or indirectly in transwells, on a series of polyethylene terephthalate-based photograft co-polymerized material Surfaces displaying distinct hydrophobic, hydrophilic/neutral, hydrophilic/anionic, and hydrophilic/cationic chemistries. After periods of 3, 7, and 10 days, cytokine production was quantified by enzyme-linked immunosorbent assay and normalized to adherent macrophage/FBGC density to yield a measure of adherent macrophage/FBGC activation. Interactions with lymphocytes enhanced adherent macrophage and FBGC production of pro-inflammatory IL-1 beta, TNF-alpha, IL-6, IL-8, and MIP-1 beta on the hydrophobic and hydrophilic/cationic surfaces but had no effect on anti-inflammatory IL-10 production indicating lymphocytes promote a pro-inflammatory response to biomaterials. Lymphocytes also did not significantly influence MMP-9, TIMP-1, and TIMP-2 production. Interactions through indirect (paracrine) signaling showed a significant effect in enhancing adherent macrophage/FBGC activation at early time points whereas interactions via direct (juxtacrine) mechanisms dominated at later time points. Biomaterial surface chemistries differentially affected the observed responses as hydrophilic/neutral and hydrophilic/anionic surfaces, evoked the highest levels of activation relative to the other surfaces but did not facilitate lymphocyte enhancement of adherent macrophage/FBGC activation. (C) 2008 Wiley Periodicals, Inc. j Biomed Mater Res 89A: 490-498, 2009
C1 [Chang, David T.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Colton, Erica; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Wolstein Res Bldg Room 5105,2103 Cornell Rd, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU National Institute of Health [T32 GM07250]; National Institute of
   Biomedical Imaging and Bioengineering [EB-000275, EB-000282]
FX Contract grant sponsors: National Institute of Biomedical Imaging and
   Bioengineering; contract grant numbers: EB-000275, EB-000282
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Brennan FM, 2006, CURR TOP MICROBIOL, V305, P177, DOI 10.1007/3-540-29714-6_9
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Burger D, 2002, ANN NY ACAD SCI, V966, P464, DOI 10.1111/j.1749-6632.2002.tb04248.x
   CHANG DT, 2008, J BIOMED MAT RES
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   Hwang JJ, 2005, J BIOMAT SCI-POLYM E, V16, P237, DOI 10.1163/1568562053115480
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002
   Ma N, 2002, J BIOMAT SCI-POLYM E, V13, P257
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881
   Nakayama Y, 2000, J BIOMED MATER RES, V53, P584, DOI 10.1002/1097-4636(200009)53:5<584::AID-JBM19>3.0.CO;2-0
   O'Connor GM, 2006, IMMUNOLOGY, V117, P1, DOI 10.1111/j.1365-2567.2005.02256.x
   Parry SL, 1997, J IMMUNOL, V158, P3673
   Santana MA, 2003, J CELL PHYSIOL, V195, P392, DOI 10.1002/jcp.10258
   Sebbag M, 1997, EUR J IMMUNOL, V27, P624, DOI 10.1002/eji.1830270308
   Sethi RK, 2003, BIOMATERIALS, V24, P2561, DOI 10.1016/S0142-9612(03)00056-5
NR 20
TC 22
Z9 22
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2009
VL 89A
IS 2
BP 490
EP 498
DI 10.1002/jbm.a.31981
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 428LR
UT WOS:000264850200022
PM 18437695
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Alcaide, M
   Serrano, MC
   Pagani, R
   Sanchez-Salcedo, S
   Nieto, A
   Vallet-Regi, M
   Portoles, MT
AF Alcaide, Maria
   Serrano, M. Concepcion
   Pagani, Raffaella
   Sanchez-Salcedo, Sandra
   Nieto, Alejandra
   Vallet-Regi, Maria
   Portoles, M. Teresa
TI L929 fibroblast and SAOS-2 osteoblast response to hydroxyapatite-beta
   TCP/agarose biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biphasic calcium phosphate; agarose; bone graft; L929 fibroblasts;
   Saos-2 osteoblasts
ID BIOARTIFICIAL PANCREAS; TRICALCIUM PHOSPHATE; CALCIUM PHOSPHATES;
   AGAROSE-GEL; SCAFFOLDS; BIOCERAMICS; FABRICATION; APOPTOSIS; CARTILAGE;
   CERAMICS
AB Biphasic calcium phosphate, a mixture of hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP), has been successfully used as an excellent bone graft substitute because of the HA capacity for direct interaction with bone and the beta-TCP resorption properties. Agarose has been recently mixtured with ceramics as natural biodegradable binder to increase the biomaterial flexibility facilitating its placement into the bone defect. In this study, the behavior of L929 fibroblasts and Saos-2 osteoblasts cultured on hydroxyapatite-beta TCP/agarose disks has been evaluated. Both call types adhere and proliferate on the biomaterial Surface maintaining their characteristic morphology. Transitory changes on cell cycle, size, and complexity are observed. The biomaterial induces apoptosis in Saos-2 osteoblasts but not in fibroblasts. A transitory stimulation of fibroblast mitochondrial activity is observed. This effect remains in osteoblasts after 9 days of culture showing a higher sensitivity of this cell type. However, the intracellular reactive oxygen species content and the lactate dehydrogenase release of Saos-2 osteoblasts indicate that hydroxyapatite-beta TCP/agarose does not induce oxidative stress in this cell type and confirm the integrity of the osteoblast plasma membrane. These results underline the good biocompatibility of hydroxyapatite-beta TCP/agarose disks and its potential utility for bone Substitution and repair. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 539-549, 2009
C1 [Alcaide, Maria; Serrano, M. Concepcion; Pagani, Raffaella; Portoles, M. Teresa] Univ Complutense, Dept Biochem & Mol Biol 1, Fac Chem, E-28040 Madrid, Spain.
   [Sanchez-Salcedo, Sandra; Nieto, Alejandra; Vallet-Regi, Maria] Univ Complutense, Dept Inorgan & Bioinorgan Chem, Fac Pharm, E-28040 Madrid, Spain.
RP Portoles, MT (reprint author), Univ Complutense, Dept Biochem & Mol Biol 1, Fac Chem, E-28040 Madrid, Spain.
EM portoles@quim.ucm.es
RI Serrano, Maria Concepcion/D-7442-2014; Vallet-Regi, Maria/M-3378-2014;
   Portoles, Maria Teresa/U-1678-2017; SANCHEZ-SALCEDO, SANDRA/N-4501-2014
OI Serrano, Maria Concepcion/0000-0002-5010-644X; Vallet-Regi,
   Maria/0000-0002-6104-4889; Portoles, Maria Teresa/0000-0002-9681-0184;
   SANCHEZ-SALCEDO, SANDRA/0000-0002-1889-2057; /0000-0003-0802-4800
FU Comunidad de Madrid [S-0505/MAT/0324]
FX Contract grant sponsor: Comunidad de Madrid; contract grant number:
   S-0505/MAT/0324
CR Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   BUROW S, 1987, EUR J CELL BIOL, V43, P128
   Cabanas MV, 2006, J BIOMED MATER RES A, V78A, P508, DOI 10.1002/jbm.a.30724
   Cascone MG, 2001, J BIOMAT SCI-POLYM E, V12, P267, DOI 10.1163/156856201750180807
   CHANCE B, 1979, PHYSIOL REV, V59, P527
   COMPORTI M, 1985, LAB INVEST, V53, P599
   DALCUSI G, 1998, BIOMATERIALS, V19, P1473
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   FRANCESCHI D, 1990, SURGERY, V108, P292
   Gu YJ, 2000, TRANSPLANT P, V32, P2494, DOI 10.1016/S0041-1345(00)01763-2
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5
   IWATA H, 1992, J BIOMED MATER RES, V26, P967, DOI 10.1002/jbm.820260711
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   JIYOUNG B, 2006, ADV DRUG DELIV REV, V58, P487
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LEGEROS RZ, 1991, CALCIUM PHOSPHATES O, P108
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murugan R, 2005, CRYST GROWTH DES, V5, P111, DOI 10.1021/cg034227s
   QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Roman J, 2008, J BIOMED MATER RES A, V84A, P99, DOI 10.1002/jbm.a.31394
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Sakai S, 2005, BIOMATERIALS, V26, P4786, DOI 10.1016/j.biomaterials.2004.11.043
   Sanchez-Salcedo S, 2008, CHEM ENG J, V137, P62, DOI 10.1016/j.cej.2007.09.01
   SANCHEZSALCEDO S, 2006, TISSUE ENG, P279
   STOKOLS S, 2006, BIOMATERIALS, V27, P289
   Tabata M, 2003, J BIOMED MATER RES B, V67B, P680, DOI 10.1002/jbm.b.10063
   Tun T, 1996, CELL TRANSPLANT, V5, pS59, DOI 10.1016/0963-6897(96)00042-5
   UCKUN FM, 1992, P NATL ACAD SCI USA, V89, P9005, DOI 10.1073/pnas.89.19.9005
   Udall J N, 1987, Adv Exp Med Biol, V216A, P821
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Wang XL, 2006, MATER LETT, V60, P455, DOI 10.1016/j.matlet.2005.09.010
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 37
TC 19
Z9 20
U1 0
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2009
VL 89A
IS 2
BP 539
EP 549
DI 10.1002/jbm.a.31985
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 428LR
UT WOS:000264850200027
PM 18437697
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Rodriguez, M
   Garcia-Honduvilla, N
   Gomez-Gil, V
   Pascual, G
   Bujan, J
AF Bellon, J. M.
   Rodriguez, M.
   Garcia-Honduvilla, N.
   Gomez-Gil, V.
   Pascual, G.
   Bujan, J.
TI Comparing the Behavior of Different Polypropylene Meshes (Heavy and
   Lightweight) in an Experimental Model of Ventral Hernia Repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE abdominal wall repair; peritoneum; polypropylene; biomechanical
   resistance; peritoneal adhesions
ID INCISIONAL HERNIA; WEIGHT; IMPACT; LIGHT
AB New generation prosthetic biomaterials for abdominal wall repair have been designed to be less dense, by having larger pores than that of the standard polypropylene meshes, to improve abdominal wall compliance. The aim of the present study was to analyze the functional and morphologic properties of these new meshes. For this purpose, 7 X 5 cm(2) defects were created in the anterior abdominal wall of 36 male New Zealand White rabbits and repaired using different polypropylene meshes: a heavyweight mesh (HW), Surgipro, and two lightweight meshes (LW), Parietene and Optilene. Six animals each implanted with biomaterial were sacrificed on postoperative days 14 and 90. Histological and morphometric analysis, adhesion assessment, and biomechanical resistance tests were performed. Similar behavior was shown by the LW and HW meshes in terms of the adhesions and macrophage response induced. After 14 days, the tensile strength of Optilene was greater than the strengths recorded for the other two biomaterials, probably because of its high elasticity. By 90 days, however, the tensile strengths of the three biomaterials were comparable. In conclusion, despite an initial tensile strength advantage shown by the mesh with larger pores, at 90 days postimplant, tensile strengths were similar. Compared with HW, LW prostheses have the benefit that less foreign material was implanted, preserving the elasticity of the recipient host tissue. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Apt Biomater 8913: 448-455, 2009
C1 [Bellon, J. M.; Rodriguez, M.] Univ Alcala de Henares, Dept Surg, Fac Med, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
   [Garcia-Honduvilla, N.; Gomez-Gil, V.; Pascual, G.; Bujan, J.] Univ Alcala de Henares, Dept Med Specialties, Fac Med, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Dept Surg, Fac Med, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
EM juanm.bellon@uah.es
OI bujan, Julia/0000-0003-2419-2476; BELLON, JUAN M./0000-0002-6071-5011;
   Garcia Honduvilla, Natalio/0000-0003-0904-6198; Gomez-Gil,
   Veronica/0000-0002-6642-5912; PASCUAL, GEMMA/0000-0002-1623-4384
CR Bellon JM, 2002, AM J SURG, V184, P154, DOI 10.1016/S0002-9610(02)00907-8
   Binnebosel M, 2007, SURGERY, V142, P365, DOI 10.1016/j.surg.2007.04.024
   Cobb WS, 2006, J SURG RES, V136, P1, DOI 10.1016/j.jss.2006.05.022
   Cobb William S, 2005, Surg Innov, V12, P63, DOI 10.1177/155335060501200109
   Conze J, 2005, BRIT J SURG, V92, P1488, DOI 10.1002/bjs.5208
   Conze J, 2004, Hernia, V8, P255
   Greca F H, 2001, Hernia, V5, P59
   Holste JL, 2005, INT SURG, V90, pS10
   Junge K, 2002, WORLD J SURG, V26, P1472, DOI 10.1007/s00268-002-6444-z
   Junge K, 2001, Hernia, V5, P113
   Klinge U, 2007, WORLD J SURG, V31, P867, DOI 10.1007/s00268-006-0670-8
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Klosterhalfen B, 2005, EXPERT REV MED DEVIC, V2, P103, DOI 10.1586/17434440.2.1.103
   O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833
   Rosch R, 2003, EUR SURG RES, V35, P445, DOI 10.1159/000072230
   Schachtrupp A, 2003, BRIT J SURG, V90, P114, DOI 10.1002/bjs.4023
   Schmidbauer S, 2005, EUR J MED RES, V10, P247
   Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0
NR 18
TC 34
Z9 37
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2009
VL 89B
IS 2
BP 448
EP 455
DI 10.1002/jbm.b.31234
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 436VU
UT WOS:000265445000019
PM 18837449
DA 2018-10-19
ER

PT J
AU Krishna, BV
   Bose, S
   Bandyopadhyay, A
AF Krishna, B. Vamsi
   Bose, Susmita
   Bandyopadhyay, Amit
TI Fabrication of Porous NiTi Shape Memory Alloy Structures Using Laser
   Engineered Net Shaping
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE laser; mechanical properties; NiTi alloy; porous; microstructure
ID TITANIUM; PARAMETERS; IMPLANTS; BEHAVIOR
AB Porous NiTi alloy samples were fabricated with 12-36% porosity from equiatomic NiTi alloy powder using laser engineered net shaping (LENS (TM)). The effects of processing parameters on density and properties of laser-processed NiTi alloy samples were investigated. It was found that the density increased rapidly with increasing the specific energy input tip to 50 J/mm(3). Further increase in the energy input had small effect on density. High cooling rates associated with LENS processing resulted in higher amount of cubic B2 phase, and increased the reverse transformation temperatures of porous NiTi samples due to thermally induced stresses and defects. Transformation temperatures were found to be independent of pore volume, though higher pore volume in the samples decreased the maximum recoverable strain from 6% to 4%. Porous NiTi alloy samples with 12-36% porosity exhibited low Young's modulus between 2 and 18 GPa as well as high compressive strength and recoverable strain. Because of high open pore volume between 36% and 62% of total volume fraction porosity, these porous NiTi alloy samples can potentially accelerate the healing process and improve biological fixation when implanted in vivo. Thus porous NiTi is a promising biomaterial for hard tissue replacements. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 89B: 481-490, 2009
C1 [Krishna, B. Vamsi; Bose, Susmita; Bandyopadhyay, Amit] Washington State Univ, Sch Mech & Mat Engn, WM Keck Biomed Mat Res Lab, Pullman, WA 99164 USA.
RP Bandyopadhyay, A (reprint author), Washington State Univ, Sch Mech & Mat Engn, WM Keck Biomed Mat Res Lab, Pullman, WA 99164 USA.
EM amitband@wsu.edu
RI Balla, Vamsi/A-7287-2010; Bandyopadhyay, Amit/A-7780-2012
OI Balla, Vamsi/0000-0003-2796-7302; Bandyopadhyay,
   Amit/0000-0003-0992-5387
CR Balla V.K., 2007, ACTA BIOMATER, V3, P997
   BALLA VK, 2007, METALL MATER TRANS A, V38, P1096
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   DAVID SA, 1992, MAT PARK, P147
   Falvo A, 2005, MAT SCI ENG A-STRUCT, V412, P235, DOI 10.1016/j.msea.2005.08.209
   Greiner C, 2005, ACTA BIOMATER, V1, P705, DOI 10.1016/j.actbio.2005.07.005
   Gyunter V., 1995, MAXILLOFACIAL SURG T
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   HEY JC, 1994, MAT SCI ENG A-STRUCT, V188, P291, DOI 10.1016/0921-5093(94)90384-0
   NIELSEN LF, 1984, J AM CERAM SOC, V67, P93, DOI 10.1111/j.1151-2916.1984.tb09622.x
   Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001
   Otsuka K., 1998, SHAPE MEMORY MAT
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   ROBERTSON DM, 1976, J BIOMED MATER RES, V10, P335, DOI 10.1002/jbm.820100304
   SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, P200
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Simchi A, 2003, MAT SCI ENG A-STRUCT, V359, P119, DOI 10.1016/S0921-5093(03)00341-1
   Tuissi A, 1999, MAT SCI ENG A-STRUCT, V273, P813, DOI 10.1016/S0921-5093(99)00422-0
   Wu SL, 2007, ACTA MATER, V55, P3437, DOI 10.1016/j.actamat.2007.01.045
   Xue W, 2007, ACTA BIOMATER, V3, P1007, DOI 10.1016/j.actbio.2007.05.009
   Yeung KWK, 2004, MAT SCI ENG A-STRUCT, V383, P213, DOI 10.1061/j.msea.2004.05.063
   Zhao Y, 2005, ACTA MATER, V53, P337, DOI 10.1016/j.actamat.2004.09.029
NR 23
TC 44
Z9 44
U1 3
U2 48
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2009
VL 89B
IS 2
BP 481
EP 490
DI 10.1002/jbm.b.31238
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 436VU
UT WOS:000265445000023
PM 18937263
DA 2018-10-19
ER

PT J
AU Sandberg, T
   Mellin, L
   Gelius, U
   Caldwell, KD
AF Sandberg, Tomas
   Mellin, Lisa
   Gelius, Ulrik
   Caldwell, Karin D.
TI Surface analysis of pure and complex mucin coatings on a real-type
   substrate using individual and combined mBCA, ELLA, and ELISA
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Mucin quantification; mBCA; ELLA; ELISA; Ellipsometry; Jacalin; Complex
   mucin coating; Surface-exposed protein; Bioactivity; XPS; IRS-MVDA;
   Principal component analysis (PCA)
ID ADSORBED PROTEIN FILMS; HYDROPHOBIC SURFACES; SERUM-ALBUMIN; ADSORPTION;
   ELLIPSOMETRY; BIOMATERIAL; CRYSTALS; ADHESION; BINDING; JACALIN
AB In the past, we introduced the idea of using mucin coatings to improve biomaterials performance. Here, we evaluate non-radioactive methods for the analysis of pure and human host protein-containing (complex) mucin coatings on a real-type substrate (Thermanox). A common protein quantification assay (mBCA) was combined with mass-calibrated, enzyme-amplified assays based on lectin (ELLA) and antibody (ELISA) recognition, to determine the total and specific amounts of surface-associated proteins. Model studies showed the mBCA assay to be of limited use at low mass loads, and steric effects to influence the ELLA at high surface layer densities. Non-specific responses due to substrate interaction were low for the ELLA and ELISAs. Cross-reactions were observed during ELLA analysis of analytes sharing high degree of O-glycosylation. Combined mBCA-ELLA-ELISA analysis suggested that mucin desorption was low upon protein addition and that low concentrations of ELISA-determined Protein for the complex coatings Could be explained in terms of low accessibility of proteins to the bulk environment. Specifically, a methodology is presented for the determination of the fraction of surface-exposed, presumed bioactive proteins in a complex mucin coating. Finally, X-ray photoelectron spectroscopy and infrared reflectance spectroscopy combined with multivariate data analysis were proven useful in the evaluation of mucin-based coatings. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Sandberg, Tomas; Mellin, Lisa; Caldwell, Karin D.] Uppsala Univ, Div Surface Biotechnol, Dept Phys & Anat Chem, BMC, SE-75123 Uppsala, Sweden.
   [Gelius, Ulrik] Uppsala Univ, Angstrom Lab, Div Surface & Interface Sci, Dept Phys & Mat Sci, SE-75123 Uppsala, Sweden.
RP Caldwell, KD (reprint author), Uppsala Univ, Div Surface Biotechnol, Dept Phys & Anat Chem, BMC, SE-75123 Uppsala, Sweden.
EM karin.caldwell@ytbioteknik.uu.se
CR Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001
   Benesch J, 2000, COLLOID SURFACE B, V18, P71, DOI 10.1016/S0927-7765(99)00136-8
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Bourne Y, 2002, BIOCHEM J, V364, P173, DOI 10.1042/bj3640173
   Cooper S. L., 2004, BIOMATERIALS SCI, P67
   CUYPERS PA, 1983, J BIOL CHEM, V258, P2426
   DARST SA, 1991, BIOPHYS J, V59, P387, DOI 10.1016/S0006-3495(91)82232-9
   DOUMAS BT, 1975, CLIN CHEM, V21, P1159
   Feiler AA, 2007, J COLLOID INTERF SCI, V315, P475, DOI 10.1016/j.jcis.2007.07.029
   HABEEB AFSA, 1983, J IMMUNOL METHODS, V65, P27, DOI 10.1016/0022-1759(83)90301-0
   Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251
   Horbett TA, 2004, BIOMATERIALS SCI INT, P237
   Horvath R, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2968127
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501
   Kabir S, 1998, J IMMUNOL METHODS, V212, P193, DOI 10.1016/S0022-1759(98)00021-0
   LHote C, 1996, THROMB HAEMOSTASIS, V76, P710
   Li P, 2003, IEEE T NANOBIOSCI, V2, P138, DOI 10.1109/TNB.2003.816228
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Mikkelsen S. R., 2004, BIOANALYTICAL CHEM, P1
   Mitchell R.N., 2004, BIOMATERIALS SCI, P304
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   Perez-Vilar J, 2004, ENCY BIOL CHEM, P758
   Powell C, 2003, NIST ELECT EFFECTIVE
   Sandberg T, 2007, MICROSC RES TECHNIQ, V70, P864, DOI 10.1002/jemt.20489
   Sandberg T, 2009, J BIOMED MATER RES A, V91A, P762, DOI 10.1002/jbm.a.32266
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   Shi L, 2000, J COLLOID INTERF SCI, V224, P372, DOI 10.1006/jcis.2000.6724
   Shi L, 2000, TRENDS GLYCOSCI GLYC, V12, P229, DOI 10.4052/tigg.12.229
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829
   Wagner MS, 2003, LANGMUIR, V19, P1708, DOI 10.1021/la0260382
   Yeon WC, 2008, LANGMUIR, V24, P12142, DOI 10.1021/la800016h
NR 35
TC 7
Z9 7
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAY 1
PY 2009
VL 333
IS 1
BP 180
EP 187
DI 10.1016/j.jcis.2009.01.069
PG 8
WC Chemistry, Physical
SC Chemistry
GA 429CA
UT WOS:000264897200024
PM 19249790
DA 2018-10-19
ER

PT J
AU Bertrand, E
   Hellmich, C
AF Bertrand, Emmanuel
   Hellmich, Christian
TI Multiscale Elasticity of Tissue Engineering Scaffolds with
   Tissue-Engineered Bone: A Continuum Micromechanics Approach
SO JOURNAL OF ENGINEERING MECHANICS
LA English
DT Article
ID MARROW STROMAL CELLS; TURKEY LEG TENDON; HYDROXYAPATITE BIOMATERIALS;
   ANISOTROPIC ELASTICITY; MINERALIZED TISSUES; MICROTOMOGRAPHY; STRENGTH;
   COLLAGEN; MATRIX; MODEL
AB Tissue engineering (TE) is the use of a combination of biological cells, engineering and materials methods, and of suitable biochemical and physicochemical factors, in order to improve or replace biological functions. It has brought the advent of entirely new classes of hierarchically organized, multiporous materials, consisting of both chemically and biologically produced parts. Here, we aim at contributing to the unsettled question of the mechanical functioning of bone tissue-engineering scaffolds with tissue-engineered bone-from a theoretical and applied mechanics viewpoint. Therefore, we build on recently developed microelasticity models for vertebrate bone and hydroxyapatite biomaterials, respectively. Tissue engineering scaffolds with tissue-engineered bone are micromechanically represented as tissue-engineered bone-coated macropores in a matrix built up by microporous hydroxyapatite polycrystals, based on an extension toward anisotropy, of Herve-Zaoui's n-layered inclusion problem. The stiffness of macroporous hydroxyapatite-based TE scaffolds with newly ingrown bone is mainly governed by their porosities [vascular (macro) porosity defined through initial scaffold design and volume fraction of ingrown bone; and intercrystalline (micro) porosity between the hydroxyapatite crystals of the scaffold matrix material], while being less influenced by the type of bone growing inside the macropores. For a given degeneration kinetics of the scaffold, the microelastic models suggest apposition rates of bone needed to maintain the stiffness characteristics of the overall biomaterial-bone construct. This can be seen as a first step toward computer-aided engineering design of tissue-engineering scaffolds for large bone defect regeneration.
C1 [Bertrand, Emmanuel; Hellmich, Christian] Vienna Univ Technol, Inst Strength Mat, A-1040 Vienna, Austria.
RP Hellmich, C (reprint author), Vienna Univ Technol, Inst Strength Mat, Karlspl 13-202, A-1040 Vienna, Austria.
EM emmanuel.bertrand@polytechnique.org; christian.hellmich@tuwien.ac.at
CR BILANIUK N, 1993, J ACOUST SOC AM, V93, P1609, DOI 10.1121/1.406819
   BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   Byers S, 2000, BONE, V27, P495, DOI 10.1016/S8756-3282(00)00357-4
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Cedola A, 2007, SPECTROCHIM ACTA B, V62, P642, DOI 10.1016/j.sab.2007.02.015
   Chowdhury S, 2005, J NANOSCI NANOTECHNO, V5, P1816, DOI 10.1166/jnn.2005.428
   Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4
   COWIN SC, 1992, J MECH PHYS SOLIDS, V40, P1459, DOI 10.1016/0022-5096(92)90029-2
   Cowin SC, 2003, TRANSPORT POROUS MED, V50, P35, DOI 10.1023/A:1020626717067
   Dormieux L, 2005, APPL MICROMECHANICS, V480
   Dormieux L, 2006, MICROPOROMECHANICS
   DORMIEUX L, 2003, INTRO MICROMECHANICS
   Dormieux L, 2007, CR MECANIQUE, V335, P25, DOI 10.1016/j.crme.2006.11.005
   ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133
   FARQUHARSON C, 1998, GROWTH PLATE CHONDRO
   Fritsch A, 2006, CR MECANIQUE, V334, P151, DOI 10.1016/j.crme.2006.01.008
   Fritsch A, 2007, J MATER SCI, V42, P8824, DOI 10.1007/s10853-007-1859-4
   Fritsch A, 2007, J THEOR BIOL, V244, P597, DOI 10.1016/j.jtbi.2006.09.013
   Fritsch A, 2009, J BIOMED MATER RES A, V88A, P149, DOI 10.1002/jbm.a.31727
   HASHIN Z, 1983, J APPL MECH-T ASME, V50, P481, DOI 10.1115/1.3167081
   Hellmich C, 2005, CISM COURSES LECT, P289
   Hellmich C, 2005, J ENG MECH-ASCE, V131, P918, DOI 10.1061/(ASCE)0733-9399(2005)131:9(918)
   Hellmich C, 2005, TRANSPORT POROUS MED, V58, P243, DOI 10.1007/s11242-004-6298-y
   Hellmich C, 2004, EUR J MECH A-SOLID, V23, P783, DOI 10.1016/j.euromechsol.2004.05.004
   Hellmich C, 2002, J ENG MECH-ASCE, V128, P898, DOI 10.1061/(ASCE)0733-9399(2002)128:8(898)
   Hellmich C, 2002, J BIOMECH, V35, P1199, DOI 10.1016/S0021-9290(02)00080-5
   Hellmich C, 2008, ANN BIOMED ENG, V36, P108, DOI 10.1007/s10439-007-9393-8
   Hellmich C, 2004, BIOMECH MODEL MECHAN, V2, P219, DOI 10.1007/S10237-004-0040-0
   Helnwein P, 2001, COMPUT METHOD APPL M, V190, P2753, DOI 10.1016/S0045-7825(00)00263-2
   HERVE E, 1993, INT J ENG SCI, V31, P1, DOI 10.1016/0020-7225(93)90059-4
   HILL R, 1963, J MECH PHYS SOLIDS, V11, P357, DOI 10.1016/0022-5096(63)90036-X
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   KATZ JL, 1971, J BIOMECH, V4, P221, DOI 10.1016/0021-9290(71)90007-8
   Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kurzydlowski KJ, 2007, MACROMOL SYMP, V253, P1, DOI 10.1002/masy.200750701
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   LEES S, 1987, CONNECT TISSUE RES, V16, P281, DOI 10.3109/03008208709005616
   Lees S, 1996, J ACOUST SOC AM, V99, P2421, DOI 10.1121/1.415430
   LEES S, 1994, CALCIFIED TISSUE INT, V55, P180, DOI 10.1007/BF00425873
   MARTIN TJ, 1980, METAB BONE DIS RELAT, V2, P167, DOI 10.1016/0221-8747(80)90024-7
   Mastrogiacomo M, 2004, TISSUE ENG, V10, P1767, DOI 10.1089/ten.2004.10.1767
   Pelled G, 2007, J BIOMECH, V40, P399, DOI 10.1016/j.jbiomech.2005.12.012
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Prostak KS, 1996, CALCIFIED TISSUE INT, V59, P474, DOI 10.1007/BF00369213
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   SALENCON J, 2001, HDB CONTINUUM MECH G
   SUQUET P, 1997, CONTINUUM MICROMECHA
   Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4
   VERMA D, 2005, MATER RES SOC S P, V898, P116
   Verma D, 2006, J BIOMED MATER RES A, V78A, P772, DOI 10.1002/jbm.a.30774
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   Zaoui A, 2002, J ENG MECH-ASCE, V128, P808, DOI 10.1061/(ASCE)0733-9399(2002)128:8(808)
   Zaoui A., 1997, CONTINUUM MICROMECHA, V377, P291
NR 56
TC 10
Z9 10
U1 1
U2 11
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 0733-9399
EI 1943-7889
J9 J ENG MECH
JI J. Eng. Mech.
PD MAY
PY 2009
VL 135
IS 5
BP 395
EP 412
DI 10.1061/(ASCE)0733-9399(2009)135:5(395)
PG 18
WC Engineering, Mechanical
SC Engineering
GA 433UR
UT WOS:000265231800005
DA 2018-10-19
ER

PT J
AU Duarte, LT
   Biaggio, SR
   Rocha, RC
   Bocchi, N
AF Duarte, Lais T.
   Biaggio, Sonia R.
   Rocha-Filho, Romeu C.
   Bocchi, Nerilso
TI Influence of hydroxyapatite on the corrosion resistance of the
   Ti-13Nb-13Zr alloy
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE COATINGS; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY;
   SIMULATED PHYSIOLOGICAL MEDIA; TITANIUM-ALLOYS; BIOCOMPATIBLE ALLOYS;
   BIOMEDICAL TITANIUM; ZIRCONIUM ALLOYS; ANODIC OXIDES; ELECTRODEPOSITION;
   FILMS
AB Electrochemical analyses on the biocompatible alloy Ti-13Nb-13Zr wt% in an electrolyte simulating physiological medium (PBS solution) are reported. Hydroxyapatite (HA) films were obtained on the alloy by electrodeposition at constant cathodic current. Samples of the alloy covered with an anodic-oxide film or an anodic-oxide/HA film were analyzed by open circuit potential and electrochemical impedance spectroscopy measurements during 180 days in the PBS electrolyte. Analyses of the open-circuit potential (E (oc)) values indicated that the oxide/HA film presents better protection characteristics than the oxide only. This behavior was corroborated by the higher film resistances obtained from impedance data, indicating that, besides improving the alloy osteointegration, the hydroxyapatite film may also increase the corrosion protection of the biomaterial.
C1 [Duarte, Lais T.; Biaggio, Sonia R.; Rocha-Filho, Romeu C.; Bocchi, Nerilso] Univ Fed Sao Carlos, Dept Quim, BR-13560970 Sao Carlos, SP, Brazil.
RP Biaggio, SR (reprint author), Univ Fed Sao Carlos, Dept Quim, CP 676, BR-13560970 Sao Carlos, SP, Brazil.
EM biaggio@ufscar.br
RI Bocchi, Nerilso/G-6839-2014; Biaggio, Sonia/D-9810-2012; Rocha-Filho,
   Romeu/E-9681-2012
OI Bocchi, Nerilso/0000-0002-9170-9925; Biaggio, Sonia/0000-0003-2127-859X;
   Rocha-Filho, Romeu/0000-0003-4699-2423
FU CNPq (Conselho Nacional de Desen-volvimento Cientifico e Tecnologico);
   CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)
FX Financial support and scholarships from the Brazilian funding agencies
   CNPq (Conselho Nacional de Desen-volvimento Cientifico e Tecnologico)
   and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)
   are gratefully acknowledged.
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Lopez-Heredia MA, 2007, J MATER SCI-MATER M, V18, P381, DOI 10.1007/s10856-006-0703-8
   Ban S, 1997, J BIOMED MATER RES, V36, P9, DOI 10.1002/(SICI)1097-4636(199707)36:1<9::AID-JBM2>3.0.CO;2-P
   Biaggio SR, 1997, ELECTROCHIM ACTA, V42, P1751, DOI 10.1016/S0013-4686(96)00375-1
   Bottino MC, 2008, MAT SCI ENG C-BIO S, V28, P223, DOI 10.1016/j.msec.2006.12.014
   BOUKAMP BA, 1986, SOLID STATE IONICS, V18-9, P136, DOI 10.1016/0167-2738(86)90100-1
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   DALKAINE CV, 1993, CORROS SCI, V34, P117, DOI 10.1016/0010-938X(93)90263-G
   DAMIEN CJ, 1990, J BIOMED MATER RES, V24, P639, DOI 10.1002/jbm.820240602
   Dhert WJA, 1998, J BIOMED MATER RES, V41, P574, DOI 10.1002/(SICI)1097-4636(19980915)41:4<574::AID-JBM9>3.0.CO;2-9
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Komlev VS, 2002, J MATER SCI-MATER M, V13, P295, DOI 10.1023/A:1014015002331
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   LOHRENGEL MM, 1994, ELECTROCHIM ACTA, V39, P1265, DOI 10.1016/0013-4686(94)E0046-3
   Lopez MF, 2002, ELECTROCHIM ACTA, V47, P1359, DOI 10.1016/S0013-4686(01)00860-X
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Marino CEB, 2006, ELECTROCHIM ACTA, V51, P6580, DOI 10.1016/j.electacta.2006.04.051
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P2068, DOI 10.1016/j.electacta.2005.07.015
   Oliveira NTC, 2005, J BIOMED MATER RES A, V74A, P397, DOI 10.1002/jbm.a.30352
   Oliveira NTC, 2004, ELECTROCHIM ACTA, V49, P4563, DOI 10.1016/j.electacta.2004.04.042
   Oliveira NTC, 2002, J BRAZIL CHEM SOC, V13, P463, DOI 10.1590/S0103-50532002000400009
   Park JH, 2005, SURF COAT TECH, V195, P252, DOI 10.1016/j.surfcoat.2004.08.185
   Park JH, 2006, MATER LETT, V60, P2573, DOI 10.1016/j.matlet.2005.07.091
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Rakngarm A, 2008, J MATER SCI-MATER M, V19, P1953, DOI 10.1007/s10856-007-3285-1
   SHIRKHANZADEH M, 1993, J MATER SCI LETT, V12, P16
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Yen S. K., 2002, MATER CHEM PHYS, V77, P70
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   Yun YH, 1996, J BIOMED MATER RES, V32, P77, DOI 10.1002/(SICI)1097-4636(199609)32:1<77::AID-JBM9>3.0.CO;2-M
   Zhang JM, 1998, J ELECTROANAL CHEM, V452, P235, DOI 10.1016/S0022-0728(98)00107-7
NR 38
TC 13
Z9 13
U1 1
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2009
VL 20
IS 5
BP 1009
EP 1015
DI 10.1007/s10856-008-3662-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 428HD
UT WOS:000264837700001
PM 19083081
DA 2018-10-19
ER

PT J
AU Khandwekar, AP
   Patil, DP
   Khandwekar, V
   Shouche, YS
   Sawant, S
   Doble, M
AF Khandwekar, Anand P.
   Patil, Deepak P.
   Khandwekar, Vaibhav
   Shouche, Yogesh S.
   Sawant, Shilpa
   Doble, Mukesh
TI TecoflexTM functionalization by curdlan and its effect on protein
   adsorption and bacterial and tissue cell adhesion
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS ADHESION; HYDROCEPHALUS SHUNT CATHETERS;
   IN-VITRO; FIBRONECTIN ADSORPTION; BIOMATERIAL SURFACES; POLY(ETHYLENE
   OXIDE); BIOCOMPATIBILITY; POLYSACCHARIDE; QUANTIFICATION; TRANSCRIPTION
AB Curdlan modified polyurethane was created by physically entrapping the former on TecoflexTM surface. ATR-FT-IR, SEM-EDAX and AFM analysis revealed the formation of stable thin curdlan layer on the film. Contact-angle measurements showed that the modified film was highly hydrophilic. Confocal laser scanning microscopy showed the existence of entrapped layer of approximately 20-25 mu m in depth. Surface entrapment of curdlan minimized both protein adsorption and mouse L929 fibroblast cell adhesion relative to the control. Surface induced cellular inflammatory response was determined from the expression levels of proinflammatory cytokine TNF-alpha, by measuring their mRNA profiles in the cells using real time polymerase chain reaction (RT-PCR) normalized to the housekeeping gene GAPDH. The inflammatory response was suppressed on the modified substrate as expression of TNF-alpha mRNA was found to be up regulated on TecoflexTM, while it was significantly lower on curdlan substrate. The adhesion of S. aureus decreased by 62% on curdlan modified surface. Using such simple surface entrapment process, it will be possible to develop well-defined surface modifications that promote specific cell interactions and perhaps better performance in the long-term as implant.
C1 [Khandwekar, Anand P.; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Chennai 600036, Tamil Nadu, India.
   [Patil, Deepak P.; Shouche, Yogesh S.] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India.
   [Khandwekar, Vaibhav] Visvesvaraya Natl Inst Technol, Nagpur 440011, Maharashtra, India.
   [Sawant, Shilpa] Bhabha Atom Res Ctr, Mumbai 400085, Maharashtra, India.
RP Doble, M (reprint author), Indian Inst Technol, Dept Biotechnol, Chennai 600036, Tamil Nadu, India.
EM mukeshd@iitm.ac.in
RI SHOUCHE, YOGESH/C-1231-2009
OI Patil, Deepak/0000-0001-8825-0327; Doble, Mukeshd/0000-0002-4335-0698
FU DBT
FX This work was partially funded by DBT. A. K and D. P would like to thank
   CSIR for providing JRF to pursue their doctoral studies.
CR An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   ARAKAWA M, 1974, IMMUNOGENICITY UNPUB
   BONGRAND P, 1988, PHYSICAL BASIS CELL, P1
   Brash J. L., 1995, ACS SYM SER, V602, P1
   Brock T.D, 1997, BIOL MICROORGANISMS
   BRUNETTE D, 2003, BIOIMPLANT INTERFACE
   Brydon HL, 1998, J NEUROL NEUROSUR PS, V64, P643, DOI 10.1136/jnnp.64.5.643
   Brydon HL, 1996, J NEUROL NEUROSUR PS, V60, P671, DOI 10.1136/jnnp.60.6.671
   Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DESAI NP, 1992, MACROMOLECULES, V25, P226, DOI 10.1021/ma00027a038
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   EGYHAZI T, 1984, REACT KINET CATAL L, V24, P1, DOI 10.1007/BF02069592
   Evans W., 1991, MEMBRANE STRUCTURE F, P1
   Fukuda M, 1994, MOL GLYCOBIOLOGY, P1
   Galliani S, 1996, J LAB CLIN MED, V127, P71, DOI 10.1016/S0022-2143(96)90168-7
   GARNER DL, 1986, BIOL REPROD, V34, P127, DOI 10.1095/biolreprod34.1.127
   GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276
   GARNER DL, 1988, THERIOGENOLOGY, V30, P369, DOI 10.1016/0093-691X(88)90184-7
   GOGOLEWSKI S, 1996, DESK REFERENCE FUNCT, P678
   Goodman SB, 1996, J LONG-TERM EFF MED, V6, P91
   GREINACHER A, 1995, THROMB HAEMOSTASIS, V74, P886
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Harris TH, 2006, INFECT IMMUN, V74, P4530, DOI 10.1128/IAI.01938-05
   HELMUS MN, 1993, CARDIOVASC PATHOL, V2, pS53
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Holland NB, 1998, NATURE, V392, P799
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   HUBBELL JA, 1994, TRENDS POLYM SCI, V2, P20
   James NR, 2006, BIOMATERIALS, V27, P160, DOI 10.1016/j.biomaterials.2005.05.099
   Jin Y, 2006, CARBOHYD RES, V341, P90, DOI [10.1016/j.carres.2005.11.003, 10.1016/j.carres.2006.04.005]
   KATSURAYA K, 1994, MACROMOLECULES, V27, P6695, DOI 10.1021/ma00101a001
   Kim BS, 2000, BIOTECHNOL LETT, V22, P1127, DOI 10.1023/A:1005636205036
   Kinnari TJ, 2005, OTOL NEUROTOL, V26, P380, DOI 10.1097/01.mao.0000169767.85549.87
   Kunz R, 1999, J MATER SCI-MATER M, V10, P649, DOI 10.1023/A:1008943909728
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Ma N, 2002, J BIOMAT SCI-POLYM E, V13, P257
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Montdargent B, 2000, INFECT CONT HOSP EP, V21, P404, DOI 10.1086/501782
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   PAVITHRA D, 2008, BIOMED MATER, V3
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   Renn DW, 1997, CARBOHYD POLYM, V33, P219, DOI 10.1016/S0144-8617(97)00058-1
   RUSS IG, 1971, STP AM SOC TESTING, V485, P154
   STEELE JG, 2004, J BIOMED MATER RES, V992, P861
   Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02
   Tang HY, 2006, COLLOID SURFACE B, V51, P16, DOI 10.1016/j.colsurfb.2006.04.011
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   WATSON PF, 1992, J ANDROL, V13, P131
   YOSHIDA T, 1994, MACROMOLECULES, V27, P6272, DOI 10.1021/ma00100a007
   Zange R, 1998, J CONTROL RELEASE, V56, P249, DOI 10.1016/S0168-3659(98)00093-5
NR 59
TC 15
Z9 17
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2009
VL 20
IS 5
BP 1115
EP 1129
DI 10.1007/s10856-008-3655-3
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 428HD
UT WOS:000264837700012
PM 19093193
DA 2018-10-19
ER

PT J
AU Patrascu, I
   Ciocan, LT
   Miculescu, F
   Niculescu, GT
AF Patrascu, I.
   Ciocan, L. T.
   Miculescu, F.
   Niculescu, G. T.
TI Morpho-com positional study of the ageing biomaterial in bone implants
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Dental addition biomaterial; Osteogenesys; Biocompatibility; ESEM
AB The restoration of the missing structure for damaged or destroyed tooth, are achieved with a variety of treatments and advanced biomaterials. Each case needs appropriate biomaterials, especially in direct implants where defects of human skeleton may occur. The biomaterials behavior related to a specific human skeleton is the most important issue in the restorative dentistry. This contribution reports few aspects referring to morphology and composition behavior of the few biomaterials used for bone recovering in dental surgery.
C1 [Patrascu, I.; Ciocan, L. T.; Niculescu, G. T.] Carol Davila Med & Pharm Univ Bucharest, Fac Dent, Bucharest, Romania.
   [Miculescu, F.] Univ Politehn Bucuresti, Bucharest, Romania.
RP Patrascu, I (reprint author), Carol Davila Med & Pharm Univ Bucharest, Fac Dent, Calea Plevnei 16,Sector 5, Bucharest, Romania.
EM dr.ipatrascu@gmail.com
RI Miculescu, Florin/A-4524-2011
OI Miculescu, Florin/0000-0001-6757-5616
CR ARTZI Z, 1997, QUINTESSENCE INT, P28
   CHITGOPKAR SD, 2008, J PEDIAT ORTHOPED B, V17, P5
   Craig RG, 2001, MAT DENT RESTAURATIV
   ERSANTI S, 2004, J PERIODONTOL, P75
   Gatin E, 2000, PHYS MEDICA, V16, P13
   Gatin E, 2000, PHYS MEDICA, V16, P3
   GATIN E, 2008, OPTOELECTRON ADV MAT, V2, P5
   GATIN E, 1999, ROMANIAN J BIOPHYSIC, V9, P2
   GATIN E, 2009, J OPTOELECTRON ADV M, V11, P4
   GATIN E, 2009, JIPS IN PRESS
   GROSSMANN Y, 2007, J PERIODONTOL, V78, P9
   HAMA R, 2004, J PERIODONTOL, P75
   HORCH H, 2006, INT J ORAL MAXILLOF, P35
   ITO K, 1995, QUINTESSENCE INT, P26
   KIM C, 2004, J PERIODONTOL, P75
   KLEPP M, 2004, J CLIN PERIODONTOL, P31
   ROMANOS E, 2008, J PEDIAT ORTHOPED B, V17, P6
   STAMATIN I, 2006, THIN SOLID FILMS, V495, P1
   STRAVROPOULUS A, 2004, J CLIN PERIODONTOL, P31
   TAKASHI N, 1999, CERAMICS JAPAN, V34, P7
   THORWARTH M, 2006, J ORAL SURG ORAL MED, P101
   USHIDA Y, 2008, J CLIN PERIODONTOL, V35, P11
NR 22
TC 0
Z9 0
U1 0
U2 0
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD MAY
PY 2009
VL 11
IS 5
BP 744
EP 749
PG 6
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 460TN
UT WOS:000267212600029
DA 2018-10-19
ER

PT J
AU Glynn, AA
   O'Donnell, ST
   Molony, DC
   Sheehan, E
   McCormack, DJ
   O'Gara, JP
AF Glynn, Aaron A.
   O'Donnell, Sinead T.
   Molony, Diarmuid C.
   Sheehan, Eoin
   McCormack, Damian J.
   O'Gara, James P.
TI Hydrogen Peroxide Induced Repression of icaADBC Transcription and
   Biofilm Development in Staphylococcus epidermidis
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE biofilm; biomaterial-related infection; oxidative stress; Staphylococcus
   epidermidis
ID INFECTION; AUREUS; ICA; ARTHROPLASTY; ADHESION; MECHANISMS; EXPRESSION;
   SIGMA(B); OPERON; IMPACT
AB Expression of the icaADBC-encoded polysaccharide intercellular adhesion by Staphylococcus epidermidis promotes biofilm formation and represents an important virulence factor in biomaterial-related infections following orthopedic surgery. Biofilm development by the pathogen can be viewed as a protective reaction to environmental stressors including osmotic stress, thermal stress, and antimicrobial chemotherapy. Oxidative stress, arising from the release of toxic oxygen radicals by polymorphonuclear cells, is encountered by bacteria entering the body perioperatively. Evasion of this and other cell-mediated immune responses by pathogenic bacteria plays on important role in the development of chronic biomaterial-related infection. Here we investigated the impact of sublethal oxidative stress induced by H(2)O(2) (<18 mM) on S. epidermidis biofilm formation. S. epidermidis grown in brain heart infusion (BHI) media supplemented with 5 mM H(2)O(2) or 10 mM H(2)O(2) formed significantly less biofilm (p < 0.01 and p < 0.001, respectively, than bacteria grown in BHI alone. Consistent with this, using reverse transcription-polymerase chain reaction expression of the ica locus was also shown to be reduced by subinhibitory concentrations of H(2)O(2). Furthermore, diminished ica operon expression correlated with increased expression of icaR, which encodes a repressor of icaADBC. Thus, these data suggest that mild oxidative stress downregulates biofilm development by S. epidermidis and may have potential in a therapeutic context. (C) 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:627-630, 2009
C1 [Glynn, Aaron A.; Molony, Diarmuid C.; Sheehan, Eoin; McCormack, Damian J.] Cappagh Natl Orthopaed Hosp, Dublin 11, Ireland.
   [O'Donnell, Sinead T.; O'Gara, James P.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Clin Microbiol, Educ & Res Ctr, Dublin 9, Ireland.
   [O'Donnell, Sinead T.; O'Gara, James P.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland.
RP Glynn, AA (reprint author), Cappagh Natl Orthopaed Hosp, Ratoath Rd, Dublin 11, Ireland.
EM aaronglynn@hotmail.com
OI O'Gara, James/0000-0003-3866-7161
FU Cappagh Hospital Trust
FX We thank the Cappagh Hospital Trust for funding for this research, and
   H. Humphreys and T. Dillane, Department of Clinical Microbiology, RCSI
   Education and Research Centre, Beaumont Hospital, for their support.
CR Ashikaga T, 2000, MUTAT RES-GEN TOX EN, V466, P1, DOI 10.1016/S1383-5718(99)00228-4
   Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cuckler JM, 2005, J ARTHROPLASTY, V20, P33, DOI 10.1016/j.arth.2005.03.004
   Gelosia A, 2001, CLIN MICROBIOL INFEC, V7, P193, DOI 10.1046/j.1469-0691.2001.00214.x
   Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000
   GRISTINA AG, 1987, ORTHOP CLIN N AM, V18, P445
   Hirakawa K, 2004, FREE RADICAL RES, V38, P439, DOI 10.1080/1071576042000206487
   Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Li BK, 2005, COLLOID SURFACE B, V41, P153, DOI 10.1016/j.colsurfb.2004.12.001
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mecikoglu M, 2006, J BONE JOINT SURG AM, V88A, P1208, DOI 10.2106/JBJS.E.00007
   Miller RA, 1997, CLIN MICROBIOL REV, V10, P1
   NELSON JP, 1990, J BONE JOINT SURG AM, V72A, P1
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   SANDERSON PJ, 1991, J HOSP INFECT, V18, P367, DOI 10.1016/0195-6701(91)90043-8
   Schlag S, 2007, J BACTERIOL, V189, P7911, DOI 10.1128/JB.00598-07
   SCULCO TP, 1995, ORTHOPEDICS, V18, P871
   Sheehan E, 2004, J ORTHOPAED RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 27
TC 10
Z9 13
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAY
PY 2009
VL 27
IS 5
BP 627
EP 630
DI 10.1002/jor.20758
PG 4
WC Orthopedics
SC Orthopedics
GA 430SW
UT WOS:000265009900009
PM 18942741
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhao, XY
   Ao, Q
   Yang, LW
   Yang, YF
   Sun, JC
   Gai, GS
AF Zhao, Xiao-Yan
   Ao, Qiang
   Yang, Lian-Wei
   Yang, Yu-Feng
   Sun, Ji-Chao
   Gai, Guo-Sheng
TI Application of superfine pulverization technology in Biomaterial
   Industry
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Review
DE Biological powder technology; Superfine powder; Biomaterials;
   Characteristics; Application; Sterilizing
ID POWDER; STERILIZATION; FEASIBILITY; FRACTIONS; STARCH
AB Biological powder technology is a new type of biomaterial processing, including plant material, animal material, mineral and microorganism, etc. With the rapid and steady development of superfine power, the scientists have realized that biological powder technology can be applied many similarly basic process-unit operations. This paper intends to analyze characteristics, functions, study methods, the development of superfine pulverization technology in biomaterial industry and sterilizing of biomaterial Superfine powder. (C) 2008 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Zhao, Xiao-Yan; Yang, Lian-Wei; Yang, Yu-Feng; Gai, Guo-Sheng] Tsinghua Univ, Dept Mat Sci & Engineer, Beijing 100084, Peoples R China.
   [Sun, Ji-Chao] Tsinghua Univ, State Key Lab Hydrosci & Engn, Beijing 100084, Peoples R China.
RP Gai, GS (reprint author), Tsinghua Univ, Dept Mat Sci & Engineer, Beijing 100084, Peoples R China.
EM zhaoxiaoy@yahoo.cn
FU National High Technology Research and Development Program of China
   [2007AA100403]
FX Finance support from National High Technology Research and Development
   Program (2007AA100403) of China for this work is gratefully
   acknowledged.
CR Allen T., 1990, PARTICLE SIZE MEASUR
   Barth H. G., 1984, MODERN METHODS PARTI
   CARL M, 1953, ARCH BIOCHEM BIOPHYS, V46, P376
   CURRV B, 1989, APPL OPTICS, V287, P1345
   Dalla Valle J.M., 1943, MICROMERITICS TECHNO
   Fang XW, 1998, RADIAT PHYS CHEM, V52, P53, DOI 10.1016/S0969-806X(98)00073-5
   Guo L, 2008, BIORESOURCE TECHNOL, V99, P3651, DOI 10.1016/j.biortech.2007.07.026
   GYUNGDON K, 2002, J APPL POLYM SCI, V85, P2890
   Harkonen H, 1997, J CEREAL SCI, V26, P95, DOI 10.1006/jcrs.1996.0106
   Hemansson A., 1982, J FOOD SCI, V47, P1965
   Jacobs H, 1998, J AGR FOOD CHEM, V46, P2895, DOI 10.1021/jf980169k
   Jin SY, 2006, BIOCHEM ENG J, V30, P225, DOI 10.1016/j.bej.2006.05.002
   Jun S, 2007, INNOV FOOD SCI EMERG, V8, P237, DOI 10.1016/j.ifset.2007.01.001
   KAYE BH, 1995, CHAOS SOLITON FRACT, V6, P245, DOI 10.1016/0960-0779(95)80031-B
   Li F, 2000, SOLID STATE SCI, V2, P767, DOI 10.1016/S1293-2558(00)01084-0
   LI JL, 2003, Patent No. 031432069
   Liu HT, 2008, MATER LETT, V62, P1949, DOI 10.1016/j.matlet.2007.10.061
   Maaroufi C, 2000, ANIM FEED SCI TECH, V85, P61, DOI 10.1016/S0377-8401(00)00127-9
   Mende S, 2003, POWDER TECHNOL, V132, P64, DOI 10.1016/S0032-5910(03)00042-1
   Riley CK, 2008, POWDER TECHNOL, V185, P280, DOI 10.1016/j.powtec.2007.10.028
   Rumpf H., 1990, PARTICLE TECHNOLOGY
   Ryu SE, 1997, J MATER SCI, V32, P6639, DOI 10.1023/A:1018600403263
   Sakata Y, 2005, COLLOID SURFACE B, V46, P92, DOI 10.1016/j.colsurfb.2005.10.002
   Santomaso A, 2003, CHEM ENG SCI, V58, P2857, DOI 10.1016/S0009-2509(03)00137-4
   Sarang S, 2008, J FOOD ENG, V87, P351, DOI 10.1016/j.jfoodeng.2007.12.012
   Schmidt W.G., 1989, CFI-CERAM FORUM INT, V66, P217
   SONG LL, 2002, J CHINESE MAT MED, V27, P12
   Tkacova K., 1998, FREIBERGER FORSCLU A, VA841, P14
   Tsujimoto H, 2004, POWDER TECHNOL, V146, P214, DOI 10.1016/j.powtec.2004.08.009
   Vaia RA, 2001, POLYMER, V42, P1055, DOI 10.1016/S0032-3861(00)00462-6
   YOSHIZAWA H, 1991, Patent No. 22F99100
   YUAN YV, 1992, FOOD CHEM, V44, P1, DOI 10.1016/0308-8146(92)90249-2
   Zhang M, 2005, J FOOD ENG, V67, P333, DOI 10.1016/j.jfoodeng.2004.04.036
   ZHANG ZZ, 1998, SUPCIFINE GRINDING T
   Ziemann PJ, 1998, TRAC-TREND ANAL CHEM, V17, P322, DOI 10.1016/S0165-9936(98)00036-3
NR 35
TC 24
Z9 32
U1 2
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD MAY
PY 2009
VL 40
IS 3
BP 337
EP 343
DI 10.1016/j.jtice.2008.10.001
PG 7
WC Engineering, Chemical
SC Engineering
GA 450HD
UT WOS:000266390700016
DA 2018-10-19
ER

PT J
AU Obradovic, RR
   Kesic, LG
   Pesevska, S
AF Obradovic, Radmila R.
   Kesic, Ljiljana G.
   Pesevska, Svetlana
TI Influence of low-level laser therapy on biomaterial osseointegration: a
   mini-review
SO LASERS IN MEDICAL SCIENCE
LA English
DT Review
DE Biomaterial; Low-level lasers; Osseointegration; Bone
ID LOW-ENERGY LASER; HUMAN GINGIVAL FIBROBLASTS; ORGANIC BOVINE BONE;
   LOW-POWER LASER; DENTAL IMPLANTS; RAMAN-SPECTROSCOPY; GENE-EXPRESSION;
   YAG LASER; 830 NM; IRRADIATION
AB The aim of this paper is to provide an overview of the available literature on low-level laser therapy (LLLT) and its influence on bone repair and the osseointegration of biomaterials. Extensive studies of alveolar bone repair, a common problem in periodontal therapy, have been conduced worldwide. The utility of LLLT in biomaterial osseointegration is still unanswered, due to lack of literature and poorly understood mechanisms. It is still difficult for one to compare studies about the action of LLLT on the osseointegration of biomaterials because the experimental models and duration of treatments are very distinct. However, it could be concluded that LLLT may offer advantages in terms of periodontal and bone functional recovery and biomaterial osseointegration.
C1 [Obradovic, Radmila R.; Kesic, Ljiljana G.] Univ Nis, Dept Oral Med & Periodontol, Dent Clin, Fac Med, Nish 18000, Serbia.
   [Pesevska, Svetlana] Univ Kiril & Metod, Dept Periodontol, Fac Dent, Skopje, Macedonia.
RP Obradovic, RR (reprint author), Univ Nis, Dept Oral Med & Periodontol, Dent Clin, Fac Med, Bul Nikole Tesle 45-19, Nish 18000, Serbia.
EM dr.rada@yahoo.com
OI Kesic, Ljiljana/0000-0003-0463-3246
CR Almeida-Lopes L, 2001, LASER SURG MED, V29, P179, DOI 10.1002/lsm.1107
   Aoki A, 2004, PERIODONTOL 2000, V36, P59, DOI 10.1111/j.1600-0757.2004.03679.x
   BARUSHKA O, 1995, BONE, V16, P47, DOI 10.1016/S8756-3282(94)00006-9
   BASFORD JR, 1995, LASER SURG MED, V16, P331, DOI 10.1002/lsm.1900160404
   COOMBE AR, 2001, CLIN ORTHOD RES, V4, P3, DOI DOI 10.1034/J.1600-0544.2001.040102.X
   David R, 1996, LASER SURG MED, V19, P458, DOI 10.1002/(SICI)1096-9101(1996)19:4<458::AID-LSM12>3.0.CO;2-Z
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   GOLDMAN L, 1987, LASER SURG MED, V6, P559, DOI 10.1002/lsm.1900060616
   GUSH RJ, 1991, MED BIOL ENG COMPUT, V29, P387, DOI 10.1007/BF02441659
   Hamajima S, 2003, LASER MED SCI, V18, P78, DOI 10.1007/s10103-003-0255-9
   Jakse N, 2007, CLIN ORAL IMPLAN RES, V18, P517, DOI 10.1111/j.1600-0501.2007.01369.x
   Khadra M, 2005, BIOMATERIALS, V26, P3503, DOI 10.1016/j.biomaterials.2004.09.033
   Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x
   Kornman KS, 2000, PERIODONTOL 2000, V22, P22, DOI 10.1034/j.1600-0757.2000.2220103.x
   Kreisler M, 2003, J CLIN PERIODONTOL, V30, P353, DOI 10.1034/j.1600-051X.2003.00001.x
   LeGeros R.Z., 1993, J BONE MINER RES, V8, P583
   Lewandrowski KU, 1996, LASER SURG MED, V19, P40, DOI 10.1002/(SICI)1096-9101(1996)19:1<40::AID-LSM6>3.3.CO;2-3
   Lirani-Galvao AP, 2006, PHOTOMED LASER SURG, V24, P735, DOI 10.1089/PHO.2006.2003
   Liu XC, 2007, PHOTOMED LASER SURG, V25, P487, DOI 10.1089/pho.2006.2075
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.0.CO;2-R
   Nicolau RA, 2003, LASER MED SCI, V18, P89, DOI 10.1007/s10103-003-0260-z
   Ninomiya T, 2003, J BONE MINER METAB, V21, P67, DOI 10.1007/s007740300011
   Nomura K, 2001, LASER MED SCI, V16, P218, DOI 10.1007/PL00011358
   Obradovic R, 2007, J ORAL LASER APPL, V7, P161
   Ohshiro T, 1991, J Clin Laser Med Surg, V9, P267
   Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2003, INT CONGR SER, V1248, P441, DOI 10.1016/S0531-5131(03)00060-8
   Pogrel MA, 1997, LASER SURG MED, V20, P426, DOI 10.1002/(SICI)1096-9101(1997)20:4<426::AID-LSM8>3.0.CO;2-S
   Qadri T, 2005, J CLIN PERIODONTOL, V32, P714, DOI 10.1111/j.1600-051X.2005.00749.x
   Rochkind S, 2004, PHOTOMED LASER SURG, V22, P249, DOI 10.1089/1549541041438579
   Romanos GE, 2000, J PERIODONTOL, V71, P810, DOI 10.1902/jop.2000.71.5.810
   Shimotoyodome A, 2001, LASER SURG MED, V29, P442, DOI 10.1002/lsm.10004
   Simonpietri-C JJ, 2000, J PERIODONTOL, V71, P904, DOI 10.1902/jop.2000.71.6.904
   TAKEDA Y, 1988, INT J ORAL MAX SURG, V17, P388, DOI 10.1016/S0901-5027(88)80070-5
   TANG XM, 1986, LASER SURG MED, V6, P346, DOI 10.1002/lsm.1900060309
   TRELLES MA, 1987, LASER SURG MED, V7, P36, DOI 10.1002/lsm.1900070107
   Walsh LJ, 2003, AUST DENT J, V48, P146, DOI 10.1111/j.1834-7819.2003.tb00025.x
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Yamamoto Y, 1996, J Clin Laser Med Surg, V14, P129
NR 45
TC 30
Z9 31
U1 0
U2 16
PU SPRINGER LONDON LTD
PI ARTINGTON
PA ASHBOURNE HOUSE, THE GUILDWAY, OLD PORTSMOUTH ROAD, ARTINGTON GU3 1LP,
   GUILDFORD, ENGLAND
SN 0268-8921
J9 LASER MED SCI
JI Lasers Med. Sci.
PD MAY
PY 2009
VL 24
IS 3
BP 447
EP 451
DI 10.1007/s10103-008-0573-z
PG 5
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA 437PL
UT WOS:000265499300022
PM 18566853
DA 2018-10-19
ER

PT J
AU Frias, C
   Frazao, O
   Tavares, S
   Vieira, A
   Marques, AT
   Simoes, J
AF Frias, C.
   Frazao, O.
   Tavares, S.
   Vieira, A.
   Marques, A. T.
   Simoes, J.
TI Mechanical characterization of bone cement using fiber Bragg grating
   sensors
SO MATERIALS & DESIGN
LA English
DT Article
AB The aim of this work was the study and understanding of the behavior and linearity of an optical fiber Bragg grating (FBG) sensor embedded in bone cement. Test its ability to monitor strains inside bone cement during different mechanical tests, at real-time. Bone cement is a biomaterials based on polymethacrylate used as fixation method in artificial joints. Work as a bonding, load transfer and optimal Stress/strain distribution inside the complex human body environment, Bone cement is the weakest element in a joint implant, being considered the main reason of prosthesis loosening.
   Inside the bone cement, its temperature, longitudinal strain and load were measured using fiber Bragg gratings. All the measurements report a linear response showing a good adaptation and optimization of the load transfer between the biomaterial and the embedded optical sensor. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Frias, C.; Tavares, S.; Vieira, A.; Marques, A. T.] Univ Porto, Fac Engn, Dept Mech, P-4200465 Oporto, Portugal.
   [Frazao, O.] Inst Engn Sistemas & Computadores Porto, INESC Porto, P-4169007 Oporto, Portugal.
   [Simoes, J.] Univ Aveiro, P-3810193 Aveiro, Portugal.
RP Frias, C (reprint author), Univ Porto, Fac Engn, Dept Mech, R Dr Roberto Frias, P-4200465 Oporto, Portugal.
EM clara.frias@fe.up.pt
RI Vieira, Andre/B-7337-2013; Frazao, Orlando/J-3692-2013; Tavares, Sergio
   MO/A-2269-2009
OI Vieira, Andre/0000-0002-6165-8899; Frazao, Orlando/0000-0001-7680-1056;
   Tavares, Sergio MO/0000-0003-0054-0771; Marques,
   Antonio/0000-0001-9388-2724; Vieira, Andre/0000-0001-8463-6994; ,
   JOSE/0000-0003-4455-1317
FU Fundacao para a ciencia e tecnologia (FCT) [SFRH/BD/22856/2005,
   PTDC/EME-PME/70824/2006]
FX This work was supported by the Fundacao para a ciencia e tecnologia
   (FCT) with a Research Grant SFRH/BD/22856/2005 and the Project
   PTDC/EME-PME/70824/2006.
CR BERGMANN G, 1993, J BIOMECH, V26, P969, DOI 10.1016/0021-9290(93)90058-M
   Berme N, 1979, J Biomed Eng, V1, P268, DOI 10.1016/0141-5425(79)90164-X
   FRADEN J, 2004, HDB MODERN SENSORS P, P66
   HANGYIN, 2006, MEASUREMENT, V39, P328
   Kersey AD, 1997, J LIGHTWAVE TECHNOL, V15, P1442, DOI 10.1109/50.618377
   MALCHAU B, 2005, WELL CEMENTED TOTAL, P53
   MANN K, 2004, J ARTHROPLASTY, V19
   VIEIRA A, 2007, EFFECT FIBER COATING
NR 8
TC 10
Z9 10
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
J9 MATER DESIGN
JI Mater. Des.
PD MAY
PY 2009
VL 30
IS 5
BP 1841
EP 1844
DI 10.1016/j.matdes.2008.07.035
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 424JA
UT WOS:000264561800060
DA 2018-10-19
ER

PT J
AU Li, WB
   Xu, XF
   Chen, BT
   Zhang, JQ
   Ren, XJ
   Guo, HP
   Wang, S
AF Li, Wenbin
   Xu, Xiufang
   Chen, Baotian
   Zhang, Jianqun
   Ren, Xuejun
   Guo, Haiping
   Wang, Sheng
TI A novel heart structure and work mode hypothesis: Parasitic ventricle
   theory
SO MEDICAL HYPOTHESES
LA English
DT Article
AB Parasitic ventricle hypothesis: a normal human heart is composed of four chambers that include two atria and two ventricles: the left ventricle is juxtaposed to the right ventricle. The left ventricle receives arterial blood from the left atrium and then ejects it into the general circulation, while the right ventricle receives venous blood from the right atrium and ejects it into the pulmonary circulation. So this structure restricts the arterial blood from mixing with the venous blood. But the heart of the patients suffering from single ventricle is composed of only one ventricle, and the patients can survive for several years, but eventually they die of hypoxemia induced by mixing up of arterial and venous blood in single ventricle. Based on these observations, we hypothesized that if an artificial akinesic ventricle device made of a biomaterial (such as pericardium autograft) (named as parasitic ventricle) is put into the single ventricle chamber of such patients, it would function as the right ventricle, and the single ventricle chamber is rendered to function as the left ventricle. Unlike the normal heart, this parasitic relationship enables to form a new type of heart structure. It has been found that the parasitic ventricle works relying on the function of the single ventricle, and the relationship of parasitism can be established between the two ventricles, "left ventricle" containing "right ventricle". This kind of heart structure can prevent the venous blood from mixing with the arterial blood; therefore, the patient in the absence of hypoxemia may survive longer. The theory is a completely new heart structure and work mode theory. We hope that this theory can open a new way to design a new operative procedure for effectively anatomically treating a patient with single ventricle. In addition, it may supply a new theory for designing a new total artificial heart with many advantages. (C) 2009 Published by Elsevier Ltd.
C1 [Li, Wenbin; Chen, Baotian; Zhang, Jianqun; Guo, Haiping; Wang, Sheng] Univ Capital Med Sci, Anzhen Hosp, Inst Heart Lung & Blood Vessel, Dept Cardiac Surg, Beijing 100029, Peoples R China.
   [Xu, Xiufang] Univ Capital Med Sci, Anzhen Hosp, Inst Heart Lung & Blood Vessel, Dept Mol Biol, Beijing 100029, Peoples R China.
   [Ren, Xuejun] Univ Capital Med Sci, Anzhen Hosp, Inst Heart Lung & Blood Vessel, Dept Cardiol, Beijing 100029, Peoples R China.
RP Li, WB (reprint author), Univ Capital Med Sci, Anzhen Hosp, Inst Heart Lung & Blood Vessel, Dept Cardiac Surg, Beijing 100029, Peoples R China.
EM Liwenbin65@vip.sina.com
FU Beijing Natural Science Foundation [7083106]
FX This work was supported by grants from the Beijing Natural Science
   Foundation (No. 7083106).
CR AboulHosn Jamil A, 2007, Congenit Heart Dis, V2, P2, DOI 10.1111/j.1747-0803.2007.00065.x
   Imachi K, 2006, ASAIO J, V52, P9, DOI 10.1097/01.mat.0000196711.98042.12
   Victor S, 2000, ANN ROY COLL SURG, V82, P297
NR 3
TC 0
Z9 0
U1 0
U2 1
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PD MAY
PY 2009
VL 72
IS 5
BP 541
EP 543
DI 10.1016/j.mehy.2008.10.028
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 426XW
UT WOS:000264742800013
PM 19201102
DA 2018-10-19
ER

PT J
AU Ditto, AJ
   Shah, PN
   Gump, LR
   Yun, YH
AF Ditto, Andrew J.
   Shah, Parth N.
   Gump, Laura R.
   Yun, Yang H.
TI Nanospheres Formulated from L-Tyrosine Polyphosphate Exhibiting
   Sustained Release of Polyplexes and In Vitro Controlled Transfection
   Properties
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE Gene delivery; nonviral; nanospheres; nanoparticles; polyplexes
ID POTENTIAL BIOMATERIAL APPLICATIONS; RECOMBINANT ADENOVIRUS VECTORS;
   MEDIATED GENE-TRANSFER; LINEAR POLYETHYLENIMINE; POLY(ETHYLENE GLYCOL);
   PROTON SPONGE; DNA DELIVERY; PLASMID DNA; THERAPY; MICROSPHERES
AB Currently, viruses are utilized as vectors for gene therapy, since they transport across cellular membranes, escape endosomes, and effectively deliver genes to the nucleus. The disadvantage of using viruses for gene therapy is their immune response. Therefore, nanospheres have been formulated as a nonviral gene vector by blending L-tyrosine-polyphosphate (LTP) with polyethylene glycol grafted to chitosan (PEG-g-CHN) and linear polyethylenimine (LPEI) conjugated to plasmid DNA (pDNA). PEG-g-CHN stabilizes the emulsion and prevents nanosphere coalescence. LPEI protects pDNA degradation during nanosphere formation, provides endosomal escape, and enhances gene expression. Previous studies show that LTP degrades within seven days and is appropriate for intracellular gene delivery. These nanospheres prepared by water-oil emulsion by sonication and solvent evaporation show diameters between 100 and 600 nm. Also, dynamic laser light scattering shows that nanospheres completely degrade after seven days. The sustained release of pDNA and pDNA-LPEI polyplexes is confirmed through electrophoresis and PicoGreen assay. A LIVE/DEAD cell viability assay shows that nanosphere viability is comparable to that of buffers. X-Gal staining shows a sustained transfection for 11 days using human fibroblasts. This result is sustained longer than pDNA-LPEI and pDNA-FuGENE 6 complexes. Therefore, LTP-pDNA nanospheres exhibit controlled transfection and can be used as a nonviral gene delivery vector.
C1 [Ditto, Andrew J.; Gump, Laura R.; Yun, Yang H.] Univ Akron, Dept Biomed Engn, Sidney Olson Res Ctr, Akron, OH 44325 USA.
   [Shah, Parth N.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
RP Ditto, AJ (reprint author), Univ Akron, Dept Biomed Engn, Sidney Olson Res Ctr, Akron, OH 44325 USA.
EM yy@uakron.edu
RI Yun, Yang/C-1937-2009
OI Yun, Yang/0000-0001-5447-8833
FU University of Akron; Firestone Fellowship
FX The authors would like to thank the University of Akron and the
   Firestone Fellowship for their financial support.
CR Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Baker AH, 2002, J CARDIAC SURG, V17, P543, DOI 10.1046/j.1540-8191.2002.01011.x
   Behr JP, 1997, CHIMIA, V51, P34
   Bell J, 1997, PHILOS T ROY SOC B, V352, P1051, DOI 10.1098/rstb.1997.0084
   Breunig M, 2007, BBA-GEN SUBJECTS, V1770, P196, DOI 10.1016/j.bbagen.2006.10.005
   Bruin K., 2008, J CONTROL RELEASE, V130, P175
   Cai Q, 2003, BIOMATERIALS, V24, P629, DOI 10.1016/S0142-9612(02)00377-0
   Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669
   Christ M, 1997, IMMUNOL LETT, V57, P19, DOI 10.1016/S0165-2478(97)00049-7
   CROTTS G, 1995, J CONTROL RELEASE, V35, P91, DOI 10.1016/0168-3659(95)00010-6
   Ditto AJ, 2009, INT J PHARM, V368, P199, DOI 10.1016/j.ijpharm.2008.10.019
   Duvvuri S, 2005, J CONTROL RELEASE, V108, P282, DOI 10.1016/j.jconrel.2005.09.002
   El-Aneed A, 2004, EUR J PHARMACOL, V498, P1, DOI 10.1016/j.ejphar.2004.06.054
   Evans CH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2411
   Fukunaka Y, 2002, J CONTROL RELEASE, V80, P333, DOI 10.1016/S0168-3659(02)00026-3
   Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102
   Haider M, 2005, J CONTROL RELEASE, V109, P108, DOI 10.1016/j.jconrel.2005.09.018
   Heese-Peck A, 1998, PLANT MOL BIOL, V38, P145, DOI 10.1023/A:1006020204649
   Hollon T, 2000, NAT MED, V6, P6, DOI 10.1038/71545
   Itaka K, 2004, J GENE MED, V6, P76, DOI 10.1002/jbm.470
   Kichler A, 2001, J GENE MED, V3, P135, DOI 10.1002/jgm.173
   Kleemann E, 2005, J CONTROL RELEASE, V109, P299, DOI 10.1016/j.jconrel.2005.09.036
   Krougliak VA, 2001, J GENE MED, V3, P51, DOI 10.1002/1521-2254(2000)9999:9999<::AID-JGM150>3.0.CO;2-#
   Latchman DS, 2001, GENE, V264, P1, DOI 10.1016/S0378-1119(01)00322-5
   Lazaridis N, 1999, CHEM ENG SCI, V54, P3251, DOI 10.1016/S0009-2509(98)00336-4
   Lecocq M, 2000, BIOCHEM BIOPH RES CO, V278, P414, DOI 10.1006/bbrc.2000.3809
   Lin Y S, 1994, Colloids Surf B Biointerfaces, V3, P49, DOI 10.1016/0927-7765(93)01114-7
   Liu CT, 2008, MOL BIOTECHNOL, V39, P141, DOI 10.1007/s12033-008-9051-x
   LODISH H, 2004, MOL CELL BIOL, P167
   Moret I, 2001, J CONTROL RELEASE, V76, P169, DOI 10.1016/S0168-3659(01)00415-1
   Park IK, 2001, J CONTROL RELEASE, V76, P349, DOI 10.1016/S0168-3659(01)00448-5
   Pfeifer BA, 2005, INT J PHARM, V304, P210, DOI 10.1016/j.ijpharm.2005.08.001
   Pouton CW, 2001, ADV DRUG DELIVER REV, V46, P187, DOI 10.1016/S0169-409X(00)00133-2
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   Read ML, 2003, J GENE MED, V5, P232, DOI 10.1002/jgm.331
   Rodriguez A, 1999, ANAL BIOCHEM, V272, P171, DOI 10.1006/abio.1999.4156
   Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G
   SchmidtWolf GD, 1996, ANN HEMATOL, V73, P207, DOI 10.1007/s002770050231
   Sen Gupta A, 2005, POLYMER, V46, P2133, DOI 10.1016/j.polymer.2005.01.023
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709
   SOKAL R, 2003, BIOMETRY, P261
   Steiner MS, 2000, J UROLOGY, V164, P1121, DOI 10.1016/S0022-5347(05)67127-3
   Tanodekaew S, 2004, BIOMATERIALS, V25, P1453, DOI 10.1016/j.biomaterials.2003.08.020
   TSENG WC, 1999, BIOCHIM BIOPHYS ACTA, V1145, P53
   Tuncel A, 2001, COLLOID POLYM SCI, V279, P240, DOI 10.1007/s003960000416
   You JO, 2005, J GENE MED, V7, P398, DOI 10.1002/jgm.695
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zaric V, 2004, J GENE MED, V6, P176, DOI 10.1002/jgm.484
NR 50
TC 17
Z9 17
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD MAY-JUN
PY 2009
VL 6
IS 3
BP 986
EP 995
DI 10.1021/mp9000316
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 453ZY
UT WOS:000266652600034
PM 19341289
DA 2018-10-19
ER

PT J
AU Geetha, M
   Singh, AK
   Asokamani, R
   Gogia, AK
AF Geetha, M.
   Singh, A. K.
   Asokamani, R.
   Gogia, A. K.
TI Ti based biomaterials, the ultimate choice for orthopaedic implants - A
   review
SO PROGRESS IN MATERIALS SCIENCE
LA English
DT Review
ID SHAPE-MEMORY METAL; DIAMOND-LIKE CARBON; NB-TA-ZR; NITROGEN
   ION-IMPLANTATION; IN-VITRO BIOCOMPATIBILITY; TITANIUM-ALLOY IMPLANTS;
   BIOMEDICAL APPLICATIONS; CORROSION BEHAVIOR; NICKEL-TITANIUM; SURFACE
   MODIFICATION
AB The field of biomaterials has become a vital area, as these materials can enhance the quality and longevity of human life and the science and technology associated with this field has now led to multi-million dollar business. The paper focuses its attention mainly on titanium-based alloys, even though there exists biomaterials made up of ceramics, polymers and composite materials. The paper discusses the biomechanical compatibility of many metallic materials and it brings out the overall superiority of Ti based alloys, even though it is costlier. As it is well known that a good biomaterial should possess the fundamental properties such as better mechanical and biological compatibility and enhanced wear and corrosion resistance in biological environment, the paper discusses the influence of alloy chemistry, thermomechanical processing and surface condition on these properties. In addition. this paper also discusses in detail the various surface modification techniques to achieve superior biocompatibility, higher wear and corrosion resistance. Overall, an attempt has been made to bring out the current scenario of Ti based materials for biomedical applications. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Geetha, M.; Asokamani, R.] Vellore Inst Technol, Vellore 632014, Tamil Nadu, India.
   [Singh, A. K.] Def Met Res Lab, Hyderabad 500058, Andhra Pradesh, India.
   [Gogia, A. K.] Kaveri Engine Program, Project Off Mat, Hyderabad 500058, Andhra Pradesh, India.
RP Geetha, M (reprint author), Vellore Inst Technol, Vellore 632014, Tamil Nadu, India.
EM geethamanivasagam@vit.ac.in
FU Defence Research and Development Organization, Ministry of Defence,
   Government of India
FX Authors AX Singh and AX Gogia are grateful to Defence Research and
   Development Organization, Ministry of Defence, Government of India for
   financial support. The authors R. Asokamani and Geetha Manivasagam are
   thankful to DST for funding the DST project on titanium alloys. Geetha
   Manivasagarn is also thankful to the Defence Metallurgical Research
   Laboratory and Indira Gandhi Center for Atomic Research for granting
   access to use their facilities, to work on some of the Titanium alloys,
   whose outcome are reproduced in this paper. She is also thankful to her
   post doctoral fellow Dr. D.Thirunavukarasu, Dr.S. Swaminathan, NUS,
   Singapore and her Ph.D. student S. Sornambikai for their help in the
   preparation of this manuscript.
CR ADRIANA B, 2008, BIOMATERIALS, V29, P1730
   AHMED T, 1995, TITANIUM 95 SCI TECH, P1760
   AKAHORI T, 2003, TITANIUM 2003 SCI TE
   Alves C, 2005, SURF COAT TECH, V194, P196, DOI 10.1016/j.surfcoat.2004.10.009
   *AM AC ORTH SURG, 1995, ORTH RES SOC ANN M O
   ARAGON PJ, 1972, J BIOMED MATER RES, V6, P155, DOI 10.1002/jbm.820060304
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   AYAD S, 1994, EXTRACELLULAR MATRIX
   Black J., 1998, HDB BIOMATERIALS PRO
   Blackwood DJ, 2003, CORROS REV, V21, P97
   Boehlert C, 2005, MAT SCI ENG C-BIO S, V25, P247, DOI 10.1016/j.msec.2004.12.008
   Bojescul JA, 2003, J BONE JOINT SURG AM, V85A, P1079, DOI 10.2106/00004623-200306000-00015
   Boyan BD, 1995, CELL MATER, V5, P323
   Brizuela M, 2002, J MATER SCI-MATER M, V13, P1129, DOI 10.1023/A:1021129718737
   Brunette DM, 1991, BONE BIOMATERIAL INT, P49
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CABRERA N, 1948, REP PROG PHYS, V12, P163
   Catledge SA, 2000, DIAM RELAT MATER, V9, P1512, DOI 10.1016/S0925-9635(00)00279-X
   CHARNLEY J, 1973, CLIN ORTHOP RELAT R, V95, P9
   CHEOL OHJ, 2004, METALL MATER TRANS A, V35, P525
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Choubey A, 2004, MAT SCI ENG A-STRUCT, V379, P234, DOI 10.1016/j.msea.2004.02.027
   Clerc CO, 1997, J BIOMED MATER RES, V38, P229, DOI 10.1002/(SICI)1097-4636(199723)38:3<229::AID-JBM7>3.0.CO;2-R
   Crawford GA, 2007, ACTA BIOMATER, V3, P359, DOI 10.1016/j.actbio.2006.08.004
   DHERT WJA, 1993, J BIOMED MATER RES, V27, P127, DOI 10.1002/jbm.820270116
   Dhert WJA, 1998, J BIOMED MATER RES, V41, P574, DOI 10.1002/(SICI)1097-4636(19980915)41:4<574::AID-JBM9>3.0.CO;2-9
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Esposito M, 1999, J BIOMED MATER RES, V48, P559, DOI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M
   FANNING JC, 1996, TITANIUM 95 SCI TECH, P1800
   Fukumoto S, 1999, MAT SCI ENG A-STRUCT, V263, P205, DOI 10.1016/S0921-5093(98)01166-6
   Geetha M, 2004, J ALLOY COMPD, V384, P131, DOI 10.1016/j.jallcom.2004.04.113
   Geetha M, 2004, SURF ENG, V20, P68, DOI 10.1179/026708404225010595
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   GEETHA M, 2003, CORROS REV, P2
   Germain MA, 2003, BIOMATERIALS, V24, P469, DOI 10.1016/S0142-9612(02)00360-5
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   GREESINK RGT, 1995, J BONE JOINT SURG BR, V77, P534
   Greiner C, 2005, ACTA BIOMATER, V1, P705, DOI 10.1016/j.actbio.2005.07.005
   GUILLEMOT F, 2003, TITANIUM 2003 SCI TE
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Hanada S, 2003, MATER SCI FORUM, V426-4, P3103, DOI 10.4028/www.scientific.net/MSF.426-432.3103
   Hanawa T, 2003, CORROS REV, V21, P161
   HARTY M, 1982, ORTHOP CLIN N AM, V13, P667
   He G, 2006, MAT SCI ENG C-BIO S, V26, P14, DOI 10.1016/j.msec.2005.03.007
   Hintermann H, 1987, US, Patent No. 4687487
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   HULBERT SF, 1973, J BIOMED MATER RES, V7, P1, DOI 10.1002/jbm.820070303
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   JONES DA, 1996, PRINCIPLES PREVENTIO, V5, P75
   Kapanen A, 2001, BIOMATERIALS, V22, P2475, DOI 10.1016/S0142-9612(00)00435-X
   KATZ JL, 1980, NATURE, V283, P106, DOI 10.1038/283106a0
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim SK, 2005, J ORAL REHABIL, V32, P346, DOI 10.1111/j.1365-2842.2004.01475.x
   KIRBY RS, 1992, J UROLOGY, V148, P1195, DOI 10.1016/S0022-5347(17)36858-1
   KOBAYASHI E, 1998, MAT SCI MAT MED, V9, P567
   KSHANG DW, 2008, J BIOMATERIALS, V29, P970
   KURODA D, 2001, TMS MINERALS METALS
   KURODA D, 2003, TITANIUM 2003 SCI TE, P3174
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   Li JG, 1997, BIOMATERIALS, V18, P691, DOI 10.1016/S0142-9612(96)00185-8
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Li SJ, 2004, WEAR, V257, P869, DOI 10.1016/j.wear.2004.04.001
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   LJ SJ, 2004, BIOMATERIALS, V25, P2525
   Long M, 2005, MAT SCI ENG C-BIO S, V25, P382, DOI 10.1016/j.msec.2005.01.027
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LONG M, 2003, TITANIUM 2003 SCI TE, P1691
   LUKE G, 2004, J BIOMATERIALS, V25, P4175
   MacDonald D E, 2000, Ann Periodontol, V5, P175, DOI 10.1902/annals.2000.5.1.175
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   MacDonald DE, 2001, J BIOMED MATER RES, V54, P480
   Machara K., 2002, MAT T, V43, P2936
   MALCHAU H, 1998, 65 ANN M AM AC ORTH, P19
   MANIVASAGAM G, 2001, 1 AS PAC C 6 NAT CON, V145
   MARGARET AM, 2000, WEAR, V241, P158
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MCCALDEN RW, 1995, T ORTHOP RES SOC, V20, P242
   McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3
   Miller P. D, 1958, WEAR, V2, P133, DOI DOI 10.1016/0043-1648(58)90428-9
   Mishra A. K., 1996, ASTM STP, V1272, P96
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   MITSUO N, 2003, SCI TECHNOLOGY ADV M, V4, P445
   Mohanty M, 2002, BIOMOL ENG, V19, P125, DOI 10.1016/S1389-0344(02)00026-6
   Mueller H J, 1970, J Biomed Mater Res, V4, P29, DOI 10.1002/jbm.820040105
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   NAKAGAWA M, 2001, UDOYH DENT MAT J, V20, P163
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   NIINOMI M, 1999, SCI TECHNOL, V1, P223
   Okazaki Y, 2001, CURR OPIN SOLID ST M, V5, P45, DOI 10.1016/S1359-0286(00)00025-5
   OKAZAKI Y, 1994, MATER T JIM, V35, P58, DOI 10.2320/matertrans1989.35.58
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   PETERSON MB, 1989, P 16 LEEDS LYON S VI
   PETERSON MB, 1989, CHINA PROGRAM
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   PREVEY PS, 2006, J ASTM INT, V3
   Probster L, 1992, INT J ORAL MAXILLOF, V7, P390
   Prymak O, 2005, BIOMATERIALS, V26, P5801, DOI 10.1016/j.biomaterials.2005.02.029
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Qazi J, 2003, TITANIUM 2003 SCI TE, V1, P651
   Qazi JI, 2005, MAT SCI ENG C-BIO S, V25, P389, DOI 10.1016/j.msec.2005.01.022
   QAZI JI, 2003, TITANIUM 2003 SCI TE
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Robert SM, 1991, BIOMATERIALS, V12, P125
   Roderic L, 1995, BIOMEDICAL ENG HDB, P309
   ROY RR, 2007, J BIOMED MAT RES B
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P363, DOI 10.1016/j.msec.2004.12.014
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P370, DOI 10.1016/j.msec.2005.04.003
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   SAUER BW, 1974, J BIOMED MATER RES, V8, P145, DOI 10.1002/jbm.820080315
   Scholes SC, 2000, PHYS MED BIOL, V45, P3721, DOI 10.1088/0031-9155/45/12/315
   SOBALLE K, 1993, J BONE JOINT SURG BR, V75, P270
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Stangl R, 2004, J BIOMED MATER RES A, V69A, P444, DOI 10.1002/jbm.a.30013
   STEINEMANN SG, 1999, MAT MED ENG, V2, P199
   STEINEMANN SG, 1993, BETA TITANIUM 1990S, P2689
   Sumner DR, 1998, J BIOMECH, V31, P909, DOI 10.1016/S0021-9290(98)00096-7
   Sundararajan T, 1998, ANTI-CORROS METHOD M, V45, P162, DOI 10.1108/00035599810216849
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   Taneichi K, 2006, ISIJ INT, V46, P292, DOI 10.2355/isijinternational.46.292
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thair L, 2004, MATER CORROS, V55, P358, DOI 10.1002/maco.200303724
   Thair L, 2003, CORROS SCI, V45, P1951, DOI 10.1016/S0010-938X(03)00027-1
   Thair L, 2002, CORROS SCI, V44, P2439, DOI 10.1016/S0010-938X(02)00034-3
   THAIR L, 2002, THESIS ANNA U CHENNA
   THOMAS JW, 2003, MATER SCI FORUM, V426, P3127
   THOMAS JW, 2000, BIOMATERIALS, V21, P1803
   Tipper JL, 1999, J MATER SCI-MATER M, V10, P353, DOI 10.1023/A:1026473723777
   Tjong SC, 2004, MAT SCI ENG R, V45, P1, DOI 10.1016/j.mser.2004.07.001
   VAMSIKRISHNA B, 2007, ACTABIOMATER
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   WANG K, 1993, BETA TITANIUM 1990S, P2697
   Wang LC, 2003, SURF COAT TECH, V167, P188, DOI 10.1016/S0257-8972(02)00894-0
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Watters EPJ, 2005, CHEM ENG J, V112, P137, DOI 10.1016/j.cej.2005.02.031
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   WEN MJ, 2007, BIOMATERIALS, V28, P1620
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wise D.L., 2000, BIOMATERIALS ENG DEV, P205
   YU J, 1993, CORROS SCI, V35, P587, DOI 10.1016/0010-938X(93)90193-K
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 154
TC 1789
Z9 1879
U1 102
U2 1101
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6425
EI 1873-2208
J9 PROG MATER SCI
JI Prog. Mater. Sci.
PD MAY
PY 2009
VL 54
IS 3
BP 397
EP 425
DI 10.1016/j.pmatsci.2008.06.004
PG 29
WC Materials Science, Multidisciplinary
SC Materials Science
GA 420XA
UT WOS:000264321300003
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Sun, GM
   Gerecht, S
AF Sun, Guoming
   Gerecht, Sharon
TI Vascular regeneration: engineering the stem cell microenvironment
SO REGENERATIVE MEDICINE
LA English
DT Review
DE biomaterial; microenvironment; regeneration; scaffolds; stem cells;
   vascular
ID ENDOTHELIAL PROGENITOR CELLS; MARROW STROMAL CELLS; BLOOD-VESSEL
   CONSTRUCTS; GROWTH-FACTOR DELIVERY; UMBILICAL-CORD BLOOD; LAMINAR
   SHEAR-STRESS; SMOOTH-MUSCLE-CELLS; HUMAN SOMATIC-CELLS; BONE-MARROW;
   IN-VIVO
AB Vascular diseases are a major threat to human health nowadays. While current treatments can cure some vascular diseases, their beneficial effects are only temporary; vascular regeneration holds the promise of permanent, effective treatments for many vascular diseases. Stem cells and endothelial progenitor cells can differentiate into vascular lineages and therefore have the potential to repair vascular systems. However, engineering appropriate microenvironments that will allow cell maturation and delivery remains the major challenge to the successful implementation of this treatment. This review introduces the cells that are being studied for vascular differentiation and regeneration; we then consider recent approaches to engineering microenvironments, including proper signaling cues and biodegradable scaffolds that will guide the development of these cells into vessels suitable for cell-based vascular therapy.
C1 [Sun, Guoming; Gerecht, Sharon] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.
RP Gerecht, S (reprint author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.
EM gerecht@jhu.edu
RI Gerecht, Sharon/A-3388-2010
CR Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   Adams B, 2007, TRENDS CARDIOVAS MED, V17, P246, DOI 10.1016/j.tcm.2007.08.005
   Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Asahara T., 1995, CIRCULATION, V92, P11365
   Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318
   Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Chen J, 2008, KIDNEY INT, V74, P879, DOI 10.1038/ki.2008.304
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cherqui S, 2006, STEM CELLS, V24, P44, DOI 10.1634/stemcells.2005-0070
   CHIAN KS, 2008, Patent No. 2008069760
   Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094
   Delo DM, 2008, STEM CELLS DEV, V17, P1185, DOI 10.1089/scd.2008.0028
   EDELMAN ER, 1992, J CLIN INVEST, V89, P465, DOI 10.1172/JCI115607
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Ekaputra AK, 2008, BIOMACROMOLECULES, V9, P2097, DOI 10.1021/bm800565u
   Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345
   Gerecht S, 2007, BIOMATERIALS, V28, P4826, DOI 10.1016/j.biomaterials.2007.07.039
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gerecht-Nir S, 2003, LAB INVEST, V83, P1811, DOI 10.1097/01.LAB.0000106502.41391.F0
   Gerecht-Nir S, 2005, DEV DYNAM, V232, P487, DOI 10.1002/dvdy.20247
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Giavaresi G, 2005, BIOMATERIALS, V26, P3001, DOI 10.1016/j.biomaterials.2004.08.027
   Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924
   Grenier G, 2007, STEM CELLS, V25, P3101, DOI 10.1634/stemcells.2006-0795
   Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896
   Guiducci S, 2008, RHEUMATOLOGY OXFO S5, V47, P18
   Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317
   Huang Haiying, 2005, J Artif Organs, V8, P110, DOI 10.1007/s10047-005-0291-2
   Huang NF, 2008, REGEN MED, V3, P877, DOI 10.2217/17460751.3.6.877
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Igreja C, 2008, EXP HEMATOL, V36, P193, DOI 10.1016/j.exphem.2007.09.001
   Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889
   Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432
   Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406
   Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Metallo CM, 2008, BIOTECHNOL BIOENG, V100, P830, DOI 10.1002/bit.21809
   MO M, 1991, AM J PHYSIOL, V260, pH1698
   Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571
   Murayama T, 2002, CURR OPIN MOL THER, V4, P395
   NEREM RM, 1992, J BIOMECH ENG-T ASME, V114, P274, DOI 10.1115/1.2891384
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Pankajakshan D, 2007, J TISSUE ENG REGEN M, V1, P389, DOI 10.1002/term.48
   Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]
   Pasqui D, 2005, LYMPHOLOGY, V38, P50
   Peattie RA, 2004, BIOMATERIALS, V25, P2789, DOI 10.1016/j.biomaterials.2003.09.054
   Peichev M, 2000, BLOOD, V95, P952
   Petit-Zeman S, 2001, NAT BIOTECHNOL, V19, P201, DOI 10.1038/85619
   Prior BM, 2004, J APPL PHYSIOL, V97, P1119, DOI 10.1152/japplphysiol.00035.2004
   Qi HX, 2006, MATER SCI FORUM, V510-511, P882, DOI 10.4028/www.scientific.net/MSF.510-511.882
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Rossi A, 2009, TISSUE ENG PT A, V15, P525, DOI 10.1089/ten.tea.2007.0421
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Sata M, 2005, CARDIOVASCULAR REGENERATION THERAPIES USING TISSUE ENGINEERING APPROACHES, P117, DOI 10.1007/4-431-27378-6_10
   Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033
   Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Shi Q, 1998, BLOOD, V92, P362
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   Slevin M, 1998, LAB INVEST, V78, P987
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149
   Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961
   Stankus JJ, 2007, BIOMATERIALS, V28, P2738, DOI 10.1016/j.biomaterials.2007.02.012
   Stellos K, 2008, PHARMACOL REP, V60, P101
   STEPHEN P, 2001, J BIOMED MATER RES, V56, P390
   Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD
   Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092
   Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9
   STUPACK DG, 2002, SCI STKE, pPE7
   Sun GM, 2006, CARBOHYD POLYM, V65, P273, DOI 10.1016/j.carbpol.2006.01.015
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tavian M, 2005, ANN NY ACAD SCI, V1044, P41, DOI 10.1196/annals.1349.006
   Thomas V, 2007, BIOMED MATER, V2, P224, DOI 10.1088/1748-6041/2/4/004
   Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5
   Van Tomme SR, 2007, EXPERT REV MED DEVIC, V4, P147, DOI 10.1586/17434440.4.2.147
   Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649
   Wang GJ, 2007, J MICROMECH MICROENG, V17, P2000, DOI 10.1088/0960-1317/17/10/011
   Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8
   Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006
   Wang XZ, 2007, SOFT COMPUT, V11, P317, DOI 10.1007/s00500-006-0083-5
   WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576
   Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042
   Williamson MR, 2006, TISSUE ENG, V12, P45, DOI 10.1089/ten.2006.12.45
   Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Ye C, 2008, CLIN BIOMECH, V23, pS118, DOI 10.1016/j.clinbiomech.2007.08.018
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522
   Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113
   Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 140
TC 13
Z9 16
U1 1
U2 21
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD MAY
PY 2009
VL 4
IS 3
BP 435
EP 447
DI 10.2217/RME.09.1
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 449WQ
UT WOS:000266361600015
PM 19438318
DA 2018-10-19
ER

PT J
AU Erickson, IE
   Huang, AH
   Chung, C
   Li, RT
   Burdick, JA
   Mauck, RL
AF Erickson, Isaac E.
   Huang, Alice H.
   Chung, Cindy
   Li, Ryan T.
   Burdick, Jason A.
   Mauck, Robert L.
TI Differential Maturation and Structure-Function Relationships in
   Mesenchymal Stem Cell- and Chondrocyte-Seeded Hydrogels
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID HYALURONIC-ACID NETWORKS; IN-VITRO CHONDROGENESIS; ASSEMBLING PEPTIDE
   SCAFFOLDS; CARTILAGE-TISSUE; ARTICULAR-CARTILAGE; EXTRACELLULAR-MATRIX;
   NEOCARTILAGE FORMATION; PROGENITOR CELLS; SEEDING DENSITY;
   GENE-EXPRESSION
AB Degenerative disease and damage to articular cartilage represents a growing concern in the aging population. New strategies for engineering cartilage have employed mesenchymal stem cells (MSCs) as a cell source. However, recent work has suggested that chondrocytes (CHs) produce extracellular matrix (ECM) with superior mechanical properties than MSCs do. Because MSC-biomaterial interactions are important for both initial cell viability and subsequent chondrogenesis, we compared the growth of MSC- and CH-based constructs in three distinct hydrogels-agarose (AG), photocrosslinkable hyaluronic acid (HA), and self-assembling peptide (Puramatrix, Pu). Bovine CHs and MSCs were isolated from the same group of donors and seeded in AG, Pu, and HA at 20 million cells/mL. Constructs were cultured for 8 weeks with biweekly analysis of construct physical properties, viability, ECM content, and mechanical properties. Correlation analysis was performed to determine quantitative relationships between formed matrix and mechanical properties for each cell type in each hydrogel. Results demonstrate that functional chondrogenesis, as evidenced by increasing mechanical properties, occurred in each MSC- seeded hydrogel. Interestingly, while CH-seeded constructs were strongly dependent on the 3D environment in which they were encapsulated, similar growth profiles were observed in each MSC- laden hydrogel. In every case, MSC- laden constructs possessed mechanical properties significantly lower than those of CH-seeded AG constructs. This finding suggests that methods for inducing MSC chondrogenesis have yet to be optimized to produce cells whose functional matrix-forming potential matches that of native CHs.
C1 [Erickson, Isaac E.; Huang, Alice H.; Li, Ryan T.; Mauck, Robert L.] Univ Penn, McKay Orthopaed Res Lab, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
   [Erickson, Isaac E.; Huang, Alice H.; Chung, Cindy; Burdick, Jason A.; Mauck, Robert L.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Mauck, RL (reprint author), Univ Penn, McKay Orthopaed Res Lab, Dept Orthopaed Surg, 424 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.
EM lemauck@mail.med.upenn.edu
RI Huang, Alice/L-2256-2015
OI Huang, Alice/0000-0002-5037-6829; Mauck, Robert/0000-0002-9537-603X
FU National Institutes of Health [RO3 AR053668, K22 DE-015761]; National
   Science Foundation; Penn Center for Musculoskeletal Disorders [NIH
   AR050950]
FX This work was supported by grants from the National Institutes of Health
   [RO3 AR053668 (R. L. M.) and K22 DE-015761 (J. A. B.)]. Additional
   support was provided through National Science Foundation Graduate
   Research Fellowships (I. E. E., A. H. H., and C. C.) and an
   NSF-sponsored REU Summer Undergraduate Research Program (R. T. L.).
   Further support was provided by the Penn Center for Musculoskeletal
   Disorders (NIH AR050950).
CR Ateshian GA, 2005, CLIN ORTHOP RELAT R, P81, DOI 10.1097/01.bio.0000171542.53342.46
   Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Chung C, 2006, TISSUE ENG, V12, P2665, DOI 10.1089/ten.2006.12.2665
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   ERICKSON IE, 2008, P BIO2008 SUMM BIOEN
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Guilak Farshid, 1997, P179
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   HUANG AH, 2008, T 54 ANN M ORTH RES
   HUANG AH, 2008, OSTEOARTHR CARTILAGE, V6, P1074
   Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kisiday JD, 2005, TISSUE ENG, V11, P141, DOI 10.1089/ten.2005.11.141
   Kisiday JD, 2004, J BIOMECH, V37, P595, DOI 10.1016/j.jbiomech.2003.10.005
   Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508
   Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82
   KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Li YC, 2007, DEV BIOL, V305, P411, DOI 10.1016/j.ydbio.2007.02.023
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025
   Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mauck RL, 2006, T ORS, V31, P775
   MORALES TI, 1988, J BIOL CHEM, V263, P3632
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Park SY, 2003, J BIOMECH, V12, P391
   Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   Stockwell RA., 1979, BIOL CARTILAGE CELLS
   Stokes DG, 2002, ARTHRITIS RHEUM, V46, P404, DOI 10.1002/art.10106
   Tallheden T, 2005, ARTHRITIS RES THER, V7, pR560, DOI 10.1186/ar1709
   Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Tran-Khanh N, 2005, J ORTHOP RES, V23, P1354, DOI 10.1016/j.orthres.2005.05.009
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
NR 62
TC 143
Z9 150
U1 2
U2 40
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2009
VL 15
IS 5
BP 1041
EP 1052
DI 10.1089/ten.tea.2008.0099
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 439ON
UT WOS:000265636600008
PM 19119920
OA Green Published
DA 2018-10-19
ER

PT J
AU Sousa, THS
   Fortulan, CA
   Purquerio, BM
AF Sousa, T. H. S.
   Fortulan, C. A.
   Purquerio, B. M.
TI Mechanical Evaluation and In Vitro Analysis of a Porous Biomaterial
   (Polymethylmethacrylate and Hydroxyapatite) for Use in Cranioplasty
   through Rapid Prototyping
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT International Bone-Tissue-Engineering Congress (BONE-TEC 2008)
CY NOV 07-09, 2008
CL Hannover, GERMANY
C1 [Sousa, T. H. S.; Fortulan, C. A.; Purquerio, B. M.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
RI Fortulan, Carlos/B-7138-2013; de Moraes Purquerio, Benedito/O-5524-2015
OI Fortulan, Carlos/0000-0002-2259-9910; de Moraes Purquerio,
   Benedito/0000-0001-8538-3378
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2009
VL 15
IS 5
MA 65
BP O22
EP O22
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 439ON
UT WOS:000265636600088
DA 2018-10-19
ER

PT J
AU Vinatier, C
   Mrugala, D
   Jorgensen, C
   Guicheux, J
   Noel, D
AF Vinatier, Claire
   Mrugala, Dorninique
   Jorgensen, Christian
   Guicheux, Jerome
   Noel, Daniele
TI Cartilage engineering: a crucial combination of cells, biomaterials and
   biofactors
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; HUMAN ARTICULAR CHONDROCYTES; BONE MORPHOGENETIC
   PROTEINS; FIBROBLAST GROWTH FACTOR-2; IN-VITRO; PROGENITOR CELLS;
   STROMAL CELLS; CHONDROGENIC DIFFERENTIATION; ENDOCHONDRAL SKELETON;
   HYALINE CARTILAGE
AB Injuries to articular cartilage are one of the most challenging issues of musculoskeletal medicine due to the poor intrinsic ability of this tissue for repair. The lack of efficient modalities of treatment has prompted research into tissue engineering combining chondrogenic cells, scaffold materials and environmental factors. The aim of this review is to focus on the recent advances made in exploiting the potential of biomaterial-assisted cell therapy for cartilage engineering. We discuss the requirements for identifying additional specific growth factors and evaluating the optimal combination of cells, growth factors and scaffolds that is able to respond to the functional demand placed upon cartilage tissue replacement in clinics. Finally, some of the major obstacles encountered in cartilage engineering are discussed, as well as future trends in clinical applications.
C1 [Mrugala, Dorninique; Jorgensen, Christian; Noel, Daniele] INSERM, U844, F-34091 Montpellier, France.
   [Mrugala, Dorninique; Jorgensen, Christian; Noel, Daniele] Univ Montpellier 1, UFR Med, F-34000 Montpellier, France.
   [Jorgensen, Christian] Hop Lapeyronie, Serv Immunorhumatol, F-34295 Montpellier, France.
   [Vinatier, Claire] Graftys SARL, F-13854 Aix En Provence, France.
   [Vinatier, Claire; Guicheux, Jerome] Univ Nantes, UFR Odontol, F-44042 Nantes, France.
   [Vinatier, Claire; Guicheux, Jerome] LIOAD, INSERM, U791, F-44042 Nantes, France.
RP Noel, D (reprint author), INSERM, U844, F-34091 Montpellier, France.
EM daniele.noel@inserm.fr
RI Vinatier, Claire/P-1686-2014; Noel, Daniele/E-5719-2016; guicheux,
   Jerome/F-7767-2013
OI Vinatier, Claire/0000-0002-6063-9901; guicheux,
   Jerome/0000-0003-2754-3024
FU Inserm Institute; University of Montpellier I; European Community
   [503161]; Societe Francaise de Rhumatologie; Arthritis Fondation
   Courtin; Fondation de l'Avenir pour la Recherche Medicale Appliquee;
   Agence Nationale de la Recherche
FX Work in the laboratory Inserm U844 is supported by the Inserm Institute,
   the University of Montpellier I and the European Community (Key action
   LSH 1.2.4-3, Integrated project: 'Adult mesenchymal stem cells
   engineering for connective tissue disorders. From the bench to the bed
   side', Contract no: 503161). Inserm U791 is supported by the 'Societe
   Francaise de Rhumatologie', the 'Arthritis Fondation Courtin', the
   'Fondation de l'Avenir pour la Recherche Medicale Appliquee' and the
   'Agence Nationale de la Recherche'. The authors thank Jean-Louis
   Pasquier for iconogaphy.
CR Alsalameh S, 2004, ARTHRITIS RHEUM, V50, P1522, DOI 10.1002/art.20269
   Archer CW, 2006, J ANAT, V209, P481, DOI 10.1111/j.1469-7580.2006.00624.x
   Arokoski JPA, 2000, SCAND J MED SCI SPOR, V10, P186, DOI 10.1034/j.1600-0838.2000.010004186.x
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bhatia Rinky, 2005, Congest Heart Fail, V11, P87, DOI 10.1111/j.1527-5299.2005.03618.x
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023
   Chen JW, 2005, CELL TISSUE RES, V319, P429, DOI 10.1007/s00441-004-1025-0
   Chen XC, 2006, CARCINOGENESIS, V27, P2434, DOI 10.1093/carcin/bgl069
   Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200
   Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10
   Church V, 2002, J CELL SCI, V115, P4809, DOI 10.1242/jcs.00152
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Davidson D, 2005, J BIOL CHEM, V280, P20509, DOI 10.1074/jbc.M410148200
   Davies LC, 2008, TISSUE ENG PT A, V14, P1251, DOI [10.1089/ten.tea.2007.0211, 10.1089/tea.2007.0211]
   Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016
   DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x
   Di Cesare PE, 2006, J ORTHOP RES, V24, P1118, DOI 10.1002/jor.20143
   Djouad F, 2006, REGEN MED, V1, P529, DOI 10.2217/17460751.1.4.529
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022
   Edwards PC, 2005, GENE THER, V12, P75, DOI 10.1038/sj.gt.3302386
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Fedele Anthony O, 2002, Mol Interv, V2, P229, DOI 10.1124/mi.2.4.229
   Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1
   Gelse K, 2008, ARTHRITIS RHEUM-US, V58, P475, DOI 10.1002/art.23124
   Grimaud E, 2002, CYTOKINE GROWTH F R, V13, P241, DOI 10.1016/S1359-6101(02)00004-7
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001
   Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Ho JE, 2007, J BIOMED MATER RES A, V83A, P1200, DOI 10.1002/jbm.a.31355
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Hoffmann A, 2002, J CELL SCI, V115, P769
   Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987
   Hunter CJ, 2004, TISSUE ENG, V10, P736, DOI 10.1089/1076327041348310
   Ishii I, 2007, J BONE JOINT SURG BR, V89B, P693, DOI 10.1302/0301-620X.89B5.18450
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   Kayakabe M, 2006, CYTOTHERAPY, V8, P343, DOI 10.1080/14653240600845070
   Kiepe D, 2001, J AM SOC NEPHROL, V12, P2400
   Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001
   Klein TJ, 2003, OSTEOARTHR CARTILAGE, V11, P595, DOI 10.1016/S1063-4584(03)00090-6
   Kuo AC, 2006, OSTEOARTHR CARTILAGE, V14, P1126, DOI 10.1016/j.joca.2006.04.004
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Kuroda R, 2006, ARTHRITIS RHEUM, V54, P433, DOI 10.1002/art.21632
   Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878
   Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048
   Long FX, 2001, DEVELOPMENT, V128, P5099
   Malda J, 2003, CRIT REV BIOTECHNOL, V23, P175, DOI 10.1080/714037688
   Malda J, 2003, TISSUE ENG, V9, P939, DOI 10.1089/107632703322495583
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   McMahon LA, 2008, REGEN MED, V3, P743, DOI 10.2217/17460751.3.5.743
   Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003
   Munirah S, 2008, EUR CELLS MATER, V15, P41, DOI 10.22203/eCM.v015a04
   Nicodemus GD, 2007, J BIOMED MATER RES A, V83A, P323, DOI 10.1002/jbm.a.31251
   Noel D, 2007, LEUKEMIA LYMPHOMA, V48, P1283, DOI 10.1080/10428190701361869
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702
   Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040
   Schipani E, 2001, GENE DEV, V15, P2865
   Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1
   Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Sontjens SHM, 2006, BIOMACROMOLECULES, V7, P310, DOI 10.1021/bm050663e
   St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Stewart AA, 2007, AM J VET RES, V68, P941, DOI 10.2460/ajvr.68.9.941
   Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   van Beuningen HM, 1998, OSTEOARTHR CARTILAGE, V6, P306, DOI 10.1053/joca.1998.0129
   Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324
   Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1
   Weizmann S, 2005, MATRIX BIOL, V24, P520, DOI 10.1016/j.matbio.2005.07.003
   Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103
NR 91
TC 246
Z9 267
U1 5
U2 76
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD MAY
PY 2009
VL 27
IS 5
BP 307
EP 314
DI 10.1016/j.tibtech.2009.02.005
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 444YZ
UT WOS:000266018100006
PM 19329205
DA 2018-10-19
ER

PT J
AU Sundaram, CS
   Viswanathan, N
   Meenakshi, S
AF Sundaram, C. Sairam
   Viswanathan, Natrayasamy
   Meenakshi, S.
TI Defluoridation of water using magnesia/chitosan composite
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE MgO; Chitosan; MgOC composite; Defluoridation; Adsorption
ID AQUEOUS-SOLUTION; FLUORIDE; ADSORPTION; REMOVAL; EQUILIBRIUM; CHITOSAN;
   KINETICS; SORPTION; ION; PB(II)
AB Magnesia (MgO) is a well-known adsorbent showing extremely high defluoridation capacity (DC). In order to over come the limitations of MgO for field applications, an attempt has been made to modify magnesia with abundant biomaterial chitosan to form magnesia/chitosan (MgOC) composite in a usable form and its merits over conventional magnesia and raw chitosan is established. Removal of fluoride from aqueous solution with MgO and MgOC composite was studied with batch equilibrium experiments. At equilibrium, MgOC composite has a DC of 4440 mg F(-)/kg while for magnesia it is only 2175 mg F-/kg. The physicochemical properties of the synthesised MgOC composite were analyzed with FTIR and SEM with EDAX studies. The equilibrium data were fitted with isotherm and kinetic models. Thermodynamic parameters viz, triangle G degrees, triangle H degrees and triangle S degrees were calculated to understand the nature of sorption. Field studies were carried out to find the suitability of these sorbents at field conditions. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Viswanathan, Natrayasamy; Meenakshi, S.] Gandhigram Rural Univ, Dept Chem, Gandhigram 624302, Tamil Nadu, India.
   [Sundaram, C. Sairam] Karaikal Polytech Coll, Dept Sci & Humanities, Puducherry 609609, India.
RP Meenakshi, S (reprint author), Gandhigram Rural Univ, Dept Chem, Gandhigram 624302, Tamil Nadu, India.
EM sairam_adithya@yahoo.com; natrayasamy_viswanathan@rediffmail.com;
   drs_meena@rediffmail.com
OI Natrayasamy, Viswanathan/0000-0003-4939-3442
FU University Grants Commission, New Delhi, India
FX The authors are thankful to University Grants Commission, New Delhi,
   India for the provision of support to carry out this research work.
CR ADHIKARY SK, 1989, DESALINATION, V71, P301, DOI 10.1016/0011-9164(89)85031-3
   Al-Degs YS, 2006, WATER RES, V40, P2645, DOI 10.1016/j.watres.2006.05.018
   [Anonymous], 1984, WHO REP FLUOR FLUOR
   [APHA AWWA WEF], 2005, STAND METH EX WAT WA
   Bulusu K. R., 1979, J I ENG, V60, P1
   Cengeloglu Y, 2002, SEP PURIF TECHNOL, V28, P81, DOI 10.1016/S1383-5866(02)00016-3
   CHEN F, 2002, MATER LETT, V57, P856
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Hichour M, 2000, SEP PURIF TECHNOL, V18, P1, DOI 10.1016/S1383-5866(99)00042-8
   Ho YS, 2006, WATER RES, V40, P119, DOI 10.1016/j.watres.2005.10.040
   Ho YS, 2000, SEPAR PURIF METHOD, V29, P189, DOI 10.1081/SPM-100100009
   Jaafari K, 2001, WATER SA, V27, P9
   Kamble SP, 2007, CHEM ENG J, V129, P173, DOI 10.1016/j.cej.2006.10.032
   Karthikeyan G, 2005, INDIAN J CHEM TECHN, V12, P263
   KHAN AA, 1987, COLLOID SURFACE, V24, P33, DOI 10.1016/0166-6622(87)80259-7
   Ku Y, 2002, WATER AIR SOIL POLL, V133, P349, DOI 10.1023/A:1012929900113
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Lopez-Ramon MV, 1999, CARBON, V37, P1215, DOI 10.1016/S0008-6223(98)00317-0
   Lv L, 2007, WATER RES, V41, P1534, DOI 10.1016/j.watres.2006.12.033
   Ma W, 2007, J HAZARD MATER, V143, P296, DOI 10.1016/j.jhazmat.2006.09.032
   MCKEE R, 1999, IND J ENV HLTH, V41, P53
   Meeenakshi S., 2007, J COLLOID INTERF SCI, V308, P438
   Mellah A, 1997, WATER RES, V31, P621, DOI 10.1016/S0043-1354(96)00294-1
   Nakano Y, 2001, WATER RES, V35, P496, DOI 10.1016/S0043-1354(00)00279-7
   POPAT KM, 1994, REACT POLYM, V23, P23, DOI 10.1016/0923-1137(94)90107-4
   Raichur AM, 2001, SEP PURIF TECHNOL, V24, P121, DOI 10.1016/S1383-5866(00)00219-7
   Thergaonkar VP, 1971, IND J ENV HLTH, V16, P241
   Wankasi D, 2005, J CHIL CHEM SOC, V50, P691, DOI 10.4067/S0717-97072005000400009
   WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204
   Weber W. J., 1964, J SANIT ENG DIV ASCE, V90, P79
   Zhou D, 2005, WATER RES, V39, P3755, DOI 10.1016/j.watres.2005.06.033
   Zhou DQ, 2003, POLYM ADVAN TECHNOL, V14, P287, DOI 10.1002/pat.308
NR 33
TC 95
Z9 98
U1 3
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD APR 30
PY 2009
VL 163
IS 2-3
BP 618
EP 624
DI 10.1016/j.jhazmat.2008.07.009
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 418PH
UT WOS:000264160000018
PM 18723280
DA 2018-10-19
ER

PT J
AU Zhou, YL
   Niinomi, M
AF Zhou, Ying-Long
   Niinomi, Mitsuo
TI Ti-25Ta alloy with the best mechanical compatibility in Ti-Ta alloys for
   biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Elastic modulus; Strength; Ti-Ta alloy; Mechanical compatibility;
   Metallic biomaterial
ID TITANIUM-ALLOYS; YOUNGS MODULUS; NANOCRYSTALLINE MATERIALS;
   CORROSION-RESISTANCE; PLASTIC-DEFORMATION; MOLECULAR-DYNAMICS;
   CAST-IRON; BIOCOMPATIBILITY; TANTALUM; BEHAVIOR
AB The microstructures. dynamic elastic modulus, and mechanical properties of the Ti-25Ta (mass%) alloy are investigated in this study in order to assess its mechanical compatibility for biomedical applications. The microstructures are examined by X-ray diffraction (XRD) analysis, scanning electron microscopy (SEM), and transmission electron microscopy (TEM). The dynamic elastic modulus is measured by the resonance vibration method and the mechanical properties are determined from uniaxial tensile tests. The experimental results indicate that the Ti-25Ta alloy exhibits an orthorhombic martensite (alpha '') twinned structure after solution treatment. The Ti-25Ta alloy has the lowest elastic modulus and the highest ratio of strength to modulus among Ti-Ta alloys. Thus. the Ti-25Ta alloy exhibits the best mechanical compatibility among Ti-Ta alloys and is a promising candidate for novel metallic biomaterials. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Zhou, Ying-Long] Foshan Univ, Dept Mechatron Engn, Sch Mechatron & Informat Engn, Foshan 528000, Guangdong, Peoples R China.
   [Niinomi, Mitsuo] Tohoku Univ, Dept Biomat Sci, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Zhou, YL (reprint author), Foshan Univ, Dept Mechatron Engn, Sch Mechatron & Informat Engn, 18 Jiangwan Yi Rd, Foshan 528000, Guangdong, Peoples R China.
EM ylzhou_2@yahoo.com
RI Niinomi, Mitsuo/B-5965-2011
CR Banerjee R, 2004, BIOMATERIALS, V25, P3413, DOI 10.1016/j.biomaterials.2003.10.041
   Boccaccini AR, 1997, Z METALLKD, V88, P23
   Boyer R., 1994, MAT PROPERTIES HDB T
   Breme J, 1989, Int J Oral Maxillofac Implants, V4, P113
   BYWATER KA, 1972, PHILOS MAG, V25, P1249, DOI 10.1080/14786437208223852
   Carlton CE, 2007, ACTA MATER, V55, P3749, DOI 10.1016/j.actamat.2007.02.021
   Collings E. W., 1984, PHYS METALLURGY TITA
   COTTON JD, 1994, METALL MATER TRANS A, V25, P461, DOI 10.1007/BF02651588
   Cui Z., 2000, METALLOGRAPHY HEAT T
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Fedotov S G, 1986, PHYS MET METALLOGR, V62, P109
   GANESAN P, 1974, J LESS-COMMON MET, V34, P209, DOI 10.1016/0022-5088(74)90161-1
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   He G, 2006, MAT SCI ENG C-BIO S, V26, P14, DOI 10.1016/j.msec.2005.03.007
   Helsen J.A., 1998, METALS BIOMATERIALS
   HUNT M, 1991, MATER ENG, V113, P27
   LAQUE FL, 1963, CORROSION RESISTANCE
   LEDBETTER H, 1992, Z METALLKD, V83, P195
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LU K, 1993, SCRIPTA METALL MATER, V28, P1465, DOI 10.1016/0956-716X(93)90576-E
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   PALUMBO G, 1991, SCRIPTA METALL MATER, V25, P679, DOI 10.1016/0956-716X(91)90114-G
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   Petch N. J., 1953, J IRON STEEL I, P174
   PLENK H, 1990, CONCISE ENCY MED DEN, P355
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Schiotz J, 1999, PHYS REV B, V60, P11971, DOI 10.1103/PhysRevB.60.11971
   SEMLITSCH M, 1987, CLIN MATER, V2, P1, DOI DOI 10.1016/0267-6605(87)90015-1
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Thair L, 2004, MATER CORROS, V55, P358, DOI 10.1002/maco.200303724
   Van Swygenhoven H, 2001, SCRIPTA MATER, V44, P1513, DOI 10.1016/S1359-6462(01)00717-5
   VILLA R, 2002, MAT T, V43, P2291
   Yamakov V, 2002, ACTA MATER, V50, P61, DOI 10.1016/S1359-6454(01)00329-9
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
NR 49
TC 65
Z9 67
U1 5
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR 30
PY 2009
VL 29
IS 3
BP 1061
EP 1065
DI 10.1016/j.msec.2008.09.012
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 452DP
UT WOS:000266520400070
DA 2018-10-19
ER

PT J
AU O'Shaughnessy, WS
   Edell, DJ
   Gleason, KK
AF O'Shaughnessy, W. S.
   Edell, D. J.
   Gleason, K. K.
TI Initiated chemical vapor deposition of a siloxane coating for insulation
   of neural probes
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Hot-Wire CVD (Cat-CVD) Process
CY AUG 20-24, 2008
CL Massachusetts Inst Technol, Cambridge, MA
HO Massachusetts Inst Technol
DE Initiated chemical vapor deposition (iCVD); Neural probes; Biomaterial
   coating
ID POLY(2-HYDROXYETHYL METHACRYLATE); POLYELECTROLYTE MULTILAYERS;
   CEREBRAL-CORTEX; THIN-FILMS; IN-VITRO; DELIVERY; PLATELETS; HYDROGELS;
   POLYMERS; ADHESION
AB Recent advances in the field of neuroprosthetics have brought the possibility of human utilization into the near term. However, current implant coating chemistries require thicknesses of similar to 25 pm in order to provide the required electrical insulation, significantly increasing the diameter of the neural probe shanks and resulting surgical damage upon implantation. In this work, a novel biopassivation coating is created through initiated chemical vapor deposition (iCVD) of trivinyl-trimethyl-cyclotrisiloxane. The resulting material is a highly crosslinked organosilicon polymer matrix which is synthesized directly on the surface of the substrate. This material possesses an electrical resistivity which allows for a coating thickness on the order of only 5 Pm. The material has also been demonstrated to retain its electrical properties in a simulated biological environment for over 3 years. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Gleason, K. K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [O'Shaughnessy, W. S.] Semprus Biosci, Cambridge, MA USA.
   [Edell, D. J.] Innersea Technol Inc, Bethesda, MA USA.
RP Gleason, KK (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM kkg@mit.edu
RI Gleason, Karen/G-1471-2013
OI Gleason, Karen/0000-0001-6127-1056
CR Bhat SV, 2002, BIOMATERIALS
   Bradley DC, 2005, J NEUROPHYSIOL, V93, P1659, DOI 10.1152/jn.01213.2003
   Chan K, 2005, CHEM VAPOR DEPOS, V11, P437, DOI 10.1002/cvde.200506381
   Chan K, 2005, LANGMUIR, V21, P8930, DOI 10.1021/la051004q
   CHAWLA AS, 1981, BIOMATERIALS, V2, P83, DOI 10.1016/0142-9612(81)90004-1
   EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Gunn J, 1999, EUR HEART J, V20, P1693, DOI 10.1053/euhj.1999.1549
   HENCH LL, 1982, BIOMATERIALS INTERFA
   ISHIKAWA Y, 1985, MAKROMOL CHEM-RAPID, V6, P495
   Kipke DR, 2003, IEEE T NEUR SYS REH, V11, P151, DOI 10.1109/TNSRE.2003.814443
   Limb SJ, 1997, J VAC SCI TECHNOL A, V15, P1814, DOI 10.1116/1.580796
   Lyles BF, 2004, LANGMUIR, V20, P3028, DOI 10.1021/la049486d
   MURTHY SK, 2003, THESIS COLL MAT SCI
   Nahar M, 2006, CRIT REV THER DRUG, V23, P259, DOI 10.1615/CritRevTherDrugCarrierSyst.v23.i4.10
   Norris P, 2005, ANTIMICROB AGENTS CH, V49, P4272, DOI 10.1128/AAC.49.10.4272-4279.2005
   O'Shaughnessy WS, 2008, THIN SOLID FILMS, V516, P684, DOI 10.1016/j.tsf.2007.06.112
   O'Shaughnessy WS, 2007, BIOMACROMOLECULES, V8, P2564, DOI 10.1021/bm070242s
   O'Shaughnessy WS, 2006, LANGMUIR, V22, P7021, DOI 10.1021/la0607858
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4
   SCHMIDT EM, 1988, MED BIOL ENG COMPUT, V26, P96, DOI 10.1007/BF02441836
   Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wood KC, 2006, P NATL ACAD SCI USA, V103, P10207, DOI 10.1073/pnas.0602884103
   Xu CY, 2002, SENSOR ACTUAT A-PHYS, V96, P78, DOI 10.1016/S0924-4247(01)00766-X
   YAMAGISHI FG, 1991, THIN SOLID FILMS, V202, P39, DOI 10.1016/0040-6090(91)90539-A
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
NR 30
TC 3
Z9 3
U1 1
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD APR 30
PY 2009
VL 517
IS 12
BP 3612
EP 3614
DI 10.1016/j.tsf.2009.01.192
PG 3
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 448YB
UT WOS:000266296800051
DA 2018-10-19
ER

PT J
AU Longinotti, MP
   Corti, HR
AF Paula Longinotti, M.
   Corti, Horacio R.
TI Fractional Walden Rule for Electrolytes in Supercooled Disaccharide
   Aqueous Solutions
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID GLASS-TRANSITION TEMPERATURE; ELECTRICAL-CONDUCTIVITY; BIOMATERIAL
   STABILIZATION; DIELECTRIC FRICTION; SUCROSE SOLUTIONS; SODIUM-CHLORIDE;
   SELF-DIFFUSION; IONIC MOBILITY; SUGAR SYSTEMS; TREHALOSE
AB The electrical conductivity of CsCl, KCl, Bu(4)NBr, and Bu(4)NI was studied in stable and supercooled (metastable) sucrose and trehalose aqueous solutions over a wide viscosity range. The results indicate that large positive deviations from the Walden rule occur in these systems due to the higher tendency of the ions to move in water-rich regions, as previously observed for NaCl and MgCl(2). The electrical molar conductivity viscosity dependence can be described with a fractional Walden rule (Lambda eta(alpha) = constant), where alpha is a decoupling parameter which increases with ionic size and varies between 0.61 and 0.74 for all of the studied electrolytes. Using the electrical molar conductivity dependence of ion-ion interactions, an effective dielectric constant was calculated for a trehalose 39 wt% aqueous solution as a function of temperature. Above 278 K, the effective and the bulk solution dielectric constants are similar, but at lower temperatures, where the carbohydrate becomes less mobile than water, the effective dielectric constant approaches the dielectric constant of water. We also conclude that the solute-solvent dielectric friction contribution can be neglected, reinforcing the idea that the observed breakdown of the Walden rule is due to the existence of local microheterogeneities. The Walden plots for the studied ionic solutes show a decoupling similar to that found for the diffusion of water in the same solutions.
C1 [Corti, Horacio R.] Comis Nacl Energia Atom, Dept Fis Mat Condensada, RA-1650 Buenos Aires, DF, Argentina.
   [Corti, Horacio R.] Univ Buenos Aires, Inst Quim Fis Mat Medio Ambiente & Energia, Fac Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina.
   [Paula Longinotti, M.] Univ Buenos Aires, Dept Quim Inorgan Analit & Quim Fis, Fac Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina.
RP Corti, HR (reprint author), Comis Nacl Energia Atom, Dept Fis Mat Condensada, Av Gen Paz 1499, RA-1650 Buenos Aires, DF, Argentina.
EM hrcorti@cnea.gov.ar
FU Agencia Nacional de Promocion; Cientifica y Tecnologica [PICT 06-32916];
   Universidad de Buenos Aires [UBACyT X-220]; CONICET [PIP5977]
FX We acknowledge financial support from Agencia Nacional de Promocion,
   Cientifica y Tecnologica (PICT 06-32916), Universidad de Buenos Aires
   (UBACyT X-220), and CONICET(PIP5977). H.R.C. is a member of CONICET.
   M.P.L. thanks a posdoctoral fellowship of CONICET.
CR Bagchi B, 1998, ACCOUNTS CHEM RES, V31, P181, DOI 10.1021/ar970226f
   BARTHEL J, 1983, J SOLUTION CHEM, V12, P449, DOI 10.1007/BF00651698
   BARTHEL J, 1980, J SOLUTION CHEM, V9, P209, DOI 10.1007/BF00648327
   BARTHEL J, 1983, TOPICS CURRENT CHEM, V3
   BERTOLINI D, 1982, J CHEM PHYS, V76, P3285, DOI 10.1063/1.443323
   BILZ W, 1926, Z ANORG ALLG CHEM, V152, P267
   Blackburn FR, 1996, J PHYS CHEM-US, V100, P18249, DOI 10.1021/jp9622041
   CARPENTER JF, 1986, ARCH BIOCHEM BIOPHYS, V250, P505, DOI 10.1016/0003-9861(86)90755-1
   CARPENTER JF, 1987, CRYOBIOLOGY, V24, P455, DOI 10.1016/0011-2240(87)90049-6
   Champion D, 1997, J PHYS CHEM B, V101, P10674, DOI 10.1021/jp971899i
   Chenlo F, 2002, J FOOD ENG, V54, P347, DOI 10.1016/S0260-8774(01)00221-7
   Corti HR, 2008, J SOLUTION CHEM, V37, P1593, DOI 10.1007/s10953-008-9329-4
   Corti HR, 2008, J PHYS CHEM B, V112, P12899, DOI 10.1021/jp802806p
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   CROWE JH, 1994, CRYOBIOLOGY, V31, P355, DOI 10.1006/cryo.1994.1043
   Elias ME, 1999, J MOL LIQ, V83, P303, DOI 10.1016/S0167-7322(99)00094-X
   Goldfarb DL, 2001, J SOLUTION CHEM, V30, P307, DOI 10.1023/A:1010334021934
   Green WH, 1908, J CHEM SOC, V93, P2049, DOI 10.1039/ct9089302049
   HUBBARD J, 1977, J CHEM PHYS, V67, P4850, DOI 10.1063/1.434664
   Lide D, 1995, CRC HDB CHEM PHYS
   Longinotti MP, 2008, J PHYS CHEM REF DATA, V37, P1503, DOI 10.1063/1.2932114
   Longinotti MP, 2007, ELECTROCHEM COMMUN, V9, P1444, DOI 10.1016/j.elecom.2007.02.003
   Longinotti MP, 2004, J SOLUTION CHEM, V33, P1029, DOI 10.1023/B:JOSL.0000048053.92048.7b
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   Mapes MK, 2006, J PHYS CHEM B, V110, P507, DOI 10.1021/jp0555955
   Matsuoka T, 2002, J MOL LIQ, V98-9, P317
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   MCLIN MG, 1991, J PHYS CHEM-US, V95, P9464, DOI 10.1021/j100176a079
   Miao WJ, 2002, J PHYS CHEM B, V106, P1392, DOI 10.1021/jp01345lu
   Miller DP, 2000, J PHYS CHEM B, V104, P10419, DOI 10.1021/jp000730t
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   MISRA V, 1977, CARBOHYD RES, V59, P35
   Mizuno F, 2006, J NON-CRYST SOLIDS, V352, P5147, DOI 10.1016/j.jnoncrysol.2006.06.006
   MOORE AW, 1993, ANAL CHEM, V65, P3550, DOI 10.1021/ac00072a004
   Mosier BP, 2002, EXP FLUIDS, V33, P545, DOI [10.1007/S00348-002-0486-8, 10.1007/s00348-002-0486-8]
   MUSTAFA MB, 1993, MACROMOLECULES, V26, P370, DOI 10.1021/ma00054a017
   MUSTAFA MB, 1989, MACROMOLECULES, V22, P1500, DOI 10.1021/ma00193a089
   PANCOAST HM, 1980, HDB SUGARS
   PARKER R, 1995, CRYOLETTERS, V16, P197
   PUGSLEY FA, 1954, CAN J CHEM, V32, P839, DOI 10.1139/v54-106
   Rampp M, 2000, CARBOHYD RES, V328, P561, DOI 10.1016/S0008-6215(00)00141-5
   ROBINSON RA, 1955, ELECTROLYTE SOLUTION
   STEEL BJ, 1958, J PHYS CHEM-US, V62, P450, DOI 10.1021/j150562a019
   STOKES JM, 1958, J PHYS CHEM-US, V62, P497, DOI 10.1021/j150562a036
   STOKES JM, 1956, J PHYS CHEM-US, V60, P217, DOI 10.1021/j150536a018
   STOKES RH, 1959, STRUCTURE ELECTROLYT
   Swallen SF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.015901
   TREINER C, 1965, J PHYS CHEM-US, V69, P2576, DOI 10.1021/j100892a016
   Walden P, 1906, Z PHYS CHEM-STOCH VE, V55, P207
   WOLYNES PG, 1980, ANNU REV PHYS CHEM, V31, P345, DOI 10.1146/annurev.pc.31.100180.002021
   Zhuo K, 2005, J CHEM ENG DATA, V50, P1589, DOI 10.1021/je050064v
   ZWANZIG R, 1970, J CHEM PHYS, V52, P3625, DOI 10.1063/1.1673535
NR 54
TC 14
Z9 14
U1 0
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD APR 23
PY 2009
VL 113
IS 16
BP 5500
EP 5507
DI 10.1021/jp810253s
PG 8
WC Chemistry, Physical
SC Chemistry
GA 434IT
UT WOS:000265269100021
PM 19326883
DA 2018-10-19
ER

PT J
AU Fernandez-Saiz, P
   Lagaron, JM
   Ocio, MJ
AF Fernandez-Saiz, P.
   Lagaron, J. M.
   Ocio, M. J.
TI Optimization of the Film-Forming and Storage Conditions of Chitosan as
   an Antimicrobial Agent
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Chitosan; active packaging; coatings; antimicrobial properties; ATR-FTIR
   spectroscopy; color
ID MOLECULAR-WEIGHT CHITOSAN; ATR-FTIR SPECTROSCOPY; POLYMER ELECTROLYTES;
   BARRIER PROPERTIES; MEMBRANE; POLYSACCHARIDE; OLIGOMERS; BACTERIA;
   QUALITY; DESIGN
AB The aim of this work was to assess the antimicrobial capacity of chitosan-based films obtained by a dissolution and solvent evaporation (solvent casting) method at various temperatures (i.e., 37, 80, and 120 degrees C) on the growth of Staphylococcus aureus and Salmonella spp. bacteria. The effect of temperature (4, 23, 37 degrees C) and relative humidity (RH; 0, 75%) during storage on the biocide performance was also investigated. Color parameters and ATR-FTIR spectra were analyzed for each sample to investigate the relationship between structural and/or chemical alterations in the films during storage and biocide performance. The results indicated that films formed at 37 and 80 degrees C presented a significant inhibitory effect for both types of bacteria; however, when cast at 120 degrees C, the films ceased to exhibit antimicrobial properties. Curiously, chitosonium acetate films were seen to diminish to a large extent their biocide properties when stored at 23 degrees C and 75% RH for 2 months or alternatively when stored and 37 degrees C and 0% RH over the same period of time. In good agreement with this behavior the FTIR results indicated that under the previous conditions a significant fraction of the biocide carboxylate chemistry remained in the polymer after contact with the bacterial solution due to a strong reduction in cast film solubility. Because biopolymer active species migration from the film to the culture media is needed for the biomaterial to exhibit measurable antimicrobial effect, proper control of temperature and humidity during film formation and storage is necessary to design the optimum performance of chitosan as a biocide.
C1 [Fernandez-Saiz, P.; Lagaron, J. M.; Ocio, M. J.] CSIC, Inst Agroquim & Tecnol Alimentos, Novel Mat & Nanotechnol Lab, Valencia 46100, Spain.
   [Ocio, M. J.] Univ Valencia, Dept Prevent Med, Fac Farm, E-46100 Valencia, Spain.
RP Ocio, MJ (reprint author), CSIC, Inst Agroquim & Tecnol Alimentos, Novel Mat & Nanotechnol Lab, Apartado Correos 73, Valencia 46100, Spain.
EM ajo@iata.csic.es
RI Ocio, Maria/H-4617-2012; Fernandez Saiz, Patricia/F-1014-2015
OI Fernandez Saiz, Patricia/0000-0002-1702-4637
CR Butler BL, 1996, J FOOD SCI, V61, P953, DOI 10.1111/j.1365-2621.1996.tb10909.x
   DEMARGERANDRE S, 1994, CARBOHYD POLYM, V23, P211, DOI 10.1016/0144-8617(94)90104-X
   ELGHAOUTH A, 1991, J FOOD SCI, V56, P1618, DOI 10.1111/j.1365-2621.1991.tb08655.x
   ERUKHIMOVITCH V, 2006, VIB SPECTROSC, V40, P40, DOI DOI 10.1016/J.VIBSPEC.2005.06.004
   Fernandez-Saiz P, 2009, FOOD HYDROCOLLOID, V23, P913, DOI 10.1016/j.foodhyd.2008.06.001
   Fernandez-Saiz P, 2006, BIOPOLYMERS, V83, P577, DOI 10.1002/bip.20589
   FERNANDEZSAIZ P, 2008, INT J FOOD MICROBIOL, V23, P913
   Gandini A, 2003, POLYMER, V44, P7565, DOI 10.1016/j.polymer.2003.09.061
   Ha T. J., 2001, J KOREAN SOC FOOD SC, V30, P630
   Hein S, 2008, MATER SCI TECH-LOND, V24, P1053, DOI 10.1179/174328408X341744
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   Jeon YJ, 2001, CARBOHYD POLYM, V44, P71, DOI 10.1016/S0144-8617(00)00200-9
   Kam HM, 1999, J BIOMED MATER RES, V48, P881, DOI 10.1002/(SICI)1097-4636(1999)48:6<881::AID-JBM18>3.0.CO;2-2
   Kaya I, 2001, POLYMER, V42, P4859, DOI 10.1016/S0032-3861(00)00883-1
   Lagaron JM, 2007, J AGR FOOD CHEM, V55, P2554, DOI 10.1021/jf063110j
   Larena A, 2004, APPL SURF SCI, V238, P273, DOI 10.1016/j.apsusc.2004.05.175
   Leane MM, 2004, INT J PHARM, V271, P241, DOI 10.1016/j.ijpharm.2003.11.023
   LEE HY, 2002, J KOREAN SOC FOOD SC, V31, P445
   LEE JW, 2000, KOREAN J FOOD SCI TE, V32, P828
   Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022
   Urreaga JM, 2007, CARBOHYD POLYM, V69, P14, DOI 10.1016/j.carbpol.2006.08.019
   *NCCLS, 1999, M26A NCCLS, V19, P18
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   No HK, 2006, CARBOHYD POLYM, V65, P174, DOI 10.1016/j.carbpol.2005.12.036
   Osman Z, 2003, ELECTROCHIM ACTA, V48, P993, DOI 10.1016/S0013-4686(02)00812-5
   Qin CQ, 2006, CARBOHYD POLYM, V63, P367, DOI 10.1016/j.carbpol.2005.09.023
   Ritthidej CC, 2002, INT J PHARM, V232, P11, DOI 10.1016/S0378-5173(01)00894-8
   Roller S, 1999, INT J FOOD MICROBIOL, V47, P67, DOI 10.1016/S0168-1605(99)00006-9
   Roller S, 2000, J FOOD PROTECT, V63, P202, DOI 10.4315/0362-028X-63.2.202
   Srinivasa PC, 2004, J FOOD ENG, V63, P79, DOI 10.1016/S0260-8774(03)00285-1
   Torres-Giner S, 2008, ENG LIFE SCI, V8, P303, DOI 10.1002/elsc.200700066
   Tsai HS, 2008, POLYM BULL, V60, P103, DOI 10.1007/s00289-007-0846-x
   Yingyuad S, 2006, PACKAG TECHNOL SCI, V19, P149, DOI 10.1002/pts.717
   ZOKIN MA, 2004, POLYM SCI, V46, P39
NR 34
TC 38
Z9 39
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD APR 22
PY 2009
VL 57
IS 8
BP 3298
EP 3307
DI 10.1021/jf8037709
PG 10
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 433TB
UT WOS:000265227600042
PM 19281273
DA 2018-10-19
ER

PT J
AU Bengali, Z
   Rea, JC
   Gibly, RF
   Shea, LD
AF Bengali, Zain
   Rea, Jennifer C.
   Gibly, Romic F.
   Shea, Lonnie D.
TI Efficacy of Immobilized Polyplexes and Lipoplexes for Substrate-Mediated
   Gene Delivery
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE gene delivery; reverse transfection; surface delivery; polyethylenimine
   (PEI); lipoplex; substratemediated
ID TRANSFECTED CELL MICROARRAYS; SELF-ASSEMBLED MONOLAYERS; DNA DELIVERY;
   IN-VIVO; INTRACELLULAR TRAFFICKING; POLYMER STRUCTURE; MAMMALIAN-CELLS;
   SURFACE; COMPLEXES; EXPRESSION
AB Non-viral gene delivery by immobilization of complexes to cell-adhesive biomaterials, a process termed substrate-mediated delivery, has many in vitro research applications Such as transfected cell arrays or models of tissue growth. In this report, we quantitatively investigate the efficiency of gene delivery by surface immobilization, and compare this efficiency to the more typical bolus delivery. The ability to immobilize vectors while allowing cellular internalization is impacted by the biomaterial and vector properties. Thus, to compare this efficiency between vector types and delivery methods, transfection conditions were initially identified that maximized transgene expression. For surface delivery from tissue culture polystyrene, DNA complexes were immobilized to pre-adsorbed serum proteins prior to cell seeding, while for bolus delivery, complexes were added to the media above adherent cells. Mathematical modeling of vector binding, release, and cell association using a two-site model indicated that the kinetics of polyplex binding to cells was faster than for lipoplexes, yet both vectors have a half-life on the surface of approximately 17 min. For bolus and surface delivery, the majority of the DNA in the system remained in solution or on the surface, respectively. For polyplexes, the efficiency of trafficking of cell-associated polyplexes to the nucleus for surface delivery is similar or less than bolus delivery, suggesting that surface immobilization may decrease the activity of the complex. The efficiency of nuclear association for cell-associated lipoplexes is similar or greater for surface delivery relative to bolus. These studies suggest that strategies to enhance surface delivery for polyplexes should target the vector design to enhance its potency, whereas enhancing lipoplex delivery should target the material design to increase internalization.
C1 [Rea, Jennifer C.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Bengali, Zain; Gibly, Romic F.] Northwestern Univ, Dept Interdepartmental Biol Sci, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Laurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
OI Rea, Jennifer/0000-0002-7405-6790
FU NIGMS NIH HHS [R01 GM066830-05, R01 GM066830, GM066830]; NIBIB NIH HHS
   [R01 EB003806, R01 EB003806-04, EB003806]
CR Akita H, 2004, MOL THER, V9, P443, DOI 10.1016/j.ymthe.2004.01.005
   Bailey SN, 2002, DRUG DISCOV TODAY, V7, pS113, DOI 10.1016/S1359-6446(02)02386-3
   Bengali Z, 2005, MRS BULL, V30, P659, DOI 10.1557/mrs2005.193
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Chang FH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh029
   Clamme JP, 2003, BIOPHYS J, V84, P1960, DOI 10.1016/S0006-3495(03)75004-8
   Dash PR, 1999, GENE THER, V6, P643, DOI 10.1038/sj.gt.3300843
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Hama S, 2006, MOL THER, V13, P786, DOI 10.1016/j.ymthe.2005.10.007
   Honma K, 2001, BIOCHEM BIOPH RES CO, V289, P1075, DOI 10.1006/bbrc.2001.6133
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   James MB, 2000, MOL THER, V1, P339, DOI 10.1006/mthe.2000.0054
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   King KR, 2007, LAB CHIP, V7, P77, DOI 10.1039/b612516f
   Lai E, 2002, J CONTROL RELEASE, V82, P149, DOI 10.1016/S0168-3659(02)00104-9
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Moriguchi R, 2006, J CONTROL RELEASE, V110, P605, DOI 10.1016/j.jconrel.2005.10.021
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pannier AK, 2008, ACTA BIOMATER, V4, P26, DOI 10.1016/j.actbio.2007.08.008
   Pannier AK, 2007, BIOTECHNOL BIOENG, V98, P486, DOI 10.1002/bit.21477
   Rea JC, 2008, J PHARM SCI-US, V97, P4794, DOI 10.1002/jps.21338
   Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Schaffer DV, 1998, J BIOL CHEM, V273, P28004, DOI 10.1074/jbc.273.43.28004
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Silva JM, 2004, P NATL ACAD SCI USA, V101, P6548, DOI 10.1073/pnas.0400165101
   Tachibana R, 2002, PHARMACEUT RES, V19, P377, DOI 10.1023/A:1015162722295
   Vanhecke D, 2004, ONCOGENE, V23, P8353, DOI 10.1038/sj.onc.1208027
   Varga CM, 2005, GENE THER, V12, P1023, DOI 10.1038/sj.gt.3302495
   Webb BL, 2003, J BIOMOL SCREEN, V8, P620, DOI 10.1177/1087057103259324
   Wheeler DB, 2005, NAT GENET, V37, pS25, DOI 10.1038/ng1560
   Wiethoff CM, 2003, J PHARM SCI, V92, P203, DOI 10.1002/jps.10286
   Yamauchi F, 2004, BBA-GEN SUBJECTS, V1672, P138, DOI 10.1016/j.bbagen.2004.03.008
   Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 44
TC 26
Z9 27
U1 1
U2 21
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD APR 15
PY 2009
VL 102
IS 6
BP 1679
EP 1691
DI 10.1002/bit.22212
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 422MX
UT WOS:000264433500015
PM 19148921
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhou, ZY
   Huang, HT
   Xu, PH
   Fan, LH
   Yu, JH
   Huang, J
AF Zhou, Ziyan
   Huang, Haitao
   Xu, Peihu
   Fan, Lihong
   Yu, Jiahui
   Huang, Jin
TI Simultaneous Enhancement of the Strength and Elongation of
   Polycaprolactone: The Role of Chitosan-graft-Polycaprolactone
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE blends; graft copolymers; mechanical properties
ID TISSUE ENGINEERING APPLICATIONS; EPSILON-CAPROLACTONE;
   STARCH-POLYCAPROLACTONE; BIODEGRADABLE POLYMERS; BLENDING CHITOSAN;
   COPOLYMERS; SCAFFOLDS; POLYSACCHARIDES; CHEMISTRY; MEMBRANE
AB Polycaprolactone (PCL) is a basic substance for biomedical materials and especially for scaffolds in tissue engineering. To improve the performance of PCL-based materials, we filled a PCL matrix with a biocompatible polysaccharide-grafted PCL, chitosan-g-polycaprolactone (CS-g-PCL). The results showed that the strength, elongation, and Young's modulus of the resultant composites were simultaneously enhanced in contrast with those of neat PCL. The structures of the PCL/CS-g-PCL blends were investigated with Fourier transform infrared, X-ray diffraction, differential scanning calorimetry, dynamic mechanical analysis, and scanning electron microscopy, and the effects of the chitosan (CS) content in CS-g-PCL and the CS-g-PCL content in the blends on the mechanical properties and structures of the blends were examined. The rigidity of CS chains and the increasing crystallinity induced by the nucleation of CS-g-PCL contributed to the enhancement of the strength, whereas the cocontinuous interfacial structure and improved miscibility between CS and PCL matrix mediated with grafted PCL chains greatly enhanced the elongation of the composite materials. This work presents a strategy for enhancing the mechanical performance of PCL as a biomaterial. (C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 112:692-699, 2009
C1 [Zhou, Ziyan; Yu, Jiahui; Huang, Jin] E China Normal Univ, Coll New Drug Innovat Res & Dev, Shanghai 200062, Peoples R China.
   [Zhou, Ziyan; Huang, Haitao; Xu, Peihu; Fan, Lihong; Huang, Jin] Wuhan Univ Technol, Coll Chem Engn, Wuhan 430070, Peoples R China.
   [Zhou, Ziyan; Huang, Haitao; Xu, Peihu; Fan, Lihong; Huang, Jin] Wuhan Univ Technol, Affiliated Hosp, Wuhan 430070, Peoples R China.
   [Huang, Jin] Chinese Acad Sci, Key Lab Cellulose & Lignocellulos Chem, Guangzhou Inst Chem, Guangzhou 510650, Guangdong, Peoples R China.
RP Yu, JH (reprint author), E China Normal Univ, Coll New Drug Innovat Res & Dev, Shanghai 200062, Peoples R China.
EM yujh109@yahoo.com.cn; huangjin@iccas.ac.cn
RI Yu, Jiahui/A-8382-2015; Huang, Jin/E-4537-2011
FU National Nature Science Foundation of China [20504010, 50843031]; Youth
   Chenguang Program of Science and Technology in Wuhan [200850731383];
   Chinese Ministry of Science and Technology [2009CB930000]; State Key
   Laboratory of Pulp and Paper Engineering; South China University of
   Technology [200514, 200716]; Key Laboratory of Cellulose and
   Lignocellulosics Chemistry; Guangzhou Institute of Chemistry; Chinese
   Academy of Sciences [LCLC-2005-172, LCLC-2008-02]
FX Contract grant sponsor: Key Laboratory of Cellulose and Lignocellulosics
   Chemistry, Guangzhou Institute of Chemistry, Chinese Academy of
   Sciences; contract grant numbers: LCLC-2005-172 and LCLC-2008-02.
CR Allen C, 2000, J CONTROL RELEASE, V63, P275, DOI 10.1016/S0168-3659(99)00200-X
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Averous L, 2000, POLYMER, V41, P4157, DOI 10.1016/S0032-3861(99)00636-9
   BASTIOLI C, 1995, J ENVIRON POLYM DEGR, V3, P81, DOI 10.1007/BF02067484
   Cascone MG, 2001, J BIOMAT SCI-POLYM E, V12, P267, DOI 10.1163/156856201750180807
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   Cruz DMG, 2008, J BIOMED MATER RES B, V85B, P303, DOI 10.1002/jbm.b.30947
   Feng H, 2006, J POLYM SCI POL CHEM, V44, P5353, DOI 10.1002/pola.21625
   Guan XP, 2007, J POLYM SCI POL CHEM, V45, P2556, DOI 10.1002/pola-22015
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Liu L, 2004, EUR POLYM J, V40, P2739, DOI 10.1016/j.eurpolymj.2004.07.016
   Liu L, 2005, BIOPOLYMERS, V78, P163, DOI 10.1002/bip.20261
   Liu L, 2005, CARBOHYD POLYM, V60, P351, DOI 10.1016/j.carbpol.2005.01.009
   Liu L, 2006, MACROMOL RAPID COMM, V27, P1988, DOI 10.1002/marc.200600508
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   Muzzarelli RAA, 2005, ADV POLYM SCI, V186, P151, DOI 10.1007/b136820
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Sarasam AR, 2007, MACROMOL BIOSCI, V7, P1160, DOI 10.1002/mabi.200700001
   Sarasam AR, 2006, BIOMACROMOLECULES, V7, P1131, DOI 10.1021/bm050935d
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   She HD, 2007, J MATER SCI, V42, P8113, DOI 10.1007/s10853-007-1706-7
   Tan PS, 2007, MAT SCI ENG C-BIO S, V27, P304, DOI 10.1016/j.msec.2006.03.010
   Woei K, 2001, TISSUE ENG, V7, P441, DOI 10.1089/10763270152436490
   WU CS, 2005, POLYMER, V46, P1147
   Yu HJ, 2006, BIOPOLYMERS, V83, P233, DOI 10.1002/bip.20551
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 30
TC 4
Z9 4
U1 0
U2 21
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 15
PY 2009
VL 112
IS 2
BP 692
EP 699
DI 10.1002/app.29432
PG 8
WC Polymer Science
SC Polymer Science
GA 412YW
UT WOS:000263761100014
DA 2018-10-19
ER

PT J
AU Sun, H
   Wu, ZW
AF Sun, Hui
   Wu, Zhongwen
TI Micropatterning functional groups on polymer surfaces via masked
   vapor-phase photografting
SO MATERIALS LETTERS
LA English
DT Article
DE Polymer; Surface; Nanostructures; Photografting
ID SOFT LITHOGRAPHY; POLY(ETHYLENE-TEREPHTHALATE); CAPILLARIES; ACRYLAMIDE
AB Controlling cell behavior oil biomaterial surface is the ultimate goal of cell and tissue engineering. Fabrication of biomaterials with alternatively hydrophilic/hydrophobic surface of parallel nanopatterned groves can provide biomaterial surfaces for the study of cell-surface interactions. In the present communication, masked vapor-phase photografting was used in patterning functional groups on flat polymeric substrates using poly (dimethylsiloxane) (PDMS) channels. Surface patterns were fabricated by W-initiated photografting in the presence of a patterned PDMS mask. The approach is exemplified by patterning maleic anhydride (MAH) and acrylamide (AAm) onto poly (methyl methacrylate) (PMMA). The method offers another means to chemically functionalize and pattern polymer surface at the same time. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Sun, Hui] Royal Inst Technol, Sch Chem Sci & Engn, Dept Fibre & Polymer Technol, SE-10044 Stockholm, Sweden.
   [Wu, Zhongwen] Jilin Univ, Coll Chem, Changchun 130023, Peoples R China.
RP Sun, H (reprint author), Royal Inst Technol, Sch Chem Sci & Engn, Dept Fibre & Polymer Technol, SE-10044 Stockholm, Sweden.
EM cnhsun@yahoo.com; rcsep@jlu.edu.cn
CR Bietsch A, 2000, J APPL PHYS, V88, P4310, DOI 10.1063/1.1289816
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297
   Edlund U, 2005, ISR J CHEM, V45, P429, DOI 10.1560/BY1J-CGHN-7MF4-QX85
   Hui S, 2004, BIOMACROMOLECULES, V5, P2275, DOI 10.1021/bm049703p
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   REFOJO MF, 1966, BIOMATERIALS SCI INT, P329
   Wirsen A, 2005, BIOMACROMOLECULES, V6, P2697, DOI 10.1021/bm050169a
   Wirsen A, 2005, BIOMACROMOLECULES, V6, P2281, DOI 10.1021/bm050170+
   Wirsen A, 2005, POLYMER, V46, P4554, DOI 10.1016/j.polymer.2005.03.074
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xia YN, 1996, CHEM MATER, V8, P1558, DOI 10.1021/cm9602196
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
NR 15
TC 2
Z9 2
U1 2
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 15
PY 2009
VL 63
IS 9-10
BP 729
EP 731
DI 10.1016/j.matlet.2008.12.032
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 419RW
UT WOS:000264238200001
DA 2018-10-19
ER

PT J
AU Onoki, T
   Wang, XM
   Zhu, SL
   Sugiyama, N
   Hoshikawa, Y
   Akao, M
   Matsushita, N
   Nakahira, A
   Yasuda, E
   Yoshimura, M
   Inoue, A
AF Onoki, Takamasa
   Wang, Xinmin
   Zhu, Shengli
   Sugiyama, Naota
   Hoshikawa, Yasuto
   Akao, Masaru
   Matsushita, Nobuhiro
   Nakahira, Atsushi
   Yasuda, Eiichi
   Yoshimura, Masahiro
   Inoue, Akihisa
TI Effects of growing integrated layer [GIL] formation on bonding behavior
   between hydroxyapatite ceramics and Ti-based bulk metallic glasses via
   hydrothermal hot-pressing
SO MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE
   MATERIALS
LA English
DT Article; Proceedings Paper
CT Joint Meeting of the 2nd International Conference on the Science and
   Technology for Advanced Ceramics/1st International Conference on the
   Science and Technology of Solid Surfaces and Interfaces
CY MAY 30-JUN 01, 2008
CL Chiba, JAPAN
DE Biomaterials; Ceramics coatings; Hydrothermal; Electrochemical; Low
   temperature
ID TITANIUM
AB The authors successfully formed a bond between bioactive hydroxyapatite (HA) ceramics and titanium (Ti)-based bulk metallic glasses (Ti(40)Zr(10)Cu(36)Pd(14): BMG) through a growing integrated layer (GIL) to develop a new type of biomaterial. The GILs were formed on the BMG surfaces by hydrothermal-electrochemical (HE) techniques. The BMG substrates were treated in a 5 mol/L NaOH solution at 90 degrees C for 10- 120 min while a constant electric current of 0.5 mA/cm(2) was maintained between the electrodes. Then the BMG disks with the GIL and a powder mixture of CaHPO(4)center dot 2H(2)O and Ca(OH)(2) were simultaneously treated with an autoclave for hydrothermal hot-pressing (HHP) (150 degrees C, 40 MPa, 2 h). Direct bonding between the HA ceramics and the BMG disks could be achieved through the above processing method. Consequently, to the best of our knowledge, this is the first demonstration of the usefulness of a series of hydrothermal techniques (HE and HHP) for direct bonding of bulk ceramics and bulk metallic materials. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Onoki, Takamasa; Nakahira, Atsushi] Osaka Prefecture Univ, Grad Sch Engn, Dept Mat Sci, Naka Ku, Osaka 5998531, Japan.
   [Wang, Xinmin; Zhu, Shengli; Yoshimura, Masahiro; Inoue, Akihisa] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
   [Sugiyama, Naota; Hoshikawa, Yasuto; Akao, Masaru; Matsushita, Nobuhiro; Yasuda, Eiichi; Yoshimura, Masahiro] Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.
RP Onoki, T (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Mat Sci, Naka Ku, 1-1 Gakuen Cho, Osaka 5998531, Japan.
EM onoki@mtr.osakafu-u.ac.jp
RI Matsushita, Nobuhiro/F-9416-2014; Inoue, Akihisa/E-5271-2015; zhu,
   shengli/A-8818-2011; Zhu, Shengli/D-5281-2009; Yoshimura,
   Masahiro/H-5938-2011
OI Zhu, Shengli/0000-0002-0190-2626; Yoshimura,
   Masahiro/0000-0003-1810-0301
CR Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051
   Bavykin DV, 2006, ADV MATER, V18, P2807, DOI 10.1002/adma.200502696
   GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Li BY, 2000, INTERMETALLICS, V8, P643, DOI 10.1016/S0966-9795(99)00140-5
   Onoki T, 2005, SCRIPTA MATER, V52, P767, DOI 10.1016/j.scriptamat.2004.12.011
   Onoki T, 2008, J CERAM SOC JPN, V116, P115, DOI 10.2109/jcersj2.116.115
   Yoshimura M, 2008, MATER SCI ENG B-ADV, V148, P2, DOI 10.1016/j.mseb.2007.09.080
   Zhu SL, 2007, MAT SCI ENG A-STRUCT, V459, P233, DOI 10.1016/j.msea.2007.01.044
NR 9
TC 10
Z9 10
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-5107
J9 MATER SCI ENG B-ADV
JI Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.
PD APR 15
PY 2009
VL 161
IS 1-3
BP 27
EP 30
DI 10.1016/j.mseb.2008.11.011
PG 4
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 464OS
UT WOS:000267515400007
DA 2018-10-19
ER

PT J
AU Zhao, QS
   Ji, QX
   Xing, K
   Li, XY
   Liu, CS
   Chen, XG
AF Zhao, Qing Sheng
   Ji, Qiu Xia
   Xing, Ke
   Li, Xiao Yan
   Liu, Cheng Sheng
   Chen, Xi Guang
TI Preparation and characteristics of novel porous hydrogel films based on
   chitosan and glycerophosphate
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; Glycerophosphate; Hydrogel films; Protein adsorption; Cell
   culture
ID IN-SITU; THERMOSENSITIVE HYDROGEL; PROTEIN ADSORPTION; MOLECULAR-WEIGHT;
   DELIVERY-SYSTEM; BIOCOMPATIBILITY; BIOMATERIAL; MEMBRANES; GROWTH; CELLS
AB In this study, we prepared thermosensitive hydrogels by adding alpha-beta-glycerophosphate (alpha-beta-GP) to chitosan (CS) solutions. Then the hydrogels were dried to form films at room temperature. Scanning electron microscope (SEM) revealed that the hydrogel films had rough surfaces and porous cross-sections. Compared with pure chitosan films, the CS/GP hydrogel films showed better elasticity and lower tensile strength. Contact angle studies indicated that all these materials have good hydrophilicity. The CS/GP hydrogel films exhibited higher protein adsorption against both negatively charged protein (bovine serum albumin) and positively charged protein (lysozyme) than pure chitosan films. The results of MTT assay performed with the extracts of the CS/GP hydrogel films revealed the films had nontoxicity. The mouse embryonic fibroblast cells Cultured on the CS/GP hydrogel films had good spreading and no apparent impairment of cell morphology. The results indicated that the CS/GP hydrogel film could be a promising candidate biomaterial for biomedicine applications. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhao, Qing Sheng; Xing, Ke; Li, Xiao Yan; Liu, Cheng Sheng; Chen, Xi Guang] Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China.
   [Ji, Qiu Xia] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266001, Peoples R China.
RP Chen, XG (reprint author), Ocean Univ China, Coll Marine Life Sci, 5 Yushan Rd, Qingdao 266003, Peoples R China.
EM xgchen@ouc.edu.cn
RI Liu, Chengsheng/L-5296-2018
OI Liu, Chengsheng/0000-0002-1454-0193
FU Ministry of Education of the People's Republic of China [20070423013];
   Natural Science Foundation of Shandong Province [Y2006C110]
FX We thank the financial support of Ministry of Education of the People's
   Republic of China (20070423013) and the Natural Science Foundation of
   Shandong Province (No. Y2006C110).
CR Arpornmaeklong P, 2007, INT J ORAL MAX SURG, V36, P328, DOI 10.1016/j.ijom.2006.09.023
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   Burns NL, 1996, J COLLOID INTERF SCI, V178, P116, DOI 10.1006/jcis.1996.0099
   Chen XG, 2002, J AGR FOOD CHEM, V50, P5915, DOI 10.1021/jf020151g
   Chen XG, 2006, BIOCHEM ENG J, V27, P269, DOI 10.1016/j.bej.2005.08.021
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Deng CM, 2007, CARBOHYD POLYM, V69, P583, DOI 10.1016/j.carbpol.2007.01.014
   Gariepy E. R., 2004, EUR J PHARM BIOPHARM, V58, P409
   Guo TY, 2005, BIOMATERIALS, V26, P5737, DOI 10.1016/j.biomaterials.2005.02.017
   Kaufmann PM, 1997, TRANSPLANT P, V29, P2032, DOI 10.1016/S0041-1345(97)00218-2
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   LI JC, 1999, TSINGHUA SCI TECHNOL, V4, P1515
   Liu CX, 2005, J MEMBRANE SCI, V267, P68, DOI 10.1016/j.memsci.2005.06.001
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mironov V, 2005, BIOMATERIALS, V26, P7628, DOI 10.1016/j.biomaterials.2005.05.061
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Park YJ, 1997, J CONTROL RELEASE, V43, P151, DOI 10.1016/S0168-3659(96)01494-0
   Peng ZG, 2004, J COLLOID INTERF SCI, V271, P277, DOI 10.1016/j.jcis.2003.12.022
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Sharma G, 2007, J CONTROL RELEASE, V118, P27, DOI 10.1016/j.jconrel.2006.11.026
   Wan Y, 2003, POLYMER, V44, P1057, DOI 10.1016/S0032-3861(02)00881-9
   Wang A, 2006, TSINGHUA SCI TECHNOL, V11, P415
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu J, 2006, INT J PHARM, V315, P1, DOI 10.1016/j.ijpharm.2006.01.045
   Wu J, 2007, BIOMATERIALS, V28, P2220, DOI 10.1016/j.biomaterials.2006.12.024
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
   Ye X, 2006, CARBOHYD POLYM, V64, P532, DOI 10.1016/j.carbpol.2005.11.005
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhou HY, 2008, CARBOHYD POLYM, V73, P265, DOI 10.1016/j.carbpol.2007.11.026
NR 34
TC 46
Z9 48
U1 5
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 9
PY 2009
VL 76
IS 3
BP 410
EP 416
DI 10.1016/j.carbpol.2008.11.020
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 438XT
UT WOS:000265590400008
DA 2018-10-19
ER

PT J
AU Costa, ES
   Barbosa-Stancioli, EF
   Mansur, AAP
   Vasconcelos, WL
   Mansur, HS
AF Costa-Junior, Ezequiel S.
   Barbosa-Stancioli, Edel F.
   Mansur, Alexandra A. P.
   Vasconcelos, Wander L.
   Mansur, Herman S.
TI Preparation and characterization of chitosan/poly(vinyl alcohol)
   chemically crosslinked blends for biomedical applications
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Biomaterial; Hydrogel; Biopolymer; Chitosan; Poly(vinyl alcohol);
   Chemical crosslinking
ID X-RAY-DIFFRACTION; POLY(VINYL ALCOHOL); CHITOSAN MEMBRANES;
   CONTROLLED-RELEASE; MECHANICAL-BEHAVIOR; PHYSICAL-PROPERTIES; FTIR
   SPECTROSCOPY; SCAFFOLD DESIGN; HYDROGELS; GLUTARALDEHYDE
AB in this study the development and characterization of novel polymer blends based on chitosan and poly (vinyl alcohol) and chemically crosslinked by glutaraldehyde for possible use in a variety of biomedical applications is reported. Mechanical properties of hybrids were evaluated by stress-strain tensile tests. Also, the microstructure, morphology and crystallinity of the blended hydrogels were characterized through X-ray diffraction, Fourier transform infrared spectroscopy and scanning electron microscopy analysis. Moreover, biocompatibility, cytotoxicity and cell viability were also performed by swelling test in simulated body fluid, MTT assay with cell culture. The relative crystallinity of pure chitosan film was reduced from approximately 23% to 18% when the polymeric network was reticulated by glutaraldehyde. A similar trend was also observed for PVA films. It was found that by increasing the chitosan content relative to PVA the swelling index of the blend has decreased from about 200% (pure PVA) to approximately 80% (50/50 chitosan/PVA), reflecting the reduction in the mobility of the polymer network and the hydrophilic behavior of the blend. The mechanical properties of the polymers were also significantly altered by changing blend composition and chemical crosslinking. Chitosan films have shown values of 50 MPa and 45% for maximum tensile strength and tensile elongation, respectively. It was verified that the average blend toughness has decreased about 40% by increasing the chitosan concentration from 25% (14.8 MJ/m(3)) to 50% (8.9 MJ/m(3)) related to a brittle characteristic of chitosan. In addition, the obtained results of elastic moduli were 0.1 GPa for PVA and 0.8 GPa for chitosan. The tested hydrogels clearly show adequate cell viability, non-toxicity and suitable mechanical properties which can be tailored to for potential use in skin engineering applications. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Mansur, Alexandra A. P.; Vasconcelos, Wander L.; Mansur, Herman S.] Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-30160030 Belo Horizonte, MG, Brazil.
   [Costa-Junior, Ezequiel S.] CEFET, Mech Technol Ctr, Belo Horizonte, MG, Brazil.
   [Barbosa-Stancioli, Edel F.] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Rua Espirito Santo,35 Sala 316, BR-30160030 Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br
OI Mansur, Alexandra/0000-0003-1526-2508; Mansur,
   Herman/0000-0002-3032-495X
FU National Council for Scientific and Technological Development (CNPq);
   State of Minas Gerais Research Foundation (FAPEMIG)
FX The author acknowledges National Council for Scientific and
   Technological Development (CNPq) and State of Minas Gerais Research
   Foundation (FAPEMIG) for financial support on this work. E.S. Costa Jr.
   thanks CEFET-MG for supporting academic activities during the PhD
   graduate term. Authors also thank Mr. Mateus Laguardia for conducting
   MTT laboratory protocols.
CR Andrade G, 2006, BIOMED MATER, V1, P221, DOI 10.1088/1748-6041/1/4/008
   [Anonymous], 2002, D88202 ASTM
   Arvanitoyannis I, 1997, CARBOHYD POLYM, V34, P9, DOI 10.1016/S0144-8617(97)00089-1
   Arvanitoyannis IS, 1999, J MACROMOL SCI R M C, VC39, P205
   Bahrami SB, 2003, IRAN POLYM J, V12, P139
   Beppu MM, 2007, J MEMBRANE SCI, V301, P126, DOI 10.1016/j.memsci.2007.06.015
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   BUNN CW, 1948, NATURE, V161, P929, DOI 10.1038/161929a0
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   CERVERA MM, 2004, AAPS PHARMSCITECH, V5, P1
   Chen RH, 1996, CARBOHYD POLYM, V29, P353
   Cho JD, 1999, MACROMOLECULES, V32, P6236, DOI 10.1021/ma9908402
   Clapper JD, 2007, POLYMER, V48, P6554, DOI 10.1016/j.polymer.2007.08.023
   Clark GL, 1936, J PHYS CHEM-US, V40, P863, DOI 10.1021/j150376a001
   COSTA ESC, 2007, AN 9 C BRAS POL CAMP, V86
   Costa ED, 2008, QUIM NOVA, V31, P1460, DOI 10.1590/S0100-40422008000600034
   Costa H, 2008, KEY ENG MAT, V361-363, P289, DOI 10.4028/www.scientific.net/KEM.361-363.289
   Costa HS, 2008, J MATER SCI, V43, P510, DOI 10.1007/s10853-007-1849-6
   Costa HS, 2008, J MATER SCI, V43, P494, DOI 10.1007/s10853-007-1875-4
   Costa Vilma Conceição, 2007, Mat. Res., V10, P21, DOI 10.1590/S1516-14392007000100006
   Cowin SC, 2000, J BIOMECH ENG-T ASME, V122, P553, DOI 10.1115/1.1324665
   Davis KA, 2002, CRIT REV THER DRUG, V19, P385, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.30
   Don TM, 2006, CARBOHYD POLYM, V63, P331, DOI 10.1016/j.carbpol.2005.08.023
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   DUNN GA, 1995, J CELL SCI, V108, P1239
   GRUPTA KC, 2007, CARBOHYD RES, V342, P2244
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Lavik EB, 2005, BIOMATERIALS, V26, P3187, DOI 10.1016/j.biomaterials.2004.08.022
   Liu HF, 2005, J BIOMATER APPL, V19, P303, DOI 10.1177/0885328205048590
   Mansur HS, 2007, SOLID STATE PHENOMEN, V121-123, P855, DOI 10.4028/www.scientific.net/SSP.121-123.855
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Mansur HS, 2008, CHEM ENG J, V137, P72, DOI 10.1016/j.cej.2007.09.036
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   MAZEAU K, 1994, MACROMOLECULES, V27, P7606, DOI 10.1021/ma00104a015
   Muzzarelli C, 2002, J INORG BIOCHEM, V92, P89, DOI 10.1016/S0162-0134(02)00486-5
   OGAWA K, 1992, BIOSCI BIOTECH BIOCH, V56, P858, DOI 10.1271/bbb.56.858
   Ogawa K, 2004, INT J BIOL MACROMOL, V34, P1, DOI 10.1016/j.ijbiomac.2003.11.002
   Okuyama K, 1999, INT J BIOL MACROMOL, V26, P285, DOI 10.1016/S0141-8130(99)00095-1
   Orefice RL, 2000, J BRAZIL CHEM SOC, V11, P78, DOI 10.1590/S0103-50532000000100014
   Peppas NA, 1997, EUR J PHARM BIOPHARM, V43, P51, DOI 10.1016/S0939-6411(96)00010-0
   Rao KSVK, 2006, CARBOHYD POLYM, V66, P333, DOI 10.1016/j.carbpol.2006.03.025
   Rao PS, 2007, IND ENG CHEM RES, V46, P2155, DOI 10.1021/ie061268n
   Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q
   Rokhade AP, 2007, CARBOHYD POLYM, V67, P605, DOI 10.1016/j.carbpol.2006.07.001
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang DA, 2004, ADV FUNCT MATER, V14, P1152, DOI 10.1002/adfm.200305018
   Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461
   Xu F, 2008, J MECH BEHAV BIOMED, V1, P172, DOI 10.1016/j.jmbbm.2007.09.001
   Zhang YY, 2007, COLLOID POLYM SCI, V285, P855, DOI 10.1007/s00396-006-1630-4
NR 54
TC 221
Z9 229
U1 18
U2 137
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 9
PY 2009
VL 76
IS 3
BP 472
EP 481
DI 10.1016/j.carbpol.2008.11.015
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 438XT
UT WOS:000265590400018
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Spanninga, SA
   Martin, DC
   Chen, Z
AF Spanninga, Sarah A.
   Martin, David C.
   Chen, Zhan
TI X-ray Photoelectron Spectroscopy Study of Counterion Incorporation in
   Poly(3,4-ethylenedioxythiophene)
SO JOURNAL OF PHYSICAL CHEMISTRY C
LA English
DT Article
ID NEURAL MICROELECTRODE ARRAYS; CHEMICAL-VAPOR-DEPOSITION;
   ELECTRONIC-STRUCTURE; PEDOT-PSS; POLY 3,4-ETHYLENEDIOXYTHIOPHENE;
   ELECTROCHEMICAL DEPOSITION; ELECTRICAL-CONDUCTIVITY; SURFACE-REACTIONS;
   BIOSENSOR; FILMS
AB Poly(3,4-ethylenedioxythiophene) (PEDOT) is widely used in organic electronics and biomaterial coatings because of its outstanding electrical properties and chemical stability. In this research, X-ray photoelectron spectroscopy (XPS) was used to investigate incorporation of different counterions during electrochemical polymerization into PEDOT. The counterions probed included both a polyanion, poly(sodium 4-styrene-sulfonate) (PSSNa), and small anions including lithium perchlorate, sodium chloride, and sodium phosphate monobasic monohydrate. In addition to these counterions, an ion mixture, phosphate-buffered saline solution (PBS), was also examined. For such mixtures, the chlorine anion from sodium chloride was found to act as the counterion during PEDOT electrochemical polymerization in PBS solution. This is important because PEDOT is being considered for biomedical applications, which may be prepared in the presence of PBS or other mixtures of ions. Various mixtures of PSSNa, lithium perchlorate, sodium p-toluenesulfonate (TosNa) and PBS counterions were investigated. We detected that the polyanion, PSS-, preferentially incorporated into PEDOT in comparison to ClO4- and Cl- anions when ion mixtures were used. Results were supplemented by those obtained via other analytical techniques including electrochemical impedance spectroscopy, cyclic voltammetry, and scanning electron microscopy.
C1 [Spanninga, Sarah A.; Martin, David C.; Chen, Zhan] Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
   [Martin, David C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Martin, David C.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Chen, Zhan] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Chen, Z (reprint author), Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
EM zhanc@umich.edu
RI Martin, David/B-1838-2008; Chen, Zhan/G-8312-2016
OI Martin, David/0000-0003-1195-3838; Chen, Zhan/0000-0001-8687-8348
FU MURI: Bio-Integrated Structural and Neural Prosthetic Materials; NSF
   Career Award
FX We thank Dr. Sarah Richardson-Burns for assistance with electrochemical
   deposition, EIS, and CV on cochlear electrodes, as well as Dr. Kai Sun
   and Dr. Haiping Sun at the University of Michigan Electron Microbeam,
   Analysis Laboratory (EMAL). Funding was provided by the MURI:
   Bio-Integrated Structural and Neural Prosthetic Materials for D.C.M. and
   by an NSF Career Award for Z.C.
CR Barisci JN, 1998, ANAL CHIM ACTA, V371, P39, DOI 10.1016/S0003-2670(98)00277-3
   Beamson G., 1992, HIGH RESOLUTION XPS
   BRIGGS D, 1993, ANAL CHEM, V65, P1517, DOI 10.1021/ac00059a006
   BRIGGS D, 1990, PRACTICAL ANAL, V1
   Briggs D., 1998, SURFACE ANAL POLYM X
   Campbell TE, 1999, ELECTROANAL, V11, P215, DOI 10.1002/(SICI)1521-4109(199904)11:4<215::AID-ELAN215>3.0.CO;2-#
   Crispin X, 2003, J POLYM SCI POL PHYS, V41, P2561, DOI 10.1002/polb.10659
   Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   DIETRICH M, 1994, J ELECTROANAL CHEM, V369, P87, DOI 10.1016/0022-0728(94)87085-3
   Fabiano S, 2002, MAT SCI ENG C-BIO S, V21, P61, DOI 10.1016/S0928-4931(02)00060-7
   GELIUS U, 1971, PHYS SCRIPTA, V3, P237, DOI 10.1088/0031-8949/3/5/008
   Gooding JJ, 2004, BIOSENS BIOELECTRON, V20, P260, DOI 10.1016/j.bios.2004.01.010
   Greczynski G, 1999, THIN SOLID FILMS, V354, P129, DOI 10.1016/S0040-6090(99)00422-8
   Greczynski G, 2001, J ELECTRON SPECTROSC, V121, P1, DOI 10.1016/S0368-2048(01)00323-1
   Groenendaal BL, 2000, ADV MATER, V12, P481, DOI 10.1002/(SICI)1521-4095(200004)12:7<481::AID-ADMA481>3.0.CO;2-C
   Heeg J, 2001, APPL SURF SCI, V180, P36, DOI 10.1016/S0169-4332(01)00316-6
   Hong KH, 2005, J APPL POLYM SCI, V97, P1326, DOI 10.1002/app.21835
   Im SG, 2007, SURF COAT TECH, V201, P9406, DOI 10.1016/j.surfcoat.2007.04.081
   Jonsson SKM, 2004, J ELECTRON SPECTROSC, V137, P805, DOI 10.1016/j.elspec.2004.02.120
   Jonsson SKM, 2003, J PHYS CHEM B, V107, P10793, DOI 10.1021/jp034249p
   Jonsson SKM, 2003, SYNTHETIC MET, V139, P1, DOI 10.1016/S0379-6779(02)01259-6
   KANG ET, 1990, MACROMOLECULES, V23, P2918, DOI 10.1021/ma00213a018
   KANG ET, 1991, PHYS REV B, V44, P10461, DOI 10.1103/PhysRevB.44.10461
   Khan MA, 2000, LANGMUIR, V16, P4171, DOI 10.1021/la991390+
   Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594
   Kim TY, 2006, POLYM INT, V55, P80, DOI 10.1002/pi.1921
   Kros A, 2001, ADV MATER, V13, P1555, DOI 10.1002/1521-4095(200110)13:20<1555::AID-ADMA1555>3.0.CO;2-7
   Lee CS, 2005, SENSOR ACTUAT A-PHYS, V121, P373, DOI 10.1016/j.sna.2005.03.005
   Li XH, 2004, J PHYS CHEM B, V108, P5192, DOI 10.1021/jp0356618
   Lock JP, 2006, MACROMOLECULES, V39, P5326, DOI 10.1021/ma060113o
   Marciniak S, 2004, SYNTHETIC MET, V141, P67, DOI 10.1016/j.synthemet.2003.08.017
   MORGAN WE, 1973, J AM CHEM SOC, V95, P751, DOI 10.1021/ja00784a018
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Nguyen TP, 2004, APPL SURF SCI, V221, P330, DOI 10.1016/S0169-4332(03)00952-8
   Nien PC, 2006, ELECTROANAL, V18, P1408, DOI 10.1002/elan.200603552
   Paczosa-Bator B, 2006, ANAL CHIM ACTA, V555, P118, DOI 10.1016/j.aca.2005.08.085
   PEI QB, 1994, POLYMER, V35, P1347, DOI 10.1016/0032-3861(94)90332-8
   Piro B, 2001, J ELECTROANAL CHEM, V512, P101, DOI 10.1016/S0022-0728(01)00595-2
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   RIGA J, 1987, SYNTHETIC MET, V21, P223, DOI 10.1016/0379-6779(87)90090-7
   Setti L, 2005, BIOSENS BIOELECTRON, V20, P2019, DOI 10.1016/j.bios.2004.09.022
   SIEGBAHN K, 1967, ESCA ATOMIC MOL SO 4, V20
   Tengstedt C, 2006, THIN SOLID FILMS, V515, P2085, DOI 10.1016/j.tsf.2006.07.005
   van der Gon AWD, 2002, ORG ELECTRON, V3, P111, DOI 10.1016/S1566-1199(02)00048-4
   Wang TJ, 2005, APPL SURF SCI, V250, P188, DOI 10.1016/j.apsusc.2004.12.051
   WINTER I, 1995, CHEM PHYS, V194, P207, DOI 10.1016/0301-0104(95)00026-K
   WREN AG, 1979, J COLLOID INTERF SCI, V70, P544, DOI 10.1016/0021-9797(79)90062-6
   WU CR, 1987, SYNTHETIC MET, V21, P197, DOI 10.1016/0379-6779(87)90086-5
   Xing KZ, 1997, SYNTHETIC MET, V89, P161, DOI 10.1016/S0379-6779(97)81212-X
   Yang JY, 2004, SENSOR ACTUAT A-PHYS, V113, P204, DOI 10.1016/j.sna.2004.02.029
   Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020
   Zotti G, 2003, MACROMOLECULES, V36, P3337, DOI 10.1021/ma021715k
NR 54
TC 48
Z9 48
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1932-7447
J9 J PHYS CHEM C
JI J. Phys. Chem. C
PD APR 9
PY 2009
VL 113
IS 14
BP 5585
EP 5592
DI 10.1021/jp811282f
PG 8
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 427UX
UT WOS:000264805700038
DA 2018-10-19
ER

PT J
AU Rajkhowa, R
   Wang, LJ
   Kanwar, J
   Wang, XG
AF Rajkhowa, Rangam
   Wang, Lijing
   Kanwar, Jagat
   Wang, Xungai
TI Fabrication of ultrafine powder from eri silk through attritor and jet
   milling
SO POWDER TECHNOLOGY
LA English
DT Article
DE Silk powder; Milling; Particle size; Eri silk
ID BEAD MILL; FIBROIN; CELLS; SIZE; CULTURE; FIBERS
AB Fibroin protein derived from silk fibres has been extensively studied with exciting outcomes for a number of potential advanced biomaterial applications. However. one of the major challenges in applications lies in engineering fibroin into a desired form using a convenient production technology. In this paper, fabrication of Ultrafine powder from eri silk is reported. The silk cocoons were degummed and the extracted silk fibres were then chopped into snippets prior to attritor and air jet milling. Effects of process control agents, material load and material to water ratio during attritor milling were studied. Compared to dry and dry-wet attritor milling, wet process emerged as the preferred option as it caused less colour change and facilitated easy handling. Ultrafine silk powder with a volume based particle size d(0.5) of around 700 nm could be prepared following the sequence of chopping -> wet attritor milling -> spray drying -> air jet milling. Unlike most reported powder production methods, this method could fabricate silk particles in a short time without any pre-treatment on degummed fibre. Moreover, the size range obtained is much smaller than that previously produced using standard milling devices. Reduction in fibre tenacity either shortened the milling time even further or helped bypassing media milling to produce fine powder directly through jet milling. However, such reduction in fibre strength did not help in increasing the ultimate particle fineness. The study also revealed that particle density and particle morphology could be manipulated through appropriate changes in the degumming process. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Rajkhowa, Rangam; Wang, Lijing; Wang, Xungai] Deakin Univ, Ctr Mat & Fibre Innovat, Geelong, Vic 3217, Australia.
   [Kanwar, Jagat] Deakin Univ, Inst Biotechnol, Geelong, Vic 3217, Australia.
RP Wang, XG (reprint author), Deakin Univ, Ctr Mat & Fibre Innovat, Geelong, Vic 3217, Australia.
EM xwang@deakin.edu.au
RI Wang, Lijing/O-3130-2018
OI Wang, Lijing/0000-0002-7300-9271
CR AMNAT J, 2006, APPL MICROBIOL BIOT, V72, P726
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   Cheema SK, 2007, INT J PHARMACEUT, V341, P221, DOI 10.1016/j.ijpharm.2007.03.043
   CLAUDIO LDC, 2002, NANOPARTICLES MECH A, P1
   ENDO Y, 2002, Patent No. 2002302879
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Hidefumi T., 2000, MACROMOLECULAR MAT E, V283, P126
   HIROAKI Y, 1990, J APPL POLYM SCI, V40, P127
   HIROSHI T, 1997, Patent No. 09137076
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin N., 2001, J APPL POLYM SCI, V81, P3008
   KAWAMURA K, 2000, Patent No. 2000220073
   KUSHAL S, 2004, J APPL POLYM SCI, V92, P1080
   KWADE A, 2005, KAGAKU KOGAKU, V69, P691
   LI Y, 2004, Patent No. 2004055250
   Liu YL, 2006, J DISPER SCI TECHNOL, V27, P983, DOI 10.1080/01932690600766975
   Lv Q, 2007, COMPOS SCI TECHNOL, V67, P3023, DOI 10.1016/j.compscitech.2007.05.003
   MINGZHONG L, 1999, J APPL POLYM SCI, V79, P2185
   Molina-Boisseau S, 1999, POWDER TECHNOL, V105, P321, DOI 10.1016/S0032-5910(99)00154-0
   Molina-Boisseau S, 2000, CHEM ENG J, V79, P31, DOI 10.1016/S1385-8947(00)00175-3
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   NAKAMURA T, 1995, Patent No. 7229024
   OHTOMO K, 1981, Patent No. 0011161
   Poza P, 2002, ENG FRACT MECH, V69, P1035, DOI 10.1016/S0013-7944(01)00120-5
   Putthanarat S, 2000, POLYMER, V41, P7735, DOI 10.1016/S0032-3861(00)00036-7
   RAJKHOWA R, 2007, 2 INT SILK C SOOCH U
   Rajkhowa R, 2008, POWDER TECHNOL, V185, P87, DOI 10.1016/j.powtec.2008.01.005
   SANO M, 1998, Patent No. 5718954
   SONIA MB, 2002, POWDER TECHNOL, V128, P99
   Stenger F, 2005, CHEM ENG SCI, V60, P4557, DOI 10.1016/j.ces.2005.02.057
   SZEVGARI A, 1999, DISPERSION PIGMENTS
   Tajima M., 1994, Japan Patent JP, Patent No. 06306772
   TSUBOCHI K, 2003, Patent No. 2002148849
   TSUBOUCHI K, 2002, Patent No. 6427933
   TSUBOUCHI K, 1999, Patent No. 11104228
   Tsubouchi Kozo, 2003, Journal of Insect Biotechnology and Sericology, V72, P65
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Xu WL, 2006, J APPL POLYM SCI, V101, P2967, DOI 10.1002/app.23529
   Xu WL, 2004, POWDER TECHNOL, V140, P136, DOI 10.1016/j.powtec.2003.12.010
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   YASUSHI T, 2005, BIOMACROMOLECULES, V6, P3100
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   YUTAKA K, 2000, SEN-I GAKKAISHI, V56, P462
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   ZHENGBING C, 2007, SOFT MATTER, V3, P910
NR 49
TC 44
Z9 46
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD APR 4
PY 2009
VL 191
IS 1-2
BP 155
EP 163
DI 10.1016/j.powtec.2008.10.004
PG 9
WC Engineering, Chemical
SC Engineering
GA 425SH
UT WOS:000264656900023
DA 2018-10-19
ER

PT J
AU Oprea, ML
   Schnoring, H
   Sachweh, JS
   Ott, H
   Biertz, J
   Vazquez-Jimenez, JF
AF Oprea, Mihaela L.
   Schnoering, Heike
   Sachweh, Joerg S.
   Ott, Hagen
   Biertz, Julia
   Vazquez-Jimenez, Jaime F.
TI Allergy to Pacemaker Silicone Compounds: Recognition and Surgical
   Management
SO ANNALS OF THORACIC SURGERY
LA English
DT Editorial Material
ID CONTACT SENSITIVITY; CARDIAC-PACEMAKER; DERMATITIS
AB Silicone is a widely used biomaterial. Contact allergy, particularly to silicone components of pacemaker coatings, is uncommon. We present a 12-year-old girl with a history of complex congenital heart disease and acquired complete heart block excluding transvenous lead placement. Contact allergy to silicone led to multiple surgical interventions until the etiology for recurrent pacemaker wound complications was discovered. The key to diagnosis was a specific manufacturer's patch test. Complete removal of the former pacing system and placement of custom-made silicone free pacemaker components and epicardial use of silicone free transvenous leads were essential for successful therapy.
C1 Rhein Westfal TH Aachen, Dept Pediat Cardiac Surg, Aachen, Germany.
   Rhein Westfal TH Aachen, Dept Dermatol, Aachen, Germany.
   Rhein Westfal TH Aachen, Dept Pediat Cardiol, Aachen, Germany.
RP Oprea, ML (reprint author), Univ Hosp Aachen, Pauwelsstr 30, D-52074 Aachen, Germany.
EM moprea@ukaachen.de
CR ABDALLAH HI, 1994, ANN THORAC SURG, V57, P1017, DOI 10.1016/0003-4975(94)90228-3
   ANDERSEN KE, 1979, ARCH DERMATOL, V115, P97, DOI 10.1001/archderm.115.1.97
   Hayes DL, 2002, J INTERV CARD ELECTR, V6, P277, DOI 10.1023/A:1019518005809
   Iguchi N, 1997, PACE, V20, P372, DOI 10.1111/j.1540-8159.1997.tb06188.x
   MAUSHAGEN E, 1994, Z KARDIOL, V83, P340
   PETERS MS, 1984, CONTACT DERMATITIS, V11, P214, DOI 10.1111/j.1600-0536.1984.tb00986.x
   RAQUE C, 1970, ARCH DERMATOL, V102, P646, DOI 10.1001/archderm.102.6.646
   Skoet R, 2003, CARDIOLOGY, V99, P112, DOI 10.1159/000069721
NR 8
TC 21
Z9 22
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
EI 1552-6259
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD APR
PY 2009
VL 87
IS 4
BP 1275
EP 1277
DI 10.1016/j.athoracsur.2008.08.028
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 423OQ
UT WOS:000264506000048
PM 19324172
DA 2018-10-19
ER

PT J
AU Elvin, CM
   Brownlee, AG
   Huson, MG
   Tebb, TA
   Kim, M
   Lyons, RE
   Vuocolo, T
   Liyou, NE
   Hughes, TC
   Ramshaw, JAM
   Werkmeister, JA
AF Elvin, Christopher M.
   Brownlee, Alan G.
   Huson, Mickey G.
   Tebb, Tracy A.
   Kim, Misook
   Lyons, Russell E.
   Vuocolo, Tony
   Liyou, Nancy E.
   Hughes, Timothy C.
   Ramshaw, John A. M.
   Werkmeister, Jerome A.
TI The development of photochemically crosslinked native fibrinogen as a
   rapidly formed and mechanically strong surgical tissue sealant
SO BIOMATERIALS
LA English
DT Article
DE Fibrinogen; Tissue sealant; Photochemical crosslinking; Dityrosine;
   Ruthenium; Biomaterial
ID SELF-ASSOCIATION; FIBRONECTIN; STRENGTH; DITYROSINE; ADHESIVES;
   COMPONENT; COLLAGEN; LINKING; BINDING; SITES
AB We recently reported the generation of a highly elastic, crosslinked protein biomaterial via a rapid photochemical process using visible light illumination. In light of these findings, we predicted that other unmodified, tyrosine-rich, self-associating proteins might also be susceptible to this covalent crosslinking method. Here we show that unmodified native fibrinogen can also be photochemically crosslinked into an elastic hydrogel biomaterial through the rapid formation of intermolecular dityrosine. Photochemically crosslinked fibrinogen forms tissue sealant bonds at least 5-fold stronger than commercial fibrin glue and is capable of producing maximum bond strength within 20 s. In vitro studies showed that components of the photochemical crosslinking reaction are non-toxic to cells. This material will find useful application in various surgical procedures where rapid curing for high strength tissue sealing is required. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
C1 [Elvin, Christopher M.; Brownlee, Alan G.; Kim, Misook; Lyons, Russell E.; Vuocolo, Tony; Liyou, Nancy E.] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4072, Australia.
   [Tebb, Tracy A.; Hughes, Timothy C.; Ramshaw, John A. M.; Werkmeister, Jerome A.] CSIRO Mol & Hlth Technol, Clayton 3169, Australia.
   [Huson, Mickey G.] CSIRO Mat Sci & Engn, Geelong, Vic 3216, Australia.
RP Elvin, CM (reprint author), CSIRO Livestock Ind, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld 4072, Australia.
EM chris.elvin@csiro.au
RI Russell, Lyons/H-7942-2013; Hughes, Timothy/A-9319-2011; Lyons,
   Russell/A-7051-2011; Ramshaw, John/A-9411-2011; Vuocolo,
   Tony/H-7533-2013; elvin, chris/H-2333-2013; Huson, Mickey/K-2474-2012
OI Russell, Lyons/0000-0002-0795-7994; Hughes, Timothy/0000-0002-7990-4509;
   Huson, Mickey/0000-0003-1859-7805
CR Alston SM, 2007, TRANSL RES, V149, P187, DOI 10.1016/j.trsl.2006.08.004
   Bar L, 2005, BLOOD COAGUL FIBRIN, V16, P111, DOI 10.1097/01.mbc.0000161564.74387.12
   BERGEL S, 1909, DEUT MED WOCHENSCHR, V35, P633
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Browdie DA, 2007, TEX HEART I J, V34, P313
   Carbon RT, 2003, BIOMATERIALS, V24, P1469, DOI 10.1016/S0142-9612(02)00522-7
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Fenaille F, 2004, J CHROMATOGR A, V1052, P77, DOI 10.1016/j.chroma.2004.08.104
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   FLAHIFF C, 1992, J BIOMED MATER RES, V26, P481, DOI 10.1002/jbm.820260406
   HOERMANN H, 1980, ARTERY, V8, P482
   Hu B-H, 2005, Orthod Craniofac Res, V8, P145, DOI 10.1111/j.1601-6343.2005.00330.x
   Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718
   Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X
   Kaetsu H, 2000, INT J ADHES ADHES, V20, P27, DOI 10.1016/S0143-7496(99)00011-1
   Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200
   KARPEL R, 1991, ISRAEL J MED SCI, V27, P61
   Kjaergard HK, 1999, EUR SURG RES, V31, P491, DOI 10.1159/000008729
   Kjaergard HK, 2000, THROMB RES, V98, P221, DOI 10.1016/S0049-3848(99)00234-0
   Kodadek T, 2005, TRENDS PHARMACOL SCI, V26, P210, DOI 10.1016/j.tips.2005.02.010
   Lee Meng-G Martin, 2005, Surg Innov, V12, P203, DOI 10.1177/155335060501200304
   Makogonenko E, 2007, BIOCHEMISTRY-US, V46, P5418, DOI 10.1021/bi7001373
   Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454
   Marx G, 2002, J LAB CLIN MED, V140, P152, DOI 10.1067/mlc.2002.126413
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Nairn KM, 2008, BIOPHYS J, V95, P3358, DOI 10.1529/biophysj.107.119107
   Nicoson ZR, 2002, BIOMED SCI INSTRUM, V38, P179
   Orr TE, 1999, J BIOMED MATER RES, V44, P308, DOI 10.1002/(SICI)1097-4636(19990305)44:3<308::AID-JBM9>3.3.CO;2-H
   Podor TJ, 2002, J BIOL CHEM, V277, P7520, DOI 10.1074/jbc.M109677200
   Sierra DH, 2000, J BIOMED MATER RES, V52, P534, DOI 10.1002/1097-4636(20001205)52:3<534::AID-JBM12>3.0.CO;2-7
   Sierra DH, 2002, J BIOMED MATER RES, V59, P1
   Takasaki S, 2005, BIOSCI BIOTECH BIOCH, V69, P1686, DOI 10.1271/bbb.69.1686
NR 34
TC 52
Z9 55
U1 4
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2009
VL 30
IS 11
BP 2059
EP 2065
DI 10.1016/j.biomaterials.2008.12.059
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 420FA
UT WOS:000264273100008
PM 19147224
DA 2018-10-19
ER

PT J
AU Chien, HW
   Chang, TY
   Tsai, WB
AF Chien, Hsiu-Wen
   Chang, Tsung Yao
   Tsai, Wei-Bor
TI Spatial control of cellular adhesion using photo-crosslinked
   micropatterned polyelectrolyte multilayer films
SO BIOMATERIALS
LA English
DT Article
DE Mechanical compliance; Topography; Co-culture; Micropatterning
ID HIPPOCAMPAL-NEURONS; THIN-FILMS; SURFACES; ATTACHMENT; POLYMER; BIOLOGY;
   CELLS; IMMOBILIZATION; HEPATOCYTES; DETACHMENT
AB Cellular patterning on biomaterial surfaces is important in fundamental studies of cell-cell and cell-substrate interactions, and in biomedical applications such as tissue engineering, cell-based biosensors, and diagnostic devices. In this study, we combined the layer-by-layer polyelectrolyte multilayer deposition and photolithographic technique to create an easy and versatile technique for cell patterning. Poly(acrylic acid) (PAA) conjugated with 4-azidoaniline was interwoven in PAA/polyacrylamide (PAM) multilayer films. After UV irradiation through a photo mask, the UV-exposed areas were crosslinked and the unexposed areas were rinsed away by alkaline water, resulting in micropatterns. Cell patterns were formed when the cell adhesion was limited to the base substrate, but not on the multilayer films. The stability of cell patterns could be modulated by simply modification of the surface chemistry of base substrate and PEM films with conjugation of bioactive macromolecules. This technique can be also applied to other PEM systems with proper rinsing protocol, and many types of substrates. Cell co-culture systems can be also achieved by this technique. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Chien, Hsiu-Wen; Chang, Tsung Yao; Tsai, Wei-Bor] Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
RP Tsai, WB (reprint author), Natl Taiwan Univ, Dept Chem Engn, 1 Roosevelt Rd,Sect 4, Taipei 106, Taiwan.
EM weibortsai@ntu.edu.tw
RI Tsai, Wei-Bor/B-7953-2011
OI Tsai, Wei-Bor/0000-0002-2316-5751
FU National Science Council, Taiwan [97-2628-E-002-028-MY2]
FX The authors thank National Science Council, Taiwan
   (97-2628-E-002-028-MY2) for financial support.
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Bhatia SN, 1999, FASEB J, V13, P1883
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Clark SL, 1997, SUPRAMOL SCI, V4, P141, DOI 10.1016/S0968-5677(96)00055-7
   DAS M, 1979, ANNU REV BIOPHYS BIO, V8, P165, DOI 10.1146/annurev.bb.08.060179.001121
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dubas ST, 2001, MACROMOLECULES, V34, P3736, DOI 10.1021/ma001720t
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Esch T, 1999, J NEUROSCI, V19, P6417
   Fery A, 2001, LANGMUIR, V17, P3779, DOI 10.1021/la102612
   Folch A, 1999, J BIOMECH ENG-T ASME, V121, P28, DOI 10.1115/1.2798038
   Hatakeyama H, 2007, BIOMATERIALS, V28, P3632, DOI 10.1016/j.biomaterials.2007.04.019
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Ito Y, 2006, BIOMATERIALS, V27, P2502, DOI 10.1016/j.biomaterials.2005.11.030
   Ito Y, 1997, LANGMUIR, V13, P2756, DOI 10.1021/la961087y
   JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795
   Kang IK, 2004, BIOMATERIALS, V25, P4225, DOI 10.1016/j.biomaterials.2003.11.004
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu HC, 2002, LAB CHIP, V2, P175, DOI 10.1039/b204944a
   Lu YX, 2008, LANGMUIR, V24, P8050, DOI 10.1021/la800998n
   Meacham KW, 2008, BIOMED MICRODEVICES, V10, P259, DOI 10.1007/s10544-007-9132-9
   Mohammed JS, 2004, BIOMACROMOLECULES, V5, P1745, DOI 10.1021/bm0498631
   Olugebefola SC, 2006, LANGMUIR, V22, P5958, DOI 10.1021/la060315d
   Park TH, 2003, BIOTECHNOL PROGR, V19, P243, DOI 10.1021/bp020143k
   Reyes DR, 2004, LANGMUIR, V20, P8805, DOI 10.1021/la049249a
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Scholl M, 2000, J NEUROSCI METH, V104, P65, DOI 10.1016/S0165-0270(00)00325-3
   Schuy S, 2008, J PHYS CHEM B, V112, P8250, DOI 10.1021/jp800711j
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Thompson MT, 2006, BIOMACROMOLECULES, V7, P1990, DOI 10.1021/bm060146b
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Watanabe J, 2008, ACTA BIOMATER, V4, P1255, DOI 10.1016/j.actbio.2008.03.009
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yang SY, 2002, J AM CHEM SOC, V124, P2100, DOI 10.1021/ja017681y
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
NR 39
TC 62
Z9 62
U1 1
U2 61
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2009
VL 30
IS 12
BP 2209
EP 2218
DI 10.1016/j.biomaterials.2008.12.060
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423RG
UT WOS:000264512800006
PM 19150738
DA 2018-10-19
ER

PT J
AU Jung, JP
   Nagaraj, AK
   Fox, EK
   Rudra, JS
   Devgun, JM
   Collier, JH
AF Jung, Jangwook P.
   Nagaraj, Arun K.
   Fox, Emily K.
   Rudra, Jai S.
   Devgun, Jason M.
   Collier, Joel H.
TI Co-assembling peptides as defined matrices for endothelial cells
SO BIOMATERIALS
LA English
DT Article
DE Self-assembly; Biomimetic material; Biomaterial immunogenicity;
   Regenerative medicine; 3-D culture
ID NEURITE OUTGROWTH; MULTIPLE COMPARISONS; CIRCULAR-DICHROISM; LAMININ
   ALPHA-1; DRUG-DELIVERY; TISSUE-REPAIR; PROTEIN; NANOFIBERS; ADHESION;
   BIOMATERIALS
AB Self-assembling peptides and peptide derivatives bearing cell-binding ligands are increasingly being investigated as defined cell culture matrices and as scaffolds for regenerative medicine. In order to systematically refine such scaffolds to elicit specific desired cell behaviors, ligand display should ideally be achieved without inadvertently altering other physicochemical properties such as viscoelasticity. Moreover, for in vivo applications, self-assembled biomaterials must exhibit low immunogenicity. In the present study, multi-peptide co-assembling hydrogels based on the beta-sheet fibrillizing peptide Q11 (QQKFQFQFEQQ) were designed such that they presented RGDS or IKVAV ligands on their fibril surfaces. In co-assemblies of the ligand-bearing peptides with Q11, ligand incorporation levels capable of influencing the attachment, spreading, morphology, and growth of human umbilical vein endothelial cells (HUVECs) did not significantly alter the materials' fibrillization, beta-turn secondary structure, or stiffness. RGDS-Q11 specifically increased HUVEC attachment, spreading, and growth when co-assembled into Q11 gels. whereas IKVAV-Q11 exerted a more subtle influence on attachment and morphology. Additionally, Q11 and RGDS-Q11 were minimally immunogenic in mice, making Q11-based biomaterials attractive candidates for further investigation as defined, modular extracellular matrices for applications in vitro and in vivo. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Jung, Jangwook P.; Rudra, Jai S.; Devgun, Jason M.; Collier, Joel H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
   [Collier, Joel H.] Univ Chicago, Div Biol Sci, Comm Mol Med, Chicago, IL 60637 USA.
   [Jung, Jangwook P.; Nagaraj, Arun K.; Fox, Emily K.; Collier, Joel H.] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45221 USA.
RP Collier, JH (reprint author), Univ Chicago, Dept Surg, 5841 S Maryland Ave,Abbott Hall AB522,Mail Code 5, Chicago, IL 60637 USA.
EM collier@uchicago.edu
FU The American Heart Association [066521813]; National Science Foundation
   [CHE-0802286]; National Institutes of Health [EB007335]
FX This research was supported in part by The American Heart Association
   (grant no. 066521813), the National Science Foundation (grant no.
   CHE-0802286), and the National Institutes of Health (NIBIB, grant no.
   EB007335). The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National
   Institute of Biomedical Imaging and BioEngineering or the National
   Institutes of Health. We thank Karl Matlin and Jose Moyano for helpful
   discussions. TEM and CD were performed at the University of Chicago
   Electron Microscopy Facility and Biophysics Core Facility, respectively.
   We thank Dr. Dale Schaefer for access to the rheometer.
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Aggeli A, 1997, J MATER CHEM, V7, P1135, DOI 10.1039/a701088e
   BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784
   Berat R, 2007, BIOINTERPHASES, V2, P165, DOI 10.1116/1.2821954
   BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X
   BUSH CA, 1978, BIOCHEMISTRY-US, V17, P4951, DOI 10.1021/bi00616a015
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850
   Collier JH, 2004, ADV MATER, V16, P907, DOI 10.1002/adma.200306379
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Collier JH, 2008, SOFT MATTER, V4, P2310, DOI 10.1039/b805563g
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fehr T, 1997, J EXP MED, V185, P1785, DOI 10.1084/jem.185.10.1785
   Freitas VM, 2007, AM J PATHOL, V171, P124, DOI 10.2353/ajpath.2007.051264
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Kapadia MR, 2008, J VASC SURG, V47, P173, DOI 10.1016/j.jvs.2007.09.005
   Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565
   Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Law B, 2006, BIOMACROMOLECULES, V7, P1261, DOI 10.1021/bm050920f
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200
   Matsumura S, 2005, MOL BIOSYST, V1, P146, DOI 10.1039/b504516a
   Melchor JP, 2000, J BIOL CHEM, V275, P9782, DOI 10.1074/jbc.275.13.9782
   Nakamura M, 2008, BIOMATERIALS, V29, P2977, DOI 10.1016/j.biomaterials.2008.04.006
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Ramachandran S, 2006, BIODRUGS, V20, P263, DOI 10.2165/00063030-200620050-00001
   RENZ H, 1993, J IMMUNOL, V151, P7206
   Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304
   Rosenberg AS, 2006, AAPS J, V8, pE501
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SCHNAPER HW, 1993, KIDNEY INT, V43, P20, DOI 10.1038/ki.1993.5
   Segers VFM, 2007, DRUG DISCOV TODAY, V12, P561, DOI 10.1016/j.drudis.2007.05.003
   Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Storrie H, 2007, BIOMATERIALS, V28, P4608, DOI 10.1016/j.biomaterials.2007.06.026
   Tamhane A. C., 1996, HANDB STAT, P587
   TAMHANE AC, 1977, COMMUN STAT A-THEOR, V6, P15, DOI 10.1080/03610927708827466
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Yano A, 2005, VACCINE, V23, P2322, DOI 10.1016/j.vaccine.2005.01.031
   Yano A, 2003, VACCINE, V22, P237, DOI 10.1016/S0264-410X(03)00561-9
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 59
TC 126
Z9 128
U1 5
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2009
VL 30
IS 12
BP 2400
EP 2410
DI 10.1016/j.biomaterials.2009.01.033
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423RG
UT WOS:000264512800025
PM 19203790
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mandal, BB
   Das, T
   Kundu, SC
AF Mandal, Biman B.
   Das, Tamal
   Kundu, S. C.
TI Non-bioengineered silk gland fibroin micromolded matrices to study
   cell-surface interactions
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE Micromolding; Non-mulberry silk; Biocompatibility; Tissue engineering;
   Biomaterials
ID TISSUE ENGINEERING APPLICATIONS; BIOMATERIALS; PROTEIN; DIFFERENTIATION;
   SCAFFOLDS; RESPONSES; SULFATE
AB Micropatterning/micromolding of protein molecules has played a significant role in developing biosensors, micro arrays, and tissue engineering devices for cellular investigations. Relevantly, there have been ample scopes for silk to be used as natural biomaterial in tissue engineering applications due to its attractive properties such as slow-controllable degradation, mechanical robustness, and inherent biocompatibility. In this paper, we report the fabrication of micromolded silk fibroin matrices, which have essentially been utilized to study cell-surface interactions. Fibroin protein has been isolated from the silk glands of nonmulberry Indian tropical tasar silkworms, Antheraea mylitta. The surface uniformity has been investigated using atomic force microscopy following the fabrication of silk micromolds. Subsequently, cellular interactions in terms of cell attachment, spreading, mitochondrial activity and proliferation have been studied in vitro using feline fibroblasts. Results have indicated a long term stability of patterns in micromolded silk matrices and negligible swelling. The versatility of described silk dissolution method coupled with ability to process large amount of silk protein into micromolded matrices and controllable surface topology may augment the desirability of silk fibroin as a natural biomaterial for bioengineering and biotechnological applications.
C1 [Mandal, Biman B.; Das, Tamal; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
FU The Department of Biotechnology [BT/PR6035/MED/14/733/2005];
   Indo-Australia Biotechnology Fund [BT/PR9552/ICD/16/755/2006]; Council
   of Scientific Industrial Research, Govt. of India; Indo-US Science and
   Technology Forum, New Delhi
FX We are grateful to Dr. Vamsi K. Yadavalli for his critical reading and
   meaningful suggestions on the manuscript. The Department of
   Biotechnology (BT/PR6035/MED/14/733/2005), Indo-Australia Biotechnology
   Fund (BT/PR9552/ICD/16/755/2006), Council of Scientific Industrial
   Research (for fellowship to BBM), Govt. of India, Indo-US Science and
   Technology Forum, New Delhi, are greatly acknowledged for funding our
   project.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARAND M, 1992, ANAL BIOCHEM, V207, P73, DOI 10.1016/0003-2697(92)90502-X
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   FOLCH A, 2007, THERAPEUTIC MICRO NA
   Ito Y, 1997, J BIOCHEM-TOKYO, V121, P514
   Ito Y, 1997, LANGMUIR, V13, P2756, DOI 10.1021/la961087y
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kundu S.C., 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI DOI 10.1016/S0965-1748(01)00049-2
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   Lussi JW, 2006, BIOMATERIALS, V27, P2534, DOI 10.1016/j.biomaterials.2005.11.027
   MAGOSHI J, 1981, J POLYM SCI POL PHYS, V19, P185, DOI 10.1002/pol.1981.180190117
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   MATSUDA T, 1995, J BIOMED MATER RES, V29, P749, DOI 10.1002/jbm.820290611
   MINGZHONG L, 1999, J APPL POLYM SCI, V79, P2185
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
NR 32
TC 13
Z9 14
U1 1
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD APR
PY 2009
VL 11
IS 2
BP 467
EP 476
DI 10.1007/s10544-008-9252-x
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 417QR
UT WOS:000264091800016
PM 19058012
DA 2018-10-19
ER

PT J
AU Chandel, AK
   Narasu, ML
   Chandrasekhar, G
   Manikyam, A
   Rao, LV
AF Chandel, Anuj K.
   Narasu, M. Lakshmi
   Chandrasekhar, G.
   Manikyam, A.
   Rao, L. Venkateswar
TI Use of Saccharum spontaneum (wild sugarcane) as biomaterial for cell
   immobilization and modulated ethanol production by thermotolerant
   Saccharomyces cerevisiae VS3
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Saccharum spontaneum; Enzymatic hydrolysis; Cell immobilization;
   Saccharomyces cerevisiae VS3; Ethanol production
ID ACID; FERMENTATION; HYDROLYSIS; LOOFA; BIOFUELS; CULTURE; BAGASSE;
   SPONGE; YEAST
AB Saccharum spontaneum is a wasteland weed consists of 45.10 +/- 0.35% cellulose and 22.75 +/- 0.28% of hemicellulose on dry solid (DS) basis. Aqueous ammonia delignified S. spontaneum yielded total reducing sugars, 53.91 +/- 0.44 g/L (539.10 +/- 0.55 mg/g of substrate) with a hydrolytic efficiency of 77.85 +/- 0.45%. The enzymes required for hydrolysis were prepared from culture supernatants of Aspergillus oryzae MTCC 1846. A maximum of 0.85 +/- 0.07 IU/mL of filter paperase (FPase), 1.25 +/- 0.04 IU/mL of carboxy methyl cellulase (CMCase) and 55.56 +/- 0.52 IU/mL of xylanase activity was obtained after 7 days of incubation at 28 +/- 0.5 degrees C using delignified S. spontaneum as carbon source under submerged fermentation conditions. Enzymatic hydrolysate of S. spontaneum was then tested for ethanol production under batch and repeated batch production system using "in-situ" entrapped Saccharomyces cerevisiae VS3 cells in S. spontaneum stalks (1 cm x 1 cm) size. Immobilization was confirmed by the scanning electron microscopy (SEM). Batch fermentation Of VS3 free cells and immobilized cells showed ethanol production, 19.45 +/- 0.55 g/L (yield, 0.410 +/- 0.010 g/g) and 21.66 +/- 0.62 g/L (yield, 0.434 +/- 0.021 g/g), respectively. Immobilized VS3 cells showed maximum ethanol production (22.85 +/- 0.44 g/L, yield, 0.45 +/- 0.04 g/g) up to 8th cycle during repeated batch fermentation followed by a gradual reduction in subsequent cycles of fermentation. (c) 2008 Elsevier Ltd. All rights reserved,
C1 [Chandel, Anuj K.; Manikyam, A.; Rao, L. Venkateswar] Osmania Univ, Dept Microbiol, Hyderabad 500007, Andhra Pradesh, India.
   [Chandel, Anuj K.; Narasu, M. Lakshmi; Chandrasekhar, G.] Jawaharlal Nehru Technol Univ, Ctr Biotechnol, Hyderabad 500072, Andhra Pradesh, India.
RP Rao, LV (reprint author), Osmania Univ, Dept Microbiol, Hyderabad 500007, Andhra Pradesh, India.
EM vrlinga@yahoo.com
RI Pogaku, Ravindra/J-1661-2016
CR Angelova M, 1997, J BIOTECHNOL, V58, P51, DOI 10.1016/S0168-1656(97)00130-2
   Antoni D, 2007, APPL MICROBIOL BIOT, V77, P23, DOI 10.1007/s00253-007-1163-x
   Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238
   Chandel A. K., 2007, International Journal of Global Energy Issues, V28, P357, DOI 10.1504/IJGEI.2007.016249
   Chandel A. K., 2007, Biotechnology and Molecular Biology Reviews, V2, P014
   Chang VS, 2000, APPL BIOCHEM BIOTECH, V85, P5
   Chen M, 2007, INT BIODETER BIODEGR, V59, P85, DOI 10.1016/j.ibiod.2006.07.011
   Dien BS, 2006, ENZYME MICROB TECH, V39, P1137, DOI 10.1016/j.enzmictec.2006.02.022
   Ellaiah P, 2004, PROCESS BIOCHEM, V39, P525, DOI 10.1016/S0032-9592(01)00340-5
   Ganguly R, 2007, BIORESOURCE TECHNOL, V98, P1246, DOI 10.1016/j.biortech.2006.05.004
   GRAY KA, 2006, BIOETHANOL CURR OPIN, V10, P1
   Hopkins W. G., 1999, INTRO PLANT PHYSL
   Iqbal M, 2005, LETT APPL MICROBIOL, V40, P178, DOI 10.1111/j.1472-765X.2004.01646.x
   Johansen CL, 1998, BIOTECHNOL PROGR, V14, P233, DOI 10.1021/bp980014x
   Kim TH, 2008, BIORESOURCE TECHNOL, V99, P5694, DOI 10.1016/j.biortech.2007.10.055
   KRUGMAN P, 2008, INT HERALD TRIBUNE
   Lakshmikant K., 1990, WORLD J MICROB BIOT, V11, P23
   Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169
   Martin C, 2002, ENZYME MICROB TECH, V31, P274, DOI 10.1016/S0141-0229(02)00112-6
   MILALA MA, 2005, RES J AGR BIOL SCI, V4, P325
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Minjares-Cassanco A., 1997, ENZYME MICROB TECHNO, V21, P26
   Mohan Naidu K., 1987, CORP INT SUG BREED W, P33
   Ogbonna JC, 1997, J FERMENT BIOENG, V84, P271, DOI 10.1016/S0922-338X(97)82069-7
   Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3
   Pasha C, 2007, J APPL MICROBIOL, V103, P1480, DOI 10.1111/j.1365-2672.2007.03375.x
   Pasha C, 2007, LETT APPL MICROBIOL, V44, P666, DOI 10.1111/j.1472-765X.2007.02116.x
   PASHA C, 2005, J APPL MICROBIOL, V98, P318
   Peinado RA, 2006, ENZYME MICROB TECH, V40, P79, DOI 10.1016/j.enzmictec.2005.10.040
   Phisalaphong M, 2007, J BIOSCI BIOENG, V104, P214, DOI 10.1263/jbb.104.214
   RAVINDER R, 2000, THESIS OSMANIA U HYD
   Santos DT, 2008, J FOOD ENG, V86, P542, DOI 10.1016/j.jfoodeng.2007.11.004
   Sastri C. S. T., 1990, PLANTS RECLAMATION W, P360
   Sharma SK, 2004, BIOMASS BIOENERG, V27, P392
   Shindo S, 2001, BIOTECHNOL LETT, V23, P2001, DOI 10.1023/A:1013774728459
   Sree NK, 1999, BIOPROCESS ENG, V20, P561, DOI 10.1007/s004490050629
   STANDING CN, 1972, APPL MICROBIOL, V23, P354
   Taherzadeh MJ, 2007, BIORESOURCES, V2, P472
   TECHNICAL ASSOCIATION OF THE PULP AND PAPER INDUSTRY-TAPPI, 1992, TAPP TEST METH
   Tu MB, 2007, BIOTECHNOL PROGR, V23, P398, DOI 10.1021/bp060354f
   Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009
NR 41
TC 66
Z9 67
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD APR
PY 2009
VL 100
IS 8
BP 2404
EP 2410
DI 10.1016/j.biortech.2008.11.014
PG 7
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 410MR
UT WOS:000263582100013
PM 19114303
DA 2018-10-19
ER

PT J
AU Ram, J
   Kumar, S
   Sukhija, J
   Severia, S
AF Ram, Jagat
   Kumar, Sunil
   Sukhija, Jaspreet
   Severia, Saurabh
TI Nd:YAG laser capsulotomy rates following implantation of square-edged
   intraocular lenses: polymethyl methacrylate versus silicone versus
   acrylic
SO CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
LA English
DT Article
DE posterior capsule opacification; Nd:YAG laser; polymethyl methacrylate;
   square-edged intraocular lens
ID PREVENTING POSTERIOR CAPSULE; CATARACT-SURGERY; YAG LASER;
   RANDOMIZED-TRIAL; CLINICAL-TRIAL; OPACIFICATION; SHARP; FIXATION;
   ADHESION; POLYMETHYLMETHACRYLATE
AB Objective:To study the influence of square-edged intraocular lenses (IOLs) on the development of posterior capsule opacification (PCO) and the requirement for laser capsulotomy.
   Design: Retrospective study.
   Participants: Three hundred seventy-seven eyes of 377 patients were included.
   Methods: All these patients underwent phacoemulsification and implantation of square polymethyl methacrylate (PMMA) (Aurolab), silicone (Tecnis Z9000), acrylic hydrophobic (AcrySof MA60AC and Sensar Optiedge), or acrylic hydrophilic (Akreos Adapt) IOLs with a minimum of 2 years' follow-up. Only those cases in which Nd:YAG laser capsulotomy had been performed for visually significant PCO were evaluated.
   Results: Three hundred seventy-seven eyes of 377 patients were included in the study. Follow-up duration ranged from 24 to 54 (mean 40.27, SD 8.42) months. The incidence of PCO requiring Nd:YAG laser capsulotomy was found to be significantly less in the silicone lens group: 1.4% as compared with an incidence of 11.7% in the PMMA lens group (p = 0.018). In the square-edged acrylic group, visually significant PCO requiring Nd:YAG laser capsulotomy was observed in 3.6%,4.8%, and 6.8% of eyes implanted with AcrySof MA60AC, Sensar Optiedge, and Akreos Adapt IOLs, respectively. In 5 of the 7 eyes (71.4%) exhibiting PCO in the PMMA group, the condition developed within the first 6 months. In the silicone and acrylic group, development of PCO was delayed.
   Conclusions: The rate of visually significant PCO as well as the need for Nd:YAG laser capsulotomy is influenced by IOL biomaterial in addition to square edge. It is significantly delayed with square-edged foldable acrylic and silicone IOLs compared with square-edged PMMA IOLs.
C1 [Ram, Jagat; Kumar, Sunil; Sukhija, Jaspreet; Severia, Saurabh] Postgrad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh 160012, India.
RP Ram, J (reprint author), Postgrad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh 160012, India.
EM drjagatram@yahoo.com
CR APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   APPLE DJ, 1984, SURV OPHTHALMOL, V29, P1, DOI 10.1016/0039-6257(84)90113-9
   Apple DJ, 1999, OPHTHALMOLOGY, V106, P1861, DOI 10.1016/S0161-6420(99)90393-7
   Apple DJ, 2001, OPHTHALMOLOGY, V108, P505, DOI 10.1016/S0161-6420(00)00589-3
   Apple DJ, 2000, J CATARACT REFR SURG, V26, P180, DOI 10.1016/S0886-3350(99)00353-3
   CUNANAN CM, 2001, J CATARACT REFR SURG, V17, P767
   Findl O, 2005, OPHTHALMOLOGY, V112, P2004, DOI 10.1016/j.ophtha.2005.06.021
   Hayashi H, 1998, ARCH OPHTHALMOL-CHIC, V116, P1579, DOI 10.1001/archopht.116.12.1579
   Hayashi K, 2005, OPHTHALMOLOGY, V112, P1550, DOI 10.1016/j.ophtha.2005.03.024
   Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7
   IBARAKI N, 1995, AM J OPHTHALMOL, V119, P706, DOI 10.1016/S0002-9394(14)72774-6
   Kugelberg M, 2006, J CATARACT REFR SURG, V32, P1627, DOI 10.1016/j.jcrs.2006.05.011
   LEISEBERG TJ, 1985, AM J OPHTHALMOL, V100, P510
   Leydolt C, 2007, OPHTHALMOLOGY, V114, P1663, DOI 10.1016/j.ophtha.2006.12.016
   Linnola RJ, 2003, J CATARACT REFR SURG, V29, P146, DOI 10.1016/S0886-3350(02)01422-0
   Nishi O, 2004, J CATARACT REFR SURG, V30, P2170, DOI 10.1016/j.jcrs.2004.05.022
   Nishi O, 1999, J CATARACT REFR SURG, V25, P521, DOI 10.1016/S0886-3350(99)80049-2
   Ram J, 1999, OPHTHALMOLOGY, V106, P883, DOI 10.1016/S0161-6420(99)00505-9
   Ram J, 1999, OPHTHALMOLOGY, V106, P891, DOI 10.1016/S0161-6420(99)00506-0
   Ram J, 2001, J CATARACT REFR SURG, V27, P1039, DOI 10.1016/S0886-3350(00)00841-5
   Ram J, 2001, OPHTHALMIC SURG LAS, V32, P375
   RIDLEY H, 1952, LANCET, V262, P118
   Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3
   Shah A, 2008, EYE, V22, P889, DOI 10.1038/sj.eye.6702747
   Shah A, 2007, J CATARACT REFR SURG, V33, P1259, DOI 10.1016/j.jcrs.2007.03.044
   Sourdille P, 1997, J CATARACT REFR SURG, V23, P1431, DOI 10.1016/S0886-3350(97)80002-8
   STARK WJ, 1985, OPHTHALMOLOGY, V92, P209
   STEINERT RF, 1991, AM J OPHTHALMOL, V112, P373, DOI 10.1016/S0002-9394(14)76242-7
   TERRY AC, 1983, AM J OPHTHALMOL, V96, P716, DOI 10.1016/S0002-9394(14)71912-9
   Ursell PG, 1998, J CATARACT REFR SURG, V24, P352, DOI 10.1016/S0886-3350(98)80323-4
   Versura P, 1999, J CATARACT REFR SURG, V25, P527
   Werner L, 2008, J CATARACT REFR SURG, V34, P310, DOI 10.1016/j.jcrs.2007.09.024
   Zemaitiene R, 2007, BRIT J OPHTHALMOL, V91, P644, DOI 10.1136/bjo.2006.103648
NR 33
TC 12
Z9 12
U1 0
U2 4
PU CANADIAN OPHTHAL SOC
PI OTTAWA
PA 1525 CARLING AVE SUITE 610, OTTAWA, ONTARIO K1Z 8R9, CANADA
SN 0008-4182
EI 1715-3360
J9 CAN J OPHTHALMOL
JI Can. J. Opthalmol.-J. Can. Opthalmol.
PD APR
PY 2009
VL 44
IS 2
BP 160
EP 164
DI 10.3129/i09-042
PG 5
WC Ophthalmology
SC Ophthalmology
GA 436QO
UT WOS:000265429900006
PM 19491949
DA 2018-10-19
ER

PT J
AU Li, J
   Zhu, BQ
   Shao, YY
   Liu, XR
   Yang, XL
   Yu, Q
AF Li, Juan
   Zhu, Baoqing
   Shao, Yingya
   Liu, Xinrong
   Yang, Xinlin
   Yu, Qun
TI Construction of anticoagulant poly (lactic acid) films via surface
   covalent graft of heparin-carrying microcapsules
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Heparin; Microcapsules; PLA films; Covalent engraftment;
   Antithrombogenicity
ID IN-VITRO ANTITHROMBOGENICITY; POLYELECTROLYTE MULTILAYER; ALGINATE
   MICROSPHERES; GLUCOSE-OXIDASE; SILK FIBROIN; POLYURETHANE;
   IMMOBILIZATION; ENCAPSULATION; COATINGS; CHITOSAN
AB Heparin has been widely investigated in medicine and biomedical applications as an anticoagulant. This paper described a covalent modification of poly (lactic acid) (PLA) films with heparin-carrying microcapsules. The heparin-carrying microcapsules were achieved by layer-by-layer (LbL) self-assembly technology by which poly (allylamine hydrochloride) (PAH) and heparin were alternately coated on the Ca2(+)-cross-linked alginate hydrogel. The microcapsules were characterized by scanning electron microscopy (SEM), zeta potential analysis and Fourier transform infrared spectroscopy (FTIR), and then grafted to PLA films by -CONH- linkage between surface PLA molecules with residual primary amino groups on the outer PAH layer of microcapsules, in the presence of catalysts of 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS). SEM and FTIR revealed the formation of -CONH- linkage. In vitro antithrombogenicity by the method of the activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin time (TT) tests showed that surface-modified PLA films had superior coagulation properties to original PLA films. It is suggested that the present method would provide a potential effective tool for biomaterial modification. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Li, Juan; Zhu, Baoqing; Shao, Yingya; Liu, Xinrong; Yang, Xinlin] Beijing Inst Technol, Sch Life Sci & Technol, Beijing 100081, Peoples R China.
   [Yu, Qun] Beijing Inst Blood Transfus, Beijing 100850, Peoples R China.
RP Yang, XL (reprint author), Univ Virginia, Sch Med, Orthopaed Res Labs, POB 800374, Charlottesville, VA 22903 USA.
EM xlyang@bit.edu.cn
RI Zhu, Baoqing/B-5887-2008
FU Beijing Municipal Science & Technology Commission [Y0905001000091]
FX This work supported by the Beijing Municipal Science & Technology
   Commission (No. Y0905001000091).
CR Alferiev IS, 2006, BIOMACROMOLECULES, V7, P317, DOI 10.1021/bm0506694
   Ariga K, 2007, PHYS CHEM CHEM PHYS, V9, P2319, DOI 10.1039/b700410a
   Badulescu R, 2008, CARBOHYD POLYM, V71, P85, DOI 10.1016/j.carbpol.2007.05.028
   Blandino A, 2001, PROCESS BIOCHEM, V36, P601, DOI 10.1016/S0032-9592(00)00240-5
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Gu JW, 2002, MAT SCI ENG C-BIO S, V20, P199, DOI 10.1016/S0928-4931(02)00033-4
   Guo F, 2007, MATER CHEM PHYS, V105, P315, DOI 10.1016/j.matchemphys.2007.04.077
   Hau WLW, 2003, J MICROMECH MICROENG, V13, P272, DOI 10.1088/0960-1317/13/2/315
   Huda MS, 2008, COMPOS SCI TECHNOL, V68, P424, DOI 10.1016/j.compscitech.2007.06.022
   Konno T, 2003, J BIOMED MATER RES A, V65A, P209, DOI 10.1002/jbm.a.10481
   Leporatti S, 2000, LANGMUIR, V16, P4059, DOI 10.1021/la991429a
   LI J, 2008, P 2 INT C BIOINF BIO, P1420
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Masuda K, 2002, J VET MED SCI, V64, P79, DOI 10.1292/jvms.64.79
   Morch YA, 2007, BIOMACROMOLECULES, V8, P2809, DOI 10.1021/bm700502b
   Nelson G, 2002, INT J PHARM, V242, P55, DOI 10.1016/S0378-5173(02)00141-2
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Shao YY, 2009, MAT SCI ENG C-BIO S, V29, P936, DOI 10.1016/j.msec.2008.08.017
   Silver PJ, 1998, THROMB RES, V91, P143, DOI 10.1016/S0049-3848(98)00093-0
   Spinelli FJ, 2008, BIOMATERIALS, V29, P1299, DOI 10.1016/j.biomaterials.2007.11.045
   Srivastava R, 2005, MACROMOL BIOSCI, V5, P717, DOI 10.1002/mabi.200500061
   Sun HX, 2004, CHINESE J POLYM SCI, V22, P399
   Vicario PP, 2008, J BIOMED MATER RES B, V86B, P136, DOI 10.1002/jbm.b.30998
   Westedt U, 2006, J CONTROL RELEASE, V111, P235, DOI 10.1016/j.jconrel.2005.12.012
   Wosnick JH, 2005, MACROMOLECULES, V38, P9287, DOI 10.1021/ma051182q
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1931, DOI 10.1021/bm0500042
   Yu DG, 2007, J BIOMED MATER RES B, V83B, P105, DOI 10.1002/jbm.b.30772
   Zhang JH, 2003, J MATER CHEM, V13, P514, DOI 10.1039/b211497f
   Zhang JT, 2006, J POLYM SCI POL CHEM, V44, P5161, DOI 10.1002/pola.21613
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhu HG, 2005, BIOCONJUGATE CHEM, V16, P1451, DOI 10.1021/bc050171z
   Zhu HG, 2005, BIOMACROMOLECULES, V6, P2221, DOI 10.1021/bm0501656
   Zhu YB, 2004, J BIOMED MATER RES A, V69A, P436, DOI 10.1002/jbm.a.30007
NR 35
TC 32
Z9 37
U1 6
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2009
VL 70
IS 1
BP 15
EP 19
DI 10.1016/j.colsurfb.2008.12.001
PG 5
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 431BU
UT WOS:000265037100003
PM 19155161
DA 2018-10-19
ER

PT J
AU Namba, N
   Yoshida, Y
   Nagaoka, N
   Takashima, S
   Matsuura-Yoshimoto, K
   Maeda, H
   Van Meerbeek, B
   Suzuki, K
   Takashiba, S
AF Namba, Naoko
   Yoshida, Yasuhiro
   Nagaoka, Noriyuki
   Takashima, Seisuke
   Matsuura-Yoshimoto, Kaori
   Maeda, Hiroshi
   Van Meerbeek, Bart
   Suzuki, Kazuomi
   Takashiba, Shogo
TI Antibacterial effect of bactericide immobilized in resin matrix
SO DENTAL MATERIALS
LA English
DT Article
DE Adhesive resin; Antibacterial effect; Bacteria; Bactericide;
   Cetylpyridinium chloride; CPC; Immobilization; Streptococcus mutans
ID STREPTOCOCCUS-MUTANS; DENTAL RESIN; PLAQUE; MDPB; CHLORHEXIDINE;
   COMPOSITE; FILLER; GREEN; RATS
AB Objective. Biomaterials with anti-microbial properties are highly desirable in the oral cavity. Ideally, bactericidal molecules should be immobilized within the biomaterial to avoid unwanted side-effects against surrounding tissues. They may then however loose much of their antibacterial efficiency. The aim of this study was to investigate how much antibacterial effect an immobilized bactericidal molecule still has against oral bacteria.
   Methods. Experimental resins containing 0, 1 and 3% cetylpyridinium chloride (CPC) were polymerized, and the bacteriostatic and bactericidal effects against Streptococcus mutans were determined. Adherent S. mutans on HAp was quantitatively determined using FE-SEM and living cells of S. mutans were quantified using real-time RT-PCR. The amount of CPC released from the 0%-, 1%- and 3%-CPC resin sample into water was spectrometrically quantified using a UV-vis recording spectrophotometer.
   Results. UV spectrometry revealed that less than 0.11 ppm of CPC was released from the resin into water for all specimens, which is lower than the minimal concentration generally needed to inhibit biofilm formation. Growth of S. mutans was significantly inhibited on the surface of the 3%-CPC-containing resin coating, although no inhibitory effect was observed on bacteria that were not in contact with its surface. When immersed in water, the antibacterial capability of 3%-CPC resin lasted for 7 days, as compared to resin that did not contain CPC.
   Significance. These results demonstrated that the bactericidal molecule still possessed significant contact bacteriostatic activity when it was immobilized in the resin matrix. (C) 2008 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Yoshida, Yasuhiro; Suzuki, Kazuomi] Okayama Univ, Dept Biomat, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan.
   [Namba, Naoko; Matsuura-Yoshimoto, Kaori; Maeda, Hiroshi; Takashiba, Shogo] Okayama Univ, Dept Pathophysiol Periodontal Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan.
   [Nagaoka, Noriyuki] Okayama Univ, Electron Microscopy Lab, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan.
   [Takashima, Seisuke] Okayama Univ, Dept Orthopaed Surg, Sch Med, Okayama 7008558, Japan.
   [Van Meerbeek, Bart] Catholic Univ Louvain, Leuven BIOMAT Res Cluster, Dept Conservat Dent, Sch Dent Oral Pathol & Maxillofacial Surg, B-3000 Louvain, Belgium.
RP Yoshida, Y (reprint author), Okayama Univ, Dept Biomat, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008525, Japan.
EM yasuhiro@md.okayama-u.ac.jp
RI Takashiba, Shogo/C-9830-2010; YOSHIDA, Yasuhiro/B-2472-2011
OI Takashiba, Shogo/0000-0002-4712-6829; 
FU Ministry of Education, Science, Sports and Culture of Japan;
   Medical-Techno-Okayama
FX This study was supported in part by a Grant-in-Aid for Scientific
   Research from the Ministry of Education, Science, Sports and Culture of
   Japan, and by funds of Medical-Techno-Okayama (2005).
CR Breen PJ, 1995, J FOOD SCI, V60, P1191, DOI 10.1111/j.1365-2621.1995.tb04553.x
   Ebi N, 2001, DENT MATER, V17, P485, DOI 10.1016/S0109-5641(01)00006-9
   Ehara A, 2000, J DENT RES, V79, P824, DOI 10.1177/00220345000790030701
   IMAZATO S, 1995, J DENT, V23, P177, DOI 10.1016/0300-5712(95)93576-N
   IMAZATO S, 1994, J DENT RES, V73, P1437, DOI 10.1177/00220345940730080701
   Imazato S, 2003, BIOMATERIALS, V24, P3605, DOI 10.1016/S0142-9612(03)00217-5
   Imazato S, 1998, J BIOMED MATER RES, V39, P511, DOI 10.1002/(SICI)1097-4636(19980315)39:4<511::AID-JBM1>3.0.CO;2-M
   Imazato S, 1998, J DENT, V26, P267, DOI 10.1016/S0300-5712(97)00013-4
   IMAZATO S, 1992, Journal of Dental Research, V71, P721
   IMAZATO S, 1998, J BIOMED MATER RES, P39
   Imazato S, 1993, DENT JPN, V30, P63
   JEDRYCHOWSKI JR, 1983, J ORAL REHABIL, V10, P373, DOI 10.1111/j.1365-2842.1983.tb00133.x
   *KUR MED INC, 2003, INTR US CLEARF PROT
   LOESCHE WJ, 1986, MICROBIOL REV, V50, P353
   Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4
   Moran J, 2000, J CLIN PERIODONTOL, V27, P37, DOI 10.1034/j.1600-051x.2000.027001037.x
   Nikolausz M, 2004, J MICROBIOL METH, V56, P365, DOI 10.1016/j.mimet.2003.11.003
   RIBEIRO J, 1991, SCAND J DENT RES, V99, P533
   ROGERS AH, 1979, INFECT IMMUN, V23, P571
   ROLLA G, 1975, J DENT RES, V54, pB57, DOI 10.1177/00220345750540022601
   Sterinberg D., 2001, J ANTIMICROB CHEMOTH, V48, P241
   SWANSON TD, 1984, J ORAL REHABIL, V11, P53, DOI 10.1111/j.1365-2842.1984.tb00552.x
   Takemura K, 1983, JAPAN J CONSERV DENT, V26, P540
   VANDERHOEVEN JS, 1979, INFECT IMMUN, V23, P206
   Witt Jon, 2005, J Contemp Dent Pract, V6, P1
   Yoshida A, 2002, MICROBIOL-SGM, V148, P3385, DOI 10.1099/00221287-148-11-3385
NR 26
TC 89
Z9 91
U1 3
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD APR
PY 2009
VL 25
IS 4
BP 424
EP 430
DI 10.1016/j.dental.2008.08.012
PG 7
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 422ZV
UT WOS:000264467100002
PM 19019421
DA 2018-10-19
ER

PT J
AU Gibson, N
   Shenderova, O
   Luo, TJM
   Moseenkov, S
   Bondar, V
   Puzyr, A
   Purtov, K
   Fitzgerald, Z
   Brenner, DW
AF Gibson, N.
   Shenderova, O.
   Luo, T. J. M.
   Moseenkov, S.
   Bondar, V.
   Puzyr, A.
   Purtov, K.
   Fitzgerald, Z.
   Brenner, D. W.
TI Colloidal stability of modified nanodiamond particles
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE Biomaterial; Nanoparticle; Nanodiamond; Surface modification; Colloid
   stability
ID ULTRADISPERSED DIAMOND HYDROSOLS; DETONATION NANODIAMOND; SURFACE
   OXIDES; AFLATOXIN B-1; CARBON; FUNCTIONALIZATION; AGGREGATION;
   ADSORPTION; POWDER; NANOSCALE
AB Colloidal stability is one of the critical factors for the use of nanodiamonds as potential enterosorbents. Although nanodiamonds are believed to be a promising enterosorbent, colloidal stability in hydrosols of raw polydispersed nanodiamonds produced by detonation is typically low. Surface modification and fractionation significantly improves colloidal stability of nanodiamond suspensions within the physiological pH range. The modification of nanodiamonds can be completed either by physical means, i.e.. plasma treatments. or by chemical methods, in the current paper an analysis of the colloidal stability of detonation nanodiamonds hydrosols, which have undergone different surface modifications, is presented based on zeta potential measurements and titration experiments. Published by Elsevier B.V.
C1 [Gibson, N.; Shenderova, O.; Luo, T. J. M.; Fitzgerald, Z.; Brenner, D. W.] N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   [Shenderova, O.] Int Technol Ctr, Res Triangle Pk, NC USA.
   [Bondar, V.; Puzyr, A.; Purtov, K.] Russian Acad Sci, Inst Biophys, Siberian Branch, Krasnoyarsk, Russia.
   [Moseenkov, S.] Boreskov Inst Catalysis SB RAS, Novosibirsk, Russia.
RP Gibson, N (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Box 7907, Raleigh, NC 27695 USA.
EM nmgibson@ncsu.edu
RI MOseenkov, Sergey/C-5332-2014; Brenner, Donald/D-1741-2009; Luo,
   Tzy-Jiun/A-5032-2010
OI Serg, Moseenkov/0000-0001-7761-5896
FU Materials World Network program of the National Science Foundation
   [DMR-0602906]; Fundamental Research Foundation of Russian Academy of
   Sciences [06-04-90234]
FX The authors acknowledge the financial support of the Materials World
   Network program of the National Science Foundation (Grant DMR-0602906)
   and Fundamental Research Foundation of Russian Academy of Sciences
   (Grant 06-04-90234). Drs. V. Kuznetsov, S. Hens, G. Cunningham, V.
   Grichko, I.Petrov are acknowledged for helpful discussions. Mark Ray is
   acknowledged for the plasma treatment of the samples, and Dr. V.
   Vorobyev is acknowledged for providing the RUDDMI nanodiamond samples.
CR Bakowicz K., 2002, Journal of Wide Bandgap Materials, V9, P261, DOI 10.1106/152451102024429
   Boehm HP, 2002, CARBON, V40, P145, DOI 10.1016/S0008-6223(01)00165-8
   Bondar' VS, 2004, PHYS SOLID STATE+, V46, P716, DOI 10.1134/1.1711457
   CHAO JI, 2007, BIOPHYS J, P2199
   Chiganova GA, 1997, COLLOID J+, V59, P87
   Chiganova GA, 2000, COLLOID J+, V62, P238
   FANNING PE, 1993, CARBON, V31, P721, DOI 10.1016/0008-6223(93)90009-Y
   Fuente E, 2003, LANGMUIR, V19, P3505, DOI 10.1021/la026778a
   GIBSON N, 2007, TECH P 2007 NSTI NAN, V2, P713
   Grant PG, 1998, J AGR FOOD CHEM, V46, P599, DOI 10.1021/jf970604v
   Grichko V., 2007, NANOBIOTECHNOLOGY, V2, P37
   HENS S, DIAMOND REL IN PRESS
   Ji SF, 1998, APPL SURF SCI, V133, P231, DOI 10.1016/S0169-4332(98)00209-8
   Jiang T, 1995, CARBON, V33, P1663, DOI 10.1016/0008-6223(95)00115-1
   Kelly JD, 1997, TOXICOL APPL PHARM, V144, P88, DOI 10.1006/taap.1997.8117
   Kruger A, 2006, J MATER CHEM, V16, P2322, DOI [10.1039/b601325b, 10.1039/b601625b]
   Kruger A, 2005, CARBON, V43, P1722, DOI 10.1016/j.carbon.2005.02.020
   Larionova I, 2006, DIAM RELAT MATER, V15, P1804, DOI 10.1016/j.diamond.2006.07.016
   LIU KK, 2007, NANOTECHNOLOGY
   Liu Y, 2004, CHEM MATER, V16, P3924, DOI 10.1021/cm048875q
   Montes-Moran MA, 2004, CARBON, V42, P1219, DOI 10.1016/j.carbon.2004.01.023
   Petrov I, 2007, DIAM RELAT MATER, V16, P2098, DOI 10.1016/j.diamond.2007.05.013
   PETROV I, 2006, TECH P 2006 NSTI NAN, P150
   PIER AC, 1992, J ANIM SCI, V70, P3964
   Puzyr AP, 2007, DIAM RELAT MATER, V16, P2124, DOI 10.1016/j.diamond.2007.07.025
   Puzyr AP, 2007, DOKL BIOCHEM BIOPHYS, V417, P299, DOI 10.1134/S1607672907060026
   Puzyr' A.P., 2004, SIB MED OBOZR, V4, P19
   Puzyr' A.P., 2005, SIBERIAN MED REV, V1, P20
   PUZYR AP, 2004, SIB MED OBOZR, P25
   PUZYR AP, 2003, Patent No. 2252192
   PUZYR AR, 2005, B SIB MED, P185
   Raty JY, 2003, NAT MATER, V2, P792, DOI 10.1038/nmat1018
   Ray MA, 2006, DIAM RELAT MATER, V15, P1809, DOI 10.1016/j.diamond.2006.06.003
   Riddick T., 1968, ZETA METER OPERATING
   Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v
   Shenderova O, 2006, DIAM RELAT MATER, V15, P1799, DOI 10.1016/j.diamond.2006.08.032
   Shenderova O.A., 2006, ULTRANANOCRYSTALLINE
   Xu X.Y., 2005, DIAM RELAT MATER, V14, P206, DOI DOI 10.1016/J.DIAM0ND2004.11
   Yu SJ, 2005, J AM CHEM SOC, V127, P17604, DOI 10.1021/ja0567081
NR 39
TC 130
Z9 132
U1 0
U2 63
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR
PY 2009
VL 18
IS 4
BP 620
EP 626
DI 10.1016/j.diamond.2008.10.049
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 422KT
UT WOS:000264427300005
DA 2018-10-19
ER

PT J
AU Wan, SW
   Qin, P
   Liu, JN
   Zhou, HX
AF Wan, Shuwen
   Qin, Pei
   Liu, Jine
   Zhou, Hongxiang
TI The positive and negative effects of exotic Spartina alterniflora in
   China
SO ECOLOGICAL ENGINEERING
LA English
DT Article
DE Exotic species; Spartina alterniflora; Ecological function; Ecological
   regulation; China
ID SALT-MARSH; ANGLICA; VEGETATION; WETLANDS; ZONES; PLANT; OIL
AB Spartina alterniflora is a perennial salt marsh grass native to the Atlantic and Gulf Coasts of North America. Recognized for its effects of diminishing strong tide even storms and accelerating sediment deposition, S. alterniflora was introduced into China in 1979. Now the artificial vegetation of Spartina has expanded to around 50 000 h m(2) along the east coast of China due to its strong capability of propagating by seeds and rhizome fragments. Although it was listed among 16 harmful exotic species in China 3 years ago, we need to evaluate its positive and negative effects in the coastal region of China objectively. This paper reviews some major positive effects of S. alterniflora in China, e.g. being a dominant primary producer, buffering against tides, accelerating accretion and reclamation, absorbing nutrients and digesting pollutants, as well as some major negative effects, e.g. occupying the niche of local species, altering the mudflat habitat, changing and even diminishing biodiversity, and damaging the aquiculture in the tidal land. In addition, its biomaterial uses and biological substitution as a means of ecological regulation is also discussed. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Wan, Shuwen; Qin, Pei; Liu, Jine; Zhou, Hongxiang] Nanjing Univ, Halophyte Res Lab, Nanjing 210093, Peoples R China.
RP Qin, P (reprint author), Nanjing Univ, Halophyte Res Lab, Nanjing 210093, Peoples R China.
EM qinpei@nju.edu.cn
FU 11.5 National Scientific Plan [2006BAD03A19]; National 908 Plan
   [JS-908-02-07]; Nanjing University 985 (II).
FX Funding for this study was provided by 11.5 National Scientific Plan
   2006BAD03A19, National 908 Plan JS-908-02-07 and Nanjing University 985
   (II). We also thank Mr. Longyou Min, Mr. Hui Cai, Dr. Wenqing Wang, and
   Dr. Pin Zuo for those photographs used in this paper.
CR Ayres DR, 1999, MOL ECOL, V8, P1179, DOI 10.1046/j.1365-294x.1999.00679.x
   Bruno JF, 2000, OECOLOGIA, V122, P98, DOI 10.1007/PL00008841
   Cantero JJ, 1998, PLANT ECOL, V137, P79, DOI 10.1023/A:1008071813231
   Cao H-L, 1997, TROP GEOGR, V17, P41
   Chung CH, 2004, ECOL ENG, V23, P135, DOI 10.1016/j.ecoleng.2004.07.004
   DAVY, 1992, COASTAL PLANT COMMUN, P157
   HUBBARD RK, 1999, RRANSAC ASAE, V42, P1331
   LIN GL, 1999, FUJIAN PASTURAGE VET, V21, P4
   Lin QX, 1998, ECOL ENG, V10, P263, DOI 10.1016/S0925-8574(98)00015-9
   Lindau CW, 1999, MAR POLLUT BULL, V38, P1216, DOI 10.1016/S0025-326X(99)00165-4
   Liu J, 2007, ECOL ENG, V30, P240, DOI 10.1016/j.ecoleng.2007.01.010
   LIU JP, 2002, HEBEI ENV SCI, V10, P45
   LONG SP, 1975, NATURE, V257, P622, DOI 10.1038/257622a0
   LU SM, 1996, ZHEJIANG HYDROL SCI, V2, P40
   MALLOTT PG, 1975, OECOLOGIA, V20, P351, DOI 10.1007/BF00345525
   Maricle BR, 2002, AQUAT BOT, V74, P109, DOI 10.1016/S0304-3770(02)00051-7
   Mitsch W. J., 1993, WETLANDS
   MITSCH WJ, 2000, WETLANDS, P270
   MYERS N, 1993, BIOSCIENCE, V43, P752, DOI 10.2307/1312319
   POMEROY LR, 1981, ECOLOGY SALT MARSH, P39
   QI GX, 1999, GUIZHOU ENV SCI, V5, P44
   Qin P, 1998, ECOL ENG, V11, P147, DOI 10.1016/S0925-8574(98)00030-5
   Qin P., 1992, APPL STUDIES SPARTIN, p[61, 105]
   Qin P., 1985, COMP BIOMASS 3 ECOTY, P226
   QIN P, 1989, FUJIAN PROVINCE MAR, V6, P23
   QIN XQ, 1998, AGR SCI E FUJIAN PRO, V2, P35
   Tanner CC, 1998, WATER RES, V32, P3046, DOI 10.1016/S0043-1354(98)00078-5
   Theodose TA, 1999, PLANT ECOL, V143, P219, DOI 10.1023/A:1009887727465
   THOMPSON JD, 1991, BIOSCIENCE, V41, P393, DOI 10.2307/1311746
   *WA SEA GRANT PROG, 2000, BIO INV BREACH NAT
   WANG BC, 1996, AGR SCI ZHEJIANG PRO, V1, P37
   Wang G, 2008, ECOL ENG, V32, P249, DOI 10.1016/j.ecoleng.2007.11.014
   ZHENG GR, 1994, EPIDEMIC PREV, V6, P21
   ZHOU H, 2007, J NANJING U, V43, P26
   Zhou HX, 2008, PEDOSPHERE, V18, P77, DOI 10.1016/S1002-0160(07)60105-2
NR 35
TC 57
Z9 63
U1 2
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-8574
J9 ECOL ENG
JI Ecol. Eng.
PD APR
PY 2009
VL 35
IS 4
BP 444
EP 452
DI 10.1016/j.ecoleng.2008.05.020
PG 9
WC Ecology; Engineering, Environmental; Environmental Sciences
SC Environmental Sciences & Ecology; Engineering
GA 446RK
UT WOS:000266138600003
DA 2018-10-19
ER

PT J
AU Abhinav, K
   Shaaban, M
   Raymond, T
   Oke, T
   Gullan, R
   Montgomery, ACV
AF Abhinav, K.
   Shaaban, M.
   Raymond, T.
   Oke, T.
   Gullan, R.
   Montgomery, A. C. V.
TI Primary reconstruction of pelvic floor defects following sacrectomy
   using Permacol (TM) graft
SO EJSO
LA English
DT Article
DE Sacrectomy; Sacral chordoma; Pelvic floor; Primary reconstruction
ID ABDOMINAL-WALL RECONSTRUCTION; PERINEAL HERNIA; INCISIONAL HERNIAS;
   MYOCUTANEOUS FLAP; MESH REPAIR; CHORDOMA; IMPLANT; MALIGNANCIES;
   EXPERIENCE; RESECTION
AB Aims: The large pelvic floor defect following sacrectonny for sacral masses leaves the challenging problem of primary closure and herniation. We present the outcome of primary repair using Permacol (TM), a biomaterial made of acellular porcine cross-linked dermal collagen and with similar tensile strength to polypropylene mesh. It is non-allergenic and possibly less likely (hall synthetic Mesh to Cause inflammation leading to small bowel adherence: fistula formation and graft extrusion. Following implantation. Permacol is colonized by host cells and resists degradation by host enzymes.
   Methods: Three patients had sacrectomy with primary repair of pelvic floor defects between March 2004 and August 2005. Two had excision of sacral chordomas and one excision of a sacrococcygeal teratoma. Repair of the defect was carried out using the Permacol graft, suturing to the sacrum. anococcygeal raphe and ischial spines. Two suction drains were placed superficial to the mesh.
   Results: All patients had gross en-bloc tumour resections and over a median follow-up period of I year (range 8-25 months), there were no complications related to primary repair.
   Conclusion: Primary closure of a large defect following sacrectomy using a Permacol graft, in our early experience seems to be convenient and safe without the development of herniation. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Abhinav, K.; Shaaban, M.; Raymond, T.; Oke, T.; Montgomery, A. C. V.] Queen Elizabeth Hosp, Dept Surg, London SE18 4QH, England.
   [Gullan, R.] Kings Coll Hosp London, Dept Neurosurg, London, England.
RP Abhinav, K (reprint author), 4 Garden Flat,Gordon Rd, Bristol BS8 1AP, Avon, England.
EM kumar.abhinav@doctors.org.uk
CR Adedeji OA, 2002, BRIT J PLAST SURG, V55, P85, DOI 10.1054/bjps.2001.3711
   Atkin G, 2003, J ROY SOC MED, V96, P28, DOI 10.1258/jrsm.96.1.28
   Bano F, 2005, INT UROGYNECOL J, V16, P147, DOI 10.1007/s00192-004-1216-y
   Bergh P, 2000, CANCER-AM CANCER SOC, V88, P2122, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2122::AID-CNCR19>3.0.CO;2-1
   Brizendine J B, 2006, Hernia, V10, P360, DOI 10.1007/s10029-006-0092-4
   Burger JWA, 2004, ANN SURG, V240, P578
   Cancrini A, 1997, G Chir, V18, P488
   Catena F, 2007, Hernia, V11, P57, DOI 10.1007/s10029-006-0171-6
   CHERNY VA, 1988, VESTN KHIR IM GREKOV, V140, P88
   Diaz J, 2003, ANN PLAS SURG, V51, P126, DOI 10.1097/01.SAP.0000063754.39566.5C
   Fourney DR, 2003, NEUROSURG FOCUS, V15, P1
   Glatt BS, 2006, ANN PLAS SURG, V56, P526, DOI 10.1097/01.sap.0000205772.15061.39
   Gokaslan ZL, 1997, J NEUROSURG, V87, P781, DOI 10.3171/jns.1997.87.5.0781
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Kaleya Ronald N, 2005, Hernia, V9, P269, DOI 10.1007/s10029-005-0003-0
   Kaplan LJ, 1996, AM SURGEON, V62, P762
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Lehto S A, 2000, Bull Hosp Jt Dis, V59, P113
   Liyanage SH, 2006, J PLAST RECONSTR AES, V59, P553, DOI 10.1016/j.bjps.2005.06.008
   Macleod TM, 2005, BRIT J PLAST SURG, V58, P518, DOI 10.1016/j.bjps.2004.12.012
   Miles WK, 2000, PLAST RECONSTR SURG, V105, P2387, DOI 10.1097/00006534-200006000-00012
   Parker David M, 2006, Curr Surg, V63, P255, DOI 10.1016/j.cursur.2006.05.003
   Patton JH, 2007, AM J SURG, V193, P360, DOI 10.1016/j.amjsurg.2006.09.021
   Radice E, 1999, BRIT J SURG, V86, P349
   SAMSON IR, 1993, J BONE JOINT SURG AM, V75A, P1476, DOI 10.2106/00004623-199310000-00008
   Santora TA, 1998, ORTHOPEDICS, V21, P203
   Saray A, 2003, AESTHET PLAST SURG, V27, P368, DOI 10.1007/s00266-003-3012-3
   So JBY, 1997, DIS COLON RECTUM, V40, P954, DOI 10.1007/BF02051204
   TEMPLE WJ, 1992, AM J SURG, V163, P370, DOI 10.1016/0002-9610(92)90035-P
   TOMITA K, 1990, SPINE, V15, P1223, DOI 10.1097/00007632-199011010-00024
   Turkcapar AG, 1998, SURG TODAY, V28, P59, DOI 10.1007/s005950050077
   Yerdel MA, 2001, ANN SURG, V233, P26, DOI 10.1097/00000658-200101000-00005
   York JE, 1999, NEUROSURGERY, V44, P74, DOI 10.1097/00006123-199901000-00041
NR 34
TC 11
Z9 12
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0748-7983
J9 EJSO-EUR J SURG ONC
JI EJSO
PD APR
PY 2009
VL 35
IS 4
BP 439
EP 443
DI 10.1016/j.ejso.2008.03.007
PG 5
WC Oncology; Surgery
SC Oncology; Surgery
GA 425JJ
UT WOS:000264632500019
PM 18439796
DA 2018-10-19
ER

PT J
AU Simonpieri, A
   Del Corso, M
   Sammartino, G
   Ehrenfest, DMD
AF Simonpieri, Alain
   Del Corso, Marco
   Sammartino, Gilberto
   Ehrenfest, David M. Dohan
TI The Relevance of Choukroun's Platelet-Rich Fibrin and Metronidazole
   During Complex Maxillary Rehabilitations Using Bone Allograft. Part 1: A
   New Grafting Protocol
SO IMPLANT DENTISTRY
LA English
DT Article
DE bone graft; fibrin; freeze-dried bone allograft; platelet concentrate;
   platelet-rich fibrin (PRF); platelet-rich plasma; metronidazole;
   sinus-lift
ID SINUS FLOOR ELEVATION; CONSENSUS CONFERENCE; IMPLANTS; PLACEMENT;
   PLASMA; PRF; OSSEOINTEGRATION; AUGMENTATION; COMBINATION; EXTRACTION
AB Extensive bone grafting remains a delicate procedure, because of the slow and difficult integration of the grafted material into the physiological architecture. The recent use of platelet concentrates aims to improve this process of integration by accelerating bone and mucosal healing. Choukroun's platelet-rich fibrin (PRF) is a healing biomaterial that concentrates in a single autologous fibrin membrane, most platelets, leukocytes, and cytokines from a 10 mL blood harvest, without artificial biochemical modification (no anticoagulant, no bovine thrombin). Whether used as a membrane or as fragments, PRF allows a significant postoperative protection of the surgical site and seems to accelerate the integration and remodeling of the grafted biomaterial. These properties are particularly helpful for vestibular bone grafting on the alveolar ridges. Moreover, it provides a very high quality of gingival maturation. A small quantity of a 0.5% metronidazole solution (10 mg) can also be used to provide an efficient protection of the bone graft against unavoidable anaerobic bacterial contamination. This article describes a new technique of total maxillary preimplant bone grafting using allograft, Choukroun's PRF membranes and metronidazole. This first part focused on the preimplant reconstructive treatment using allogeneic bone granules. PRF membranes are particularly helpful to protect the surgical site and foster soft tissue healing. This fibrin biomaterial represents a new opportunity to improve both the maturation of bone grafts and the final esthetic result of the peri-implant soft tissue. (Implant Dent 2009;18:102-111)
C1 [Ehrenfest, David M. Dohan] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, S-41390 Gothenburg, Sweden.
   [Sammartino, Gilberto] Univ Naples Federico II, Dept Odonto Stomatol & Maxillo Facial Sci, Naples, Italy.
   [Del Corso, Marco] Univ Turin, Dept Periodont, Turin, Italy.
RP Ehrenfest, DMD (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Medicinaregatan 8B, S-41390 Gothenburg, Sweden.
EM LoB5@mac.com
RI Dohan Ehrenfest, David/C-8866-2012
OI Del Corso, Marco/0000-0002-2882-8139
CR Boeck-Neto R, 2002, J PERIODONTOL, V73, P266, DOI 10.1902/jop.2002.73.3.266
   CHARRIER JB, REV LARYNGO IN PRESS
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J., 2001, IMPLANTODONTIE, V42, P55
   Choukroun J I, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P27
   Choukroun J, 2008, IMPLANT DENT, V17, P257, DOI 10.1097/ID.0b013e318181349a
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Diss A, 2008, ORAL SURG ORAL MED O, V105, P572, DOI 10.1016/j.tripleo.2007.08.021
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P305, DOI 10.1016/j.tripleo.2006.10.009
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P587, DOI 10.1016/j.tripleo.2007.03.016
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Geurs NC, 2001, INT J PERIODONT REST, V21, P517
   Goga D, 2000, Rev Stomatol Chir Maxillofac, V101, P303
   Holmquist P, 2008, CLIN IMPLANT DENT R, V10, P86, DOI 10.1111/j.1708-8208.2007.00063.x
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Kassolis JD, 2000, J PERIODONTOL, V71, P1654, DOI 10.1902/jop.2000.71.10.1654
   Le Lorc'h-Bukiet I, 2005, CLIN ORAL IMPLAN RES, V16, P244, DOI 10.1111/j.1600-0501.2004.01102.x
   Lozada Jaime, 2002, J Oral Implantol, V28, P9, DOI 10.1563/1548-1336(2002)028<0009:CRAHEO>2.3.CO;2
   Lundgren S, 1999, INT J ORAL MAX SURG, V28, P31, DOI 10.1034/j.1399-0020.1999.280108.x
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Minichetti John C, 2004, J Oral Implantol, V30, P74, DOI 10.1563/0.693.1
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P279, DOI 10.1034/j.1600-0501.2001.012003279.x
   SAADOUN AP, 2007, PRACT PROCED AESTHET, V19, P81
   Shulman LB, 1998, INT J ORAL MAX IMPL, V13, P5
   Simon JA, 2004, LUPUS, V13, P177, DOI 10.1191/0961203304lu526oa
   Simonpieri A., 2005, IMPLANT, V11, P33
   Soadoun A.P., 2007, PRACT PROCED AESTHET, V19, P88
   Tulasne J.-F., 1999, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V100, P265
   Tulasne J-F, 2003, Rev Stomatol Chir Maxillofac, V104, P159
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Weibrich G, 2003, CLIN ORAL IMPLAN RES, V14, P233, DOI 10.1034/j.1600-0501.2003.140215.x
NR 36
TC 57
Z9 63
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2009
VL 18
IS 2
BP 102
EP 111
DI 10.1097/ID.0b013e318198cf00
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 431PM
UT WOS:000265075100002
PM 19359860
DA 2018-10-19
ER

PT J
AU Cao, Y
   Wang, BC
AF Cao, Yang
   Wang, Bochu
TI Biodegradation of Silk Biomaterials
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE Biodegradation; Silk Biomaterials; Enzymatic Degradation
ID BOMBYX-MORI; IN-VITRO; MECHANICAL-PROPERTIES; SECONDARY STRUCTURE;
   SUTURE MATERIALS; FIBROIN; PROTEIN; VIVO; DEGRADATION; SCAFFOLDS
AB Silk fibroin from the silkworm, Bombyx mori, has excellent properties such as biocompatibility, biodegradation, non-toxicity, adsorption properties, etc. As a kind of ideal biomaterial, silk fibroin has been widely used since it was first utilized for sutures a long time ago. The degradation behavior of silk biomaterials is obviously important for medical applications. This article will focus on silk-based biomaterials and review the degradation behaviors of silk materials.
C1 [Cao, Yang; Wang, Bochu] Jiangsu Univ Sci & Technol, Coll Biol & Environm Engn, Zhenjiang 212018, Jiangsu, Peoples R China.
   [Wang, Bochu] Chongqing Univ, Coll Bioengn, Chongqing 400030, Peoples R China.
RP Wang, BC (reprint author), Jiangsu Univ Sci & Technol, Coll Biol & Environm Engn, Zhenjiang 212018, Jiangsu, Peoples R China.
EM bestmancy@163.com; wangbc2000@126.com
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya Chitrangada, 2008, Biotechnol J, V3, P226, DOI 10.1002/biot.200700120
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   BUCKNALL TE, 1983, EUR SURG RES, V15, P59, DOI 10.1159/000128334
   Chen Guoding, 1996, Journal of Sericultural Science of Japan, V65, P182
   CHEN K, 1991, Journal of Sericultural Science of Japan, V60, P402
   Chen Kaili, 1996, Journal of Sericultural Science of Japan, V65, P131
   CHITRANGADA A, 2008, BIOMATERIALS, V29, P4665
   CHITRANGADA A, 2009, ACTA BIOMATER, V5, P429
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   HESLOT H, 1998, BIOCHIMIC, V80, P9
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Huang J, 2007, POLYM REV, V47, P29, DOI 10.1080/15583720601109560
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kojthung A, 2008, INT BIODETER BIODEGR, V62, P487, DOI 10.1016/j.ibiod.2007.12.012
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lloyd Andrew W, 2002, Med Device Technol, V13, P18
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Postlethwait RW, 1969, REPAIR REGENERATION, P263
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   SALTHOUSE TN, 1977, AM J OPHTHALMOL, V84, P224, DOI 10.1016/0002-9394(77)90856-X
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   Tsukada M, 1986, J SERIC SCI JPN, V55, P120
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VONRECUM AF, 1995, J APPL BIOMATER, V6, P137, DOI 10.1002/jab.770060209
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zou B, 2006, J MATER SCI, V41, P3357
NR 58
TC 205
Z9 216
U1 4
U2 86
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2009
VL 10
IS 4
BP 1514
EP 1524
DI 10.3390/ijms10041514
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 438BJ
UT WOS:000265530600007
PM 19468322
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Yamatogi, S
   Amemiya, Y
   Ikeda, T
   Kuroda, A
   Yokoyama, S
AF Yamatogi, Shinya
   Amemiya, Yoshiteru
   Ikeda, Takeshi
   Kuroda, Akio
   Yokoyama, Shin
TI Si Ring Optical Resonators for Integrated On-Chip Biosensing
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT International Conference on Solid State Devices and Materials
CY SEP 24-26, 2008
CL Tsukuba, JAPAN
SP Tsukuba Int Congress Ctr, Japan Soc Appl Phys & Tech, IEEE Electron Devices Soc
ID BIOTINYLATION; PROTEINS
AB Si ring optical resonators were fabricated for integrated on-chip biosensing, and tested for their sensing ability using sucrose solution. Resonance wavelength shifts were observed depending on the concentration of the solution. By detecting the output intensity change at a fixed wavelength, the detection sensitivity of the resonator became ten times larger than that obtained by detecting a resonance wavelength shift directly. Si ring optical resonators were applied to biomaterial sensing such as streptavidin and bacterial cells using the silicon-binding protein Si-tag, which enables receptors to be immobilized directly on the Si dioxide surface. For biosensing in aqueous solutions, the simulation results show that a wavelength of 1.3 mu m is suitable. The results of this work indicate the possibility of further increasing sensing ability. (C) 2009 The Japan Society of Applied Physics
C1 [Yamatogi, Shinya; Amemiya, Yoshiteru; Ikeda, Takeshi; Kuroda, Akio; Yokoyama, Shin] Hiroshima Univ, Res Inst Nanodevice & Bio Syst, Hiroshima 7398527, Japan.
   [Ikeda, Takeshi; Kuroda, Akio] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima 7398530, Japan.
RP Yamatogi, S (reprint author), Hiroshima Univ, Res Inst Nanodevice & Bio Syst, 1-4-2 Kagamiyama, Hiroshima 7398527, Japan.
EM yokoyama-shin@hiroshima-u.ac.jp
RI Ikeda, Takeshi/B-4792-2008
OI Ikeda, Takeshi/0000-0001-7159-5660
CR Ahmed ABF, 2007, J BIOSCI BIOENG, V104, P55, DOI 10.1263/jbb.104.55
   Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921
   Cull MG, 2000, METHOD ENZYMOL, V326, P430
   De Vos K, 2007, OPT EXPRESS, V15, P7610, DOI 10.1364/OE.15.007610
   HANCOCK K, 2001, LIFE SCI NEWS, V8, P14
   Ikeda T, 2009, ANAL BIOCHEM, V385, P132, DOI 10.1016/j.ab.2008.11.001
   Kokubun Y., 2003, Oyo Buturi, V72, P1364
   PALMER KF, 1974, J OPT SOC AM, V64, P1107, DOI 10.1364/JOSA.64.001107
   Ramachandran A, 2008, BIOSENS BIOELECTRON, V23, P939, DOI 10.1016/j.bios.2007.09.007
   Sambrook J, 2001, MOL CLONING LAB MANU
   Taniguchi K, 2007, BIOTECHNOL BIOENG, V96, P1023, DOI 10.1002/bit.21208
   Tanushi Y, 2007, JPN J APPL PHYS 1, V46, P2364, DOI 10.1143/JJAP.46.2364
NR 12
TC 17
Z9 17
U1 2
U2 4
PU JAPAN SOC APPLIED PHYSICS
PI TOKYO
PA KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO,
   102-0073, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD APR
PY 2009
VL 48
IS 4
SI SI
AR 04C188
DI 10.1143/JJAP.48.04C188
PN 2
PG 6
WC Physics, Applied
SC Physics
GA 439UL
UT WOS:000265652700189
DA 2018-10-19
ER

PT J
AU Faucheux, C
   Verron, E
   Soueidan, A
   Josse, S
   Arshad, MD
   Janvier, P
   Pilet, P
   Bouler, JM
   Bujoli, B
   Guicheux, J
AF Faucheux, C.
   Verron, E.
   Soueidan, A.
   Josse, S.
   Arshad, M. D.
   Janvier, P.
   Pilet, P.
   Bouler, J. M.
   Bujoli, B.
   Guicheux, J.
TI Controlled release of bisphosphonate from a calcium phosphate
   biomaterial inhibits osteoclastic resorption in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bisphosphonate; calcium phosphate biomaterial; drug delivery system;
   osteoblast
ID MEVALONATE PATHWAY; DEFICIENT APATITE; BONE-RESORPTION; OSTEOPOROSIS;
   APOPTOSIS; GROWTH; HYDROXYAPATITE; IMPLANTS; RECEPTOR; DELIVERY
AB Calcium phosphate biomaterials such as calcium deficient apatite (CDA) have been contemplated as carrier for delivery of bisphosphonate in bone tissues. In the present work, we have investigated the in vitro biological properties of Zoledronate-loaded CDA. CDA was loaded with zoledronate according to a previously described coating process. (31)p MAS NMR spectra demonstrated the effective loading of zoledronate onto CDA. Using (14)C labeled zoledronate, we then demonstrated the in vitro release of zoledronate from CDA. In a first set of experiments, we confirmed that Zoledronate reduced the number of TRAP-, vitronectin receptor-, and F-actin ring-positive cells as well as the resorption activity of osteoclasts obtained from a total rabbit bone cell culture. Interestingly, Zoledronate-loaded CDA and its extractive solutions decreased the osteoclastic resorption. Finally, zoledronate-loaded CDA did not affect the viability and alkaline phosphatase activity of primary osteoblastic cells. These data demonstrate that CDA is effective for loading and release of zoledronate. The released zoledronate inhibited osteoclastic resorption without affecting osteoblasts. Our findings therefore suggest that such a drug delivery system would allow an increase in the efficiency of bisphosphonates by being locally available. Further experiments are now required to evaluate the in vivo antiresorptive activity of this concept. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 46-56, 2009
C1 [Faucheux, C.; Verron, E.; Soueidan, A.; Arshad, M. D.; Pilet, P.; Bouler, J. M.; Guicheux, J.] LIOAD, INSERM, U791, F-44042 Nantes, France.
   [Faucheux, C.; Verron, E.; Soueidan, A.; Arshad, M. D.; Pilet, P.; Bouler, J. M.; Guicheux, J.] Univ Nantes, F-44042 Nantes, France.
   [Josse, S.; Janvier, P.; Bujoli, B.] CNRS, UMR 6513, Organ Synth Lab, Fac Sci, Nantes, France.
RP Guicheux, J (reprint author), LIOAD, INSERM, U791, F-44042 Nantes, France.
EM jerome.guicheux@nantes.inserm.fr
RI Paul, Pilet/A-3755-2015; Verron, Elise/P-2645-2014; guicheux,
   Jerome/F-7767-2013; Soueidan, Assem/P-1781-2014
OI Verron, Elise/0000-0003-4276-5127; guicheux, Jerome/0000-0003-2754-3024;
   BOULER, Jean-Michel/0000-0001-9784-5584
FU Fondation de IAvenir pour la Recherche Medicale Appliquee [Etude
   ET2-321, ET5-405]; CPER "Biomateriaux"; CNRS (Programme Materiaux
   Nouveaux-Fonctionnalites Nouvelles); French Ministry of Research (ACI
   "Technologie pour la Sante"); ANR [RNTS 2005]
FX Contract grant sponsors: CPER "Biomateriaux", CNRS (Programme Materiaux
   Nouveaux-Fonctionnalites Nouvelles), The French Ministry of Research
   (ACI "Technologie pour la Sante"), ANR RNTS 2005 "MIADROS"
CR Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Chaplet ML, 2004, BIOCHEM J, V384, P591, DOI 10.1042/BJ20040380
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Denissen H, 1997, J PERIODONTAL RES, V32, P40, DOI 10.1111/j.1600-0765.1997.tb01380.x
   Faucheux C, 2002, J BONE MINER RES, V17, P455, DOI 10.1359/jbmr.2002.17.3.455
   Fisher JE, 2000, ENDOCRINOLOGY, V141, P4793, DOI 10.1210/en.141.12.4793
   FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0
   Fulfaro F, 1998, PAIN, V78, P157, DOI 10.1016/S0304-3959(98)00135-3
   GALLAGHER A, 1993, ENDOCRINOLOGY, V133, P2787, DOI 10.1210/en.133.6.2787
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   GAUTHIER O, 1999, BONE S, V25, pS17
   GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O
   Green JR, 2002, AM J CLIN ONCOL-CANC, V25, pS3, DOI 10.1097/00000421-200212001-00002
   Grimandi G, 2006, MICROSC RES TECHNIQ, V69, P606, DOI 10.1002/jemt.20326
   Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060
   Guicheux J, 1998, BONE, V22, P25, DOI 10.1016/S8756-3282(97)00224-X
   Heymann D, 1998, CYTOKINE, V10, P155, DOI 10.1006/cyto.1997.0277
   Josse S, 2005, BIOMATERIALS, V26, P2073, DOI 10.1016/j.biomaterials.2004.05.019
   Josse S, 2004, ADV MATER, V16, P1423, DOI 10.1002/adma.200306340
   LAKKAKORPI PT, 1991, J CELL BIOL, V115, P1179, DOI 10.1083/jcb.115.4.1179
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581
   Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430
   MAGNE D, 2002, DRUG DISCOV TODAY, V7, P928
   Obadia L, 2003, BIOMATERIALS, V24, P1265, DOI 10.1016/S0142-9612(02)00446-5
   Obadia L, 2007, J BIOMED MATER RES B, V80B, P32, DOI 10.1002/jbm.b.30565
   Orcel P, 2005, JOINT BONE SPINE, V72, P461, DOI 10.1016/j.jbspin.2005.09.002
   Papapoulos SE, 2005, BEST PRACT RES CL RH, V19, P965, DOI 10.1016/j.berh.2005.06.009
   Raisz LG, 2003, ENDOCRIN METAB CLIN, V32, P15, DOI 10.1016/S0889-8529(02)00055-5
   Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C
   Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640
   Roussiere H, 2005, J MATER CHEM, V15, P3869, DOI 10.1039/b503680a
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Schindeler A, 2005, BIOCHEM BIOPH RES CO, V338, P710, DOI 10.1016/j.bbrc.2005.09.198
   Schmidt-Rohr K., 1994, MULTIDIMENSIONAL SOL
   Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057
   Weinstein RS, 2000, AM J MED, V108, P153, DOI 10.1016/S0002-9343(99)00420-9
   Widler L, 2002, J MED CHEM, V45, P3721, DOI 10.1021/jm020819i
NR 43
TC 34
Z9 39
U1 2
U2 33
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2009
VL 89A
IS 1
BP 46
EP 56
DI 10.1002/jbm.a.31989
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 416BX
UT WOS:000263981300005
PM 18404716
DA 2018-10-19
ER

PT J
AU Rodriguez, A
   Meyerson, H
   Anderson, JM
AF Rodriguez, Analiz
   Meyerson, Howard
   Anderson, James M.
TI Quantitative in vivo cytokine analysis at synthetic biomaterial implant
   sites
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cage implant system; multiplex immunoassay; cytokines; synthetic
   biomaterials
ID GIANT-CELL FORMATION; SURFACE-CHEMISTRY; MACROPHAGE ACTIVATION;
   MONOCYTES MACROPHAGES; ADHERENT MACROPHAGES; FUSION; VITRO;
   INTERLEUKIN-4; EXPRESSION; CHEMOKINES
AB To further elucidate the foreign body reaction, investigation of cytokines at biomaterial implant sites was carried out using a multiplex immunoassay and ELISA. Macrophage activation cytokines (IL-1 beta, IL-6, and TNF alpha), cytokines important for macrophage fusion (IL-4 and IL-13), anti inflammatory cytokines (IL-10 and TGF beta), chemokines (GRO/KC, MCPA.), and the T-cell activation cytokine IL-2 were quantified at biomaterial implant sites. Empty cages (controls) or cages containing synthetic biomedical polymer (Elasthane 80A (PEU), silicone rubber (SR), or polyethylene terephthalate (PET)) were implanted subcutaneously in Sprague-Dawley rats for 4, 7, or 14 days, and cytokines in exudate supernatants and macrophage surface adhesion and fusion were quantified. The presence of a polymer implant did not affect the levels of IL-1 beta, TGF beta, and MCP-1 in comparison to the control group. IL-2 was not virtually detected in any of the samples. Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNF alpha were significantly greater in those animals implanted with PEU and SR, materials that do not promote fusion. The results indicate that differential material-dependent cytokine profiles are produced by surface adherent macrophages and foreign body giant cells in vivo. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 152-159, 2009
C1 [Rodriguez, Analiz; Meyerson, Howard; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU National Institutes of Health [EB-000282]
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: EB-000282
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   CHANG DT, 2008, J BIOMED MAT RES
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   de Jager W, 2006, METHODS, V38, P294, DOI 10.1016/j.ymeth.2005.11.008
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010
   Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Heijmans-Antonissen C, 2006, MEDIAT INFLAMM, DOI 10.1155/MI/2006/28398
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   Hernandez-Pando R, 2000, IMMUNOLOGY, V100, P352, DOI 10.1046/j.1365-2567.2000.00025.x
   Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Kaplan D, 1996, IMMUNOL TODAY, V17, P303, DOI 10.1016/0167-5699(96)30017-0
   Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003
   Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lagrelius M, 2006, CYTOKINE, V33, P156, DOI 10.1016/j.cyto.2006.01.005
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   McNally AK, 1996, AM J PATHOL, V149, P975
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245
   Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162
   RODRIGUEZ A, J BIOMED MA IN PRESS
   Rollins BJ, 1997, BLOOD, V90, P909
   Schuster M, 2002, HUM IMMUNOL, V63, P211, DOI 10.1016/S0198-8859(01)00380-9
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
NR 49
TC 53
Z9 57
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2009
VL 89A
IS 1
BP 152
EP 159
DI 10.1002/jbm.a.31939
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 416BX
UT WOS:000263981300014
PM 18431759
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Okamura, Y
   Goto, T
   Niwa, D
   Fukui, Y
   Otsuka, M
   Motohashi, N
   Osaka, T
   Takeoka, S
AF Okamura, Yosuke
   Goto, Takahiro
   Niwa, Daisuke
   Fukui, Yoshihito
   Otsuka, Masanobu
   Motohashi, Norikazu
   Osaka, Tetsuya
   Takeoka, Shinji
TI Fabrication of free-standing albumin-nanosheets having heterosurfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE albumin; nanosheet; free-standing; biocompatibility; crosslinking
ID SELF-ASSEMBLED MONOLAYERS; PHOSPHOLIPID-VESICLES; SPECTROSCOPIC RULER;
   PROTEIN ADSORPTION; ENERGY-TRANSFER; FLOW CONDITIONS; OXYGEN CARRIER;
   POLYMER-FILMS; IN-VITRO; MEMBRANES
AB Sheet-shaped carriers, having both obverse and reverse surfaces and thus a large contact area for targeting a site, have several advantages over spherical-shaped carriers, which have an extremely small contact area for targeting sites. Here, we proposed a novel method to prepare a free-standing ultrathin and biocompatible nanosheet having heterosurfaces, by a combination of four processes: (1) specific adsorption of recombinant human serum albumin (rHSA) molecules onto a patterned octadecyltrimethoxysilane self-assembled monolayer region (ODS-SAM), (2) preparation of nanosheets of rHSA molecules bearing thiol groups (SH-rHSA) via two-dimensionally disulfide crosslinking, (3) surface modification of the resulting nanosheet, and. (4) preparation of the free-standing nanosheet by detachment from the ODS-SAM. The SH-rHSA molecules at pH 5.0 and a concentration of 1 mu g/ml, were specifically adsorbed on the patterned ODS-SAM regions by hydrophobic interaction, and were two-dimensionally crosslinked in the presence of copper ion as an oxidant. The rHSA-nanosheets were then simply detached from the ODS-SAM by treatment with surfactant. We succeeded in the preparation of rectangular (10 mu m X 30 mu m) and ultrathin (4.5 +/- 1.0 nm) rHSA-nanosheets on a patterned ODS-SAM, and could also obtain free-standing rHSA-nanosheets having heterosurfaces by Surface modification with fluorescent latex beads. Thus, the rHSA-nanosheets having heterosurfaces could be regarded as a new biomaterial for drug carriers, hemostatic reagents, wound dressing for burn injury, and so forth. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 89A: 233-241, 2009
C1 [Okamura, Yosuke; Goto, Takahiro; Niwa, Daisuke; Fukui, Yoshihito; Otsuka, Masanobu; Motohashi, Norikazu; Osaka, Tetsuya; Takeoka, Shinji] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Tokyo 1698555, Japan.
RP Takeoka, S (reprint author), Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Tokyo 1698555, Japan.
EM takeoka@waseda.jp
OI Osaka, Tetsuya/0000-0001-8307-132X
FU JSPS for Young Scientists; Japan Health Sciences Foundation
FX Y.O. was the recipient of a Research Fellowships from the JSPS for Young
   Scientists and the recipient of Japan Health Sciences Foundation.
CR CARTER RO, 1994, POLYM DEGRAD STABIL, V45, P1, DOI 10.1016/0141-3910(94)90172-4
   CAVALLINI D, 1969, ARCH BIOCHEM BIOPHYS, V130, P354, DOI 10.1016/0003-9861(69)90044-7
   DEPALMA V, 1989, LANGMUIR, V5, P868, DOI 10.1021/la00087a049
   Eck W, 2005, ADV MATER, V17, P2583, DOI 10.1002/adma.200500900
   Ferapontova EE, 2007, BIOSENS BIOELECTRON, V22, P2508, DOI 10.1016/j.bios.2006.09.034
   Huck WTS, 2000, ANGEW CHEM INT EDIT, V39, P1058, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1058::AID-ANIE1058>3.0.CO;2-6
   Khoshtariya DE, 2003, J AM CHEM SOC, V125, P7704, DOI 10.1021/ja034719t
   Komatsu T, 2005, BIOMACROMOLECULES, V6, P3397, DOI 10.1021/bm050454u
   Komatsu T, 2004, BBA-GEN SUBJECTS, V1675, P21, DOI 10.1016/j.bbagen.2004.08.010
   Mallwitz F, 2005, ADV MATER, V17, P1296, DOI 10.1002/adma.200401123
   Mallwitz F, 2001, ANGEW CHEM INT EDIT, V40, P2645, DOI 10.1002/1521-3773(20010716)40:14<2645::AID-ANIE2645>3.0.CO;2-H
   Mamedov AA, 2000, LANGMUIR, V16, P5530, DOI 10.1021/1a000560b
   Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747
   Mattsson J, 2000, PHYS REV E, V62, P5187, DOI 10.1103/PhysRevE.62.5187
   Nardin C, 2000, LANGMUIR, V16, P7708, DOI 10.1021/la000204t
   Niwa D, 2004, J PHYS CHEM B, V108, P3240, DOI 10.1021/jp036099o
   Norde W, 1995, COLLOID SURFACE B, V5, P255, DOI 10.1016/0927-7765(95)01223-9
   Okamura Y, 2005, BIOCONJUGATE CHEM, V16, P1589, DOI 10.1021/bc050178g
   Okamura Y, 2005, TRANSFUSION, V45, P1221, DOI 10.1111/j.1537-2995.2005.00173.x
   Okamura Yosuke, 2006, J Artif Organs, V9, P251, DOI 10.1007/s10047-006-0345-0
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   SIQUEIRAPETRI DF, 1999, LANGMUIR, V15, P4520
   STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719
   STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131
   Sugimura H, 2000, LANGMUIR, V16, P885, DOI 10.1021/la990953e
   Takeoka S, 2003, BIOCHEM BIOPH RES CO, V312, P773, DOI 10.1016/j.bbrc.2003.10.184
   Takeoka S, 2002, BIOCHEM BIOPH RES CO, V296, P765, DOI 10.1016/S0006-291X(02)00934-8
   Takeoka S, 2001, BIOMACROMOLECULES, V2, P1192, DOI 10.1021/bm015554o
   Takeoka S, 2000, BIOMACROMOLECULES, V1, P290, DOI 10.1021/bm0055293
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Teramura Y, 2003, BIOCHEM BIOPH RES CO, V306, P256, DOI 10.1016/S0006-291X(03)00943-4
   Tomii Y, 2002, CURR PHARM DESIGN, V8, P467, DOI 10.2174/1381612023395871
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   Wadu-Mesthrige K, 2000, SCANNING, V22, P380
   Xu H, 2002, LANGMUIR, V18, P2363, DOI 10.1021/la011026m
   ZENG J, 2004, LANGMUIR, V20, P8931
NR 37
TC 4
Z9 4
U1 0
U2 22
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2009
VL 89A
IS 1
BP 233
EP 241
DI 10.1002/jbm.a.31934
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 416BX
UT WOS:000263981300023
PM 18431782
DA 2018-10-19
ER

PT J
AU Belcarz, A
   Ginalska, G
   Zalewska, J
   Rzeski, W
   Slosarczyk, A
   Kowalczulk, D
   Godlewski, P
   Niedzwiadek, J
AF Belcarz, Anna
   Ginalska, Grazyna
   Zalewska, Justyna
   Rzeski, Wojciech
   Slosarczyk, Anna
   Kowalczulk, Dorota
   Godlewski, Piotr
   Niedzwiadek, Justyna
TI Covalent Coating of Hydroxyapatite by Keratin Stabilizes Gentamicin
   Release
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; porosity; keratin; antibacterial; controlled drug
   release; osteoblasts
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; POROUS HYDROXYAPATITE;
   MECHANICAL-PROPERTIES; CHRONIC OSTEOMYELITIS; ORBITAL IMPLANTS;
   DELIVERY-SYSTEM; BONE IMPLANTS; FABRICATION; SCAFFOLDS
AB A novel hybrid hydroxyapatite (HAP) matrix, covalently coated with rarely applied, hardly degradable keratin and effectively modified by gentanmicin immobilized in mixed-type mode (via interactions of diverse strength), was created. This hybrid showed a remarkably high drug immobilization yield and the most sustainable antibiotic release among all tested composites. It was also able to inhibit bacterial growth, both in surrounding liquid and on matrix surface, much longer (for at least 121 days of experiment) than analogous gelatin-modified and nonmodified matrices. Gentamicin-keratin-coated-HAP granules were nontoxic to human osteoblasts and enabled their proliferation with a rate similar as noncoated HAP. Presence of keratin on HAP granules seemed to slightly enhance the osteoblast proliferation. The results indicate that newly created HAP hybrid with covalently immobilized keratin and gentamicin-nontoxic and osteoblast-friendly-is a promising biomaterial of significantly prolonged antibacterial activity. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 89B: 102-113, 2009
C1 [Belcarz, Anna; Ginalska, Grazyna; Zalewska, Justyna] Med Univ Lublin, Dept Biochem, PL-20093 Lublin, Poland.
   [Rzeski, Wojciech] Inst Agr Med, Dept Toxicol, PL-20950 Lublin, Poland.
   [Slosarczyk, Anna] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
   [Kowalczulk, Dorota] Med Univ Lublin, Dept Med Chem, PL-20090 Lublin, Poland.
   [Godlewski, Piotr] Med Univ Lublin, Dept Orthoped & Traumatol, PL-20954 Lublin, Poland.
   [Niedzwiadek, Justyna] Med Univ Lublin, Dept Med Microbiol, PL-20093 Lublin, Poland.
RP Belcarz, A (reprint author), Med Univ Lublin, Dept Biochem, PL-20093 Lublin, Poland.
EM anna.belcarz@am.lublin.pl
RI Rzeski, Wojciech/S-5419-2018
OI Rzeski, Wojciech/0000-0002-4511-1498; Belcarz, Anna/0000-0001-9899-5314;
   Kowalczuk, Dorota/0000-0001-7458-5054
CR [Anonymous], 1999, BRIT PHARMACOPOEIA, V1, P695
   Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   Aronov D, 2007, J EUR CERAM SOC, V27, P4181, DOI 10.1016/j.jeurceramsoc.2007.02.121
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Baro M, 2002, J CONTROL RELEASE, V83, P353, DOI 10.1016/S0168-3659(02)00179-7
   Belcarz A., 2005, ENG BIOMATER, V47-53, P34
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Boanini E, 2006, BIOMATERIALS, V27, P4428, DOI 10.1016/j.biomaterials.2006.04.019
   Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1
   Cabanillas PF, 2000, INT J PHARM, V209, P15
   Cerroni L, 2002, BIOMOL ENG, V19, P119, DOI 10.1016/S1389-0344(02)00027-8
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chole RA, 2001, JARO, V2, P65
   CLARK WB, 1985, INFECT IMMUN, V47, P730
   DION A, 2005, BIOMATERIALS, V26, P276
   Gerritsma-Bleeker CLE, 2000, J BONE JOINT SURG BR, V82B, P97, DOI 10.1302/0301-620X.82B1.10058
   Ginalska G, 2005, EUR J VASC ENDOVASC, V29, P419, DOI 10.1016/j.ejvs.2004.12.030
   Ginalska G, 2005, INT J PHARM, V288, P131, DOI 10.1016/j.ijpharm.2004.09.021
   Ginalska G, 2004, J BIOMATER APPL, V18, P279, DOI 10.1177/0885328204041443
   GINALSKA G, 2004, Patent No. 358934
   Ginalska G, 2007, INT J PHARM, V339, P39, DOI 10.1016/j.ijpharm.2007.02.016
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Ichida JM, 2001, J MICROBIOL METH, V47, P199, DOI 10.1016/S0167-7012(01)00302-5
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   Joosten U, 2005, BIOMATERIALS, V26, P5251, DOI 10.1016/j.biomaterials.2005.01.001
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Jordan DR, 1999, OPHTHALMOLOGY, V106, P505, DOI 10.1016/S0161-6420(99)90108-2
   Kino R, 2007, J BIOSCI BIOENG, V103, P514, DOI 10.1263/jbb.103.514
   Ramnani P, 2005, CAN J MICROBIOL, V51, P191, DOI 10.1139/W04-123
   Riffel A, 2003, ARCH MICROBIOL, V179, P258, DOI 10.1007/s00203-003-0525-8
   Rozalska Barbara, 1998, Medycyna Doswiadczalna i Mikrobiologia, V50, P115
   Sanchez E, 2001, EUR J PHARM BIOPHARM, V52, P151, DOI 10.1016/S0939-6411(01)00169-2
   SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X
   SENYK GF, 1987, J DAIRY SCI, V70, P1152, DOI 10.3168/jds.S0022-0302(87)80126-1
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Slosarczyk A, 2000, BIOMATERIALS, V21, P1215, DOI 10.1016/S0142-9612(99)00269-0
   SOBINSKY KR, 1986, SURGERY, V100, P629
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   STITGER M, 2004, J CONTROL RELEASE, V99, P127
   STITGER M, 2002, BIOMATERIALS, V23, P4143, DOI DOI 10.1016/S0142-9612(02)00157-6
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tanaka T, 2007, MAT SCI ENG C-BIO S, V27, P817, DOI 10.1016/j.msec.2006.09.019
   Thian ES, 2006, BIOMATERIALS, V27, P2692, DOI 10.1016/j.biomaterials.2005.12.019
   Verret DJ, 2005, OTOLARYNG HEAD NECK, V133, P897, DOI 10.1016/j.otohns.2005.09.001
   Weetall H H, 1976, Methods Enzymol, V44, P134
   Wen J, 2000, BIOMATERIALS, V21, P1339, DOI 10.1016/S0142-9612(99)00273-2
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Yamashita Y, 1998, INT ORTHOP, V22, P247, DOI 10.1007/s002640050252
   Yamauchi K, 2003, MAT SCI ENG C-BIO S, V23, P467, DOI 10.1016/S09284931(02)00280-1
   You JR, 2003, JPN J OPHTHALMOL, V47, P512, DOI 10.1016/S0021-5155(03)00137-0
NR 56
TC 20
Z9 21
U1 2
U2 26
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2009
VL 89B
IS 1
BP 102
EP 113
DI 10.1002/jbm.b.31192
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 422XE
UT WOS:000264460200012
PM 18698616
DA 2018-10-19
ER

PT J
AU Katz, JM
   Nataraj, C
   Jaw, R
   Deigl, E
   Bursac, P
AF Katz, Jordan M.
   Nataraj, Chandra
   Jaw, Rebecca
   Deigl, Elizabeth
   Bursac, Predrag
TI Demineralized Bone Matrix as on Osteoinductive Biomaterial and In Vitro
   Predictors of Its Biological Potential
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT 2004 Pittsburgh Bone Symposium Meeting
CY 2004
CL Pittsburgh, PA
DE demineralization; bone graft; cell proliferation; growth factors
ID GROWTH-FACTOR-BETA; MORPHOGENETIC PROTEIN; EXTRACELLULAR-MATRIX;
   CALVARIAL DEFECTS; OSTEOGENIN; DIFFERENTIATION; EXPRESSION; INDUCE;
   CELLS; PROLIFERATION
AB The osteoinductivity of demineralized bone matrix (DBM) varies from donor to donor as a result of varying levels of multiple growth factors, matrix integrity, and artifacts from material processing. Many in vitro assays are currently used for screening the osteoinductivity of DBM. The objectives of this study were to determine the correlation of specific growth factors and in vitro mitotic stimulation to in vivo ectopic bone formation capacity with a large number of DBM samples. Samples were assayed using HASA methods for BMP-2/4 and TGF-beta 1 (n = 304) and cell proliferation using SAOS-2 osteoblasts (n = 239). All samples were then implanted intramuscularly in the abdomen of nude rats. All in vitro assays showed significant variability for any particular level of ostoinductivity determined by in vivo model. A significant, but only very weak, positive correlation to in vivo results was found for TGF-beta 1 (r(2) = 0.016), BMP 2/4 (r(2) = 0.065), and SAOS-2 cell proliferation (r(2) = 0.053). The results of this study ainplify the notion that a multitude of factors and their relative interplay, rather than a single factor are likely to determine the potency of any particular lot of DBM. (C) 2008 Wiley Periodicals. Inc. J Biomed Mater Res Part-B: Appl Biomater 89B: 127- 134. 2009
C1 [Katz, Jordan M.; Nataraj, Chandra; Jaw, Rebecca; Deigl, Elizabeth; Bursac, Predrag] RTI Biol, Res & Dev, Alachua, FL USA.
RP Bursac, P (reprint author), RTI Biol, Res & Dev, Alachua, FL USA.
EM pbursac@rtix.com
CR Adkisson HD, 2000, J ORTHOPAED RES, V18, P503, DOI 10.1002/jor.1100180326
   Carnes DL, 1999, J PERIODONTOL, V70, P353, DOI 10.1902/jop.1999.70.4.353
   CARRINGTON JL, 1988, J CELL BIOL, V107, P1969, DOI 10.1083/jcb.107.5.1969
   CHANG SC, 1994, J BIOL CHEM, V269, P28227
   CHENG H, 2003, BONE MORPHOGENETIC P
   Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513
   DOUGLAS J, 1995, AM J VET RES, V56, P649
   Edwards JT, 1998, CLIN ORTHOP RELAT R, P219
   Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893
   Glowacki Julie, 2005, Cell and Tissue Banking, V6, P3, DOI 10.1007/s10561-005-4252-z
   Han B, 2003, J ORTHOPAED RES, V21, P648, DOI 10.1016/S0736-0266(03)00005-6
   Honsawek Sittisak, 2005, J Med Assoc Thai, V88 Suppl 4, pS260
   Honsawek Sittisak, 2005, Cell and Tissue Banking, V6, P13, DOI 10.1007/s10561-005-1445-4
   HUANG DST, 1988, J ORAL MAXIL SURG, V46, P460, DOI 10.1016/0278-2391(88)90411-9
   JAW RYY, 2001, QUANTITATIVE ASSAY B
   LANDESMAN R, 1989, CALCIFIED TISSUE INT, V45, P348, DOI 10.1007/BF02556005
   Lehmann W, 2005, BONE, V36, P300, DOI 10.1016/j.bone.2004.10.010
   Li G, 2005, J ORTHOP RES, V23, P680, DOI 10.1016/j.orthres.2004.12.005
   LINDHOLM TS, 1980, CLIN ORTHOP RELAT R, P288
   MARDEN LJ, 1993, J CLIN INVEST, V92, P2897, DOI 10.1172/JCI116912
   MUTHUKUMARAN N, 1988, COLLAGEN REL RES, V8, P433
   Praul CA, 2002, J CELL BIOCHEM, V84, P359, DOI 10.1002/jcb.1300
   RIPAMONTI U, 1993, PLAST RECONSTR SURG, V91, P27, DOI 10.1097/00006534-199301000-00005
   RIPAMONTI U, 1991, MATRIX, V11, P404, DOI 10.1016/S0934-8832(11)80195-2
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   SAMPATH TK, 1984, BIOCHEM BIOPH RES CO, V119, P949, DOI 10.1016/0006-291X(84)90865-9
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VUKICEVIC S, 1990, BIOCHEM BIOPH RES CO, V166, P750, DOI 10.1016/0006-291X(90)90873-L
   Wang J, 1999, CALCIFIED TISSUE INT, V65, P156, DOI 10.1007/s002239900676
   WILDEMAN B, 2003, DIFFERENTIATION NOT
   Zhang M, 1997, J PERIODONTOL, V68, P1076, DOI 10.1902/jop.1997.68.11.1076
   Zhou FH, 2004, BONE, V35, P1307, DOI 10.1016/j.bone.2004.09.014
NR 32
TC 32
Z9 35
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2009
VL 89B
IS 1
BP 127
EP 134
DI 10.1002/jbm.b.31195
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 422XE
UT WOS:000264460200015
PM 18780340
DA 2018-10-19
ER

PT J
AU Peng, HT
   Blostein, MD
   Shek, PN
AF Peng, Henry T.
   Blostein, Mark D.
   Shek, Pang N.
TI Experimental Optimization of an In Situ Forming Hydrogel for Hemorrhage
   Control
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE in situ forming; hydrogel; polyethylene glycol; polyallylamine;
   hemorrhage control
ID POLYETHYLENE-GLYCOL; POLY(ETHYLENE GLYCOL); CITRATE STORAGE;
   CROSS-LINKING; FIBRIN; POLYMER; BLOOD; THROMBOELASTOGRAPHY; SEALANTS;
   GELATION
AB The fabrication of a novel in situ forming hydrogel composed of a multifunctional poly(ethylene glycol) (PEG) N-hydroxysuccinimide ester (NHS) and poly(allylamine hydrochloride) (PAA) was investigated. FTIR confirmed that PAA formed the hydrogel matrix (i.e., the formation of a PAA-like hydrogel). A factorial experiment was conducted to identify the key parameters that controlled gelation time, gel content, and swelling properties. The type of PEG (e.g., 4- and 6-arm) appeared to play a major role in determining all three performance parameters, with the greatest effect on gelation time. Other influencing factors include (a) the PEG concentration, which contributes to the gelation time and gel content; (b) pH of the buffer used for dissolving each polymer, which can affect the gelation time; and (c) PAA molecular weights, which contribute to the gel content and swelling. The concentration of PAA solution had no significant effects on hydrogel formation and properties within the investigated range, presumably due to negligible changes in the crosslinking density of the hydrogels. The PAA buffer pH influenced the gel content as well. Finally, thromboelastography was used to examine the effects of each polymer and their in situ gelation on blood coagulation in vitro. All individual polymers tested reduced clot strength, while the gelation of the polymers enhanced overall procoagulant effects. These results suggest that the biomaterial can be optimized to provide a combination of rapid gelation and swelling properties suitable for hemorrhage control and thus warrant further studies in animal bleeding models. (C) 2008 Wiley Periodicals. Inc. J Biomed Mater Res Part B: Appl Biomater 89B: 199-209, 2009
C1 [Peng, Henry T.; Shek, Pang N.] Def Res & Dev Canada Toronto, Toronto, ON M3M 3B9, Canada.
   [Blostein, Mark D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.
RP Peng, HT (reprint author), Def Res & Dev Canada Toronto, Toronto, ON M3M 3B9, Canada.
EM henry.peng@drdc-rddc.gc.ca
OI Peng, Henry/0000-0001-5276-9573
CR Alam HB, 2003, J TRAUMA, V54, P1077, DOI 10.1097/01.TA.0000068258.99048.70
   Barker TH, 2001, J BIOMED MATER RES, V56, P529, DOI 10.1002/1097-4636(20010915)56:4<529::AID-JBM1124>3.0.CO;2-2
   Bennett SL, 2003, J CARDIAC SURG, V18, P494, DOI 10.1046/j.0886-0440.2003.00303.x
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Bowbrick VA, 2000, ANESTH ANALG, V90, P1086, DOI 10.1097/00000539-200005000-00015
   Camenzind V, 2000, ANESTHESIOLOGY, V92, P1242, DOI 10.1097/00000542-200005000-00011
   CARLIN G, 1976, THROMB RES, V9, P623, DOI 10.1016/0049-3848(76)90109-2
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Dinerman AA, 2002, BIOMATERIALS, V23, P4203, DOI 10.1016/S0142-9612(02)00164-3
   Donkerwolcke M, 1998, BIOMATERIALS, V19, P1461, DOI 10.1016/S0142-9612(98)00059-3
   FENTON JW, 1974, THROMB RES, V4, P809, DOI 10.1016/0049-3848(74)90024-3
   Gagnon MA, 2007, APPL SPECTROSC, V61, P374, DOI 10.1366/000370207780466136
   GANOPOLSKY JG, 2006, BLOOD, V108
   Gennisson JL, 2006, ULTRASOUND MED BIOL, V32, P1529, DOI 10.1016/j.ultrasmedbio.2006.06.008
   Glidden PF, 2000, CLIN APPL THROMB-HEM, V6, P226, DOI 10.1177/107602960000600408
   Goldberg DI, 1998, NEPHROL DIAL TRANSPL, V13, P2303, DOI 10.1093/ndt/13.9.2303
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hiemstra C, 2007, MACROMOLECULES, V40, P1165, DOI 10.1021/ma062468d
   Hill A, 2001, J BIOMED MATER RES, V58, P308, DOI 10.1002/1097-4636(2001)58:3<308::AID-JBM1022>3.0.CO;2-P
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Kioussis DR, 2001, J APPL POLYM SCI, V80, P2073, DOI 10.1002/app.1307
   Kofinas P, 1997, BIOMATERIALS, V18, P1361, DOI 10.1016/S0142-9612(97)00077-X
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Larson RS, 2001, BIOCONJUGATE CHEM, V12, P861, DOI 10.1021/bc000137e
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Li JS, 1997, J BIOMED MATER RES, V37, P190, DOI 10.1002/(SICI)1097-4636(199711)37:2<190::AID-JBM7>3.3.CO;2-8
   McLemore R, 2006, J BIOMED MATER RES B, V79B, P398, DOI 10.1002/jbm.b.30554
   MOTOYASHIKI Y, 2001, Patent No. 6200595
   Murakami Y, 2007, J BIOMED MATER RES A, V80A, P421, DOI 10.1002/jbm.a.30911
   Na DH, 2003, RAPID COMMUN MASS SP, V17, P2241, DOI 10.1002/rcm.1175
   Nakayama Y, 1999, J BIOMED MATER RES, V48, P511, DOI 10.1002/(SICI)1097-4636(1999)48:4<511::AID-JBM17>3.3.CO;2-M
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Ohya S, 2005, BIOMATERIALS, V26, P655, DOI 10.1016/j.biomaterials.2004.03.002
   Oliveira ED, 2003, MACROMOLECULES, V36, P6189, DOI 10.1021/ma021468k
   PATHAK CP, 2003, Patent No. 6566406
   PENG HT, 2007, C INT SOC THROMB HEM
   Rivas BL, 1996, POLYM BULL, V37, P463, DOI 10.1007/BF00556806
   Salooja N, 2001, BLOOD COAGUL FIBRIN, V12, P327, DOI 10.1097/00001721-200107000-00001
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schexneider KI, 2004, CURR OPIN HEMATOL, V11, P323, DOI 10.1097/01.moh.0000142104.21058.df
   Schmieder AH, 2007, BIOTECHNOL BIOENG, V96, P967, DOI 10.1002/bit.21199
   Shin MS, 2002, J APPL POLYM SCI, V86, P498, DOI 10.1002/app.11008
   Shung AK, 2003, TISSUE ENG, V9, P243, DOI 10.1089/107632703764664710
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
   Snedecor GW, 1967, STATISTICAL METHODS, P339
   Taguchi T, 2005, BIOMATERIALS, V26, P1247, DOI 10.1016/j.biomaterials.2004.04.029
   Tanaka K, 1999, ANN THORAC SURG, V68, P1308, DOI 10.1016/S0003-4975(99)00757-2
   Torchiana DF, 2003, J CARDIAC SURG, V18, P504, DOI 10.1046/j.0886-0440.2003.00305.x
   Vig S, 2001, BLOOD COAGUL FIBRIN, V12, P555, DOI 10.1097/00001721-200110000-00008
   Wallace DG, 2001, J BIOMED MATER RES, V58, P545, DOI 10.1002/jbm.1053
   Wang Michael Y., 2001, Neurosurgery (Baltimore), V49, P962, DOI 10.1097/00006123-200110000-00031
   Wathier M, 2006, CHEMMEDCHEM, V1, P821, DOI 10.1002/cmdc.200600090
   WEST JL, 1995, BIOMATERIALS, V16, P1153, DOI 10.1016/0142-9612(95)93579-3
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
   Zambruni A, 2004, BLOOD COAGUL FIBRIN, V15, P103, DOI 10.1097/01.mbc.0000114364.44793.84
NR 58
TC 14
Z9 14
U1 0
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2009
VL 89B
IS 1
BP 199
EP 209
DI 10.1002/jbm.b.31206
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 422XE
UT WOS:000264460200024
PM 18777584
DA 2018-10-19
ER

PT J
AU Patil, N
   Lee, K
   Goodman, SB
AF Patil, Nilesh
   Lee, Kevin
   Goodman, Stuart B.
TI Porous Tantalum in Hip and Knee Reconstructive Surgery
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE porous; bone ingrowth; total joint replacement
ID MONOBLOCK ACETABULAR COMPONENT; TRABECULAR METAL; BONE LOSS; REVISION
   ARTHROPLASTY; TISSUE INGROWTH; IMPLANTS; ATTACHMENT; TITANIUM; AUGMENTS;
   SALVAGE
AB Conventional porous-coated joint prostheses used in hip and knee reconstruction have demonstrated good clinical results, however, these implants possess some inherent shortcomings such as low volumetric porosity, suboptimal frictional characteristics, and higher modulus of elasticity relative to that of bone. Porous tantalum, a novel porous biomaterial was developed to address these limitations. Extensive laboratory studies have revealed that porous tantalum has physical, mechanical and tissue in growth properties that makes it a potentially improved biomaterial particularly in complex joint reconstructions. Porous tantalum is a highly porous biomaterial with good biocompatibility, excellent corrosion resistance, and high coefficient of friction. The short term clinical results of porous tantalum in primary hip, revision hip, and knee reconstructive surgery are encouraging but further studies will be needed to determine whether the theoretical advantages of porous tantalum can provide long term biological fixation and stability. This review presents the biomaterial properties and clinical results of porous tantalum devices in hip and knee reconstructive surgeries. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 89B: 242-251, 2009
C1 [Patil, Nilesh; Lee, Kevin; Goodman, Stuart B.] Stanford Univ, Med Ctr, Dept Orthopaed Surg, Stanford, CA 94305 USA.
RP Goodman, SB (reprint author), Stanford Univ, Med Ctr, Dept Orthopaed Surg, Stanford, CA 94305 USA.
EM goodbone@stanford.edu
CR BARGIOTAS K, 2005, 72 AAOS ANN M WASH D
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Bermudez MD, 2005, WEAR, V258, P693, DOI 10.1016/j.wear.2004.09.023
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Bobyn J. Dennis, 1996, P75
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOSCAINES PJ, CLIN ORTHOP RELAT R, DOI DOI 10.2106/JBJS.E.00088
   Chalkin B, 2005, J ARTHROPLASTY, V20, P127, DOI 10.1016/j.arth.2004.09.029
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   GARBUZ DS, 2004, OPER TECH ORTHOP, V14, P117
   Goodman S, 2004, J ARTHROPLASTY, V19, P436, DOI 10.1016/j.arth.2003.11.015
   Gordon WJ, 2005, J BIOMED MATER RES B, V75B, P229, DOI 10.1002/jbm.b.30242
   Gross AE, 2004, CLIN ORTHOP RELAT R, P193, DOI 10.1097/01.blo.0000149822.49890.5e
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Hanssen Arlen D, 2004, Instr Course Lect, V53, P201
   HOLT GE, CLIN ORTHOP IN PRESS
   JASTY M, 1993, J BIOMED MATER RES, V27, P639, DOI 10.1002/jbm.820270511
   Joshi AB, 2002, J ARTHROPLASTY, V17, P643, DOI 10.1054/arth.2002.32106
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   LEWIS RJ, 2003, ANN M AM AC ORTH SUR
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   MARDONES RM, 2005, 72 AAOS ANN M WASH D
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Mulier Michiel, 2006, Acta Orthop Belg, V72, P326
   Nasser S, 2004, J ARTHROPLASTY, V19, P562, DOI 10.1016/j.arth.2004.02.025
   NEHME A, 2004, CLIN ORTHOP RELAT R, V429, P201
   Nelson CL, 2003, J ARTHROPLASTY, V18, P37, DOI 10.1054/S0883-5403(03)00290-0
   Paprosky WG, 2005, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.000194311.20901.f9
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   Rahbek O, 2005, INT ORTHOP, V29, P368, DOI 10.1007/s00264-005-0008-4
   Reach JS, 2007, J BONE JOINT SURG AM, V89A, P1000, DOI 10.2106/JBJS.E.00886
   Ries MD, 2006, CLIN ORTHOP RELAT R, P166, DOI 10.1097/01.blo.0000229359.27491.9f
   Rorabeck CH, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000092982.12414.a0
   Rose PS, 2006, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000238854.16121.a3
   Shinar AA, 1997, J BONE JOINT SURG AM, V79A, P159, DOI 10.2106/00004623-199702000-00001
   Springer BD, 2005, J BONE JOINT SURG AM, V87A, P2626, DOI 10.2106/JBJS.E.00088
   STEIN T, 1991, ORTHOP T, V15, P178
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
NR 46
TC 27
Z9 31
U1 1
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2009
VL 89B
IS 1
BP 242
EP 251
DI 10.1002/jbm.b.31198
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 422XE
UT WOS:000264460200028
PM 18837451
DA 2018-10-19
ER

PT J
AU Jeger, R
   Lichtenfeld, Y
   Peretz, H
   Shany, B
   Vago, R
   Baranes, D
AF Jeger, Rina
   Lichtenfeld, Yona
   Peretz, Hagit
   Shany, Boaz
   Vago, Razi
   Baranes, Danny
TI Visualization of the ultrastructural interface of cells with the outer
   and inner-surface of coral skeletons
SO JOURNAL OF ELECTRON MICROSCOPY
LA English
DT Article
DE transmission electron microscopy; electron opacity; carbonate skeleton;
   coral; neurons; cell-material interface
ID NATURAL CORAL; BONE-GRAFT; BIOMATRICES; MATRIX
AB Crystalline, porous biomaterials, such as marine invertebrate skeletons, have been widely used for functional reconstruction of human tissues like bone and dental implants. Since in such an abrasive microenvironment adequate cell-material interactions are crucial for a successful treatment, it is of great importance to improve the means to examine these interactions. We developed a method that reveals the ultrastructure of the interface between coral skeletons and cultured neural cells to a higher quality than do traditional methods as it does not include damaging procedures like decalcification or sectioning non-decalcified skeletons. It is rather based on generating two electron opacity distinct Araldite masks, of the skeleton and its surrounding, by polymerizing them to different durations. The contrast created at the border of the two masks outlined the fine and fragile crystals of the coral skeleton's outer and inner surfaces and their contact sites with the cells. The skeleton's internal structure contains a mesh of narrow (few microns wide) and large channel-shaped gaps interrupted by irregular-shaped crystalline material. Neural cells grew on the skeleton surface by stretching between crystal tips, with occasional rearrangements of cytoskeletal fibers located near the anchorage focal adherence points. Cell processes infiltrated the skeleton interior by stretching between inter-surface crystals and by adjusting their volume to the space of the conduits they grew into. The technique advances the study of coral biology and of neural cells-hard biomaterial interaction; it can be applied to other biomaterials and cell types and open new ways for studying tissue development and engineering.
C1 [Jeger, Rina; Peretz, Hagit; Shany, Boaz; Baranes, Danny] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
   [Lichtenfeld, Yona] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.
   [Vago, Razi] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   [Baranes, Danny] Ariel Univ, Ctr Samaria, IL-44837 Ariel, Israel.
RP Baranes, D (reprint author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
EM dbaranes@bgu.ac.il
FU National Institute for Biotechnology in the Negev; Horowitz foundation
FX This work was supported by a grant from the National Institute for
   Biotechnology in the Negev, and partly by the Horowitz foundation.
CR Birk RZ, 2006, TISSUE ENG, V12, P21, DOI 10.1089/ten.2006.12.21
   Cervino JM, 2004, SYMBIOSIS, V37, P63
   Chen FL, 2004, BRIT J ORAL MAX SURG, V42, P532, DOI 10.1016/j.bjoms.2004.08.007
   Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042
   DAWES CJ, 1971, BIOLOGICAL TECHNIQUE
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   GLYNN PW, 1985, DIS AQUAT ORGAN, V1, P29, DOI 10.3354/dao001029
   GOTTLIBABRAMOWI.L, 2006, TISSUE ENG, V12, P729
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Guo WH, 2003, DENT MATER, V19, P334, DOI 10.1016/S0109-5641(02)00063-5
   Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036
   Kuckleburg CJ, 2008, SHOCK, V29, P189, DOI 10.1097/shk.0b013e318070c49e
   MAXWELL S, 2005, MED DEEP
   MICHAEL J, 1993, DYKSTRA MANUAL APPL, P20
   Peretz H, 2008, J TISSUE ENG REGEN M, V2, P463, DOI 10.1002/term.118
   Peretz H, 2007, TISSUE ENG, V13, P461, DOI 10.1089/ten.2005.0522
   PETERS KR, 1985, J CELL BIOL, V101, P2233, DOI 10.1083/jcb.101.6.2233
   PRESS OW, 1989, CANCER RES, V49, P4906
   RIM K, 1992, BIOL BULL, V182, P195
   Shany B, 2006, TISSUE ENG, V12, P1763, DOI 10.1089/ten.2006.12.1763
   SHANY B, 2005, TISSUE ENG, V11, P586
   SPARKS NHC, 1990, J EXP BIOL, V151, P371
   VANDERMEULEN JH, 1973, MAR BIOL, V23, P47, DOI 10.1007/BF00394111
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
NR 24
TC 4
Z9 6
U1 2
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-0744
J9 J ELECTRON MICROSC
JI J. Electron Microsc.
PD APR
PY 2009
VL 58
IS 2
BP 47
EP 53
DI 10.1093/jmicro/dfp005
PG 7
WC Microscopy
SC Microscopy
GA 419AL
UT WOS:000264191400003
PM 19218486
DA 2018-10-19
ER

PT J
AU Tsutsumi, H
   Pugdee, K
   Hayakawa, T
   Abiko, Y
AF Tsutsumi, Haruhiko
   Pugdee, Kamolparn
   Hayakawa, Tohru
   Abiko, Yoshimitsu
TI Discoidin Domain Receptor-1 Gene Expression of Osteoblasts on
   Fibronectin Coated Titanium Disks
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE Osteoblast; Fibronectin; RGD peptide; DDR-1; Gene expression
ID PLASMA FIBRONECTIN; TYROSINE KINASE; CELLS; BONE; COLLAGEN;
   SIALOPROTEIN; ACTIVATION; SURFACES
AB Enhancement of osteoblastic adhesion and migration on a titanium (Ti) surface increases the successful rate of osseointegration in implant therapy by stimulating osteoblastic differentiation. It has been reported that Ti surfaces coated with fibronectin (FN) or GRGDSP peptide derived from FN had improved initial cell attachment and supported osteoblastic cell differentiation. However, the differences in gene expression by osteoblasts grown on FN and GRGDSP coated Ti disks have not been elucidated. Ti disks were coated with FN or GRGDSP peptide, then MC3T3-E1 osteoblastic cells were cultured on those surfaces. After 15 days, the levels of gene expression of the cells were examined. Those levels were mostly similar between the FN and GRGDSP coated disks, though that of discoidin domain receptor-1 (DDR-1) was significantly greater in cells cultured on the FN coated disks. The elevated mRNA level of the DDR-1 gene was then confirmed by reverse transcription-polymerase chain reaction (RT-PCR) and real-time PCR assays. In addition to the ability of the RGD domain to bind with integrins, FN also binds to fibrillin, proteoglycan, and collagen by their specific binding domains, thus the higher level of DDR-1 gene expression seen in our experiments may have been induced by those and not by the RGD domain. For future developing biomaterial as coating for Ti implants using synthetic peptides, binding domains other than the RGD domain in FN may be useful and important.
C1 [Tsutsumi, Haruhiko; Pugdee, Kamolparn; Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Chiba 2718587, Japan.
   [Hayakawa, Tohru] Nihon Univ, Sch Dent Matsudo, Dept Dent Biomat, Chiba 2718587, Japan.
   [Hayakawa, Tohru; Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsudo, Res Inst Oral Sci, Chiba 2718587, Japan.
RP Abiko, Y (reprint author), 2-870-1 Sakaecho Nishi, Chiba 2718587, Japan.
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [2007-2011]
FX This work was supported by the "Academic Frontier" Project for Private
   Universities, a matching fund subsidy from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan, 2007-2011.
CR Abiko Y, 2007, INT J ORAL MED SCI, V6, P97
   Bierbaum S, 2003, J BIOMED MATER RES A, V67A, P431, DOI 10.1002/jbm.a.10084
   Dean J W 3rd, 1995, Int J Oral Maxillofac Implants, V10, P721
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Globus RK, 1998, J CELL SCI, V111, P1385
   Hayakawa T, 2003, J BIOMED MATER RES A, V67A, P684, DOI 10.1002/jbm.a.10143
   HAYAKAWA T, 2008, MED BIOL, V152, P286
   Hilbig H, 2007, EUR J MED RES, V12, P6
   Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029
   Jonsson Marzieh, 2001, Journal of Cell Science, V114, P2043
   L'Hote Corine G. M., 2002, FASEB Journal, V16, P234
   Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MOURSI AM, 1996, J CELL SCI, V109, P369
   Pugdee K, 2007, DENT MATER J, V26, P647, DOI 10.4012/dmj.26.647
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0
   TETI A, 1992, J AM SOC NEPHROL, V10, pS83
   Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779
   VOGEL W, 1997, MOL CELL, V1, P1
   Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012
   WATANABE N, 2008, J JAP SOC ORAL IMPLA, V21, P1
   YAMAMICHI N, 2007, DENT MATER J, V27, P744
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
NR 25
TC 2
Z9 2
U1 0
U2 0
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD APR
PY 2009
VL 18
IS 1
BP 13
EP 18
DI 10.2485/jhtb.18.13
PG 6
WC Engineering, Biomedical
SC Engineering
GA 589PA
UT WOS:000277163100003
OA Bronze
DA 2018-10-19
ER

PT J
AU Baccari, P
   Nifosi, J
   Ghirardelli, L
   Staudacher, C
AF Baccari, Paolo
   Nifosi, Jacopo
   Ghirardelli, Luca
   Staudacher, Carlo
TI Laparoscopic Incisional and Ventral Hernia Repair Without Sutures: A
   Single-Center Experience with 200 Cases
SO JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES
LA English
DT Article
ID MESH; COMPLICATIONS
AB Background: Laparoscopic incisional and ventral herniorraphy (LIVH), using a mesh, has gained recognition as an effective method and is associated with lower complication and recurrence. Controversies in the operative technique still exist about biomaterial, method of fixation, and overlap of the mesh over the defect. The aim of this study was to evaluate the outcomes achieved with LIVH in 200 consecutive patients treated in a single hospital, using fixation of the mesh with only tacks. Results of the first 100 (group A) and the last 100 (group B) operations were also compared.
   Methods: From 2003 through 2007, 200 patients underwent LIVH. Overlap of the mesh was 3-5 cm. The mesh was secured with tacks alone, with the "double crown" technique. In group B, adhesiolysis was performed, avoiding high energies.
   Results: Mean ventral defect was 107.5 (+/- 95.4) cm(2). The recurrent ventral hernia rate was 20%, and the conversion rate was 2.5%. Mean operative time was 77.5 (+/- 33.9) minutes. Mean mesh dimension was 326.4 (+/- 166.8) cm(2). The overall morbidity rate was 10.5%. Bowel injuries were 5 (2.5 %). Minor complications were 8.0%. Median postoperative hospital stay was 3 days. Recurrence rate was 3.5%, with a mean follow-up of 22.5 months. Chronic pain was 1%. No difference was seen between groups A and B regarding minor complications, whereas a significant difference was found regarding enterotomies (5 vs. 0; P = 0.024) and recurrences (6 vs. 1; P = 0.056).
   Conclusions: Fixation of the mesh with the sole use of tacks was demonstrated to be safe and effective. Avoiding high energies, no case of enterotomy occurred.
C1 [Baccari, Paolo; Nifosi, Jacopo; Ghirardelli, Luca; Staudacher, Carlo] Univ Hosp, San Raffaele Sci Inst, Div Gastrointestinal Surg, Dept Gen Surg, I-20132 Milan, Italy.
RP Baccari, P (reprint author), Univ Hosp, San Raffaele Sci Inst, Div Gastrointestinal Surg, Dept Gen Surg, Via Olgettina 60, I-20132 Milan, Italy.
EM Paolo.Baccari@hsr.it
OI Baccari, Paolo/0000-0002-2720-3444
CR Anthony T, 2000, WORLD J SURG, V24, P95, DOI 10.1007/s002689910018
   Barbaros U, 2007, Hernia, V11, P51
   Berger D, 2002, SURG ENDOSC, V16, P1720, DOI 10.1007/s00464-002-9036-y
   Carbajo MA, 1999, SURG ENDOSC-ULTRAS, V13, P250, DOI 10.1007/s004649900956
   Cassar K, 2002, BRIT J SURG, V89, P534, DOI 10.1046/j.1365-2168.2002.02083.x
   Franklin ME, 1998, SURG LAPAROSC ENDOSC, V8, P294, DOI 10.1097/00019509-199808000-00012
   Heniford BT, 2003, ANN SURG, V238, P391, DOI 10.1097/01.sla.0000086662.49499.ab
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LeBlanc KA, 2007, SURG ENDOSC, V21, P508, DOI 10.1007/s00464-006-9032-8
   LEBLANC KA, 1993, SURG LAPAROSC ENDOSC, V3, P39
   LIAKAKOS T, 1994, BRIT J SURG, V81, P248, DOI 10.1002/bjs.1800810230
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Luijendijk RW, 1997, WORLD J SURG, V21, P62, DOI 10.1007/s002689900194
   Misra MC, 2006, SURG ENDOSC, V20, P1839, DOI 10.1007/s00464-006-0118-0
   Olmi S, 2007, SURG ENDOSC, V21, P555, DOI 10.1007/s00464-007-9229-5
   PALANIVELU C, 2007, HERNIA
   Park A, 1996, SURG LAPAROSC ENDOSC, V6, P123, DOI 10.1097/00019509-199604000-00007
   READ RC, 1989, ARCH SURG-CHICAGO, V124, P485
   Rudmik L R, 2006, Hernia, V10, P110, DOI 10.1007/s10029-006-0066-6
   Salameh J R, 2002, Hernia, V6, P182
   STOPPA RE, 1989, WORLD J SURG, V13, P545, DOI 10.1007/BF01658869
   Ujiki MB, 2004, AM J SURG, V188, P593, DOI 10.1016/j.amjsurg.2004.07.010
   van't Riet M, 2002, SURG ENDOSC, V16, P1713, DOI 10.1007/s00464-001-9202-7
   White TJ, 1998, AM SURGEON, V64, P276
   Wright BE, 2002, AM SURGEON, V68, P291
NR 25
TC 21
Z9 21
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1092-6429
EI 1557-9034
J9 J LAPAROENDOSC ADV S
JI J. Laparoendosc. Adv. Surg. Tech.
PD APR
PY 2009
VL 19
IS 2
BP 175
EP 179
DI 10.1089/lap.2008.0244
PG 5
WC Surgery
SC Surgery
GA 431TM
UT WOS:000265086900010
PM 19216699
DA 2018-10-19
ER

PT J
AU Ye, HZ
   Liu, XY
   Hong, HP
AF Ye, Hezhou
   Liu, Xing Yang
   Hong, Hanping
TI Characterization of sintered titanium/hydroxyapatite biocomposite using
   FTIR spectroscopy
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FUNCTIONALLY GRADED BIOMATERIAL; THERMAL-DECOMPOSITION; HEAT-TREATMENT;
   HYDROXYAPATITE COATINGS; TETRACALCIUM PHOSPHATE; MECHANICAL-PROPERTIES;
   POWDER-METALLURGY; TITANIUM; BONE; TI
AB Fourier transform infrared (FTIR) spectroscopy was employed to characterize the phase changes of hydroxyapatite (Ca(10)(PO(4))(6)(OH)(2), HA) in a titanium/HA biocomposite during sintering. The effects of sintering temperature and the presence of Ti on the decomposition of HA were examined. It was observed that pure HA was stable in argon atmosphere at temperatures up to 1,200A degrees C, although the dehydroxylation of pure HA was promoted by the increase in sintering temperature. In the Ti/HA system, on the other hand, the presence of Ti accelerated dehydroxylation and the decomposition of HA was detected at a temperature as low as 800A degrees C. Tetracalcium phosphate (Ca(4)P(2)O(9), TTCP) and calcium oxide (CaO) were the dominant products of the decomposition, but no tricalcium phosphate (Ca(3)(PO(4))(2), TCP) was detected due to phosphorus diffusion and possible reactions during the thermal process. The main decomposed constituents of HA in Ti/HA system at high temperatures (a parts per thousand yen1,200A degrees C) would be CaO and amorphous phases.
C1 [Ye, Hezhou; Hong, Hanping] Univ Western Ontario, Fac Engn, London, ON N6A 5B8, Canada.
   [Liu, Xing Yang] Natl Res Council Canada, Inst Ind Mat, London, ON N6G 4X8, Canada.
RP Ye, HZ (reprint author), Univ Western Ontario, Fac Engn, London, ON N6A 5B8, Canada.
EM hye5@uwo.ca
FU Natural Science and Engineering Research Council of Canada
FX This work is supported by the Natural Science and Engineering Research
   Council of Canada. The valuable discussions and help from Prof. P. J
   Ragogna, Mr. Jason L. Dutton and Mr. Caleb Martin of the University of
   Western Ontario related to this research work are gratefully
   acknowledged.
CR Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   Aoki H., 1991, SCI MED APPL HYDROXY, P137
   BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   Chen JY, 1997, J BIOMED MATER RES, V34, P15, DOI 10.1002/(SICI)1097-4636(199701)34:1<15::AID-JBM3>3.0.CO;2-Q
   Chu CL, 2006, J MATER SCI-MATER M, V17, P245, DOI 10.1007/s10856-006-7310-6
   Chu CL, 2003, MAT SCI ENG A-STRUCT, V348, P244, DOI 10.1016/S0921-5093(02)00738-4
   Chu CL, 2001, MAT SCI ENG A-STRUCT, V316, P205, DOI 10.1016/S0921-5093(01)01239-4
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   Cihlar J, 1999, J MATER SCI, V34, P6121, DOI 10.1023/A:1004769820545
   DEWITH G, 1981, J MATER SCI, V16, P1592
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   FILIAGGI MJ, 1993, J BIOMED MATER RES, V27, P191, DOI 10.1002/jbm.820270208
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   Fung YC, 1993, BIOMECHANICS MECH PR, V2nd, P510
   GERGS MK, 2007, INT J MAT SCI, V2, P81
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Gross KA, 1998, J MATER SCI, V33, P3985, DOI 10.1023/A:1004605014652
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HONG L, 1992, Journal of Biomedical Materials Research, V26, P7, DOI 10.1002/jbm.820260103
   Jalota S, 2005, J AM CERAM SOC, V88, P3353, DOI 10.1111/j.1551-2916.2005.00623.x
   JI HX, 1993, BIOMATERIALS, V14, P64, DOI 10.1016/0142-9612(93)90077-F
   Jillavenkatesa A, 1998, SPECTROSC LETT, V31, P1619, DOI 10.1080/00387019808007439
   KREIDLER ER, 1967, INORG CHEM, V6, P884, DOI 10.1021/ic50051a007
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   KUKURA M, 1972, J PHYS CHEM-US, V76, P900, DOI 10.1021/j100650a019
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   LIU DM, 1994, J MATER SCI-MATER M, V5, P147, DOI 10.1007/BF00053335
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Ning CQ, 2004, BIOMATERIALS, V25, P3379, DOI 10.1016/j.biomaterials.2003.10.017
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Ning CQ, 2000, J MATER SCI LETT, V19, P1243, DOI 10.1023/A:1006725529837
   Nishikawa H, 2001, MATER LETT, V50, P364, DOI 10.1016/S0167-577X(01)00318-4
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   NYQUIST RA, 1997, HDB INFRARED RAMAN S, V45, P207
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   Popa C, 2005, J MATER SCI-MATER M, V16, P1165, DOI 10.1007/s10856-005-4724-5
   Posset U, 1998, J BIOMED MATER RES, V40, P640, DOI 10.1002/(SICI)1097-4636(19980615)40:4<640::AID-JBM16>3.0.CO;2-J
   Prokopiev O, 2006, MAT SCI ENG A-STRUCT, V431, P218, DOI 10.1016/j.msea.2006.05.158
   Rapacz-Kmita A, 2005, J MOL STRUCT, V744, P653, DOI 10.1016/j.molstruc.2004.11.070
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Ribeiro CC, 2006, BIOMATERIALS, V27, P1749, DOI 10.1016/j.biomaterials.2005.09.043
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Sargin Y, 1997, J EUR CERAM SOC, V17, P963, DOI 10.1016/S0955-2219(96)00196-3
   Vecchio KS, 2007, ACTA BIOMATER, V3, P910, DOI 10.1016/j.actbio.2007.06.003
   Wang T, 2004, MATER LETT, V58, P3025, DOI 10.1016/j.matlet.2004.05.033
   WENG J, 1994, J MATER SCI LETT, V13, P159, DOI 10.1007/BF00278148
   ZHOU JM, 1993, J MATER SCI-MATER M, V4, P83, DOI 10.1007/BF00122983
NR 48
TC 42
Z9 42
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2009
VL 20
IS 4
BP 843
EP 850
DI 10.1007/s10856-008-3647-3
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 411WK
UT WOS:000263683900002
PM 19034619
DA 2018-10-19
ER

PT J
AU Kirchhof, K
   Hristova, K
   Krasteva, N
   Altankov, G
   Groth, T
AF Kirchhof, Kristin
   Hristova, Kamelia
   Krasteva, Natalia
   Altankov, George
   Groth, Thomas
TI Multilayer coatings on biomaterials for control of MG-63 osteoblast
   adhesion and growth
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CELL-ADHESION; POLYELECTROLYTE MULTILAYERS; SUBSTRATUM CHEMISTRY;
   SURFACE-PROPERTIES; FIBROBLAST-GROWTH; FIBRONECTIN; POLYMERS; CHITOSAN;
   POLYSACCHARIDES; WETTABILITY
AB Here, the layer-by-layer technique (LbL) was used to modify glass as model biomaterial with multilayers of chitosan and heparin to control the interaction with MG-63 osteoblast-like cells. Different pH values during multilayer formation were applied to control their physico-chemical properties. In the absence of adhesive proteins like plasma fibronectin (pFN) both plain layers were rather cytophobic. Hence, the preadsorption of pFN was used to enhance cell adhesion which was strongly dependent on pH. Comparing the adhesion promoting effects of pFN with an engineered repeat of the FN III fragment and collagen I which both lack a heparin binding domain it was found that multilayers could bind pFN specifically because only this protein was capable of promoting cell adhesion. Multilayer surfaces that inhibited MG-63 adhesion did also cause a decreased cell growth in the presence of serum, while an enhanced adhesion of cells was connected to an improved cell growth.
C1 [Kirchhof, Kristin; Groth, Thomas] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut & Biopharmaceut, Biomed Mat Grp, D-06120 Halle, Saale, Germany.
   [Hristova, Kamelia; Krasteva, Natalia; Altankov, George] Bulgarian Acad Sci, Inst Biophys, BU-1113 Sofia, Bulgaria.
   [Altankov, George] ICREA, Barcelona, Spain.
   [Altankov, George] Inst Bioengn Catalunya, Barcelona, Spain.
RP Groth, T (reprint author), Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut & Biopharmaceut, Biomed Mat Grp, Heinrich Damerow Str 4, D-06120 Halle, Saale, Germany.
EM thomas.groth@pharmazie.uni-halle.de
OI Groth, Thomas/0000-0001-6647-9657
FU Graduiertenforderung des Landes Sachsen-Anhalt; German Academic Exchange
   Service (DAAD); ICREA
FX This work was supported by Graduiertenforderung des Landes
   Sachsen-Anhalt with a Ph. D. scholarship to KK and the German Academic
   Exchange Service (DAAD) in the frame of a bilateral exchange program
   between Germany and Bulgaria. Dr. J. Vogel is acknowledged for
   scientific support and discussion.
CR Altankov G, 2003, MATERIALWISS WERKST, V34, P1120, DOI 10.1002/mawe.200300699
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AYAD S, 1994, EXTRACELLULAR MATRIX
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Boddohi S, 2008, BIOMACROMOLECULES, V9, P2021, DOI 10.1021/bm8002573
   Boese G, 2007, TISSUE ENG, V13, P2995, DOI 10.1089/ten.2006.0442
   BOONTHEEKUL T, 2003, CURR OPIN BIOTECH, V14, P1
   CASU B, 1994, CARBOHYDR EUR, V11, P18
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Decher G., 2003, MULTILAYER THIN FILM
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   GROTH T, 2009, NATO SCI SE IN PRESS
   GROTH T, 2007, MEMBRANES LIFE SCI, P27
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   He LZ, 2006, CHEM ENG SCI, V61, P989, DOI 10.1016/j.ces.2005.05.064
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Kang IK, 1996, J MATER SCI-MATER M, V7, P135, DOI 10.1007/BF00121251
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Krasteva N, 2005, J BIOMAT SCI-POLYM E, V16, P1, DOI 10.1163/1568562052843348
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Roessler S, 2001, J MATER SCI-MATER M, V12, P871, DOI 10.1023/A:1012807621414
   Salloum DS, 2004, BIOMACROMOLECULES, V5, P1089, DOI 10.1021/bm034522t
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Schoeler B, 2006, BIOMACROMOLECULES, V7, P2065, DOI 10.1021/bm060378a
   SCHOEN P, 1991, ANTICOAGULANT ACTIVI
   Seifert B, 1996, J MATER SCI-MATER M, V7, P465, DOI 10.1007/BF00705426
   Sim B, 2004, J BIOMED MATER RES A, V68A, P352, DOI 10.1002/jbm.a.20022
   Sukhishvili SA, 2006, MACROMOLECULES, V39, P8873, DOI 10.1021/ma061617p
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tan HP, 2007, J MATER SCI-MATER M, V18, P1961, DOI 10.1007/s10856-007-3095-5
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Tzoneva R, 2007, BBA-GEN SUBJECTS, V1770, P1538, DOI 10.1016/j.bbagen.2007.07.008
   Vitte J, 2004, Eur Cell Mater, V7, P52
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
NR 44
TC 27
Z9 28
U1 0
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2009
VL 20
IS 4
BP 897
EP 907
DI 10.1007/s10856-008-3639-3
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 411WK
UT WOS:000263683900008
PM 19034623
DA 2018-10-19
ER

PT J
AU Nichifor, M
   Constantin, M
   Mocanu, G
   Fundueanu, G
   Branisteanu, D
   Costuleanu, M
   Radu, CD
AF Nichifor, M.
   Constantin, M.
   Mocanu, G.
   Fundueanu, G.
   Branisteanu, D.
   Costuleanu, M.
   Radu, C. D.
TI New multifunctional textile biomaterials for the treatment of leg venous
   insufficiency
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID LASER-SCANNING MICROSCOPY; O-(BETA-HYDROXYETHYL)-RUTOSIDES; ULCERS; WALL
AB Acryloyl monomers have been synthesized by reaction of beta-cyclodextrin and troxerutin with acryloyl chloride and grafted on a knitted material obtained from polyamide 6.6 and polyurethane fibers. Polyamide grafted with beta-cyclodextrin derivative binds troxerutin as a physical complex. The obtained biomaterials have been tested in vivo on rats for their ability to deliver troxerutin (a flebotonic drug) to different skin areas (epidermis, dermis and vascular wall). The results showed that the new synthesized materials can act as multifunctional bioactive textiles that can display both compression (given by the textile material) and sustained venotonic and haemostatic properties (given by the troxerutin delivered from biomaterial to the skin).
C1 [Nichifor, M.; Constantin, M.; Mocanu, G.; Fundueanu, G.] Petru Poni Inst Macromol Chem, Dept Bioact & Biocompatible Polymers, Iasi 700487, Romania.
   [Branisteanu, D.; Costuleanu, M.] Gr T Popa Univ Med & Pharm, Iasi, Romania.
   [Radu, C. D.] Gh Asachi Tech Univ, Fac Text & Leather Engn, Iasi 700050, Romania.
RP Nichifor, M (reprint author), Petru Poni Inst Macromol Chem, Dept Bioact & Biocompatible Polymers, Gr Ghica Voda 41A, Iasi 700487, Romania.
EM nichifor@icmpp.ro
RI Costuleanu, Marcel/A-6807-2010; Constantin, Marieta/G-5199-2016;
   Fundueanu, Gheorghe/B-6794-2012
OI Costuleanu, Marcel/0000-0003-2645-9533; 
CR ALBERT F, 1962, ANALIZA CHIMICA ORGA, P146
   Beckers C, 2001, PHLEBOLOGY DIGEST, V14, P8
   Belcaro G, 2008, ANGIOLOGY, V59, p7S, DOI 10.1177/0003319707312021
   Bongiovanni CM, 2006, ANGIOLOGY, V57, P139, DOI 10.1177/000331970605700202
   Cesarone M. R., 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, pS25, DOI 10.1177/107424840200700107
   Ceschel GC, 2001, STP PHARMA SCI, V11, P239
   CONNORS KA, 1995, J PHARM SCI, V84, P843, DOI 10.1002/jps.2600840712
   Denter U, 1997, ANGEW MAKROMOL CHEM, V248, P165, DOI 10.1002/apmc.1997.052480111
   Gawish SM, 2006, J APPL POLYM SCI, V99, P2586, DOI 10.1002/app.22888
   Guo XL, 2004, BIOMED CHROMATOGR, V18, P559, DOI 10.1002/bmc.356
   MARTE O, 2006, Patent No. 2006007753
   NEUMANN HAM, 1992, EUR J CLIN PHARMACOL, V43, P423, DOI 10.1007/BF02220620
   Patterson MJ, 2000, EXP PHYSIOL, V85, P869, DOI 10.1111/j.1469-445X.2000.02058.x
   PATWARDHAN A, 1995, J CARDIOVASC SURG, V36, P381
   Sackheim K, 2006, DERMATOL THER, V19, P338, DOI 10.1111/j.1529-8019.2006.00092.x
   Saihi D, 2004, J TEXTILE APPAREL TE, V4, P1
   Schafer-Korting M, 2007, ADV DRUG DELIVER REV, V59, P427, DOI 10.1016/j.addr.2007.04.006
   Sentchouk V V, 2007, Journal of Applied Spectroscopy, V74, P731, DOI 10.1007/s10812-007-0117-5
   WALLACE RA, 1966, J POLYM SCI A1, V4, P1179, DOI 10.1002/pol.1966.150040517
   Wollina U, 2003, CURR PROBL DERMATOL, V31, P82
NR 20
TC 13
Z9 13
U1 6
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2009
VL 20
IS 4
BP 975
EP 982
DI 10.1007/s10856-008-3653-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 411WK
UT WOS:000263683900017
PM 19052847
DA 2018-10-19
ER

PT J
AU Edwards, HK
   Fay, MW
   Anderson, SI
   Scotchford, CA
   Grant, DM
   Brown, PD
AF Edwards, H. K.
   Fay, M. W.
   Anderson, S. I.
   Scotchford, C. A.
   Grant, D. M.
   Brown, P. D.
TI An appraisal of ultramicrotomy, FIBSEM and cryogenic FIBSEM techniques
   for the sectioning of biological cells on titanium substrates for TEM
   investigation
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE Biomaterial; cryogenic FIBSEM; FIBSEM; human osteoblast; mesenchymal
   stem cell; titanium
ID FOCUSED-ION-BEAM; TRANSMISSION ELECTRON-MICROSCOPY; FOCAL ADHESION
   SITES; SPECIMEN PREPARATION; BONE; INTERFACES; BEHAVIOR;
   BIOCOMPATIBILITY; IMPLANTS; ALLOYS
AB Ultramicrotomy, focused ion beam scanning electron microscopy (FIBSEM) and cryogenic FIBSEM (cryo-FIBSEM) techniques, as developed for the controlled cross-sectioning of mesenchymal stem cells (MSCs) and human osteoblasts (HObs) on titanium (Ti) substrates for transmission electron microscopy (TEM) investigation, are compared. Conventional ultramicrotomy has been used to section cells on Ti-foil substrates embedded in resin, but significant problems with cell detachment using this technique restricted its general applicability. Conventional FIBSEM 'lift-out' procedures were found to be effective for the preparation of uniform sections of fixed and dehydrated cell/Ti specimens, but the control of cell staining remains an issue. Cryo-FIBSEM procedures used with an 'H-bar' sample geometry enabled the sectioning of fixed and hydrated cell/Ti specimens, but issues remain over ion beam-induced artefacts and control of frost on the sample foils.
C1 [Edwards, H. K.; Scotchford, C. A.; Grant, D. M.; Brown, P. D.] Univ Nottingham, Dept Mech Mat & Mfg Engn, Nottingham NG7 2RD, England.
   [Fay, M. W.] Univ Nottingham, Nottingham Nanotechnol & Nanosci Ctr, Nottingham NG7 2RD, England.
   [Anderson, S. I.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2RD, England.
RP Brown, PD (reprint author), Univ Nottingham, Dept Mech Mat & Mfg Engn, Univ Pk, Nottingham NG7 2RD, England.
EM paul.brown@nottingham.ac.uk
OI Fay, Michael/0000-0003-0017-5196; Scotchford, Colin/0000-0003-1937-6692;
   Grant, David/0000-0002-6786-7720; Brown, Paul/0000-0002-1911-5225
FU EPSRC [EP/E015379/1.]; Engineering and Physical Sciences Research
   Council [EP/E015379/1]
FX The authors would like to acknowledge Marie Smith and Denise Christie
   for the preparation of ultramicrotomy sections. Thanks also to Martin
   Roe for technical assistance with the cryo-FIBSEM experiments. This work
   was supported by the EPSRC under grant EP/E015379/1.
CR Armitage DA, 2003, J BIOMED MATER RES A, V66A, P129, DOI 10.1002/jbm.a.10549
   BONFIELD W, 1991, BONE-BIOMATERIAL INTERFACE, P89
   Engqvist H, 2006, J BIOMED MATER RES A, V78A, P20, DOI 10.1002/jbm.a.30696
   Engqvist H, 2008, J MATER SCI-MATER M, V19, P467, DOI 10.1007/s10856-006-0042-9
   Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0
   Giannuzzi LA, 2007, J ORAL MAXIL SURG, V65, P737, DOI 10.1016/j.joms.2006.10.025
   Hayles MF, 2007, J MICROSC-OXFORD, V226, P263, DOI 10.1111/j.1365-2818.2007.01775.x
   Heeren A, 2006, MICROELECTRON ENG, V83, P1602, DOI 10.1016/j.mee.2006.01.114
   Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006
   Iliescu M, 2004, SURF COAT TECH, V187, P131, DOI 10.1016/j.surfcoat.2004.01.022
   Jarmar T, 2008, CLIN IMPLANT DENT R, V10, P11, DOI 10.1111/j.1708-8208.2007.00056.x
   Langford RM, 2001, J VAC SCI TECHNOL A, V19, P2186, DOI 10.1116/1.1378072
   Li J, 2006, MATER CHARACT, V57, P64, DOI 10.1016/j.matchar.2005.12.007
   LI P, 2002, SOC BIOM 28 ANN M T, P332
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014
   Martinez E, 2008, MICRON, V39, P111, DOI 10.1016/j.micron.2006.12.003
   Mcgeoch JEM, 2007, J MICROSC-OXFORD, V227, P172, DOI 10.1111/j.1365-2818.2007.01798.x
   Milani M, 2006, SCANNING, V28, P148, DOI 10.1002/sca.4950280303
   Owen GRH, 2001, CELL BIOL INT, V25, P1251, DOI 10.1006/cbir.2001.0846
   Palmquist A, 2008, ACTA ORTHOP, V79, P78, DOI 10.1080/17453670710014806
   Plant SD, 2005, BIOMATERIALS, V26, P5359, DOI 10.1016/j.biomaterials.2005.01.067
   Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Richards RG, 2001, CELL BIOL INT, V25, P1237, DOI 10.1006/cbir.2001.0807
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   STOKES DJ, 2005, MICROSC MICROANAL, V11, P1260
NR 27
TC 22
Z9 22
U1 0
U2 12
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD APR
PY 2009
VL 234
IS 1
BP 16
EP 25
DI 10.1111/j.1365-2818.2009.03152.x
PG 10
WC Microscopy
SC Microscopy
GA 421QO
UT WOS:000264373600003
PM 19335453
OA Bronze
DA 2018-10-19
ER

PT J
AU Tamasan, M
   Baciut, M
   Coman, V
   Simon, V
AF Tamasan, M.
   Baciut, M.
   Coman, V.
   Simon, V.
TI Thermal kinetics analysis of bone tissue organic phase
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Biomaterials; Deer antler; Hydroxyapatite; Thermal analysis; Activation
   energy
ID RADIATION STERILIZATION; PHARMACEUTICALS; DECOMPOSITION; BIOMATERIALS;
   ANTLER
AB The rapid self-regeneration properties of deer antler tissue recommend this material as a potential bone regenerating biomaterial, because after high temperature treatments and gamma sterilization it represents a special source of hydoxyapatite. In order to investigate the decomposition of the organic phase existing in the bonelike antler tissue and the apatite type structural stability of the inorganic phase, thermal analyses were conducted at different heating rates, both on non-irradiated and gamma irradiated samples.
C1 [Tamasan, M.; Simon, V.] Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania.
   [Tamasan, M.; Simon, V.] Univ Babes Bolyai, Inst Interdisciplinary Expt Res, Cluj Napoca 400084, Romania.
   [Baciut, M.] Iuliu Hatieganu Univ Med & Pharm, Dept Craniomaxillofacial Surg, Cluj Napoca 400029, Romania.
   [Coman, V.] Univ Babes Bolyai, Raluca Ripan Inst Res Chem, Cluj Napoca 400294, Romania.
RP Tamasan, M (reprint author), Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania.
EM mtamasan@phys.ubbcluj.ro
FU Romanian Excellence Research Program. [CEEX 73/2006]
FX The study was supported by the scientific research project CEEX 73/2006
   of the Romanian Excellence Research Program.
CR Baciut M, 2007, J OPTOELECTRON ADV M, V9, P2547
   BOGL W, 1985, RADIAT PHYS CHEM, V25, P425, DOI 10.1016/0146-5724(85)90290-0
   Currey J, 2001, NATURE, V414, P699, DOI 10.1038/414699a
   Daniels G, 2006, ISBT SCI SERIES, V1, P3, DOI 10.1111/j.1751-2824.2006.00002.x
   Eglin D, 2005, SOFT MATTER, V1, P129, DOI 10.1039/b503019f
   GOPAL NGS, 1988, RADIAT PHYS CHEM, V32, P619
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Hiller JC, 2003, BIOMATERIALS, V24, P5091, DOI 10.1016/S0142-9612(03)00427-7
   Koga N, 2008, THERMOCHIM ACTA, V467, P11, DOI 10.1016/j.tca.2007.10.016
   Li CY, 2005, ANAT REC PART A, V282A, P163, DOI 10.1002/ar.a.20148
   ROVERI N, 2006, NANOTECHNOLOGIES LIF, V9, P283
   SIMON S, 2007, P 1 INT C ADV MED HL, P56501
   Tamasan M, 2008, J OPTOELECTRON ADV M, V10, P948
   Vecchio S, 2008, THERMOCHIM ACTA, V467, P1, DOI 10.1016/j.tca.2007.10.015
NR 14
TC 0
Z9 0
U1 0
U2 3
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD APR
PY 2009
VL 11
IS 4
BP 479
EP 483
PG 5
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 446EL
UT WOS:000266103300020
DA 2018-10-19
ER

PT J
AU Crespi, R
   Mariani, E
   Benasciutti, E
   Cappare, P
   Cenci, S
   Gherlone, E
AF Crespi, Roberto
   Mariani, Elisabetta
   Benasciutti, Elisa
   Cappare, Paolo
   Cenci, Simone
   Gherlone, Enrico
TI Magnesium-Enriched Hydroxyapatite Versus Autologous Bone in Maxillary
   Sinus Grafting: Combining Histomorphometry With Osteoblast Gene
   Expression Profiles Ex Vivo
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Biomaterial; bone formation; bone graft; bone resorption; osteoblast;
   osteoclast
ID IN-VITRO; CELLS; DIFFERENTIATION; AUGMENTATION; FLOOR; SUBSTITUTE;
   CERAMICS; MARROW; GROWTH
AB Background: Many biomaterials are proposed for sinus floor lifting and grafting in the posterior maxilla for insufficient bone volume (BV). The aim of this study was to compare the use of magnesium-enriched hydroxyapatite (mHA) versus autogenous bone graft (AB) for maxillary sinus lift procedures by histomorphometric and ex vivo gene expression profiling.
   Methods: Fifteen patients requiring bilateral maxillary sinus augmentation received autologous bone particles (group A) and mHA (group B) (split-mouth design). Five months later, implants were placed, and biopsies were obtained. Bone specimens were analyzed by histomorphometry, BV and vital bone (VB) percentages were calculated, and ex vivo osteoblast expansion followed by highly sensitive osteoblast specific gene expression profiling for cbfa1, osteocalcin, osteopontin, Collagen type I, receptor activator of nuclear factor-kappa B ligand (RANKL), and osteoprotegerin (OPG) by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) were performed. Comparisons were made using the Student t test.
   Results: After healing with no complications, BV was comparable in the two groups (80.79% +/- 14.27% for autologous versus 76.72% +/- 11.47% for mHA; P = not statistically significant), but VB was lower in the mHA group (29.65% +/- 9.81% versus 78.40% +/- 16.72%; P<0.05). Real-time RT-PCR analyses showed significantly higher expression of the osteoblast differentiation factor Cbfa1 and the matrix formation marker osteocalcin in the mHA group compared to the AB group, whereas type I Collagen was comparable, and osteopontin was decreased. Attesting to a lower osteoclastogenic potential, the RANKL/OPG ratio was diminished.
   Conclusions: Autogenous bone samples provided higher vital over comparable total bone levels than mHA-grafted sites. Osteoblast gene expression profiles from mHA grafts revealed higher expression of certain specific markers of osteoblast differentiation and bone formation, associated with a lower osteoclastogenic potential. J Periodontol 2009;80:586-593.
C1 [Crespi, Roberto; Cappare, Paolo; Gherlone, Enrico] Ist Sci San Raffaele, Dept Dent, I-20132 Milan, Italy.
   [Crespi, Roberto; Mariani, Elisabetta; Benasciutti, Elisa; Cenci, Simone; Gherlone, Enrico] Ist Sci San Raffaele, Div Cell Biol & Genet, BoNetwork, I-20132 Milan, Italy.
   [Crespi, Roberto; Mariani, Elisabetta; Benasciutti, Elisa; Cappare, Paolo; Cenci, Simone; Gherlone, Enrico] Univ Vita Salute San Raffaele, Milan, Italy.
RP Crespi, R (reprint author), Ist Sci San Raffaele, Dept Dent, Via Olgettina 58, I-20132 Milan, Italy.
EM robcresp@libero.it
RI Gherlone, Enrico/M-7376-2016; Cenci, Simone/J-7700-2016; Cappare,
   Paolo/A-2025-2016
OI Cenci, Simone/0000-0003-1215-7518; Cappare, Paolo/0000-0002-7277-6583
CR Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Beekmans HCS, 2008, INT J ORAL MAX SURG, V37, P768, DOI 10.1016/j.ijom.2008.02.008
   Boyce Brendan F, 2007, Curr Osteoporos Rep, V5, P98
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Carinci F, 2006, ARCH ORAL BIOL, V51, P154, DOI 10.1016/j.archoralbio.2005.06.006
   Carinci F, 2004, J BIOMED MATER RES B, V71B, P260, DOI 10.1002/jbm.b.30133
   CAWOOD JI, 1991, INT J ORAL MAX SURG, V20, P75, DOI 10.1016/S0901-5027(05)80711-8
   CRESPI R, 1992, BIOTECH HISTOCHEM, V67, P202, DOI 10.3109/10520299209110067
   Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Gungormus M, 2002, J ORAL MAXIL SURG, V60, P1316, DOI 10.1053/joms.2002.35731
   Knabe C, 2008, J BIOMED MATER RES A, V84A, P856, DOI 10.1002/jbm.a.31383
   Knabe C, 2005, CLIN ORAL IMPLAN RES, V16, P119, DOI 10.1111/j.1600-0501.2004.01066.x
   Kubler Alexander, 2004, Implant Dent, V13, P171
   Lee YM, 2006, INT J PERIODONT REST, V26, P471
   Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1
   Lian JB, 2003, CONNECT TISSUE RES, V44, P141, DOI 10.1080/03008200390152232
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   Mangano Carlo, 2006, J Oral Implantol, V32, P122, DOI 10.1563/796.1
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Misch CM, 1997, INT J ORAL MAX IMPL, V12, P767
   Rochet N, 2003, BONE, V32, P602, DOI 10.1016/S8756-3282(03)00093-0
   Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Sibilla P, 2006, J DENT RES, V85, P354, DOI 10.1177/154405910608500414
   Smeets Ralf, 2008, Schweiz Monatsschr Zahnmed, V118, P203
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 32
TC 32
Z9 33
U1 0
U2 5
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD APR
PY 2009
VL 80
IS 4
BP 586
EP 593
DI 10.1902/jop.2009.080466
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 433TD
UT WOS:000265227800007
PM 19335078
DA 2018-10-19
ER

PT J
AU Sterodimas, A
   de Faria, J
   Correa, WE
   Pitanguy, I
AF Sterodimas, Aris
   de Faria, Jose
   Correa, Wanda Elizabeth
   Pitanguy, Ivo
TI Tissue engineering and auricular reconstruction: a review
SO JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY
LA English
DT Review
DE Auricular reconstruction; Biomaterial; Bio-molecules; Stem cell; Tissue
   engineering
ID MESENCHYMAL STEM-CELLS; IN-VITRO; CARTILAGE GRAFTS; AUTOLOGOUS
   CARTILAGE; ALGINATE BEADS; CULTURE; CHONDROCYTES; SCAFFOLD; AURICLE;
   PERICHONDRIUM
AB This article provides an up-to-date review of the strategies used in auricular cartilage engineering. The currently available options in stem cell, biomaterial and bio-molecules and the crucial issues for the auricular cartilage engineering are presented. Researchers have demonstrated that neo-cartilage can be constituted in a predetermined shape and in complex three-dimensional structures, such as a human ear, by using cell. transplantation on polymer constructs. Despite this, many unsolved problems still remain. No perfect materials and methods have been found to substitute the shapely elastic cartilage normally present in the ear, and the current constructs have not proven to be durable over time. The recent advances in surgical techniques and biotechnology can promise clinical application of bio-engineered cultured cartilage in the future. Further tong-term in vitro and in vivo studies must be done before tissue engineering can be applied to reconstructive surgery of the auricle. (C) 2008 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Sterodimas, Aris; de Faria, Jose; Correa, Wanda Elizabeth; Pitanguy, Ivo] Pontif Univ Catholic Rio de Janeiro, Ivo Pitanguy Inst, Dept Plast Surg, BR-22280020 Rio De Janeiro, Brazil.
RP Sterodimas, A (reprint author), Pontif Univ Catholic Rio de Janeiro, Ivo Pitanguy Inst, Dept Plast Surg, Rua Dona Mariana 65, BR-22280020 Rio De Janeiro, Brazil.
EM aris@sterodimas.com
CR ALBREKTSSON T, 1987, PLAST RECONSTR SURG, V79, P721, DOI 10.1097/00006534-198705000-00007
   Brent B, 1999, PLAST RECONSTR SURG, V104, P319, DOI 10.1097/00006534-199908000-00001
   Brent B, 1999, PLAST RECONSTR SURG, V104, P335
   Cao Y, 1997, PLAST RECONSTR SURG, V100, P303
   Chang JS, 2007, ARCH FACIAL PLAST S, V9, P161, DOI 10.1001/archfaci.9.3.161
   Chang SCN, 2003, PLAST RECONSTR SURG, V112, P793, DOI 10.1097/01.PRS.0000069711.31021.94
   Chetty A, 2008, J BIOMED MATER RES A, V84A, P475, DOI 10.1002/jbm.a.31465
   Chung C, 2006, TISSUE ENG, V12, P2665, DOI 10.1089/ten.2006.12.2665
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X
   FUJISAWA T, 2008, OSTEOARTHRITIS  0218
   Fussenegger M, 2003, ANN PLAS SURG, V51, P493, DOI 10.1097/01.sap.0000067726.32731.E1
   Jeon YH, 2007, J CRANIOFAC SURG, V18, P1249, DOI 10.1097/scs.0b013e3181577b55
   Kamil SH, 2003, LARYNGOSCOPE, V113, P90, DOI 10.1097/00005537-200301000-00017
   Lee HJ, 2006, ARTIF ORGANS, V30, P707, DOI 10.1111/j.1525-1594.2006.00288.x
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Naumann A, 2008, HNO, V56, P109, DOI 10.1007/s00106-007-1651-4
   Naumann A, 2004, TISSUE ENG, V10, P1695, DOI 10.1089/ten.2004.10.1695
   Naumann A, 2003, EUR ARCH OTO-RHINO-L, V260, P568, DOI 10.1007/s00405-003-0636-5
   Ruszymah BHI, 2007, INT J PEDIATR OTORHI, V71, P1225, DOI 10.1016/j.ijporl.2007.04.014
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tan HP, 2007, J MATER SCI-MATER M, V18, P1961, DOI 10.1007/s10856-007-3095-5
   TANZER RC, 1967, PLAST RECONSTR SURG, V40, P547, DOI 10.1097/00006534-196740060-00006
   Togo T, 2006, LAB INVEST, V86, P445, DOI 10.1038/labinvest.3700409
   van Osch GJVM, 2000, TISSUE ENG, V6, P321, DOI 10.1089/107632700418047
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   WEERDA H, 1998, FACIAL PLAST SURG, V5, P399
   Wu W, 2007, J ORAL MAXIL SURG, V65, P1951, DOI 10.1016/j.joms.2006.11.044
   Xu JW, 2005, PLAST RECONSTR SURG, V115, P1633, DOI 10.1097/01.PRS.0000161465.21513.5D
   Yasuda A, 2006, TISSUE ENG, V12, P1237, DOI 10.1089/ten.2006.12.1237
NR 32
TC 31
Z9 32
U1 1
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-6815
J9 J PLAST RECONSTR AES
JI J. Plast. Reconstr. Aesthet. Surg.
PD APR
PY 2009
VL 62
IS 4
BP 447
EP 452
DI 10.1016/j.bjps.2008.11.046
PG 6
WC Surgery
SC Surgery
GA 435BK
UT WOS:000265318000007
PM 19114322
DA 2018-10-19
ER

PT J
AU Holand, W
   Rheinberger, V
   Apel, E
   Ritzberger, C
   Rothbrust, F
   Kappert, H
   Krumeich, F
   Nesper, R
AF Hoeland, W.
   Rheinberger, V.
   Apel, E.
   Ritzberger, C.
   Rothbrust, F.
   Kappert, H.
   Krumeich, F.
   Nesper, R.
TI Future perspectives of biomaterials for dental restoration
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article; Proceedings Paper
CT Workshop on Advanced Materials and Innovative Glass Melting Technologies
CY MAR 29-29, 2008
CL Brig, SWITZERLAND
SP European Forum New Glass Applicat
DE Glass ceramics; Ceramics; High toughness; Dental materials; Dental
   restoration; Esthetics; Colour
ID DISILICATE GLASS-CERAMICS; CRYSTALLIZATION; ZIRCONIA; LEUCITE; GROWTH
AB The development of biomaterials that can be used to substitute metals in dental restorations represents the main challenge of future research activities until the year 2020. Therefore, the authors will focus on the presentation of two types of biomaterials for dental restoration: glass-ceramics and sintered ceramics. Dental biomaterials must have a highly aesthetic appearance that is comparable to that of natural teeth. Furthermore, they must be more durable than natural teeth and show good mechanical properties at ambient temperatures.
   Based on the state of the art and the latest research activities, the presentation is focused on glass-ceramics with high toughness, glass-ceramics with optical properties comparable to those of natural teeth and glass-ceramics that are processed with preferred techniques, for example, those which are moulded on different types of high-strength substrate materials. In addition, high-strength and high-toughness materials Such as lithium disilicate glass-ceramics can be processed either by moulding or by a new method, that is, machining. Possible directions will be presented for moulding different types of glass-ceramics such as fluoroapatite containing glass-ceramics on high-toughness substrates made of glass-ceramics or very tough sintered ceramics.
   The focal point of this presentation is the demonstration of the high-strength and high-toughness sintered ceramics of the ZrO(2) type. The preferred processing method or this type of biomaterials for dental restoration is machining using CAD/CAM technologies. Future activities will be focused on improving the quality of the ZrO(2)-type biomaterial. At present ZrO(2) ceramics are white opaque. One of the main aims is to achieve optical properties comparable to those of natural teeth in ZrO(2) ceramic. Therefore, the material has to be developed in special dental colours with the same mechanical properties and good durability as that of the white ZrO(2). The authors will show future directions for developing coloured ZrO2 sintered ceramics.
   Future research activities will be focused on gaining a better understanding of the phenomena and mechanisms of toughening glass-ceramics and ceramics. With the acquired knowledge on the toughening mechanisms, new directions for developing ceramics until the year 2020 will be explored. The technology to achieve this goal will be applied nanotechnology. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Hoeland, W.; Rheinberger, V.; Apel, E.; Ritzberger, C.; Rothbrust, F.; Kappert, H.] Ivoclar Vivadent AG, Res & Dev, LI-9494 Schaan, Liechtenstein.
   [Krumeich, F.; Nesper, R.] ETH, Anorgan Chem Lab, CH-8093 Zurich, Switzerland.
RP Holand, W (reprint author), Ivoclar Vivadent AG, Res & Dev, Bendererstr 2, LI-9494 Schaan, Liechtenstein.
EM wolfram.hoeland@ivoclarvivadent.com
OI Krumeich, Frank/0000-0001-5625-1536
CR ADAIR PJ, 1984, INT J PERIODONT REST, P33
   ANUSAVICE KJ, 2005, IVOCLAR VIVADENT INT
   Apel E, 2008, J MECH BEHAV BIOMED, V1, P313, DOI 10.1016/j.jmbbm.2007.11.005
   Apel E, 2007, J EUR CERAM SOC, V27, P1571, DOI 10.1016/j.jeurceramsoc.2006.04.103
   BEALL GH, 1977, SPEC PUBL AM CER SOC, V5, P251
   Bondioli F, 2005, J AM CERAM SOC, V88, P633, DOI 10.1111/j.1551-2916.2005.00093.x
   BRODBECK U, 1996, SIGNATURE, P8
   BURKE H, 2006, IPS E MAX PRESS IPS, P6
   Deville S, 2004, ACTA MATER, V52, P5709, DOI 10.1016/j.actamat.2004.08.036
   DONG JK, 1992, QUINTESSENZ, V43, P1373
   EDELHOFF D, 2006, PRESENTATION DENTAL
   EDELHOFF D, 2000, DTSCH ZAHNARZTL Z, V55, P326
   Fradeani M, 2002, QUINTESSENCE INT, V33, P503
   FREIMAN SW, 1972, J AM CERAM SOC, V55, P86, DOI 10.1111/j.1151-2916.1972.tb11216.x
   HEINZMANN JL, 1990, J DENT RES, V69, P161
   Holand W, 2008, J MATER CHEM, V18, P1318, DOI 10.1039/b714913a
   Holand W, 2008, WOODHEAD PUBL MATER, P548, DOI 10.1533/9781845694227.2.548
   Holand W, 2006, J MATER SCI-MATER M, V17, P1037, DOI 10.1007/s10856-006-0441-y
   Holand W, 2006, J NON-CRYST SOLIDS, V352, P4041, DOI 10.1016/j.jnoncrysol.2006.06.039
   Holand W, 2003, PHILOS T ROY SOC A, V361, P575, DOI 10.1098/rsta.2002.1152
   HOLAND W, 1995, J NON-CRYST SOLIDS, V180, P292, DOI 10.1016/0022-3093(94)00464-1
   Holand W, 2002, GLASS CERAMIC TECHNO
   Holand W, 2007, J EUR CERAM SOC, V27, P1521, DOI 10.1016/j.jeurceramsoc.2006.04.101
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   MALAMENT KA, 1987, J PROSTHET DENT, V57, P674, DOI 10.1016/0022-3913(87)90362-3
   RHEINBERGER VM, 1997, GLASTECH BER GLASS C, V70, P393
   ROTHBRUST F, 2006, IPS E MAX ZIRCAD, P17
   RUHLE M, 1989, PROG MATER SCI, V33, P85, DOI 10.1016/0079-6425(89)90005-4
   SCHWEIGER M, 2006, REPORT IVOCLAR VIVAD, P25
   Schweiger M, 1998, QUINTESSENCE DENT TE, V21, P73
   STOOKEY SD, 1959, IND ENG CHEM, V51, P805, DOI 10.1021/ie50595a022
   Studart AR, 2007, DENT MATER, V23, P106, DOI 10.1016/j.dental.2005.12.008
   Wohlwend A, 1990, QUINTESSENZ ZAHNTECH, V16, P966
NR 33
TC 26
Z9 29
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD APR
PY 2009
VL 29
IS 7
BP 1291
EP 1297
DI 10.1016/j.jeurceramsoc.2008.08.023
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA 441SD
UT WOS:000265789900013
DA 2018-10-19
ER

PT J
AU Guitar, A
   Vigna, G
   Luppo, MI
AF Guitar, A.
   Vigna, G.
   Luppo, M. I.
TI Microstructure and tensile properties after thermohydrogen processing of
   Ti-6Al-4V
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
ID HYDROGEN
AB Thermohydrogen processing (THP), a technique in which hydrogen is used as a temporary alloying element, can refine the microstructure and improve the final mechanical properties of the Ti-6Al-4V alloy. THP allows microstructural modification of titanium alloys near net shape such as biomaterial components obtained by powder metallurgy and castings, since it does not require mechanical working. Two THP, called THP-A and THP-B, have been evaluated in samples of Ti-6Al-4V with a coarse and lamellar microstructure typical of castings and powder metallurgy. The THP-A is based in the eutectoid decomposition of the beta(H) phase to alpha phase and hydride phase. The THP-B is based in the isothermal decomposition of alpha" martensite phase, obtained by quenching of hydrogenated samples. The refinement of the microstructure due to THP has been evaluated by means of optical and electron microscopy. Tensile tests showed that while both processes were able to increase the strength of the alloy as compared with the starting material, the ductility in samples subjected to THP-B was severely reduced. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Guitar, A.; Vigna, G.; Luppo, M. I.] Comis Nacl Energia Atom, Dept Mat, Ctr Atom Constituyentes, Pcia De Buenos Aires, Argentina.
RP Luppo, MI (reprint author), Comis Nacl Energia Atom, Dept Mat, Ctr Atom Constituyentes, Av Gral Paz 1499 B1650KNA San Martin, Pcia De Buenos Aires, Argentina.
EM luppo@cnea.gov.ar
CR Akahori T, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P91
   Fang TY, 1998, MATER CHEM PHYS, V56, P35, DOI 10.1016/S0254-0584(98)00137-0
   Froes F.H., 1990, HYDROGEN EFFECTS MAT, P261
   Froes FH, 1998, NON-AEROSPACE APPLICATIONS OF TITANIUM, P111
   Fukui H, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P107
   Kerr W. R., 1980, P 4 INT C TIT KYOT J, P2477
   KERR WR, 1985, METALL TRANS A, V16, P1077, DOI 10.1007/BF02811677
   KOHN DH, 1991, J MATER SCI, V26, P534, DOI 10.1007/BF00576555
   Leguey T, 2002, J NUCL MATER, V305, P52, DOI 10.1016/S0022-3115(02)00888-7
   Manchester F., 2000, H TI HIDROGEN TITANI, P238
   NIINOMI M, 1995, METALL MATER TRANS A, V26, P1141, DOI 10.1007/BF02670611
   QAZY JI, 2003, MAT SCI ENG A-STRUCT, V359, P137
   QAZY JI, 2000, LIGHT METALS 2000, P885
   QAZY JI, 2001, METALL MATER TRANS A, V32, P2453
   Senkov ON, 1999, INT J HYDROGEN ENERG, V24, P565, DOI 10.1016/S0360-3199(98)00112-8
NR 15
TC 21
Z9 21
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD APR
PY 2009
VL 2
IS 2
BP 156
EP 163
DI 10.1016/j.jmbbm.2008.06.002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423PT
UT WOS:000264508900005
PM 19627819
DA 2018-10-19
ER

PT J
AU Takahashi, M
   Kikuchi, M
   Okuno, O
AF Takahashi, Masatoshi
   Kikuchi, Masafumi
   Okuno, Osamu
TI Grindability of Dental Cast Ti-Zr Alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; titanium alloy; grindability; microstructure; dental alloy
ID BINARY TITANIUM-ZIRCONIUM; MECHANICAL-PROPERTIES; CU ALLOYS; PHASE; AG
AB The purpose of this study was to improve the grindability of titanium by alloying with zirconium. The grindability of dental case Ti-Zr alloys (10, 20, 30, 40 and 50 mass% Zr) was evaluated using a carborundum wheel. The Ti-Zr alloys up to 30 mass% Zr formed an alpha structure, and the 40 mass% Zr and 50 mass% Zr alloys formed an alpha' structure. The Ti-40 mass% Zr alloy at up to 1000 m/min and the Ti-50 mass% Zr alloy at up to 1250 m/min exhibited significantly higher grindability than titanium. More than twice the volume of metal was removed from the alloys than from titanium per minute. The improved grindability could be attributed to the alpha' structure in addition to the decrease in elongation. The Ti-Zr alloys, which formed an alpha' phase structure, are candidates for use as machinable biomaterial in dental applications. [doi:10.2320/matertrans.MRA2008403]
C1 [Takahashi, Masatoshi; Kikuchi, Masafumi; Okuno, Osamu] Tohoku Univ, Grad Sch Dent, Div Dent Biomat, Sendai, Miyagi 9808575, Japan.
RP Takahashi, M (reprint author), Tohoku Univ, Grad Sch Dent, Div Dent Biomat, Sendai, Miyagi 9808575, Japan.
CR Boyer R., 1994, MAT PROPERTIES HDB T, P1051
   Chan KS, 2006, METALL MATER TRANS A, V37A, P1323, DOI 10.1007/s11661-006-1084-9
   Davis JR, 1992, ASM MAT ENG DICT, P127
   DUWEZ P, 1952, J I MET, V80, P525
   ETCHU Y, 1992, J JPN SOC DENT MAT D, V11, P270
   GILL JL, 1981, J DAIRY SCI, V64, P1494, DOI 10.3168/jds.S0022-0302(81)82717-8
   HATT BA, 1957, NATURE, V180, P1406, DOI 10.1038/1801406a0
   Ho WF, 2008, J MATER SCI-MATER M, V19, P3179, DOI 10.1007/s10856-008-3454-x
   Hsu J.C., 1996, MULTIPLE COMPARISONS, P119
   HUANG YC, 1970, P INT C, P691
   Ikarashi Y, 2005, MATER TRANS, V46, P2260, DOI 10.2320/matertrans.46.2260
   IMGRAM AG, 1962, J LESS-COMMON MET, V4, P217, DOI 10.1016/0022-5088(62)90068-1
   Kikuchi M, 2006, J BIOMED MATER RES B, V77B, P34, DOI 10.1002/jbm.b.30411
   Kikuchi M, 2003, DENT MATER J, V22, P328, DOI 10.4012/dmj.22.328
   Kikuchi M, 2003, DENT MATER J, V22, P191, DOI 10.4012/dmj.22.191
   Kikuchi M, 2008, DENT MATER J, V27, P216, DOI 10.4012/dmj.27.216
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kobayashi S, 2001, MATER TRANS, V42, P2398, DOI 10.2320/matertrans.42.2398
   MACHADO AR, 1990, P I MECH ENG B-J ENG, V204, P53, DOI 10.1243/PIME_PROC_1990_204_047_02
   Murray J. L., 1987, PHASE DIAGRAMS BINAR, P340
   Okabe T, 2004, JOM-US, V56, P46, DOI 10.1007/s11837-004-0145-z
   OKUNO A, 1985, J J DENT MAT, V4, P708
   Oliveira NTC, 2005, J BIOMED MATER RES A, V74A, P397, DOI 10.1002/jbm.a.30352
   Takahashi M, 2004, DENT MATER J, V23, P203, DOI 10.4012/dmj.23.203
   Takahashi M, 2000, J JPN I MET, V64, P1120, DOI 10.2320/jinstmet1952.64.11_1120
   Tsuchiya T, 1998, TISSUE ENG, V4, P197, DOI 10.1089/ten.1998.4.197
   Tukey J.W, 1991, STAT SCI, V6, P100, DOI DOI 10.1214/SS/1177011945
   Vander Voort G.F., 2004, ASM HDB, V9, P899
   YU S Y, 2001, J ELECTROCHEM SOC, V148, P68
NR 30
TC 10
Z9 11
U1 0
U2 7
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2009
VL 50
IS 4
BP 859
EP 863
DI 10.2320/matertrans.MRA2008403
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 449CT
UT WOS:000266309100027
OA Bronze
DA 2018-10-19
ER

PT J
AU Nagase, T
   Kinoshita, K
   Nakano, T
   Umakoshi, Y
AF Nagase, Takeshi
   Kinoshita, Koichi
   Nakano, Takayoshi
   Umakoshi, Yukichi
TI Fabrication of Ti-Zr Binary Metallic Wire by Arc-Melt-Type
   Melt-Extraction Method
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-based alloy; rapidly quenched wire; melt-extraction method;
   biomaterial
ID CO-SI-B; MECHANICAL-PROPERTIES; ROTATING-WATER; BIOMEDICAL APPLICATIONS;
   SPINNING PROCESS; TITANIUM-ALLOYS; FIBER; FILAMENTS; STRENGTH; LIQUID
AB Ti-Zr binary metallic wires without toxic elements were developed by an are-melt-type melt-extraction method for potential application as biomedical materials. The Ti-Zr binary alloy showed high wire forming capability during the melt-extraction process, independent of the Ti concentration. Therefore, it was possible to form rapidly quenched wires using Ti100-xZrx (x = 10 at% to 80 at%) alloys. Continuous binary Ti-Zr alloy wires had good white luster, negligible surface roughness, high tensile strength, and high bending ductility. [doi:10.2320/matertrans.MRA2008379]
C1 [Nagase, Takeshi] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Ibaraki 5670047, Japan.
   [Nagase, Takeshi; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan.
   [Kinoshita, Koichi] Osaka Univ, Grad Sch Engn, Dept Mech Sci & Bioengn, Toyonaka, Osaka 5608531, Japan.
   [Umakoshi, Yukichi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RP Nagase, T (reprint author), Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Ibaraki 5670047, Japan.
EM t-nagase@uhvem.osaka-u.ac.jp
RI NAKANO, Takayoshi/F-8140-2011; Nagase, Takeshi/M-1189-2015
OI Nagase, Takeshi/0000-0003-4868-0773
FU Ministry of Education, Culture. Sports. Science and Technology of Japan
   (MEXT); Priority Assistance for the Formation of Worldwide Renowned
   Centers of Research
FX This study was supported by a Grant-in-Aid for Scientific Research on
   Priority Area A, "Materials Science of Metallic Glasses" from the
   Ministry of Education, Culture. Sports. Science and Technology of Japan
   (MEXT). This study was partly supported by Priority Assistance for the
   Formation of Worldwide Renowned Centers of Research-The Global COE
   Program (Project: Center of Excellence for Advanced Structural and
   Functional Materials Design)-and a Grant-in-Aid for Scientific Research
   and Development from MEXT, Japan.
CR BUNGE HJ, 1976, Z METALLKD, V67, P720
   GOTO T, 1985, J MATER SCI, V20, P1883, DOI 10.1007/BF00555297
   HAGIWARA M, 1982, MATER SCI ENG, V54, P197, DOI 10.1016/0025-5416(82)90114-8
   HAGIWARA M, 1992, B JPN I MET, V31, P464
   Hanawa T, 2007, METALS BIOMATERIALS
   INOUE A, 1994, MATER T JIM, V35, P485, DOI 10.2320/matertrans1989.35.485
   INOUE A, 1995, MATER T JIM, V36, P802, DOI 10.2320/matertrans1989.36.802
   INOUE A, 1995, MATER T JIM, V36, P858, DOI 10.2320/matertrans1989.36.858
   ISAMA K, 2007, 29 ANN M JAP SOC BIO, P387
   ISHIKAWA H, 1993, TOKIN TECH, V19, P1
   ISHIKAWA H, 1991, TOKIN TECH REV, V18, P1
   KAVESH S, 1976, METALLIC GLASSES, P36
   KIMURA H, 1999, J JPN SOC POWDER POW, V47, P427
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Maringer R. E., 1975, U. S. Patent, Patent No. [3 871 439, 3871439]
   MARINGER RE, 1974, J VAC SCI TECHNOL, V11, P1067, DOI 10.1116/1.1318681
   Massalski T.B., 1996, BINARY ALLOY PHASE D
   NAGASE T, 2008, P MAT RES SOC S, V1048
   Nagase T, 2008, MATER TRANS, V49, P1385, DOI 10.2320/matertrans.MRA2008006
   Narushima T, 2005, J JPN I LIGHT METALS, V55, P561
   NHK SPRING DAIDO STE, 2001, Patent No. 2001107164
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   NIINOMI M, 2002, SOKEIZAI, V43, P8
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   OHNAKA I, 1981, J JPN I MET, V45, P751, DOI 10.2320/jinstmet1952.45.7_751
   OKUNO O, 1985, J JPN SOC DENT MAT D, V4, P708
   Ono Y, 1997, J JPN I MET, V61, P650, DOI 10.2320/jinstmet1952.61.7_650
   Ono Y, 2005, TETSU TO HAGANE, V91, P511
   PARADOE GWF, 1978, J MATER SCI, V13, P786
   RUDKOWSKI P, 1991, MAT SCI ENG A-STRUCT, V133, P158, DOI 10.1016/0921-5093(91)90038-O
   Shimaoka M, 1997, J JPN I MET, V61, P1115, DOI 10.2320/jinstmet1952.61.10_1115
   SHIMAOKA M, 2004, RES REP, V40, P33
   STROMOLSEN J, 1994, MAT SCI ENG A-STRUCT, V178, P239, DOI 10.1016/0921-5093(94)90549-5
   Taylor GF, 1924, PHYS REV, V23, P655, DOI 10.1103/PhysRev.23.655
NR 36
TC 5
Z9 6
U1 0
U2 4
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2009
VL 50
IS 4
BP 872
EP 878
DI 10.2320/matertrans.MRA2008379
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 449CT
UT WOS:000266309100029
OA Bronze
DA 2018-10-19
ER

PT J
AU Kang, HW
   Rhie, JW
   Cho, DW
AF Kang, Hyun-Wook
   Rhie, Jong-Won
   Cho, Dong-Woo
TI Development of a bi-pore scaffold using indirect solid freeform
   fabrication based on microstereolithography technology
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT 34th International Conference on Micro- and Nano-Engineering
CY SEP 15-18, 2008
CL Athens, GREECE
DE Tissue engineering; Bi-pore scaffold; Indirect solid freeform
   fabrication; Microstereolithography
ID STEREOLITHOGRAPHY; REGENERATION; COMPOSITES
AB Precise control over the biomaterial, porosity, and inner architecture of a scaffold is essential for tissue regeneration. This paper proposes a new bi-pore scaffold that has both global and local pores in its structure. The global pores can serve as channels for supplying cells with nutrients and oxygen, while the local pores provide space for cell growth. A lost mold shape-forming process based on high-resolution microstereolithography technology was used to form the global pores, and conventional scaffold fabrication methods, such as salt leaching and phase inversion, were added to the molding process to generate local pores. This resulted in the fabrication of 300 to 400 mu m global pores with the lost molding process; local pores of 30 to 100 mu m and 1 to 5 mu m were achieved with salt leaching and phase inversion, respectively. Compared to other processes, this fabrication process provides a powerful method for bi-pore scaffold fabrication. (C) 2008 Elsevier B.V. Ail rights reserved.
C1 [Kang, Hyun-Wook; Cho, Dong-Woo] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang 790784, Gyeongbuk, South Korea.
   [Rhie, Jong-Won] Catholic Univ Korea, Coll Med, Dept Plast Surg, Seoul, South Korea.
RP Cho, DW (reprint author), Pohang Univ Sci & Technol, Dept Mech Engn, Pohang 790784, Gyeongbuk, South Korea.
EM dwcho@postech.ac.kr
RI Rhie, Jong Won/C-4652-2012
OI Rhie, Jong Won/0000-0002-9398-8059
CR Bertsch A, 1999, SENSOR ACTUAT A-PHYS, V73, P14, DOI 10.1016/S0924-4247(98)00249-0
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Kang HW, 2004, J MANUF SCI E-T ASME, V126, P766, DOI 10.1115/1.1811116
   Lee M, 2005, BIOMATERIALS, V26, P4281, DOI 10.1016/j.biomaterials.2004.10.040
   Liska R, 2005, J APPL POLYM SCI, V97, P2286, DOI 10.1002/app.22025
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Maruo S, 2002, SENSOR ACTUAT A-PHYS, V100, P70, DOI 10.1016/S0924-4247(02)00043-2
   Park K, 2007, MACROMOL SYMP, V249, P145, DOI 10.1002/masy.200750324
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Sim JH, 2007, INT J PRECIS ENG MAN, V8, P50
   Sun C, 2005, SENSOR ACTUAT A-PHYS, V121, P113, DOI 10.1016/j.sna.2004.12.011
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
NR 12
TC 16
Z9 16
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD APR-JUN
PY 2009
VL 86
IS 4-6
BP 941
EP 944
DI 10.1016/j.mee.2008.11.054
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 461NG
UT WOS:000267273300127
DA 2018-10-19
ER

PT J
AU Bakeine, GJ
   Ban, J
   Grenci, G
   Pozzato, A
   Dal Zilio, S
   Prasciolu, M
   Businaro, L
   Tormen, M
   Ruaro, ME
AF Bakeine, Gerald James
   Ban, Jelena
   Grenci, Gianluca
   Pozzato, Alessandro
   Dal Zilio, Simone
   Prasciolu, Mauro
   Businaro, Luca
   Tormen, Massimo
   Ruaro, Maria Elisabetta
TI Design, fabrication and evaluation of nanoscale surface topography as a
   tool in directing differentiation and organisation of embryonic
   stem-cell-derived neural precursors
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT 34th International Conference on Micro- and Nano-Engineering
CY SEP 15-18, 2008
CL Athens, GREECE
DE Mouse embryonic stem cells (mESC); Nano-biomaterials; Surface
   topography; Neural differentiation; Tissue organisation
ID IN-VITRO; NEURONS
AB A major limitation in the translation of stem cells technology to clinical applications is the lack of efficient control over their proliferation and differentiation.
   Recent in vitro research findings suggest that biomaterials with nanoscale surface topography can influence cell behaviour like adhesion, proliferation and differentiation. Therefore, the identification of biomaterials that support appropriate ES cell attachment, proliferation and differentiation into cells of interest is an attractive strategy worth investigation.
   In this study we present the design and fabrication of thin films of gold with surface topography of varying roughness using a combination of microfabrication techniques. We then explored their biomimetic potential to direct differentiation of ES cell-derived neural precursors. Standard glass coverslips and tissue culture plastic were used as reference materials. Our preliminary results show that ES-derived neural precursors best adhered on gold and underwent the highest differentiation on gold films with root mean square surface roughness (R(q)) of 21 nm (72 +/- 6%) after five days of culture in the absence of traditional soluble neurotrophic factors. Moreover, when cells were seeded on a combination of micro-scale grooves with nanoscale surface roughness, axonal outgrowth orientation was observed to be influenced by the grating axis.
   This data identifies gold as a potential biomaterial candidate with suitable cytocompatibility for ES cell research. It further lends support to the hypothesis that biomaterial design may optimize ES cell-derived neural differentiation and organisation. This may find utility as a tool to synergically complement soluble chemical factors currently used in in vitro protocols for the stimulation and modelling of ES differentiation. Ultimately, substrate patterning may hold special utility in the design of neural prostheses because repair of neurological injuries requires directional guidance. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Bakeine, Gerald James] Univ Pavia, Dipartimento Med Sperimentali, Interfac Ctr Tissue Engn, Sez Anat Umana Normale, I-27100 Pavia, Italy.
   [Ban, Jelena; Ruaro, Maria Elisabetta] ISAS SISSA, Trieste, Italy.
   [Bakeine, Gerald James; Grenci, Gianluca; Pozzato, Alessandro; Dal Zilio, Simone; Prasciolu, Mauro; Businaro, Luca; Tormen, Massimo] INFM TASC, Natl Lab Adv Technol & NanoSci, Trieste, Italy.
   [Ruaro, Maria Elisabetta] Glance Vis Technol, Trieste, Italy.
RP Bakeine, GJ (reprint author), Univ Pavia, Dipartimento Med Sperimentali, Interfac Ctr Tissue Engn, Sez Anat Umana Normale, Via Forlanini 8, I-27100 Pavia, Italy.
EM jamesbakeine1@yahoo.com
RI businaro, luca/F-9545-2012; Ban, Jelena/R-3337-2018
OI businaro, luca/0000-0002-5251-093X; Ban, Jelena/0000-0001-5792-3998;
   Prasciolu, Mauro/0000-0003-0094-9825; Tormen,
   Massimo/0000-0001-7919-0692; Grenci, Gianluca/0000-0001-9313-6748
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004419900074
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Ban J, 2007, STEM CELLS, V25, P738, DOI 10.1634/stemcells.20060246
   CECCHINI M, 2007, NANOTECHNOLOGY, V81
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, IEEE T NANOBIOSCI, V1, P12, DOI 10.1109/TNB.2002.806930
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FLEMMING RG, 1995, BIOMATERIALS, V2, P73
   Heng BC, 2004, J BONE MINER RES, V19, P1379, DOI 10.1359/JBMR.040714
   Kang XH, 2007, BIOMATERIALS, V28, P450, DOI 10.1016/j.biomaterials.2006.08.052
   Khan SP, 2005, NANOMED-NANOTECHNOL, V1, P125, DOI 10.1016/j.nano.2005.03.007
   Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
NR 17
TC 22
Z9 23
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD APR-JUN
PY 2009
VL 86
IS 4-6
BP 1435
EP 1438
DI 10.1016/j.mee.2009.01.032
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 461NG
UT WOS:000267273300259
DA 2018-10-19
ER

PT J
AU Lee, JW
   Jung, JH
   Kim, DS
   Lim, G
   Cho, DW
AF Lee, Jin Woo
   Jung, Jin Hwa
   Kim, Dae Shick
   Lim, Geunbae
   Cho, Dong-Woo
TI Estimation of cell proliferation by various peptide coating at the
   PPF/DEF 3D scaffold
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT 34th International Conference on Micro- and Nano-Engineering
CY SEP 15-18, 2008
CL Athens, GREECE
DE Micro-stereolithography (MSTL); Poly (propylene fumarate) (PPF); Peptide
   coating; 3D scaffold fabrication; Surface modification
AB Surface properties play important roles in determining the initial response of living cells to a biomaterial, as well as in controlling cellular events. However, developing a biomaterial having good mechanical properties that also possesses suitable surface properties for biomedical applications is difficult. Poly (propylene fumarate) (PPF)-based materials are good candidates for bone regeneration due to their nontoxic biodegradable products and excellent mechanical properties. Their surface properties, however, including hydrophobicity, are disadvantageous. Therefore, we tried to immobilize peptides on a three-dimensional (3D) scaffold of PPF-based materials. And because conventional scaffold fabrication methods cannot realize the standardized 3D environment, we used micro-stereolithography (MSTL), which has the highest resolution among solid free-form fabrication (SFF) technologies that can produce scaffolds as designed. in this study, we successfully fabricated scaffolds that possess regular pores and line structures using MSTL and PPF-based materials. We estimated the cell adhesion and proliferation with various peptides in a standardized 3D scaffold environment. We found that a scaffold functionalized with a mixture of RGD and KRSR enhanced osteoblast adhesion and proliferation compared to scaffolds with RGD or KRSR alone. Our results indicate the usefulness of the surface modification of the synthetic polymer PPF/DEF with peptide mixtures. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Lee, Jin Woo; Jung, Jin Hwa; Lim, Geunbae; Cho, Dong-Woo] POSTECH, Dept Mech Engn, Pohang 790784, Gyeongbuk, South Korea.
   [Kim, Dae Shick] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea.
   [Lim, Geunbae; Cho, Dong-Woo] POSTECH, Dept Integrat Biosci & Bioengn, Pohang 790784, Gyeongbuk, South Korea.
RP Cho, DW (reprint author), POSTECH, Dept Mech Engn, Pohang 790784, Gyeongbuk, South Korea.
EM dwcho@postech.ac.kr
CR BANNO A, 2007, BONE, V40, P693
   Domb A. J., 1989, US patent, Patent No. 4888413
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   Frazier DD, 1997, J BIOMED MATER RES, V35, P383, DOI 10.1002/(SICI)1097-4636(19970605)35:3<383::AID-JBM12>3.0.CO;2-G
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Sim JH, 2007, INT J PRECIS ENG MAN, V8, P50
NR 6
TC 8
Z9 8
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD APR-JUN
PY 2009
VL 86
IS 4-6
BP 1451
EP 1454
DI 10.1016/j.mee.2008.12.052
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 461NG
UT WOS:000267273300263
DA 2018-10-19
ER

PT J
AU Bakeine, GJ
   Bertolotti, A
   Zennaro, C
   Grenci, G
   Pozzato, A
   Dal Zilio, S
   Prasciolu, M
   Carraro, M
   Businaro, L
   Tormen, M
   Alessiani, M
   Nano, R
   Dionigi, P
AF Bakeine, G. J.
   Bertolotti, A.
   Zennaro, C.
   Grenci, G.
   Pozzato, A.
   Dal Zilio, S.
   Prasciolu, M.
   Carraro, M.
   Businaro, L.
   Tormen, M.
   Alessiani, M.
   Nano, R.
   Dionigi, P.
TI Design and fabrication of large area nano-structured substrates for use
   in pancreatic beta-cell engineering
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT 34th International Conference on Micro- and Nano-Engineering
CY SEP 15-18, 2008
CL Athens, GREECE
DE Nano-structured biomaterial; Insulinoma; Adhesion; Pancreatic beta-cell
   proliferation; Insulin secretion
AB Islet transplantation has great potential in restoring normoglycemia in diabetic patients. However, current clinical islet transplantation is associated with high graft failure the reasons of which still remain obscure. It is noteworthy that the process of islet isolation exposes the islet to a variety of cellular stresses, including disruption of the cell-matrix relationship, an event associated with induction of apoptotic pathways. This may adversely affect islet viability and function leading to the observed failure of islet transplantation. The cell-matrix relationship, characterised by adhesion interactions between membrane integrin receptors and the extracellular matrix molecules at the nanoscale, is known to modulate cell survival and growth. The aim of this study is to present a unique method of fabricating large area artificial substrates with biomimetic nanoscale surface topography. The substrates were realised by thermal evaporation of tin on silicon wafers to form randomly assembled nano-islands. Using the nano-islands as masks, the wafers were plasma etched to transfer the pattern onto silicon. We then examined the hypothesis of whether beta-cell function and survival can be enhanced by optimized restoration of cell-matrix adhesion. The results of in vitro cell cultures show that insulinoma cells significantly adhered and enhanced insulin secretion when cultured on these nano-structured substrates compared to planar controls. With this unique fabrication process we propose a simple, robust and accessible technology for fabricating platforms for potential use in the investigation and modulation of early pancreatic beta-cell behaviour which may find utility in the development of strategies for pancreatic islet engineering and transplantation. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Bakeine, G. J.] Univ Pavia, Dipartimento Med Sperimentale, Interfac Ctr Tissue Engn, Sez Anat Umana Normale, I-27100 Pavia, Italy.
   [Bertolotti, A.; Nano, R.] Univ Pavia, Dept Anim Biol, I-27100 Pavia, Italy.
   [Zennaro, C.; Carraro, M.] Univ Trieste, Dept Clin Med & Neurol, I-34127 Trieste, Italy.
   [Bakeine, G. J.; Grenci, G.; Prasciolu, M.; Businaro, L.; Tormen, M.] INFM TASC, Natl Lab Adv Technol & NanoSci, Trieste, Italy.
   [Pozzato, A.; Dal Zilio, S.] Univ Padua, Padua, Italy.
   [Alessiani, M.; Dionigi, P.] San Matteo Univ Hosp, Dept Surg, Pavia, Italy.
   [Alessiani, M.; Dionigi, P.] San Matteo Univ Hosp, Inst Hepatopancreat Surg, Pavia, Italy.
RP Bakeine, GJ (reprint author), Univ Pavia, Dipartimento Med Sperimentale, Interfac Ctr Tissue Engn, Sez Anat Umana Normale, Via Forlanini 8, I-27100 Pavia, Italy.
EM jamesbakeine1@yahoo.com
RI businaro, luca/F-9545-2012
OI businaro, luca/0000-0002-5251-093X; Grenci,
   Gianluca/0000-0001-9313-6748; Prasciolu, Mauro/0000-0003-0094-9825;
   CARRARO, MICHELE/0000-0002-8940-3361; ZENNARO,
   Cristina/0000-0003-4755-1064; Tormen, Massimo/0000-0001-7919-0692;
   DIONIGI, PAOLO/0000-0002-0768-9395
CR Bogaerts A, 2002, SPECTROCHIM ACTA B, V57, P609, DOI 10.1016/S0584-8547(01)00406-2
   HIRSHBERG B, 2007, CURR DIABETES REP, V7, P4301
   PARASKEVAS S, 2000, PANCREAS, V20, P3
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
NR 4
TC 4
Z9 4
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD APR-JUN
PY 2009
VL 86
IS 4-6
BP 1468
EP 1472
DI 10.1016/j.mee.2008.12.059
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 461NG
UT WOS:000267273300268
DA 2018-10-19
ER

PT J
AU Zhao, C
   Brinkhoff, T
   Burchardt, M
   Simon, M
   Wittstock, G
AF Zhao, Chuan
   Brinkhoff, Thorsten
   Burchardt, Malte
   Simon, Meinhard
   Wittstock, Gunther
TI Surface selection, adhesion, and retention behavior of marine bacteria
   on synthetic organic surfaces using self-assembled monolayers and atomic
   force microscopy
SO OCEAN DYNAMICS
LA English
DT Article
DE Marine bacteria; Surface chemistry; AFM; Bacterial adhesion; Biofilm
ID ESCHERICHIA-COLI; FREE-ENERGY; STAPHYLOCOCCUS-AUREUS; BIOMATERIAL
   SURFACES; MICROBIAL-CELLS; SOLID-SURFACES; GOLD; ATTACHMENT; SUBSTRATA;
   PROTEINS
AB Adhesion of two marine bacteria Shewanella sp. strain T1 and Pseudoalteromonas sp. strain T8, on differently terminated alkanethiolate self-assembled monolayers on gold was investigated. The selected model surfaces-terminated by CH3, OH, NH2, COOH, OH-terminated oligo(ethylene glycol), and methyl-terminated oligo(ethylene glycol)-are characterized by contact angle measurement using water, methylene iodide, 1-bromonaphthalene, and formamide. Surface free energies were calculated. Cell counting of the two bacterial strains on the model surfaces after different times revealed differences between the two strains by at least one order of magnitude. For the different surfaces, the bacteria showed comparably small selectivity. Atomic force microscopy images of adhered bacteria showed very different fingerprints on the different surfaces.
C1 [Burchardt, Malte; Wittstock, Gunther] Carl von Ossietzky Univ Oldenburg, Dept Pure & Appl Chem, D-26111 Oldenburg, Germany.
   [Zhao, Chuan; Brinkhoff, Thorsten; Simon, Meinhard] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-26111 Oldenburg, Germany.
RP Wittstock, G (reprint author), Carl von Ossietzky Univ Oldenburg, Dept Pure & Appl Chem, D-26111 Oldenburg, Germany.
EM gunther.wittstock@uni-oldenburg.de
RI Wittstock, Gunther/H-1367-2011
OI Wittstock, Gunther/0000-0002-6884-5515
FU Deutsche Forschungsgemeinschaft [Wi 1617/6]
FX The work was supported by Deutsche Forschungsgemeinschaft (Wi 1617/6)
   within the research group "Biogeochemistry of Tidal Flats." Sincere
   thanks are given to Prof. Henny van der Mei (University Medical Center
   Groningen and University of Groningen, 9700 AD Groningen, The
   Netherlands) for experimental guidance and discussion.
CR ABARZUA S, 1995, MAR ECOL PROG SER, V123, P301, DOI 10.3354/meps123301
   ALLISON DG, 1987, J GEN MICROBIOL, V133, P1319
   Amoldi M, 1998, APPL PHYS A-MATER, V66, pS613, DOI 10.1007/s003390051210
   Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Bakker DP, 2004, APPL ENVIRON MICROB, V70, P3758, DOI 10.1128/AEM.70.6.3758-3760.2004
   Beech IB, 2002, COLLOID SURFACE B, V23, P231, DOI 10.1016/S0927-7765(01)00233-8
   Bowman J. P., 2005, BERGEYS MANUAL SYSTE, P480
   Brinkhoff T, 2004, APPL ENVIRON MICROB, V70, P2560, DOI 10.1128/AEM.70.4.2560-2565.2003
   Busscher HJ, 2008, LANGMUIR, V24, P10968, DOI 10.1021/la8016968
   BUSSCHER HJ, 1990, J MICROBIOL METH, V12, P101, DOI 10.1016/0167-7012(90)90020-7
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Callow JA, 2000, PLANTA, V211, P641, DOI 10.1007/s004250000337
   Callow ME, 2000, APPL ENVIRON MICROB, V66, P3249, DOI 10.1128/AEM.66.8.3249-3254.2000
   Camesano TA, 2000, LANGMUIR, V16, P4563, DOI 10.1021/la990805o
   Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176
   Cantin S, 2006, COLLOID SURFACE A, V276, P107, DOI 10.1016/j.colsurfa.2005.10.025
   CHARACKLIS WG, 1981, BIOTECHNOL BIOENG, V23, P1923, DOI 10.1002/bit.260230902
   COOKSEY KE, 1995, AQUAT MICROB ECOL, V9, P87, DOI 10.3354/ame009087
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Doktycz MJ, 2003, ULTRAMICROSCOPY, V97, P209, DOI 10.1016/S0304-3991(03)00045-7
   Doyle RJ, 1990, MICROBIAL CELL SURFA
   DUBOIS LH, 1990, J AM CHEM SOC, V112, P570, DOI 10.1021/ja00158a013
   Dufrene YF, 1999, J BACTERIOL, V181, P5350
   Dufrene YF, 2002, J BACTERIOL, V184, P5205, DOI 10.1128/JB.184.19.5205-5213.2002
   Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   FOLKERS JP, 1992, LANGMUIR, V8, P1330, DOI 10.1021/la00041a015
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Grasland B, 2003, BIOFOULING, V19, P307, DOI 10.1080/0892701031000121041
   HAMILTON WA, 1989, STRUCTURE FUNCTION B, V46, P199
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9
   Kiorboe T, 2002, APPL ENVIRON MICROB, V68, P3996, DOI 10.1128/AEM.68.8.3996-4006.2002
   Lee JH, 2007, P NATL ACAD SCI USA, V104, P20410, DOI 10.1073/pnas.0707595104
   Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   Lunau M, 2005, ENVIRON MICROBIOL, V7, P961, DOI 10.1111/j.1462-2920.2005.00767.x
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   Nishino T, 2004, J OCEANOGR, V60, P219, DOI 10.1023/B:JOCE.0000038328.54339.e4
   Nunez ME, 2005, METHOD ENZYMOL, V397, P256, DOI 10.1016/S0076-6879(05)97015-8
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Qian XP, 2002, ANAL CHEM, V74, P1805, DOI 10.1021/ac0110420
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   Rozkiewicz DI, 2005, LANGMUIR, V21, P6337, DOI 10.1021/la050438i
   Schneider RP, 1997, J COLLOID INTERF SCI, V188, P504, DOI 10.1006/jcis.1996.4748
   Schonherr H, 1998, MACROMOLECULES, V31, P3679, DOI 10.1021/ma9714474
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Silin VI, 2002, J AM CHEM SOC, V124, P14676, DOI 10.1021/ja026585+
   Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175
   Sjollema J., 1988, Biofouling, V1, P101
   Stoderegger KE, 2004, AQUAT MICROB ECOL, V36, P29, DOI 10.3354/ame036029
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Touhami A, 2004, J BACTERIOL, V186, P3286, DOI 10.1128/JB.186.11.3286-3295.2004
   Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x
   Ulman A, 1996, THIN SOLID FILMS, V273, P48, DOI 10.1016/0040-6090(95)06994-1
   van der Mei HC, 2000, BIOPHYS J, V78, P2668, DOI 10.1016/S0006-3495(00)76810-X
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Velegol SB, 2002, LANGMUIR, V18, P5256, DOI 10.1021/la011818g
   Velegol SB, 2003, LANGMUIR, V19, P851, DOI 10.1021/la026440g
   Visser J, 1997, EXP THERM FLUID SCI, V14, P407, DOI 10.1016/S0894-1777(96)00142-2
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000
   Wiencek KM, 1997, BIOFOULING, V11, P293, DOI 10.1080/08927019709378338
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
   Zhao C, 2006, ANGEW CHEM INT EDIT, V45, P5469, DOI 10.1002/anie.200601151
NR 76
TC 8
Z9 8
U1 0
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1616-7341
EI 1616-7228
J9 OCEAN DYNAM
JI Ocean Dyn.
PD APR
PY 2009
VL 59
IS 2
SI SI
BP 305
EP 315
DI 10.1007/s10236-009-0184-7
PG 11
WC Oceanography
SC Oceanography
GA 438EV
UT WOS:000265539600011
DA 2018-10-19
ER

PT J
AU Alb, C
   Moldovan, M
   Prejmerean, C
   Trif, M
   Sarosi, C
   Dudea, D
   Simon, V
AF Alb, C.
   Moldovan, M.
   Prejmerean, C.
   Trif, M.
   Sarosi, C.
   Dudea, D.
   Simon, V.
TI Microstructure, mechanical properties and tissue/biomaterial interface
   behaviour of new dental restorative composites
SO OPTOELECTRONICS AND ADVANCED MATERIALS-RAPID COMMUNICATIONS
LA English
DT Article
DE Dental composites; Mechanical properties; Bioceramics; Hydroxyapatite;
   Interfaces
ID IN-VITRO INVESTIGATIONS; RELIABLY SEAL CAVITIES; RESIN COMPOSITES;
   ADHESIVE SYSTEMS; BOND STRENGTH; MICROLEAKAGE; FILLER; SENSITIVITY;
   ADAPTATION; SILANATION
AB Four new dental composites with different inorganic phases were submitted to comparative study regarding their structure, compressive strength, diametral tensile strength, flexural strength and Vickers hardness, as well as composite-hard tissue interface. The composites containing bioceramic show the best integration of silanized filler into the organic matrix. SEM analysis reveals the development between tooth and composite material of a continuous interface consisting in a zone that is different from both bonding resin and dentine. The results of this study prove the effects of filler composition on mechanical properties of the composite resins, and at the same time on the interface between composite and tooth hard tissues.
C1 [Simon, V.] Univ Babes Bolyai, Fac Phys, R-3400 Cluj Napoca, Romania.
   [Alb, C.; Dudea, D.] Iuliu Hatieganu Univ Med & Pharm, Fac Med Dent, Cluj Napoca, Romania.
   [Moldovan, M.; Prejmerean, C.; Trif, M.; Sarosi, C.] Univ Babes Bolyai, Raluca Ripan Inst Res Chem, R-3400 Cluj Napoca, Romania.
RP Simon, V (reprint author), Univ Babes Bolyai, Fac Phys, R-3400 Cluj Napoca, Romania.
EM viosimon@Phys.UBBCluj.Ro
RI Sarosi, Codruta/A-5036-2017; Dudea, Diana/N-5693-2017; Moldovan,
   Marioara/N-6387-2017
OI Sarosi, Codruta/0000-0003-2960-9832; 
FU European Project COST [D33/2006]
FX This work was supported by European Project COST D33/2006.
CR BRAEM M, 1989, DENT MATER, V5, P346, DOI 10.1016/0109-5641(89)90128-0
   Brosh T, 1999, DENT MATER, V15, P174, DOI 10.1016/S0109-5641(99)00029-9
   Cardoso PEC, 1999, AM J DENT, V12, P291
   CHUNG KH, 1990, J ORAL REHABIL, V17, P487, DOI 10.1111/j.1365-2842.1990.tb01419.x
   Finger WJ, 1996, AM J DENT, V9, P206
   Frankenberger R, 2000, OPER DENT, V25, P11
   Gritco A, 2005, J OPTOELECTRON ADV M, V7, P2845
   Hilton TJ, 2002, AM J DENT, V15, P279
   Hilton TJ, 2002, AM J DENT, V15, P198
   Ikejima I, 2003, DENT MATER, V19, P206, DOI 10.1016/S0109-5641(02)00031-3
   Meredith N, 1997, J DENT, V25, P331, DOI 10.1016/S0300-5712(96)00047-4
   MOHSEN NM, 1995, J ORAL REHABIL, V22, P183, DOI 10.1111/j.1365-2842.1995.tb01562.x
   Opdam NJM, 1998, AM J DENT, V11, P229
   Osorio R, 2003, J BIOMED MATER RES B, V66B, P399, DOI 10.1002/jbm.b.10024
   Pashley DH, 2002, AM J DENT, V15, P97
   Perdigao J, 2003, J AM DENT ASSOC, V134, P1621, DOI 10.14219/jada.archive.2003.0109
   Perdigao Jorge, 2002, J Esthet Restor Dent, V14, P31, DOI 10.1111/j.1708-8240.2002.tb00145.x
   Radu T, 2008, J OPTOELECTRON ADV M, V10, P958
   Rao KK, 2002, MATER LETT, V54, P205, DOI 10.1016/S0167-577X(01)00564-X
   Rosales-Leal JI, 2001, DENT MATER, V17, P526, DOI 10.1016/S0109-5641(01)00014-8
   ROULET JF, 1989, SCANNING MICROSCOPY, V3, P147
   Santos C, 2001, J MATER SCI-MATER M, V12, P565, DOI 10.1023/A:1011291723503
   Simon V, 2007, J OPTOELECTRON ADV M, V9, P3350
   St-Georges AJ, 2003, DENT MATER, V19, P406, DOI 10.1016/S0109-5641(02)00084-2
   St-Georges AJ, 2002, AM J DENT, V15, P244
   Tamas C, 2005, J OPTOELECTRON ADV M, V7, P2849
   Xu HHK, 2007, J DENT RES, V86, P378, DOI 10.1177/154405910708600415
   Yoshikawa T, 1999, J DENT RES, V78, P898, DOI 10.1177/00220345990780041001
NR 28
TC 3
Z9 3
U1 0
U2 10
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1842-6573
J9 OPTOELECTRON ADV MAT
JI Optoelectron. Adv. Mater.-Rapid Commun.
PD APR
PY 2009
VL 3
IS 4
BP 350
EP 355
PG 6
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 478XM
UT WOS:000268622000014
DA 2018-10-19
ER

PT J
AU You, XY
   Xiao, X
AF You, X. Y.
   Xiao, Xia
TI APPLYING SURFACE ACOUSTIC WAVES TECHNIQUE FOR FILM ADHESIVENESS
   DETERMINATION
SO SURFACE REVIEW AND LETTERS
LA English
DT Article
DE Surface acoustic waves (SAWs); adhesiveness; layered film structure;
   biomaterial film
ID MECHANICAL-PROPERTIES; SUBSTRATE; ADHESION; THIN
AB Layered film structures are widely applied. The adhesiveness of thin layer, which controls the product quality, is a key factor to be known. The possibility of applying the surface acoustic waves (SAWs) technique to determine the adhesiveness quality of film and substrate is explored by a theoretical approach, where the interface adhesiveness is modeled by the spring model. Numerical results show that the proposed SAWs technique has a high resolution on determining the interface adhesiveness. Meanwhile, SAWs can also be applied to detect the parameters of film such as the elastic modulus, thickness, density, and Poisson's ratio nondestructively.
C1 [You, X. Y.] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.
   [Xiao, Xia] Tianjin Univ, Sch Elect & Informat Engn, Tianjin 300072, Peoples R China.
RP You, XY (reprint author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.
EM xyyou@tju.edu.cn
FU Natural Science Foundation of China [60876072]; National Center for
   Educational Technology, State Education Ministry of China
FX The authors are grateful to the financial support provided by Natural
   Science Foundation of China (60876072) and National Center for
   Educational Technology, State Education Ministry of China.
CR ANGEL YC, 1985, J APPL MECH-T ASME, V52, P33, DOI 10.1115/1.3169023
   Baltazar A, 2003, J ACOUST SOC AM, V114, P1424, DOI 10.1121/1.1600723
   Flannery CM, 2001, THIN SOLID FILMS, V388, P1, DOI 10.1016/S0040-6090(01)00827-6
   Guo ZQ, 2001, THIN SOLID FILMS, V394, P189
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Keuren JFW, 2003, BIOMATERIALS, V24, P1917, DOI 10.1016/S0142-9612(02)00620-8
   Leng YX, 2006, SURF COAT TECH, V201, P1012, DOI 10.1016/j.surfcoat.2006.01.024
   Rokhlin SI, 1997, REV PROG Q, V16, P1585
   Schneider D, 2002, SURF COAT TECH, V153, P252, DOI 10.1016/S0257-8972(01)01664-4
   Xiao X, 2003, REV SCI INSTRUM, V74, P4539, DOI 10.1063/1.1611615
   Xiao X, 2007, SURF COAT TECH, V201, P9594, DOI 10.1016/j.surfcoat.2007.04.040
   Xiao X, 2006, APPL SURF SCI, V253, P2958, DOI 10.1016/j.apsusc.2006.06.039
NR 12
TC 1
Z9 1
U1 1
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-625X
J9 SURF REV LETT
JI Surf. Rev. Lett.
PD APR
PY 2009
VL 16
IS 2
BP 287
EP 290
DI 10.1142/S0218625X09012603
PG 4
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 438AC
UT WOS:000265527300014
DA 2018-10-19
ER

PT J
AU Shi, K
   Kokini, JL
   Huang, QR
AF Shi, Ke
   Kokini, Jozef L.
   Huang, Qingrong
TI Engineering Zein Films with Controlled Surface Morphology and
   Hydrophilicity
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Zein; surface morphology; hydrophilicity; tapping mode atomic force
   microscopy; X-ray photoelectron spectroscopy
ID DRUG-DELIVERY; MECHANICAL-PROPERTIES; CORN PROTEIN; FISH LARVAE;
   IN-VITRO; MAIZE; BIOCOMPATIBILITY; ACIDS; MICROSPHERES; BIOMATERIAL
AB A new method to engineer zein films with controlled surface morphology and hydrophilicity has been developed. The resulting surface morphology and surface hydrophilicity have been studied by tapping mode atomic force microscopy (TP-AFM) and a combination of water contact angle measurements and X-ray photoelectron spectroscopy (XPS), respectively. Our AFM results revealed that zein films cast from acetic acid showed much smoother surfaces as compared to those cast from ethanol aqueous solutions. Furthermore, zein films of controlled hydrophilicity have been engineered through the use of UV/ozone treatment, which can efficiently decrease the water contact angles of zein films from similar to 80 degrees to less than 100 within 130 s. XPS results suggest that the difference in surface hydrophilicity of zein films is due to the difference in surface elemental composition, and UV/ozone treatment converted some of the surface methyl groups mainly to carbonyl groups, therefore decreasing the water contact angles and increasing the surface hydrophilicity of zein films. This research opens up new opportunities of using zein as barrier materials and delivery vehicles for functional food ingredients, drugs, and dietary supplements.
C1 [Kokini, Jozef L.] Illinois Agr Expt Stn, Urbana, IL 61801 USA.
   [Shi, Ke; Huang, Qingrong] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
RP Kokini, JL (reprint author), Illinois Agr Expt Stn, 211B Mumford Hall,1301 Gregory Dr, Urbana, IL 61801 USA.
EM kokini@uiuc.edu; qhuang@aesop.rutgers.edu
FU U.S. Department of Agriculture National Research Initiative
   [2007-35603-17744]
FX This project is supported by a U.S. Department of Agriculture National
   Research Initiative grant (2007-35603-17744).
CR ARGOS P, 1982, J BIOL CHEM, V257, P9984
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Forato LA, 2004, J AGR FOOD CHEM, V52, P2382, DOI 10.1021/jf035020+
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gao ZB, 2007, INT J PHARM, V328, P57, DOI 10.1016/j.ijpharm.2006.07.048
   Ghanbarzadeh B, 2008, INT J BIOL MACROMOL, V43, P209, DOI 10.1016/j.ijbiomac.2008.05.006
   Gillgren T, 2008, FOOD BIOPHYS, V3, P287, DOI 10.1007/s11483-008-9074-7
   Ha TT, 2001, T ASAE, V44, P1223
   Hurtado-Lopez P, 2005, J DRUG DELIV SCI TEC, V15, P267, DOI 10.1016/S1773-2247(05)50048-0
   Jiang HL, 2007, MACROMOL BIOSCI, V7, P517, DOI 10.1002/mabi.200600277
   Liu LS, 2006, DRUG DELIV, V13, P417, DOI 10.1080/10717540500394935
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Macmanus LF, 1999, J POLYM SCI POL CHEM, V37, P2489, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2489::AID-POLA23>3.0.CO;2-G
   Matsushima N, 1997, BBA-PROTEIN STRUCT M, V1339, P14, DOI 10.1016/S0167-4838(96)00212-9
   Muthuselvi L, 2006, COLLOID SURFACE B, V51, P39, DOI [10.1016/j.colsurfb.2006.05.012, 10.1016/colsurfb.2006.05.012]
   Onal U, 2005, AQUACULT NUTR, V11, P351, DOI 10.1111/j.1365-2095.2005.00356.x
   Onal U, 2005, MAR BIOL, V146, P1031, DOI 10.1007/s00227-004-1506-4
   Osborne TB, 1897, J AM CHEM SOC, V19, P525
   PAULIS JW, 1981, CEREAL CHEM, V58, P542
   PEDERSEN K, 1982, CELL, V29, P1015, DOI 10.1016/0092-8674(82)90465-2
   Phely-Bobin TS, 2000, ABSTR PAP AM CHEM S, V219, pU451
   Reddy N, 2008, MACROMOL MATER ENG, V293, P614, DOI 10.1002/mame.200800031
   Schwaller K., 1993, EP, Patent No. [US5271961, 5271961]
   Selling G, 2007, IND CROP PROD, V25, P63, DOI 10.1016/j.indcrop.2006.07.003
   Selling GW, 2007, CEREAL CHEM, V84, P265, DOI 10.1094/CCHEM-84-3-0265
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Sun QS, 2005, BIOPOLYMERS, V78, P268, DOI 10.1002/bip.20298
   TATHAM AS, 1993, J BIOL CHEM, V268, P26253
   Torres-Giner S, 2008, FOOD HYDROCOLLOID, V22, P601, DOI 10.1016/j.foodhyd.2007.02.005
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Wang Q, 2008, ACTA BIOMATER, V4, P844, DOI 10.1016/j.actbio.2008.01.017
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhong QX, 2008, FOOD BIOPHYS, V3, P186, DOI 10.1007/s11483-008-9059-6
NR 34
TC 61
Z9 63
U1 3
U2 64
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAR 25
PY 2009
VL 57
IS 6
BP 2186
EP 2192
DI 10.1021/jf803559v
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 420QC
UT WOS:000264303300013
PM 19231898
DA 2018-10-19
ER

PT J
AU Pan, YS
   Xiong, DS
AF Pan, Yusong
   Xiong, Dangsheng
TI Friction properties of nano-hydroxyapatite reinforced poly(vinyl
   alcohol) gel composites as an articular cartilage
SO WEAR
LA English
DT Article
DE Nano-HA/PVA gel composites; Stainless steel ball; Friction coefficient;
   Lubricant
ID ARTIFICIAL KNEE-JOINT; HYDROGEL; WEAR; UHMWPE; REPLACEMENT; BEHAVIOR
AB Nano-hydroxyapatite reinforced poly(vinyl alcohol) gel (nano-HA/PVA gel) composite has been proposed as a promising biomaterial, especially used as an articular cartilage repair biomaterial. In this paper, nano-HA/PVA gel composite was prepared by in situ synthesis method and incorporation with freeze-thaw cycle process. The effects of various factors on the friction coefficient of the gel composites and stainless steel ball counterpart were investigated by a ball-plate friction and wear tester. The variations of the friction coefficient with influence factors were explored by Hertzian contact theory and elastohydrodynamic lubrication theory. The results show that the friction coefficient of the gel composites is positively to the normal load and inversely proportional to the sliding speed and the diameter of stainless steel ball. Furthermore, the friction coefficient of the gel composites is obviously lower than that in distilled water or in physiological saline, whereas, friction coefficient has little difference between in distilled water and in physiological saline. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Pan, Yusong] An Hui Univ Sci & Technol, Dept Mat Sci & Engn, Huainan 232001, Peoples R China.
   [Pan, Yusong; Xiong, Dangsheng] Nan Jing Univ Sci & Technol, Dept Mat Sci & Engn, Nanjing 210094, Peoples R China.
RP Pan, YS (reprint author), An Hui Univ Sci & Technol, Dept Mat Sci & Engn, Huainan 232001, Peoples R China.
EM yusongpan@163.com
RI xiong, dangsheng/B-1823-2015
OI xiong, dangsheng/0000-0003-3210-3728
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Auger D D, 1995, Proc Inst Mech Eng H, V209, P73, DOI 10.1243/PIME_PROC_1995_209_323_02
   Chanda A, 1997, CERAM INT, V23, P437, DOI 10.1016/S0272-8842(96)00052-1
   Cho HJ, 2004, MATER CHEM PHYS, V88, P9, DOI 10.1016/j.matchemphys.2003.10.021
   Dowson D, 1986, Eng Med, V15, P63
   DOWSON D, 1967, P I MECH ENG, V81, P45
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   GONG J, 1998, CHEM PHYS, V109, P8062
   Grant C, 2006, BIOTECHNOL PROGR, V22, P1400, DOI 10.1021/bp060181u
   Huang H. Y., 1997, CLIN NEUROL NEUROSUR, V99, P20
   Jalali-Vahid D, 2001, J BIOMECH, V34, P261, DOI 10.1016/S0021-9290(00)00181-0
   Jamari J, 2006, TRIBOL LETT, V21, P262, DOI 10.1007/s11249-006-9038-3
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Liu XJ, 2004, WEAR, V257, P665, DOI 10.1016/j.wear.2004.02.005
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P209, DOI 10.1299/jsmec.47.209
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   VLADIMIR IL, 1996, ENZYME MICROB TECHNO, V18, P561
   Xiong DS, 2001, WEAR, V250, P242, DOI 10.1016/S0043-1648(01)00647-0
   YUSONG P, 2007, WEAR, V262, P1021
   YUSONG P, 2006, CENTRAL S U TECHNOL, V15, P27
   YUSONG P, 2007, KEY ENG MATER, V330, P1297
   YUSONG P, 2007, MAT SCI, V42, P5129
NR 22
TC 46
Z9 53
U1 6
U2 44
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD MAR 25
PY 2009
VL 266
IS 7-8
BP 699
EP 703
DI 10.1016/j.wear.2008.08.012
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 435LP
UT WOS:000265345700012
DA 2018-10-19
ER

PT J
AU Mendes, PN
   Rahal, SC
   Pereira-Junior, OCM
   Fabris, VE
   Lenharo, SLR
   de Lima-Neto, JF
   Landim-Alvarenga, FD
AF Mendes, Pericles Nobrega
   Rahal, Sheila Canevese
   Marques Pereira-Junior, Oduvaldo Camara
   Fabris, Viciany Erique
   Rahal Lenharo, Sara Lais
   de Lima-Neto, Joao Ferreira
   Landim-Alvarenga, Fernanda da Cruz
TI In vivo and in vitro evaluation of an Acetobacter xylinum synthesized
   microbial cellulose membrane intended for guided tissue repair
SO ACTA VETERINARIA SCANDINAVICA
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; BONE REGENERATION; BACTERIAL CELLULOSE;
   BIOMEDICAL APPLICATIONS; RABBIT RADIUS; DEFECTS; NEOGENESIS; SCAFFOLD;
   REENTRY; RATS
AB Background: Barrier materials as cellulose membranes are used for guided tissue repair. However, it is essential that the surrounding tissues accept the device. The present study histologically evaluated tissue reaction to a microbial cellulose membrane after subcutaneous implantation in mice. Furthermore, the interaction between mesenchymal stem cells and the biomaterial was studied in vitro to evaluate its ability to act as cellular scaffold for tissue engineering.
   Methods: Twenty-five Swiss Albino mice were used. A 10 x 10 mm cellulose membrane obtained through biosynthesis using Acetobacter xylinum bacteria was implanted into the lumbar subcutaneous tissue of each mouse. The mice were euthanatized at seven, 15, 30, 60, and 90 days, and the membrane and surrounding tissues were collected and examined by histology.
   Results: A mild inflammatory response without foreign body reaction was observed until 30 days post-surgery around the implanted membrane. Polarized microscopy revealed that the membrane remained intact at all evaluation points. Scanning electron microscopy of the cellulose membrane surface showed absence of pores. The in vitro evaluation of the interaction between cells and biomaterial was performed through viability staining analysis of the cells over the biomaterial, which showed that 95% of the mesenchymal stem cells aggregating to the cellulose membrane were alive and that 5% were necrotic. Scanning electron microscopy showed mesenchymal stem cells with normal morphology and attached to the cellulose membrane surface.
   Conclusion: The microbial cellulose membrane evaluated was found to be nonresorbable, induced a mild inflammatory response and may prove useful as a scaffold for mesenchymal stem cells.
C1 [Mendes, Pericles Nobrega; Rahal, Sheila Canevese; Marques Pereira-Junior, Oduvaldo Camara; de Lima-Neto, Joao Ferreira; Landim-Alvarenga, Fernanda da Cruz] UNESP, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, Botucatu, SP, Brazil.
   [Fabris, Viciany Erique] UNESP, Botucatu Med Sch, Dept Pathol, Botucatu, SP, Brazil.
   [Rahal Lenharo, Sara Lais] Dept Fed Police, Brasilia, DF, Brazil.
RP Pereira-Junior, OCM (reprint author), UNESP, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, Botucatu, SP, Brazil.
EM periclesmendes@hotmail.com; sheilacr@fmvz.unesp.br;
   odujunior@yahoo.com.br; fabris@fmb.unesp.br; sara.slrl@dpf.gov.br;
   joaoferreiralima@yahoo.com.br; fernanda@fmvz.unesp.br
RI Rahal, Sheila/E-9264-2012
OI Rahal, Sheila/0000-0002-9211-4093
CR AABOE M, 1993, CLIN ORAL IMPLAN RES, V4, P172, DOI 10.1034/j.1600-0501.1993.040402.x
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   dos Anjos B, 1998, J PERIODONTOL, V69, P454, DOI 10.1902/jop.1998.69.4.454
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Lekovic V, 2001, J PERIODONTOL, V72, P583, DOI 10.1902/jop.2001.72.5.583
   LINDE A, 1993, J PERIODONTOL, V64, P1116, DOI 10.1902/jop.1993.64.11s.1116
   Macedo N., 2004, BRAZ J ORAL SCI, V3, P395
   Meinig RP, 1996, J ORTHOP TRAUMA, V10, P178, DOI 10.1097/00005131-199604000-00006
   Mello LR, 1997, J NEUROSURG, V86, P143, DOI 10.3171/jns.1997.86.1.0143
   MENDENHALL HV, 1999, HDB BIOMATERIALS EVA, P481
   NIELSEN FF, 1992, ACTA ORTHOP SCAND, V63, P66, DOI 10.3109/17453679209154853
   PEIXOTO R, 1988, Revista Brasileira de Cirurgia, V78, P141
   Salata LA, 2001, CLIN ORAL IMPLAN RES, V12, P62, DOI 10.1034/j.1600-0501.2001.012001062.x
   Simonpietri-C JJ, 2000, J PERIODONTOL, V71, P904, DOI 10.1902/jop.2000.71.6.904
   Stal S, 2001, J CRANIOFAC SURG, V12, P41, DOI 10.1097/00001665-200101000-00007
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Takata T, 2001, CLIN ORAL IMPLAN RES, V12, P332, DOI 10.1034/j.1600-0501.2001.012004332.x
   Teixeira JOC, 1998, ARCH ORTHOP TRAUM SU, V117, P27, DOI 10.1007/BF00703435
   Torres MFP, 2003, ARQ BRAS MED VET ZOO, V55, P557, DOI 10.1590/S0102-09352003000500007
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937
   Zellin G, 1997, SCAND J PLAST RECONS, V31, P97, DOI 10.3109/02844319709085475
   Zellin G, 1996, BIOMATERIALS, V17, P695, DOI 10.1016/0142-9612(96)86739-1
NR 30
TC 26
Z9 26
U1 0
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA CURRENT SCIENCE GROUP, MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T
   4LB, ENGLAND
SN 0044-605X
J9 ACTA VET SCAND
JI Acta Vet. Scand.
PD MAR 24
PY 2009
VL 51
AR 12
DI 10.1186/1751-0147-51-12
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA 438CU
UT WOS:000265534300001
PM 19317903
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Lomakin, J
   Eichler, C
   Arakane, Y
   Kramer, KJ
   Beeman, RW
   Kanost, MR
   Gehrke, SH
AF Lomakin, Joseph
   Eichler, Christian
   Arakane, Yasuyuki
   Kramer, Karl J.
   Beeman, Richard W.
   Kanost, Michael R.
   Gehrke, Stevin H.
TI Mechanical properties of beetle elytral cuticle, a hierarchically
   ordered, multicomponent biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Lomakin, Joseph; Eichler, Christian; Gehrke, Stevin H.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66049 USA.
   [Arakane, Yasuyuki; Kramer, Karl J.; Kanost, Michael R.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.
   [Beeman, Richard W.] ARS, USDA, Grain Mkt & Prod Res Ctr, Manhattan, KS 66502 USA.
EM jlomakin@ku.edu; ceichler@gmail.com; subaru@ku.edu; kjkramer@ksu.edu;
   beeman@gmprc.ksu.edu; kanost@ku.edu; shgehrke@ku.edu
NR 0
TC 0
Z9 0
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 22
PY 2009
VL 237
MA 97-PMSE
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V16GJ
UT WOS:000207857807254
DA 2018-10-19
ER

PT J
AU Cestari, A
   Bandeira, LC
   Calefi, PS
   Nassar, EJ
   Ciuffi, KJ
AF Cestari, Alexandre
   Bandeira, Lucimara C.
   Calefi, Paulo S.
   Nassar, Eduardo J.
   Ciuffi, Katia J.
TI Preparation of calcium fluoroaluminosilicate glasses containing sodium
   and phosphorus by the nonhydrolytic sol-gel method
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Amorphous materials; Sol-gel processes; Luminescence; X-ray diffraction
ID POLYALKENOATE CEMENTS; IONOMER CEMENTS; PART I; ALUMINUM; ROUTE;
   CERAMICS; EU(III); OXIDES
AB Aluminum and silicon oxide-based inorganic matrices have been extensively studied because of their countless applications. Dental cements consist of aluminum and silicon-based amorphous polymeric materials containing fluoride, sodium, phosphorus and calcium, which are also good candidates for bone replacement. The nonhydrolytic sol-gel method has emerged as an alternative route for the preparation of these materials under milder conditions than those employed in traditional methods, such as oxide fusion. The main advantages of the nonhydrolytic sol-gel method include the use of low temperatures and the ready availability and easy purification of the precursors. Together, these factors have contributed to the production of highly pure materials with controlled porosity and nanometric particles. Dental restorations based on aluminosilicate matrices are known as glass ionomer cements. These materials have interesting physical and dental properties, mainly because they display anticariogenic activity and exhibit prolonged adhesiveness to the dental structure. The base of the ionomer is an aluminosilicate that is industrially synthesized by the fusion of SiO(2), Al(2)O(3), AlF(3), CaF(2), NaF and AlPO(4), in various concentrations. The characterizations conducted in this study reveal that this ionomer displays interesting properties, so its use as a precursor of dental cement and a biomaterial for bone replacement is highly recommended. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Cestari, Alexandre; Bandeira, Lucimara C.; Calefi, Paulo S.; Nassar, Eduardo J.; Ciuffi, Katia J.] Univ Franca, BR-14404600 Franca, SP, Brazil.
RP Nassar, EJ (reprint author), Univ Franca, Av Dr Armando Salles Oliveira 201,Pq Univ, BR-14404600 Franca, SP, Brazil.
EM ejnassar@unifran.br
RI Nassar, Eduardo/H-7354-2013; Ciuffi, katia/D-5980-2015; ciuffi,
   Katia/B-8788-2012; Cestari, Alexandre/I-2940-2015; Sergio Calefi,
   Paulo/D-1704-2013
OI Ciuffi, katia/0000-0001-8270-0286; Cestari,
   Alexandre/0000-0003-3224-9217; 
FU FAPESP; CNPq; CAPES (Brazil)
FX The authors gratefully acknowledge the financial support of FAPESP. CNPq
   and CAPES (Brazil).
CR Billington RW, 2006, J DENT, V34, P544, DOI 10.1016/j.jdent.2005.09.008
   Bouget L., 1998, J NONCRYST SOLIDS, V242, P81
   BUNZLI JCG, 1989, LANTHANIDE PROBES LI
   Caetano BL, 2006, APPL CATAL A-GEN, V311, P122, DOI 10.1016/j.apcata.2006.06.028
   CESTARI A, MAT CHEM PHYS UNPUB
   Ciuffi KJ, 2007, APPL CATAL A-GEN, V319, P153, DOI 10.1016/j.apcata.2006.11.026
   CORRIU RJP, 1992, J NON-CRYST SOLIDS, V146, P301, DOI 10.1016/S0022-3093(05)80505-8
   Culbertson BM, 2001, PROG POLYM SCI, V26, P577, DOI 10.1016/S0079-6700(01)00006-5
   De Barra E, 2000, BIOMATERIALS, V21, P563, DOI 10.1016/S0142-9612(99)00215-X
   Gorman CM, 2003, DENT MATER, V19, P320, DOI 10.1016/S0109-5641(02)00061-1
   Griffin SG, 2000, BIOMATERIALS, V21, P693, DOI 10.1016/S0142-9612(99)00216-1
   Griffin SG, 1999, BIOMATERIALS, V20, P1579, DOI 10.1016/S0142-9612(99)00058-7
   Griffin SG, 2000, BIOMATERIALS, V21, P399, DOI 10.1016/S0142-9612(99)00202-1
   GUA YW, 2004, BIOMATERIALS, V25, P4029
   Hadley PC, 2001, BIOMATERIALS, V22, P1563, DOI 10.1016/S0142-9612(00)00316-1
   Hatton PV, 2006, J DENT, V34, P598, DOI 10.1016/j.jdent.2004.10.027
   Hay JN, 1998, J SOL-GEL SCI TECHN, V13, P109, DOI 10.1023/A:1008615708489
   Larraz E, 2006, DENT MATER, V22, P506, DOI 10.1016/j.dental.2005.06.003
   Matsuya S, 2007, J NON-CRYST SOLIDS, V353, P237, DOI 10.1016/j.jnoncrysol.2006.12.001
   Milne KA, 1997, J MATER SCI-MATER M, V8, P349, DOI 10.1023/A:1018576715479
   Nassar EJ, 2007, QUIM NOVA, V30, P1567, DOI 10.1590/S0100-40422007000700013
   Nassar EJ, 2007, J SOL-GEL SCI TECHN, V43, P21, DOI 10.1007/s10971-007-1546-6
   Nassar EJ, 2005, J LUMIN, V111, P159, DOI 10.1016/j.jlumin.2004.07.007
   Nicholson JW, 1998, BIOMATERIALS, V19, P485, DOI 10.1016/S0142-9612(97)00128-2
   Pereira PFS, 2007, J LUMIN, V126, P378, DOI 10.1016/j.jlumin.2006.08.085
   Phillips R. W., 1993, SKINNER MAT DENTARIO
   Rocha LA, 2007, MATER CHEM PHYS, V101, P238, DOI 10.1016/j.matchemphys.2006.04.002
   Stamboulis A, 2004, KEY ENG MAT, V254-2, P99, DOI 10.4028/www.scientific.net/KEM.254-256.99
   Vioux A, 1997, CHEM MATER, V9, P2292, DOI 10.1021/cm970322a
   Wright J. D., 2001, SOL GEL MAT CHEM APP, V4
   Xie D, 2000, DENT MATER, V16, P129, DOI 10.1016/S0109-5641(99)00093-7
NR 31
TC 15
Z9 16
U1 2
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD MAR 20
PY 2009
VL 472
IS 1-2
BP 299
EP 306
DI 10.1016/j.jallcom.2008.04.053
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 427CK
UT WOS:000264757200057
DA 2018-10-19
ER

PT J
AU Kempen, DHR
   Yaszemski, MJ
   Heijink, A
   Hefferan, TE
   Creemers, LB
   Britson, J
   Maran, A
   Classic, KL
   Dhert, WJA
   Lu, LC
AF Kempen, Diederik H. R.
   Yaszemski, Michael J.
   Heijink, Andras
   Hefferan, Theresa E.
   Creemers, Laura B.
   Britson, Jason
   Maran, Avudaiappan
   Classic, Kelly L.
   Dhert, Wouter J. A.
   Lu, Lichun
TI Non-invasive monitoring of BMP-2 retention and bone formation in
   composites for bone tissue engineering using SPECT/CT and scintillation
   probes
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Drug delivery; Controlled release; Bone morphogenetic protein-2; Single
   photon emission computed tomography; Scintillation probes;
   Micro-computed tomography
ID GROWTH-FACTOR RELEASE; RAT ECTOPIC MODEL; IN-VIVO; MORPHOGENETIC
   PROTEIN-2; BIOMATERIAL CARRIERS; SUSTAINED DELIVERY; CALCIUM-PHOSPHATE;
   MOLECULAR-WEIGHT; DRUG DISCOVERY; RHBMP-2
AB Non-invasive imaging can provide essential information for the optimization of new drug delivery-based bone regeneration strategies to repair damaged or impaired bone tissue. This study investigates the applicability of nuclear medicine and radiological techniques to monitor growth factor retention profiles and subsequent effects on bone formation. Recombinant human bone morphogenetic protein-2 (BMP-2, 6.5 mu g/scaffold) was incorporated into a sustained release vehicle consisting of poly(lactic-co-glycolic acid) microspheres embedded in a poly(propylene fumarate) scaffold surrounded by a gelatin hydrogel and implanted subcutaneously and in 5-mm segmental femoral defects in 9 rats for a period of 56 days. To determine the pharmacokinetic profile, BMP-2 was radiolabeled with (125)I and the local retention of (125)I-BMP-2 was measured by single photon emission computed tomography (SPECT), scintillation probes and ex vivo scintillation analysis. Bone formation was monitored by micro-computed tomography (mu CT). The scaffolds released BMP-2 in a sustained fashion over the 56-day implantation period. A good correlation between the SPECT and scintillation probe measurements was found and there were no significant differences between the non-invasive and ex-vivo counting method after 8 weeks of follow up. SPECT analysis of the total body and thyroid counts showed a limited accumulation of 1251 within the body. Ectopic bone formation was induced in the scaffolds and the femur defects healed completely. In vivo mu CT imaging detected the first signs of bone formation at days 14 and 28 for the orthotopic and ectopic implants, respectively, and provided a detailed profile of the bone formation rate. Overall, this study clearly demonstrates the benefit of applying non-invasive techniques in drug delivery-based bone regeneration strategies by providing detailed and reliable profiles of the growth factor retention and bone formation at different implantation sites in a limited number of animals. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kempen, Diederik H. R.; Yaszemski, Michael J.; Heijink, Andras; Hefferan, Theresa E.; Britson, Jason; Maran, Avudaiappan; Lu, Lichun] Mayo Clin, Tissue Engn & Biomat Lab, Dept Orthoped Surg, Rochester, MN 55905 USA.
   [Kempen, Diederik H. R.; Yaszemski, Michael J.; Heijink, Andras; Hefferan, Theresa E.; Britson, Jason; Maran, Avudaiappan; Lu, Lichun] Mayo Clin, Tissue Engn & Biomat Lab, Dept Biomed Engn, Rochester, MN 55905 USA.
   [Kempen, Diederik H. R.; Creemers, Laura B.; Dhert, Wouter J. A.] Univ Med Ctr, Dept Orthoped, NL-3508 GA Utrecht, Netherlands.
RP Lu, LC (reprint author), Mayo Clin, Tissue Engn & Biomat Lab, Dept Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA.
EM lu.lichun@mayo.edu
OI Kempen, Diederik/0000-0002-4504-7756; Creemers,
   Laura/0000-0002-1585-3052
FU National Institutes of Health [R01 AR45871, R01 EB03060]; Netherlands
   Organization for Health Research and Development ZonMW [Agiko
   920-03-325]
FX The authors thank Dr. Shanfeng Wang and Mr. James A. Greutzmacher from
   the Tissue Engineering and Biornaterials laboratory, Mrs. Teresa
   Decklever and Dr. Bradley Kemp from the Department of Nuclear Medicine,
   Dr. Erik Ritman, Mrs. Patricia Beighley and Mr. Andrew Vercnocke from
   the Physiological Imaging Research Laboratory and Mrs. Julie Burges and
   Mr. Jim Herrick from the Bone Histomorphometry Laboratory for their
   contributions to this work. The authors gratefully acknowledge the
   National Institutes of Health (R01 AR45871 and R01 EB03060) and The
   Netherlands Organization for Health Research and Development ZonMW
   (Agiko 920-03-325) for financial support.
CR Abdiu A, 1998, LIFE SCI, V62, P1911, DOI 10.1016/S0024-3205(98)00159-3
   Beckmann N, 2007, NMR BIOMED, V20, P154, DOI 10.1002/nbm.1153
   BLOOMER WD, 1981, INT J NUCL MED BIOL, V8, P171, DOI 10.1016/0047-0740(81)90071-1
   Delgado JJ, 2006, J CONTROL RELEASE, V114, P223, DOI 10.1016/j.jconrel.2006.05.026
   DONLACH I, 1976, J ENDOCRINOL, V71, P109
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Gao TJ, 2001, J BIOMED MATER RES, V57, P92, DOI 10.1002/1097-4636(200110)57:1<92::AID-JBM1146>3.0.CO;2-1
   GOLDENBERG DM, 1992, J NUCL MED, V33, P803
   Gross S, 2006, CURR OPIN CHEM BIOL, V10, P334, DOI 10.1016/j.cbpa.2006.06.028
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Jorgensen S.M., 1998, AM J PHYSIOL, V275, P1103
   Kempen DHR, 2008, J CONTROL RELEASE, V130, P15, DOI 10.1016/j.jconrel.2008.05.004
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Louis-Ugbo J, 2002, J ORTHOPAED RES, V20, P1050, DOI 10.1016/S0736-0266(02)00011-6
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Peremans K, 2005, VET RADIOL ULTRASOUN, V46, P162, DOI 10.1111/j.1740-8261.2005.00031.x
   Rose FRAJ, 2004, J PHARM PHARMACOL, V56, P415, DOI 10.1211/0022357023312
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Uludag H, 2000, BIOTECHNOL PROGR, V16, P1115, DOI 10.1021/bp000066y
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Wang SF, 2006, BIOMACROMOLECULES, V7, P1976, DOI 10.1021/bm060096a
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yokota S, 2003, INT J PHARM, V251, P57, DOI 10.1016/S0378-5173(02)00581-1
NR 30
TC 34
Z9 34
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAR 19
PY 2009
VL 134
IS 3
BP 169
EP 176
DI 10.1016/j.jconrel.2008.11.023
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 426QE
UT WOS:000264722000003
PM 19105972
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Xu, LC
   Siedlecki, CA
AF Xu, Li-Chong
   Siedlecki, Christopher A.
TI Atomic Force Microscopy Studies of the Initial Interactions between
   Fibrinogen and Surfaces
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; TIME-DEPENDENT CHANGES; PLATELET-ADHESION;
   CONFORMATIONAL-CHANGES; ADSORBED FIBRINOGEN; PROTEIN ADSORPTION;
   LOADING-RATE; AFM; BIOMATERIALS; SPECTROSCOPY
AB Atomic force microscopy (AFM) was used to analyze the interactions between fibrinogen and model surfaces having different levels of water wettability. In contrast to most AFM studies, proteins were coupled to the substrate while model surface colloids were attached to the end of the AFM probe, thereby ensuring that proteins undergo only a single compression/decompression cycle. Similar values of adhesion force were observed between fibrinogen and all of the highly wettable surfaces; in the same manner, fibrinogen showed similar adhesion forces against all poorly wettable surfaces, with a step-like transition observed between the two groups. Relationships between the adhesion forces and loading rates were used to analyze the energy profiles involved in protein/surface interactions. Multiple energy barriers were found in the interaction of proteins with poorly wettable surfaces; whereas a single energy barrier was found for protein interactions with highly wettable surfaces. Contact time-dependent adhesion data were fit to an exponential model and showed that the rate constants of the protein unfolding process on highly wettable surface were smaller at low loading rates, but increased rapidly to yield values similar to those on poorly wettable surfaces at high loading rates. The activation energies of protein unfolding derived from the data offer insight into the role of surface wettability in affecting adhesion, conformational changes, and ultimately, the activity of proteins at biomaterial surfaces.
C1 [Xu, Li-Chong; Siedlecki, Christopher A.] Penn State Univ Hosp, Hematol Biomat Interfaces Res Grp, Dept Surg, Coll Med,Biomed Engn Inst, Hershey, PA 17033 USA.
   [Siedlecki, Christopher A.] Penn State Univ Hosp, Hematol Biomat Interfaces Res Grp, Dept Bioengn, Coll Med,Biomed Engn Inst, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ Hosp, Hematol Biomat Interfaces Res Grp, Dept Surg, Coll Med,Biomed Engn Inst, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
FU National Institutes of Health [RO1 HL69965]; National Science Foundation
   [DMR-0804873]; Dorothy Foehr Huck and J. Lloyd Huck Institutes of the
   Life Sciences; Pennsylvania Department of Health
FX We acknowledge Dr. Bruce Logan for assistance with the modification of
   colloid AFM probes and measurements of spring constants of cantilevers.
   We also acknowledge financial support for this work provided by the
   National Institutes of Health (RO1 HL69965), the National Science
   Foundation (DMR-0804873), the Dorothy Foehr Huck and J. Lloyd Huck
   Institutes of the Life Sciences, and by a grant from the Pennsylvania
   Department of Health. The Pennsylvania Department of Health specifically
   disclaims responsibility for any analyses, interpretations or
   conclusions.
CR Agnihotri A, 2005, ULTRAMICROSCOPY, V102, P257, DOI 10.1016/j.ultramic.2004.10.006
   Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   BERG JM, 1994, LANGMUIR, V10, P1225, DOI 10.1021/la00016a041
   Buijs J, 1997, J COLLOID INTERF SCI, V190, P171, DOI 10.1006/jcis.1997.4876
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CHOCE JH, 2004, J APPL POLYM SCI, V92, P599
   Chowdhury PB, 1998, COLLOID SURFACE A, V143, P53, DOI 10.1016/S0927-7757(98)00408-7
   Craig VSJ, 2001, LANGMUIR, V17, P6018, DOI 10.1021/la010424m
   Dupont-Gillain CC, 2003, J BIOMED MATER RES A, V67A, P548, DOI 10.1002/jbm.a.10092
   Evans-Nguyen KM, 2006, LANGMUIR, V22, P5115, DOI 10.1021/la053070y
   Evans-Nguyen KM, 2005, LANGMUIR, V21, P1691, DOI 10.1021/la047303h
   Fang F, 2005, BIOPHYS J, V89, P1516, DOI 10.1529/biophysj.104.055079
   Geer CB, 2007, ACTA BIOMATER, V3, P663, DOI 10.1016/j.actbio.2007.03.004
   GOODMAN SL, 1993, J BIOMED MATER RES, V27, P683, DOI 10.1002/jbm.820270516
   Hantgan RR, 1994, HEMOSTASIS THROMBOSI, P277
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Hussain MA, 2005, LANGMUIR, V21, P6979, DOI 10.1021/la046943h
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Kidoaki S, 2002, COLLOID SURFACE B, V23, P153, DOI 10.1016/S0927-7765(01)00232-6
   LEE SJ, 1994, J VAC SCI TECHNOL A, V12, P2949, DOI 10.1116/1.578920
   Liu C, 2007, LANGMUIR, V23, P9140, DOI 10.1021/la7013804
   Lo YS, 2001, LANGMUIR, V17, P3741, DOI 10.1021/la001569g
   Lu SQ, 2006, POLYMER, V47, P2539, DOI 10.1016/j.polymer.2005.11.095
   Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Mondon M, 2003, ANAL BIOANAL CHEM, V375, P849, DOI 10.1007/s00216-003-1751-2
   Montdargent B, 2000, INFECT CONT HOSP EP, V21, P404, DOI 10.1086/501782
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Sagvolden G, 1998, LANGMUIR, V14, P5984, DOI 10.1021/la980271b
   Santore MM, 2005, LANGMUIR, V21, P10172, DOI 10.1021/la051059s
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Steiner G, 2007, ANAL CHEM, V79, P1311, DOI 10.1021/ac061341j
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   Xu LC, 2006, LANGMUIR, V22, P4720, DOI 10.1021/la053443v
   Xu LC, 2005, LANGMUIR, V21, P7491, DOI 10.1021/la0509091
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yoon RH, 1997, J COLLOID INTERF SCI, V185, P363, DOI 10.1006/jcis.1996.4583
   Yu JP, 2007, CHEM-ASIAN J, V2, P284, DOI 10.1002/asia.200600230
NR 42
TC 31
Z9 32
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 17
PY 2009
VL 25
IS 6
BP 3675
EP 3681
DI 10.1021/la803258h
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 418JR
UT WOS:000264145000052
PM 19275182
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Chamberlain, LM
   Godek, ML
   Gonzalez-Juarrero, M
   Grainger, DW
AF Chamberlain, Lisa M.
   Godek, Marisha L.
   Gonzalez-Juarrero, Mercedes
   Grainger, David W.
TI Phenotypic non-equivalence of murine (monocyte-) macrophage cells in
   biomaterial and inflammatory models
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophage; biomaterials; in vitro model; inflammatory; cytokines
ID IN-VITRO; MYCOBACTERIUM-TUBERCULOSIS; BIOLOGICAL RESPONSES; PROTEIN
   EXPRESSION; KINASE ACTIVATION; DIFFERENTIATION; ADHESION; LINE;
   PROLIFERATION; PARTICLES
AB Cells of the mononuclear phagocytic system including monocytes and macrophages (e.g., pooled human monocytes, bone marrow-derived macrophages, etc.) are often employed for in vitro assessment of novel biomaterials and to assay anti-inflammatory drug activity. In this context, numerous macrophage cells are treated interchangeably in the literature despite a lack of demonstrated equivalence among immortalized cell lines and further, between cell lines and primary-derived macrophages of different species. Three murine (monocyte-) macrophage cell lines (IC-21, J774A.1, and RAW 264.7), commonly utilized in biomaterial and pharmaceutical screening research, have been compared with primary-derived murine bone marrow macrophages. Significant differences were discovered in the expression of cell surface proteins requisite for cell adhesion and activation among cell lines and primary-derived cells as well as between the different cell lines. Results demonstrate activation but with reduced cytokine expression to chemical stimulus (lipopolysaccharide) by cell lines compared with that of primary-derived macrophages. Limited correlation between cultured primary and immortalized cells in cytokine production, phenotype and intrinsic activation states has relevance to fidelity for in vitro testing. These differences warrant justification for selection of various cell lines for specific assay purposes, and merit caution if comparisons to primary cell types (i.e., for biocompatibility) are required. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 88A: 858-871, 2009
C1 [Chamberlain, Lisa M.; Grainger, David W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Chamberlain, Lisa M.; Godek, Marisha L.; Gonzalez-Juarrero, Mercedes; Grainger, David W.] Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA.
   [Gonzalez-Juarrero, Mercedes] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Grainger, David W.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
RP Grainger, DW (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
EM david.grainger@utah.edu
FU NIH [EB000894]
FX Contract grant sponsor: NIH; contract grant number: EB000894
CR Agis H, 1996, IMMUNOLOGY, V87, P535, DOI 10.1046/j.1365-2567.1996.493578.x
   Ainslie KM, 2007, LANGMUIR, V23, P747, DOI 10.1021/la060948s
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 2006, JOINT REPLACE BONE R, P255
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Bailey LO, 2005, BIOMATERIALS, V26, P5296, DOI 10.1016/j.biomaterilas.2005.01.055
   Bailey LO, 2004, J BIOMED MATER RES A, V69A, P305, DOI 10.1002/jbm.a.20134
   Ball M, 2004, J BIOMED MATER RES A, V70A, P380, DOI 10.1002/jbm.a.30066
   Bhatia SK, 2007, BIOTECHNOL LETT, V29, P1645, DOI 10.1007/s10529-007-9465-8
   Bogdan C, 2006, TRENDS IMMUNOL, V27, P282, DOI 10.1016/j.it.2006.04.004
   BURKE BLC, 2002, MACROPHAGE
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   Dhanji S, 2005, J IMMUNOL, V174, P1253, DOI 10.4049/jimmunol.174.3.1253
   Dimitrievska S, 2008, J BIOMED MATER RES A, V84A, P44, DOI 10.1002/jbm.a.31338
   DOUGHERTY GJ, 1989, HUMAN MONOCYTES, P49
   Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N
   Fernandez N, 2002, J IMMUNOL, V169, P3321, DOI 10.4049/jimmunol.169.6.3321
   Godek ML, 2006, J BIOMAT SCI-POLYM E, V17, P1141, DOI 10.1163/156856206778530731
   Godek Marisha L, 2004, Biomed Sci Instrum, V40, P7
   Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gutting BW, 2005, TOXICOL IN VITRO, V19, P221, DOI 10.1016/j.tiv.2004.08.007
   HADDEN EM, 1982, CANCER RES, V42, P3064
   HIRSCH S, 1981, J EXP MED, V154, P713, DOI 10.1084/jem.154.3.713
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1
   Liu GW, 2006, J CELL PHYSIOL, V209, P341, DOI 10.1002/jcp.20732
   LopezGuerrero JA, 1997, J GEN VIROL, V78, P1977
   Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McNally AK, 1996, AM J PATHOL, V149, P975
   Naureckiene Saule, 2007, Journal of Pharmacological and Toxicological Methods, V55, P303, DOI 10.1016/j.vascn.2006.08.002
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3
   Rhoades ER, 1998, MECH AGEING DEV, V106, P145, DOI 10.1016/S0047-6374(98)00113-4
   Risbud M, 2001, CELL TRANSPLANT, V10, P195
   Schutt C, 1999, INT J BIOCHEM CELL B, V31, P545, DOI 10.1016/S1357-2725(98)00153-8
   Shelley CS, 2002, J IMMUNOL, V168, P3887, DOI 10.4049/jimmunol.168.8.3887
   SILVERMAN J, 2000, IACUC HDB
   Smythe CDW, 2003, ATHEROSCLEROSIS, V170, P213, DOI 10.1016/S0021-9150(03)00285-5
   THEUS SA, 2004, INFECT IMMUN, V72, P7169
   VADDI K, 1994, J LEUKOCYTE BIOL, V55, P756
   Van den Beucken JJJP, 2007, J BIOMED MATER RES A, V80A, P612, DOI 10.1002/jbm.a.30971
   Vigo E, 2005, J PHARM PHARMACOL, V57, P383, DOI 10.1211/0022357055605
   WARD WK, 2006, TRENDS INFLAMMATION, P137
   Whelan RDH, 1999, CELL GROWTH DIFFER, V10, P271
   Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010
   Yagil-Kelmer E, 2004, J ORTHOPAED RES, V22, P832, DOI 10.1016/j.orthres.2003.10.022
   Zuckerman ST, 2006, BIOMATERIALS, V27, P3745, DOI 10.1016/j.biomaterials.2006.02.028
NR 53
TC 48
Z9 50
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2009
VL 88A
IS 4
BP 858
EP 871
DI 10.1002/jbm.a.31930
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 407SD
UT WOS:000263383700003
PM 18357567
DA 2018-10-19
ER

PT J
AU Paternolli, C
   Neebe, M
   Stura, E
   Barbieri, F
   Ghisellini, P
   Hampp, N
   Nicolini, C
AF Paternolli, Cristina
   Neebe, Martin
   Stura, Enrico
   Barbieri, Francesca
   Ghisellini, Paola
   Hampp, Norbert
   Nicolini, Claudio
TI Photoreversibility and photostability in films of octopus rhodopsin
   isolated from octopus photoreceptor membranes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE photoreversibility; photostability; octopus rhodopsin; octopus
   photoreceptor membranes; AFM
ID LANGMUIR-BLODGETT-FILMS; PROTEINS
AB In this work, anew biomaterial resulting from the isolation of octopus rhodopsin (OR) starting from octopus photoreceptor membranes is presented. Mass spectroscopic characterization was employed in order to verify the presence of rhodopsin in the extract. Photoreversibility and photochromic properties were investigated using spectrophotometric measurements and pulsed light. Thin films of OR were realized using the gel-matrix entrapment method in polyvinyl alcohol solution. The results indicate that the photoreversibility and the photostability of the OR in gel-matrices are maintained. Several measurements were performed to test the stability of the resulting biomaterial in time and at room temperature. Preliminary tests demonstrate that the photoreversibility and the photostability are still found after few days from the biomaterial preparation and after the exposure for several hours at room temperature. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 88A: 947-951, 2009
C1 [Paternolli, Cristina; Stura, Enrico; Nicolini, Claudio] Fdn Elba, I-00100 Rome, Italy.
   [Neebe, Martin; Hampp, Norbert] Univ Marburg, Inst Phys Chem, D-35032 Marburg, Germany.
   [Barbieri, Francesca; Ghisellini, Paola; Nicolini, Claudio] Univ Genoa, Nanoworld Inst, I-16132 Genoa, Italy.
   [Barbieri, Francesca; Ghisellini, Paola; Nicolini, Claudio] Univ Genoa, Div Biophys, I-16132 Genoa, Italy.
RP Nicolini, C (reprint author), Fdn Elba, Piazza SS,Apostoli 66, I-00100 Rome, Italy.
EM manuscript@ibf.unige.it
OI Ghisellini, Paola/0000-0003-0505-0106
FU Ministero dell'Istruzione, Universita a Ricerca (MIUR) [RBIN04RXHS];
   University of Genova
FX Contract grant sponsor: Ministero dell'Istruzione, Universita a Ricerca
   (MIUR; for FIRB International Grant on Proteomiss and Cell Cycle);
   contract grant number: RBIN04RXHS to CIRSDNNOB-Nanoworld Institute of
   the University of Genova
CR Antonini M, 2004, TALANTA, V62, P945, DOI 10.1016/j.talanta.2003.10.023
   Bertoncello P, 2003, IEEE T NANOBIOSCI, V2, P124, DOI 10.1109/TNB.2003.813940
   BIRGE RR, 1995, SCI AM, V3, P90
   Druzhko AB, 1996, PHOTOCHEM PHOTOBIOL, V64, P867, DOI 10.1111/j.1751-1097.1996.tb01849.x
   FACCI P, 1994, THIN SOLID FILMS, V243, P403, DOI 10.1016/0040-6090(93)04223-F
   Hampp N, 2002, P SOC PHOTO-OPT INS, V4677, P121, DOI 10.1117/12.462703
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Maccioni E, 1996, THIN SOLID FILMS, V284, P898, DOI 10.1016/S0040-6090(95)08474-6
   MAXIA L, 1995, BIOPHYS J, V69, P1440, DOI 10.1016/S0006-3495(95)80013-5
   Nakagawa M, 1997, BIOPHYS J, V72, P2320, DOI 10.1016/S0006-3495(97)78876-3
   Nicolini C, 1998, NANOTECHNOLOGY, V9, P223, DOI 10.1088/0957-4484/9/3/013
   Nicolini C, 1999, BIOSENS BIOELECTRON, V14, P427, DOI 10.1016/S0956-5663(98)00132-8
   Ostrovsky MA, 1998, BIOSENS BIOELECTRON, V13, P61, DOI 10.1016/S0956-5663(97)00078-X
   Paternolli C, 2004, LANGMUIR, V20, P11706, DOI 10.1021/la048081q
   Pepe IM, 1996, THIN SOLID FILMS, V284, P739, DOI 10.1016/S0040-6090(95)08435-5
   Pepe IM, 1998, THIN SOLID FILMS, V327, P118, DOI 10.1016/S0040-6090(98)00611-7
   Pepe IM, 1996, J PHOTOCH PHOTOBIO B, V33, P191, DOI 10.1016/1011-1344(96)07289-2
   STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511
   TSUDA M, 1987, PHOTOCHEM PHOTOBIOL, V45, P915, DOI 10.1111/j.1751-1097.1987.tb07903.x
   TSUDA M, 1986, FEBS LETT, V198, P5, DOI 10.1016/0014-5793(86)81173-5
NR 20
TC 9
Z9 10
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2009
VL 88A
IS 4
BP 947
EP 951
DI 10.1002/jbm.a.31925
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 407SD
UT WOS:000263383700012
PM 18384162
DA 2018-10-19
ER

PT J
AU Bai, ZJ
   Filiaggi, MJ
   Dahn, JR
AF Bai, Zhijun
   Filiaggi, M. J.
   Dahn, J. R.
TI Fibrinogen adsorption onto 316L stainless steel, Nitinol and titanium
SO SURFACE SCIENCE
LA English
DT Article
DE Protein adsorption; Fibrinogen; Adsorption isotherm; Adsorption
   kinetics; Wavelength dispersive spectroscopy; Spectroscopic
   ellipsometry; BET isotherm; Multilayer structure
ID ATOMIC-FORCE MICROSCOPY; ACUTE INFLAMMATORY RESPONSES; PROTEIN
   ADSORPTION; OXIDE SURFACES; NANOMETER-SCALE; CONFORMATIONAL-CHANGES;
   BIOMATERIAL SURFACES; ELECTRON-MICROPROBE; ADSORBED PROTEIN;
   SERUM-ALBUMIN
AB Fibrinogen adsorption onto mechanically polished biomedical grade 316L stainless steel (316LSS), nickel titanium alloy (Nitinol) and commercially pure titanium (CpTi) surfaces were studied by measurements of adsorption isotherms and adsorption kinetics using an ex-situ wavelength dispersive spectroscopy technique (WDS). Surface composition, roughness and wettability of these materials were characterized by X-ray photoelectron spectroscopy (XPS), atomic force microscopy (AFM) and water contact angle (WCA) measurements. Adsorption isotherm results showed that surface protein concentration on these materials increased with increasing concentration of fibrinogen in phosphate buffer solution. The fibrinogen adsorption isotherms were modeled by both the monolayer Langmuir isotherm and the multilayer Brunauer-Emmett-Teller (BET) isotherm. The results strongly suggest that fibrinogen forms multilayer structures on these materials when the concentration in solution is high. Complementary measurements on the absorbed fibrinogen films by spectroscopic ellipsometry (SE) support this view. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Bai, Zhijun; Dahn, J. R.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada.
   [Bai, Zhijun; Filiaggi, M. J.] Dalhousie Univ, Sch Biomed Engn, Halifax, NS B3H 3J5, Canada.
   [Filiaggi, M. J.] Dalhousie Univ, Fac Dent, Dept Appl Oral Sci, Halifax, NS B3H 3J5, Canada.
   [Dahn, J. R.] Dalhousie Univ, Dept Chem, Halifax, NS B3H 3J5, Canada.
RP Dahn, JR (reprint author), Dalhousie Univ, Dept Phys & Atmospher Sci, 6310 Coburg Rd, Halifax, NS B3H 3J5, Canada.
EM jeff.dahn@dal.ca
RI Bai, Zhijun/D-6522-2011
FU Medtronic, Inc. (USA)
FX The authors thank Dr. Zeynel Bayindir, Mark McArthur and Trevor Byrne
   for their help in XPS, contact angle, AFM and ellipsometry measurements.
   The financial support of Medtronic, Inc. (USA) is greatly acknowledged.
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   BAI Z, 2006, ASM HDB C, V13, P837
   Bai ZJ, 2008, SURF SCI, V602, P795, DOI 10.1016/j.susc.2007.12.009
   Bai ZJ, 2010, J BIOMED MATER RES A, V92A, P521, DOI 10.1002/jbm.a.32398
   Bren L, 2004, J ADHES SCI TECHNOL, V18, P1711, DOI 10.1163/1568561042708403
   Brown JH, 2000, P NATL ACAD SCI USA, V97, P85, DOI 10.1073/pnas.97.1.85
   Byrne T, 2008, SURF SCI, V602, P2927, DOI 10.1016/j.susc.2008.07.020
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Clarke B, 2007, ACTA BIOMATER, V3, P103, DOI 10.1016/j.actbio.2006.07.006
   Clarke J, 1997, J MOL BIOL, V270, P771, DOI 10.1006/jmbi.1997.1147
   COHEN C, 1983, ANN NY ACAD SCI, V408, P194, DOI 10.1111/j.1749-6632.1983.tb23245.x
   Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799
   DEKEERE IV, 2008, LANGMUIR, V24, P1844
   Desroches MJ, 2007, BIOMACROMOLECULES, V8, P2836, DOI 10.1021/bm070289d
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   FENG L, 1994, BIOMATERIALS, V15, P323
   FENG L, 1995, PROTEINS INTERFACES, V2, P66
   Fuss C, 2001, J VASC INTERV RADIOL, V12, P677, DOI 10.1016/S1051-0443(07)61437-7
   Gettens RTT, 2005, J BIOMED MATER RES A, V72A, P246, DOI 10.1002/jbm.a.30218
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   Han M, 2003, LANGMUIR, V19, P9868, DOI 10.1021/la030132g
   HILL TL, 1946, J CHEM PHYS, V14, P263, DOI 10.1063/1.1724129
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Jackson DR, 2000, LANGMUIR, V16, P5449, DOI 10.1021/la991497x
   Kamath S, 2003, QJM-INT J MED, V96, P711, DOI 10.1093/qjmed/hcg129
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Liu FY, 1998, APPL RADIAT ISOTOPES, V49, P67
   LUNDSTROM I, 1985, PROG COLL POL SCI S, V70, P76
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   Marchin KL, 2003, LANGMUIR, V19, P9883, DOI 10.1021/la035127r
   McPherson TB, 1997, J BIOMED MATER RES, V38, P289
   Mikhalovska LI, 2004, THROMB HAEMOSTASIS, V92, P1032, DOI 10.1160/TH04-03-0171
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   RATNER BD, 1982, ADV CHEM SER, P9
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Santore MM, 2005, LANGMUIR, V21, P10172, DOI 10.1021/la051059s
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Shabalovskaya S, 2008, BIO-MED MATER ENG, V18, P1
   Sheardown H, 1997, COLLOID SURFACE B, V10, P29, DOI 10.1016/S0927-7765(97)00045-3
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sit PS, 2001, SURF SCI, V491, P421, DOI 10.1016/S0039-6028(01)01308-5
   SLACK SM, 1991, J BIOMAT SCI-POLYM E, V3, P49
   Sprague EA, 2005, J ENDOVASC THER, V12, P594, DOI 10.1583/05-1555.1
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TANG LP, 1993, CLIN RES, V41, pA164
   TANG LP, 1994, CELL MATER, V4, P429
   Tengvall P, 2003, COLLOID SURFACE B, V28, P261, DOI 10.1016/S0927-7765(02)00151-0
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
NR 60
TC 47
Z9 47
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD MAR 15
PY 2009
VL 603
IS 6
BP 839
EP 846
DI 10.1016/j.susc.2009.01.040
PG 8
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 429LH
UT WOS:000264921400004
DA 2018-10-19
ER

PT J
AU Lutzner, N
   Patzold, B
   Zoll, S
   Stehle, T
   Kalbacher, H
AF Luetzner, Nicolas
   Paetzold, Bernhard
   Zoll, Sebastian
   Stehle, Thilo
   Kalbacher, Hubert
TI Development of a novel fluorescent substrate for Autolysin E, a
   bacterial type II amidase
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Staphylococcus epidermidis; Biofilms; Peptidoglycan; Biomaterial-related
   infection; Antibiotics; Amidase enzyme assay; N-acetylmuramoyl-L-alanine
   amidase; Autolysin E (EC 3.5.1.28)
ID PEPTIDOGLYCAN RECOGNITION PROTEINS; STAPHYLOCOCCUS-EPIDERMIDIS;
   MECHANISMS; AUREUS
AB The bifunctional Autolysin E from Staphylococcus epidermidis. contains a Zn(2+)-dependent N-acetylmuramoyl-L-alanine amidase AmiE (EC 3.5.1.28). This enzyme hydrolyzes the amide bond between the carbohydrate chain and the peptide stem of bacterial peptidoglycan. Since peptidoglycan is the mayor component of bacterial cell walls, type 11 amidases like Autolysin E play an essential role in the bacterial life cycle. Therefore bacterial amidases are appropriate drug targets in the development of antibiotics. The drug discovery process relies on sensitive enzyme assay systems to test possible lead candidates for enzyme inhibition. However, specific determination of bacterial amidase activity is complicated because a simple and accurate enzyme assay is currently unavailable. In this study we developed a sensitive fluorescent substrate for the type II amidase Autolysin E from S. epidermidis, which is suitable for quantifying amidase activity in a high throughput compatible fashion. Using derivatives of the substrate Mca-Ala-D-isoGln-Lys(Dnp)-D-Ala-Arg-OH, we were further able to characterize the amidase substrate specificity of Autolysin E. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Luetzner, Nicolas; Paetzold, Bernhard; Zoll, Sebastian; Stehle, Thilo; Kalbacher, Hubert] Univ Tubingen, Interfac Inst Biochem, D-72074 Tubingen, Germany.
   [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA.
   [Kalbacher, Hubert] Univ Tubingen, Med & Nat Sci Res Ctr, D-72074 Tubingen, Germany.
RP Kalbacher, H (reprint author), Univ Tubingen, Interfac Inst Biochem, Ob Himmelreich 7, D-72074 Tubingen, Germany.
EM kalbacher@uni-tuebingen.de
OI Zoll, Sebastian/0000-0001-5376-9698
FU Deutsche Forschungsgemeinschaft [SFB-685, SFB-TR34]
FX We gratefully acknowledge Andreas Dittmar and Florian Kratrier for their
   technical assistance. We thank Daniel Bichle and Karl-Heinz Wiesmbller
   for their support and Andreas Maurer for critically reading the
   manuscript. This work was supported by Deutsche Forschungsgemeinschaft
   Grants SFB-685 (H.K.) and SFB-TR34 (T.S.).
CR BARRETT FF, 1968, NEW ENGL J MED, V279, P441, DOI 10.1056/NEJM196808292790901
   BISWAS R, 2006, CHARACTERIZATION STA
   Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104
   Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232
   FOSTER SJ, 1995, J BACTERIOL, V177, P5723, DOI 10.1128/jb.177.19.5723-5725.1995
   Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Li X, 2007, IMMUNITY, V27, P518, DOI 10.1016/j.immuni.2007.07.020
   Lutzner N, 2008, J BIOL CHEM, V283, P36185, DOI 10.1074/jbc.M806500200
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Rupp ME, 1994, CLIN INFECT DIS, V19, P244
   Sabath L D, 1968, Antimicrob Agents Chemother (Bethesda), V8, P302
   Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x
   Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200
   WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324
NR 19
TC 14
Z9 14
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 13
PY 2009
VL 380
IS 3
BP 554
EP 558
DI 10.1016/j.bbrc.2009.01.140
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 419LZ
UT WOS:000264222400023
PM 19284999
DA 2018-10-19
ER

PT J
AU Crouzier, T
   Ren, K
   Nicolas, C
   Roy, C
   Picart, C
AF Crouzier, Thomas
   Ren, Kefeng
   Nicolas, Claire
   Roy, Chrstian
   Picart, Catherine
TI Layer-By-Layer Films as a Biomimetic Reservoir for rhBMP-2 Delivery:
   Controlled Differentiation of Myoblasts to Osteoblasts
SO SMALL
LA English
DT Article
DE biomimetics; cells; multilayers; polyelectrolytes
ID BONE MORPHOGENETIC PROTEIN-2; POLYELECTROLYTE MULTILAYER FILMS;
   FIBROBLAST-GROWTH-FACTOR; CELL-ADHESION; EXTRACELLULAR MATRICES;
   STEM-CELLS; IN-VIVO; TISSUE; BMP-2; RAT
AB Efficient delivery of growth or survival factors to cells is one of the most important long-term challenges of current cell-based tissue engineering strategies. The extracellular matrix acts as a reservoir for a number of growth factors through interactions with its components. In the matrix, growth factors are protected against circulating proteases and locally concentrated. Thus, the localized and long-lasting delivery of a matrix-bound recombinant human bone morphogenetic- protein 2 (rhBMP-2) from a biomaterial surface would mimic in vivo conditions and increase BMP-2 efficiency by limiting its degradation. Herein, it is shown that crosslinked poly(L-lysine)/hyaluronan (HA) layer-by-layer films can serve as a reservoir for rhBMP-2 delivery to myoblasts and induce their differentiation into osteoblasts in a dose-dependent manner. The amount of rhBMP-2 loaded in the films is controlled by varying the deposition conditions and the film thickness. Its local concentration in the film is increased up to approximate to 500-fold when compared to its initial solution concentration. Its adsorption on the films, as well as its diffusion within the films, is evidenced by microfluorimetry and confocal microscopy observations. A direct interaction of rhBMP-2 with HA is demonstrated by size-exclusion chromatography, which could be at the origin of the rhBMP-2 "trapping" in the film and of its low release from the films. The bioactivity of rhBMP-2-loaded films is due neither to film degradation nor to rhBMP-2 release. The rhBMP-2-containing films are extremely resistant and could sustain three successive culture sequences while remaining bioactive, thus confirming the important and protective effect of rhBMP-2 immobilization. These films may find applications in the local delivery of immobilized growth factors for tissue-engineered constructs and for metallic biomaterial surfaces, as they can be deposited on a wide range of substrates with different shapes, sizes, and composition.
C1 [Crouzier, Thomas; Ren, Kefeng; Nicolas, Claire; Roy, Chrstian; Picart, Catherine] Univ Montpellier 2, CNRS, UMR 5235, DIMNP, F-34095 Montpellier, France.
   [Crouzier, Thomas; Ren, Kefeng; Nicolas, Claire; Roy, Chrstian; Picart, Catherine] Univ Montpellier 1, CNRS, UMR 5235, DIMNP, F-34095 Montpellier, France.
RP Picart, C (reprint author), Univ Montpellier 2, CNRS, UMR 5235, DIMNP, CC 107, F-34095 Montpellier, France.
EM catherine.picart@univ-montp2.fr
RI PICART, Catherine/C-9132-2011; Ren, Ke-feng/I-3593-2012
OI Crouzier, Thomas/0000-0002-1981-3736; PICART,
   Catherine/0000-0003-0130-1000; PICART, Catherine/0000-0002-4854-6366
FU "Association Francaise centre les Myopathies (AFM)" [12671];
   "Association pour la Recherche sur la Cancer" [7918]; "Fondation
   Recherche Medicale" [INE20061108297]; "Agence Nationale pour la
   Recherche" [ANR-06-NANO-006]; "Institut Universitaire de France"
FX This work was supported by the "Association Francaise centre les
   Myopathies" (AFM, grant no. 12671), the "Association pour la Recherche
   sur la Cancer" (equipment grant no. 7918), the "Fondation Recherche
   Medicale" (equipment grant no. INE20061108297), and the "Agence
   Nationale pour la Recherche" (grant ANR-06-NANO-006). We thank Michel
   Puceat (INSERM UMR861, Evry, France) for fruitful discussions. We ore
   grateful to Catherine Royer and Florian Rehfeld for careful reading of
   the manuscript and for their critical comments. We thank Julien Cau and
   Pierre Travo for use of the Montpellier Rio imaging platform. C.P. is a
   Junior Member of the "Institut Universitaire de France" whose support is
   gratefully acknowledged. K.R. is indebted to the CNRS for providing a
   postdoctoral fellowship and T.C. thanks the AFM for a PhD fellowship.
CR ABBATIELLO SE, PROT SOC M BOST, V99
   Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657
   AXELROD D, 1983, J MICROSC-OXFORD, V129, P19, DOI 10.1111/j.1365-2818.1983.tb04158.x
   Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com
   BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Boyan BD, 1999, J BIOMED MATER RES, V46, P51, DOI 10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.0.CO;2-I
   BRUNOT C, 2008, DENT MATER, V8, P1025
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dierich A, 2007, ADV MATER, V19, P693, DOI 10.1002/adma.200601271
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Haxaire K, 2003, BIOPOLYMERS, V72, P149, DOI 10.1002/bip.10342
   Hubbel JA, 2004, CURR OPIN BIOTECH, V15, P381, DOI 10.1016/j.copbio.2004.08.015
   Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Katagiri T, 1997, EXP CELL RES, V230, P342, DOI 10.1006/excr.1996.3432
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kofron MD, 2004, CURR OPIN BIOTECH, V15, P399, DOI 10.1016/j.copbio.2004.07.004
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Levine JP, 1997, ANN PLAS SURG, V39, P158, DOI 10.1097/00000637-199708000-00008
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Liu Y, 2007, J DENT RES, V86, P84, DOI 10.1177/154405910708600114
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156
   Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b
   Morin R, 2006, BIOMACROMOLECULES, V7, P131, DOI 10.1021/bm050461i
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nadiri A, 2007, SMALL, V3, P1577, DOI 10.1002/smll.200700115
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   Rinckenbach S, 2007, J BIOMED MATER RES A, V84A, P576
   RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schneider A, 2006, BIOMACROMOLECULES, V7, P2882, DOI 10.1021/bm0605208
   SCHWARTZ D, 2005, THESIS LUDWIG MAXIMI
   Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086
   SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5
   Spagnoli C, 2005, CARBOHYD RES, V340, P929, DOI 10.1016/j.carres.2005.01.024
   Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200
   Tezcaner A, 2006, BIOMACROMOLECULES, V7, P86, DOI 10.1021/bm0506134
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   van den Beucken JJJP, 2006, J CONTROL RELEASE, V113, P63, DOI 10.1016/j.jconrel.2006.03.016
   VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2
   Vodouhe C, 2005, BIOMATERIALS, V26, P545, DOI 10.1016/j.biomaterials.2004.02.057
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200
NR 62
TC 165
Z9 171
U1 1
U2 65
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1613-6810
J9 SMALL
JI Small
PD MAR 6
PY 2009
VL 5
IS 5
BP 598
EP 608
DI 10.1002/smll.200800804
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 427PP
UT WOS:000264791500012
PM 19219837
DA 2018-10-19
ER

PT J
AU Rusu, MC
   Ibanescu, C
   Ichim, IC
   Riess, G
   Popa, M
   Rusu, D
   Rusu, M
AF Rusu, Marius Ciprian
   Ibanescu, Constanta
   Ichim, Ionut Cameliu
   Riess, Gerard
   Popa, Marcel
   Rusu, Daniela
   Rusu, Mihai
TI Radiopaque Acrylic Bone Cements with Bromine-Containing Monomer
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; acrylic bone cements; bromine-containing acrylic monomer;
   rheology; radiopacity
ID WATER-ABSORPTION CHARACTERISTICS; IODINE-CONTAINING MONOMERS;
   MECHANICAL-PROPERTIES; BARIUM-SULFATE; P/L RATIO; METHACRYLATE;
   POLYMERIZATION; SHRINKAGE; FORMULATIONS; BIOMATERIAL
AB One important issue for the acrylic bone cements concerns the radiopacity, which may be achieved by different ways. In this work, a new bromine-containing acrylic monomer, the 2-(2-bromopropionyloxy) propyl methacrylate (BPPM), was synthesized and proposed to be used for providing radiopaque bone cements. Different acrylic bone cements were realized by partially replacing the methyl methacrylate (MMA) monomer phase with 5-20% w/w of BPPM-comonomer. The effect of this comonomer on the curing parameters of acrylic bone cements, on their thermal and rheological properties, water absorption, density, contact angle, compression tests, and radiopacity was studied. It appears that the presence of BPPM does provide radiopacity, improves the curing parameters by decreasing the Maximum curing temperature and increasing the Setting time. The new BPPM-acrylic bone cements exhibit lower glass transition temperature and better thermal stability when compared with the classical radiolucent acrylic cements. Rheological measurements have shown that 10-20% w/w of BPPM in the liquid phase of acrylic bone cement formulations increase its flexibility, and may also induce a slight crosslinking reaction during the Curing phase. BPPM-modified acrylic bone cements present lower polymerization shrinkage and higher compression strength, and similar water uptake, porosity, and water contact angle as the radiolucent PMMA-cements. (c) 2008 Wiley Periodicals, Inc. J Appl Polym Sci 111: 2493-2506, 2009
C1 [Rusu, Marius Ciprian; Ibanescu, Constanta; Ichim, Ionut Cameliu; Popa, Marcel; Rusu, Mihai] Gh Asachi Tech Univ, Chem Engn Fac, Iasi 700050, Romania.
   [Riess, Gerard] ENSCMu, Lab Chim Macromol, F-68093 Mulhouse, France.
   [Rusu, Daniela] Ecole Mines Paris ParisTech, CEMEF, Sophia Antipolis, France.
RP Rusu, MC (reprint author), Gh Asachi Tech Univ, Chem Engn Fac, Iasi 700050, Romania.
EM mrusu@ch.tuiasi.ro
RI RUSU, Mihai/C-2257-2008; RUSU, Daniela/A-6918-2008
OI RUSU, Mihai/0000-0002-4143-6818; RUSU, Daniela/0000-0001-6475-6841;
   Ibanescu, Constanta/0000-0002-4182-7384
FU Romanian Ministry of Education and Research
FX Contract grant sponsor: Romanian Ministry of Education and Research.
CR Aldenhoff YBJ, 2002, BIOMATERIALS, V23, P881, DOI 10.1016/S0142-9612(01)00197-1
   ALLEN PEM, 1992, EUR POLYM J, V28, P347, DOI 10.1016/0014-3057(92)90252-W
   [Anonymous], 1996, ANN BOOK ASTM STANDA
   Artola A, 2003, BIOMATERIALS, V24, P4071, DOI 10.1016/S0142-9612(03)00298-9
   Barnes H.A., 2000, HDB ELEMENTARY RHEOL
   BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   BERRIEJ A, 1968, WATER POLYM
   Bettencourt A, 2004, INT J PHARMACEUT, V278, P181, DOI 10.1016/j.ijpharm.2004.03.011
   BOWEN RL, 1982, J DENT RES, V61, P654, DOI 10.1177/00220345820610050701
   BRADEN M, 1984, BIOMATERIALS, V5, P369, DOI 10.1016/0142-9612(84)90038-3
   BRAUER GM, 1986, J BIOMED MATER RES, V20, P839, DOI 10.1002/jbm.820200614
   Cervantes-Uc JM, 2005, BIOMATERIALS, V26, P4063, DOI 10.1016/j.biomaterials.2004.10.030
   Coleman MM, 1991, SPECIFIC INTERACTION
   Crank J., 1956, MATH DIFFUSION
   DAVY KWM, 1997, POLYM INT, V43, P142
   DEB S, 1995, BIOMATERIALS, V16, P1095, DOI 10.1016/0142-9612(95)98906-U
   Deb S, 1999, J BIOMED MATER RES, V48, P719, DOI 10.1002/(SICI)1097-4636(1999)48:5<719::AID-JBM18>3.0.CO;2-H
   Deb S, 2001, BIOMATERIALS, V22, P2177, DOI 10.1016/S0142-9612(00)00409-9
   Demian HW, 1998, BIOMATERIALS, V19, P1607, DOI 10.1016/S0142-9612(97)00122-1
   DiMaio FR, 2002, ORTHOPEDICS, V25, P1399
   DNEBOSKY J, 1975, J DENT RES, V54, P772, DOI 10.1177/00220345750540041301
   DUNNE NJ, 2000, 12 C EUR SOC BIOM DU, P447
   El'Sheikh HF, 2003, J MATER PROCESS TECH, V143, P249, DOI 10.1016/S0924-0136(03)00352-2
   Ginebra MP, 2002, BIOMATERIALS, V23, P1873, DOI 10.1016/S0142-9612(01)00314-3
   HASS SS, 1975, J BONE JOINT SURG AM, V57, P380
   HRABAK F, 1978, MAKROMOL CHEM, V179, P2593
   Huiskes R., 1980, ACTA ORTHOP SCAND, V51, P43
   Ichim IC, 2007, E-POLYMERS
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   JEFFERIS CD, 1975, J BONE JOINT SURG AM, V37, P380
   KRAUSE WR, 1982, ENCY MED DEVICES INS, V1
   KUHN KD, 2000, BONE CEMENTS UP TO D
   Larraz E, 2005, BIOMACROMOLECULES, V6, P2058, DOI 10.1021/bm050055z
   LAUTENSCHLAGER EP, 1974, J BIOMED MATER RES S, V5, P185
   Lewis G, 2003, J BIOMED MATER RES B, V66B, P457, DOI 10.1002/jbm.b.10018
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2005, J BIOMED MATER RES B, V73B, P77, DOI 10.1002/jbm.b.30176
   LOSHACK S, 1953, J AM CHEM ASS, V75, P544
   MANERO JM, 2004, J ENG MED, V218, P3
   MEXGER TG, 2006, HDB USERS ROTATIONAL
   MIGLIARESI C, 1994, BIOMATERIALS, V15, P875, DOI 10.1016/0142-9612(94)90110-4
   Molino LN, 1996, J BIOMED MATER RES, V31, P131, DOI 10.1002/(SICI)1097-4636(199605)31:1<131::AID-JBM14>3.0.CO;2-Q
   MOLNAR EJ, 1968, J DENT RES, V47, P665, DOI 10.1177/00220345680470042701
   NEUMANN L, 1994, J BONE JOINT SURG BR, V76B, P245
   Pascual B, 1999, J BIOMED MATER RES, V48, P447, DOI 10.1002/(SICI)1097-4636(1999)48:4<447::AID-JBM8>3.0.CO;2-I
   Pascual B, 1999, BIOMATERIALS, V20, P465, DOI 10.1016/S0142-9612(98)00192-6
   Pascual B, 1999, BIOMATERIALS, V20, P453, DOI 10.1016/S0142-9612(98)00191-4
   PATEL MP, 1987, BIOMATERIALS, V8, P53, DOI 10.1016/0142-9612(87)90030-5
   RAVELL PA, 1998, BIOMATERIALS, V19, P1579
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   ROSE E E, 1958, J Am Dent Assoc, V56, P375
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   Silikas N, 2005, BIOMATERIALS, V26, P197, DOI 10.1016/j.biomaterials.2004.02.028
   Vazquez B, 2002, J BIOMED MATER RES, V63, P88, DOI 10.1002/jbm.10092
   Vazquez B, 1999, BIOMATERIALS, V20, P2047, DOI 10.1016/S0142-9612(99)00108-8
   WARD IM, 1993, INTRO MATH PROPERTIE
NR 56
TC 6
Z9 6
U1 0
U2 15
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 5
PY 2009
VL 111
IS 5
BP 2493
EP 2506
DI 10.1002/app.29253
PG 14
WC Polymer Science
SC Polymer Science
GA 392SQ
UT WOS:000262322900039
DA 2018-10-19
ER

PT J
AU Le Bolay, N
   Santran, V
   Dechambre, G
   Combes, C
   Drouet, C
   Lamure, A
   Rey, C
AF Le Bolay, Nadine
   Santran, Veronique
   Dechambre, Gerard
   Combes, Christele
   Drouet, Christophe
   Lamure, Alain
   Rey, Christian
TI Production, by co-grinding in a media mill, of porous biodegradable
   polylactic acid-apatite composite materials for bone tissue engineering
SO POWDER TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Symposium on Powder Science and Technology - Powders and Sintered
   Material
CY MAY 23-25, 2007
CL Albi, FRANCE
DE Composite biomaterial; Biodegradable; Polylactic acid; Apatite;
   Co-grinding; Porosity
ID HYDROXYAPATITE; COLLAGEN; SCAFFOLDS
AB This paper presents the results of a study of the production of porous biodegradable composite materials by co-grinding, followed by scaffolding. Dry powders of polylactic acid and nanocrystalline carbonated apatite, analogous to bone mineral were co-ground in a tumbling ball mill in order to disperse the mineral filler within the polymer. Porous scaffolds were then made by hot moulding the mixture of the two components along with a pore-forming agent which was subsequently eliminated by washing. The mechanical resistance of the scaffolds was evaluated in order to determine the best operating conditions to produce implants offering optimised properties for use as bone substitutes. It was shown that 30 wt.% of filler and 70 wt.% of pore-forming agent produce scaffolds which are sufficiently porous and resistant. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Le Bolay, Nadine] ENSIACET, CNRS, UMR UPS INPT 5503, Lab Genie Chim, F-31106 Toulouse 1, France.
   [Santran, Veronique; Dechambre, Gerard; Combes, Christele; Drouet, Christophe; Lamure, Alain; Rey, Christian] ENSIACET, CNRS, UMR UPS INPT 5085, Inst Carnot CIRIMOT, F-31077 Toulouse, France.
RP Le Bolay, N (reprint author), ENSIACET, CNRS, UMR UPS INPT 5503, Lab Genie Chim, 5 Rue Paulin Talabot, F-31106 Toulouse 1, France.
EM Nadine.LeBolay@ensiacet.fr
RI Drouet, Christophe/A-8023-2008; Drouet, Christophe/S-1680-2018
OI Drouet, Christophe/0000-0002-8471-8719; Drouet,
   Christophe/0000-0002-8471-8719
CR BrucknerFoit A, 1997, J EUR CERAM SOC, V17, P689, DOI 10.1016/S0955-2219(96)00085-4
   Cazalbou S, 2004, J MATER CHEM, V14, P2148, DOI 10.1039/b401318b
   Chen GP, 2001, J BIOMED MATER RES, V57, P8, DOI 10.1002/1097-4636(200110)57:1<8::AID-JBM1135>3.0.CO;2-H
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kim HW, 2005, J BIOMED MATER RES B, V74B, P686, DOI 10.1002/jbm.b.30236
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X
   PETITE H, 2000, NAT TECH, V18, P569
   Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Van de Velde K, 2002, POLYM TEST, V21, P433, DOI 10.1016/S0142-9418(01)00107-6
   Zapata C, 2004, CHEM ENG RES DES, V82, P631, DOI 10.1205/026387604323142685
   Zapata-Massot C, 2004, POWDER TECHNOL, V143, P215, DOI 10.1016/j.powtec.2004.04.016
NR 16
TC 8
Z9 8
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0032-5910
J9 POWDER TECHNOL
JI Powder Technol.
PD MAR 5
PY 2009
VL 190
IS 1-2
BP 89
EP 94
DI 10.1016/j.powtec.2008.04.043
PG 6
WC Engineering, Chemical
SC Engineering
GA 422MR
UT WOS:000264432900018
DA 2018-10-19
ER

PT J
AU Sivaraman, B
   Fears, KP
   Latour, RA
AF Sivaraman, Balakrishnan
   Fears, Kenan P.
   Latour, Robert A.
TI Investigation of the Effects of Surface Chemistry and Solution
   Concentration on the Conformation of Adsorbed Proteins Using an Improved
   Circular Dichroism Method
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; HUMAN SERUM-ALBUMIN; SECONDARY STRUCTURE;
   PLATELET-ADHESION; PLASMON RESONANCE; FUNCTIONAL-GROUPS; MODEL SURFACES;
   CELL-ADHESION; IN-VITRO; ADSORPTION
AB In this paper we present the development of methods using circular dichroism spectropolarimetry with a custom-designed cuvette to increase the signal-to-noise ratio for the measurement of the secondary structure of adsorbed proteins, thus providing enhanced sensitivity and reproducibility. These methods were then applied to investigate how surface chemistry and solution concentration influence both the amount of adsorbed proteins and their secondary structure. Human fibrinogen and albumin were adsorbed onto alkanethiol self-assembled monolayers (SAMs) on gold with CH(3), OCH(2)-CF(3), NH(2), COOH, and OH terminal groups from both dilute (0.1 mg/mL) and moderately concentrated (1.0 mg/mL) solutions. An increase in surface hydrophobicity was found to cause an increase in both the amount of the protein adsorbed and the degree of structural change that was caused by the adsorption process, while an increase in solution concentration caused an increase in the amount of protein adsorbed but a decrease in the degree of conformational change, with these effects being more pronounced on the more hydrophobic surfaces. The combined use of these two parameters (i.e., surface chemistry and solution concentration) thus provides a means of independently varying the degree of structural change following adsorption from the amount of adsorbed protein. Further studies are underway to examine which of these factors most strongly influences platelet response, with the overall goal of developing a better understanding of the fundamental factors governing the hemocompatibility of biomaterial surfaces.
C1 [Sivaraman, Balakrishnan; Fears, Kenan P.; Latour, Robert A.] Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
EM latourr@clemson.edu
RI Sivaraman, Balakrishnan/G-6886-2012
OI Sivaraman, Balakrishnan/0000-0002-4538-8665
FU NIH [P20 RR-016461]; National Center for Research Resources
FX This project was supported by NIH Grant Number P20 RR-016461 from the
   National Center for Research Resources, and its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the NIH. We are also grateful to Dr. James E. Harriss
   at Clemson University for fabrication of the gold-coated surfaces used
   in our studies, and Ms. Megan Grobman, Dr. Lara Gamble, and Dr. David
   Castner at the University of Washington for assistance with the
   characterization of our surfaces using XPS.
CR *1A36, PROT DAT BANK, P12408
   AKAIKE T, 1979, KOBUNSHI RONBUNSHU, V36, P217, DOI 10.1295/koron.36.217
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   [Anonymous], 2008, ENCY BIOMATERIALS BI, P270
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Baker BR, 2004, FARADAY DISCUSS, V126, P209, DOI 10.1039/b305291e
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   BUDZYNSKI AZ, 1971, BIOCHIM BIOPHYS ACTA, V229, P663, DOI 10.1016/0005-2795(71)90282-0
   CASSIM JY, 1969, BIOCHEMISTRY-US, V8, P1947, DOI 10.1021/bi00833a026
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Coelho MAN, 2003, LANGMUIR, V19, P7544, DOI 10.1021/la034445n
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Fears KP, 2008, LANGMUIR, V24, P837, DOI 10.1021/la701760s
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   Goncalves S, 2007, J PHOTOCH PHOTOBIO B, V86, P170, DOI 10.1016/j.jphotobiol.2006.09.001
   Gooding JJ, 2003, ELECTROANAL, V15, P81, DOI 10.1002/elan.200390017
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204
   HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P313, DOI 10.1006/jcis.1995.1039
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1
   Hirata I, 2003, J BIOMED MATER RES A, V66A, P669, DOI 10.1002/jbm.a.10067
   HORBETT TA, 1987, ACS SYM SER, V343, P1
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   *IEI3, PROT DAT BANK, P12408
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   KLOCZEWIAK M, 1976, THROMB RES, V9, P359, DOI 10.1016/0049-3848(76)90136-5
   Latour RA, 2006, J BIOMED MATER RES A, V78A, P843, DOI 10.1002/jbm.a.30818
   LEE DC, 1990, BIOCHEMISTRY-US, V29, P9185, DOI 10.1021/bi00491a012
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   MCMILLIN CR, 1974, J COLLOID INTERF SCI, V48, P345, DOI 10.1016/0021-9797(74)90170-2
   Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320
   Rixman MA, 2003, LANGMUIR, V19, P6202, DOI 10.1021/la026551f
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Sreerama N, 2004, BIOPHYS J, V86, p102A
   Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404
   Sreerama N, 2004, METHODS ENZYMOL, V383, P318
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Wagner R, 1998, APPL ORGANOMET CHEM, V12, P265, DOI 10.1002/(SICI)1099-0739(199804)12:4<265::AID-AOC704>3.0.CO;2-7
   Werner C, 1999, COLLOID SURFACE A, V156, P3, DOI 10.1016/S0927-7757(99)00007-2
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
NR 50
TC 84
Z9 87
U1 0
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 3
PY 2009
VL 25
IS 5
BP 3050
EP 3056
DI 10.1021/la8036814
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 413CP
UT WOS:000263770800076
PM 19437712
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Rea, JC
   Gibly, RF
   Barron, AE
   Shea, LD
AF Rea, Jennifer C.
   Gibly, Romie F.
   Barron, Annelise E.
   Shea, Lonnie D.
TI Self-assembling peptide-lipoplexes for substrate-mediated gene delivery
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Gene delivery; Peptide; Lipoplex; Substrate-mediated; Self-assembly
ID MULTILAYERED POLYELECTROLYTE FILMS; DNA COMPLEXES; PLASMID DNA;
   NANOPARTICLES; DENSITY; CELLS; EXPRESSION
AB The efficiency of biomaterial-based gene delivery is determined by the interaction of the material and the vector. For lipoplexes, surface immobilization has been used to transfect cells for applications such as cell arrays and model tissue formation through patterned transfection. Further increases in the delivery efficiency are limited by cellular internalization, which may be overcome by altering the material/vector interactions. In this report, we investigated the modification of the lipoplex physical properties through self-assembly with cationic peptides, and subsequently quantified cellular association, internalization and nuclear accumulation of DNA and transfection. Relative to lipid alone, peptide-lipoplexes enhanced transfection by up to 4.6-fold. The presence of the peptide in the lipoplex increased internalization efficiency by up to 4.5-fold, decreased the percentage of lysosomal DNA by 2.1-fold and increased the efficiency of nuclear accumulation by 3.0-fold. In addition, an analysis of internalization pathways for peptide-lipoplexes indicated a greater role of clathrin and caveolae-mediated endocytosis relative to macropinocytois, which was not observed for peptide-free lipoplexes. These results demonstrate peptide-induced enhancement of gene transfer by surface immobilization due to increased cellular internalization and nuclear accumulation, which has numerous applications ranging from cell-based assays to regenerative medicine. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Rea, Jennifer C.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Gibly, Romie F.] Northwestern Univ, Dept Interdepartmental Biol Sci, Evanston, IL 60208 USA.
   [Barron, Annelise E.] Stanford Univ, Dept Bioengn, James H Clark Ctr W300B, Stanford, CA 94305 USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Tech E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009; Barron, Annelise/B-7639-2009
OI Rea, Jennifer/0000-0002-7405-6790
FU NIH [R01 EB003806-01, R01 GM066830]; Institute for BioNanotechnology in
   Medicine (IBNAM) at Northwestern University; Ford Foundation Predoctoral
   Fellowship
FX Support for this research was provided in part by the NIH (R01
   EB003806-01 (A.E.B., L.D.S.) and R01 GM066830 (L.D.S.)), the Institute
   for BioNanotechnology in Medicine (IBNAM) at Northwestern University,
   and a Ford Foundation Predoctoral Fellowship (J.C.R.). Confocal
   microscopy images were obtained at the Biological Imaging Facility (BIF)
   at Northwestern University. ESI and MALDI-TOF mass spectrometry were
   performed at the Analytical Services Laboratory at Northwestern
   University. We would like to thank William Russin for technical
   assistance.
CR Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   BENGALI Z, EFFICACY IMMOB UNPUB
   Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   El-Sayed A, 2008, J BIOL CHEM, V283, P23450, DOI 10.1074/jbc.M709387200
   Gao X, 1996, BIOCHEMISTRY-US, V35, P1027, DOI 10.1021/bi952436a
   JANG JH, 2005, J BIOMED MAT RES A
   Jewell CM, 2006, BIOMACROMOLECULES, V7, P2483, DOI 10.1021/bm0604808
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Khalil IA, 2007, GENE THER, V14, P682, DOI 10.1038/sj.gt.3302910
   Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200
   Khalil KA, 2008, INT J PHARMACEUT, V354, P39, DOI 10.1016/j.ijpharm.2007.12.003
   Moriguchi R, 2006, J CONTROL RELEASE, V110, P605, DOI 10.1016/j.jconrel.2005.10.021
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Pannier AK, 2008, ACTA BIOMATER, V4, P26, DOI 10.1016/j.actbio.2007.08.008
   Rea JC, 2008, J PHARM SCI-US, V97, P4794, DOI 10.1002/jps.21338
   Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Tagawa T, 2002, GENE THER, V9, P564, DOI 10.1038/sj.gt.3301686
   Varga CM, 2005, GENE THER, V12, P1023, DOI 10.1038/sj.gt.3302495
   Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 25
TC 26
Z9 27
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2009
VL 5
IS 3
BP 903
EP 912
DI 10.1016/j.actbio.2008.10.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 425FJ
UT WOS:000264622100011
PM 18990615
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wollensak, G
   Iomdina, E
AF Wollensak, Gregor
   Iomdina, Elena
TI Long-term biomechanical properties of rabbit sclera after collagen
   crosslinking using riboflavin and ultraviolet A (UVA)
SO ACTA OPHTHALMOLOGICA
LA English
DT Article
DE collagen crosslinking; sclera; UVA-riboflavin-progressive myopia;
   Young's modulus
ID MYOPIA PROGRESSION; OCULAR-TISSUES; REINFORCEMENT; KERATOCONUS;
   COMPONENTS; DAMAGE
AB Scleral crosslinking by the photosensitizer riboflavin and ultraviolet A (UVA) has been shown to increase significantly the scleral biomechanical rigidity and might therefore become a possible sclera-based treatment modality for progressive myopia. In the present study, the long-term effect of the new crosslinking method on biomechanical properties was investigated in the rabbit sclera.
   A 10 x 10 mm sector of the equatorial sclera of nine Chinchilla rabbit eyes was treated in vivo using a UVA double diode of 370 nm with a surface irradiance of 3 mW/cm(2) and application of 0.1% riboflavin-5-phosphate drops as photosensitizer for 30 min. Three days, 4 months and 8 months postoperatively, biomechanical stress-strain measurements of the treated scleral strips were performed and compared to contralateral control sclera using a microcomputer-controlled biomaterial tester. In addition, routine histological controls were performed.
   Following the crosslinking treatment, Young's modulus was increased by 320% after 3 days, 277% after 4 months and 502% after 8 months, and ultimate stress by 341% after 3 days, 131% after 4 months and 213.8% after 8 months versus the controls. The decrease in ultimate strain was between 24% and 44.8%. On histology, no tissue damage was detected.
   Our new method of scleral collagen crosslinking proved very effective and constant over a time interval of up to 8 months in increasing the scleral biomechanical strength. Therefore, the new treatment might become an option for strengthening scleral tissue in progressive myopia and other conditions associated with weakened sclera. There were no side-effects on the retina or retinal pigment epithelium. The new crosslinking treatment could now be tested in a suitable myopia model (like the tree shrew) and finally in human eyes.
C1 [Wollensak, Gregor] Univ Halle Wittenberg, Dept Ophthalmol, Halle, Germany.
   [Iomdina, Elena] Moscow Helmholtz Res Inst Eye Dis, Moscow, Russia.
RP Wollensak, G (reprint author), Wildentensteig 4, D-14195 Berlin, Germany.
EM gwollens@hotmail.com
CR Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181
   Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618
   AWETISSOW ES, 1980, KLIN MONATSBL AUGENH, V176, P777, DOI 10.1055/s-2008-1057552
   BAILEY AJ, 1987, EYE-T OPHTH SOC UK, V1, P175, DOI 10.1038/eye.1987.34
   BALDWIN WR, 1981, AM J OPTOM PHYS OPT, V58, P516
   BELL GR, 1978, J AM OPTOM ASSOC, V49, P1399
   BOSE SK, 1986, PHOTOCHEM PHOTOBIOL, V43, P525, DOI 10.1111/j.1751-1097.1986.tb09530.x
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   de la Rochette A, 2000, PHOTOCHEM PHOTOBIOL, V72, P815, DOI 10.1562/0031-8655(2000)072<0815:RPAPEA>2.0.CO;2
   FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314
   Gilmartin B, 2004, CLIN EXP OPHTHALMOL, V32, P305, DOI 10.1111/j.1442-9071.2004.00831.x
   Iomdina E.N., 1993, P 14 C BIOM PAR INT, P616
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   LEE RE, 1981, EXP EYE RES, V32, P737, DOI 10.1016/0014-4835(81)90023-3
   Logstrup N, 1997, BRIT J OPHTHALMOL, V81, P343, DOI 10.1136/bjo.81.5.343
   MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133
   McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0
   McBrien NA, 2001, CURR EYE RES, V23, P313, DOI 10.1076/ceyr.23.5.313.5440
   MECHANIC G, 1972, BIOCHEM BIOPH RES CO, V47, P267, DOI 10.1016/S0006-291X(72)80038-X
   Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004
   NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3
   Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009
   Rose K, 2001, CLIN EXP OPHTHALMOL, V29, P116, DOI 10.1046/j.1442-9071.2001.00389.x
   Saw SM, 2002, OPHTHALMOLOGY, V109, P415, DOI 10.1016/S0161-6420(01)00972-1
   Saw SM, 2002, BRIT J OPHTHALMOL, V86, P1306, DOI 10.1136/bjo.86.11.1306
   Tano Y, 2002, AM J OPHTHALMOL, V134, P645, DOI 10.1016/S0002-9394(02)01883-4
   THOMPSON FB, 1978, AM J OPHTHALMOL, V86, P782, DOI 10.1016/0002-9394(78)90121-6
   Touzeau O, 2004, J FR OPHTALMOL, V27, P765, DOI 10.1016/S0181-5512(04)96211-0
   Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4
   Weale RA, 2003, SURV OPHTHALMOL, V48, P515, DOI 10.1016/S0039-6257(03)00086-9
   Weiss AH, 2003, BRIT J OPHTHALMOL, V87, P1025, DOI 10.1136/bjo.87.8.1025
   WHITMORE WG, 1987, OPHTHALMIC SURG LAS, V18, P503
   Wildsoet CF, 1999, OPTOMETRY VISION SCI, V76, P341, DOI 10.1097/00006324-199906000-00001
   Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25
   ZUCLICH JA, 1989, HEALTH PHYS, V56, P671, DOI 10.1097/00004032-198905000-00012
NR 38
TC 48
Z9 57
U1 2
U2 8
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1755-375X
J9 ACTA OPHTHALMOL
JI Acta Ophthalmol.
PD MAR
PY 2009
VL 87
IS 2
BP 193
EP 198
DI 10.1111/j.1755-3768.2008.01229.x
PG 6
WC Ophthalmology
SC Ophthalmology
GA 412SR
UT WOS:000263745000013
PM 18803623
OA Bronze
DA 2018-10-19
ER

PT J
AU Saunders, BR
   Laajam, N
   Daly, E
   Teow, S
   Hu, XH
   Stepto, R
AF Saunders, Brian R.
   Laajam, Nadiah
   Daly, Emma
   Teow, Stephanie
   Hu, Xinhua
   Stepto, Robert
TI Microgels: From responsive polymer colloids to biomaterials
SO ADVANCES IN COLLOID AND INTERFACE SCIENCE
LA English
DT Article
ID POLY(N-ISOPROPYLACRYLAMIDE) MICROGELS; N-ISOPROPYLACRYLAMIDE;
   INTERVERTEBRAL DISC; SWELLING BEHAVIOR; PHASE-TRANSITION;
   METHACRYLIC-ACID; CROSS-LINKERS; PARTICLES; RELEASE; DISPERSIONS
AB Microgels are network polymer colloid particles that can swell in a good solvent or as a result of electrostatic repulsion between charged groups produced by pH-triggered neutralisation. They have attracted considerable interest as both model colloids and for their potential applications. This discussion reviews the properties of microgel particles and the current understanding of their structure. The review concentrates on the period after an earlier microgel review by Saunders and Vincent [Adv. Coll. Interf. Sci., 1999, 80, 1]. A key challenge for microgel research has involved elucidation of the internal particle structure. Most microgels prepared by emulsion or precipitation polymerisation have a core-shell structure. The segment density is usually highest in the core. Here, we discuss relationships between microgel structure and dispersion stability. The reasons for the exceptional stability of microgel dispersions are considered. There are a number of favourable structural features that make microgels candidates for biomaterial applications and these are discussed. The main potential biomaterial applications that have been investigated for microgels to date are drug delivery and regenerative medicine. Poly(NIPAM) (N-isopropylacrylamide) microgels have been extensively studied in the context of drug delivery. Regenerative medicine research for microgels is an emerging area. Recent work involving the use of gelled microgel dispersions to support biomechanically meaningful loads is considered. We conclude with a discussion of promising directions for microgel research as biomaterials. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Saunders, Brian R.; Laajam, Nadiah; Teow, Stephanie; Stepto, Robert] Univ Manchester, Sch Mat, Polymer Sci & Engn Grp, Manchester M1 7HS, Lancs, England.
   [Daly, Emma] Univ Adelaide, Dept Chem, Adelaide, SA 5005, Australia.
   [Hu, Xinhua] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Sichuan, Peoples R China.
RP Saunders, BR (reprint author), Univ Manchester, Sch Mat, Polymer Sci & Engn Grp, Grosvenor St, Manchester M1 7HS, Lancs, England.
EM brian.saunders@manchester.ac.uk
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   BAKER WO, 1949, IND ENG CHEM, V41, P511, DOI 10.1021/ie50471a016
   Bouillot P, 2000, COLLOID POLYM SCI, V278, P74, DOI 10.1007/s003960050012
   Bradley M, 2007, LANGMUIR, V23, P9237, DOI 10.1021/la701571w
   Brandrup J, 1974, POLYM HDB
   Bulmus V, 2007, MACROMOL BIOSCI, V7, P446, DOI 10.1002/mabi.200600258
   CASTROLOPEZ V, 2005, INT J PHARMACEUT, V292, P137
   Cho EC, 2008, NANO LETT, V8, P168, DOI 10.1021/nl072346e
   CLARKE J, 1981, J CHEM SOC FARAD T 1, V77, P1831, DOI 10.1039/f19817701831
   CREAGER SE, 1994, LANGMUIR, V10, P3675, DOI 10.1021/la00022a048
   Dalmont H, 2008, LANGMUIR, V24, P2834, DOI 10.1021/la703597a
   Daly E, 2000, LANGMUIR, V16, P5546, DOI 10.1021/la991292o
   Das M, 2006, ADV MATER, V18, P80, DOI 10.1002/adma.200501043
   Das M, 2007, LANGMUIR, V23, P196, DOI 10.1021/la061596s
   DENA JA, 1999, LANGES HDB CHEM
   Dowding PJ, 2000, J COLLOID INTERF SCI, V221, P268, DOI 10.1006/jcis.1999.6593
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   English RJ, 1999, J RHEOL, V43, P1175, DOI 10.1122/1.551026
   Fernandez-Nieves A, 2000, J PHYS-CONDENS MAT, V12, P3605, DOI 10.1088/0953-8984/12/15/309
   Fernandez-Nieves A, 2000, MACROMOLECULES, V33, P2114, DOI 10.1021/ma991520l
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Goller MI, 1997, COLLOID SURFACE A, V123, P183, DOI 10.1016/S0927-7757(96)03777-6
   Hall RJ, 2004, COLLOID SURFACE A, V233, P25, DOI 10.1016/j.colsurfa.2003.06.004
   Higgins J., 1996, POLYM NEUTRON SCATTE
   Hoare T, 2008, BIOMACROMOLECULES, V9, P733, DOI 10.1021/bm701203r
   Hoare T, 2008, LANGMUIR, V24, P1005, DOI 10.1021/la7024507
   Hoare T, 2006, LANGMUIR, V22, P7342, DOI 10.1021/la0608718
   Islam AM, 1995, ADV COLLOID INTERFAC, V62, P109, DOI 10.1016/0001-8686(95)00276-V
   Jenkins P, 1996, ADV COLLOID INTERFAC, V68, P57, DOI 10.1016/S0001-8686(96)90046-9
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   KIMINTA DMO, 1995, POLYMER, V36, P4827, DOI 10.1016/00323-8619(59)9299A-
   Kiser PF, 2000, J CONTROL RELEASE, V68, P9, DOI 10.1016/S0168-3659(00)00236-4
   Lally S, 2007, J COLLOID INTERF SCI, V316, P367, DOI 10.1016/j.jcis.2007.08.030
   Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732
   Loxley A, 1997, COLLOID POLYM SCI, V275, P1108, DOI 10.1007/s003960050190
   Marcucci F, 2004, DRUG DISCOV TODAY, V9, P219, DOI 10.1016/S1359-6446(03)02988-X
   Mason TG, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.040801
   Meunier F, 2006, COLLOID POLYM SCI, V284, P1287, DOI 10.1007/s00396-006-1514-7
   Morris GE, 1997, J COLLOID INTERF SCI, V190, P198, DOI 10.1006/jcis.1997.4843
   Murthy N, 2002, J AM CHEM SOC, V124, P12398, DOI 10.1021/ja026925r
   Neyret S, 1997, POLYMER, V38, P6129, DOI 10.1016/S0032-3861(97)00173-0
   Nolan CM, 2005, BIOMACROMOLECULES, V6, P2032, DOI 10.1021/bm0500087
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   PELTON RH, 1986, COLLOID SURFACE, V20, P247, DOI 10.1016/0166-6622(86)80274-8
   Philippova OE, 1997, MACROMOLECULES, V30, P8278, DOI 10.1021/ma970957v
   Pinprayoon O, 2008, J COLLOID INTERF SCI, V321, P315, DOI 10.1016/j.jcis.2008.02.037
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k
   RODRIGUEZ BE, 1994, MACROMOLECULES, V27, P6642, DOI 10.1021/ma00100a058
   Routh AF, 2002, LANGMUIR, V18, P5366, DOI 10.1021/la011869d
   Routh AF, 2003, J COLLOID INTERF SCI, V261, P547, DOI 10.1016/S0021-9797(03)00124-3
   Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2
   Saunders BR, 1997, COLLOID POLYM SCI, V275, P9, DOI 10.1007/s003960050047
   Saunders BR, 2004, LANGMUIR, V20, P3925, DOI 10.1021/la036390v
   Saunders JM, 2007, SOFT MATTER, V3, P486, DOI 10.1039/b613943d
   Shaw DJ, 1992, COLLOID SURFACE CHEM
   SNOWDEN MJ, 1994, COLLOID POLYM SCI, V272, P1273, DOI 10.1007/BF00657781
   SNOWDEN MJ, 1992, J CHEM SOC CHEM COMM, P803, DOI 10.1039/c39920000803
   Staudinger H, 1935, BER DTSCH CHEM GES, V68, P1618, DOI 10.1002/cber.19350680841
   Stieger M, 2004, LANGMUIR, V20, P7283, DOI 10.1021/la049518x
   STONEMASUI J, 1975, J COLLOID INTERF SCI, V52, P479, DOI 10.1016/0021-9797(75)90273-8
   Suzuki D, 2007, J AM CHEM SOC, V129, P8088, DOI 10.1021/ja072258w
   Tan JPK, 2007, J CONTROL RELEASE, V118, P87, DOI 10.1016/j.jconrel.2006.11.017
   TANII H, 1991, TOXICOL LETT, V58, P209
   Thornton PD, 2008, SOFT MATTER, V4, P821, DOI 10.1039/b714750c
   Varga I, 2001, J PHYS CHEM B, V105, P9071, DOI 10.1021/jp004600w
   Vihola H, 2002, EUR J PHARM SCI, V16, P69, DOI 10.1016/S0928-0987(02)00076-3
   VINCENT B, 2006, COLLOID STABILITY 2, V2
   VYAS I, 1985, NEUROTOXICOLOGY, V6, P123
   Wang Q, 2007, COLLOID POLYM SCI, V285, P515, DOI 10.1007/s00396-006-1592-6
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005
   WILLIAMS DF, 1986, DEFINITIONS BIOMATER, P49
   WU X, 1994, COLLOID POLYM SCI, V272, P467, DOI 10.1007/BF00659460
   Xia XH, 2003, MACROMOLECULES, V36, P3695, DOI 10.1021/ma0216728
   Zhang H, 2006, BIOMACROMOLECULES, V7, P1568, DOI 10.1021/bm050912z
   Zhou G, 2004, POLYM INT, V53, P603, DOI 10.1002/pi.1439
   Zhou J, 2008, BIOMACROMOLECULES, V9, P142, DOI 10.1021/bm700918d
NR 77
TC 207
Z9 210
U1 7
U2 200
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-8686
EI 1873-3727
J9 ADV COLLOID INTERFAC
JI Adv. Colloid Interface Sci.
PD MAR-JUN
PY 2009
VL 147-48
SI SI
BP 251
EP 262
DI 10.1016/j.cis.2008.08.008
PG 12
WC Chemistry, Physical
SC Chemistry
GA 426ZB
UT WOS:000264746300022
PM 18809173
DA 2018-10-19
ER

PT J
AU Kwon, SW
   Yang, WS
   Lee, HM
   Kim, WK
   Son, GS
   Yoon, DH
   Lee, SD
   Lee, HY
AF Kwon, S. W.
   Yang, W. S.
   Lee, H. M.
   Kim, W. K.
   Son, G. S.
   Yoon, D. H.
   Lee, S. -D.
   Lee, H. -Y.
TI The fabrication of polymer-based evanescent optical waveguide for
   biosensing
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Polymer waveguide; Optical-biosensor; Titanium dioxide; Evanescent
   field; Refractive index; Birefringence
ID COMPOSITE; INTERFEROMETER; ROUGHNESS; SENSOR
AB A polymer waveguide was fabricated to amplify the evanescent optical field for biosensing. The structure of waveguide was designed to propagate a normal single mode at the input and output regions for low loss beam coupling and propagation. A sensing region was formed in the middle of the waveguide to activate the evanescent mode and to induce high birefringence by depositing a thin dielectric film with a high refractive index on a single mode waveguide. A polymer waveguide with the dimensions of 7 mu m-width and 2.5 mu m-thickness was fabricated by photolithography and dry-etching. The active region of the TiO(2) thin film was fabricated with the dimensions of 20 mm-length, 20 nm-thickness and 2 mm-tapered tail. A polarimetric interference technique was used to evaluate the evanescent waveguide biosensor, and biomaterial such as glycerol was tested. The sensitivity of the sensor increased with increasing TiO(2) film thickness. For the fabricated waveguide with a 20 nm-thick TiO(2) film, the measured index change to the lead phase variation of 2 pi was 1.8 x 10(4). Crown Copyright (C) 2008 Published by Elsevier B. V. All rights reserved.
C1 [Kwon, S. W.; Yoon, D. H.] Sungkyunkwan Univ, Sch Adv Mat Sci & Engn, Suwon 440746, South Korea.
   [Yang, W. S.; Lee, H. M.; Kim, W. K.; Lee, H. -Y.] Korea Elect Technol Inst, Nano Biophoton Team, Bundang 463816, South Korea.
   [Son, G. S.] Kwangwoon Univ, Seoul 4471, South Korea.
   [Lee, S. -D.] Infopia Co Ltd, Biosensor Team, Anyang 431716, Kyunggi, South Korea.
RP Yoon, DH (reprint author), Sungkyunkwan Univ, Sch Adv Mat Sci & Engn, Suwon 440746, South Korea.
EM dhyoon@skku.edu
FU Infopia Co. Ltd; RA Scholarship, Sungkyunkwan University
FX This work was supported by Infopia Co. Ltd., and RA Scholarship,
   Sungkyunkwan University.
CR Cvelbar U, 2003, APPL SURF SCI, V210, P255, DOI 10.1016/S0169-4332(02)01286-2
   KWON SW, 2007, FUNCT MAT, V14, P446
   LIU Y, 1992, APPL PHYS B-PHOTO, V54, P18, DOI 10.1007/BF00331729
   LUKOSZ W, 1991, BIOSENS BIOELECTRON, V6, P215, DOI 10.1016/0956-5663(91)80006-J
   Nagamura T, 2005, TALANTA, V65, P1071, DOI 10.1016/j.talanta.2004.04.042
   Pani SK, 2005, APPL SURF SCI, V239, P445, DOI 10.1016/j.apsusc.2004.06.019
   Prieto F, 2003, NANOTECHNOLOGY, V14, P907, DOI 10.1088/0957-4484/14/8/312
   Qi ZM, 2000, OPT LETT, V25, P1427, DOI 10.1364/OL.25.001427
   Qi ZM, 2002, SENSOR ACTUAT B-CHEM, V81, P254, DOI 10.1016/S0925-4005(01)00960-1
   Stamm C, 1996, SENSOR ACTUAT B-CHEM, V31, P203, DOI 10.1016/0925-4005(96)80067-0
   Worth C, 2001, IEEE J SEL TOP QUANT, V7, P874, DOI 10.1109/2944.983287
   Yimit A, 2003, SENSOR ACTUAT B-CHEM, V88, P239, DOI 10.1016/S0925-4005(02)00324-6
   Zhao Y, 2004, MICROELECTRON J, V35, P605, DOI 10.1016/j.mejo.2004.02.005
NR 13
TC 15
Z9 15
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 1
PY 2009
VL 255
IS 10
BP 5466
EP 5470
DI 10.1016/j.apsusc.2008.09.095
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 414LK
UT WOS:000263865000081
DA 2018-10-19
ER

PT J
AU Boesel, LF
   Reis, RL
   Roman, JS
AF Boesel, Luciano F.
   Reis, Rui L.
   Roman, Julio San
TI Innovative Approach for Producing Injectable, Biodegradable Materials
   Using Chitooligosaccharides and Green Chemistry
SO BIOMACROMOLECULES
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; POLY(PROPYLENE FUMARATE); CHITOSAN COPOLYMER;
   AQUEOUS-SOLUTIONS; DRUG-DELIVERY; CROSS-LINKING; NETWORKS;
   POLY(N-ISOPROPYLACRYLAMIDE); CYTOTOXICITY; HYDROGELS
AB Although there are a number of injectable biomaterials currently under development, they present some drawbacks such as being based on synthetic polymers, needing toxic or aggressive synthesis procedures or using raw materials with low availability and/or high production costs. Having this in mind, a novel injectable biomaterial using chitooligosaccharides as starting materials was developed. This system uses a widely available and cheap polymer from marine biomass (chitosan), which can be turned into an injectable material by water-based and ecologically friendly reactions, Chitooligosaccharides were functionalized with methacrylic groups, to allow in situ cross-linking. The degree of substitution, as determined by (1)H NMR, varied between 5 and 50%. The system was characterized in terms of kinetics of gel formation, rheology, degradation behavior and in vitro cytotoxicity. The gelation time could be easily tailored between 1.5 and 60 min by changing the conditions of the methacrylation reaction, and the final get presented rheological properties typical of strong gels, that is, shear stresses in the kPa range. The cross-linked gel was degradable and nontoxic, presenting indeed an interesting cytokinetic effect. Injectable materials based on chitooligosaccharides are, therefore, an innovative system combining adequate biological performance, ease of preparation, and an ecologically friendly concept of production.
C1 [Boesel, Luciano F.; Roman, Julio San] Spanish Natl Res Council CSIC, Dept Biomat, Inst Sci & Technol Polymers, Madrid 28006, Spain.
   [Reis, Rui L.] Univ Minho, Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4710057 Braga, Portugal.
   [Reis, Rui L.; Roman, Julio San] PT Govt Associated Lab, IBB Inst Biotechnol & Bioengn, Braga, Portugal.
RP Roman, JS (reprint author), Spanish Natl Res Council CSIC, Dept Biomat, Inst Sci & Technol Polymers, Madrid 28006, Spain.
EM jsroman@ictp.csic.es
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129
FU European Commission
FX The authors thank Dr. Mar Fernandez for the cytotoxicity tests. L.F.B.
   thanks the European Commission for supporting this work through a Marie
   Curie-IIF fellowship.
CR Anseth KS, 2001, MACROMOL RAPID COMM, V22, P564, DOI 10.1002/1521-3927(20010501)22:8<564::AID-MARC564>3.0.CO;2-S
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   BOESEL LF, 2004, BIODEGRADABLE SYSTEM, P13
   Cabrera JC, 2006, PHYSIOL PLANTARUM, V127, P44, DOI 10.1111/j.1399-3054.2006.00677.x
   Cabrera JC, 2005, BIOCHEM ENG J, V25, P165, DOI 10.1016/j.bej.2005.04.025
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   DUBOIS M, 1956, ANAL CHEM, V28, P356, DOI DOI 10.1021/AC60111A017
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Jeong B, 2003, J PHYS CHEM B, V107, P10032, DOI 10.1021/jp027339n
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Krauland AH, 2006, INT J PHARMACEUT, V307, P270, DOI 10.1016/j.ijphann.2005.10.016
   Krauland AH, 2005, DRUG DEV IND PHARM, V31, P885, DOI 10.1080/03639040590405002791985
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   MINAMI S, 2007, ADV CHITIN SCI, P199
   Najjar AMK, 2000, J APPL POLYM SCI, V77, P2314, DOI 10.1002/1097-4628(20000906)77:10<2314::AID-APP25>3.0.CO;2-7
   Ohya S, 2005, J BIOMAT SCI-POLYM E, V16, P809, DOI 10.1163/1568562054255736
   Shastri VP, 2004, BIOMATERIALS, V25, P715, DOI 10.1016/S0142-9612(03)00563-5
   Taira M, 2000, INT J PROSTHODONT, V13, P311
   Temenoff JS, 2003, BIOMACROMOLECULES, V4, P1605, DOI 10.1021/bm030056w
   Wang SF, 2008, BIOMACROMOLECULES, V9, P1229, DOI 10.1021/bm7012313
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Winter HH, 1997, ADV POLYM SCI, V134, P165
   Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5
NR 28
TC 11
Z9 11
U1 1
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2009
VL 10
IS 3
BP 465
EP 470
DI 10.1021/bm801332u
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 417EN
UT WOS:000264059400001
PM 19182891
DA 2018-10-19
ER

PT J
AU Chan, AW
   Whitney, RA
   Neufeld, RJ
AF Chan, Ariel W.
   Whitney, Ralph A.
   Neufeld, Ronald J.
TI Semisynthesis of a Controlled Stimuli-Responsive Alginate Hydrogel
SO BIOMACROMOLECULES
LA English
DT Article
ID CROSS-LINKING; GLUTARALDEHYDE; DELIVERY; IMMOBILIZATION; C-13-NMR;
   CELLS; GELS; PH
AB Benefits of the use of natural polymers include biodegradability, biocompatibility, natural abundance, and unique physicochemical/biological properties. Native alginate was used to semisynthesize a new class of biomaterial in which the physical properties such as swelling and pore size can be chemically tailored for desired end use. Semisynthetic network alginate polymer (SNAP) was prepared by reaction with glutaraldehyde, forming an acetal-linked network polymer gel with carboxylate moieties preserved as stimuli-responsive sensors. The molecular structure of the hydrogel was confirmed by cross-polarization magic-angle spinning (13)C solid state NMR, and reaction parameters affecting the polymer synthesis, including reactant, catalyst concentrations, and solvent composition, were characterized by gel equilibrium swelling. The acetalization reaction can be thermodynamically controlled, offering fine-tuned control of gel swelling and pore properties. In addition, SNAP demonstrated pronounced swelling at alkaline pH and contraction in acidic environment with oscillatory response to repeated pH-stimuli, yielding a potential pulsatile, oral drug delivery vehicle. Through selection of reaction conditions, gel swelling, pore size, and stimuli-responsive characteristics can be specifically tailored for applications such as a tissue scaffold in regenerative medicine, as a targeted delivery vehicle, and as a superabsorbent in environmental cleanup.
C1 [Chan, Ariel W.; Neufeld, Ronald J.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
   [Whitney, Ralph A.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada.
RP Neufeld, RJ (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
EM ron.neufeld@chee.queensu.ca
FU Natural Sciences and Engineering Research Council of Canada
FX The authors thank the Natural Sciences and Engineering Research Council
   of Canada for financial support.
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bernkop-Schnurch A, 2001, J CONTROL RELEASE, V71, P277, DOI 10.1016/S0168-3659(01)00227-9
   CARRAHER CEJ, 2003, DERIVATIVES NATURAL, P365
   Chan AW, 2008, BIOMACROMOLECULES, V9, P2536, DOI 10.1021/bm800594f
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Draget KI, 2003, BIOMACROMOLECULES, V4, P1661, DOI 10.1021/bm034105g
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   GRASDALEN H, 1981, CARBOHYD RES, V89, P179, DOI 10.1016/S0008-6215(00)85243-X
   Hartmann M, 2006, CARBOHYD POLYM, V63, P257, DOI 10.1016/j.carbpol.2005.08.052
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Kim YJ, 2000, J APPL POLYM SCI, V78, P1797, DOI 10.1002/1097-4628(20001205)78:10<1797::AID-APP110>3.0.CO;2-M
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Kulkarni AR, 2000, J CONTROL RELEASE, V63, P97, DOI 10.1016/S0168-3659(99)00176-5
   Lattner D, 2003, INT J BIOL MACROMOL, V33, P81, DOI 10.1016/S0141-8130(03)00070-9
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   MARGEL S, 1980, MACROMOLECULES, V13, P19, DOI 10.1021/ma60073a004
   Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001
   McEntee MKE, 2008, J APPL POLYM SCI, V107, P2956, DOI 10.1002/app.27478
   Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01
   Morch YA, 2007, BIOMACROMOLECULES, V8, P2809, DOI 10.1021/bm700502b
   Orive G, 2005, BIOMACROMOLECULES, V6, P927, DOI 10.1021/bm049380x
   Purss HK, 2005, J APPL POLYM SCI, V96, P780, DOI 10.1002/app.21511
   Quignard F, 2008, NEW J CHEM, V32, P1300, DOI 10.1039/b808218a
   Russo R, 2007, BIOMACROMOLECULES, V8, P3193, DOI 10.1021/bm700565h
   Sarmento B, 2007, PHARM RES, V24, P2198, DOI 10.1007/s11095-007-9367-4
   Sharma A, 2000, PROTEIN EXPRES PURIF, V18, P111, DOI 10.1006/prep.1999.1172
   Sharma S, 2001, BIOTECHNOL APPL BIOC, V33, P161, DOI 10.1042/BA20000093
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   SMIDSROD O, 1968, ACTA CHEM SCAND, V22, P1989, DOI 10.3891/acta.chem.scand.22-1989
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
NR 33
TC 56
Z9 60
U1 3
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2009
VL 10
IS 3
BP 609
EP 616
DI 10.1021/bm801316z
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 417EN
UT WOS:000264059400019
PM 19196004
DA 2018-10-19
ER

PT J
AU Att, W
   Takeuchi, M
   Suzuki, T
   Kubo, K
   Anpo, M
   Ogawa, T
AF Att, Wael
   Takeuchi, Masato
   Suzuki, Takeo
   Kubo, Katsutoshi
   Anpo, Masakazu
   Ogawa, Takahiro
TI Enhanced osteoblast function on ultraviolet light-treated zirconia
SO BIOMATERIALS
LA English
DT Article
DE Osseointegration; Photocatalysis; Dental and endosseous implant; Bone;
   Hydrocarbon; Hydrophilicity
ID SURFACE TOPOGRAPHIES; TITANIUM; IMPLANTS; BONE; TISSUE;
   OSSEOINTEGRATION; HYDROPHILICITY; DECOMPOSITION; BIOMATERIAL; PARTICLES
AB Unlike titanium, surface roughening of zirconia for enhanced bone integration has been technically challenging. The photochemical reaction of semiconductor oxides, e.g., titanium dioxide, has earned considerable and broad interest in environmental and clean energy sciences. This study determined whether ultraviolet (UV) light treatment of zirconia enhances its bioactivity on osteoblasts. Machined zirconia disks were treated with UV light for various time periods LIP to 48 h. UV light treatment for 48 h increased the rates of attachment, spread, and proliferation of rat bone marrow-derived osteoblasts. Alkaline phosphatase-positive and mineralized nodule areas doubled on UV light-treated zirconia. The expression of osteoblastic genes, such as osteopontin and osteocalcin, was not modulated by UV light treatment. X-ray diffraction and X-ray photoelectron spectroscopy analyses showed that zirconia disks consisted of monoclinic and tetragonal phases of ZrO(2) and Y(2)O(3) having a wide light absorption band of 200-400 non with its peak at < 250 nm. UV light treatment transformed the zirconia surface from hydrophobic to hydrophilic status and reduced the atomic percentage of surface carbon in a UV light dose-dependent manner. These results suggest that UV treatment of yttrium-containing partially stabilized zirconia enhances its bioactivity on osteoblasts, in terms of their attachment, proliferation, and eventually mineralization. This biofunctionalization was associated with UV light-catalytic hydrophilic conversion of zirconia surfaces and progressive removal of hydrocarbons. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Att, Wael; Suzuki, Takeo; Kubo, Katsutoshi; Ogawa, Takahiro] Univ Calif Los Angeles, Sch Dent, LBIS,Div Adv Prosthodont Biomat & Hosp Dent, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA.
   [Takeuchi, Masato; Anpo, Masakazu] Osaka Prefecture Univ, Dept Appl Chem, Grad Sch Engn, Sakai, Osaka 591, Japan.
RP Ogawa, T (reprint author), Univ Calif Los Angeles, Sch Dent, LBIS,Div Adv Prosthodont Biomat & Hosp Dent, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, 10833 Conte Ave B3-081 CHS,Box 951668, Los Angeles, CA 90095 USA.
EM togawa@dentistry.ucla.edu
RI Anpo, Masakazu/B-2036-2010
FU National Institute of Health [C06RR014529]
FX This work was supported by JAMSEA and Implant-Perio Study Group. This
   study was conducted in a facility constructed with support from the
   Research Facilities Improvement Program, grant no. C06RR014529, of the
   National Center for Research Resources, National Institute of Health.
CR Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Degidi M, 2007, QUINTESSENCE INT, V38, P193
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   HAN Y, 2008, J BIOMED MAT RES A
   He B, 2004, BIOMATERIALS, V25, P5239, DOI 10.1016/j.biomaterials.2003.12.030
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Keleher J, 2002, WORLD J MICROB BIOT, V18, P133, DOI 10.1023/A:1014455310342
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Liu Z, 2005, J PHYS CHEM B, V109, P1251, DOI 10.1021/jp046368q
   Nakashima T, 2003, J PHOTOCH PHOTOBIO A, V160, P115, DOI 10.1016/S1010-6030(03)00229-6
   PALMIERI A, 2008, CLIN IMPLANT DENT RE
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Saruwatari L, 2005, J BONE MINER RES, V20, P2002, DOI 10.1359/JBMR-050703
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Takeuchi M, 2005, J PHYS CHEM B, V109, P15422, DOI 10.1021/jp058075i
   Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233
   Wang XC, 2006, ENVIRON SCI TECHNOL, V40, P2369, DOI 10.1021/es052000a
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0
   Weinlaender M, 1992, Int J Oral Maxillofac Implants, V7, P491
   Zubkov T, 2005, J PHYS CHEM B, V109, P15454, DOI 10.1021/jp058101c
NR 34
TC 51
Z9 52
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2009
VL 30
IS 7
BP 1273
EP 1280
DI 10.1016/j.biomaterials.2008.11.024
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 402MM
UT WOS:000263017800004
PM 19095298
DA 2018-10-19
ER

PT J
AU Lawrence, BD
   Marchant, JK
   Pindrus, MA
   Omenetto, FG
   Kaplan, DL
AF Lawrence, Brian D.
   Marchant, Jeffrey K.
   Pindrus, Mariya A.
   Omenetto, Fiorenzo G.
   Kaplan, David L.
TI Silk film biomaterials for cornea tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Biomimetic material; Cornea; Fibroblast; Porosity; Scaffold; Silk
ID POLY(ETHYLENE OXIDE); FIBROIN MEMBRANES; EPITHELIAL-CELLS; V COLLAGEN;
   STROMA; FIBROBLASTS; TOPOGRAPHY; RESPONSES; ALIGNMENT; FIBRILLOGENESIS
AB Biomaterials for corneal tissue engineering must demonstrate several critical features for potential utility in vivo, including transparency, mechanical integrity, biocompatibility and slow biodegradation. Silk film biomaterials were designed and characterized to meet these functional requirements. Silk protein films were used in a biomimetic approach to replicate cortical stromal tissue architecture. The films were 2 mu m thick to emulate corneal collagen lamellae dimensions, and were surface patterned to guide cell ment. To enhance trans-lamellar diffusion of nutrients and to promote cell-cell interaction, pores with 0.5-5.0 mu m diameters were introduced into the silk films. Human and rabbit corneal fibroblast proliferation, alignment and corneal extracellular matrix expression on these films in both 2D and 3D cultures were demonstrated. The mechanical properties, optical clarity and surface patterned features of these films, combined with their ability to support corneal cell functions suggest that this new biomaterial system offers important potential benefits for corneal tissue regeneration. (c) 2008 Elsevier Ltd. All rights reserved
C1 [Lawrence, Brian D.; Pindrus, Mariya A.; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Marchant, Jeffrey K.] Tufts Univ, Dept Mol Cell & Dev Biol, Boston, MA 02111 USA.
   [Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [P41]
FX We are grateful to Zhiyi Cao and Noorjahan Panjwani at the Sackler
   Graduate School for Biomedical Sciences at Tufts University, Boston, MA
   for help in isolating primary rabbit corneal flbroblasts. The authors
   would also like to thank Laurence Daheron from the Harvard Stem Cell
   Institute for performing the GFP transfection of the primary rabbit
   corneal fibroblasts. 'file authors would like to extend their thanks to
   May Griffith at the University of Ottawa Eye Institute for contributing
   the human corneal fibroblasts, and to Jonathan Levitt and Catherine Chui
   for their technical assistance with imaging and silk materials work
   respectively. This work was supported by the NIH P41 Tissue Engineering
   Resource Center.
CR Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   BAYAN C, 2007, THESIS TUFTS U MEDFO
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   CHAN KY, 1989, INVEST OPHTH VIS SCI, V30, P2488
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]
   CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543
   Crabb RAB, 2006, TISSUE ENG, V12, P1565, DOI 10.1089/ten.2006.12.1565
   CUNIBERTI C, 1972, POLYMER, V13, P379, DOI 10.1016/0032-3861(72)90058-4
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   DOANE KJ, 1991, EXP CELL RES, V195, P432, DOI 10.1016/0014-4827(91)90394-A
   Doutch J, 2008, BIOPHYS J, V95, P5092, DOI 10.1529/biophysj.108.132316
   DUNN GA, 1986, J CELL SCI, V83, P313
   Ethier CR, 2004, ANNU REV BIOMED ENG, V6, P249, DOI 10.1146/annurev.bioeng.6.040803.140055
   *EYE BANK ASS AM, 2005, 2005 ANN REP EYE BAN
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   George AJT, 2004, AM J TRANSPLANT, V4, P678, DOI 10.1111/j.1600-6143.2004.00417.x
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hu XJ, 2005, TISSUE ENG, V11, P1710, DOI 10.1089/ten.2005.11.1710
   Ilhan-Sarac Ozge, 2005, Curr Opin Ophthalmol, V16, P246, DOI 10.1097/01.icu.0000172829.33770.d3
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Myung D, 2007, BIOMED MICRODEVICES, V9, P911, DOI 10.1007/s10544-006-9040-4
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wu YH, 2006, ANAL CHIM ACTA, V558, P179, DOI 10.1016/j.aca.2005.11.031
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Zhang Y-Q., 2006, Molecular & Cellular Biomechanics, V3, P141
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
NR 51
TC 209
Z9 225
U1 8
U2 126
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2009
VL 30
IS 7
BP 1299
EP 1308
DI 10.1016/j.biomaterials.2008.11.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 402MM
UT WOS:000263017800007
PM 19059642
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Brown, BN
   Valentin, JE
   Stewart-Akers, AM
   McCabe, GP
   Badylak, SF
AF Brown, Bryan N.
   Valentin, Jolene E.
   Stewart-Akers, Ann M.
   McCabe, George P.
   Badylak, Stephen F.
TI Macrophage phenotype and remodeling outcomes in response to biologic
   scaffolds with and without a cellular component
SO BIOMATERIALS
LA English
DT Article
DE ECM (extracellular matrix); Biocompatibility; Macrophage; Monocyte;
   Wound healing
ID SMALL-INTESTINAL SUBMUCOSA; XENOGENEIC EXTRACELLULAR-MATRIX;
   GENE-EXPRESSION; WALL REPAIR; DOG-MODEL; POLARIZATION; ACTIVATION;
   TISSUE; XENOTRANSPLANTATION; RECONSTRUCTION
AB Recently, macrophages have been characterized as having an MI or M2 phenotype based on receptor expression, cytokine and effector molecule production, and function. The effects of macrophage phenotype upon tissue remodeling following the implantation of a biomaterial are largely unknown. The objectives of this Study were to determine the effects of a cellular component within an implanted extracellular matrix (ECM) Scaffold upon macrophage phenotype, and to determine the relationship between macrophage phenotype and tissue remodeling. Partial-thickness defects in the abdominal wall musculature of Sprague-Dawley rats were repaired with autologous body wall tissue, acellular allogeneic rat body wall ECM, xenogeneic pig urinary bladder tissue, or acellular xenogeneic pig urinary bladder ECM. At 3, 7, 14, and 28 days the host tissue response was characterized using histologic, immunohistochemical, and RT-PCR methods. The acellular test articles were shown to elicit a predominantly M2 type response and resulted in constructive remodeling, while those containing a cellular component. even an autologous cellular component, elicited a predominantly MI type response and resulted in deposition of dense connective tissue and/or scarring. We conclude that the presence of cellular material within in ECM scaffold modulates the phenotype of the macrophages participating in the Host response following implantation, and that the phenotype of the macrophages participating in the host response appears to be related to tissue remodeling Outcome. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Brown, Bryan N.; Valentin, Jolene E.; Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA.
   [Brown, Bryan N.; Valentin, Jolene E.; Stewart-Akers, Ann M.; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Stewart-Akers, Ann M.; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA.
   [McCabe, George P.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA.
RP Badylak, SF (reprint author), Suite 200,100 Technol Dr, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
FU NIBIB NIH HHS [F31 EB007914-01A2, F31 EB007914]
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   BOUDREAU N, 1995, TRENDS CELL BIOL, V5, P1, DOI 10.1016/S0962-8924(00)88924-2
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9
   Gilbert TW, 2007, TISSUE ENG, V13, P1313, DOI 10.1089/ten.2006.0318
   Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   INGBER D, 1991, J CELL BIOCHEM, V47, P236, DOI 10.1002/jcb.240470309
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   McPherson TB, 2000, TISSUE ENG, V6, P233, DOI 10.1089/10763270050044416
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Parker W, 2001, TRANSPLANTATION, V71, P440, DOI 10.1097/00007890-200102150-00018
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2005, IMMUNOL REV, V205, P60, DOI 10.1111/j.0105-2896.2005.00260.x
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   VANDERREST M, 1991, FASEB J, V5, P2814
   Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015
   Xu H, 2008, TISSUE ENG PT A, V14, P2009, DOI 10.1089/ten.tea.2007.0316
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 36
TC 396
Z9 407
U1 9
U2 84
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2009
VL 30
IS 8
BP 1482
EP 1491
DI 10.1016/j.biomaterials.2008.11.040
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 407ZJ
UT WOS:000263402500004
PM 19121538
OA Green Accepted
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Hung, HS
   Wu, CC
   Chien, S
   Hsu, SH
AF Hung, Huey-Shan
   Wu, Chia-Ching
   Chien, Shu
   Hsu, Shan-hui
TI The behavior of endothelial cells on polyurethane nanocomposites and the
   associated signaling pathways
SO BIOMATERIALS
LA English
DT Article
DE Migration; Polyurethane (PU); Endothelial cell (EC); Endothelial nitric
   oxide synthase (eNOS); Phosphoinositide 3-kinase (PI3K)
ID NITRIC-OXIDE SYNTHASE; GLYCOL) DIBLOCK COPOLYMERS; IN-VITRO; NANOPHASE
   SEPARATION; INTIMAL HYPERPLASIA; MIGRATION; ANGIOGENESIS;
   BIOCOMPATIBILITY; KINASE; AKT
AB A Series of nanocomposites from polyurethane (PU) incorporated With various low concentrations ( 17.4-174 ppm) of gold nanoparticles (approximately 5 nm) (denoted "PU-Au") were Used as a model system to Study the mechanisms that influenced endothelial cell (EC) migration oil biomaterial Surfaces. The migration rate of ECs oil the PU-Au nanocomposites was determined by a real-time image system. It was found that ECs had the highest migration rate oil the nanocomposite containing 43.5 ppm of gold ("PU-Au 43.5 ppm"). The high EC migration rate was associated with increased levels of endothelial nitric oxide synthase (eNOS) and phosphorylated-Akt (p-Akt) expressed by ECs cultured oil PU-Au The inductions Of both eNOS and p-Akt oil PU-Au were abolished by the addition of LY294002 (PI3K inhibitor), Suggesting that these cellular events may be regulated through the PI3K signaling pathway. Using a biotinylated VEGF-165 that recognizes VEGF receptors and by FACS analysis, slightly higher expression of VEGF receptors for ECs oil PU-Au was also demonstrated. Phalloidin staining showed that actin appeared as a circumferential band Surrounding each cell oil tissue Culture polystyrene, whereas oil PU-Au, especially oil PU-Au 43.5 ppm, the cells had their margin spread out and extend processes with stress fibers in the protruding lamellipodia. Moreover, the higher EC migration rate oil PU-Au 43.5 ppm Was Suppressed by LY294002. The higher protein expression of focal adhesion kinase (FAK) oil PU-Au 43.5 ppm was observed in FAK-GFP transfected ECs. It was concluded that PU-Au nanocomposites activated FAK and the PI3K/Akt signaling pathway in ECs, leading to proliferation and migration of ECs on these Surfaces. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Hsu, Shan-hui] Natl Chung Hsing Univ, Inst Biomed Engn, Taichung 402, Taiwan.
   [Hsu, Shan-hui] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 402, Taiwan.
   [Hung, Huey-Shan] Natl Chung Hsing Univ, Ctr Tissue Engn & Stem Cells Res, Taichung 402, Taiwan.
   [Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Wu, Chia-Ching] Natl Cheng Kung Univ, Sch Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan.
RP Hsu, SH (reprint author), Natl Chung Hsing Univ, Dept Chem Engn, Taichung 402, Taiwan.
EM shhsu@nchu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
FU National Health Research Institutes; National Science Council, Taiwan
FX This work was supported by the National Health Research Institutes and
   the National Science Council, Taiwan.
CR Abid Md. Ruhul, 2004, Arteriosclerosis Thrombosis and Vascular Biology, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06
   Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88
   Cardinal KO, 2006, TISSUE ENG, V12, P3431, DOI 10.1089/ten.2006.12.3431
   CHOU CW, 2007, J BIOMED MATER RES A, V84, P785
   Cooney R, 2007, GENE THER, V14, P396, DOI 10.1038/sj.gt.3302882
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Doukas J, 2006, P NATL ACAD SCI USA, V103, P19866, DOI 10.1073/pnas.0606956103
   Doyle B, 2005, CIRCULATION, V112, pE359, DOI 10.1161/CIRCULATIONAHA.105.575688
   Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790
   Goetze S, 2002, HYPERTENSION, V40, P748, DOI 10.1161/01.HYP.0000035522.63647.D3
   Hsu PP, 2001, BIOCHEM BIOPH RES CO, V285, P751, DOI 10.1006/bbrc.2001.5221
   Hsu SH, 2004, MACROMOL BIOSCI, V4, P891, DOI 10.1002/mabi.200400062
   Hsu SH, 2004, BIOMATERIALS, V25, P5593, DOI 10.1016/j.biomaterials.2004.01.061
   HSU SH, 2007, J MED BIOL ENG, V27, P15
   Hsu SH, 2008, BIOMACROMOLECULES, V9, P241, DOI 10.1021/bm700471k
   Hsu SH, 2007, MACROMOL BIOSCI, V7, P482, DOI 10.1002/mabi.200600248
   Hsu SH, 2006, J BIOMED MATER RES A, V79A, P759, DOI 10.1002/bm.a.30879
   Hsu SH, 2008, ACTA BIOMATER, V4, P1797, DOI 10.1016/j.actbio.2008.06.015
   Izhar U, 2001, J SURG RES, V95, P152, DOI 10.1006/jsre.2000.6042
   Kannan RY, 2006, CELL BIOCHEM BIOPHYS, V45, P129, DOI 10.1385/CBB:45:2:129
   Kim YM, 2007, BIOL PHARM BULL, V30, P1674, DOI 10.1248/bpb.30.1674
   Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200
   Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614
   Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099
   LINDENBLATT N, 2006, J AM COLL CARDIOL, V47, P2536
   Lindenblatt N, 2007, ARTERIOSCL THROM VAS, V27, P1191, DOI 10.1161/ATVBAHA.107.141580
   Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Rowlands AS, 2007, BIOMATERIALS, V28, P2109, DOI 10.1016/j.biomaterials.2006.12.032
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Tang JR, 2007, AM J PHYSIOL-LUNG C, V293, pL1271, DOI 10.1152/ajplung.00224.2007
   Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445
   van der Zijpp Y. J., 2003, Archives of Physiology and Biochemistry, V111, P415, DOI 10.3109/13813450312331342274
   Varma S, 2005, AM J PHYSIOL-HEART C, V289, pH1744, DOI 10.1152/ajpheart.01088.2004
   Wang CR, 2002, J BIOMED MATER RES, V62, P315, DOI 10.1002/jbm.10137
   Wang JY, 2005, LIFE SCI, V76, P2257, DOI 10.1016/j.lfs.2004.12.003
   Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804
   Zheng ZZ, 2007, INT J BIOCHEM CELL B, V39, P340, DOI 10.1016/j.biocel.2006.09.001
NR 39
TC 48
Z9 48
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2009
VL 30
IS 8
BP 1502
EP 1511
DI 10.1016/j.biomaterials.2008.12.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 407ZJ
UT WOS:000263402500006
PM 19118895
DA 2018-10-19
ER

PT J
AU Xu, LP
   Pan, F
   Yu, GN
   Yang, L
   Zhang, EL
   Yang, K
AF Xu, Liping
   Pan, Feng
   Yu, Guoning
   Yang, Lei
   Zhang, Erlin
   Yang, Ke
TI In vitro and in vivo evaluation of the surface bioactivity of a calcium
   phosphate coated magnesium alloy
SO BIOMATERIALS
LA English
DT Article
DE Magnesium; Calcium phosphate coating; Bioactivity; Biocompatility; Bone;
   in vitro rest
ID BONE IMPLANT APPLICATION; SIMULATED BODY-FLUID; CORROSION PROPERTIES;
   BIOMEDICAL APPLICATIONS; OSTEOBLAST ADHESION; MG; ZINC; HYDROXYAPATITE;
   TITANIUM; TI
AB Magnesium has shown potential application as a bio-absorbable biomaterial, Such as for bone screws and plates. In order to improve the Surface bioactivity. a calcium phosphate was coated oil a magnesium alloy by a phosphating process (Ca-P coating). The Surface characterization showed that a porous and netlike CaGPO(4)center dot 2H(2)O layer with small amounts of Mg-21 and Zn-21 was formed oil the surface of the Mg alloy. Cells L929 showed significantly good adherence and significantly high growth rate and proliferation characteristics oil the Ca-P coated magnesium alloy (p < 0.05) in in-vitro cell experiments, demonstrating that the Surface cytocompatibility of magnesium was significantly improved by the Ca-P coating. In vivo implantations of the Ca-P coated and the naked alloy rods were carried Out to investigate the bone response at the early stage. Both routine pathological examination and immunohistochemical analysis demonstrated that the Ca-P coating provided magnesium with a significantly good Surface bioactivity (p < 0.05) and promoted early bone growth at the implant/bone interface. It Was suggested that the Ca-P coating might be all effective method to improve the surface bioactivity of magnesium alloy. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Xu, Liping; Yang, Lei; Zhang, Erlin; Yang, Ke] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
   [Xu, Liping; Yang, Lei] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China.
   [Pan, Feng] China Med Univ, Shenyang 110001, Peoples R China.
   [Zhang, Erlin] Jiamusi Univ, Jiamusi 154007, Peoples R China.
   [Yu, Guoning] Peoples Hosp Liaoning Prov, Shenyang 110016, Peoples R China.
RP Zhang, EL (reprint author), Chinese Acad Sci, Inst Met Res, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
EM erlin.zhang@imr.ac.cn
RI Zhang, Erlin/N-6608-2014; yang, lei/H-1843-2012
OI Zhang, Erlin/0000-0002-6152-6546; 
FU Institute of Metal Research (IMR); Chinese Academy of Sciences (CAS);
   Shenyang Science and Technology Institute [1062109-1-00]; Heilongjiang
   Province Natural Funding [E2007-18]
FX One of the authors (Erlin Zhang) would like to acknowledge the financial
   Support from the Institute of Metal Research (IMR), Chinese Academy of
   Sciences (CAS), Shenyang Science and Technology Institute (Program No.
   1062109-1-00), and Heilongjiang Province Natural Funding (No. E2007-18).
CR Assender H, 2002, SCIENCE, V297, P973, DOI 10.1126/science.1074955
   BECK LS, 1993, J BONE MINER RES, V8, P753
   Chiu LH, 2005, SURF COAT TECH, V191, P181, DOI 10.1016/j.surfcoat.2004.02.035
   Chiu LH, 2003, MATER SCI FORUM, V419-4, P909, DOI 10.4028/www.scientific.net/MSF.419-422.909
   Cui F, 2008, FRONT MAT SCI CHINA, V2, P143
   Derynck R, 1996, CURR BIOL, V6, P1226, DOI 10.1016/S0960-9822(96)00702-6
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Grandjean-Laquerrier A, 2006, BIOMATERIALS, V27, P3195, DOI 10.1016/j.biomaterial.2006.01.024
   Helm C, 2001, ENVIRON VALUE, V10, P5, DOI 10.3197/096327101129340714
   Helm GA, 1997, J NEUROSURG, V86, P93, DOI 10.3171/jns.1997.86.1.0093
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Kouisni L, 2004, SURF COAT TECH, V185, P58, DOI 10.1016/j.surfcoat.2003.10.061
   LeGeros RZ, 2004, KEY ENG MAT, V254-2, P127, DOI 10.4028/www.scientific.net/KEM.254-256.127
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2007, MAT SCI ENG A-STRUCT, V456, P350, DOI 10.1016/j.msea.2006.12.020
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   NIELSEN HM, 1994, ACTA ORTHOP SCAND, V65, P37, DOI 10.3109/17453679408993715
   NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991
   Paital SR, 2007, BIOMED MATER, V2, P274, DOI 10.1088/1748-6041/2/4/011
   Paul W, 2006, AM J BIOCH BIOTECHNO, V2, P41, DOI DOI 10.3844/AJBBSP.2006.41.48
   Paul W, 2007, J MATER SCI-MATER M, V18, P699, DOI 10.1007/s10856-006-0005-1
   REDEPENNING J, 1990, CHEM MATER, V2, P625, DOI 10.1021/cm00012a001
   Santos MH, 2008, MAT SCI ENG C-BIO S, V28, P563, DOI 10.1016/j.msec.2007.07.002
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916
   VIJAYARAGHAVAN TV, 1994, J MATER SCI LETT, V13, P1782, DOI 10.1007/BF00776358
   Vojtech D, 2006, KOVOVE MATER, V44, P211
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Xu LP, 2009, J MATER SCI-MATER M, V20, P859, DOI 10.1007/s10856-008-3648-2
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   Yin DS, 2008, T NONFERR METAL SOC, V18, P763, DOI 10.1016/S1003-6326(08)60131-4
   Zhang E, 2005, SCRIPTA MATER, V53, P523, DOI 10.1016/j.scriptamat.2005.05.009
   Zhang E, 2006, 2006 BEIJING INT MAT, P317
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
   Zhang GD, 2007, ACTA METALL SIN, V43, P1186
   Zhang H, 2003, BIOMATERIALS, V24, P2013, DOI 10.1016/S0142-9612(02)00616-6
   Zheng CY, 2007, MAT SCI ENG C-BIO S, V27, P824, DOI 10.1016/j.msec.2006.09.021
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 58
TC 291
Z9 328
U1 12
U2 196
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2009
VL 30
IS 8
BP 1512
EP 1523
DI 10.1016/j.biomaterials.2008.12.001
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 407ZJ
UT WOS:000263402500007
PM 19111896
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Laib, S
   Fellah, BH
   Fatimi, A
   Quillard, S
   Vinatier, C
   Gauthier, O
   Janvier, P
   Petit, M
   Bujoli, B
   Bohic, S
   Weiss, P
AF Laib, Samia
   Fellah, Borhane H.
   Fatimi, Ahmed
   Quillard, Sophie
   Vinatier, Claire
   Gauthier, Olivier
   Janvier, Pascal
   Petit, Marc
   Bujoli, Bruno
   Bohic, Sylvain
   Weiss, Pierre
TI The in vivo degradation of a ruthenium labelled polysaccharide-based
   hydrogel for bone tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Bone healing; Hydrogel; Degradation; In vivo test; Fluorescence;
   Siloxane
ID INJECTABLE CALCIUM-PHOSPHATE; HYDROXYPROPYL METHYLCELLULOSE HYDROGEL;
   3-DIMENSIONAL CULTURE; GENERAL-PROPERTIES; SUBSTITUTE; CELLS; CEMENT;
   CHONDROCYTES; BIOMATERIAL; CARTILAGE
AB In this paper we report a new method that permitted for the first time to selectively track a polysaccharide-based hydrogel on bone tissue explants, several weeks after its implantation. The hydrogel, which was developed for bone healing and tissue engineering, was labelled with a ruthenium complex and implanted into rabbit bone defects in order to investigate its in vivo degradation. 1, 2. 3 and 8 weeks after surgery, the bone explants were analyzed by synchrotron X-ray microfluorescence, infrared mapping spectroscopy, scanning electron microscopy, and optical microscopy after histological coloration. The results showed that the labelled polysaccharide-based hydrogel was likely to Undergo phagocytosis that seemed to Occur from the edge to the center of the implantation site Lip to at least the 8th week. (C) 2008 Elsevier Ltd. All rights reserved
C1 [Laib, Samia; Fellah, Borhane H.; Fatimi, Ahmed; Quillard, Sophie; Vinatier, Claire; Gauthier, Olivier; Weiss, Pierre] Univ Nantes, Fac Chirurg Dent, Lab Ingn Osteo Articulaire & Dent, INSERM,UMRS 791, F-44042 Nantes 1, France.
   [Fellah, Borhane H.; Gauthier, Olivier] Ecole Natl Vet Nantes, Serv Chirurg Expt, F-44307 Nantes 3, France.
   [Janvier, Pascal; Petit, Marc; Bujoli, Bruno] Univ Nantes, UFR Sci & Tech, CNRS, UMR 6230, F-44322 Nantes 03, France.
   [Bohic, Sylvain] ESRF, Grenoble Inst Neurosci, Equipe Rayonnement Synchroton & Rech Med, INSERM,U836, F-38043 Grenoble 1, France.
RP Weiss, P (reprint author), Univ Nantes, Fac Chirurg Dent, Lab Ingn Osteo Articulaire & Dent, INSERM,UMRS 791, 1 Pl Alexis Ricordeau, F-44042 Nantes 1, France.
EM pweiss@sante.univ-nantes.fr
RI Fatimi, Ahmed/F-2936-2012; Vinatier, Claire/P-1686-2014; BOHIC,
   Sylvain/F-6464-2013; petit, marc/C-8828-2015; Weiss, Pierre/P-1372-2014;
   Gauthier, Olivier/A-4639-2015; FELLAH, Borhane/L-6266-2015
OI Vinatier, Claire/0000-0002-6063-9901; BOHIC,
   Sylvain/0000-0001-6355-7592; petit, marc/0000-0001-6298-2087; Weiss,
   Pierre/0000-0002-6159-8590; 
FU INSERM
FX We acknowledge financial support from the INSERM and the Region Pays de
   la Loire through CPER Biomateriaux S3 and Bioregos grants, and PhD
   studentship (Samia Laib). We also acknowledge the European Synchrotron
   Radiation Facility, DESY and the European Community for provision of
   synchrotron radiation facilities, and we would like to thank Sylvain
   Bohic and Karen Rickers for their assistance in using beamlines ID18F
   and L, respectively.
CR Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Bourges X, 2001, J BIOMAT SCI-POLYM E, V12, P573, DOI 10.1163/156856201316883412
   BOURGES X, 2003, TBM RBM, V24, P185
   Bui P, 2004, Ann Chir Plast Esthet, V49, P486, DOI 10.1016/j.anplas.2004.08.007
   Daculsi G, 1999, BONE, V25, p59S, DOI 10.1016/S8756-3282(99)00135-0
   Daculsi G, 1995, CNRS patent, Patent No. [9521634, WO 95/21634]
   Elabd C, 2007, BIOCHEM BIOPH RES CO, V361, P342, DOI 10.1016/j.bbrc.2007.06.180
   Elsner Andreas, 2005, J Foot Ankle Surg, V44, P390, DOI 10.1053/j.jfas.2005.07.003
   Fatimi A, 2008, KEY ENG MATER, V361-363, P365, DOI 10.4028/www.scientific.net/KEM.361-363.365
   Fatimi A, 2008, BIOMATERIALS, V29, P533, DOI 10.1016/j.biomaterials.2007.10.032
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gauthier O, 2003, J BIOMED MATER RES A, V66A, P47, DOI 10.1002/jbm.a.10506
   Gauthier O, 2001, J MATER SCI-MATER M, V12, P385, DOI 10.1023/A:1011284517429
   Guelcher SA, 2008, BIOMATERIALS, V29, P1762, DOI 10.1016/j.biomaterials.2007.12.046
   GUICHEUX J, 2003, Patent No. 032927532
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Horstmann WG, 2003, INJURY, V34, P141, DOI 10.1016/S0020-1383(02)00105-5
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019
   Laib S, 2008, CR CHIM, V11, P641, DOI 10.1016/j.crci.2008.01.013
   LAPKOWSKI M, 1997, Patent No. 9705911
   Link DP, 2008, BIOMATERIALS, V29, P675, DOI 10.1016/j.biomaterials.2007.10.029
   Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430
   Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361
   MOVAT HZ, 1955, ARCH PATHOL, V60, P289
   Ooms EM, 2003, BIOMATERIALS, V24, P749, DOI 10.1016/S0142-9612(02)00408-8
   Relic B, 2001, J IMMUNOL, V166, P2775, DOI 10.4049/jimmunol.166.4.2775
   RUSSELL HK, 1972, ARCH PATHOL, V94, P187
   Stanton DC, 2004, J ORAL MAXIL SURG, V62, P235, DOI 10.1016/j.joms.2002.12.005
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Trojani C, 2005, BIOMATERIALS, V26, P5509, DOI 10.1016/j.biomaterials.2005.02.001
   Turner TM, 2008, SPINE J, V8, P482, DOI 10.1016/j.spinee.2006.12.007
   Vinatier C, 2006, BIO-MED MATER ENG, V16, pS107
   Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867
   Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 43
TC 27
Z9 27
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2009
VL 30
IS 8
BP 1568
EP 1577
DI 10.1016/j.biomaterials.2008.11.031
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 407ZJ
UT WOS:000263402500013
PM 19101030
OA Green Published
DA 2018-10-19
ER

PT J
AU Hozumi, K
   Yamagata, N
   Otagiri, D
   Fujimori, C
   Kikkawa, Y
   Kadoya, Y
   Nomizu, M
AF Hozumi, Kentaro
   Yamagata, Natsumi
   Otagiri, Dai
   Fujimori, Chikara
   Kikkawa, Yamato
   Kadoya, Yuichi
   Nomizu, Motoyoshi
TI Mixed peptide-chitosan membranes to mimic the biological activities of a
   multifunctional laminin alpha 1 chain LG4 module
SO BIOMATERIALS
LA English
DT Article
DE Cell adhesion; Chitin/chitosan; ECM (extracellular matrix); Integrin;
   Laminin; Peptide
ID HOMOLOGOUS LOOP REGIONS; CELL-BINDING SEQUENCES; G-DOMAIN; SYNTHETIC
   PEPTIDES; DYSTROGLYCAN BINDING; SUBMANDIBULAR-GLAND; NEURITE OUTGROWTH;
   HEPARIN; INTEGRIN; IDENTIFICATION
AB Laminin alpha 1 chain LG4 module is multifunctional and interacts with syndecans and integrin alpha 2 beta 1 via AG73 (RKRLQVQLSIRT) and EF-1 (DYATLQLQEGRLHFMFDLG) sites, respectively. Here, We Conjugated the AG73 and EF1zz (ATLQLQEGRLHFXFDLGKGR, X: Nle) peptides on a chitosan membrane in various ratios to develop an LG4 mimic biomaterial. The AG73-chitosan membrane promoted strong cell attachment with membrane ruffling and the EF1zz-chitosan membrane promoted integrin-mediated cell adhesion with well-organized actin stress fibers. When AC73 and EF1zz were Conjugated on a chitosan membrane with 1:9 molar ratio, the mixed peptide-chitosan membrane promoted the strong cell attachment and neurite Outgrowth similar to that Oil the recombinant LG4 protein. Well-organized actin stress fibers and vinculin accumulated focal contacts were observed in the cells attached on the AG73:EF1zz (molar ratio= 1:9)-chitosan membrane. These results suggest that the mixed peptide-chitosan membrane interacts with both syndecans and integrin alpha 2 beta 1 and mimics the cell adhesion of a Multifunctional LG4 protein. The mixed peptide-chitosan approach has potential as a multifunctional biomaterial for cell and tissue engineering. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Hozumi, Kentaro; Yamagata, Natsumi; Otagiri, Dai; Fujimori, Chikara; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Tokyo 1920392, Japan.
   [Kadoya, Yuichi] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2288555, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Tokyo 1920392, Japan.
EM nomizu@ps.toyaku.ac.jp
RI Kikkawa, Yamato/D-1503-2010
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [17390024, 17014081]; Suzuken memorial foundation
FX This work was supported by Grants-in-Aid for Scientific Research from
   the Ministry of Education, Cultures, Sports, Science and Technology of
   Japan (17390024 and 17014081) and Suzuken memorial foundation. We are
   grateful to Dr. Hynda K. Kleinman (National Institute of Dental and
   Craniofacial Research, National institutes of Health, Bethesda, MD) for
   critical reading of this manuscript.
CR Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606
   Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171
   Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510
   Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521
   Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Durbeej M, 2001, DIFFERENTIATION, V69, P121, DOI 10.1046/j.1432-0436.2001.690206.x
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200
   Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Kadoya Y, 1998, DEV DYNAM, V212, P394
   Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k
   Kim WH, 1998, INT J CANCER, V77, P632, DOI 10.1002/(SICI)1097-0215(19980812)77:4<632::AID-IJC25>3.0.CO;2-6
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   MASUDA R, WOUND REPAI IN PRESS
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221
   Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8
   Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304
   Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sung U, 1997, EUR J BIOCHEM, V250, P138, DOI 10.1111/j.1432-1033.1997.00138.x
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863
   Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9
   Yokoyama F, 2005, BIOCHEMISTRY-US, V44, P9581, DOI 10.1021/bi050598t
NR 37
TC 23
Z9 23
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2009
VL 30
IS 8
BP 1596
EP 1603
DI 10.1016/j.biomaterials.2008.12.011
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 407ZJ
UT WOS:000263402500016
PM 19124151
DA 2018-10-19
ER

PT J
AU Neuss, S
   Blomenkamp, I
   Stainforth, R
   Boltersdorf, D
   Jansen, M
   Butz, N
   Perez-Bouza, A
   Knuchel, R
AF Neuss, Sabine
   Blomenkamp, Iris
   Stainforth, Rebekah
   Boltersdorf, Dagmar
   Jansen, Marc
   Butz, Nick
   Perez-Bouza, Alberto
   Knuechel, Ruth
TI The use of a shape-memory poly(is an element
   of-caprolactone)dimethacrylate network as a tissue engineering scaffold
SO BIOMATERIALS
LA English
DT Article
DE Shape memory; Mesenchymal stem cells; Cell adhesion; Cytotoxicity;
   Biocompatibility
ID MESENCHYMAL STEM-CELLS; IN-VITRO; OLIGO(EPSILON-CAPROLACTONE) SEGMENTS;
   MESOTHELIAL CELL; POLYMERS; BIOCOMPATIBILITY; POLYURETHANE; EXPRESSION
AB Shape-memory polymers produced from many natural or synthetic raw polymers are able to undergo a shape transformation after exposure to a specific external stimulus. This feature enables their use in minimal-invasive surgery with a small, compact starting material switching over to a more voluminous structure in the body. The use of biomaterials in modern medicine calls for compatibility tests with cell types, encountering the biomaterial during a short-term or long-term in vivo application. We analysed the cell behaviour of L929 mouse fibroblasts, human mesenchymal stem cells, human mesothelial cells and rat mesothelial cells on a biodegradable shape-memory polymer network to assess its suitability for medical applications. Further, we investigated the differentiation capacity of mesenchymal stem cells into osteoblasts and adipocytes on the polymer and we analysed the influence of the shape-memory The polymer was cytocompatible for all tested cell types, supporting cell viability effect on adherent cells. and proliferation. The differentiation capacity of mesenchymal stem cells was supported by the polymer and shape-memory effect activation did not affect the majority of adherent cells. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Neuss, Sabine; Stainforth, Rebekah; Perez-Bouza, Alberto; Knuechel, Ruth] Univ Aachen, Rhein Westfal TH Aachen, Inst Pathol, D-52074 Aachen, Germany.
   [Blomenkamp, Iris; Boltersdorf, Dagmar] MNEMOSCIENCE GmbH, Uebach Palenberg, Germany.
   [Jansen, Marc; Butz, Nick] Univ Aachen, Rhein Westfal TH Aachen, Dept Surg, D-52074 Aachen, Germany.
RP Neuss, S (reprint author), Univ Aachen, Rhein Westfal TH Aachen, Inst Pathol, Pauwelsstr 30, D-52074 Aachen, Germany.
EM sneuss-stein@ukaachen.de
FU BMBF; German federal ministry of education and research [FKZ 0313065]
FX Financial support has been provided by the BMBF (Bundesministeriurn fur
   Bildung und Forschung - German federal ministry of education and
   research), FKZ 0313065 and mNEMOSCIENCE GmbH in equal shares. Polymer
   syntheses and characterisation were performed at mNEMOSCIENCE (iris
   Blomenkamp, Dagmar Boltersdorf). Cell/polymer interactions were
   evaluated at the Institute of Pathology (Sabine Neuss, Rebekah
   Stainforth, Alberto PerezBouza, Ruth KnUchel). HOMC and ROMC were
   provided by the Department of Surgery (Marc Jansen, Nick Butz).
CR Aoki D, 2007, BIOMACROMOLECULES, V8, P3749, DOI 10.1021/bm7006828
   Baer GM, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-43
   Bellin I, 2006, P NATL ACAD SCI USA, V103, P18043, DOI 10.1073/pnas.0608586103
   Cabanlit M, 2007, MACROMOL BIOSCI, V7, P48, DOI 10.1002/mabi.200600177
   Chen MC, 2007, BIOMACROMOLECULES, V8, P2774, DOI 10.1021/bm7004615
   Es-Souni M, 2005, ANAL BIOANAL CHEM, V381, P557, DOI 10.1007/s00216-004-2888-3
   Fare S, 2005, J BIOMED MATER RES A, V73A, P1, DOI 10.1002/jbm.a.30193
   Jansen M, 2006, LANGENBECK ARCH SURG, V391, P96, DOI 10.1007/s00423-006-0025-9
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, Med Device Technol, V16, P12
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   LENDLEIN A, 2002, KIRK OTHMER ENCY CHE, P1
   Lendlein A, 2002, ENCY POLYM SCI TECHN, P125
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Mutsaers S E, 2007, Cancer Treat Res, V134, P1
   Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5
   Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405
   Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Ortega JM, 2007, IEEE T BIO-MED ENG, V54, P1722, DOI 10.1109/TBME.2007.892927
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Porada Christopher D, 2006, Curr Stem Cell Res Ther, V1, P365
   Rickert D, 2005, BIOMED TECH, V50, P92, DOI 10.1515/BMT.2005.013
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Small W, 2007, IEEE T BIO-MED ENG, V54, P1157, DOI 10.1109/TBME.2006.889771
   Tietze L, 1999, EXP MOL PATHOL, V66, P131, DOI 10.1006/exmp.1999.2252
   Yung S, 2006, PERITON DIALYSIS INT, V26, P162
NR 29
TC 90
Z9 94
U1 4
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2009
VL 30
IS 9
BP 1697
EP 1705
DI 10.1016/j.biomaterials.2008.12.027
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 412RV
UT WOS:000263742800005
PM 19121539
DA 2018-10-19
ER

PT J
AU Yang, YM
   Liu, M
   Gu, Y
   Lin, SY
   Ding, F
   Gu, XS
AF Yang, Yumin
   Liu, Mei
   Gu, Yun
   Lin, Sheyu
   Ding, Fei
   Gu, Xiaosong
TI Effect of chitooligosaccharide on neuronal differentiation of PC-12
   cells
SO CELL BIOLOGY INTERNATIONAL
LA English
DT Article
DE Chitosan; Chitooligosaccharide; Nerve cell affinity; Neuronal
   differentiation; PC-12 cells
ID NERVE REGENERATION; IN-VITRO; NEUROFILAMENTS; EXPRESSION; VIVO
AB Chitosan is now being widely used biomaterial in the tissue engineering field, and has great potential as a candidate material for preparing nerve guidance conduits due to its various favorable properties, especially that of good nerve cell affinity. Chitosan can be degraded in vivo into chitooligosaccharide. We have investigated the in vitro effects of chitooligosaccharide on neuronal differentiation of PC-12 cells to see what effects chitooligosaccharide have on certain functions in the regenerating neurons. The morphologic observation and assessment using the specific reagent of tetrazolium salt WST-8 indicated that neurite outgrowths from PC-12 cells and the viability of PC-12 cells were enhanced by treatment of chitooligosaccharide. The real-time quantitative RT-PCR and Western blot analysis revealed showed that chitooligosaccharide could upregulate the expression of neurofilament-H mRNA or protein and N-cadherin protein in PC-12 cells. The maximum effect of 0.1 mg/ml chitooligosaccharide was obtained after 2 week culture. All the data suggest that chitooligosaccharide possesses good nerve cell affinity by supporting nerve cell adhesion and promoting neuronal differentiation and neurite outgrowth. (C) 2009 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
C1 [Yang, Yumin; Liu, Mei; Gu, Yun; Lin, Sheyu; Ding, Fei; Gu, Xiaosong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
RP Gu, XS (reprint author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
EM neurongu@public.nt.js.cn
OI Liu, Mei/0000-0003-1168-6119
FU Hi-Tech Research and Development Program of China [2006AA02A128]; Nature
   Science Foundation of china [30770585]; Basic Research Program of
   Jiangsu Education Department [07KJA31025]; Program for New Century
   Excellent Talents in University
FX The financial supports of the Hi-Tech Research and Development Program
   of China ( 863 Program, Grant no. 2006AA02A128), the Nature Science
   Foundation of china ( Grant no. 30770585), Basic Research Program of
   Jiangsu Education Department ( Grant no. 07KJA31025) and Program for New
   Century Excellent Talents in University are gratefully acknowledged.
CR Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253
   CHRISTINA A, 2006, J CELLULAR MOL MED, V10, P770
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   GIANLUCA C, 2006, MACROMOLECULAR BIOSC, V6, P13
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Huang R, 2006, LIFE SCI, V78, P2399, DOI 10.1016/j.lfs.2005.09.039
   ISAMU Y, 2003, BIOMATERIALS, V24, P3285
   Jacomy H, 1999, J NEUROCHEM, V73, P972, DOI 10.1046/j.1471-4159.1999.0730972.x
   Jia ZS, 2002, CARBOHYD POLYM, V49, P393, DOI 10.1016/S0144-8617(02)00026-7
   Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5
   Jung WK, 2006, LIFE SCI, V78, P970, DOI 10.1016/j.lfs.2005.06.006
   LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337
   Liu M, 2006, J MOL NEUROSCI, V29, P123, DOI 10.1385/JMN/29:02:123
   Mendis E, 2007, LIFE SCI, V80, P2118, DOI 10.1016/j.lfs.2007.03.016
   Ohara N, 2004, BIOMATERIALS, V25, P1749, DOI 10.1016/j.biomaterials.2003.08.022
   SHAO J, 2003, POLYM DEGRADATION ST, V82, P393
   SUZUKI S, 1992, ADV CHITIN CHITOSAN, P277
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Yang YM, 2006, EUR FOOD RES TECHNOL, V222, P36, DOI 10.1007/s00217-005-0028-8
   Yang YM, 2004, BIOTECHNOL LETT, V26, P1793, DOI 10.1007/s10529-004-4611-z
   Yannas IV, 2004, BIOMATERIALS, V25, P1593, DOI 10.1016/S0142-9612(03)00505-2
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zheng F, 2007, LIFE SCI, V80, P388, DOI 10.1016/j.lfs.2006.09.040
NR 25
TC 35
Z9 53
U1 0
U2 18
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1065-6995
J9 CELL BIOL INT
JI Cell Biol. Int.
PD MAR
PY 2009
VL 33
IS 3
BP 352
EP 356
DI 10.1016/j.cellbi.2009.01.005
PG 5
WC Cell Biology
SC Cell Biology
GA 414UH
UT WOS:000263890200012
PM 19272331
DA 2018-10-19
ER

PT J
AU Nyan, M
   Sato, D
   Kihara, H
   Machida, T
   Ohya, K
   Kasugai, S
AF Nyan, Myat
   Sato, Daisuke
   Kihara, Hidemichi
   Machida, Tetsu
   Ohya, Keiichi
   Kasugai, Shohei
TI Effects of the combination with alpha-tricalcium phosphate and
   simvastatin on bone regeneration
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE alpha-TCP; BMP-2; bone formation; bone regeneration; simvastatin
ID MARROW STROMAL CELLS; MORPHOGENETIC PROTEIN-2; IN-VITRO; OSTEOBLAST
   DIFFERENTIATION; GROWTH; STATINS; PROLIFERATION; INFLAMMATION;
   EXPRESSION; DEFECTS
AB Although local application of statins stimulates bone formation, high dose of simvastatin induces inflammation.
   A study was conducted to test the hypothesis that maximum bone regeneration with less inflammation would be achieved by combining an optimal dose of simvastatin with alpha-tricalcium phosphate (alpha-TCP), which is an osteoconductive biomaterial capable of releasing the drug gradually.
   Bilateral 5-mm-diameter calvarial defects were created in adult Wistar rats and filled with preparations of different doses of simvastatin (0, 0.01, 0.1, 0.25 and 0.5 mg) combined with alpha-TCP particles or left empty. The animals were sacrificed at 2, 4 and 8 weeks and analyzed radiologically and histologically. Half of the animals of 4 and 8 weeks were labeled with fluorescence dyes and histomorphometrically analyzed.
   Simvastatin doses of 0.25 and 0.5 mg caused inflammation of the soft tissue at the graft site whereas control and other doses did not. The micro-CT analysis revealed that the alpha-TCP with 0.1 mg simvastatin (TCP-0.1) group yielded significantly higher bone volumes than untreated control group at all three time points (249%, 227% and 266% at 2, 4 and 8 weeks, respectively). The percentage of defect closure, bone mineral content and bone mineral density were also higher in the TCP-0.1 group than in the other groups.
   When combined with alpha-TCP particles, 0.1 mg simvastatin is the optimal dose for stimulation of the maximum bone regeneration in rat calvarial defects without inducing inflammation and it could be applied as an effective bone graft material.
   To cite this article:Nyan M, Sato D, Kihara H, Machida T, Ohya K, Kasugai S. Effects of the combination with alpha-tricalcium phosphate and simvastatin on bone regeneration.Clin. Oral Impl. Res. 20, 2009; 280-287.doi: 10.1111/j.1600-0501.2008.01639.x.
C1 [Nyan, Myat; Kasugai, Shohei] Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Bunkyo Ku, Tokyo 1138549, Japan.
   [Ohya, Keiichi] Tokyo Med & Dent Univ, Dept Hard Tissue Engn, Pharmacol Sect, Tokyo 1138549, Japan.
RP Nyan, M (reprint author), Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.
EM myatnyan@gmail.com
FU Tooth and Bone in Tokyo Medical and Dental University; Ministry of
   Education, Science and Culture, Japan [19390513]
FX This research was supported by the grant for Center of Excellence
   Program for Frontier Research on Molecular Destruction and
   Reconstruction of Tooth and Bone in Tokyo Medical and Dental University
   and by a Grant (19390513) from the Ministry of Education, Science and
   Culture, Japan.
CR Baek KH, 2005, J KOREAN MED SCI, V20, P438, DOI 10.3346/jkms.2005.20.3.438
   Blom EJ, 2000, J BIOMED MATER RES, V50, P67, DOI 10.1002/(SICI)1097-4636(200004)50:1<67::AID-JBM10>3.0.CO;2-E
   Bradley JD, 2007, J PERIODONTAL RES, V42, P267, DOI 10.1111/j.1600-0765.2006.00943.x
   Bunn RJ, 2005, J BONE JOINT SURG BR, V87- B, P265, DOI [10.1161/01.CIR.91.6.1872, DOI 10.1161/01.CIR.91.6.1872]
   DOWNES S, 1991, J MATER SCI-MATER M, V2, P176, DOI 10.1007/BF00692977
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Garrett IR, 2007, J ORTHOP RES, V25, P1351, DOI 10.1002/jor.20391
   Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762
   Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Guicheux J, 1998, J BIOMED MATER RES, V40, P560, DOI 10.1002/(SICI)1097-4636(19980615)40:4<560::AID-JBM7>3.0.CO;2-D
   Kihara H, 2006, J BIOMED MATER RES B, V79B, P284, DOI 10.1002/jbm.b.30540
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002.220682
   Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232
   Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K
   Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184
   Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597
   Ozec I, 2007, J CRANIOFAC SURG, V18, P546
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Sato D, 2005, J ORAL TISSUE ENG, V2, P81
   Skoglund B, 2002, J BONE MINER RES, V17, P2004, DOI 10.1359/jbmr.2002.17.11.2004
   Song CL, 2003, BIOCHEM BIOPH RES CO, V308, P458, DOI 10.1016/S0006-291X(03)01408-6
   Stein D, 2005, J PERIODONTOL, V76, P1861, DOI 10.1902/jop.2005.76.11.1861
   Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697
   Sugiyama T, 2007, ORAL DIS, V13, P228, DOI 10.1111/j.1601-0825.2006.01271.x
   Szpaderska AM, 2005, SURGERY, V137, P571, DOI 10.1016/j.surg.2005.01.006
   Thylin MR, 2002, J PERIODONTOL, V73, P1141, DOI 10.1902/jop.2002.73.10.1141
   von Knoch F, 2005, BIOMATERIALS, V26, P5783, DOI 10.1016/j.biomaterials.2005.02.008
   Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
   Wong RWK, 2005, J ORAL MAXIL SURG, V63, P1515, DOI 10.1016/j.joms.2005.06.009
   Wong RWK, 2005, BRIT J ORAL MAX SURG, V43, P46, DOI 10.1016/j.bjoms.2004.08.014
   Wong RWK, 2003, BRIT J ORAL MAX SURG, V41, P244, DOI 10.1016/S0266-4356(03)00081-0
   Yan WZ, 2004, J WUHAN UNIV TECHNOL, V19, P30
   Ziegler J, 2002, J BIOMED MATER RES, V59, P422, DOI 10.1002/jbm.1258
NR 42
TC 54
Z9 60
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAR
PY 2009
VL 20
IS 3
BP 280
EP 287
DI 10.1111/j.1600-0501.2008.01639.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 404EH
UT WOS:000263133000009
PM 19397639
DA 2018-10-19
ER

PT J
AU Balli, E
   Comelekoglu, U
   Yalin, E
   Yilmaz, N
   Aslantas, S
   Sogut, F
   Berkoz, M
   Yalin, S
AF Balli, Ebru
   Comelekoglu, Ulku
   Yalin, Erdinc
   Yilmaz, Nejat
   Aslantas, Suat
   Sogut, Fatma
   Berkoz, Mehmet
   Yalin, Serap
TI Exposure to gamma rays induces early alterations in skin in rodents:
   Mechanical, biochemical and structural responses
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Gamma rays; Skin; Biomechanic; Collagen; Dermis; Lipid peroxidation
ID IONIZING-RADIATION; OXIDATIVE STRESS; ULTRAVIOLET-B; IRRADIATION;
   ANTIOXIDANTS; KERATINOCYTES; RATS
AB In this study, the effect of gamma rays has been investigated on the normal rat skin using biomechanical, biochemical and histological techniques. Seventeen male Wistar albino rats were divided into two groups (control (n = 7) and irradiated (n = 10)). The irradiated group was treated with a Co-60 gamma source at a dose of 10Gy at room temperature. Skin biomechanics were measured with tensile test using biomaterial testing machine and maximum load, stiffness, energy absorption capacity, ultimate stress, ultimate strain and elastic modulus were calculated. In the irradiated group, energy, strain and toughness were significantly lower than in the control group (p < 0.05). However, strength, displacement, stiffness, stress and elastic modulus were similar to that of the control group (p > 0.05). Catalase (CAT) activities and the levels of malondialdehyde (MDA) in the skin of rats were measured using the biochemical methods. MDA levels significantly increased whereas CAT activities decreased in the irradiated group as compared with the control group (p < 0.05). Diameters of collagen fibers were measured by transmission electron microscopy. There was no significant difference (p>0.05) between control and irradiated groups for collagen fiber diameter. Thickness of epidermis was significantly lower than the control group. There were no changes in the epidermis between the irradiated group and the control group ultrastructurally. The results of this study show that the gamma irradiation has a significant effect on normal healthy skin (c) 2008 Elsevier Inc. All rights reserved.
C1 [Comelekoglu, Ulku; Sogut, Fatma] Mersin Univ, Sch Med, Dept Biophys, TR-33169 Mersin, Turkey.
   [Balli, Ebru; Yilmaz, Nejat] Mersin Univ, Sch Med, Dept Histol & Embryol, TR-33169 Mersin, Turkey.
   [Yalin, Erdinc] Cukurova Univ, Sch Med, Dept Biochem, Adana, Turkey.
   [Aslantas, Suat] Numune Hosp, Dept Radiat Oncol, Adana, Turkey.
   [Berkoz, Mehmet; Yalin, Serap] Mersin Univ, Fac Pharm, Dept Biochem, Mersin, Turkey.
RP Comelekoglu, U (reprint author), Mersin Univ, Sch Med, Dept Biophys, TR-33169 Mersin, Turkey.
EM ucomelek@yahoo.com
RI yalin, serap/A-3195-2012; Arslantas, Hasan Suat/F-4628-2018;
   Comelekoglu, Ulku/E-2239-2016; YALIN, Ali Erdinc/O-8852-2015
OI Arslantas, Hasan Suat/0000-0002-3415-2147; Comelekoglu,
   Ulku/0000-0001-8060-6333; YALIN, Ali Erdinc/0000-0002-3351-6885; Sogut,
   Fatma/0000-0002-1108-8947
FU Mersin University Medical Faculty.
FX Our study was financially supported by the Grant from Mersin University
   Medical Faculty.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   ANBER M, 1985, CLIN BIOPHYSICS, P193
   Baghdoyan S, 2005, J BIOL CHEM, V280, P15836, DOI 10.1074/jbc.M414216200
   BROWN BH, 1999, MED PHYS BIOMEDICAL, P672
   Chang C, 2003, J PHOTOCH PHOTOBIO B, V72, P79, DOI 10.1016/j.jphotobiol.2003.06.001
   Chen YJ, 1999, BIOL PHARM BULL, V22, P703
   Chi CP, 2005, CHEM PHARM BULL, V53, P1411, DOI 10.1248/cpb.53.1411
   Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1
   Donetti E, 2005, BRIT J DERMATOL, V153, P881, DOI 10.1111/j.1365-2133.2005.06804.x
   Dreher F, 2001, CURR PROBL DERMATOL, V29, P157
   EWING D, 1987, ARCH BIOCHEM BIOPHYS, V254, P53, DOI 10.1016/0003-9861(87)90080-4
   Fangman WL, 2005, DERMATOL SURG, V31, P966, DOI 10.1097/00042728-200508000-00015
   Franchi A, 2006, CLIN EXP DERMATOL, V31, P793, DOI 10.1111/j.1365-2230.2006.02218.x
   Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X
   Hebbar S. A., 2002, Journal of Radiological Protection, V22, P63, DOI 10.1088/0952-4746/22/1/306
   Hoashi T, 2008, BRIT J DERMATOL, V158, P597, DOI [10.1111/j.1365-2133.2007.08306.x, 10.1111/j.1365-2133.2008.08475.x]
   Jagetia GC, 2003, CLIN CHIM ACTA, V332, P111, DOI [10.1016/S0009-881(03)00132-3, 10.1016/S0009-8981(03)00132-3]
   Kohen R, 2000, TOXICOLOGY, V148, P149, DOI 10.1016/S0300-483X(00)00206-7
   Kohen R, 1999, BIOMED PHARMACOTHER, V53, P181, DOI 10.1016/S0753-3322(99)80087-0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu WW, 2000, BRIT J PLAST SURG, V53, P225, DOI 10.1054/bjps.1999.3264
   Lyng FM, 2004, RADIAT RES, V162, P226, DOI 10.1667/RR3216
   Muller K, 2006, ANTICANCER RES, V26, P2735
   NIGG BM, 1999, BIOMECHANICS MUSCULO, P49
   Ran XZ, 2004, J TRAUMA, V57, P1087, DOI 10.1097/01.TA.0000141885.72033.C7
   RANU HS, 1975, PHYS MED BIOL, V20, P96, DOI 10.1088/0031-9155/20/1/009
   RANU HS, 1991, IEEE ENG MED BIOL, P55
   Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8
   RIDGE MD, 1966, J APPL PHYSIOL, V21, P1602
   Shindo Y, 1998, J DERMATOL SCI, V17, P140, DOI 10.1016/S0923-1811(98)00008-5
   Silver FH, 2003, SKIN RES TECHNOL, V9, P3, DOI 10.1034/j.1600-0846.2003.00358.x
   Tilleman TR, 2004, ISRAEL MED ASSOC J, V6, P753
   Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9
   Yagi K, 1998, Methods Mol Biol, V108, P107
NR 34
TC 10
Z9 11
U1 3
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD MAR
PY 2009
VL 72
IS 3
BP 889
EP 894
DI 10.1016/j.ecoenv.2008.09.021
PG 6
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 412ZG
UT WOS:000263762100032
PM 19012966
DA 2018-10-19
ER

PT J
AU Wise, SG
   Weiss, AS
AF Wise, Steven G.
   Weiss, Anthony S.
TI Tropoelastin
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Tropoelastin; Elastin; Extracellular matrix; Biomaterial
ID ELASTIC FIBER FORMATION; DOMAIN; GENE
AB Tropoelastin is a 60-72 kDa alternatively spliced extracellular matrix protein and a key component of elastic fibres. It is found in all vertebrates except for cyclostomes. Secreted tropoelastin is tethered to the cell surface, where it aggregates into organised spheres for cross-linking and incorporation into growing elastic fibres. Tropoelastin is characterised by alternating hydrophobic and hydrophilic domains and is highly flexible. The conserved C-terminus is an area of the molecule of particular biological importance in that it is required for both incorporation into elastin and for cellular interactions. Mature cross-linked tropoelastin gives elastin, which confers resilience and elasticity on a diverse range of tissues. Elastin gene disruptions in disease states and knockout mice emphasise the importance of proper tropoelastin production and assembly, particularly in vascular tissue. Tropoelastin constructs hold promise as biomaterials as they mimic many of elastin's physical and biological properties with the capacity to replace damaged elastin-rich tissue. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Wise, Steven G.; Weiss, Anthony S.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.
EM a.weiss@mmb.usyd.edu.au
RI Wise, Steven/G-2630-2018; Wise, Steven/B-1858-2009
OI Wise, Steven/0000-0001-7964-819X; Wise, Steven/0000-0001-7964-819X;
   WEISS, ANTHONY/0000-0002-8106-4836
CR Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   Chung MIS, 2006, MATRIX BIOL, V25, P492, DOI 10.1016/j.matbio.2006.08.258
   Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3
   HU Q, 2006, J INVEST DERMATOL, V126, P1426
   Hu QR, 2006, J INVEST DERMATOL, V126, P283, DOI 10.1038/sj.jid.5700047
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200
   Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9
   Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Muiznieks LD, 2007, BIOCHEMISTRY-US, V46, P8196, DOI 10.1021/bi700139k
   Pepe A, 2007, NANOMEDICINE-UK, V2, P203, DOI 10.2217/17435889.2.2.203
   Pezet M, 2008, REJUV RES, V11, P97, DOI 10.1089/rej.2007.0587
   Pierce RA, 2006, AM J PHYSIOL-LUNG C, V291, pL391, DOI 10.1152/ajplung.00441.2004
   Piontkivska H, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-31
   Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001
   Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060
   SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111
NR 26
TC 102
Z9 103
U1 0
U2 36
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD MAR
PY 2009
VL 41
IS 3
BP 494
EP 497
DI 10.1016/j.biocel.2008.03.017
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 405AZ
UT WOS:000263195800011
PM 18468477
DA 2018-10-19
ER

PT J
AU Keong, LC
   Halim, AS
AF Keong, Lim Chin
   Halim, Ahmad Sukari
TI In Vitro Models in Biocompatibility Assessment for Biomedical-Grade
   Chitosan Derivatives in Wound Management
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE Biopolymer; chitosan; biocompatibility; biomedical-grade chitosan; in
   vitro toxicity examinations; cytocompatibility; genotoxicity; skin
   pro-inflammatory cytokine expression
ID PROTEIN-KINASE-C; EPIDERMAL-KERATINOCYTES; BIOLOGICAL-PROPERTIES;
   INDIVIDUAL CELLS; COMET ASSAY; DNA-DAMAGE; TOXICITY; CHITIN;
   PROLIFERATION; CYTOTOXICITY
AB One of the ultimate goals of wound healing research is to find effective healing techniques that utilize the regeneration of similar tissues. This involves the modification of various wound dressing biomaterials for proper wound management. The biopolymer chitosan (beta-1,4-D-glucosamine) has natural biocompatibility and biodegradability that render it suitable for wound management. By definition, a biocompatible biomaterial does not have toxic or injurious effects on biological systems. Chemical and physical modifications of chitosan influence its biocompatibility and biodegradability to an uncertain degree. Hence, the modified biomedical-grade of chitosan derivatives should be pre-examined in vitro in order to produce high-quality, biocompatible dressings. In vitro toxicity examinations are more favorable than those performed in vivo, as the results are more reproducible and predictive. In this paper, basic in vitro tools were used to evaluate cellular and molecular responses with regard to the biocompatibility of biomedical-grade chitosan. Three paramount experimental parameters of biocompatibility in vitro namely cytocompatibility, genotoxicity and skin pro-inflammatory cytokine expression, were generally reviewed for biomedical-grade chitosan as wound dressing.
C1 [Keong, Lim Chin; Halim, Ahmad Sukari] Univ Sains Malaysia, Sch Med Sci, Reconstruct Sci Unit, Kubang Kerian, Kelantan, Malaysia.
RP Halim, AS (reprint author), Univ Sains Malaysia, Sch Med Sci, Reconstruct Sci Unit, Kubang Kerian, Kelantan, Malaysia.
EM ashalim@kb.usm.my
OI Halim, Ahmad Sukari/0000-0001-8999-6403
FU Intensification of Research in Priority Area Programme (IRPA)
   [03-03-01-0000-PR0071/05]; Ministry of Science, Technology and
   Innovation (MOSTI) Malaysia
FX This paper was supported by a grant (No.: 03-03-01-0000-PR0071/05) from
   Intensification of Research in Priority Area Programme (IRPA), Ministry
   of Science, Technology and Innovation (MOSTI) Malaysia.
CR ABOUSEREIH A, 2007, J APPL SCI RES, V3, P450
   ACOSTA D, 1985, IN VITRO CELL DEV B, V21, P495
   Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Allen DG, 2001, TOXICOL LETT, V119, P209, DOI 10.1016/S0378-4274(00)00316-7
   AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782
   Arroyo CM, 1999, HUM EXP TOXICOL, V18, P1, DOI 10.1191/096032799678839329
   CHABOTFLETCHER M, 1994, J INVEST DERMATOL, V103, P509, DOI 10.1111/1523-1747.ep12395658
   Chellat F, 2000, J BIOMED MATER RES, V51, P107, DOI 10.1002/(SICI)1097-4636(200007)51:1<107::AID-JBM14>3.0.CO;2-F
   Cheong HI, 2008, TOXICOL IN VITRO, V22, P1070, DOI 10.1016/j.tiv.2008.01.013
   Christian MS, 1996, J AM COLL TOXICOL, V15, P1
   CHRISTINE C, 1999, BIOMATERIALS, V20, P1237
   Cotelle S, 1999, ENVIRON MOL MUTAGEN, V34, P246
   de Sa Ferreira I C, 1999, Phytother Res, V13, P397
   Deng CM, 2007, CARBOHYD POLYM, V69, P583, DOI 10.1016/j.carbpol.2007.01.014
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   DINARELLO CA, 1993, NEW ENGL J MED, V328, P106
   DORI RG, 1997, J MUTAT RES, V386, P209
   ECKERT RL, 1989, PHYSIOL REV, V69, P1316
   FLINT OP, 1990, ATLA-ALTERN LAB ANIM, V18, P11
   Geurtsen W, 1998, J BIOMED MATER RES, V41, P474, DOI 10.1002/(SICI)1097-4636(19980905)41:3<474::AID-JBM18>3.0.CO;2-I
   Giri AK, 1999, MUTAGENESIS, V14, P613
   Halim AS, 1998, INJURY, V29, P261, DOI 10.1016/S0020-1383(97)00194-0
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   Ikken Y, 1999, J AGR FOOD CHEM, V47, P3257, DOI 10.1021/jf990166n
   ISHIDATE M, 1979, TISSUE CULTURE, V5, P115
   *ISO, 1993, 109933 ISO NAT ORG S
   *ISO, 1992, 109935 ISO NAT ORG S
   JANVIKUL W, 2005, J MET MAT MINER, V15, P59
   Je JY, 2006, BIOORG MED CHEM LETT, V16, P2122, DOI 10.1016/j.bmcl.2006.01.060
   Jung BO, 2007, J IND ENG CHEM, V13, P772
   Kenawy ER, 2005, J BIOACT COMPAT POL, V20, P95, DOI 10.1177/0883911505049655
   Koo HN, 2002, J NUTR BIOCHEM, V13, P245, DOI 10.1016/S0955-2863(01)00218-2
   Korting Hans C., 1994, Journal of Dermatological Science, V7, P119, DOI 10.1016/0923-1811(94)90085-X
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Larry L. H., 1998, BIOMATERIALS, V19, P1419
   Lazutka JR, 1996, MUTAT RES-ENVIR MUTA, V361, P95, DOI 10.1016/S0165-1161(96)00027-1
   Lee JK, 2002, BIOORG MED CHEM LETT, V12, P2949, DOI 10.1016/S0960-894X(02)00530-9
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Lim CK, 2007, J APPL BIOMATER BIOM, V5, P82
   Lovschall H, 2002, TOXICOL IN VITRO, V16, P63, DOI 10.1016/S0887-2333(01)00093-5
   Majd ES, 2003, BIOMATERIALS, V24, P3
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9
   Mei N, 2005, J BIOMATER APPL, V19, P323, DOI 10.1177/0885328205048630
   MICHAEL IL, 1995, TOXICOL LETT, V83, P471
   Mitchelmore CL, 1998, MUTAT RES-FUND MOL M, V399, P135, DOI 10.1016/S0027-5107(97)00252-2
   Miyatake K, 2003, CARBOHYD POLYM, V53, P417, DOI 10.1016/S0144-8617(03)00102-4
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MURAKI E, 1993, CARBOHYD RES, V239, P227, DOI 10.1016/0008-6215(93)84217-T
   Muramatsu K, 2004, J BIOMED MATER RES A, V71A, P635, DOI 10.1002/jbm.a.30197
   Nacci DE, 1996, AQUAT TOXICOL, V35, P197, DOI 10.1016/0166-445X(96)00016-1
   Neamnark A, 2007, CARBOHYD POLYM, V68, P166, DOI 10.1016/j.carbpol.2006.07.024
   Nishiyama Y, 2000, J CHEM SOC PERK T 1, P1161, DOI 10.1039/a908145c
   ONO I, 1995, BURNS, V21, P352, DOI 10.1016/0305-4179(95)00005-4
   OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X
   PAOLA P, 2002, J BIOCH PHARM, V64, P1617
   Prabaharan M, 2006, CARBOHYD POLYM, V63, P153, DOI 10.1016/j.carbpol.2005.08.051
   RASMUSSEN HH, 1993, J INVEST DERMATOL, V101, P560, DOI 10.1111/1523-1747.ep12365986
   Roller S, 1999, INT J FOOD MICROBIOL, V47, P67, DOI 10.1016/S0168-1605(99)00006-9
   SALMENOVA D, 1997, MUTAT RES, V383, P243
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   SAVAGE J R K, 1976, Journal of Medical Genetics, V13, P103
   SHIGEMASA Y, 1994, INT J BIOL MACROMOL, V16, P43, DOI 10.1016/0141-8130(94)90010-8
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Umbuzeiro-Valent G, 1999, ENVIRON MOL MUTAGEN, V33, P325, DOI 10.1002/(SICI)1098-2280(1999)33:4<325::AID-EM10>3.0.CO;2-E
   Ushio H, 1999, TOXICOL LETT, V105, P17, DOI 10.1016/S0378-4274(98)00379-8
   Van T. N., 2006, J CHEM TECH BIOTECH, V81, P1113
   YUSPA SH, 1994, J INVEST DERMATOL, V103, pS90, DOI 10.1111/1523-1747.ep12399255
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 74
TC 55
Z9 56
U1 1
U2 30
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2009
VL 10
IS 3
BP 1300
EP 1313
DI 10.3390/ijms10031300
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 424KJ
UT WOS:000264565300033
PM 19399250
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Gunaydin, S
AF Gunaydin, Serdar
TI CLINICAL IMPACT AND BIOMATERIAL EVALUATION OF BONE MARROW ASPIRATE AND
   PLATELET GEL IN CARDIAC SURGERY
SO IUBMB LIFE
LA English
DT Meeting Abstract
C1 [Gunaydin, Serdar] Kirikkale Univ, Dept Cardiovasc Surg, Kirikkale, Turkey.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1521-6543
J9 IUBMB LIFE
JI IUBMB Life
PD MAR
PY 2009
VL 61
IS 3
BP 295
EP 295
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 417PV
UT WOS:000264089500062
DA 2018-10-19
ER

PT J
AU Aurognzeb, D
AF Aurognzeb, Deeder
TI Origin of high strength and nanophotonic properties of crab shell
   (Paralithodes camtschaticus)
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
DE biomechanics; biomedical materials; bio-optics; mechanical strength;
   nanoparticles; scanning electron microscopy; X-ray chemical analysis
AB Understanding biomaterial is very important for superior material development. Here, we report structural and nanophotonic properties of crab shell. The fibrous shell is composed of nanocrystalline calcite, which gives the structure very high strength. Scanning electron microscope cross section and energy dispersive x-ray shows top surface (reddish) is fibrous with metal nanoparticle segregation, while the bottom layer is composed of layered nanohole array similar to air-dielectric photonic lattice structure. The air-dielectric nanohole arrays are disordered but correlated with fractal dimension >1 and able to block infrared. Nanocrystalline calcite and metal nanoparticles can also block extreme level of UV.
C1 Univ Maryland, James A Clark Sch Engn, College Pk, MD 20742 USA.
RP Aurognzeb, D (reprint author), Univ Maryland, James A Clark Sch Engn, College Pk, MD 20742 USA.
EM daurongz@umd.edu
CR Abramowitz AA, 1935, P NATL ACAD SCI USA, V21, P677, DOI 10.1073/pnas.21.12.677
   AIBA S, 1985, CARBOHYD POLYM, V5, P285, DOI 10.1016/0144-8617(85)90036-0
   Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   Bruet BJF, 2008, NAT MATER, V7, P748, DOI 10.1038/nmat2231
   Fujino S, 2000, P SOC PHOTO-OPT INS, V4102, P324, DOI 10.1117/12.405300
   Gumus C, 2005, THIN SOLID FILMS, V492, P1, DOI 10.1016/j.tsf.2005.06.016
   Gupta P, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2204648
   Hovel KA, 1999, J EXP MAR BIOL ECOL, V237, P107, DOI 10.1016/S0022-0981(98)00221-4
   Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO
   Parker AR, 2001, NATURE, V409, P36, DOI 10.1038/35051168
   Quintero-Torres R, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.032901
   Ruparelia JP, 2008, DESALINATION, V232, P145, DOI 10.1016/j.desal.2007.08.023
   Wang WX, 2008, COMP BIOCHEM PHYS C, V148, P315, DOI 10.1016/j.cbpc.2008.04.003
NR 13
TC 2
Z9 2
U1 1
U2 10
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD MAR 1
PY 2009
VL 105
IS 5
AR 056108
DI 10.1063/1.3079511
PG 2
WC Physics, Applied
SC Physics
GA 418NZ
UT WOS:000264156300118
DA 2018-10-19
ER

PT J
AU Li, QL
   Huang, N
   Chen, JL
   Chen, C
   Chen, JY
   Chen, H
AF Li, Quan-Li
   Huang, Nan
   Chen, Jialong
   Chen, Cheng
   Chen, Junying
   Chen, Hui
TI Endothelial Cell and Platelet Behavior on Titanium Modified with a
   Mutilayer of Polyelectrolytes
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE titanium; layer-by-layer self-assembly; chitosan; sulfated chitosan;
   platelet adhesion; endothelial cells; tissue engineering
ID FIBROBLAST HPLF FUNCTION; IN-VITRO; COMPLEX PEC; CHITOSAN; ADSORPTION;
   SURFACES; ADHESION; BIOMATERIAL; ACTIVATION; COATINGS
AB Endothelial cell seeding, a promising method for improving the performance of vascular grafts, often requires immobilizing biological molecules on the surface of the substrate material. In this study, chitosan (CS) and sulfated chitosan (SCS) multilayers were coated on pure titanium using a layer-by-layer self-assembly technique. The CS-SCS multilayer growth was carried out by first depositing a single layer of positively charged poly(L-lysine) (PLL) on the NaOH-treated titanium substrate, followed by alternate deposition of negatively charged SCS and positively charged CS, and terminated by an outermost layer of SCS. Platelet-rich plasma (PRP) and endothelial cells were seeded on NaOH treated titanium and CS-SCS coated titanium samples, respectively, to evaluate the adhesion and activation of platelets and the behavior of endothelial cells in vitro. The multilayer processed surfaces displayed reduced platelet adhesion and activation, and promoted endothelial cell attachment and growth in vitro. This approach may be used for the fabrication of titanium-based vascular implant surfaces for endothelial promotion.
C1 [Li, Quan-Li; Huang, Nan; Chen, Jialong; Chen, Cheng; Chen, Junying] SW Jiaotong Univ, Key Lab Adv Technol Mat, Educ Minist China, Chengdu, Peoples R China.
   [Chen, Hui] China Natl Logging Corp, Beijing, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Key Lab Adv Technol Mat, Educ Minist China, Chengdu, Peoples R China.
EM nhuang@263.net
RI Chen, Jialong/E-4388-2015
OI Chen, Jialong/0000-0002-5323-1801
FU Key Basic Resaerch of China [2005CB623904, NSFC 30318006, NSFC
   20603027]; China postdoctoral science foundation [20060401019]
FX This work was financially supported by Key Basic Resaerch 2005CB623904,
   NSFC 30318006, NSFC 20603027 of China and China postdoctoral science
   foundation No. 20060401019. The authors would like to thank Dr Ian Brown
   for help in the manuscript preparation.
CR AMIJI MM, 1995, BIOMATERIALS, V16, P593, DOI 10.1016/0142-9612(95)93856-9
   Amiji MM, 1998, COLLOID SURFACE B, V10, P263, DOI 10.1016/S0927-7765(98)00005-8
   AMZAZADE A, 1997, CARBOHYD POLYM, V34, P113
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   BEENA MS, 1995, ARTIF CELL BLOOD SUB, V23, P175, DOI 10.3109/10731199509117937
   Bruni S, 2005, ACTA BIOMATER, V1, P223, DOI 10.1016/j.actbio.2004.11.001
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   DAVID C, 2008, J BIOACT COMPAT POLY, V23, P49
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   FENG B, 2003, MATER CHARACT, V49, P129, DOI DOI 10.1016/S1044-5803(02)00341-8
   Grech JMR, 2008, J BIOACT COMPAT POL, V23, P367, DOI 10.1177/0883911508093389
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Hamano T, 1998, J BIOMED MATER RES, V41, P270, DOI 10.1002/(SICI)1097-4636(199808)41:2<270::AID-JBM12>3.3.CO;2-B
   HAMANO T, 2002, POLYM ADVAN TECHNOL, V13, P46
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hughes-Wassell Diana T., 1996, Biomaterials, V17, P859
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Jansson E, 2004, COLLOID SURFACE B, V35, P45, DOI 10.1016/j.colsurfb.2004.02.007
   KENNEDY JF, 1976, NATURE, V261, P242, DOI 10.1038/261242a0
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kumari TV, 2002, BIO-MED MATER ENG, V12, P329
   Kurotobi K, 2003, ARTIF ORGANS, V27, P582, DOI 10.1046/j.1525-1594.2003.07016.x
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   Li Cheng, 2004, Hemodial Int, V8, P360, DOI 10.1111/j.1492-7535.2004.80412.x
   Li QL, 2007, KEY ENG MATER, V330-332, P645, DOI 10.4028/www.scientific.net/KEM.330-332.645
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Matsuda N, 2003, BIOMATERIALS, V24, P4771, DOI 10.1016/S0142-9612(03)00375-2
   Nagahata M, 2005, BIOMATERIALS, V26, P5138, DOI 10.1016/j.biomaterials.2005.01.041
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P3, DOI 10.1016/0142-9612(91)90123-R
   Otto M, 2004, J MATER SCI-MATER M, V15, P35, DOI 10.1023/B:JMSM.0000010095.19693.67
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   Plant SD, 2005, BIOMATERIALS, V26, P5359, DOI 10.1016/j.biomaterials.2005.01.067
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P1003, DOI 10.1002/jbm.820260804
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Takemoto S, 2001, J SOL-GEL SCI TECHN, V21, P97, DOI 10.1023/A:1011269802356
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   VONGCHAN P, 2002, CARBOHYD RES, V337, P1233
   Yan Y, 2007, J BIOACT COMPAT POL, V22, P323, DOI 10.1177/0883911507078386
NR 42
TC 20
Z9 21
U1 3
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2009
VL 24
IS 2
BP 129
EP 150
DI 10.1177/0883911508101553
PG 22
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 416DO
UT WOS:000263985700002
DA 2018-10-19
ER

PT J
AU Wang, YJ
   Ke, Y
   Ren, L
   Wu, G
   Chen, XF
   Zha, QC
AF Wang, Yingjun
   Ke, Yu
   Ren, Li
   Wu, Gang
   Chen, Xiaofeng
   Zha, Qichun
TI Surface engineering of PHBV by covalent collagen immobilization to
   improve cell compatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PHBV; collagen; surface modification; wettability; cell compatibility
ID CONTACT-ANGLE HYSTERESIS; IN-VITRO; FILMS; POLYHYDROXYALKANOATES;
   POLYACRYLAMIDE; BIOMATERIALS; POLYMERS; ACID
AB Covalent immobilization of collagen onto poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) film was achieved to improve its cell compatibility. Amide groups photografted on PHBV films were initially converted into amine groups through Hofmann degradation and collagen was then chemically bonded to amine groups, consequently forming the amide, amine, and collagen-modified PHBV. The structures of these modified PHBV films were confirmed by ATR-FTIR, XPS, and SEM analyses. Compared with that of PHBV film, surface wett-ability of the modified PHBV films enhanced remarkably. In particular, water contact angle of the collagen-modified PHBV film decreased from 65.0 degrees to 2.1 degrees within 130 s. Sheep chondrocytes cultured on PHBV and modified PHBV films were evaluated by cell adhesion test, MTT assay, and morphological observation under SEM. Results showed that the collagen-modified PHBV film had better cell adhesion and proliferation than other modified PHBV films and PHBV film. Chondrocytes on the collagen-modified PHBV film adhered through filopodia, spread by cytoplasmic webbing, and formed cells layer earlier than other modified ones, indicating that the collagen-modified PHBV is a promising biomaterial for cartilage tissue engineering. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 88A: 616-627,2009
C1 [Wang, Yingjun; Ke, Yu; Ren, Li; Wu, Gang; Chen, Xiaofeng] S China Univ Technol, Coll Mat Sci & Engn, Biomat Res Inst, Guangzhou, Guangdong, Peoples R China.
   [Wang, Yingjun; Ren, Li; Wu, Gang; Chen, Xiaofeng] S China Univ Technol, Key Lab Specially Funct Mat & Adv Mfg Technol, Guangzhou, Guangdong, Peoples R China.
   [Zha, Qichun] Anhui Prov Hosp, Dept Orthoped, Hefei, Peoples R China.
RP Wang, YJ (reprint author), S China Univ Technol, Coll Mat Sci & Engn, Biomat Res Inst, Guangzhou, Guangdong, Peoples R China.
EM imwangyj@scut.edu.cn; psliren@scut.edu.cn
RI Wu, Gang/A-1149-2009; ren, li/L-2454-2017
OI Wu, Gang/0000-0002-4730-4971; Ke, Yu/0000-0002-8176-0014; Ren,
   Li/0000-0003-0604-9166
CR ANASTASIOS PA, 1999, J COLLOID INTERF SCI, V212, P419
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   GU QS, 2003, COLLAGEN BASED BIOMA
   Hu SG, 2004, CARBOHYD POLYM, V58, P173, DOI 10.1016/j.carbpol.2004.06.039
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   Ke Y, 2007, J APPL POLYM SCI, V104, P4088, DOI 10.1002/app.25678
   Keen I, 2006, BIOMACROMOLECULES, V7, P427, DOI 10.1021/bm050497a
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Kumarasuriyar A, 2005, TISSUE ENG, V11, P1281, DOI 10.1089/ten.2005.11.1281
   Lam CNC, 2002, ADV COLLOID INTERFAC, V96, P169, DOI 10.1016/S0001-8686(01)00080-X
   Lam CNC, 2001, J COLLOID INTERF SCI, V243, P208, DOI 10.1006/jcis.2001.7840
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   McHale G, 2004, LANGMUIR, V20, P10146, DOI 10.1021/la0486584
   Moran MT, 2007, J BIOMED MATER RES A, V81A, P870, DOI 10.1002/jbm.a.31089
   Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o
   Pouton CW, 1996, ADV DRUG DELIVER REV, V18, P133, DOI 10.1016/0169-409X(95)00092-L
   Pu QS, 2007, LANGMUIR, V23, P1577, DOI 10.1021/la062662t
   Ranby B, 1999, INT J ADHES ADHES, V19, P337, DOI 10.1016/S0143-7496(98)00066-9
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Tadmor R, 2004, LANGMUIR, V20, P7659, DOI 10.1021/la049410h
   Tesema Y, 2004, J APPL POLYM SCI, V93, P2445, DOI 10.1002/app.20787
   Tsuboi Y, 2001, J PHOTOCH PHOTOBIO A, V145, P209, DOI 10.1016/S1010-6030(01)00584-6
   van der Walle GAM, 2001, ADV BIOCHEM ENG BIOT, V71, P263
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Wirsen A, 2005, BIOMACROMOLECULES, V6, P2281, DOI 10.1021/bm050170+
   Wirsen A, 1996, BIOMATERIALS, V17, P1881, DOI 10.1016/0142-9612(95)00306-1
   Yamada K, 2006, J APPL POLYM SCI, V102, P4886, DOI 10.1002/app.24861
   Yin C, 2003, J BIOMED MATER RES A, V67A, P1093, DOI 10.1002/jbm.a.10033
   ZHAO YX, 1992, SPECTRA ANAL CHARACT
NR 35
TC 28
Z9 30
U1 0
U2 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2009
VL 88A
IS 3
BP 616
EP 627
DI 10.1002/jbm.a.31858
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404BP
UT WOS:000263126000007
PM 18314894
DA 2018-10-19
ER

PT J
AU Anderl, JN
   Robey, TE
   Stayton, PS
   Murry, CE
AF Anderl, Jeff N.
   Robey, Thomas E.
   Stayton, Patrick S.
   Murry, Charles E.
TI Retention and biodistribution of microspheres injected into ischemic
   myocardium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cardiac repair; myocardial infarction; microsphere delivery; biomaterial
   injection; cardiac injection
ID FIBROBLAST-GROWTH-FACTOR; CARDIOMYOCYTE TRANSPLANTATION; WOUND
   DRESSINGS; THERAPY; HEART; ANGIOGENESIS
AB Intramyocardial injection of therapeutic agents may enhance heart repair after infarction. Incomplete retention of intramyocardial injections has been reported, but modes of loss are undefined. We determined the fate of neutron-activated microspheres injected into acutely ischemic rat myocardium using saline, Pluronic F127, or Matrigel as vehicle. Twenty minutes after injection in saline, 63% +/- 12% Of 10-mu m microspheres was retained in the heart. Similar retention was observed after 6 days. Injection site leakage accounted for 14% +/- 5% of the microspheres, whereas exit via coronary veins resulted in 11.2% +/- 9.5% collecting in the lungs. Microspheres distribution to other organs was minimal. Retention of 40-mu m microspheres was similar to that observed with the 10-mu m microspheres. Pluronic F127 and Matrigel reduced immediate leakage to 4% +/- 1% and 2% +/- 1%, respectively. Surprisingly, microsphere retention in the heart was not improved at 20 min using either gelling vehicle, suggesting that leakage occurs over a prolonged period. Thus, most injected particles are retained in the ischemic rat heart following direct injection, but significant fractions are lost from the injection site and through coronary veins. Gelling agents reduced short-term leakage, but failed to enhance longer-term retention. Hydrogels with stiffer mechanical properties might enhance retention and reduce variability. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 88A: 704-710, 2009
C1 [Anderl, Jeff N.; Robey, Thomas E.; Stayton, Patrick S.; Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Robey, Thomas E.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Pathol, Seattle, WA 98109 USA.
RP Murry, CE (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM murry@u.washington.edu
OI Robey, Thomas/0000-0001-6461-4421
FU NIGMS NIH HHS [T32 GM007266]; NHLBI NIH HHS [P01HL3174, HL84642,
   HL61553, HL64387]; NIBIB NIH HHS [T32 EB001650]
CR Altman Peter A, 2003, Lymphat Res Biol, V1, P47, DOI 10.1089/15396850360495691
   ANDERSEN KS, 1983, AM J PHYSIOL, V244, pH121
   Annex BH, 2005, CARDIOVASC RES, V65, P649, DOI 10.1016/j.cardiores.2004.09.004
   CASTRONUOVO JJ, 1983, SURGERY, V94, P351
   CONSIGNY PM, 1982, AM J PHYSIOL, V242, pH392
   Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011
   Freshney RI, 2000, CULTURE ANIMAL CELLS
   Grossman PM, 2002, CATHETER CARDIO INTE, V55, P392, DOI 10.1002/ccd.10136
   Hou D, 2005, CIRCULATION, V112, P1150
   Huang S, 2006, J MICROENCAPSUL, V23, P277, DOI 10.1080/02652040500435170
   Ismail JA, 2003, CARDIOVASC PATHOL, V12, P82, DOI 10.1016/S1054-8807(02)00166-7
   JUGDUTT BI, 1979, CIRC RES, V45, P746, DOI 10.1161/01.RES.45.6.746
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   LAFLAMME MA, 2007, NAT BIOTECHNOL, V9, P1015
   Laham RJ, 2005, DRUG METAB DISPOS, V33, P1101, DOI 10.1124/dmd.104.002774
   LUDWIG J, 1971, LYMPHOLOGY, V4, P18
   MILLER AJ, 1982, LYMPHATICS HEART
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Reinhardt CP, 2001, AM J PHYSIOL-HEART C, V280, pH108
   Saeed M, 2005, EUR RADIOL, V15, P851, DOI 10.1007/s00330-004-2622-8
   Saeed M, 2006, RADIOLOGY, V240, P419, DOI 10.1148/radiol.2402051086
   Sakakibara Y, 2003, EUR J CARDIO-THORAC, V24, P105, DOI 10.1016/S1010-7940(03)00159-3
   Sakakibara Y, 2002, J THORAC CARDIOV SUR, V124, P50, DOI 10.1067/mtc.2002.121293
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Varde NK, 2004, EXPERT OPIN BIOL TH, V4, P35, DOI 10.1517/eobt.4.1.35.25256
   Yamamoto M, 2003, ARTIF ORGANS, V27, P181, DOI 10.1046/j.1525-1594.2003.06993.x
NR 28
TC 21
Z9 21
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2009
VL 88A
IS 3
BP 704
EP 710
DI 10.1002/jbm.a.31917
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404BP
UT WOS:000263126000017
PM 18335529
DA 2018-10-19
ER

PT J
AU John, R
   Lee, S
AF John, Ranjit
   Lee, Sangjin
TI The Biological Basis of Thrombosis and Bleeding in Patients with
   Ventricular Assist Devices
SO JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
LA English
DT Article
DE Ventricular Assist Devices; Bleeding; Thrombosis; Heart Failure
ID TISSUE FACTOR EXPRESSION; VON-WILLEBRAND-FACTOR; SICKLE-CELL-ANEMIA;
   ENDOTHELIAL-CELLS; AORTIC-STENOSIS; LVAD RECIPIENTS; THROMBOEMBOLIC
   COMPLICATIONS; HEART-TRANSPLANTATION; CIRCULATORY SUPPORT; SYSTEM
AB The clinical success of left ventricular assist devices (LVADs) has been tempered by significant hemorrhagic and thromboembolic complications. In the case of LVADs, where the biomaterial is in direct contact with the blood circulation, significant changes in systemic immunologic and thrombostatic functions have been well documented. Although further investigation is warranted, significant advances have been made in both cellular biology and LVAD technology to better understand the delicate balance between the procoagulant milieu predisposing to thrombosis and the risks of both surgical and non-surgical bleeding.
C1 [John, Ranjit] Univ Minnesota, Div Cardiothorac Surg, Minneapolis, MN 55455 USA.
   [John, Ranjit] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA.
   [Lee, Sangjin] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA.
RP John, R (reprint author), Univ Minnesota, Div Cardiothorac Surg, Minneapolis, MN 55455 USA.
EM johnx008@umn.edu
CR BOLEY SJ, 1977, GASTROENTEROLOGY, V72, P650
   CLARK RE, 1995, J THORAC CARDIOV SUR, V109, P249, DOI 10.1016/S0022-5223(95)70386-1
   Delgado R, 2005, J HEART LUNG TRANSPL, V24, P231, DOI 10.1016/j.healun.2003.10.023
   Esmore D, 2008, J HEART LUNG TRANSPL, V27, P579, DOI 10.1016/j.healun.2008.02.012
   Frazier OH, 2004, ANN THORAC SURG, V77, P133, DOI 10.1016/S0003-4975(03)01321-3
   FRAZIER OH, 1993, TEX HEART I J, V20, P78
   Frazier OH, 2001, J THORAC CARDIOV SUR, V122, P1186, DOI 10.1067/mtc.2001.118274
   Frazier OH, 2003, ANN SURG, V237, P631, DOI 10.1097/00000658-200305000-00005
   Furlan M, 1996, ANN HEMATOL, V72, P341, DOI 10.1007/s002770050184
   Geisen U, 2008, EUR J CARDIO-THORAC, V33, P679, DOI 10.1016/j.ejcts.2007.12.047
   GEORGIADIS D, 1994, STROKE, V25, P587, DOI 10.1161/01.STR.25.3.587
   Goldstein DJ, 1998, NEW ENGL J MED, V339, P1522, DOI 10.1056/NEJM199811193392107
   Goldstein DJ, 2003, ANN THORAC SURG, V75, pS42, DOI 10.1016/S0003-4975(03)00478-8
   GOLDSTEIN DJ, 1995, ANN THORAC SURG, V59, P1063, DOI 10.1016/0003-4975(95)00086-Z
   Griffith BP, 2001, ANN THORAC SURG, V71, pS116, DOI 10.1016/S0003-4975(00)02639-4
   Grossi P, 2001, TRANSPLANT P, V33, P1969, DOI 10.1016/S0041-1345(00)02757-3
   Haj-Yahia S, 2007, J THORAC CARDIOV SUR, V134, P199, DOI 10.1016/j.jtvcs.2007.01.002
   Hampton CR, 2002, ARTIF ORGANS, V26, P902, DOI 10.1046/j.1525-1594.2002.07122.x
   Hebbel RP, 1997, J CLIN INVEST, V99, P2561, DOI 10.1172/JCI119442
   HEYDE EC, 1958, NEW ENGL J MED, V259, P196
   HIMMELREICH G, 1995, ASAIO J, V41, pM790, DOI 10.1097/00002480-199507000-00122
   Itescu S, 2003, ANN THORAC SURG, V75, pS58, DOI 10.1016/S0003-4975(03)00480-6
   John R, 2003, J THORAC CARDIOV SUR, V125, P578, DOI 10.1067/mtc.2003.30
   John R, 2000, ANN SURG, V232, P302, DOI 10.1097/00000658-200009000-00002
   JOHN R, 2008, J THORACIC IN PRESS
   John R, 2008, ANN THORAC SURG, V86, P1227, DOI 10.1016/j.athoracsur.2008.06.030
   JOYCE L, 2007, ASAIO J, V53, pA50
   Kasirajan V, 2000, Semin Thorac Cardiovasc Surg, V12, P229
   Kavarana MN, 2002, ANN THORAC SURG, V73, P745, DOI 10.1016/S0003-4975(01)03406-3
   Korfer R, 2000, J THORAC CARDIOV SUR, V119, P596, DOI 10.1016/S0022-5223(00)70142-5
   Koster A, 2000, ANN THORAC SURG, V70, P533, DOI 10.1016/S0003-4975(00)01404-1
   Lazar RM, 2004, CIRCULATION, V109, P2423, DOI 10.1161/01.CIR.0000129414.95137.CD
   Letsou GV, 2005, J HEART LUNG TRANSPL, V24, P105, DOI 10.1016/j.healun.2003.10.018
   Livingston ER, 1996, CIRCULATION, V94, P227
   McCarthy PM, 1998, J THORAC CARDIOV SUR, V115, P904, DOI 10.1016/S0022-5223(98)70373-3
   MENCONI MJ, 1995, J CELL BIOCHEM, V57, P557, DOI 10.1002/jcb.240570320
   Moazami N, 1997, ASAIO J, V43, P177
   Morgan JA, 2004, J THORAC CARDIOV SUR, V127, P1309, DOI 10.1016/j.jtcvs.2003.07.035
   Nabavi DG, 2003, J THORAC CARDIOV SUR, V126, P160, DOI 10.1016/S0022-5223(03)00019-9
   Panch SR, 2008, J HEART LUNG TRANSPL, V27, pS93, DOI 10.1016/j.healun.2007.11.101
   Panch SR, 2007, CIRCULATION, V116, P643
   ROSE EA, 1994, CIRCULATION, V90, P87
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Ruggeri ZM, 2003, CURR OPIN HEMATOL, V10, P142, DOI 10.1097/00062752-200303000-00008
   Schmid C, 1998, ANN THORAC SURG, V65, P1703, DOI 10.1016/S0003-4975(98)00299-9
   Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203
   Solovey A, 1998, J CLIN INVEST, V101, P1899, DOI 10.1172/JCI1932
   Spanier T, 1996, J THORAC CARDIOV SUR, V112, P1090, DOI 10.1016/S0022-5223(96)70111-3
   Spanier TB, 1999, J THORAC CARDIOV SUR, V118, P404, DOI 10.1016/S0022-5223(99)70176-5
   Thoennissen NH, 2005, J THORAC CARDIOV SUR, V130, P1159, DOI 10.1016/j.jtcvs.2005.02.068
   Tsukui H, 2007, J THORAC CARDIOV SUR, V134, P114, DOI 10.1016/j.jtcvs.2007.02.044
   Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831
   WARKENTIN TE, 1992, LANCET, V340, P35, DOI 10.1016/0140-6736(92)92434-H
   Westaby S, 1998, CIRCULATION, V98, P1568, DOI 10.1161/01.CIR.98.15.1568
   Wilhelm CR, 1998, ANN THORAC SURG, V65, P1071, DOI 10.1016/S0003-4975(98)00111-8
   Wilhelm CR, 1999, STROKE, V30, P2554, DOI 10.1161/01.STR.30.12.2554
NR 56
TC 31
Z9 33
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1937-5387
EI 1937-5395
J9 J CARDIOVASC TRANSL
JI J. Cardiovasc. Transl. Res.
PD MAR
PY 2009
VL 2
IS 1
BP 63
EP 70
DI 10.1007/s12265-008-9072-7
PG 8
WC Cardiac & Cardiovascular Systems; Medicine, Research & Experimental
SC Cardiovascular System & Cardiology; Research & Experimental Medicine
GA 686IK
UT WOS:000284689800009
PM 20559970
DA 2018-10-19
ER

PT J
AU Anirudhan, TS
   Radhakrishnan, PG
AF Anirudhan, T. S.
   Radhakrishnan, P. G.
TI Improved performance of a biomaterial-based cation exchanger for the
   adsorption of uranium(VI) from water and nuclear industry wastewater
SO JOURNAL OF ENVIRONMENTAL RADIOACTIVITY
LA English
DT Article
DE Tamarind fruit shell; Graft copolymerization; Uranium(VI) adsorption;
   Isotherm; Desorption
ID AQUEOUS-SOLUTIONS; ACTIVATED CARBON; REMOVAL; EQUILIBRIUM; ISOTHERM;
   SORPTION; BIOSORPTION; MODELS
AB The amine-modified polyhydroxyethylmethacrylate (poly(HEMA))-grafted biomaterial (tamarind fruit shell, TFS) carrying carboxyl functional groups at the chain end (PGTFS-COOH) was prepared and used as an adsorbent for the removal of uranium(VI) from water and nuclear industry wastewater. MR spectral analysis revealed that U(VI) ions and PGTFS-COOH formed a chelate complex. The adsorption process was relatively fast, requiring only 120 min to attain equilibrium. The adsorption kinetic data were best described by the pseudo-second-order equation. The equilibrium adsorption data were correlated with the Sips isotherm model. The maximum U(VI) ions uptake with PGTFS-COOH was estimated to be 100.79 mg/g. The complete removal of 10 mg/L U(VI) from simulated nuclear industry wastewater was achieved by 3.5 g/L PGTFS-COOH. The reusability of the adsorbent was demonstrated over 4 cycles using NaCl (1.0 M) + HCI (0.5 MI) solution mixture to de-extract the U(VI). The results show that the PGTFS-COOH tested is very promising for the recovery of U(VI) from water and wastewater. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Anirudhan, T. S.; Radhakrishnan, P. G.] Univ Kerala, Dept Chem, Trivandrum 695581, Kerala, India.
RP Anirudhan, TS (reprint author), Univ Kerala, Dept Chem, Trivandrum 695581, Kerala, India.
EM tsani@rediffmail.com
CR Allen SJ, 2003, BIORESOURCE TECHNOL, V88, P143, DOI 10.1016/S0960-8524(02)00281-X
   Anirudhan TS, 2007, J COLLOID INTERF SCI, V316, P268, DOI 10.1016/j.jcis.2007.08.051
   Anirudhan TS, 2007, J APPL POLYM SCI, V104, P3670, DOI 10.1002/app.25002
   Cestari AR, 2006, J CHEM THERMODYN, V38, P1092, DOI 10.1016/j.jct.2005.11.011
   CLIFFORD D, 1994, J AM WATER WORKS ASS, V86, P214
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   GEESEY G, 1990, MICROBIAL MINERAL RE, P223
   Havel J, 2002, POLYHEDRON, V21, P1411, DOI 10.1016/S0277-5387(02)00947-6
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Hu MZC, 1999, AICHE J, V45, P2333, DOI 10.1002/aic.690451109
   Hu MZC, 1996, BIOTECHNOL BIOENG, V51, P237, DOI 10.1002/(SICI)1097-0290(19960720)51:2<237::AID-BIT14>3.0.CO;2-J
   JanssonCharrier M, 1996, WATER SCI TECHNOL, V34, P169, DOI 10.1016/S0273-1223(96)00711-1
   Khan AR, 1997, J COLLOID INTERF SCI, V194, P154, DOI 10.1006/jcis.1997.5041
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   LANGMUIR I, 1918, J AM CHEM SOC, V40, P1403
   Lee ST, 2001, POLYMER, V42, P1879, DOI 10.1016/S0032-3861(00)00402-X
   McBride MB, 1997, CLAY CLAY MINER, V45, P598, DOI 10.1346/CCMN.1997.0450412
   Mellah A, 2006, J COLLOID INTERF SCI, V296, P434, DOI 10.1016/j.jcis.2005.09.045
   Pasquali CEL, 1997, THERMOCHIM ACTA, V293, P39, DOI 10.1016/S0040-6031(97)00059-2
   Porter JF, 1999, CHEM ENG SCI, V54, P5863, DOI 10.1016/S0009-2509(99)00178-5
   REDLICH O, 1959, J PHYS CHEM-US, V63, P1024, DOI 10.1021/j150576a611
   SANDELL EB, 1944, CALORIMETRIC DETERMI
   Saraydin D, 2001, POLYM BULL, V47, P81, DOI 10.1007/s002890170024
   Seko N., 2005, SEP SCI TECHNOL, V39, P3753
   SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922
   TOTH J, 1971, ACTA CHIM HUNG, V69, P311
   TSEZOS M, 1981, BIOTECHNOL BIOENG, V23, P583, DOI 10.1002/bit.260230309
   U. S. EPA, 1996, EPA INT RISK INF SYS
   Ulusoy U, 2003, ADSORPTION, V9, P165, DOI 10.1023/A:1024297411400
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
NR 30
TC 57
Z9 62
U1 0
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0265-931X
J9 J ENVIRON RADIOACTIV
JI J. Environ. Radioact.
PD MAR
PY 2009
VL 100
IS 3
BP 250
EP 257
DI 10.1016/j.jenvrad.2008.12.006
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 422GU
UT WOS:000264416300006
PM 19168265
DA 2018-10-19
ER

PT J
AU Zhou, JY
   Jiang, H
   Wang, D
   Hu, SS
AF Zhou, Jianye
   Jiang, Hong
   Wang, De
   Hu, Shengshou
TI A Novel Anti-Calcification Strategy of Bovine Pericardium Using Sodium
   Bisulfite Modification
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article
ID BIOPROSTHETIC HEART-VALVES; GLUTAMIC ACID TREATMENT; GLUTARALDEHYDE
   FIXATION; CROSS-LINKING; AORTIC-WALL; SHEEP MODEL; TISSUE; BIOMATERIAL;
   PREVENTION; BIOCOMPATIBILITY
AB Background and aim of the study: Calcification is the major contributory factor of clinical failure of glutaraldehyde (GA)-fixed bioprosthetic heart valves. The study aim was to evaluate a novel approach to prevent calcification using a sodium bisulfite (SB) modification.
   Methods: A series of bovine pericardium samples was fixed in 0.625% (w/v) GA and stored in 0.3% GA solution. One half of these samples were used as a control group; the second half were transferred into SB solution for 24 h and served as the experimental group. Both groups were analyzed with Fourier transform infrared (FTIR) spectroscopy, and characterized on the basis of their shrinkage temperature, mechanical properties and resistance to collagenase digestion. In addition, samples from each group were implanted subcutaneously into 10 juvenile Sprague-Dawley rats for 21 and 60 days, respectively. The calcium content of the explanted tissues was assessed using atomic absorption spectrometry, and calcium deposition demonstrated histologically with von Kossa staining.
   Results: SB-modified bovine pericardium samples demonstrated a slightly lower shrinkage temperature than GA-treated samples. FTIR demonstrated an alternation in aldehyde banding among the bands from bovine pericardial tissues. The resistance to enzymic digestion was comparable in both groups, but the biomechanical properties of the SB-modified samples were superior to those of controls. Calcium deposition was significantly lower in the SB group at both 21 days (3.5 +/- 0.6 versus 63.3 +/- 0.1 mg/g tissue) and 60 days (5.1 +/- 0.1 versus 79.8 +/- 7.4 mg/g) (p <0.001). These quantitative data were confirmed histologically with von Kossa staining.
   Conclusion: The additional SB modification of GA-fixed bovine pericardium resulted in an increased pericardial extensibility and strength. SB treatment also led to a significant reduction in pericardial calcification in a subcutaneous rat model.
C1 Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China.
   Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100037, Peoples R China.
   Peking Union Med Coll, Beijing 100021, Peoples R China.
RP Zhou, JY (reprint author), A167 Beilishi Rd, Beijing 100037, Peoples R China.
EM jianyezhou@yahoo.com
FU Beijing Science and Technology Program [Y0405003040291]
FX These studies were supported by the Beijing Science and Technology
   Program (Y0405003040291). The authors are very grateful for the
   excellent technical assistance provided by the FT-IR Laboratory of
   Peking University in the FTIR spectroscopy analyses.
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   CHANDA J, 1994, ARTIF ORGANS, V18, P408, DOI 10.1111/j.1525-1594.1994.tb02223.x
   CHEN WL, 1994, CIRCULATION, V90, P323, DOI 10.1161/01.CIR.90.1.323
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Girardot JMD, 1996, J HEART VALVE DIS, V5, P518
   GRABENWOGER M, 1992, J BIOMED MATER RES, V26, P1231, DOI 10.1002/jbm.820260912
   GRIMM M, 1991, J THORAC CARDIOV SUR, V102, P195
   GRIMM M, 1992, J CARDIAC SURG, V7, P58, DOI 10.1111/j.1540-8191.1992.tb00775.x
   Han SH, 2007, ETRI J, V29, P641, DOI 10.4218/etrij.07.0106.0316
   HU QM, 2003, ORGANIC CHEM, P336
   Isenburg JC, 2005, BIOMATERIALS, V26, P1237, DOI 10.1016/j.biomaterials.2004.04.034
   Jee KS, 2003, BIOMATERIALS, V24, P3409, DOI 10.1016/S0142-9612(03)00204-7
   MOORE MA, 1994, J BIOMED MATER RES, V28, P611, DOI 10.1002/jbm.820280511
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Trantina-Yates AE, 2003, J HEART VALVE DIS, V12, P93
   Vyavahare NR, 1998, J BIOMED MATER RES, V40, P577, DOI 10.1002/(SICI)1097-4636(19980615)40:4<577::AID-JBM9>3.3.CO;2-B
   Weissenstein C, 2000, J HEART VALVE DIS, V9, P230
   ZHANG T, 2008, BEIJING BIOMEDICAL E, V27, P123
   Zilla P, 2001, J BIOMED MATER RES, V56, P56, DOI 10.1002/1097-4636(200107)56:1<56::AID-JBM1068>3.0.CO;2-3
NR 20
TC 3
Z9 3
U1 0
U2 6
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD HA6 2ET,
   ENGLAND
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD MAR
PY 2009
VL 18
IS 2
BP 180
EP 186
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 431CB
UT WOS:000265037800010
PM 19455893
DA 2018-10-19
ER

PT J
AU Kokkinos, PA
   Zarkadis, IK
   Panidis, TT
   Deligianni, DD
AF Kokkinos, Petros A.
   Zarkadis, Ioannis K.
   Panidis, Thrassos T.
   Deligianni, Despina D.
TI Estimation of hydrodynamic shear stresses developed on human osteoblasts
   cultured on Ti-6Al-4V and strained by four point bending. Effects of
   mechanical loading to specific gene expression
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OSCILLATORY FLUID-FLOW; IN-VITRO; EXTRACELLULAR-MATRIX; NITRIC-OXIDE;
   BONE-CELLS; DISTRACTION OSTEOGENESIS; PROSTAGLANDIN E-2; OSTEOPONTIN;
   MECHANOTRANSDUCTION; DIFFERENTIATION
AB The aim of the present investigation was to study the effects of mechanical strain on the orthopedic biomaterial Ti-6Al-4V-osteoblast interface, using an in vitro model. Homogeneous strain was applied to Human Bone Marrow derived Osteoblasts (HBMDOs) cultured on Ti-6Al-4V, at levels which are considered physiological, by a four-point bending mechanostimulatory system. A simple model for the estimation of maximum hydrodynamic shear stresses developed on cell culture layer and induced by nutrient medium flow during mechanical loading, as a function of the geometry of the culture plate and the load characteristics, is proposed. Shear stresses were lower than those which can elicit cell response. Mechanical loading was found that contributes to the regulation of osteoblast differentiation by influencing the expression of the osteoblast-specific transcription factor Cbfa1, both at the mRNA and protein level, and also the osteocalcin expression, whereas osteopontin gene expression was unaffected by mechanical loading at all experimental conditions.
C1 [Kokkinos, Petros A.; Deligianni, Despina D.] Univ Patras, Biomed Engn Lab, Dept Aeronaut & Mech Engn, Patras 26500, Greece.
   [Zarkadis, Ioannis K.] Univ Patras, Dept Biol, Sch Med, Patras 26500, Greece.
   [Panidis, Thrassos T.] Univ Patras, LAT, Dept Aeronaut & Mech Engn, Patras 26500, Greece.
RP Deligianni, DD (reprint author), Univ Patras, Biomed Engn Lab, Dept Aeronaut & Mech Engn, Patras 26500, Greece.
EM deligian@mech.upatras.gr
RI Panidis, Thrassos/A-7597-2010
OI Panidis, Thrassos/0000-0002-0523-2383
FU Research Committee of the University of Patras [2992]
FX This project was financially supported by the project, "K.
   Karatheodori'' (2992) of the Research Committee of the University of
   Patras. The authors wish to express their gratitude to Dr. P.
   Korovessis, for providing bone marrow.
CR Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179
   Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138
   Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1
   Bannister SR, 2002, J BIOMED MATER RES, V60, P167, DOI 10.1002/jbm.10037
   Basso N, 2002, BONE, V30, P347, DOI 10.1016/S8756-3282(01)00678-0
   Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009
   Bhatt KA, 2007, J SURG RES, V143, P329, DOI 10.1016/j.jss.2007.01.023
   Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971
   Bottlang M, 1997, BIOMED TECH, V42, P305, DOI 10.1515/bmte.1997.42.11.305
   Brand R A, 2001, J Orthop Sci, V6, P295, DOI 10.1007/s007760100051
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   Brown TD, 1998, AM J MED SCI, V316, P162, DOI 10.1097/00000441-199809000-00003
   Burger EH, 1999, FASEB J, V13, pS101
   Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2
   Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X
   Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6
   Di Palma F, 2005, BIOMATERIALS, V26, P4249, DOI 10.1016/j.biomaterials.2004.10.041
   Di Palma F, 2004, BIOMATERIALS, V25, P2565, DOI 10.1016/j.biomaterials.2003.09-026
   Di Palma F, 2003, BIOMATERIALS, V24, P3139, DOI 10.1016/S0142-9612(03)00152-2
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   FROST HM, 1992, BONE MINER, V19, P257, DOI 10.1016/0169-6009(92)90875-E
   GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650
   Hamill OP, 2001, PHYSIOL REV, V81, P685
   HARTER LV, 1995, ENDOCRINOLOGY, V136, P528, DOI 10.1210/en.136.2.528
   Jackson RA, 2006, J CELL PHYSIOL, V209, P894, DOI 10.1002/jcp.20779
   Jagodzinski M, 2004, Eur Cell Mater, V7, P35
   Jessop HL, 2002, BONE, V31, P186, DOI 10.1016/S8756-3282(02)00797-4
   Kanno T, 2005, J ORAL MAXIL SURG, V63, P499, DOI 10.1016/j.joms.2004.07.023
   Kaspar D, 2002, J BIOMECH, V35, P873, DOI 10.1016/S0021-9290(02)00058-1
   Kaspar D., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P161
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   KleinNulend J, 1997, J CELL PHYSIOL, V170, P174, DOI 10.1002/(SICI)1097-4652(199702)170:2<174::AID-JCP9>3.0.CO;2-L
   Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y
   Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008
   Labat B, 2000, BIOMATERIALS, V21, P1275, DOI 10.1016/S0142-9612(00)00013-2
   Li YJ, 2004, J ORTHOP RES, V22, P1283, DOI 10.1016/j.orthes.2004.04.002
   Liu D, 2004, EUR J ORTHODONT, V26, P143, DOI 10.1093/ejo/26.2.143
   McGarry JG, 2005, BIOCHEM BIOPH RES CO, V330, P341, DOI 10.1016/j.bbrc.2005.02.175
   Meazzini MC, 1998, J ORTHOP RES, V16, P170, DOI 10.1002/jor.1100160204
   Meyer U, 2001, Mund Kiefer Gesichtschir, V5, P166, DOI 10.1007/s100060100293
   Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810
   Papagerakis P, 2002, BONE, V30, P377, DOI 10.1016/S8756-3282(01)00683-4
   Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556
   SCHLICHTING H, 2000, GERSTEN K BOUNDARY L
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Standal T, 2004, EXP ONCOL, V26, P179
   Tang LL, 2004, J BIOMECH, V37, P157, DOI 10.1016/S0021-9290(03)00237-9
   Toma CD, 1997, J BONE MINER RES, V12, P1626, DOI 10.1359/jbmr.1997.12.10.1626
   Walboomers XF, 2004, J BIOMED MATER RES A, V69A, P131, DOI 10.1002/jbm.a.20127
   Winter LC, 2002, ANN BIOMED ENG, V30, P1242, DOI 10.1114/1.1529195
   YANG YQ, 2006, FRONT BIOSCI, V1, P776
   You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161
   You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200
   Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200
NR 56
TC 8
Z9 8
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2009
VL 20
IS 3
BP 655
EP 665
DI 10.1007/s10856-008-3602-3
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 409JJ
UT WOS:000263501700001
PM 18941870
DA 2018-10-19
ER

PT J
AU Marques, JMS
   Gomes, PS
   Silva, MA
   Cabrita, AMS
   Santos, JD
   Fernandes, MH
AF Silva Marques, J. M.
   Gomes, P. S.
   Silva, M. A.
   Silverio Cabrita, A. M.
   Santos, J. D.
   Fernandes, M. H.
TI Growth and phenotypic expression of human endothelial cells cultured on
   a glass-reinforced hydroxyapatite
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SYNTHETIC BONE-GRAFT; TISSUE REGENERATION; ANGIOGENESIS; BONELIKE(R);
   VASCULARIZATION; NEOVASCULARIZATION; COMPOSITES; SCAFFOLDS; IMPLANTS
AB Glass-reinforced hydroxyapatite composites (GR-HA) are bone regenerative materials that are characterized by their increased mechanical properties, when compared to synthetic hydroxyapatite. Bonelike(A (R)) is a GR-HA that is a result of the addition of a CaO-P2O5 based glass to a HA matrix. This biomaterial has been successfully applied in clinical bone regenerative applications. This work aims to evaluate the ability of Bonelike(A (R)) to support the adhesion, proliferation and phenotypic expression of human endothelial cells, aiming to establish new bone tissue engineering pre-endothelialization strategies. Bonelike(A (R)) discs, regardless of being submitted to a pre-immersion treatment with culture medium, were seeded with first passage human umbilical vein endothelial cells, and characterized regarding proliferation and differentiation events. Pre-immersed Bonelike(A (R)) allowed the adhesion, proliferation and phenotype expression of endothelial cells. Seeded materials presented positive immunofluorescent staining for PECAM-1 and a tendency for the formation of cord-like arrangements under angiogenesis-stimulating conditions, although, compared to standard culture plates, a slight decreased cell growth was observed. In this way, Bonelike(A (R)) may be a suitable candidate for pre-endothelialization approaches in bone tissue engineering applications.
C1 [Gomes, P. S.; Fernandes, M. H.] Univ Porto, Lab Farmacol Biocompatibilidade Celular, Fac Med Dent, P-4200393 Oporto, Portugal.
   [Silva Marques, J. M.] Cooperat Ensino Super Egas Moniz, Monte De Caparica, Portugal.
   [Silva, M. A.; Santos, J. D.] Univ Porto, Fac Engn, P-4100 Oporto, Portugal.
   [Silverio Cabrita, A. M.] Univ Coimbra, Inst Patol Expt, Fac Med, Coimbra, Portugal.
RP Fernandes, MH (reprint author), Univ Porto, Lab Farmacol Biocompatibilidade Celular, Fac Med Dent, Rua Dr Manuel Pereira da Silva, P-4200393 Oporto, Portugal.
EM mhfernandes@fmd.up.pt
RI Gomes, Pedro/K-2433-2014; Fernandes, Maria Helena/K-6917-2014
OI Gomes, Pedro/0000-0001-5365-2123; Lopes, Maria A./0000-0003-4105-8148;
   Silva, Marta/0000-0002-4833-3686; Santos, Jose
   Domingos/0000-0002-6871-9850; Cabrita, Antonio/0000-0001-5165-5849;
   Fernandes, Maria Helena/0000-0001-9391-9574
FU Faculdade de Medicina Dentaria da Universidade do Porto (FMDUP)
FX This work was partially supported by Faculdade de Medicina Dentaria da
   Universidade do Porto (FMDUP).
CR Alessandri G, 2004, ANN NY ACAD SCI, V1015, P271, DOI 10.1196/annals.1302.023
   ANDERSON JS, 1987, SURGERY, V101, P577
   Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521
   Costa MA, 2004, KEY ENG MAT, V254-2, P821, DOI 10.4028/www.scientific.net/KEM.254-256.821
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Fang TD, 2005, J BONE MINER RES, V20, P1114, DOI 10.1359/JBMR.050301
   Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010
   Gutierres M, 2008, ACTA BIOMATER, V4, P370, DOI 10.1016/j.actbio.2007.06.009
   Gutierres M, 2007, J MATER SCI-MATER M, V18, P2377, DOI 10.1007/s10856-007-3171-x
   Gutierres M, 2006, J ORTHOP RES, V24, P953, DOI 10.1002/jor.20117
   Haller A, 1763, OPERA MINORA, V2, P400
   Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Hussain SN, 2007, SURFACE ENG SURG TOO, P477
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Kidd KR, 2004, J BIOMED MATER RES A, V69A, P294, DOI 10.1002/jbm.a.20133
   Kidd KR, 2002, J BIOMED MATER RES, V59, P366, DOI 10.1002/jbm.1253
   Kirkpatrick CJ, 2007, BIOMATERIALS, V28, P5193, DOI 10.1016/j.biomaterials.2007.08.012
   Kirkpatrick CJ, 2003, J MATER SCI-MATER M, V14, P677, DOI 10.1023/A:1024903514335
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   Ko HCH, 2007, EUR CELLS MATER, V14, P1
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033
   Lobato JV, 2006, THIN SOLID FILMS, V515, P279, DOI 10.1016/j.tsf.2005.12.151
   Lobato JV, 2006, THIN SOLID FILMS, V515, P362, DOI 10.1016/j.tsf.2005.12.153
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   McLucas E, 2006, ENDOTHELIUM-J ENDOTH, V13, P35, DOI 10.1080/10623320600660185
   Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333
   Moldovan NI, 2002, ARCH PATHOL LAB MED, V126, P320
   Santos JD, 1999, European. Patent, Patent No. [0068164, WO 0068164]
   Santos MI, 2007, BIOMATERIALS, V28, P240, DOI 10.1016/j.biomaterials.2006.08.006
   Soker S, 2000, WORLD J UROL, V18, P10, DOI 10.1007/PL00007070
   Sousa RC, 2008, J BIOMATER APPL, V22, P373, DOI 10.1177/0885328207078260
   Stamenovic D, 2005, ACTA BIOMATER, V1, P255, DOI 10.1016/j.actbio.2005.01.004
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Zhu YB, 2004, J MATER SCI-MATER M, V15, P283, DOI 10.1023/B:JMSM.0000015489.27261.f0
NR 45
TC 8
Z9 8
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2009
VL 20
IS 3
BP 725
EP 731
DI 10.1007/s10856-008-3628-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 409JJ
UT WOS:000263501700009
PM 18987948
DA 2018-10-19
ER

PT J
AU Macocinschi, D
   Filip, D
   Butnaru, M
   Dimitriu, CD
AF Macocinschi, Doina
   Filip, Daniela
   Butnaru, Maria
   Dimitriu, Cristina Daniela
TI Surface characterization of biopolyurethanes based on cellulose
   derivatives
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CONTACT-ANGLE MEASUREMENTS; CROSS-LINKED BLENDS; POLYURETHANE; POLYMERS;
   TENSION; BIOMATERIALS
AB Surface tension parameters and surface morphology of biopolyurethanes based on cellulose derivatives thin films, before and after HF cold plasma treatment has been investigated. Calculations are based on the geometric mean approach of Owens and Wendt, Rabel and Kalble, on the Lifshitz-van der Waals acid/base approach of van Oss and co-workers and on the theoretical methods involving quantitative structure-property relationship. For all the investigated samples the polar component contributes significantly to the total surface tensions, as due to the large electron donor interactions. HF cold plasma treatment modifies the surface energy of biopolyurethanes by changing their surface polarity and hydrophilicity. The hydrophilic/hydrophobic balance was studied by means of the free energy of hydration between the biomaterial film and water. The protein adsorption tests of fibrinogen were effected to evaluate the applicability of these biopolyurethanes as biomedical thromboresistant devices.
C1 [Macocinschi, Doina; Filip, Daniela] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
   [Butnaru, Maria; Dimitriu, Cristina Daniela] Gr T Popa Univ Med & Pharm, Fac Med Bioengn, Iasi 700115, Romania.
RP Macocinschi, D (reprint author), Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
EM eradro2002@yahoo.com
RI Filip, Daniela/F-6636-2013; Macocinschi, Doina/C-2565-2012; Butnaru,
   Maria/I-8195-2016
FU Romanian Academy [GAR 53/2008]
FX The authors gratefully acknowledge Romanian Academy (GAR 53/2008) for
   financial support for this work.
CR Abraham GA, 2002, BIOMATERIALS, V23, P1625, DOI 10.1016/S0142-9612(01)00289-7
   Adhikari R., 2003, EUR CELLS MATER, V5, P1
   Bicerano J, 1996, J MACROMOL SCI R M C, VC36, P161
   BLOOM AL, 1987, HAEMOSTASIS THROMBOS
   Cooper S., 1997, POLYURETHANES BIOMED
   Desai S, 2000, EUR POLYM J, V36, P711, DOI 10.1016/S0014-3057(99)00114-7
   El-Rehim H. A. Abd, 2004, J BIOMED MATER RES B, V68, P209
   ERBIL Y, 1997, CRC HDB SURFACE COLL, pCH9
   Faibish RS, 2002, J COLLOID INTERF SCI, V256, P341, DOI 10.1006/jcis.2002.8612
   Freij-Larsson C, 2000, BIOMATERIALS, V21, P307, DOI 10.1016/S0142-9612(99)00195-7
   GAST AP, 1986, MACROMOLECULES, V19, P686, DOI 10.1021/ma00157a035
   Ioanid G. E., 2005, Romanian Journal of Physics, V50, P1071
   Kalble D. H., 1969, J ADHESION, V1, P102
   Korematsu A, 1999, ACTA POLYM, V50, P363
   Lelah MD, 1993, POLYURETHANES MED
   LUPU M, 2007, J OPTOELECTRON ADV M, V9, P11
   MACOCINSCHI D, 2008, E-POLYMERS, V62, P1
   Napper DH, 1983, STERIC STABILIZATION
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Ozdemir Y, 2002, J MATER SCI-MATER M, V13, P1147, DOI 10.1023/A:1021185803716
   Plank H., 1987, PROGR BIOMEDICAL ENG, V3
   Rabel W., 1977, Physikalische Blaetter, V33, P151
   Ramis X, 2001, POLYMER, V42, P9469, DOI 10.1016/S0032-3861(01)00492-X
   Rankl M, 2003, COLLOID SURFACE B, V30, P177, DOI 10.1016/S0927-7765(03)00085-7
   STROM G, 1987, J COLLOID INTERF SCI, V119, P352, DOI 10.1016/0021-9797(87)90280-3
   Van Krevelen D.W., 1990, PROPERTIES POLYM
   VANOSS CJ, 1989, J COLLOID INTERF SCI, V128, P313, DOI 10.1016/0021-9797(89)90345-7
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Yoo HJ, 2005, BIOMATERIALS, V26, P2877, DOI 10.1016/j.biomaterials.2004.09.001
   Yoo HJ, 2004, J APPL POLYM SCI, V91, P2348, DOI 10.1002/app.13377
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 34
TC 27
Z9 27
U1 0
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2009
VL 20
IS 3
BP 775
EP 783
DI 10.1007/s10856-008-3626-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 409JJ
UT WOS:000263501700015
PM 19020959
DA 2018-10-19
ER

PT J
AU Lu, H
   Zhang, T
   Wang, XP
   Fang, QF
AF Lu, H.
   Zhang, T.
   Wang, X. P.
   Fang, Q. F.
TI Electrospun submicron bioactive glass fibers for bone tissue scaffold
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM SILICATE-GLASSES; GEL-DERIVED GLASSES; CAO-SIO2 SYSTEM;
   NANOFIBERS; NANOINDENTATION; MINERALIZATION; NANOCOMPOSITES;
   SPECTROSCOPY; BIOMATERIAL
AB Submicron bioactive glass fibers 70S30C (70 mol% SiO(2), 30 mol% CaO) acting as bone tissue scaffolds were fabricated by electrospinning method. The scaffold is a hierarchical pore network that consists of interconnected fibers with macropores and mesopores. The structure, morphological characterization and mechanical properties of the submicron bioactive glass fibers were studied by XRD, EDS, FIIR, SEM, N(2) gas absorption analyses and nanoindentation. The effect of the voltage on the morphology of electrospun bioactive glass fibers was investigated. It was found that decreasing the applied voltage from 19 to 7 kV can facilitate the formation of finer fibers with fewer bead defects. The hardness and Young's modulus of submicron bioactive glass fibers were measured as 0.21 and 5.5 GPa, respectively. Comparing with other bone tissue scaffolds measured by nanoindentation, the elastic modulus of the present scaffold was relatively high and close to the bone.
C1 [Lu, H.; Zhang, T.; Wang, X. P.; Fang, Q. F.] Chinese Acad Sci, Key Lab Mat Phys, Inst Solid State Phys, Hefei 230031, Peoples R China.
RP Fang, QF (reprint author), Chinese Acad Sci, Key Lab Mat Phys, Inst Solid State Phys, Hefei 230031, Peoples R China.
EM qffang@issp.ac.cn
CR ALMEIDA RM, 1990, J APPL PHYS, V68, P4225, DOI 10.1063/1.346213
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   Fischer-Cripps AC, 2006, SURF COAT TECH, V200, P4153, DOI 10.1016/j.surfcoat.2005.03.018
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2003, J MATER SCI, V38, P3783, DOI 10.1023/A:1025988301542
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Kim HW, 2008, J BIOMED MATER RES A, V85A, P651, DOI 10.1002/jbm.a.31339
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Lewis G, 2006, J BIOMED MATER RES B, V78B, P312, DOI 10.1002/jbm.b.30489
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Ni GX, 2006, BIOMATERIALS, V27, P1963, DOI 10.1016/j.biomaterials.2005.09.044
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5
   Saravanapavan P, 2004, BIO-MED MATER ENG, V14, P467
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P14, DOI 10.1016/S0022-3093(02)01882-3
   Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P1, DOI 10.1016/S0022-3093(02)01864-1
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   Skipper LJ, 2005, J MATER CHEM, V15, P2369, DOI 10.1039/b501496d
   Skipper LJ, 2004, J BIOMED MATER RES A, V70A, P354, DOI 10.1002/jbm.a.30093
   Sombatmankhong K, 2007, POLYMER, V48, P1419, DOI 10.1016/j.polymer.2007.01.014
   Song JH, 2008, J BIOMED MATER RES A, V84A, P875, DOI 10.1002/jbm.a.31330
   Srouji S, 2008, J MATER SCI-MATER M, V19, P1249, DOI 10.1007/s10856-007-3218-z
   Tan SH, 2005, POLYMER, V46, P6128, DOI 10.1016/j.polymer.2005.05.068
   Venugopal J, 2008, J MATER SCI-MATER M, V19, P2039, DOI 10.1007/s10856-007-3289-x
   Xia W, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/13/135601
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 34
TC 44
Z9 44
U1 0
U2 45
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2009
VL 20
IS 3
BP 793
EP 798
DI 10.1007/s10856-008-3649-1
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 409JJ
UT WOS:000263501700017
PM 19020952
DA 2018-10-19
ER

PT J
AU Zhu, YX
   Liu, TQ
   Song, KD
   Jiang, B
   Ma, XH
   Cui, ZF
AF Zhu, Yanxia
   Liu, Tianqing
   Song, Kedong
   Jiang, Bo
   Ma, Xuehu
   Cui, Zhanfeng
TI Collagen-chitosan polymer as a scaffold for the proliferation of human
   adipose tissue-derived stem cells
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CROSS-LINKING; STROMAL CELLS; CULTURE; DIFFERENTIATION; MATRIX;
   EXPANSION; GROWTH; ACID; GEL
AB The architecture and biomaterial are vital for three-dimensional culture of cells in scaffolds, so collagen-chitosan scaffolds suitable for the proliferation of adipose tissue-derived stem cells (ADSCs) were fabricated in this study. Chitosan was fully mixed with collagen with different volume ratio and cross-linked. The microstructure, pore size, bibulous ability, water content, interval porosity, enzyme degradation and affinity were examined before and after cross-linking. During ADSCs cultured in scaffold, the viability and metabolic rates were measured. After 14 days, the surface markers, specific transcription factors and multi-differentiation potential were assayed to identify the stemness of expanded cells. According to the pore size, bibulous ability, interval porosity, degradation rate and affinity of the scaffold, we chose cross-linked scaffolds of 7:3 material ratio as a better scaffold for ADSCs proliferation, and ADSCs could be expanded by more than 20 times. All expanded cells still maintained stem cell characteristics and pluripotency. So our developed collagen-chitosan scaffolds can promote ADSCs adhesion, expansion, and maintain pluripotency.
C1 [Zhu, Yanxia; Liu, Tianqing; Song, Kedong; Jiang, Bo; Ma, Xuehu] Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, Dalian 116024, Peoples R China.
   [Cui, Zhanfeng] Univ Oxford, Dept Engn Sci, Oxford Ctr Tissue Engn & Bioproc, Oxford OX1 3PJ, England.
RP Liu, TQ (reprint author), Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, Dalian 116024, Peoples R China.
EM liutq@dlut.edu.cn
FU National Natural Sciences Foundation of China; Young Teacher Culture
   Foundation of Dalian University of Technology
FX This work was supported by The National Natural Sciences Foundation of
   China and Young Teacher Culture Foundation of Dalian University of
   Technology.
CR Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116
   Buttafoco L, 2006, J BIOMED MATER RES B, V77B, P357, DOI 10.1002/jbm.b.30444
   Chen DC, 2007, J BIOMED MATER RES A, V80A, P399, DOI 10.1002/jbm.a.30932
   Chen RN, 2006, BIOMACROMOLECULES, V7, P1058, DOI 10.1021/bm050754b
   Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007
   Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031
   Gabbay JS, 2006, ANN PLAS SURG, V57, P89, DOI 10.1097/01.sap.0000205378.89052.d3
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Hao W, 2008, CELLS TISSUES ORGANS, V187, P89, DOI 10.1159/000109946
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009
   Kim M, 2006, BIOCHEM BIOPH RES CO, V348, P386, DOI 10.1016/j.bbrc.2006.07.063
   Lei L, 2007, SCI CHINA SER C, V50, P320, DOI 10.1007/s11427-007-0019-z
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   Lin J, 2007, J TISSUE ENG REGEN M, V1, P211, DOI 10.1002/term.27
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Osborne CS, 1999, BIOMATERIALS, V20, P283, DOI 10.1016/S0142-9612(98)00179-3
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Patel SD, 2000, BIOTECHNOL PROGR, V16, P885, DOI 10.1021/bp000080a
   Powell HM, 2007, BIOMATERIALS, V28, P1084, DOI 10.1016/j.biomaterials.2006.10.011
   Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303
   Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331
   Taguchi T, 2002, J BIOMED MATER RES, V61, P330, DOI 10.1002/jbm.10147
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   Ueda T, 2000, J CLIN INVEST, V105, P1013, DOI 10.1172/JCI8583
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   Varma MJO, 2007, STEM CELLS DEV, V16, P91, DOI 10.1089/scd.2006.0026
   Villinger F, 2001, J MED PRIMATOL, V30, P254, DOI 10.1034/j.1600-0684.2001.d01-57.x
   Wang B, 2007, NEUROSCI LETT, V421, P191, DOI 10.1016/j.neulet.2007.04.081
   Wang Xin, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P120
   WILLIAMS JL, 1994, BIORHEOLOGY, V31, P163
   Yan JH, 2006, ARTIF CELL BLOOD SUB, V34, P27, DOI [10.1080/10731190500430024, 10.1080/107311090500430024]
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488
NR 40
TC 49
Z9 55
U1 0
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2009
VL 20
IS 3
BP 799
EP 808
DI 10.1007/s10856-008-3636-6
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 409JJ
UT WOS:000263501700018
PM 19020954
DA 2018-10-19
ER

PT J
AU Lopez, MJ
   McIntosh, KR
   Spencer, ND
   Borneman, JN
   Horswell, R
   Anderson, P
   Yu, G
   Gaschen, L
   Gimble, JM
AF Lopez, Mandi J.
   McIntosh, Kevin R.
   Spencer, Nakia D.
   Borneman, Jade N.
   Horswell, Ronald
   Anderson, Paul
   Yu, Gang
   Gaschen, Lorrie
   Gimble, Jeffrey M.
TI Acceleration of Spinal Fusion Using Syngeneic and Allogeneic Adult
   Adipose Derived Stem Cells in a Rat Model
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE adipose; adult stem cells; spine; fusion; rat
ID BONE MORPHOGENETIC PROTEIN; MARROW STROMAL CELLS; IN-VIVO; REGENERATIVE
   MEDICINE; DIFFERENTIATION; GRAFT; IMMUNOGENICITY; STIMULATION; RABBIT;
   MATRIX
AB Posterolateral spinal fusion is the standard treatment for lumbar compression fractures. Adult adipose tissue-derived stem cells (ASCs) promote osteogenesis in vivo and in vitro. The hypothesis tested in this study was that syngeneic and allogeneic ASCs on a biomaterial scaffold composed of tricalcium phosphate and collagen I will accelerate spinal fusion in a rat model. ASCs from male Fischer or ACI rats were loaded onto scaffolds (53,571 cells/mm(3)) and cultured in stromal media for 48 h. Male Fisher rats were assigned to 4 cohorts (n =14/cohort) after bilateral decortication of the L4 and L5 transverse processes: (1) No treatment; (2) scaffold only; (3) scaffold + syngeneic ASCs; or (4) scaffold + allogeneic ASCs. Half of each cohort was harvested 4 or 8 weeks after surgery. Spinal fusion was evaluated with radiographs, microcomputed tomography, and light microscopy. Callus did not form in spines without scaffolds. There were no significant differences in callus formation among scaffold cohorts 4 weeks after surgery. Callus formation was more mature in both ASC cohorts versus scaffold alone 8 weeks after surgery based on microstructure as well as radiographic and microcomputed tomographic evidence of active bone formation. Inflammatory cell infiltrate was significantly lower in both ASC cohorts (syngeneic =18.3 +/- 0.85%; allogeneic = 23.5 +/- 2.33%n) versus scaffold alone (46.8 +/- 11.8%) 4 weeks after surgery. Results of this study support syngeneic and allogeneic ASC acceleration of posterior lumbar spinal fusion in a rat model. (C) 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:366-373, 2009
C1 [Lopez, Mandi J.; Spencer, Nakia D.; Gaschen, Lorrie] Louisiana State Univ, Sch Vet Med, Dept Vet Clin Sci, Lab Equine & Comparat Orthoped Res, Baton Rouge, LA 70803 USA.
   [McIntosh, Kevin R.; Borneman, Jade N.] Cognate BioServ Inc, Baltimore, MD 21227 USA.
   [Horswell, Ronald; Yu, Gang; Gimble, Jeffrey M.] Louisiana State Univ, Pennington Biomed Res Ctr, Stem Cell Lab, Baton Rouge, LA 70808 USA.
   [Anderson, Paul] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53792 USA.
RP Lopez, MJ (reprint author), Louisiana State Univ, Sch Vet Med, Dept Vet Clin Sci, Lab Equine & Comparat Orthoped Res, Skip Bertman Dr, Baton Rouge, LA 70803 USA.
EM mlopez@vetmed.lsu.edu
FU Pennington Biomedical Research Foundation; NIAMS [R41AR052542,
   AR008523-05]; CNRU Center [1P30 DK072476]; NIDDK
FX This work was supported in part by funding from the Pennington
   Biomedical Research Foundation, the NIAMS (R41AR052542) (M.J.L., K.R.M.,
   J.M.G.) and AR008523-05 (M.J.L.), and the CNRU Center Grant #1P30
   DK072476 sponsored by NIDDK (G.Y., J.M.G.). The authors wish to
   acknowledge Dr. Xiying Wu, Sandra Robinson, and Olga Borkhsenious for
   technical assistance.
CR Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Burkus JK, 2004, ORTHOP CLIN N AM, V35, P25, DOI 10.1016/S0030-5898(03)00053-1
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Cui QJ, 2001, SPINE, V26, P2305, DOI 10.1097/00007632-200111010-00003
   Djouad F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2153
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Glassman SD, 2008, SPINE J, V8, P443, DOI 10.1016/j.spinee.2007.03.004
   Helder MN, 2007, TISSUE ENG, V13, P1799, DOI 10.1089/ten.2006.0165
   Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005
   Kim UK, 2006, J ORAL MAXIL SURG, V64, P1498, DOI 10.1016/j.joms.2006.03.028
   Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7
   Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780
   Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6
   LINDHOLM TS, 1988, CLIN ORTHOP RELAT R, P296
   Lu SS, 2007, SPINE J, V7, P50, DOI 10.1016/j.spinee.2006.04.020
   Mankani MH, 2007, EXP HEMATOL, V35, P995, DOI 10.1016/j.exphem.2007.01.051
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Minamide A, 2001, SPINE, V26, P933, DOI 10.1097/00007632-200104150-00017
   Minamide A, 2007, SPINE, V32, P1067, DOI 10.1097/01.brs.0000261626.32999.8a
   Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114
   Peterson B, 2005, SPINE, V30, P283, DOI 10.1097/01.brs.0000152380.71248.fe
   Rao RD, 2008, SPINE J, V8, P563, DOI 10.1016/j.spinee.2007.04.017
   Sengenes C, 2007, STEM CELLS, V25, P2269, DOI 10.1634/stemcells.2007-0180
   Sheyn D, 2008, STEM CELLS, V26, P1056, DOI 10.1634/stemcells.2007-0858
   Valdes M, 2007, SPINE J, V7, P318, DOI 10.1016/j.spinee.2006.02.005
   Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302
   WONG DA, 2007, SPINE J
   Wrage PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001453
   Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
NR 34
TC 34
Z9 36
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAR
PY 2009
VL 27
IS 3
BP 366
EP 373
DI 10.1002/jor.20735
PG 8
WC Orthopedics
SC Orthopedics
GA 406PK
UT WOS:000263307200014
PM 18752292
OA Bronze, Green Accepted
DA 2018-10-19
ER

PT J
AU Sanpo, N
   Tan, ML
   Cheang, P
   Khor, KA
AF Sanpo, Noppakun
   Tan, Meng Lu
   Cheang, Philip
   Khor, Khiam Aik
TI Antibacterial Property of Cold-Sprayed HA-Ag/PEEK Coating
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article
DE characterization of HA biomaterial; cold gas dynamic spraying of
   nanopowders; nanopowders; spray deposition
ID HYDROXYAPATITE; IONS; AG+
AB The antibacterial behavior of HA-Ag (silver-doped hydroxyapatite) nanopowder and their composite coatings were investigated against Escherichia coli (DH5 alpha). HA-Ag nanopowder and PEEK (poly-ether-ether-ketone)-based HA-Ag composite powders were synthesized using in-house powder processing techniques. Bacteria culture assay of HA-Ag nanopowder and their composite powders displayed excellent bacteriostatic activity against E. coli. The antibacterial activity increased with increasing concentration of HA-Ag nanoparticle in these composite powders. These nanocomposite powders were subsequently used as feedstock to generate antibacterial coatings via cold spray technology. The ratios of HA-Ag to PEEK in their composite powders were 80:20, 60:40, 40:60, and 20:80 (wt.%). Microstructural characterization and phase analysis of feedstock powders and as-deposited coatings were carried out using FESEM/EDX and XRD. Antibacterial nanocomposite HA-Ag/PEEK coatings were successfully deposited using cold spraying parameters of 11-12 bars at preheated air temperature between 150 and 160 A degrees C. These as-sprayed coatings of HA-Ag/PEEK composite powders comprising varying HA-Ag and PEEK ratios retained their inherent antibacterial property as verified from bacterial assay. The results indicated that the antibacterial activity increased with increasing HA-Ag nanopowder concentration in the composite powder feedstock and cold-sprayed coating.
C1 [Sanpo, Noppakun; Tan, Meng Lu; Cheang, Philip; Khor, Khiam Aik] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.
RP Sanpo, N (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.
EM noppakuns@hotmail.com; tanml@ntu.edu.sg; ashncheang@ntu.edu.sg;
   mkakhor@ntu.edu.sg
RI Khor, Khiam Aik (Michael)/B-6929-2009; Khor, Khiam Aik/G-2827-2010
OI KHOR, Khiam/0000-0003-1954-8423
FU Nanyang Technological University [RG1/04]; joint research collaboration
   with ST Kinetics (Singapore)
FX We wish to acknowledge the funding support for this project (RG1/04)
   from Nanyang Technological University, and the joint research
   collaboration with ST Kinetics (Singapore).
CR Bhagat R. B., 1997, THERMAL SPRAY UNITED, P361
   Feng QL, 1998, THIN SOLID FILMS, V335, P214, DOI 10.1016/S0040-6090(98)00956-0
   Karthikeyan J, 2001, THERMAL SPRAY 2001: NEW SURFACES FOR A NEW MILLENNIUM, P383
   Karthikeyan J., 2000, THERMAL SPRAY SURFAC, P255
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Liao HL, 2001, THERMAL SPRAY 2001: NEW SURFACES FOR A NEW MILLENNIUM, P315
   McCune RC, 1996, THERMAL SPRAY: PRACTICAL SOLUTIONS FOR ENGINEERING PROBLEMS, P397
   SANPO N, 2008, P 2008 INT C BIOMEDI, P488
   SHIRKHANZADEH M, 1995, MATER LETT, V24, P7, DOI 10.1016/0167-577X(95)00059-3
   Stoltenhoff T, 2001, THERMAL SPRAY 2001: NEW SURFACES FOR A NEW MILLENNIUM, P409
   Yamamoto O, 2001, CARBON, V39, P1643, DOI 10.1016/S0008-6223(00)00289-X
   Yin J, 2008, POLYM BULL, V61, P157, DOI 10.1007/s00289-008-0942-6
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
NR 13
TC 34
Z9 35
U1 6
U2 60
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9630
EI 1544-1016
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD MAR
PY 2009
VL 18
IS 1
BP 10
EP 15
DI 10.1007/s11666-008-9283-0
PG 6
WC Materials Science, Coatings & Films
SC Materials Science
GA 403KG
UT WOS:000263080900003
DA 2018-10-19
ER

PT J
AU Kawase, T
   Okuda, K
   Kogami, H
   Nakayama, H
   Nagata, M
   Nakata, K
   Yoshie, H
AF Kawase, Tomoyuki
   Okuda, Kazuhiro
   Kogami, Hiroyuki
   Nakayama, Hitoshi
   Nagata, Masaki
   Nakata, Koh
   Yoshie, Hiromasa
TI Characterization of human cultured periosteal sheets expressing
   bone-forming potential: in vitro and in vivo animal studies
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE periostium; bone regeneration; osteoblast; implantation;
   differentiation; tissue engineering
ID LEUKEMIA INHIBITORY FACTOR; MATRIX DERIVATIVE EMDOGAIN(R); IMMOBILIZED
   PH GRADIENTS; SAMPLE APPLICATION; TGF-BETA; PROTEINS; PROLIFERATION;
   INTERLEUKIN-6; DEXAMETHASONE; OSTEOBLASTS
AB Our recent clinical studies have demonstrated that autologous implantation of human cultured periosteal (hCP) sheets in combination with porous hydroxylapatite (HAp) particles at the site of periodontal bone defects strikingly facilitates tissue regeneration. To better understand how the hCP sheet functions at the implantation site, we have now examined its biochemical and morphological characteristics in vitro and its ectopic osteoinductivity in nude mice. Cultured human periosteal tissue segments produced periosteal cells that migrated out from the central region within 4-8 days and grew more rapidly with longer culture times. Alkaline phosphatase activity increased in parallel with actual osteoblastic induction. Cytokine array assays demonstrated that osteoblastic induction downregulated IL-6 and thrombopoietin, but upregulated IL-8, IL-13, IGF-I and IGFBP-2 in hCP sheets. When differentiated hCP sheets were implanted alone, areas of osteoid and mineralized tissue were formed within 2 weeks, but non-induced, immature hCP sheets did not produce much mineralization. These findings suggest that mature hCP sheets potentially function not only as seeds of ectopic bone formation without the need of synthetic tissue scaffolds, but also as living drug-delivery systems, to influence cells near implantation sites by producing several important cytokines. These two major characteristics indicate that a mature hCP sheet is a promising osteoinductive biomaterial, even without conventional scaffolds for periodontal regenerative therapy. Copyright (c) 2009 John Wiley & Sons, Ltd.
C1 [Kawase, Tomoyuki; Kogami, Hiroyuki; Nakayama, Hitoshi] Niigata Univ, Inst Med & Dent, Dept Tissue Regenerat & Reconstitut, Div Oral Bioengn, Niigata 9518514, Japan.
   [Okuda, Kazuhiro; Yoshie, Hiromasa] Niigata Univ, Inst Med & Dent, Dept Oral Biol Sci, Div Periodontol, Niigata 9518514, Japan.
   [Nakayama, Hitoshi] Japan Sci & Technol Agcy Innovat Satellite Niigat, Nagaoka, Niigata 9402127, Japan.
   [Nagata, Masaki] Niigata Univ, Inst Med & Dent, Dept Oral Hlth Sci, Div Oral & Maxillolfacial Surg, Niigata 9518514, Japan.
   [Nakata, Koh] Niigata Univ, Med & Dent Hosp, Biosci Med Res Ctr, Niigata 9518520, Japan.
RP Kawase, T (reprint author), Niigata Univ, Inst Med & Dent, Dept Tissue Regenerat & Reconstitut, Div Oral Bioengn, Niigata 9518514, Japan.
EM kawase@dent.niigata-u.ac.jp
FU Ministry of Education, Sports, Science and Technology, Japan [17390558,
   19592140, 20500406]; Japan Science and Technology Agency
FX The authors wish to acknowledge Dr Douglas M. Burns for proofreading and
   editorial assistance. This project was funded through support by a
   grant-in-aid for Scientific Research from the Ministry of Education,
   Sports, Science and Technology, Japan (Grant Nos 17390558, 19592140 and
   20500406) and by Research for Promoting Technological Seeds 2007 and
   Practical Application Research from the Japan Science and Technology
   Agency. References
CR Calvert JW, 2008, CARDIOVASC RES, V77, P2, DOI 10.1093/cvr/cvm064
   COOPER LF, 1994, J BIOL CHEM, V269, P7869
   Cornish J, 1997, BONE, V21, P243, DOI 10.1016/S8756-3282(97)00144-0
   Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127
   Garrido C, 1999, FASEB J, V13, P2061
   Guenal I, 1997, ONCOGENE, V15, P347, DOI 10.1038/sj.onc.1201182
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x
   KARPATKIN S, 2005, HAEMATOLOGICA REPORT, V1, P25
   Kawase T, 2002, J PERIODONTAL RES, V37, P255, DOI 10.1034/j.1600-0765.2002.01615.x
   Kawase T, 2001, J PERIODONTAL RES, V36, P367, DOI 10.1034/j.1600-0765.2001.360604.x
   Kawase T, 2000, J PERIODONTAL RES, V35, P291, DOI 10.1034/j.1600-0765.2000.035005291.x
   Kristensen DB, 2000, ELECTROPHORESIS, V21, P430, DOI 10.1002/(SICI)1522-2683(20000101)21:2<430::AID-ELPS430>3.3.CO;2-S
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Lopez MF, 2000, ELECTROPHORESIS, V21, P3673, DOI 10.1002/1522-2683(200011)21:17<3673::AID-ELPS3673>3.0.CO;2-M
   LOWE C, 1991, J BONE MINER RES, V6, P1277
   MANOLAGAS SC, 1995, BONE, V17, pS63, DOI 10.1016/8756-3282(95)00180-L
   Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027
   Mizuno H, 2006, TISSUE ENG, V12, P1227, DOI 10.1089/ten.2006.12.1227
   OKUDA K, 2009, J INT ACAD IN PRESS
   Peter SJ, 1998, J CELL BIOCHEM, V71, P55, DOI 10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0
   RABILLOUD T, 1994, ELECTROPHORESIS, V15, P1552, DOI 10.1002/elps.11501501223
   Sanchez JC, 1997, ELECTROPHORESIS, V18, P324, DOI 10.1002/elps.1150180305
   Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9
   TENENBAUM HC, 1985, ENDOCRINOLOGY, V117, P2211, DOI 10.1210/endo-117-5-2211
   Yamagata A, 2002, PROTEOMICS, V2, P1267, DOI 10.1002/1615-9861(200209)2:9<1267::AID-PROT1267>3.0.CO;2-R
   Yamamiya K, 2008, J PERIODONTOL, V79, P811, DOI [10.1902/jop.2008.070518, 10.1902/jop.2008.070518 ]
   Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200
NR 27
TC 37
Z9 39
U1 0
U2 5
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2009
VL 3
IS 3
BP 218
EP 229
DI 10.1002/term.156
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 434IM
UT WOS:000265268400006
PM 19266490
DA 2018-10-19
ER

PT J
AU Hryniewicz, T
   Rokosz, K
   Filippi, M
AF Hryniewicz, Tadeusz
   Rokosz, Krzysztof
   Filippi, Massimiliano
TI Biomaterial Studies on AISI 316L Stainless Steel after
   Magnetoelectropolishing
SO MATERIALS
LA English
DT Article
DE 316L stainless steel; magnetoelectropolishing; polarization curves; SEM;
   Auger spectroscopy; XPS
AB The polarisation characteristics of the electropolishing process in a magnetic field (MEP - magnetoelectropolishing), in comparison with those obtained under standard/conventional process (EP) conditions, have been obtained. The occurrence of an EP plateau has been observed in view of the optimization of MEP process. Up-to-date stainless steel surface studies always indicated some amount of free-metal atoms apart from the detected oxides and hydroxides. Such a morphology of the surface film usually affects the thermodynamic stability and corrosion resistance of surface oxide layer and is one of the most important features of stainless steels. With this new MEP process we can improve metal surface properties by making the stainless steel more resistant to halides encountered in a variety of environments. Furthermore, in this paper the stainless steel surface film study results have been presented. The results of the corrosion research carried out by the authors on the behaviour of the most commonly used material. medical grade AISI 316L stainless steel both in Ringer's body fluid and in aqueous 3% NaCl solution have been investigated and presented earlier elsewhere, though some of these results, concerning the EIS Nyquist plots and polarization curves are also revealed herein. In this paper an attempt to explain this peculiar performance of 316L stainless steel has been undertaken. The SEM studies, Auger electron spectroscopy (AES) and X-ray photoelectron spectroscopy (XPS) were performed on 316L samples after three treatments: MP - abrasive polishing (800 grit size), EP - conventional electrolytic polishing, and MEP - magnetoelectropolishing. It has been found that the proposed magnetoelectropolishing (MEP) process considerably modifies the morphology and the composition of the surface film, thus leading to improved corrosion resistance of the studied 316L SS.
C1 [Hryniewicz, Tadeusz; Rokosz, Krzysztof] Koszalin Univ Technol, Div Surface Electrochem, PL-75620 Koszalin, Poland.
   [Filippi, Massimiliano] Fdn Bruno Kessler Irst, I-38050 Trento, Italy.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Div Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl; Krzysztof.Rokosz@tu.koszalin.pl
CR BARON A, 2006, J ACHIEV MAT MANUF E, V18, P55
   Dettner P., 1988, ELECTROLYTIC CHEM PO
   Honeycombe R. W. K, 1995, STEELS MICROSTRUCTUR
   Hryniewicz T, 2008, CORROSION, V64, P660, DOI 10.5006/1.3279927
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T., 1981, STUDY ELECTROPOLISHI, P122
   HRYNIEWICZ T, 2007, SURF ENG D, V2, P1
   HRYNIEWICZ T, 2007, P 16 INT MET MAT C M, P1
   HRYNIEWICZ T, 2002, SURF COAT TECH, V2002, P1668
   HRYNIEWICZ T, 2005, ELECTROCHEMISTRY SUR, P386
   HRYNIEWICZ T, 2006, COMP AUGER STUDIES 3
   HRYNIEWICZ T, 2007, SURFACE TREATMENT ME, P155
   HRYNIEWICZ T, 2007, 10 SLUPSK FOR MOT SL, P141
   Hryniewicz T., 2007, P 15 ANN INT C COMP, P345
   HRYNIEWICZ T, 2007, PHYS MET SCI C ADV M
   HRYNIEWICZ T, 2007, CORROS SCI, V50, P2676
   Hryniewicz T., 1989, MONOGRAFIE WSI KOSZA, V26, P161
   Hryniewicz T., 2007, P 4 INT C PREC MACH, V2, P159
   Kajzer W, 2006, J ACHIEV MAT MANUF E, V18, P115
   KERBER JS, 2000, ADV MATER PROCESS, P33
   Kocijan A, 2007, CORROS SCI, V49, P2083, DOI 10.1016/j.corsci.2006.11.001
   Lu ZP, 2006, CORROS SCI, V48, P3049, DOI 10.1016/j.corsci.2005.11.014
   Lu ZP, 2005, CORROS SCI, V47, P1471, DOI 10.1016/j.corsci.2004.07.043
   NAWRAT G, 1995, POL J APPL CHEM, V39, P477
   Rokicki R., 2008, MED DEVICE DIAGN IND, V30, P102
   ROKICKI R, 2006, MED DEVICE DIAGNOST
   ROKICKI R, 2006, Patent No. 2006124472
   Sedriks AJ., 1996, CORROSION STAINLESS
   SELVADURAY G, 2005, P C MAT PROC MES DEV
   Wang C, 2001, J SERB CHEM SOC, V66, P477
NR 31
TC 28
Z9 28
U1 1
U2 14
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2009
VL 2
IS 1
BP 129
EP 145
DI 10.3390/ma2010129
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA V20KS
UT WOS:000208139500008
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Archakov, A
   Ivanov, Y
   Lisitsa, A
   Zgoda, V
AF Archakov, Alexander
   Ivanov, Yurii
   Lisitsa, Andrey
   Zgoda, Victor
TI Biospecific irreversible fishing coupled with atomic force microscopy
   for detection of extremely low-abundant proteins
SO PROTEOMICS
LA English
DT Article
DE Atomic-force microscopy; Biospecific fishing; Detection limit; Molecular
   detectors; Optical biosensor
ID POLYACRYLAMIDE-GELS; COMPLEX-FORMATION; PLASMA-PROTEOME; DNA-MOLECULES;
   DYNAMIC-RANGE; CROSS-LINKING; LABEL-FREE; SYSTEM; ARRAYS; STATE
AB In the absence of an analog of PCR for proteins, the concentration detection limit (DL) becomes a real challenge. The problem may be solved by means of a combination of biospecific irreversible fishing with atomic force microscopy (AFM). AFM offers the ability to register individual molecules and their complexes, while biospecific fishing takes advantage of an affine interaction between analyte molecules spread over a large volume of biomaterial and ligand molecules immobilized on the chip surface. Fishing may be conducted in Kd-dependent reversible mode and in Kd-independent irreversible mode. In this study, the DLs of two previously applied proteomic approaches were determined and compared to the DL of a newly developed analytical method. The first approach, based on M S analysis of biomaterial after 2-DE or LC separation of proteins, attained a DL at the level of 10(-8)-10(-10) M. The second approach, based on the optical biosensor analysis of molecular interactions in the format of proteomic microarrays, had a DL of 10(-9)-10(-10) M. Our proposed method which combines biospecific fishing with AFM allowed us to attain DL values of 10(-11) M under reversible binding conditions and 10(-16) M under irreversible binding conditions.
C1 [Archakov, Alexander; Ivanov, Yurii; Lisitsa, Andrey; Zgoda, Victor] Inst Biomed Chem, Moscow, Russia.
RP Archakov, A (reprint author), Pogodinskaya Str 10, Moscow 119121, Russia.
EM alexander.archakov@ibmc.msk.ru
RI Archakov, Alexander/B-5194-2012; Lisitsa, Andrey/B-5260-2012
CR Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473
   Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   Archakov AI, 2007, MOL BIOSYST, V3, P336, DOI 10.1039/b618285b
   Archakov AI, 2003, PROTEOMICS, V3, P380, DOI 10.1002/pmic.200390053
   Archakov AI, 2007, PROTEOMICS, V7, P4, DOI 10.1002/pmic.200600467
   Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.0.CO;2-C
   Cutler P, 2003, PROTEOMICS, V3, P3, DOI 10.1002/pmic.200390007
   Garbis S, 2005, J CHROMATOGR A, V1077, P1, DOI 10.1016/j.chroma.2005.04.059
   Ghatnekar-Nilsson S, 2007, PROTEOMICS, V7, P540, DOI 10.1002/pmic.200600485
   Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797
   Hansma PK, 2006, SCIENCE, V314, P601, DOI 10.1126/science.1133497
   HARTLEY RW, 1993, BIOCHEMISTRY-US, V32, P5978, DOI 10.1021/bi00074a008
   Hinterdorfer P, 2001, J Biotechnol, V82, P25
   Horvatovich P, 2006, ANALYST, V131, P1193, DOI 10.1039/b607833h
   HUNSUCKER SW, 2006, PROTEOMICS, V6, P137
   Ivanov YD, 2006, PROTEOMICS, V6, P1399, DOI 10.1002/pmic.200402087
   Ivanov YD, 1999, BIOCHEM MOL BIOL INT, V47, P327
   Johnson CJ, 2008, PROTEOMICS, V8, P715, DOI 10.1002/pmic.200700665
   Kiselyova OI, 1999, ARCH BIOCHEM BIOPHYS, V371, P1, DOI 10.1006/abbi.1999.1412
   Kuznetsov VY, 2004, PROTEOMICS, V4, P2390, DOI 10.1002/pmic.200300751
   LI HH, 1990, P NATL ACAD SCI USA, V87, P4580, DOI 10.1073/pnas.87.12.4580
   Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965
   Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200
   Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v
   MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726
   MIKKELSEN RB, 1976, J BIOL CHEM, V251, P7413
   Miller I, 2006, PROTEOMICS, V6, P5385, DOI 10.1002/pmic.200600323
   Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3
   NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603
   Nielsen ML, 2006, MOL CELL PROTEOMICS, V5, P2384, DOI 10.1074/mcp.M600248-MCP200
   Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358
   Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003
   Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101
   Qureshi N, 2003, J IMMUNOL, V171, P1515, DOI 10.4049/jimmunol.171.3.1515
   Radko S. P., 2007, Biomeditsinskaya Khimiya, V53, P5
   Rose K, 2004, PROTEOMICS, V4, P2125, DOI 10.1002/pmic.200300718
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SAMATOV TR, 2005, NUCLEIC ACIDS RES, V33, P300
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Sinensky AK, 2007, NAT NANOTECHNOL, V2, P653, DOI 10.1038/nnano.2007.293
   Varnum Susan M, 2004, Methods Mol Biol, V264, P161
   Vettiger P, 2000, IBM J RES DEV, V44, P323, DOI 10.1147/rd.443.0323
   Wilkins MR, 2006, PROTEOMICS, V6, P4, DOI 10.1002/pmic.200500856
   Wingren C, 2007, DRUG DISCOV TODAY, V12, P813, DOI 10.1016/j.drudis.2007.08.003
   WIRTH PJ, 1995, J CHROMATOGR A, V698, P123, DOI 10.1016/0021-9673(94)00879-E
   WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2
   Yu XB, 2006, PROTEOMICS, V6, P5493, DOI 10.1002/pmic.200600216
NR 47
TC 37
Z9 51
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD MAR
PY 2009
VL 9
IS 5
BP 1326
EP 1343
DI 10.1002/pmic.200800598
PG 18
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 426GL
UT WOS:000264695900017
PM 19253286
DA 2018-10-19
ER

PT J
AU Niendorf, T
   Canadinc, D
   Maier, HJ
   Karaman, I
AF Niendorf, T.
   Canadinc, D.
   Maier, H. J.
   Karaman, I.
TI The role of grain size and distribution on the cyclic stability of
   titanium
SO SCRIPTA MATERIALIA
LA English
DT Article
DE Titanium; Ultrafine-grained material; Microstructure; Texture; Fatigue
ID INTERSTITIAL-FREE STEEL; STRESS-STRAIN RESPONSE; MICROSTRUCTURAL
   STABILITY; CORROSION PROPERTIES; FATIGUE BEHAVIOR; ULTRAFINE; COPPER;
   ALLOYS; TI; IMPLANTS
AB The role of grain refinement and microstructural inhomogeneities on the cyclic stability of ultrafine-grained (UFG), coarse-grained and bimodal titanium of commercial purity was investigated. The observed superior fatigue performance and the proven biocompatibility of UFG Ti promote its utility as a biomaterial. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Niendorf, T.; Maier, H. J.] Univ Gesamthsch Paderborn, Lehrstuhl Werkstoffkunde Mat Sci, D-33095 Paderborn, Germany.
   [Canadinc, D.] Koc Univ, Dept Mech Engn, TR-34450 Istanbul, Turkey.
   [Karaman, I.] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.
RP Niendorf, T (reprint author), Univ Gesamthsch Paderborn, Lehrstuhl Werkstoffkunde Mat Sci, Pohlweg 47-49, D-33095 Paderborn, Germany.
EM niendorf@mail.uni-paderborn.de
RI Karaman, Ibrahim/E-7450-2010
OI Karaman, Ibrahim/0000-0001-6461-4958; Niendorf,
   Thomas/0000-0003-2622-5817; Maier, Hans J./0000-0003-2119-824X
FU Deutsche Forschungsgemeinschaft; National Science Foundation [CMMI
   01-34554]; College of Engineering at Koc University
FX The help of Benedikt Wiethoff with the experiments is acknowledged. This
   work was supported by Deutsche Forschungsgemeinschaft, within the
   Research Unit Program "Mechanische Eigenschaften und Grenzflachen
   ultrafeinkorniger Werkstoffe", and by the National Science Foundation
   contract CMMI 01-34554, Materials Design and Surface Engineering
   Program. D.C. acknowledges the financial support by the College of
   Engineering at Koc University.
CR Afonso CRM, 2007, MAT SCI ENG C-BIO S, V27, P908, DOI 10.1016/j.msec.2006.11.001
   Balyanov A, 2004, SCRIPTA MATER, V51, P225, DOI 10.1016/j.scriptamat.2004.04.011
   Gabor P, 2007, METALL MATER TRANS A, V38A, P1916, DOI 10.1007/s11661-007-9230-6
   Geetha M, 2004, J ALLOY COMPD, V384, P131, DOI 10.1016/j.jallcom.2004.04.113
   Hadzima B, 2006, MATER SCI FORUM, V503-504, P883, DOI 10.4028/www.scientific.net/MSF.503-504.883
   Hadzima B, 2007, MAT SCI ENG A-STRUCT, V462, P243, DOI 10.1016/j.msea.2005.11.081
   Hoppel HW, 2006, INT J FATIGUE, V28, P1001, DOI 10.1016/j.ijfatigue.2005.08.014
   Hoppel HW, 2002, Z METALLKD, V93, P641
   Janecek M, 2005, KOVOVE MATER, V43, P258
   Kunz L, 2006, MAT SCI ENG A-STRUCT, V424, P97, DOI 10.1016/j.msea.2006.02.029
   Maier HJ, 2006, INT J FATIGUE, V28, P243, DOI 10.1016/j.ijfatigue.2005.05.004
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   May J, 2007, METALL MATER TRANS A, V38A, P1941, DOI 10.1007/s11661-007-9110-0
   Niendorf T, 2008, INT J FATIGUE, V30, P426, DOI 10.1016/j.ijfatigue.2007.04.015
   Niendorf T, 2007, METALL MATER TRANS A, V38A, P1946, DOI 10.1007/s11661-007-9154-1
   Niendorf T, 2007, ACTA MATER, V55, P6596, DOI 10.1016/j.actamat.2007.08.015
   Niendorf T, 2009, MAT SCI ENG A-STRUCT, V499, P518, DOI 10.1016/j.msea.2008.09.033
   NIENDORF T, UNPUB
   Niendorf T, 2006, INT J MATER RES, V97, P1328, DOI 10.3139/146.101377
   SAITOVA LR, 2008, INT J FATIGUE
   SAITOVA LR, 2008, MAT SCI ENG A-STRUCT
   Vinogradov AY, 2001, MAT SCI ENG A-STRUCT, V318, P163, DOI 10.1016/S0921-5093(01)01262-X
   Wielage B, 2008, MATER SCI FORUM, V584-586, P988, DOI 10.4028/www.scientific.net/MSF.584-586.988
   Yapici GG, 2006, MAT SCI ENG A-STRUCT, V434, P294, DOI 10.1016/j.msea.2006.06.082
NR 24
TC 25
Z9 27
U1 2
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD MAR
PY 2009
VL 60
IS 5
BP 344
EP 347
DI 10.1016/j.scriptamat.2008.10.033
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 395WD
UT WOS:000262553300020
DA 2018-10-19
ER

PT J
AU Stall, AC
   Becker, E
   Ludwig, SC
   Gelb, D
   Poelstra, KA
AF Stall, Alec C.
   Becker, Ed
   Ludwig, Steven C.
   Gelb, Daniel
   Poelstra, Kornelis A.
TI Reduction of Postoperative Spinal Implant Infection Using Gentamicin
   Microspheres
SO SPINE
LA English
DT Article
DE postoperative infection; biomaterial centered; PLGA; gentamicin;
   Staphylococcus aureus; rabbit model
ID ACRYLIC BONE-CEMENT; TOTAL KNEE ARTHROPLASTY; TOTAL HIP-ARTHROPLASTY;
   IN-VITRO; ELUTION CHARACTERISTICS; BACTERIAL ADHERENCE; BIOFILM
   FORMATION; WOUND INFECTIONS; DEEP INFECTION; TOBRAMYCIN
AB Study Design. Three noncontiguous spinal implant sites in 1 rabbit were challenged with Staphylococcus aureus and local antibiotic prophylaxis was given with gentamicin in controlled-release microspheres (poly(lactic-coglycolic-acid) [PLGA]). Postoperative biomaterial-centered infection on and around the titanium rods was assessed using standard bacterial quantification essays.
   Objective. To assess surgical site and biomaterial-centered infection reduction with controlled release gentamicin from microspheres against S. aureus.
   Summary of Background Data. A postoperative biomaterial-centered infection can be devastating after successful thoracolumbar spinal surgery and puts a high burden on patients, families, surgeons, and hospitals, endangering both our healthcare budget and our ability to perform challenging cases in patients with increasing numbers of comorbidities. Systemic antibiotics often do not reach "dead-space" hematomas where bacteria harbor after surgery, whereas local, controlled release gentamicin prophylaxis through PLGA microspheres showed favorable pharmacokinetics data to achieve local bactericidal concentrations for up to 7 days after surgery.
   Methods. A well published rabbit spinal implant model with systemic cephalosporin prophylaxis was challenged to create a baseline infection of similar to 70% in control sites. We then challenged 3 noncontiguous titanium rods inside the laminectomy defect with 10e6 colony forming units S. aureus and randomly treated 2 sites with gentamicin PLGA microspheres and 1 site with PLGA carrier only (control). Standard quantification techniques were used to assess biomaterial centered and soft tissue bacterial growth after 7 days.
   Results. After establishing reliable infection rates in control sites, the therapeutic arm of the study was started. Surgical site infections were found in 75% of control sites, whereas gentamicin microspheres reduced the incidence down to 38% in the same rabbits. Biomaterial-centered infection was reduced from 58% to 23% only in all sites challenged with 10e6 S. aureus.
   Conclusion. Postoperative, biomaterial-centered infection was reduced at least 50% with intraoperative gentamicin microspheres in the face of systemic cephalosporin prophylaxis and high dose S. aureus in a laminectomy defect in rabbits. The data are statistically and clinically significant, and further animal testing is planned to confirm these results.
C1 [Stall, Alec C.; Becker, Ed; Ludwig, Steven C.; Gelb, Daniel; Poelstra, Kornelis A.] Univ Maryland, Ctr Shock Trauma, Baltimore, MD 21212 USA.
RP Poelstra, KA (reprint author), Univ Maryland, Ctr Shock Trauma, 22 S Greene St,Suite 11B, Baltimore, MD 21212 USA.
EM kpoelstra@gmail.com
CR Andreshak TG, 1997, J SPINAL DISORD, V10, P376
   Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937
   Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174
   BUCHHOLZ HW, 1981, J BONE JOINT SURG BR, V63, P342
   Calderone RR, 1996, ORTHOP CLIN N AM, V27, P171
   DeLuise M, 2004, ORTHOPEDICS, V27, P1289
   Duncan C P, 1995, Instr Course Lect, V44, P305
   Glassman SD, 1996, SPINE, V21, P2163, DOI 10.1097/00007632-199609150-00021
   Gold HS, 1996, NEW ENGL J MED, V335, P1445, DOI 10.1056/NEJM199611073351907
   GRIFFITHS HJ, 1995, RADIOL CLIN N AM, V33, P401
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   HANSSEN AD, 1994, CLIN ORTHOP RELAT R, P44
   HOPE PG, 1989, J BONE JOINT SURG BR, V71, P851
   Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010
   Kendall RW, 1995, J ARTHROPLASTY, V10, P817, DOI 10.1016/S0883-5403(05)80081-6
   Kendall RW, 1996, CLIN ORTHOP RELAT R, P273
   Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572
   LAWSON KJ, 1990, ORTHOPEDICS, V13, P521
   Levi ADO, 1997, J NEUROSURG, V86, P975, DOI 10.3171/jns.1997.86.6.0975
   Lewis G, 2005, BIOMATERIALS, V26, P4317, DOI 10.1016/j.biomaterials.2004.11.003
   Maathuis PGM, 2005, CLIN ORTHOP RELAT R, P136, DOI 10.1097/01.blo.0000149997.14631.0c
   MASSIE JB, 1992, CLIN ORTHOP RELAT R, P99
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26
   MICLAU T, 1995, J ORTHOP TRAUMA, V9, P401, DOI 10.1097/00005131-199505000-00007
   Neut D, 2003, ACTA ORTHOP SCAND, V74, P670, DOI 10.1080/00016470310018180
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   OGA M, 1993, ACTA ORTHOP SCAND, V64, P273, DOI 10.3109/17453679308993623
   Penner MJ, 1996, J ARTHROPLASTY, V11, P939, DOI 10.1016/S0883-5403(96)80135-5
   Penner MJ, 1999, J ARTHROPLASTY, V14, P209, DOI 10.1016/S0883-5403(99)90128-6
   Poelstra KA, 2000, SPINE, V25, P406, DOI 10.1097/00007632-200002150-00003
   Poelstra KA, 2007, 53 ORTH RES SOC ORS
   Schwank S, 1998, ANTIMICROB AGENTS CH, V42, P895, DOI 10.1128/AAC.42.4.895
   Sculco T P, 1993, Instr Course Lect, V42, P349
   Sheridan R L, 1994, Adv Surg, V27, P43
   Springer BD, 2004, CLIN ORTHOP RELAT R, P47, DOI 10.1097/01.blo.0000144476.43661.10
   Sterling GJ, 2003, J BONE JOINT SURG BR, V85B, P646, DOI 10.1302/0301-620X.85B5.13746
   THALGOTT JS, 1991, SPINE, V16, P981, DOI 10.1097/00007632-199108000-00020
   Theiss SM, 1996, ORTHOP CLIN N AM, V27, P105
   Thomes B, 2002, J Bone Joint Surg Br, V84, P758
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   van de Belt H, 2000, ACTA ORTHOP SCAND, V71, P625, DOI 10.1080/000164700317362280
NR 43
TC 30
Z9 33
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD MAR 1
PY 2009
VL 34
IS 5
BP 479
EP 483
DI 10.1097/BRS.0b013e318197e96c
PG 5
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 440BT
UT WOS:000265673900009
PM 19247168
DA 2018-10-19
ER

PT J
AU Ponnappan, RK
   Serhan, H
   Zarda, B
   Patel, R
   Albert, T
   Vaccaro, AR
AF Ponnappan, Ravi K.
   Serhan, Hassan
   Zarda, Brett
   Patel, Ravi
   Albert, Todd
   Vaccaro, Alexander R.
TI Biomechanical evaluation and comparison of polyetheretherketone rod
   system to traditional titanium rod fixation
SO SPINE JOURNAL
LA English
DT Article
DE PEEK; Polyetheretherketone; Lumbar; Instrumentation; Fusion;
   Biomechanics
ID LUMBAR SPINE; INSTRUMENTATION; FUSION; ARTHRODESIS; CURVES; MODEL
AB BACKGROUND CONTEXT: Polyetheretherketone (PEEK) has been increasingly used as a biomaterial for spinal implants. PEEK lumbar fusion rods have recently become available for use in posterior lumbar fusion procedures.
   PURPOSE: To compare Polyetheretherketone Rod System to traditional titanium rod fixation in a cadaveric model and provide mechanical test data for the PEEK system.
   STUDY DESIGN: Biomechanical testing.
   METHODS: Cadaveric biomechanical testing was conducted to compare Expedium 5.5 min PEEK rods to titanium rods of equivalent diameter. Biomaterials testing was performed to determine static and dynamic performance of Expedium 5.5 mm PEEK rods with 6% BaSo4 in compressive bending and torsion.
   RESULTS: Cadaveric testing demonstrated that PEEK rods can significantly reduce the range of motion of a destabilized segment. The testing showed no significant difference in the stability provided by PEEK and titanium rods in posterolateral fusion (PLF) or posterior lumbar interbody fusion (PLIF) constructs. PEEK static compressive bending tests showed 67 degrees displacement without fracture of the rod. Torsion testing showed 30 degrees of rotation without yield or plastic deformation. Dynamic compression testing revealed two fatigue runouts at 23 degrees.
   CONCLUSIONS: PEEK rods provide comparable stability to titanium rods of equivalent diameter in cadaveric testing. Mechanical testing suggests PEEK rods can withstand far beyond the angular displacements suggested by cadaveric testing and that of normal physiologic range of motion. Potential advantages to PEEK rods include better anterior column load sharing, reduced stress at bone-to-screw interface, and reduced computed tomography and magnetic resonance imaging scatter and artifact. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Ponnappan, Ravi K.; Patel, Ravi; Albert, Todd; Vaccaro, Alexander R.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.
   [Serhan, Hassan; Zarda, Brett] DePuy Spine, Raynham, MA USA.
RP Ponnappan, RK (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Orthopaed Surg, 925 Chestnut St, Philadelphia, PA 19107 USA.
EM Ravi.Ponnappan@rothmaninstitute.com
OI Serhan, Hassan/0000-0003-4914-5027
FU ARV and TA: Royalties; HS and BZ
FX The following authors acknowledge a financial relationship: ARV and TA:
   Royalties; HS and BZ: Other office in the company, which may indirectly
   relate to the subject of this research.
CR Asher MA, 2007, J SPINAL DISORD TECH, V20, P549, DOI 10.1097/BSD.0b013e31804c98e5
   Dobbs MB, 2006, SPINE, V31, P2386, DOI 10.1097/01.brs.0000238965.81013.c5
   Gerber M, 2006, SPINE, V31, P762, DOI 10.1097/01.brs.0000206360.83728.d2
   Grob D, 2005, SPINE, V30, P324, DOI 10.1097/01.brs.0000152584.46266.25
   Highsmith Jason M, 2007, Neurosurg Focus, V22, pE11
   Kowalski R J, 2001, Neurosurg Focus, V10, pE2
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Mandigo Christopher E, 2007, Neurosurg Focus, V22, pE9
   Narayan P, 2002, J NEUROSURG, V97, P277, DOI 10.3171/spi.2002.97.3.0277
   PANJABI MM, 1977, ORTHOP CLIN N AM, V8, P181
   Phillips Frank M, 2006, Spine J, V6, P714, DOI 10.1016/j.spinee.2006.02.003
   Rivard CH, 2002, J BIOMED MATER RES, V62, P488, DOI 10.1002/jbm.10159
   SCHWAB FJ, 1995, SPINE, V20, P2023, DOI 10.1097/00007632-199509150-00014
   Senegas J, 2002, EUR SPINE J, V11, pS164, DOI 10.1007/s00586-002-0423-9
   Spenciner David, 2006, Spine J, V6, P248, DOI 10.1016/j.spinee.2005.08.020
   Stanford RE, 2004, SPINE, V29, P367, DOI 10.1097/01.BRS.0000092369.50397.85
   Thomsen K, 1997, SPINE, V22, P2813, DOI 10.1097/00007632-199712150-00004
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce
   Wang Julia Y, 2005, Med Immunol, V4, P4, DOI 10.1186/1476-9433-4-4
   Wedemeyer M, 2007, SPINE, V32, P42, DOI 10.1097/01.brs.0000251036.99413.20
   Welch William C, 2007, Neurosurg Focus, V22, pE8
NR 22
TC 74
Z9 85
U1 1
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1529-9430
EI 1878-1632
J9 SPINE J
JI Spine Journal
PD MAR
PY 2009
VL 9
IS 3
BP 263
EP 267
DI 10.1016/j.spinee.2008.08.002
PG 5
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 414SQ
UT WOS:000263885900010
PM 18838341
DA 2018-10-19
ER

PT J
AU Sha, JM
   Tao, YQ
   Yan, ZY
   Li, DH
   Hu, HF
AF Sha, Ji-ming
   Tao, Yi-qin
   Yan, Zhong-ya
   Li, Dao-hang
   Hu, Hai-feng
TI Cytotoxicity Evaluation of Hydroxyapatite on Human Umbilical Cord Vein
   Endothelial Cells for Mechanical Heart Valve Prosthesis Applications
SO THORACIC AND CARDIOVASCULAR SURGEON
LA English
DT Article
DE MTT assay; hydroxyapatite; biocompatibility; human umbilical vein
   endothelial cells; mechanical heart valve prostheses
ID PHENOTYPE EXPRESSION; BLOOD COMPATIBILITY; COLORIMETRIC ASSAY; BONE;
   CERAMICS; IMPLANTS; SURGERY; GROWTH; REPAIR
AB Background: Valvular heart disease is a significant cause of morbidity and mortality worldwide. Artificial heart valves are currently the most widely accepted biomedical material. However, the material's blood compatibility is still not sufficient. Biomaterial with a good biocompatibility has not yet appeared. Our initial study was to evaluate the probable cytotoxicity of hydroxyapatite (HA) on human umbilical vein endothelial cells (HUVEC) for mechanical heart valve prosthesis applications.
   Methods and Results: Cell growth was tested by MTT assay and the cell relative growth rate (RGR) was calculated. Cells were cultured in media consisting of either leaching extracts of hydroxyapatite at 37 degrees C or leaching extracts at 121 degrees C or a negative and a positive control group, respectively. The cytotoxicity was graded using generally accepted standards. The RGR of cell lines cultured in the Culture media consisting of either normal or heat temperature leaching extracts of hydroxyapatite and the negative controls were higher than in the positive controls. For 24 In, 48 In, and 72 h cultures, the cytotoxicity grade of HA was 0 in the normal temperature leaching extracts of hydroxyapatite and 1 in the heat temperature leaching extracts of hydroxyapatite.
   Conclusions: Human umbilical cord endothelial cells grew well in the HA extracts. Our results indicate that HA possesses good in vitro bioactivity and biocompatibility with human umbilical cord endothelial cells and could be used as film on mechanical heart valve prostheses.
C1 [Sha, Ji-ming; Tao, Yi-qin; Li, Dao-hang; Hu, Hai-feng] Chao Hu First Peoples Hosp, Chao Hu 2380000, Peoples R China.
   [Yan, Zhong-ya] AnHui Prov Hosp, Hefei, Peoples R China.
RP Sha, JM (reprint author), Chao Hu First Peoples Hosp, Chao Hu 2380000, Peoples R China.
EM shajiming@163.com
CR Akahane M, 1999, J BONE MINER RES, V14, P561, DOI 10.1359/jbmr.1999.14.4.561
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Cooke F W, 1992, Clin Orthop Relat Res, P135
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   GUOPING C, 2002, MACROMOL BIOSCI, V2, P67
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HEO DS, 1990, CANCER RES, V50, P3681
   Hing KA, 1998, P I MECH ENG H, V212, P437, DOI 10.1243/0954411981534204
   HONGO T, 1990, CANCER-AM CANCER SOC, V65, P1263, DOI 10.1002/1097-0142(19900315)65:6<1263::AID-CNCR2820650602>3.0.CO;2-S
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEMONS JE, 1988, CLIN ORTHOP RELAT R, P220
   Leng YX, 2001, THIN SOLID FILMS, V398, P471, DOI 10.1016/S0040-6090(01)01448-1
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   MCINTYRE JP, 1991, AM CERAM SOC BULL, V70, P1499
   Mitamura Y, 1989, J Biomater Appl, V4, P33, DOI 10.1177/088532828900400103
   Mol A, 2004, INT J CARDIOL, V95, pS57, DOI 10.1016/j.ijcard.2004.04.000
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.3.CO;2-3
   OONISHI H, 1989, J BONE JOINT SURG BR, V71, P213
   Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Tsiridis E, 2006, INJURY, V37, pS10, DOI 10.1016/j.injury.2006.08.019
   Vitale N, 2004, ANN THORAC SURG, V77, P527, DOI 10.1016/S0003-4975(03)01347-X
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 37
TC 3
Z9 3
U1 1
U2 7
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0171-6425
EI 1439-1902
J9 THORAC CARDIOV SURG
JI Thorac. Cardiovasc. Surg.
PD MAR
PY 2009
VL 57
IS 2
BP 74
EP 78
DI 10.1055/s-2008-1038986
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 424CG
UT WOS:000264542500002
PM 19241307
DA 2018-10-19
ER

PT J
AU Lim, JY
AF Lim, Jung Yul
TI Topographic Control of Cell Response to Synthetic Materials
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Anisotropic and isotropic topography; contact guidance; micro- and
   nanotexture
ID OSTEOBLAST-LIKE CELLS; MICROTEXTURED SILICONE; NANOSCALE TOPOGRAPHY;
   FIBROBLAST RESPONSE; SURFACE-ROUGHNESS; IN-VITRO; ADHESION;
   NANOTOPOGRAPHY; ATTACHMENT; ALIGNMENT
AB How to control cell behavior at cell-biomaterial interfaces is a critical task in today's implant science, tissue engineering, and regenerative medicine. Various biomaterial surface modification techniques, either chemical or topographical, have been introduced to induce optimal regulation of cell behavior. Among them, topographic control of cell behavior has long been recognized, for example, cells align to the anisotropic direction of ridge and groove topographies (contact guidance). In this review, cell sensing and response to Substratum surface topographies will be reviewed in terms of anisotropic vs. isotropic topographies and microscale vs. nanoscale topographies. It is clear that anisotropic topographies induce morphological cell reaction(cell orientation) and then downstream cell responses. Oil the other hand, isotropic topographies do not induce contact guidance while influencing collective cell functions(such as degree of adhesion, proliferation rate, degree of differentiation, etc). For both topographies, there exist threshold topographic scales from which specific cell sensing and response occur. Clear understanding of cell response to substrate topographies would be very helpful for developing novel regenerative medicine protocols.
C1 Univ Nebraska, Dept Engi Mech, Lincoln, NE 68588 USA.
RP Lim, JY (reprint author), Univ Nebraska, Dept Engi Mech, Lincoln, NE 68588 USA.
EM jlim4@unl.edu
FU NSF-Nebraska EPSCoR
FX This work was supported by NSF-Nebraska EPSCoR Research Infrastructure
   Improvement(RLI) Grant(EPS-0701892), Army Research Office(W91 I NF-08- I
   0483), and University of Nebraska-Lincoln Faculty Seed Grant(VV`BS
   #26-1110-9002-010).
CR Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bannister SR, 2002, J BIOMED MATER RES, V60, P167, DOI 10.1002/jbm.10037
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   Hamilton DW, 2005, CELL BIOL INT, V29, P408, DOI 10.1016/j.cellbi.2004.12.008
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Lee SJ, 2008, TISSUE ENG REGEN MED, V5, P33
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   LIM JY, 2007, BIOMATERIALS, V29, P1787
   LIM JY, 2006, 52 ORTH RES SOC CHIC
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Mata A, 2002, J BIOMED MATER RES, V62, P499, DOI 10.1002/jbm.10353
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   STOTHARD BW, 1995, CELL MOTIL CYTOSKEL, V31, P147
   STOTHARD BW, 1996, EXP CELL RES, V223, P426
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Walboomers XF, 2000, J BIOMED MATER RES, V51, P529, DOI 10.1002/1097-4636(20000905)51:3<529::AID-JBM30>3.0.CO;2-R
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   YIM EK, 2007, EXP CELL RES, V15, P1820
   Yun SH, 2008, TISSUE ENG REGEN MED, V5, P835
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
NR 40
TC 12
Z9 12
U1 1
U2 18
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JEONJU
PA CHONBUK NATIONAL UNIV, DEPT POLYMER-NANO SCIENCE & TECH, 664-14,
   DUCKJIN, JEONJU, 561-756, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD MAR
PY 2009
VL 6
IS 1-3
BP 365
EP 370
PG 6
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 418TI
UT WOS:000264171500051
DA 2018-10-19
ER

PT J
AU Oliveira, SM
   Mijares, DQ
   Turner, G
   Amaral, IF
   Barbosa, MA
   Teixeira, CC
AF Oliveira, Serafim M.
   Mijares, Dindo Q.
   Turner, Gloria
   Amaral, Isabel F.
   Barbosa, Mario A.
   Teixeira, Cristina C.
TI Engineering Endochondral Bone: In Vivo Studies
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID GROWTH-PLATE CHONDROCYTES; CALCIUM-PHOSPHATE BIOMATERIAL;
   ARTICULAR-CARTILAGE DEFECTS; MARROW STROMAL CELLS; MATRIX VESICLES;
   CORTICAL BONE; COMPOSITE; REPAIR; MINERALIZATION; GENE
AB The use of biomaterials to replace lost bone has been a common practice for decades. More recently, the demands for bone repair and regeneration have pushed research into the use of cultured cells and growth factors in association with these materials. Here we report a novel approach to engineer new bone using a transient cartilage scaffold to induce endochondral ossification. Chondrocyte/chitosan scaffolds (both a transient cartilage scaffold-experimental-and a permanent cartilage scaffold-control) were prepared and implanted subcutaneously in nude mice. Bone formation was evaluated over a period of 5 months. Mineralization was assessed by Faxitron, micro computed tomography, backscatter electrons, and Fourier transform infrared spectroscopy analyses. Histological analysis provided further information on tissue changes in and around the implanted scaffolds. The deposition of ectopic bone was detected in the surface of the experimental implants as early as 1 month after implantation. After 3 months, bone trabeculae and bone marrow cavities were formed inside the scaffolds. The bone deposited was similar to the bone of the mice vertebra. Interestingly, no bone formation was observed in control implants. In conclusion, an engineered transient cartilage template carries all the signals necessary to induce endochondral bone formation in vivo.
C1 [Oliveira, Serafim M.; Turner, Gloria; Teixeira, Cristina C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA.
   [Oliveira, Serafim M.; Amaral, Isabel F.; Barbosa, Mario A.] ESTV, Dept Mech Engn, Viseu, Portugal.
   [Oliveira, Serafim M.] INEB Inst Engn Biomed, Div Biomat, Oporto, Portugal.
   [Oliveira, Serafim M.; Barbosa, Mario A.] Univ Porto, Fac Engn, Dept Met & Mat, P-4100 Oporto, Portugal.
   [Mijares, Dindo Q.; Teixeira, Cristina C.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
RP Teixeira, CC (reprint author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 E 24th St, New York, NY 10010 USA.
EM ct40@nyu.edu
RI Amaral, Isabel/K-1732-2013; Barbosa, Mario/F-5964-2011
OI Amaral, Isabel/0000-0003-2921-3627; Barbosa, Mario/0000-0003-3568-7482;
   Melo de Oliveira, Serafim Paulo/0000-0002-3499-6681
FU Luso-American Development Foundation (Portugal); Calouste Gulbenkian
   Foundation (Portugal); PRODEP (Portugal); American Association of
   Orthodontics Foundation; NIDCR [5K08DE017426]
FX This work was supported by the Luso-American Development Foundation
   (Portugal), the Calouste Gulbenkian Foundation (Portugal), PRODEP
   (Portugal), the American Association of Orthodontics Foundation, and
   NIDCR grant 5K08DE017426. The authors would like to thank Mr. Nuno
   Pontes for the illustration work.
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266
   Bikram M, 2007, ANN BIOMED ENG, V35, P796, DOI 10.1007/s10439-007-9263-4
   Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043
   Cadet ER, 2003, J BONE JOINT SURG AM, V85A, P1739, DOI 10.2106/00004623-200309000-00013
   CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9
   Case ND, 2003, TISSUE ENG, V9, P587, DOI 10.1089/107632703768247296
   Chan C, 2002, INT J ORAL MAX SURG, V31, P73, DOI 10.1054/ijom.2001.0143
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Dong J, 2001, MAT SCI ENG C-BIO S, V17, P37, DOI 10.1016/S0928-4931(01)00333-2
   Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034
   Dupraz A, 1998, J BIOMED MATER RES, V42, P368, DOI 10.1002/(SICI)1097-4636(19981205)42:3<368::AID-JBM4>3.3.CO;2-V
   Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2
   Garimella R, 2004, BONE, V34, P961, DOI 10.1016/j.bone.2004.02.010
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gauthier O, 2003, J BIOMED MATER RES A, V66A, P47, DOI 10.1002/jbm.a.10506
   Gerber HP, 1999, NAT MED, V5, P623
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439
   HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606
   Iwamoto M, 2001, OSTEOARTHR CARTILAGE, V9, pS41, DOI 10.1053/joca.2001.0443
   JIKKO A, 1993, DEV BIOL, V156, P372, DOI 10.1006/dbio.1993.1084
   Kim H, 2005, BIOCHEM BIOPH RES CO, V332, P1053, DOI 10.1016/j.bbrc.2005.05.051
   Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149
   Kojima K, 2003, ANN THORAC SURG, V76, P1884, DOI 10.1016/S0003-4975(03)01193-7
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   LEE C, 2006, CARTILAGE TISSUE ENG, V2, P1
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   Maroudas A, 1998, ARCH BIOCHEM BIOPHYS, V350, P61, DOI 10.1006/abbi.1997.0492
   Montufar-Solis D, 2004, ANN BIOMED ENG, V32, P504, DOI 10.1023/B:ABME.0000017546.29064.fc
   Musgrave DS, 2000, CLIN ORTHOP RELAT R, P290
   Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9
   OLIVEIRA SM, 2007, ENG ENDOCHONDRAL BON
   Petersen W, 2002, J ANAT, V201, P153, DOI 10.1046/j.1469-7580.2002.00085.x
   Pountos I, 2006, J BONE JOINT SURG BR, V88B, P421, DOI 10.1302/0301-620x.88B4.17060
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Tanck E, 2006, J ANAT, V208, P73, DOI 10.1111/j.1469-7580.2006.00503.x
   Trepczik B, 2007, BONE, V40, P597, DOI 10.1016/j.bone.2006.10.011
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Valimaki VV, 2005, TISSUE ENG, V11, P387, DOI 10.1089/ten.2005.11.387
   van Gaalen SM, 2004, TISSUE ENG, V10, P231, DOI 10.1089/107632704322791871
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P1513, DOI 10.1016/S0142-9612(99)00062-9
   YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002
NR 47
TC 34
Z9 36
U1 0
U2 11
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR
PY 2009
VL 15
IS 3
BP 635
EP 643
DI 10.1089/ten.tea.2008.0052
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 415DG
UT WOS:000263913900019
PM 18759673
OA Green Published, Green Accepted
DA 2018-10-19
ER

PT J
AU Elvassore, N
AF Elvassore, N.
TI Injectable Photocuring Biomaterial Shaping 3D Cell Delivery
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 3rd Congress on Regenerative Biology and Medicine/3rd Congress of the
   German-Society-for-Stem-Cell-Research
CY OCT 09-11, 2008
CL Stuttgart, GERMANY
SP German Soc Stem Cell Res
C1 [Elvassore, N.] Univ Padua, BioERA Lab, Dept Chem Engn, I-35100 Padua, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR
PY 2009
VL 15
IS 3
BP 679
EP 679
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 415DG
UT WOS:000263913900030
DA 2018-10-19
ER

PT J
AU Goepfert, C
   Fritsch, D
   Richter, T
   Janssen, R
   Portner, R
AF Goepfert, C.
   Fritsch, D.
   Richter, T.
   Janssen, R.
   Poertner, R.
TI Modification of Biomaterial Surface Structures for the In Vitro
   Generation of Osteochondral Implants
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 3rd Congress on Regenerative Biology and Medicine/3rd Congress of the
   German-Society-for-Stem-Cell-Research
CY OCT 09-11, 2008
CL Stuttgart, GERMANY
SP German Soc Stem Cell Res
C1 [Goepfert, C.; Fritsch, D.; Richter, T.; Janssen, R.; Poertner, R.] Tech Univ Hamburg, Hamburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR
PY 2009
VL 15
IS 3
BP 726
EP 727
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 415DG
UT WOS:000263913900180
DA 2018-10-19
ER

PT J
AU Cui, TK
   Yan, YN
   Zhang, RJ
   Liu, L
   Xu, W
   Wang, XH
AF Cui, Tongkui
   Yan, Yongnian
   Zhang, Renji
   Liu, Li
   Xu, Wei
   Wang, Xiaohong
TI Rapid Prototyping of a Double-Layer Polyurethane-Collagen Conduit for
   Peripheral Nerve Regeneration
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID BIOARTIFICIAL LIVERS; NEURITE EXTENSION; REPAIR; GRAFT; GUIDE;
   MANUFACTURE; GROWTH; GAP
AB A new technique for preparing double-layer polyurethane (PU)-collagen nerve conduits for peripheral nerve repair via a double-nozzle, low-temperature, deposition manufacturing (DLDM) system has been developed. The DLDM system is based on a digital prototyping approach, and uses a combination of thermally induced phase separation and freeze-drying. With this system, two kinds of biomaterials with different properties can be combined to produce scaffold structures with good biocompatibility in the inner layer and with the desired mechanical strength protruded by the outer. The forming precision is high, the wall thickness can be controlled, and a tight connection between the two layers can be achieved. The effects of changing the processing parameters and the material temperature on the structure of the scaffolds have been investigated. Additionally, the effect of material concentration on the mechanical strength and hydrophilic properties of the scaffolds has also been studied. Ideal peripheral nerve repair conduits, comprising an outer microporous layer of PU and internal oriented filaments of collagen, have been manufactured through optimizing the processing parameters and the biomaterial concentrations.
C1 [Cui, Tongkui; Yan, Yongnian; Zhang, Renji; Liu, Li; Xu, Wei; Wang, Xiaohong] Tsinghua Univ, Dept Mech Engn, Ctr Organ Mfg, Beijing 100084, Peoples R China.
   [Cui, Tongkui; Yan, Yongnian; Zhang, Renji; Liu, Li; Xu, Wei; Wang, Xiaohong] Minist Educ Res, Key Lab Adv Mat Proc Technol, Beijing, Peoples R China.
   [Cui, Tongkui; Yan, Yongnian; Zhang, Renji; Liu, Li; Xu, Wei; Wang, Xiaohong] Tsinghua Univ, Inst Life Sci & Med, Beijing 100084, Peoples R China.
RP Wang, XH (reprint author), Tsinghua Univ, Dept Mech Engn, Ctr Organ Mfg, Beijing 100084, Peoples R China.
EM wangxiaohong@tsinghua.edu.cn
FU National Natural Science Foundation of China [50731160625, 30540060,
   30440043]; Foundation of Key Laboratory for Advanced Materials
   Processing Technology; Ministry of Education of China [2006009]; Beijing
   Municipal Science and Technology Commission [H060920050530]
FX This study was supported by the National Natural Science Foundation of
   China/the Research Grants Council of Hong Kong (NSFC/RGC, Grant No.
   50731160625), the Foundation of Key Laboratory for Advanced Materials
   Processing Technology, Ministry of Education of China (Grant No.
   2006009), and the National Natural Science Foundation of China (Grant
   No. 30540060 & 30440043). The authors gratefully thank Beijing Municipal
   Science and Technology Commission for its contribution to this project
   (Grant No. H060920050530).
CR AEBISCHER P, 1988, BRAIN RES, V454, P179, DOI 10.1016/0006-8993(88)90817-7
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   CUI TK, J BIOACT CO IN PRESS
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   denDunnen WFA, 1996, J BIOMED MATER RES, V31, P105, DOI 10.1002/(SICI)1097-4636(199605)31:1<105::AID-JBM13>3.0.CO;2-M
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   HENTZ VR, 1991, J HAND SURG-AM, V16A, P251, DOI 10.1016/S0363-5023(10)80106-6
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   LIU L, 2008, 3 INT C ADV RES VIRT
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   MOLANDER H, 1982, MUSCLE NERVE, V5, P54, DOI 10.1002/mus.880050110
   ROBINSON PH, 1991, MICROSURG, V12, P412, DOI 10.1002/micr.1920120608
   Rutkowski GE, 2002, BIOTECHNOL PROGR, V18, P362, DOI 10.1021/bp020300f
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sundback C, 2003, BIOMATERIALS, V24, P819, DOI 10.1016/S0142-9612(02)00409-X
   Wan ACA, 2001, BIOMATERIALS, V22, P1147, DOI 10.1016/S0142-9612(00)00355-0
   Wang XH, 2005, J BIOMAT SCI-POLYM E, V16, P1063, DOI 10.1163/1568562054798554
   WANG XH, J BIOACT CO IN PRESS
   Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Xu W, 2008, J BIOACT COMPAT POL, V23, P409, DOI 10.1177/0883911508095517
   Xu W, 2008, J BIOACT COMPAT POL, V23, P103, DOI 10.1177/0883911507088271
   Yan Y, 2007, J BIOACT COMPAT POL, V22, P323, DOI 10.1177/0883911507078386
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yin DZ, 2007, J BIOACT COMPAT POL, V22, P143, DOI 10.1177/0883911506076063
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
NR 32
TC 39
Z9 40
U1 2
U2 34
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD MAR
PY 2009
VL 15
IS 1
BP 1
EP 9
DI 10.1089/ten.tec.2008.0354
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 415DE
UT WOS:000263913700001
PM 18844602
DA 2018-10-19
ER

PT J
AU Geng, L
   Zhang, BP
   Li, AB
   Dong, CC
AF Geng, L.
   Zhang, B. P.
   Li, A. B.
   Dong, C. C.
TI Microstructure and mechanical properties of Mg-4.0Zn-0.5Ca alloy
SO MATERIALS LETTERS
LA English
DT Article
DE As-casting; Mechanical properties; Extrusion; Microstructure
ID CA-ZN ALLOYS; MAGNESIUM ALLOYS; HIGH-STRENGTH; BEHAVIOR; SOLIDIFICATION;
   ADDITIONS
AB A new kind of Mg-4.0 wt.%Zn-0.5 wt.%Ca alloy is fabricated by casting and hot extrusion for used as a high performance structure material as well as a biomaterial. In the as-cast alloy, the average grain size of the alpha-Mg is 120-150 mu m and the precipitated second phases are distributed uniformly in alpha-Mg grains. The as-cast Mg-4.0 wt.%Zn-0.5 wt.%Ca alloy shows a good balance between the tensile strength (211 MPa) and ductility (17% in elongation). After hot extrusion at 593 K, the second phase is greatly refined and the average grain size of the alpha-Mg is reduced to 8-12 mu m which is resulted from dynamic re-crystallization during hot extrusion. In this case, it exhibits a high tensile strength (273 MPa) and a high ductility (34% in elongation) at room temperature. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Geng, L.; Zhang, B. P.; Li, A. B.; Dong, C. C.] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Geng, L (reprint author), Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
EM genglingroup@gmail.com
FU Foundation of Outstanding Young Research of Heilongjiang Province, China
FX This work is supported by the Foundation of Outstanding Young Research
   of Heilongjiang Province, China.
CR Avedesian MM, 1999, ASM SPECIALTY HDB MA, P15
   Bettles CJ, 2004, SCRIPTA MATER, V51, P193, DOI 10.1016/j.scriptamat.2004.04.020
   Gao X, 2005, SCRIPTA MATER, V53, P1321, DOI 10.1016/j.scriptamat.2005.08.035
   Hamua G.B., 2007, MAT SCI ENG A-STRUCT, V447, P35
   Koike J, 2003, MATER SCI FORUM, V419-4, P189, DOI 10.4028/www.scientific.net/MSF.419-422.189
   Koike J, 2003, ACTA MATER, V51, P2055, DOI 10.1016/S1359-6454(03)00005-3
   Larionova TV, 2001, SCRIPTA MATER, V45, P7, DOI 10.1016/S1359-6462(01)00982-4
   Levi G, 2006, ACTA MATER, V54, P523, DOI 10.1016/j.actamat.2005.09.023
   Li Q, 2005, MATER LETT, V59, P2549, DOI 10.1016/j.matlet.2005.03.044
   Mendis CL, 2007, SCRIPTA MATER, V57, P485, DOI 10.1016/j.scriptamat.2007.05.031
   MIYAZAKI T, 1994, MAT SCI ENG A-STRUCT, V181, P1410, DOI 10.1016/0921-5093(94)90874-5
   Oh JC, 2005, SCRIPTA MATER, V53, P675, DOI 10.1016/j.scriptamat.2005.05.030
   Ortega Y, 2008, MATER LETT, V62, P3893, DOI 10.1016/j.matlet.2008.05.021
   Ortega Y, 2005, SCRIPTA MATER, V52, P181, DOI 10.1016/j.scriptamat.2004.09.033
   Somekawa H, 2007, MAT SCI ENG A-STRUCT, V459, P366, DOI 10.1016/j.msea.2007.01.021
   Sustek V, 1996, SCRIPTA MATER, V35, P449, DOI 10.1016/1359-6462(96)00141-8
   You BS, 2000, SCRIPTA MATER, V42, P1089, DOI 10.1016/S1359-6462(00)00344-4
NR 17
TC 61
Z9 63
U1 3
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD FEB 28
PY 2009
VL 63
IS 5
BP 557
EP 559
DI 10.1016/j.matlet.2008.11.044
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 400RS
UT WOS:000262886900015
DA 2018-10-19
ER

PT J
AU Hryniewicz, T
   Rokicki, R
   Rokosz, K
AF Hryniewicz, T.
   Rokicki, R.
   Rokosz, K.
TI Corrosion and surface characterization of titanium biomaterial after
   magnetoelectropolishing
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Titanium biomaterial; Electrolytic polishing; Magnetoelectropolishing;
   Corrosion resistance; Fracture
AB The paper deals with the titanium biomaterial characterization after electrolytic polishing in a magnetic field in comparison with a conventional electropolishing. Both surface roughness characteristics and corrosion behaviour of Ti biomaterial wire in a physiological body fluid, Ringer's solution, were studied. Comparison results are presented concerning surface after abrasive polishing (using the paper of grit size up to 1000) MP, standard electropolishing EP, and magnetoelectropolishing MER All obtained results concerning generally the titanium biomaterial surface roughness, and corrosion resistance in halide media have been considerably improved in the process of MEP and are much better than after a conventional EP. To underline the advantage of MEP process against up-to-date surface treatments, a mechanical bending test was carried out revealing much better resistance to fracture. At the end, this fatigue test has been supported by scanning electron microscopy SEM images of Ti wire biomaterial fracture. A considerable difference in fracture pattern may be observed indicating more plastic behaviour of sample after MEP. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Hryniewicz, T.; Rokosz, K.] Politech Koszalinska, Div Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Rokicki, R.] Electrobright, Macungie, PA USA.
RP Hryniewicz, T (reprint author), Politech Koszalinska, Div Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl; info@electrobright.com
CR ALKHATEEB E, 2005, INFLUENCE SURFACE SE, P934, DOI DOI 10.1002/JBM.A.30508
   [Anonymous], 4287 ISO
   BATCHELOR AW, 2004, SERIES BIOMATERIALS, V3, P22
   Brunette D. M., 2001, TITANIUM MED, P145
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   HANAWA T, 1999, BIOMATERIALS, V1, P767
   HANAWA T, 1999, BONE BIOMATERIAL INT, V1, P496
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Higuchi T, 2003, AIP CONF PROC, V671, P203
   HIN TS, 2004, ENG MAT BIOMEDICAL A, P156
   Hryniewicz T, 2008, SURF COAT TECH, V202, P1668, DOI 10.1016/j.surfcoat.2007.07.067
   HRYNIEWICZ T, 1994, SURF COAT TECH, V64, P75, DOI 10.1016/S0257-8972(09)90006-8
   HRYNIEWICZ T, 1981, STUDY ELECTROPOLISHI
   HRYNIEWICZ T, 2008, MATER LETT, V62, P3035
   Hryniewicz T., 2007, P 15 ANN INT C COMP, P345
   Hryniewicz T., 2005, ELECTROCHEMISTRY SUR
   HRYNIEWICZ T, 1989, MONOGRAPH WSI KOSZAL, V26
   KOZLOWSKI MR, 1988, SURF SCI, V194, P505, DOI 10.1016/0039-6028(88)90866-7
   Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601
   *POL STAND, PN75M80002 POL STAND
   *POL STAND, 1999, 4287 PNEN ISO POL ST
   RAMAN V, 2005, TRENDS BIOMATER ARTI, V18, P137
   Rokicki R, 2008, T I MET FINISH, V86, P280, DOI 10.1179/174591908X345040
   Rokicki R., 2008, MED DEVICE DIAGN IND, V30, P102
   ROKICKI R, 1990, MET FINISH, V88, P69
   UFNALSKI W, 1996, ELEMENTS ELECTROCHEM
   Zhang LC, 2008, ADV MAT RES, V32, P1, DOI [10.1109/CVPRW.2008.4563097, 10.4028/0-87849-475-8.1, 10.1155/2008/314762]
NR 27
TC 39
Z9 40
U1 2
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB 25
PY 2009
VL 203
IS 10-11
BP 1508
EP 1515
DI 10.1016/j.surfcoat.2008.11.028
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 411AD
UT WOS:000263618600033
DA 2018-10-19
ER

PT J
AU Ditto, AJ
   Shah, PN
   Lopina, ST
   Yun, YH
AF Ditto, Andrew J.
   Shah, Parth N.
   Lopina, Stephanie T.
   Yun, Yang H.
TI Nanospheres formulated from L-tyrosine polyphosphate as a potential
   intracellular delivery device
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Nanospheres; Nanoparticles; Biomaterials; Biodegradable; L-tyrosine;
   Intracellular delivery
ID GENE DELIVERY; SUSTAINED-RELEASE; EMULSION COPOLYMERIZATION; CYTOPLASMIC
   DELIVERY; DRUG-DELIVERY; POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES;
   BIODEGRADABLE NANOPARTICLES; BIOMATERIAL APPLICATIONS; HYDROLYTIC
   DEGRADATION; ALGINATE MICROSPHERES
AB Current delivery devices for drugs and genes such as films and microspheres are usually formulated from polymers that degrade over a period of months. In general, these delivery systems are designed to achieve an extracellular release of their encapsulated drugs. For drugs that require interaction with cellular machinery, the efficacies of both macroscopic and microscopic delivery systems are normally low. in contrast, nano-sized drug delivery vehicles could achieve high delivery efficiencies, but they must degrade quickly, and the delivery system itself should be nontoxic to cells. In this aspect, biodegradable nanospheres formulated from L-tyrosine polyphosphate (LTP) have been produced from an emulsion of oil and water for the potential use as an intracellular delivery device. Scanning electron microscopy (SEM) and dynamic laser light scattering (DLS) show that LTP nanospheres possess a diameter range between 100 and 600 nm. SEM reveals nanospheres formulated from LTP are spherical and smooth. Additionally, DLS studies demonstrate that nanospheres degrade hydrolytically in 7 days. Confocal microscopy reveals LTP nanospheres are internalized within human fibroblasts. Finally, the cell viability after exposure to LTP nanospheres and determined with a LIVE/DEAD (R) Cell Viability Assay is comparable to a buffer control. In conclusion, our nanospheres have been shown to be nontoxic to human cells, possess the appropriate size for endocytosis by human cells, and degrade within 7 days. Therefore LTP nanospheres can be used for a sustained intracellular delivery device. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Ditto, Andrew J.; Yun, Yang H.] Univ Akron, Dept Biomed Engn, Sidney Olson Res Ctr, Akron, OH 44325 USA.
   [Shah, Parth N.; Lopina, Stephanie T.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
RP Yun, YH (reprint author), Univ Akron, Dept Biomed Engn, Sidney Olson Res Ctr, Akron, OH 44325 USA.
EM yy@uakron.edu
RI Yun, Yang/C-1937-2009
OI Yun, Yang/0000-0001-5447-8833
FU University of Akron and the Firestone Fellowship
FX The authors would like to thank the University of Akron and the
   Firestone Fellowship for their financial support. Jeanette G. Killius at
   NEOUCOM provided assistance in confocal microscopy.
CR Akhtar S, 2007, ADV DRUG DELIVER REV, V59, P164, DOI 10.1016/j.addr.2007.03.010
   Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   Ameller T, 2004, EUR J PHARM SCI, V21, P361, DOI 10.1016/j.ejps.2003.11.002
   Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   ASTIER A, 1988, CANCER RES, V48, P1835
   Barbato F, 2001, BIOMATERIALS, V22, P1371, DOI 10.1016/S0142-9612(00)00291-X
   Behr JP, 1997, CHIMIA, V51, P34
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   Cai Q, 2003, BIOMATERIALS, V24, P629, DOI 10.1016/S0142-9612(02)00377-0
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Chan LW, 2002, BIOMATERIALS, V23, P1319, DOI 10.1016/S0142-9612(01)00250-2
   Chen CP, 2007, FEBS LETT, V581, P1891, DOI 10.1016/j.febslet.2007.03.076
   Chen X, 2006, J BIOMATER APPL, V20, P287, DOI 10.1177/0885328206054265
   Chern CS, 1997, POLYMER, V38, P1977, DOI 10.1016/S0032-3861(96)00708-2
   CHU CJ, 1990, PHARM RES-DORDR, V7, P824, DOI 10.1023/A:1015908831507
   Cook RO, 2005, J CONTROL RELEASE, V104, P79, DOI 10.1016/j.jconrel.2005.01.003
   COUVREUR P, 1977, FEBS LETT, V84, P323, DOI 10.1016/0014-5793(77)80717-5
   CROTTS G, 1995, J CONTROL RELEASE, V35, P91, DOI 10.1016/0168-3659(95)00010-6
   De SJ, 2003, J CONTROL RELEASE, V89, P101, DOI 10.1016/S0168-3659(03)00098-1
   Desai MP, 1997, PHARMACEUT RES, V14, P1568, DOI 10.1023/A:1012126301290
   Dunne M, 2000, BIOMATERIALS, V21, P1659, DOI 10.1016/S0142-9612(00)00040-5
   Duvvuri S, 2005, J CONTROL RELEASE, V108, P282, DOI 10.1016/j.jconrel.2005.09.002
   Gorner T, 1999, J CONTROL RELEASE, V57, P259, DOI 10.1016/S0168-3659(98)00121-7
   Hallow DM, 2007, J CONTROL RELEASE, V118, P285, DOI 10.1016/j.jconrel.2006.12.029
   Hara K, 2008, INT J PHARM, V356, P267, DOI 10.1016/j.ijpharm.2007.12.041
   Hawley AE, 1997, PHARMACEUT RES, V14, P657, DOI 10.1023/A:1012117531448
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Inoue T, 1997, J CONTROL RELEASE, V49, P167, DOI 10.1016/S0168-3659(97)00072-2
   Ishizu K, 1997, POLYMER, V38, P5471, DOI 10.1016/S0032-3861(97)00085-2
   Itaka K, 2004, J GENE MED, V6, P76, DOI 10.1002/jbm.470
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Jeong JH, 2002, J CONTROL RELEASE, V82, P159, DOI 10.1016/S0168-3659(02)00131-1
   Jiang HL, 2004, J BIOMAT SCI-POLYM E, V15, P279, DOI 10.1163/156856204322977184
   Kamiya H, 2001, ADV DRUG DELIVER REV, V52, P153, DOI 10.1016/S0169-409X(01)00216-2
   Kichler A, 2001, J GENE MED, V3, P135, DOI 10.1002/jgm.173
   Kim H, 2003, BIOMATERIALS, V24, P4671, DOI 10.1016/S0142-9612(03)00358-2
   Kim SY, 2003, BIOMATERIALS, V24, P55, DOI 10.1016/S0142-9612(02)00248-X
   KIMURA Y, 2003, BIOMATERIALS, V24
   Labhasetwar V, 1999, COLLOID SURFACE B, V16, P281, DOI 10.1016/S0927-7765(99)00079-X
   LADISH H, 2004, MOL CELL BIOL
   Lazaridis N, 1999, CHEM ENG SCI, V54, P3251, DOI 10.1016/S0009-2509(98)00336-4
   Lee ES, 2007, BIOMATERIALS, V28, P2754, DOI 10.1016/j.biomaterials.2007.01.049
   Lee TK, 2001, TOXICOL APPL PHARM, V174, P207, DOI 10.1006/taap.2001.9208
   Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6
   Li HY, 2005, COMPOS SCI TECHNOL, V65, P2226, DOI 10.1016/j.compscitech.2005.04.051
   Lin Y S, 1994, Colloids Surf B Biointerfaces, V3, P49, DOI 10.1016/0927-7765(93)01114-7
   Lu W, 2007, J CONTROL RELEASE, V118, P38, DOI 10.1016/j.jconrel.2006.11.015
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   MCGEE JP, 1995, J CONTROL RELEASE, V34, P77
   Monkkonen J, 1998, ADV DRUG DELIVER REV, V34, P37, DOI 10.1016/S0169-409X(98)00004-0
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nijenhuis AJ, 1996, POLYMER, V37, P5849, DOI 10.1016/S0032-3861(96)00455-7
   Ouchi T, 1998, POLYMER, V39, P5171, DOI 10.1016/S0032-3861(97)10020-9
   Panyam J, 2004, MOL PHARMACEUT, V1, P77, DOI 10.1021/mp034002c
   Park IK, 2001, J CONTROL RELEASE, V76, P349, DOI 10.1016/S0168-3659(01)00448-5
   Raghunand N, 2000, DRUG RESIST UPDATE, V3, P39, DOI 10.1054/drup.2000.0119
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Sen Gupta A, 2005, POLYMER, V46, P2133, DOI 10.1016/j.polymer.2005.01.023
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Shah LK, 2006, PHARM RES, V23, P2638, DOI 10.1007/s11095-006-9101-7
   SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709
   Shima M, 2004, COLLOID SURFACE A, V238, P83, DOI 10.1016/j.colsurfa.2004.02.018
   SOKAL RR, 2003, BIOMETRY
   Stayton PS, 2000, J CONTROL RELEASE, V65, P203, DOI 10.1016/S0168-3659(99)00236-9
   Suh HR, 1998, J BIOMED MATER RES, V42, P331, DOI 10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L
   Tanodekaew S, 2004, BIOMATERIALS, V25, P1453, DOI 10.1016/j.biomaterials.2003.08.020
   Tidefelt U, 1996, CANCER CHEMOTH PHARM, V38, P476, DOI 10.1007/s002800050514
   Tsuda A, 1999, AM J RESP CELL MOL, V21, P455, DOI 10.1165/ajrcmb.21.4.3351
   Tuncel A, 2001, COLLOID POLYM SCI, V279, P240, DOI 10.1007/s003960000416
   van der Lubben IM, 2001, BIOMATERIALS, V22, P687, DOI 10.1016/S0142-9612(00)00231-3
   Varga CM, 2000, BIOTECHNOL BIOENG, V70, P593, DOI 10.1002/1097-0290(20001220)70:6<593::AID-BIT1>3.0.CO;2-N
   Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008
   WEISSENBOCK A, 2004, J CONTROL RELEASE, V99, P382
   Witt C, 2000, BIOMATERIALS, V21, P931, DOI 10.1016/S0142-9612(99)00262-8
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Wu Y, 2006, POLYMER, V47, P5287, DOI 10.1016/j.polymer.2006.05.017
   Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3
   You XR, 2001, J APPL POLYM SCI, V82, P1691, DOI 10.1002/app.2009.abs
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zielhuis SW, 2007, J BIOMED MATER RES A, V82A, P892, DOI 10.1002/jbm.a.31183
   Zweers MLT, 2004, J CONTROL RELEASE, V100, P347, DOI 10.1016/j.jconrel.2004.09.008
NR 85
TC 19
Z9 19
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD FEB 23
PY 2009
VL 368
IS 1-2
BP 199
EP 206
DI 10.1016/j.ijpharm.2008.10.019
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 414ET
UT WOS:000263847400029
PM 19026734
DA 2018-10-19
ER

PT J
AU Huang, J
   Cebe, P
   Kaplan, DL
AF Huang, Jia
   Cebe, Peggy
   Kaplan, David L.
TI Hierarchical Assembly of Collagen-Like Peptides in vitro Provides
   Structural Causes of Osteogenesis Imperfecta
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE collagen; liquid crystal; osteogenesis imperfecta; optical ellipsometry
ID LIQUID CRYSTALLINITY; GLYCINE SUBSTITUTIONS; MUTATION DATABASE; MODEL
   PEPTIDES; TRIPLE-HELIX; SYSTEMS; SERINE; ORDER; BONE; OI
AB Collagen type I peptides, representative of native to disease states for the bone disease, Osteogenesis imperfecta, were studied with regard to self-assembly into triple helices and liquid crystalline mesophases. The purpose of the study was to establish insight into collagen mutations in terms of propagation of single chain defects up the scale of materials hierarchy, toward solid state fibril assemblies formed from collagen. Studies carried out in vitro demonstrated the value of this approach in establishing in vitro disease models, as the degree of collagen disruption could be recapitulated by the point mutations to show major impact on macroscopic features. Fourier transform infrared spectroscopy, circular dichroism, atomic force microscopy and optical ellipsometry were used to assess the structural and morphological changes at the various length scales post assembly. The results demonstrated that glycine to alanine to aspartic acid single substitutions in the Collagen peptides progressively disrupted normal assembly, reflected in lower thermal stability, loss of triple helical structure and loss of mesophase formation. This approach can provide a basis upon which to study Collagen biomaterial templates for controlled hydroxyapatite formation and changes in cell signaling related to bone remodeling, related to the severity of the disease.
C1 [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Huang, Jia] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Cebe, Peggy] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Cebe, Peggy/0000-0002-8721-644X
FU Tissue Engineering Resource Center [NIH P41]; NASA
FX We thank the Tissue Engineering Resource Center (NIH P41) and NASA for
   support of the study. The authors thank Brian Feinberg for performing
   ellipsometry measurements.
CR Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5
   Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097
   Bhate M, 2002, BIOCHEMISTRY-US, V41, P6539, DOI 10.1021/bi020070d
   Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k
   BRODSKY B, 2008, NUCLEIC ACIDS RES, V89, P345
   Burnei G, 2008, J AM ACAD ORTHOP SUR, V16, P356, DOI 10.5435/00124635-200806000-00008
   Cabral WA, 2001, MOL GENET METAB, V72, P326, DOI 10.1006/mgme.2001.3155
   Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253
   Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181
   GEORGIEV GY, 2001, POLYM MAT SCI ENG, V84, P1012
   Giraud-Guille MM, 2008, CURR OPIN COLLOID IN, V13, P303, DOI 10.1016/j.cocis.2008.03.002
   Giraud-Guille MM, 2008, CR CHIM, V11, P245, DOI 10.1016/j.crci.2007.05.005
   Giraud-Guille MM, 2003, J BIOMECH, V36, P1571, DOI 10.1016/S0021-9290(03)00134-9
   HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7
   Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200
   JAKOBSEN RJ, 1983, SCIENCE, V220, P1288, DOI 10.1126/science.6857249
   Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008
   Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200
   Liu XY, 1998, BIOCHEMISTRY-US, V37, P15528, DOI 10.1021/bi981147u
   MARINI JC, 1993, J BIOL CHEM, V268, P2667
   Mosser G, 2006, MATRIX BIOL, V25, P3, DOI 10.1016/j.matbio.2005.09.002
   Nuytinck L, 2000, J MED GENET, V37, P371, DOI 10.1136/jmg.37.5.371
   Nuytinck L, 1996, HUM GENET, V97, P324, DOI 10.1007/s004390050043
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   PACE N, 1996, PROTEIN STRUCTURES P
   Roughley P. J., 2003, European Cells & Materials, V5, P41
   Valluzzi R, 2000, BIOPOLYMERS, V53, P350, DOI 10.1002/(SICI)1097-0282(20000405)53:4<350::AID-BIP7>3.0.CO;2-O
   Valluzzi R, 2003, MACROMOLECULES, V36, P3580, DOI 10.1021/ma0340659
   VERNAGLIA BA, 2004, CHEM BIOL ENG, P190
   Yang W, 1997, BIOCHEMISTRY-US, V36, P6930, DOI 10.1021/bi970051h
NR 30
TC 2
Z9 2
U1 1
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD FEB 18
PY 2009
VL 30
IS 4-5
BP 336
EP 344
DI 10.1002/marc.200800591
PG 9
WC Polymer Science
SC Polymer Science
GA 414NY
UT WOS:000263872600009
PM 21706609
DA 2018-10-19
ER

PT J
AU Dhayal, M
   Ratner, DA
AF Dhayal, Marshal
   Ratner, Daniel A.
TI XPS and SPR Analysis of Glycoarray Surface Density
SO LANGMUIR
LA English
DT Article
ID PROTEIN-CARBOHYDRATE INTERACTIONS; SELF-ASSEMBLED MONOLAYERS; PLASMON
   RESONANCE; TOF-SIMS; MICROARRAYS; BINDING; GOLD; GLYCOBIOLOGY;
   SPECTROSCOPY; BIOMATERIAL
AB Despite the fact that the carbohydrate microarray has seen increasing use within the field of glycobiology, the surface chemistry of the glycoarray remains largely unexplored. Motivated by the need to develop surface analytical techniques to characterize carbohydrate-modified surfaces, we developed a quantitative X-ray photoelectron spectroscopy (XPS) and surface plasmon resonance imaging (SPR imaging) method to study glycan biosensors. We performed a comparative analysis on the relative coverage of mixed self-assembled monolayers (SAMs) on gold, consisting of a thiol-functionalized trimannoside (Man alpha 1,2Man alpha 1,2Man alpha-OEG-SH) at varying concentrations (0-100%) mixed separately with two thiol-containing polyethylene glycol oligomers. XPS Cl score level analysis was used to identify the O-C-O functionality unique to the carbohydrate acetal moiety and to separate and quantify the relative coverage of sugar in carbohydrate/OEG mixed SAMs. XPS spectra of the mixed SAMs demonstrated a proportional increase in the acetal signature of the glycan with increasing sugar concentration. To relate surface glycan density with biological function, we carried out a kinetic analysis of Concanavalin A (ConA) binding to SAMs of varying densities of carbohydrate using SPR imaging. We observed protein binding that was highly dependent on both glycan density and the nature of the OEG-thiol used in the mixed self-assembly. These results illustrate the utility of surface analytical techniques such as XPS and SPR in carbohydrate biosensor characterization and optimization.
C1 [Dhayal, Marshal; Ratner, Daniel A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Ratner, DA (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM dratner@u.washington.edu
RI Dhayal, Marshal/G-8247-2011
FU Washington Research Foundation; University of Washington Royalty
   Research Fund; Department of Bioengineering; NESAC/BIO (NTH) [P41
   EB002027]
FX This work was supported by the Washington Research Foundation, the
   University of Washington Royalty Research Fund, and the Department of
   Bioengineering. The authors gratefully acknowledge NESAC/BIO (NTH Grant
   P41 EB002027) for XPS analysis. Special thanks to David Castner for his
   inspiration and useful discussion, Jim Hull and Lara Gamble for XPS
   assistance, Paul Yager for UV cleaning of our Au surfaces, Huy Q. Nguyen
   for synthesis of OEG-thiol, and Jeff Chamberlain for his assistance in
   reading of the manuscript and for his useful comments.
CR Adams EW, 2004, CHEM BIOL, V11, P875, DOI 10.1016/j.chembiol.2004.04.010
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Coen MC, 2001, J COLLOID INTERF SCI, V233, P180, DOI 10.1006/jcis.2000.7240
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056
   Davis SJ, 1996, J MATER CHEM, V6, P479, DOI 10.1039/jm9960600479
   Dhayal M, 2006, APPL SURF SCI, V252, P7957, DOI 10.1016/j.apsusc.2005.10.005
   Disney MD, 2007, BIOCHEMISTRY-US, V46, P11223, DOI 10.1021/bi701071h
   Dufrene YF, 1997, J BACTERIOL, V179, P1023, DOI 10.1128/jb.179.4.1023-1028.1997
   Gong P, 2006, ANAL CHEM, V78, P3326, DOI 10.1021/ac052138b
   HARDMAN KD, 1972, BIOCHEMISTRY-US, V11, P4910, DOI 10.1021/bi00776a006
   Heme T. M., 1997, J AM CHEM SOC, V119, P8916
   Kansas GS, 1996, BLOOD, V88, P3259
   Karamanska R, 2008, GLYCOCONJUGATE J, V25, P69, DOI 10.1007/s10719-007-9047-y
   Karlsson KA, 1999, BIOCHEM SOC T, V27, P471, DOI 10.1042/bst0270471
   Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42
   LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011
   Lee CY, 2007, J AM CHEM SOC, V129, P9429, DOI 10.1021/ja071879m
   Leonard D, 2001, SURF INTERFACE ANAL, V31, P457, DOI 10.1002/sia.1071
   Liang MN, 2000, P NATL ACAD SCI USA, V97, P13092, DOI 10.1073/pnas.230451697
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Nimrichter L, 2004, GLYCOBIOLOGY, V14, P197, DOI 10.1093/glycob/cwh022
   Ratner DM, 2004, CHEMBIOCHEM, V5, P1375, DOI 10.1002/cbic.200400106
   Ratner DM, 2004, CHEMBIOCHEM, V5, P379, DOI 10.1002/cbic.200300804
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j
   SELLERS H, 1993, J AM CHEM SOC, V115, P9389, DOI 10.1021/ja00074a004
   Smith EA, 2003, J AM CHEM SOC, V125, P6140, DOI 10.1021/ja034165u
   Smith EA, 2003, APPL SPECTROSC, V57, p320A, DOI 10.1366/000370203322554446
   TAYLOR ME, 2003, INTRO GLYCOBIOLOGY, P24102
   Wang WY, 2004, NANO LETT, V4, P643, DOI 10.1021/nl049870v
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
   Yu Robert K., 2006, CNS & Neurological Disorders-Drug Targets, V5, P415, DOI 10.2174/187152706777950675
NR 35
TC 76
Z9 76
U1 1
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 17
PY 2009
VL 25
IS 4
BP 2181
EP 2187
DI 10.1021/la8031122
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 407OG
UT WOS:000263373600044
PM 19199748
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Vidal, CV
   Munoz, AI
AF Vidal, C. Valero
   Munoz, A. Igual
TI Effect of thermal treatment and applied potential on the electrochemical
   behaviour of CoCrMo biomedical alloy
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE CoCrMo alloy; Biocorrosion; Protein; Passivity; EIS; Thermal treatment
ID CO-CR-MO; SIMULATED PHYSIOLOGICAL SOLUTION; CORROSION BEHAVIOR; IMPLANT
   ALLOY; ORTHOPEDIC IMPLANTS; PASSIVE FILM; HIP IMPLANTS; COBALT;
   CHROMIUM; CAST
AB CoCrMo alloy are one of the most important biomaterials for orthopaedic applications, widely used in total joint replacements. The thermal treatments applied to CoCrMo alloys modifies the microstructure of the alloy and change the electrochemical and mechanical properties of the biomaterial. Thus, the aim of this research is to characterize the electrochemical behaviour of CoCrMo alloy depending on the thermal treatment at different applied potentials (according to the cathodic, anodic and transpassive electrochemical domains of the alloy).
   Metallographic study and electrochemical techniques such as potentiodynamic curves, potentiostatic tests at different potentials (selected according to the electrochemical regions of the potentiodynamic curves) and electrochemical impedance spectroscopy (EIS) are employed to characterize the CoCrMo, alloy after three different thermal treatments in simulated body fluid (bovine serum solution).
   The same corrosion mechanisms were observed for the CoCrMo alloy under the three thermal treatments at different applied potentials, however, the rate of the corrosion reactions which take place on the metallic surfaces depends on those thermal treatments and it is related to the amount of carbide inclusions. At passive potentials the study reveals that the properties of the passive layer depend on the microstructure of the alloy. EIS results show that the resistance of the passive layer in bovine serum solution increased with the carbides solubilisation. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Vidal, C. Valero; Munoz, A. Igual] Univ Politecn Valencia, ETSI Ind, Dept Ingn Quim & Nucl, E-46071 Valencia, Spain.
RP Munoz, AI (reprint author), Univ Politecn Valencia, ETSI Ind, Dept Ingn Quim & Nucl, POB 22012, E-46071 Valencia, Spain.
EM anigmu@iqn.upv.es
RI Valero-Vidal, Carlos/B-2681-2018
OI Valero-Vidal, Carlos/0000-0001-7420-4194
FU Spanish Government; Ministerio de Educacion y Ciencia
   [CIT-300100-2007-49]
FX We wish to express our gratitude to the Spanish Government, "Ministerio
   de Educacion y Ciencia" CIT-300100-2007-49 for the economic support.
CR BASTOS AC, 2005, CORROSION SCI
   Bommersbach P, 2005, ELECTROCHIM ACTA, V51, P1076, DOI 10.1016/j.electacta.2005.06.001
   BORRAS VA, 2002, NAT C MECH PROP SOL, P487
   Cawley J, 2003, WEAR, V255, P999, DOI 10.1016/S0043-1648(03)00046-2
   CLEMOW AJT, 1979, J BIOMED MATER RES, V13, P265, DOI 10.1002/jbm.820130208
   Codaro EN, 2000, RUSS J ELECTROCHEM+, V36, P1117, DOI 10.1007/BF02757531
   Contu F, 2005, CORROS SCI, V47, P1863, DOI 10.1016/j.corsci.2004.09.003
   CROOK P, 1987, METALS HDB CORROSION, V13
   DOBBS HS, 1983, J MATER SCI, V18, P391, DOI 10.1007/BF00560627
   Dorner-Reisel A, 2004, SURF COAT TECH, V177, P830, DOI 10.1016/j.surfcoat.2003.06.015
   Emregul KC, 2000, CORROS SCI, V42, P2051, DOI 10.1016/S0010-938X(00)00055-X
   FERREIRA MGS, 1985, J ELECTROCHEM SOC, V132, P760, DOI 10.1149/1.2113954
   Foelske A, 2000, SURF INTERFACE ANAL, V29, P548, DOI 10.1002/1096-9918(200008)29:8<548::AID-SIA902>3.0.CO;2-Q
   GEORGETTE FS, 1986, J BIOMED MATER RES, V20, P1229, DOI 10.1002/jbm.820200812
   GROWCOCK FB, 1989, J ELECTROCHEM SOC, V136, P2310, DOI 10.1149/1.2097847
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   Hodgson AWE, 2004, ELECTROCHIM ACTA, V49, P2167, DOI 10.1016/j.electacta.2003.12.043
   JACOBS JJ, 1990, J ORTHOPAED RES, V8, P874, DOI 10.1002/jor.1100080613
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kocijan A, 2004, J MATER SCI-MATER M, V15, P643, DOI 10.1023/B:JMSM.0000030204.08616.3d
   Kocijan A, 2004, J APPL ELECTROCHEM, V34, P517, DOI 10.1023/B:JACH.0000021868.10122.96
   Lewis AC, 2005, J BIOMED MATER RES A, V73A, P456, DOI 10.1002/jbm.a.30368
   Lin HY, 2004, BIOMATERIALS, V25, P1233, DOI 10.1016/j.biomaterials.2003.08.016
   Metikos-Hukovic M, 2006, ACTA BIOMATER, V2, P693, DOI 10.1016/j.actbio.2006.06.002
   Milosev I, 2005, J ORTHOP RES, V23, P526, DOI 10.1016/j.orthres.2004.12.007
   Milosev I, 2003, ELECTROCHIM ACTA, V48, P2767, DOI 10.1016/S0013-4686(03)00396-7
   Munoz AI, 2007, J ELECTROCHEM SOC, V154, pC562, DOI 10.1149/1.2764238
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   Ouerd A, 2008, ELECTROCHIM ACTA, V53, P4461, DOI 10.1016/j.electacta.2008.01.025
   Placko HE, 1998, J BIOMED MATER RES, V39, P292, DOI 10.1002/(SICI)1097-4636(199802)39:2<292::AID-JBM17>3.0.CO;2-F
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Sargeant A, 2007, MATER DESIGN, V28, P155, DOI 10.1016/j.matdes.2005.05.018
   Shettlemore MG, 2001, BIOMATERIALS, V22, P2215, DOI 10.1016/S0142-9612(00)00410-5
   TAYLOR SR, 1995, CORROSION, V51, P664, DOI 10.5006/1.3293628
   Vidal CV, 2008, CORROS SCI, V50, P1954, DOI 10.1016/j.corsci.2008.04.002
   Williams D.F., 1981, BIOCOMPATIBILITY CLI, V1
   Yan Y, 2007, TRIBOL INT, V40, P1492, DOI 10.1016/j.triboint.2007.02.019
   2001, E38499 STAND TEST ME
NR 38
TC 45
Z9 47
U1 3
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD FEB 15
PY 2009
VL 54
IS 6
BP 1798
EP 1809
DI 10.1016/j.electacta.2008.10.018
PG 12
WC Electrochemistry
SC Electrochemistry
GA 408NN
UT WOS:000263441800022
DA 2018-10-19
ER

PT J
AU Fathi, MH
   Zahrani, EM
AF Fathi, M. H.
   Zahrani, E. Mohammadi
TI Mechanical alloying synthesis and bioactivity evaluation of
   nanocrystalline fluoridated hydroxyapatite
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
DE Biomaterials; Characterization; Crystallites; Nanostructures; X-ray
   diffraction; Nanomaterials
ID MECHANOCHEMICAL-HYDROTHERMAL SYNTHESIS; SIMULATED BODY-FLUID;
   SUBSTITUTED HYDROXYAPATITE; APATITE FORMATION; FLUORAPATITE; CERAMICS;
   FLUORINE; CRYSTALLIZATION; COMPOSITES; SOLUBILITY
AB The aim of this work was preparation, characterization and bioactivity evaluation of nanocrystalline fluoridated hydroxyapatite (FHA) with different degree of fluoridation via the mechanical alloying (MA) method, and investigating the effect of MA parameters on the synthesizing process. Nanocrystalline FHA with a chemical composition of Ca(10)(PO(4))(6)OH(2-x)F(x) (where x values were selected equal to 0.0, 0.5. 1.0, 1.5 and 2.0) were synthesized using different milling conditions. X-ray diffraction (XRD), Fourier transform infrared (FTIR). transmission electron microscopy (TEM), scanning electron microscopy (SEM) and ICP-OES analysis techniques were utilized to characterize the synthesized FHA. In vitro tests were performed by immersing the prepared FHA in simulated body fluid (SBF). The changes of pH of the SBF were measured at pre-determined time intervals using a pH meter. The calcium and phosphorous ion concentrations of SBF were determined using the ICP-OES analysis. Bone-like apatite formation on the surface of the immersed samples was investigated by SEM. The results showed that only the FHA nanopowders, which were synthesized after 6 h of high-energy ball milling under optimized MA parameters including: 300 rpm of rotation speed, ball-to-powder weight ratio (B/P) equal to 35, and 8 balls with 20 mm in diameter, could fulfill the requirements of ASTM F1185-88 to be used as a biomaterial. In vitro test indicated that the dissolution rate of FHA decreased as the result of increasing the fluorine content of nanocrystalline FHA. Larger quantity of tiny nucleus was observed on the surface of samples with higher fluorine content after 8 h of soaking in the SBF. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Fathi, M. H.; Zahrani, E. Mohammadi] Isfahan Univ Technol, Biomat Grp, Dept Mat Engn, Esfahan 8415683111, Iran.
RP Fathi, MH (reprint author), Isfahan Univ Technol, Biomat Grp, Dept Mat Engn, Esfahan 8415683111, Iran.
EM fathimoh@yahoo.com
RI Mohammadi Zahrani, Ehsan/G-6037-2011
OI Mohammadi Zahrani, Ehsan/0000-0001-7562-3569
FU Isfahan University of Technology
FX The authors are grateful for support of this research by the Isfahan
   University of Technology.
CR *ASTM, 1988, F118588 ASTM, P415
   CHAIKINAIN MV, 2002, MEHANOHIMIJA PRIRODN, P12102
   Chen CW, 2004, J CRYST GROWTH, V270, P615, DOI 10.1016/j.jcrysgro.2004.06.051
   Chen YM, 2005, BIOMATERIALS, V26, P1205, DOI 10.1016/j.biomaterials.2004.04.027
   Cheng K, 2005, BIOMATERIALS, V26, P6288, DOI 10.1016/j.biomaterials.2005.03.041
   Cheng K, 2004, J BIOMED MATER RES B, V69B, P33, DOI 10.1002/jbm.b.20027
   Cheng K, 2003, MATER RES BULL, V38, P89, DOI 10.1016/S0025-5408(02)00985-6
   Chiu CY, 2007, CERAM INT, V33, P715, DOI 10.1016/j.ceramint.2005.12.008
   ELLIOTT JC, 1994, STUDIES INORGANIC CH, V18, P12102
   Fathi MH, 2007, MATER LETT, V61, P3978, DOI 10.1016/j.matlet.2007.01.028
   FATHI MH, 2008, J MATER PROCESS TECH, V2, P536
   Freund F., 1977, J CHEM SOC DA, V6, P1136
   GERMAN RM, 1996, SINTERING THEORY PRA, P12102
   HENCH LL, 1998, ADV CERAMIC SOC, V1, P139
   KAY M, 1964, NATURE, V204, P3056
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim HW, 2004, BIOMATERIALS, V25, P2919, DOI 10.1016/j.biomaterials.2003.09.074
   Kim HW, 2003, J MATER SCI-MATER M, V14, P899, DOI 10.1023/A:1025638811361
   KINGERY WD, 1976, INTRO CERAMIC, P12102
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lafon JP, 2008, J EUR CERAM SOC, V28, P139, DOI 10.1016/j.jeurceramsoc.2007.06.009
   Lu X, 2005, J CRYST GROWTH, V284, P506, DOI 10.1016/j.jcrysgro.2005.07.032
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   Murugan R, 2005, J CRYST GROWTH, V274, P209, DOI 10.1016/j.jcrysgro.2004.09.069
   Nikcevic I, 2004, J SOLID STATE CHEM, V177, P2565, DOI 10.1016/j.jssc.2004.03.024
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Okazaki M, 1998, BIOMATERIALS, V19, P611, DOI 10.1016/S0142-9612(97)00151-8
   Qu HB, 2006, ACTA BIOMATER, V2, P113, DOI 10.1016/j.actbio.2005.09.003
   REY C, 1995, BONE, V16, P583, DOI 10.1016/8756-3282(95)00101-I
   Ribeiro C, 2004, MAT SCI ENG C-BIO S, V24, P631, DOI 10.1016/j.msec.2004.08.006
   Rodriguez-Lorenzo LM, 2003, BIOMATERIALS, V24, P3777, DOI 10.1016/S0142-9612(03)00259-X
   Shuk P, 2001, J MATER RES, V16, P1231, DOI 10.1557/JMR.2001.0170
   Sung YM, 2004, J CRYST GROWTH, V262, P467, DOI 10.1016/j.jcrysgro.2003.10.001
   Sung YM, 2003, J CRYST GROWTH, V254, P411, DOI 10.1016/S0022-0248(03)01191-6
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Wei M, 2003, J MATER SCI-MATER M, V14, P311, DOI 10.1023/A:1022975730730
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
   Yoon BH, 2005, BIOMATERIALS, V26, P2957, DOI 10.1016/j.biomaterials.2004.07.062
   Zhang HG, 2005, MATER RES BULL, V40, P1326, DOI 10.1016/j.materresbull.2005.04.005
NR 40
TC 90
Z9 90
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD FEB 15
PY 2009
VL 311
IS 5
BP 1392
EP 1403
DI 10.1016/j.jcrysgro.2008.11.100
PG 12
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA 429VJ
UT WOS:000264947900030
DA 2018-10-19
ER

PT J
AU Chevalier, E
   Viana, M
   Artaud, A
   Haddouchi, S
   Chulia, D
AF Chevalier, E.
   Viana, M.
   Artaud, A.
   Haddouchi, S.
   Chulia, D.
TI A novel application of the T-cell for flow-through dissolution: The case
   of bioceramics used as ibuprofen carrier
SO TALANTA
LA English
DT Article
DE T-cell; Flow-through cell apparatus; In vitro dissolution; Drug delivery
   system; Ibuprofen; Calcium phosphate pellets
ID DRUG-DELIVERY; RELEASE KINETICS; IN-VITRO; HYDROXYAPATITE; BEADS;
   POLYMETHYLMETHACRYLATE; COMPOSITES; APPARATUS; CHAMBER; SURFACE
AB This paper describes the use of a novel flow cell, the T-cell, adapted to the flow-through cell apparatus. for the study of ibuprofen release from implantable loaded pellets and its performance in comparison to the compendial tablet cell. In fact, the drug targeting with a local delivery system becomes increasingly used to achieve therapeutic doses directly on the implantation site while maintaining a low systemic drug level. Due to the long and expensive in vivo studies necessary to evaluate the efficacy of such delivery systems, in vitro dissolution techniques are performed despite there being no standard method in the biomaterial field. In this work, dissolution profiles obtained with the T-cell configuration clearly indicate a prolonged release of ibuprofen. Dissolution data fitted to Higuchi, Hixson-Crowell, Ritger-Peppas and Kopcha equations indicate the coexistence of diffusion and erosion mechanisms governing ibuprofen release. T-cell adapted to the standard flow-through dissolution apparatus is shown to better simulate in vivo conditions than the tablet cell. This is relevant for in vivo/in vitro correlations. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Chevalier, E.; Viana, M.; Chulia, D.] Univ Limoges, CNRS, SPCTS,UMR 6638, Fac Pharm,Lab Pharm Galen, F-87025 Limoges, France.
   [Artaud, A.; Haddouchi, S.] SPS Pharma Serv, F-63000 Clermont Ferrand, France.
RP Viana, M (reprint author), Univ Limoges, CNRS, SPCTS,UMR 6638, Fac Pharm,Lab Pharm Galen, 2 Rue Dr Marcland, F-87025 Limoges, France.
EM marylene.viana@unilim.fr
FU Region Limousin
FX The authors thank the Region Limousin for its financial support. They
   are grateful to Mickael Palard and Eric Champion (SPCTS, Limoges) for
   calcination.
CR Borovac T, 2006, J CONTROL RELEASE, V115, P266, DOI 10.1016/j.jconrel.2006.08.008
   CHEVALIER E, BIOCERAMICS PROPERTI
   Corchon MAG, 2006, BIOMATERIALS, V27, P1778, DOI 10.1016/j.biomaterials.2005.10.015
   Corry D, 1998, BIOMATERIALS, V19, P1295, DOI 10.1016/S0142-9612(98)00012-X
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   *COUNC EUR, 2006, EUR PHARM
   Delalonde M, 2008, CHEM ENG PROCESS, V47, P370, DOI 10.1016/j.cep.2007.01.003
   F Amyot, 2002, ITBM RBM, V23, P285
   Gbureck U, 2008, ACTA BIOMATER, V4, P1480, DOI 10.1016/j.actbio.2008.02.027
   GIBASSIER D, 1982, LAB PHARM PROB TECHN, V30, P250
   Gonzalez MV, 2008, J MATER SCI-MATER M, V19, P767, DOI 10.1007/s10856-006-0040-y
   Guicheux J, 1997, J BIOMED MATER RES, V34, P165, DOI 10.1002/(SICI)1097-4636(199702)34:2<165::AID-JBM4>3.0.CO;2-O
   Hall EW, 2004, DIAGN MICR INFEC DIS, V50, P261, DOI 10.1016/j.diagmicrobio.2004.03.004
   Hasegawa M, 2004, J BIOMED MATER RES B, V70B, P332, DOI 10.1002/jbm.b.30047
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hixson AW, 1931, IND ENG CHEM, V23, P923, DOI 10.1021/ie50260a018
   KOPCHA M, 1991, J PHARM PHARMACOL, V43, P382, DOI 10.1111/j.2042-7158.1991.tb03493.x
   Krajewski A, 2000, J MATER SCI-MATER M, V11, P763, DOI 10.1023/A:1008988127294
   Li LC, 2002, ADV DRUG DELIVER REV, V54, P963
   MANDAL TK, 1994, DRUG DEV IND PHARM, V20, P1753, DOI 10.3109/03639049409038391
   Medvecky L, 2007, CHEM PAP, V61, P477, DOI 10.2478/s11696-007-0065-9
   Melville AJ, 2008, J MATER SCI-MATER M, V19, P1187, DOI 10.1007/s10856-007-3185-4
   Mendez JA, 2004, BIOMATERIALS, V25, P2381, DOI 10.1016/j.biomaterials.2003.09.004
   Missaghi S, 2005, INT J PHARM, V293, P35, DOI 10.1016/j.ijpharm.2004.12.024
   Murugan R, 2004, BIOMATERIALS, V25, P3073, DOI 10.1016/j.biomaterials.2003.09.089
   Palazzo B, 2005, MAT SCI ENG C-BIO S, V25, P207, DOI 10.1016/j.msec.2005.01.011
   Paul W, 1999, J MATER SCI-MATER M, V10, P383, DOI 10.1023/A:1008918412198
   Peltonen L, 2003, EUR J PHARM SCI, V19, P395, DOI 10.1016/S0928-0987(03)00140-4
   PERRY AC, 2002, CLIN ORTHOP RELAT R, V403, P49
   Pillay V, 1998, J CONTROL RELEASE, V55, P45, DOI 10.1016/S0168-3659(98)00022-4
   Pillay V, 1999, J PHARM SCI, V88, P843, DOI 10.1021/js990139b
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Sachs CJ, 2005, AM FAM PHYSICIAN, V71, P913
   Sundar M, 2005, TRENDS BIOMATER ARTI, V18, P213
   Tang Y, 2006, J CONTROL RELEASE, V116, pE55, DOI 10.1016/j.jconrel.2006.09.047
   United States Pharmacopeia, 2006, US PHARM
   *US DEP HHS FOOD D, 1997, GUID IND DISS TEST I
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Victor SP, 2008, J MATER SCI-MATER M, V19, P283, DOI 10.1007/s10856-006-0044-7
NR 39
TC 9
Z9 9
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD FEB 15
PY 2009
VL 77
IS 4
BP 1545
EP 1548
DI 10.1016/j.talanta.2008.09.046
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 398WF
UT WOS:000262761500045
PM 19084677
DA 2018-10-19
ER

PT J
AU Sellam, A
   Al-Niemi, T
   McInnerney, K
   Brumfield, S
   Nantel, A
   Suci, PA
AF Sellam, Adnane
   Al-Niemi, Thamir
   McInnerney, Kathleen
   Brumfield, Susan
   Nantel, Andre
   Suci, Peter A.
TI A Candida albicans early stage biofilm detachment event in rich medium
SO BMC MICROBIOLOGY
LA English
DT Article
ID CELL-SURFACE HYDROPHOBICITY; GENE-EXPRESSION; PSEUDOMONAS-AERUGINOSA;
   IN-VITRO; FILAMENTATION PATHWAY; INDUCED DISPERSION; AMPHOTERICIN-B;
   EPIDEMIOLOGY; INFECTIONS; PROTEINS
AB Background: Dispersal from Candida albicans biofilms that colonize catheters is implicated as a primary factor in the link between contaminated catheters and life threatening blood stream infections ( BSI). Appropriate in vitro C. albicans biofilm models are needed to probe factors that induce detachment events.
   Results: Using a flow through system to culture C. albicans biofilms we characterized a detachment process which culminates in dissociation of an entire early stage biofilm from a silicone elastomer surface. We analyzed the transcriptome response at time points that bracketed an abrupt transition in which a strong adhesive association with the surface is weakened in the initial stages of the process, and also compared batch and biofilm cultures at relevant time points. K means analysis of the time course array data revealed categories of genes with similar patterns of expression that were associated with adhesion, biofilm formation and glycoprotein biosynthesis. Compared to batch cultures the biofilm showed a pattern of expression of metabolic genes that was similar to the C. albicans response to hypoxia. However, the loss of strong adhesion was not obviously influenced by either the availability of oxygen in the medium or at the silicone elastomer surface. The detachment phenotype of mutant strains in which selected genes were either deleted or overexpressed was characterized. The microarray data indicated that changes associated with the detachment process were complex and, consistent with this assessment, we were unable to demonstrate that transcriptional regulation of any single gene was essential for loss of the strong adhesive association.
   Conclusion: The massive dispersal of the early stage biofilm from a biomaterial surface that we observed is not orchestrated at the level of transcriptional regulation in an obvious manner, or is only regulated at this level by a small subpopulation of cells that mediate adhesion to the surface.
C1 [Suci, Peter A.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA.
   [Suci, Peter A.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA.
   [Sellam, Adnane] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada.
   [Al-Niemi, Thamir; Brumfield, Susan] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA.
   [McInnerney, Kathleen] Montana State Univ, Dept Microbiol, Genom Core Facil, Bozeman, MT 59717 USA.
RP Suci, PA (reprint author), Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA.
EM adnane.sellam@cnrc-nrc.gc.ca; thamir@montana.edu;
   kmcinnerney@montana.edu; uplsb@montana.edu; andre.nantel@cnrc-nrc.gc.ca;
   peter_s@erc.montana.edu
RI Sellam, Adnane/H-9765-2013
OI Sellam, Adnane/0000-0002-0506-7752
FU NIH [1 R21 GM070554-01A1]
FX This work was supported by a grant from NIH (1 R21 GM070554-01A1) to P.
   A. S We are grateful to Aaron Mitchell, Clarissa Nobile, Frank Smith,
   Bruce Granger, Jennifer Carbrey, Paola Zucchi and Carol Kumamoto for
   generously providing us with mutant strains. We are grateful to
   Jean-Sebastien Deneault and the members of the BRI microarray lab for
   technical help. We also would like to thank Herve Hogues for
   bioinformatic assistance. We thank Mark Young and Trevor Douglas at MSU
   for their intellectual and monetary (CBIN) support. This is NRC
   publication number 49572.
CR Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0
   Alem MAS, 2006, EUKARYOT CELL, V5, P1770, DOI 10.1128/EC.00219-06
   Allison DG, 1998, FEMS MICROBIOL LETT, V167, P179, DOI 10.1016/S0378-1097(98)00386-3
   Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x
   Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004
   Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P1900, DOI 10.1128/AAC.42.8.1900
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P2146, DOI 10.1128/AAC.42.8.2146
   Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06
   Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003
   Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043
   Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001
   Castillo L, 2006, FUNGAL GENET BIOL, V43, P124, DOI 10.1016/j.fgb.2005.12.002
   Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130
   Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101
   Crump JA, 2000, EUR J CLIN MICROBIOL, V19, P1, DOI 10.1007/s100960050001
   Dennis Glynn Jr, 2003, Genome Biol, V4, pP3, DOI 10.1186/gb-2003-4-5-p3
   Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6
   Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546
   FONZI WA, 1993, GENETICS, V134, P717
   Fridkin SK, 1996, CLIN MICROBIOL REV, V9, P499
   Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x
   Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004
   Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x
   Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044
   Granger BL, 2005, MICROBIOL-SGM, V151, P1631, DOI 10.1099/mic.0.27663-0
   Green CB, 2005, MICROBIOL-SGM, V151, P1051, DOI 10.1099/mic.0.27696-0
   Guillemette T, 2004, CURR GENET, V45, P214, DOI 10.1007/s00294-003-0479-z
   HAWSER SP, 1994, INFECT IMMUN, V62, P915
   HAZEN BW, 1988, INFECT IMMUN, V56, P2521
   HAZEN KC, 1992, INFECT IMMUN, V60, P1499
   HAZEN KC, 1993, FEMS MICROBIOL LETT, V107, P83, DOI 10.1016/0378-1097(93)90358-9
   Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002
   Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004
   Khot PD, 2006, ANTIMICROB AGENTS CH, V50, P3708, DOI 10.1128/AAC.00997-06
   Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102
   Li F, 2003, EUKARYOT CELL, V2, P1266, DOI 10.1128/EC.2.6.1266-1273.2003
   LOPEZRIBOT JL, 1991, INFECT IMMUN, V59, P2324
   Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x
   Marchais V, 2005, FEMS MICROBIOL LETT, V245, P25, DOI 10.1016/j.femsle.2005.02.014
   Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06
   Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06
   Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005
   Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI [10.1091/mbc.E02-05-0272, 10.1091/mbc.E05-05-0272]
   Nantel A, 2006, FUNGAL GENET BIOL, V43, P311, DOI 10.1016/j.fgb.2006.01.002
   NAVARROGARCIA F, 1995, MOL CELL BIOL, V15, P2197
   Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047
   Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06
   Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063
   Perez A, 2006, FEMS YEAST RES, V6, P1074, DOI 10.1111/j.1567-1364.2006.00131.x
   Purevdorj-Gage B, 2005, MICROBIOL-SGM, V151, P1569, DOI 10.1099/mic.0.27536-0
   Puschel B, 2005, HISTOCHEM CELL BIOL, V124, P275, DOI 10.1007/s00418-005-0041-9
   RAHARY L, 1985, FEMS MICROBIOL LETT, V30, P383
   Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005
   Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002
   Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1016/S0378-1097(02)00853-4
   Rice SA, 2005, J BACTERIOL, V187, P3477, DOI 10.1128/JB.187.10.3477-3485.2005
   Sachs MS, 1998, FUNGAL GENET BIOL, V23, P117, DOI 10.1006/fgbi.1998.1041
   Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004
   Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6
   Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040
   Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005
   Singleton DR, 2005, FEMS MICROBIOL LETT, V244, P373, DOI 10.1016/j.femsle.2005.02.010
   Singleton DR, 2001, J BACTERIOL, V183, P3582, DOI 10.1128/JB.183.12.3582-3588.2001
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705
   Tan LH, 2004, CHEST, V125, P410, DOI 10.1378/chest.125.2.410
   Tanghe A, 2005, APPL ENVIRON MICROB, V71, P6434, DOI 10.1128/AEM.71.10.6434-6437.2005
   Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006
   Tiraboschi IN, 2000, MED MYCOL, V38, P199, DOI 10.1080/744118734
   Vats N, 2000, ARCH ORAL BIOL, V45, P305, DOI 10.1016/S0003-9969(99)00139-9
   Vediyappan G, 2006, MYCOPATHOLOGIA, V161, P3, DOI 10.1007/s11046-005-0167-2
   Voss A, 1997, INFECTION, V25, P8, DOI 10.1007/BF02113499
   Warit S, 2000, MOL MICROBIOL, V36, P1156, DOI 10.1046/j.1365-2958.2000.01944.x
   Wilson RB, 1999, J BACTERIOL, V181, P1868
   Yeater KM, 2007, MICROBIOL-SGM, V153, P2373, DOI 10.1099/mic.0.2007/006163-0
   ZHANG H, 2006, GLOBAL ADV MAT PROCE, P1
   Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0
   Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0
NR 81
TC 33
Z9 40
U1 0
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD FEB 2
PY 2009
VL 9
AR 25
DI 10.1186/1471-2180-9-25
PG 22
WC Microbiology
SC Microbiology
GA 418PA
UT WOS:000264159300002
PM 19187560
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Yao, L
   Wang, SG
   Cui, WJ
   Sherlock, R
   O'Connell, C
   Damodaran, G
   Gorman, A
   Windebank, A
   Pandit, A
AF Yao, Li
   Wang, Shenguo
   Cui, Wenjin
   Sherlock, Richard
   O'Connell, Claire
   Damodaran, Gopinath
   Gorman, Adrienne
   Windebank, Anthony
   Pandit, Abhay
TI Effect of functionalized micropatterned PLGA on guided neurite growth
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Guided regeneration; Micropatterning; Laminin peptide; PLGA
ID PERIPHERAL-NERVE REGENERATION; SCHWANN-CELL GROWTH; RAT SPINAL-CORD;
   INTEGRIN ALPHA-3-BETA-1; PHEOCHROMOCYTOMA CELLS; BIODEGRADABLE POLYMERS;
   TOPOGRAPHICAL CONTROL; BASEMENT-MEMBRANE; PC12 CELLS; OUTGROWTH
AB When coaptation is not possible in the repair of nerve injuries, a bridge of biomaterial scaffold provides a structural support for neuronal cell growth and guides nerve regeneration. Poly(lactide-co-glycolide) (PLGA) scaffolds have been widely investigated for neural tissue engineering applications. In order to investigate guided neurite growth, we have fabricated micropatterns on PLGA films using laser ablation methods. The micropatterned PLGA films were coated with collagen type I or laminin peptide (PPFLMLLKGSTR) to promote axon growth. Micropatterned PLGA films provide a guidance effect on both early stage neurite outgrowth and elongation. Small (5 mu m) grooves showed more statistically significant parallel neurite growth compared with larger size grooves (10 mu m). Micropatterned PLGA films coated with laminin peptide showed more parallel neurite growth compared with those coated with collagen type I. Primary neurite number and total neurite length per cell decreased oil micropatterned PLGA films compared with the controls. Neurites showed a preference for growth in the microgrooves rather than on the spaces. This study indicates that surface micropatterned structures with conjugated functional molecules can be used to guide neurite growth. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Yao, Li; Damodaran, Gopinath; Pandit, Abhay] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland.
   [Sherlock, Richard; O'Connell, Claire] Natl Univ Ireland, Natl Ctr Laser Applicat, Galway, Ireland.
   [Gorman, Adrienne] Natl Univ Ireland, Dept Biochem, Galway, Ireland.
   [Wang, Shenguo; Cui, Wenjin] Chinese Acad Sci, Inst Chem, State Key Lab Polymer Phys & Chem, BNLMS, Beijing 100080, Peoples R China.
   [Windebank, Anthony] Mayo Clin, Dept Neurol, Rochester, MN USA.
RP Pandit, A (reprint author), Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Gorman, Adrienne/B-6525-2008; Yao, Li/J-1372-2016; Pandit,
   Abhay/B-6187-2008; cui, wenjin/D-8326-2012
OI Gorman, Adrienne/0000-0002-6068-0058; Pandit, Abhay/0000-0002-6292-4933;
   Damodaran, Gopinath/0000-0002-1697-0357
CR Agius E, 1998, J NEUROSCI, V18, P328
   Aguilar CA, 2005, BIOMATERIALS, V26, P7642, DOI 10.1016/j.biomaterials.2005.04.053
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   Ashley WW, 2006, J NEUROSURG, V105, P452, DOI 10.3171/ped.2006.105.6.452
   Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x
   Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P928, DOI 10.1021/bm061088x
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Culley B, 2001, NEUROSCI LETT, V301, P83, DOI 10.1016/S0304-3940(01)01615-9
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   Dyck PJ, 2005, PERIPHERAL NEUROPATH, P733
   Foley JD, 2005, BIOMATERIALS, V26, P3639, DOI 10.1016/j.biomaterials.2004.09.048
   Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621
   GIANNINI C, 1990, J NEUROPATH EXP NEUR, V49, P550, DOI 10.1097/00005072-199011000-00002
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5
   HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Hsu SH, 2005, BIOTECHNOL BIOENG, V92, P579, DOI 10.1002/bit.20634
   Itoh S, 1996, MICROSURG, V17, P525, DOI 10.1002/(SICI)1098-2752(1996)17:10<525::AID-MICR1>3.0.CO;2-P
   KAVANAGH ET, 2006, BIOCHEM BIOPH RES CO, V29, P890
   Kim JM, 2005, EXP CELL RES, V304, P317, DOI 10.1016/j.yexcr.2004.11.009
   Li B, 2005, BIOMATERIALS, V26, P1487, DOI 10.1016/j.biomaterials.2004.05.004
   [李德志 LI Dezhi], 2006, [中华神经外科杂志, Chinese Journal of Neurosurgery], V22, P174
   Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325
   MAYHEW TM, 1991, EXP PHYSIOL, V76, P639, DOI 10.1113/expphysiol.1991.sp003533
   Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   NORDLANDER RH, 1982, DEV BRAIN RES, V4, P181, DOI 10.1016/0165-3806(82)90041-4
   NORDLANDER RH, 1982, EXP NEUROL, V75, P221, DOI 10.1016/0014-4886(82)90020-6
   O'Driscoll CM, 2005, NEUROSCIENCE, V131, P321, DOI 10.1016/j.neuroscience.2004.11.015
   Previtali SC, 2003, MOL CELL NEUROSCI, V23, P210, DOI 10.1016/S1044-7431(03)00014-9
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046
   SCHNEIDER BF, 1990, J COMP NEUROL, V299, P462, DOI 10.1002/cne.902990406
   SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P5184, DOI 10.1073/pnas.74.11.5184
   Smith BE, 1996, CELL ADHES COMMUN, V3, P451, DOI 10.3109/15419069609081022
   SORENSON EJ, 1993, J NEUROPATH EXP NEUR, V52, P216, DOI 10.1097/00005072-199305000-00005
   Thompson DM, 2004, ANN BIOMED ENG, V32, P1120
   Thompson DM, 2001, TISSUE ENG, V7, P247, DOI 10.1089/10763270152044125
   Wang SG, 2003, J BIOMED MATER RES A, V66A, P522, DOI 10.1002/jbm.a.10008
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
NR 50
TC 87
Z9 91
U1 2
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2009
VL 5
IS 2
BP 580
EP 588
DI 10.1016/j.actbio.2008.09.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 397TI
UT WOS:000262684600006
PM 18835227
DA 2018-10-19
ER

PT J
AU Wollensak, G
   Iomdina, E
AF Wollensak, Gregor
   Iomdina, Elena
TI Long-term biomechanical properties of rabbit cornea after photodynamic
   collagen crosslinking
SO ACTA OPHTHALMOLOGICA
LA English
DT Article
DE biomechanics; cornea; cross-linking; longterm effect; riboflavin; UVA
ID ULTRAVIOLET-A; PORCINE CORNEA; OCULAR-TISSUES; KERATOCONUS; RIBOFLAVIN;
   TRANSPLANTS; BEHAVIOR; UVA
AB Photodynamic riboflavin/ultraviolet-A (UVA)-induced collagen cross-linking, which increases the biomechanical stiffness of the human cornea by about 300%, has been introduced recently as a possible treatment for progressive keratoconus. The present study was undertaken to evaluate the longterm biomechanical effects of this new cross-linking treatment as a necessary prerequisite to its clinical success.
   The corneas of the left eyes of nine male rabbits were cross-linked. The contralateral eyes served as controls. After removal of the central 7 mm of the epithelium, the corneas were treated with the photosensitizer riboflavin and UVA irradiation for 30 mins with an irradiance of 3 mW/cm(2) using a 370-nm UVA double diode. Groups of three animals were killed immediately after treatment and at 3 and 8 months, respectively. Biomechanical stress-strain measurements were performed using a microcomputer-controlled biomaterial tester on 4 x 10-mm corneal strips.
   Corneal thickness in the treated rabbit cornea was 408 +/- 20 mu m. A constant and significant increase in ultimate stress (of 69.7-106.0%), Young's modulus of elasticity (of 78.4-87.4%) and a decrease in ultimate strain (of 0.57-78.4%) were found over a time period of up to 8 months after cross-linking treatment.
   Riboflavin/UVA-induced collagen cross-linking leads to a longterm increase in biomechanical rigidity which remains stable over time. These data support our previous longterm clinical observations and give hope that this new treatment will halt progressive keratoconus definitively.
C1 [Iomdina, Elena] Moscow Helmholtz Res Inst Eye Dis, Moscow, Russia.
   [Wollensak, Gregor] Univ Halle Wittenberg, Dept Ophthalmol, Eye Laser Ctr, Halle, Germany.
RP Wollensak, G (reprint author), Wildentensteig 4, D-14195 Berlin, Germany.
EM gwollens@hotmail.com
CR ANDREASSEN TT, 1980, EXP EYE RES, V31, P435, DOI 10.1016/S0014-4835(80)80027-3
   BAI PM, 1992, CONNECT TISSUE RES, V28, P1, DOI 10.3109/03008209209014224
   Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5
   BAILEY AJ, 1987, EYE-T OPHTH SOC UK, V1, P175, DOI 10.1038/eye.1987.34
   BELLOWS JG, 1976, ANN OPHTHALMOL, V8, P1457
   BETTELHEIM FA, 1974, EXP EYE RES, V19, P511, DOI 10.1016/0014-4835(74)90088-8
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   JAEGER MJ, 1987, CORNEA, V6, P131
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092
   LEE RE, 1981, EXP EYE RES, V32, P737, DOI 10.1016/0014-4835(81)90023-3
   MAFFEZZOLI A, 1994, BIOMATERIALS, V15, P1221, DOI 10.1016/0142-9612(94)90273-9
   MARSHALL GE, 1993, BRIT J OPHTHALMOL, V77, P515, DOI 10.1136/bjo.77.8.515
   MEISENBERG G, 2006, PRINCIPLES MED BIOCH, P233
   SEITZ R, 1963, Klin Monbl Augenheilkd, V142, P943
   SMELSER GK, 1965, EXP EYE RES, V4, P349, DOI 10.1016/S0014-4835(65)80051-3
   Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182
   Spoerl E, 2004, OPHTHALMOLOGICA, V218, P136, DOI 10.1159/000076150
   Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78
   Wollensak G, 1999, EXP EYE RES, V68, P341, DOI 10.1006/exer.1998.0611
   Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f
   Wollensak G, 2004, CORNEA, V23, P43, DOI 10.1097/00003226-200401000-00008
   Wollensak G, 2003, OPHTHALMOLOGE, V100, P44, DOI 10.1007/s00347-002-0700-3
   Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Wollensak G, 2007, J CATARACT REFR SURG, V33, P516, DOI 10.1016/j.jcrs.2006.11.015
   Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25
NR 27
TC 100
Z9 103
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-375X
EI 1755-3768
J9 ACTA OPHTHALMOL
JI Acta Ophthalmol.
PD FEB
PY 2009
VL 87
IS 1
BP 48
EP 51
DI 10.1111/j.1755-3768.2008.01190.x
PG 4
WC Ophthalmology
SC Ophthalmology
GA 399UZ
UT WOS:000262826100007
PM 18547280
OA Bronze
DA 2018-10-19
ER

PT J
AU Peramo, A
   Marcelo, C
   Goldstein, S
   Martin, D
AF Peramo, Antonio
   Marcelo, Cynthia L.
   Goldstein, Steven A.
   Martin, David C.
TI Novel Organotypic Cultures of Human Skin Explants with an Implant-tissue
   Biomaterial Interface
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Organotypic culture; Wound healing; Skin biomaterial; Implant interface;
   External fixation
ID ORGAN-CULTURE; EXTERNAL FIXATION; INFECTIONS; OSSEOINTEGRATION;
   PREVENTION; DEVICES; PINS
AB A novel in vitro culture system of organotypic human skin explants interfacing with external fixator pins is presented. The system was used to observe changes in skin morphology on the skin at the pin interface. To evaluate the performance of this novel system, histological analysis of human skin explants cultured for 5 days at the air-liquid interface was performed. Compared to control explants, specimens interfaced with pins (treated or not with a physiological saline solution) showed a deteriorating basal layer, a disappearing stratum spinosum and increased lost of elastic fibers in the dermis. The model system makes it possible to perform rapid, repeatable studies of living skin response to chronically implanted materials and devices.
C1 [Peramo, Antonio; Martin, David C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Marcelo, Cynthia L.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.
   [Goldstein, Steven A.] Univ Michigan, Dept Orthoped Surg, Ann Arbor, MI 48109 USA.
   [Goldstein, Steven A.; Martin, David C.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Martin, David C.] Univ Michigan, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA.
RP Peramo, A (reprint author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
EM aperamo@umich.edu
RI Martin, David/B-1838-2008
OI Martin, David/0000-0003-1195-3838
FU Army Research Office Multidisciplinary University Research Initiative
FX We thank Harald Eberhart, College of Engineering, University of
   Michigan, for help with the glass lid design. We thank Marta Dzaman,
   Morphology Core, University of Michigan for advice on specimen
   sectioning and staining. This report is presented as part of the
   research efforts within the Army Research Office Multidisciplinary
   University Research Initiative award on Bio-Integrating Structural and
   Neural Prosthetic Materials and we gratefully acknowledge the funding
   provided.
CR ARO HT, 1993, J TRAUMA, V35, P776, DOI 10.1097/00005373-199311000-00022
   Bedoni M, 2007, J DERMATOL SCI, V46, P139, DOI 10.1016/j.jdermsci.2006.12.005
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   GREEN SA, 1984, J BONE JOINT SURG AM, V66A, P1092, DOI 10.2106/00004623-198466070-00017
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   LEPOOLE IC, 1994, PIGM CELL RES, V7, P33
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   MOONEY V, 1977, ANN BIOMED ENG, V5, P34, DOI 10.1007/BF02409337
   MORONI A, 1994, BIOCERAMICS, V7, P229
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   PERAMO A, 2007, NOVEL IN VITRO TISSU
   Pickup JC, 2005, BIOSENS BIOELECTRON, V20, P1897, DOI 10.1016/j.bios.2004.08.016
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   RESAU JH, 1991, CYTOTECHNOLOGY, V7, P137, DOI 10.1007/BF00365924
   Schalamon J, 2007, J PEDIATR SURG, V42, P1584, DOI 10.1016/j.jpedsurg.2007.04.022
   Solomon S, 2003, AM J INFECT CONTROL, V31, P481
   STOSCHECK CM, 1992, J INVEST DERMATOL, V99, P645, DOI 10.1111/1523-1747.ep12668143
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Svensjo T, 2000, PLAST RECONSTR SURG, V106, P602, DOI 10.1097/00006534-200009030-00012
   TAMMI R, 1979, J INVEST DERMATOL, V73, P138, DOI 10.1111/1523-1747.ep12581579
   Tavakkol A, 1999, ARCH DERMATOL RES, V291, P643, DOI 10.1007/s004030050469
   TEBBS SE, 1994, BRIT J ANAESTH, V72, P587, DOI 10.1093/bja/72.5.587
   VARANI J, 1993, AM J PATHOL, V142, P189
   Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   WINTER GD, 1974, J BIOMED MATER RES S, V5, P99
   Xu W, 2006, P I MECH ENG H, V220, P661, DOI 10.1243/09544119JEIM84
NR 29
TC 10
Z9 10
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2009
VL 37
IS 2
BP 401
EP 409
DI 10.1007/s10439-008-9614-9
PG 9
WC Engineering, Biomedical
SC Engineering
GA 395WP
UT WOS:000262554500011
PM 19052870
DA 2018-10-19
ER

PT J
AU Emans, P
   Schreinemacher, M
   Gijbels, M
   Beets, G
   Greve, JW
   Koole, L
   Bouvy, N
AF Emans, Pieter J.
   Schreinemacher, Marc H. F.
   Gijbels, Marion J. J.
   Beets, Geerard L.
   Greve, Jan-Willem M.
   Koole, Leo H.
   Bouvy, Nicole D.
TI Polypropylene Meshes to Prevent Abdominal Herniation. Can Stable
   Coatings Prevent Adhesions in the Long Term?
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Abdomen; Adhesion; Biocompatibility; Surgical mesh; Surface
   modification; Inflammation
ID RANDOMIZED CONTROLLED-TRIAL; INCISIONAL HERNIA; PROSTHETIC MESH;
   DRUG-DELIVERY; SUTURE REPAIR; RAT MODEL; FOLLOW-UP; COMPOSITE;
   BIOCOMPATIBILITY; RECONSTRUCTION
AB Abdominal surgery is associated with a significant risk for incisional herniation. Hernia repair is routinely performed by implantation of synthetic meshes. Such meshes may cause serious adhesions between the implanted material and organs leading to intestinal obstruction or enterocutaneous fistulas. This study compares three knitted meshes for their capacity to prevent adhesion formation in an in vivo study. The meshes evaluated are polypropylene (Prolene(A (R))), polypropylene coated with oxygenated regenerated cellulose-in principle-a biodegradable biomaterial (Proceed(A (R))), and Prolene(A (R)) coated with a nondegradable copolymer of the hydrophilic building block N-vinyl pyrrolidone (NVP) and the hydrophobic building block n-butylmethacrylate (BMA). The meshes were implanted in the abdomen of rats (follow-up 7 or 30 days). After 7 days, the formation of adhesions decreased in the order: Prolene(A (R)) > NVP/BMA-coated Prolene(A (R)) > Proceed(A (R)); after 30 days, this order changed into: Proceed(A (R)) > Prolene(A (R)) > NVP/BMA-coated Prolene(A (R)). Both at 7 and at 30 days, Proceed(A (R)) was the only mesh surrounded by macrophage cells that contained foreign materials, presumably degradation products of the (biodegradable) surface coating. The data indicate that long-term protection of implanted meshes against excessive adhesions may be achieved through stable biocompatible hydrogel surface coatings.
C1 [Emans, Pieter J.; Koole, Leo H.] Maastricht Univ, Med Ctr, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   [Emans, Pieter J.; Schreinemacher, Marc H. F.; Beets, Geerard L.; Greve, Jan-Willem M.; Bouvy, Nicole D.] Maastricht Univ, Med Ctr, Dept Gen Surg, NL-6200 MD Maastricht, Netherlands.
   [Emans, Pieter J.] Maastricht Univ, Med Ctr, Dept Orthoped Surg, NL-6200 MD Maastricht, Netherlands.
   [Gijbels, Marion J. J.] Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.
   [Gijbels, Marion J. J.] Maastricht Univ, Med Ctr, Dept Pathol, Maastricht, Netherlands.
RP Emans, P (reprint author), Maastricht Univ, Med Ctr, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
EM pj.emans@orthop.unimaas.nl; l.koole@biochem.unimaas.nl
RI Schreinemacher, Marc/D-5591-2009; Beets, Geerard/G-2682-2013
OI Beets, Geerard/0000-0002-1671-9912
CR Aldenhoff YBJ, 2004, BIOMATERIALS, V25, P3125, DOI 10.1016/j.biomaterials.2003.10.012
   Baptista ML, 2000, J AM COLL SURGEONS, V190, P271, DOI 10.1016/S1072-7515(99)00277-X
   Binnebosel M, 2008, WORLD J SURG, V32, P296, DOI 10.1007/s00268-007-9330-x
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Burger JWA, 2004, ANN SURG, V240, P578
   Burger JWA, 2004, ANN SURG, V240, P583
   Cassar K, 2002, BRIT J SURG, V89, P534, DOI 10.1046/j.1365-2168.2002.02083.x
   DIAMOND MP, 1994, FERTIL STERIL, V62, P984
   Eisner L, 1997, CHIRURG, V68, P304, DOI 10.1007/s001040050193
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Greenawalt KE, 2000, J SURG RES, V94, P92, DOI 10.1006/jsre.2000.6020
   Hanssen HHL, 1999, J BIOMED MATER RES, V48, P820, DOI 10.1002/(SICI)1097-4636(1999)48:6<820::AID-JBM9>3.0.CO;2-K
   Hooker GD, 1999, SURGERY, V125, P211, DOI 10.1067/msy.2099.94987
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Judge TW, 2007, J AM COLL SURGEONS, V204, P276, DOI 10.1016/j.jamcollsurg.2006.11.003
   Kayaoglu HA, 2005, J INVEST SURG, V18, P89, DOI 10.1080/08941930590926357
   Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0
   Kingsnorth A, 2006, ANN ROY COLL SURG, V88, P252, DOI 10.1308/003588406X106324
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   Korenkov M, 2002, BRIT J SURG, V89, P50, DOI 10.1046/j.0007-1323.2001.01974.x
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Matthews BD, 2005, J SURG RES, V123, P227, DOI 10.1016/j.jss.2004.08.012
   MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127
   Pijls RT, 2005, EUR J PHARM BIOPHARM, V59, P283, DOI 10.1016/j.ejpb.2004.08.011
   Scheidbach H, 2004, EUR SURG RES, V36, P313, DOI 10.1159/000079917
   Scheidbach H, 2004, SURG ENDOSC, V18, P211, DOI 10.1007/s00464-003-8113-1
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091
NR 28
TC 35
Z9 38
U1 1
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2009
VL 37
IS 2
BP 410
EP 418
DI 10.1007/s10439-008-9608-7
PG 9
WC Engineering, Biomedical
SC Engineering
GA 395WP
UT WOS:000262554500012
PM 19034665
OA Other Gold
DA 2018-10-19
ER

PT J
AU Rabotyagova, OS
   Cebe, P
   Kaplan, DL
AF Rabotyagova, Olena S.
   Cebe, Peggy
   Kaplan, David L.
TI Self-Assembly of Genetically Engineered Spider Silk Block Copolymers
SO BIOMACROMOLECULES
LA English
DT Article
ID INFRARED-SPECTROSCOPY; DRAGLINE SILK; SYNTHETIC-POLYMERS; GENE DELIVERY;
   PROTEIN; MORPHOLOGY; POLYPEPTIDES; BIOMATERIAL; SEQUENCES; VESICLES
AB The design, construction, and preliminary characterization of a novel family of spider silk-like block copolymers are described, The design was based on the assembly of individual spider silk modules, in particular, polyalanine (A) and glycine-rich (B) blocks, that display different phase behavior in aqueous solution. Spider silk was chosen as a model for these block copolymer studies based on its extraordinary material properties, such a,; toughness, biocompatibility, and biodegradability. Trends in spider silk-like block copolymer secondary structure and assembly behavior into specific material morphologies were determined as a function of the number of hydrophobic blocks, the presence of a hydrophilic purification tag and solvent effects. Structures and morphologies were assessed by Fourier transform infrared spectroscopy and scanning electron microscopy. In terms of structure, beta-sheet content increased with an increase in the number of polyalanine blocks, and the purification tag had significant impact on the secondary structure. In terms of morphology, spheres, rod-like structures, bowl-shaped micelles, and giant compound micelles were observed and the morphologies were linked with the size of the hydrophobic block, the presence of the purification tag, and the solvent environment. This study provides a basis for future designs of smart biomaterials based on spider silk chemistries, with controlled structure-architecture-function relationships.
C1 [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   Tufts Univ, Dept Phys, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Cebe, Peggy/0000-0002-8721-644X
FU AFOSR; NSF
FX We thank the AFOSR and the NSF for support of these studies.
CR Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Chen THH, 2008, PHARM RES, V25, P683, DOI 10.1007/s11095-007-9382-5
   Deng C, 2007, J POLYM SCI POL CHEM, V45, P3218, DOI 10.1002/pola.22071
   Deng C, 2007, POLYMER, V48, P139, DOI 10.1016/j.polymer.2006.10.046
   Farmer RS, 2006, MACROMOLECULES, V39, P162, DOI 10.1021/ma051534t
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   Fredrickson GH, 1996, ANNU REV MATER SCI, V26, P501, DOI 10.1146/annurev.ms.26.080196.002441
   Garside P, 2005, APPL SPECTROSC, V59, P1242, DOI 10.1366/000370205774430855
   Ghoroghchian PP, 2006, MACROMOLECULES, V39, P1673, DOI 10.1021/ma0519009
   Gore T, 2001, LANGMUIR, V17, P5352, DOI 10.1021/la010223i
   Hadjichristidis N., 2003, BLOCK COPOLYMERS, P419
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Hamley IW, 2005, BIOMACROMOLECULES, V6, P1310, DOI 10.1021/bm049286g
   Hasegawa H, 2008, AIP CONF PROC, V989, P65, DOI 10.1063/1.2906096
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Higashiya S, 2007, BIOMACROMOLECULES, V8, P1487, DOI 10.1021/bm061098y
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Knight DP, 2002, PHILOS T R SOC B, V357, P155, DOI 10.1098/rstb.2001.1030
   Krysmann MJ, 2008, MACROMOL CHEM PHYS, V209, P883, DOI 10.1002/macp.200700605
   Lao UL, 2007, BIOMACROMOLECULES, V8, P3736, DOI 10.1021/bm700662n
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Lindman B., 2000, AMPHIPHILIC BLOCK CO, P448
   Matsen MW, 1996, MACROMOLECULES, V29, P1091, DOI 10.1021/ma951138i
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Osborne JL, 2008, ACTA BIOMATER, V4, P49, DOI 10.1016/j.actbio.2007.07.007
   Pinol R, 2007, MACROMOLECULES, V40, P5625, DOI 10.1021/ma071064y
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   RABOTYAGOVA S, 2008, MAT SCI E C IN PRESS
   Riegel IC, 2002, LANGMUIR, V18, P3358, DOI 10.1021/la015592t
   Shen HW, 2000, ANGEW CHEM INT EDIT, V39, P3310, DOI 10.1002/1521-3773(20000915)39:18<3310::AID-ANIE3310>3.3.CO;2-U
   Tian Z, 2008, J POLYM SCI POL CHEM, V46, P1042, DOI 10.1002/pola.22447
   Vandermeulen GWM, 2004, MACROMOL BIOSCI, V4, P383, DOI 10.1002/mabi.200300079
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VOET D, 2005, BIOCHEMISTRY-US, P1616
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   XU C, 2008, J PHARM RES, V25, P674
   Yu YS, 1997, J AM CHEM SOC, V119, P8383, DOI 10.1021/ja9709740
   ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728
   Zhou CC, 2006, BIOMACROMOLECULES, V7, P2415, DOI 10.1021/bm060199t
NR 49
TC 83
Z9 86
U1 3
U2 52
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2009
VL 10
IS 2
BP 229
EP 236
DI 10.1021/bm800930x
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 405LM
UT WOS:000263226300005
PM 19128057
DA 2018-10-19
ER

PT J
AU Ishii, D
   Ying, TH
   Mahara, A
   Murakami, S
   Yamaoka, T
   Lee, WK
   Iwata, T
AF Ishii, Daisuke
   Ying, Tang Hui
   Mahara, Atsushi
   Murakami, Sunao
   Yamaoka, Tetsuji
   Lee, Won-ki
   Iwata, Tadahisa
TI In Vivo Tissue Response and Degradation Behavior of PLLA and
   Stereocomplexed PLA Nanofibers
SO BIOMACROMOLECULES
LA English
DT Article
ID ENANTIOMERIC POLY(LACTIDE)S; ENZYMATIC DEGRADATION; VITRO DEGRADATION;
   THIN-FILMS; HYDROLYSIS; POLYMER; FIBERS; POLY(L-LACTIDE); SCAFFOLDS;
   BLENDS
AB Biocompatibility of PLLA and stereocomplexed PLA nanofibers was evaluated by subcutaneous implantation in rats for 4-12 weeks. Characterization of the nanofibers was performed by GPC, SEM, wide-angle X-ray diffraction, and optical microscopy of hematoxylin-eosin stained ultrathin sections of explanted nanofibers. Stereocomplexed PLA nanofiber showed slower degradation than PLLA nanofiber and thus retained their shape after prolonged implantation. Furthermore, stereocomplexed PLA nanofiber caused milder inflammatory reaction than PLLA nanofiber. These results offer the potential use of PLLA and stereocomplexed PLA nanofibers as a biomaterial for short-term and long-term tissue regeneration, respectively. Stereocomplexed PLA nanofiber after in vitro degradation showed smaller degree of swelling than PLLA nanofiber. Taking the results of in vivo degradation together with in vitro degradation into consideration, bioabsorption mechanism of the in vivo degradation of the nanofibers is proposed.
C1 [Ishii, Daisuke; Ying, Tang Hui; Iwata, Tadahisa] Riken Inst Phys & Chem Res, Polymer Chem Lab, Wako, Saitama 3510198, Japan.
   [Ying, Tang Hui] Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia.
   [Mahara, Atsushi; Murakami, Sunao; Yamaoka, Tetsuji] Natl Cardiovasc Ctr, Res Inst, Adv Med Engn Ctr, Dept Biomed Engn, Osaka 5658565, Japan.
   [Lee, Won-ki] Pukyong Natl Univ, Div Chem Engn, Pusan 608739, South Korea.
RP Iwata, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
EM atiwata@mail.ecc.u-tokyo.ac.jp
RI Ishii, Daisuke/H-8779-2015
OI Ishii, Daisuke/0000-0003-4304-6554
FU Ecomolecular Research H in RIKEN Institute (The Institute of Physical
   and Chemical Research), Japan; Ministry of Education, Culture, Sports,
   Science and Technology, Japan [19350075]
FX This work has been supported by a grant provided for Ecomolecular
   Research H in RIKEN Institute (The Institute of Physical and Chemical
   Research), Japan, and by a Grant-in-Aid from the Ministry of Education,
   Culture, Sports, Science and Technology, Japan (No. 19350075, to T.I.).
   We thank Ms. Noreen Fundador for the English correction of our
   manuscript.
CR Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301
   Furuhashi Y, 2007, J POLYM SCI POL PHYS, V45, P218, DOI 10.1002/polb.21035
   Hasirci V, 2001, J BIOTECHNOL, V86, P135, DOI 10.1016/S0168-1656(00)00409-0
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034
   Ishii D, 2007, J BIOTECHNOL, V132, P318, DOI 10.1016/j.jbiotec.2007.03.019
   Iwata T, 2001, SEN-I GAKKAISHI, V57, P172
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Morota K, 2004, J COLLOID INTERF SCI, V279, P484, DOI 10.1016/j.jcis.2004.06.075
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   OKIHARA T, 1991, J MACROMOL SCI PHYS, VB30, P119, DOI 10.1080/00222349108245788
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Takasaki M, 2003, J MACROMOL SCI PHYS, VB42, P57, DOI 10.1081/MB-120015750
   TAN HY, 2008, BIOMATERIALS, V29, P1307
   Tsuji H, 2005, MACROMOL BIOSCI, V5, P569, DOI 10.1002/mabi.200500062
   Tsuji H, 2000, POLYMER, V41, P3621, DOI 10.1016/S0032-3861(99)00545-5
   Tsuji H, 2001, SEN-I GAKKAISHI, V57, P198
   Tsuji H, 2001, BIOMACROMOLECULES, V2, P597, DOI 10.1021/bm010048k
   Tsuji H, 2006, BIOMACROMOLECULES, V7, P3316, DOI 10.1021/bm060786e
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   You Y, 2005, J APPL POLYM SCI, V95, P193, DOI 10.1002/app.21116
   Zeng J, 2004, MACROMOL BIOSCI, V4, P1118, DOI 10.1002/mabi.200400092
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
   Zong XH, 2003, BIOMACROMOLECULES, V4, P416, DOI 10.1021/bm025717o
NR 26
TC 83
Z9 86
U1 5
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2009
VL 10
IS 2
BP 237
EP 242
DI 10.1021/bm8009363
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 405LM
UT WOS:000263226300006
PM 19117403
DA 2018-10-19
ER

PT J
AU Wu, DF
   Zhang, YS
   Zhang, M
   Yu, W
AF Wu, Defeng
   Zhang, Yisheng
   Zhang, Ming
   Yu, Wei
TI Selective Localization of Multiwalled Carbon Nanotubes in
   Poly(epsilon-caprolactone)/Polylactide Blend
SO BIOMACROMOLECULES
LA English
DT Article
ID IMMISCIBLE POLYMER BLENDS; PHASE MORPHOLOGY ANALYSIS; GLYCOL)
   BLOCK-COPOLYMERS; BIODEGRADABLE POLYMERS; MECHANICAL-PROPERTIES;
   ISOTHERMAL CRYSTALLIZATION; ELECTRICAL-CONDUCTIVITY; RHEOLOGICAL
   PROPERTIES; ENZYMATIC DEGRADATION; LAYERED SILICATE
AB Poly(epsilon-caprolactone)/polylactide blend (PCL/PLA) is an interesting biomaterial because PCL and PLA present good complementarity in their physical properties and biodegradability. However, the thermodynamic incompatibility between two component polymers restricts further applications of their blend. In this work, we used functionalized multiwalled carbon nanotube (MWCNT) to control the morphology of immiscible PCL/PLA blend. The ternary PCL/PLA/MWCNTs composites were hence prepared by melt mixing for the morphology and the properties investigation. It is interesting to find that the functionalized MWCNTs are selectively dispersed in the matrix PCL phase and on the interface between two polymer phases, leading to simultaneous occurrence of thermodynamically and kinetically driven compatibility. Those interface-localized MWCNTs prevent coalescence of the discrete domains and enhance the phase interfacial adhesion as well. As a result, the phase morphology of the ternary composites is improved remarkably in contrast to that of the blank PCL/PLA blend. Owing to that unique selective interface-localization and improved phase morphology, the ternary composites present far lower rheological and conductive percolation thresholds than those of the binary composites, and also present extraordinary mechanical properties even at very low loading levels of the MWCNTs. Therefore, the amphiphilic MWCNTs are believed to act as the reinforcements as well as the compatibilizer in the immiscible PCL/PLA blend.
C1 [Wu, Defeng; Zhang, Yisheng; Zhang, Ming] Yangzhou Univ, Sch Chem & Chem Engn, Jiangsu 225002, Peoples R China.
   [Wu, Defeng; Zhang, Yisheng; Zhang, Ming] Prov Key Labs Environm Mat & Engn, Jiangsu 225002, Peoples R China.
   [Yu, Wei] Shanghai Jiao Tong Univ, Dept Polymer Sci & Engn, Shanghai 200030, Peoples R China.
RP Wu, DF (reprint author), Yangzhou Univ, Sch Chem & Chem Engn, Jiangsu 225002, Peoples R China.
EM dfwu@yzu.edu.cn
RI Defeng, WU/K-8865-2012
FU National Natural Science Foundation of China [50803052]; Startup Program
   of Innovative Talent of Jiangsu Province [BK2007559]; Key Program of
   Jiangsu Province [06KJA15011]
FX This work was supported by the research grants from the National Natural
   Science Foundation of China (No. 50803052), the Startup Program of
   Innovative Talent of Jiangsu Province (No. BK2007559), and the Key
   Program of Jiangsu Province (No. 06KJA15011).
CR Bhattacharya SK, 1986, METAL FILLED POLYM
   Bogdanov B, 1999, MACROMOLECULES, V32, P726, DOI 10.1021/ma980226a
   Broz ME, 2003, BIOMATERIALS, V24, P4181, DOI 10.1016/S0142-9612(03)00314-4
   Chow WS, 2003, POLYMER, V44, P7427, DOI 10.1016/j.polymer.2003.09.006
   Dell'Erba R, 2001, POLYMER, V42, P7831, DOI 10.1016/S0032-3861(01)00269-5
   Du FM, 2004, MACROMOLECULES, V37, P9048, DOI 10.1021/ma049164g
   Eastmond GC, 2000, ADV POLYM SCI, P59, DOI DOI 10.1007/3-540-48838-3_2
   Gan ZH, 1999, POLYMER, V40, P2859, DOI 10.1016/S0032-3861(98)00549-7
   Han S, 1998, POLYMER, V39, P1113, DOI 10.1016/S0032-3861(97)00327-3
   Hong JS, 2007, RHEOL ACTA, V46, P469, DOI [10.1007/s00397-006-0123-1, 10.1007/S00397-006-0123-1]
   Hu GJ, 2006, POLYMER, V47, P480, DOI 10.1016/j.polymer.2005.11.028
   Ishiaku US, 2002, EUR POLYM J, V38, P393, DOI 10.1016/S0014-3057(01)00125-2
   Jung R, 2008, POLYMER, V49, P2071, DOI 10.1016/j.polymer.2008.02.045
   Khatua BB, 2004, MACROMOLECULES, V37, P2454, DOI 10.1021/ma0352072
   LEE HM, 1994, J RHEOL, V38, P1405, DOI 10.1122/1.550551
   Li SM, 2003, BIOMACROMOLECULES, V4, P372, DOI 10.1021/bm025748j
   Li YJ, 2005, MACROMOL RAPID COMM, V26, P710, DOI 10.1002/marc.200400654
   Li YJ, 2004, POLYMER, V45, P7381, DOI 10.1016/j.polymer.2004.09.018
   Liang HJ, 1999, MACROMOLECULES, V32, P8204, DOI 10.1021/ma990563z
   Liu LJ, 2000, BIOMACROMOLECULES, V1, P350, DOI 10.1021/bm000046k
   Lopez-Rodriguez N, 2006, POLYM ENG SCI, V46, P1299, DOI 10.1002/pen.20609
   Maglio G, 1999, MACROMOL RAPID COMM, V20, P236, DOI 10.1002/(SICI)1521-3927(19990401)20:4<236::AID-MARC236>3.0.CO;2-V
   Mei F, 2007, BIOMACROMOLECULES, V8, P3729, DOI 10.1021/bm7006295
   Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p
   Na YH, 2002, BIOMACROMOLECULES, V3, P1179, DOI 10.1021/bm020050r
   Nogales A, 2004, MACROMOLECULES, V37, P7669, DOI 10.1021/ma049440r
   Paul DR, 2000, POLYM BLENDS FORMULA
   Pitt C. G., 1980, BIODEGRADABLE DRUG D
   Potschke P, 2007, COMPOS SCI TECHNOL, V67, P855, DOI 10.1016/j.compscitech.2006.02.034
   Potschke P, 2002, POLYMER, V43, P3247, DOI 10.1016/S0032-3861(02)00151-9
   Potschke P, 2004, POLYMER, V45, P8863, DOI 10.1016/j.polymer.2004.10.040
   Ray SS, 2005, PROG MATER SCI, V50, P962, DOI 10.1016/j.pmatsci.2005.05.002
   Ray SS, 2005, MACROMOL RAPID COMM, V26, P1639, DOI 10.1002/marc.200500447
   Ray SS, 2004, POLYMER, V45, P8403, DOI 10.1016/j.polymer.2004.10.009
   Rezgui F, 2005, POLYMER, V46, P7370, DOI 10.1016/j.polymer.2005.03.116
   Roy X, 2006, ADV MATER, V18, P1015, DOI 10.1002/adma.200501210
   Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065
   Sarazin P, 2008, POLYMER, V49, P599, DOI 10.1016/j.polymer.2007.11.029
   Shi XF, 2005, NANOTECHNOLOGY, V16, pS531, DOI 10.1088/0927-4484/16/7/030
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Smith R., 2005, BIODEGRADABLE POLYM
   Subramoney S, 1998, ADV MATER, V10, P1157, DOI 10.1002/(SICI)1521-4095(199810)10:15<1157::AID-ADMA1157>3.0.CO;2-N
   Tsuji H, 2001, MACROMOL BIOSCI, V1, P59
   Utracki L., 1989, POLYM ALLOYS BLENDS
   Van Gurp M., 1998, RHEOL B, V67, P5
   Vert M., 1992, BIODEGRADABLE POLYM
   Wang Y, 2003, MACROMOL RAPID COMM, V24, P231, DOI 10.1002/marc.200390026
   Wu DF, 2008, POLYM DEGRAD STABIL, V93, P1577, DOI 10.1016/j.polymdegradstab.2008.05.001
   Wu DF, 2008, EUR POLYM J, V44, P2171, DOI 10.1016/j.eurpolymj.2008.04.023
   Wu DF, 2008, J POLYM SCI POL PHYS, V46, P1265, DOI 10.1002/polb.21461
   Wu D, 2007, J POLYM SCI POL PHYS, V45, P3137, DOI 10.1002/polb.21309
   Wu DF, 2007, J POLYM SCI POL PHYS, V45, P2239, DOI 10.1002/polb.21233
   Xie WH, 2007, POLYMER, V48, P6791, DOI 10.1016/j.polymer.2007.09.021
   Yu W, 2002, J RHEOL, V46, P1401, DOI 10.1122/1.1517303
   Zou H, 2006, POLYMER, V47, P6, DOI 10.1016/j.polymer.2005.11.031
   Zou H, 2006, POLYMER, V47, P7821, DOI 10.1016/j.polymer.2006.09.008
NR 56
TC 217
Z9 224
U1 9
U2 106
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2009
VL 10
IS 2
BP 417
EP 424
DI 10.1021/bm801183f
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 405LM
UT WOS:000263226300028
PM 19140730
DA 2018-10-19
ER

PT J
AU Mithieux, SM
   Tu, YD
   Korkmaz, E
   Braet, F
   Weiss, AS
AF Mithieux, Suzanne M.
   Tu, Yidong
   Korkmaz, Emine
   Braet, Filip
   Weiss, Anthony S.
TI In situ polymerization of tropoelastin in the absence of chemical
   cross-linking
SO BIOMATERIALS
LA English
DT Article
DE Biomimetic material; Elastin; Elasticity; Extracellular matrix;
   Hydrogel; Self-assembly
ID ELASTIC FIBER FORMATION; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS;
   PROTEIN; COACERVATION; BIOMATERIAL; COLLAGEN; GENE
AB Tropoelastin, the polypeptide monomer precursor of elastin, is covalently cross-linked to give stable elastic structures. We show here that elastic biomaterials can be generated from tropoelastin in the absence of the classically accepted cross-linking pathway. Under alkaline conditions tropoelastin proceeds through a sol-gel transition leading to the formation of an irreversible hydrogel. This does not Occur at neutral pH. The resulting biomaterial is stable, elastic and flexible. Scanning electron microscopy revealed that the hydrogel forms through the coalescence of similar to I mu m quantized protein spheres. These spheres resemble the tropoelastin-rich globules that accumulate on Cultured cell surfaces during elastin formation. In vitro cell Culture Studies demonstrate that the hydrogel can Support human skin fibroblast proliferation. In vivo studies demonstrate that following injection, the tropoelastin solution undergoes rapid localized gelation to form a persistent mass. These subcutaneous rodent injection data establish the material's potential as a novel cell-compatible elastic scaffold that can be formed in situ. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Mithieux, Suzanne M.; Tu, Yidong; Weiss, Anthony S.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.
   [Korkmaz, Emine; Braet, Filip] Univ Sydney, Australian Key Ctr Microscopy & Microanal, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol & Microbial Biosci, Bldg G08, Sydney, NSW 2006, Australia.
EM a.weiss@usyd.edu.au
OI Mithieux, Suzanne/0000-0001-6160-9352; WEISS,
   ANTHONY/0000-0002-8106-4836
FU Australian Research Council
FX A.S.W. acknowledges Support from the Australian Research Council.
CR Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bochicchio B, 2007, BIOMACROMOLECULES, V8, P3478, DOI 10.1021/bm700636a
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Chilkoti A, 2006, CURR OPIN CHEM BIOL, V10, P652, DOI 10.1016/j.cbpa.2006.10.010
   Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105
   Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2008, TISSUE ENG PT A, V14, P349, DOI 10.1089/tea.2007.0076
   DICKSON CP, 1988, HISTOCHEMISTRY, V89, P105, DOI 10.1007/BF00489912
   EPPLEY BL, 1994, AESTHET PLAST SURG, V18, P413, DOI 10.1007/BF00451350
   Fung YC, 1993, BIOMECHANICS MECH PR
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900
   LEMPERLE G, 2003, AESTHET PLAST SURG, V27, P367
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Ma K, 2001, BIOCHEMISTRY-US, V40, P3427, DOI 10.1021/bi0022792
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   ODELL BL, 1966, NATURE, V209, P401, DOI 10.1038/209401a0
   Osborne JL, 2008, ACTA BIOMATER, V4, P49, DOI 10.1016/j.actbio.2007.07.007
   ROSENBLOOM J, 1984, LAB INVEST, V51, P605
   SIEGEL RC, 1970, BIOCHEMISTRY-US, V9, P4486, DOI 10.1021/bi00825a004
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   TU Y, 2008, BIOMACROMOLECULES
   Vieth S, 2007, BIOPOLYMERS, V85, P199, DOI 10.1002/bip.20619
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
NR 28
TC 53
Z9 53
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2009
VL 30
IS 4
BP 431
EP 435
DI 10.1016/j.biomaterials.2008.10.018
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 389BR
UT WOS:000262065500001
PM 18996590
DA 2018-10-19
ER

PT J
AU Fan, Y
   Sun, Z
   Moradian-Oldak, J
AF Fan, Yuwei
   Sun, Zhi
   Moradian-Oldak, Janet
TI Controlled remineralization of enamel in the presence of amelogenin and
   fluoride
SO BIOMATERIALS
LA English
DT Article
DE Amelogenin; Fluoride; Enamel remineralization; Fluoridated
   hydroxyapatite
ID APATITE CRYSTAL-GROWTH; HYDROXYAPATITE CRYSTALS; OCTACALCIUM PHOSPHATE;
   RECOMBINANT AMELOGENIN; MOUSE AMELOGENINS; TOOTH ENAMEL; MICROSTRUCTURE;
   NANORODS; MATRIX; MODEL
AB Reconstructing enamel-like structures on teeth have been an important topic Of Study in the material sciences and dentistry. The important role of amelogenin in modulating the mineralization of organized calcium phosphate crystals has been previously reported. We used amelogenin and utilized a modified biomimetic deposition method to remineralize the surface of etched enamel to form mineral layers containing organized needle-like fluoridated hydroxyapatite crystals. The effect of a recombinant amelogenins (rP172) on the microstructure of the mineral in the coating was analyzed by SEM, XRD and FTIR. At rP172 concentrations below 33 [mu g/mL. no significant effect was observed. In the presence of I mg/L F and at a concentration of 33 mu g/mL rP172, formation of fused crystals growing from the enamel surface was initiated. Amelogenin promoted the oriented bundle formation of needle-like fluoridated hydroxyapatite in a dose dependent manner. Biomimetic synthesis of the amelogenin fluoridated hydroxyapatite nano-composite is one of the primary steps towards the development and design of novel biomaterial for future application in reparative and restorative dentistry. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Fan, Yuwei; Sun, Zhi; Moradian-Oldak, Janet] Univ So Calif, Ctr Craniofacial Mol Biol, HSC, Los Angeles, CA 90033 USA.
RP Moradian-Oldak, J (reprint author), Univ So Calif, Ctr Craniofacial Mol Biol, HSC, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.
EM joldak@usc.edu
RI Sun, Zhi/A-7311-2010; Fan, Yuwei/A-2951-2009
OI Fan, Yuwei/0000-0001-8477-8458
FU NIDCR NIH HHS [R01 DE015644-04, R01 DE015644, R01 DE013414, R01
   DE013414-06, R01 DE020099]
CR Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001
   Boyde A, 1997, CIBA F SYMP, V205, P18
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Chen HF, 2005, J COLLOID INTERF SCI, V288, P97, DOI 10.1016/j.jcis.2005.02.064
   Fan YW, 2007, BIOMATERIALS, V28, P3034, DOI 10.1016/j.biomaterials.2007.02.016
   Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130
   Fowler CE, 2005, J MATER CHEM, V15, P3317, DOI 10.1039/b503312h
   Habelitz S, 2004, J DENT RES, V83, P698, DOI 10.1177/154405910408300908
   Iijima M, 2005, BIOMATERIALS, V26, P1595, DOI 10.1016/j.biomaterials.2004.05.009
   Iijima M, 2004, J MATER CHEM, V14, P2189, DOI 10.1039/b401961j
   Iijima M, 2002, J DENT RES, V81, P69, DOI 10.1177/154405910208100115
   IIJIMA M, 1992, CALCIFIED TISSUE INT, V50, P357, DOI 10.1007/BF00301634
   Iijima M, 2006, EUR J ORAL SCI, V114, P304, DOI 10.1111/j.1600-0722.2006.00324.x
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   MANLY R. S., 1939, JOUR DENTAL RES, V18, P203, DOI 10.1177/00220345390180030301
   Moriwaki Y., 1983, MECH TOOTH ENAMEL FO, P239
   Onuma K, 2005, J CRYST GROWTH, V282, P199, DOI 10.1016/j.jcrysgro.2005.04.085
   Ryu OH, 1999, J DENT RES, V78, P743, DOI 10.1177/00220345990780030601
   Wang LJ, 2008, J PHYS CHEM C, V112, P5892, DOI 10.1021/jp077105+
   Wen HB, 1999, BIOMATERIALS, V20, P1717, DOI 10.1016/S0142-9612(99)00085-X
   Ye W, 2007, MATER LETT, V61, P4062, DOI 10.1016/j.matlet.2007.01.040
   Zhan JH, 2005, ADV FUNCT MATER, V15, P2005, DOI 10.1002/adfm.200500274
NR 22
TC 104
Z9 107
U1 4
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2009
VL 30
IS 4
BP 478
EP 483
DI 10.1016/j.biomaterials.2008.10.019
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 389BR
UT WOS:000262065500007
PM 18996587
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Katopodi, T
   Tew, SR
   Clegg, PD
   Hardingham, TE
AF Katopodi, Theoni
   Tew, Simon R.
   Clegg, Peter D.
   Hardingham, Timothy E.
TI The influence of donor and hypoxic conditions on the assembly of
   cartilage matrix by osteoarthritic human articular chondrocytes on
   Hyalograft matrices
SO BIOMATERIALS
LA English
DT Article
DE Cartilage; Chondrocyte; Hyaluronan; ECM; Cell culture
ID LOW-OXYGEN TENSION; HUMAN MENISCUS CELLS; GENE-EXPRESSION; PHENOTYPE;
   CULTURE; HYALURONAN; SOX9; REDIFFERENTIATION; TRANSDUCTION; REPAIR
AB Resurfacing of cartilage defects using cell-seeded, biomaterial grafts is a promising approach for articular cartilage repair and in this study we investigated the ability of human chondrocytes from osteoarthritic joints to generate cartilage tissue under standard conditions ill Cultured over 21 days on Hyalograft matrices under normoxic (20% O(2)) and hypoxic (5% O(2)) conditions. The results showed that constructs were more chondrogenic when cultured under hypoxic conditions, which resulted in greater production of sulphated glycosaminoglycan and collagen type 11 within the constructs and the cells expressed higher levels of genes encoding cartilage matrix proteins and chondrocyte transcription factors. However, there were very wide differences in the chondrogenic potential amongst donors as the weight ratio of total sulphated glycosaminoglycan to DNA in constructs varied from above 200 to below 10. These results establish that the generation of cartilage from human OA chondrocytes on biodegradable Supports is favoured in lowered oxygen, but that under standard conditions, even at low passage, there is a large variation in the chondrogenic potential amongst chondrocytes from different donors. Further analysis of this variation Suggested that the gene expression ratio of COL2A1/COL1A1 mRNA in the chondrocytes in monolayer culture may predict their subsequent performance in forming cartilage matrix on the Hyalograft scaffold. (C) 2008 Elsevier Ltd. All rights reserved
C1 [Katopodi, Theoni; Hardingham, Timothy E.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.
   [Tew, Simon R.; Clegg, Peter D.] Univ Liverpool, Vet Teaching Hosp, Neston CH64 7TE, Cheshire, England.
RP Hardingham, TE (reprint author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM timothy.e.hardingham@manchester.ac.uk
OI Tew, Simon/0000-0002-1213-5418; Katopodi, Theoni/0000-0003-1497-604X;
   Hardingham, Timothy/0000-0001-8271-6763
FU Medical Research Council; Biotechnology and Biological Sciences Research
   Council
CR Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929
   Adesida AB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2267
   Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BREW CJ, 2004, T ORTHOP RES SOC, V50, P940
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Freed LE, 1993, J BIOMED MATER RES, V27, P11
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grimshaw MJ, 2001, OSTEOARTHR CARTILAGE, V9, P357, DOI 10.1053/joca.2000.0396
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   Hardingham Tim, 2002, Arthritis Res, V4 Suppl 3, pS63, DOI 10.1186/ar561
   Khan WS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2211
   KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743
   Kurz B, 2004, TISSUE ENG, V10, P1277, DOI 10.1089/ten.2004.10.1277
   Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200
   Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878
   LAURENT TC, 1992, FASEB J, V6, P2397
   Li Y, 2004, TISSUE ENG, V10, P575, DOI 10.1089/107632704323061933
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   Murphy CL, 2001, CONNECT TISSUE RES, V42, P87, DOI 10.3109/03008200109014251
   Nehrer S, 2006, EUR J RADIOL, V57, P3, DOI 10.1016/j.ejrad.2005.08.005
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Tew SR, 2005, OSTEOARTHR CARTILAGE, V13, P80, DOI 10.1016/j.joca.2004.10.011
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   WARDALE RJ, 1993, J CELL SCI, V105, P975
   Zhou SD, 2004, ARTHRITIS RHEUM, V50, P3915, DOI 10.1002/art.20675
NR 30
TC 20
Z9 20
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2009
VL 30
IS 4
BP 535
EP 540
DI 10.1016/j.biomaterials.2008.09.064
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 389BR
UT WOS:000262065500013
PM 18990440
DA 2018-10-19
ER

PT J
AU Bodugoz-Senturk, H
   Macias, CE
   Kung, JH
   Muratoglu, OK
AF Bodugoz-Senturk, Hatice
   Macias, Celia E.
   Kung, Jean H.
   Muratoglu, Orhun K.
TI Poly(vinyl alcohol)-acrylamide hydrogels as load-bearing cartilage
   substitute
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Polyvinyl alcohol; Polyacrylamide; Cartilage; Lubricity;
   Coefficient of friction
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; H ARTIFICIAL MENISCUS;
   ARTICULAR-CARTILAGE; ALCOHOL) HYDROGELS; POLYVINYL-ALCOHOL; PVA
   HYDROGELS; IN-VIVO; REPAIR; MICROFRACTURE; KNEE
AB Poly(vinyl alcohol) (PVA) has been advanced as a biomaterial for the fabrication of medical devices to be used as synthetic articular cartilage because of its viscoelastic nature, high water content, and biocompatibility. Key material requirements for such devices are high creep resistance to prevent mechanical instability in the joint and high water content to maintain a lubricious surface to minimize wear and damage of the cartilage counterface during articulation. The creep resistance of PVA hydrogels can be increased by high temperature annealing: however this process also collapses the pores, reducing the water content and consequently reducing the lubricity of the hydrogel surface [Bodugoz-Senturk H, Choi J, Oral E, Kung JH, Macias CE, Braithwaite G, et al. The effect of polyethylene glycol on the stability of pores in polyvinyl alcohol hydrogels during annealing. Biomaterials 2008;29(2):141-9.]. We hypothesized that polymerizing acrylamide (AAm) in the pores of the PVA hydrogel Would minimize the loss of lubricity during annealing by preventing the collapse of the pores and loss of water content. Increasing AAm content increased porosity and equilibrium water content and decreased the coefficient of friction, tear strength, crystallinity, and creep resistance in annealed PVA hydrogels. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Bodugoz-Senturk, Hatice; Macias, Celia E.; Kung, Jean H.; Muratoglu, Orhun K.] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA.
   [Bodugoz-Senturk, Hatice; Muratoglu, Orhun K.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA.
RP Muratoglu, OK (reprint author), Massachusetts Gen Hosp, Harris Orthopaed Biomech & Biomat Lab, 55 Fruit St,GRJ 1206, Boston, MA 02114 USA.
EM omuratoglu@partners.org
CR ASSENDER H, 1998, POLYMER, V18, P4295
   Assender HE, 1998, POLYMER, V39, P4303, DOI 10.1016/S0032-3861(97)10297-X
   Azuma C, 2007, J BIOMED MATER RES A, V81A, P373, DOI 10.1002/jbm.a.31043
   Bae DK, 2006, ARTHROSCOPY, V22, P367, DOI 10.1016/j.arthro.2006.01.015
   Bajpai SK, 2002, J APPL POLYM SCI, V84, P1133, DOI 10.1002/app.10402
   Bodugoz-Senturk H, 2008, BIOMATERIALS, V29, P141, DOI 10.1016/j.biomaterials.2007.09.015
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   CHA WI, 1993, MAKROMOL CHEM, V194, P2433
   Cha WI, 1996, MACROMOL SYMP, V109, P115, DOI 10.1002/masy.19961090111
   Choi J, 2006, BIOMATERIALS, V28, P772
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2
   Doi Y, 2005, LANGMUIR, V21, P9420, DOI 10.1021/la0512502
   DOROTKA R, 2005, BIOMATERIALS, V26, P29
   Fergg F, 2001, COLLOID POLYM SCI, V279, P61, DOI 10.1007/s003960000398
   GIANNINI S, 2008, AM J SPORTS MED, P1
   Gong JP, 2006, SOFT MATTER, V2, P544, DOI 10.1039/b603209p
   Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011
   HANGODY L, 2003, J BONE JOINT SU A S2, V85, P32
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   Hassan CM, 2000, J APPL POLYM SCI, V76, P2075, DOI 10.1002/(SICI)1097-4628(20000628)76:14<2075::AID-APP11>3.0.CO;2-V
   HORIA M, 2007, J MACROMOL SCI CHEM, V44, P47
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kavehpour HP, 2004, TRIBOL LETT, V17, P327, DOI 10.1023/B:TRIL.0000032471.06795.ea
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Kobayashi M, 2004, BIO-MED MATER ENG, V14, P505
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Messner K, 1996, ACTA ORTHOP SCAND, V67, P523, DOI 10.3109/17453679608996682
   MINAS F, 1997, ORTHOPEDICS, V20
   Mishra S, 2006, J MATER SCI-MATER M, V17, P1305, DOI 10.1007/s10856-006-0605-9
   Mithoefer K, 2005, J BONE JOINT SURG AM, V87A, P1911, DOI 10.2106/JBJS.D.02846
   Oka M, 2000, P I MECH ENG H, V214, pPart H
   Patrick T, 2004, SEMIN CUTAN MED SURG, V23, P233, DOI 10.1016/j.sder.2004.09.003
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   PEPPAS NA, 1977, J BIOMED MATER RES, V11, P423, DOI 10.1002/jbm.820110309
   Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q
   Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613
   Ruberti JW, 2004, Patent US Pub, Patent No. 20040092653
   Sanchez-Diaz JC, 2006, POLYM BULL, V56, P437, DOI 10.1007/s00289-006-0512-8
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Steadman J Richard, 2003, J Knee Surg, V16, P83
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   UCHIDA E, 1994, LANGMUIR, V10, P481, DOI 10.1021/la00014a023
   Ushio K, 2004, J BIOMED MATER RES B, V68B, P59, DOI 10.1002/jbm.b.10076
   Wang BL, 2000, RADIAT PHYS CHEM, V59, P91, DOI 10.1016/S0969-806X(00)00188-2
   Willcox PJ, 1999, J POLYM SCI POL PHYS, V37, P3438
   Wong SS, 2004, POLYMER, V45, P5151, DOI 10.1016/j.polymer.2004.05.037
   YASUNARI I, 2005, WEAR, V261, P500
NR 52
TC 90
Z9 100
U1 10
U2 94
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2009
VL 30
IS 4
BP 589
EP 596
DI 10.1016/j.biomaterials.2008.10.010
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 389BR
UT WOS:000262065500020
PM 18996584
DA 2018-10-19
ER

PT J
AU Parsons, C
   McCoy, CP
   Gorman, SP
   Jones, DS
   Bell, SEJ
   Brady, C
   McGlinchey, SM
AF Parsons, Carole
   McCoy, Colin P.
   Gorman, Sean P.
   Jones, David S.
   Bell, Steven E. J.
   Brady, Clare
   McGlinchey, Seana M.
TI Anti-infective photodynamic biomaterials for the prevention of
   intraocular lens-associated infectious endophthalmitis
SO BIOMATERIALS
LA English
DT Article
DE Antimicrobial; Bacterial adhesion; Copolymer; Hydrogel; Intraocular
   lens; Photosensitization
ID INTERPENETRATING POLYMER NETWORKS; TUBE POLY(VINYL CHLORIDE);
   WATER-SOLUBLE PORPHYRINS; OPTICAL OXYGEN SENSORS; PURE SINGLET OXYGEN;
   PHYSICOCHEMICAL CHARACTERIZATION; PHOTOBACTERICIDAL MATERIALS; URETERAL
   BIOMATERIALS; CATARACT-SURGERY; IN-VITRO
AB Bacterial attachment onto intraocular lenses (IOLs) during cataract extraction and IOL implantation is a prominent aetiological factor in the pathogenesis of infectious endophthalmitis. Photodynamic therapy (PDT) and photodynamic antimicrobial chemotherapy (PACT) have shown that photosensitizers are effective treatments for cancer, and in the photoinactivation of bacteria, viruses, fungi and parasites, in the presence of light. To date, no method of localizing the photocytotoxic effect of a photosensitizer at a biomaterial surface has been demonstrated. Here we show a method for concentrating this effect at a material surface to prevent bacterial colonization by attaching a porphyrin photosensitizer at, or near to, that surface, and demonstrate the principle using IOL biomaterials. Anionic hydrogel copolymers were shown to permanently bind a cationic porphyrin through electrostatic interactions as a thin Surface layer. The mechanical and thermal properties of the materials showed that the porphyrin acts as a surface cross-linking agent, and renders surfaces more hydrophilic. Importantly, Staphylococcus epidermidis adherence was reduced by up to 99.02 +/- 0.42% relative to the control in intense light conditions and 91.76 +/- 5.99% in the dark. The ability to concentrate the photocytotoxic effect at a Surface, together with a significant dark effect, provides a platform for a range of light-activated anti-infective biomaterial technologies. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Parsons, Carole; McCoy, Colin P.; Gorman, Sean P.; Jones, David S.; McGlinchey, Seana M.] Queens Univ Belfast, McClay Res Ctr, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland.
   [Bell, Steven E. J.; Brady, Clare] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast BT9 5AG, Antrim, North Ireland.
RP McCoy, CP (reprint author), Queens Univ Belfast, McClay Res Ctr, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM c.mccoy@qub.ac.uk
OI McCoy, Colin/0000-0002-6468-2018
CR Bonnett R, 2006, WATER RES, V40, P1269, DOI 10.1016/j.watres.2006.01.014
   BONNETT R, 1993, J MATER CHEM, V3, P323, DOI 10.1039/jm9930300323
   Borissevitch IE, 1998, J PHOTOCH PHOTOBIO A, V114, P201, DOI 10.1016/S1010-6030(98)00216-0
   Bozja J, 2003, J POLYM SCI POL CHEM, V41, P2297, DOI 10.1002/pola.10773
   Brady C, 2007, J PHYS CHEM B, V111, P527, DOI 10.1021/jp066217i
   Bressler NM, 2000, INVEST OPHTH VIS SCI, V41, P624
   Claydon PE, 2004, PHOTODIAGN PHOTODYN, V1, P203, DOI 10.1016/S1572-1000(04)00062-6
   DAHL TA, 1989, J BACTERIOL, V171, P2188, DOI 10.1128/jb.171.4.2188-2194.1989
   DAHL TA, 1987, PHOTOCHEM PHOTOBIOL, V46, P345, DOI 10.1111/j.1751-1097.1987.tb04779.x
   Dedic R, 2004, J LUMIN, V108, P117, DOI 10.1016/j.jlumin.2004.01.027
   Delmarre D, 1999, ANAL CHIM ACTA, V401, P125, DOI 10.1016/S0003-2670(99)00515-2
   Demidova TN, 2005, ANTIMICROB AGENTS CH, V49, P2329, DOI 10.1128/AAC.49.6.2329-2335.2005
   Desai P, 1999, BRIT J OPHTHALMOL, V83, P1336, DOI 10.1136/bjo.83.12.1336
   Doan Kim T, 2002, Curr Opin Ophthalmol, V13, P24, DOI 10.1097/00055735-200202000-00006
   Gandini SCM, 2003, J INORG BIOCHEM, V94, P127, DOI 10.1016/S0162-0134(02)00615-3
   GORDON M, 1952, J APPL CHEM, V2, P493
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   GORMAN SP, 1991, MECH ACTION CHEM BIO
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a
   Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053
   Han DP, 1996, AM J OPHTHALMOL, V122, P1
   Inbaraj JJ, 2003, J APPL POLYM SCI, V89, P3925, DOI 10.1002/app.12610
   Jenkins MP, 1999, BRIT J SURG, V86, P1258, DOI 10.1046/j.1365-2168.1999.01247.x
   Jimenez-Hernandez ME, 2006, SOL ENERGY, V80, P1382, DOI 10.1016/j.solener.2005.04.027
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Jones DS, 1997, J MATER SCI-MATER M, V8, P713, DOI 10.1023/A:1018596109061
   Jones DS, 2005, J PHARM PHARMACOL, V57, P1251, DOI 10.1211/jpp.57.10.0003
   Jones DS, 2005, BIOMATERIALS, V26, P1761, DOI 10.1016/j.biomaterials.2004.06.002
   Jones DS, 2002, PHARMACEUT RES, V19, P818, DOI 10.1023/A:1016104516034
   Jori G, 2004, PHOTOCH PHOTOBIO SCI, V3, P403, DOI 10.1039/b311904c
   Kodjikian L, 2002, INVEST OPHTH VIS SCI, V43, P3717
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4388, DOI 10.1167/iovs-03-0186
   Lee SK, 1997, ANALYST, V122, P81, DOI 10.1039/a604885d
   Merrett K, 2002, J BIOMAT SCI-POLYM E, V13, P593, DOI 10.1163/156856202320269111
   Mills A, 1997, ANAL CHEM, V69, P4653, DOI 10.1021/ac970430g
   Mitra A, 2006, PHOTODIAGN PHOTODYN, V3, P116, DOI 10.1016/S1572-1000(06)00035-4
   Olson RJ, 2004, SURV OPHTHALMOL, V49, P55
   PAPKOVSKY DB, 1992, BIOSENS BIOELECTRON, V7, P199, DOI 10.1016/0956-5663(92)87016-I
   PAPKOVSKY DB, 1995, ANAL CHEM, V67, P4112, DOI 10.1021/ac00118a013
   Papkovsky DB, 2000, BIOCHEM SOC T, V28, P74, DOI 10.1042/bst0280074
   Patito IA, 2001, BIOL CELL, V93, P285, DOI 10.1016/S0248-4900(01)01118-2
   Recchia FM, 2005, ARCH OPHTHALMOL-CHIC, V123, P341, DOI 10.1001/archopht.123.3.341
   Reid G, 1999, INT J ANTIMICROB AG, V11, P223, DOI 10.1016/S0924-8579(99)00020-5
   Rockson SG, 2000, CIRCULATION, V102, P591
   SANDERSON KE, 1974, CAN J MICROBIOL, V20, P1135, DOI 10.1139/m74-176
   Seal DV, 2006, J CATARACT REFR SURG, V32, P396, DOI 10.1016/j.jcrs.2006.02.014
   Triesscheijn M, 2006, ONCOLOGIST, V11, P1034, DOI 10.1634/theoncologist.11-9-1034
   Vasil'ev VV, 2002, SENSOR ACTUAT B-CHEM, V82, P272, DOI 10.1016/S0925-4005(01)01063-2
   Vinodu MV, 2001, J PORPHYR PHTHALOCYA, V5, P763, DOI 10.1002/jpp.543
   Vinodu MV, 2001, J POLYM SCI POL CHEM, V39, P326, DOI 10.1002/1099-0518(20010115)39:2<326::AID-POLA90>3.0.CO;2-4
   Wainwright M, 2006, J PHOTOCH PHOTOBIO B, V84, P227, DOI 10.1016/j.jphotobiol.2006.03.002
   Wang SZ, 2004, J MATER CHEM, V14, P487, DOI 10.1039/b311429e
   Wisniewski SR, 2000, OPHTHALMOLOGY, V107, P1274, DOI 10.1016/S0161-6420(00)00165-2
NR 56
TC 51
Z9 54
U1 2
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2009
VL 30
IS 4
BP 597
EP 602
DI 10.1016/j.biomaterials.2008.10.015
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 389BR
UT WOS:000262065500021
PM 18996591
DA 2018-10-19
ER

PT J
AU van Putten, SM
   Wubben, M
   Hennink, WE
   van Luyna, MJA
   Harmsen, MC
AF van Putten, S. M.
   Wuebben, M.
   Hennink, W. E.
   van Luyna, M. J. A.
   Harmsen, M. C.
TI The downmodulation of the foreign body reaction by cytomegalovirus
   encoded interleukin-10
SO BIOMATERIALS
LA English
DT Article
DE Foreign body reaction; Immunomodulation; Cytomegalovirus;
   Interleukin-10; CmvIL-10
ID BIODEGRADABLE BIOMATERIAL; TISSUE REACTION; GIANT-CELLS; IL-10;
   COLLAGEN; RATS; METALLOPROTEINASE; ANGIOGENESIS; EXPRESSION; EVASION
AB The foreign body reaction (FBR) is of great importance for the function and turnover of biomaterial scaffolds. The development of biological tools that modulate the FBR will augment scaffold functionality and benefit regenerative medicine. The human cytomegalovirus encodes a functional homolog of the potent anti-inflammatory human cytokine interleukin-10 (cmvIL-10). We hypothesized that cmvIL-10 downmodulates the FBR, impairing degradation of biomaterial. We studied the effect of cmvIL-10 on the FBR to subcutaneously implanted hexamethylenediisocyanate-crosslinked dermal sheep collagen (HDSC) discs in rats. CmvIL-10 impaired macrophage influx, vascularization and ingrowth into the discs up to 21 days. It also impaired the formation of giant cells and the degradation of HDSC. At day 10, deposited fibrin fibers were still present in cmvIL-10 discs. Impaired collagenase activity coincided with the impaired HDSC degradation. These results indicate that cmvIL-10 downmodulates the FBR, impairing the progression of the FBR. This study demonstrates the feasibility of interleukin-10 as a biomolecular tool in biomaterials for regenerative medicine. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [van Putten, S. M.; Wuebben, M.; van Luyna, M. J. A.; Harmsen, M. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands.
   [Hennink, W. E.] Univ Utrecht, UIPS, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands.
RP Harmsen, MC (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1,EA11, NL-9713 GZ Groningen, Netherlands.
EM m.c.harmsen@med.umcg.nl
FU Dutch Platform for Tissue Engineering (DPTE) [6731]
FX This work was supported by the Dutch Platform for Tissue Engineering
   (DPTE, project number 6731). We thank Josee Plantinga and Linda Brouwer
   for their excellent technical support.
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Boomker JM, 2005, BIOMATERIALS, V26, P4874, DOI 10.1016/j.biomaterials.2004.11.059
   Boomker JM, 2005, CYTOKINE GROWTH F R, V16, P91, DOI 10.1016/j.cytogfr.2004.12.002
   Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.820.8731.2004
   Jones BC, 2002, P NATL ACAD SCI USA, V99, P9404, DOI 10.1073/pnas.152147499
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695
   LACRAZ S, 1995, J CLIN INVEST, V96, P2304, DOI 10.1172/JCI118286
   Lockridge KM, 2000, VIROLOGY, V268, P272, DOI 10.1006/viro.2000.0195
   Luttikhuizen DT, 2007, J BIOMED MATER RES A, V83A, P879, DOI 10.1002/jbm.a.31420
   Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002
   Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004
NR 23
TC 15
Z9 16
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2009
VL 30
IS 5
BP 730
EP 735
DI 10.1016/j.biomaterials.2008.10.043
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 395VW
UT WOS:000262552600004
PM 19038442
DA 2018-10-19
ER

PT J
AU Yu, J
   Gu, Y
   Du, KT
   Mihardja, S
   Sievers, RE
   Lee, RJ
AF Yu, Jiashing
   Gu, Yiping
   Du, Kim T.
   Mihardja, Shirley
   Sievers, Richard E.
   Lee, Randall J.
TI The effect of injected RGD modified alginate on angiogenesis and left
   ventricular function in a chronic rat infarct model
SO BIOMATERIALS
LA English
DT Article
DE Alginate; RGD peptides; Hydrogel; Myocardial infarction
ID SYNTHETIC EXTRACELLULAR-MATRIX; MYOCARDIAL-INFARCTION; CARDIAC-FUNCTION;
   IN-VITRO; TISSUE; HEART; ADHESION; BONE; MICROENVIRONMENT;
   DIFFERENTIATION
AB Congestive heart failure (CHF) is a chronic disease with a high mortality rate. Managing CHF patients has been one of the most severe health care problems for years. Scaffold materials have been predominantly investigated in acute myocardial infarction (MI) studies and have shown promising improvement in LV function. in this study we examined whether surface modification of a biomaterial can influence the myocardial microenvironment and improve myocardial function in a rodent model of ischemic cardiomyopathy. In vitro cell culture and in vivo rat studies were performed. RGD peptides conjugated to alginate improved human umbilical vein endothelial cell (HUVEC) proliferation and adhesion when compared to a non-modified alginate group. Injection of the alginate hydrogel into the infarct area of rats 5 weeks post-MI demonstrated that both modified and non-modified alginate improve heart function, while LV function in the control group deteriorated. Both the RGD modified alginate and non-modified alginate increased the arteriole density compared to control, with the RGD modified alginate having the greatest angiogenic response. These results suggest that in situ use of modified polymers may influence the tissue microenvironment and serve as a potential therapeutic agent for patients with chronic heart failure. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Yu, Jiashing; Gu, Yiping; Lee, Randall J.] Univ Calif Berkeley, Berkeley, CA 94720 USA.
   [Yu, Jiashing; Gu, Yiping; Lee, Randall J.] Univ Calif San Francisco, Joint Bioengn Grad Grp, San Francisco, CA 94143 USA.
   [Du, Kim T.; Mihardja, Shirley; Sievers, Richard E.; Lee, Randall J.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA.
RP Lee, RJ (reprint author), MU E Tower,Box 1354, San Francisco, CA 94143 USA.
EM lee@medicine.ucsf.edu
OI Yu, Jiashing/0000-0002-0782-2328
FU Symphony Medical, Inc
FX Research was partially supported by a grant from Symphony Medical, Inc.
CR Bonaros Nikolaos, 2008, Interact Cardiovasc Thorac Surg, V7, P249
   Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Doursout MF, 2001, ULTRASOUND MED BIOL, V27, P195, DOI 10.1016/S0301-5629(00)00330-6
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hennessy KM, 2008, BIOMATERIALS, V24, P24
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Jeon YH, 2007, J CRANIOFAC SURG, V18, P1249, DOI 10.1097/scs.0b013e3181577b55
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   LITWIN SE, 1995, CIRCULATION, V91, P2642, DOI 10.1161/01.CIR.91.10.2642
   Maguire T, 2006, BIOTECHNOL BIOENG, V93, P581, DOI 10.1002/bit.20748
   Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200
   Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2
   Pattison M, 2007, MACROMOL BIOSCI, V7, P690, DOI 10.1002/mabi.200600297
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   SIEVERS RE, 1989, MAGNET RESON MED, V10, P172, DOI 10.1002/mrm.1910100203
   Thiagarajan P, 1996, BIOCHEMISTRY-US, V35, P4169, DOI 10.1021/bi952532b
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   Wang B, 2007, AM J PHYSIOL-HEART C, V293, pH3732, DOI 10.1152/ajpheart.00735.2007
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
NR 33
TC 118
Z9 124
U1 2
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2009
VL 30
IS 5
BP 751
EP 756
DI 10.1016/j.biomaterials.2008.09.059
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 395VW
UT WOS:000262552600007
PM 19010528
DA 2018-10-19
ER

PT J
AU Gross-Aviv, T
   Vago, R
AF Gross-Aviv, Talia
   Vago, Razi
TI The role of aragonite matrix surface chemistry on the chondrogenic
   differentiation of mesenchymal stem cells
SO BIOMATERIALS
LA English
DT Article
DE Cartilage tissue engineering; Aragonite biomaterial; Surface
   modification; Mesenchymal stem cells (MSCs); Differentiation
ID GROWTH-FACTOR-I; ARTICULAR-CARTILAGE; TRANSFORMING GROWTH-FACTOR-BETA-1;
   PROTEIN EXPRESSION; NATURAL CORAL; HUMAN BONE; TISSUE; PROLIFERATION;
   BIOMATERIALS; SCAFFOLDS
AB In the present research we study the effects of surface chemistry of an aragonite crystalline biomatrix on the chondrogenesis of mesenchymal stem cells (MSCs). An aragonite matrix obtained from the coral Porites lutea and a gold-coated P. lutea matrix were seeded with MSCs, with and without the addition of growth factors (GFs). Scanning electron microscopy, histochemical staining, immunofluorescence, biochemical analyses and quantitative polymerase chain reaction showed that the chemistry of the matrix influenced the differentiation process of the MSCs. The calcium carbonate composition of the coral promoted osteogenesis, while impeding cell-material contact (by gold coating) altered the differentiation lineage of MSCs towards chondrogenic fate. Supplementation of the culture medium with GFs intensified the influence of the surface composition on the differentiation of MSCs, and the synergistic effect of the biomatrix surface composition and the GFs induced chondrogenesis and facilitated maintenance of the chondrocyte phenotype. Therefore, we suggest that scaffolding material candidates for tissue engineering should be examined for their effects on the MSCs differentiation process and their effect on signal transduction events in the cells. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Gross-Aviv, Talia; Vago, Razi] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
RP Gross-Aviv, T (reprint author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
EM taliag@bgu.ac.il
FU USA-Israel Binational Foundation (BSF) [2001045]
FX The author thanks Dr. L. Abramovitch-Gottlib, for her support and Ms. I.
   Mureinik for critically reviewing the manuscript. The work was supported
   in part by the USA-Israel Binational Foundation (BSF) # 2001045.
CR Abramovitch-Gottlib L, 2006, TISSUE ENG, V12, P729, DOI 10.1089/ten.2006.12.729
   Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Azrad E, 2006, J RAMAN SPECTROSC, V37, P480, DOI 10.1002/jrs.1420
   Baranes D, 2007, TISSUE ENG, V13, P473, DOI 10.1089/ten.2006.0052
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Cohen M, 2006, EMBO J, V25, P302, DOI 10.1038/sj.emboj.7600960
   Cohen M, 2007, SOFT MATTER, V3, P327, DOI 10.1039/b613770a
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   DENNIS JE, 2004, STEM CELLS HDB, P104
   Freyria AM, 2004, BIOMATERIALS, V25, P687, DOI 10.1016/S0142-9612(03)00568-4
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   Fukumoto T, 2003, OSTEOARTHR CARTILAGE, V11, P55, DOI 10.1053/joca.2002.0869
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hu J, 2000, J MATER SCI TECHNOL, V16, P591
   HU JCY, 2003, HDB HISTOLOGY METHOD, P73
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   KINNER B, 2002, METHODS TISSUE ENG, P317
   Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105
   Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   MAKARAND V, 2002, TRENDS BIOTECHNOL, V20, P351
   McPherson JM, 2000, PRINCIPLES TISSUE EN, P697
   Mooney DJ, 2007, NAT MATER, V6, P327, DOI 10.1038/nmat1896
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Peretz H, 2007, TISSUE ENG, V13, P461, DOI 10.1089/ten.2005.0522
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   RUPPERT EE, 1994, INVERTEBRATES ZOOLOG
   Schmidmaier G, 2003, J BIOMED MATER RES B, V65B, P157, DOI 10.1002/jbm.b.10513
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shintani N, 2007, ARTHRITIS RHEUM, V56, P1869, DOI 10.1002/art.22701
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Vago R, 2008, MAR BIOTECHNOL, V10, P343, DOI 10.1007/s10126-008-9103-z
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Vuola J, 2000, J BIOMED MATER RES, V51, P117, DOI 10.1002/(SICI)1097-4636(200007)51:1<117::AID-JBM15>3.0.CO;2-9
   WANG Y, 2006, BIOMATERIALS, V36, P6064
   Worster AA, 2001, J ORTHOPAED RES, V19, P738, DOI 10.1016/S0736-0266(00)00054-1
   Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659
NR 50
TC 9
Z9 9
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2009
VL 30
IS 5
BP 770
EP 779
DI 10.1016/j.biomaterials.2008.10.026
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 395VW
UT WOS:000262552600010
PM 19036431
DA 2018-10-19
ER

PT J
AU Guglielmi, F
   Monti, DM
   Arciello, A
   Torrassa, S
   Cozzolino, F
   Pucci, P
   Relini, A
   Piccoli, R
AF Guglielmi, Fulvio
   Monti, Daria M.
   Arciello, Angela
   Torrassa, Silvia
   Cozzolino, Flora
   Pucci, Piero
   Relini, Annalisa
   Piccoli, Renata
TI Enzymatically active fibrils generated by the self-assembly of the
   ApoA-I fibrillogenic domain functionalized with a catalytic moiety
SO BIOMATERIALS
LA English
DT Article
DE Self-assembly; Bioactivity; Apolipoprotein; Nanobiomaterials;
   Functionalized amyloid fibrils; Catalytic fibrils
ID AMYLOID FIBRILS; SPIDER SILK; PROTEIN; AGGREGATION; BIOMATERIAL;
   NANOWIRES; MECHANISM; DISEASE; DESIGN
AB Enzymatically active fibrils were produced by self-assembly of a bifunctional chimeric protein, made up of a fibrillogenic and a catalytic moiety. For this purpose, the fibrillogenic domain of Apolipoprotein A-I (ApoA-I), a 93-residue polypeptide named [1-93]ApoA-I, was functionalized with the enzyme glutathione S-transferase (GST). The fusion protein GST-[1-93]ApoA-I was expressed, isolated to homogeneity and characterized. In the soluble form, GST-[1-93]ApoA-I was found to be fully active as a GST enzyme, and to have high propensity to self-aggregate. Upon incubation for 3 weeks at pH 6.4, insoluble aggregates were generated. Analyzed by AFM, they were found to contain fibrillar structures often organized into large fiber networks. Fibrils were loaded on the membrane of a microfiltration unit and tested for enzymatic activity by filtering the substrate through the fibrillar network. Fibrils were shown to be catalytically active, stable over time and reusable, as no loss of activity was detected when fibrils were repeatedly tested. Our findings suggest that catalytically active fibrils may be of interest for biocatalytic applications in nanobiotechnology. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Guglielmi, Fulvio; Monti, Daria M.; Arciello, Angela; Piccoli, Renata] Univ Naples Federico 2, Dept Struct & Funct Biol, Sch Biotechnol Sci, I-80126 Naples, Italy.
   [Torrassa, Silvia; Relini, Annalisa] Univ Genoa, Dept Phys, I-16146 Genoa, Italy.
   [Cozzolino, Flora; Pucci, Piero] Univ Naples Federico 2, Dept Organ Chem & Biochem, I-80126 Naples, Italy.
   [Cozzolino, Flora; Pucci, Piero] Ceinge Biotechnol Avanzate, I-80145 Naples, Italy.
RP Piccoli, R (reprint author), Univ Naples Federico 2, Dept Struct & Funct Biol, Sch Biotechnol Sci, Via Cinthia 4, I-80126 Naples, Italy.
EM piccolio@unina.it
OI PUCCI, Pietro/0000-0002-5885-1495; cozzolino, flora/0000-0002-4648-8107
FU MIUR, Ministero, dell'Universita e della Ricerca Scientifica, Italy
   [2005053998004, 2006058958003]; University of Genoa (Fondi di Ateneo)
FX This work was supported by MIUR, Ministero, dell'Universita e della
   Ricerca Scientifica, Italy (PRIN 2005, Project N. 2005053998004 and PRIN
   2006, Project N. 2006058958003) and by the University of Genoa (Fondi di
   Ateneo). We thank Prof. A. Gliozzi for helpful discussion.
CR ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001
   Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673
   Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Di Gaetano S, 2006, BIOCHEM BIOPH RES CO, V351, P223, DOI 10.1016/j.bbrc.2006.10.026
   Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Gras SL, 2007, AUST J CHEM, V60, P333, DOI 10.1071/CH06485
   Hamada D, 2004, TRENDS BIOTECHNOL, V22, P93, DOI 10.1016/j.tibtech.2003.12.003
   Heyman A, 2007, NANO LETT, V7, P1575, DOI 10.1021/nl070450q
   Kaplan W, 1997, PROTEIN SCI, V6, P399
   Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Klunk WE, 1999, METHOD ENZYMOL, V309, P285
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LeVine H, 1999, METHOD ENZYMOL, V309, P274
   Mostaert A.S., 2007, NANOTECHNOLOGY, V18, P1
   Mostaert AS, 2006, J BIOL PHYS, V32, P393, DOI 10.1007/s10867-006-9023-y
   Obici L, 1999, AM J PATHOL, V155, P695, DOI 10.1016/S0002-9440(10)65167-X
   OBICI L, 2006, AMYLOID, V3, P1
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916
   Schaffer C, 2007, SMALL, V3, P1549, DOI 10.1002/smll.200700200
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Serio TR, 1999, METHOD ENZYMOL, V309, P649
   Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201
   Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Stefani M, 2003, J MOL MED-JMM, V81, P678, DOI 10.1007/s00109-003-0464-5
   WALKER PD, 1993, J AM CHEM SOC, V115, P12423, DOI 10.1021/ja00079a025
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 37
TC 16
Z9 16
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2009
VL 30
IS 5
BP 829
EP 835
DI 10.1016/j.biomaterials.2008.10.036
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 395VW
UT WOS:000262552600017
PM 19027944
DA 2018-10-19
ER

PT J
AU Chen, GJ
   Wang, Z
   Bai, H
   Li, JM
   Cai, H
AF Chen, G. J.
   Wang, Z.
   Bai, H.
   Li, J. M.
   Cai, H.
TI A preliminary study on investigating the attachment of soft tissue onto
   micro-arc oxidized titanium alloy implants
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID BONE RESPONSE; SURFACE-PROPERTIES; OXIDE FILMS; PROSTHESES; AMPUTEES;
   BEHAVIOR; CA; REHABILITATION; OXIDATION; INVITRO
AB Intraosseous transcutaneous amputation prostheses (ITAP) rely on the integrity of the soft tissue-implant interface as a barrier to exogenous agents, and in the prevention of avulsion and marsupilization. This experimental work aimed at the in vivo evaluation of soft tissue attachment to Ti alloy (Ti(6)Al(4)V) transcutaneous custom-made screws treated by a micro-arc oxidation (MAO) method. Prior to implantation, the surface of the MAO treated implants was analyzed by scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS) and x-ray diffraction (XRD). The experimental model comprised implantation of 16 transcutaneous screws (two groups: MAO and machined (control); total eight implants/group) in the medial aspect of the left tibia of eight female goats. The animals were euthanized at eight weeks and the samples harvested and processed for histological and histomorphometrical analysis of soft tissue attachment to the implant surface. Significant higher soft tissue attachment was observed in the MAO-modified group compared to the control. The in vivo data indicated that MAO-modified Ti alloy could be a useful biomaterial for tissue engineering and benefit applications where bone-anchored transcutaneous implants are used.
C1 [Chen, G. J.; Wang, Z.] Fourth Mil Med Univ, Dept Orthopaed, Xijing Hosp, Xian 710032, Peoples R China.
   [Bai, H.] Fourth Mil Med Univ, Dept Toxicol, Xian 710032, Peoples R China.
   [Li, J. M.] Xian Univ Technol, Sch Mat Sci & Engn, Xian 710048, Peoples R China.
   [Cai, H.] Xi An Jiao Tong Univ, Sch Sci, Xian 710049, Peoples R China.
RP Chen, GJ (reprint author), Fourth Mil Med Univ, Dept Orthopaed, Xijing Hosp, Xian 710032, Peoples R China.
EM wangzhen_fmmu@live.cn
FU Xijing hospital, Fourth Military Medical University
FX The work is supported by the Subject promoting project of Xijing
   hospital, Fourth Military Medical University.
CR Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Branemark P I, 1999, Clin Implant Dent Relat Res, V1, P2, DOI 10.1111/j.1708-8208.1999.tb00086.x
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Brunette D. M., 2001, TITANIUM MED
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1992, J BIOMED MATER RES, V26, P493, DOI 10.1002/jbm.820260407
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Giavaresi G, 2003, BIOMATERIALS, V24, P1583, DOI 10.1016/S0142-9612(02)00548-3
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Han Y, 2002, MATER LETT, V56, P744, DOI 10.1016/S0167-577X(02)00606-7
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   HEANEY TG, 1977, ARCH ORAL BIOL, V22, P167, DOI 10.1016/0003-9969(77)90150-9
   Holgers KM, 2000, AUDIOLOGY, V39, P253
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   KOHLER P, 1989, PROSTHET ORTHOT INT, V13, P149
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lee VSP, 1997, P I MECH ENG H, V211, P167, DOI 10.1243/0954411971534287
   LEVY SW, 1995, CUTIS, V55, P297
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   PRITHAM CH, 1990, PROSTHET ORTHOT INT, V14, P9
   Shin Y, 1997, ARTIF ORGANS, V21, P995
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sul YT, 2001, J MATER SCI-MATER M, V12, P1025, DOI 10.1023/A:1012837905910
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
NR 31
TC 10
Z9 11
U1 3
U2 21
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2009
VL 4
IS 1
AR 015017
DI 10.1088/1748-6041/4/1/015017
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403GN
UT WOS:000263071200020
PM 19141873
DA 2018-10-19
ER

PT J
AU John, A
   Varma, HK
   Vijayan, S
   Bernhardt, A
   Lode, A
   Vogel, A
   Burmeister, B
   Hanke, T
   Domaschke, H
   Gelinsky, M
AF John, A.
   Varma, H. K.
   Vijayan, S.
   Bernhardt, A.
   Lode, A.
   Vogel, A.
   Burmeister, B.
   Hanke, Th
   Domaschke, H.
   Gelinsky, M.
TI In vitro investigations of bone remodeling on a transparent
   hydroxyapatite ceramic
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS; TITANIUM
   SURFACE-ROUGHNESS; CALCIUM-PHOSPHATE; POROUS HYDROXYAPATITE; OSTEOGENIC
   DIFFERENTIATION; MARROW-CELLS; BIOCERAMICS; BIOMATERIAL; VIVO
AB transmission mode is impossible because many of these materials are opaque. In order to enable direct viewing of living cells and to perform time-lapse studies, nearly transparent bioceramic materials were developed. A dense and fine-grained transparent hydroxyapatite (tHA) was processed by a gel-casting route followed by low-temperature sintering (1000 degrees C). By virtue of its transparency, direct visualization of cellular events on this material is possible in transmitted light. In this study, the interaction of different bone cell types with the tHA ceramic was envisaged. Investigation of rat calvaria osteoblasts (RCO) cultured on tHA by means of transmission light microscopy indicated good cytocompatibility of tHA. Microscopic analysis of osteogenic-induced human bone marrow stromal cells (hBMSC) on tHA and quantitative analysis of their lactate dehydrogenase (LDH) activity at different time points of culture revealed favorable proliferation as well. An increase of the alkaline phosphatase (ALP) activity indicated the differentiation of osteogenic-induced hBMSC towards the osteoblastic lineage. In addition, the differentiation of human monocytes to osteoclast-like cells could also be demonstrated on tHA and was confirmed by fluorescent microscopy imaging of multinucleated cells on the transparent material.
C1 [John, A.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
   [Bernhardt, A.; Lode, A.; Vogel, A.; Burmeister, B.; Hanke, Th; Gelinsky, M.] Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, D-01069 Dresden, Germany.
   [Domaschke, H.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Pediat Clin, D-01307 Dresden, Germany.
RP John, A (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Satelmond Palace Campus, Trivandrum 695012, Kerala, India.
EM ajkari@sctimst.ac.in
RI Bernhardt, Anne/O-1242-2015; Gelinsky, Michael/A-9680-2012
OI Bernhardt, Anne/0000-0002-1903-1929; Gelinsky,
   Michael/0000-0001-9075-5121
CR Abiraman S, 2002, B MATER SCI, V25, P419, DOI 10.1007/BF02708021
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   AOKI H, 1991, SCI MED APPL HYDROXY, P101
   AYAKO O, 2006, CHEM LETT, V35, P1300
   Barralet JE, 2000, J MATER SCI-MATER M, V11, P719, DOI 10.1023/A:1008975812793
   Barralet JE, 2003, J MATER SCI, V38, P3979, DOI 10.1023/A:1026258515285
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DAVIES JE, 1991, CELL MATER, V1, P3
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   Domaschke H, 2006, TISSUE ENG, V12, P949, DOI 10.1089/ten.2006.12.949
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   GROSS UM, 1990, BIOMATERIALS, V11, P83
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   Hu J, 2000, J MATER SCI TECHNOL, V16, P591
   IOKU K, 2002, T MAT RES SOC JPN, V27, P447
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   JAN M, 1997, J MATER RES, V12, P198
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   John A, 2002, B MATER SCI, V25, P141, DOI 10.1007/BF02706235
   Kotobuki N, 2004, KEY ENG MAT, V254-2, P1055, DOI 10.4028/www.scientific.net/KEM.254-256.1055
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   KOTOBUKI N, 2006, J MATER SCI-MATER M, V40, P33
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   MALIK MA, 1992, BIOMATERIALS, V13, P123, DOI 10.1016/0142-9612(92)90008-C
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   OWEN M, 1988, J CELL SCI, P63
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Sepp A, 1996, J IMMUNOL METHODS, V196, P175, DOI 10.1016/0022-1759(96)00112-3
   Takikawa K, 1996, J MATER SCI-MATER M, V7, P439, DOI 10.1007/BF00122014
   Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
   Varma H, 2002, J AM CERAM SOC, V85, P493
   Varma HK, 1996, PHOSPHORUS RES B, V6, P35
   Vogel A.I., 1980, TXB QUANTITATIVE INO
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
   Yubao L, 1993, Biomaterials, V14, P969
NR 51
TC 10
Z9 10
U1 1
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2009
VL 4
IS 1
AR 015007
DI 10.1088/1748-6041/4/1/015007
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403GN
UT WOS:000263071200010
PM 19020346
DA 2018-10-19
ER

PT J
AU Kallukalam, BC
   Jayabalan, M
   Sankar, V
AF Kallukalam, B. C.
   Jayabalan, M.
   Sankar, V.
TI Studies on chemically crosslinkable carboxy terminated-poly(propylene
   fumarate-co-ethylene glycol)-acrylamide hydrogel as an injectable
   biomaterial
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID BONE-CEMENT; TISSUE; GROWTH; OPPORTUNITIES; FABRICATION; DESIGN; CELLS
AB Carboxy terminated-poly(propylene fumarate)-co-ethylene glycol) (CT-PPF-co-PEG) was prepared and set into crosslinked hydrogel material with acrylamide. The setting studies reveal that this copolymer system can be used as an injectable material. The hydrogel material exhibits a higher degree of swelling, good mechanical strength and flexibility. The hydrogel favours adhesion of L929 fibroblast cells without proliferation on the surface. However, cardiac fibroblast cells (isolated from new born rat (Wistar) hearts) adhere and proliferate on the hydrogel due to the formation of synergistic hydrophilic-hydrophobic surface-by-surface reorganization.
C1 [Kallukalam, B. C.; Jayabalan, M.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Polymer, Trivandrum 695012, Kerala, India.
   [Sankar, V.] Sree Chitra Tirunal Inst Med Sci & Technol, Div Cellular & Mol Cardiol, Trivandrum 695012, Kerala, India.
RP Kallukalam, BC (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Polymer, Trivandrum 695012, Kerala, India.
EM muthujayabalan@rediffmail.com
FU Department of Biotechnology, New Delhi [BT/PR6524/Med/14/831/2005]
FX The authors are grateful to Professor K Mohandas, Director, Sree Chitra
   Tirunal Institute for Medical sciences and Technology and Dr G S
   Bhuvaneshwar, Head, Biomedical Technology Wing, SCTIMST, Trivandrum for
   providing the support and facilities. The authors acknowledge the
   financial support of Department of Biotechnology, New Delhi ( No
   BT/PR6524/Med/14/831/2005).
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   ANITHA NS, 1999, J INDIAN I SCI, V79, P431
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Celin D, 2000, INDIAN J ENG MATER S, V7, P160
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hoffman AS, 2001, ANN NY ACAD SCI, V944, P62
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jayabalan M, 2001, BIOMATERIALS, V22, P2749, DOI 10.1016/S0142-9612(01)00018-7
   Jayabalan M, 2000, BIO-MED MATER ENG, V10, P57
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leor J, 2004, ANN NY ACAD SCI, V1015, P312, DOI 10.1196/annals.1302.026
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   Murray P.R., 1999, MANUAL CLIN MICROBIO, P1527
   NAIR RR, 1988, J TISSUE ENG METHODS, V11, P211
   Noh IS, 2006, BIOMED MATER, V1, P116, DOI 10.1088/1748-6041/1/3/004
   Shalumon KT, 2009, J MATER SCI-MATER M, V20, P161, DOI 10.1007/s10856-008-3503-5
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   SLEPIAN MJ, 2002, Patent No. 6443941
   Subramani K, 2006, BIOMED MATER, V1, P144, DOI 10.1088/1748-6041/1/3/009
   THOMAS V, 2008, J BIOMED MAT RES A
   YOSHIMATSU N, 1958, J KYOTO PREF MED U, V64, P553
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
NR 29
TC 5
Z9 6
U1 2
U2 15
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2009
VL 4
IS 1
AR 015002
DI 10.1088/1748-6041/4/1/015002
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403GN
UT WOS:000263071200005
PM 18981542
DA 2018-10-19
ER

PT J
AU Feinstein, E
   Alsberg, E
   Ingber, D
   Prentiss, M
AF Feinstein, Efraim
   Alsberg, Eben
   Ingber, Donald
   Prentiss, Mara
TI A Novel Self-Assembled, Self-Healing, Ordered Biomaterial
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 [Feinstein, Efraim; Prentiss, Mara] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.
   [Feinstein, Efraim] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Ingber, Donald] Harvard Med Sch, Harvard Inst Biol Inspired Engn, Harvard Sch Engn Appl Sci, Boston, MA USA.
   [Ingber, Donald] Childrens Hosp, Boston, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 2009
VL 96
IS 3
SU 1
MA 3274-Pos
BP 635A
EP 635A
PG 1
WC Biophysics
SC Biophysics
GA VC0MS
UT WOS:000426362200363
DA 2018-10-19
ER

PT J
AU Barriada, JL
   Caridad, S
   Lodeiro, P
   Herrero, R
   de Vicente, MES
AF Barriada, Jose L.
   Caridad, Sergio
   Lodeiro, Pablo
   Herrero, Roberto
   Sastre de Vicente, Manuel E.
TI Physicochemical characterisation of the ubiquitous bracken fern as
   useful biomaterial for preconcentration of heavy metals
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Bracken fern; Cadmium(II); Lead(II) Preconcentration
ID AQUEOUS-SOLUTION; CADMIUM(II) BIOSORPTION; WHEAT BRAN; TREE FERN;
   ADSORPTION; REMOVAL; BINDING; EQUILIBRIUM; SORPTION; BIOMASS
AB Batch experiments with dry bracken fern have been done to determine cadmium and lead sequestering capacity of this biomaterial. Biomass characterisation was done by infrared spectroscopy and potentiometric analysis. The effect of pH of the metal containing solution, contact time and initial metal concentration has been studied, together with the acid-base properties of the biomaterial. Results obtained have been analysed using mathematical and modelling techniques. Effect of pH on metal sequestration has been correlated with observed acid-base properties of the natural substrate. Kinetic data analysis provided relevant information about metal sequestration rate, showing important differences between lead and Cadmium, Maximum uptake was found to be the same for both metals 0.410 mmol/g. This value was,also clearly correlated to the number of acidic groups determined for this material which was found to be 0.432 mmol of acidic groups per gram of fern. Results obtained indicate that acidic groups are the functional groups responsible of the sequestration of metal ions and that bracken fern is a promising material for metal preconcentration. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Caridad, Sergio; Lodeiro, Pablo; Herrero, Roberto; Sastre de Vicente, Manuel E.] Univ A Coruna, Dept Quim Fis & Ingn Quim 1, La Coruna 15008, Spain.
   [Barriada, Jose L.] Univ A Coruna, Inst Univ Med Ambiente, Oleiros, A Coruna, Spain.
RP Herrero, R (reprint author), Univ A Coruna, Dept Quim Fis & Ingn Quim 1, C Alejandro de la Sota 1, La Coruna 15008, Spain.
EM erob@udc.es
RI Lodeiro, Pablo/L-2409-2015; de Vicente, Sastre/I-4604-2015; Lodeiro
   Fernandez, Pablo/B-7925-2011; Barriada, Jose/L-6684-2015; Herrero,
   Roberto/E-2266-2016
OI Lodeiro, Pablo/0000-0002-2557-5391; de Vicente,
   Sastre/0000-0002-1657-2930; Barriada, Jose/0000-0001-6438-9834; Herrero,
   Roberto/0000-0002-8709-9247
FU Ministerio de Educacion y Ciencia [CTM2006-03142]
FX Authors wish to thank Ministerio de Educacion y Ciencia for the
   financial support through the research project CTM2006-03142.
CR Aksu Z, 2001, SEP PURIF TECHNOL, V21, P285, DOI 10.1016/S1383-5866(00)00212-4
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Barriada JL, 2007, J CHEM TECHNOL BIOT, V82, P39, DOI 10.1002/jctb.1633
   Bouanda J, 2002, ANAL BIOANAL CHEM, V373, P174, DOI 10.1007/s00216-002-1305-z
   Demirbas A, 2005, J COLLOID INTERF SCI, V282, P20, DOI 10.1016/j.jcis.2004.08.147
   EPHRAIM J, 1986, ENVIRON SCI TECHNOL, V20, P354, DOI 10.1021/es00146a007
   Godlewska-Zylkiewicz B, 2006, ANAL BIOANAL CHEM, V384, P114, DOI 10.1007/s00216-005-0142-2
   Herrero R, 2006, MAR CHEM, V99, P106, DOI 10.1016/j.marchem.2005.05.009
   Ho YS, 2004, PROCESS BIOCHEM, V39, P759, DOI 10.1016/S0032-9592(03)00184-5
   Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5
   Ho YS, 1996, ENVIRON TECHNOL, V17, P71, DOI 10.1080/09593331708616362
   KATCHALSKY A, 1947, J POLYM SCI, V2, P432, DOI 10.1002/pol.1947.120020409
   Kobya M, 2005, BIORESOURCE TECHNOL, V96, P1518, DOI 10.1016/j.biortech.2004.12.005
   Lodeiro P, 2006, ENVIRON POLLUT, V142, P264, DOI 10.1016/j.envpol.2005.10.001
   Lodeiro P, 2005, BIORESOURCE TECHNOL, V96, P1796, DOI 10.1016/j.biortech.2005.01.002
   Lodeiro P, 2004, BIOTECHNOL BIOENG, V88, P237, DOI 10.1002/bit.20229
   Lodeiro P, 2006, ENVIRON CHEM, V3, P400, DOI 10.1071/EN06043
   Low KS, 2000, PROCESS BIOCHEM, V36, P59, DOI 10.1016/S0032-9592(00)00177-1
   MADRID Y, 2000, COMPR ANAL CHEM, V33, P41
   Martell A.E, 1977, CRITICAL STABILITY C, V3
   MASRI MS, 1974, J APPL POLYM SCI, V18, P675, DOI 10.1002/app.1974.070180305
   Naja G, 2005, WATER RES, V39, P579, DOI [10.1016/j.watres.2004.11.008, 10.1016/j.watres.2004.1.008]
   Pagnanelli F, 2002, WASTE MANAGE, V22, P901, DOI 10.1016/S0956-053X(02)00086-7
   Pagnanelli F, 2008, WATER RES, V42, P2953, DOI 10.1016/j.watres.2008.03.012
   Puziy AM, 2007, CARBON, V45, P1941, DOI 10.1016/j.carbon.2007.06.014
   Ravat C, 2000, WATER RES, V34, P1327, DOI 10.1016/S0043-1354(99)00255-9
   Rey-Castro C, 2003, ENVIRON SCI TECHNOL, V37, P5159, DOI 10.1021/es0343353
   Schiewer S, 2008, J HAZARD MATER, V157, P8, DOI 10.1016/j.jhazmat.2007.12.076
   Suhas, 2007, BIORESOURCE TECHNOL, V98, P2301, DOI 10.1016/j.biortech.2006.08.008
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   Volesky B., 2003, SORPTION BIOSORPTION
   Wase J, 1997, BIOSORBENTS METAL IO
   Yan GY, 2003, WATER RES, V37, P4486, DOI 10.1016/S0043-1354(03)00409-3
   Zhou D, 2004, WATER RES, V38, P2643, DOI 10.1016/j.watres.2004.03.026
NR 34
TC 10
Z9 10
U1 2
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD FEB
PY 2009
VL 100
IS 4
BP 1561
EP 1567
DI 10.1016/j.biortech.2008.09.027
PG 7
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 386EL
UT WOS:000261865000008
PM 18954980
DA 2018-10-19
ER

PT J
AU Rabiee, S
   Mortazavi, S
   Moztarzadeh, F
   Sharifi, D
   Fakhrejahani, F
   Khafaf, A
   Ahmadi, SAH
   Nosoudi, N
   Ravarian, R
AF Rabiee, S. M.
   Mortazavi, S. M. J.
   Moztarzadeh, F.
   Sharifi, D.
   Fakhrejahani, F.
   Khafaf, A.
   Ahmadi, S. A. Houshiar
   Nosoudi, N.
   Ravarian, R.
TI Association of a synthetic bone graft and bone marrow cells as a
   composite biomaterial
SO BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
LA English
DT Article
DE synthetic bone graft; porous tricalcium phosphate; bone marrow;
   mechanical properties
ID POROUS HYDROXYAPATITE; TRICALCIUM PHOSPHATE; SUBSTITUTE; BEHAVIOR;
   FRACTURES; DEFECTS
AB Porous calcium phosphates have osteoconductive properties. The aim of this study was to obtain synthetic calcium phosphate bone graft substitute. X-ray diffraction was employed to investigate the formation of the beta-tricalcium phosphate (beta-TCP) phase. We evaluated the effects of bone marrow on the osteoconductivity and mechanical properties of synthetic bone graft (SG). SG cylinders loaded with bone marrow (SGBM) and SG alone were implanted into rabbits femoral condyle bone defects. Histological examinations revealed the resorption of the SG, trabecular bone with osteoblasts and osteoid substance around the implants, and colonization inside the porous beta-TCP by newly formed bone. Histomorphometry conducted after three months revealed the osteoid surface to be higher in SGBM than SG (p < 0.05). The compressive strengths of SG and SGBM were significantly higher than the anatomic control at all time periods. The elastic modulus of SBG and SGBM became weaker after implantation. The present results indicate that gB-TCP is a good matrix for bone marrow, which contributes osteoinductive properties in an orthotopic. The composite biomaterial may be useful in reconstructive bone surgery.
C1 [Rabiee, S. M.] Babol Noshirvani Univ Technol, Dept Mech Engn, Mazandaran, Babol, Iran.
   [Rabiee, S. M.; Moztarzadeh, F.; Ahmadi, S. A. Houshiar; Nosoudi, N.; Ravarian, R.] Amirkabir Univ, Dept Med Engn, Tehran, Iran.
   [Mortazavi, S. M. J.; Fakhrejahani, F.; Khafaf, A.] Univ Tehran Med Sci, Dept Orthoped Surg, Tehran, Iran.
   [Sharifi, D.] Univ Tehran, Fac Vet Med, Dept Clin Sci, Tehran, Iran.
RP Rabiee, S (reprint author), Babol Noshirvani Univ Technol, Dept Mech Engn, Mazandaran, Babol, Iran.
EM rabiee@nit.ac.ir
RI NOSOUDI, NASIM/B-5572-2012
OI Moztarzadeh, Fathollah/0000-0001-9109-0264
CR BAIN JJ, 2004, MATER LETT, V58, P347
   BUCHOLZ RW, 1989, CLIN ORTHOP RELAT R, P53
   Chapman MW, 1997, J BONE JOINT SURG AM, V79A, P495, DOI 10.2106/00004623-199704000-00004
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   Flautre B, 1999, J MATER SCI-MATER M, V10, P811, DOI 10.1023/A:1008923625599
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   Lane JM, 1999, CLIN ORTHOP RELAT R, pS107
   Lu JX, 1999, BONE, V25, p41S, DOI 10.1016/S8756-3282(99)00131-3
   Lu X, 2005, BIOMATERIALS, V26, P1097, DOI 10.1016/j.biomaterials.2004.05.034
   Orr TE, 2001, BIOMATERIALS, V22, P1953, DOI 10.1016/S0142-9612(00)00370-7
   Rabiee SM, 2008, AM CERAM SOC BULL, V87, P43
   Rabiee SM, 2008, BIOTECHNOL BIOPROC E, V13, P204, DOI [10.1007/s12257-007-0163-0, 10.1007/S12257-007-0163-0]
   Rabiee SM, 2007, MATER SCI-POLAND, V25, P1019
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Tian JT, 2001, J MATER SCI, V36, P3061, DOI 10.1023/A:1017935411108
   Wong LH, 2002, MAT SCI ENG C-BIO S, V20, P111, DOI 10.1016/S0928-4931(02)00020-6
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
NR 18
TC 6
Z9 6
U1 0
U2 2
PU KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING
PI SEOUL
PA KOREAN SCIENCE TECHNOLOGY CENTER, #704 YEOGSAM-DONG, KANGNAM-KU, SEOUL
   135-703, SOUTH KOREA
SN 1226-8372
J9 BIOTECHNOL BIOPROC E
JI Biotechnol. Bioprocess Eng.
PD FEB
PY 2009
VL 14
IS 1
BP 1
EP 5
DI 10.1007/s12257-008-0089-1
PG 5
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 416CE
UT WOS:000263982000001
DA 2018-10-19
ER

PT J
AU Wang, XJ
   Cong, Q
   Zhang, JJ
   Wan, YL
AF Wang XiaoJun
   Cong Qian
   Zhang JianJun
   Wan YanLing
TI Multivariate coupling mechanism of NOCTUIDAE moth wings' surface
   superhydrophobicity
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE NOCTUIDAE moth; scale; hydrophobicity; biomaterial; shape; structure;
   coupling
AB The surface shape, structure, biomaterial and wettability of moth wings (10 NOCTUIDAE species) from the northeast region of China were qualitatively and quantitatively studied by means of a stereoscopic microscope, a scanning electronic microscope, fourier transform infrared spectroscopy(FT-IR) and the interface contact angle measurement. The observation shows that there are scales arranged like overlapping tiles on the surface of the moth wings. The shapes of the scales are different between species. They overlap horizontally and there is particular space vertically in the direction of the wing veins. The surface of the scale is structured by micron-class grooves and nanometer-class vertical gibbosities. The biomaterial components of the moth wing scale are mostly made up of protein, lipids and chitin. The observation also shows that the contact angle for wings with scales is in the range from 144.8A degrees to 152.9A degrees, while that for those without scales is from 90.0A degrees to 115.9A degrees. It indicates that the surfaces of the wings with scales are more hydrophobic. According as Cassie model, the equation of wettability on the NOCTUIDAE moth wing surface is established and the hydrophobic mechanism is analyzed. It is concluded that the hydrophobicity of the moth wings is induced by the multivariate coupling of the shape, structures and biomaterial of the scales.
C1 [Wang XiaoJun; Cong Qian; Zhang JianJun; Wan YanLing] Jilin Univ, Minist Educ, Key Lab Terrain Machine Bion Engn, Changchun 130025, Peoples R China.
   [Wang XiaoJun] Changchun Univ Technol, Sch Biol Engn, Changchun 130012, Peoples R China.
RP Cong, Q (reprint author), Jilin Univ, Minist Educ, Key Lab Terrain Machine Bion Engn, Changchun 130025, Peoples R China.
EM congqian@jlu.edu.cn
FU National Natural Science Foundation [50635030]; Specialized Research
   Fund for Doctoral Program of Higher Education of China [20040183048];
   Graduate Student Innovation Foundation of JiLin University [20080210]
FX Supported by the Key Research Project under the National Natural Science
   Foundation (Grant No. 50635030), Specialized Research Fund for Doctoral
   Program of Higher Education of China (Grant No. 20040183048) and
   Graduate Student Innovation Foundation of JiLin University (985 Project)
   (Grant No. 20080210)
CR ABRAHAM M, 2004, LANGMUIR, P3517
   Adamson A. W., 1997, PHYS CHEM SURFACES
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856
   BO H, 2004, COLLOID SURFACE A, P101
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Fang Y, 2007, CHINESE SCI BULL, V52, P711, DOI 10.1007/s11434-007-0120-5
   Gao Xue-Feng, 2006, Wuli, V35, P559
   Guo ZG, 2007, PLANT SCI, V172, P1103, DOI 10.1016/j.plantsci.2007.03.005
   HERMAN S, 2002, GLOBAL COSM IND, V170, P32
   [江雷 Jiang Lei], 2003, [化工进展, Chemical Industry and Engineering Progress], V22, P1258
   [路晓 Lu Xiao], 2006, [材料导报, Materials Review], V20, P63
   MA ML, 2006, CURR OPIN COLLOID IN
   MICHAEL N, 2007, MICROELECTRON ENG, P382
   Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400
   Wang JD, 2006, CHINESE SCI BULL, V51, P2297, DOI 10.1007/s11434-006-2129-6
   WANG LY, 1982, ICONOGRAPHIA HETEROC
   Yan X.C., 2005, INTERFACE CHEM
   Yuan ZQ, 2007, SURF COAT TECH, V201, P7138, DOI 10.1016/j.surfcoat.2007.01.021
   ZHU HF, 1980, MOTH SPECIES ILLUSTR
NR 20
TC 12
Z9 13
U1 1
U2 7
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
EI 1861-9541
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD FEB
PY 2009
VL 54
IS 4
BP 569
EP 575
DI 10.1007/s11434-009-0071-0
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 407JB
UT WOS:000263358300007
DA 2018-10-19
ER

PT J
AU Shumaker, PR
   Sakas, EL
   Swann, MH
   Greenway, HT
AF Shumaker, Peter R.
   Sakas, E. Lawrence
   Swann, Michael H.
   Greenway, Hubert T., Jr.
TI Calcium Hydroxylapatite Tissue Filler Discovered 6 Years after
   Implantation into the Nasolabial Fold: Case Report and Review
SO DERMATOLOGIC SURGERY
LA English
DT Article
ID HYALURONIC-ACID; AUGMENTATION; BIOMATERIAL; TRIAL; HYDROXYAPATITE;
   MULTICENTER; SUBSTANCES; PARTICLES; RESPONSES; HISTOLOGY
AB Injectable calcium hydroxylapatite is becoming increasingly popular as a facial soft tissue filler, due in part to its purported longevity of esthetic correction compared with other materials, but little is known about its long-term histologic appearance and persistence in facial skin. We recently encountered calcium hydroxylapatite microspheres incidentally during Mohs surgery of the nasolabial fold 6 years after implantation.
   To describe the long-term histologic appearance of calcium hydroxylapatite microspheres in human facial skin and review the relevant literature with a consideration of clinical implications.
   Routine hematoxylin and eosin staining was performed on frozen and fixed excised tissue containing calcium hydroxylapatite microspheres. Additional fixed sections were stained using Movat's pentachrome method.
   Numerous 4- to 20-mu m round vacuoles were present throughout the reticular dermis associated with focal fibrosis, interstitial mucin, and little surrounding inflammation.
   Calcium hydroxylapatite microspheres and associated fibrosis may persist in facial dermis at least 6 years after implantation, long after its clinical effects are thought to subside. Dermatologists and dermatopathologists must be mindful of dermal implants because it is likely that incidental encounters will be an increasingly common occurrence.
   The authors have indicated no significant interest with commercial supporters.
C1 [Sakas, E. Lawrence] Scripps Clin, Div Pathol, La Jolla, CA 92037 USA.
   [Shumaker, Peter R.; Swann, Michael H.; Greenway, Hubert T., Jr.] Scripps Clin, Mohs Dermatol Surg Div, La Jolla, CA 92037 USA.
RP Greenway, HT (reprint author), Scripps Clin Torrey Pines, 10666 N Torrey Pines Rd,MS 112A, La Jolla, CA 92037 USA.
EM greenway.hugh@scrippshealth.org
CR Alam M, 2007, J AM ACAD DERMATOL, V56, P285, DOI 10.1016/j.jaad.2006.09.014
   Bennett R, 2005, DERMATOL SURG, V31, P1366, DOI 10.1097/00042728-200510000-00023
   *BIOF MED INC, 2006, RAD INJ IMPL PROD IN
   DROBECK HP, 1984, J ORAL MAXIL SURG, V42, P143, DOI 10.1016/S0278-2391(84)80024-5
   Flaharty Patrick, 2004, Facial Plast Surg, V20, P165, DOI 10.1055/s-2004-861759
   FRAME JW, 1987, INT J ORAL MAX SURG, V16, P642, DOI 10.1016/S0901-5027(87)80048-6
   Iezzi G, 2007, J PERIODONTOL, V78, P940, DOI 10.1902/jop.2007.060271
   Jansen DA, 2006, PLAST RECONSTR SURG, V118, p22S, DOI 10.1097/01.prs.0000234903.55310.6a
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   Laeschke K, 2004, SEMIN CUTAN MED SURG, V23, P214, DOI 10.1016/j.sder.2004.09.005
   Lemperle G, 2004, PLAST RECONSTR SURG, V113, P1380, DOI 10.1097/01.PRS.0000112764.22839.7A
   Lemperle G, 2003, AESTHET PLAST SURG, V27, P354, DOI 10.1007/s00266-003-3022-1
   Marmur Ellen S, 2004, J Cosmet Laser Ther, V6, P223, DOI 10.1080/147641704100003048
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Moers-Carpi M, 2007, DERMATOL SURG, V33, pS144, DOI 10.1111/j.1524-4725.2007.33354.x
   Moers-Carpi MM, 2008, DERMATOL SURG, V34, P210, DOI 10.1111/j.1524-4725.2007.34039.x
   Morhenn VB, 2002, DERMATOL SURG, V28, P484, DOI 10.1046/j.1524-4725.2002.01273.x
   Nicolau PJ, 2007, PLAST RECONSTR SURG, V119, P2271, DOI 10.1097/01.prs.0000260710.30934.a1
   Proussaefs P, 2002, J PROSTHET DENT, V87, P481, DOI 10.1037/mpr.2002.122961
   Sankar V, 2007, J AM DENT ASSOC, V138, P1093, DOI 10.14219/jada.archive.2007.0321
   Silvers SL, 2006, PLAST RECONSTR SURG, V118, p34S, DOI 10.1097/01.prs.0000234847.36020.52
NR 21
TC 7
Z9 8
U1 0
U2 5
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1076-0512
J9 DERMATOL SURG
JI Dermatol. Surg.
PD FEB
PY 2009
VL 35
IS 1
BP 375
EP 379
DI 10.1111/j.1524-4725.2008.01050.x
PG 5
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 402TL
UT WOS:000263035900011
PM 19207328
DA 2018-10-19
ER

PT J
AU Sauerzapfe, B
   Krenek, K
   Schmiedel, J
   Wakarchuk, WW
   Pelantova, H
   Kren, V
   Elling, L
AF Sauerzapfe, Birgit
   Krenek, Karel
   Schmiedel, Judith
   Wakarchuk, Warren W.
   Pelantova, Helena
   Kren, Vladimir
   Elling, Lothar
TI Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-LacNAc)
   structures and their characterization for CGL2-galectin-mediated binding
   of ECM glycoproteins to biomaterial surfaces
SO GLYCOCONJUGATE JOURNAL
LA English
DT Article
DE Poly-LacNAc; Chemo-enzymatic synthesis; Galectin binding; ECM
   glycoproteins; Biomaterials
ID FRONTAL AFFINITY-CHROMATOGRAPHY; SOLID-PHASE SYNTHESIS; I-EXTENSION
   ENZYME; NEISSERIA-MENINGITIDIS; CAMPYLOBACTER-JEJUNI;
   ALPHA-DYSTROGLYCAN; ESCHERICHIA-COLI; USEFUL CATALYST; CELL-BINDING;
   GALECTIN-1
AB Poly-N-acetyllactosamine (poly-LacNAc) structures have been identified as important ligands for galectin-mediated cell adhesion to extra-cellular matrix (ECM) proteins. We here present the biofunctionalization of surfaces with poly-LacNAc structures and subsequent binding of ECM glycoproteins. First, we synthesized beta-GlcNAc glycosides carrying a linker for controlled coupling onto chemically functionalized surfaces. Then we produced poly-LacNAc structures with defined lengths using human beta 1,4-galactosyltransferase-1 and beta 1,3-N-acetylglucosaminyltransferase from Helicobacter pylori. These compounds were also used for kinetic characterization of glycosyltransferases and lectin binding assays. A mixture of poly-LacNAc-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model galectin His(6)CGL2. We further demonstrate for the first time that these poly-LacNAc surfaces are suitable for further galectin-mediated binding of the ECM glycoproteins laminin and fibronectin. This new technology should facilitate cell adhesion to biofunctionalized surfaces by imitating the natural ECM microenvironment.
C1 [Elling, Lothar] Rhein Westfal TH Aachen, Inst Biotechnol, Lab Biomat, D-52074 Aachen, Germany.
   [Krenek, Karel; Pelantova, Helena; Kren, Vladimir] Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague 4, Czech Republic.
   [Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada.
   Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
RP Elling, L (reprint author), Rhein Westfal TH Aachen, Inst Biotechnol, Lab Biomat, D-52074 Aachen, Germany.
EM l.elling@biotec.rwth-aachen.de
RI Kren, Vladimir/H-8461-2014; Pelantova, Helena/R-4974-2017; Elling,
   Lothar/B-3711-2013; Wakarchuk, Warren/Q-9514-2017
OI Pelantova, Helena/0000-0002-2523-7413; Elling,
   Lothar/0000-0002-3654-0397; Wakarchuk, Warren/0000-0002-1539-1679
FU DFG Research Training Group 1035 "Biointerface"; DAAD-AV CR
   [PPP-D7-CZ26/04-05D/03/44448]; Boehringer Ingelheim Foundation Travel
   Allowances;  [MSMT LC06010];  [GAAVCR IAA400200503]
FX The authors thank Prof. Dr. Markus Aebi (ETH Zurich) and Prof. Dr. Eric
   G. Berger (Zurich University) for providing the CGL2 plasmid and alpha
   3GalT plasmid, respectively. L. E. and B. S acknowledge financial
   support by the DFG Research Training Group 1035 "Biointerface". Part of
   this work was supported by a bilateral grant from DAAD-AV CR project
   PPP-D7-CZ26/04-05D/03/44448 (V. K. & L. E.) and by projects MSMT LC06010
   and GAAVCR IAA400200503. B. S. thanks the Boehringer Ingelheim
   Foundation Travel Allowances for financial support during a stay in Dr.
   Wakarchuk's laboratory. Dr. P. Halada (Inst. Microbiol., Prague) is
   thanked for the MS measurements. The excellent technical assistance
   (HPLC/ESI-MS and CE) by Dipl.-Ing. Dennis Hirtz (Laboratory for
   Biomaterials, RWTH Aachen University) is gratefully acknowledged.
CR Alvarez RA, 2006, METHOD ENZYMOL, V415, P292, DOI 10.1016/S0076-6879(06)15018-1
   Barboni EAM, 1999, GLYCOCONJUGATE J, V16, P365, DOI 10.1023/A:1007004330048
   BENALIL A, 1991, TETRAHEDRON, V47, P8177, DOI 10.1016/S0040-4020(01)91013-0
   Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200
   Blixt O, 2005, CARBOHYD RES, V340, P1963, DOI 10.1016/j.carres.2005.06.008
   Blixt O, 2004, ACS SYM SER, V873, P93
   Blixt O, 1999, GLYCOBIOLOGY, V9, P1061, DOI 10.1093/glycob/9.10.1061
   Blixt O, 2001, J ORG CHEM, V66, P2442, DOI 10.1021/jo0057809
   Boulianne RP, 2000, MICROBIOL-SGM, V146, P1841, DOI 10.1099/00221287-146-8-1841
   Brinkmann N, 2001, BIOORG MED CHEM LETT, V11, P2503, DOI 10.1016/S0960-894X(01)00474-7
   Bulter T, 2001, Chembiochem, V2, P884, DOI 10.1002/1439-7633(20011203)2:12<884::AID-CBIC884>3.0.CO;2-2
   Campbell CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-236
   Cooper DNW, 1997, TRENDS GLYCOSCI GLYC, V9, P57, DOI 10.4052/tigg.9.57
   Daines AM, 2004, CURR OPIN CHEM BIOL, V8, P106, DOI 10.1016/j.cbpa.2001.02.003
   de Paz JL, 2006, METHOD ENZYMOL, V415, P269, DOI 10.1016/S0076-6879(06)15017-X
   Di Virgilio S, 1999, GLYCOBIOLOGY, V9, P353, DOI 10.1093/glycob/9.4.353
   Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200
   Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2
   HORMANN H, 1984, H-S Z PHYSIOL CHEM, V365, P517, DOI 10.1515/bchm2.1984.365.1.517
   HORTON D, 1966, ORG SYNTH, V46, P1, DOI DOI 10.15227/0RGSYN.046.0001
   Hughes R. Colin, 2004, Glycoconjugate Journal, V19, P621
   Hughes RC, 2001, BIOCHIMIE, V83, P667
   Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200
   KNIBBS RN, 1989, BIOCHEMISTRY-US, V28, P6379, DOI 10.1021/bi00441a034
   Koeller KM, 2000, CHEM REV, V100, P4465, DOI 10.1021/cr990297n
   Krist P, 2004, CHEMBIOCHEM, V5, P445, DOI 10.1002/cbic.200300669
   Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04
   Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200
   Liu Y, 2006, METHOD ENZYMOL, V415, P326, DOI 10.1016/S0076-6879(06)15020-X
   Logan SM, 2005, GLYCOBIOLOGY, V15, P721, DOI 10.1093/glycob/cwi057
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Murata T, 2005, BBA-GEN SUBJECTS, V1722, P60, DOI 10.1016/j.bbagen.2004.11.008
   Nakamura-Tsuruta S, 2006, METHOD ENZYMOL, V415, P311, DOI 10.1016/S0076-6879(06)15019-3
   Namdjou DJ, 2007, ADV SYNTH CATAL, V349, P314, DOI 10.1002/adsc.200606169
   Nicolaou KC, 1998, ANGEW CHEM INT EDIT, V37, P1559, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1559::AID-ANIE1559>3.0.CO;2-E
   Niemela R, 1998, J BIOL CHEM, V273, P4021, DOI 10.1074/jbc.273.7.4021
   Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063
   Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785
   Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324
   Romer U, 2004, J BIOTECHNOL, V107, P135, DOI 10.1016/j.jbiotec.2003.10.017
   Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294
   Sauerzapfe B, 2008, J MOL CATAL B-ENZYM, V50, P128, DOI 10.1016/j.molcatb.2007.09.009
   Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899
   Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122
   Shibatani S, 2001, J BIOSCI BIOENG, V91, P85, DOI 10.1263/jbb.91.85
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823
   Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R
   Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018
   Stults CLM, 1999, GLYCOBIOLOGY, V9, P661, DOI 10.1093/glycob/9.7.661
   Tajiri M, 2005, GLYCOBIOLOGY, V15, P1332, DOI 10.1093/glycob/cwj019
   Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432
   Uchiyama N, 2006, METHOD ENZYMOL, V415, P341, DOI 10.1016/S0076-6879(06)15021-1
   Uhrin D, 1997, J MAGN RESON, V126, P248, DOI 10.1006/jmre.1997.1156
   Ujita M, 2000, J BIOL CHEM, V275, P15868, DOI 10.1074/jbc.M001034200
   Ujita M, 1999, J BIOL CHEM, V274, P9296, DOI 10.1074/jbc.274.14.9296
   Unverzagt C, 2002, J MED CHEM, V45, P478, DOI 10.1021/jm0110237
   Vasiliu D, 2006, CARBOHYD RES, V341, P1447, DOI 10.1016/j.carres.2006.03.043
   Wakarchuk Warren W, 2003, Methods Mol Biol, V213, P263
   Wakarchuk WW, 1998, PROTEIN ENG, V11, P295, DOI 10.1093/protein/11.4.295
   Wakarchuk WW, 2001, J BIOL CHEM, V276, P12785, DOI 10.1074/jbc.M011293200
   Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002
   Werz DB, 2005, CHEM-EUR J, V11, P3194, DOI 10.1002/chem.200500025
   Wu AM, 2006, GLYCOBIOLOGY, V16, P524, DOI 10.1093/glycob/cwj102
   Zervosen A, 1996, J AM CHEM SOC, V118, P1836, DOI 10.1021/ja953495e
NR 65
TC 47
Z9 48
U1 3
U2 42
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0282-0080
EI 1573-4986
J9 GLYCOCONJUGATE J
JI Glycoconjugate J.
PD FEB
PY 2009
VL 26
IS 2
BP 141
EP 159
DI 10.1007/s10719-008-9172-2
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 408EE
UT WOS:000263417500003
PM 18758940
DA 2018-10-19
ER

PT J
AU Cobb, WS
   Peindl, RM
   Zerey, M
   Carbonell, AM
   Heniford, BT
AF Cobb, W. S.
   Peindl, R. M.
   Zerey, M.
   Carbonell, A. M.
   Heniford, B. T.
TI Mesh terminology 101
SO HERNIA
LA English
DT Article
CT Annual Meeting of the American-Hernia-Society
CY MAR 07-10, 2007
CL Hollywood, FL
SP Amer Hernia Soc
DE Biomaterials; Surgical mesh; Mechanical testing; Terminology; Hernia
ID HERNIA; REPAIR; GROIN
AB In any collaborative endeavor, when fields like medicine and bioengineering overlap, the proper use of technical vocabulary takes on added importance. It is important that scientists and clinicians, while coming from different backgrounds and educational systems, agree upon and utilize a common language based on mutually understood concepts and definitions. Regarding biomaterial testing applications, numerous terms are used to describe a wide variety of material behaviors when test specimens are subjected to mechanical, chemical, electrical and thermal stressors. In this discussion we will limit ourselves to the mechanical properties of materials which are utilized for soft tissue or fascial-based repairs. Following a literature search combining the keywords surgical mesh and biomaterials testing, common terms used to describe the mechanical properties of mesh were selected. Our analysis seeks to define the following terms and describe their applicability within the context of biomaterials for hernia repair: elasticity, stiffness, flexibility, tensile strength, distension, deformation, bending stiffness, and compliance. Unfortunately, in the technical literature, terms are often altered or extrapolated without adequate explanation. In other cases, related but technically different terms are mistakenly used interchangeably. With the mounting interest in biomaterials for the use in repair of abdominal wall defects, there is a need to standardize the terminology used to describe the biomechanical properties of mesh.
C1 [Cobb, W. S.; Carbonell, A. M.] Greenville Hosp Syst Univ, Med Grp, Minimally Invas Surg Serv, Greenville, SC 29605 USA.
   [Peindl, R. M.; Zerey, M.; Heniford, B. T.] Carolinas Med Ctr, Div Gastrointestinal & Minimally Invas Surg, Charlotte, NC 28203 USA.
RP Cobb, WS (reprint author), Greenville Hosp Syst Univ, Med Grp, Minimally Invas Surg Serv, 701 Grove Rd, Greenville, SC 29605 USA.
EM wcobb@ghs.org
CR Burger JWA, 2004, ANN SURG, V240, P578
   CAREW E.O., 2004, BIOMATERIALS SCI INT, P23
   Chao EY, 1991, BASIC ORTHOPAEDIC BI
   DeBord JR, 1998, SURG CLIN N AM, V78, P973, DOI 10.1016/S0039-6109(05)70365-0
   Grant A, 2000, BRIT J SURG, V87, P854
   PARK JB, 1992, BIOMATERIALS INTRO, P29
   STOPPA RE, 1989, WORLD J SURG, V13, P545, DOI 10.1007/BF01658869
NR 7
TC 42
Z9 43
U1 2
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1265-4906
J9 HERNIA
JI Hernia
PD FEB
PY 2009
VL 13
IS 1
BP 1
EP 6
DI 10.1007/s10029-008-0428-3
PG 6
WC Surgery
SC Surgery
GA 403IK
UT WOS:000263076100001
PM 18795413
DA 2018-10-19
ER

PT J
AU Swanson, B
   Anderson, S
AF Swanson, B.
   Anderson, S.
TI Evolution of complex biomaterial performance: the case of spider silk
SO INTEGRATIVE AND COMPARATIVE BIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the Society-for-Integrative-and-Comparative-Biology
CY JAN 03-07, 2009
CL Boston, MA
SP Soc Integrat & Comparat Biol
C1 [Swanson, B.; Anderson, S.] Gonzaga Univ, Spokane, WA USA.
EM swansonb@gonzaga.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1540-7063
J9 INTEGR COMP BIOL
JI Integr. Comp. Biol.
PD FEB
PY 2009
VL 49
BP E166
EP E166
PG 1
WC Zoology
SC Zoology
GA 481KL
UT WOS:000268808800662
DA 2018-10-19
ER

PT J
AU Singhrao, SK
   Gilbert, SJ
   Khan, I
   Duance, VC
   Archer, CW
AF Singhrao, Sim. K.
   Gilbert, Sophie. J.
   Khan, Ilyas
   Duance, Victor C.
   Archer, Charles W.
TI Biological responses of chondrocytes to poly(ethylene
   terephthalate)/polycaprolactone, (PET/PCL) co-polymer flat scaffolds as
   a potential biomaterial for matrix-induced autologous chondrocyte
   implantation (MACI)
SO INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
LA English
DT Meeting Abstract
CT Annual General Meeting of the British-Society-for-Matrix-Biology
CY APR 07-08, 2008
CL York Univ, York, ENGLAND
SP British Soc Matrix Biol
HO York Univ
C1 [Singhrao, Sim. K.; Gilbert, Sophie. J.; Khan, Ilyas; Duance, Victor C.; Archer, Charles W.] Cardiff Univ, Sch Biosci, Connect Tissue Biol Labs, Cardiff CF10 3US, S Glam, Wales.
CR Krishnan SP, 2006, J BONE JOINT SURG BR, V88B, P203, DOI 10.1302/0301-620X.88B2.17009
   MARCACCI, 2005, CLIN ORTHOP RELAT R, V435, P96
   NEHER, 2006, EUR J RADIOL, V57, P3
NR 3
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0959-9673
J9 INT J EXP PATHOL
JI Int. J. Exp. Pathol.
PD FEB
PY 2009
VL 90
IS 1
BP A68
EP A69
PG 2
WC Pathology
SC Pathology
GA 395HW
UT WOS:000262516200049
DA 2018-10-19
ER

PT J
AU Schildhauer, TA
   Peter, E
   Muhr, G
   Koller, M
AF Schildhauer, T. A.
   Peter, E.
   Muhr, G.
   Koeller, M.
TI Activation of human leukocytes on tantalum trabecular metal in
   comparison to commonly used orthopedic metal implant materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chemotaxis; cytokines; phagocytosis; leukocytes; tantalum; trabecular
   metal
ID COLONY-STIMULATING FACTOR; POROUS TANTALUM; IN-VIVO; MONONUCLEAR
   LEUKOCYTES; SURFACE-TOPOGRAPHY; WHOLE-BLOOD; BONE; RESPONSES; ADHESION;
   GRANULOCYTES
AB We analyzed leukocyte functions and cytokine response of human leukocytes toward porous tantalum foam biomaterial (Trabecular Metal (TM), TM) in comparison to equally sized solid orthopedic metal implant materials (pure titanium, titanium alloy, stainless steel, pure tantalum, and tantalum coated stainless steel). Isolated peripheral blood mononuclear cells (PBMC) and polymorphonuclear neutrophil leukocytes (PMN) were cocultured with equally sized metallic test discs for 24 h. Supernatants were analyzed for cytokine content by enzyme-linked immunosorbent assay. Compared to the other used test materials there was a significant increase in the release of IL, (interleukin)-1ra and IL-8 from PMN, and of IL-1ra, IL-6,and TNF-alpha from PBMC in response to the TM material. The cytokine release correlated with surface roughness of the materials. In contrast, the release of IL-2 was not induced showing that mainly myeloid leukocytes were activated. In addition, supernatants of these leukocyte/material interaction (conditioned media, CM) were subjected to whole blood cell function assays (phagocytosis, chemotaxis, bacterial killing). There was a significant increase in the phagocytotic capacity of leukocytes in the presence of TM-conditioned media. The chemotactic response of leukocytes toward TM-conditioned media was significantly higher compared to CM obtained from other test materials. Furthermore, the bactericidal capacity of whole blood was enhanced in the presence of TM-conditioned media. These results indicate that leukocyte activation at the surface of TM material induces a microenvironment, which may enhance local host defense mechanisms. (C) 2008 Wiley periodicals, Inc. J Biomed Mater Res 88A: 332-341, 2009
C1 [Schildhauer, T. A.; Peter, E.; Muhr, G.] Ruhr Univ Bochum, Berufsgenossenschaftliches Univ Klinikum Bergmann, Chirurg Klin & Poliklin, Bochum, Germany.
RP Schildhauer, TA (reprint author), Ruhr Univ Bochum, Berufsgenossenschaftliches Univ Klinikum Bergmann, Chirurg Klin & Poliklin, Bochum, Germany.
EM thomas.a.schildhauer@rub.de
OI Schildhauer, Thomas/0000-0002-3232-9869
FU Chirurgische Klinik and Poliklinik, Berufsgenossenschaftliches
   Universitatsklinikum Bergmannsheil, Ruhr-Universitat Bochum, Bochum,
   Germany
FX Contract grant sponsor: Chirurgische Klinik and Poliklinik,
   Berufsgenossenschaftliches Universitatsklinikum Bergmannsheil,
   Ruhr-Universitat Bochum, Bochum, Germany
CR Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bogdanski D, 2004, BIOMATERIALS, V25, P4627, DOI 10.1016/j.biomaterials.2003.12.001
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brooks RA, 2002, J BONE JOINT SURG BR, V84B, P295, DOI 10.1302/0301-620X.84B2.12061
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Davies John E, 2003, J Dent Educ, V67, P932
   Eisenbarth E, 2007, BIOMOL ENG, V24, P27, DOI 10.1016/j.bioeng.2006.05.016
   ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4
   Eriksson C, 2003, J BIOMED MATER RES A, V66A, P662, DOI 10.1002/jbm.a.10029
   Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3
   Eriksson C, 2001, J LAB CLIN MED, V137, P56, DOI 10.1067/mlc.2001.111470
   Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Horowitz MC, 1998, J CLIN DENSITOM, V1, P187, DOI 10.1385/JCD:1:2:187
   Koller M, 2006, MATERIALWISS WERKST, V37, P558, DOI 10.1002/mawe.200600037
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   Mescher AL, 2005, ADV BIOCHEM ENG BIOT, V93, P39, DOI 10.1007/b99966
   Mitchell GB, 2003, INFECT IMMUN, V71, P1643, DOI [10.1128/IAI.71.4.1643-1649.2003, 10.1128/IAI.71.41643-1649.2003]
   Otto M, 2003, J MATER SCI-MATER M, V14, P263, DOI 10.1023/A:1022840909038
   Rahbek O, 2005, INT ORTHOP, V29, P368, DOI 10.1007/s00264-005-0008-4
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   ROILIDES E, 1991, J INFECT DIS, V163, P579, DOI 10.1093/infdis/163.3.579
   Schildhauer TA, 2006, J BIOMED MATER RES A, V78A, P104, DOI 10.1002/jbm.a.30784
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   Schroder AK, 2006, IMMUNOLOGY, V119, P317, DOI 10.1111/j.1365-2567.2006.02435.x
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 34
TC 23
Z9 24
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2009
VL 88A
IS 2
BP 332
EP 341
DI 10.1002/jbm.a.31850
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 391IZ
UT WOS:000262228300007
PM 18286637
DA 2018-10-19
ER

PT J
AU Tschon, M
   Fini, M
   Giavaresi, G
   Rimondini, L
   Ambrosio, L
   Giardino, R
AF Tschon, Matilde
   Fini, Millena
   Giavaresi, Gianiuca
   Rimondini, Lia
   Ambrosio, Luigi
   Giardino, Roberto
TI In Vivo Preclinical Efficacy of a PDLLA/PGA Porous Copolymer for Dental
   Application
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE polylactic acid; polyglycolic acid; minipig; trabecular bone;
   postextraction sockets
ID HUMAN OSTEOGENIC PROTEIN-1; HUMAN EXTRACTION SOCKETS; BONE REGENERATION;
   MANDIBULAR RECONSTRUCTION; TUBULAR CHAMBER; FOLLOW-UP; PART 1; DEFECTS;
   GRAFTS; BIOMATERIAL
AB This study aimed to analyze surface morphology and physical-chemical properties of a copolymer of polylactic/polyglycolic acid (Fisiograft, Ghimas SpA, Casalecchio di Reno, Italy) by scanning electron microscopy (SEM), porosimetry, and rheological analysis. Then the material was implanted in vivo to test its efficacy at promoting bone healing and new bone formation in postextraction sockets. Under general anaesthesia, sockets were created in 12 minipigs and then randomly filled with the porous copolymer in SPONGE or GEL form and compared with commercial BioOss (Geistlich Biomaterials) and Biocoral (Inoteb, France). At 15, 30, and 60 days from surgery, the newly formed trabecular bone quality was evaluated by means of histology and histomorphometry. The SEM and rheological analyses performed on GEL showed a surface microporosity and a rheological shear thinning behavior, whereas the SPONGE porosimetric measurements revealed larger pores. At 15 days, the new bone regrowth was observed in all treated sockets but appeared immature, as the trabeculae were very dense and thin. At 30 days, GEL and SPONGE were degraded, and the sockets were filled with bone that, in terms of bone volume fraction, trabecular number, and separation, was not statistically different from normal bone. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 88B: 349-357, 2009
C1 [Tschon, Matilde; Fini, Millena; Giavaresi, Gianiuca; Rimondini, Lia; Giardino, Roberto] Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Dept Expt Surg, Bologna, Italy.
   [Rimondini, Lia] Univ Eastern Piedmount, Dept Med Sci, Novara, Italy.
   [Ambrosio, Luigi] CNR, Inst Composite & Biomed Mat, Naples, Italy.
   [Giardino, Roberto] Univ Bologna, Dept Clin Med & Appl Biotechnol, Bologna, Italy.
RP Fini, M (reprint author), Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Dept Expt Surg, Bologna, Italy.
EM milena.fini@ior.it
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570; Giavaresi,
   Gianluca/0000-0001-7843-5969; AMBROSIO, LUIGI/0000-0002-8367-2405
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   ATWOOD DA, 1971, J PROSTHET DENT, V26, P280, DOI 10.1016/0022-3913(71)90070-9
   Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1
   Becker W, 1996, J PERIODONTOL, V67, P1025, DOI 10.1902/jop.1996.67.10.1025
   Buser D, 1996, J ORAL MAXILLOFAC SU
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Cranin A N, 1995, J Vet Dent, V12, P53
   Crump TB, 1996, ORAL SURG ORAL MED O, V82, P365
   Cuisinier F J G, 2004, J Appl Biomater Biomech, V2, P88
   Damien E, 2004, J Appl Biomater Biomech, V2, P65
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P203, DOI 10.1034/j.1600-0501.2002.130211.x
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Ferretti C, 2002, ORAL SURG ORAL MED O, V93, P534, DOI 10.1067/moe.2002.124091
   Fiorito S, 2003, J BONE JOINT SURG BR, V85B, P1202, DOI 10.1302/0301-620X.85B8.12799
   Froum S, 2000, Pract Periodontics Aesthet Dent, V12, P393
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Fugazzotto PA, 2005, J PERIODONTOL, V76, P821, DOI 10.1902/jop.2005.76.5.821
   Giardino R, 1998, INT J ARTIF ORGANS, V21, P473
   Giardino R, 2000, INT J ARTIF ORGANS, V23, P331
   Gorustovich Alejandro, 2004, Acta Odontol Latinoam, V17, P9
   Hammerle CHF, 2001, CLIN ORAL IMPLAN RES, V12, P9, DOI 10.1034/j.1600-0501.2001.012001009.x
   Houshmand B, 2007, J PERIODONTAL RES, V42, P119, DOI 10.1111/j.1600-0765.2006.00923.x
   Imbronito AV, 2005, J BIOMED MATER RES A, V74A, P215, DOI 10.1002/jbm.a.30350
   Jahangiri L, 1998, J PROSTHET DENT, V80, P224, DOI 10.1016/S0022-3913(98)70116-7
   Jensen SS, 2005, INT J ORAL MAX IMPL, V20, P703
   Koo KT, 2005, J CLIN PERIODONTOL, V32, P104, DOI 10.1111/j.1600-051X.2004.00632.x
   Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3
   Murray PE, 2002, CRIT REV ORAL BIOL M, V13, P509, DOI 10.1177/154411130201300607
   Nair PNR, 2004, ORAL SURG ORAL MED O, V97, P559, DOI 10.1016/j.tripleo.2003.10.013
   NEVINS M, 1994, INT J PERIODONT REST, V14, P97
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Peltoniemi H, 2002, ORAL SURG ORAL MED O, V94, P5, DOI 10.1067/moe.2002.122160
   PORTNEY LG, 1993, FDN CLIN RES APPL PR, P430
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Sandor GKB, 2003, DENT TRAUMATOL, V19, P221, DOI 10.1034/j.1600-9657.2003.00164.x
   Schacht E H, 1990, Med Device Technol, V1, P15
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P469, DOI 10.1054/ijom.2000.0008
   Thompson Dennis M, 2006, Implant Dent, V15, P89, DOI 10.1097/01.id.0000202426.62007.60
   Tschon M, 2007, INT J ARTIF ORGANS, V30, P352
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
   ZELLIN G, 1995, BIOMATERIALS, V16, P601, DOI 10.1016/0142-9612(95)93857-A
   Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x
NR 45
TC 5
Z9 5
U1 2
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2009
VL 88B
IS 2
BP 349
EP 357
DI 10.1002/jbm.b.31062
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 397TB
UT WOS:000262683900007
PM 18386840
DA 2018-10-19
ER

PT J
AU Hisbergues, M
   Vendeville, S
   Vendeville, P
AF Hisbergues, Michael
   Vendeville, Sophie
   Vendeville, Philippe
TI Zirconia: Established Facts and Perspectives for a Biomaterial in Dental
   Implantology
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE zirconia; biocompatibility; osseointegration; periointegration;
   bacterial colonization; bacterial adhesion
ID PARTIALLY-STABILIZED ZIRCONIA; ENDOTHELIAL GROWTH-FACTOR;
   OSTEOBLAST-LIKE CELLS; IN-VITRO EVALUATION; FLEXURAL STRENGTH; TITANIUM
   IMPLANTS; POLYETHYLENE PARTICLES; BACTERIAL-COLONIZATION; TETRAGONAL
   ZIRCONIA; HUMAN FIBROBLASTS
AB Currently, zirconia is widely used in biomedical area as a material for prosthetic devices because of its good mechanical and chemical properties. Largely employed in clinical area for total hip replacement, zirconia ceramics (ZrO2) are becoming a prevalent biomaterial in dentistry and dental implantology. Although titanium is used in dental implantology currently, there is a trend to develop new ceramic-based implants as an alternative to monolithic titanium. This article reviews the evolution and development of zirconia through data published between 1963 and January 2008 in English language. Articles were identified via a MEDLINE search using the following keywords: zirconia, zirconia/biocompatibility, zirconia/osseointegration, zirconia/periointegration, zirconia/review, and zirconia/bacterial adhesion or colonization. This review of the literature aims at highlighting and discussing zirconia properties in biological systems for their future use in dental implantology. In conclusion, zirconia with its interesting microstructural properties has been confirmed to be a material of choice for the "new generation" of implants, thanks to its biocompatibility, osseoconductivity, tendency to reduce plaque accumulation, and interaction with soft tissues, which leads to periointegration. However, scientific studies are promptly needed to fulfill gaps like long-term clinical evaluations of "all zirconia implants," currently leading to propose an alternative use of "hybrid systems" (i.e., titanium screw with zirconia collar) and also bacterial colonization of zirconia. Moreover, there is a permanent need for consistent information about topography and chemistry of zirconia allowing easier cross-product comparisons of clinical devices. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 88B: 519-529, 2009
C1 [Vendeville, Sophie; Vendeville, Philippe] Polyclin Parc, R & D Unit Biomat & Calcified Tissues, St Saulve, France.
   [Hisbergues, Michael] Inst Pasteur, Lab Lact Acid Bacteria & Mucosal Immunol, F-59019 Lille, France.
RP Vendeville, P (reprint author), Polyclin Parc, R & D Unit Biomat & Calcified Tissues, St Saulve, France.
EM vendeville@orange.fr
CR AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x
   ANTOLIN AB, 2007, MED ORAL PATOL ORAL, V12, pE323
   Ardlin BI, 2002, DENT MATER, V18, P590, DOI 10.1016/S0109-5641(01)00095-1
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   Basu B, 2004, MAT SCI ENG A-STRUCT, V380, P215, DOI 10.1016/j.msea.2004.03.065
   Basu B, 2004, J EUR CERAM SOC, V24, P2031, DOI 10.1016/S0955-2219(03)00355-8
   Basu B, 2004, MAT SCI ENG A-STRUCT, V366, P338, DOI 10.1016/j.msea.2003.08.063
   Bianchi A E, 2004, J Appl Biomater Biomech, V2, P143
   BORTZ SA, 1973, CER B, V52, P898
   BUKAT A, 1990, BIOCERAMICS, V3, P355
   Catelas I, 1999, BIOMATERIALS, V20, P625, DOI 10.1016/S0142-9612(98)00214-2
   Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.3.CO;2-7
   Chang YS, 1996, J BIOMED MATER RES, V30, P117, DOI 10.1002/(SICI)1097-4636(199601)30:1<117::AID-JBM15>3.0.CO;2-L
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   CHRISTEL PS, 1989, B HOSP JOINT DIS ORT, V49, P170
   CRANIN AN, 1975, J BIOMED MATER RES, V9, P257, DOI 10.1002/jbm.820090429
   De Riccardis MF, 2007, J COLLOID INTERF SCI, V307, P109, DOI 10.1016/j.jcis.2006.10.037
   Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   Franchi M, 2007, J PERIODONTOL, V78, P879, DOI 10.1902/jop.2007.060280
   GARVIE RC, 1972, J AM CERAM SOC, V55, P152, DOI 10.1111/j.1151-2916.1972.tb11241.x
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Glauser R, 2004, INT J PROSTHODONT, V17, P285
   GRECO F, 1993, MINERVA ORTOP TRAUMA, V44, P913
   Groessner-Schreiber B, 2004, EUR J ORAL SCI, V112, P516, DOI 10.1111/j.1600-0722.2004.00171.x
   Groessner-Schreiber B, 2003, J BIOMED MATER RES A, V64A, P591, DOI 10.1002/jbm.a.10417
   Grossner-Schreiber B, 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI 10.1111/j.1600-0501.2006.01277.x
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Hao L, 2005, J MATER SCI-MATER M, V16, P719, DOI 10.1007/s10856-005-2608-3
   HARMAND MF, 1995, P 12 ESB C BIOM OP P, P141
   HELMER JC, 1969, RES BIOCERAMICS
   Huang Hui, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P327
   Huang Hui, 2007, Shanghai Kou Qiang Yi Xue, V16, P413
   ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B
   Ito A., 1993, Clinical Materials, V12, P203, DOI 10.1016/0267-6605(93)90074-H
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Kanno T, 2007, CLIN IMPLANT DENT R, V9, P156, DOI 10.1111/j.1708-8208.2007.00044.x
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   LANGE FF, 1982, J MATER SCI, V17, P240, DOI 10.1007/BF00809059
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leonhardt A, 2002, CLIN ORAL IMPLAN RES, V13, P127, DOI 10.1034/j.1600-0501.2002.130202.x
   Li J., 1993, Clinical Materials, V12, P197, DOI 10.1016/0267-6605(93)90073-G
   Liagre B, 2002, J BONE JOINT SURG BR, V84B, P920, DOI 10.1302/0301-620X.84B6.12457
   Lohmann CH, 2002, BIOMATERIALS, V23, P1855, DOI 10.1016/S0142-9612(01)00312-X
   LUTHY H, 1993, P 1993 MONT VER BMS
   Mabboux F, 2004, COLLOID SURFACE B, V39, P199, DOI 10.1016/j.colsurfb.2004.08.002
   MACCAURO G, 1992, P 8 ESB M ROM IT JUN, P110
   Maksoud Mohamed A, 2003, J Oral Implantol, V29, P120, DOI 10.1563/1548-1336(2003)029<0120:MOTPIT>2.3.CO;2
   Marsh PD, 2004, CARIES RES, V38, P204, DOI 10.1159/000077756
   MCCOLLUM J, 1992, J PERIODONTOL, V63, P802, DOI 10.1902/jop.1992.63.10.802
   MEBOUTANKAMGEU E, 2000, J BIOMED MATER RES, V52, P587
   MIAO X, 2008, CERAM INT IN PRESS
   Nakamura T, 2007, DENT MATER J, V26, P623, DOI 10.4012/dmj.26.623
   NAKAZATO G, 1989, INT J ORAL MAXILLOF, V4, P312
   NATH S, CERAM INT IN PRESS
   OGA M, 1993, ACTA ORTHOP SCAND, V64, P273, DOI 10.3109/17453679308993623
   ONG ESM, 1992, J PERIODONTOL, V63, P200, DOI 10.1902/jop.1992.63.3.200
   Papanagiotou HP, 2006, J PROSTHET DENT, V96, P154, DOI 10.1016/j.prosdent.2006.08.004
   Park BS, 2005, J BIOMED MATER RES A, V74A, P640, DOI 10.1002/jbm.a.30326
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x
   Quirynen M, 1990, CLIN ORAL IMPLAN RES, V1, P8, DOI 10.1034/j.1600-0501.1990.010102.x
   Quirynen M, 2006, J CLIN PERIODONTOL, V33, P639, DOI 10.1111/j.1600-051X.2006.00959.x
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Ruff O, 1929, Z ANORG ALLG CHEM, V180, P215, DOI 10.1002/zaac.19291800122
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Scarano Antonio, 2003, J Oral Implantol, V29, P80, DOI 10.1563/1548-1336(2003)029<0080:BAOTNA>2.3.CO;2
   Scotti R, 2007, INT J PROSTHODONT, V20, P419
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Siegrist BE, 1991, CLIN ORAL IMPLAN RES, V2, P38, DOI 10.1034/j.1600-0501.1991.020105.x
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Sollazzo V, 2008, J BIOMED MATER RES B, V84B, P550, DOI 10.1002/jbm.b.30903
   Sterner T, 2004, BIOMED TECH, V49, P340, DOI 10.1515/BMT.2004.063
   STYLES J A, 1976, Annals of Occupational Hygiene, V19, P63, DOI 10.1093/annhyg/19.1.63
   Sul YT, 2006, CLIN ORAL IMPLAN RES, V17, P521, DOI 10.1111/j.1600-0501.2005.01230.X
   Sul YT, 2006, INT J PROSTHODONT, V19, P319
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Suthin K, 2003, J PERIODONTAL RES, V38, P90, DOI 10.1034/j.1600-0765.2003.01646.x
   TATEISHI T, 1992, ADV BIOMAT, V10, P89
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Torricelli P, 2001, BIOMATERIALS, V22, P2535, DOI 10.1016/S0142-9612(00)00444-0
   Tschernitschek H, 2005, QUINTESSENCE INT, V36, P523
   Unlu F, 2003, J PERIODONTOL, V74, P181, DOI 10.1902/jop.2003.74.2.181
   VOLZ U, 2004, QUINTESSENCE J DENT, V2, P324
   Wagner W, 1986, BIOL BIOMECHANICAL P, P129
   WALTER A, 1994, T 11 ESB PIS IT, P404
   Wang ML, 2002, J ARTHROPLASTY, V17, P335, DOI 10.1054/arth.2002.30416
   Wiskott HWA, 2007, INT J ORAL MAX IMPL, V22, P249
   ZHOU J, 2007, ITBM RBM, V28, P42
NR 94
TC 162
Z9 167
U1 5
U2 68
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2009
VL 88B
IS 2
SI SI
BP 519
EP 529
DI 10.1002/jbm.b.31147
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 397TB
UT WOS:000262683900026
PM 18561291
OA Bronze
DA 2018-10-19
ER

PT J
AU Norowski, PA
   Bumgardner, JD
AF Norowski, P. Andrew, Jr.
   Bumgardner, Joel D.
TI Biomaterial and Antibiotic Strategies for Peri-implantitis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE dental/endosteal implants; peri-implantitis; antimicrobials; drug
   delivery/release; surface modification
ID OSSEOINTEGRATED TITANIUM IMPLANTS; GUIDED TISSUE REGENERATION;
   CONTROLLED-RELEASE CHLORHEXIDINE; BONE MORPHOGENETIC PROTEIN-2;
   OF-THE-LITERATURE; IN-VITRO; ORAL IMPLANTS; DENTAL IMPLANTS;
   LOCAL-DELIVERY; PERIODONTAL MAINTENANCE
AB Dental implants have 89% plus survival rates at 10-15 years, but peri-implantitis or dental implant infections may be as high as 14%. Peri-implantitis can limit clinical success and impose health and financial burdens to patients and health providers. The pathogenic species associated with periodontitis (e.g., Fusobacterium ssp, A. actinomycetemcomitans, P. gingivalis) are also associated with peri-implantitis. Incidence of peri-implantitis is highest within the first 12 months after implantation, and is higher in patients who smoke or have poor oral health as well as with calcium-phosphate-coated or surface-roughened implants. Biomaterial therapies using fibers, gels, and beads to deliver antibiotics have been used in the treatment of Peri-implantitis though clinical efficacy is not well documented. Guided tissue regeneration membranes (e.g., collagen, poly-lactic/glycolic acid, chitosan, ePTFE) loaded with antimicrobials have shown success in reosseointegrating infected implants in animal models but have not been proven in humans. Experimental approaches include the development of anti-bioadhesion coatings, coating surfaces with antimicrobial agents (e.g., vancomycin, Ag, Zn) or antimicrobial releasing coatings (e.g., calcium phosphate, polylactic acid, chitosan). Future strategies include the development of surfaces that become antibacterial in response to infection, and improvements in the permucosal seal. Research is still needed to identify strategies to prevent bacterial attachment and enhance normal cell/tissue attachment to implant surfaces. (C) 2008 Wiley Periodicals. Inc. J Biomed Mater Res Part B: Appl Biomater 88B: 530-543, 2009
C1 [Norowski, P. Andrew, Jr.] Univ Memphis, Dept Biomed Engn, Herff Coll Engn, Memphis, TN 38152 USA.
   Univ Memphis, Joint Biomed Engn Program, Memphis, TN 38152 USA.
   Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA.
RP Norowski, PA (reprint author), Univ Memphis, Dept Biomed Engn, Herff Coll Engn, Memphis, TN 38152 USA.
EM pnorowsk@memphis.edu
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P365
   Antoci V, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e318073c2b2
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1119
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   Augthun M, 1998, J PERIODONTOL, V69, P857, DOI 10.1902/jop.1998.69.8.857
   Bahna P, 2007, INT J ANTIMICROB AG, V29, P593, DOI 10.1016/j.ijantimicag.2006.12.013
   Bain C A, 1996, Int J Oral Maxillofac Implants, V11, P756
   Bain C A, 1993, Int J Oral Maxillofac Implants, V8, P609
   Becker J, 2006, CLIN ORAL INVEST, V10, P217, DOI 10.1007/s00784-006-0049-0
   Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Berglundh T, 2004, J CLIN PERIODONTOL, V31, P341, DOI 10.1111/j.1600-051X.2004.00486.x
   Berglundh T, 2002, J CLIN PERIODONTO S3, V29
   Binon P P, 1992, Int J Oral Maxillofac Implants, V7, P168
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0
   Broggini N, 2006, J DENT RES, V85, P473, DOI 10.1177/154405910608500515
   Buchter A, 2004, BRIT J ORAL MAX SURG, V42, P439, DOI 10.1016/j.bjoms.2004.06.005
   Callan Donald P, 2007, Compend Contin Educ Dent, V28, P482
   CALLAN DP, 2007, COMPEND CONTIN ED DE, V28, P486
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   CARLSSON L, 1986, ACTA ORTHOP SCAND, V57, P285, DOI 10.3109/17453678608994393
   Chang CY, 2000, J PERIODONTOL, V71, P1086, DOI 10.1902/jop.2000.71.7.1086
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chen YT, 2003, J PERIODONTOL, V74, P1652, DOI 10.1902/jop.2003.74.11.1652
   Chen ZB, 2007, BIOMATERIALS, V28, P1597, DOI 10.1016/j.biomaterials.2006.12.001
   Choi JY, 2007, J BIOMED MATER RES B, V80B, P353, DOI 10.1002/jbm.b.30604
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   COSTERTON JW, 2005, CLIN ORTHOP RELAT R, V437, P7
   Daneshmand N, 2002, J PERIODONTAL RES, V37, P375, DOI 10.1034/j.1600-0765.2002.01003.x
   DANSER MM, 1995, J CLIN PERIODONTOL, V22, P854, DOI 10.1111/j.1600-051X.1995.tb01784.x
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   DEBRUYN H, 1994, CLIN ORAL IMPLAN RES, V5, P260, DOI 10.1034/j.1600-0501.1994.050410.x
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   DENNISON DK, 1994, J PERIODONTOL, V65, P942, DOI 10.1902/jop.1994.65.10.942
   Duyck J, 1998, Clin Oral Investig, V2, P102, DOI 10.1007/s007840050054
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   Eick S, 2004, J PERIODONTOL, V75, P1327, DOI 10.1902/jop.2004.75.10.1327
   Ellegaard B, 1997, CLIN ORAL IMPLAN RES, V8, P180, DOI 10.1034/j.1600-0501.1997.080304.x
   ERICSSON I, 1995, J CLIN PERIODONTOL, V22, P255
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Esposito M, 1999, INT J ORAL MAX IMPL, V14, P473
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Ferreira SD, 2006, J CLIN PERIODONTOL, V33, P929, DOI 10.1111/j.1600-051X.2006.01001.x
   Fini M, 2006, J BONE JOINT SURG BR, V88B, P123, DOI 10.1302/0301-620X.88B1.16496
   Fourmousis I, 1998, J CLIN PERIODONTOL, V25, P737, DOI 10.1111/j.1600-051X.1998.tb02515.x
   Garrett S, 2000, J PERIODONTOL, V71, P22, DOI 10.1902/jop.2000.71.1.22
   GEORGE K, 1994, J PERIODONTOL, V65, P766, DOI 10.1902/jop.1994.65.8.766
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   GOODSON JM, 1983, J PERIODONTOL, V54, P575, DOI 10.1902/jop.1983.54.10.575
   Gualini F, 2003, J CLIN PERIODONTOL, V30, P14, DOI 10.1034/j.1600-051X.2003.300103.x
   Hanes Philip J, 2003, Ann Periodontol, V8, P79, DOI 10.1902/annals.2003.8.1.79
   Harris LG, 2006, J BIOMED MATER RES A, V78A, P50, DOI 10.1002/jbm.a.30611
   Harris Llinos G, 2006, Injury, V37 Suppl 2, pS3, DOI 10.1016/j.injury.2006.04.003
   Heitz-Mayfield LJA, 2004, INT J ORAL MAX IMPL, V19, P128
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Heuer W, 2007, J ORAL REHABIL, V34, P377, DOI 10.1111/j.1365-2842.2007.01725.x
   Heydenrijk K, 2002, INT J ORAL MAX IMPL, V17, P829
   HILL M, 2004, PERIODONTICS MED SUR, P277
   HOBKIRK J, 1995, COLOR ATLAS TEXT DEN
   Holtom Paul D, 2003, Instr Course Lect, V52, P745
   Hutton J E, 1995, Int J Oral Maxillofac Implants, V10, P33
   Jansen VK, 1997, INT J ORAL MAX IMPL, V12, P527
   Jansson H, 2005, CLIN IMPLANT DENT R, V7, P51, DOI 10.1111/j.1708-8208.2005.tb00047.x
   Jeffcoat MK, 1998, J PERIODONTOL, V69, P989, DOI 10.1902/jop.1998.69.9.989
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Kalicke T, 2006, J ORTHOP RES, V24, P1622, DOI 10.1002/jor.20193
   Karoussis IK, 2003, CLIN ORAL IMPLAN RES, V14, P329, DOI 10.1034/j.1600-0501.000.00934.x
   KENNEDY JF, 1976, ANTIMICROB AGENTS CH, V9, P766, DOI 10.1128/AAC.9.5.766
   Killoy W J, 1998, Dent Clin North Am, V42, P263
   Killoy WJ, 1998, INT DENT J, V48, P305, DOI 10.1111/j.1875-595X.1998.tb00721.x
   Klinge Bjorn, 2005, Dent Clin North Am, V49, P661, DOI 10.1016/j.cden.2005.03.007
   Kurtis B, 2002, J PERIODONTOL, V73, P694, DOI 10.1902/jop.2002.73.7.694
   Lang N P, 1997, Ann Periodontol, V2, P343, DOI 10.1902/annals.1997.2.1.343
   Lavda M, 2004, J PERIODONTOL, V75, P1663, DOI 10.1902/jop.2004.75.12.1663
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee KH, 1999, J PERIODONTOL, V70, P131, DOI 10.1902/jop.1999.70.2.131
   Legeay G, 2006, INT J ARTIF ORGANS, V29, P453
   Lekholm U, 1999, INT J ORAL MAX IMPL, V14, P639
   LEKHOLM U, 1986, J CLIN PERIODONTOL, V13, P558, DOI 10.1111/j.1600-051X.1986.tb00847.x
   LEMONS J, 1986, DENT CLIN N AM, V30, P3
   Leonhardt A, 2002, CLIN ORAL IMPLAN RES, V13, P127, DOI 10.1034/j.1600-0501.2002.130202.x
   LEONHARDT A, 1993, CLIN ORAL IMPLAN RES, V4, P113, DOI 10.1034/j.1600-0501.1993.040301.x
   Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x
   Liljenberg B, 1996, J CLIN PERIODONTOL, V23, P1008, DOI 10.1111/j.1600-051X.1996.tb00529.x
   Listgarten MA, 1999, J PERIODONTOL, V70, P220, DOI 10.1902/jop.1999.70.2.220
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   LOOMER P, 2004, PERIODONTICS MED SUR, P70
   MALMSTROM HS, 1990, J PERIODONTOL, V61, P300, DOI 10.1902/jop.1990.61.5.300
   Marco F, 2005, MICRON, V36, P630, DOI 10.1016/j.micron.2005.07.008
   Matarasso S, 1996, CLIN ORAL IMPLAN RES, V7, P64, DOI 10.1034/j.1600-0501.1996.070108.x
   MCCOLLUM J, 1992, J PERIODONTOL, V63, P802, DOI 10.1902/jop.1992.63.10.802
   McKee MD, 2002, J ORTHOP TRAUMA, V16, P622, DOI 10.1097/01.BOT.0000031145.58425.82
   MEFFERT RM, 1992, J PERIODONTOL, V63, P859, DOI 10.1902/jop.1992.63.11.859
   Meffert RM, 1996, CRIT REV ORAL BIOL M, V7, P278, DOI 10.1177/10454411960070030501
   Minabe M, 2001, Periodontal Clin Investig, V23, P20
   MISCH CE, 1993, CONT IMPLANT DENT
   Mombelli A, 1997, CURR OPIN PERIODONT, V4, P127
   Mombelli A, 1997, J CLIN PERIODONTOL, V24, P470, DOI 10.1111/j.1600-051X.1997.tb00214.x
   Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x
   MOMBELLI A, 1995, J CLIN PERIODONTOL, V22, P124
   Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x
   Mombelli A, 2001, CLIN ORAL IMPLAN RES, V12, P287, DOI 10.1034/j.1600-0501.2001.012004287.x
   Mombelli A, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P281
   Mombelli A, 1998, PERIODONTOL 2000, V17, P63, DOI 10.1111/j.1600-0757.1998.tb00124.x
   Mombelli A, 1993, Adv Dent Res, V7, P202
   Morra M, 2007, EXPERT REV MED DEVIC, V4, P361, DOI 10.1586/17434440.4.3.361
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   NOROWSKI P, 2007, T 32 ANN M SOC BIOM
   O'Mahony A, 1999, J Ir Dent Assoc, V45, P44
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   Ong JL, 1997, INT J ORAL MAX IMPL, V12, P649
   Oosterbos CJM, 2002, J BIOMED MATER RES, V60, P339, DOI 10.1002/jbm.1288
   Oringer RJ, 2002, J PERIODONTOL, V73, P835, DOI 10.1902/jop.2002.73.8.835
   Park YJ, 2000, J BIOMED MATER RES, V51, P391, DOI 10.1002/1097-4636(20000905)51:3<391::AID-JBM13>3.0.CO;2-9
   Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74
   PECORA G, 2006, T 31 ANN M SOC BIOM
   PEDRAZZOLI V, 1992, J CLIN PERIODONTOL, V19, P715, DOI 10.1111/j.1600-051X.1992.tb02534.x
   Persson LG, 1996, CLIN ORAL IMPLAN RES, V7, P90, DOI 10.1034/j.1600-0501.1996.070201.x
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   PIATTELLI A, 1995, BIOMATERIALS, V16, P917, DOI 10.1016/0142-9612(95)93116-U
   Piattelli A, 1998, BIOMATERIALS, V19, P643, DOI 10.1016/S0142-9612(97)00158-0
   POLSON AM, 1985, J PERIODONTOL, V56, P25, DOI 10.1902/jop.1985.56.11s.1
   Porter JA, 2005, GEN DENT, V53, P433
   Porter JA, 2005, GEN DENT, V53, P446
   Porter Judith A, 2005, Gen Dent, V53, P423
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Puleo David A, 2006, Dent Clin North Am, V50, P323, DOI 10.1016/j.cden.2006.03.001
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Quirynen M, 2006, CLIN ORAL IMPLAN RES, V17, P25, DOI 10.1111/j.1600-0501.2005.01194.x
   Quirynen M, 2003, PERIODONTOL 2000, V33, P119, DOI 10.1046/j.0906-6713.2003.03310.x
   Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x
   Quirynen M, 1990, CLIN ORAL IMPLAN RES, V1, P8, DOI 10.1034/j.1600-0501.1990.010102.x
   Quirynen M, 2001, J CLIN PERIODONTOL, V28, P499, DOI 10.1034/j.1600-051x.2001.028006499.x
   Quirynen M, 2007, J CLIN PERIODONTOL, V34, P805, DOI 10.1111/j.1600-051X.2007.01106.x
   Radin S, 2005, BIOMATERIALS, V26, P1043, DOI 10.1016/j.biomaterials.2004.04.004
   Radin S, 2007, BIOMATERIALS, V28, P1721, DOI 10.1016/j.biomaterials.2006.11.035
   RICHARDS RG, 2006, INJURY, V37, pS113
   Romeo E, 2004, Minerva Stomatol, V53, P215
   Roos-Jansaker AM, 2003, J CLIN PERIODONTOL, V30, P467, DOI 10.1034/j.1600-051X.2003.00296.x
   Roos-Jansaker AM, 2007, J CLIN PERIODONTOL, V34, P625, DOI 10.1111/j.1600-051X.2007.01102.x
   ROSE L, 2004, PERIODONTICS MED SUR, P611
   Rosenberg ES, 2004, INT J ORAL MAX IMPL, V19, P873
   Saito N, 2005, ADV DRUG DELIVER REV, V57, P1037, DOI 10.1016/j.addr.2004.12.016
   Salvi GE, 2002, J CLIN PERIODONTOL, V29, P540, DOI 10.1034/j.1600-051X.2002.290611.x
   Sanz M, 1991, CLIN ORAL IMPLAN RES, V2, P128, DOI 10.1034/j.16000501.1991.020305.x
   Sato S, 2004, J PERIODONTOL, V75, P1269, DOI 10.1902/jop.2004.75.9.1269
   SBORDONE L, 1995, J PERIODONTOL, V66, P69, DOI 10.1902/jop.1995.66.1.69
   Sbordone L, 1999, J PERIODONTOL, V70, P1322, DOI 10.1902/jop.1999.70.11.1322
   Sbordone L, 2003, CLIN ORAL INVEST, V7, P181, DOI 10.1007/s00784-003-0236-1
   Schenk G, 1997, CLIN ORAL IMPLAN RES, V8, P427, DOI 10.1034/j.1600-0501.1997.080510.x
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   Schou S, 2004, INT J ORAL MAX IMPL, V19, P140
   Schwarz F, 2005, CLIN ORAL INVEST, V9, P111, DOI 10.1007/s00784-005-0305-8
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   SHARAWAY M, 1993, CONT IMPLANT DENT, P355
   Silverstein LH, 1994, IMPLANT DENT, V3, P170
   Siqueira JF, 2002, ORAL SURG ORAL MED O, V94, P281, DOI 10.1067/moe.2002.126163
   Snauwaert K, 2000, Clin Oral Investig, V4, P13, DOI 10.1007/s007840050107
   Sollazzo V, 2007, J CRANIOFAC SURG, V18, P806, DOI 10.1097/scs.0b013e3180a7728f
   Soskolne WA, 2003, J PERIODONTOL, V74, P420, DOI 10.1902/jop.2003.74.4.420
   Stigter M, 2002, BIOMATERIALS, V23, P4143, DOI 10.1016/S0142-9612(02)00157-6
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Suzuki Y, 1998, J BIOMED MATER RES, V42, P112, DOI 10.1002/(SICI)1097-4636(199810)42:1<112::AID-JBM14>3.0.CO;2-N
   Takanashi Kiyotoshi, 2004, Bull Tokyo Dent Coll, V45, P77, DOI 10.2209/tdcpublication.45.77
   ten Cate JM, 2006, ODONTOLOGY, V94, P1, DOI 10.1007/s10266-006-0063-3
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tonetti M S, 1999, Adv Dent Res, V13, P173
   Tonetti MS, 1998, PERIODONTOL 2000, V17, P55, DOI 10.1111/j.1600-0757.1998.tb00123.x
   VANHOUTE J, 1994, J DENT RES, V73, P672, DOI 10.1177/00220345940730031301
   Verran J, 2005, INT J ARTIF ORGANS, V28, P1138
   Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146
   Weyant R J, 1994, Int J Oral Maxillofac Implants, V9, P95
   WEYANT RJ, 1993, J DENT RES, V72, P2, DOI 10.1177/00220345930720010201
   Wikesjo UME, 2005, CLIN IMPLANT DENT R, V7, P112, DOI 10.1111/j.1708-8208.2005.tb00054.x
   Williams RC, 2001, J PERIODONTOL, V72, P1535, DOI 10.1902/jop.2001.72.11.1535
   Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05
   Wu-Yuan C D, 1995, J Oral Implantol, V21, P207
   Xu Ming-fang, 2006, J Zhejiang Univ Sci B, V7, P586, DOI 10.1631/jzus.2006.B0586
   Yang Y, 2006, JOM-US, V58, P71, DOI 10.1007/s11837-006-0146-1
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Zybutz MD, 2000, J CLIN PERIODONTOL, V27, P169, DOI 10.1034/j.1600-051x.2000.027003169.x
NR 190
TC 152
Z9 156
U1 4
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2009
VL 88B
IS 2
SI SI
BP 530
EP 543
DI 10.1002/jbm.b.31152
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 397TB
UT WOS:000262683900027
PM 18698626
OA Bronze
DA 2018-10-19
ER

PT J
AU Chopra, PM
   Johnson, M
   Nagy, TR
   Lemons, JE
AF Chopra, Preeti M.
   Johnson, Maria
   Nagy, Tim R.
   Lemons, Jack E.
TI Clinical Device-Related Article Micro-Computed Tomographic Analysis of
   Bone Healing Subsequent to Graft Placement
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE microCT; bone healing; TCP; gray level; threshold
ID TRABECULAR BONE; MORPHOMETRIC-ANALYSIS; CANCELLOUS BONE;
   MECHANICAL-PROPERTIES; IN-VIVO; ARCHITECTURE; BIOPSIES; SECTIONS; MODEL
AB A micro-computed tomographic (mu CT) analysis of bone healing subsequent to graft (tri calcium phosphate/TCP) placement in the maxillary sinus prior to dental endosteal implant placement was the focus of the current study. Ten trephined rod shaped human bone cores were obtained three months after the placement of particulate graft material. Using the mu CT, samples were evaluated at 6 and 20 pin resolutions. The images exhibited regions of different grey scale (GL) magnitudes for bone and graft allowing a differentiation and quantification of the two sample regions. The GL threshold magnitudes at 20 mu m resolution were determined to be less than 235 for organic and fluid, 235-450 for bone, 400-600 for bone and graft, and 600 and above for the graft material. The graft material was integrated with the bone showing the osteoconductivity of the TCP material, the mean bone volume was 25.50 (11.28) ranging from 5.66 to 37.9 and the mean graft volume was 0.42 (0.37) ranging from 0.01 to 1.17. The mean graft to bone volume ratio was 0.015 (0.01) with a range from 0.002 to 0.024. The structural data and observations from two- and three-dimensional images provided a valuable assessment of the graft distribution, its relation to modeling bone and also the anatomy of the healing bone. Thus this study demonstrated the capability to uniquely evaluate the status of healing bone associated with this TCP grafting biomaterial with opportunities for subsequent correlations with histomorphometrical studies and clinical outcomes of these type implant treatments. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 88B: 611-618, 2009
C1 [Chopra, Preeti M.; Lemons, Jack E.] Univ Alabama, Sch Dent, Dept Prosthodont, Birmingham, AL 35294 USA.
   [Johnson, Maria; Nagy, Tim R.] Univ Alabama, Dept Nutr Sci, Birmingham, AL 35294 USA.
RP Chopra, PM (reprint author), Univ Alabama, Sch Dent, Dept Prosthodont, Birmingham, AL 35294 USA.
EM preetimchopra@gmail.com
FU UAB Center for Metabolic Bone Disease [P30AR046031]
FX Contract grant sponsor: UAB Center for Metabolic Bone Disease; Contract
   grant number: P30AR046031
CR Borah B, 2000, J BONE MINER RES, V15, P1786, DOI 10.1359/jbmr.2000.15.9.1786
   Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   HABAL MB, 1994, CLIN PLAST SURG, V21, P525
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   JENSEN KS, 1990, BONE, V11, P417, DOI 10.1016/8756-3282(90)90137-N
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lu M, 2004, INT J ORAL MAX SURG, V33, P369, DOI 10.1016/j.ijom.2003.09.009
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Muller R, 1996, BONE, V18, P215, DOI 10.1016/8756-3282(95)00489-0
   ODGAARD A, 1994, BONE, V15, P335, DOI 10.1016/8756-3282(94)90297-6
   Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0
   Siffert RS, 1996, BONE, V18, P197, DOI 10.1016/8756-3282(95)00446-7
   SINGH I, 1978, J ANAT, V127, P305
   Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8
   van Loon CJM, 2000, J BONE JOINT SURG BR, V82B, P436, DOI 10.1302/0301-620X.82B3.9491
NR 17
TC 16
Z9 17
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2009
VL 88B
IS 2
BP 611
EP 618
DI 10.1002/jbm.b.31232
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 397TB
UT WOS:000262683900032
PM 18837447
DA 2018-10-19
ER

PT J
AU Mukesh, U
   Kulkarni, V
   Tushar, R
   Murthy, RSR
AF Mukesh, Ukawala
   Kulkarni, Vijay
   Tushar, Rajyaguru
   Murthy, R. S. R.
TI Methotrexate Loaded Self Stabilized Calcium Phosphate Nanoparticles: A
   Novel Inorganic Carrier for Intracellular Drug Delivery
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Calcium Phosphate; Methotrexate; Reverse Micelle; Hydroxyapatite;
   Intracellular Localization
ID HYDROXYAPATITE; ACID; NANOCRYSTALS; ADSORPTION
AB Calcium phosphate is considered as a potential biomaterial for drug and gene delivery because of its excellent features. In this study, we reported the formulation and characterization of calcium phosphate nanoparticle containing anticancer drug, methotrexate (MTX). Calcium phosphate nanoparticles containing MTX (CaPi-MTX) were prepared by reverse micelles technique. CaPi-MTX nanoparticles of average size 262 +/- 7.64 nm with entrapment efficiency of 58.04 +/- 4.09% were obtained. The IR spectrum of CaPi-MTX showed characteristics of composite formation of hydroxyapatite with MTX. X-RD analysis revealed that, CaPi-MTX nanoparticles were crystalline and in hydroxyapatite form. TEM studies showed that CaPi-MTX nanoparticles were spherical in shape. In vitro release study of CaPi-MTX nanoparticles showed slow release of MTX at physiological pH (pH 7.4) while >90% release was observed within 3-4 hours at endosomal pH (pH 5.5 and pH 6.0). Confocal microscopy was performed using CHO cell lines, showed intracellular localization of FITC-Dextran loaded calcium phosphate nanoparticles. Results indicate that prepared CaPi-MTX nanoparticles could serve the purpose for intracellular drug delivery.
C1 [Mukesh, Ukawala; Kulkarni, Vijay; Tushar, Rajyaguru; Murthy, R. S. R.] Fac Engn & Technol, TIFAC CORE NDDS, Dept Pharm, Fateh Gunj 390002, Vadodara, India.
RP Murthy, RSR (reprint author), Fac Engn & Technol, TIFAC CORE NDDS, Dept Pharm, GH Patel Bldg, Fateh Gunj 390002, Vadodara, India.
CR Al-Qasas NS, 2005, SEP SCI TECHNOL, V40, P3187, DOI 10.1080/01496390500385400
   Barroug A, 2004, J ORTHOPAED RES, V22, P703, DOI 10.1016/j.orthres.2003.10.016
   Bertoni E, 1999, J MATER CHEM, V9, P779, DOI 10.1039/a807890d
   Bigi A, 2004, J SOLID STATE CHEM, V177, P3092, DOI 10.1016/j.jssc.2004.05.018
   Bigi A, 2004, J MATER CHEM, V14, P274, DOI 10.1039/b308687a
   Boanini E, 2006, BIOMATERIALS, V27, P4428, DOI 10.1016/j.biomaterials.2006.04.019
   FILGUEIRASA MR, 2006, J CRYST GROWTH, V15, P60
   HARIVARDHAN L, 2005, AAPS PHARMSCITECH, V6, P158
   HARIVARDHAN L, 2006, PHARM DEV TECHNOL, V11, P167
   Harivardhan Reddy L., 2004, Biomedical Papers (Olomouc), V148, P161
   HARTLEY TS, 2004, CHEM MATER, V16, P4942
   *JOINT COMM POWD D, 1986, 9432 JOINT COMM POWD
   KANDORI K, 1995, COLLOID SURFACE A, V94, P225, DOI 10.1016/0927-7757(94)02969-5
   Kim SY, 2001, BIOMATERIALS, V22, P2049, DOI 10.1016/S0142-9612(00)00393-8
   Kingsley JD, 2006, J NEUROIMMUNE PHARM, V1, P340, DOI 10.1007/s11481-006-9032-4
   Koutsopoulos S, 2000, J CRYST GROWTH, V217, P410, DOI 10.1016/S0022-0248(00)00502-9
   Kulkarni Vijay I, 2006, Expert Opin Drug Deliv, V3, P235, DOI 10.1517/17425247.3.2.235
   Lai C, 2005, MATER LETT, V59, P210, DOI 10.1016/j.matlet.2004.08.037
   Liou SC, 2003, BIOMATERIALS, V24, P3981, DOI 10.1016/S0142-9612(03)00303-X
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Rautaray D, 2005, LANGMUIR, V21, P5185, DOI 10.1021/la048541f
   Roy I, 2003, INT J PHARM, V250, P25, DOI 10.1016/S0378-5173(02)00452-0
   Savita B., 2005, INT J PHARMACEUT, V288, P157
   Subramanian N., 2004, AAPS PHARMSCITECH, V5, P1
   Tse-Ying L, 2005, J CONTROL RELEASE, V107, P112
   Viktoriya V.S., 2006, BIOMATERIALS, V27, P3147
   Wang YJ, 2006, MATER LETT, V60, P3227, DOI 10.1016/j.matlet.2006.02.077
   YOSHINORI K, 2004, J CONTROL RELEASE, V97, P345
   YOUSSEF M, 1988, ANTIMICROB AGENTS CH, V32, P1204, DOI 10.1128/AAC.32.8.1204
   YUTAKA M, 2006, J CONTROL RELEASE, V110, P260
   ZHI PX, 2006, CHEM ENG SCI, V61, P1027
NR 31
TC 34
Z9 36
U1 1
U2 23
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD FEB
PY 2009
VL 5
IS 1
BP 99
EP 105
DI 10.1166/jbn.2009.026
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 411YF
UT WOS:000263689500011
PM 20055112
DA 2018-10-19
ER

PT J
AU Gunaydin, S
   Farsak, B
   Mccusker, K
   Vijay, V
   Sari, T
   Onur, MA
   Gurpinar, A
   Zorlutuna, Y
AF Gunaydin, Serdar
   Farsak, Bora
   Mccusker, Kevin
   Vijay, Venkataramana
   Sari, Tamer
   Onur, M. Ali
   Gurpinar, Aylin
   Zorlutuna, Yaman
TI Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded
   extracorporeal circuits with reduced versus full systemic
   anticoagulation in reoperation for coronary revascularization
SO JOURNAL OF CARDIOVASCULAR MEDICINE
LA English
DT Article
DE biocompatible; cardiopulmonary bypass; coated materials; coronary artery
   bypass; hyaluronan; oxygenator
ID COATED CARDIOPULMONARY BYPASS; DURAFLO-II; BLOOD; BIOCOMPATIBILITY;
   PERFORMANCE; SURFACE
AB Objective This prospective randomized study compares full and reduced heparinization on novel hyaluronan-based heparin-bonded circuits vs. uncoated controls under challenging clinical setting including biomaterial evaluation.
   Methods 100 patients undergoing reoperation for coronary artery bypass grafting were allocated into two equal groups (n = 50): Group one was treated with hyaluronan-based heparin bonded preconnected circuits (Vision HFOGBS, Gish, California, USA) and Group two with identical uncoated controls (Vision HFO, Gish, USA). In the study group, half of the patients (n = 25) received low-systemic heparin (125 IU/kg, ACT>250 s) or full dose like control group. Blood samples were collected after induction of anesthesia (T1) and heparin administration before cardiopulmonary bypass (CPB) (T2),15 min after initiation of CPB (T3), before cessation of CPB (T4),15 min after reversal with protamine (T5), and the first postoperative day at 08: 00 h (T6).
   Results Platelet counts were preserved significantly better at T5, T6 in hyaluronan groups (P<0.05 vs. control). Serum IL-2 levels were significantly lower at T4, T5 in both hyaluronan groups and C3a levels at T4 and T5 only in low-dose group (P<0.05). Troponin-T levels in coronary sinus blood demonstrated well preserved myocardium in hyaluronan groups. No significant differences in thrombin-antithrombin levels were observed between full and low-dose heparin groups at any time point. Amount of desorbed protein was 1.41 +/- 0.01 in full and 1.43 +/- 0.01 in low dose vs. 1.78 +/- 0.01 mg/dl in control (P<0.05).
   Conclusion Hyaluronan-based heparin-bonded circuits provided better clinical outcome and less inflammatory response compared with uncoated surfaces. Reduced systemic heparinization combined with hyaluronan-based heparin-bonded circuits is feasible and clinically well tolerated. J Cardiovasc Mad 10:135-142 (C) 2009 Italian Federation of Cardiology.
C1 [Gunaydin, Serdar] Kirikkale Univ, Kirikkale, Turkey.
   [Farsak, Bora; Onur, M. Ali; Gurpinar, Aylin] Hacettepe Univ, Ankara, Turkey.
   [Mccusker, Kevin] New York Med Coll, Brooklyn, NY USA.
   [Vijay, Venkataramana] State Univ Now York, Brooklyn, NY USA.
   [Sari, Tamer; Zorlutuna, Yaman] Bayindir Hosp, Ankara, Turkey.
RP Gunaydin, S (reprint author), Kirikkale Univ, Dept Cardiovasc Surg, Angora Evleri G-8 Bl 1, TR-06800 Ankara, Turkey.
EM sgunaydin@isnet.net.tr
RI ONUR, MEHMET/G-9137-2013
OI ONUR, MEHMET/0000-0002-3630-7982
CR Amrani M, 2007, J CARDIOVASC MED, V8, P89, DOI 10.2459/01.JCM.0000260213.76326.c5
   Andrew P, 2007, J CARDIOVASC MED, V8, P990, DOI 10.2459/JCM.0b013e32801411e5
   De Vroege R, 2005, ASAIO J, V51, P103, DOI 10.1097/01.MAT.0000151147.24915.49
   Gunaydin S, 2004, PERFUSION-UK, V19, pS33, DOI 10.1191/0267659104pf718oa
   Gunaydin S, 2002, ANN THORAC SURG, V74, P819, DOI 10.1016/S0003-4975(02)03796-7
   Gunaydin Serdar, 2004, Curr Med Chem Cardiovasc Hematol Agents, V2, P295, DOI 10.2174/1568016043356237
   Gunaydin Serdar, 2005, J Extra Corpor Technol, V37, P290
   Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   MARCUS AJ, 1994, SEMIN HEMATOL, V31, P261
   McCarthy PM, 1999, ANN THORAC SURG, V67, P1268, DOI 10.1016/S0003-4975(99)00136-8
   Ovrum E, 2003, J CARDIAC SURG, V18, P140, DOI 10.1046/j.1540-8191.2003.02007.x
   Ovrum E, 2001, J THORAC CARDIOV SUR, V121, P324, DOI 10.1067/mtc.2001.111205
   OVRUM E, 1995, CIRCULATION, V92, P2579
   Palatianos GM, 2003, ANN THORAC SURG, V76, P129, DOI 10.1016/S0003-4975(03)00338-2
   REPO H, 1993, J IMMUNOL METHODS, V164, P193, DOI 10.1016/0022-1759(93)90312-U
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Ulusoy AH, 2003, J BIOMAT SCI-POLYM E, V14, P1299, DOI 10.1163/156856203322553509
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P794, DOI 10.1016/S0022-5223(99)70301-6
NR 19
TC 5
Z9 6
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1558-2027
J9 J CARDIOVASC MED
JI J. Cardiovasc. Med.
PD FEB
PY 2009
VL 10
IS 2
BP 135
EP 142
DI 10.2459/JCM.0b013e32831eef9d
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 404AS
UT WOS:000263123700005
PM 19377380
DA 2018-10-19
ER

PT J
AU Shi, SK
   Chen, SY
   Zhang, X
   Shen, W
   Li, X
   Hu, WL
   Wang, HP
AF Shi, Shuaike
   Chen, Shiyan
   Zhang, Xiang
   Shen, Wei
   Li, Xin
   Hu, Weili
   Wang, Huaping
TI Biomimetic mineralization synthesis of calcium-deficient
   carbonate-containing hydroxyapatite in a three-dimensional network of
   bacterial cellulose
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE CaDHCAp/BC nanocomposite; biomimetic mineralization; bacterial
   cellulose; formation mechanism
ID SIMULATED BODY-FLUID; BIOMEDICAL APPLICATIONS; REACTION CHEMISTRY;
   ACETATE POLYMER; NANOPARTICLES; APATITE; CARBOXYMETHYLCELLULOSE;
   BIOCOMPATIBILITY; BIOSYNTHESIS; PHOSPHATE
AB BACKGROUND: Both hydroxyapatites (HAp) and bacterial cellulose (BC) are excellent biomaterials. The former has outstanding osteoconductivity and bioactivity, while the latter has been proven to be a remarkably versatile biomaterial. By alkaline treatment, Ca(2+) activation, and biomimetic mineralization, the nanocomposites (CaDHCAp/BC) consisting of calcium-deficient carbonate-containing hydroxyapatite (CaDHCAp) in the three-dimensional (3D) network of BC nanofibers were synthesized.
   RESULTS: The CaDHCAp/BC nanocomposites obtained were characterized by inductively coupled plasma atomic emission spectroscopy (ICP-AES), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and X-ray diffraction spectroscopy (XRD). The results indicated that alkaline treatment improved the apatite nucleation ability of BC, and the apatite crystals deposited along BC nanofibers were partially substituted with calcium carbonate and the uniform spherical apatite particles were composed of squama-shaped nano-sized apatite crystals. The crystallite sizes of apatite crystals are below 10 nm and the crystallinities are below 1 %. The formation mechanism of CaDHCAp crystals along the BC fibers was described.
   CONCLUSION: Alkaline treatment was introduced before the biomimetic mineralization process. Compared with the results without alkaline treatment, the mineralization efficiency was obviously improved. The nanocomposites obtained may have potential application as an orthopedic biomaterial. (C) 2008 Society of Chemical Industry
C1 [Shi, Shuaike; Chen, Shiyan; Zhang, Xiang; Shen, Wei; Li, Xin; Hu, Weili; Wang, Huaping] Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China.
RP Wang, HP (reprint author), Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China.
EM wanghp@dhu.edu.cn
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
FU School Fund, 111 Project [1307024]; New Century Excellent Talents in
   University [NCET-05-0420]; Shanghai Leading Academic Discipline [B603]
FX This work was financially supported by School Fund, 111 Project
   (1307024), New Century Excellent Talents in University (NCET-05-0420)
   and Shanghai Leading Academic Discipline Project (B603).
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Brown RM, 1996, TRENDS PLANT SCI, V1, P149
   BROWN RM, 1985, J CELL SCI, P13
   Cao LY, 2005, MATER LETT, V59, P1902, DOI 10.1016/j.matlet.2005.02.007
   Chen Y, 2008, J MATER SCI-MATER M, V19, P2261, DOI 10.1007/s10856-007-3335-8
   Choi YJ, 2004, J CHEM TECHNOL BIOT, V79, P79, DOI 10.1002/jctb.942
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Dumitrius S., 1996, POLYSACCHARIDES MED, P125
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   He JH, 2003, CHEM MATER, V15, P4401, DOI 10.1021/cm034720r
   HOFFMAN I, 2006, SURF COAT TECHOL, V201, P2392
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   JOHNSON DC, 1985, CELLULOSE CHEM ITS A
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   LEE JH, 1994, P NATL ACAD SCI USA, V91, P7425, DOI 10.1073/pnas.91.16.7425
   Lin JHC, 2001, J MATER SCI-MATER M, V12, P731, DOI 10.1023/A:1011280828663
   Martens WN, 2003, AM MINERAL, V88, P501, DOI 10.2138/am-2003-0404
   Mello LR, 1997, J NEUROSURG, V86, P143, DOI 10.3171/jns.1997.86.1.0143
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Nge TT, 2007, J BIOMED MATER RES A, V81A, P124, DOI 10.1002/jbm.a.31020
   Olaru N, 1998, J APPL POLYM SCI, V67, P481
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Risbud MV, 2001, J BIOMED MATER RES, V54, P436, DOI 10.1002/1097-4636(20010305)54:3<436::AID-JBM180>3.3.CO;2-#
   Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155
   Shim IW, 2002, B KOR CHEM SOC, V23, P563
   Shim IW, 2001, B KOR CHEM SOC, V22, P772
   Shukla A, 2002, J HAZARD MATER, V95, P137, DOI 10.1016/S0304-3894(02)00089-4
   Sosnik A, 2005, BIOMATERIALS, V26, P7425, DOI 10.1016/j.biomaterials.2005.05.086
   Tanaka H, 2007, MATER RES BULL, V42, P1364, DOI 10.1016/j.materresbull.2006.10.003
   Villalonga R, 2000, J MOL CATAL B-ENZYM, V10, P483, DOI 10.1016/S1381-1177(00)00003-5
   VOGT S, 1995, CARBOHYD RES, V266, P315, DOI 10.1016/0008-6215(94)00263-F
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wilson RM, 2004, BIOMATERIALS, V25, P2205, DOI 10.1016/j.biomaterials.2003.08.057
NR 36
TC 32
Z9 33
U1 2
U2 49
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0268-2575
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD FEB
PY 2009
VL 84
IS 2
BP 285
EP 290
DI 10.1002/jctb.2037
PG 6
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 399GT
UT WOS:000262789100020
DA 2018-10-19
ER

PT J
AU Wang, H
   Ma, L
   Yang, SH
   Shao, ZW
   Meng, CQ
   Duan, DY
   Li, YJ
AF Wang, Hong
   Ma, Liang
   Yang, Shuhua
   Shao, Zengwu
   Meng, Chunqing
   Duan, Deyu
   Li, Yanjun
TI Effect of RGD-modified Silk Material on the Adhesion and Proliferation
   of Bone Marrow-derived Mesenchymal Stem Cells
SO JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL
   SCIENCES
LA English
DT Article
DE RGD peptide; silk scaffold; mesenchymal stem cell; adhesion;
   proliferation
ID PEPTIDE; MATRIX; BIOMATERIALS; TENDON; ATTACHMENT; MIGRATION; POLYMERS;
   GROWTH
AB In order to investigate the effect of Arg-Gly-Asp (RGD) peptide-modified silk biomaterial on the adhesion and proliferation of bone marrow-derived mesenchymal stem cells (MSCs), MSCs of third generation were seeded onto the surface of RGD-decorated silk (silk-RGD group), silk alone (silk group) or tissue culture plate (TCP group). After incubation for 4 or 12 h, MSCs were examined quantitatively by using precipitation method for cell attachment. The cell proliferation, which was defined as cell density, was compared among the three groups after culture for 1, 2, 3, and 4 days. Cell skeleton, which was labeled fluorescently, was observed under laser confocal microscope after 24 h of culture. The results showed that cell adhesion rate in silk-RGD group was higher than in silk group (P<0.05), but similar to that in TCP group after incubation for 4 or 12 h (P>0.05). There were no significant differences in the cell proliferation among the three groups at different time points (P>0.05 for all). Laser confocal microscopy revealed that in silk-RGD group, MSCs, strongly fluorescently stained, spread fully, with stress fibers clearly seen, while in silk group, actin filaments were sparsely aligned and less stress fibers were found. It was concluded that RGD peptide could improve the adhesion of MSCs to the silk scaffold, but had no impact on the proliferation of the cells.
C1 [Wang, Hong; Ma, Liang; Yang, Shuhua; Shao, Zengwu; Meng, Chunqing; Duan, Deyu; Li, Yanjun] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
RP Wang, H (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
EM wanghwh@126.com
RI Shao, Zengwu/E-9301-2018
OI Shao, Zengwu/0000-0003-1616-8118
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Anderson K, 2001, AM J SPORT MED, V29, P689, DOI 10.1177/03635465010290060301
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Hoffmann A, 2006, REGEN MED, V1, P563, DOI 10.2217/17460751.1.4.563
   Horan RL, 2006, J BIOMECH, V39, P2232, DOI 10.1016/j.jbiomech.2005.07.007
   HUVENEERS S, 2007, INT J RADIAT BIOL, V14, P1
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Leo AJ, 2006, CELLS TISSUES ORGANS, V183, P112, DOI 10.1159/000095985
   Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Oliva IB, 2007, TOXICON, V50, P1053, DOI 10.1016/j.toxicon.2007.07.016
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Reches M, 2007, J NANOSCI NANOTECHNO, V7, P2239, DOI 10.1166/jnn.2007.645
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930
   Vitte J, 2005, CLIN HEMORHEOL MICRO, V33, P167
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zhao CH, 2003, BIOPOLYMERS, V69, P253, DOI 10.1002/bip.10350
NR 25
TC 12
Z9 16
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1672-0733
J9 J HUAZHONG U SCI-MED
JI J. Huazhong Univ. Sci. Tech.-Med.
PD FEB
PY 2009
VL 29
IS 1
BP 80
EP 83
DI 10.1007/s11596-009-0117-1
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 409MF
UT WOS:000263509100017
PM 19224169
DA 2018-10-19
ER

PT J
AU Nocca, D
   Aggarwal, R
   Deneve, E
   Picot, MC
   Sanders, G
   Pourquier, D
   Taillade, H
   Millat, B
   Gagner, M
   Fabre, JM
AF Nocca, David
   Aggarwal, Rajesh
   Deneve, Eric
   Picot, Marie Christine
   Sanders, Grant
   Pourquier, Didier
   Taillade, H.
   Millat, B.
   Gagner, Michel
   Fabre, J. M.
TI Use of Collagen Wrap from Bovine Origin for the Management of Colic
   Perforation. Preliminary Study in a Pig Model
SO JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES
LA English
DT Article
ID INTESTINAL ANASTOMOSES; COLONIC ANASTOMOSIS; FIBRIN SEALANT;
   REINFORCEMENT; PATCHES; WALL; MESH
AB Introduction: The prevention or the management of digestive fistulae may be performed by using an external wrap of collagen of animal origin. To evaluate this treatment, an experimental study creating a hole in the colon of pig covered by a resorbable collagen belt was performed. Results are very interesting and collagen wrap is very well tolerated by the colon wall.
   Background: Digestive perforations, whether colorectal, jejunal, esophageal, or biliodigestive, are common emergency situations and can threaten the patient's condition or extend their hospital stay. The evolution of biomaterials of animal origin, and the biocompatibility proven after some human surgical procedures, have led our team to propose an experimental study in a pig model to treat colic perforation by positioning a resorbable bilayer collagen band of bovine origin over the area of an experimental hole.
   Materials/Methods: A first group of 10 pigs was operated upon, and a 1 cm(2) hole was experimentally created in the distal part of the colon. Then, a belt of resorbable collagen sponge joined to a collagen film, from bovine origin, was placed and fixed around the outer part of the colon to cover the fistula without closing the hole by sutures. After an average of two weeks, all the animals were sacrificed. The abdominal cavity was examined in a macroscopic and microscopic manner. A second group of 10 pigs was tested under a different protocol to assess the efficiency of the bowel wrap prosthesis in a septic field.
   Results: In the first group of pigs, there were no complications during the procedures. The mortality rate was zero during this period. No pig was operated on urgently to manage an acute complication. The complication rate was 10% due to one wound infection. The macroscopic examinations of the explanted colon articles didn't find any stricture under the prosthesis location for the 10 pigs. Local smooth adhesions were noted in 7 pigs (70%). Among the second group of pigs, the mortality rate was 10% due to a myocardial infarction during the period of peritonitis. No pig was operated on urgently to manage an acute complication. The complication rate was 20% due to 2 wound infections. The macroscopic examination of the explanted colon articles found one case of stricture under the prosthesis location (10%). Local smooth adhesions were noted in 7 pigs (70%). No histologic rejection was noted during the anatomopathologic tests for all pigs.
   Conclusion: The use of bovine collagen bilayer prosthesis in digestive surgery may prove to be safe and effective to treat digestive leakage. It may be feasible to use this type of biomaterial to prevent fistula of the digestive tract, including anastomotic. A prospective trial would need to be performed to complete this research to give the surgeons an opportunity to improve treatment in many digestive procedures.
C1 [Nocca, David; Deneve, Eric; Picot, Marie Christine; Sanders, Grant; Taillade, H.; Millat, B.; Fabre, J. M.] Univ Hosp Ctr Montpellier, Fac Med, Montpellier, France.
   [Aggarwal, Rajesh] Univ London Imperial Coll Sci Technol & Med, Dept Surg Oncol & Technol, London, England.
   [Pourquier, Didier] Canc Inst Val dAurelle Paul Lamarque, Montpellier, France.
   [Gagner, Michel] Cornell Univ, Weill Coll Med, New York Presbyterian Hosp, Miami, FL USA.
RP Nocca, D (reprint author), 368 Rue Jeu Mail Abbes, F-34000 Montpellier, France.
EM d.nocca@wanadoo.fr
CR ADAMS W, 1992, DIS COLON RECTUM, V35, P731, DOI 10.1007/BF02050320
   Arunkalaivanan AS, 2003, INT UROGYNECOL J, V14, P17, DOI 10.1007/s00192-002-1000-9
   Arunkalaivanan AS, 2003, INT UROGYNECOL J PEL, V14, P21
   Astarcioglu H, 2001, AM J SURG, V181, P309, DOI 10.1016/S0002-9610(01)00586-4
   Buch N, 2002, EUR J SURG, V168, P165, DOI 10.1080/110241502320127784
   CUILLERET J, 1991, J CHIR-PARIS, V128, P351
   HENNEBRUNS D, 1990, EUR SURG RES, V22, P224, DOI 10.1159/000129105
   JANSSON OK, 1991, DIS COLON RECTUM, V34, P557, DOI 10.1007/BF02049894
   Mutter D, 1997, EUR J SURG, V163, P287
   Oh DS, 2002, ANN SURG, V235, P708, DOI 10.1097/00000658-200205000-00013
   Oh DS, 2002, ANN SURG, V235, P711
   RABOFF W, 1994, AM SURGEON, V60, P721
   Rosen M, 2002, SURGERY, V132, P480, DOI 10.1067/msy.2002.126505
   Saez LAG, 2003, EUR SURG RES, V35, P372, DOI 10.1159/000070609
   Stammberger U, 2000, ANN THORAC SURG, V70, P1820, DOI 10.1016/S0003-4975(00)01903-2
   Tebala GD, 1995, SURG TODAY, V25, P1069, DOI 10.1007/BF00311697
   VANDERHAM AC, 1992, DIS COLON RECTUM, V35, P884, DOI 10.1007/BF02047878
   VANDERHAM AC, 1991, BRIT J SURG, V78, P49, DOI 10.1002/bjs.1800780117
   VANDERHAM AC, 1993, EUR J SURG, V159, P425
NR 19
TC 2
Z9 2
U1 1
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1092-6429
J9 J LAPAROENDOSC ADV S
JI J. Laparoendosc. Adv. Surg. Tech.
PD FEB
PY 2009
VL 19
IS 1
BP 79
EP 83
DI 10.1089/lap.2008.0028
PG 5
WC Surgery
SC Surgery
GA 409JT
UT WOS:000263502700019
PM 19196092
DA 2018-10-19
ER

PT J
AU Sandberg, T
   Carlsson, J
   Ott, MK
AF Sandberg, Tomas
   Carlsson, Jan
   Ott, Marjam Karlsson
TI Interactions between human neutrophils and mucin-coated surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GASTRIC MUCIN; VISCOELASTIC PROPERTIES; RESPIRATORY BURST; SALIVARY
   MUCIN; CELL-SURFACE; QCM-D; SERUM; PH; AGGREGATION; ADSORPTION
AB Recently, we showed microscopically that bovine (BSM), porcine (PGM) and human (MG1) mucin coatings could suppress the adhesion of neutrophils to a polyethylene terephthalate-based model biomaterial (Thermanox). Here, using the release of reactive oxygen species (ROS) as a marker of material-induced neutrophil activation, the strong surface-passivating effects of these mucin coatings were corroborated. Under optimal adsorption conditions, all mucin species performed equally well, thus indicating a high degree of functional homology between the mucins. Cell adhesion and morphology correlated well with the release of ROS. Quartz crystal microbalance (QCM-D) analysis linked low neutrophil activation to efficient mucin surface-shielding. Interestingly, the shielding power appeared equal for thick expanded and thin compact mucin coatings. Combined mucin-serum coatings were found to be highly surface-passivating. Particularly, since our data suggested partly synergistic mucin-serum action, we highlight the possibility that pre-adsorbed mucins could provide favorable support for adsorbing host components.
C1 [Sandberg, Tomas; Carlsson, Jan; Ott, Marjam Karlsson] Uppsala Univ, Div Surface Biotechnol, Dept Phys & Analyt Chem, BMC, S-75123 Uppsala, Sweden.
RP Sandberg, T (reprint author), Uppsala Univ, Div Surface Biotechnol, Dept Phys & Analyt Chem, BMC, S-75123 Uppsala, Sweden.
EM tomas.sandberg@ytbioteknik.uu.se
CR Aknin MLR, 2004, CELL TISSUE RES, V318, P545, DOI 10.1007/s00441-004-0957-8
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001
   Bromberg LE, 2000, BIOMACROMOLECULES, V1, P325, DOI 10.1021/bm005532m
   Cao XX, 1999, BIOPHYS J, V76, P1250, DOI 10.1016/S0006-3495(99)77288-7
   Cooper S. L., 2004, BIOMATERIALS SCI, P67
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   DOUMAS BT, 1975, CLIN CHEM, V21, P1159
   Feiler AA, 2007, J COLLOID INTERF SCI, V315, P475, DOI 10.1016/j.jcis.2007.07.029
   Fischer BM, 2002, AM J RESP CELL MOL, V26, P447, DOI 10.1165/ajrcmb.26.4.4473
   HAKANSSON L, 1980, SCAND J IMMUNOL, V11, P271, DOI 10.1111/j.1365-3083.1980.tb00235.x
   Hanson S., 2004, BIOMATERIALS SCI INT, P332
   Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659
   HOFFMAN AS, 2004, BIOMATERIALS SCI INT, P225
   Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251
   Hong ZN, 2005, BIOMACROMOLECULES, V6, P3458, DOI 10.1021/bm0505843
   HOROR F, 1998, LANGMUIR, V14, P729
   Johnson R.J., 2004, BIOMATERIALS SCI INT, P318
   Kao JM, 1999, J BIOMED MATER RES, V47, P537, DOI 10.1002/(SICI)1097-4636(19991215)47:4<537::AID-JBM10>3.0.CO;2-I
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   KLINKEN BJW, 1995, AM J PHYSIOL, V269, pG613
   Lee S, 2005, LANGMUIR, V21, P8344, DOI 10.1021/la050779w
   Lindh L, 2007, J COLLOID INTERF SCI, V310, P74, DOI 10.1016/j.jcis.2007.01.086
   Mitchell R.N., 2004, BIOMATERIALS SCI, P304
   Nygren H, 2001, COLLOID SURFACE B, V22, P87, DOI 10.1016/S0927-7765(00)00216-2
   O'Boyle KP, 2000, SCAND J IMMUNOL, V52, P46
   Perez-Vilar J, 2004, ENCY BIOL CHEM, P758
   Prakobphol A, 1999, BIOCHEMISTRY-US, V38, P6817, DOI 10.1021/bi990145m
   SANDBERG T, J COLLOID INTE UNPUB
   Sandberg T, 2007, MICROSC RES TECHNIQ, V70, P864, DOI 10.1002/jemt.20489
   Sandberg T, 2009, J BIOMED MATER RES A, V91A, P762, DOI 10.1002/jbm.a.32266
   Shi L, 2000, TRENDS GLYCOSCI GLYC, V12, P229, DOI 10.4052/tigg.12.229
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Tammelin T, 2004, LANGMUIR, V20, P10900, DOI 10.1021/la0487693
   Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702
   Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
NR 38
TC 13
Z9 13
U1 1
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2009
VL 20
IS 2
BP 621
EP 631
DI 10.1007/s10856-008-3595-y
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403DR
UT WOS:000263063300025
PM 18925363
DA 2018-10-19
ER

PT J
AU Shapira-Schweitzer, K
   Habib, M
   Gepstein, L
   Seliktar, D
AF Shapira-Schweitzer, Keren
   Habib, Manhal
   Gepstein, Lior
   Seliktar, Dror
TI A photopolymerizable hydrogel for 3-D culture of human embryonic stem
   cell-derived cardiomyocytes and rat neonatal cardiac cells
SO JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
LA English
DT Article
DE Cardiac tissue engineering; Fibrin; Poly(ethylene glycol); Contraction;
   Myocardial infarction
ID MYOCARDIAL-INFARCTION; HEART-MUSCLE; TISSUE; MATRIX; FIBRINOGEN;
   SCAFFOLDS; SURVIVAL; REPAIR; DIFFERENTIATION; TRANSPLANTATION
AB The purpose of this study was to assess the in vitro ability of two types of cardiomyocytes (cardiomyocytes derived from human embryonic stem cells (hESC-CM) and rat neonatal cardiomyocytes (rN-CM)) to survive and generate a functional cardiac syncytium in a three-dimensional in situ polymerizable hydrogel environment. Each cell type was cultured in a PEGylated fibrinogen (PF) hydrogel for up to two weeks while maturation and cardiac function were documented in terms of spontaneous contractile behavior and biomolecular organization. Quantitative contractile parameters including contraction amplitude and synchronization were measured by non-invasive image analysis. The rN-CM demonstrated the fastest maturation and the most significant spontaneous contraction, The hESC-CM maturation occurred between 10-14 days in Culture, and exhibited less contraction amplitude and synchronization in comparison to the rN-CMs. The maturation of both cell types within the hydrogels was confirmed by cardiac-specific biomolecular markers, including alpha-sarcomeric actin, actinin, and connexin-43. Cellular responsiveness to isoproterenol, carbamylcholine and heptanol provided further evidence of the cardiac maturation in the 3-D PF hydrogel as well as identified a potential to use this system for in vitro drug screening. These findings indicate that the PF hydrogel biomaterial can be used as an in situ polymerizable biomaterial for stem cells and their cardiomyocyte derivatives. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Shapira-Schweitzer, Keren; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Habib, Manhal; Gepstein, Lior] Technion Israel Inst Technol, Fac Med, IL-32000 Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
RI Gepstein, Lior/H-9458-2012
OI Seliktar, Dror/0000-0001-6964-8567
FU Israel Science Foundation [1140/04]
FX The authors gratefully acknowledge the financial support of the Israel
   Science Foundation (grant no. 1140/04).
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Atkins BZ, 1999, J SURG RES, V85, P234, DOI 10.1006/jsre.1999.5681
   BETTIOL E, 2007, REV PHYSL BIOCH PHAR, V160, P1
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Dorfman J, 1998, J THORAC CARDIOV SUR, V116, P744, DOI 10.1016/S0022-5223(98)00451-6
   Eschenhagen T, 1997, FASEB J, V11, P683
   Eschenhagen T, 2002, TRANSPL IMMUNOL, V9, P315, DOI 10.1016/S0966-3274(02)00011-4
   Field LJ, 2004, ANN NY ACAD SCI, V1015, P160, DOI 10.1196/annals.1302.013
   Gonen-Wadmany M, 2004, ANN NY ACAD SCI, V1015, P299, DOI 10.1196/annals.1302.025
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   Hayashi T, 2004, J BIOMED MATER RES B, V71B, P367, DOI 10.1002/jbm.b.30099
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Huang YC, 2007, J BIOMED MATER RES A, V80A, P719, DOI 10.1002/jbm.a.31090
   Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Kofidis T, 2005, CIRCULATION, V112, P1173
   Leo AJ, 2006, CELLS TISSUES ORGANS, V183, P112, DOI 10.1159/000095985
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2004, ANN NY ACAD SCI, V1015, P312, DOI 10.1196/annals.1302.026
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Naito H, 2006, CIRCULATION, V114, P172, DOI DOI 10.1161/CIRCULATIONAHA.105.001560
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193
   Reinlib L, 2000, CIRCULATION, V101, pE182
   ROBINSON KA, 2005, CIRCULATION, V112, P1135
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Siepe M, 2007, ARTIF ORGANS, V31, P425, DOI 10.1111/j.1525-1594.2007.00385.x
   Suzuki K, 2004, CIRCULATION S1, V110, DOI DOI 10.1161/01.CIR.0000138388.55416.06
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
NR 44
TC 50
Z9 52
U1 0
U2 14
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2828
EI 1095-8584
J9 J MOL CELL CARDIOL
JI J. Mol. Cell. Cardiol.
PD FEB
PY 2009
VL 46
IS 2
BP 213
EP 224
DI 10.1016/j.yjmcc.2008.10.018
PG 12
WC Cardiac & Cardiovascular Systems; Cell Biology
SC Cardiovascular System & Cardiology; Cell Biology
GA 398BY
UT WOS:000262707500013
PM 19027751
DA 2018-10-19
ER

PT J
AU Kim, J
   Lee, J
   Kwon, S
   Jeong, S
AF Kim, Jonghoon
   Lee, Jungeun
   Kwon, Soonchul
   Jeong, Sunghoon
TI Preparation of Biodegradable Polymer/Silver Nanoparticles Composite and
   Its Antibacterial Efficacy
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Nanoscience and Technology
CY JUN 04-06, 2007
CL Beijing, PEOPLES R CHINA
SP Natl Steering Comm Nanotechnol, Natl Ctr Nanosci Technol, Minist Sci & Technol China, Natl Nat Sci Fdn China, Minist Educ China, Chinese Acad Sci, China Assoc Sci & Technol
DE Silver Nanoparticles; Electrospinning; Antibacterial Efficacy
ID SILVER NANOPARTICLES; FIBERS; NANOFIBERS
AB Biodegradable poly(ethylene oxide) nanofibers containing silver nanoparticles were successfully prepared by the electrospinning without the further reduction process which could cause the damages of nanofibers. Transmission electron microscopy showed that the silver nanoparticles were dispersed in poly(ethylene oxide) nanofibers without aggregation. This facile process would be the effective method to prepare the silver nanoparticles/polymer nanocomposites. Moreover, the silver nanoparticles embedded in the poly(ethylene oxide) nanofibers were responsible for the antibacterial activities against Staphylococcus aureus and Klebsiella pneumoniae, respectively. Therefore, it is expected that the silver nanoparticles/poly(ethylene oxide) nanocomposites can be used for practical applications as the biomaterial.
C1 [Kim, Jonghoon; Lee, Jungeun; Kwon, Soonchul; Jeong, Sunghoon] Hanyang Univ, Coll Engn, Dept Fiber & Polymer Engn, Seoul 133791, South Korea.
RP Jeong, S (reprint author), Hanyang Univ, Coll Engn, Dept Fiber & Polymer Engn, 17 Haengdang Dong, Seoul 133791, South Korea.
CR Hong KH, 2006, J POLYM SCI POL PHYS, V44, P2468, DOI 10.1002/polb.20913
   Jeong SH, 2005, J MATER SCI, V40, P5407, DOI 10.1007/s10853-005-4339-8
   Lee HK, 2005, MATER LETT, V59, P2977, DOI 10.1016/j.matlet.2005.05.005
   Li ZY, 2006, NANOTECHNOLOGY, V17, P917, DOI 10.1088/0957-4484/17/3/050
   Lu JW, 2006, POLYMER, V47, P8026, DOI 10.1016/j.polymer.2006.09.027
   Lu XF, 2005, NANOTECHNOLOGY, V16, P2233, DOI 10.1088/0957-4484/16/10/043
   Shang TC, 2006, SMALL, V2, P1007, DOI 10.1002/smll.200500533
   Son WK, 2004, MACROMOL RAPID COMM, V25, P1632, DOI 10.1002/marc.200400323
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Wang YZ, 2006, NANOTECHNOLOGY, V17, P3304, DOI 10.1088/0957-4484/17/13/037
   Wang YZ, 2005, MATER LETT, V59, P3046, DOI 10.1016/j.matlet.2005.05.016
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   Yang BD, 2004, MATER CHEM PHYS, V83, P334, DOI 10.1016/j.matchemphys.2003.10.003
   Yang QB, 2003, SYNTHETIC MET, V137, P973, DOI 10.1016/S0379-6779(02)00963-3
NR 14
TC 26
Z9 26
U1 0
U2 11
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD FEB
PY 2009
VL 9
IS 2
BP 1098
EP 1102
DI 10.1166/jnn.2009.C096
PG 5
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 411MI
UT WOS:000263653300096
PM 19441464
DA 2018-10-19
ER

PT J
AU Catros, S
   Zwetyenga, N
   Bareille, R
   Brouillaud, B
   Renard, M
   Amedee, J
   Fricain, JC
AF Catros, Sylvain
   Zwetyenga, Narcisse
   Bareille, Reine
   Brouillaud, Brigitte
   Renard, Martine
   Amedee, Joelle
   Fricain, Jean-Christophe
TI Subcutaneous-Induced Membranes Have No Osteoinductive Effect on
   Macroporous HA-TCP In Vivo
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE induced membranes; osteoinduction; calcium phosphate
ID BONE REGENERATION; RECONSTRUCTION; PHOSPHATE; DEFECTS; MUSCLES; SHEEP
AB Induced Membranes Technique was first described to enhance bone reconstruction of large osseous defects. Previous in vitro studies established their osteoinductive potential, due to the presence of opteoblasts precursors and to high amounts of growth factors contained within. The purpose of this study was to test. in vivo the osteoinductive properties of induced membranes on a macroporous HA-TCP in a nonosseous subcutaneous site. Subcutaneous-induced membranes were obtained in 21 rabbits; 1 month later, the membranes were filled with a biphasic calcium phosphate material composed of 75% hydroxyapatite (HA) and 25% beta-tricalcium phosphate associated or not with autograft. Histological and immunohistochemical studies were performed on membrane biopsies. Undecalcified and decalcified sections were qualitatively and quantitatively analyzed. (45)Ca uptake was observed and quantified on the sections using microimager analysis. Dense vascularity was found in the induced membranes. New bone formation was detected in the HA-TCP + autograft samples and increased significantly from 3 to 6 months (p < 0.05). No bone was detected in the biomaterial graft alone; in the induced membranes at any time. This study showed that induced membranes placed in a nonosseous site have no osteoinductive properties on a macroporous biphasic calcium phosphate biomaterial. 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:155-161, 2009
C1 [Catros, Sylvain; Zwetyenga, Narcisse; Bareille, Reine; Brouillaud, Brigitte; Renard, Martine; Amedee, Joelle; Fricain, Jean-Christophe] INSERM, U577, F-33076 Bordeaux, France.
   [Catros, Sylvain; Zwetyenga, Narcisse; Bareille, Reine; Brouillaud, Brigitte; Renard, Martine; Amedee, Joelle; Fricain, Jean-Christophe] Univ Bordeaux 2, UMR 577, F-33076 Bordeaux, France.
   [Renard, Martine] CIC IT Biomat PTIB, F-33604 Pessac, France.
RP Catros, S (reprint author), INSERM, U577, F-33076 Bordeaux, France.
EM sylvaincatros@hotmail.com
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013
FU La fondation des gueules cassees; La fondation de I'avenir
FX The authors thank La fondation des gueules cassees and La fondation de
   I'avenir for financial support, and B. Pippenger for language
   corrections.
CR Barthe N, 2004, NUCL INSTRUM METH A, V527, P41, DOI 10.1016/j.nima.2004.03.014
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Duan YR, 2005, J MATER SCI-MATER M, V16, P795, DOI 10.1007/s10856-005-3577-2
   Goodger NM, 2005, J ORAL MAXIL SURG, V63, P1048, DOI 10.1016/j.joms.2005.03.024
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   HIDALGO DA, 1989, PLAST RECONSTR SURG, V84, P71, DOI 10.1097/00006534-198907000-00014
   ILIZAROV GA, 1988, B HOSP JOINT DIS ORT, V48, P1
   Kleinheinz J, 2005, J ORAL MAXIL SURG, V63, P1310, DOI 10.1016/j.joms.2005.05.303
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   Le Nihouannen D, 2008, J MATER SCI-MATER M, V19, P667, DOI 10.1007/s10856-007-3206-3
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   MARX RE, 1988, J ORAL MAXIL SURG, V46, P196, DOI 10.1016/0278-2391(88)90083-3
   Masquelet A C, 2000, Ann Chir Plast Esthet, V45, P346
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pelissier P, 2004, J ORTHOPAED RES, V22, P73, DOI 10.1016/S0736-0266(03)00165-7
   Pelissier P, 2002, BRIT J PLAST SURG, V55, P596, DOI 10.1054/bjps.2002.3936
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pothuaud L, 2005, BIOMATERIALS, V26, P6788, DOI 10.1016/j.biomaterials.2005.04.002
   Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024
   Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x
   Viateau V, 2007, J ORTHOP RES, V25, P741, DOI 10.1002/jor.20352
   WOLF E, 1992, VIRCHOWS ARCH A, V420, P17, DOI 10.1007/BF01605979
NR 22
TC 21
Z9 25
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD FEB
PY 2009
VL 27
IS 2
BP 155
EP 161
DI 10.1002/jor.20738
PG 7
WC Orthopedics
SC Orthopedics
GA 395OL
UT WOS:000262533300003
PM 18683892
DA 2018-10-19
ER

PT J
AU Trombelli, L
   Farina, R
   Franceschetti, G
   Calura, G
AF Trombelli, Leonardo
   Farina, Roberto
   Franceschetti, Giovanni
   Calura, Giorgio
TI Single-Flap Approach With Buccal Access in Periodontal Reconstructive
   Procedures
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Case series; periodontitis; reconstructive surgery; surgical flaps
ID INVASIVE SURGICAL TECHNIQUE; INTRA-BONY DEFECTS; PAPILLA PRESERVATION
   TECHNIQUE; GUIDED TISSUE REGENERATION; ENAMEL MATRIX PROTEINS;
   MICROVASCULAR RESPONSE; CLINICAL-OUTCOMES; HEALING RESPONSE; SURGERY;
   MORBIDITY
AB Background: New surgical techniques have been developed to optimize primary closure as well as to minimize the surgical trauma in the reconstructive procedures of periodontal intraosseous defects. Recently, we proposed a minimally invasive procedure, the single-flap approach (SFA), specifically indicated when the defect extension is prevalent on the buccal or oral side. The basic principle of the SFA is the elevation of a flap to access the defect only on one side (buccal or oral), leaving the opposite side intact. The present case series reports preliminary data on the clinical effectiveness of SFA with buccal access in conjunction with a collagen membrane and a hydroxyapatite (HA)-based biomaterial in the reconstructive treatment of deep periodontal intraosseous defects.
   Methods: Ten intraosseous defects in 10 patients were accessed with a buccal SFA and treated with a collagen membrane and an HA-based graft biomaterial. The follow-up period following the regenerative procedure ranged from 6 to 74 months (mean: 10.0 +/- 3.0 months).
   Results: Clinical attachment level (CAL) decreased from 17.2 +/- 2.6 mm presurgery to 6.4 +/- 7.9 mm post-surgery. Probing depth was 9.0 +/- 2.8 mm before surgery and 3.8 +/- 7.5 mm post-surgery. Gingival recession increased from 2.2 +/- 1.9 mm presurgery to 2.6 +/- 1.3 mm post-surgery.
   Conclusions: Challenging intraosseous defects, surgically accessed with a buccal SFA and treated with a combined graft/guided tissue regeneration technique, may heal with a substantial CAL gain. Limited postsurgical recession indicates that SFA may represent a suitable option to surgically treat defects in areas with high esthetic demands. J Periodontol 2009;80:353-360.
C1 [Trombelli, Leonardo; Farina, Roberto; Franceschetti, Giovanni; Calura, Giorgio] Univ Ferrara, Res Ctr Study Periodontal Dis, I-44100 Ferrara, Italy.
RP Trombelli, L (reprint author), Univ Ferrara, Res Ctr Study Periodontal Dis, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM leonardo.trombelli@unife.it
RI Franceschetti, Giovanni/J-1527-2015; Farina, Roberto/D-6561-2015;
   Trombelli, Leonardo/I-4671-2015; Calura, Giorgio/J-3925-2015
OI Franceschetti, Giovanni/0000-0002-0326-8999; Farina,
   Roberto/0000-0002-4621-7809; Trombelli, Leonardo/0000-0002-1147-2199;
   Calura, Giorgio/0000-0002-8042-5767
FU Research Center for the Study of Periodontal Diseases, University of
   Ferrara; GABA International, Munchenstein, Switzerland; University of
   Ferrara
FX This study was supported by the Research Center for the Study of
   Periodontal Diseases, University of Ferrara; GABA International,
   Munchenstein, Switzerland; and a grant from the University of Ferrara.
   The authors report no conflicts of interest related to this case series.
CR Becker W, 1988, Int J Periodontics Restorative Dent, V8, P8
   Benque E, 1997, J CLIN PERIODONTOL, V24, P550, DOI 10.1111/j.1600-051X.1997.tb00228.x
   Binderman I, 2001, J PERIODONTOL, V72, P1348, DOI 10.1902/jop.2001.72.10.1348
   Burkhardt R, 2005, J CLIN PERIODONTOL, V32, P287, DOI 10.1111/j.1600-051X.2005.00660.x
   Cortellini P, 1999, INT J PERIODONT REST, V19, P589
   Cortellini P, 2001, J PERIODONTOL, V72, P559, DOI 10.1902/jop.2001.72.4.559
   CORTELLINI P, 1995, J PERIODONTOL, V66, P261, DOI 10.1902/jop.1995.66.4.261
   Cortellini P, 2008, J CLIN PERIODONTOL, V35, P605, DOI 10.1111/j.1600-051X.2008.01242.x
   Cortellini P, 2007, J CLIN PERIODONTOL, V34, P1082, DOI 10.1111/j.1600-051X.2007.01144.x
   Cortellini P, 2007, J CLIN PERIODONTOL, V34, P87, DOI 10.1111/j.1600-051X.2006.01020.x
   Harrel SK, 2005, J PERIODONTOL, V76, P380, DOI 10.1902/jop.2005.76.3.380
   Harrel SK, 1999, J PERIODONTOL, V70, P1547, DOI 10.1902/jop.1999.70.12.1547
   Harrel SK, 1999, J PERIODONTOL, V70, P1558, DOI 10.1902/jop.1999.70.12.1558
   Kilic AR, 1997, J CLIN PERIODONTOL, V24, P372, DOI 10.1111/j.1600-051X.1997.tb00200.x
   Michaelides PL, 1996, INT J PERIODONT REST, V16, P389
   Murphy KG, 1996, INT J PERIODONT REST, V16, P463
   Nobuto T, 2005, J PERIODONTOL, V76, P1346, DOI 10.1902/jop.2005.76.8.1346
   Nobuto T, 2003, J PERIODONTOL, V74, P521, DOI 10.1902/jop.2003.74.4.521
   OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38
   PAPAPANOU PN, 1988, J CLIN PERIODONTOL, V15, P469, DOI 10.1111/j.1600-051X.1988.tb01602.x
   Santarelli G, 1996, INT J PERIODONT REST, V16, P69
   SELVIG KA, 1993, J PERIODONTOL, V64, P730, DOI 10.1902/jop.1993.64.8.730
   TAKEI HH, 1985, J PERIODONTOL, V56, P204, DOI 10.1902/jop.1985.56.4.204
   TAL H, 1984, J PERIODONTOL, V55, P149, DOI 10.1902/jop.1984.55.3.149
   Tonetti MS, 2002, J CLIN PERIODONTOL, V29, P317, DOI 10.1034/j.1600-051X.2002.290407.x
   TONETTI MS, 1993, J PERIODONTOL, V64, P934, DOI 10.1902/jop.1993.64.10.934
   Trombelli L, 1997, J CLIN PERIODONTOL, V24, P366, DOI 10.1111/j.1600-051X.1997.tb00199.x
   Trombelli L, 2007, DENT CADMOS, V8, P15
NR 28
TC 37
Z9 38
U1 0
U2 5
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD FEB
PY 2009
VL 80
IS 2
BP 353
EP 360
DI 10.1902/jop.2009.080420
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 406QQ
UT WOS:000263310400023
PM 19186978
DA 2018-10-19
ER

PT J
AU Chiang, HS
   Jiang, CC
AF Chiang, Hongsen
   Jiang, Ching-Chuan
TI Repair of Articular Cartilage Defects: Review and Perspectives
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Review
DE cartilage repair
ID MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERED CARTILAGE; FULL-THICKNESS
   DEFECTS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; AUTOGENOUS PERIOSTEAL
   GRAFTS; CONTINUOUS PASSIVE MOTION; DIFFERENTIATION IN-VITRO; MARROW
   STROMAL CELLS; LONG-TERM CULTURE; 5-YEAR FOLLOW-UP
AB Articular cartilage defects heal poorly and lead to catastrophic degenerative arthritis. Clinical experience has indicated that no existing medication substantially promotes the healing process and the cartilage defect requires surgical replacement, preferably with an autograft. However, there is a shortage of articular cartilage that can be donated for autografting. A review of previous unsuccessful experiences reveals the reason for the current strategy to graft cartilage defects with regenerated cartilage. Autologous cartilage regeneration is a cell-based therapy in which autogenous chondrocytes or other chondrogenic cells are cultured to constitute cartilaginous tissue according to the principles of tissue engineering. Current studies are concentrating on improving such techniques from the three elements of tissue engineering, namely the cells, biomaterial scaffolds, and culture conditions. Some models of articular cartilage regeneration have yielded good repair of cartilage defects, in animal models and clinical settings, but the overall results suggest that there is room for improvement of this technique before its routine clinical application. Autologous cartilage regeneration remains the mainstay for repairing articular cartilage defects but more studies are required to optimize the efficacy of regeneration. A more abundant supply of more stable cells, i.e. capable of maintaining the phenotype of chondrogenesis, has to be identified. Porous scaffolds of biocompatible, biodegradable materials that maintain and support the presentation of the chondrogenic cells need to be fabricated. If the cells are not implanted early to allow their in vivo constitution of cartilage, a suitable in vitro cultivation method has to be devised for a consistent yield of regenerative cartilage. [J Formos Med Assoc 2009; 108(2):87-101]
C1 [Chiang, Hongsen; Jiang, Ching-Chuan] Natl Taiwan Univ Hosp & Coll Med, Dept Orthoped Surg, Taipei 100, Taiwan.
RP Jiang, CC (reprint author), Natl Taiwan Univ Hosp & Coll Med, Dept Orthoped Surg, 7 Chung Shan S Rd, Taipei 100, Taiwan.
EM ccj@ntu.edu.tw
OI Chiang, Hongsen/0000-0001-8781-5146; Jiang,
   Ching-Chuan/0000-0001-7954-0875
CR Agung M, 2004, ARTHROSCOPY, V20, P1075, DOI 10.1016/j.arthro.2004.04.039
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   ASAHINA I, 1993, J CELL BIOL, V123, P921, DOI 10.1083/jcb.123.4.921
   Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215
   Baragi VM, 1997, OSTEOARTHR CARTILAGE, V5, P275, DOI 10.1016/S1063-4584(97)80023-4
   Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   Bernardo ME, 2007, CONNECT TISSUE RES, V48, P132, DOI 10.1080/03008200701228464
   Biddulph D M, 2000, Methods Cell Sci, V22, P9, DOI 10.1023/A:1009824106368
   Bouwmeester SJM, 1997, INT ORTHOP, V21, P313, DOI 10.1007/s002640050175
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2001, CLIN ORTHOP RELAT R, pS337
   Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Chaipinyo K, 2004, J ORTHOPAED RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   CHEN P, 1991, EXP CELL RES, V195, P509, DOI 10.1016/0014-4827(91)90403-H
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chiang HS, 2005, J ORTHOP RES, V23, P584, DOI 10.1016/j.orthres.2004.11.003
   ChimalMonroy J, 1997, INT J DEV BIOL, V41, P91
   Chow JCY, 2004, ARTHROSCOPY, V20, P681, DOI 10.1016/j.arthro.2004.06.005
   De Bari C, 2008, BIO-MED MATER ENG, V18, pS11
   Dumont J, 1999, CONNECT TISSUE RES, V40, P259, DOI 10.3109/03008209909000704
   Farquharson C, 1998, EUR J CELL BIOL, V76, P110, DOI 10.1016/S0171-9335(98)80023-X
   Fortier LA, 2002, AM J VET RES, V63, P301, DOI 10.2460/ajvr.2002.63.301
   French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Fuss M, 2000, ANN ANAT, V182, P303
   Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187
   Giannini Sandro, 2002, Foot Ankle Clin, V7, P621, DOI 10.1016/S1083-7515(02)00023-2
   Giannoni P, 2006, CELLS TISSUES ORGANS, V184, P1, DOI 10.1159/000096946
   Gole MD, 2004, J ORTHOP RES, V22, P781, DOI 10.1016/j.orthres.2003.11.006
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, V269, P274
   Grad S, 2005, TISSUE ENG, V11, P249, DOI 10.1089/ten.2005.11.249
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   Hangody L, 2001, CLIN ORTHOP RELAT R, pS328, DOI 10.1097/00003086-200110001-00030
   Hangody L, 2008, INJURY, V39, pS32, DOI 10.1016/j.injury.2008.01.041
   HARMAND MF, 1984, J CELL PHYSIOL, V119, P359, DOI 10.1002/jcp.1041190315
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Ito Y, 2001, OSTEOARTHR CARTILAGE, V9, P215, DOI 10.1053/joca.2000.0378
   IWASAKI M, 1993, ENDOCRINOLOGY, V132, P1603, DOI 10.1210/en.132.4.1603
   JAKOB RP, 2002, CLIN ORTHOP RELAT R, V401, P170
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   JIANG TX, 1993, DEV BIOL, V155, P545, DOI 10.1006/dbio.1993.1051
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   KATO Y, 1987, J CELL BIOL, V104, P311, DOI 10.1083/jcb.104.2.311
   KON M, 1981, EUR SURG RES, V13, P387, DOI 10.1159/000128206
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Kulyk WM, 1996, EXP CELL RES, V223, P290, DOI 10.1006/excr.1996.0084
   KULYK WM, 1991, DEV BIOL, V146, P38, DOI 10.1016/0012-1606(91)90444-8
   Kus W M, 1999, Ann Transplant, V4, P101
   Lee David A, 2004, Methods Mol Biol, V238, P159
   Lee HS, 2003, STEM CELLS, V21, P190, DOI 10.1634/stemcells.21-2-190
   LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W
   Liao CJ, 2007, J BIOMED MATER RES A, V81A, P567, DOI 10.1002/jbm.a.31035
   LU L, 2001, CLIN ORTHOP S, V391, pS251
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Malda J, 2004, TISSUE ENG, V10, P987, DOI 10.1089/1076327041887637
   Malpeli M, 2004, TISSUE ENG, V10, P145, DOI 10.1089/107632704322791790
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MIKHAILOV AT, 1988, CELL DIFFER DEV, V22, P145, DOI 10.1016/0045-6039(88)90026-7
   Miyamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P644, DOI 10.1016/S1063-4584(03)00118-3
   Mukherjee N, 2001, J ORTHOPAED RES, V19, P524, DOI 10.1016/S0736-0266(00)00045-0
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015
   O'Driscoll SW, 1999, CLIN ORTHOP RELAT R, pS186, DOI 10.1097/00003086-199910001-00020
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Ogueta S, 2002, MOL CELL ENDOCRINOL, V190, P51, DOI 10.1016/S0303-7207(02)00013-8
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Phipatanakul Wesley P, 2004, Am J Orthop (Belle Mead NJ), V33, P345
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Quarto R, 1997, ENDOCRINOLOGY, V138, P4966, DOI 10.1210/en.138.11.4966
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Redman S N, 2005, Eur Cell Mater, V9, P23
   REVILLIONCARETTE F, 1986, DIFFERENTIATION, V33, P121, DOI 10.1111/j.1432-0436.1986.tb00417.x
   Rohde RS, 2004, CLIN ORTHOP RELAT R, P226, DOI 10.1097/01.blo.0000138955.27186.8e
   Ronziere MC, 2003, BIOMATERIALS, V24, P851, DOI 10.1016/S0142-9612(02)00418-0
   Samuel RE, 2002, HUM GENE THER, V13, P791, DOI 10.1089/10430340252898975
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Seidel JO, 2004, BIORHEOLOGY, V41, P445
   Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Siebler T, 2002, BONE, V31, P457, DOI 10.1016/S8756-3282(02)00855-4
   Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Steinwachs MR, 2008, INJURY, V39, pS26, DOI 10.1016/j.injury.2008.01.042
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Tonon R, 2000, J BONE MINER RES, V15, P1669, DOI 10.1359/jbmr.2000.15.9.1669
   Toolan BC, 1996, J BIOMED MATER RES, V31, P273, DOI 10.1002/(SICI)1097-4636(199606)31:2<273::AID-JBM15>3.0.CO;2-M
   Trzeciak T, 2006, TRANSPLANT P, V38, P305, DOI 10.1016/j.transproceed.2005.12.028
   TSONIS PA, 1991, DEV BIOL, V143, P130, DOI 10.1016/0012-1606(91)90060-G
   Tsukazaki T, 1994, Osteoarthritis Cartilage, V2, P259, DOI 10.1016/S1063-4584(05)80078-0
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x
   van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806
   Visna P, 2004, ACTA CHIR BELG, V104, P709, DOI 10.1080/00015458.2004.11679648
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wakitani S, 2008, J BONE MINER METAB, V26, P115, DOI 10.1007/s00774-007-0802-8
   Williams KA, 2002, BIOTECHNOL PROGR, V18, P951, DOI 10.1021/bp020087n
   Williams RJ, 2004, AM J SPORT MED, V32, P132, DOI 10.1177/0095399703258733
   Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239
NR 120
TC 81
Z9 90
U1 0
U2 38
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD FEB
PY 2009
VL 108
IS 2
BP 87
EP 101
DI 10.1016/S0929-6646(09)60039-5
PG 15
WC Medicine, General & Internal
SC General & Internal Medicine
GA 416VP
UT WOS:000264033900002
PM 19251544
OA Bronze
DA 2018-10-19
ER

PT J
AU Pereira, RC
   Scaranari, M
   Castagnola, P
   Grandizio, M
   Azevedo, HS
   Reis, RL
   Cancedda, R
   Gentili, C
AF Pereira, R. C.
   Scaranari, M.
   Castagnola, P.
   Grandizio, M.
   Azevedo, H. S.
   Reis, R. L.
   Cancedda, R.
   Gentili, C.
TI Novel injectable gel (system) as a vehicle for human articular
   chondrocytes in cartilage tissue regeneration
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE cartilage tissue engineering; cell culture; biomaterial; animal model;
   extracellular matrix (ECM)
ID MESENCHYMAL STEM-CELLS; STABLE FIBRIN GELS; IN-VITRO; BIODEGRADABLE
   HYDROGELS; REPAIR; GROWTH; BONE; DELIVERY; THERAPY; MOUSE
AB We developed a novel injectable carrageenan/fibrin/hyaluronic acid-based hydrogel with in situ gelling properties to be seeded with chondrogenic cells and used for cartilage tissue engineering applications. We first analysed the distribution within the hydrogel construct and the phenotype of human articular chondrocytes (HACs) cultured for 3 weeks in vitro. We observed a statistically significant increase in the cell number during the first 2 weeks and maintenance of cell viability throughout the cell culture, together with the deposition/formation of a cartilage-specific extracellular matrix (ECM). Taking advantage of a new in vivo model that allows the integration between newly formed and preexisting cartilage in immunodeficient mice to be investigated, we showed that injectable hydrogel seeded with human articular chondrocytes was able to regenerate and repair an experimentally made lesion in bovine articular cartilage, thus demonstrating the potential of this novel cell delivery system for cartilage tissue engineering. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Castagnola, P.; Cancedda, R.; Gentili, C.] Ist Nazl Ric Canc, I-16132 Genoa, Italy.
   [Pereira, R. C.; Scaranari, M.; Cancedda, R.; Gentili, C.] Univ Genoa, Dipartimento Biol Oncol & Genet, Genoa, Italy.
   [Pereira, R. C.; Azevedo, H. S.; Reis, R. L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Taipas, Guimaraes, Portugal.
   [Pereira, R. C.; Azevedo, H. S.; Reis, R. L.] PT Associated Lab, IBB, Guimaraes, Portugal.
   [Grandizio, M.] ASL 3 Genovese, Osped S Antonio Recco, Genoa, Italy.
RP Gentili, C (reprint author), Ist Nazl Ric Canc, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.
EM chiara.gentili@istge.it
RI Azevedo, Helena/A-8298-2011; castagnola, patrizio/H-2029-2012; Group,
   3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Azevedo, Helena/0000-0002-5470-1844; castagnola,
   patrizio/0000-0003-2008-9199; Group, 3Bs/0000-0002-5195-3456; Reis, Rui
   L./0000-0002-4295-6129; Pereira, Rui/0000-0002-5105-5082
FU Italian MUR (FIRB-Tissuenet project); European Union; HIPPOCRATES
   [NMP3-CT-2003-505758]; European NoE EXPERTISSUES [NMP3-CT-2004-500283]
FX The authors are grateful to Recco orthopaedic staff members for the
   collaboration and patients for bioptic material donation as well as to
   Mrs Daniela Marubbi for histological assistance. This work was supported
   by funds from the Italian MUR (FIRB-Tissuenet project), the European
   Union-funded STREP project, HIPPOCRATES (Grant No. NMP3-CT-2003-505758)
   and the European NoE EXPERTISSUES project (Grant No.
   NMP3-CT-2004-500283).
CR Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030
   Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0
   Bartkowiak A, 2001, COLLOID SURFACE B, V21, P285, DOI 10.1016/S0927-7765(00)00211-3
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Dozin B, 2002, MATRIX BIOL, V21, P449, DOI 10.1016/S0945-053X(02)00028-8
   Endres M, 2007, TISSUE CELL, V39, P293, DOI 10.1016/j.tice.2007.05.002
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Eyrich D, 2007, TISSUE ENG, V13, P2207, DOI 10.1089/ten.2006.0358
   Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457
   Gelse K, 2006, ADV DRUG DELIVER REV, V58, P259, DOI 10.1016/j.addr.2006.01.019
   Giannoni P, 2006, CELLS TISSUES ORGANS, V184, P1, DOI 10.1159/000096946
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hunziker EB, 2000, BIORHEOLOGY, V37, P163
   Hunziker EB, 1999, CLIN ORTHOP RELAT R, pS135
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Liu W, 2007, BIOMATERIALS, V28, P5078, DOI 10.1016/j.biomaterials.2007.07.028
   Malpeli M, 2004, TISSUE ENG, V10, P145, DOI 10.1089/107632704322791790
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Mueller-Rath R, 2007, BIO-MED MATER ENG, V17, P357
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Piyakulawat P, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0804097
   Schuller GC, 2008, J TISSUE ENG REGEN M, V2, P202, DOI 10.1002/term.84
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Thommes M, 2008, PHARM DEV TECHNOL, V13, P27, DOI 10.1080/10837450701702537 
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   Ulivi V, 2006, J CELL PHYSIOL, V206, P728, DOI 10.1002/jcp.20511
NR 38
TC 39
Z9 40
U1 2
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD FEB
PY 2009
VL 3
IS 2
BP 97
EP 106
DI 10.1002/term.145
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 421VA
UT WOS:000264385200004
PM 19172577
DA 2018-10-19
ER

PT J
AU Lode, A
   Bernhardt, A
   Kroonen, K
   Springer, M
   Briest, A
   Gelinsky, M
AF Lode, Anja
   Bernhardt, Anne
   Kroonen, Kathrin
   Springer, Marco
   Briest, Arne
   Gelinsky, Michael
TI Development of a mechanically stable support for the osteoinductive
   biomaterial COLLOSS (R) E
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE COLLOSS (R) E; osteoinductive; mineralized collagen; mesenchymal stem
   cells; bone marrow stromal cells; osteogenic differentiation; alkaline
   phosphatase
ID BONE PROTEIN EXTRACT; LUMBAR INTERBODY FUSION; MESENCHYMAL STEM-CELLS;
   MINERALIZED COLLAGEN; SCAFFOLDING MATERIAL; DIFFERENTIATION; INDUCTION;
   MATRIX
AB The application of bone graft substitutes with osteoinductive properties is of high importance for the repair of large bone defects. COLLOSS(R) E, a protein lyophilizate extracted from equine long bones, exhibits an osteoinductive potential which has been proven in several studies. in this work, a mechanically stable, but biodegradable support for COLLOSS(R) E has been developed aiming at a bone graft substitute that retains shape and size when coming in contact with body fluids. Mineralization of collagen type I, isolated from horse tendon, resulted in a stable collagen hydroxyapatite nanocomposite. By means of freeze drying, this composite was used to prepare 3D scaffolds which can be filled with the cotton-wool like COLLOSS(R) E material. These scaffolds exhibit a porous microstructure and a good mechanical stability in dry and wet state. Cell culture experiments with human bone marrow stromal cells (hBMSC) revealed the cytocompatibility of the newly developed composite material. Cells were able to adhere, proliferate and differentiate into the osteoblastic lineage. The osteoinductive nature of COLLOSS(R) E has been demonstrated by a significant higher activity of the osteogenic marker alkaline phosphatase (ALP) on combined scaffolds (mineralized collagen scaffolds filled with COLLOSS(R) E) compared to pure scaffolds. The combination of COLLOSS(R) E with scaffolds made of a collagen hydroxyapatite composite results in a synthetic bone graft substitute which can be completely remodelled into vital bone tissue opening an interesting new possibility for the therapy of bone defects. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Lode, Anja; Bernhardt, Anne; Kroonen, Kathrin; Gelinsky, Michael] Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, D-01069 Dresden, Germany.
   [Springer, Marco; Briest, Arne] Ossacur AG, D-71720 Oberstenfeld, Germany.
RP Lode, A (reprint author), Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, Budapester Str 27, D-01069 Dresden, Germany.
EM anja.lode@nano.tu-dresden.de
RI Bernhardt, Anne/O-1242-2015; Gelinsky, Michael/A-9680-2012
OI Bernhardt, Anne/0000-0002-1903-1929; Gelinsky,
   Michael/0000-0001-9075-5121
FU OSSACUR AG
FX The authors thank Ortrud Zieschang for preparation of the scaffolds and
   Professor Martin Bornhauser and his co-workers, Medical Clinic 1,
   Dresden University Hospital 'Carl Gustav Carus', for providing hBMSCs.
   OSSACUR AG provided a grant for this study, as well as COLLOSS(R) E and
   the equine collagen suspension.
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Baas J, 2006, ACTA ORTHOP, V77, P791, DOI 10.1080/17453670610013015
   Bernhardt A, 2009, J BIOMED MATER RES A, V90A, P852, DOI 10.1002/jbm.a.32144
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   BODEN S, 2005, EUR CELLS MAT S3, V10, P51
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   El-Sabban ME, 2007, REGEN MED, V2, P383, DOI 10.2217/17460751.2.4.383
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Huffer WE, 2006, ADV EXP MED BIOL, V585, P87
   Huffer WE, 2007, J BIOMED MATER RES B, V82B, P460, DOI 10.1002/jbm.b.30751
   Li HS, 2007, SPINE, V32, pE126, DOI 10.1097/01.brs.0000255210.67616.2b
   Li HS, 2006, ADV EXP MED BIOL, V585, P393
   Li HS, 2005, SPINE, V30, P890, DOI 10.1097/01.brs.0000159097.74426.ea
   Nienhuijs MEL, 2006, BIOMATERIALS, V27, P3109, DOI 10.1016/j.biomaterials.2006.01.021
   NIENHUIJS MEL, 2008, J BIOMED B IN PRESS
   Walboomers XF, 2005, BIOMATERIALS, V26, P4779, DOI 10.1016/j.biomaterials.2004.11.029
   Woo C, 2006, J BIOMED MATER RES A, V79A, P552, DOI 10.1002/jbm.a.30892
NR 17
TC 5
Z9 6
U1 0
U2 3
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD FEB
PY 2009
VL 3
IS 2
BP 149
EP 152
DI 10.1002/term.138
PG 4
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 421VA
UT WOS:000264385200010
PM 19051216
DA 2018-10-19
ER

PT J
AU Pignatello, R
   Cenni, E
   Micieli, D
   Fotia, C
   Salerno, M
   Granchi, D
   Avnet, S
   Sarpietro, M
   Castelli, F
   Baldini, N
AF Pignatello, Rosario
   Cenni, Elisabetta
   Micieli, Dorotea
   Fotia, Caterina
   Salerno, Manuela
   Granchi, Donatella
   Avnet, Sofia
   Sarpietro, Maria
   Castelli, Francesco
   Baldini, Nicola
TI A novel biomaterial for osteotropic drug nanocarriers: synthesis and
   biocompatibility evaluation of a PLGA-ALE conjugate
SO NANOMEDICINE
LA English
DT Article
DE alendronate; biocompatibility; bisphosphonates; nanoparticles; ODDS;
   poly(lactide-co-glycolide); polymer conjugates; osteotropic
   drug-delivery systems
ID DELIVERY-SYSTEMS; IN-VITRO; BONE; NANOPARTICLES; BISPHOSPHONATE;
   MICROSPHERES; RELEASE; POLY(D,L-LACTIDE-CO-GLYCOLIDE); PROTEINS;
   ADHESION
AB Background & aims: Osteotropic drug-delivery systems have been proposed as a means to provide drugs with affinity to bone tissues. Drugs or proteins have been linked chemically to bone-seeking agents, such as bisphosphonates (BPs); alternatively, drug-loaded nanoparticles have been used to target specific tissues, such as tumor areas. In our current research, these approaches were merged by synthesizing a novel bone-seeking polymer conjugate, from which targetable nanoparticles can be produced. Materials & methods: An amino-BP, alendronate (ALE) was bound covalently to a biodegradable polymer, poly (lactic-co-glycolide) (PLGA), containing a free end carboxylic group. Blood compatibility and cytotoxicity were assessed in vitro. Results & discussion: By a classical solvent-evaporation method, nanoparticles with a mean size of 200300 nm were prepared from the conjugate; sterilization was achieved by gamma-irradiation, confirming their potential as injectable drug nanocarriers. Owing to the presence of the BP residue, PLGA-ALE nanoparticles were adsorbed onto hydroxyapatite to a higher extent than pure PLGA nanoparticles. The PLGA-ALE conjugate did not induce either hemolysis or alterations of the plasmatic phase of coagulation, or cytotoxic effects on endothelial cells and trabecular osteoblasts. Conclusion: The prepared conjugate represents a novel biomaterial that is able to provide nanoparticles, which can be further loaded with drugs, such as anticancer agents, and addressed to osteolytic or other bone diseases.
C1 [Pignatello, Rosario] Univ Catania, Citta Univ, Dept Pharmaceut Sci, Catania, Italy.
   [Cenni, Elisabetta; Salerno, Manuela; Granchi, Donatella; Avnet, Sofia; Baldini, Nicola] Ist Ortoped Rizzoli, Lab Pathophysiol Orthoped Implants, I-40136 Bologna, Italy.
   [Micieli, Dorotea; Sarpietro, Maria; Castelli, Francesco] Univ Catania, Dept Chem Sci, Catania, Italy.
   [Baldini, Nicola] Univ Catania, Dept Human Anat & Musculoskeletal Pathophysiol, Catania, Italy.
RP Pignatello, R (reprint author), Univ Catania, Citta Univ, Dept Pharmaceut Sci, Catania, Italy.
EM r.pignatello@unict.it
RI Baldini, Nicola/J-4806-2016; Avnet, Sofia/B-3220-2018; Granchi,
   Donatella/J-3647-2016
OI Baldini, Nicola/0000-0003-2228-3833; Avnet, Sofia/0000-0002-7843-0591;
   Granchi, Donatella/0000-0001-7225-0023; CASTELLI,
   Francesco/0000-0002-1982-8065; Pignatello, Rosario/0000-0002-5937-4192
CR Astete CE, 2006, J BIOMAT SCI-POLYM E, V17, P247, DOI 10.1163/156856206775997322
   Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20
   Barrett J, 2004, J CLIN PHARMACOL, V44, P951, DOI 10.1177/0091270004267594
   Blanco-Prieto MJ, 2004, J CONTROL RELEASE, V96, P437, DOI 10.1016/j.jconrel.2004.02.015
   Bondi ML, 2007, DRUG DELIV, V14, P61, DOI 10.1080/10717540600739914
   Choi SW, 2007, J CONTROL RELEASE, V122, P24, DOI 10.1016/j.jconrel.2007.06.003
   Costantino L, 2005, J CONTROL RELEASE, V108, P84, DOI 10.1016/j.jconrel.2005.07.013
   Crivellari D, 2001, ANN ONCOL, V12, P353, DOI 10.1023/A:1011132609055
   CUTRIGHT DE, 1974, ORAL SURG ORAL MED O, V37, P142, DOI 10.1016/0030-4220(74)90171-6
   DISILVIO L, 2001, OSTEOBLASTS HUMAN CE, V5, pCH11
   Ezra A, 2000, J MED CHEM, V43, P3641, DOI 10.1021/jm980645y
   Gittens SA, 2005, ADV DRUG DELIVER REV, V57, P1011, DOI 10.1016/j.addr.2004.12.015
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Greish K, 2007, J DRUG TARGET, V15, P457, DOI 10.1080/10611860701539584
   HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9
   Hengst V, 2007, INT J PHARM, V331, P224, DOI 10.1016/j.ijpharm.2006.11.024
   Hirabayashi H, 2003, CLIN PHARMACOKINET, V42, P1319, DOI 10.2165/00003088-200342150-00002
   Hirabayashi H, 2001, J CONTROL RELEASE, V70, P183, DOI 10.1016/S0168-3659(00)00355-2
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Langer R, 1998, NATURE, V392, P5
   Lin JH, 1996, BONE, V18, P75, DOI 10.1016/8756-3282(95)00445-9
   Liu XM, 2008, BIOMATERIALS, V29, P1686, DOI 10.1016/j.biomaterials.2007.12.023
   Liu XM, 2007, J CONTROL RELEASE, V122, P54, DOI 10.1016/j.jconrel.2007.06.021
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Lu W, 2006, CANCER RES, V66, P11878, DOI 10.1158/0008-5472.CAN-06-2354
   MCKENNA GB, 1988, COMPREHENSIVE POLYM, V1
   Mitra A, 2006, CURR PHARM DESIGN, V12, P4729, DOI 10.2174/138161206779026317
   Nalwa HS, 2006, CANC NANOTECHNOLOGY
   Niemi R, 1999, J MED CHEM, V42, P5053, DOI 10.1021/jm991109o
   NOEL TR, 1995, INT J BIOL MACROMOL, V17, P81, DOI 10.1016/0141-8130(95)93521-X
   Ogawa K, 2006, J NUCL MED, V47, P2042
   Okada H, 1997, ADV DRUG DELIVER REV, V28, P43, DOI 10.1016/S0169-409X(97)00050-1
   PETRIE SEB, 1972, J POLYM SCI A2, V10, P1255, DOI 10.1002/pol.1972.160100706
   Pridgen EM, 2007, NANOMEDICINE-UK, V2, P669, DOI 10.2217/17435889.2.5.669
   RODRIGUEZLORENZ.V, 2006, 20 EUR C BIOM NANT F
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Tosi G, 2005, BIOMATERIALS, V26, P4189, DOI [10.1016/j.biomaterials.2004.10.025, 10.1016/biomaterials.2004.10.025]
   von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059
   Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011
   Wang D, 2003, BIOCONJUGATE CHEM, V14, P853, DOI 10.1021/bc034090j
   Wright JEI, 2006, BIOMATERIALS, V27, P769, DOI 10.1016/j.biomaterials.2005.06.012
   ZIMMER A, 1995, ADV DRUG DELIVER REV, V16, P61, DOI 10.1016/0169-409X(95)00017-2
NR 42
TC 35
Z9 35
U1 1
U2 18
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD FEB
PY 2009
VL 4
IS 2
BP 161
EP 175
DI 10.2217/17435889.4.2.161
PG 15
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 411BA
UT WOS:000263621200012
PM 19193183
DA 2018-10-19
ER

PT J
AU Tabesh, H
   Amoabediny, G
   Nik, NS
   Heydari, M
   Yosefifard, M
   Siadat, SOR
   Mottaghy, K
AF Tabesh, H.
   Amoabediny, Gh.
   Nik, N. Salehi
   Heydari, M.
   Yosefifard, M.
   Siadat, S. O. Ranaei
   Mottaghy, K.
TI The role of biodegradable engineered scaffolds seeded with Schwann cells
   for spinal cord regeneration
SO NEUROCHEMISTRY INTERNATIONAL
LA English
DT Review
DE Spinal cord regeneration; Biomaterial; Scaffold; Schwann cell
ID NERVE GUIDE MATERIAL; IN-VITRO; AXONAL GROWTH; TISSUE; FABRICATION;
   GUIDANCE; BIOCOMPATIBILITY; REPAIR; CHANNELS; INJURY
AB Spinal cord injury is very complicated, as there are factors in the body that inhibit its repair. Although regeneration of the mammalian central nervous system (CNS) was once thought to be impossible, studies over the past two decades have shown that axonal growth after spinal cord injury can occur when provided with the correct substratum. Traditionally, tissue transplantation or peripheral nerve grafting are used to repair damaged or diseased regions of the CNS, but donor shortage and immunological problems associated with infectious disease are often encountered. Fortunately, recent advances in neuroscience, cell culture, and biomaterials provide optimistic future using new treatments for nerve injuries.
   Biomaterial scaffold creates substrate within which cells are instructed to form a tissue or an organ in a highly controlled way. The principal function of a scaffold is to direct cell behavior such as migration, proliferation, differentiation, maintenance of phenotype, and apoptosis by facilitating sensing and responding to the environment via cell-matrix and cell-cell communications. Therefore. having such abilities provides scaffolds seeded with a special type of cell as an important part of tissue engineering and regenerative medicine which spinal cord regeneration is an example of. Nevertheless, the vast number of biodegradable synthetic and natural biopolymers makes choosing the right one very difficult. In this review article, it was tried to provide an inclusive survey of biopolymers seeded with Schwann cells (SCs) to be used for axonal regeneration in the nervous system. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Tabesh, H.; Amoabediny, Gh.; Nik, N. Salehi] Univ Tehran, Dept Chem Eng, Tehran, Iran.
   [Tabesh, H.; Mottaghy, K.] Rhein Westfal TH Aachen, Dept Physiol, Aachen, Germany.
   [Heydari, M.] Iran Uni Sci & Technol, Dept Chem Eng, Tehran, Iran.
   [Yosefifard, M.] Shahed Univ, Dept Physiol, Tehran, Iran.
   [Siadat, S. O. Ranaei] Shaheed Beheshti Univ, Dep Nanotechnol, Fac New Technol & Energy Eng, Tehran, Iran.
RP Amoabediny, G (reprint author), Univ Tehran, Dept Chem Eng, Tehran, Iran.
EM hadi.tabesh@rwth-aachen.de; amoabedini@ut.ac.ir
OI Tabesh, Hadi/0000-0003-0529-221X
FU Iranian Center of Spinal Cord Regeneration
FX This work was supported by the Iranian Center of Spinal Cord
   Regeneration. The help and assistance of the members of the center and
   specifically Dr. Noorozi as its director is gratefully appreciated.
CR Ahmed Z, 2003, TISSUE ENG, V9, P219, DOI 10.1089/107632703764664693
   ALLEN T, 2003, ALS, pH398
   ALOVSKAYA A, 2007, TOP TISSUE ENG, P3
   BOWLIN GL, 2001, APPAREL TECHNOL, P1
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Chunlin Y., 2004, BIODRUGS, V18, P103
   Cole A, 2005, TOXICOL IN VITRO, V19, P215, DOI 10.1016/j.tiv.2004.10.007
   Cuy J, 2004, BIOMATERIALS TUTORIA
   Duerstock BS, 2002, J EXP BIOL, V205, P13
   Ebner R., 2006, Bulletin of the Polish Academy of Sciences, Technical Sciences, V54, P167
   EDWARDS SL, 2004, AUTEX RES J, P4
   Elmstedt N., 2006, THESIS STOCKHOLM
   ERSCHBAMER M, 2007, THESIS KAROLINSKA I
   FANG D, 2001, APPAREL TECHNOL, P1
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   Kricheldorf HR, 2001, CHEMOSPHERE, V43, P49, DOI 10.1016/S0045-6535(00)00323-4
   Li JM, 2007, J NEUROSCI METH, V165, P257, DOI 10.1016/j.jneumeth.2007.06.006
   Liu W, 2007, BIOMATERIALS, V28, P5078, DOI 10.1016/j.biomaterials.2007.07.028
   Ljungberg C, 1999, MICROSURG, V19, P259, DOI 10.1002/(SICI)1098-2752(1999)19:6<259::AID-MICR1>3.0.CO;2-Q
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MANZANEDO D, 2005, THESIS MIT
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   MATIN S, 2004, THESIS J HOPKINS U
   MIKOS A, 2003, EJB ELECT J BIOTECHN, P3
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Mohan N., 2005, TRENDS BIOMATERIALS, V18, P219
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   MOSAHEBI G, 2001, GENETIC LABELLING TR
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Onose G., 2008, DIG J NANOMATER BIOS, V2, P307
   Oudega M, 2005, BRAZ J MED BIOL RES, V38, P825, DOI 10.1590/S0100-879X2005000600003
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   Radulescu D, 2007, MAT SCI ENG C-BIO S, V27, P534, DOI 10.1016/j.msec.2006.05.050
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sangsanoh P, 2007, BIOMACROMOLECULES, V8, P1587, DOI 10.1021/bm061152a
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   STOKOLS S, 2004, BIOMATERIALS
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Venugopal J, 2005, CELL BIOL INT, V29, P861, DOI 10.1016/j.cellbi.2005.03.026
   Venugopal J, 2005, NANOTECHNOLOGY, V16, P2138, DOI 10.1088/0957-4484/16/10/028
   VENUGOPAL J, 2005, IMECHE, V218, P35
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
NR 63
TC 71
Z9 79
U1 0
U2 36
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0197-0186
J9 NEUROCHEM INT
JI Neurochem. Int.
PD FEB
PY 2009
VL 54
IS 2
BP 73
EP 83
DI 10.1016/j.neuint.2008.11.002
PG 11
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 423SS
UT WOS:000264516600001
PM 19084565
DA 2018-10-19
ER

PT J
AU Ruiter, GCW
   Malessy, MJA
   Yaszemski, MJ
   Windebank, AJ
   Spinner, RJ
AF Ruiter, Godard C. W. de
   Malessy, Martijn J. A.
   Yaszemski, Michael J.
   Windebank, Anthony J.
   Spinner, Robert J.
TI Designing ideal conduits for peripheral nerve repair
SO NEUROSURGICAL FOCUS
LA English
DT Article
DE biomaterial; growth factor; nerve conduit; nerve guide; nerve tube;
   polymer; Schwann cell
ID TISSUE ENGINEERING SCAFFOLD; RAT SCIATIC-NERVE; SCHWANN-CELLS;
   GROWTH-FACTOR; GUIDANCE CHANNELS; COLLAGEN FILAMENTS; AXON REGENERATION;
   SILICONE TUBES; LONG GAPS; GUIDES
AB Nerve tubes, guides, or conduits are a promising alternative for autologous nerve graft repair. The first biodegradable empty single lumen or hollow nerve tubes are currently available for clinical use and are being used mostly in the repair of small-diameter nerves with nerve defects of <3 cm. These nerve tubes are made of different biomaterials using various fabrication techniques. As a result these tubes also differ in physical properties. In addition, several modifications to the common hollow nerve tube (for example, the addition of Schwann cells, growth factors, and internal frameworks) are being investigated that may increase the gap that can be bridged. This combination of chemical, physical, and biological factors has made the design of a nerve conduit into a complex process that demands close collaboration of bioengineers, neuroscientists, and peripheral nerve surgeons. In this article the authors discuss the different steps that are involved in the process of the design of an ideal nerve conduit for peripheral nerve repair. (DOI: 10.3171/FOC.2009.26.2.E5)
C1 [Spinner, Robert J.] Mayo Clin Rochester, Dept Neurosurg, Rochester, MN 55905 USA.
   [Ruiter, Godard C. W. de; Malessy, Martijn J. A.] Leiden Univ, Med Ctr, Dept Neurosurg, NL-2300 RA Leiden, Netherlands.
   [Yaszemski, Michael J.] Mayo Clin Rochester, Dept Orthoped Surg, Rochester, MN 55905 USA.
   [Yaszemski, Michael J.] Mayo Clin Rochester, Biomed Engn Lab, Rochester, MN 55905 USA.
   [Windebank, Anthony J.] Mayo Clin Rochester, Dept Neurol, Rochester, MN 55905 USA.
   [Windebank, Anthony J.] Mayo Clin Rochester, Neurosci Lab, Rochester, MN 55905 USA.
RP Spinner, RJ (reprint author), Mayo Clin Rochester, Dept Neurosurg, 200 1st St SW, Rochester, MN 55905 USA.
EM spinner.robert@mayo.edu
FU NIBIB NIH HHS [R01 EB002390, R01 EB002390-04]
CR AEBISCHER P, 1990, BRAIN RES, V531, P211, DOI 10.1016/0006-8993(90)90776-8
   AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   Ansselin AD, 1997, NEUROPATH APPL NEURO, V23, P387
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Braga-Silva J, 1999, J HAND SURG-BRIT EUR, V24B, P703, DOI 10.1054/jhsb.1999.0276
   BUSSCHER HJ, 1983, J COLLOID INTERF SCI, V95, P23, DOI 10.1016/0021-9797(83)90067-X
   de Ruiter GC, 2008, NEUROSURGERY, V63, P144, DOI [10.1227/01.NEU.0000335081.47352.78, 10.1227/01.NEU.0000319521.28683.75]
   de Ruiter GC, 2008, J BIOMED MATER RES A, V84A, P643, DOI 10.1002/jbm.a.31298
   de Ruiter GCW, 2009, NEUROSURG CLIN N AM, V20, P91, DOI 10.1016/j.nec.2008.08.001
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   DENDUNNEN WFA, 1995, J BIOMED MATER RES, V29, P757, DOI 10.1002/jbm.820290612
   DERBY A, 1993, EXP NEUROL, V119, P176, DOI 10.1006/exnr.1993.1019
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fan WM, 2008, MICROSURG, V28, P238, DOI 10.1002/micr.20488
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   Francel PC, 1997, J NEUROSURG, V87, P887, DOI 10.3171/jns.1997.87.6.0887
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006
   HOLLOWELL JP, 1990, EXP NEUROL, V110, P45, DOI 10.1016/0014-4886(90)90050-3
   Hung V, 2008, J HAND SURG-AM, V33A, P313, DOI 10.1016/j.jhsa.2007.12.008
   Inada Yuji, 2007, Neurosurgery, V61, pE1105
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   JENQ C-B, 1985, Brain Research, V361, P233, DOI 10.1016/0006-8993(85)91294-6
   KIM DH, 1994, J NEUROSURG, V80, P254, DOI 10.3171/jns.1994.80.2.0254
   Labrador RO, 1998, EXP NEUROL, V149, P243, DOI 10.1006/exnr.1997.6650
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Lee KW, 2006, TISSUE ENG, V12, P2801, DOI 10.1089/ten.2006.12.2801
   LI S-T, 1992, Clinical Materials, V9, P195, DOI 10.1016/0267-6605(92)90100-8
   Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7
   Lundborg G, 1996, SCAND J PLAST RECONS, V30, P105, DOI 10.3109/02844319609056391
   MADISON R, 1985, EXP NEUROL, V88, P767, DOI 10.1016/0014-4886(85)90087-1
   MADISON RD, 1988, BRAIN RES, V447, P325, DOI 10.1016/0006-8993(88)91135-3
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Meek MF, 2004, J BIOMED MATER RES A, V68A, P43, DOI 10.1002/jbm.a.10157
   Meek MF, 2001, BIOMATERIALS, V22, P1177, DOI 10.1016/S0142-9612(00)00340-9
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Mimura T, 2004, J NEUROSURG, V101, P806, DOI 10.3171/jns.2004.101.5.0806
   MOLANDER H, 1982, MUSCLE NERVE, V5, P54, DOI 10.1002/mus.880050110
   Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040
   Rodriguez FJ, 1999, BIOMATERIALS, V20, P1489, DOI 10.1016/S0142-9612(99)00055-1
   Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315
   ROSSON GD, 2008, MICROSURGERY
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Sinis N, 2005, J NEUROSURG, V103, P1067, DOI 10.3171/jns.2005.103.6.1067
   Sterne GD, 1997, EUR J NEUROSCI, V9, P1388, DOI 10.1111/j.1460-9568.1997.tb01493.x
   Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x
   VALENTINI RF, 1987, EXP NEUROL, V98, P350, DOI 10.1016/0014-4886(87)90247-0
   Verdu E, 2002, RESTOR NEUROL NEUROS, V20, P169
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Whitworth IH, 1996, J HAND SURG-BRIT EUR, V21B, P514, DOI 10.1016/S0266-7681(96)80058-1
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1
   Yoshii S, 2003, J BIOMED MATER RES A, V67A, P467, DOI 10.1002/jbm.a.10103
   Yoshii S, 2001, BRAIN RES, V888, P158, DOI 10.1016/S0006-8993(00)03025-0
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   ZHAO Q, 1993, RESTOR NEUROL NEUROS, V5, P197, DOI 10.3233/RNN-1993-5304
NR 64
TC 131
Z9 133
U1 1
U2 32
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI ROLLING MEADOWS
PA 5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA
SN 1092-0684
J9 NEUROSURG FOCUS
JI Neurosurg. Focus
PD FEB
PY 2009
VL 26
IS 2
AR E5
DI 10.3171/FOC.2009.26.2.E5
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 402OZ
UT WOS:000263024300004
PM 19435445
OA Bronze, Green Accepted
DA 2018-10-19
ER

PT J
AU Schmahl, WW
   Griesshaber, E
   Neuser, RD
   Goetz, A
   Luter, C
AF Schmahl, Wolfgang W.
   Griesshaber, Erika
   Neuser, Rolf D.
   Goetz, Andreas
   Lueter, Carsten
TI Electron Backscatter Diffraction Study of Brachiopod Shell Calcite -
   Microscale Phase and Texture Analysis of a Polycrystalline Biomaterial
SO PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION
LA English
DT Article
DE calcite biomaterials; hierarchical structure; hybrid composite; nacre;
   SEM-EBSD; texture; ultrastructure
ID MICROSTRUCTURE; ORIENTATION; PATTERNS; LAYER
AB Electron backscatter diffraction (EBSD) is an easy to use and highly automated microdiffraction method suitable for the determination of crystallographic phase and crystallite orientation. The high level of hierarchical structural organization in the shells of marine organisms was studied. Calcite brachiopod shell materials were found to belong to three types of microstructure: nano to microcrystalline layers of acicular crystals, fiber composites with calcite single crystal fibers with [uv0] morphological axes, and material formed by columnar crystals with [001] morphological axes selected by competitive growth.
C1 [Schmahl, Wolfgang W.; Griesshaber, Erika; Goetz, Andreas] Univ Munich, GeoBio Ctr, D-80333 Munich, Germany.
   [Schmahl, Wolfgang W.; Griesshaber, Erika; Goetz, Andreas] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany.
   [Neuser, Rolf D.] Ruhr Univ Bochum, Inst Geol Mineral & Geophys, D-44780 Bochum, Germany.
   [Lueter, Carsten] Humboldt Univ, Museum Nat Kunde, D-10099 Berlin, Germany.
RP Schmahl, WW (reprint author), Univ Munich, GeoBio Ctr, D-80333 Munich, Germany.
EM wolfgang.schmahl@lrz.uni-muenchen.de
RI Lueter, Carsten/G-6767-2012; Schmahl, Wolfgang/J-7571-2012
OI Schmahl, Wolfgang/0000-0002-0165-5952
FU Federal Ministry of Education and Research (BMBF)
FX We thank the Deutsche Forschungsgemeinschaft, DFG, for financial
   support. We are indepted to E. Kessler, T. Westphal, and E. Dettmer from
   Ruhr-Universitat Bochum for their help and excellent preparation of
   sample cross sections and surfaces. Thanks are also due the crew and
   scientific shipboard party of FS SONNE during the cruise SO 168
   ZEALANDIA. Financial support to CL by the Federal Ministry of Education
   and Research (BMBF) is gratefully acknowledged.
CR Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Deal A, 2008, ULTRAMICROSCOPY, V108, P116, DOI 10.1016/j.ultramic.2007.03.010
   Dingley D, 2004, J MICROSC-OXFORD, V213, P214, DOI 10.1111/j.0022-2720.2004.01321.x
   Griesshaber E, 2005, MATER RES SOC SYMP P, V844, P99
   Griesshaber E, 2005, MATER RES SOC SYMP P, V844, P93
   Griesshaber E, 2007, AM MINERAL, V92, P722, DOI 10.2138/am.2007.2220
   Mayer G, 2002, EXP MECH, V42, P395, DOI 10.1007/BF02412144
   MAYER G, 2005, SCIENCE, V310, P44
   Parkinson D, 2005, CHEM GEOL, V219, P193, DOI 10.1016/j.chemgeo.2005.02.002
   Schmahl WW, 2004, EUR J MINERAL, V16, P693, DOI 10.1127/0935-1221/2004/0016-0693
   SCHMIDT NH, 1989, CAN MINERAL, V27, P15
   WILLIAMS A, 2000, BRACHIOPODA, P107
   Zaefferer S, 2008, METALL MATER TRANS A, V39A, P374, DOI 10.1007/s11661-007-9418-9
NR 13
TC 7
Z9 7
U1 3
U2 19
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0934-0866
J9 PART PART SYST CHAR
JI Part. Part. Syst. Charact.
PD FEB
PY 2009
VL 25
IS 5-6
BP 474
EP 478
DI 10.1002/ppsc.200800014
PG 5
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 428EL
UT WOS:000264830700009
DA 2018-10-19
ER

PT J
AU Dimri, MC
   Stern, R
   Kashyap, SC
   Bhatti, KP
   Dube, DC
AF Dimri, Mukesh C.
   Stern, R.
   Kashyap, Subhash C.
   Bhatti, K. P.
   Dube, D. C.
TI Magnetic and dielectric properties of pure and doped barium hexaferrite
   nanoparticles at microwave frequencies
SO PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE
LA English
DT Article
ID FERRITE COMPOSITE NANOPARTICLES; REVERSE MICELLE TECHNIQUE; BIOMATERIAL
   SYSTEM; HIGH-COERCIVITY; DRUG-DELIVERY; PARTICLES; NICKEL; BAFE12O19;
   SHELL; CORE
AB Preparation of barium hexaferrite nanoparticles by chemical route and investigations of their dielectric and magnetic properties at microwave frequencies (8-12 GHz) are reported in the present paper. Measurements of these properties were carried out at microwave frequencies by using a cavity perturbation technique. It is observed that the values of the permittivity and permeability of nanoparticles are lower than the corresponding values for the bulk material. The effects of particle size, calcination temperature and compositional dependence on structural, microstructural and magnetic properties are also discussed. (C) 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
C1 [Dimri, Mukesh C.; Stern, R.] NICPB, Tallinn, Estonia.
   [Kashyap, Subhash C.; Bhatti, K. P.; Dube, D. C.] Indian Inst Technol Delhi, Dept Phys, New Delhi 110016, India.
RP Dimri, MC (reprint author), NICPB, Tallinn, Estonia.
EM mukeshdimri@yahoo.com
RI Stern, Raivo/A-5387-2008
OI Stern, Raivo/0000-0002-6724-9834
CR Afsar MN, 2005, IEEE T MAGN, V41, P3472, DOI 10.1109/TMAG.2005.854885
   CABANAS MV, 1992, J SOLID STATE CHEM, V101, P265, DOI 10.1016/0022-4596(92)90183-V
   Che S, 2003, J PHYS-CONDENS MAT, V15, pL335, DOI 10.1088/0953-8984/15/22/101
   Chen JP, 1996, PHYS REV B, V54, P9288, DOI 10.1103/PhysRevB.54.9288
   Culity B. D., 1967, ELEMENTS XRAY DIFFRA
   Dimri MC, 2004, CERAM INT, V30, P1623, DOI 10.1016/j.ceramint.2003.12.173
   Dionne GF, 1996, IEEE T MICROW THEORY, V44, P1361, DOI 10.1109/22.508241
   FUJIWARA T, 1987, IEEE T MAGN, V23, P3125, DOI 10.1109/TMAG.1987.1065462
   Gruskova A, 2002, CZECH J PHYS, V52, P135, DOI 10.1023/A:1014482604472
   Gubbala S, 2004, PHYSICA B, V348, P317, DOI 10.1016/j.physb.2003.12.017
   HANEDA K, 1974, J AM CERAM SOC, V57, P354, DOI 10.1111/j.1151-2916.1974.tb10921.x
   HANEDA K, 1987, IEEE T MAGN, V23, P3134, DOI 10.1109/TMAG.1987.1065394
   KRYDER MH, 1990, J MAGN MAGN MATER, V83, P1, DOI 10.1016/0304-8853(90)90410-R
   Lee SW, 2003, IEEE T MAGN, V39, P2899, DOI 10.1109/TMAG.2003.815741
   Lide D.R., 2005, CRC HDB CHEM PHYS, P12
   Liu JH, 2005, J MATER SCI, V40, P2573, DOI 10.1007/s10853-005-2077-6
   LOOYENGA H, 1965, PHYSICA, V31, P401, DOI 10.1016/0031-8914(65)90045-5
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   PILLAI V, 1993, COLLOID SURFACE A, V80, P69, DOI 10.1016/0927-7757(93)80225-4
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rao BP, 2006, J OPTOELECTRON ADV M, V8, P991
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   SHARROCK MP, 1989, IEEE T MAGN, V25, P4374, DOI 10.1109/20.45317
   SHARROCK MP, 1986, IEEE T MAGN, V22, P723, DOI 10.1109/TMAG.1986.1064545
   SMIT J, 1959, FERRITES, P199
   Smit J., 1959, FERRITES
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Thomas R, 1997, ELECTRON LETT, V33, P218, DOI 10.1049/el:19970137
   Zhang J, 2008, ACTA BIOMATER, V4, P40, DOI 10.1016/j.actbio.2007.06.006
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
   Zhong W, 1997, J MAGN MAGN MATER, V168, P196, DOI 10.1016/S0304-8853(96)00664-6
NR 33
TC 4
Z9 4
U1 1
U2 11
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1862-6300
J9 PHYS STATUS SOLIDI A
JI Phys. Status Solidi A-Appl. Mat.
PD FEB
PY 2009
VL 206
IS 2
BP 270
EP 275
DI 10.1002/pssa.200824381
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 416MJ
UT WOS:000264009900016
DA 2018-10-19
ER

PT J
AU Little, U
   Buchanan, F
   Harkin-Jones, E
   McCaigue, M
   Farrar, D
   Dickson, G
AF Little, Uel
   Buchanan, Fraser
   Harkin-Jones, Eileen
   McCaigue, Mervyn
   Farrar, David
   Dickson, Glenn
TI Accelerated degradation behaviour of poly(epsilon-caprolactone) via melt
   blending with poly(aspartic acid-co-lactide) (PAL)
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Degradation; Poly(epsilon-caprolactone); Poly(aspartic acid-co-lactide);
   Additive; Mechanical properties; Microstructure
ID AMPHIPHILIC BIODEGRADABLE COPOLYMER; POLY(LACTIC ACID); POLYMERS;
   POLYCAPROLACTONE; MOLECULES; DSC
AB Poly(epsilon-caprolactone) (PCL) has many favourable attributes for tissue engineering scaffold applications. A major drawback, however, is its slow degradation rate, typically greater than 3 years. In this study PCL was melt blended with a small percentage of poly(aspartic acid-co-lactide) (PAL) and the degradation behaviour was evaluated in phosphate buffer solution (PBS) at 37 degrees C. The addition of PAL was found to significantly enhance the degradation profile of PCL. Subsequent degradation behaviour was investigated in terms of the polymer's mechanical properties, Molecular weight (M(w)), mass changes and thermal characteristics. The results indicate that the addition of PAL accelerates the degradation of PCL, with 20% mass loss recorded after just 7 months in vitro for samples containing 8 wt% PAL. The corresponding pure PCL samples exhibited no mass loss over the same time period. In vitro assessment of PCL and PCL/PAL composites in tissue Culture medium in the absence of cells revealed stable pH readings with time. SEM studies of cell/biomaterial interactions demonstrated biocompatibility of C(3)H(10)T(1/2) cells with PCL and PCL/PAL composites at all concentrations of PAL additive. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Little, Uel; Buchanan, Fraser; Harkin-Jones, Eileen] Queens Univ Belfast, Sch Mech & Aerosp Engn, Belfast BT9 5AH, Antrim, North Ireland.
   [McCaigue, Mervyn; Dickson, Glenn] Queens Univ Belfast, Sch Med & Dent, Belfast BT9 5AH, Antrim, North Ireland.
   [Farrar, David] Smith & Nephew Res Ctr, York, N Yorkshire, England.
RP Buchanan, F (reprint author), Queens Univ Belfast, Sch Mech & Aerosp Engn, Ashby Bldg,Stranmillis Rd, Belfast BT9 5AH, Antrim, North Ireland.
EM f.buchanan@qub.ac.uk
OI harkin-jones, eileen/0000-0001-5901-4624
FU DEL
FX The authors would like to thank Smith & Nephew (UK) for providing
   molecular weight analysis and DEL for the financial support provided.
CR Chmielewski AG, 2005, NUCL INSTRUM METH B, V236, P44, DOI 10.1016/j.nimb.2005.03.2247
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   DAVER F, 1995, J APPL POLYM SCI, V58, P2429, DOI 10.1002/app.1995.070581310
   Fann DM, 1998, POLYM ENG SCI, V38, P265, DOI 10.1002/pen.10187
   Kong Y, 2002, POLYMER, V43, P3873, DOI 10.1016/S0032-3861(02)00235-5
   KRYSZEWSKI M, 1979, PURE APPL CHEM, V51, P2395, DOI 10.1351/pac197951122395
   Langlois V, 2002, POLYM DEGRAD STABIL, V76, P411, DOI 10.1016/S0141-3910(02)00042-3
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Nitta KH, 1999, J POLYM SCI POL PHYS, V37, P357, DOI 10.1002/(SICI)1099-0488(19990215)37:4<357::AID-POLB9>3.0.CO;2-I
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Shinoda H, 2003, POLYM DEGRAD STABIL, V80, P241, DOI 10.1016/S0141-3910(02)00404-4
   Shinoda H, 2003, MACROMOL BIOSCI, V3, P34, DOI 10.1002/mabi.200390007
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Tsuji H, 2006, MACROMOL MATER ENG, V291, P1245, DOI 10.1002/mame.200600276
   Weir NA, 2003, PLAST RUBBER COMPOS, V32, P265, DOI 10.1179/146580103225010264
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
NR 16
TC 18
Z9 18
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD FEB
PY 2009
VL 94
IS 2
BP 213
EP 220
DI 10.1016/j.polymdegradstab.2008.11.001
PG 8
WC Polymer Science
SC Polymer Science
GA 405HC
UT WOS:000263212700012
DA 2018-10-19
ER

PT J
AU Bai, W
   Zhang, ZP
   Li, Q
   Chen, DL
   Chen, HC
   Zhao, N
   Xiong, CD
AF Bai, Wei
   Zhang, Zhi-ping
   Li, Qing
   Chen, Dong-Liang
   Chen, He-Chun
   Zhao, Na
   Xiong, Cheng-Dong
TI Miscibility, morphology and thermal properties of
   poly(para-dioxanone)/poly(D,L-lactide) blends
SO POLYMER INTERNATIONAL
LA English
DT Article
DE poly(para-dioxanone); poly(D,L-lactide); blends; biomaterial
ID IN-VIVO; CRYSTALLIZATION; POLY(P-DIOXANONE); DEGRADATION; COPOLYMERS;
   COMPOSITE; IMPLANTS; BEHAVIOR; SYSTEM
AB BACKGROUND: Poly(para-dioxanone) (PPDO) is a biodegradable polyester with excellent biodegradability, bioabsorbability, biocompatibility and mechanical flexibility. However, its high cost and relatively fast degradation rate have hindered the development of commercial applications. Blending with other polymers is a simple and convenient way of modifying the properties of aliphatic polyesters. Poly(D,L-lactide) (PDLLA) is another polyester that has been extensively studied for biomedical applications due to its biocompatibility and suitable degradation rate. However, to our knowledge, blends of PPDO/PDLLA have not been reported in the literature.
   RESULTS: A series of biodegradable polymers were blended by solution co-precipitation of PPDO and PDLLA in various blend ratios. The miscibility, morphology and thermal properties of the materials were investigated. DSC curves for all blends revealed two discrete glass transition temperatures which matched the values for pure PPDO and PDLLA. SEM images of fracture surfaces displayed evidence of phase separation consistent with the DSC results. The contact angles increased with the addition of PDLLA.
   CONCLUSION: PPDO/PDLLA blends exhibit two distinct glass transition temperatures that remain nearly constant and correspond to the glass transition temperatures of the homopolymers for all blend compositions, indicating that blends of PPDO and PDLLA are immiscible. Images of the surface obtained using SEM were also suggestive of a two-phase material. The crystallinity of the PPDO phase in the blends was affected by the PDLLA content. The mechanical properties of the blends changed dramatically with composition. Adding PDLLA makes the blends less hydrophilic than PPDO. (C) 2008 Society of Chemical Industry
C1 [Bai, Wei; Zhang, Zhi-ping; Li, Qing; Chen, Dong-Liang; Chen, He-Chun; Zhao, Na; Xiong, Cheng-Dong] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   [Bai, Wei; Zhao, Na] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China.
RP Xiong, CD (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
EM xcd1633@yahoo.com.cn
FU West Light Foundation of the Chinese Academy of Sciences
FX The authors are grateful for the financial support from the West Light
   Foundation of the Chinese Academy of Sciences.
CR CACHIA VV, 1999, Patent No. 5893850
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Chen SC, 2007, J BIOMED MATER RES A, V80A, P453, DOI 10.1002/jbm.a.30938
   Cheng H. C., 2007, CHIN POLYM B, V19, P41
   Edlund U, 2000, J POLYM SCI POL CHEM, V38, P786, DOI 10.1002/(SICI)1099-0518(20000301)38:5<786::AID-POLA2>3.0.CO;2-7
   FORSCHNER TC, 1997, Patent No. 9721753
   Gertzman A., 1986, US Pat., Patent No. 4591630
   Hasegawa S, 2005, J BIOMED MATER RES A, V75A, P567, DOI 10.1002/jbm.a.30460
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   Ishikiriyama K, 1998, J MACROMOL SCI PHYS, VB37, P27, DOI 10.1080/00222349808220453
   MATTEI PV, 1984, Patent No. 4440789
   Muller AJ, 2005, ADV POLYM SCI, V190, P1, DOI 10.1007/12_001
   Park JM, 2004, COMPOS SCI TECHNOL, V64, P847, DOI 10.1016/j.composcitech.2003.09.009
   Pezzin APT, 2006, J APPL POLYM SCI, V101, P1899, DOI 10.1002/app.23646
   Pezzin APT, 2003, J APPL POLYM SCI, V88, P2744, DOI 10.1002/app.11984
   Sabino MA, 2000, MACROMOL CHEM PHYSIC, V201, P2687, DOI 10.1002/1521-3935(20001201)201:18<2687::AID-MACP2687>3.0.CO;2-#
   Sabino MA, 2007, POLYM DEGRAD STABIL, V92, P986, DOI 10.1016/j.polymdegradstab.2007.03.010
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449
   Tsuji H, 1996, POLYMER, V37, P595, DOI 10.1016/0032-3861(96)83146-6
   Wang XL, 2004, ACTA MATER, V52, P4899, DOI 10.1016/j.actamat.2004.06.044
   Yang KK, 2002, J MACROMOL SCI-POL R, VC42, P373, DOI 10.1081/MC-120006453
   Zhang LL, 1996, POLYMER, V37, P235, DOI 10.1016/0032-3861(96)81093-7
   Zhang LL, 1998, J APPL POLYM SCI, V70, P811, DOI 10.1002/(SICI)1097-4628(19981024)70:4<811::AID-APP22>3.0.CO;2-Y
   ZHANG LL, 1995, J APPL POLYM SCI, V56, P103, DOI 10.1002/app.1995.070560114
   Zhang RY, 2004, MACROMOL BIOSCI, V4, P100, DOI 10.1002/mabi.200300017
   Zheng L, 2005, EUR POLYM J, V41, P1243, DOI 10.1016/j.eurpolymj.2004.12.018
   Zhou ZX, 2006, POLYM INT, V55, P383, DOI 10.1002/pi.1904
NR 28
TC 17
Z9 19
U1 0
U2 19
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD FEB
PY 2009
VL 58
IS 2
BP 183
EP 189
DI 10.1002/pi.2512
PG 7
WC Polymer Science
SC Polymer Science
GA 402LH
UT WOS:000263014700010
DA 2018-10-19
ER

PT J
AU Li, X
   Wang, CT
   Zhang, WG
   Li, YC
AF Li, X.
   Wang, C-T
   Zhang, W-G
   Li, Y-C
TI Properties of a porous Ti-6Al-4V implant with a low stiffness for
   biomedical application
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE Ti-6Al-4V; mechanical properties; rapid prototyping; electron beam
   melting
ID ORTHOPEDIC APPLICATIONS; JOINT REPLACEMENT; BONE INGROWTH; TITANIUM;
   COMPONENTS
AB Porous Ti-6Al-4V alloy was fabricated using the electron beam melting (EBM) process. The phases of the as-received powder and fabricated samples were characterized using X-ray diffraction (XRD) analysis. The XRD peaks of both diffraction patterns agree well, which indicated that the EBM process has not changed the composition of Ti-6Al-4V. The fabricated samples exhibited a Vickers microhardness value of around 428HV. The compression and three-point bending tests were performed to evaluate the mechanical properties of the porous Ti-6Al-4V implant with a porosity of around 60 per cent. The compressive yield strength, Young's modulus, and ultimate compressive strength were 194.6 MPa, 4.25 GPa, and 222.6 MPa respectively. The bending stiffness and bending strength were 3.7 GPa and 126.3 MPa respectively. These results demonstrated that the porous Ti-6Al-4V implant with a low stiffness and high porosity could be a promising biomaterial for biomedical applications.
C1 [Li, X.; Wang, C-T; Zhang, W-G; Li, Y-C] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200240, Peoples R China.
RP Li, X (reprint author), Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200240, Peoples R China.
EM xiangjimli@gmail.com
FU Medicine and Engineering Foundation of Shanghai Jiaotong University
   [YG2007MS17]
FX This work was supported by the Medicine and Engineering Foundation of
   Shanghai Jiaotong University under Grant YG2007MS17.
CR CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   Collier DP, 1998, CLIN ORTHOP RELAT R, V3, P249
   ENGH CA, 1995, J BONE JOINT SURG AM, V77A, P903, DOI 10.2106/00004623-199506000-00011
   ENGH CA, 1993, J BONE JOINT SURG AM, V75A, P814, DOI 10.2106/00004623-199306000-00003
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Upcraft S, 2003, ASSEMBLY AUTOM, V23, P318, DOI 10.1108/01445150310698634
   Xue W, 2007, ACTA BIOMATER, V3, P1007, DOI 10.1016/j.actbio.2007.05.009
NR 14
TC 16
Z9 16
U1 0
U2 14
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD FEB
PY 2009
VL 223
IS H2
BP 173
EP 178
DI 10.1243/09544119JEIM466
PG 6
WC Engineering, Biomedical
SC Engineering
GA 413BH
UT WOS:000263767400004
PM 19278194
DA 2018-10-19
ER

PT J
AU Zani, A
   Pierro, A
   Elvassore, N
   De Coppi, P
AF Zani, Augusto
   Pierro, Agostino
   Elvassore, Nicola
   De Coppi, Paolo
TI Tissue engineering: an option for esophageal replacement?
SO SEMINARS IN PEDIATRIC SURGERY
LA English
DT Article
DE Esophagus; Stem cell; Esophageal atresia; Prosthesis; Patch
AB Esophageal replacement is required in several pediatric surgical conditions, like long-gap esophageal atresia. Although several techniques have been described to bridge the gap, all of them could be followed by postoperative complications. Esophageal tissue engineering could represent a valid alternative thanks to the recent advances in biomaterial science and cellular biology. Numerous attempts to shape a new esophagus in vitro have been described in the last decade. Herein, we review the main studies on the experimental use of nonabsorbable and absorbable materials as well as the development of cellularized patches. Furthermore, we describe the future perspectives of esophageal tissue engineering characterized by the use of stem cells seeded on new biopolymers. This opens to the construction of a functional allograft that could allow an anatomical replacement that grows with the children and does not severely impair their anatomy. (C) 2009 Published by Elsevier Inc.
C1 [Zani, Augusto; Pierro, Agostino; De Coppi, Paolo] Inst Child Hlth, Dept Paediat Surg, London WC1N 1EH, England.
   [Zani, Augusto; Pierro, Agostino; De Coppi, Paolo] Great Ormond St Hosp Sick Children, London WC1N 3JH, England.
   [Elvassore, Nicola] Univ Padua, Dept Chem Engn, Padua, Italy.
RP De Coppi, P (reprint author), Inst Child Hlth, Surg Unit, 30 Guilford St, London WC1N 1EH, England.
EM p.decoppi@ich.ucl.ac.uk
OI De Coppi, Paolo/0000-0002-1659-0207
FU Great Ormond Street Hospital Childrens Charity [V1230]
CR Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Beckstead BL, 2005, BIOMATERIALS, V26, P6217, DOI 10.1016/j.biomaterials.2005.04.010
   Bhrany AD, 2006, TISSUE ENG, V12, P319, DOI 10.1089/ten.2006.12.319
   BIRCHER E, 1907, ZENTRALBL CHIR, V34, P1479
   Choi RS, 1997, TRANSPLANT P, V29, P848, DOI 10.1016/S0041-1345(96)00164-9
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Deurloo JA, 2005, ARCH SURG-CHICAGO, V140, P976, DOI 10.1001/archsurg.140.10.976
   Epperly MW, 2004, RADIAT RES, V162, P233, DOI 10.1667/RR3224
   FUKUSHIMA M, 1983, SURGERY, V93, P70
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Grikscheit T, 2003, J THORAC CARDIOV SUR, V126, P537, DOI 10.1016/S0022-5223(03)00032-1
   Grikscheit TC, 2002, SURGERY, V132, P200, DOI 10.1067/msy.2002.125310
   Hayashi K, 2004, ASAIO J, V50, P261, DOI 10.1097/01.MAT.0000123688.45717.A4
   Hori Y, 2003, INT J ARTIF ORGANS, V26, P241
   Houben CH, 2008, PRENATAL DIAG, V28, P667, DOI 10.1002/pd.1938
   Isch JA, 2001, J PEDIATR SURG, V36, P266, DOI 10.1053/jpsu.2001.20685
   Jansen PL, 2004, EUR SURG RES, V36, P104, DOI 10.1159/000076650
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lopes MF, 2006, J INVEST SURG, V19, P105, DOI 10.1080/08941930600569621
   Marzaro M, 2006, J BIOMED MATER RES A, V77A, P795, DOI 10.1002/jbm.a.30666
   NEUHOF H, 1922, SURG GYNECOL OBSTET, V34, P767
   Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Ozeki M, 2006, J BIOMED MATER RES A, V79A, P771, DOI 10.1002/jbm.a.30885
   Romeo C, 2000, J PEDIATR SURG, V35, P740, DOI 10.1053/jpsu.2000.6048
   Sarosi G, 2008, DIS ESOPHAGUS, V21, P43, DOI 10.1111/j.1442-2050.2007.00744.x
   Sato M, 1994, ASAIO J, V40, pM389, DOI 10.1097/00002480-199407000-00028
   Shinhar D, 1998, PEDIATR SURG INT, V13, P84, DOI 10.1007/s003830050254
   Somppi E, 1998, J PEDIATR SURG, V33, P1341, DOI 10.1016/S0022-3468(98)90003-3
   Spitz L., 2006, PEDIAT SURG, P1093
   Spitz L, 2006, J PEDIATR SURG, V41, P1635, DOI 10.1016/j.jpedsurg.2006.07.004
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takimoto Y, 1998, J THORAC CARDIOV SUR, V116, P98, DOI 10.1016/S0022-5223(98)70247-8
   Urita Y, 2007, PEDIATR SURG INT, V23, P21, DOI 10.1007/s00383-006-1799-0
   Watanabe M, 2005, ASAIO J, V51, P158, DOI 10.1097/01.MAT.0000154644.44891.F1
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
NR 37
TC 20
Z9 22
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1055-8586
J9 SEMIN PEDIATR SURG
JI Semin. Pediatr. Surg.
PD FEB
PY 2009
VL 18
IS 1
BP 57
EP 62
DI 10.1053/j.sempedsurg.2008.10.011
PG 6
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA V28NY
UT WOS:000208688700011
PM 19103424
DA 2018-10-19
ER

PT J
AU Rajab, TK
   Wallwiener, CW
   Brochhausen, C
   Hierlemann, H
   Kraemer, B
   Wallwiener, M
AF Rajab, Taufiek Konrad
   Wallwiener, Christian Wilhelm
   Brochhausen, Christoph
   Hierlemann, Helmut
   Kraemer, Bernhard
   Wallwiener, Markus
TI Adhesion prophylaxis using a copolymer with rationally designed material
   properties
SO SURGERY
LA English
DT Article
ID ABDOMINAL ADHESIONS; SKIN SUBSTITUTE; PREVENTION; MEMBRANE
AB Background. Physical barriers are the only licensed adjuncts for adhesion prophylaxis in the United States and Europe. Here, we investigate D,L-polylactide-is an element of-caprolactonetrimethylenecarbonate (PCT copolymer), which is a rationally designed biomaterial, as an adhesion barrier.
   Methods. PCT copolymer membranes were produced by polymerization of the monomers, dissolution in organic solvents, and subsequently processing them by means of modified phase inversion and freeze drying. In vitro cytotoxicity was assayed by fibroblast culture. In, vivo adhesion prophylaxis was studied in a rat model that involved standardized traumatization by electrocautery and suturing. The quantity and quality of the resulting adhesions were scored 14 days postoperatively. Complete autopsy was performed in each animal, and the implantation sites were examined histologically. The suitability for human laparoscopic application was investigated in a patient admitted for routine myomectomy.
   Results. The PCT copolymer had no effect on the proliferation of cultured cells. in vitro. The in vivo model showed that the quantity of adhesions that cover the traumatized areas was significantly less in animals treated. with PCT copolymer membrane (32%) than in. untreated animals (78%) (P < .01). Adhesions of both dense and filmy quality were affected. In the animals, autopsy and histologic examination of the relevant tissues revealed no indication of adverse reactions to the PCT copolymer. Human laparoscopic application was successful.
   Conclusion. The PCT copolymer membrane is biocompatible with the abdominal cavity and decreased adhesions in the animal model. It is also suitable for human laparoscopic application. Therefore, the PCT copolymer represents a candidate for additional clinical evaluation. (Surgery 2009;145:196-201.)
C1 [Rajab, Taufiek Konrad; Wallwiener, Christian Wilhelm; Kraemer, Bernhard; Wallwiener, Markus] Univ Tubingen, Tubingen, Germany.
   [Wallwiener, Christian Wilhelm] Univ London Imperial Coll Sci Technol & Med, London, England.
   [Brochhausen, Christoph] Johannes Gutenberg Univ Mainz, Mainz, Germany.
   [Hierlemann, Helmut] German Ctr Biomat & Organ Replacement, Denkendorf, Germany.
RP Rajab, TK (reprint author), Univ Frauenklin, Calwerstr 7, D-72076 Tubingen, Germany.
EM taufiek.rajab@imperial.ac.uk
FU German Ministry of Education and Research (Minimally Invasive
   Technologies and Techniques Project); Research Foundation of the
   Universitats-Frauenklinik Tubingen
FX Supported by a grant from the German Ministry of Education and Research
   (Minimally Invasive Technologies and Techniques Project) and a grant
   front the Research Foundation of the Universitats-Frauenklinik Tubingen.
CR Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Boland GM, 2006, J SURG RES, V132, P3, DOI 10.1016/j.jss.2005.12.002
   Darzi A, 2002, BRIT MED J, V324, P31, DOI 10.1136/bmj.324.7328.31
   ELLIS RJ, 1999, CELL BIOL, V1, P1
   Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5
   HARRIS ES, 1995, SURGERY, V117, P663, DOI 10.1016/S0039-6060(95)80010-7
   HOLMDAHL L, 1994, EUR SURG RES, V26, P248, DOI 10.1159/000129342
   Ozel H, 2005, WOUND REPAIR REGEN, V13, P358, DOI 10.1111/j.1067-1927.2005.130402.x
   Schild SE, 2008, J THORAC ONCOL, V3, P1, DOI 10.1097/JTO.0b013e31815f662c
   Schwarze H, 2008, ANN PLAS SURG, V60, P181, DOI 10.1097/SAP.0b013e318056bbf6
   Uhlig C, 2007, BURNS, V33, P221, DOI 10.1016/j.burns.2006.04.024
   van der Krabben AA, 2000, BRIT J SURG, V87, P467, DOI 10.1046/j.1365-2168.2000.01394.x
   Vrijland WW, 2002, ANN SURG, V235, P193, DOI 10.1097/00000658-200202000-00006
NR 13
TC 20
Z9 20
U1 0
U2 7
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD FEB
PY 2009
VL 145
IS 2
BP 196
EP 201
DI 10.1016/j.surg.2008.08.019
PG 6
WC Surgery
SC Surgery
GA 404KU
UT WOS:000263151200010
PM 19167975
DA 2018-10-19
ER

PT J
AU Burdick, JA
   Vunjak-Novakovic, G
AF Burdick, Jason A.
   Vunjak-Novakovic, Gordana
TI Engineered Microenvironments for Controlled Stem Cell Differentiation
SO TISSUE ENGINEERING PART A
LA English
DT Review
ID GROWTH-FACTOR DELIVERY; MARROW STROMAL CELLS; MINERALIZED MATRIX
   DEPOSITION; PERFUSION BIOREACTOR SYSTEM; HYALURONIC-ACID NETWORKS;
   IN-VITRO; CARDIAC TISSUE; 3-DIMENSIONAL CULTURE; PROGENITOR CELLS;
   SELF-RENEWAL
AB In a developing organism, tissues emerge from coordinated sequences of cell renewal, differentiation, and assembly that are orchestrated by spatial and temporal gradients of multiple regulatory factors. The composition, architecture, signaling, and biomechanics of the cellular microenvironment act in concert to provide the necessary cues regulating cell function in the developing and adult organism. With recent major advances in stem cell biology, tissue engineering is becoming increasingly oriented toward biologically inspired in vitro cellular microenvironments designed to guide stem cell growth, differentiation, and functional assembly. The premise is that to unlock the full potential of stem cells, at least some aspects of the dynamic three-dimensional (3D) environments that are associated with their renewal, differentiation, and assembly in native tissues need to be reconstructed. In the general context of tissue engineering, we discuss the environments for guiding stem cell function by an interactive use of biomaterial scaffolds and bioreactors, and focus on the interplay between molecular and physical regulatory factors. We highlight some illustrative examples of controllable cell environments developed through the interaction of stem cell biology and tissue engineering at multiple levels.
C1 [Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu; gv2131@columbia.edu
RI vunjak-novakovic, gordana/J-9279-2012
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIH [K22DE015761, DE16525, HL076485, EB002520, CO21631]; Packard
   Fellowship in Science and Engineering
FX The authors would like to acknowledge funding from the NIH (Grant
   K22DE015761 to J.A.B.; Grants DE16525, HL076485, EB002520, and CO21631
   to G.V.N.) and a Packard Fellowship in Science and Engineering (to
   J.A.B.).
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Altman Greg, 2002, FASEB Journal, V16, P270
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   Baksh D, 2007, BIOTECHNOL BIOENG, V98, P1195, DOI 10.1002/bit.21556
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003
   Bauwens C, 2005, BIOTECHNOL BIOENG, V90, P452, DOI 10.1002/bit.20445
   Botchwey EA, 2003, BIORHEOLOGY, V40, P299
   Braccini A, 2005, STEM CELLS, V23, P1066, DOI 10.1634/stemcells.2005-0002
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Chang CF, 2007, J BIOMED MATER RES A, V80A, P466, DOI 10.1002/jbm.a.30963
   Chao PHG, 2007, J ORTHOP SCI, V12, P398, DOI 10.1007/s00776-007-1147-9
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254
   Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Dean SK, 2006, TRANSPLANTATION, V82, P1175, DOI 10.1097/01.tp.0000239518.23354.64
   Demirci U, 2007, LAB CHIP, V7, P1139, DOI 10.1039/b704965j
   Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204
   Dvir T, 2006, TISSUE ENG, V12, P2843, DOI 10.1089/ten.2006.12.2843
   Engelmayr GC, 2008, ANN BIOMED ENG, V36, P700, DOI 10.1007/s10439-008-9447-6
   Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Fong WJ, 2005, BIOPROC BIOSYST ENG, V27, P381, DOI 10.1007/s00449-005-0421-5
   FRESHNEY I, 2007, PRINCIPLES TISSUE EN, P155
   GERECHT S, 2007, HUMAN EMBRYONIC STEM, P149
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Glowacki J, 1998, CELL TRANSPLANT, V7, P319, DOI 10.1016/S0963-6897(98)00003-7
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924
   Gottwald E, 2007, LAB CHIP, V7, P777, DOI 10.1039/b618488j
   Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009
   GRAYSON WL, 2008, TISSUE ENG IN PRESS
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Harrison RG, 1907, ANAT REC, V1, P116, DOI 10.1002/ar.1090010503
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Khademhosseini A, 2003, ADV MATER, V15, P1995, DOI 10.1002/adma.200305433
   Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707
   Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f
   King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034
   Kino-Oka M, 2005, TISSUE ENG, V11, P535, DOI 10.1089/ten.2005.11.535
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732
   Liu H, 2006, BIOMATERIALS, V27, P6004, DOI 10.1016/j.biomaterials.2006.06.016
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   NG YL, 2007, BIOPROCESS IN PRESS
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   O'Cearbhaill ED, 2008, BIOMATERIALS, V29, P1610, DOI 10.1016/j.biomaterials.2007.11.042
   Oh SKW, 2005, BIOTECHNOL BIOENG, V91, P523, DOI 10.1002/bit.20650
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028
   Ruhnke M, 2003, STEM CELLS, V21, P428, DOI 10.1634/stemcells.21-4-428
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228
   Thomson H, 2007, TRENDS BIOTECHNOL, V25, P224, DOI 10.1016/j.tibtech.2007.03.003
   Timmins NE, 2007, TISSUE ENG, V13, P2021, DOI 10.1089/ten.2006.0158
   Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h
   Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Wendt D, 2005, J BIOSCI BIOENG, V100, P489, DOI 10.1263/jbb.100.489
   Wendt D, 2006, BIORHEOLOGY, V43, P481
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   Zhao F, 2005, BIOTECHNOL BIOENG, V91, P482, DOI 10.1002/bit.20532
   Zhao XJ, 2007, MACROMOL BIOSCI, V7, P13, DOI 10.1002/mabi.200600230
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann Wolfram-Hubertus, 2007, Trends Cardiovasc Med, V17, P134, DOI 10.1016/j.tcm.2007.02.007
NR 110
TC 237
Z9 244
U1 3
U2 64
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2009
VL 15
IS 2
BP 205
EP 219
DI 10.1089/ten.tea.2008.0131
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 403BR
UT WOS:000263057300002
PM 18694293
OA Green Published, Green Accepted
DA 2018-10-19
ER

PT J
AU Cheng, NC
   Estes, BT
   Awad, HA
   Guilak, F
AF Cheng, Nai-Chen
   Estes, Bradley T.
   Awad, Hani A.
   Guilak, Farshid
TI Chondrogenic Differentiation of Adipose-Derived Adult Stem Cells by a
   Porous Scaffold Derived from Native Articular Cartilage Extracellular
   Matrix
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; LOW-OXYGEN TENSION; BONE-MARROW;
   CHONDRAL DEFECTS; IN-VITRO; STROMAL CELLS; ARTHROSCOPIC DEBRIDEMENT;
   OSTEOCHONDRAL ALLOGRAFTS; ABRASION ARTHROPLASTY; MECHANICAL-PROPERTIES
AB Adipose-derived adult stem cells (ASCs) have the ability to differentiate into a chondrogenic phenotype in response to specific environmental signals such as growth factors or artificial biomaterial scaffolds. In this study, we examined the hypothesis that a porous scaffold derived exclusively from articular cartilage can induce chondrogenesis of ASCs. Human ASCs were seeded on porous scaffolds derived from adult porcine articular cartilage and cultured in standard medium without exogenous growth factors. Chondrogenesis of ASCs seeded within the scaffold was evident by quantitative RT-PCR analysis for cartilage-specific extracellular matrix (ECM) genes. Histological and immunohistochemical examination showed abundant production of cartilage-specific ECM components-particularly, type II collagen-after 4 or 6 weeks of culture. After 6 weeks of culture, the cellular morphology in the ASC-seeded constructs resembled those in native articular cartilage tissue, with rounded cells residing in the glycosaminoglycan-rich regions of the scaffolds. Biphasic mechanical testing showed that the aggregate modulus of the ASC-seeded constructs increased over time, reaching 150 kPa by day 42, more than threefold higher than that of the unseeded controls. These results suggest that a porous scaffold derived from articular cartilage has the ability to induce chondrogenic differentiation of ASCs without exogenous growth factors, with significant synthesis and accumulation of ECM macromolecules, and the development of mechanical properties approaching those of native cartilage. These findings support the potential for a processed cartilage ECM as a biomaterial scaffold for cartilage tissue engineering. Additional in vivo evaluation is necessary to fully recognize the clinical implication of these observations.
C1 [Guilak, Farshid] Duke Univ, Med Ctr, Dept Surg, Orthopaed Res Labs,Div Orthopaed Surg, Durham, NC 27710 USA.
   [Cheng, Nai-Chen; Estes, Bradley T.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
   [Cheng, Nai-Chen] Natl Taiwan Univ, Dept Surg, Taipei 10764, Taiwan.
   [Cheng, Nai-Chen] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
   [Awad, Hani A.] Univ Rochester, Dept Biomed Engn, Ctr Musculoskeletal Res, Rochester, NY USA.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Surg, Orthopaed Res Labs,Div Orthopaed Surg, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Cheng, Naichen/H-7596-2013; Awad, Hani/G-6976-2014
OI Cheng, Naichen/0000-0003-4071-5628; Awad, Hani/0000-0003-2197-2610;
   Guilak, Farshid/0000-0001-7380-0330
FU NIAMS NIH HHS [R01 AR048852, P01 AR050245, R01 AR048182]; NIA NIH HHS
   [R01 AG015768]
CR Ahmed Nazish, 2007, Cell Physiol Biochem, V20, P665, DOI 10.1159/000107728
   AICHROTH PM, 1991, INT ORTHOP, V15, P351
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Aubin P P, 2001, Clin Orthop Relat Res, pS318, DOI 10.1097/00003086-200110001-00029
   Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Basile P, 2008, MOL THER, V16, P466, DOI 10.1038/sj.mt.6300395
   BAUMGAERTNER MR, 1990, CLIN ORTHOP RELAT R, P197
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439, DOI 10.2106/00004623-199710000-00001
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Dausse Y, 2003, OSTEOARTHR CARTILAGE, V11, P16, DOI 10.1053/joca.2002.0859
   Denoncourt P M, 1986, Orthop Rev, V15, P652
   Domm C, 2004, TISSUE ENG, V10, P1796, DOI 10.1089/ten.2004.10.1796
   Emmerson BC, 2007, AM J SPORT MED, V35, P907, DOI 10.1177/0363546507299932
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Estes RT, 2006, J CELL PHYSIOL, V209, P987, DOI 10.1002/jcp.20808
   EYRE DR, 1980, BIOCHEM J, V188, P823, DOI 10.1042/bj1880823
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   FRIEDMAN MJ, 1984, CLIN ORTHOP RELAT R, P200
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Ghazavi MT, 1997, J BONE JOINT SURG BR, V79B, P1008, DOI 10.1302/0301-620X.79B6.7534
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Guilak F, 2004, BIORHEOLOGY, V41, P389
   Guilak F, 2001, Clin Orthop Relat Res, pS295, DOI 10.1097/00003086-200110001-00027
   Guilak F., 2005, BASIC ORTHOPAEDIC BI, P259
   Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   JOHNSON LL, 2001, CLIN ORTHOP S, V391, pS306
   Kang Y, 2006, J BIOMED MATER RES A, V77A, P331, DOI 10.1002/jbm.a.30607
   Kim HA, 2001, J RHEUMATOL, V28, P2038
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kish G, 1999, CLIN SPORT MED, V18, P45, DOI 10.1016/S0278-5919(05)70129-0
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Kuo CK, 2008, J BIOMED MATER RES A, V84A, P899, DOI 10.1002/jbm.a.31375
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Kurz B, 2004, TISSUE ENG, V10, P1277, DOI 10.1089/ten.2004.10.1277
   Larson CM, 2002, MATRIX BIOL, V21, P349, DOI 10.1016/S0945-053X(02)00026-4
   Lee CR, 2000, J ORTHOPAED RES, V18, P790, DOI 10.1002/jor.1100180517
   Lee WK, 2003, J BIOMED MATER RES A, V67A, P1087, DOI 10.1002/jbm.a.10570
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Maquart FX, 2004, CRIT REV ONCOL HEMAT, V49, P199, DOI 10.1016/j.critrevonc.2003.06.007
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mehlhorn AT, 2006, TISSUE ENG, V12, P2853, DOI 10.1089/ten.2006.12.2853
   Mierisch CM, 2002, ARTHROSCOPY, V18, P892, DOI 10.1053/jars.2002.36117
   Minas T, 2001, CLIN ORTHOP RELAT R, pS349
   MOW VC, 1980, SIAM REV, V22, P275, DOI 10.1137/1022056
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Murugan R, 2008, J MATER SCI-MATER M, V19, P2423, DOI 10.1007/s10856-007-3111-9
   Nehrer S, 1999, Clin Orthop Relat Res, P149, DOI 10.1097/00003086-199908000-00020
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Ng KW, 2008, AMINO ACIDS, V35, P433, DOI 10.1007/s00726-007-0583-3
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095
   Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Sheyn D, 2008, STEM CELLS, V26, P1056, DOI 10.1634/stemcells.2007-0858
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Stokes DG, 2002, ARTHRITIS RHEUM, V46, P404, DOI 10.1002/art.10106
   Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X
   Thirion S, 2004, METH MOLEC MED, V100, P1
   Toolan BC, 1998, J BIOMED MATER RES, V41, P244, DOI 10.1002/(SICI)1097-4636(199808)41:2<244::AID-JBM9>3.0.CO;2-I
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Wei YY, 2008, J ORTHOP RES, V26, P27, DOI 10.1002/jor.20468
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   WOUTERS E, 1992, AM J SPORT MED, V20, P141, DOI 10.1177/036354659202000208
   Xu CC, 2007, TISSUE ENG, V13, P551, DOI 10.1089/ten.2006.0169
NR 99
TC 139
Z9 146
U1 1
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2009
VL 15
IS 2
BP 231
EP 241
DI 10.1089/ten.tea.2008.0253
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 403BR
UT WOS:000263057300004
PM 18950290
OA Green Published
DA 2018-10-19
ER

PT J
AU Hsiong, SX
   Boontheekul, T
   Huebsch, N
   Mooney, DJ
AF Hsiong, Susan X.
   Boontheekul, Tanyarut
   Huebsch, Nathaniel
   Mooney, David J.
TI Cyclic Arginine-Glycine-Aspartate Peptides Enhance Three-Dimensional
   Stem Cell Osteogenic Differentiation
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MARROW STROMAL CELLS; BONE-MARROW; RGD PEPTIDES; OSTEOBLAST CULTURES;
   ALGINATE HYDROGELS; GENE-EXPRESSION; DRUG-DELIVERY; IN-VITRO; ADHESION;
   MATRIX
AB The role of morphogens in bone regeneration has been widely studied, whereas the effect of matrix cues, particularly on stem cell differentiation, are less well understood. In this work, we investigated the effects of arginine-glycine-aspartate (RGD) ligand conformation (linear vs cyclic RGD) on primary human bone marrow stromal cell (hBMSC) and D1 stem cell osteogenic differentiation in three-dimensional (3D) culture and compared their response with that of committed MC3T3-E1 preosteoblasts to determine whether the stage of cell differentiation altered the response to the adhesion ligands. Linear RGD densities that promoted osteogenic differentiation of committed cells (MC3T3-E1 preosteoblasts) did not induce differentiation of hBMSCs or D1 stem cells, although matrices presenting the cyclic form of this adhesion ligand enhanced osteoprogenitor differentiation in 3D culture. This may be due to enhanced integrin-ligand binding. These studies indicate that biomaterial design parameters optimized for differentiated cell types may not directly translate to stem cell populations, because less-committed cells may require more instruction than differentiated cells. It is likely that design of synthetic extracellular matrices tailored to promote stem cell differentiation may enhance bone regeneration by transplanted cells.
C1 [Hsiong, Susan X.] Univ Ann Arbor, Dept Chem Engn, Ann Arbor, MI USA.
   [Hsiong, Susan X.; Huebsch, Nathaniel; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Boontheekul, Tanyarut] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore, Singapore.
   [Huebsch, Nathaniel] Harvard Univ, Harvard Massachusetts Inst Technol Div Hlth Sci, Cambridge, MA 02138 USA.
RP Mooney, DJ (reprint author), Harvard Univ SEAS, Engn Sci Lab, 325 Pierce Hall, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Huebsch, Nathaniel/0000-0002-3329-0214
FU U. S. Army Research Laboratory; U. S. Army Research Office
   [DAAD190310168]; National Institutes of Health [R37 DE013033]
FX This work was supported by the U. S. Army Research Laboratory and the U.
   S. Army Research Office Grant DAAD190310168 and the National Institutes
   of Health (R37 DE013033).
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Bennett JH, 2001, ARCH ORAL BIOL, V46, P229, DOI 10.1016/S0003-9969(00)00114-X
   Betz VM, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2724
   Bogdanowich-Knipp SJ, 1999, J PEPT RES, V53, P530, DOI 10.1034/j.1399-3011.1999.00052.x
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Carpenter TO, 1998, ENDOCRINOLOGY, V139, P35, DOI 10.1210/en.139.1.35
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7
   DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012
   Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Holland TA, 2006, ADV BIOCHEM ENG BIOT, V102, P161, DOI 10.1007/b137205
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7
   Li XD, 2003, BONE, V33, P652, DOI 10.1016/S8756-3282(03)00239-4
   Lian JB, 1997, ENDOCRINOLOGY, V138, P2117, DOI 10.1210/en.138.5.2117
   Lieb E, 2005, BIOMATERIALS, V26, P2333, DOI 10.1016/j.biomaterials.2004.07.010
   Liu S, 2006, MOL PHARMACEUT, V3, P472, DOI 10.1021/mp060049x
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   Luppen CA, 2003, J BONE MINER RES, V18, P1186, DOI 10.1359/jbmr.2003.18.7.1186
   Macdonald KK, 2007, J TISSUE ENG REGEN M, V1, P314, DOI 10.1002/term.31
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   PFAFF M, 1994, J BIOL CHEM, V269, P20233
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Pistone M, 1996, CELL BIOL INT, V20, P471, DOI 10.1006/cbir.1996.0062
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201
   SHAPIRO HS, 1993, MATRIX, V13, P431, DOI 10.1016/S0934-8832(11)80109-5
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Stevens B, 2008, J BIOMED MATER RES B, V85B, P573, DOI 10.1002/jbm.b.30962
   Torigoe I, 2007, CELL TRANSPLANT, V16, P729, DOI 10.3727/000000007783465109
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103
   Yanai T, 2001, J BONE MINER METAB, V19, P345, DOI 10.1007/s007740170003
   CLINICALTRIALS GOV R
NR 52
TC 57
Z9 57
U1 2
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2009
VL 15
IS 2
BP 263
EP 272
DI 10.1089/ten.tea.2007.0411
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 403BR
UT WOS:000263057300007
PM 18783323
OA Green Published, Green Accepted
DA 2018-10-19
ER

PT J
AU da Silva, MA
   Crawford, A
   Mundy, J
   Martins, A
   Araujo, JV
   Hatton, PV
   Reis, RL
   Neves, NM
AF da Silva, Marta Alves
   Crawford, Aileen
   Mundy, Jenifer
   Martins, Albino
   Araujo, Jose V.
   Hatton, Paul V.
   Reis, Rui L.
   Neves, Nuno M.
TI Evaluation of Extracellular Matrix Formation in Polycaprolactone and
   Starch-Compounded Polycaprolactone Nanofiber Meshes When Seeded with
   Bovine Articular Chondrocytes
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MARROW STROMAL CELLS; TISSUE-ENGINEERING SCAFFOLDS; FLOW PERFUSION
   BIOREACTOR; MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS; IN-VITRO;
   OSTEOGENIC DIFFERENTIATION; BIOMEDICAL APPLICATIONS; LEUKOCYTE ADHESION;
   PROTEIN ADSORPTION
AB Cartilage defects are a major health problem. Tissue engineering has developed different strategies and several biomaterial morphologies, including natural-based ones, for repairing these defects. We used electrospun polycaprolactone (PCL) and starch-compounded PCL (SPCL) nanofiber meshes to evaluate extracellular matrix (ECM) formation by bovine articular chondrocytes (BACs). The main aim of this work was to evaluate the suitability of PCL and SPCL nanofiber meshes in chondrocyte cultures, and their capability to produce ECM when seeded onto these nanostructured materials. The effect of culture conditions (static vs dynamic) on ECM formation was also assessed. BACs were seeded onto PCL and SPCL nanofiber meshes using a dynamic cell-seeding procedure and cultured under static or dynamic conditions for 4 weeks. Constructs were characterized using scanning electron microscopy, histology, immunolocalization of collagen types I and II, and glycosaminoglycan (GAG) quantification. Results show an extensive cell colonization of the entire nanofiber mesh, for both materials, and that chondrocytes presented typical spherical morphology. Some degree of cell infiltration inside the nanofiber meshes was noticeable for both materials. ECM formation and GAG were detected throughout the materials, evidencing typical construct maturation. PCL and SPCL nanofiber meshes are suitable as supports for ECM formation and therefore are adequate for cartilage tissue-engineering approaches.
C1 [da Silva, Marta Alves; Martins, Albino; Araujo, Jose V.; Reis, Rui L.; Neves, Nuno M.] Univ Minho, Dept Polymer Engn, Res Grp 3Bs, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [da Silva, Marta Alves; Martins, Albino; Araujo, Jose V.; Reis, Rui L.; Neves, Nuno M.] Inst Biotechnol & Bioengn, PT Associated Lab, Braga, Portugal.
   [da Silva, Marta Alves; Crawford, Aileen; Mundy, Jenifer; Hatton, Paul V.] Univ Sheffield, Sch Clin Dent, Ctr Biomat & Tissue Engn, Sheffield, S Yorkshire, England.
RP da Silva, MA (reprint author), Univ Minho, Dept Polymer Engn, Res Grp 3Bs, Avepk,Zona Ind Gandra, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM msilva@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Alves da Silva,
   Marta/O-2545-2013; Martins, Albino/C-8432-2012; Neves, Nuno/B-4685-2008
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Alves
   da Silva, Marta/0000-0002-5146-9728; Martins,
   Albino/0000-0003-3868-0251; Neves, Nuno/0000-0003-3041-0687; Hatton,
   Paul/0000-0001-5234-1104; Crawford, Aileen/0000-0002-1594-5862
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/28708/2006]; Marie Curie Actions-ALEA JACTA EST
   [MEST-CT-2004-008104]; European NoE EXPERTISSUES [NMP3-CT-2004-500283];
   IP GENOSTEM [LSHB-CT-2003-503161]; NATURALLY NANO [POCTI/EME/58982/2004]
FX M. Alves da Silva would like to acknowledge the Portuguese Foundation
   for Science and Technology (FCT) for her grant (SFRH/BD/28708/2006),
   Marie Curie Actions-ALEA JACTA EST (MEST-CT-2004-008104), European NoE
   EXPERTISSUES (NMP3-CT-2004-500283), IP GENOSTEM (LSHB-CT-2003-503161)
   and NATURALLY NANO (POCTI/EME/58982/2004).
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Alves CM, 2003, J MATER SCI-MATER M, V14, P157, DOI 10.1023/A:1022023930825
   AZEVEDO H, 2006, NATURAL ORIGIN DEGRA
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Brandt K D, 2000, Am J Ther, V7, P75, DOI 10.1097/00045391-200007020-00005
   Costa SA, 2004, J MATER SCI-MATER M, V15, P335, DOI 10.1023/B:JMSM.0000021098.75103.3a
   CRAWFORD A, 2004, SYDN AUSTR T 7 WORLD, P594
   CRAWFORD A, 2004, CHONDROCYTE ISOLATIO
   Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492
   Ivirico JLE, 2007, J BIOMED MATER RES B, V83B, P266, DOI 10.1002/jbm.b.30792
   Freed LE, 1999, CLIN ORTHOP RELAT R, pS46
   Freemont AJ, 2006, EUR J RADIOL, V57, P32, DOI 10.1016/j.ejrad.2005.08.008
   GAISSMAIER C, 2005, BIOMATERIALS, V26
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gooch KJ, 2001, BIOTECHNOL BIOENG, V72, P402, DOI 10.1002/1097-0290(20000220)72:4<402::AID-BIT1002>3.0.CO;2-Q
   HATTON PV, 2004, SYDN AUSTR T 7 WORLD, P1621
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hutcheon GA, 2001, BIOMATERIALS, V22, P667, DOI 10.1016/S0142-9612(00)00229-5
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Marques AP, 2005, J MATER SCI-MATER M, V16, P1029, DOI 10.1007/s10856-005-4757-9
   Marques AP, 2005, MACROMOL BIOSCI, V5, P775, DOI 10.1002/mabi.200500010
   Marques AP, 2005, J MATER SCI-MATER M, V16, P833, DOI 10.1007/s10856-005-3580-7
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   Marques AP, 2003, J MATER SCI-MATER M, V14, P167, DOI 10.1023/A:1022028114896
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Oliveira AL, 2004, J MATER SCI-MATER M, V15, P533, DOI 10.1023/B:JMSM.0000021134.34651.d3
   Oliveira JT, 2007, J MATER SCI-MATER M, V18, P295, DOI 10.1007/s10856-006-0692-7
   Pashkuleva I, 2005, J MATER SCI-MATER M, V16, P81, DOI 10.1007/s10856-005-6450-4
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Ringe J, 2007, EXPERT OPIN BIOL TH, V7, P283, DOI 10.1517/14712598
   SAH RLY, 1990, BIOCHEM J, V267, P803, DOI 10.1042/bj2670803
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Santos MI, 2007, BIOMATERIALS, V28, P240, DOI 10.1016/j.biomaterials.2006.08.006
   SANTOS MI, 2006, BIOMATERIALS, V28, P240
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Venugopal J, 2005, CELL BIOL INT, V29, P861, DOI 10.1016/j.cellbi.2005.03.026
   Venugopal J, 2005, APPL BIOCHEM BIOTECH, V125, P147, DOI 10.1385/ABAB:125:3:147
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Wang YM, 2005, MACROMOL MATER ENG, V290, P792, DOI 10.1002/mame.200500003
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
NR 56
TC 32
Z9 32
U1 0
U2 22
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2009
VL 15
IS 2
BP 377
EP 385
DI 10.1089/ten.tea.2007.0327
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 403BR
UT WOS:000263057300017
PM 18759665
DA 2018-10-19
ER

PT J
AU Weber, A
   Strehl, A
   Springer, E
   Hansen, T
   Schad, A
   Kirkpatrick, C
AF Weber, Achim
   Strehl, Annette
   Springer, Erik
   Hansen, Torsten
   Schad, Arno
   Kirkpatrick, C. James
TI Biomaterial-induced sarcomagenesis is not associated with microsatellite
   instability
SO VIRCHOWS ARCHIV
LA English
DT Article
DE Biomaterials; Sarcoma; Microsatellite instability; Mutator phenotype
ID FOREIGN-BODY; TUMORS; INFLAMMATION; EXPRESSION; SEQUENCES; SARCOMAS;
   CANCER
AB Sarcomagenesis, in contrast to carcinogenesis, is poorly understood. Microsatellite instability has been implicated in the development of many cancers, in particular those associated with chronic inflammatory conditions. In an experimental animal model, rats developed not only a peri-implantational chronic inflammatory reaction, but also malignant mesenchymal tumors in response to different biomaterials. Therefore, it was the aim of our study to test if the development of biomaterial-induced sarcomas is characterized by a mutator phenotype. A multiplex-PCR approach was designed to screen biomaterial-induced sarcomas for the presence of microsatellite instability. Seven different microsatellite loci were tested in ten tumors for microsatellite instability using a fluorochrome-labelled multiplex-PCR and subsequent fragment analysis. All tumors provided a microsatellite-stable phenotype at all loci tested. Our data suggest that microsatellite instability is rarely or not at all a feature of malignant transformation of biomaterial-induced soft tissue tumors. Thus, there is no evidence that a mutator phenotype is a hallmark of biomaterial-induced sarcomagenesis.
C1 [Weber, Achim; Strehl, Annette; Springer, Erik; Hansen, Torsten; Schad, Arno; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RP Weber, A (reprint author), Univ Zurich Hosp, Inst Surg Pathol, Dept Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.
EM achim.weber@usz.ch
FU state of Rhineland-Palatinate
FX We thank Mrs U. Hildebrand for her expert technical assistance and the
   state of Rhineland-Palatinate for financial support.
CR BRAND KG, 1975, CANCER RES, V35, P279
   Chang CL, 2002, AM J PHYSIOL-CELL PH, V283, pC148, DOI 10.1152/ajpcell.00422.2001
   Doglioni C, 2000, J PATHOL, V190, P523
   Donaldson K, 2002, INHAL TOXICOL, V14, P5, DOI 10.1080/089583701753338613
   Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348
   French JE, 2001, CARCINOGENESIS, V22, P99, DOI 10.1093/carcin/22.1.99
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757
   IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0
   Kawaguchi K, 2005, ONCOL REP, V13, P241
   KINDBLOM LG, 1995, VIRCHOWS ARCH, V427, P19
   Kirkpatrick CJ, 2000, AM J PATHOL, V156, P1455, DOI 10.1016/S0002-9440(10)65014-6
   Lee SH, 2003, J IMMUNOL, V170, P2214, DOI 10.4049/jimmunol.170.4.2214
   Martin SS, 1998, ANN SURG ONCOL, V5, P356, DOI 10.1007/BF02303500
   MENTZEL T, 2000, J PATHOL, V190, P531
   MIRONOV NM, 1995, MOL CARCINOGEN, V13, P1, DOI 10.1002/mc.2940130102
   OTTINI L, 1995, CANCER RES, V55, P5677
   Sambrook J, 1989, MOL CLONING LAB MANU
   SERIKAWA T, 1992, GENETICS, V131, P701
   Sourvinos G, 1999, CARDIOVASC RES, V42, P728, DOI 10.1016/S0008-6363(98)00339-3
   SPIRTAS R, 1994, OCCUP ENVIRON MED, V51, P804, DOI 10.1136/oem.51.12.804
   Tazawa H, 2007, CARCINOGENESIS, V28, P191, DOI 10.1093/carcin/bgl128
   THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122
   Walchle C, 1999, TOXICOL APPL PHARM, V157, P9, DOI 10.1006/taap.1999.8662
   WOODRUFF JM, 1994, AM J SURG PATHOL, V18, P882, DOI 10.1097/00000478-199409000-00003
NR 25
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD FEB
PY 2009
VL 454
IS 2
BP 195
EP 201
DI 10.1007/s00428-008-0705-7
PG 7
WC Pathology
SC Pathology
GA 404MJ
UT WOS:000263156600008
PM 19096872
DA 2018-10-19
ER

PT J
AU Masarudin, MJ
   Yusoff, K
   Rahim, RA
   Hussein, MZ
AF Masarudin, Mas Jaffri
   Yusoff, Khatijah
   Rahim, Raha Abdul
   Hussein, Mohd Zobir
TI Successful transfer of plasmid DNA into in vitro cells transfected with
   an inorganic plasmid-Mg/Al-LDH nanobiocomposite material as a vector for
   gene expression
SO NANOTECHNOLOGY
LA English
DT Article
ID LAYERED DOUBLE HYDROXIDES; DELIVERY; INTERCALATION; NANOHYBRID; RELEASE;
   SYSTEM; MG
AB The delivery of a full plasmid, encoding the green fluorescent protein gene into African monkey kidney (Vero3) cells, was successfully achieved using nanobiocomposites based on layered double hydroxides. This demonstrated the potential of using the system as an alternative DNA delivery vector. Intercalation of the circular plasmid DNA, pEGFP-N2, into Mg/Al-NO(3)(-) layered double hydroxides (LDH) was accomplished through anion exchange routes to form the nanobiocomposite material. The host was previously synthesized at the Mg(2+) to Al(3+) molar ratio R(i) = 2 and subsequently intercalated with plasmid DNA. Size expansion of the interlamellae host from 8.8 angstrom in LDH to 42 angstrom was observed in the resulting nanobiocomposite, indicating stable hybridization of the plasmid DNA. The powder x-ray diffraction (PXRD) results, supplemented with Fourier-transform infrared (FTIR) spectroscopy, compositional and electrophoresis studies confirmed the encapsulation episode of the biomaterial. In order to elucidate the use of this resulting nanobiocomposite as a delivery vector, an MTT assay was performed to determine any cytotoxic effects of the host towards cells. The intercalated pEGFP-N2 anion was later successfully recovered through acidification with HNO(3) after treatment with DNA-degrading enzymes, thus also showing the ability of the LDH host to protect the intercalated biomaterial from degradation. Cell transfection studies on Vero3 cells were then performed, where cells transfected with the nanobiocomposite exhibited fluorescence as early as 12 h post-treatment compared to naked delivery of the plasmid itself.
C1 [Hussein, Mohd Zobir] Univ Putra Malaysia, Inst Adv Technol, Upm Serdang 43400, Malaysia.
   [Masarudin, Mas Jaffri; Yusoff, Khatijah; Rahim, Raha Abdul] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Upm Serdang 43400, Malaysia.
RP Hussein, MZ (reprint author), Univ Putra Malaysia, Inst Adv Technol, Upm Serdang 43400, Malaysia.
EM mzobir@science.upm.edu.my
OI HUSSEIN, MOHD ZOBIR/0000-0002-0741-261X; MASARUDIN, MAS
   JAFFRI/0000-0003-0695-2136
FU Malaysian Ministry of Science, Technology and Innovation (MOSTI); IRPA
   [01-02-04-003-BTK/ER-006]
FX This study received funding from the Malaysian Ministry of Science,
   Technology and Innovation (MOSTI) under the IRPA grant
   01-02-04-003-BTK/ER-006. MJM would like to thank Universiti Putra
   Malaysia for study leave and a scholarship.
CR Aisawa S, 2006, J PHYS CHEM SOLIDS, V67, P920, DOI 10.1016/j.jpcs.2006.01.004
   Choy JH, 2000, ANGEW CHEM INT EDIT, V39, P4042
   Choy JH, 2007, APPL CLAY SCI, V36, P122, DOI 10.1016/j.clay.2006.07.007
   Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021
   Hussein M. Z. b., 2005, SCI TECHNOL ADV MAT, V6, P956, DOI DOI 10.1016/J.STAM.2005.09.004
   Hussein M. Z. B., 2002, MAT SCI ENG B, V88, P98
   HUSSEIN MZB, 2002, J CONTROL RELEASE, V82, P417
   Jin S, 2007, SCI TECHNOL ADV MAT, V8, P67, DOI 10.1016/j.stam.2006.09.003
   Kwak SY, 2004, BIOMATERIALS, V25, P5995, DOI 10.1016/j.biomaterials.2004.01.056
   Kwak SY, 2002, SOLID STATE IONICS, V151, P229, DOI 10.1016/S0167-2738(02)00714-2
   Li BX, 2004, APPL CLAY SCI, V27, P199, DOI 10.1016/j.clay.2004.07.02
   MacDiarmid CW, 1996, PLANT PHYSIOL, V112, P1101, DOI 10.1104/pp.112.3.1101
   Oh JM, 2006, J PHYS CHEM SOLIDS, V67, P1028, DOI 10.1016/j.jpcs.2006.01.080
   Oh JM, 2006, J PHYS CHEM SOLIDS, V67, P1024, DOI 10.1016/j.jpcs.2006.01.033
   Ren LG, 2002, J MOL CATAL B-ENZYM, V18, P3, DOI 10.1016/S1381-1177(02)00008-5
   Schildknecht Pedro H. P. A., 2004, Toxicological and Environmental Chemistry, V86, P63
   Tammaro L, 2007, INT J ANTIMICROB AG, V29, P417, DOI 10.1016/j.ijantimicag.2006.11.019
   Thomas GS, 2006, J CHEM SCI, V118, P127, DOI 10.1007/BF02708774
   Trikeriotis M, 2007, INT J PHARMACEUT, V332, P176, DOI 10.1016/j.ijpharm.2006.09.031
   Tyner KM, 2004, J CONTROL RELEASE, V100, P399, DOI 10.1016/j.jconrel.2004.07.035
   Wang M, 2006, AM J PHYSIOL-CELL PH, V291, pC83
   Xu ZP, 2006, CHEM ENG SCI, V61, P1027, DOI 10.1016/j.ces.2005.06.019
   Yang QZ, 2006, INT J PHARM, V326, P148, DOI 10.1016/j.ijpharm.2006.06.037
NR 23
TC 30
Z9 31
U1 3
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD JAN 28
PY 2009
VL 20
IS 4
AR 045602
DI 10.1088/0957-4484/20/4/045602
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 393BF
UT WOS:000262345200014
PM 19417322
DA 2018-10-19
ER

PT J
AU Porter, D
   Vollrath, F
AF Porter, David
   Vollrath, Fritz
TI Silk as a Biomimetic Ideal for Structural Polymers
SO ADVANCED MATERIALS
LA English
DT Article
ID SPIDER SILK; DRAGLINE SILK; PROTEINS; BIOMATERIAL; FIBERS; AGGREGATION;
   NANOFIBRILS; EVOLUTION; PROLINE; WATER
AB Two factors are critical for understanding silks: the nanoscale semicrystalline folding structure, which gives high strength as well as exceptional toughness and the degree of hydration of the disordered fraction, which modifies these material properties. The combination of these two factor allows for a massive range of mechanical properties. Understanding and controlling these two principal factors are the key to the functionality of protein elastomers, and render silk an ideal model protein for (bio)material design.
C1 [Porter, David; Vollrath, Fritz] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
RP Vollrath, F (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
EM fritz.vollrath@zoo.ox.ac.uk
FU British EPSRC; NERC research councils [GR/NO1538/01, EP/E039715/1,
   EP/F021860/1]; European Commission [G5RD-CT-2002-00738,
   COOP.CT-2005-018060, EC-MTKD-CT-2004-014533]; Engineering and Physical
   Sciences Research Council [EP/F021860/1]
FX We thank the British EPSRC and NERC research councils (GR/NO1538/01,
   EP/E039715/1, EP/F021860/1,) and the European Commission
   (G5RD-CT-2002-00738,COOP.CT-2005-018060,EC-MTKD-CT-2004-014533) for
   funding.; For his consistent and visionary long-term support of our silk
   research we are very grateful to Dr. H. DeLong from the American AFOSR
   (F49620-03-1-0111). Drs C. Dicko, A. Terry, D. Knight, Z. Shao, Y. Liu
   and C. Holland have provided much stimulation and important insights.
   This article is part of a special issue on Biomaterials.
CR Abbott A, 2008, WOODHEAD PUBL TEXT, pXIX
   Asakura T., 1994, ENCY AGR SCI, P1
   Asakura T, 2006, KOBUNSHI RONBUNSHU, V63, P707, DOI 10.1295/koron.63.707
   Blackburn R. S., 2005, BIODEGRADABLE SUSTAI
   Cellmer T, 2007, TRENDS BIOTECHNOL, V25, P254, DOI 10.1016/j.tibtech.2007.03.011
   Chen CW, 2008, IEEE T CIRC SYST VID, V18, P1, DOI 10.1109/TCSVT.2008.915632
   Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231
   CRAIG CL, 2003, SPIDER WEBS SILKS
   Dicko C, 2008, BIOMACROMOLECULES, V9, P216, DOI 10.1021/bm701069y
   Dicko C, 2006, ADV PROTEIN CHEM, V73, P17, DOI 10.1016/S0065-3233(06)73002-9
   Dobson CM, 2001, PHILOS T ROY SOC B, V356, P133, DOI 10.1098/rstb.2000.0758
   Ebenstein DM, 2006, J MATER RES, V21, P2035, DOI 10.1557/JMR.2006.0246
   EICHHORN S, HDB FIBRE S IN PRESS
   Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a
   Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718
   Holland C, 2007, POLYMER, V48, P3388, DOI 10.1016/j.polymer.2007.04.019
   Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   KAPLAN DL, 1994, SILK POLYM MAT SCI B, P1
   Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670
   KINLOCH AJ, 1973, FRACTURE BEHAV POLYM
   Knight D, 1999, TISSUE CELL, V31, P617, DOI 10.1054/tice.1999.0076
   Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Moriya M, 2008, POLYMER, V49, P952, DOI 10.1016/j.polymer.2007.12.032
   Porter D, 2008, SOFT MATTER, V4, P328, DOI 10.1039/b713972a
   Porter D, 2007, WOODHEAD PUBL MATER, P261, DOI 10.1533/9781845693374.261
   Porter D, 1995, GROUP INTERACTION MO
   Porter D, 2007, NANO TODAY, V2, P6, DOI 10.1016/S1748-0132(07)70071-3
   Putthanarat S, 2000, POLYMER, V41, P7735, DOI 10.1016/S0032-3861(00)00036-7
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   SARRIKAYA M, 1995, BIOMIMETICS DESIGN P
   Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005
   SHREWRY B, 2003, ELASTOMERIC PROTEINS
   STEINBUCHEL A, 2003, HDB BIOPOLYMERS
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Viney C, 1997, SUPRAMOL SCI, V4, P75, DOI 10.1016/S0968-5677(96)00059-4
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   VOLLRATH F, 2003, HDB BIOPOLYMERS, P25
   Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   WINKLER AS, 2000, REV MOL BIOTECHNOL, V74, P85
NR 51
TC 129
Z9 133
U1 8
U2 108
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JAN 26
PY 2009
VL 21
IS 4
BP 487
EP 492
DI 10.1002/adma.200801332
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 403KQ
UT WOS:000263081900019
DA 2018-10-19
ER

PT J
AU Taglienti, A
   Sequi, P
   Valentini, M
AF Taglienti, Anna
   Sequi, Paolo
   Valentini, Massimiliano
TI Kinetics of drug release from a hyaluronan-steroid conjugate
   investigated by NMR spectroscopy
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE Hyaluronan; Methylprednisolone; Release; NMR spectroscopy; Transverse
   relaxation times
ID 500-730 KDA; CLINICAL-TRIAL; OSTEOARTHRITIS; KNEE; HYALGAN(R);
   DERIVATIVES; HYDROGELS; ACID
AB The methylprednisolone steroid ester of hyaluronan was hydrolyzed under physiological conditions in vitro, and the kinetics of drug release was investigated by NMR spectroscopy. Transverse relaxation times are correlated with the molecular rotational freedom, which undergoes large changes for methylprednisolone when released. Multi-exponential decays were observed, which together with the corresponding population gave valuable insights into the conformational changes that occur in the biopolymer during hydrolysis. The biomaterial exists in aqueous solution in two conformations, 'collapsed' and 'water-exposed', in equilibrium. Under physiological conditions, the methylprednisolone is completely released within 48 h. Transverse relaxation times proved to be ail appropriate tool for monitoring the drug release in vitro. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Taglienti, Anna; Valentini, Massimiliano] Instrumental Ctr Tor Mancina, Res Ctr Soil Plant Syst, Agr Res Council, I-00015 Monterotondo, Rome, Italy.
   [Sequi, Paolo] Res Ctr Soil Plant Syst, Agr Res Council, I-00184 Rome, Italy.
RP Taglienti, A (reprint author), Instrumental Ctr Tor Mancina, Res Ctr Soil Plant Syst, Agr Res Council, SP Pascolarese Str Neve Km 1, I-00015 Monterotondo, Rome, Italy.
EM anna.taglienti@entecra.it; massimiliano.valentini@entecra.it
CR Altman RD, 1998, J RHEUMATOL, V25, P2203
   ARSHINOFF SA, 2002, USE OPHTHALMIC VISCO, P119
   BRAUN S, 1996, 100 MORE BASIC NMR E
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   CARR HY, 1954, PHYS REV, V94, P638
   CLARIDGE TDW, 1999, HIGH RESOLUTION NMR
   Crescenzi V, 2002, BIOPOLYMERS, V64, P86, DOI 10.1002/bip.10131
   Day R, 2004, J RHEUMATOL, V31, P775
   Della Valle F, 1989, U.S. Patent, Patent No. [4,851,521, 4851521, 4851521A]
   Guidolin DD, 2001, OSTEOARTHR CARTILAGE, V9, P371, DOI 10.1053/joca.2000.0398
   Hiemstra C, 2007, MACROMOLECULES, V40, P1165, DOI 10.1021/ma062468d
   Jubb RW, 2003, INT J CLIN PRACT, V57, P467
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Laurent TC, 1998, CHEM BIOL MED APPL H
   Listrat V, 1997, OSTEOARTHR CARTILAGE, V5, P153, DOI 10.1016/S1063-4584(97)80010-6
   Luo Y, 1999, BIOCONJUGATE CHEM, V10, P755, DOI 10.1021/bc9900338
   Maheu E, 2002, INT J CLIN PRACT, V56, P804
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   Meyer K, 1934, J BIOL CHEM, V107, P629
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   PAYAN E, 1995, J CONTROL RELEASE, V34, P145, DOI 10.1016/0168-3659(95)00002-P
   SHAH MV, 2003, Patent No. 03059391
   Taglienti A, 2005, BIOMACROMOLECULES, V6, P1648, DOI 10.1021/bm049221d
   Taglienti A, 2006, MACROMOL BIOSCI, V6, P611, DOI 10.1002/mabi.200600041
   WEISS C, 1999, NEW FRONTIERS MED SC, P89
NR 26
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
J9 CARBOHYD RES
JI Carbohydr. Res.
PD JAN 26
PY 2009
VL 344
IS 2
BP 245
EP 249
DI 10.1016/j.carres.2008.10.010
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 399KL
UT WOS:000262798700014
PM 18977473
DA 2018-10-19
ER

PT J
AU Hou, AQ
   Zhou, ME
   Wang, XJ
AF Hou, Aiqin
   Zhou, Minge
   Wang, Xiaojun
TI Preparation and characterization of durable antibacterial cellulose
   biomaterials modified with triazine derivatives
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Surface modification; Cellulose; Antibacterial; Chemical structure
ID ELECTROSPUN NANOFIBERS; SILVER NANOPARTICLES; DIFFUSION PROPERTIES;
   BACTERIAL CELLULOSE; REACTIVE DYES; COTTON; CHITOSAN; FABRICS
AB Cellulose fabric was chemically modified with the triazine derivatives containing the multi-cationic benzyl groups. The novel durable antibacterial cellulose biomaterial containing the multi-cationic benzyl groups was prepared. The chemical structure and thermal property of the antibacterial cellulose biomaterial were investigated with FT-IR spectra, nitrogen content analysis, and differential scanning calorimetry (DSC). The results show that the thermal stability of the novel antibacterial cellulose was slightly decreased. Physical properties of the novel antibacterial cellulose had not significant change. The novel antibacterial cellulose imparted excellent durable antibacterial properties. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Hou, Aiqin; Zhou, Minge; Wang, Xiaojun] Donghua Univ, Natl Engn Res Ctr Dyeing & Finishing Text, Shanghai 201620, Peoples R China.
RP Hou, AQ (reprint author), Donghua Univ, Natl Engn Res Ctr Dyeing & Finishing Text, 3H,2999 N Renmin Rd, Shanghai 201620, Peoples R China.
EM aiqinhou@dhu.edu.cn
CR Adamopoulos L, 2007, CARBOHYD POLYM, V69, P805, DOI 10.1016/j.carbpol.2007.02.019
   Barud HS, 2008, MAT SCI ENG C-BIO S, V28, P515, DOI 10.1016/j.msec.2007.05.001
   Fu BX, 2001, POLYMER, V42, P599, DOI 10.1016/S0032-3861(00)00389-X
   He JH, 2007, POLYM INT, V56, P1323, DOI 10.1002/pi.2370
   Kulpinski P, 2005, J APPL POLYM SCI, V98, P1793, DOI 10.1002/app.22279
   Lee SB, 2004, BIOMACROMOLECULES, V5, P877, DOI 10.1021/bm034352k
   Lim SH, 2004, CARBOHYD POLYM, V56, P227, DOI 10.1016/j.carbpol.2004.02.005
   Lin J, 2002, BIOTECHNOL LETT, V24, P801, DOI 10.1023/A:1015584423358
   Lu J, 2001, J APPL POLYM SCI, V82, P300, DOI 10.1002/app.1852.abs
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Schramm C, 2002, COLOR TECHNOL, V118, P244
   Wang SQ, 2008, POLYM INT, V57, P1079, DOI 10.1002/pi.2447
   Wang X, 2004, CARBOHYD POLYM, V56, P21, DOI 10.1016/j.carbpol.2003.11.007
   Xie KL, 2006, J APPL POLYM SCI, V100, P4388, DOI 10.1002/app.23897
   Xie KL, 2006, J APPL POLYM SCI, V100, P720, DOI 10.1002/app.23424
   Xie KL, 2007, J APPL POLYM SCI, V103, P2166, DOI 10.1002/app.25097
   Xie KL, 2008, CARBOHYD POLYM, V72, P646, DOI 10.1016/j.carbpol.2007.10.005
NR 17
TC 59
Z9 61
U1 3
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 22
PY 2009
VL 75
IS 2
BP 328
EP 332
DI 10.1016/j.carbpol.2008.07.032
PG 5
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 375UA
UT WOS:000261137600019
DA 2018-10-19
ER

PT J
AU Cheng, CL
   Sun, DS
   Chu, WC
   Tseng, YH
   Ho, HC
   Wang, JB
   Chung, PH
   Chen, JH
   Tsai, PJ
   Lin, NT
   Yu, MS
   Chang, HH
AF Cheng, Chia-Liang
   Sun, Der-Shan
   Chu, Wen-Chen
   Tseng, Yao-Hsuan
   Ho, Han-Chen
   Wang, Jia-Bin
   Chung, Pei-Hua
   Chen, Jiann-Hwa
   Tsai, Pei-Jane
   Lin, Nien-Tsung
   Yu, Mei-Shiuan
   Chang, Hsin-Hou
TI The effects of the bacterial interaction with visible-light responsive
   titania photocatalyst on the bactericidal performance
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
ID FERRITE COMPOSITE NANOPARTICLES; CALCIUM OSCILLATION; BIOMATERIAL
   SYSTEM; MAGNETIC CORE; RECOMBINANT RHODOSTOMIN; ANTIMICROBIAL ACTIVITY;
   ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; DOPED TIO2; ANATASE
AB Bactericidal activity of traditional titanium dioxide (TiO(2)) photocatalyst is effective only upon irradiation by ultraviolet light, which restricts the potential applications of TiO(2) for use in our living environments. Recently carbon-containing TiO(2) was found to be photoactive at visible-light illumination that affords the potential to overcome this problem; although, the bactericidal activity of these photocatalysts is relatively lower than conventional disinfectants. Evidenced from scanning electron microscopy and confocal Raman spectral mapping analysis, we found the interaction with bacteria was significantly enhanced in these anatase/rutile mixed-phase carbon-containing TiO2. Bacteria-killing experiments indicate that a significantly higher proportion of all tested pathogens including Staphylococcus aureus, Shigella flexneri and Acinetobacter baumannii, were eliminated by the new nanoparticle with higher bacterial interaction property. These findings suggest the created materials with high bacterial interaction ability might be a useful strategy to improve the antimicrobial activity of visible-light-activated TiO(2).
C1 [Cheng, Chia-Liang; Chang, Hsin-Hou] Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan.
   [Cheng, Chia-Liang; Wang, Jia-Bin; Chung, Pei-Hua] Natl Dong Hwa Univ, Dept Phys, Hualien, Taiwan.
   [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Inst Mol Biol & Human Genet, Hualien, Taiwan.
   [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.
   [Chu, Wen-Chen] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan.
   [Tseng, Yao-Hsuan] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan.
   [Ho, Han-Chen] Tzu Chi Univ, Dept Anat, Hualien, Taiwan.
   [Chen, Jiann-Hwa] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan.
   [Tsai, Pei-Jane] Tzu Chi Univ, Inst Med Biotechnol, Hualien, Taiwan.
   [Lin, Nien-Tsung; Yu, Mei-Shiuan] Tzu Chi Univ, Inst Microbiol Immunol & Mol Med, Hualien, Taiwan.
RP Chang, HH (reprint author), Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan.
EM clcheng@mail.ndhu.edu.tw; dssun@mail.tcu.edu.tw;
   sheila731110@yahoo.com.tw; tyh@mail.ntust.edu.tw; hcho@mail.tcu.edu.tw;
   ben1223w@yahoo.com.tw; m9314001@gmail.com; jhchen@dragon.nchu.edu.tw;
   pjtsai@mail.tcu.edu.tw; ntlin@mail.tcu.edu.tw;
   meishiuan@mail.tcu.edu.tw; hhchang@mail.tcu.edu.tw
RI Dom, Rekha/B-7113-2012; Tsai, Pei-Jane/G-3563-2011
FU National Science Council of Taiwan ROC [NSC 95-2314-B-320-009-MY3, NSC
   95-2120-M-259-003]
FX The authors appreciate the financial support of National Science Council
   of Taiwan ROC under grant Nos. NSC 95-2314-B-320-009-MY3 and NSC
   95-2120-M-259-003.
CR Aiello AE, 2003, LANCET INFECT DIS, V3, P501, DOI 10.1016/S1473-3099(03)00723-0
   Angelo A, 2001, CURR OPIN INFECT DIS, V14, P547
   Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051
   Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547
   Chang HH, 1998, TOXICON, V36, P1087, DOI 10.1016/S0041-0101(98)00088-9
   Chiou CS, 2001, J CLIN MICROBIOL, V39, P1048, DOI 10.1128/JCM.39.3.1048-1056.2001
   Chou PW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357879
   Egerton TA, 2006, PHYS CHEM CHEM PHYS, V8, P398, DOI 10.1039/b507516e
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269
   Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014
   Inagaki M, 2003, CARBON, V41, P2619, DOI 10.1016/S0008-6223(03)00340-3
   Iwasaki M, 2000, J COLLOID INTERF SCI, V224, P202, DOI 10.1006/jcis.1999.6694
   Jacoby WA, 1998, ENVIRON SCI TECHNOL, V32, P2650, DOI 10.1021/es980036f
   Kau JH, 2005, J INFECT DIS, V192, P1465, DOI 10.1086/491477
   Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167
   Kisch H, 2002, CHEMPHYSCHEM, V3, P399, DOI 10.1002/1439-7641(20020517)3:5<399::AID-CPHC399>3.0.CO;2-H
   LEGRINI O, 1993, CHEM REV, V93, P671, DOI 10.1021/cr00018a003
   Li Q, 2007, ENVIRON SCI TECHNOL, V41, P5050, DOI 10.1021/es062753c
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Martino MC, 2005, J INFECT DIS, V192, P136, DOI 10.1086/430740
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147
   Mitoraj D, 2007, PHOTOCH PHOTOBIO SCI, V6, P642, DOI 10.1039/b617043a
   Murray PR, 2003, MANUAL CLIN MICROBIO
   Navon-Venezia S, 2005, CURR OPIN INFECT DIS, V18, P306, DOI 10.1097/01.qco.0000171920.44809.f0
   Ohno T, 2001, J PHYS CHEM B, V105, P2417, DOI 10.1021/jp003211z
   Ohno T, 2001, J CATAL, V203, P82, DOI 10.1006/jcat.2001.3316
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Rengifo-Herrera JA, 2008, APPL CATAL B-ENVIRON, V84, P448, DOI 10.1016/j.apcatb.2008.04.030
   Russell AD, 2004, J HOSP INFECT, V57, P97, DOI 10.1016/j.jhin.2004.01.004
   Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8
   SALYERS AA, 1994, BACTERIAL PATHOGENES, P122
   Sliney DH, 1997, PHYS MED BIOL, V42, P981, DOI 10.1088/0031-9155/42/5/016
   Slominski A, 1998, CLIN DERMATOL, V16, P503, DOI 10.1016/S0738-081X(98)00023-6
   Sousa SR, 2005, J MATER SCI-MATER M, V16, P1173, DOI 10.1007/s10856-005-4725-4
   Sun DS, 2005, J BIOMED SCI, V12, P937, DOI 10.1007/s11373-005-9016-z
   Sun DS, 2005, J BIOMED SCI, V12, P321, DOI 10.1007/s11373-005-0979-6
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   TRESCHEV SY, 2007, APPL CATAL B-ENVIRON, V79, P8
   TRYBA B, 2008, INT J PHOTOENERGY, P1
   Tseng YH, 2006, NANOTECHNOLOGY, V17, P2490, DOI 10.1088/0957-4484/17/10/009
   Vohra A, 2005, J IND MICROBIOL BIOT, V32, P364, DOI 10.1007/s10295-005-0006-y
   Wong HC, 2000, APPL ENVIRON MICROB, V66, P3981, DOI 10.1128/AEM.66.9.3981-3986.2000
   Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05
   Yu JC, 2005, ENVIRON SCI TECHNOL, V39, P1175, DOI 10.1021/es035374h
   Yu JG, 2001, MATER RES BULL, V36, P97, DOI 10.1016/S0025-5408(00)00475-X
NR 50
TC 62
Z9 62
U1 2
U2 40
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1021-7770
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD JAN 15
PY 2009
VL 16
AR 7
DI 10.1186/1423-0127-16-7
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 419DB
UT WOS:000264198200002
PM 19272171
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Chaari, K
   Ben Ayed, F
   Bouaziz, J
   Bouzouita, K
AF Chaari, K.
   Ben Ayed, F.
   Bouaziz, J.
   Bouzouita, K.
TI Elaboration and characterization of fluorapatite ceramic with controlled
   porosity
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; Sintering; Fluorapatite; Porosity; Biomedical applications
ID CALCIUM-PHOSPHATE CERAMICS; POROUS HYDROXYAPATITE; MECHANICAL
   RESISTANCE; SINTERED FLUORAPATITE; CANCELLOUS BONE; COMPOSITES;
   ZIRCONIA; SUBSTITUTION; BIOCERAMICS; BIOMATERIAL
AB Porous fluorapatite ceramics were fabricated using poly vinyl butyral as a porosifier. The conditions of specimens heat treating were optimized. The effects of preparation conditions involving polyvinyl butyral particle concentration, sintering time, and forming pressure (die-pressing technique) on the resultant pore size/structure as well as the pore size distribution were investigated. The experimental results showed that the Fap ceramics with controlled pore characteristics such as pore volume fraction, pore size and pore structure are achievable. It provides the possibility to design Fap ceramics with diverse porosities simulating that of natural bone. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Chaari, K.; Ben Ayed, F.; Bouaziz, J.] Ecole Natl Ingenieurs Sfax, Unite Ceram, Lab Chim Ind 2, Sfax 3038, Tunisia.
   [Bouzouita, K.] Inst Super Etud Technol Sousse, Sousse Erriadh 4023, Tunisia.
RP Chaari, K (reprint author), Ecole Natl Ingenieurs Sfax, Unite Ceram, Lab Chim Ind 2, Sfax 3038, Tunisia.
EM Kamel70tn@yahoo.fr
OI bouaziz, jamel/0000-0002-2598-7302
CR [Anonymous], 1984, ANN BOOK ASTM STAND, V0.042, P336
   ARITA IH, 1995, J MATER SCI-MATER M, V6, P19, DOI 10.1007/BF00121241
   BASSET J, 1978, VOGELS TXB QUANTITAT, P589
   Ben Ayed F, 2001, ANN CHIM-SCI MAT, V26, P75, DOI 10.1016/S0151-9107(01)80101-X
   Ben Ayed F, 2001, J ALLOY COMPD, V322, P238, DOI 10.1016/S0925-8388(01)01200-2
   Ben Ayed F, 2000, J EUR CERAM SOC, V20, P1069, DOI 10.1016/S0955-2219(99)00272-1
   Ben Ayed F, 2008, J EUR CERAM SOC, V28, P1995, DOI 10.1016/j.jeurceramsoc.2008.02.004
   Ben Ayed F, 2007, CR PHYS, V8, P101, DOI 10.1016/j.crhy.2006.10.017
   Ben Ayed F, 2006, ANN CHIM-SCI MAT, V31, P393, DOI 10.3166/acsm.31.393-406
   BIENIAWSKI ZT, 1978, INT J ROCK MECH MIN, V15, P99
   Brunauer S., 1938, J AM CHEM SOC, V60, P310
   Chaari K, 2005, J COLLOID INTERF SCI, V285, P469, DOI 10.1016/j.jcis.2004.12.026
   Chaari K, 2004, ANN CHIM-SCI MAT, V29, P1, DOI 10.3166/acsm.29.4.1-13
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   FABBRI M, 1995, BIOMATERIALS, V16, P225, DOI 10.1016/0142-9612(95)92121-L
   FABBRI M, 1994, BIOMATERIALS, V15, P474, DOI 10.1016/0142-9612(94)90228-3
   Fidancevska E, 2007, MATER CHEM PHYS, V103, P95, DOI 10.1016/j.matchemphys.2007.01.015
   Franz E.D., 1987, HIGH TECH CERAM, P31
   GEE A, 1953, ANAL CHEM, V25, P1320, DOI 10.1021/ac60081a006
   HEUGHEBAERT JC, 1977, THESIS INP TOULOUSE
   HOLMES R, 1984, CLIN ORTHOP RELAT R, P252
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim HW, 2004, BIOMATERIALS, V25, P2919, DOI 10.1016/j.biomaterials.2003.09.074
   Kim HW, 2003, J AM CERAM SOC, V86, P2019, DOI 10.1111/j.1151-2916.2003.tb03602.x
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Liu DM, 1996, J MATER SCI LETT, V15, P419
   LIU DM, 1955, BIOMATERIALS, V1996
   ODGAARD A, 1991, J BIOMECH, V24, P691, DOI 10.1016/0021-9290(91)90333-I
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   ROYER A, 1993, J MATER SCI-MATER M, V4, P76, DOI 10.1007/BF00122982
   SHORS EC, 1989, MATER RES SOC S P, V110, P211
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   VANAUDEKERCHE R, 1984, MECH PROPERTIES CANC, P88
   WHITE E, 1986, DENT CLIN N AM, V30, P49
NR 42
TC 7
Z9 7
U1 1
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD JAN 15
PY 2009
VL 113
IS 1
BP 219
EP 226
DI 10.1016/j.matchemphys.2008.07.079
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 393AO
UT WOS:000262343500042
DA 2018-10-19
ER

PT J
AU Salinas, AJ
   Vallet-Regi, M
   Toledo-Fernandez, JA
   Mendoza-Serna, R
   Pinero, M
   Esquivias, L
   Ramirez-Castellanos, J
   Gonzalez-Calbet, JM
AF Salinas, Antonio J.
   Vallet-Regi, Maria
   Toledo-Fernandez, Jose A.
   Mendoza-Serna, Roberto
   Pinero, Manuel
   Esquivias, Luis
   Ramirez-Castellanos, Julio
   Gonzalez-Calbet, Jose M.
TI Nanostructure and Bioactivity of Hybrid Aerogels
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID MEDICAL APPLICATIONS; APATITE FORMATION; WOLLASTONITE; ADSORPTION;
   SILICA; CERAMICS; GLASSES
AB Hybrid sono-aerogels in the CaO-SiO(2)-poly(dimethyl siloxane) (PDMS) system with low density and high surface area and pore volume were investigated to be used as biomaterials. Their in vitro bioactivity was monitored by soaking in a simulated body fluid (SBF). All the aerogels exhibited similar wetting and dissolution properties, but only the aerogel of composition 20 wt % PDMS-20 wt % CaO (S20Ca20) exhibited a bioactive response in SBF. To investigate the relationship between the different in vitro behaviours and the hybrids nanostructure, samples were studied by high-resolution transmission electron microscopy (HRTEM). All the aerogels showed similar basic microstructural features exhibiting amorphous Ca-free areas characterized by Si-O-Si distances of 0.23 nm. However, crystallized nanodomains containing calcium were also detected in S20Ca20. These domains, identified as pseudowollastonite and other Ca-Si-O phases, could explain the bioactive response of this material. Bioactivity and good textural and mechanical properties turn S20Ca20 aerogel into a candidate as biomaterial.
C1 [Salinas, Antonio J.; Vallet-Regi, Maria] Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
   [Toledo-Fernandez, Jose A.; Mendoza-Serna, Roberto] Univ Cadiz, Fac Ciencias, Dept Fis Mat Condensada, Cadiz 11510, Spain.
   [Pinero, Manuel] Univ Cadiz, CASEM, Dept Fis Aplicada, E-11510 Puerto Real, Cadiz, Spain.
   [Esquivias, Luis] Univ Seville, Fac Fis, Dept Fis Mat Condensada, E-41012 Seville, Spain.
   [Ramirez-Castellanos, Julio; Gonzalez-Calbet, Jose M.] Univ Complutense, Fac CC Quim, Dept Quim Inorgan, E-28040 Madrid, Spain.
RP Salinas, AJ (reprint author), Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
EM salinus@farm.ucm.es; vallet@farm.ucm.es
RI Salinas, Antonio/M-3316-2014; Vallet-Regi, Maria/M-3378-2014; Esquivias,
   Luis/A-6104-2008
OI Salinas, Antonio/0000-0002-8408-3389; Vallet-Regi,
   Maria/0000-0002-6104-4889; Esquivias, Luis/0000-0002-6773-5963; Pinero
   de los Rios, Manuel/0000-0001-8898-4371
FU CICYT (Spain) [MAT2005-1486, MAT2007-61927]; Comunidad de Madrid
   [S-505-MAT-0324]; European Union [FP6-500159-1]
FX Financial support of CICYT (Spain) through research projects
   MAT2005-1486 and MAT2007-61927, Comunidad de Madrid through
   S-505-MAT-0324, and the European Union through FAME NoE, FP6-500159-1.
CR BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   BUERGER MJ, 1961, P NATL ACAD SCI USA, V47, P1884, DOI 10.1073/pnas.47.12.1884
   Chen Q, 1999, BIOMATERIALS, V20, P1127, DOI 10.1016/S0142-9612(99)00015-0
   Colilla M, 2006, CHEM MATER, V18, P5676, DOI 10.1021/cm0612043
   DELAROSAFOX N, 1990, J NON-CRYST SOLIDS, V121, P211, DOI 10.1016/0022-3093(90)90134-8
   DOLAROSAFOX N, 1987, DIFFUS DEFECT DATA, V53, P363
   DOLAROSAFOX N, 2009, KEY ENG MATER, V391, P45
   Elliott J. C., 1994, STRUCTURE CHEM APATI, P59
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HUTCHISON JL, 1977, CONTRIB MINERAL PETR, V61, P11, DOI 10.1007/BF00375942
   INGRIN J, 1993, PHYS CHEM MINER, V20, P56
   Kamitakahara M, 2003, J MATER SCI-MATER M, V14, P1067, DOI 10.1023/B:JMSM.0000004003.41223.36
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kruk M, 1997, LANGMUIR, V13, P6267, DOI 10.1021/la970776m
   Kruk M, 2001, CHEM MATER, V13, P3169, DOI 10.1021/cm0101069
   Martin AI, 2005, J EUR CERAM SOC, V25, P3533, DOI 10.1016/j.jeurceramsoc.2004.09.030
   MOZZI RL, 1969, J APPL CRYSTALLOGR, V2, P164, DOI 10.1107/S0021889869006868
   Pereira APV, 2000, J NON-CRYST SOLIDS, V273, P180, DOI 10.1016/S0022-3093(00)00166-6
   Salinas AJ, 2007, J BIOMED MATER RES B, V81B, P274, DOI 10.1002/jbm.b.30663
   SALINAS AJ, 2007, ANORG ALLG CHEM, P1762
   Santos A, 2007, IND ENG CHEM RES, V46, P103, DOI 10.1021/ie0609214
   Tsuru K, 1997, J MATER SCI-MATER M, V8, P157, DOI 10.1023/A:1018523203667
   Vallet-Regi M, 2005, CHEM MATER, V17, P1874, DOI 10.1021/cm047956j
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
   Wan XH, 2005, MAT SCI ENG C-BIO S, V25, P455, DOI 10.1016/j.msec.2004.12.003
   YAMANAKA T, 1981, ACTA CRYSTALLOGR B, V37, P1010, DOI 10.1107/S0567740881004962
   ZARZYCKI J, 1988, J NON-CRYST SOLIDS, V100, P359, DOI 10.1016/0022-3093(88)90046-4
NR 32
TC 14
Z9 15
U1 3
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD JAN 13
PY 2009
VL 21
IS 1
BP 41
EP 47
DI 10.1021/cm800511r
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 391XC
UT WOS:000262266500011
DA 2018-10-19
ER

PT J
AU Aaltonen, O
   Jauhiainen, O
AF Aaltonen, Olli
   Jauhiainen, Olli
TI The preparation of lignocellulosic aerogels from ionic liquid solutions
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Aerogels; Cellulose; Lignocellulose; Lignin; Xylan; Critical point
   drying; Supercritical; Carbon dioxide; Ionic liquids
ID NANOFIBRILLAR CELLULOSE AEROGELS; DISSOLUTION
AB Nanofibrillar aerogels were prepared from cellulose, spruce wood and from mixtures of cellulose, lignin and xylan. The lignocellulosic polymers were first dissolved in an ionic liquid and coagulated from solution by adding aqueous ethanol. The obtained gel was washed with ethanol and liquid carbon dioxide and finally dried by releasing the carbon dioxide from the porous structure at supercritical temperature to obtain the aerogel. The bulk densities of the biopolymer aerogels ranged from 25 to 114 g/l and the internal surface areas (BET) from 108 to 539 m(2)/g depending on the biopolymer mix and on the polymer concentration in the ionic liquid solution. All aerogels were compressible and consisted of nanofibrillar biomaterial network with open-pore structure. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Aaltonen, Olli; Jauhiainen, Olli] VTT Proc Chem, Espoo 02044, Finland.
RP Aaltonen, O (reprint author), VTT Proc Chem, POB 1000, Espoo 02044, Finland.
EM olli.aaltonen@vtt.fi
FU VTT
FX The authors gratefully acknowledge Mr. Unto Tapper for the skillful
   scanning electronic microscopy of the samples and the 'Biorefinery
   Research Program' of VTT for funding the work.
CR AALTONEN O, 1977, PAPERI JA PUU, V11, P739
   BARRET EP, 1951, J AM CHEM SOC, V73, P380
   Brunauer S., 1938, J AM CHEM SOC, V60, P310
   GRAENACHER C, 1937, Patent No. 1943176
   Hoepfner S, 2008, CELLULOSE, V15, P121, DOI 10.1007/s10570-007-9146-8
   HUSEMANN E, 1969, MAKROMOLEKUL CHEM, V128, P288
   Innerlohinger J, 2006, MACROMOL SYMP, V244, P126, DOI 10.1002/masy.200651212
   Jin H, 2004, COLLOID SURFACE A, V240, P63, DOI 10.1016/j.colsurfa.2004.03.007
   KADOKAWA J, 2007, 234 ACS NAT M BOST M, P19
   Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e
   Kistler S. S., 1931, NATURE, V127, P3211
   Rosenau T., 2007, RES LETT MAT SCI
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   Tan CB, 2001, ADV MATER, V13, P644, DOI 10.1002/1521-4095(200105)13:9<644::AID-ADMA644>3.0.CO;2-#
NR 14
TC 112
Z9 118
U1 13
U2 142
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 5
PY 2009
VL 75
IS 1
BP 125
EP 129
DI 10.1016/j.carbpol.2008.07.008
PG 5
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 361SY
UT WOS:000260148600020
DA 2018-10-19
ER

PT J
AU Trombino, S
   Cassano, R
   Bloise, E
   Muzzalupo, R
   Tavano, L
   Picci, N
AF Trombino, Sonia
   Cassano, Roberta
   Bloise, Ermelinda
   Muzzalupo, Rita
   Tavano, Lorena
   Picci, Nevio
TI Synthesis and antioxidant activity evaluation of a novel cellulose
   hydrogel containing trans-ferulic acid
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Cellulose microcrystalline; Trans-ferulic acid; Antioxidant hydrogel;
   Lipid peroxidation; Radical-scavenging effect
ID VITAMIN-E; IN-VITRO; LIPOPROTEIN; OXIDATION
AB in the present work, we report the synthesis of cellulose hydrogel containing ferulic moieties and the evaluation of its antioxidant and scavenger activity. Acrylic groups were inserted onto cellulose backbone by a heterogeneous synthesis to produce two cellulose monomers with different degree of substitution (DS). The radical copolymerization of acrylcellulose (AcrC) with N,N-dimethylacrylamide (DMAA) was carried out in NH3/Urea aqueous solution, in a range of composition between 24 and 60 wt% of AcrC. The obtained hydrogels were characterized by infrared spectroscopy (FT-IR). Their equilibrium swelling degree (alpha%) was evaluated. They showed good swelling behavior in simulating gastric, intracellular and intestinal fluids and no more different at various pH. The ferulic moieties were directly grafted on the free hydroxylic groups of cellulose hydrogel by acylation, using dicyclohexylcarbodiimide (DCC) and 4-hydroxybenzotriazole (HBT) as condensation agents. Finally, the antioxidant activity in inhibiting the lipid peroxidation, in rat-liver microsomal membranes, induced in vitro by two different sources of free radicals, 2,2'-azobis (2-amidinopropane) (AAPH) and tert-butyl hydroperoxide (tert-BOOH), was evaluated. The effects of scavenging DPPH (1,1-diphenyl-2-picrylhydrazyl) radicals were also investigated. Hydrogel was found to be very efficient scavengers of DPPH radicals. The results strongly suggested that the antioxidant hydrogel neutralize free radicals. This biomaterial could be successfully applied in pharmaceutical held both as prodrug of trans-ferulic acid than as carrier for photo and thermo-degradable drugs to improve their stability. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Trombino, Sonia; Cassano, Roberta; Bloise, Ermelinda; Muzzalupo, Rita; Tavano, Lorena; Picci, Nevio] Univ Calabria, Dept Pharmaceut Sci, I-87036 Cosenza, Italy.
RP Cassano, R (reprint author), Univ Calabria, Dept Pharmaceut Sci, I-87036 Cosenza, Italy.
EM roberta.cassano@unical.it
OI MUZZALUPO, RITA/0000-0003-3486-6120; Tavano, Lorena/0000-0002-2986-6241;
   BLOISE, Ermelinda/0000-0003-3380-3996; Trombino,
   Sonia/0000-0001-9939-4457; Picci, Nevio/0000-0003-1985-2724
FU Academic Funds (Year 2007)
FX This work was financially supported by Academic Funds (Year 2007). The
   authors thank Mrs. V. Filippelli for her assistance in English
   corrections.
CR ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1
   Bojanic V, 1996, J APPL POLYM SCI, V60, P1719, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1719::AID-APP24>3.0.CO;2-Y
   Brand-Williams W., 1995, Lebensmittel-Wissenschaft and Technologie, V28, P25, DOI 10.1016/S0023-6438(95)80008-5
   CHOWDARY KPR, 2003, AAPS PHARMSCITECH, V4, DOI DOI 10.1208/PT040339
   HALL BH, 1990, BROOKINGS PAP ECO AC, P85
   Jung BO, 2006, J APPL POLYM SCI, V99, P3500, DOI 10.1002/app.22974
   McCall MR, 1999, FREE RADICAL BIO MED, V26, P1034, DOI 10.1016/S0891-5849(98)00302-5
   Ortiz C, 1998, POLYMER, V39, P4107, DOI 10.1016/S0032-3861(97)10375-5
   Pinchuk I, 2002, PROG LIPID RES, V41, P279, DOI 10.1016/S0163-7827(01)00026-1
   Plasencia MA, 1999, J MATER SCI-MATER M, V10, P641, DOI 10.1023/A:1008991825657
   Sannino A, 2006, J APPL POLYM SCI, V102, P1524, DOI 10.1002/app.24468
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Steinbrecher UP, 1999, BBA-MOL CELL BIOL L, V1436, P279, DOI 10.1016/S0005-2760(98)00127-1
   Trombino S, 2004, J AGR FOOD CHEM, V52, P2411, DOI 10.1021/jf0303924
   Trombino S, 2008, MACROMOL BIOSCI, V8, P86, DOI 10.1002/mabi.200700110
   Vinson JA, 1998, J AGR FOOD CHEM, V46, P3630, DOI 10.1021/jf980295o
   Wang MF, 1998, J AGR FOOD CHEM, V46, P4869, DOI 10.1021/jf980614b
   Wang W, 2006, J MATER CHEM, V16, P3252, DOI 10.1039/b603595g
   WILDENRA.HL, 1974, AM J ENOL VITICULT, V25, P119
   Yamada T, 2001, YAKUGAKU ZASSHI, V121, P239, DOI 10.1248/yakushi.121.239
NR 20
TC 35
Z9 37
U1 2
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 5
PY 2009
VL 75
IS 1
BP 184
EP 188
DI 10.1016/j.carbpol.2008.05.018
PG 5
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 361SY
UT WOS:000260148600029
DA 2018-10-19
ER

PT J
AU Monticelli, C
   Zucchi, F
   Tampieri, A
AF Monticelli, C.
   Zucchi, F.
   Tampieri, A.
TI Triboelectrochemical behaviour of a Si(3)N(4)-TiN ceramic composite and
   a titanium alloy commonly used in biomedical applications
SO WEAR
LA English
DT Article
DE Ti6Al4V; Ceramic matrix composite; Biomaterials; Corrosion-wear; EIS;
   Profilometry
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; SODIUM-CHLORIDE SOLUTION;
   SILICON-NITRIDE; METALLIC BIOMATERIALS; CORROSION BEHAVIOR; WEAR
   BEHAVIOR; IN-VITRO; FRETTING-CORROSION; ORTHOPEDIC TIALV; PASSIVE FILM
AB In this paper the corrosion and tribocorrosion behaviour of a traditional metallic biomaterial (Ti6Al4V) and a Si(3)N(4)/TiN (SN/TiN) ceramic composite are studied and compared during exposures to 1% NaCl and 1% NaCl + 1% lactic acid solutions.
   Electrochemical impedance spectroscopy (EIS) data collected on Ti6Al4V in both neutral and acidic solution have been interpreted on the basis of a double layer surface oxide film. which is completely removed from the wear track during the sliding tests. Under these conditions, the impedance of the depassivated region dominates the overall electrode impedance.
   Previous EIS tests performed on SN/TiN evidence that even this material exposed to neutral solution is covered by a double layer film, while a porous monolayer film forms in acid solution. Under pure corrosion conditions, SN/TiN exhibits corrosion rates which are quite comparable to those measured on Ti6Al4V. During tribocorrosion tests the EIS response of the ceramic material does not change much. Its corrosion rates are two orders of magnitude lower than those measured on Ti6Al4V.
   Profilometer analysis shows that on both materials most of overall tribocorrosion damage is due to mechanical wear.
   The tests suggest that SN/TiN is a promising biomaterials for applications where sliding conditions occur. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Monticelli, C.; Zucchi, F.] Univ Ferrara, Ctr Studi Sulla Corros A Dacco, I-44100 Ferrara, Italy.
   [Tampieri, A.] Ist Sci & Tecnol Mat Ceram, CNR, I-48018 Farenza, RA, Italy.
RP Monticelli, C (reprint author), Univ Ferrara, Ctr Studi Sulla Corros A Dacco, Via Saragat 4A, I-44100 Ferrara, Italy.
EM cecilia.monticelli@unife.it
RI Monticelli, Cecilia/L-2653-2015
OI Monticelli, Cecilia/0000-0001-6397-2649
CR Barril S, 2005, WEAR, V259, P282, DOI 10.1016/j.wear.2004.12.012
   Barril S, 2004, WEAR, V256, P963, DOI 10.1016/j.wear.2003.11.003
   Barril S, 2001, TRIBOL INT, V34, P599, DOI 10.1016/S0301-679X(01)00052-4
   Barril S, 2002, WEAR, V252, P744, DOI 10.1016/S0043-1648(02)00027-3
   BLACKWOOD DJ, 2002, P 15 INT CORR C GRAN
   Bracisiewicz M, 2002, APPL SURF SCI, V202, P139, DOI 10.1016/S0169-4332(02)00498-1
   Carrasquero E, 2005, INT J REFRACT MET H, V23, P391, DOI 10.1016/j.ijrmhm.2005.06.004
   Contu F, 2004, ELECTROCHIM ACTA, V50, P33, DOI 10.1016/j.electacta.2004.07.024
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Dearnley PA, 2004, WEAR, V256, P469, DOI 10.1016/S0043-1648(03)00557-X
   Duisabeau L, 2004, WEAR, V256, P805, DOI 10.1016/S0043-1648(03)00522-2
   Eisenbarth E, 2002, BIOMOL ENG, V19, P243, DOI 10.1016/S1389-0344(02)00032-1
   ENOMOTO Y, 1995, TRIBOL INT, V28, P1, DOI 10.1016/0301-679X(95)99483-2
   ESTEBAN JM, 1991, J ELECTROCHEM SOC, V138, P67, DOI 10.1149/1.2085580
   Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4
   GORBACHEV AK, 1983, PROT MET+, P212
   Hanawa T, 2002, SCI TECHNOL ADV MAT, V3, P289, DOI 10.1016/S1468-6996(02)00028-1
   HITZIG J, 1986, J ELECTROCHEM SOC, V133, P887, DOI 10.1149/1.2108756
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   Li Y, 2003, CORROS SCI, V45, P1367, DOI 10.1016/S0010-938X(02)00223-8
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MACDONALD DD, 1985, J ELECTROCHEM SOC, V133, P2018
   MACDONALD JR, 1987, IMPEDANCE SPECTROSCO, P154
   MAIER HR, 2004, DKG, V81, pE33
   MANSFELD F, 1988, J ELECTROCHEM SOC, V135, P828, DOI 10.1149/1.2095786
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   MIZUHARA K, 1993, P EUROTRIB C BUD
   Monteverde F, 2001, CORROS SCI, V43, P1851, DOI 10.1016/S0010-938X(00)00193-1
   MONTICELLI C, MAT CHEM PHYS UNPUB
   Neumann A, 2006, OTOLARYNG HEAD NECK, V134, P923, DOI 10.1016/j.otohns.2006.01.022
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Park J, 2003, THIN SOLID FILMS, V435, P102, DOI 10.1016/S0040-6090(03)00412-7
   Paschoal AL, 2003, ARTIF ORGANS, V27, P461, DOI 10.1046/j.1525-1594.2003.07241.x
   Piscanec S, 2004, ACTA MATER, V52, P1237, DOI 10.1016/j.actamat.2003.11.020
   Ponthiaux P, 2004, WEAR, V256, P459, DOI 10.1016/S0043-1648(03)00556-8
   POURBAIX M, 1963, ATLAS EQUILIBRES ELE, P213
   Qu J, 2005, WEAR, V258, P1348, DOI 10.1016/j.wear.2004.09.062
   Raimondi MT, 2000, BIOMATERIALS, V21, P907
   Sargeant A, 2007, MATER DESIGN, V28, P155, DOI 10.1016/j.matdes.2005.05.018
   Sharkawy SW, 1998, CORROS SCI, V40, P1119, DOI 10.1016/S0010-938X(98)00011-0
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Steinemann S G, 1980, EVALUATION BIOMATERI, V1
   TOMIZAWA H, 1987, ASLE TRANS, V30, P41
   Venugopalan R, 2000, BIOMATERIALS, V21, P1669, DOI 10.1016/S0142-9612(00)00049-1
   Vieira AC, 2006, WEAR, V261, P994, DOI 10.1016/j.wear.2006.03.031
   Wan GJ, 2004, SURF COAT TECH, V186, P136, DOI 10.1016/j.surfcoat.2004.04.037
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wu PQ, 1996, WEAR, V201, P171, DOI 10.1016/S0043-1648(96)07244-4
   Xu JG, 1997, WEAR, V205, P55, DOI 10.1016/S0043-1648(96)07283-3
   YILBAS BS, 1995, CORROS SCI, V37, P1627, DOI 10.1016/0010-938X(95)00065-R
   Zhou YS, 1997, WEAR, V210, P171, DOI 10.1016/S0043-1648(97)00066-5
NR 58
TC 13
Z9 14
U1 2
U2 18
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD JAN 5
PY 2009
VL 266
IS 1-2
BP 327
EP 336
DI 10.1016/j.wear.2008.07.005
PG 10
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 381LY
UT WOS:000261538800038
DA 2018-10-19
ER

PT S
AU Rezende, R
   Rezende, M
   Bartolo, P
   Mendes, A
   Maciel, R
AF Rezende, Rodrigo
   Rezende, Mylene
   Bartolo, Paulo
   Mendes, Ausenda
   Maciel Filho, Rubens
BE deBritoAlves, RM
   doNascimento, CAO
   Biscaia, EC
TI Optimization of Scaffolds in Alginate for Biofabrication by Genetic
   Algorithms
SO 10TH INTERNATIONAL SYMPOSIUM ON PROCESS SYSTEMS ENGINEERING
SE Computer Aided Chemical Engineering
LA English
DT Proceedings Paper
CT 10th International Symposium on Process Systems Engineering
CY AUG 16-20, 2009
CL Salvador, BRAZIL
DE Genetic Algorithms (GAs); Scaffolds; Biofabrication; Tissue Engineering;
   Alginate
AB With an increasing in the rate of transplants due to damaged or affected tissues or organs by accidents or diseases and also by the aging of the population in many countries as Brazil, have motivated the research of some novel and alternative ways focused on restoring and replacing tissues. Biofabrication by means of Rapid Prototyping techniques can help in the fashioning and final production of scaffolds devoted to support and stimulate the growth of new tissues. For soft tissues, a biomaterial known as Alginate has been studied and used as raw-material for scaffolds fabrication. A scaffold must guarantee good strength and stiffness at the same time the material degrades gradually. In this work, a single mathematical model experimentally obtained that describes an interesting mechanical behavior of the degradation of alginated-scaffolds is developed. The optimization process scheme using Genetic Algorithms to maximize the elastic modulus and therefore to aid the design of scaffolds in alginate is proposed. The optimization is very welcome to tissue engineering and Biofabrication.
C1 [Rezende, Rodrigo; Rezende, Mylene; Maciel Filho, Rubens] Univ Estadual Campinas, POB 6066, BR-13083970 Campinas, SP, Brazil.
   [Bartolo, Paulo; Mendes, Ausenda] Ctr Rapid & Sustainable Product Dev, Polytech Inst Leiria, Leiria, Portugal.
RP Rezende, R (reprint author), Univ Estadual Campinas, POB 6066, BR-13083970 Campinas, SP, Brazil.
RI Rezende, Rodrigo/H-4893-2014; Bartolo, Paulo/F-2421-2013
OI Rezende, Rodrigo/0000-0002-6604-5880; Bartolo,
   Paulo/0000-0003-3683-726X; Mendes, Ausenda/0000-0003-3004-8972
CR KHALIL SED, 2005, THESIS DREXEL U
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Nair K, 2008, J APPL BIOMATER BIOM, V6, P35
   REZENDE MCA, 2007, ADV RES VIRTUAL RAPI, V3, P81
   REZENDE RA, 2007, 8 INT C CHEM PROC EN, V11, P509
NR 5
TC 1
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-7946
BN 978-0-444-53472-9
J9 COMPUT-AIDED CHEM EN
PY 2009
VL 27
BP 1935
EP 1940
PG 6
WC Engineering, Chemical; Operations Research & Management Science
SC Engineering; Operations Research & Management Science
GA BTP80
UT WOS:000287727800323
DA 2018-10-19
ER

PT S
AU Huang, JH
   Parab, HJ
   Liu, RS
   Lai, TC
   Hsiao, M
   Chen, CH
   Tsai, DP
   Hwu, YK
AF Huang, J. -H.
   Parab, H. J.
   Liu, R. S.
   Lai, T. -C.
   Hsiao, M.
   Chen, C. H.
   Tsai, D. -P.
   Hwu, Y-K.
BE Lim, CT
   Goh, JCH
TI The Synthesis of Iron Oxide Nanoparticles via Seed-Mediated Process and
   its Cytotoxicity Studies
SO 13TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, VOLS 1-3
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 13th International Conference on Biomedical Engineering (ICBME)
CY DEC 03-06, 2008
CL Singapore, SINGAPORE
SP AMTI, BES Technol, ESLSYS, VICON, INSTRON, Process Engn Publishing, Wiley Blackwell
DE magnetite; Fe3O4; nanoparticles; cytotoxicity and biomaterial
ID MAGNETIC NANOCRYSTALS; MONODISPERSE
AB The development of a seed-mediated growth method for synthesis of iron oxide nanoparticles with tunable size distribution and magnetic properties is reported. The detailed investigation of the size distribution of seed as well as iron oxide nanoparticles during the growth process has been carried out using transmission electron microscopy (TEM). It was observed that the distribution of size gradually becomes narrow with time via the intra-particle ripening process and Oswald ripening process. The monodispersed iron oxide nanoparticles with sizes between 5 - 10 nm were fabricated using this method by varying the experimental parameters. The magnetic nanoparticles showed well-defined superparamagnetic and blocking temperature due to the size effects in consistent with the TEM images. The thermogravimetric analyses exhibited the size-dependent weight loss of the magnetic nanoparticles. The in vitro cytotoxicity tests were also performed in order to determine the cell viability as a function of size and concentration of the magnetic nanoparticles. The as-prepared iron oxide nanoparticles showed biocompatibility and nontoxicity against the normal as well as cancerous cell lines.
C1 [Huang, J. -H.; Parab, H. J.; Liu, R. S.] Natl Taiwan Univ, Dept Chem, Sec 4,Roosvelt Rd, Taipei 106, Taiwan.
   [Lai, T. -C.; Hsiao, M.; Chen, C. H.] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.
   [Tsai, D. -P.] Natl Taiwan Univ, Dept Phys, Taipei 106, Taiwan.
   [Parab, H. J.; Hwu, Y-K.] Acad Sinica, Inst Phys, Taipei 115, Taiwan.
RP Liu, RS (reprint author), Natl Taiwan Univ, Dept Chem, Sec 4,Roosvelt Rd, Taipei 106, Taiwan.
EM rsliu@ntu.edu.tw
OI Hsiao, Michael/0000-0001-8529-9213
FU National Science Council of Taiwan [NSC 97-2113-M-002-012-MY3, NSC
   97-2120-M-002-013, NSC 97-2120-M-001-006]
FX The authors would like thank the National Science Council of Taiwan for
   financially supporting this research under Contract Nos. NSC
   97-2113-M-002-012-MY3, NSC 97-2120-M-002-013 and NSC 97-2120-M-001-006.
CR Daou TJ, 2006, CHEM MATER, V18, P4399, DOI 10.1021/cm060805r
   Gas J, 2006, ADV FUNCT MATER, V16, P71, DOI 10.1002/adfm.200500335
   Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155
   Park J, 2005, ANGEW CHEM INT EDIT, V44, P2872, DOI 10.1002/anie.200461665
   Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251
   Song HT, 2005, J AM CHEM SOC, V127, P9992, DOI 10.1021/ja051833y
   Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852
   Weizmann Y, 2003, J AM CHEM SOC, V125, P3452, DOI 10.1021/ja028850x
NR 8
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-92840-9
J9 IFMBE PROC
PY 2009
VL 23
IS 1-3
BP 802
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BKJ09
UT WOS:000268245600197
DA 2018-10-19
ER

PT S
AU Lodererova, M
   Rybnicek, J
   Steidl, J
   Richter, J
   Boivie, K
   Karlsen, R
   Asebo, O
AF Lodererova, M.
   Rybnicek, J.
   Steidl, J.
   Richter, J.
   Boivie, K.
   Karlsen, R.
   Asebo, O.
BE Lim, CT
   Goh, JCH
TI Biocompatibility of Metal Sintered Materials in Dependence on
   Multi-Material Graded Structure
SO 13TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, VOLS 1-3
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 13th International Conference on Biomedical Engineering (ICBME)
CY DEC 03-06, 2008
CL Singapore, SINGAPORE
SP AMTI, BES Technol, ESLSYS, VICON, INSTRON, Process Engn Publishing, Wiley Blackwell
DE functionally graded; biomaterial; rapid prototyping
ID ALLOYS
AB Rapid prototyping of real products, which are customized to the needs of individual patients, became very successful in the field of biomaterials recently. But meanwhile the production is increasing, demands for the newly developed materials and new approaches became more and more important. In this respect multi-material functionally graded sintering has been introduced into production of materials. Certain combinations of materials with different mechanical properties tend to be promising in the field of bio-implants production as well as the Rapid prototyping methods such as Selective Laser Sintering (SLS) and 3D printing (3DP). In this study a possibility of application of functionally graded metal structures was evaluated. The two materials, CoCr alloy and Ti6Al4V alloy, were joined together by multi-material sintering procedure. Both materials are known to be used in orthopedics because of their excellent biocompatibility. In this case the testing samples were made as graded structures, having CoCr alloy on one end and Ti6Al4V alloy on the other end. Different sintering temperatures were applied. The obtained samples were tested in terms of biocompatibility where the manufacturing conditions, especially the sintering temperature, and surface structure were taken into account. The used cells were Balb/c Mouse Fibroblasts and the viability was assessed by MMT test. Samples were further examined for influence on PBMC (Peripheral Blood Mononuclear Cells) by Flow Cytometry analysis (FACS).
C1 [Lodererova, M.; Rybnicek, J.; Steidl, J.] Czech Tech Univ, Dept Mat Engn, Karlovo Namesti 13, Prague 12135 2, Czech Republic.
   [Richter, J.] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic.
   [Boivie, K.; Karlsen, R.; Asebo, O.] SINTEF, Trondheim, Norway.
RP Lodererova, M (reprint author), Czech Tech Univ, Dept Mat Engn, Karlovo Namesti 13, Prague 12135 2, Czech Republic.
EM michaela.lodererova@fs.cvut.cz
CR BAIER R, 2006, WILEY ENCY BIOMEDICA
   Becker BS, 1995, POWDER METALL, V38, P305, DOI 10.1179/pom.1995.38.4.305
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   DOURANDISH M, 2007, MAT SCI ENG IN PRESS
   Frosch K.-H., 2006, EUR J TRAUMA, V32, P149, DOI DOI 10.1007/S00068-006-6041-1
   Hunt JA, 2005, BIOMATERIALS, V26, P5890, DOI 10.1016/j.biomaterials.2005.03.004
   LODEREROVA M, 2007, P 27 INT C SAMP EUR
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   RACK HJ, 2005, MAT SCI E C IN PRESS
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   VANDEREIJK C, 2004, P WORLD PM2004 C VIE
NR 11
TC 1
Z9 1
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-92840-9
J9 IFMBE PROC
PY 2009
VL 23
IS 1-3
BP 1204
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BKJ09
UT WOS:000268245600295
DA 2018-10-19
ER

PT S
AU Lai, PS
AF Lai, P. S.
BE Lim, CT
   Goh, JCH
TI Star-Shaped Porphyrin-polylactide Formed Nanoparticles for
   Chemo-Photodynamic Dual Therapies
SO 13TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, VOLS 1-3
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 13th International Conference on Biomedical Engineering (ICBME)
CY DEC 03-06, 2008
CL Singapore, SINGAPORE
SP AMTI, BES Technol, ESLSYS, VICON, INSTRON, Process Engn Publishing, Wiley Blackwell
DE Photodynamic therapy; chemotherapy; Doxorubicin; polylactide;
   nanoparticles
ID POLYAMIDOAMINE DENDRIMER CONJUGATION; POLYION COMPLEX MICELLES;
   PHOTOCHEMICAL INTERNALIZATION; POLYMERIC MICELLES; DELIVERY; CANCER;
   PHOTOSENSITIZER
AB One potential way to overcome the side effects of chemotherapy is to develop therapeutic drug delivery systems that can enhance tumor cytotoxicity but reduce the adverse effects to the normal cells. Recently the studies of nanoparticle formulation of anticancer devices via drugs associated with synthetic polymers have been used as delivery systems or this purpose. In this study, we attempt to synthesize a novel star-shaped biodegradable polylactide (PLA) with chemo-photodynamic dual therapeutics for cancer treatments.
   The branched star porphyrin-PLA (BSPPLA) conjugate was synthesized by ring-opening polymerization of lactides from porphyrins with benzyl alcohol. The doxorubicin-loaded BSPPLA nanoparticles with 59.8 +/- 21.4 nm were fabricated by a modified solvent evaporation/extraction technique. Intracellular distribution, cell viability and phototoxicity of this novel BSPPLA nanoparticle were evaluated in vitro. The results show that BSPPLA nanoparticles, mainly localized in endosome/lysosome compartments, was non-toxic below 10 mu M, but significantly induced cell death after suitable irradiation in MCF-7 cells. Furthermore, the photodynamic treatment obviously improved the cytotoxicity of doxorubicin-loaded BSPPLA nanoparticle through synergistic effects by median effect analysis. In conclusion, doxorubicin loaded BSPPLA nanoparticle showed considerable potential as a bimodal biomaterial for chemo-photodynamic drug delivery system for cancer therapy.
C1 Natl Chung Hsing Univ, Dept Chem, Taichung 402, Taiwan.
RP Lai, PS (reprint author), Natl Chung Hsing Univ, Dept Chem, 250 Kuo Kuang Rd, Taichung 402, Taiwan.
EM f89548003@gmail.com
CR Berg K, 1999, CANCER RES, V59, P1180
   Chen HY, 2007, POLYMER, V48, P2257, DOI 10.1016/j.polymer.2007.02.030
   Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071
   Ideta R, 2005, NANO LETT, V5, P2426, DOI 10.1021/nl051679d
   Jang WD, 2006, J CONTROL RELEASE, V113, P73, DOI 10.1016/j.jconrel.2006.03.009
   Kopecek J, 2001, J CONTROL RELEASE, V74, P147, DOI 10.1016/S0168-3659(01)00330-3
   Lai PS, 2008, J BIOMED MATER RES A, V87A, P147, DOI 10.1002/jbm.a.31760
   Lai PS, 2007, J CONTROL RELEASE, V122, P39, DOI 10.1016/j.jconrel.2007.06.012
   Liu JB, 2004, J PHARM SCI-US, V93, P132, DOI 10.1002/jps.10533
   Peng CL, 2008, BIOMATERIALS, V29, P3599, DOI 10.1016/j.biomaterials.2008.05.018
   Shuai XT, 2004, BIOCONJUGATE CHEM, V15, P441, DOI 10.1021/bc034113u
   Snyder JW, 2003, CANCER RES, V63, P8126
   Takeuchi Y, 2004, J CONTROL RELEASE, V97, P231, DOI 10.1016/j.jconrel.2004.03.030
   Torchilin VP, 2004, CELL MOL LIFE SCI, V61, P2549, DOI 10.1007/s00018-004-4153-5
   Vargas A, 2004, INT J PHARM, V286, P131, DOI 10.1016/j.ijpharm.2004.07.029
   Zhang GD, 2003, J CONTROL RELEASE, V93, P141, DOI 10.1016/j.jconrel.2003.05.002
NR 16
TC 2
Z9 2
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-92840-9
J9 IFMBE PROC
PY 2009
VL 23
IS 1-3
BP 1447
EP 1450
PG 4
WC Engineering, Biomedical
SC Engineering
GA BKJ09
UT WOS:000268245600357
DA 2018-10-19
ER

PT S
AU Liu, HF
   Fan, HB
   Toh, SL
   Goh, JCH
AF Liu, Haifeng
   Fan, Hongbin
   Toh, Siew Lok
   Goh, James C. H.
BE Lim, CT
   Goh, JCH
TI In Vivo Study of ACL Regeneration Using Silk Scaffolds In a Pig Model
SO 13TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, VOLS 1-3
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 13th International Conference on Biomedical Engineering (ICBME)
CY DEC 03-06, 2008
CL Singapore, SINGAPORE
SP AMTI, BES Technol, ESLSYS, VICON, INSTRON, Process Engn Publishing, Wiley Blackwell
DE Silk scaffold; MSC; ACL; Pig model
ID MESENCHYMAL STEM-CELLS; LIGAMENT FIBROBLASTS
AB Although most in vitro studies indicate that silk is a suitable biomaterial for ligament tissue engineering, in vivo studies of implanted silk scaffolds for ligament reconstruction are still lacking, especially in a big animal. The objective of this study is to investigate anterior cruciate ligament (ACL) regeneration using mesenchymal stem cells (MSCs) and silk scaffold in a pig model. The scaffold was fabricated by incorporating microporous silk sponges into knitted silk mesh, which mimicked the structures of ligament extracellular matrix (ECM). In vitro culture already demonstrated that MSCs on scaffolds proliferated vigorously and produced abundant collagen. The MSCs/scaffold was implanted to regenerate ACL in a pig model. After 24 weeks, histology observation showed that MSCs were distributed throughout the regenerated ligament and exhibited fibroblast morphology. The key ligament ECM components including collagen I, collagen III, and tenascin-C were produced prominently. The tensile strength of regenerated ligament also met the mechanical requirements. In conclusion, the results imply that silk scaffold has great potentials in future clinical applications.
C1 [Liu, Haifeng; Fan, Hongbin; Goh, James C. H.] Natl Univ Singapore, Dept Orthopaed Surg, 27 Med Dr, Singapore 117548, Singapore.
   [Toh, Siew Lok; Goh, James C. H.] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.
   [Toh, Siew Lok] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
RP Goh, JCH (reprint author), Natl Univ Singapore, Dept Orthopaed Surg, 27 Med Dr, Singapore 117548, Singapore.
EM dosgohj@nus.edu.sg
FU Biomedical Research Council, Singapore
FX This research was supported by a grant from the Biomedical Research
   Council, Singapore.
CR Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
NR 4
TC 2
Z9 2
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-92840-9
J9 IFMBE PROC
PY 2009
VL 23
IS 1-3
BP 1512
EP 1514
PG 3
WC Engineering, Biomedical
SC Engineering
GA BKJ09
UT WOS:000268245600374
DA 2018-10-19
ER

PT B
AU Jay, SM
   Shepherd, BR
   Andrejecsk, JW
   Kyriakides, TR
   Pober, JS
   Saltzman, WM
AF Jay, Steven M.
   Shepherd, Benjamin R.
   Andrejecsk, Jillian W.
   Kyriakides, Themis R.
   Pober, Jordan S.
   Saltzman, W. Mark
GP IEEE
TI Engineered Molecular Delivery for Control and Enhancement of
   Transplanted Endothelial Cell Fate in Tissue Engineering
SO 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT 35th Annual Northeast Bioengineering Conference
CY APR 03-05, 2009
CL Cambridge, MA
ID GROWTH-FACTOR DELIVERY; THERAPEUTIC ANGIOGENESIS; SYSTEM; LIMB
AB A successful engineered tissue construct must acquire a functional microvascular network that rapidly connects to the host circulation. Suspended endothelial cells (EC) within a construct will spontaneously organize into a microvascular system, but maturation depends on recruitment of host mural cells and is slow and limited. We have integrated protein delivery with transplantation of EC to create multifunctional hydrogels for use in tissue engineering. These gels consist of a protein matrix that facilitates formation of nascent endothelium and alginate microparticles capable of sustained release of multiple protein therapeutics. We have shown that delivery of vascular endothelial growth factor (VEGF) accelerates the development of graft perfusion. In this study, we examine the effects of concurrent delivery of VEGF and monocyte chemoattractant protein-1 (MCP-1). We show MCP-1 release can be achieved at physiologically relevant levels for 48-72 hours, enhancing recruitment of host monocytes, a cell population that may foster angiogenesis and vascular remodeling (arteriogeneisis). Furthermore, our results indicate combining VEGF with MCP-1 delivery facilitates improved engraftment of transplanted EC in a mouse model. These data herald the utility of combined delivery of arteriogenic (MCP-1) and angiogenic (VEGF) growth factors from EC-containing hydrogels as a promising biomaterial strategy for advanced tissue engineering.
C1 [Jay, Steven M.; Andrejecsk, Jillian W.; Kyriakides, Themis R.; Saltzman, W. Mark] Yale Univ, Dept Biomed Engn, New Haven, CT 06510 USA.
   [Shepherd, Benjamin R.; Pober, Jordan S.] Yale Univ, Dept Immunobiol, New Haven, CT 06510 USA.
   [Jay, Steven M.; Shepherd, Benjamin R.; Kyriakides, Themis R.; Pober, Jordan S.; Saltzman, W. Mark] Yale Univ, Vascular Biol & Therapeut, New Haven, CT 06510 USA.
   [Kyriakides, Themis R.] Yale Univ, Dept Pathol, New Haven, CT 06510 USA.
RP Jay, SM (reprint author), Yale Univ, Dept Biomed Engn, New Haven, CT 06510 USA.
FU NIH [HL085416]
FX The authors acknowledge funding from NIH grant HL085416 (to J.S.P. and
   W.M.S.). VEGF was generously provided by the Biological Resources Branch
   of the National Cancer Institute
CR Ito WD, 1997, CIRC RES, V80, P829
   Jay SM, 2008, FASEB J, V22, P2949, DOI 10.1096/fj.08-108803
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rissanen TT, 2001, EUR J CLIN INVEST, V31, P651, DOI 10.1046/j.1365-2362.2001.00864.x
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   SHEPHERD BR, TISSUE ENG IN PRESS
   Shireman PK, 2007, J VASC SURG, V45, p48A, DOI 10.1016/j.jvs.2007.02.030
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   van Weel V, 2004, CIRC RES, V95, P58, DOI 10.1161/01.RES.0000133247.69803.c3
NR 10
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4362-8
PY 2009
BP 163
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BKP77
UT WOS:000268886300078
DA 2018-10-19
ER

PT B
AU Harwood, S
   Tew, GN
   Bhatia, SR
AF Harwood, Stuart
   Tew, Gregory N.
   Bhatia, Surita R.
GP IEEE
TI Effect of Gelation Temperature on PLA-PEO-PLA Physical Hydrogel
   Morphology
SO 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT 35th Annual Northeast Bioengineering Conference
CY APR 03-05, 2009
CL Cambridge, MA
AB Poly(lactic acid)-poly(ethylene oxide)-poly(lactic acid) (PLA-PEO-PLA) triblock copolymer hydrogels are a promising biomaterial, with applications to drug delivery and cell scaffolds for tissue engineering. Using L-lactic acid gives PLLA-PEO-PLLA, which has stereoregular end blocks. The resulting system forms lamellae with hydrophobic semi crystalline domains of PLLA with hydrophilic domains of PEO connecting them. Gelation is achieved by raising the temperature of the polymer/water mixture, and this study focuses on the effect on the nano- and microscale structures of the gel that the gelation temperature has. By confocal microscopy, we determine the average particle size on the microscale increases from 2.3 mu m to 3 mu m from an increase in gelation temperature of 40 degrees C to 80 degrees C. Meanwhile, small angle x-ray scattering indicates that the nanoscale structures, the lamellae, are unchanged over the same range. This implies that an annealing effect is occurring. The lamellae align to a greater degree with a higher temperature, increasing the size of the semi-crystalline domains.
C1 [Harwood, Stuart; Bhatia, Surita R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
   [Tew, Gregory N.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
RP Harwood, S (reprint author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
RI Bhatia, Surita/B-4536-2008
FU NSF [EEC-0649041]; NSF-sponsored UMass MRSEC on Polymers [DMR-0213695];
   NSF-sponsored Center for Hierarchical Manufacturing [DMI-0531171]
FX This work was supported by the NSF-funded REU Summer Site on Cellular
   Engineering, EEC-0649041. Central facilities of the NSF-sponsored UMass
   MRSEC on Polymers (DMR-0213695) and the NSF-sponsored Center for
   Hierarchical Manufacturing (DMI-0531171) were also used.
CR Agrawal SK, 2007, LANGMUIR, V23, P5039, DOI 10.1021/la063390x
   Agrawal SK, 2006, J MATER RES, V21, P2118, DOI 10.1557/JMR.2006.0261
   AGRAWAL SK, 2008, THESIS U MASSACHUSET
NR 3
TC 0
Z9 0
U1 1
U2 26
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4362-8
PY 2009
BP 204
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BKP77
UT WOS:000268886300099
DA 2018-10-19
ER

PT B
AU Unadkat, HV
   Papenburg, BJ
   Truckenmuellel, R
   Stamatialis, D
   Wessling, M
   van Blitterswijk, CA
   de Boer, J
AF Unadkat, H. V.
   Papenburg, B. J.
   Truckenmuellel, R.
   Stamatialis, D.
   Wessling, M.
   van Blitterswijk, C. A.
   de Boer, J.
GP IEEE
TI High-throughput screening of cell-surface topographic interactions
SO 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT 35th Annual Northeast Bioengineering Conference
CY APR 03-05, 2009
CL Cambridge, MA
AB In the present study we describe a high throughput screening approach to screen the biological interactions of cells with surface topographies created on biomaterial substrates.
C1 [Unadkat, H. V.; Truckenmuellel, R.; van Blitterswijk, C. A.; de Boer, J.] Univ Twente, Dept Tissue Regenerat, Postbus 217, NL-7500 AE Enschede, Netherlands.
   [Papenburg, B. J.; Truckenmuellel, R.; Stamatialis, D.; Wessling, M.] Univ Twente, Membrane Sci & Technol Grp, NL-7500 AE Enschede, Netherlands.
RP Unadkat, HV (reprint author), Univ Twente, Dept Tissue Regenerat, Postbus 217, NL-7500 AE Enschede, Netherlands.
RI Wessling, Matthias/K-4797-2012; Unadkat, Hemant/E-7827-2012
OI Wessling, Matthias/0000-0002-7874-5315; Unadkat,
   Hemant/0000-0002-6916-3874
FU Marie Curie EST
FX The Marie Curie EST JOIN(ed)T program is acknowledged for funding this
   project.
CR Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Luo W, 2008, LANGMUIR, V24, P12129, DOI 10.1021/la802836g
   WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
NR 4
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4362-8
PY 2009
BP 232
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BKP77
UT WOS:000268886300114
DA 2018-10-19
ER

PT B
AU Seil, JT
   Taylor, EN
   Webster, TJ
AF Seil, Justin T.
   Taylor, Erik N.
   Webster, Thomas J.
GP IEEE
TI Reduced activity of Staphylococcus epidermidis in the presence of
   sonicated piezoelectric zinc oxide nanoparticles
SO 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT 35th Annual Northeast Bioengineering Conference
CY APR 03-05, 2009
CL Cambridge, MA
ID PARTICLE-SIZE
AB Particulate zinc oxide (ZnO) is a known antibacterial agent. Studies have shown that reducing the size of ZnO particles to nanoscale dimensions further enhances their antibacterial properties. ZnO is also piezoelectric. Upon mechanical deformation of ZnO, a transient electrical charge across the material is produced. The purpose of the present in vitro study was to investigate the antibacterial properties of ultrasonically stimulated ZnO nanoparticles. Staphylococcus epidermidis bacteria were seeded at a known cell density into 96-well plates and observed for 48 h with a 10 min ultrasonication period at 24 h. Optical density reading data was collected every 12 h, with an additional reading taken immediately after the ultrasonication period. Bacteria activity was significantly reduced in experimental groups exposed to nanoparticles and ultrasonication compared to groups exposed to nanoparticles or ultrasonication alone. Developing methods and understanding mechanisms for reducing bacteria activity may help reduce potential infection complications following biomaterial implantation.
C1 [Seil, Justin T.; Taylor, Erik N.; Webster, Thomas J.] Brown Univ, Div Engn, Lab Nanomed Res, Providence, RI 02912 USA.
RP Seil, JT (reprint author), Brown Univ, Div Engn, Lab Nanomed Res, Providence, RI 02912 USA.
CR Dodd AC, 2006, J NANOPART RES, V8, P43, DOI 10.1007/s11051-005-5131-z
   Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687
   Wang XD, 2007, SCIENCE, V316, P102, DOI 10.1126/science.1139366
   Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4362-8
PY 2009
BP 306
EP 307
PG 2
WC Engineering, Biomedical
SC Engineering
GA BKP77
UT WOS:000268886300151
DA 2018-10-19
ER

PT B
AU Pathi, SP
   Kowalczewski, CJ
   Tadipatri, R
   Fischbach, C
AF Pathi, S. P.
   Kowalczewski, C. J.
   Tadipatri, R.
   Fischbach, C.
GP IEEE
TI Biomineralized Scaffolds as an in vitro Platform for Studying Metastatic
   Bone Disease
SO 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT 35th Annual Northeast Bioengineering Conference
CY APR 03-05, 2009
CL Cambridge, MA
AB Osteolytic bone metastasis is a devastating complication of breast cancer that causes severe reduction in quality of life and is frequently the cause of death in breast cancer patients. Biomimetic model systems are invaluable tools for studying how microenvironmental conditions control tumorigenesis and metastasis in vivo. Biomaterial design principles and tissue engineering strategies were employed to create three-dimensional biomineralized polymeric scaffolds to simulate bone microenvironmental conditions for the study of metastatic disease. The PLG-based composite scaffolds were used to investigate the effects of the presence of the bone mineral hydroxyapatite (HA) on the metastatic behavior of breast cancer cells in the bone microenvironment. Our findings indicate that tumor cell behavior is dramatically altered towards a more malignant and metastatic phenotype in the presence of HA. Breast cancer cells cultured in biomineralized scaffolds also showed decreased sensitivity to chemotherapeutic agents relative to control conditions. Finally, HA changed the secretory behavior of tumor cells, inducing upregulated secretion of factors responsible for the predominantly osteolytic nature of breast cancer bone metastasis. Our study shows that biomineralized scaffolds can serve as a basis for the development of biomimetic bone metastasis models. In the future, they may help to reveal novel pathways for therapeutic targeting of bone metastasis, while also providing an innovative platform for studying cancer in vitro.
C1 [Pathi, S. P.; Kowalczewski, C. J.; Tadipatri, R.; Fischbach, C.] Cornell Univ, Ithaca, NY 14853 USA.
RP Pathi, SP (reprint author), Cornell Univ, Tower Rd, Ithaca, NY 14853 USA.
RI Fischbach, Claudia/C-8550-2009
OI Fischbach, Claudia/0000-0002-9368-0150
CR Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867
NR 5
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4362-8
PY 2009
BP 358
EP 359
PG 2
WC Engineering, Biomedical
SC Engineering
GA BKP77
UT WOS:000268886300176
DA 2018-10-19
ER

PT B
AU Wang, L
   Murthy, SK
   Barabino, G
   Carrier, RL
AF Wang, L.
   Murthy, S. K.
   Barabino, G.
   Carrier, R. L.
GP IEEE
TI Intestinal Epithelial Cell Behavior on Collagen Substrates with
   Biomimetic Micro-topography
SO 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT 35th Annual Northeast Bioengineering Conference
CY APR 03-05, 2009
CL Cambridge, MA
AB Modification of biomaterial scaffolds used in tissue engineering has traditionally focused more on chemical and mechanical properties than on topography. Microfabrication was used to produce topographic analogs of intestinal basal lamina crypts. A test pattern of micro-wells with dimensions (50-400 mu m in diameter, 100 mu m in depth) similar to those of native crypt structures was produced in a type I collagen membrane. Caco-2 cells attached and spread faster and to a greater extent on flat surfaces than on those with micro-well structures. It was found that Caco-2 cells were able to span across well structure with small diameters (i.e. 50 and 100 mu m). Cells cultured on microwell surfaces had higher mitochondrial activity initially (3 days in culture), and then decreased to a level lower than that of cells seeded on flat surfaces after 7 days. Micro-well topography also affected differentiation; cells on patterned substrates had lower alkaline phosphatase and alanine aminopetidase activities than cells on flat surfaces. In general, the presence of crypt-like topography delayed cell spreading, migration, and differentiation. This study will aid in understanding the unique role intestinal topography plays in cell development and provide design parameters for a scaffold for tissue engineered intestine to treat intestinal disease.
C1 [Wang, L.; Murthy, S. K.; Carrier, R. L.] Northeastern Univ, 360 Huntington Ave, Boston, MA 02148 USA.
   [Barabino, G.] Georgia Inst Technol, Atlanta, GA 30332 USA.
RP Wang, L (reprint author), Northeastern Univ, 360 Huntington Ave, Boston, MA 02148 USA.
FU National Science Foundation [CBET 0700764]
FX This work is supported by National Science Foundation (Grant No. CBET
   0700764).
CR BEAULIEU JF, 1999, FRONT BIOSCI, V4, P310
   LOUISPHILIPPE P, 2000, MICROSC RES TECHNIQ, V49, P394
NR 2
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4362-8
PY 2009
BP 422
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BKP77
UT WOS:000268886300208
DA 2018-10-19
ER

PT B
AU Tran, PA
   Sarin, L
   Hurt, RH
   Webster, TJ
AF Tran, Phong A.
   Sarin, Love
   Hurt, Robert H.
   Webster, Thomas J.
GP IEEE
TI Selenium Nanocluster Coatings for Anti-Cancer Orthopedic Applications
SO 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT 35th Annual Northeast Bioengineering Conference
CY APR 03-05, 2009
CL Cambridge, MA
ID ENHANCED FUNCTIONS; CANCER PREVENTION; SUPPLEMENTATION; OSTEOBLASTS;
   TRIAL
AB There are currently no orthopedic materials which are made to prevent either the occurrence or reoccurrence of cancer. Due to the above, the objective of this study was to create a new biomaterial which can both restore bone and, at the same time, prevent cancer growth at the implant interface. In the present study, three types of surfaces with different surface densities were prepared. Competitive cell co-culture studies showed promoted growth of healthy bone cells and inhibited growth of cancerous cells when they were co-seeded on high dose selenium (Se) coated titanium (Ti) substrates. Thus, this study provided for the first time a material to the orthopedic community which may inhibit bone cancer growth and promote healthy bone growth.
C1 [Tran, Phong A.] Brown Univ, Dept Phys, Providence, RI 02912 USA.
   [Sarin, Love; Hurt, Robert H.] Brown Univ, Div Engn, Providence, RI 02912 USA.
   [Webster, Thomas J.] Brown Univ, Dept Engn, Dept Orthoped Surgery, Providence, RI 02912 USA.
RP Tran, PA (reprint author), Brown Univ, Dept Phys, Providence, RI 02912 USA.
FU AFM; Hermann Foundation
FX The authors thank Anthony W. McCormick for help with AFM and the Hermann
   Foundation for funding.
CR Clark LC, 1998, BRIT J UROL, V81, P730
   Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   TRAN PA, 2009, J BIOMED A IN PRESS
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
NR 5
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4362-8
PY 2009
BP 442
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BKP77
UT WOS:000268886300218
DA 2018-10-19
ER

PT B
AU Liu, H
   Wang, JN
AF Liu, Hua
   Wang, Jing
GP IEEE
TI Preparation of Calcium Phosphate-Based Bone Repair Materials
SO 2009 3RD INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL
   ENGINEERING, VOLS 1-11
LA English
DT Proceedings Paper
CT 3rd International Conference on Bioinformatics and Biomedical
   Engineering
CY JUN 11-16, 2009
CL Beijing, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Gordon Life Sci Inst, Fudan Univ, Beijing Univ Posts & Telecommunicat, Beijing Inst Technol, Wuhan Univ, Journal Biomed Sci & Engn
DE calcium phosphate; chitosan; citric acid; bone substitute material;
   osteoinductivity
ID ALVEOLAR RIDGE; HYDROXYLAPATITE; AUGMENTATION
AB We developed a calcium phosphate cement that could be molded into any desired shape due to its chewing-gum-like consistency after mixing. The powder component of the cement consists of tricalcium phosphate (TCP). The liquid component consists of chitosan, citric acid and glucose solution. In this study, we used four groups of cement to investigate the mechanical properties and biocompatibility of the new biomaterial in vivo. The setting times of the cements were 5-30 min. X-ray diffraction analysis showed that the products were hydroxyapatite (HA) and dicalcium phosphate anhydrous. When the concentration of citric acid was increased, the compressive strength of specimen increased. The animal experiments showed that the material was nontoxic and osteoinductivity.
C1 [Liu, Hua] Guangdong Pharmaceut Univ, Coll Med Informat Engn, Guangzhou 510006, Guangdong, Peoples R China.
   [Wang, Jing] First Affiliated Hosp Jinan Univ, Dept Orthopaed, Guangzhou 510632, Guangdong, Peoples R China.
RP Liu, H (reprint author), Guangdong Pharmaceut Univ, Coll Med Informat Engn, Guangzhou 510006, Guangdong, Peoples R China.
EM liuhuajnu@yahoo.com.cn; wangj@jnu.edu.cn
FU science and technology plan of Guangdong province [2008B010400002]
FX This study was supported by science and technology plan of Guangdong
   province (2008B010400002). The authors would like to acknowledge the
   assistance of Dr. Zhizhong Li in this study.
CR Brown WE, 1986, CEMENTS RES PROGR, P351
   Chow L. C., 1991, J CERAM SOC JPN, V99, P954
   CHOW LC, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P127
   HUPP JR, 1988, J ORAL MAXIL SURG, V46, P538, DOI 10.1016/0278-2391(88)90143-7
   KENT JN, 1990, J AM DENT ASSOC, V121, P138, DOI 10.14219/jada.archive.1990.0138
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P37, DOI 10.1016/0278-2391(86)90012-1
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   MONMA H, 1997, J JPN SOC BIOMATER, V15, P24
   Takechi M, 1998, BIOMATERIALS, V19, P2057, DOI 10.1016/S0142-9612(98)00114-8
   WITTKAMPF ARM, 1988, J ORAL MAXIL SURG, V46, P1019, DOI 10.1016/0278-2391(88)90344-8
NR 10
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-2901-1
PY 2009
BP 1062
EP +
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BTB33
UT WOS:000286342800262
DA 2018-10-19
ER

PT S
AU Khetan, S
   Chung, C
   Burdick, JA
AF Khetan, Sudhir
   Chung, Cindy
   Burdick, Jason A.
GP IEEE
TI Tuning Hydrogel Properties for Applications in Tissue Engineering
SO 2009 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-20
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 03-06, 2009
CL Minneapolis, MN
SP IEEE Engn Med & Biol Soc
ID DIFFERENTIATION
AB Biomaterial design is an important component towards tissue engineering applications. There are many parameters that may be adjusted including physical properties (i.e., degradation and mechanics) and chemical properties (e.g., adhesion and cellular interactions). These design components may dictate the success or failure of a tissue engineering approach. Our group is particularly interested in the use of swollen hydrogels as cell carriers. One material that is used to fabricate hydrogels is hyaluronic acid (HA), which is found in many tissues in the body. Here, we show the control over hydrogel degradation, both in the bulk and locally to cells to control both the distribution of extracellular matrix by cells and whether or not a cell spreads in the hydrogels. These signals are important in the final structure and mechanical properties of engineered tissues, and potentially the differentiation of encapsulated stem cells.
C1 [Khetan, Sudhir; Chung, Cindy; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu
FU NIDCR NIH HHS [K22DE015761]
CR BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Goossen LJ, 2004, SYNLETT, P263, DOI 10.1055/s-2003-44986
   KHETAN S, 2009, SOFT MATTER IN PRESS
   LANGER R, 1993, SCIENCE, V920, P260
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   SENECHAL H, 1984, IN VITRO CELL DEV B, V20, P692
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576
NR 11
TC 4
Z9 4
U1 0
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-3295-0
J9 IEEE ENG MED BIO
PY 2009
BP 2094
EP 2096
DI 10.1109/IEMBS.2009.5332484
PG 3
WC Engineering, Biomedical
SC Engineering
GA BQB05
UT WOS:000280543601257
PM 19963530
OA Green Published
DA 2018-10-19
ER

PT S
AU Straley, K
   Heilshorn, SC
AF Straley, Karin
   Heilshorn, Sarah C.
GP IEEE
TI Designer Protein-Based Scaffolds for Neural Tissue Engineering
SO 2009 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-20
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 03-06, 2009
CL Minneapolis, MN
SP IEEE Engn Med & Biol Soc
ID EXTRACELLULAR-MATRIX PROTEINS; CELL; REGENERATION; STRATEGIES; BEHAVIOR;
   REPAIR; DOMAIN
AB A key attribute missing from many current biomaterials is the ability to independently tune multiple biomaterial properties without simultaneously affecting other material parameters. Because cells are well known to respond to changes in the initial elastic modulus, degradation rate, and cell adhesivity of a biomaterial, it is critical to develop synthetic design strategies that allow decoupled tailoring of each individual parameter in order to systematically optimize cell-scaffold interactions. We present the development of a family of biomimetic scaffolds composed of chemically crosslinked, elastin-like proteins designed to support neural regeneration through a combination of cell adhesion and cell-induced degradation and remodeling. Through use of a modular protein-design strategy, a range of biomaterials is created that allows independent tuning over the initial elastic modulus, degradation rate, cell adhesivity, and neurite outgrowth. By combining these engineered proteins into composite structures, biomaterials are created with 3D patterns that emerge over time in response to cell-secreted enzymes. These dynamic 3D structures enable the delivery of multiple drugs with precise spatial and temporal resolution and also enable the design of biomaterials that adapt to changing scaffold needs.
C1 [Straley, Karin; Heilshorn, Sarah C.] Stanford Univ, Stanford, CA 94305 USA.
RP Straley, K (reprint author), Stanford Univ, Stanford, CA 94305 USA.
EM Heilshom@stanford.edu
CR Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Fry EJ, 2001, CLIN EXP PHARMACOL P, V28, P253, DOI 10.1046/j.1440-1681.2001.03417.x
   Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Meiners S, 2003, MOL NEUROBIOL, V27, P177, DOI 10.1385/MN:27:2:177
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   RUMMLER LS, 2004, CURR OPIN ORTHOP, V15, P215
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Seeds NW, 1997, CELL TISSUE RES, V290, P367, DOI 10.1007/s004410050942
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
NR 13
TC 5
Z9 5
U1 0
U2 8
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-3295-0
J9 IEEE ENG MED BIO
PY 2009
BP 2101
EP 2102
DI 10.1109/IEMBS.2009.5334310
PG 2
WC Engineering, Biomedical
SC Engineering
GA BQB05
UT WOS:000280543601259
PM 19964779
DA 2018-10-19
ER

PT S
AU Parsonage, E
   Girton, T
   Knapp, D
AF Parsonage, Ed
   Girton, Tim
   Knapp, David
GP IEEE
TI Biomaterial Considerations for Drug-Eluting Stents
SO 2009 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-20
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 03-06, 2009
CL Minneapolis, MN
SP IEEE Engn Med & Biol Soc
AB The ultimate test for implant biomaterials is determined by the long-term, post-market clinical product performance. This is a key consideration in the initial design and development for drug-eluting stents. To insure this ultimate clinical success, a rigorous series of bench-top, preclinical and clinical evaluations must be performed. The factors in the biomaterial choice which are important for each stage in this development process include pharmaceutical, physical, and biological elements. This presentation will outline the steps taken by Boston Scientific in each of these stages to achieve the desired clinical end-points.
C1 [Parsonage, Ed; Girton, Tim; Knapp, David] Boston Sci Corp, Maple Grove, MN 55311 USA.
RP Parsonage, E (reprint author), Boston Sci Corp, Maple Grove, MN 55311 USA.
EM knappd@bsci.com
CR Acharya G, 2006, ADV DRUG DELIVER REV, V58, P387, DOI 10.1016/j.addr.2006.01.016
   BAROCAS V, DISSOLUTION IN PRESS
   KAMATH KR, 2006, ADV DRUG DELIVERY RE, P421
   Schwartz RS, 2002, CIRCULATION, V106, P1867, DOI 10.1161/01.CIR.0000033485.20594.6F
   Seifert PS, 2007, CARDIOVASC REVASCULA, V8, P251, DOI 10.1016/j.carrev.2007.08.002
NR 5
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-3295-0
J9 IEEE ENG MED BIO
PY 2009
BP 2416
EP +
DI 10.1109/IEMBS.2009.5335396
PG 2
WC Engineering, Biomedical
SC Engineering
GA BQB05
UT WOS:000280543601341
PM 19965199
DA 2018-10-19
ER

PT S
AU Winter, JO
   Han, N
   Jensen, R
   Cogan, SF
   Rizzo, JF
AF Winter, Jessica O.
   Han, Ning
   Jensen, Ralph
   Cogan, Stuart F.
   Rizzo, Joseph F., III
GP IEEE
TI Adhesion Molecules Promote Chronic Neural Interfaces Following
   Neurotrophin Withdrawal
SO 2009 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-20
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 03-06, 2009
CL Minneapolis, MN
SP IEEE Engn Med & Biol Soc
ID NERVE GROWTH-FACTOR; DRUG-DELIVERY VEHICLES; HYDROGEL COATINGS; NEURITE
   OUTGROWTH; CELLS; DIFFERENTIATION; MODEL; CNS
AB Neural prostheses and recording devices have been successfully interfaced with the nervous system; however, substantial integration issues exist at the biomaterial-tissue interface. In particular, the loss of neurons at the implantation site and the formation of a gliotic scar capsule diminish device performance. We have investigated the potential of a tissue-engineered coating, consisting of adhesion molecule-modified surfaces (i.e., polylysine and collagen) in combination with neurotrophin application (i.e., brain derived neurotrophic factor, BDNF), to enhance the electrode-host interface. Neurite length and density were examined in a retinal explant model. In the presence of BDNF for 7 days, we found no synergistic effect of BDNF and adhesion molecule-modified surfaces on neurite length, although there was a possible increase in neurite density for collagen-coated surfaces. After BDNF withdrawal (7 days BDNF+/7 days BDNF- medium), we found that both polylysine and collagen treated surfaces displayed increases in neurite length and density over negative, untreated control surfaces. These results suggest that adhesion molecules may be used to support chronic neuron-electrode interfaces induced by neurotrophin exposure.
C1 [Winter, Jessica O.; Han, Ning] Ohio State Univ, William G Lowrie Dept Chem Engn, Columbus, OH 43210 USA.
   [Jensen, Ralph] Vet Adm Med Ctr Jamaica Plain, Boston, MA 02130 USA.
   [Cogan, Stuart F.] EIC Lab, Norwood, MA 02062 USA.
   [Rizzo, Joseph F., III] Vet Adm Med Ctr Jamaica Plain, Boston, MA 02130 USA.
RP Winter, JO (reprint author), Ohio State Univ, William G Lowrie Dept Chem Engn, Columbus, OH 43210 USA.
EM winter.63@osu.edu; han.234@osu.edu; ralph.jensen@med.va.gov;
   scogan@eiclabs.com; joseph_rizzo@meei.harvard.edu
FU Department of Veterans Affairs; Veterans Health Administration;
   Rehabilitation Research and Development Service; Ohio State University
FX This work was supported by grants from the Department of Veterans
   Affairs, Veterans Health Administration, Rehabilitation Research and
   Development Service and from the Ohio State University.
CR Attiah DG, 2003, J MATER SCI-MATER M, V14, P1005, DOI 10.1023/A:1026363018805
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Jhaveri SJ, 2009, BIOMACROMOLECULES, V10, P174, DOI 10.1021/bm801101e
   KENNEDY PR, 1989, J NEUROSCI METH, V29, P181, DOI 10.1016/0165-0270(89)90142-8
   KESHMIRIAN J, 1989, J NEUROCYTOL, V18, P491, DOI 10.1007/BF01474545
   Kishino A, 2001, NEUROREPORT, V12, P1067, DOI 10.1097/00001756-200104170-00040
   Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445
   Lewis GP, 1999, INVEST OPHTH VIS SCI, V40, P1530
   Meilander NJ, 2001, J CONTROL RELEASE, V71, P141, DOI 10.1016/S0168-3659(01)00214-0
   Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321
   Piotrowicz A, 2006, BIOMATERIALS, V27, P2018, DOI 10.1016/j.biomaterials.2005.09.042
   Sakisaka T, 2005, J CELL SCI, V118, P5407, DOI 10.1242/jcs.02672
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Winter JO, 2008, MAT SCI ENG C-BIO S, V28, P448, DOI 10.1016/j.msec.2007.04.011
   Winter JO, 2007, J BIOMED MATER RES B, V81B, P551, DOI 10.1002/jbm.b.30696
NR 16
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-3295-0
J9 IEEE ENG MED BIO
PY 2009
BP 7151
EP +
DI 10.1109/IEMBS.2009.5335356
PG 2
WC Engineering, Biomedical
SC Engineering
GA BQB05
UT WOS:000280543605244
PM 19965267
DA 2018-10-19
ER

PT B
AU Cui, TK
   Yan, YN
   Zhang, RJ
   Wang, XH
AF Cui, Tongkui
   Yan, Yongnian
   Zhang, Renji
   Wang, Xiaohong
GP IEEE
TI Biomodeling and fabricating of a hybrid PU-collagen nerve regeneration
   conduit
SO 2009 IEEE INTERNATIONAL CONFERENCE ON VIRTUAL ENVIRONMENTS,
   HUMAN-COMPUTER INTERFACES AND MEASUREMENT SYSTEMS
LA English
DT Proceedings Paper
CT IEEE International Conference on Virtual Environments, Human-Computer
   Interfaces and Measurement Systems
CY MAY 11-13, 2009
CL Hong Kong, PEOPLES R CHINA
SP IEEE
DE doable-nozzle low-temperature deposition manufacturing (DLDM); nerve
   conduit; polyurethane (PU); collagen
ID BIOARTIFICIAL LIVERS; POLYURETHANE; MANUFACTURE; REPAIR
AB A new technique for preparing double layer polyurethane (PU)-collagen nerve conduits for peripheral nerve repair via a double-nozzle low-temperature deposition manufacturing (DLDM) system has been developed. The DLDM system is based on a digital prototyping approach, and uses a combination of thermally induced phase separation and freeze-drying. With this system, two kinds of biomaterials with different properties can be combined to produce scaffold structures with good biocompatibility in the inner layer and with the desired mechanical strength protruded by the outer layer. The forming precision is high, the wall thickness can be controlled, and a tight connection between the two layers can be achieved. The effects of changing the processing parameters and the material temperature on the structure of the scaffolds have been investigated. Ideal peripheral nerve repair conduits, comprising an outer microporous layer of polyurethane (PU) and internal oriented filaments of collagen, have been manufactured through optimizing the processing parameters and the biomaterial concentrations.
C1 [Cui, Tongkui; Yan, Yongnian; Zhang, Renji; Wang, Xiaohong] Tsinghua Univ, Dept Mech Engn, Ctr Organ Mfg, Beijing 100084, Peoples R China.
RP Cui, TK (reprint author), Tsinghua Univ, Dept Mech Engn, Ctr Organ Mfg, Beijing 100084, Peoples R China.
EM wangxiaohong@tsinghua.edu.cn
CR CUI TK, J BIOACT CO IN PRESS
   CUI TK, TISSUE EN C IN PRESS
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sundback C, 2003, BIOMATERIALS, V24, P819, DOI 10.1016/S0142-9612(02)00409-X
   Wan ACA, 2001, BIOMATERIALS, V22, P1147, DOI 10.1016/S0142-9612(00)00355-0
   Wang XH, 2005, J BIOMAT SCI-POLYM E, V16, P1063, DOI 10.1163/1568562054798554
   WANG XH, J BIOACT CO IN PRESS
   Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Xu W, 2008, J BIOACT COMPAT POL, V23, P409, DOI 10.1177/0883911508095517
   Xu W, 2008, J BIOACT COMPAT POL, V23, P103, DOI 10.1177/0883911507088271
   Yan Y, 2007, J BIOACT COMPAT POL, V22, P323, DOI 10.1177/0883911507078386
   Yin DZ, 2007, J BIOACT COMPAT POL, V22, P143, DOI 10.1177/0883911506076063
NR 16
TC 0
Z9 0
U1 1
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-3808-2
PY 2009
BP 79
EP 84
DI 10.1109/VECIMS.2009.5068870
PG 6
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BLQ11
UT WOS:000270760700016
DA 2018-10-19
ER

PT B
AU Georgakoudi, I
   Levitt, J
   Rice, W
   Kaplan, D
AF Georgakoudi, Irene
   Levitt, Jonathan
   Rice, William
   Kaplan, David
GP IEEE
TI QUANTITATIVE MULTIPARAMETRIC TWO-PHOTON IMAGING OF TISSUES
SO 2009 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO
   MACRO, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT IEEE Internaional Symposium on Biomedical Imaging - From Nano to Macro
CY JUN 28-JUL 01, 2009
CL Boston, MA
SP IEEE
DE two-photon imaging; tissue engineering; intrinsic fluorescence; spectral
   imaging; cancer diagnostics
AB The characterization of engineered tissue development has been performed via invasive means that have limited abilities to capture the dynamic nature of the interactions and changes that occur. Optical spectroscopic imaging could serve as a non-invasive approach to overcome this limitation. Implemented on a two-photon microscopy platform, spectroscopic imaging can provide information on the biochemistry, structure and organization of the cellular, extracellular matrix and biomaterial scaffolds that make up engineered tissues. We find that distinct spectral shifts characterize the secondary structure of biomaterial silk scaffolds, as well as the differentiation status of epithelial and mesenchymal stem cells. The knowledge we gain is relevant not only for the optimization of tissue regeneration, but also for disease diagnostic and therapeutic applications.
C1 [Georgakoudi, Irene; Levitt, Jonathan; Rice, William; Kaplan, David] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Georgakoudi, I (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
CR ORAEVSKY AA, 2009, PHOTOACOUSTIC IMAGIN, pCH33
   Wang L. V., 2009, PHOTOACOUSTIC IMAGIN
NR 2
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-3931-7
PY 2009
BP 1198
EP 1200
DI 10.1109/ISBI.2009.5193273
PG 3
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA BLO57
UT WOS:000270678400305
DA 2018-10-19
ER

PT S
AU Habijan, T
   Glogowski, T
   Kuhn, S
   Pohl, M
   Muhr, G
   Koller, M
AF Habijan, T.
   Glogowski, T.
   Kuehn, S.
   Pohl, M.
   Muhr, G.
   Koeller, M.
BE VanderSloten, J
   Verdonck, P
   Nyssen, M
   Haueisen, J
TI Experimental setup for high mechanical strain induction to cell loaded
   metallic biomaterials
SO 4TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND
   BIOLOGICAL ENGINEERING
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 4th European Conference of the International Federation for Medical and
   Biological Engineering (ECIFMBE)
CY NOV 23-27, 2008
CL Antwerp, BELGIUM
DE nickel-titanium; human mesenchymal stem cells; biomaterial; nickel
   release; dynamic load
ID MESENCHYMAL STEM-CELLS; NITI SHAPE-MEMORY; MEDICAL APPLICATIONS; NICKEL;
   ALLOYS; MARROW; DNA; BIOCOMPATIBILITY; REPAIR
AB Analysis of mechanically-strained cell-loaded tensile specimens bridges the gap between in vitro and in vivo studies and is of special relevance for special metallic biomaterials such as nickel-titanium shape memory alloys (NiTi-SMA). NiTi-SMA are of increasing biomedical interest due to an unusual pseudo-elasticity and the shape memory effect. However, the high nickel content of NiTi-SMA may result in adverse tissue reactions especially with long-term implants under mechanical strain. It was reported that mechanical strain resulted in nickel ion release from NiTi-wires. NiTi is currently analyzed as carrier material for human mesenchymal stem cells (hMSCs). HMSCs are the most promising cell type for regenerative medicine and tissue engineering due to their ability to differentiate into several tissues such as bone, cartilage, tendon or muscle. For the treatment of local bone defects expanded hMSCs may be applied, loaded on a NiTi carrier matrix. In order to analyze biocompatibility of mechanically strained NiTi-SMA tensile specimens were preloaded with hMSCs. The specimens were transferred to a sterile PTFE cell culture tube equipped with a cell culture circulation system and fixed to the pull rods of the tensile testing machine. The cell culture tube was located into a conventional cell culture incubator located within the tensile testing machine. 86,400 strain cycles were performed for a period of 24h and 7d. Subsequently, the cell culture tube was transferred to a cell culture hood. The cell culture medium from the tube was aspirated and stored at -80 degrees C. Interleukin-6 and nickel ion release were determined. The cells on the tensile specimen were stained by calcein-AM and propidium iodine to analyze cell viability.
   The presented experimental approach will provide information on the biocompatibility and fatigue behavior of metallic specimens using sample size and dynamic strain relevant for orthopedic implants.
C1 [Habijan, T.; Muhr, G.; Koeller, M.] Univ Bochum, Bergmannsheil Univ Hosp Surg Res, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.
   [Glogowski, T.; Kuehn, S.; Pohl, M.] Univ Bochum, Fac Mech Engn Mat Testing, D-44789 Bochum, Germany.
RP Habijan, T (reprint author), Univ Bochum, Bergmannsheil Univ Hosp Surg Res, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.
EM Tim.Habijan@rub.de
FU Deutsche Forschungsgemeinschaft (SFB 459: Shape Memory Technique)
FX This work was supported by a grant of the Deutsche
   Forschungsgemeinschaft (SFB 459: Shape Memory Technique). This work is
   part of T.H.s Ph. D. thesis.
CR Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   BUNDY KJ, 1986, J BIOMED MATER RES, V20, P493, DOI 10.1002/jbm.820200406
   BUNDY KJ, 1991, BIOMATERIALS, V12, P627, DOI 10.1016/0142-9612(91)90108-M
   CAPLAN AI, 1993, ANTERIOR CRUCIATE LI
   Ermolli M, 2001, TOXICOLOGY, V159, P23, DOI 10.1016/S0300-483X(00)00373-5
   Es-Souni M, 2005, ANAL BIOANAL CHEM, V381, P557, DOI 10.1007/s00216-004-2888-3
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   KADIYALA S, 1996, T TISSUE ENG SOC, V1, P20
   Karaczyn AA, 2006, EXP CELL RES, V312, P3252, DOI 10.1016/j.yexcr.2006.06.025
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   LEE YW, 1995, MOL CELL BIOL, V15, P2547
   LEECHEN SF, 1993, BIOL TRACE ELEM RES, V37, P39, DOI 10.1007/BF02789400
   Peitsch T, 2007, J BIOMED MATER RES A, V82A, P731, DOI 10.1002/bjm.a.31097
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pohl M, 2004, MAT SCI ENG A-STRUCT, V378, P191, DOI 10.1016/j.msea.2003.11.080
   Saito T, 1995, Tissue Eng, V1, P327, DOI 10.1089/ten.1995.1.327
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Undisz A, 2008, J BIOMED MA IN PRESS
   Wozniak K, 2004, CELL MOL BIOL LETT, V9, P83
   Zhu L., 2003, OXIDATION NITINOL IT
NR 24
TC 1
Z9 1
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-89207-6
J9 IFMBE PROC
PY 2009
VL 22
IS 1-3
BP 2165
EP 2168
PG 4
WC Engineering, Biomedical
SC Engineering
GA BYS76
UT WOS:000299998500517
DA 2018-10-19
ER

PT S
AU Maher, PS
   Keatch, RP
   Donnelly, K
   Paxton, JZ
AF Maher, P. S.
   Keatch, R. P.
   Donnelly, K.
   Paxton, J. Z.
BE VanderSloten, J
   Verdonck, P
   Nyssen, M
   Haueisen, J
TI Formed 3D Bio-Scaffolds via Rapid Prototyping Technology
SO 4TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND
   BIOLOGICAL ENGINEERING
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 4th European Conference of the International Federation for Medical and
   Biological Engineering (ECIFMBE)
CY NOV 23-27, 2008
CL Antwerp, BELGIUM
DE Tissue Engineering (TE); Scaffold; Hydrogel; Bioplotting; Poly-ethylene
   glycol (PEG)
ID TISSUE; HYDROGELS
AB The construction of biomaterial scaffolds for cell seeding is now seen as the most common approach for producing artificial tissue as compared with cell self-assembly and Acellular matrix techniques. This paper describes the use of synthetic and natural polymeric material shaped into 3D biological matrices by using Rapid Prototyping (RP) technology. Recent advances in RP technology have greatly enhanced the range of biomaterials that can now be constructed into scaffolds, also allowing for maximized control of the pore size and architecture. Bioplotting is one such method which allows the dispensing of various biomaterials into a media bath which has similar rheological properties and acts as mechanical support and in most cases a cross-linking agent to produce high quality scaffolds. This method was used to construct scaffolds using agarose and gelatin with tight interconnecting pores which aim to enhance cell growth. Bioplotting was also used to pattern microchanneled layers in one direction with a PEG gel containing cell adhesive RGD peptide sequence, when seeded with C2C12 myoblasts demonstrated that cells responded to their topographical environment and aligned along the direction of the layered microchannels. This result indicates that this technique can be used to produce 3D scaffolds which aid tissue regeneration for physiologically functional tissue.
C1 [Maher, P. S.; Keatch, R. P.; Donnelly, K.] Univ Dundee, Div Mech Engn & Mechatron, Dundee, Scotland.
   [Paxton, J. Z.] Univ Dundee, Div Mol Physiol, Dundee, Scotland.
RP Maher, PS (reprint author), Univ Dundee, Div Mech Engn & Mechatron, Dundee, Scotland.
RI Keatch, Robert/Q-6958-2016; Paxton, Jennifer/A-1577-2012
OI Keatch, Robert/0000-0002-2109-8305; Paxton, Jennifer/0000-0002-6061-8051
CR Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   KREEGER PK, 2002, BIOMIMETIC MAT DESIG, P283
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Lu LC, 1996, MRS BULL, V21, P28
   Pachence J. M., 2000, PRINCIPLES TISSUE EN
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
NR 6
TC 11
Z9 11
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-89207-6
J9 IFMBE PROC
PY 2009
VL 22
IS 1-3
BP 2200
EP 2204
PG 5
WC Engineering, Biomedical
SC Engineering
GA BYS76
UT WOS:000299998500526
DA 2018-10-19
ER

PT S
AU Hu, YQ
   Barbour, ME
   Allen, GC
AF Hu, Yanqing
   Barbour, Michele E.
   Allen, Geoffrey C.
BE VanderSloten, J
   Verdonck, P
   Nyssen, M
   Haueisen, J
TI Time and pH dependence of adsorption of chlorhexidine on anatase and
   rutile titanium dioxide
SO 4TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND
   BIOLOGICAL ENGINEERING
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 4th European Conference of the International Federation for Medical and
   Biological Engineering (ECIFMBE)
CY NOV 23-27, 2008
CL Antwerp, BELGIUM
DE adsorption; titanium; anatase; rutile; chlorhexidine
AB Titanium is a widely used biomaterial for medical implants in dentistry and restorative surgery. The titanium surface oxidizes spontaneously forming a titanium dioxide (TiO2) layer in air. TiO2 is most commonly found in one of two crystal structures, anatase and rutile. Chlorhexidine (CHX) is considered to be one of the most effective and thoroughly tested antimicrobial agents. Recently, there are more and more applications of using pre-surgical CHX rinse in dental implantation which suggest that antiseptic-coated implant devices may provide inhibition against bacteria and infection. This study presents the adsorption of CHX onto anatase and rutile TiO2 in citric acid-phosphate buffer. The effects of time and pH on adsorption process were investigated. The amount of CHX adsorbed to anatase and rutile TiO2 was determined by measuring the UV adsorption of CHX solution at the adsorption peak of 255 nm using a UV-visible spectrophotometer. The mean mass of CHX adsorbed to anatase and rutile TiO2 did not change significantly after the first 60 seconds exposure. Difference between the amount of CHX adsorbed to anatase and the amount of CHX adsorbed to rutile was observed. More CHX adsorbed to anatase than rutile at lower pH such as pH 2.40 but less CHX adsorbed to anatase than rutile at higher pH such as pH 7.96 and 8.92. These might attribute to the different point of zero charge values for anatase and rutile surfaces. The Maximum adsorption was observed at pH 5.75. These could be related to the pH effect on electrostatic attraction between adsorbate and adsorbent. In conclusion, the adsorption of CHX on anatase and rutile TiO2 was affected by pH but not by time greatly. The results presented in this study could suggest the reasonable time and optimum pH condition for pre-surgical antimicrobial treatment in dental implantation.
C1 [Hu, Yanqing; Allen, Geoffrey C.] Univ Bristol, Fac Sci, Interface Anal Ctr, St Michaels Hill, Bristol, Avon, England.
   [Barbour, Michele E.] Univ Bristol, Fac Med & Dent, Dept Oral & Dent Sci, Bristol BS8 1TH, Avon, England.
RP Hu, YQ (reprint author), Univ Bristol, Fac Sci, Interface Anal Ctr, St Michaels Hill, Bristol, Avon, England.
EM phxyh@bristol.ac.uk
CR Barbour ME, 2007, SURF COATINGS UNPUB
   Barbour ME, 2007, COLLOID SURFACE A, V307, P116, DOI 10.1016/j.colsurfa.2007.05.010
   Chin MYH, 2007, BIOMATERIALS, V28, P2032, DOI 10.1016/j.biomaterials.2006.12.014
   Kosmulski M, 2002, ADV COLLOID INTERFAC, V99, P255, DOI 10.1016/S0001-8686(02)00080-5
   Kozlovsky A, 2006, J PERIODONTOL, V77, P1194, DOI 10.1902/jop.2006.050401
   Lambert PM, 1997, J ORAL MAXIL SURG, V55, P25, DOI 10.1016/S0278-2391(16)31194-6
   Young MPJ, 2002, CLIN ORAL IMPLAN RES, V13, P20, DOI 10.1034/j.1600-0501.2002.130102.x
NR 7
TC 1
Z9 1
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-89207-6
J9 IFMBE PROC
PY 2009
VL 22
IS 1-3
BP 2265
EP 2268
PG 4
WC Engineering, Biomedical
SC Engineering
GA BYS76
UT WOS:000299998500543
DA 2018-10-19
ER

PT S
AU Krasteva, N
   Hristova, K
   Radeva, E
   Pecheva, E
   Dimitrova, R
   Pramatarova, L
AF Krasteva, N.
   Hristova, K.
   Radeva, E.
   Pecheva, E.
   Dimitrova, R.
   Pramatarova, L.
BE Angelopoulos, A
   Fildisis, T
TI Effect of Ammonia Plasma Treatment on the Biological Performance of
   Plasma Polymerized Hexamethyldisiloxane
SO 7TH INTERNATIONAL CONFERENCE OF THE BALKAN PHYSICAL UNION VOLS 1 AND 2
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 7th International Conference of the Balkan-Physical-Union
CY SEP 09-13, 2009
CL Alexandroupolis, GREECE
SP Balkan Phys Union, Helen Phys Soc, Univ Crete, Univ Athens, Univ Ioannina, Univ Petras, Univ Thessaloniki, TEAK, Prefecture Evros, Reg Adm Eastern Macedonia & Thrace
DE polyhexamethyldisoloxane; ammonia plasma deposition; wettability;
   osteoblasts; biocompatibility
ID SURFACES; WETTABILITY; FILM
AB Plasma polymerized hexamethyldisiloxane (PPHMDS) is a polymer frequently considered for biomedical application due to its easy fabrication, low cost and biocompatibility However, a drawback of using PPHMDS in osteosubstitutive engineering is its high hydrophobicity, causing extremely low cellular interaction. Surface wettability can be altered in many ways such as plasma treatment, surface coating, introduction of hydrophilic or hydrophobic groups by self-assembled monolayers, etc. Among all these methods plasma treatment is one of most effective and economical ways to modify surface wettability of a material Here, we investigated three different PPHMDS layers prepared by plasma polymerization (PP) of HMDS on cover glass (CG) under two different technological regimes In order to improve cellular interactions, PPHMDS films obtained by the second operating mode were further hydrophylized in NH3 plasma. Cell-biomaterial interactions were characterized by human osteoblast-like MG63 cell model, where overall cell morphology, viability, proliferation and alkaline phosphatase activity were measured after 1, 3, 7 and 10 days of cultivation. The results emphasize a potential of ammonia plasma treatment for polymer hydrophilization and improved osteoblast-material interactions in order to use them in bone tissue engineering
C1 [Krasteva, N.; Hristova, K.] Bulgarian Acad Sci, Inst Biophys, BU-1113 Sofia, Bulgaria.
   [Radeva, E.; Pecheva, E.; Pramatarova, L.] Bulgarian Acad Sci, Inst Solid State Phys, BU-1784 Sofia, Bulgaria.
   [Dimitrova, R.] Bulgarian Acad Sci, Inst Organ Chem, BU-1113 Sofia, Bulgaria.
RP Krasteva, N (reprint author), Bulgarian Acad Sci, Inst Biophys, BU-1113 Sofia, Bulgaria.
FU Bulgarian National Scientific Research Fund [TK-X-1708/07]; Agency of
   Innovation of Bulgaria [NIF 02-54/07]; NATO [CBP.EAR.RIG.982693]
FX This work is supported by two National projects: the Bulgarian National
   Scientific Research Fund (grant TK-X-1708/07) and the Agency of
   Innovation of Bulgaria (grant NIF 02-54/07). NATO grant
   CBP.EAR.RIG.982693 is also acknowledged.
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Hayakawa T, 2004, BIOMATERIALS, V25, P119, DOI 10.1016/S0142-9612(03)00484-8
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Inagaki N, 2004, J ADHES SCI TECHNOL, V18, P1427, DOI 10.1163/1568561042323275
   Prasad GR, 2005, SURF COAT TECH, V200, P1031, DOI 10.1016/j.surfcoat.2005.02.009
   RADEVA E, 1993, J APPL POLYM SCI, V50, P165, DOI 10.1002/app.1993.070500118
   RADEVA E, 2009, J OPTOELECTR ADV MAT, V11
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
NR 9
TC 1
Z9 1
U1 0
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0740-4
J9 AIP CONF PROC
PY 2009
VL 1203
BP 688
EP +
PG 2
WC Physics, Applied
SC Physics
GA BQP19
UT WOS:000281467300127
DA 2018-10-19
ER

PT J
AU Torres-Giner, S
   Gimeno-Alcaniz, JV
   Ocio, MJ
   Lagaron, JM
AF Torres-Giner, Sergio
   Gimeno-Alcaniz, Jose V.
   Ocio, Maria J.
   Lagaron, Jose M.
TI Comparative Performance of Electrospun Collagen Nanofibers Cross-linked
   by Means of Different Methods
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE electrospinning; collagen; cross-linking; bone tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; DERMAL SHEEP COLLAGEN; LINKING AGENT
   GENIPIN; I COLLAGEN; MICROBIAL TRANSGLUTAMINASE; POLYMER NANOFIBERS;
   BIOCOMPATIBILITY; MINERALIZATION; CARBODIIMIDE; CYTOTOXICITY
AB Collagen, as the major structural protein of the extracellular matrix in animals, is a versatile biomaterial of great interest in various engineering applications. Electrospun nanofibers of collagen are regarded as very promising materials for tissue engineering applications because they can reproduce the morphology of the natural bone but have as a drawback a poor structural consistency in wet conditions. In this paper, a comparative study between the performance of different cross-linking methods such as a milder enzymatic treatment procedure using transglutaminase, the use of N-[3-(dimethylamino)propyl]-N'-ethylcarbodiimide hydrochloride/N-hydroxysuccinimide, and genipin, and the use of a physical method based on exposure to ultraviolet light was carried out. The chemical and enzymatic treatments provided. in this order, excellent consistency, morphology, cross-linking degree. and osteoblast viability for the collagen nanofibers. Interestingly, the enzymatically cross-linked collagen mats, which are considered to be a more biological treatment, promoted adequate cell adhesion, making the biomaterial biocompatible and with an adequate degree of porosity for cell seeding and in-growth.
C1 [Torres-Giner, Sergio; Ocio, Maria J.; Lagaron, Jose M.] CSIC, IATA, Novel Mat & Nanotechnol Lab, Burjassot 46100, Spain.
   [Gimeno-Alcaniz, Jose V.] CSIC, IATA, Cell Culture Lab, Burjassot 46100, Spain.
   [Ocio, Maria J.] Univ Valencia, Fac Pharm, Dept Prevent Med, E-46100 Burjassot, Spain.
RP Lagaron, JM (reprint author), CSIC, IATA, Novel Mat & Nanotechnol Lab, Apartado Correos 73, Burjassot 46100, Spain.
EM lagaron@iata.csic.es
RI Ocio, Maria/H-4617-2012; Torres-Giner, Sergio/B-3726-2016
OI Torres-Giner, Sergio/0000-0001-9071-9542
FU EU integrated project NEWBONE; company Nanobiomatters Ltd. (Paterna,
   Spain); Spanish MEC [MAT2006-0261-C03]
FX The authors acknowledge the EU integrated project NEWBONE, the company
   Nanobiomatters Ltd. (Paterna, Spain), and the Spanish MEC (Project
   MAT2006-0261-C03) for financial support and Impex Quimica Corp. for
   supplying TG.
CR AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402
   AKIN H, 1995, J APPL POLYM SCI, V58, P95, DOI 10.1002/app.1995.070580110
   ANDRIANARIVO AG, 1992, J CELL PHYSIOL, V153, P256, DOI 10.1002/jcp.1041530205
   Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chen RN, 2005, BIOMATERIALS, V26, P4229, DOI 10.1016/j.biomaterials.2004.11.012
   DE Jong GAH, 2002, J FOOD SCI, V67, P2798, DOI 10.1111/j.1365-2621.2002.tb08819.x
   FOLK JE, 1980, ANN REV BIOCH, V49, P17
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GREENBERG CS, 1991, FASEB J, V5, P3071
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206
   KAKADE ML, 1969, ANAL BIOCHEM, V27, P273, DOI 10.1016/0003-2697(69)90032-3
   Khew ST, 2008, BIOMATERIALS, V29, P3034, DOI 10.1016/j.biomaterials.2008.03.023
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kitano A, 2006, J CATARACT REFR SURG, V32, P1727, DOI 10.1016/j.jcrs.2006.05.015
   Knott L, 1997, BIOCHEM J, V322, P535, DOI 10.1042/bj3220535
   Lannutti J, 2007, MAT SCI ENG C-BIO S, V27, P504, DOI 10.1016/j.msec.2006.05.019
   Lastowka A, 2005, J AM LEATHER CHEM AS, V100, P196
   Lee SW, 2003, ANAL CHIM ACTA, V480, P267, DOI 10.1016/S0003-2670(03)00023-0
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Lien SM, 2008, MAT SCI ENG C-BIO S, V28, P36, DOI 10.1016/j.msec.2006.12.015
   Liu BS, 2003, J BIOMED MATER RES A, V67A, P1163, DOI 10.1002/jbm.a.20017
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McClure MJ, 2008, J ENG FIBER FABR, V3, P1
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   Nimni ME, 1988, COLLAGEN, VIII, P1
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   RABOTYAGOVA OS, 2008, MAT SCI ENG C-BIO S
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Torres-Giner S, 2008, ENG LIFE SCI, V8, P303, DOI 10.1002/elsc.200700066
   Torres-Giner S, 2008, FOOD HYDROCOLLOID, V22, P601, DOI 10.1016/j.foodhyd.2007.02.005
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5
   Zeeman R, 1999, J BIOMED MATER RES, V46, P424, DOI 10.1002/(SICI)1097-4636(19990905)46:3<424::AID-JBM16>3.0.CO;2-R
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
NR 56
TC 60
Z9 63
U1 1
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JAN
PY 2009
VL 1
IS 1
BP 218
EP 223
DI 10.1021/am800063x
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 463HE
UT WOS:000267421200031
PM 20355775
DA 2018-10-19
ER

PT J
AU Sanz-Herrera, JA
   Garcia-Aznar, JM
   Doblare, M
AF Sanz-Herrera, J. A.
   Garcia-Aznar, J. M.
   Doblare, M.
TI On scaffold designing for bone regeneration: A computational multiscale
   approach
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone tissue engineering; Porous scaffold; Computational mechanobiology;
   Multiscale analysis
ID BMP-INDUCED OSTEOGENESIS; MECHANICAL-PROPERTIES; TISSUE DIFFERENTIATION;
   IN-VITRO; CELLS; SIMULATION; POROSITY; STRAIN; GROWTH; FABRICATION
AB Scaffold design for bone tissue engineering applications involves many parameters that directly influence the rate of bone tissue regeneration onto its microstructural surface. To improve scaffold functionality, increasing interest is being focused on in vitro and in vivo research in order to obtain the optimal scaffold design for a specific application. However, the evaluation of the effect of each specific scaffold parameter on tissue regeneration using these techniques requires costly protocols and long-term experiments. In this paper, we elucidate the effect of some scaffold parameters on bone tissue regeneration by means of a mathematically based approach. By virtue of in silico experiments, factors such as scaffold stiffness, porosity, resorption kinetics, pore size and pre-seeding are analyzed in a specific bone tissue application found in the literature. The model predicts the in vivo rate of bone formation within the scaffold, the scaffold degradation and the interaction between the implanted scaffold and the surrounding bone. Results show an increasing rate of bone regeneration with increasing scaffold stiffness, scaffold mean pore size and pre-seeding, whereas the collapse of the scaffold occurs for a faster biomaterial resorption kinetics. Requiring further experimental validation, the model can be useful for the assessment of scaffold design and for the analysis of scaffold parameters in tissue regeneration. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Sanz-Herrera, J. A.] Univ Zaragoza, Grp Struct Mech & Mat Modeling, Aragon Inst Engn Res 13A, Zaragoza 50018, Spain.
   Aragon Inst Hlth Sci, CIBER BBN Networking Ctr Bioengn Biomat & Nanomed, Zaragoza, Spain.
RP Sanz-Herrera, JA (reprint author), Univ Zaragoza, Grp Struct Mech & Mat Modeling, Aragon Inst Engn Res 13A, Torres Quevedo Bldg,Maria Luna 3, Zaragoza 50018, Spain.
EM jose@unizar.es
RI Garcia-Aznar, Jose Manuel/F-8256-2010; Sanz-Herrera, Jose/E-6598-2010
OI Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Sanz-Herrera,
   Jose/0000-0001-8371-3820; /0000-0001-8741-6452
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Adachi T, 2001, J BIOMECH ENG-T ASME, V123, P403, DOI 10.1115/1.1392315
   Adachi T, 1997, JSME INT J C-MECH SY, V40, P782, DOI 10.1299/jsmec.40.782
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   BEAUPRE GS, 1990, J ORTHOP RES, V8, P651, DOI 10.1002/jor.1100080506
   Biskobing DM, 2002, CHEST, V121, P609, DOI 10.1378/chest.121.2.609
   Brigido-Diego R, 2007, J BIOMED MATER RES B, V81B, P448, DOI DOI 10.1002/JBM.B.30683
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   CARTER DR, 1987, J BIOMECH, V20, P785, DOI 10.1016/0021-9290(87)90058-3
   Cheng G, 2006, BIOPHYS J, V90, P713, DOI 10.1529/biophysj.105.063701
   COWIN SC, 1976, J ELASTICITY, V6, P313, DOI 10.1007/BF00041724
   Dennis J E, 1993, J Oral Implantol, V19, P106
   Dennis J E, 1992, Cell Transplant, V1, P23
   Di Palma F, 2005, BIOMATERIALS, V26, P4249, DOI 10.1016/j.biomaterials.2004.10.041
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Gomez-Benito MJ, 2005, J THEOR BIOL, V235, P105, DOI 10.1016/j.jtbi.2004.12.023
   Gopferich A, 1997, MACROMOLECULES, V30, P2598, DOI 10.1021/ma961627y
   GULDBERG RE, 1998, J BIOMECH ENG, V27, P433
   Gushue DL, 2005, J ORTHOP RES, V23, P735, DOI 10.1016/j.orthres.2005.01.005
   *HKS INC, 2001, AB US MAN V 6 2
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holtorf HL, 2006, ADV EXP MED BIOL, V585, P225
   HONG Z, 2007, J BIOMED MATER RES A, V81, P512
   HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Jacobs C.R., 1994, THESIS STANFORD U
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   KARAGEORGIOU V, 2005, BIOMATERIALS
   Kelly DJ, 2006, TISSUE ENG, V12, P2509, DOI 10.1089/ten.2006.12.2509
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Mimics Materialise, 2006, MIM MAT NV V10 0
   Moreo P, 2008, ACTA BIOMATER, V4, P613, DOI 10.1016/j.actbio.2007.10.014
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OWEN M, 1985, BONE MINERAL RES, V1, P1
   Pauwels F, 1965, GESAMMELTE ABHANDLUN
   Pavlin D, 2001, CRIT REV ORAL BIOL M, V12, P414, DOI 10.1177/10454411010120050401
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sanz-Herrera JA, 2008, COMPUT METHOD APPL M, V197, P3092, DOI 10.1016/j.cma.2008.02.010
   SANZHERRERA JA, BIOMECH MOD IN PRESS
   Savarino L, 2007, BIOMATERIALS, V28, P3101, DOI 10.1016/j.biomaterials.2007.03.011
   Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   SUQUET PM, 1983, LECT NOTE PHYS, V272, P193
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tang L, 2006, BIOCHEM BIOPH RES CO, V344, P122, DOI 10.1016/j.bbrc.2006.03.123
   Terada K, 1998, COMPUT METHOD APPL M, V153, P223, DOI 10.1016/S0045-7825(97)00071-6
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Williams D, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00232-9
NR 59
TC 85
Z9 89
U1 0
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2009
VL 5
IS 1
BP 219
EP 229
DI 10.1016/j.actbio.2008.06.021
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386ZV
UT WOS:000261922400023
PM 18725187
DA 2018-10-19
ER

PT J
AU Oliveira, NTC
   Guastaldi, AC
AF Oliveira, N. T. C.
   Guastaldi, A. C.
TI Electrochemical stability and corrosion resistance of Ti-Mo alloys for
   biomedical applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Ti-Mo alloys; Corrosion resistance; Biocompatible alloys; Titanium
   alloys
ID IN-VITRO CORROSION; TITANIUM-ALLOYS; IMPEDANCE SPECTROSCOPY;
   TI-13NB-13ZR ALLOYS; BODY-FLUID; BEHAVIOR; TI-6AL-4V; WEAR; FILM;
   MICROSTRUCTURE
AB Electrochemical behavior of pure Ti and Ti-Mo alloys (6-20 wt.% Mo) was investigated as a function of immersion time in electrolyte simulating physiological media. Open-circuit potential values indicated that all Ti-Mo alloys studied and pure Ti undergo spontaneous passivation due to spontaneously formed oxide film passivating the metallic surface, in the chloride-containing solution. It also indicated that the addition of Mo to pure Ti up to 15 wt.% seems to improve the protection characteristics of its spontaneous oxides. Electrochemical impedance spectroscopy (EIS) studies showed high impedance values for all samples, increasing with immersion time, indicating an improvement in corrosion resistance of the spontaneous oxide film. The fit obtained suggests a single passive film present on the metals' surface, improving their resistance with immersion time, presenting the highest values to Ti-15Mo alloy. Potentiodynamic polarization showed a typical valve-metal behavior, with anodic formation of barrier-type oxide films, without pitting corrosion, even in chloride-containing solution. In all cases, the passive current values were quite small, and decrease after 360 h of immersion. All these electrochemical results suggest that the Ti-15Mo alloy is a promising material for orthopedic devices, since electrochemical stability is directly associated with biocompatibility and is a necessary condition for applying a material as biomaterial. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Oliveira, N. T. C.; Guastaldi, A. C.] UNESP, Inst Quim, Dept Quim Fis, Grp Biomat, BR-14801970 Araraquara, SP, Brazil.
RP Oliveira, NTC (reprint author), UNESP, Inst Quim, Dept Quim Fis, Grp Biomat, Rua Francisco Degni S-N,POB 355, BR-14801970 Araraquara, SP, Brazil.
EM ntco@yahoo.com
RI Oliveira, Nilson/G-4429-2015; Guastaldi, Antonio/O-7379-2014
OI Guastaldi, Antonio/0000-0002-6433-3555
FU FAPESP [04/11751-8, 2005/04050-6]
FX The authors are grateful to FAPESP for scholarships (Proc. 04/11751-8)
   and Grants (Proc. 2005/04050-6) that made this work possible.
CR BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8
   Cai Z, 2003, BIOMATERIALS, V24, P213, DOI 10.1016/S0142-9612(02)00293-4
   Czarnowska E., 1999, J MATER PROCESS TECH, V92-93, P190
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Guo H, 2006, SCRIPTA MATER, V54, P1409, DOI 10.1016/j.scriptamat.2005.11.053
   Habazaki H, 2003, SURF COAT TECH, V169, P151, DOI 10.1016/S0257-8972(03)00216-0
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Kuroda D., 1995, J BIOMED MATER RES, V29, P943
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   LIU Y, 2003, J CENTRAL S U TECHNO, V2, P81
   Lopez MF, 2002, ELECTROCHIM ACTA, V47, P1359, DOI 10.1016/S0013-4686(01)00860-X
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P2068, DOI 10.1016/j.electacta.2005.07.015
   Oliveira NTC, 2005, J BIOMED MATER RES A, V74A, P397, DOI 10.1002/jbm.a.30352
   Oliveira NTC, 2004, ELECTROCHIM ACTA, V49, P4563, DOI 10.1016/j.electacta.2004.04.042
   Popa MV, 2005, REV CHIM-BUCHAREST, V56, P908
   SAKAGUCHI S, 1999, MET MATER INT, V2, P193
   Schmidt H, 1998, MATER SCI TECH-LOND, V14, P592, DOI 10.1179/mst.1998.14.6.592
   Shukla AK, 2006, CORROS SCI, V48, P1696, DOI 10.1016/j.corsci.2005.06.003
   Sugano M., 1998, MAT SCI ENG A-STRUCT, V1-2, P163
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Yoshimitsu D, 2003, MAT SCI ENG A-STRUCT, V1-3, P133
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
NR 30
TC 135
Z9 144
U1 5
U2 61
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2009
VL 5
IS 1
BP 399
EP 405
DI 10.1016/j.actbio.2008.07.010
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386ZV
UT WOS:000261922400042
PM 18707926
DA 2018-10-19
ER

PT J
AU Acharya, C
   Ghosh, SK
   Kundu, SC
AF Acharya, Chitrangada
   Ghosh, Sudip K.
   Kundu, S. C.
TI Silk fibroin film from non-mulberry tropical tasar silkworms: A novel
   substrate for in vitro fibroblast culture
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk fibroin; Adhesion; Biocompatibility; Contact angle; FTIR
ID BOMBYX-MORI; CELL ATTACHMENT; CYNTHIA-RICINI; GROWTH; TISSUE; PROTEIN;
   BIOMATERIALS; FIBRONECTIN; ADHESION
AB The silk protein fibroin, isolated from the cocoon of the domesticated mulberry silkworm, Bombyx mori, is used extensively in biomaterial design and in cell and tissue culture. We report here for the first time the potential application of fibroin obtained from the cocoon of non-mulberry tropical silkworm, Antheraea mylitta, as a substrate for in vitro cell culture. The mechanical strength of A. mylitta silk fibers indicates a stronger thread composition. The contact angle of A. mylitta fibroin films suggests that it has lower hydrophilicity and lower solubility in organic solvents compared to B. mori fibroin films. Retention of a secondary structure of fibroin in both A. mylitta and B. mori films is confirmed by Fourier transform infrared analysis. The adherence, growth and proliferation patterns of feline fibroblast cells on A. mylitta fibroin films suggest that this kind of film has a greater ability to support cell growth than B. mori fibroin films and is comparable to that of control. This study demonstrates that, as well as being non-toxic to dermal fibroblast cells, non-mulberry fibroin might be a useful alternative substrate to the more common B. mori fibroin for a variety of biomedical applications. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Acharya, Chitrangada; Ghosh, Sudip K.; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijh.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
FU Council of Scientific and Industrial Research and Department of
   Biotechnology, New Delhi; Department of Biomedical Engineering, Tufts
   University; NIH Tissue Engineering Resource Center [P41 EB 002520]
FX This work was financially supported by the Council of Scientific and
   Industrial Research and Department of Biotechnology, New Delhi. The
   Central Tasar Research and Training Institute, Ranchi, the Central
   Sericulture Research and Training Institute, Berhampore, and the
   Directorate of Sericulture, Midnapore, West Bengal, provided the silk
   cocoons and fibers. S.C.K. wishes to record the support received from
   the Department of Biomedical Engineering, Tufts University and the NIH
   Tissue Engineering Resource Center (P41 EB 002520).
CR Akai H., 1998, 3 INT C WILD SILK MO, P255
   Asakura T, 2004, BIOMATERIALS, V25, P617, DOI 10.1016/S0142-9612(03)00570-2
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Datta A, 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI 10.1016/S0965-1748(01)00049-2
   Freij-Larsson C, 2000, BIOMATERIALS, V21, P307, DOI 10.1016/S0142-9612(99)00195-7
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Gaussier H, 2003, APPL ENVIRON MICROB, V69, P6777, DOI 10.1128/AEM.69.11.6777-6784.2003
   Gilbert V, 2005, BIOMATERIALS, V26, P7471, DOI 10.1016/j.biomaterials.2005.05.085
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Halsted WS, 1913, J AMER MED ASSOC, V60, P1119, DOI 10.1001/jama.1913.04340150001001
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Kirimura J., 1962, B SERIC EXP STN, V17, P447
   Kommireddy DS, 2006, BIOMATERIALS, V27, P4296, DOI 10.1016/j.biomaterials.2006.03.042
   Lee Y., 1999, B UN FAO, V136
   LUCAS F, 1968, COMPR BIOCH
   Mikos A., 2001, ELECTRON J BIOTECHN, V3, P114
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MORI H, 2000, REV MOL BIOTECHNOL, V74, P95, DOI DOI 10.1016/S1389-0352(00)00004-0
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   PANDIT MW, 1972, ARCH BIOCHEM BIOPHYS, V149, P259, DOI 10.1016/0003-9861(72)90321-9
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   REMONDETTO G, 2003, BIOPOLYMERS, V69, P469
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   SHAMITHA G, 1998, 3 INT C WILD SILK MO, P274
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   TAMURA T, 1988, INSECT BIOCHEM, V18, P169, DOI 10.1016/0020-1790(88)90021-2
   TAMURA T, 1988, DETERMINATION MOL WE
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Yamamoto K, 2007, BIOMATERIALS, V28, P1838, DOI 10.1016/j.biomaterials.2006.11.045
NR 39
TC 56
Z9 57
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2009
VL 5
IS 1
BP 429
EP 437
DI 10.1016/j.actbio.2008.07.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386ZV
UT WOS:000261922400045
PM 18676188
DA 2018-10-19
ER

PT J
AU Ferreira, AM
   Gonzalez, G
   Gonzalez-Paz, RJ
   Feijoo, JL
   Lira-Olivares, J
   Noris-Suarez, K
AF Ferreira, A. M.
   Gonzalez, G.
   Gonzalez-Paz, R. J.
   Feijoo, J. L.
   Lira-Olivares, J.
   Noris-Suarez, K.
TI BONE COLLAGEN ROLE IN PIEZOELECTRIC MEDIATED REMINERALIZATION
SO ACTA MICROSCOPICA
LA English
DT Article
DE bone collagen; intelligent biomaterial; SEM; bone piezoelectricity;
   biomimetic method
ID MINERALIZED TISSUES; DEPOSITION
AB Bone tissue is characterized by its mineral structure, showing unique properties as mechanical resistance, toughness and elasticity. These are due to its composite nature of collagen (the most important constituent protein in the bone matrix), with hydroxyapatite crystals. The place of collagen in the organization and growth promotion of mineral bone tissue is still under study. In this paper an evaluation of the piezoelectric effect of collagen, using the biomimetic method and scanning electron microscopy, is presented. It was found that after 3.5 weeks of exposure, deformed collagen initiate the precipitation of, at the collagen fiber "holes", but only on the compressed side. This precipitation process, completely cover the surface in 5 weeks of exposure to the Simulated Body Fluid (SBF). This confirms that the piezoelectric effect is a probable mechanism for apatite nucleation and that the collagen fiber "holes" are preferential sites, however they don't promote nucleation by themselves. Thus Wolf's Law seems to be dictated by piezoelectricity alone.
C1 [Ferreira, A. M.; Noris-Suarez, K.] Univ Simon Bolivar, Dpto Biol Celular, Lab Ingn Tejidos, Caracas, Venezuela.
   [Gonzalez-Paz, R. J.; Feijoo, J. L.; Lira-Olivares, J.] Univ Simon Bolivar, GPUSB, Dpto Ciencia Mat, Caracas, Venezuela.
RP Noris-Suarez, K (reprint author), Univ Simon Bolivar, Dpto Biol Celular, Lab Ingn Tejidos, Caracas, Venezuela.
EM knoris@usb.ve
OI Ferreira-Duarte, Ana/0000-0002-7728-1619
FU Venezuelan National Science Foundation FONACIT [G-200100900]; Research
   and Development Unit (DID) of Simon Bolivar University, GPUSB [GID-02,
   GID-08]
FX We thank the Venezuelan National Science Foundation FONACIT through
   grant G-200100900 and the Research and Development Unit (DID) of Simon
   Bolivar University, GPUSB (GID-02, GID-08), for the support given to
   accomplish this work. A. M. Ferreira is a recipient of a graduate
   research assistantship from the DID, Universidad Simon Bolivar.
CR Ahn AC, 2009, MED ENG PHYS, V31, P733, DOI 10.1016/j.medengphy.2009.02.006
   Banse X, 2002, BONE, V31, P70, DOI 10.1016/S8756-3282(02)00800-1
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   GLIMCHER MJ, 1959, REV MOD PHYS, V31, P359, DOI 10.1103/RevModPhys.31.359
   GLIMCHER MJ, 1968, ORG STRUCTURE BONE M, P68
   GONZALEZPAZ R, 2007, 4 LAT AM C BIOM ENG
   Landis WJ, 2009, CELLS TISSUES ORGANS, V189, P20, DOI 10.1159/000151454
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   LANDIS WJ, 2006, J MATER CHEM, V16, P9
   LEES S, 1988, CONNECT TISSUE RES, V18, P41, DOI 10.3109/03008208809019071
   MARINO AA, 1971, CALC TISS RES, V8, P177, DOI 10.1007/BF02010135
   Noris-Suarez K, 2007, BIOMACROMOLECULES, V8, P941, DOI 10.1021/bm060828z
   OZAWA H, 2008, J ORAL BIOSCIENCE, V50
   Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155
   Takano Y, 1996, J BONE MINER RES, V11, P1292
   WUTHIER RE, 1989, CONNECT TISSUE RES, V22, P653, DOI 10.3109/03008208909114117
   WUTHIER RE, 1982, CLIN ORTHOP RELAT R, V169, P23
NR 17
TC 8
Z9 8
U1 1
U2 18
PU COMITE INTERAMERICANO SOC MICROSCOPIA ELECTRONICA-CIASEM
PI CARACAS
PA CARRETERA PANAMERICANA KM 11, APARTADO POSTAL 20632, CARACAS, 1020-A,
   VENEZUELA
SN 0798-4545
EI 2224-8927
J9 ACTA MICROSC
JI Acta Microsc.
PY 2009
VL 18
IS 3
BP 278
EP 286
PG 9
WC Microscopy
SC Microscopy
GA 586HT
UT WOS:000276898000009
DA 2018-10-19
ER

PT J
AU Okroj, W
   Walkowiak-Przybylo, M
   Rosniak-Bak, K
   Klimek, L
   Walkowiak, B
AF Okroj, Wieslawa
   Walkowiak-Przybylo, Magdalena
   Rosniak-Bak, Kinga
   Klimek, Leszek
   Walkowiak, Bogdan
TI Comparison of microscopic methods for evaluating platelet adhesion to
   biomaterial surfaces
SO ACTA OF BIOENGINEERING AND BIOMECHANICS
LA English
DT Article
DE biomaterials; medical steel AISI 316L; platelet adhesion; platelet
   activation; thrombogenicity; surface imaging
ID PROTEIN ADSORPTION; WHOLE-BLOOD; ACTIVATION; TITANIUM; PLASMA; FILMS
AB Microscopic methods usable for sample surface imaging and subsequent qualitative and quantitative evaluation of platelet adhesion to the surface of the biomaterial studied were compared. It was shown, making use of the samples of medical steel (AISI 316L), that such tools as surface imaging with scanning electron microscopy (SEM), glutaraldehyde induced fluorescence technique (GIFT) and metallurgical microscopy (MM) are equivalent in evaluating surface platelet adhesion. The importance of biological variability of blood samples for a proper result assessment and the necessity of using internal standards were also considered.
C1 [Walkowiak, Bogdan] Tech Univ Lodz, Inst Mat Sci, Dept Biophys, PL-90924 Lodz, Poland.
   [Okroj, Wieslawa; Walkowiak-Przybylo, Magdalena; Klimek, Leszek; Walkowiak, Bogdan] Tech Univ Lodz, Ctr Excellence NANODIAM, PL-90924 Lodz, Poland.
   [Okroj, Wieslawa; Walkowiak-Przybylo, Magdalena; Klimek, Leszek; Walkowiak, Bogdan] Ctr Adv Technol BioTechMed, Lodz, Poland.
   [Rosniak-Bak, Kinga] Med Univ Lodz, Dept Lab Diagnost & Clin Biochem, Lodz, Poland.
   [Klimek, Leszek] Med Univ Lodz, Dept Biophys, Lodz, Poland.
   [Walkowiak, Bogdan] Med Univ Lodz, Dept Mol & Med Biophys, Lodz, Poland.
RP Walkowiak, B (reprint author), Tech Univ Lodz, Inst Mat Sci, Dept Biophys, Stefanowskiego 1-15, PL-90924 Lodz, Poland.
EM bogdan.walkowiak@umed.lodz.pl
RI Klimek, Leszek/K-5958-2015
OI Klimek, Leszek/0000-0003-3617-8225; Walkowiak,
   Bogdan/0000-0003-4867-5456
CR [Anonymous], 10993 EN ISO
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kamath S, 2001, EUR HEART J, V22, P1561, DOI 10.1053/euhj.2000.2515
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   Krishnan LK, 2002, BIOMOL ENG, V19, P251, DOI 10.1016/S1389-0344(02)00029-1
   Liu Y, 2007, SURF COAT TECH, V201, P6851, DOI 10.1016/j.surfcoat.2006.09.021
   Nygren H, 1996, COLLOID SURFACE B, V6, P329, DOI 10.1016/0927-7765(96)01270-2
   Resmi KR, 2004, THROMB RES, V114, P121, DOI 10.1016/j.thromres.2004.05.014
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
NR 12
TC 9
Z9 9
U1 0
U2 7
PU WROCLAW UNIV TECHNOLOGY
PI WROCLAW
PA WROCLAW UNIV TECHNOLOGY, MECHANICAL DEPT, WYBRZEZE WYSPIANSKIEGO 27,
   WROCLAW, 50-370, POLAND
SN 1509-409X
J9 ACTA BIOENG BIOMECH
JI Acta Bioeng. Biomech.
PY 2009
VL 11
IS 2
BP 45
EP 49
PG 5
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 520PU
UT WOS:000271858400005
PM 19839561
DA 2018-10-19
ER

PT J
AU Calasans-Maia, MD
   Ascoli, FO
   Novellino, ATNA
   Rossi, AM
   Granjeiro, JM
AF Calasans-Maia, Monica Diuana
   Ascoli, Fabio Oliveira
   Neves Alves Novellino, Adriana Terezinha
   Rossi, Alexandre Malta
   Granjeiro, Jose Mauro
TI COMPARATIVE HISTOLOGICAL EVALUATION OF TIBIAL BONE REPAIR IN RABBITS
   TREATED WITH XENOGRAFTS
SO ACTA ORTOPEDICA BRASILEIRA
LA English
DT Article
DE Bone transplantation; Rabbits; Materials testing
ID OSTEOINDUCTION; MATRIX; SYSTEM; RATS
AB Objective: Xenografts are an alternative to autogenous grafts and must be osteoconductive and biocompatible. A recent study has demonstrated that the physical and chemical characteristics of commercially available hydroxyapatites do not fit the manufacturers' descriptions. This study evaluates the bio-compatibility and osteoconduction of a xenograft derived from bovine medullary bone. Methods: Fifteen adult rabbits weighing between 2,500 g and 3,000 g each were anesthetized and subjected to surgical procedures to create three perforations in the tibia, with a diameter of 2 mm. These were filled with blood clot, Osseus (R) and Bio-Oss (R). The animals were euthanized after 7, 14 and 28 days. Results: Histopathological analysis of the interface between the bone and the biomaterial showed a slight inflammatory response after 7 days, which was absent in the subsequent periods. Both materials were partially replaced by bone tissue directly in contact with the surface of the materials, without the occurrence of fibrosis. Conclusion: We concluded that both materials are biocompatible and absorbable, allowing for progressive bone apposition on the surface throughout the evaluation period.
C1 [Calasans-Maia, Monica Diuana; Granjeiro, Jose Mauro] Univ Fed Fluminense, Postgrad Program Pathol, Niteroi, RJ, Brazil.
   [Calasans-Maia, Monica Diuana; Granjeiro, Jose Mauro] Univ Fed Fluminense, Coll Dent, Niteroi, RJ, Brazil.
   [Ascoli, Fabio Oliveira] Univ Fed Fluminense, Dept Physiol & Pharmacol, Inst Biomed, Niteroi, RJ, Brazil.
   [Neves Alves Novellino, Adriana Terezinha] Univ Gama Filho, Coll Dent, Rio De Janeiro, Brazil.
   [Rossi, Alexandre Malta] Brazilian Phys Res Ctr, Biomat Lab LABIOMATAT MCT, Rio De Janeiro, Brazil.
   [Granjeiro, Jose Mauro] Univ Fed Fluminense, Cell Therapy Ctr, Niteroi, RJ, Brazil.
   [Granjeiro, Jose Mauro] Univ Fed Fluminense, Inst Biol, Niteroi, RJ, Brazil.
RP Calasans-Maia, MD (reprint author), Av Rui Barbosa 582-501, Rio De Janeiro, Brazil.
EM monicacalasans@terra.com.br
RI Calasans-Maia, Monica/G-6203-2013; Granjeiro, Jose/D-8289-2012
OI Granjeiro, Jose/0000-0002-8027-8293
FU SIN Implant System, Sao Paulo, Brazil; National Council for Scientific
   and Technological Development (CNPO); Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (Cientista do Nosso
   Estado); Ministry of Health
FX This study was partially financed by SIN Implant System, Sao Paulo,
   Brazil, but without any influence on its execution and analysis Dr
   Granjeiro and Dr Rossi were partly financed by the National Council for
   Scientific and Technological Development (CNPO), Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Cientista do
   Nosso Estado) and the Department of Science and Technology of the
   Ministry of Health (DECIT/MS)
CR CALASANSMAIA MD, 2007, BIOCERAMICO, V20, P273
   Conz Marcio Baltazar, 2005, J. Appl. Oral Sci., V13, P136, DOI 10.1590/S1678-77572005000200008
   Eid K, 2001, J ORTHOPAED RES, V19, P962, DOI 10.1016/S0736-0266(00)00080-2
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Macedo CAS, 1999, REV BRAS ORTOP, V34, P529
   Misch CE, 1999, CONT IMPLANT DENTIST
   Pruss A, 2003, BIOLOGICALS, V31, P287, DOI 10.1016/j.biologicals.2003.08.002
   ROSA AL, 2000, PESQ ODONTOL BRAS SA, V14, P273
   Sanada Jefferson Tomio, 2003, J. Appl. Oral Sci., V11, P209, DOI 10.1590/S1678-77572003000300010
   Sicca Cm, 2000, REV FAC ODONTOL BAUR, V8, P1
   Sverzut CE, 2008, INT J EXP PATHOL, V89, P91, DOI 10.1111/j.1365-2613.2007.00569.x
   Torricelli P, 2002, J PERIODONTOL, V73, P1003, DOI 10.1902/jop.2002.73.9.1003
   Torricelli P, 1999, INT ORTHOP, V23, P178, DOI 10.1007/s002640050341
   Wang XD, 1998, BIO-MED MATER ENG, V8, P1
   WENTZ B, 2001, BIOMATERIALS, V22, P1599
   Williams D.F., 1986, P CONS C EUR SOC BIO
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   ZAMBUZZI WF, 2006, REVTA BRAS ORTOP, V41, P227
NR 20
TC 3
Z9 5
U1 0
U2 5
PU ATHA COMUNICACAO & EDITORA
PI SAO PAULO SP
PA RUA MACHADO BITTENCOURT, 190-40 ANDAR, CONJ 410, SAO PAULO SP, 00000,
   BRAZIL
SN 1413-7852
J9 ACTA ORTOP BRAS
JI Acta Ortop. Bras.
PY 2009
VL 17
IS 6
BP 340
EP 343
DI 10.1590/S1413-78522009000600005
PG 4
WC Orthopedics
SC Orthopedics
GA 577FO
UT WOS:000276207900005
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Gurbuz, F
AF Gurbuz, Fatma
TI Removal of Toxic Hexavalent Chromium Ions from Aqueous Solution by a
   Natural Biomaterial: Batch and Column Adsorption
SO ADSORPTION SCIENCE & TECHNOLOGY
LA English
DT Article
ID DEAD FUNGAL BIOMASS; WASTE-WATER; ASPERGILLUS-NIGER; RHIZOPUS-ARRHIZUS;
   PENICILLIUM-CHRYSOGENUM; NICKEL BIOSORPTION; CHLORRELA-VULGARIS; CR(VI)
   REDUCTION; MARINE-ALGAE; MECHANISM
AB The results of the removal of chromium(VI) ions from the aqueous phase employing different algal biomasses as bio-adsorbents are presented. Batch and column experiments were performed to determine the maximum adsorption capacity of the selected adsorbents. Algae were immobilised by employing pumice or silica gel as alternative substances for polymer matrices. The effects of pH, contact time, initial Cr(VI) ion concentration and adsorbent concentration were tested.
   Results are presented showing that the maximum adsorption capacity occurred at pH 2 when Scenetiesmus obliquus and Arthospira maxima were employed as adsorbents. A biphasic Cr(VI) ion removal pattern was observed in all experiments. The effects of Cr(VI) ion loading on both the free and immobilised biomass were tested to allow the applications to be compared. The maximum removal extent of Cr(VI) ions from the aqueous phase was 18.98 +/- 0.32 mg/mg free S. obliqtats and 18.37 +/- 0.28 mg/mg immobilised S. obliquus. The results show that immobilisation of the biomaterial made only a small difference to the extent of Cr(VI) ion removal. However, it is a much more suitable process for industrial applications since it can be continuously applied. The recovery of loaded metal ions was studied when it was found that HCl was very effective for desorbing Cr(VI) ions adsorbed onto the biomass.
   The results indicate that S. obliquus biomass is a potential candidate for the development of an efficient adsorbent for the removal of Cr(VI) ions from wastewater.
C1 Univ Aksaray, Aksaray, Turkey.
RP Gurbuz, F (reprint author), Univ Aksaray, Aksaray, Turkey.
EM fgurbuz@fef.sdu.edu.tr
RI University, Aksaray/A-1857-2018
CR Akbal FO, 2000, TALANTA, V53, P131, DOI 10.1016/S0039-9140(00)00380-5
   AKSU Z, 1991, ENVIRON TECHNOL, V12, P915, DOI 10.1080/09593339109385086
   ANDRIEVSKAYA MD, 1989, SOV J WATER TREATMEN, V11, P253
   Appenroth KJ, 2000, J INORG BIOCHEM, V78, P235, DOI 10.1016/S0162-0134(00)00018-0
   Bai RS, 2003, BIORESOURCE TECHNOL, V87, P17
   BARTLETT R, 1979, J ENVIRON QUAL, V8, P31, DOI 10.2134/jeq1979.00472425000800010008x
   Basha S, 2008, CHEM ENG J, V137, P480, DOI 10.1016/j.cej.2007.04.038
   Chojnacka K, 2005, CHEMOSPHERE, V59, P75, DOI 10.1016/j.chemosphere.2004.10.005
   Deepa KK, 2006, CHEMOSPHERE, V62, P833, DOI 10.1016/j.chemosphere.2005.04.087
   Elangovan R, 2008, CHEM ENG J, V141, P99, DOI 10.1016/j.cej.2007.10.026
   Elangovan R, 2008, J HAZARD MATER, V152, P100, DOI 10.1016/j.jhazmat.2007.06.067
   Ertugay N, 2008, J HAZARD MATER, V154, P432, DOI 10.1016/j.jhazmat.2007.10.070
   Ferguson CR, 1989, BIOTECHNOLOGY MINERA, P193
   Font J, 1999, J SOC LEATH TECH CH, V83, P300
   FOUREST E, 1994, FEMS MICROBIOL REV, V14, P325
   Fu YZ, 2003, WATER SA, V29, P465
   Gadd G. M., 1990, MICROBIAL MINERAL RE, P249
   Geitgey R.P., 1994, IND MINERALS ROCKS, P803
   Gupta VK, 2008, J HAZARD MATER, V154, P347, DOI 10.1016/j.jhazmat.2007.10.032
   Gupta VK, 2001, WATER RES, V35, P4079, DOI 10.1016/S0043-1354(01)00138-5
   Gurbuz F, 2004, HYDROMETALLURGY, V72, P167, DOI 10.1016/j.hydromet.2003.10.004
   Gurbuz F, 2008, B ENVIRON CONTAM TOX, V81, P323, DOI 10.1007/s00128-008-9458-x
   HEMERICK G, 1978, HDB PHYCOLOGICAL MET, P255
   HOLAN ZR, 1993, BIOTECHNOL BIOENG, V41, P819, DOI 10.1002/bit.260410808
   HUGHES JC, 2007, SOIL USE MANAGE, V4, P107
   ISHIBASHI Y, 1990, APPL ENVIRON MICROB, V56, P2268
   JONES A, 1986, CAN J CHEM ENG, V64, P547, DOI 10.1002/cjce.5450640404
   KARAHAN AG, 2001, J FISH AQUAT SCI, V18, P173
   Katircioglu H, 2008, BIORESOURCE TECHNOL, V99, P4185, DOI 10.1016/j.biortech.2007.08.068
   Katz S. A., 1994, BIOL ENV CHEM CHROMI
   Kiptoo JK, 2005, CHEM SPEC BIOAVAILAB, V17, P103, DOI 10.3184/095422905782774900
   Laxman RS, 2002, MINER ENG, V15, P831, DOI 10.1016/S0892-6875(02)00128-0
   Matheickal JT, 1996, WATER SCI TECHNOL, V34, P1, DOI 10.1016/S0273-1223(96)00780-9
   McLean J, 2001, APPL ENVIRON MICROB, V67, P1076, DOI 10.1128/AEM.67.3.1076-1084.2001
   Meric S, 2005, CHEMOSPHERE, V61, P208, DOI 10.1016/j.chemosphere.2005.02.037
   Mungasavalli DP, 2007, COLLOID SURFACE A, V301, P214, DOI 10.1016/j.colsurfa.2006.12.060
   NAKAJIMA A, 1993, J BIOTECHNOL, V57, P59
   Njau KN, 2003, WATER SCI TECHNOL, V48, P85
   NOURBAKHSH M, 1994, PROCESS BIOCHEM, V29, P1, DOI 10.1016/0032-9592(94)80052-9
   Onyancha D, 2008, J HAZARD MATER, V158, P605, DOI 10.1016/j.jhazmat.2008.02.043
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2008, HYDROMETALLURGY, V93, P72, DOI 10.1016/j.hydromet.2008.03.003
   Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007
   Philip L, 1998, J ENVIRON ENG-ASCE, V124, P1165, DOI 10.1061/(ASCE)0733-9372(1998)124:12(1165)
   Pinto G, 2003, BIOTECHNOL LETT, V25, P1657, DOI 10.1023/A:1025667429222
   PONS MP, 1993, APPL MICROBIOL BIOT, V39, P661, DOI 10.1007/BF00205071
   Prakasham RS, 1999, ENVIRON POLLUT, V104, P421, DOI 10.1016/S0269-7491(98)00174-2
   Preetha B, 2007, SEP PURIF TECHNOL, V57, P126, DOI 10.1016/j.seppur.2007.03.015
   *PUM UK LTD, 2000, PUM US WAT WAST TREA
   Quintelas C, 2008, CHEM ENG J, V136, P195, DOI 10.1016/j.cej.2007.03.082
   RAPPORT AI, 1995, PROCESS BIOCHEM, V30, P145
   Richmond A., 1986, HDB MICROALGAL MASS, P528
   SADDETIN S, 2007, ENZYME MICROB TECHNO, V41, P175
   Sanchez A, 1999, FEMS MICROBIOL REV, V23, P527, DOI 10.1016/S0168-6445(99)00019-4
   Sekhar KC, 1998, INT J MINER PROCESS, V53, P107, DOI 10.1016/S0301-7516(97)00061-6
   STANDEVEN AM, 1989, J AM COLL TOXICOL, V8, P1275, DOI 10.3109/10915818909009118
   Tam NFY, 2001, ENVIRON POLLUT, V114, P85, DOI 10.1016/S0269-7491(00)00202-5
   TSEZOS M, 1981, BIOTECHNOL BIOENG, V23, P583, DOI 10.1002/bit.260230309
   Ucun H, 2002, BIORESOURCE TECHNOL, V85, P155, DOI 10.1016/S0960-8524(02)00086-X
   VEGILO F, 1999, PROCESS BIOCHEM, V34, P367
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   Vieira MGA, 2008, BIORESOURCE TECHNOL, V99, P3094, DOI 10.1016/j.biortech.2007.05.071
   Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002
   VISHWANATHAM M, 1997, P INT C IND POLL CON, P491
   Volesky Bohumil, 1990, BIOSORPTION HEAVY ME
   Vonshak A., 1986, HDB MICROALGAL MASS, P117
   WOHANKA W, 1999, ACTA HORTIC, V481, P539
   Wong JPK, 2000, BIORESOURCE TECHNOL, V73, P133, DOI 10.1016/S0960-8524(99)00175-3
   Yang JB, 1999, ENVIRON SCI TECHNOL, V33, P4079, DOI 10.1021/es990435q
   Zhou JL, 1998, ENVIRON POLLUT, V101, P67, DOI 10.1016/S0269-7491(98)00034-7
NR 71
TC 6
Z9 6
U1 2
U2 14
PU MULTI SCIENCE PUBL CO LTD
PI BRENTWOOD
PA 5 WATES WAY, BRENTWOOD CM15 9TB, ESSEX, ENGLAND
SN 0263-6174
J9 ADSORPT SCI TECHNOL
JI Adsorpt. Sci. Technol.
PY 2009
VL 27
IS 8
BP 745
EP 759
DI 10.1260/0263-6174.27.8.745
PG 15
WC Chemistry, Applied; Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 587MF
UT WOS:000276995900002
OA Bronze
DA 2018-10-19
ER

PT S
AU Liu, ZG
   Zhang, YM
   Shi, HA
   Xu, LJ
   Chen, YY
   Woo, KD
AF Liu Zhiguang
   Zhang Yumei
   Shi Huan
   Xu Lijuan
   Chen Yuyong
   Woo, K. D.
BE Lu, J
TI Porous Ti/HA Biocomposites for Biomaterial Applications
SO ADVANCED MATERIALS SCIENCE AND TECHNOLOGY
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th International Forum on Advanced Material Science and Technology
CY JUN 12-14, 2008
CL Hong Kong Polytech Univ, Hong Kong, PEOPLES R CHINA
SP Saitama Inst Technol, Hong Kong Soc Theoret & Appl Mech
HO Hong Kong Polytech Univ
DE Ti; HA; Biocomposites; Powder metallurgy
ID MECHANICAL-PROPERTIES; TITANIUM
AB In the present study, we tried to make Ti matrix/hydroxyapatite biocomposites using powder metallurgy and chemical treatments. Three composites were produced: Ti-30vol%HA, Ti15Mo-30vol%HA and Ti13Nb13Zr-44vol%HA. After mechanical milling and spark plasma sintering, Ti/HA composite compacts were produced. Microstructure observations and mechanical property tests showed that composites with two components (Ti-HA) have high hardness. moderate compress strength and lower density. The produced Ti/HA bulk composites were subjected to chemical treatment of immersion into phosphoric acid Solution and porous structure was obtained. The obtained porous structure was characterized.
C1 [Liu Zhiguang; Zhang Yumei; Shi Huan; Xu Lijuan; Chen Yuyong] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
   [Liu Zhiguang] Harbin Inst Technol, Micronanotechnol Res Ctr, Harbin 150001, Peoples R China.
   [Woo, K. D.] Chonbuk Natl Univ, Coll Engn, Chonju, South Korea.
RP Liu, ZG (reprint author), Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
EM zhiguang@hit.edu.cn; zym@hit.edu.cn; shihuan@hit.edu.cn;
   xlijuan@hit.edu.cn; yychen@hit.edu.cn; k.d.woo@chonbuk.ac.kr
CR Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Dunand DC, 2004, ADV ENG MATER, V6, P369, DOI 10.1002/adem.200405576
   GEESINK RGT, 1990, CLIN ORTHOP RELAT R, P39
   Karanjai M, 2007, MAT SCI ENG A-STRUCT, V447, P19, DOI 10.1016/j.msea.2006.10.154
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Wen CE, 2002, J MATER SCI-MATER M, V13, P397, DOI 10.1023/A:1014344819558
   [张国珍 Zhang Guozhen], 2004, [粉末冶金技术, Powder Metallurgy Technology], V22, P16
NR 9
TC 1
Z9 1
U1 2
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2009
VL 614
BP 73
EP 78
DI 10.4028/www.scientific.net/MSF.614.73
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJH82
UT WOS:000265957600011
DA 2018-10-19
ER

PT S
AU Mallick, KK
AF Mallick, Kajal K.
BE Narayan, RJ
   Kumta, PN
   Wagner, WR
TI DEVELOPMENT, SYNTHESIS AND CHARACTERIZATION OF POROUS BIOMATERIAL
   SCAFFOLDS FOR TISSUE ENGINEERING
SO ADVANCES IN BIOMEDICAL AND BIOMIMETIC MATERIALS
SE Ceramic Transactions
LA English
DT Proceedings Paper
CT Materials Science and Technology Conference and Exhibition (MS&T 08)
CY OCT 05-09, 2008
CL Pittsburgh, PA
ID BONE-GRAFT SUBSTITUTES; BIOACTIVE GLASS 45S5; TAPE CAST; PORE-SIZE;
   HYDROXYAPATITE; CERAMICS; INGROWTH; CRYSTALLIZATION; REGENERATION;
   TEMPERATURE
AB This paper describes recent progress towards the development of freeze casting techniques using variation of camphene (CFC) and water and glycerol (WGFC) to fabricate highly porous network structures of Bioglass, hydroxyapatite (HAP), tricalcium phosphates (TCP), as well as their composites for applications in bone tissue engineering. Solid loading of 10 to 60% of ball milled ceramic slurries were freeze cast followed by sublimation at -70 to 60 degrees C. The green bodies equilibrated at room temperature were then sintered in air to a maximum temperature of 1100 degrees C for 4h, which produced excellent defect free and three-dimensionally interconnected structures with open micro and macropores. The nature of the pore channels varied from dendritic to lamellar geometry with a maximum size of similar to 100 mu m and the uniform strut thickness varying from 1-8 mu m. The porosity of the bioscaffolds increased monotonically from 10 to 70% with the decrease in loading volume. Microstructural analysis of porous structures was used to extract information on geometry, porosity and pore size distribution. DTA-TGA, SEM, XRD and density were used to characterize precursor powders, slurry and sintered products. The study proved particularly useful to assess the suitability of the 3-D structures produced by these methods for tissue engineering applications.
C1 Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England.
RP Mallick, KK (reprint author), Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England.
EM k.k.mallick@warwick.ac.uk
RI Narayan, Roger/J-2789-2013
OI Narayan, Roger/0000-0002-4876-9869
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Banchet V, 2004, SURF INTERFACE ANAL, V36, P658, DOI 10.1002/sia.1916
   Bata H.E., 2003, MATER CHEM PHYS, V80, P599
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chatzistavrou X, 2004, PHYS STATUS SOLIDI A, V201, P944, DOI 10.1002/pssa.200306776
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Clark AE, 1994, J BIOMED RES, V28, P693
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   Clupper DC, 2002, BIOMATERIALS, V23, P2599, DOI 10.1016/S0142-9612(01)00398-2
   Clupper DC, 2001, J BIOMED MATER RES, V57, P532, DOI 10.1002/1097-4636(20011215)57:4<532::AID-JBM1199>3.0.CO;2-3
   Dhara S, 2003, J AM CERAM SOC, V86, P1645, DOI 10.1111/j.1151-2916.2003.tb03534.x
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   El-Ghannam A, 2001, J BIOMED MATER RES, V55, P387, DOI 10.1002/1097-4636(20010605)55:3<387::AID-JBM1027>3.0.CO;2-V
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   Fu Q, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025005
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1991, AM CERAM SOC J, V74, P1487
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   HOLMES E, 1984, CLIN ORTHOP RELAT R, V188, P252
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Jun IK, 2006, J AM CERAM SOC, V89, P391, DOI 10.1111/j.1551-2916.2005.00707.x
   KELER KA, 1996, PROCESSING FABRICATI, P557
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   KOCHS M, 1991, INT J HEAT MASS TRAN, V34, P2395, DOI 10.1016/0017-9310(91)90064-L
   Kokubo T, 1997, AN QUIM, V93, pS49
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kuehne Jobst-Henner, 1994, Acta Orthopaedica Scandinavica, V65, P246
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   Lu K, 2006, J AM CERAM SOC, V89, P2459, DOI 10.1111/j.1551-2916.2006.01111.x
   Mikos A. G., 1998, FRONTIERS TISSUE ENG, P3
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   RUBENSTEIN ER, 1991, J CRYST GROWTH, V112, P97
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   Sofie SW, 2001, J AM CERAM SOC, V84, P1459
   TUCK C, 1996, J MATER SCI LETT, V18, P1003
   Vallet-Regi M, 2003, J BIOMED MATER RES A, V66A, P580, DOI 10.1002/jbm.a.10576
   Wang C, 2005, J MATER SCI-MATER M, V16, P739, DOI 10.1007/s10856-005-2611-8
   YOON BH, 2007, J AM CERAM SOC, V90, P1774
NR 49
TC 0
Z9 0
U1 0
U2 8
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 1042-1122
BN 978-0-470-40847-6
J9 CERAM TRANS
PY 2009
VL 206
BP 115
EP 128
DI 10.1002/9780470538357.ch11
PG 14
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BTR04
UT WOS:000287824700011
DA 2018-10-19
ER

PT S
AU Hiebl, B
   Rickert, D
   Fuhrmann, R
   Jung, F
   Lendlein, A
   Franke, RP
AF Hiebl, B.
   Rickert, D.
   Fuhrmann, R.
   Jung, F.
   Lendlein, A.
   Franke, R. -P.
BE Shastri, VP
   Lendlein, A
   Liu, L
   Mikos, A
   Mitragotri, S
TI Tissue Integration of Two Different Shape-Memory Polymers with
   Poly(epsilon-Caprolactone) Switching Segment in Rats
SO ADVANCES IN MATERIAL DESIGN FOR REGENERATIVE MEDICINE, DRUG DELIVERY AND
   TARGETING/IMAGING
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Advances in Material Design for Regenerative Medicine, Drug
   Delivery and Targeting/Imaging held at the 2008 MRS Fall Meeting
CY DEC 01-03, 2008
CL Boston, MA
SP Mat Res Soc
ID BIOMATERIALS; STENTS; BIOCOMPATIBILITY; DEGRADATION; MODEL
AB One of the major challenges in biomaterial science is to achieve a strong connection between polymer-based biomaterials and the surrounding tissue guaranteeing a long-term-durable integration which resists mechanically induced stress like tensile loads and shear stress [1, 15, 17]. This biomaterial-tissue integration can be affected by the bio functionality of the biomaterial in use [13, 14, 16]. For degradable polymers like poly[(L-lactide)-co-glycolide] it has been reported that the integration is influenced by the pH at the polymer-tissue interface [2, 4, 6, 11]. Also the formation of a thick fibrous capsule around the polymer implant can undermine polymer-tissue integration by disrupting the blood supply to the site of polymer-tissue interface. Insufficient blood supply to the site of interface disturbs necessary pH compensation and also the removal of degradation products. In addition, the surrounding tissues can not be supplied with nutrients without sufficient blood supply, and cells like monocytes/macrophages known to be necessary for tissue re-organisation processes.
   Thus in the present study, we examined the integration of two different shape-memory polymers containing poly(E-caprolactone) segments into the subcutis of a rat focussing on the pH change directly at the polymer-tissue interface and also on the characterisation of the periimplantary tissue nearby the polymer-tissue interface.
C1 [Hiebl, B.; Jung, F.; Lendlein, A.; Franke, R. -P.] Ctr Biomat Dev, Teltow, Germany.
RP Hiebl, B (reprint author), Ctr Biomat Dev, Teltow, Germany.
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P116, DOI 10.1097/00001665-199703000-00010
   GRIES G, 1961, Z RHEUMAFORSCH, V20, P122
   Korpela A, 1999, CHEST, V115, P490, DOI 10.1378/chest.115.2.490
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lochbihler H, 1997, J PEDIATR SURG, V32, P717, DOI 10.1016/S0022-3468(97)90013-0
   Rickert D, 2006, EUR ARCH OTO-RHINO-L, V263, P215, DOI 10.1007/s00405-005-0950-1
   Rickert D, 2005, BIOMED TECH, V50, P92, DOI 10.1515/BMT.2005.013
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P301
   Robey TC, 2000, ARCH OTOLARYNGOL, V126, P985, DOI 10.1001/archotol.126.8.985
   Romeis B., 1989, MIKROSKOPISCHE TECHN
   SCHAUWECKER HH, 1989, ARTIF ORGANS, V13, P216, DOI 10.1111/j.1525-1594.1989.tb02866.x
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   van Blitterswijk CA, 2008, ACAD PR SER BIOM ENG, pXIII
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 18
TC 10
Z9 10
U1 1
U2 5
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-112-4
J9 MATER RES SOC SYMP P
PY 2009
VL 1140
BP 143
EP 149
PG 7
WC Biotechnology & Applied Microbiology; Materials Science,
   Multidisciplinary
SC Biotechnology & Applied Microbiology; Materials Science
GA BMR09
UT WOS:000273377400022
DA 2018-10-19
ER

PT S
AU Wise, SG
   Mithieux, SM
   Weiss, AS
AF Wise, Steven G.
   Mithieux, Suzanne M.
   Weiss, Anthony S.
BE McPherson, A
TI ENGINEERED TROPOELASTIN AND ELASTIN-BASED BIOMATERIALS
SO ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 78
SE Advances in Protein Chemistry and Structural Biology
LA English
DT Review; Book Chapter
ID RECOMBINANT HUMAN TROPOELASTIN; EXPRESSED HUMAN ELASTIN; IN-VITRO;
   COVALENT IMMOBILIZATION; EXTRACELLULAR-MATRIX; SECONDARY STRUCTURE;
   FIBER FORMATION; LYSYL OXIDASE; PROTEIN; POLYPEPTIDES
AB Elastin is a key mammalian extracellular matrix protein that is critical to the elasticity, compliance, and resilience of a range of tissues including the vasculature, skin, and lung. In addition to providing mechanical integrity to tissues, elastin also has critical functions in the regulation of cell behavior and may help to modulate the coagulation cascade. The high insolubility of elastin has limited its use to researchers, while soluble derivatives of elastin including elastin peptides, digested elastins, and tropoelastin have much broader applications. Recombinantly produced tropoelastin, the soluble monomer of elastin, has been shown to exhibit many of the properties intrinsic to the mature biopolymer. As such, recombinant human tropoelastin provides a versatile building block for the manufacture of biomaterials with potential for diverse applications in elastic tissues. One of the major benefits of soluble elastins is that they can be engineered into a range of physical forms. As a dominant example, soluble elastins including tropoelastin can form hydrogels when they are chemically cross-linked. These self-organized constructs swell when transferred from a saline to aqueous environment and are highly elastic; these tunable responses are dependent on the types of cross-linker and elastin used. Soluble elastins can also be drawn into fine fibers using electrospinning. The morphology of these fibers can be altered by modifying spinning parameters that include delivery flow rate and the starting protein concentration. The resulting fibers then accumulate to form porous scaffolds, and can be wound around mandrils to create conduits for vascular applications. Electrospun scaffolds retain the elasticity and cell-interactive properties inherent in the tropoelastin precursor. Additionally, soluble elastins serve as versatile biomaterial coatings, enhancing cellular interactions and modulating the blood compatibility of polymer- and metal-based prostheses. Soluble elastins, and in particular tropoelastin, have highly favorable intrinsic physical and cell-interactive properties, warranting their adaption through incorporation into biomaterials and modification of implantable devices. The multiple choices of ways to produce elastin-based biomaterials mean that they are well suited to the tailoring of elastic biomaterials and hybrid constructs.
C1 [Wise, Steven G.; Mithieux, Suzanne M.; Weiss, Anthony S.] Univ Sydney, Sch Mol & Microbial Biosci G08, Sydney, NSW 2006, Australia.
RP Wise, SG (reprint author), Univ Sydney, Sch Mol & Microbial Biosci G08, Sydney, NSW 2006, Australia.
RI Wise, Steven/B-1858-2009; Wise, Steven/G-2630-2018
OI Wise, Steven/0000-0001-7964-819X; Wise, Steven/0000-0001-7964-819X;
   Mithieux, Suzanne/0000-0001-6160-9352; WEISS,
   ANTHONY/0000-0002-8106-4836
CR Annabi N, 2009, BIOMATERIALS, V30, P4550, DOI 10.1016/j.biomaterials.2009.05.014
   Annabi N, 2009, BIOMATERIALS, V30, P1, DOI 10.1016/j.biomaterials.2008.09.031
   BARNES MJ, 1979, HAEMOSTASIS, V8, P158
   BAUMGARTNER HR, 1976, THROMB HAEMOSTASIS, V35, P124, DOI 10.1055/s-0038-1647919
   Bax DV, 2009, ACTA BIOMATER, V5, P3371, DOI 10.1016/j.actbio.2009.05.016
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Bellingham CM, 2004, CURR OPIN SOLID ST M, V8, P135, DOI 10.1016/j.cossms.2004.01.007
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Cantarelli B, 2009, FEBS LETT, V583, P2385, DOI 10.1016/j.febslet.2009.06.037
   Chilkoti A, 2006, CURR OPIN CHEM BIOL, V10, P652, DOI 10.1016/j.cbpa.2006.10.010
   COX BA, 1974, J BIOL CHEM, V249, P997
   COX BA, 1973, BIOCHIM BIOPHYS ACTA, V317, P209, DOI 10.1016/0005-2795(73)90215-8
   Debelle L, 1998, EUR J BIOCHEM, V258, P533, DOI 10.1046/j.1432-1327.1998.2580533.x
   DEBELLE L, 1995, J BIOL CHEM, V270, P26099, DOI 10.1074/jbc.270.44.26099
   Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200
   Fung YC, 1993, BIOMECHANICS MECH PR
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   INDIK Z, 1990, ARCH BIOCHEM BIOPHYS, V280, P80, DOI 10.1016/0003-9861(90)90521-Y
   JENSEN DE, 1995, J BIOL CHEM, V270, P6555, DOI 10.1074/jbc.270.12.6555
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413
   KAHARI VM, 1992, J BIOL CHEM, V267, P26134
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Kondyurin A, 2008, ION BEAM TREATMENT OF POLYMERS: APPLICATION ASPECTS FROM MEDICINE TO SPACE, P1
   Kondyurin A, 2008, ACTA BIOMATER, V4, P1218, DOI 10.1016/j.actbio.2008.04.017
   Kuang PP, 2003, AM J PHYSIOL-CELL PH, V285, pC1349, DOI 10.1152/ajpcell.00173.2003
   LANSING AI, 1952, ANAT RECORD, V114, P555, DOI 10.1002/ar.1091140404
   Lau AK, 2003, CIRCULATION, V107, P2031, DOI 10.1161/01.CIR.0000062682.40051.43
   Leach JB, 2005, ACTA BIOMATER, V1, P155, DOI 10.1016/j.actbio.2004.12.001
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Li B, 2002, J MUSCLE RES CELL M, V23, P561, DOI 10.1023/A:1023474909980
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   McMillan RA, 2000, MACROMOLECULES, V33, P4809, DOI 10.1021/ma9921091
   MECHAM RP, 1979, BIOCHIM BIOPHYS ACTA, V577, P147, DOI 10.1016/0005-2795(79)90017-5
   Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018
   Miyamoto K, 2009, INT J BIOL MACROMOL, V45, P33, DOI 10.1016/j.ijbiomac.2009.03.014
   Nagapudi K, 2005, BIOMATERIALS, V26, P4695, DOI 10.1016/j.biomaterials.2004.11.027
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   NIVISONSMITH L, 2009, ACTA BIOMAT IN PRESS, DOI DOI 10.1016/JACTBIO.2009.08.011
   Parks WC, 1997, AM J RESP CELL MOL, V17, P1
   Petersen E, 2002, EUR J VASC ENDOVASC, V24, P440, DOI 10.1053/ejvs.2002.1750
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   ROBERT L, 1992, ANN NY ACAD SCI, V673, P331, DOI 10.1111/j.1749-6632.1992.tb27468.x
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   SANDBERG LB, 1986, BIOCHEM BIOPH RES CO, V136, P672, DOI 10.1016/0006-291X(86)90493-6
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   SEEGER J M, 1988, Journal of Vascular Surgery, V8, P476, DOI 10.1067/mva.1988.avs0080476
   Sell SA, 2006, BIOMED MATER, V1, P72, DOI 10.1088/1748-6041/1/2/004
   Smith MJ, 2008, ACTA BIOMATER, V4, P58, DOI 10.1016/j.actbio.2007.08.001
   STARCHER BC, 1973, BIOCHIM BIOPHYS ACTA, V310, P481, DOI 10.1016/0005-2795(73)90132-3
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Stone PJ, 2001, AM J RESP CELL MOL, V24, P733, DOI 10.1165/ajrcmb.24.6.4304
   SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899
   Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Urry D W, 1977, Adv Exp Med Biol, V79, P685
   Vieth S, 2007, BIOPOLYMERS, V85, P199, DOI 10.1002/bip.20619
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Wu KK, 1996, ANNU REV MED, V47, P315
   Yin YB, 2009, SURF COAT TECH, V203, P1310, DOI 10.1016/j.surfcoat.2008.10.035
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
NR 77
TC 39
Z9 42
U1 3
U2 43
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1876-1623
BN 978-0-12-374827-0
J9 ADV PROTEIN CHEM STR
JI Adv. Protein Chem. Struct. Biol.
PY 2009
VL 78
BP 1
EP 24
DI 10.1016/S1876-1623(09)78001-5
PG 24
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BOD34
UT WOS:000276287000001
PM 20663482
DA 2018-10-19
ER

PT J
AU Bedini, R
   Meleo, D
   Pecci, R
   Pacifici, L
AF Bedini, Rossella
   Meleo, Deborah
   Pecci, Raffaella
   Pacifici, Luciano
TI The use of microtomography in bone tissue and biomaterial
   three-dimensional analysis
SO ANNALI DELL ISTITUTO SUPERIORE DI SANITA
LA English
DT Article
DE X-ray microtomography; bone tissue; biocompatible materials; bone
   substitutes
AB X-ray computed microtomography (micro-CT, microComputerised Tomography) is a miniaturized form of conventional computerized axial tomography (CAT). This sophisticated technology enables 3D riconstruction of the internal structure of small X-ray opaque objects without sample destruction or preparation. The aim of this study is to show the possible applications of micro-CT in the analysis of bone graft materials of different origins (i.e. homologous, heterologous, alloplastic) in order to define their morphometric properties by means of SkyScan 1072 3D microtomography system. Since there is a close relationship between the properties of the materials and their microstructure, it is necessary to examine them using the highest levels of resolution before being able to improve existing materials or create new products.
C1 [Bedini, Rossella; Pecci, Raffaella] Ist Super Sanita, Dipartimento Tecnol & Salute, I-00161 Rome, Italy.
   [Meleo, Deborah; Pacifici, Luciano] Univ Roma La Sapienza, Dipartimento Sci Odontostomatol, Rome, Italy.
RP Bedini, R (reprint author), Ist Super Sanita, Dipartimento Tecnol & Salute, Viale Regina Elena 299, I-00161 Rome, Italy.
EM rossella.bedini@iss.it
RI Pecci, Raffaella/B-2508-2013; Bedini, Rossella/B-2465-2013
OI Bedini, Rossella/0000-0002-0830-6632
CR Basillais A, 2007, J ORTHOP SCI, V12, P141, DOI 10.1007/s00776-006-1104-z
   Beaupied H, 2006, PHYS MED BIOL, V51, P4621, DOI 10.1088/0031-9155/51/18/011
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205
   Chiapasco M, 2002, RIABILITAZIONE IMPLA
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Gielkens PFM, 2008, ARCH ORAL BIOL, V53, P558, DOI 10.1016/j.archoralbio.2007.11.011
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Huang J, 2007, J MATER SCI-MATER M, V18, P2151, DOI 10.1007/s10856-007-3201-8
   Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014
   Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449
   KUHN JL, 1990, J ORTHOPAED RES, V8, P833, DOI 10.1002/jor.1100080608
   Lattanzi W, 2008, GENE THER, V15, P1330, DOI 10.1038/gt.2008.116
   Lin-Gibson S, 2007, BIOMACROMOLECULES, V8, P1511, DOI 10.1021/bm061139q
   Lu M, 2003, BRIT J ORAL MAX SURG, V41, P385, DOI 10.1016/S0266-4356(03)00169-4
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Papadimitropoulos A, 2007, BIOTECHNOL BIOENG, V98, P271, DOI 10.1002/bit.21418
   Perilli E, 2006, J MICROSC-OXFORD, V222, P124, DOI 10.1111/j.1365-2818.2006.01580.x
   Sasov A, 1998, J MICROSC-OXFORD, V191, P151
   Stauber Martin, 2008, V455, P273, DOI 10.1007/978-1-59745-104-8_19
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1983, P SOC EXP BIOL MED, V173, P194
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
   Waarsing JH, 2004, J BONE MINER RES, V19, P1640, DOI 10.1359/JBMR.040705
NR 29
TC 5
Z9 5
U1 0
U2 4
PU EDITRICE KURTIS S R L
PI MILAN
PA VIA LUIGI ZOJA 30, 20153 MILAN, ITALY
SN 0021-2571
J9 ANN I SUPER SANITA
JI Ann. Ist. Super. Sanita
PY 2009
VL 45
IS 2
BP 178
EP 184
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V15SO
UT WOS:000207821900009
PM 19636170
OA DOAJ Gold
DA 2018-10-19
ER

PT S
AU Catana, D
   Scarneciu, I
   Popescu, R
AF Catana, Dorin
   Scarneciu, Ioan
   Popescu, Rodica
BE Katalinic, B
TI TECHNOLOGICAL PROCESSES INFLUENCE REGARDING TITANIUM ALLOYS BIOMATERIALS
   CORROSION
SO ANNALS OF DAAAM FOR 2009 & PROCEEDINGS OF THE 20TH INTERNATIONAL DAAAM
   SYMPOSIUM
SE Annals of DAAAM and Proceedings
LA English
DT Proceedings Paper
CT 20th International
   Danube-Adria-Association-for-Automation-and-Manufacturing Symposium
CY NOV 25-28, 2009
CL Vienna, AUSTRIA
SP Danube Adria Assoc Automat & Mfg Int Vienna, Vienna Univ Technol, Univ Appl Sci Technikum Vienna, Austrian Soc Engineers & Architects
DE corrosion; titanium alloy; biomaterials; human implant
AB Considering that human body is a complex environment and biomaterials are selected to be used, a series of lab tests have to be done in order to observe time behaviour. Beside hardness tests another required one is corrosion resistance test. In this paper is presented the influence of different treating processes regarding the corrosion of biomaterials. As well, the influence of human body physiological environment over biomaterial hardness is studied in this paper. The study of formation of the protective film and biomaterial passivity on electrolyte contact has been made by analyzing electrode potential in open circuit.
RI CATANA, Dorin/A-6354-2013; Scarneciu, Ioan/D-4151-2011
CR CATANA D, 2002, ADV MAT PROCESSING
   CATANA D, 2008, P 19 INT DAAAM S INT, P209
   RAE T, 1986, BIOMATERIALS, V7, P30, DOI 10.1016/0142-9612(86)90085-2
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   WUSINCZKY D, 2007, B POLYTECHNIC I JASS, V53, P339
NR 5
TC 0
Z9 0
U1 0
U2 4
PU DAAAM INT VIENNA
PI WIEN
PA VIENNA UNIV TECHNOLOGY, KARLSPLATZ 13, WIEN, A-1040, AUSTRIA
SN 1726-9679
BN 978-3-901509-70-4
J9 ANN DAAAM
PY 2009
VL 20
BP 483
EP 484
PG 2
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA BRC23
UT WOS:000282335600242
DA 2018-10-19
ER

PT S
AU Guibert, G
   Rossel, T
   Weder, G
   Betschart, B
   Meunier, C
   Mikhailov, S
AF Guibert, G.
   Rossel, T.
   Weder, G.
   Betschart, B.
   Meunier, C.
   Mikhailov, S.
BE McDaniel, FD
   Doyle, BL
TI Surface Treatment of Polymers by Ion Beam Irradiation to Control the
   Human Osteoblast Adhesion: Fluence and Current Density Study
SO APPLICATION OF ACCELERATORS IN RESEARCH AND INDUSTRY
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 20th International Conference on Application of Accelerators in Research
   and Industry
CY AUG 10-15, 2008
CL Ft Worth, TX
SP Univ N Texas, Sandia Natl Lab
DE surface treatment; ion beam; cell adhesion; polymer; current density
ID BIOMEDICAL POLYMERS; MEDICAL APPLICATIONS; METAL COMPOSITES; HEAVY-IONS;
   FILMS; ATTACHMENT; BIOMATERIALS; IMPLANTATION; CELLS; PTFE
AB In the biomaterial field, the modification of surfaces are used to create polymers with high performances, preserving their bulk properties and creating specific interactions between the designed surfaces and the cells or tissues. The polymers were irradiated with a 900 keV Helium beam to modify their surface properties. Cell cultivation on the samples was done using human osteoblasts cells (hFOB 1.19). For PTFE, PS and PEEK polymers, the cell adhesion occurs after reached some threshold values of fluences. For PET or PMMA polymers, the cells adhere on the non irradiated samples, however the fluence value modifies the cell density. For PMMA and PTFE both, the fluence and the current density influence the cell adhesion. By modifying the appropriate parameters on each material, the control of the cell adhesion is possible. Indeed the surface treatment must be selected and adapted according to the further application: for biosensors, tissue engineering, tissue regeneration, neural probes, drug delivery, bio-actuators etc.
C1 [Guibert, G.; Mikhailov, S.] Haute Ecole Arc, Inst Microtechnol Appl IMA Arc, La Chaux De Fonds, Switzerland.
   [Rossel, T.; Weder, G.; Betschart, B.] Univ Neuchatel, Inst Biol, Neuchatel, Switzerland.
   [Meunier, C.] Univ Franche Comte, Inst Femto ST, Montbeliard, France.
RP Guibert, G (reprint author), Haute Ecole Arc, Inst Microtechnol Appl IMA Arc, La Chaux De Fonds, Switzerland.
FU Haute Ecole Arc; MaCHop network; CSEM; University of Neuchatel
FX This research was supported by Haute Ecole Arc and MaCHop network in
   collaboration with CSEM and University of Neuchatel.
CR Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   Colwell JM, 2003, SURF COAT TECH, V168, P216, DOI 10.1016/S0257-8972(03)00204-4
   Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8
   Delcorte A, 2005, NUCL INSTRUM METH B, V236, P1, DOI 10.1016/j.nimb.2005.03.242
   Delto R, 2002, NUCL INSTRUM METH B, V190, P318, DOI 10.1016/S0168-583X(01)01190-9
   Drotleff S, 2004, EUR J PHARM BIOPHARM, V58, P385, DOI 10.1016/j.ejpb.2004.03.018
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Eschbach L., 2000, INT J CARE INJURED, V31
   Garcia ITS, 2004, APPL SURF SCI, V228, P63, DOI 10.1016/j.apsusc.2003.12.027
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gonin Y, 2003, APPL SURF SCI, V217, P289, DOI 10.1016/S0169-4332(03)00534-8
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   Ishihara K, 1998, MAT SCI ENG C-BIO S, V6, P253, DOI 10.1016/S0928-4931(98)00059-9
   Iwaki M, 2001, NUCL INSTRUM METH B, V175, P368, DOI 10.1016/S0168-583X(00)00543-7
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   Kaneko T, 2004, NUCL INSTRUM METH B, V219, P236, DOI 10.1016/j.nimb.2004.01.060
   Kikuchi A, 2005, J CONTROL RELEASE, V101, P69, DOI 10.1016/j.jconrel.2004.08.026
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   MAROIS Y, ASAIO, V45, P272
   Mehta GK, 1996, NUCL INSTRUM METH A, V382, P335, DOI 10.1016/S0168-9002(96)00402-0
   Mitchell SA, 2004, BIOMATERIALS, V25, P4079, DOI 10.1016/j.biomaterials.2003.11.010
   Munnik F, 2003, MICROELECTRON ENG, V67-8, P96, DOI 10.1016/S0167-9317(03)00064-9
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Sasuga T, 1999, POLYMER, V40, P5095, DOI 10.1016/S0032-3861(98)00725-3
   Schiwietz G, 2001, NUCL INSTRUM METH B, V175, P1, DOI 10.1016/S0168-583X(00)00544-9
   Shahinpoor M, 2004, SMART MATER STRUCT, V13, P1362, DOI 10.1088/0964-1726/13/6/009
   Shahinpoor M, 2005, SMART MATER STRUCT, V14, P197, DOI 10.1088/0964-1726/14/1/020
   Suzuki Y, 2003, NUCL INSTRUM METH B, V206, P501, DOI 10.1016/S0168-583X(03)00808-5
   Torrisi L, 1996, NUCL INSTRUM METH A, V382, P361, DOI 10.1016/S0168-9002(96)00626-2
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Tsuji H, 1999, NUCL INSTRUM METH B, V148, P1136, DOI 10.1016/S0168-583X(98)00802-7
   Turos A, 2003, VACUUM, V70, P201, DOI 10.1016/S0042-207X(02)00643-7
   Zhang Y, 2000, NUCL INSTRUM METH B, V168, P29, DOI 10.1016/S0168-583X(99)00719-3
   Ziegler JF, 2004, NUCL INSTRUM METH B, V219, P1027, DOI 10.1016/j.nimb.2004.01.208
NR 40
TC 3
Z9 3
U1 0
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0633-9
J9 AIP CONF PROC
PY 2009
VL 1099
BP 511
EP +
PG 2
WC Physics, Applied; Spectroscopy
SC Physics; Spectroscopy
GA BJH43
UT WOS:000265828500111
DA 2018-10-19
ER

PT S
AU Li, DS
   Garmestani, H
   Davis, SC
   Moss, LK
   Siddiqi, AK
   Guthrie, JB
   Johansen, N
   Matrisciano, L
AF Li, D. S.
   Garmestani, H.
   Davis, S. C.
   Moss, L. K.
   Siddiqi, A. K.
   Guthrie, J. B.
   Johansen, N.
   Matrisciano, L.
BE Rollett, AD
TI WEAR RESISTANCE AND TEXTURE EVOLUTION OF ULTRA HIGH MOLECULAR WEIGHT
   POLYETHYLENES DURING UNIAXIAL COMPRESSION
SO APPLICATIONS OF TEXTURE ANALYSIS
SE Ceramic Transactions
LA English
DT Proceedings Paper
CT 15th International Conference on Textures of Materials
CY JUN 01-06, 2008
CL Pittsburgh, PA
SP Natl Sci Fdn, Air Force Off Sci Res, Alcoa Technical Ctr
ID HIP; ORIENTATION; ARTHROPLASTY; BEHAVIOR
AB Texture and wear resistance of joint arthroplasty biomaterial, ultra high molecular weight polyethylene (UHMWPE) was studied in hip implant material during uniaxial compression. It is shown that the anisotropic wear resistance developed during uniaxial compression is directly related to the texture evolution due to mechanical deformation. The preliminary study shows the possibility of utilizing texture as a design parameter to improve wear resistance in replacement joint along specific directions.
C1 [Li, D. S.; Garmestani, H.; Davis, S. C.; Moss, L. K.; Siddiqi, A. K.; Guthrie, J. B.; Johansen, N.] Georgia Inst Technol, Sch Mat Sci & Engn, 771 Ferst Dr, Atlanta, GA 30332 USA.
   [Matrisciano, L.] MediTECH Med Polymers, Ft Wayne, IN 46809 USA.
RP Li, DS (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, 771 Ferst Dr, Atlanta, GA 30332 USA.
CR Affatato S, 2005, BIOMATERIALS, V26, P3259, DOI 10.1016/j.biomaterials.2004.07.070
   Agarwal S, 2004, CURR ORTHOPAED, V18, P220, DOI 10.1016/j.cuor.2004.03.002
   Boontongkong Y, 1998, POLYMER, V39, P6391, DOI 10.1016/S0032-3861(98)00163-3
   BURREL R, 2006, MECH PROPERTY RESPON
   Cho HJ, 2004, MATER CHEM PHYS, V88, P9, DOI 10.1016/j.matchemphys.2003.10.021
   Hall RM, 1997, BIOMATERIALS, V18, P1017, DOI 10.1016/S0142-9612(97)00034-3
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   LAFRANCE CP, 1993, J POLYM SCI POL PHYS, V31, P255, DOI 10.1002/polb.1993.090310303
   Li D, 2001, POLYMER, V42, P4903, DOI 10.1016/S0032-3861(00)00829-6
   LI D, 2003, POLYMER, V44, pU63
   LI DS, POLYM J IN PRESS
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   SEOUL C, 1988, J POLYM SCI POL PHYS, V26, P1965, DOI 10.1002/polb.1988.090260912
NR 13
TC 1
Z9 1
U1 0
U2 1
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 1042-1122
BN 978-0-470-40835-3
J9 CERAM TRANS
PY 2009
VL 201
BP 595
EP +
PG 3
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Characterization & Testing
SC Materials Science
GA BTL61
UT WOS:000287220000065
DA 2018-10-19
ER

PT J
AU Karagoz, P
   Erhan, E
   Keskinler, B
   Ozkan, M
AF Karagoez, Pinar
   Erhan, Elif
   Keskinler, Bulent
   Oezkan, Melek
TI The Use of Microporous Divinyl Benzene Copolymer for Yeast Cell
   Immobilization and Ethanol Production in Packed-Bed Reactor
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE 3-D support biomaterials; Ethanol production; Microporous divinyl
   benzene copolymer; Yeast immobilization
ID SACCHAROMYCES-CEREVISIAE; SURFACE-HYDROPHOBICITY; CANDIDA-ALBICANS;
   FERMENTATION; POLYMERS; ADHESION; SCAFFOLDS; CULTURE
AB Microporous divinyl benzene copolymer (MDBP) was used for the first time as immobilization material for Saccharomyces cerevisiae ATCC 26602 cells in a bed reactor and ethanol production from glucose was studied as a model system. A very homogenous thick layer of yeast cells were seen from the scanning electron micrographs on the outer walls of biopolymer. The dried weight of the cells was found to be approximately 2 g per gram of cell supporting material. Hydrophobic nature of polymer is an important factor increasing cell adhesion on polymer pieces. The dynamic flow conditions through the biomaterial due to its microporous architecture prevented exopolysaccharide matrix formation around cells and continuous washing out of toxic metabolites and dead and degraded cells from the reactor provided less diffusional limitations and dynamic living environment to the cells. In order to see the ethanol production performance of immobilized yeast cells, a large initial concentration range of glucose between 6.7 and 300 g/l was studied at 1 ml/min in continuous packed-bed reactor. The inhibition effect of glucose with increasing initial concentration was observed at above 150 g/l, a relatively high substrate concentration. The continuous fluid flow around the microenvironment of the attached cells and mass transferring ability of cell immobilized on MDBP can help in decreasing the inhibition effect of ethanol accumulation and high substrate concentration in the vicinity of the cells.
C1 [Karagoez, Pinar; Erhan, Elif; Keskinler, Bulent; Oezkan, Melek] Gebze Inst Technol, Dept Environm Engn, TR-41400 Gebze, Kocaeli, Turkey.
RP Ozkan, M (reprint author), Gebze Inst Technol, Dept Environm Engn, TR-41400 Gebze, Kocaeli, Turkey.
EM mozkan@gyte.edu.tr
FU Turkish Scientific and Technical Research Council [105Y075]
FX The authors wish to thank Turkish Scientific and Technical Research
   Council for supporting this study ( Project no: 105Y075). Special thanks
   to Assoc. Prof. Dr. Mehmet Ali GULGUN (Sabanci University, TURKEY) for
   helping in the scanning electron microscope examinations.
CR Akay G, 2005, BIOTECHNOL BIOENG, V90, P180, DOI 10.1002/bit.20376
   AKAY G, 2004, J CHEM TECHNOLOGY BI, V79, P195, DOI DOI 10.1002/JCTB.938
   AKAY G, 2002, Patent No. 1183328
   Birol G, 1998, PROCESS BIOCHEM, V33, P763, DOI 10.1016/S0032-9592(98)00047-8
   Bokhari M, 2003, ADV EXP MED BIOL, V534, P247
   Bokhari M, 2007, J MATER CHEM, V17, P4088, DOI 10.1039/b707499a
   Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x
   Callewaert M, 2005, J ADHES SCI TECHNOL, V19, P765, DOI 10.1163/1568561054867837
   Erhan E, 2004, J CHEM TECHNOL BIOT, V79, P195, DOI 10.1002/jctb.938
   GRIFFITHS MS, 1993, ENZYME MICROB TECH, V15, P109, DOI 10.1016/0141-0229(93)90033-X
   Hartmeier W., 1972, THESIS TU BERLIN
   HAZEN KC, 1989, INFECT IMMUN, V57, P1894
   INOLES DS, 1983, APPL ENVIRON MICROB, V46, P264
   Jirku V, 1999, PROCESS BIOCHEM, V34, P193, DOI 10.1016/S0032-9592(98)00086-7
   Kopsahelis N, 2007, BIORESOURCE TECHNOL, V98, P1440, DOI 10.1016/j.biortech.2006.03.030
   Kourkoutas Y, 2003, PROCESS BIOCHEM, V39, P143, DOI 10.1016/S0032-9592(02)00320-5
   Najafpour G, 2004, BIORESOURCE TECHNOL, V92, P251, DOI 10.1016/j.biortech.2003.09.009
   Park Sang E, 2003, J Prosthodont, V12, P249
   Samaranayake YH, 2003, MYCOSES, V46, P375, DOI 10.1046/j.0933-7407.2003.00919.x
   TSOI TV, 1987, MOL GENET MIKROBIOL, V11, P18
   WOJCIECHOWICZ D, 1993, MOL CELL BIOL, V13, P2554, DOI 10.1128/MCB.13.4.2554
NR 21
TC 13
Z9 13
U1 1
U2 16
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD JAN
PY 2009
VL 152
IS 1
BP 66
EP 73
DI 10.1007/s12010-008-8336-7
PG 8
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 392CN
UT WOS:000262280600007
PM 18712507
DA 2018-10-19
ER

PT J
AU Kim, MM
   Boahene, KDO
   Byrne, PJ
AF Kim, Michael M.
   Boahene, Kofi D. O.
   Byrne, Patrick J.
TI Use of Customized Polyetheretherketone (PEEK) Implants in the
   Reconstruction of Complex Maxillofacial Defects
SO Archives of Facial Plastic Surgery
LA English
DT Article
ID INTERBODY FUSION; BIOCOMPATIBILITY; CAGES
AB Extensive maxillofacial defects resulting from trauma or oncologic resection present reconstructive challenges. Various autografts and alloplastic materials in conjunction with standard soft-tissue techniques have been used in the reconstruction of these types of defects. Polyetheretherketone (PEEK) is a semicrystalline polyaromatic linear polymer exhibiting an excellent combination of strength, stiffness, durability, and environmental resistance. Recent investigations of PEEK as a biomaterial resulted in the successful treatment of cervical disk disease. Wedescribe a series of 4 patients whose defects were reconstructed using customized PEEK implants. All had excellent postoperative aesthetic and functional results without complications such as infections or extrusions. Because PEEK implants are customizable, easily workable, inert, and nonporous, they represent an ideal alloplastic material for maxillofacial reconstruction.
C1 [Kim, Michael M.; Boahene, Kofi D. O.; Byrne, Patrick J.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.
   [Boahene, Kofi D. O.; Byrne, Patrick J.] Johns Hopkins Univ, Sch Med, Div Facial Plast & Reconstruct Surg, Baltimore, MD 21205 USA.
RP Byrne, PJ (reprint author), Johns Hopkins Sch Med, Div Facial Plast & Reconstruct Surg, Dept Otolaryngol Head & Neck Surg, Johns Hopkins Outpatient Ctr, 6th Floor,601 N Caroline St, Baltimore, MD 21287 USA.
EM pbyrne2@jhmi.edu
CR [Anonymous], 2004, PSI PAT SPEC IMPL
   Cho DY, 2003, NEUROSURGERY, V52, P693
   JOCKISCH KA, 1992, J BIOMED MATER RES, V26, P133, DOI 10.1002/jbm.820260202
   MAAS CS, 1990, ARCH OTOLARYNGOL, V116, P551
   Mastronardi L, 2006, ACTA NEUROCHIR, V148, P307, DOI 10.1007/s00701-005-0657-5
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   Scolozzi P, 2007, J CRANIOFAC SURG, V18, P224, DOI 10.1097/01.scs.0000249359.56417.7e
   Sekerci Z, 2006, NEUROL RES, V28, P568, DOI 10.1179/016164106X110382
   Spruit M, 2005, EUR SPINE J, V14, P752, DOI 10.1007/s00586-005-0961-z
   TESSIER P, 1982, CLIN PLAST SURG, V9, P531
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
NR 12
TC 42
Z9 42
U1 2
U2 19
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610-0946 USA
SN 1521-2491
J9 ARCH FACIAL PLAST S
JI Arch. Facial Plast. Surg.
PD JAN-FEB
PY 2009
VL 11
IS 1
BP 53
EP 57
PG 5
WC Surgery
SC Surgery
GA 395XN
UT WOS:000262556900009
PM 19153294
DA 2018-10-19
ER

PT J
AU Pankajakshan, D
   Krishnan, LK
AF Pankajakshan, Divya
   Krishnan, Lissy K.
TI Design of Fibrin Matrix Composition to Enhance Endothelial Cell Growth
   and Extracellular Matrix Deposition for In Vitro Tissue Engineering
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Fibrin; Vascular tissue engineering; Extracellular matrix; Elastin;
   Collagen IV; Tissue remodeling; Growth factors; Fibronectin
ID BLOOD-VESSELS; CYTOSKELETON; FIBRONECTIN; COLLAGEN; IDENTIFICATION;
   PROLIFERATION; FIBROBLASTS; BIOMATERIAL; CULTURE; PROTEIN
AB Tissue-engineered blood vessel substitutes should closely resemble native vessels in terms of structure, composition, mechanical properties, and function. Successful cardiovascular tissue engineering requires optimization of in vitro culture environment that would produce functional constructs. The extracellular matrix (ECM) protein elastin plays an essential role in the cardiovascular system to render elasticity to blood vessel wall, whereas collagen is responsible for providing mechanical strength. The objective of this study was to understand the significance of various ECM components on endothelial cell (EC) growth and tissue generation. We demonstrate that, even though fibrin is a good matrix for EC growth, fibronectin is the crucial component of the fibrin matrix that enhances EC adhesion, spreading, and proliferation. Vascular EC growth factor is known to influence in vitro growth of EC, but, so far, ECM deposition in in vitro culture has not been reported. In this study, it is shown that incorporation of a mixture of hypothalamus-derived angiogenic growth factors with fibrin matrix enhances synthesis and deposition of insoluble elastin and collagen in the matrix, within 10 days of in vitro culture. The results suggest that a carefully engineered fibrin composite matrix may support EC growth, survival, and remodeling of ECM in vitro and impart optimum properties to the construct for resisting the shear stress at the time of implantation.
C1 [Pankajakshan, Divya; Krishnan, Lissy K.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
RP Krishnan, LK (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
EM lissykk@sctimst.ac.in
FU University Grants Commission, Government of India
FX We thank Prof. K. Mohandas, Director, SCTIMST and Dr. G.S. Bhuvaneshwar,
   Head, BMT Wing for their encouragement and support. We appreciate Dr.
   T.V. Anilkumar for providing the confocal microscope facility, Dr.
   Krishna C. Prasad for assistance with flow cytometry analysis, and Ms.
   P.R. Sreerekha and Ms. Mary Vasantha Bai for their technical support.
   The fellowship support awarded to Ms. Divya from University Grants
   Commission, Government of India is acknowledged.
CR Alenghat FJ, 2000, BIOCHEM BIOPH RES CO, V277, P93, DOI 10.1006/bbrc.2000.3636
   AVNUR Z, 1981, CELL, V25, P121, DOI 10.1016/0092-8674(81)90236-1
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   DAVIDSON JM, 1993, J CELL PHYSIOL, V155, P149, DOI 10.1002/jcp.1041550119
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431
   Heydarkhan-Hagvall S, 2006, TISSUE ENG, V12, P831, DOI 10.1089/ten.2006.12.831
   Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje
   HYNES RO, 1978, CELL, V15, P875, DOI 10.1016/0092-8674(78)90272-6
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249
   MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674
   MAYNE R, 1986, ARTERIOSCLEROSIS, V6, P585, DOI 10.1161/01.ATV.6.6.585
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   PERTTILA J, 1990, INTENS CARE MED, V16, P41, DOI 10.1007/BF01706323
   Prasad C.K., 2005, BIOMATERIALS, V26, P5658, DOI DOI 10.1016/J.BIOMATERIALS.2005.02.024
   Prasad CK, 2007, J BIOMED MATER RES A, V80A, P644, DOI 10.1002/jbm.a.30968
   Prasad CK, 2006, ENDOTHELIUM-J ENDOTH, V13, P341, DOI 10.1080/10623320600972036
   Resmi KR, 2002, THROMB RES, V107, P23, DOI 10.1016/S0049-3848(02)00154-8
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sahni A, 2000, BLOOD, V96, P3772
   Sahni A, 2000, THROMB HAEMOSTASIS, V83, P736
   SHIVAKUMAR K, 1992, J MOL CELL CARDIOL, V24, P775, DOI 10.1016/0022-2828(92)93391-V
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
NR 32
TC 11
Z9 11
U1 2
U2 8
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JAN
PY 2009
VL 33
IS 1
BP 16
EP 25
DI 10.1111/j.1525-1594.2008.00670.x
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 397AM
UT WOS:000262634200003
PM 19178437
DA 2018-10-19
ER

PT J
AU Nielsen, VG
   Kirklin, JK
   Holman, WL
   Steenwyk, BL
AF Nielsen, Vance G.
   Kirklin, James K.
   Holman, William L.
   Steenwyk, Brad L.
TI Clot Lifespan Model Analysis of the Effects of Warfarin on Thrombus
   Growth and Fibrinolysis: Role of Contact Protein and Tissue Factor
   Initiation
SO ASAIO JOURNAL
LA English
DT Article
ID ENHANCES FIBRINOLYSIS; HUMAN PLASMA; FACTOR-XIII; FACTOR-VII; INHIBITOR;
   ACTIVATION; COAGULATION; ANTICOAGULATION; KALLIKREIN; PROSTHESES
AB Warfarin therapy has served as the backbone of chronic anticoagulation therapy for decades to prevent thrombotic morbidity secondary to blood-biomaterial interfaces. Unfortunately, thrombotic and bleeding complications are observed despite maintenance of therapeutic international normalized ratio (INR) values. We proposed to define the effects of warfarin therapy on thrombus growth and disintegration following contact pathway protein or tissue factor (TF) initiation. Normal subject or patient plasma with INR values between 1.8 and 9.6 were exposed to TF or celite and tissue-type plasminogen activator (tPA). Thrombus growth/disintegration kinetics were determined by changes in resistance over time with the clot lifespan model (CSLM), a thrombelastographic-based methodology. Data were collected until clot lysis time was observed. Linear relationships of the difference between the CLSM parameter values obtained from paired celite and TF-activated samples and corresponding INR value were determined and reported as r(2). The time to clot initiation was progressively prolonged with increasing INR values in all samples, and speed of clot formation, clot strength, and time to onset of fibrinolysis decreased as INR increased. Throughout the range of INR values tested, contact activation resulted in faster growing, stronger, and longer lived thrombi when compared with matched TF-activated plasma samples. Only the time to maximum rate of lysis was correlated with INR (r(2) = 0.36, p = 0.005). INR values have little correlation with the difference between contact protein and TF-activated coagulation/fibrinolysis. ASAIO journal 2009; 55:33-40.
C1 [Nielsen, Vance G.; Steenwyk, Brad L.] Univ Alabama, Dept Anesthesiol, Birmingham, AL 35249 USA.
   [Nielsen, Vance G.; Kirklin, James K.; Holman, William L.] Univ Alabama, Dept Surg, Birmingham, AL 35249 USA.
RP Nielsen, VG (reprint author), Univ Alabama, Dept Anesthesiol, 901 S 19th St,Basic Med Res 2,Room 206, Birmingham, AL 35249 USA.
EM vnielsen@uab.edu
FU Departments of Anesthesiology and Surgery
FX This investigation was supported by the Departments of Anesthesiology
   and Surgery.
CR Akins CW, 1995, ANN THORAC SURG, V60, P1836, DOI 10.1016/0003-4975(95)00766-0
   Bayliss Andrew, 2007, Interact Cardiovasc Thorac Surg, V6, P390, DOI 10.1510/icvts.2007.152819
   Isawa H, 2007, INSECT BIOCHEM MOLEC, V37, P466, DOI 10.1016/j.ibmb.2007.02.002
   Jerkeman A, 2000, THROMB RES, V98, P467, DOI 10.1016/S0049-3848(00)00203-6
   Koertke H, 2007, EUR HEART J, V28, P2479, DOI 10.1093/eurheartj/ehm391
   Leissinger CA, 2008, AM J HEMATOL, V83, P137, DOI 10.1002/ajh.21046
   Nielsen VG, 2008, ASAIO J, V54, P351, DOI 10.1097/MAT.0b013e31817f3e03
   Nielsen VG, 2008, BLOOD COAGUL FIBRIN, V19, P283, DOI 10.1097/MBC.0b013e3282ff76c3
   Nielsen VG, 2007, BLOOD COAGUL FIBRIN, V18, P647, DOI 10.1097/MBC.0b013e3282a167dc
   Nielsen VG, 2006, J HEART LUNG TRANSPL, V25, P1247, DOI 10.1016/j.healun.2006.06.009
   Nielsen VG, 2008, BLOOD COAGUL FIBRIN, V19, P793, DOI 10.1097/MBC.0b013e328317f5aa
   Nielsen VG, 2006, BLOOD COAGUL FIBRIN, V17, P75, DOI 10.1097/01.mbc.0000198047.35010.77
   Nielsen VG, 2005, ACTA ANAESTH SCAND, V49, P222, DOI 10.1111/j.1399-6576.2004.00602.x
   SARODE R, 2005, BRIT J HAEMATOL, V132, P604
   Schaefer EJ, 2006, ATHEROSCLEROSIS SUPP, V7, P10
   Taketomi T, 2008, BLOOD COAGUL FIBRIN, V19, P135, DOI 10.1097/MBC.0b013e3282f41e6d
   ULMER JS, 1995, FEBS LETT, V365, P159, DOI 10.1016/0014-5793(95)00466-M
NR 17
TC 9
Z9 9
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD JAN-FEB
PY 2009
VL 55
IS 1
BP 33
EP 40
DI 10.1097/MAT.0b013e318190c1a9
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 394DI
UT WOS:000262425400009
PM 19092656
DA 2018-10-19
ER

PT J
AU Bhatia, T
   Sharma, RK
   Prasad, KK
   Prasad, K
AF Bhatia, T.
   Sharma, R. K.
   Prasad, K. K.
   Prasad, K.
TI Studies on Some Physical Properties of Protein-rich Legume (Lens
   esculantus) Splits
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article
CT National Conference on Advanced Materials and Radiation Physics
   (AMRP-2009)
CY MAR 09-SEP 10, 2009
CL Longowal, INDIA
SP Sant Longowal Inst Engn Technol, Dept Phys
DE Biomaterial; Lens esculantus; color; physical properties
AB Basic physical properties of biomaterials that are often required in order to design production equipment, processes and assessment of the effect of processing on nutrients were determined for an important legume Lens esculantus splits, at a moisture content of 10.06 +/- 0.59 % on dry weight basis. The average longitudinal, transverse and thickness dimensions were 3.67, 3.46 and 0.47 mm, respectively, The geometric mean diameter, sphericity, aspect ratio and true density were 1.79 mm, 49.69 %, 94.36 % and 3.35 g/ml, respectively. However, static coefficient of friction varied on two different surfaces from 0.191 on glass to 0.469 on galvanized steel sheet with the legumes perpendicular to the direction of motion, while the angle of repose was 31.89 degrees. The optical parameters were evaluated using hunter color technique on L, a & b scale and found 61.078, 27.756 and 27.524, respectively confirming the characteristic color of selected biomaterial.
C1 [Bhatia, T.; Prasad, K.] St Longowal Inst Engn & Technol, Dept Food Engn & Technol, Longowal 148106, India.
   [Sharma, R. K.] SCI India Pvt Ltd, Bhagalpur 812002, India.
   [Prasad, K. K.] PGIMER, Dept Superspecial Gastroenterol, Chandigarh 160012, India.
RP Bhatia, T (reprint author), St Longowal Inst Engn & Technol, Dept Food Engn & Technol, Longowal 148106, India.
EM dr_k_prasad@rediffmail.com
RI Prasad, Kamlesh/P-1057-2016
OI Prasad, Kamlesh/0000-0001-7086-9391
CR ALONGE AF, 1999, P 21 ANN C NIG SOC A
   GHADGE PN, 2008, CIGR EJOURNAL UNPUB, V10
   GOPALAN C, 1995, NUTR VALUE INDIAN FO, V156
   Mohsenin N. N., 1970, PHYS PROPERTIES PLAN, V1
   Omobuwajo TO, 2000, J FOOD ENG, V45, P43, DOI 10.1016/S0260-8774(00)00040-6
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
J9 ASIAN J CHEM
JI Asian J. Chem.
PY 2009
VL 21
IS 10
BP 103
EP 107
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 514JR
UT WOS:000271391000023
DA 2018-10-19
ER

PT J
AU de Mel, A
   Punshon, G
   Ramesh, B
   Sarkar, S
   Darbyshire, A
   Hamilton, G
   Seifalian, AM
AF de Mel, Achala
   Punshon, Geoffrey
   Ramesh, Bala
   Sarkar, Sandip
   Darbyshire, Arnold
   Hamilton, George
   Seifalian, Alexander M.
TI In situ endothelialisation potential of a biofunctionalised
   nanocomposite biomaterial-based small diameter bypass graft
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 5th International Meeting on Cell Therapy, Bioengineering and
   Regenerative Medicine
CY SEP, 2008
CL Nancy, FRANCE
DE Endothelialisation; RGD peptides; progenitor stem cells; polyhedral
   oligomeric silsesquioxane; vascular grafts; nanocomposite
ID OLIGOMERIC SILSESQUIOXANE NANOCOMPOSITES; PROGENITOR CELLS; STEM-CELLS;
   VASCULAR GRAFT; ENGINEERING APPLICATIONS; CARDIOVASCULAR GRAFT;
   SHEAR-STRESS; POLYMER; SURFACE; DIFFERENTIATION
AB Endothelial dysfunction or the lack of an endothelium associated with cardiovascular grafts is a major cause of graft failure which is linked to thrombosis and related complications. This study was aimed to (1) biofunctionalise a nanocomposite biomaterial, Polyhedral Oligomeric silsesquioxane modified polycarbonate urea-urethane (POSS-PCU), based small diameter vascular graft and to (2) induce endothelialisation with EPC containing monocytes, which were extracted from peripheral blood. (1) Biofunctionalisation of the nanocomposite polymer: bioactive RGD peptide, which is a functional domain of an extracellular matrix component, fibronectin, was synthesised using fmoc chemistry. A lauric acid hydrophobic "tail" was attached to optimise the RGD orientation on the biomaterial. The peptide was cross linked to POSS-PCU. The presence of RGD on the nanocomposite was tested with water contact angle measurements and specificity tests were carried out with the peptide RAD (2) Progenitor cells were extracted from peripheral blood of adult healthy volunteers and cultured on porous biofunctionalised nanocomposite polymer under static conditions. Cells were also introduced to a circuit to which the grafts are connected and non static pulsatile flow conditions were introduced after 72 h following cell introduction. The degree of cell growth was tested with Alamar Blue assay. Endothelialisation was confirmed with SEM and by immunostaining for endothelial cell markers, CD34, CD31 and eNOS. Water contact angle measurement indicated that biofunctionalisation had increased hydrophilicity of the nanocomposite polymer. Alamar blue indicated a greater presence of cells on biofunctionalised nanocomposite and this relative increase in cell viability was specific to RGD as confirmed with RAD peptides. SEM provided evidence for endothelial cell morphology and this was confirmed with endothelial cell markers with immunostaining. Biofunctionalised nanocomposite polymer-based small diameter bypass graft demonstrated the potential for relatively rapid endothelialisation from cells extracted from peripheral blood.
C1 [de Mel, Achala; Punshon, Geoffrey; Ramesh, Bala; Sarkar, Sandip; Darbyshire, Arnold; Hamilton, George; Seifalian, Alexander M.] UCL, Div Surg & Intervent Sci, Ctr Nanotechnol Biomat & Tissue Engn, London, England.
   [Hamilton, George; Seifalian, Alexander M.] Royal Free Hampstead NHS Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, Div Surg & Intervent Sci, Ctr Nanotechnol Biomat & Tissue Engn, London, England.
EM a.seifalian@ucl.ac.uk
RI Punshon, Geoffrey/K-5352-2013; Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
CR Adams B, 2007, TRENDS CARDIOVAS MED, V17, P246, DOI 10.1016/j.tcm.2007.08.005
   ALLENDER S, 2007, CORONARY HEART DIS S
   Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   CONFORTI G, 1989, BLOOD, V73, P1576
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   DiMuzio P, 2007, J VASC SURG, V45, p99A, DOI 10.1016/j.jvs.2007.02.046
   Hoenig MR, 2006, ENDOTHELIUM-J ENDOTH, V13, P385, DOI 10.1080/10623320601061615
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Kallmes DF, 1997, AM J NEURORADIOL, V18, P1243
   Kannan RY, 2006, CELL BIOCHEM BIOPHYS, V45, P129, DOI 10.1385/CBB:45:2:129
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kawamoto A, 2008, TRENDS CARDIOVAS MED, V18, P33, DOI 10.1016/j.tcm.2007.11.004
   Kawamoto A, 2007, CATHETER CARDIO INTE, V70, P477, DOI 10.1002/ccd.21292
   Kidane AG, 2006, J BIOMED MATER RES A, V79A, P606, DOI 10.1002/jbm.a.30817
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Olbrich M, 2007, J BIOMAT SCI-POLYM E, V18, P453, DOI 10.1163/156856207780425059
   Punshon G, 2008, CELL PROLIFERAT, V41, P321, DOI 10.1111/j.1365-2184.2008.00523.x
   Rashid ST, 2008, FASEB J, V22, P2084, DOI 10.1096/fj.07-096586
   Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   Salacinski HJ, 2000, EUR J VASC ENDOVASC, V20, P342, DOI 10.1053/ejvs.2000.1185
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   Sarkar S, 2009, J BIOMECH, V42, P722, DOI 10.1016/j.jbiomech.2009.01.003
   Seifalian AM, 2001, J BIOMED MATER RES, V55, P637, DOI 10.1002/1097-4636(20010615)55:4<637::AID-JBM1058>3.0.CO;2-Z
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   Tang C, 2009, J BIOMED MATER RES A, V88A, P348, DOI 10.1002/jbm.a.31888
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Vara DS, 2006, BIOTECHNOL APPL BIOC, V45, P119, DOI 10.1042/BA20060051
   Vara DS, 2008, ARTIF ORGANS, V32, P978, DOI 10.1111/j.1525-1594.2008.00659.x
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yaseen M, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034123
   Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081
NR 44
TC 59
Z9 62
U1 1
U2 41
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2009
VL 19
IS 4-5
BP 317
EP 331
DI 10.3233/BME-2009-0597
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 554AW
UT WOS:000274408900008
PM 20042799
DA 2018-10-19
ER

PT S
AU Bernstein, A
   Gildenhaar, R
   Berger, G
   Mayr, HO
AF Bernstein, A.
   Gildenhaar, R.
   Berger, G.
   Mayr, H. O.
BE Prado, M
   Zavaglia, C
TI In vitro and in vivo behaviour of a ceramic with interconnected
   macroporosity
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE ceramics; porosity; biomaterial; bone; biocompatibility; surface
   reaction
ID SCAFFOLDS
AB Bioactive ceramics such as beta-tricalcium phosphate (beta-TCP) promote and enhance biological fixation. Ceramics with a porous interconnected structure are suited for facilitation of bony ingrowth. An interconnected pore system with pore diameters in excess of 100 pm is required for cell penetration, tissue ingrowth, vascularization and nutrient delivery to the centre of the regenerating tissue. Human osteoblasts were cultured on the surface of a ceramic. In an in-vivo study, beta-TCP samples with a porous interconnected structure were implanted into the femur of sheep and then investigated 6 weeks after operation. Histological analysis was performed on the area surrounding the implant. An indentation test was performed to complete failure of the bone/ceramic compound. Linear load, peak load and stiffness were recorded. All cylinders were found to be biocompatible and osteoconductive. Bone was more abundant in the outer ring than in the rest of the cylinder. The ceramic/bone compound was of low mechanical grade.
C1 [Bernstein, A.; Mayr, H. O.] Univ Halle, Dept Orthopaed, Magdeburger Str 22, D-06097 Halle, Germany.
   [Gildenhaar, R.; Berger, G.] Fed Inst Mat Res & Testing, D-12200 Berlin, Germany.
RP Bernstein, A (reprint author), Univ Halle, Dept Orthopaed, Magdeburger Str 22, D-06097 Halle, Germany.
EM anke.bernstein@medizin.uni-halle.de; renate.gildenhaar@bam.de;
   georg.berger@bam.de; hermann.mayr@medizin.uni-halle.de
CR Bohner M, 2003, BIOMATERIALS, V24, P2721, DOI 10.1016/S0142-9612(03)00086-3
   De Aza PN, 2003, BIOMATERIALS, V24, P1437, DOI 10.1016/S0142-9612(02)00530-6
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Galois Laurent, 2004, Acta Orthop Belg, V70, P598
   Hing KA, 1998, P I MECH ENG H, V212, P437, DOI 10.1243/0954411981534204
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Schwartzwalder K., 1963, Patent US, Patent No. [3090094 A, 3090094, 3,090,094]
   von Doernberg MC, 2006, BIOMATERIALS, V27, P5186, DOI 10.1016/j.biomaterials.2006.05.051
NR 8
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2009
VL 396-398
BP 19
EP 22
DI 10.4028/www.scientific.net/KEM.396-398.19
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300005
DA 2018-10-19
ER

PT S
AU Calasans-Maia, M
   Santos, SRA
   Rossi, AM
   Granjeiro, JM
AF Calasans-Maia, M.
   Santos, S. R. A.
   Rossi, A. M.
   Granjeiro, J. M.
BE Prado, M
   Zavaglia, C
TI In vivo behavior of hydroxyapatite evaluated by attenuated total
   reflection infrared microscopy (ATR-FTIR)
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE ATR; FTIR; Hydroxyapatite; Rabbit tibia
ID SPECTROSCOPY
AB The study aimed the evaluation of the effect of osseous repair in the synthetic hydroxyapatite cylinder (HA) implanted in rabbit's tibia. Fifteen adult animals, weighing around 2.5 and 3.0 Kg, sourced by the Fluminense Federal University Animal Lab were anesthetized with spinal anesthesia, and two perforations were created in right tibia and filled with cylinders (2 x 6 mm) of HA. The animals were killed after 28 days for evaluating the HA cylinder through attenuated total reflection infrared microscopy (ATR-FTIR). The two fragments of tibia with the cylinder were collected and fixed in alcohol 70 degrees prior to dehydration in successive alcohol solutions and then impregnated and embedded in methyl-methacrylate. Not stained neither pasted to lamina, sections of 200 mu m thickness were analyzed in a Shimadzu IRPrestige-21 Automatic Infrared Microscope (AIM-8800) with ATR Objective Mirror (ATR-8800M). Prior to implantation, HA cylinder was characterized by X-Ray diffraction (XRD), Attenuated Total Reflection- Infra Red microscopy (ATR-FTIR) and X-Ray Fluorescence (XRF). After the implantation, the spectrum of the ATR-FTIR at the interface to neoformed bone was acquired. The hydroxyapatite synthesized was crystalline and stoichiometric with Ca/P ratio of 1.66, becoming carbonated after 28 days of implantation. We conclude that attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) is a useful tool for biomaterial evaluation and able to detect the modification of the chemical HA cylinder pattern occurred probably by ions migration in the biological environment.
C1 [Calasans-Maia, M.; Granjeiro, J. M.] Univ Fed Fluminense, Inst Biol, Lab Bioengn & Biomat, Niteroi, RJ, Brazil.
   [Calasans-Maia, M.; Granjeiro, J. M.] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Unidade Pesquisa Clin, Nucleo Terapia Celular, Niteroi, RJ, Brazil.
   [Santos, S. R. A.; Rossi, A. M.] Cent Brasileiro Pesquisas Fis, MCT, Lab Biomat, LABIOMAT, Rio De Janeiro, Brazil.
RP Calasans-Maia, M (reprint author), Univ Fed Fluminense, Inst Biol, Lab Bioengn & Biomat, Niteroi, RJ, Brazil.
EM monicacalasans@terra.com.br; silvia@cbpf.br; rossi@cbpf.br;
   jmgranjeiro@terra.com.br
RI Calasans-Maia, Monica/G-6203-2013
OI Granjeiro, Jose/0000-0002-8027-8293
FU Fluminense Federal University; CNPq; FINEP; FAPERJ; Capes
FX Special thanks to Fluminense Federal University, CNPq, FINEP, FAPERJ and
   Capes by the financial support.
CR Accorsi-Mendonça Thais, 2008, Braz. oral res., V22, P5, DOI 10.1590/S1806-83242008000100002
   Brancaleon L, 2001, J INVEST DERMATOL, V116, P380, DOI 10.1046/j.1523-1747.2001.01262.x
   McNaughton D, 2005, AUSTR BIOCH, V36, P55
   Mendez JA, 2004, KEY ENG MAT, V254-2, P177, DOI 10.4028/www.scientific.net/KEM.254-256.177
   Moreira Adriana Santos Barone, 2003, Acta ortop. bras., V11, P240, DOI 10.1590/S1413-78522003000400007
   Munhoz EA, 2006, DENTOMAXILLOFAC RAD, V35, P371, DOI 10.1259/dmfr/64880289
   OLIVARES J, 1999, PSICOL CONDUCT, V7, P85
   Picard F, 1999, BIOPHYS J, V76, P539, DOI 10.1016/S0006-3495(99)77222-X
   Sanada Jefferson Tomio, 2003, J. Appl. Oral Sci., V11, P209, DOI 10.1590/S1678-77572003000300010
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
NR 10
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2009
VL 396-398
BP 61
EP 64
DI 10.4028/www.scientific.net/KEM.396-398.61
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300014
DA 2018-10-19
ER

PT S
AU Hermansson, L
   Loof, J
   Jarmar, T
AF Hermansson, Leif
   Loeoef, Jesper
   Jarmar, Tobias
BE Prado, M
   Zavaglia, C
TI Integration Mechanisms Towards Hard Tissue of Ca-aluminate based
   Biomaterials
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE Chemically bonded biomaterial; calcium aluminate; tissue contact zone;
   integration mechanisms
ID CALCIUM ALUMINATE; IN-VIVO; VERTEBROPLASTY; BONE
AB Six mechanisms have been identified, which control how Ca-aluminate materials are integrated onto tissue; 1) Main reaction, the hydration step of CA, 2) Apatite formation in presence of phosphate ions in the biomaterial, 3) Apatite formation in the contact zone in presence of body liquid, 4) Transformation of hydrated Ca-aluminate into apatite and gibbsite, 5) Biological induced integration and ingrowth, i.e. bone formation at the contact zone, and 6) Mass increase reaction, especially important when un-hydrated CA is used as coatings or as augmentation pastes. These six mechanisms affect the integration differently depending on a) what type of tissue the biornaterial is in contact with, b) in what state (un-hydrated or hydrated) the CA is introduced, and c) what type of application is aimed at (cementation, dental fillings, endodontic fillings, sealants, coatings and augmentation products). Both a pure nanostructural mechanically controlled integration, and a chemically induced integration seem plausible.
C1 [Hermansson, Leif; Loeoef, Jesper; Jarmar, Tobias] Doxa AB, SE-75451 Uppsala, Sweden.
RP Hermansson, L (reprint author), Doxa AB, Axel Johanssons Gata 4-6, SE-75451 Uppsala, Sweden.
EM leif.hermansson@doxa.se; jesper.loof@doxa.se; tobias.jarmar@doxa.se
CR Axen N, 2005, KEY ENG MAT, V284-286, P831, DOI 10.4028/www.scientific.net/KEM.284-286.831
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   Engqvist H., 2006, Advances in Science and Technology, V49, P275, DOI 10.4028/www.scientific.net/AST.49.275
   Engqvist H, 2008, TRENDS BIOMATER ARTI, V21, P98
   Hermansson L, 2003, KEY ENG MAT, V247, P437, DOI 10.4028/www.scientific.net/KEM.247.437
   Jarmar T, 2008, KEY ENG MATER, V361-363, P373, DOI 10.4028/www.scientific.net/KEM.361-363.373
   KRAFT L, 2002, P AM CERAM SOC B, V23
   Li JG, 2000, J MATER SCI, V35, P5879, DOI 10.1023/A:1026733130062
   Loof J, 2008, KEY ENG MATER, V361-363, P369
   Loof J, 2003, J MATER SCI-MATER M, V14, P1033, DOI 10.1023/B:JMSM.0000003999.52349.0d
   PALMQUIST A, 2008, J BIOMED MAT B UNPUB
NR 11
TC 8
Z9 8
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2009
VL 396-398
BP 183
EP 186
DI 10.4028/www.scientific.net/KEM.396-398.183
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300042
DA 2018-10-19
ER

PT S
AU Weska, RF
   Nogueira, GM
   Vieira, WC
   Beppu, MM
AF Weska, Raquel F.
   Nogueira, Grinia M.
   Vieira, Wellington C.
   Beppu, Marisa M.
BE Prado, M
   Zavaglia, C
TI Porous Silk Fibroin Membrane as a Potential Scaffold for Bone
   Regeneration
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE silk fibroin; porous membrane; in vitro calcification; scaffold
ID SIMULATED BODY-FLUID; MINERALIZATION; DEPOSITION; BEHAVIOR
AB The requirements for scaffolds for bone tissue engineering include appropriate chemistry, morphology and structure to promote cell adhesion and synthesis of new bone matrix. Silk fibroin (SF) represents an important biomaterial for biomedical application, due to its suitable mechanical properties, biodegradability, biocompatibility, and versatility in processing. Our group has developed a new method to obtain a porous SF membrane, and the study of its potential for use as a scaffold for bone regeneration was the aim of this study. Porous membranes were obtained from SF solution, through the compression of a material generated by phase separation. For in vitro calcification experiments, porous SF membrane samples were immersed in SBF at pH 7.4 placed in polyethylene flasks. The experiments were carried out for seven days, at 36.5 +/- 0.5 degrees C. After 48 and 96h, the solutions were changed for fresh SBF with the ion concentration 1.5-fold higher than that of the standard one, to accelerate the calcification process. The characterization of morphology and composition of samples was performed by using scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS), respectively. The SEM micrographs indicated that the porous SF membranes presented calcium phosphate deposits after undergoing in vitro calcification. These results were confirmed by EDS spectra, which showed a stoichiometric molar Ca/P ratio ranging from 1.27 to 1.52. This fact may suggest that calcification deposits consisted of mixtures of HAP (Ca/P ratio = 1.67) and transient HAP precursor phases, such as octacalcium phosphate (Ca/P = 1.33) and dicalcium phosphate dehydrate (Ca/P = 1), indicating early stage mineralization. The porous silk fibroin membrane analysed in the current study is a promising material to be used as scaffolds for bone regeneration.
C1 [Weska, Raquel F.; Nogueira, Grinia M.; Vieira, Wellington C.; Beppu, Marisa M.] Univ Estadual Campinas, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
RP Weska, RF (reprint author), Univ Estadual Campinas, Sch Chem Engn, POB 6066, BR-13083970 Campinas, SP, Brazil.
EM raquelweska@terra.com.br; grinia@feq.unicamp.br; wevieira@uol.com.br;
   beppu@feq.unicamp.br
RI BEPPU, MARISA/E-1057-2012
CR BEPPU M, 2006, PI06019757 INPI
   Hsu SH, 2007, BIO-MED MATER ENG, V17, P53
   KIM HJ, 2008, BONE
   Kino R, 2006, J APPL POLYM SCI, V99, P2822, DOI 10.1002/app.22910
   Kino R, 2007, J BIOSCI BIOENG, V103, P514, DOI 10.1263/jbb.103.514
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Mikroulis D, 2002, J MATER SCI-MATER M, V13, P885, DOI 10.1023/A:1016556514203
   Wolke JGC, 2003, BIOMATERIALS, V24, P2623, DOI 10.1016/S0142-9612(03)00067-X
NR 11
TC 5
Z9 5
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2009
VL 396-398
BP 187
EP 190
DI 10.4028/www.scientific.net/KEM.396-398.187
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300043
DA 2018-10-19
ER

PT S
AU Rodrigues, CVM
   Fernandes, LL
   Soares, GDA
AF Rodrigues, Carla Valeria M.
   Fernandes, Ligia L.
   Soares, Gloria D. A.
BE Prado, M
   Zavaglia, C
TI Brazilian Research Academy and Scientific Evidence on Calcium Phosphate
   Bone Grafts
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE biomaterials; bone grafts; calcium phosphate; dentistry; orthopaedics
AB Different types of bone grafts are available in Brazil due to the increase of use of biomaterials for hard tissue replacement. This study was designed to evaluate the scientific production of Brazilian research groups on safety and efficacy of calcium phosphate bone grafts of commercial use in Brazil. The calcium phosphate bone grafts approved for commercial use in Brazil were searched at the National Health Regulatory Agency's database (ANVISA). The main leaders' names of the Brazilian Research Groups on these health technologies were obtained by applying the search strategies to the National Council of Technological and Scientific Development's database (CNPq). Afterwards, it was performed a systematic search of studies conducted by these leaders on calcium phosphate bone grafts and published from 2000 to May 2008 at the following databases: Medline, Lilacs and Scielo. Twenty-nine bone grafts composed by calcium phosphates were registered at Anvisa in May 2008. From those products, 17 and 12 were from imported and national origin respectively. There were twenty-four Brazilian research groups on calcium phosphate bone grafts whose scientific production consisted of 5 studies on bone grafts registered at Anvisa: 3 experiments conducted in animals on the Brazilian bovine bone graft GenOX (R) one prospective comparative study and one case report both evaluating the clinical performance of a national biomaterial composed by BMP, demineralized bovine bone, inorganic bovine bone and bovine collagen with the commercial name Gen-Tech (R) for dentistry applications and 6 months of follow-up. However, all the included studies had poor methodological quality and could not be used for further recommendations despite their good results. The scientific evidence produced by the Brazilian research groups on safety and efficacy of calcium phosphate bone grafts of commercial use in Brazil is still scant. Additional studies are necessary to evaluate these technologies.
C1 [Rodrigues, Carla Valeria M.; Fernandes, Ligia L.; Soares, Gloria D. A.] UFRJ, COPPE, PEMM, BR-21941972 Rio De Janeiro, Brazil.
RP Rodrigues, CVM (reprint author), UFRJ, COPPE, PEMM, POB 68505, BR-21941972 Rio De Janeiro, Brazil.
EM carla@mvirtual.com.br; ligialf@metalmat.ufrj.br; gloria@metalmat.ufrj.br
CR Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Galois L, 2002, INT ORTHOP, V26, P109, DOI 10.1007/s00264-001-0329-x
   Goncalves F, 2005, IMPLANTNEWS, V2, P491
   HOLZHAUSEN M, 2002, RPG REV POSGRAD, V9, P37
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Marins Lucele Vieira, 2004, J. Appl. Oral Sci., V12, P62, DOI 10.1590/S1678-77572004000100012
   Munhoz EA, 2006, DENTOMAXILLOFAC RAD, V35, P371, DOI 10.1259/dmfr/64880289
   Phillips B., 2001, OXFORD CTR EVIDENCE
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   RODRIGUES CVM, 2008, 8 WORLD BIOM C
   Sanada Jefferson Tomio, 2003, J. Appl. Oral Sci., V11, P209, DOI 10.1590/S1678-77572003000300010
   Sicca Cm, 2000, REV FAC ODONTOL BAUR, V8, P1
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
NR 14
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2009
VL 396-398
BP 217
EP 220
DI 10.4028/www.scientific.net/KEM.396-398.217
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300050
DA 2018-10-19
ER

PT S
AU Szesz, EM
   Marino, CEB
   Ponte, HA
   Nascimento, FC
   Lepienski, CM
   Kuromoto, NK
AF Szesz, Eduardo Mioduski
   Marino, Claudia E. B.
   Ponte, Haroldo A.
   Nascimento, Fabiana C.
   Lepienski, Carlos M.
   Kuromoto, Neide K.
BE Prado, M
   Zavaglia, C
TI Surface and Electrochemical Analysis of Titanium Submitted to Alkaline
   Treatment by SEM, XRD and EIS
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE Titanium; alkali treatment; apatite; electrochemical impedance
   spectroscopy
ID TI; ALLOYS
AB Although titanium metal has been used intensively in the last years as biomaterial in the medical and dental areas its surface is not bioactive. In this work, titanium metal was submitted to an alkali treatment in order to make the metal surface bioactive. The samples were submitted to alkaline treatment (AT) using NaOH 5M aqueous solution at 60 degrees C for 24 h and after that they were heated thermically to stabilize the layer obtained with AT. The bioactivity of the samples was evaluated soaking them into the simulated body fluid (SBF) at 36,5 degrees C for 28 days. The morphological, structural changes and the electrochemical characterization were analyzed using scanning electron microscopy, x-ray diffraction and electrochemical impedance spectroscopy (EIS), respectively. It was verified that after AT plus heat treatment (HT) a sodium titanate layer was formed on the samples surface and after the bioactivity tests an apatite layer was formed. Impedance analysis show that the resistance of film on Ti is high and this value increases when the sample is soaked in SBF. It means that the apatite (HPA) film is occurring and the value of the capacitance with the presence of the HPA film (C-p) values indicate that the film maintain a compact and uniform characteristics.
C1 [Szesz, Eduardo Mioduski] PG MEC UFPR, POB 19011, BR-81531990 Curitiba, Parana, Brazil.
   [Marino, Claudia E. B.; Ponte, Haroldo A.] PG MEC UFPR, DEQ, BR-81531990 Curitiba, Parana, Brazil.
   [Nascimento, Fabiana C.; Lepienski, Carlos M.; Kuromoto, Neide K.] PG MEC UFPR, DFIS, BR-81531990 Curitiba, Parana, Brazil.
RP Szesz, EM (reprint author), PG MEC UFPR, POB 19011, BR-81531990 Curitiba, Parana, Brazil.
EM eduszesz@gmail.com; marino@quimica.ufpr.br; hponte@ufpr.br;
   fabiana.cristina@pesquisador.cnpq.br; lepiensm@fisica.ufpr.br;
   kuromoto@fisica.ufpr.br
RI Szesz, Eduardo/H-2163-2014; MARINO, CLAUDIA/H-8169-2017; Ponte,
   Haroldo/C-9147-2013
OI MARINO, CLAUDIA/0000-0003-2660-4577; Ponte, Haroldo/0000-0002-5596-8946;
   Kuromoto, Neide Kazue/0000-0001-8032-5523; Lepienski, Carlos
   Mauricio/0000-0002-9759-9704
CR Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   LASIA A, 2006, MOD ASPECT ELECTROC, V32, P2
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Marino CEB, 2004, J ELECTROANAL CHEM, V568, P115, DOI 10.1016/j.elechem.2004.01.011
NR 6
TC 1
Z9 1
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2009
VL 396-398
BP 381
EP 384
DI 10.4028/www.scientific.net/KEM.396-398.381
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300090
DA 2018-10-19
ER

PT S
AU dos Santos, AR
   Silva, FCE
   Soares, GD
AF dos Santos, Aline Raybolt
   Costa e Silva, Fernando
   Soares, Gloria de Almeida
BE Prado, M
   Zavaglia, C
TI The Interaction between Human Osteoblastic Cells and Titanium Anodized
   with Sulphuric Acid coated or not with Human Plasma Fibronectin
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE Biomaterial; titanium; anodization; osteoblast; cellular adhesion;
   fibronectin
ID BIOMATERIALS; ADHESION
AB In this study, commercially pure titanium (Ti-cp) sheets grade 2 were used as substrates. To investigate the role of composition and characteristics of titanium surface oxides in cellular behavior of osteoblasts, the surface of titanium were modified by anodic oxidation with sulphuric acid. Subsequently were treated part of anodized samples with FN and cultured with osteoblast cells for 30, 120 and 240 minutes. The chemical composition and topography have influenced the interaction between fibronectin and substrate. Cells were found more associated to the surfaces that have been submitted to anodization and FN coating than to the related controls.
C1 [dos Santos, Aline Raybolt; Soares, Gloria de Almeida] UFRJ PEMM COPPE, POB 68505, BR-21941972 Rio De Janeiro, Brazil.
   [Costa e Silva, Fernando] Univ Fed Rio de Janeiro, Biophys Inst Carlos Chagas Filho, Progr Bioengn & Anim Biotechnol, BR-21949900 Rio de Janeiro, Brazil.
RP dos Santos, AR (reprint author), UFRJ PEMM COPPE, POB 68505, BR-21941972 Rio De Janeiro, Brazil.
EM raybolt98@yahoo.com; fcsf@biof.ufrj.br; gloria@metalmat.ufrj.br
FU CNPq; CAPES; FUJB-UFRJ; FAPERJ [E-26/152.729/2006, E-26/110.333/2007]
FX The authors are grateful for financial support from CNPq, CAPES,
   FUJB-UFRJ and FAPERJ (Process number E-26/152.729/2006 and
   E-26/110.333/2007).
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Antia M, 2006, BIOMATERIALS, V27, P679, DOI 10.1016/j.biomaterials.2005.06.014
   Kirbs A, 2003, MAT SCI ENG C-BIO S, V23, P425, DOI 10.1016/S0928-4931(02)00315-6
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   SANTOS EA, 2007, MAT SCI ENG C, V27, P61
   Santos E, 2007, MATER CHEM PHYS, V102, P92, DOI 10.1016/j.matchemphys.2006.11.010
NR 6
TC 1
Z9 1
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2009
VL 396-398
BP 389
EP 392
DI 10.4028/www.scientific.net/KEM.396-398.389
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300092
DA 2018-10-19
ER

PT S
AU Salgado, CL
   Solomao, Z
   Silva, PB
   Sanchez, EMS
   Zavaglia, CAC
AF Salgado, Christiane L.
   Solomao, Zenaide
   Silva, Priscilla B.
   Sanchez, Elisabete M. S.
   Zavaglia, Cecilia A. C.
BE Prado, M
   Zavaglia, C
TI Biocompatibility and Osteo-Differentiation Study of Poly
   (epsilon-Caprolactone) and beta-Tricalcium Phosphate Composite Membranes
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE Porous membranes; Poly(epsilon-caprolactone); beta-tricalcium phosphate;
   Mesenquimal stem cell; Alkaline phosphatase
AB The Tissue Engineering appears with a modern proposal for the treatment of damages or diseases, The study of materials and methods for tissues and organs regeneration by the patient cells culture had been developed on the last years but still couldn't be used for all different tissues. In this multidisciplinary research field, the present work joins the biodegradability of poly(epsilon-caprolactone) (PCL) with the osteoconductive properties of beta-tricalcium phosphate (beta-TCP) in order to create a composite which acts as a temporary support for cell culture without a second surgery to remove the biomaterial. This work evaluates three membranes types, obtained by casting in chloroform, on the biocompatibility and differentiation on mesenquimal stem cells (hMSC). These analyses showed cell viability with the rezasurin method and the alkaline phosphatase activity (ALP). DMA analyses, MEV and OPM were performed.
C1 [Salgado, Christiane L.; Solomao, Zenaide; Silva, Priscilla B.; Sanchez, Elisabete M. S.; Zavaglia, Cecilia A. C.] Univ Estadual Campinas, Dept Mat Engn, Campinas, SP, Brazil.
RP Salgado, CL (reprint author), Univ Estadual Campinas, Dept Mat Engn, Campinas, SP, Brazil.
EM christiane@fem.unicamp.br; zsolomao@unimep.br; pri.brands@gmail.com;
   bete@fem.unicamp.br; zavagl@fem.unicamp.br
RI Salgado, Christiane/K-5498-2013
OI Salgado, Christiane/0000-0002-3844-1667
CR BARBANTI SH, 2001, THESIS UNICAMP CAMPI
   BROWN S, 2001, BIOCERAMICS, V14, P213
   Gabelnick HL, 1983, ADV HUMAN FERTILITY, V2, P149
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P325, DOI 10.1016/S0901-5027(03)00199-1
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N
NR 8
TC 1
Z9 1
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2009
VL 396-398
BP 399
EP 402
DI 10.4028/www.scientific.net/KEM.396-398.399
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300094
DA 2018-10-19
ER

PT S
AU Baptista, LS
   Pedrosa, CSG
   da Silva, KR
   do Amaral, RJFC
   Kochem, MCL
   Menezes, H
   Sterodimas, A
   de Faria, J
   de Oliveria, MRR
   Borojevic, R
AF Baptista, Leandra S.
   Pedrosa, Carolina S. G.
   da Silva, Karina R.
   do Amaral, Ronaldo J. F. C.
   Kochem, Michele C. L.
   Menezes, Helio
   Sterodimas, Aris
   de Faria, Jose
   de Oliveria, Marcio R. R.
   Borojevic, Radovan
BE Prado, M
   Zavaglia, C
TI Fibroin-Based Material from Natural Silk Can Be Associated with Alginate
   And Mesenchymal Progenitor Cells
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE fibroin-based material; tissue engineering; perichondrium mesenchymal
   progenitor cells
ID CARTILAGE
AB Silks are naturally occurring polymers and fibroin, its filament core protein, has been shown to support stem cell differentiation in vitro, and promote tissue repair in vivo. The aim of this study is to develop a biomaterial based on silk-fibroin fibers that can be associated with mesenchymal progenitor cells from human perichondrium in vitro, in order to promote auricular. reconstruction in vivo. Silk-fibroin concentrate was dissolved with formic acid solution and freeze-dried in auricular moulds. Fibroin-based material was characterized by scanning electron microscopy and by cytotoxic assays. Perichondrium, mesenchymal progenitor cells were characterized by flow cytometry. They expressed the standard mesenchymal stem cell markers, and were able to differentiate into several mesenchymal lineages in vitro. This fibroin-based material is a three-dimensional fibrillar scaffold, non-woven and biocompatible, which was also well integrated with alginate and mesenchymal cells.
EM leandra@excellion.com.br; carolsgp@yahoo.com.br; karinaxu@yahoo.com.br;
   ronaldojfca@yahoo.com.br; michele@excellion.com.br;
   helio@excellion.com.br; aris@sterodimas.com; j.faria@openlink.com.br;
   marciori@int.gov.br; radovan@excellion.com.br
RI Baptista, L/D-4259-2013
OI Baptista, L/0000-0001-9998-8044; Borojevic, Radovan/0000-0002-2393-7280
CR BAPTISTA LS, 2008, THESIS U FEDERAL RIO
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Rogero Sizue Ota, 2003, Mat. Res., V6, P317, DOI 10.1590/S1516-14392003000300003
   Togo T, 2006, LAB INVEST, V86, P445, DOI 10.1038/labinvest.3700409
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Xu JW, 2005, PLAST RECONSTR SURG, V115, P1633, DOI 10.1097/01.PRS.0000161465.21513.5D
NR 6
TC 0
Z9 0
U1 1
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2009
VL 396-398
BP 437
EP 440
DI 10.4028/www.scientific.net/KEM.396-398.437
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300102
DA 2018-10-19
ER

PT S
AU Chen, B
   Sun, ST
   Peng, XH
AF Chen, Bin
   Sun, Shitao
   Peng, Xianghe
BE Prado, M
   Zavaglia, C
TI Hydroxyapatite-sheet Microstructure of Shinbone
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE Bone; hydroxyapatite sheets; parallel distribution; pullout energy;
   fracture toughness
ID BONE; CRYSTALS
AB Bone is a kind of biomaterial in nature. It behaves favorable strength, stiffness and fracture toughness which are closely related to its fine microstructures. Scanning electron microscope (SEM) observation on a shinbone shows that the bone is a kind of natural bioceramic composite consisting of hydroxyapatite layers and collagen matrix. The hydroxyapatite layers are arranged in a parallel distribution and consist of many hydroxyapatite sheets. The fracture toughness of the bone was analyzed based on the representative model of the microstructure in the bone and the idea of maximum pullout energy. The analytical result shows that the long and thin shape as well as the parallel distribution of the hydroxyapatite sheets increase the maximum pullout energy of the sheets and enhance the fracture toughness of the bone.
C1 [Chen, Bin; Sun, Shitao; Peng, Xianghe] Chongqing Univ, Dept Engn Mech, Coll Resource & Environm Sci, Chongqing 400044, Peoples R China.
RP Chen, B (reprint author), Chongqing Univ, Dept Engn Mech, Coll Resource & Environm Sci, Chongqing 400044, Peoples R China.
EM bchen@cqu.edu.cn
CR Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   FRATZL P, 1992, J BONE MINER RES, V7, P329
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Glimcher M.J., 1992, DISORDERS BONE MINER, P265
   LEES S, 1988, CONNECT TISSUE RES, V18, P41, DOI 10.3109/03008208809019071
   Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6
   WEBER M, 2005, STRUC MECH BEHAV BIO, V847, P79
   Woesz A, 2005, MAT SCI ENG C-BIO S, V25, P181, DOI 10.1016/j.msec.2005.01.014
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 9
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MAT
PY 2009
VL 396-398
BP 441
EP 444
DI 10.4028/www.scientific.net/KEM.396-398.441
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300103
DA 2018-10-19
ER

PT S
AU Braga, FJC
AF Braga, F. J. C.
BE Prado, M
   Zavaglia, C
TI The relationship of the oxide phases on irradiated titanium surface by
   Nd:YVO4 laser with the Ca,P deposited layer
SO BIOCERAMICS 21
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 21st International Symposium on Ceramics in Medicine
CY OCT 21-24, 2008
CL Buzios, BRAZIL
SP Int Soc Ceram Med
DE Surface modification; Titanium; Laser ablation; Hydroxyapatite;
   Biomaterial
ID IMPLANT SURFACES
AB The scope of this paper is focused on surface modification process by laser beam irradiation in pure metallic titanium inducing by ablation phenomenon such non stable oxides formation oil the irradiated surface. The present study correlates the pulsed laser beam parameter conditions used to irradiate pure metallic titanium and its resulting crystalline phases on the surface with the deposited calcium phosphate layer on it.
C1 IPEN CNEN SP, Ctr Ciencia & Tecnol Mat, BR-05508000 Sao Paulo, Brazil.
RP Braga, FJC (reprint author), IPEN CNEN SP, Ctr Ciencia & Tecnol Mat, Av Prof Lineu Prestes,2242 Cidade Univ, BR-05508000 Sao Paulo, Brazil.
EM fjcbraga@ipen.br
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Albrektsson T., 1985, TISSUE INTEGRATED PR, P129
   [Anonymous], 2004, CRYST SEARCH MATCH V
   Binon P P, 1992, Int J Oral Maxillofac Implants, V7, P168
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Gaggl A, 2000, BIOMATERIALS, V21, P1067, DOI 10.1016/S0142-9612(00)00002-8
   Gyorgy E, 2004, SURF COAT TECH, V187, P245, DOI 10.1016/j.surfcoat.2004.03.015
   Gyorgy E, 2004, APPL PHYS A-MATER, V78, P765, DOI 10.1007/s00339-002-2054-8
   KLOOSTERMAN AB, 1998, THESIS U GRONINGEN H
   Kraus W., 2000, POWDER CELL WINDOWS
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   Olefjord I, 1993, Int J Oral Maxillofac Implants, V8, P32
   UITTO VJ, 1992, J DENT RES, V71, P1203, DOI 10.1177/00220345920710051301
NR 13
TC 0
Z9 0
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2009
VL 396-398
BP 565
EP 568
DI 10.4028/www.scientific.net/KEM.396-398.565
PG 4
WC Engineering, Biomedical; Materials Science, Multidisciplinary; Materials
   Science, Biomaterials
SC Engineering; Materials Science
GA BJE92
UT WOS:000265306300133
DA 2018-10-19
ER

PT J
AU Chen, RX
   Cole, N
   Willcox, MDP
   Park, J
   Rasul, R
   Carter, E
   Kumar, N
AF Chen, Renxun
   Cole, Nerida
   Willcox, Mark D. P.
   Park, Josephine
   Rasul, Riaz
   Carter, Elizabeth
   Kumar, Naresh
TI Synthesis, characterization and in vitro activity of a surface-attached
   antimicrobial cationic peptide
SO BIOFOULING
LA English
DT Article
DE antimicrobial cationic peptides; biomaterial; Pseudomonas;
   Staphylococcus
ID CENTRAL VENOUS CATHETERS; CONTROLLED-TRIAL; CONTACT-LENSES; ARYL
   NITRENE; INFECTION; PREVENTION; PROTEIN; IMMOBILIZATION; COLONIZATION;
   VIABILITY
AB Infection associated with implanted biomaterials is common and costly and such infections are extremely resistant to antibiotics and host defenses. Consequently, there is a need to develop surfaces which resist bacterial adhesion and colonization. The broad spectrum synthetic cationic peptide melimine has been covalently linked to a surface via two azide linkers, 4-azidobenzoic acid (ABA) or 4-fluoro-3-nitrophenyl azide (FNA), and the resulting surfaces characterized by X-ray photoelectron spectroscopy and contact angle measurements. The quantity of bound peptide was estimated by a modified Bradford assay. The antimicrobial efficacy of the two melimine-modified surfaces against Pseudomonas aeruginosa and Staphylococcus aureus was compared by scanning electron microscopy (SEM) and fluorescence microscopy. Attachment of melimine via ABA gave an approximately 4-fold greater quantity of melimine bound to the surface than attachment via FNA. Surfaces melimine-modified by either attachment strategy showed significantly reduced bacterial adhesion for both strains of bacteria. P. aeruginosa exposed to ABA-melimine and FNA-melimine surfaces showed marked changes in cell morphology when observed by SEM and a reduction of approximately 15-fold (p < 0.001) in the numbers of adherent bacteria compared to controls. For the ABA-melimine surface there was a 33% increase in cells showing damaged membranes (p = 0.0016) while for FNA-melimine there was no significant difference. For S. aureus there were reductions in bacterial adhesion of approximately 40-fold (p < 0.0001) and 5-fold (p = 0.008) for surfaces modified with melimine via ABA or FNA, respectively. There was an increase in cells showing damaged membranes on ABA-melimine surfaces of approximately 87% (p = 0.001) compared to controls, while for FNA-melimine there was no significant difference observed. The data presented in this study show that melimine has excellent potential for development as a broad spectrum antimicrobial coating for biomaterial surfaces. Further, it was observed that the efficacy of antimicrobial activity is related to the method of attachment.
C1 [Chen, Renxun; Park, Josephine; Rasul, Riaz; Kumar, Naresh] Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
   [Cole, Nerida; Willcox, Mark D. P.] Eye Res Inst, Sydney, NSW 2052, Australia.
   [Cole, Nerida; Willcox, Mark D. P.] Vis CRC, Sydney, NSW 2052, Australia.
   [Cole, Nerida; Willcox, Mark D. P.; Rasul, Riaz] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW 2052, Australia.
   [Carter, Elizabeth] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.
RP Kumar, N (reprint author), Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
EM n.kumar@unsw.edu.au
RI Chen, Renxun/G-7015-2014
OI Chen, Renxun/0000-0003-0828-9980; Carter, Elizabeth/0000-0001-6318-7771;
   cole, nerida/0000-0002-9866-4694
FU Australian Research Council's Discovery Projects [DP0663368]
FX This research was supported under the Australian Research Council's
   Discovery Projects funding scheme (project number DP0663368). The
   authors would like to thank Dr Scott Rice for assistance with
   fluorescence analysis of biofilms and Jenny Norman of the Electron
   Microscopy Unit at the University of New South Wales Analytical Centre
   for assistance with the electron micrographs.
CR Bach A, 1996, INTENS CARE MED, V22, P1066, DOI 10.1007/BF01699229
   BARRAUD N, 2006, J BACTERIOL, V188, P7244
   BONDE M, 1992, ANAL BIOCHEM, V200, P195, DOI 10.1016/0003-2697(92)90298-L
   Bong JJ, 2003, J CLIN PATHOL, V56, P731, DOI 10.1136/jcp.56.10.731
   Bryers JD, 2006, BIOMATERIALS, V27, P5039, DOI 10.1016/j.biomaterials.2006.05.034
   Ciresi DL, 1996, AM SURGEON, V62, P641
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   FLEET GWJ, 1972, BIOCHEM J, V128, P499, DOI 10.1042/bj1280499
   FLEET GWJ, 1969, NATURE, V224, P511, DOI 10.1038/224511a0
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Guire P, 1976, Methods Enzymol, V44, P280
   HARMER MA, 1991, LANGMUIR, V7, P2010, DOI 10.1021/la00058a007
   Inamori K, 2008, ANAL CHEM, V80, P643, DOI 10.1021/ac701667g
   Jones JR, 2006, J MATER SCI-MATER M, V17, P989, DOI 10.1007/s10856-006-0434-x
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0
   Klotz SA, 1990, MICROBIAL CELL SURFA, P107
   Lam PK, 2004, BRIT J BIOMED SCI, V61, P125, DOI 10.1080/09674845.2004.11732656
   Leung D, 2005, BIOMATERIALS, V26, P7145, DOI 10.1016/j.biomaterials.2005.05.014
   Madkour AE, 2008, POLYM INT, V57, P6, DOI 10.1002/pi.2399
   MAKI DG, 1988, AM J MED, V85, P307, DOI 10.1016/0002-9343(88)90579-7
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Nahar P, 2001, ANAL BIOCHEM, V294, P148, DOI 10.1006/abio.2001.5168
   NELSON CL, 1979, ARCH SURG-CHICAGO, V114, P778
   NEU HC, 1992, SCIENCE, V257, P1073
   Rasband W. S., 1997, IMAGEJ SOFTWARE
   Ravikumar T, 2006, BIOMACROMOLECULES, V7, P2762, DOI 10.1021/bm060476w
   Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007
   Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069
   Thornton J, 1996, ANAESTHESIA, V51, P1018, DOI 10.1111/j.1365-2044.1996.tb14994.x
   Willcox MDP, 2008, J APPL MICROBIOL, V105, P1817, DOI 10.1111/j.1365-2672.2008.03942.x
   WILLCOX MDP, 2004, Patent No. 2004126409
   Williams TJ, 2003, CURR EYE RES, V27, P227, DOI 10.1076/ceyr.27.4.227.16602
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
NR 37
TC 39
Z9 40
U1 2
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
J9 BIOFOULING
JI Biofouling
PY 2009
VL 25
IS 6
BP 517
EP 524
DI 10.1080/08927010902954207
PG 8
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA 439NH
UT WOS:000265633300004
PM 19408136
DA 2018-10-19
ER

PT J
AU Alcaide, M
   Serrano, MC
   Pagani, R
   Sanchez-Salcedo, S
   Vallet-Regi, M
   Portoles, MT
AF Alcaide, Maria
   Serrano, Maria-Concepcion
   Pagani, Raffaella
   Sanchez-Salcedo, Sandra
   Vallet-Regi, Maria
   Portoles, Maria-Teresa
TI Biocompatibility markers for the study of interactions between
   osteoblasts and composite biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Biphasic calcium phosphate; Agarose; Bone graft; Saos-2 osteoblasts;
   Nitric oxide
ID BETA-TRICALCIUM PHOSPHATE; NITRIC-OXIDE; CELL-DEATH; ANNEXIN-V;
   APOPTOSIS; BONE; PHOSPHATIDYLSERINE; FABRICATION; EXPRESSION; CERAMICS
AB Biphasic calcium phosphate (BCP), a mixture of hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP), has attracted attention as an excellent bone graft substitute. Mixtures of ceramics with agarose, as natural biodegradable binder, have been recently performed in order to increase the flexibility of the ceramic component and to facilitate the biomaterial preparation. In previous studies we have evaluated the response of both L929 fibroblasts and Saos-2 osteoblasts to hydroxyapatite-beta TCP/agarose disks observing a higher sensitivity of osteoblasts to this biomaterial. In the present study, the use of specific fluorescent probes and antibodies has allowed to evaluate different cell function parameters as biocompatibility markers for the cell/biomaterial interaction of Saos-2 osteoblasts cultured for 7 days on hydroxyapatite-beta TCP/agarose disks. The cell cycle subG(1) fraction, the exposition of phosphatidylserine on the outside surface of the plasma membrane and the analysis of plasma membrane integrity versus cell size, indicate that the interaction with the biomaterial induces a light increase of apoptosis in osteoblasts without producing cell necrosis. The high percentage of viable cells on the biomaterial and the preservation of endothelial nitric oxide synthase (eNOS) expression, eNOS activity and mitochondrial membrane potential (Delta psi(m)), demonstrate the good biocompatibility of hydroxyapatite-beta TCP/agarose disks and its potential utility for bone substitution and repair. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Alcaide, Maria; Serrano, Maria-Concepcion; Pagani, Raffaella; Portoles, Maria-Teresa] Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.
   [Sanchez-Salcedo, Sandra; Vallet-Regi, Maria] Univ Complutense, Fac Pharm, Dept Inorgan & Bioinorgan Chem, E-28040 Madrid, Spain.
   [Sanchez-Salcedo, Sandra; Vallet-Regi, Maria] Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain.
RP Portoles, MT (reprint author), Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.
EM portoles@quim.ucm.es
RI Portoles, Maria Teresa/U-1678-2017; Serrano, Maria
   Concepcion/D-7442-2014; Vallet-Regi, Maria/M-3378-2014; SANCHEZ-SALCEDO,
   SANDRA/N-4501-2014
OI Portoles, Maria Teresa/0000-0002-9681-0184; Serrano, Maria
   Concepcion/0000-0002-5010-644X; Vallet-Regi, Maria/0000-0002-6104-4889;
   SANCHEZ-SALCEDO, SANDRA/0000-0002-1889-2057
FU Comunidad de Madrid [S-0505/MAT/0324]; Universidad Complutense de Madrid
FX This study was supported by research grant from Comunidad de Madrid
   (S-0505/MAT/0324). M. Alcaide is greatly indebt to the Universidad
   Complutense de Madrid for a fellowship. The authors wish to express
   their thanks to Dr. N. Vilaboa (Research Unit, "La Paz" Hospital,
   Madrid) for supplying the human Saos-2 osteoblasts. The authors wish to
   thank also to Dr. Alberto Alvarez-Barrientos and to Elvira Arza (Flow
   Cytometry Service, CNIC, Carlos III Institute, Spain) for the assistance
   in the flow cytometry studies, and to the Flow Cytometry and Confocal
   Microscopy Staff (CAI, UCM, Spain) for the assistance in the confocal
   microscopy studies.
CR Aguirre J, 2001, AM J PATHOL, V158, P247, DOI 10.1016/S0002-9440(10)63963-6
   Alcaide M, 2009, J BIOMED MATER RES A, V89A, P539, DOI 10.1002/jbm.a.31985
   Cabanas MV, 2006, J BIOMED MATER RES A, V78A, P508, DOI 10.1002/jbm.a.30724
   COLLINOSDOBY P, 1995, J CELL BIOCHEM, V57, P399, DOI 10.1002/jcb.240570305
   Corbett SA, 1999, J BONE JOINT SURG BR, V81B, P531, DOI 10.1302/0301-620X.81B3.8852
   DALCUSI G, 1998, BIOMATERIALS, V19, P1473
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   Darzynkiewicz Z., 2001, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0804S01
   Facompre Michael, 2000, Molecular Cell Biology Research Communications, V4, P37, DOI 10.1006/mcbr.2000.0251
   FADOK VA, 1992, J IMMUNOL, V148, P22
   Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974
   Hortelano S, 2003, J IMMUNOL, V171, P6059, DOI 10.4049/jimmunol.171.11.6059
   Kanduc D, 2002, INT J ONCOL, V21, P165
   KENNETH J, 2001, ARTHRITIS RHEUM, V44, P2790
   KOOPMAN G, 1994, BLOOD, V84, P1415
   Koshkaryev A, 2003, AM J PHYSIOL-CELL PH, V285, pC720, DOI 10.1152/ajpcell.00542.2002
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2
   Nishimura D, 2006, INT J ONCOL, V29, P713
   Roman J, 2008, J BIOMED MATER RES A, V84A, P99, DOI 10.1002/jbm.a.31394
   Sanchez-Salcedo S, 2008, CHEM ENG J, V137, P62, DOI 10.1016/j.cej.2007.09.01
   SANCHEZSALCEDO S, 2006, TISSUE ENG, P279
   van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R
   van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x
   Wang XL, 2006, MATER LETT, V60, P455, DOI 10.1016/j.matlet.2005.09.010
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 28
TC 41
Z9 43
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2009
VL 30
IS 1
BP 45
EP 51
DI 10.1016/j.biomaterials.2008.09.012
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 375UN
UT WOS:000261139100006
PM 18838165
DA 2018-10-19
ER

PT J
AU Zhang, PB
   Hong, ZK
   Yu, T
   Chen, XS
   Jing, XB
AF Zhang, Peibiao
   Hong, Zhongkui
   Yu, Ting
   Chen, Xuesi
   Jing, Xiabin
TI In vivo mineralization and osteogenesis of nanocomposite scaffold of
   poly (lactide-co-glycolide) and hydroxyapatite surface-grafted with
   poly(L-lactide)
SO BIOMATERIALS
LA English
DT Article
DE Poly(lactide-co-glycolide); Hydroxyapatite; Nanocomposite;
   Mineralization; Osteogenesis; Bone repair
ID BONE-TISSUE; COMPOSITE SCAFFOLDS; BIOMATERIAL; BEHAVIOR
AB Nanocomposite of hydroxyapatite (HAP) surface-grafted with poly(L-lactide) (PLLA) (g-HAP) shows a wide application for bone fixation materials due to its improved interface compatibility, mechanical property and biocompatibility in our previous study. In this paper, a 3-D porous scaffold of g-HAP/poly (lactide-co-glycolide) (PLGA) was fabricated using the solvent casting/particulate leaching method to investigate its applications in bone replacement and tissue engineering. The composite of un-grafted HAP/PLGA and neat PLGA were used as controls. Their in vivo mineralization and osteogenesis were investigated by intramuscular implantation and replacement for repairing radius defects of rabbits. After surface modification, more uniform distribution of g-HAP particles but a lower calcium exposure on the surface of g-HAP/PLGA was observed. Intramuscular implantation study showed that the scaffold of g-HAP/PLGA was more stable than that of PLGA, and exhibited similar mineralization and biodegradability to HAP/PLGA at the 12-20 weeks post-surgery. The implantation study for repairing critical radius defects showed that the scaffold of g-HAP/PLGA exhibited rapid and strong mineralization and osteo-conductivity, and the incorporation of BMP-2 could enhance the osteogenic process of the composite implant. The new bone formation with the intact structure of a long bone was guided by the implant of g-HAP/PLGA. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhang, Peibiao; Hong, Zhongkui; Chen, Xuesi; Jing, Xiabin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   [Yu, Ting] Jilin Univ, Sch Publ Hlth, Changchun 130021, Peoples R China.
RP Chen, XS (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, 5625 Renmin St, Changchun 130022, Peoples R China.
EM xschen@ciac.jl.cn
FU National Natural Science Foundation of China [50673090]; National Fund
   for Distinguished Young Scholar [50425309]; Ministry of Science and
   Technology of China [2007AA03Z320, 20071314]
FX This project is financially supported by the National Natural Science
   Foundation of China (no. 50673090), National Fund for Distinguished
   Young Scholar (no. 50425309) and the "863" Project (2007AA03Z320) from
   the Ministry of Science and Technology of China, as well as Major
   Project of International cooperation from the Ministry of Science and
   Technology of China (20071314).
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Cleries L, 2000, BIOMATERIALS, V21, P1861, DOI 10.1016/S0142-9612(00)00060-0
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   HOLLINGER JO, 1983, J BIOMED MATER RES, V17, P71, DOI 10.1002/jbm.820170107
   Hong ZK, 2007, J BIOMED MATER RES A, V81A, P515, DOI 10.1002/jbm.a.31038
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   Jing X. B., 2004, POLYMER, V45, P6705
   Jung Y, 2005, BIOMATERIALS, V26, P6314, DOI 10.1016/j.biomaterials.2005.04.007
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Laurencin C. T., 1999, CURR OPIN ORTHOP, V10, P445, DOI DOI 10.1097/00001433-199912000-00005
   NELSON JF, 1977, ORAL SURG ORAL MED O, V43, P836, DOI 10.1016/0030-4220(77)90075-5
   Odgren P.R., 2002, PRINCIPLES BONE BIOL, P3
   Pezzatini S, 2006, J BIOMED MATER RES A, V76A, P656, DOI 10.1002/jbm.a.30524
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Stayton PS, 2003, CRIT REV ORAL BIOL M, V14, P370, DOI 10.1177/154411130301400507
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   WEI J, 2004, EUR POLYM J, V40, P509, DOI DOI 10.1016/J.EURP0LYMJ.2003.10.028
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   ZIMMERMANN B, 1991, CELL TISSUE RES, V263, P483, DOI 10.1007/BF00327281
NR 28
TC 161
Z9 172
U1 8
U2 127
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2009
VL 30
IS 1
BP 58
EP 70
DI 10.1016/j.biomaterials.2008.08.041
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 375UN
UT WOS:000261139100008
PM 18838160
DA 2018-10-19
ER

PT J
AU Smith, MJ
   White, KL
   Smith, DC
   Bowlin, GL
AF Smith, Matthew J.
   White, Kimber L., Jr.
   Smith, Donna C.
   Bowlin, Gary L.
TI In vitro evaluations of innate and acquired immune responses to
   electrospun polydioxanone-elastin blends
SO BIOMATERIALS
LA English
DT Article
DE Immune response; Immunomodulation; Polydioxanone; Elastin;
   Electrospinning
ID BIORESORBABLE VASCULAR GRAFTS; FEMALE B6C3F1 MICE; MACROPHAGE FUNCTION;
   CROSS-LINKING; BIOCOMPATIBILITY; CELLS; ACTIVATION; FIBROBLASTS;
   GENERATION; LIPOPOLYSACCHARIDE
AB Immune response testing of biomaterials is an essential component of biocompatibility assessment, particularly when the materials of interest are used to design bioresorbable scaffolds with the potential to promote in situ regeneration. Current trends in immune response testing of biomaterials typically examine few elements of the immune system, and they often undertake a mechanistic approach without first determining if material exposure results in physiologically relevant modulation of both innate and acquired immunity. Here, we present a comprehensive in vitro evaluation of biomaterial-induced modulation of acquired (i.e. cell-mediated and humoral) and innate immune responses following exposure to electrospun blends of polydioxanone (PDC) and elastin (ELAS). Results indicated that in vitro exposure of murine spleen cells to PDO-ELAS blends produced statistically significant immunosuppression in multiple cell-mediated and humoral endpoints. Results suggested that ELAS is the primary cause of cell-mediated immunosuppression. In contrast, PDO and FLAS were equally suppressive of humoral immune responses, while blends of the two were more immunosuppressive than either pure polymer alone. Evaluations of innate immune responses demonstrated few significant effects, with statistically significant immunosuppression observed in natural killer cell activity but not in macrophage functional assays. This work presents an approach for assessing potential modulation of immune responses resulting from exposure to biomaterials, and such evaluations are essential to obtaining comprehensive assessments of biocompatibility. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Smith, Matthew J.; Bowlin, Gary L.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.
   [White, Kimber L., Jr.; Smith, Donna C.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Strauss Res Labs, Richmond, VA 23298 USA.
   [Smith, Donna C.] Altria Client Serv, Richmond, VA 23231 USA.
RP Bowlin, GL (reprint author), Virginia Commonwealth Univ, Dept Biomed Engn, 401 W Main St,POB 843067, Richmond, VA 23284 USA.
EM glbowlin@vcu.edu
RI Bowlin, Gary/E-8617-2010
FU NIEHS NIH HHS [ES 05454]
CR ALAM R, 2003, J ALLERGY CLIN IMM S, V111, pS473
   Andrade MGS, 2006, J MATER SCI-MATER M, V17, P949, DOI 10.1007/s10856-006-0185-8
   Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   BARROWS TH, 1991, HIGH PERFORMANCE BIO, P243
   BLUESTONE JA, 1987, NATURE, V326, P82, DOI 10.1038/326082a0
   Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003
   Boland ED, 2004, J BIOMED MATER RES B, V71B, P144, DOI 10.1002/jbm.b.30105
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Debret R, 2005, ARTERIOSCL THROM VAS, V25, P1353, DOI 10.1161/01.ATV.000168412.50855.9f
   Debret R, 2006, J INVEST DERMATOL, V126, P1860, DOI 10.1038/sj.jid.5700337
   DEFRANCO AL, 1982, IMMUNOL REV, V64, P161, DOI 10.1111/j.1600-065X.1982.tb00423.x
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   GREISLER HP, 1991, SURGERY, V110, P645
   Guo TL, 2000, DRUG CHEM TOXICOL, V23, P433, DOI 10.1081/DCT-100100127
   Guo TL, 2001, J NUTR, V131, P3251
   HOLSAPPLE MP, 1984, J PHARMACOL EXP THER, V229, P493
   Huhtala A, 2007, J BIOMED MATER RES A, V83A, P407, DOI 10.1002/jbm.a.31319
   Jerne NK, 1963, CELL BOUND ANTIBODIE, P109
   KEARNEY JF, 1975, J IMMUNOL, V115, P671
   KOOB TJ, 2004, ENCY BIOMATERIALS BI, P335
   LUSTER MI, 1992, FUND APPL TOXICOL, V18, P200, DOI 10.1016/0272-0590(92)90047-L
   McClure LV, 2008, CELL HOST MICROBE, V3, P1, DOI 10.1016/j.chom.2007.12.002
   Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MISHELL RI, 1966, SCIENCE, V153, P1004, DOI 10.1126/science.153.3739.1004
   Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23
   PAUL WE, 2003, FUNDAMENTAL IMMUNOLO, P1
   Pitcher LA, 2005, EUR J IMMUNOL, V35, P3643, DOI 10.1002/eji.200535136
   PREMACK BA, 1992, AM J PHYSIOL, V263, pC1119
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   REYNOLDS CW, 1981, J IMMUNOL, V126, P1581
   Ridnour LA, 2000, ANAL BIOCHEM, V281, P223, DOI 10.1006/abio.2000.4583
   Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Sell SA, 2006, BIOMED MATER, V1, P72, DOI 10.1088/1748-6041/1/2/004
   SENIOR RM, 1982, J CLIN INVEST, V70, P614, DOI 10.1172/JCI110654
   SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870
   Smith MJ, 2007, J ENG FIBER FABR, V2, P41
   Smith MJ, 2008, ACTA BIOMATER, V4, P58, DOI 10.1016/j.actbio.2007.08.001
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   STAVE JW, 1983, DEV COMP IMMUNOL, V7, P269, DOI 10.1016/0145-305X(83)90008-3
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   Ustyugova IV, 2007, TOXICOL SCI, V97, P364, DOI 10.1093/toxsci/kfm048
   Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647
   WEISS A, 1987, J IMMUNOL, V138, P2169
   WHITE KL, 1986, TOXICOL APPL PHARM, V82, P493, DOI 10.1016/0041-008X(86)90284-X
   WRENN DS, 1986, BIOCHEMISTRY-US, V25, P5172, DOI 10.1021/bi00366a028
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
NR 52
TC 33
Z9 36
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2009
VL 30
IS 2
BP 149
EP 159
DI 10.1016/j.biomaterials.2008.09.019
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377SY
UT WOS:000261272100003
PM 18851880
DA 2018-10-19
ER

PT J
AU Schutte, RJ
   Xie, LL
   Klitzman, B
   Reichert, WM
AF Schutte, Robert J.
   Xie, Lola
   Klitzman, Bruce
   Reichert, William M.
TI In vivo cytokine-associated responses to biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Foreign body response; Cytokine; Cage implant; Inflammation; Wound
   healing; Biomaterial
ID CAGE IMPLANT SYSTEM; FOREIGN-BODY REACTION; INVIVO BIOCOMPATIBILITY;
   MODIFIED POLYURETHANES; BIOSTABILITY; POLYETHYLENE; CHEMISTRY; DELIVERY;
   RECEPTOR; OXIDE)
AB Cytokines, chemokines, and growth factors were analyzed periodically over eight weeks from the wound exudate fluid surrounding biomaterials implanted subcutaneously within stainless steel mesh cages. TNF-alpha, MCP-1, MIP-1 alpha, IL-2, IL-6, IL-15, VEGF, IL-4, and IL-10 were measured from exudate samples collected from cages containing specimens of polyethylene (PE), polyurethane (PU), or organotin polyvinyl chloride (ot-PVC). Empty cages served as negative controls, and lipopolysaccharide (LPS) served as a positive control. Cytokine, chemokine, and growth factor concentrations decreased from the time of implantation to eight weeks post-implantation, and there was an overall increase in cytokine, chemokine, and growth factor production for material-containing cages compared to empty cages. However, cytokine production was only modestly affected by the different Surface chemistries of the three implanted polymeric materials. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Schutte, Robert J.; Xie, Lola; Klitzman, Bruce; Reichert, William M.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Klitzman, Bruce] Duke Univ, Kenan Plast Surg Labs, Durham, NC 27708 USA.
RP Reichert, WM (reprint author), Duke Univ, Dept Biomed Engn, 136 Hudson Hall,Box 90281, Durham, NC 27708 USA.
EM reichert@duke.edu
FU National Institutes of Health (NIH) [DK54932]; National Science
   Foundation Graduate Research Fellowship
FX The authors would like to thank Dr. George Truskey and Ms. Anita Sawyer
   for helpful discussion. This work was funded by the National Institutes
   of Health (NIH DK54932) and a National Science Foundation Graduate
   Research Fellowship (RJS).
CR ALAVIMOGHADAM F, 1975, EUR POLYM J, V11, P649, DOI 10.1016/0014-3057(75)90057-9
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   [Anonymous], 1999, 109935 ISO
   BANCHEREAU J, 1994, STEM CELLS, V12, P278, DOI 10.1002/stem.5530120304
   Beamson G, 1996, POLYM DEGRAD STABIL, V54, P85, DOI 10.1016/0141-3910(96)00103-6
   BERGSMA JE, 1995, J BIOMED MATER RES, V29, P173, DOI 10.1002/jbm.820290206
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Christenson EM, 2005, J BIOMED MATER RES A, V74A, P141, DOI 10.1002/jbm.a.30317
   Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91
   JAIN RK, 1990, CANCER METAST REV, V9, P253, DOI 10.1007/BF00046364
   Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev
   Kim DH, 2007, BIOMATERIALS, V28, P3369, DOI 10.1016/j.biomaterials.2007.04.010
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Neufeld G, 1999, FASEB J, V13, P9
   Park JH, 2003, J BIOMED MATER RES A, V64A, P309
   PETILLO O, 1994, J BIOMED MATER RES, V28, P635, DOI 10.1002/jbm.820280514
   Prichard HL, 2007, BIOMATERIALS, V28, P936, DOI 10.1016/j.biomaterials.2006.09.012
   PRICHARD HL, STEM CELLS IN PRESS
   Sanders JE, 2002, J BIOMED MATER RES, V60, P36, DOI 10.1002/jbm.1279
   SCHUTTE RJ, J BIOMEDICA IN PRESS
   Simmons A, 2004, BIOMATERIALS, V25, P4887, DOI 10.1016/j.biomaterials.2004.01.004
   SMITH KA, 1992, CURR OPIN IMMUNOL, V4, P271, DOI 10.1016/0952-7915(92)90076-Q
   SMITH MD, 1995, J BIOMAT SCI-POLYM E, V7, P453
   Stenken JA, 2002, ANAL CHEM, V74, P4849, DOI 10.1021/ac020234w
   Suska F, 2005, BIOMATERIALS, V26, P519, DOI 10.1016/j.biomaterials.2004.02.066
   *UCSD NAT, 2002, SIGN GAT
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
NR 36
TC 72
Z9 74
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2009
VL 30
IS 2
BP 160
EP 168
DI 10.1016/j.biomaterials.2008.09.026
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377SY
UT WOS:000261272100004
PM 18849070
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bryan, N
   Rhodes, NP
   Hunt, JA
AF Bryan, Nicholas
   Rhodes, Nicholas P.
   Hunt, John A.
TI Derivation and performance of an entirely autologous injectable hydrogel
   delivery system for cell-based therapies
SO BIOMATERIALS
LA English
DT Article
DE stem cells; Injectable gel; Hydrogel; Fibrin; Animal model
ID MESENCHYMAL STEM-CELLS; T-CELLS; TISSUE; DIFFERENTIATION; PROLIFERATION;
   HYPOXIA; CHONDROCYTES; ENHANCEMENT; SURFACES; ACID
AB A host-derived hydrogel has been designed and validated as an entirely autologous, injectable delivery system for cells with potential for cell-based therapies and tissue engineering applications. Each individual has components in their blood from which can be formed a mechanically stable hydrogel having the capacity to maintain cellular phenotype and support cellular proliferation of multiple cell types through several Culture passages ex vivo. The hydrogel can be triggered to gel at the time of implantation into the patient through an injection system that facilitates a liquid injection of components of the donor plasma and cells into the site of interest. This results in stable ectopic tissue formation at the site of implantation. Our Studies have demonstrated excellent integration of the neotissue with host tissues with maintenance of the phenotype of implanted cells whilst observing minimal host innate immune cell recruitment. These findings could provide the fundamental basis for new hydrogel-based biomaterial therapies, overcoming the histocompatibility factors associated with implantable biomaterials whilst providing a stable three dimensional medium for cellular growth both in vivo and ex vivo. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Bryan, Nicholas; Rhodes, Nicholas P.; Hunt, John A.] Univ Liverpool, Sch Clin Sci, UKCTE, Div Clin Engn, Liverpool L69 3GA, Merseyside, England.
RP Hunt, JA (reprint author), Univ Liverpool, Sch Clin Sci, UKCTE, Div Clin Engn, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.
EM huntja@liverpool.ac.uk
RI Hunt, John/G-6366-2012
OI Hunt, John/0000-0002-5168-4778
FU STEPS; EU; FP6-500465
FX These studies were gratefully supported by STEPS, a systems approach to
   tissue engineering processes and practices: EU grant number FP6-500465.
CR Al-Daccak R, 2004, CURR OPIN IMMUNOL, V16, P108, DOI 10.1016/j.coi.2003.11.006
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   CAZEAU C, 1999, EUR J ORTHOP SURG TR, V9, P171
   DEMOSS M, 2007, BMC MUSCULOSKELETAL, V8
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054
   Ho MH, 2007, MACROMOL BIOSCI, V7, P467, DOI 10.1002/mabi.200600241
   Hynd MR, 2007, J NEUROSCI METH, V162, P255, DOI 10.1016/j.jneumeth.2007.01.024
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Komata T, 2003, IMMUNOL CELL BIOL, V81, P283, DOI 10.1046/j.0818-9641.2003.01160.x
   Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081
   Li X, 2007, MED HYPOTHESES, V69, P629, DOI 10.1016/j.mehy.2006.12.050
   Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200
   Nakayama K, 2007, ARTIF ORGANS, V31, P500, DOI 10.1111/j.1525-1594.2007.00418.x
   Pfander D, 2007, CURR OPIN RHEUMATOL, V19, P457, DOI 10.1097/BOR.0b013e3282ba5693
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Porter K, 2006, MOL BIOL REP, V33, P1, DOI 10.1007/s11033-005-4535-2
   Ring S, 2006, EUR J IMMUNOL, V36, P2981, DOI 10.1002/eji.200636207
   Rotunda AM, 2006, DERMATOL THER, V19, P151, DOI 10.1111/j.1529-8019.2006.00069.x
   Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284
   Takahashi T, 2007, TISSUE ENG, V13, P1583, DOI 10.1089/ten.2006.0322
   Tu QS, 2007, WOUND REPAIR REGEN, V15, P404, DOI 10.1111/j.1524-475X.2007.00243.x
   van Osch GJVM, 2001, BIOCHEM BIOPH RES CO, V280, P806, DOI 10.1006/bbrc.2000.4168
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang XY, 2006, MATER TODAY, V9, P44, DOI 10.1016/S1369-7021(06)71742-4
   WOO MK, 2007, BIOMATERIALS, V28, P343
   XU XD, 2006, J BIOMEDICAL MAT RES, V81, P418
   Zhu W, 2006, J APPL POLYM SCI, V99, P2375, DOI 10.1002/app.22674
NR 29
TC 20
Z9 20
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2009
VL 30
IS 2
BP 180
EP 188
DI 10.1016/j.biomaterials.2008.09.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377SY
UT WOS:000261272100006
PM 18849072
DA 2018-10-19
ER

PT J
AU Tsur-Gang, O
   Ruvinov, E
   Landa, N
   Holbova, R
   Feinberg, MS
   Leor, J
   Cohen, S
AF Tsur-Gang, Orna
   Ruvinov, Emil
   Landa, Natalie
   Holbova, Radka
   Feinberg, Micha S.
   Leor, Jonathan
   Cohen, Smadar
TI The effects of peptide-based modification of alginate on left
   ventricular remodeling and function after myocardial infarction
SO BIOMATERIALS
LA English
DT Article
DE Alginate modification; Cell adhesion peptides; Myocardial infaction;
   Tissue regeneration; BioLineRx BL-1040 myocardial implant
ID MYOBLAST PHENOTYPE; MATRIX; BIOMATERIALS; INJECTION; MODEL; RAT
AB Adverse cardiac remodeling and dysfunction after myocardial infarction (MI) is associated with excessive damage to the extracellular matrix. Biomaterials, such as the in situ-forming alginate hydrogel (BioLineRx, BL-1040 myocardial implant), provide temporary support and attenuate these processes. Here, we tested the effects of decorating alginate biomaterial with cell adhesion peptides, containing the sequences RGD and YIGSR, or a non-specific peptide (RGE), in terms of therapeutic Outcome soon after MI. The biomaterial (i.e., both unmodified and peptide-modified alginate) solutions retained the ability to flow after cross-linking with calcium ions, and could be injected into 7-day infarcts, where they underwent phase transition into hydrogels. Serial echocardiography studies performed before and 60 days after treatment showed that alginate modification with the peptides reduced the therapeutical effects of the hydrogel, as revealed by the extent of scar thickness, left ventricle dilatation and function. Histology and immunohistochemistry revealed no significant differences in blood vessel density, scar thickness, myofibroblast or macrophage infiltration or cell proliferation between the experimental groups BioLineRx BL-1040 myocardial implant. Our studies thus reveal that the chemical and physical traits of the bioniaterial can affect its therapeutical efficacy in attenuating left ventricle remodeling and function, post-MI. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Tsur-Gang, Orna; Ruvinov, Emil; Cohen, Smadar] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   [Landa, Natalie; Holbova, Radka; Feinberg, Micha S.; Leor, Jonathan] Tel Aviv Univ, Sheba Med Ctr, Neufeld Cardiac Res Inst, Tel Hashomer, Israel.
RP Cohen, S (reprint author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
EM scohen@bgu.ac.il
RI COHEN, SMADAR/F-1901-2012; Leor, Jonathan/O-2930-2017
FU Israel Science Foundation [793/04]
FX We thank Ms. Pat Benjamin for her excellent assistance with
   echocardiography. This research was supported by a grant from the Israel
   Science Foundation (793/04). Smadar Cohen holds the Claire & Harold
   Oshry Professor Chair in Biotechnology.
CR Audebrand M, 2006, BIOMACROMOLECULES, V7, P2811, DOI 10.1021/bm060297e
   Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356
   Brower GL, 2006, EUR J CARDIO-THORAC, V30, P604, DOI 10.1016/j.ejcts.2006.07.006
   Bu HT, 2004, BIOMACROMOLECULES, V5, P1470, DOI 10.1021/bm049947+
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Etzion S, 2001, J MOL CELL CARDIOL, V33, P1321, DOI 10.1006/jmcc.2001.1391
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2000, CIRCULATION, V102, P56
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
NR 18
TC 91
Z9 98
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2009
VL 30
IS 2
BP 189
EP 195
DI 10.1016/j.biomaterials.2008.09.018
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377SY
UT WOS:000261272100007
PM 18849071
DA 2018-10-19
ER

PT J
AU Meyers, SR
   Khoo, XJ
   Huang, X
   Walsh, EB
   Grinstaff, MW
   Kenan, DJ
AF Meyers, Steven R.
   Khoo, Xiaojuan
   Huang, Xin
   Walsh, Elisabeth B.
   Grinstaff, Mark W.
   Kenan, Daniel J.
TI The development of peptide-based interfacial biomaterials for generating
   biological functionality on the surface of bioinert materials
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Engineered peptides; Peptide coating; Bioactive surface;
   Interfacial biology; Surface modification
ID PHAGE DISPLAY; BACTERIAL BIOFILMS; DRUG-DELIVERY; CELL-ADHESION;
   IN-VIVO; FIBRONECTIN; APOPTOSIS; RGD; INTEGRINS; MATRIX
AB Biomaterials used in implants have traditionally been selected based on their mechanical properties, chemical stability, and biocompatibility. However, the durability and clinical efficacy of implantable biomedical devices remain limited in part due to the absence of appropriate biological interactions at the implant interface and the lack of integration into adjacent tissues. Herein, we describe a robust peptide-based coating technology capable of modifying the surface of existing biomaterials and medical devices through the non-covalent binding of modular biofunctional peptides. These peptides contain at least one material binding sequence and at least one biologically active sequence and thus are termed, "Interfacial Biomaterials" (IFBMs). IFBMs can simultaneously bind the biomaterial surface while endowing it with desired biological functionalities at the interface between the material and biological realms. We demonstrate the capabilities of model IFBMs to convert native polystyrene, a bioinert surface, into a bioactive Surface that can support a range of cell activities. We further distinguish between simple cell attachment with insufficient integrin interactions, which in some cases can adversely impact downstream biology, versus biologically appropriate adhesion, cell spreading, and cell survival mediated by IFBMs. Moreover, we show that we can use the coating technology to create spatially resolved patterns of fluorophores and cells on substrates and that these patterns retain their borders in culture. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Meyers, Steven R.; Khoo, Xiaojuan; Grinstaff, Mark W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Meyers, Steven R.; Khoo, Xiaojuan; Grinstaff, Mark W.] Boston Univ, Dept Chem, Boston, MA 02215 USA.
   [Huang, Xin] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Walsh, Elisabeth B.] Duke Univ, Dept Chem, Durham, NC 27708 USA.
   [Kenan, Daniel J.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.
RP Grinstaff, MW (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
EM mgrin@bu.edu; dan.kenan@duke.edu
RI Grinstaff, Mark/U-2829-2017
OI Grinstaff, Mark/0000-0002-5453-3668; Meyers, Steven/0000-0002-8999-7868
FU National Institutes of Health [CA-77042, CA-81088, EB-000501]; North
   Carolina Biotechnology Center Collaborative
FX M.W.G. and DJX thank the National Institutes of Health for funding
   through grants CA-77042 (DJ.K.), CA-81088 (D.J.K.), and EB-000501
   (M.W.G.). Xin Huang was supported by a North Carolina Biotechnology
   Center Collaborative Funding Grant.
CR ADEY NB, 1995, GENE, V156, P27, DOI 10.1016/0378-1119(95)00058-E
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S095506740200371X
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8
   Burritt JB, 1996, ANAL BIOCHEM, V238, P1, DOI 10.1006/abio.1996.0241
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Dwyer MA, 2000, CHEM BIOL, V7, P263, DOI 10.1016/S1074-5521(00)00102-2
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   GARDNER JM, 1985, CELL, V42, P439, DOI 10.1016/0092-8674(85)90101-1
   Gauvreau V, 2005, BIOCONJUGATE CHEM, V16, P1088, DOI 10.1021/bc049717s
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gifford R, 2006, BIOMATERIALS, V27, P2587, DOI 10.1016/j.biomaterials.2005.11.033
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   HARBERS GM, 2006, INTRO BIOMATERIALS, P15
   Hoess RH, 2001, CHEM REV, V101, P3205, DOI 10.1021/cr000056b
   HOFMANN G O, 1992, Clinical Materials, V10, P75, DOI 10.1016/0267-6605(92)90088-B
   Horbett T. A., 1999, BMES BULL, V13, P5
   HUANG X, PEPTIDE INTERF UNPUB
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   KAY BK, 1996, PHAGE DISPLAY PEPTID
   Kenan DJ, 2006, CHEM BIOL, V13, P695, DOI 10.1016/j.chembiol.2006.06.013
   Kim HS, 2006, BIOCHEM BIOPH RES CO, V344, P1172, DOI 10.1016/j.bbrc.2006.03.180
   Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5
   Kim S, 2002, J CLIN INVEST, V110, P933, DOI 10.1172/JCI200214268
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Meyers SR, 2007, ADV MATER, V19, P2492, DOI 10.1002/adma.200700029
   MIDDLETON C, 2002, T 28 BIOM ANN M, P213
   Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   POLUNOVSKY VA, 1994, EXP CELL RES, V214, P584, DOI 10.1006/excr.1994.1296
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   RATNER BD, 2000, BIOMATERIALS SCI INT
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Sheiban I, 2002, Minerva Cardioangiol, V50, P443
   Sidhu S. S., 2005, PHAGE DISPLAY BIOTEC
   Slottow T. L. P., 2007, AM J CARDIOL, V100, pS10
   Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d
   Staples M, 2006, PHARM RES, V23, P847, DOI 10.1007/s11095-006-9906-4
   Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070
   SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   *U AUT BARC MICR S, CELL PORT SCHEM AD M
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   Van Belle E, 2007, J THROMB HAEMOST, V5, P238, DOI 10.1111/j.1538-7836.2007.02486.x
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
   YAMADA KM, 1987, J CELL PHYSIOL, V130, P21, DOI 10.1002/jcp.1041300105
   Yamada KM, 1997, MATRIX BIOL, V16, P137, DOI 10.1016/S0945-053X(97)90001-9
   Zhao HB, 2005, MOL ENDOCRINOL, V19, P771, DOI 10.1210/me.2004-0161
NR 71
TC 47
Z9 49
U1 2
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2009
VL 30
IS 3
BP 277
EP 286
DI 10.1016/j.biomaterials.2008.08.042
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 381XK
UT WOS:000261569000001
PM 18929406
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wolchok, JC
   Brokopp, C
   Underwood, CJ
   Tresco, PA
AF Wolchok, Jeffrey C.
   Brokopp, Chad
   Underwood, Clayton J.
   Tresco, Patrick A.
TI The effect of bioreactor induced vibrational stimulation on
   extracellular matrix production from human derived fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE Bioreactor; Vibration; Polyurethane; Collagen; Vocal fold
ID COLLAGEN SPONGE CONSTRUCTS; PATELLAR TENDON REPAIR; FOCAL ADHESION
   KINASE; FLUID SHEAR-STRESS; HUMAN VOCAL FOLD; GROWTH-FACTOR;
   ENDOTHELIAL-CELLS; GENE-EXPRESSION; MECHANICAL STIMULATION; CULTURED
   CHONDROCYTES
AB To study the affect of mechanical stimuli on human laryngeal fibroblasts, we developed bioreactors capable of vibrating cell seeded substrates at frequencies and displacements comparable to measured phonation values in human subjects. In addition, we developed a means of harvesting the secreted matrix as a bulk biomaterial by removing the polymer foam using an organic solvent. Using the system human derived laryngeal fibroblasts were Subjected to vibrational stimuli (100 Hz) for 1-21 days. Following mechanical conditioning, extracellular matrix and matrix related gene expression, cytokine production, matrix protein accumulation, and construct material properties were assessed with DNA microarray, enzyme linked immunosorbent, indirect immunofluorescent, and uni-axial tensile assays respectively. The results show that vocal fold-like vibrational stimuli is sufficient to influence the expression of several key matrix and matrix related genes, enhance the secretion of the profibrotic cytokine TGF beta 1, increase the accumulation of the extracellular matrix proteins, fibronectin and collagen type 1, as well as enhance construct stiffness compared to non-stimulated controls. Our results demonstrate that high frequency substrate vibration, like cyclic strain, can accelerate matrix deposition from human derived laryngeal fibroblasts. The study supports the notion that preconditioning regimens using human cells may be useful for producing cell derived biomaterials for therapeutic application. (C) 2008 Published by Elsevier Ltd.
C1 [Wolchok, Jeffrey C.; Brokopp, Chad; Underwood, Clayton J.; Tresco, Patrick A.] Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, 20S 2030 E Biomed Polymers Res Bldg,Room 108, Salt Lake City, UT 84112 USA.
EM patrick.tresco@m.cc.utah.edu
CR Androjna C, 2007, TISSUE ENG, V13, P233, DOI 10.1089/ten.2006.0050
   Baijens L, 2007, EUR ARCH OTO-RHINO-L, V264, P565, DOI 10.1007/s00405-006-0224-6
   BLATTI SP, 1988, P NATL ACAD SCI USA, V85, P1119, DOI 10.1073/pnas.85.4.1119
   Breen EC, 2000, J APPL PHYSIOL, V88, P203
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   de Melo ECM, 2003, LARYNGOSCOPE, V113, P2187
   Dieterich P, 2000, BIOPHYS J, V79, P1285, DOI 10.1016/S0006-3495(00)76382-X
   Doellinger M, 2006, J VOICE, V20, P401, DOI 10.1016/j.jvoice.2005.08.003
   ESKIN SG, 1984, MICROVASC RES, V28, P87, DOI 10.1016/0026-2862(84)90031-1
   FITCH JL, 1970, ARCHIV OTOLARYNGOL, V92, P379
   GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779
   Gloe T, 2002, J BIOL CHEM, V277, P23453, DOI 10.1074/jbc.M203889200
   Gokorsch S, 2004, INT J ARTIF ORGANS, V27, P962
   Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115
   Gutierrez JA, 1999, AM J PHYSIOL-GASTR L, V277, pG1074, DOI 10.1152/ajpgi.1999.277.5.G1074
   HIRANO M, 1995, ACTA OTO-LARYNGOL, V115, P553, DOI 10.3109/00016489509139366
   Hirschi SD, 2002, J VOICE, V16, P310, DOI 10.1016/S0892-1997(02)00102-9
   Honda K, 2000, EUR J CELL BIOL, V79, P601, DOI 10.1078/0171-9335-00089
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036
   JIANG JJ, 1993, LARYNGOSCOPE, V103, P872, DOI 10.1288/00005537-199308000-00008
   Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P2291, DOI 10.1089/ten.2006.12.2291
   Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5
   Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200
   Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099
   Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455
   Liu J, 2001, RES EXP MED, V200, P183
   Magid R, 2003, J BIOL CHEM, V278, P32994, DOI 10.1074/jbc.M304799200
   Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   MASUDA T, 1993, ACTA OTO-LARYNGOL, V113, P547, DOI 10.3109/00016489309135861
   PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403
   QUAGLINO D, 1991, J INVEST DERMATOL, V97, P34
   Riser BL, 1998, J AM SOC NEPHROL, V9, P827
   Sato J. D., 2001, CURR PROTOC CELL BIO
   Schuster M, 2005, EUR ARCH OTO-RHINO-L, V262, P477, DOI 10.1007/s00405-004-0862-5
   Screen HRC, 2005, BIOCHEM BIOPH RES CO, V336, P424, DOI 10.1016/j.bbro.2005.08.102
   Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18
   Takeuchi R, 2006, ARTHRITIS RHEUM, V54, P1897, DOI 10.1002/art.21895
   Titze IR, 2004, J BIOMECH, V37, P1521, DOI 10.1016/j.jbiomech.2004.01.007
   Urbich C, 2000, CIRC RES, V87, P683, DOI 10.1161/01.RES.87.8.683
   Wang JF, 2003, WOUND REPAIR REGEN, V11, P220, DOI 10.1046/j.1524-475X.2003.11311.x
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026
NR 45
TC 36
Z9 37
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2009
VL 30
IS 3
BP 327
EP 335
DI 10.1016/j.biomaterials.2008.08.035
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 381XK
UT WOS:000261569000006
PM 18937972
DA 2018-10-19
ER

PT J
AU Bhakta, G
   Lee, KH
   Magalhaes, R
   Wen, F
   Gouk, SS
   Hutmacher, DW
   Kuleshova, LL
AF Bhakta, Gajadhar
   Lee, Kong Heng
   Magalhaes, Raquel
   Wen, Feng
   Gouk, Sok Siam
   Hutmacher, Dietmar W.
   Kuleshova, Lilia L.
TI Cryoreservation of alginate-fibrin beads involving bone marrow derived
   mesenchymal stromal cells by vitrification
SO BIOMATERIALS
LA English
DT Article
DE Biocompatibility; Bone regeneration; Cell proliferation; Cell viability;
   Cryopreservation; Vitrification
ID SLOW-COOLING PROTOCOLS; EMBRYONIC STEM-CELLS; ENCAPSULATED HEPATOCYTES;
   ETHYLENE-GLYCOL; IN-VITRO; CRYOPRESERVATION; DIFFERENTIATION; VIABILITY;
   SCAFFOLD; TRANSPLANTATION
AB Application of cell-biomaterial systems in regenerative medicine can be facilitated by their successful low temperature preservation. Vitrification, which avoids ice crystal formation by amorphous solidification, is an emerging approach to cryopreservation. Developing vitrification strategy, effective cryopreservation of alginate-fibrin beads with porcine mesenchymal stromal cells has been achieved in this study. The cell-biomaterial constructs were pre-cultured for 20 days before cryopreservation, allowing for cell proliferation and construct stabilization. Ethylene glycol (EG) was employed as the basic cryoprotectant for two equilibration solutions. Successful cryopreservation of the constructs was achieved using vitrification solution composed of penetrating (EG MW 62 Da) and non-penetrating (sucrose MW 342 Da) cryoprotectants. Stepwise procedure of introduction to and removal of cryoprotectants was brief; direct plunging into liquid nitrogen was applied. Cell viability, evaluated by combining live/death staining and confocal laser microscopy, was similar for both control and vitrified cells in the beads. No detectable damage of microstructure of cryopreserved beads was found as shown by scanning electron microscopy. Both osteogenically induced control and vitrified cells in the constructs were equally capable of mineral production and deposition. There was no statistically significant difference in metabolic activity and proliferation between both groups during the entire culture period. Our study leads to the conclusion that the developed cryopreservation protocol allowed to maintain the integrity of the beads while preserving the ability of the pig bone marrow derived mesenchymal stromal cells to proliferate and subsequently differentiate; demonstrating that vitrification is a promising approach for cryopreservation of "ready-to-use" cell-biomaterial constructs. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Bhakta, Gajadhar; Lee, Kong Heng; Magalhaes, Raquel; Wen, Feng; Gouk, Sok Siam; Kuleshova, Lilia L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Med Inst, Low Temp Preservat Unit, Singapore 117597, Singapore.
   [Hutmacher, Dietmar W.] Natl Univ Singapore, Fac Engn, Div Bioengn, Singapore 119260, Singapore.
RP Kuleshova, LL (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Med Inst, Low Temp Preservat Unit, Block MD11 03-01C,10 Med Dr, Singapore 117597, Singapore.
EM dietmar.hutmacher@qut.edu.au; nmikl@nus.edu.sg
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134
FU BMRC of Singapore [R-364-000-043-305]
FX This work is supported by the BMRC of Singapore, Grant No.:
   R-364-000-043-305. We are grateful to Mr. Ho Saey Tuan, Mr. Andrew
   Krishna Ekaputra and Ms. Divya Mainali for their advice and technical
   assistance.
CR Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8
   Han B, 2004, CRYOBIOLOGY, V48, P8, DOI 10.1016/j.cryobiol.2003.11.002
   Heng BC, 2004, J MICROENCAPSUL, V21, P455, DOI 10.1080/02652040410001729250
   Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9
   Hutmacher DW, 2003, BIOMATERIALS, V24, P4445, DOI 10.1016/S0142-9612(03)00350-8
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Ishiguro K, 2004, EUR J BIOCHEM, V271, P2379, DOI 10.1111/j.1432-1033.2004.04157.x
   Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x
   Katkov II, 2006, INT J REFRIG, V29, P346, DOI 10.1016/j.ijrefrig.2005.11.004
   Kimelman N, 2007, TISSUE ENG, V13, P1135, DOI 10.1089/ten.2007.0096
   Kotobuki N, 2005, TISSUE ENG, V11, P663, DOI 10.1089/ten.2005.11.663
   Kuleshova L, 1999, HUM REPROD, V14, P3077, DOI 10.1093/humrep/14.12.3077
   Kuleshova LL, 2007, BIOMATERIALS, V28, P1585, DOI 10.1016/j.biomaterials.2006.11.047
   Kuleshova LL, 2004, CRYOLETTERS, V25, P241
   Kuleshova LL, 1999, CRYOBIOLOGY, V38, P119, DOI 10.1006/cryo.1999.2153
   KULESHOVA LL, 2004, CRYOBIOLOGY, V49, P321
   KULESHOVA LL, CELL TRANSP IN PRESS
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Liu BL, 2004, CELL PRESERV TECHNOL, V2, P133
   Magalhaes R, 2008, CELL TRANSPLANT, V17, P813, DOI 10.3727/096368908786516765
   Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   MCGANN LE, 1988, CRYOBIOLOGY, V25, P178, DOI 10.1016/0011-2240(88)90024-7
   Mukherjee N, 2005, CELL TRANSPLANT, V14, P449, DOI 10.3727/000000005783982882
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Perka C, 2001, TISSUE ENG, V7, P359, DOI 10.1089/10763270152044215
   Richards M, 2004, STEM CELLS, V22, P779, DOI 10.1634/stemcells.22-5-779
   ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Shaw JM, 1997, CRYOBIOLOGY, V35, P219, DOI 10.1006/cryo.1997.2043
   Takamatsu H, 2006, CRYOBIOLOGY, V53, P1, DOI 10.1016/j.cryobiol.2006.03.005
   Tan FCK, 2007, CRYOLETTERS, V28, P445
   Terai H, 2002, MAT SCI ENG C-BIO S, V20, P3, DOI 10.1016/S0928-4931(02)00006-1
   Ueyama Y, 2002, BIOMATERIALS, V23, P2027, DOI 10.1016/S0142-9612(01)00332-5
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   Wu YN, 2007, TISSUE ENG, V13, P649, DOI 10.1089/ten.2006.0075
   Xiang Ying, 2007, Journal of Zhejiang University-Science B, V8, P136, DOI 10.1631/jzus.2007.B0136
   Zhou YF, 2007, BIOMATERIALS, V28, P814, DOI 10.1016/j.biomaterials.2006.09.032
   Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1
NR 43
TC 38
Z9 40
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2009
VL 30
IS 3
BP 336
EP 343
DI 10.1016/j.biomaterials.2008.09.030
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 381XK
UT WOS:000261569000007
PM 18930316
DA 2018-10-19
ER

PT S
AU Christophy, C
   Rashid, N
   Di Silvio, L
   Hing, KA
AF Christophy, C.
   Rashid, N.
   Di Silvio, L.
   Hing, K. A.
BE Vincenzini, P
   DeRossi, D
TI Encouraging Nature with Ceramics: The roles of surface roughness and
   physio-chemistry on cell response to substituted apatites
SO BIOMEDICAL APPLICATIONS OF SMART MATERIALS, NANOTECHNOLOGY AND
   MICRO/NANO ENGINEERING
SE Advances in Science and Technology
LA English
DT Proceedings Paper
CT 3rd International Conference on Smart Materials, Structures and Systems
CY JUN 08-13, 2008
CL Acireale, ITALY
DE Physio-chemistry; topography; substituted apatite; cell response;
   protein adsorption
ID CALCIUM-PHOSPHATE CERAMICS; PROTEIN ADSORPTION; CARBONATE APATITE;
   HYDROXYAPATITE; ADHESION; SILICATE; BONE; DIFFERENTIATION;
   OSTEOINDUCTION; PROLIFERATION
AB The success or failure of a bioactive ceramic implant material in the body depends on a complex interaction between a synthetic foreign body and the host. These interactions occur at many levels from the nano-structural level, where subtle changes in surface physio-chemistry substantially alters the nature of the biomaterial-host tissue interface, to the meso- or macro-structural level where dependence on porosity mediates bioactivity through its effect on nutrient transfer and scaffold mechanics. Thus the factors that control the biological response to implant materials are a complex combination of mechanical, physical and chemical attributes which when combined favorably lead to 'bioactivity' in a material, or more correctly a 'bioactive' response to the material. This is illustrated in the successful use of porous bioactive ceramic scaffolds as synthetic bone graft substitute materials, where micro and meso-porosity, bulk and surface chemistry are manipulated to provide a framework that is highly conducive to the process of bone regeneration, balancing bone apposition and remodeling. Moreover, we now have the opportunity to developing an understanding of the complex balance of forces at play during bone grafting through investigation of these biological responses.
C1 [Christophy, C.; Rashid, N.; Hing, K. A.] Queen Mary Univ London, Sch Engn & Mat, IRC Biomed Mat, London E1 4NS, England.
   [Di Silvio, L.] Univ London, Guys Kings St Thomas Dent Inst, Dept Biomat & Biomimet, London SE1 1UL, England.
RP Christophy, C (reprint author), Queen Mary Univ London, Sch Engn & Mat, IRC Biomed Mat, London E1 4NS, England.
EM k.a.hing@qmul.ac.uk
FU Engineering and Physical Sciences Research Counicil; ApaTech Ltd
FX The authors would like to thank Neelam Gurav and Monisha Philips for
   their technical assistance. We also acknowledge the financial support of
   the Engineering and Physical Sciences Research Counicil and ApaTech Ltd.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Balas F, 2003, J BIOMED MATER RES A, V66A, P364, DOI 10.1002/jbm.a.10579
   Barralet J, 2000, J BIOMED MATER RES, V49, P176, DOI 10.1002/(SICI)1097-4636(200002)49:2<176::AID-JBM4>3.3.CO;2-#
   Barralet JE, 2002, J BIOMED MATER RES, V60, P360, DOI 10.1002/jbm.10070
   Bender SA, 2000, BIOMATERIALS, V21, P299, DOI 10.1016/S0142-9612(99)00183-0
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chen X, 2008, BIOMATERIALS, V29, P2423, DOI 10.1016/j.biomaterials.2008.02.002
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060
   Hasegawa M, 2003, J BONE JOINT SURG BR, V85B, P142, DOI 10.1302/0301-620X.85B1.13414
   HING KA, 1999, BIOCERAMICS, V12, P195
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   KATO K, 1979, BIOMATER ARTIF CELL, V7, P291, DOI 10.3109/10731197909117584
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   ONG JL, 1994, J BIOMED MATER RES, V28, P1337, DOI 10.1002/jbm.820281112
   Patel N, 2005, J MATER SCI-MATER M, V16, P429, DOI 10.1007/s10856-005-6983-6
   Rashid N, 2008, International Journal of Nano and Biomaterials, V1, P299, DOI 10.1504/IJNBM.2008.016877
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Suzuki T, 1997, J BIOMED MATER RES, V34, P507, DOI 10.1002/(SICI)1097-4636(19970315)34:4<507::AID-JBM11>3.3.CO;2-P
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 31
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1662-0356
BN 978-3-908158-23-3
J9 ADV SCI TECH
PY 2009
VL 57
BP 22
EP +
PG 3
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA BJG14
UT WOS:000265592100004
DA 2018-10-19
ER

PT S
AU Saito, S
   Oyake, Y
   Asaoka, T
AF Saito, S.
   Oyake, Y.
   Asaoka, T.
BE Vincenzini, P
   DeRossi, D
TI Fabrication of titanium fiber scaffold for biomaterial use
SO BIOMEDICAL APPLICATIONS OF SMART MATERIALS, NANOTECHNOLOGY AND
   MICRO/NANO ENGINEERING
SE Advances in Science and Technology
LA English
DT Proceedings Paper
CT 3rd International Conference on Smart Materials, Structures and Systems
CY JUN 08-13, 2008
CL Acireale, ITALY
DE titanium; biomaterial; hydroxyapatite; scaffold
AB In the event of a significant injury, human bone must be repaired by artificial means. In the present study, we used titanium (Ti) to create a scaffold for cell renewal with an emphasis on strength. Because scaffolds for cell renewal require a microporous structure that enables supply of oxygen and nutrients, sintered Ti fiber was used. However, although titanium has a high fracture toughness, it does not bind to hydroxyapatite (HAp), the main component of bone, and thus requires addition of bioactivity. Following treatment by sodium hydroxide, titanium fibers were heated and immersed in simulated body fluid. Through this process, HAp was formed on the titanium surface to create a bioactive material with both a high strength and biocompatibility. Following approximately two weeks of immersion in simulated body fluid, HAp was formed such that it covered the surroundings of titanium fibers without any gaps. In addition, the fracture condition of HAp was analyzed by conducting mechanical tests, such as tensile strength and compression tests, on the titanium fibers on which HAp was formed. Furthermore, collagen coating was performed on the titanium surface, and the material was immersed in simulated body fluid to investigate and compare HAp formation.
C1 [Saito, S.; Oyake, Y.] Tokyo Denki Univ, Course Intelligent Mech Engn, Grad Sch Sci & Engn, Ishizaka Hatoyama Hiki S 3500394, Japan.
   [Asaoka, T.] Tokyo Denki Univ, Sch Sci & Engn, Dept Intelligent Mech Engn, Saitama 3500394, Japan.
RP Saito, S (reprint author), Tokyo Denki Univ, Course Intelligent Mech Engn, Grad Sch Sci & Engn, Ishizaka Hatoyama Hiki S 3500394, Japan.
EM 07smn09@ms.dendai.ac.jp; asaoka@n.dendai.ac.jp
CR HANAWA T, 2003, METALLIC MAT RECONST, V38, P16
   KANEKO M, 2000, J JAPAN SOC POWDER P, V47, P458
   KOKUBO T, 2003, RECENT PROGR CERAMIC, V38, P1
   KOKUBO T, 2004, TISSUE ENG, V3, P31
NR 4
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1662-0356
BN 978-3-908158-23-3
J9 ADV SCI TECH
PY 2009
VL 57
BP 131
EP +
PG 2
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA BJG14
UT WOS:000265592100021
DA 2018-10-19
ER

PT S
AU Koide, N
   Suzuki, K
   Tsuda, M
   Asaoka, T
AF Koide, N.
   Suzuki, K.
   Tsuda, M.
   Asaoka, T.
BE Vincenzini, P
   DeRossi, D
TI Addition of surface function to zirconia for biomaterial use
SO BIOMEDICAL APPLICATIONS OF SMART MATERIALS, NANOTECHNOLOGY AND
   MICRO/NANO ENGINEERING
SE Advances in Science and Technology
LA English
DT Proceedings Paper
CT 3rd International Conference on Smart Materials, Structures and Systems
CY JUN 08-13, 2008
CL Acireale, ITALY
DE zirconia; surface function; biomaterial; sps
AB Due to the merits of zirconia ceramics such as high strength, toughness, and abrasion resistance, as well as chemical stability in vivo, yttria-stabilized tetragonal zirconia polycrystals (Y-TZP) are currently used in the femoral head of hip prostheses. However, this material has a limited range of use because it is a bioinert material that does not interact with bone tissue and thus does not easily integrate directly with bone. Therefore, addition of a material surface that enables the in vivo formation of a bone-like apatite layer that exhibits bioactivity and facilitates interactions and integration with bone tissue is desired. In addition, by developing a surface structure that enhances mechanical bonding, this material can be expected to be used as an alternative aggregate under load bearing conditions. In the present study, structural design of the material surface, addition of bioactivity using reagents treatment, confirmation of formation of the apatite layer using immersion in simulated body fluid, mechanical assessment, and wettability testing were conducted with the objective of controlling interactions between zirconia ceramics and the body.
C1 [Koide, N.; Suzuki, K.; Tsuda, M.] Tokyo Denki Univ, Grad Sch Sci & Engn, Course Intelligent Mech Engn, Ishizaka Hatoyama Hiki S 3500394, Japan.
   [Asaoka, T.] Tokyo Denki Univ, Sch Sci & Engn, Dept Intelligent Mech Engn, Ishizaka Hatoyama Hiki S 3500394, Japan.
RP Koide, N (reprint author), Tokyo Denki Univ, Grad Sch Sci & Engn, Course Intelligent Mech Engn, Ishizaka Hatoyama Hiki S 3500394, Japan.
EM 07smn08@ms.dendai.ac.jp; 07smn12@ms.dendai.ac.jp; asaoka@n.dendai.ac.jp
CR Fujisawa A., 2003, CERAMICS JAPAN, V38-1, P40
   Kokubo T., 2004, REGEN MED, V3-2, P31
   Suzuki J., 2005, P 49 JAP C MAT RES, P92
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   Yamashita K., 2005, J JAPAN SOC POWDER P, V52-5, P347
   Yoshida M., 2004, P 8 JAP S BIOM CER, P9
NR 6
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1662-0356
BN 978-3-908158-23-3
J9 ADV SCI TECH
PY 2009
VL 57
BP 139
EP +
PG 2
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA BJG14
UT WOS:000265592100023
DA 2018-10-19
ER

PT S
AU van Griensven, M
   Diederichs, S
   Roeker, S
   Boehm, S
   Peterbauer, A
   Wolbank, S
   Riechers, D
   Stahl, F
   Kasper, C
AF van Griensven, M.
   Diederichs, S.
   Roeker, S.
   Boehm, S.
   Peterbauer, A.
   Wolbank, S.
   Riechers, D.
   Stahl, F.
   Kasper, C.
BE Kasper, C
   VanGriensven, M
   Portner, R
TI Mechanical Strain Using 2D and 3D Bioreactors Induces Osteogenesis:
   Implications for Bone Tissue Engineering
SO BIOREACTOR SYSTEMS FOR TISSUE ENGINEERING
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE Biomaterials; Bone; Mechanical strain; Rotating bed bioreactor; Tissue
   engineering
ID MARROW STROMAL CELLS; PATELLAR TENDON FIBROBLASTS; MESENCHYMAL
   STEM-CELLS; OSTEOBLAST-LIKE CELLS; EXTRACELLULAR-MATRIX; IN-VITRO;
   MORPHOGENETIC PROTEIN-2; BIODEGRADABLE MATERIALS; PROLIFERATIVE
   RESPONSE; SIGNAL-TRANSDUCTION
AB Fracture healing is a complicated process involving many growth factors, cells, and physical forces. In cases, where natural healing is not able, efforts have to be undertaken to improve healing. For this purpose, tissue engineering, may be an option. In order to stimulate cells to form a bone tissue several factors are needed: cells, scaffold, and growth factors. Stem cells derived from bone marrow or adipose tissues are the most useful in this regard. The differentiation of the cells can be accelerated using mechanical stimulation. The first part of this chapter describes the influence of longitudinal strain application. The second part uses a sophisticated approach with stem cells on a newly developed biomaterial (Sponceram) in a rotating bed bioreactor with the administration of bone morphogenetic protein-2. It is shown that such an approach is able to produce bone tissue constructs. This may lead to production of larger constructs that can be used in clinical applications.
C1 [van Griensven, M.; Diederichs, S.; Peterbauer, A.; Wolbank, S.] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
   [Diederichs, S.; Roeker, S.; Boehm, S.; Riechers, D.; Stahl, F.; Kasper, C.] Leibniz Univ Hannover, Inst Tech Chem, D-30167 Hannover, Germany.
RP van Griensven, M (reprint author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria.
EM Martijn.van.Griensven@lbitrauma.org; Diederichs@iftc.uni-hannover.de;
   Rocker@iftc.uni-hannover.de; Boehm@iftc.uni-hannover.de;
   Anja.Peterbauer@lbitrauma.org; Susanne.Wolbank@lbitrauma.org;
   Riechers@iftc.uni-hannover.de; Stahl@iftc.uni-hannover.de;
   Kasper@iftc.uni-hannover.de
RI Gabriel, Christian/A-1689-2014; Diederichs, Solvig/T-9240-2017; van
   Griensven, Martijn/F-5808-2012
OI Gabriel, Christian/0000-0003-2043-9320; Diederichs,
   Solvig/0000-0002-2527-9517; van Griensven, Martijn/0000-0001-5104-9881
FU European NoE [NMP3-CT-2004-500283];  [MEST-CT-2004-8104]
FX This work was partially carried out under the scope of the European NoE
   "EXPERTISSUES" (NMP3-CT-2004-500283). Solvig Diederichs was a student in
   the early research training program Marie Curie "Alea Jacta EST"
   (MEST-CT-2004-8104). The Sponceram ceramics were kindly provided by
   Zellwerk GmbH (Oberkramer, Germany) and the BMP-2 was a gift from Prof.
   Walter Sebald (University of Wurzburg).
CR Alam MI, 2001, BIOMATERIALS, V22, P1643
   Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Aubin Jane E., 1996, P51
   Barkhausen T, 2003, EXP TOXICOL PATHOL, V55, P153, DOI 10.1078/0940-2993-00302
   BERESFORD JN, 1992, J CELL SCI, V102, P341
   Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413
   BINDERMAN I, 1988, CALCIFIED TISSUE INT, V42, P261, DOI 10.1007/BF02553753
   Bohner M, 2000, INJURY, V31, pS37
   BRIGHTON CT, 1992, J ORTHOPAED RES, V10, P385, DOI 10.1002/jor.1100100311
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   El Haj AJ, 1999, MED BIOL ENG COMPUT, V37, P403, DOI 10.1007/BF02513320
   ELHAJ AJ, 1990, J BONE MINER RES, V5, P923
   Glowacki J, 1998, CELL TRANSPLANT, V7, P319, DOI 10.1016/S0963-6897(98)00003-7
   Grenier G, 2005, TISSUE ENG, V11, P90, DOI 10.1089/ten.2005.11.90
   Hardouin P, 2000, JOINT BONE SPINE, V67, P419
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Huang CYC, 2005, STEM CELLS, V23, P1113, DOI 10.1634/stemcells.2005-0202
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Jagodzinski M, 2004, Eur Cell Mater, V7, P35
   Jagodzinski M, 2004, ORTHOPADE, V33, P1394, DOI 10.1007/s00132-004-0733-1
   JONES DB, 1991, BIOMATERIALS, V12, P101, DOI 10.1016/0142-9612(91)90186-E
   Kamata A, 1998, BIOCHEM BIOPH RES CO, V246, P404, DOI 10.1006/bbrc.1998.8632
   Kaspar D, 2002, J BIOMECH, V35, P873, DOI 10.1016/S0021-9290(02)00058-1
   Kaspar D., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P161
   Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1
   Kuhnel F, 2000, J BIOL CHEM, V275, P6421, DOI 10.1074/jbc.275.9.6421
   KUROKI Y, 1992, BIOCHEM BIOPH RES CO, V182, P1389, DOI 10.1016/0006-291X(92)91887-V
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   LEBLANC AD, 1990, J BONE MINER RES, V5, P843
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779
   MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643
   Mueller SM, 1999, J BONE MINER RES, V14, P2118, DOI 10.1359/jbmr.1999.14.12.2118
   Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2
   NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109
   OLDBERG A, 1988, J BIOL CHEM, V263, P19433
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PRINCE RL, 1991, NEW ENGL J MED, V325, P1189, DOI 10.1056/NEJM199110243251701
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   RAMBAUT PC, 1985, LANCET, V2, P1050
   Reddi A. Hari, 1992, Current Opinion in Cell Biology, V4, P850
   SANDY JR, 1989, BONE MINER, V5, P155, DOI 10.1016/0169-6009(89)90093-7
   SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514
   Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081
   Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086
   SEFTON MV, 1998, J CUTAN MED SURG, V3, P18
   Seshi B, 2000, BLOOD CELL MOL DIS, V26, P234, DOI 10.1006/bcmd.2000.0301
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   SHU R, 2008, J BIOMED MATER RES A, V67, P1196
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   SIMKIN A, 1987, CALCIFIED TISSUE INT, V40, P59, DOI 10.1007/BF02555706
   SIMMONS DJ, 1986, BONE MINER, V1, P485
   Skutek M, 2003, KNEE SURG SPORT TR A, V11, P122, DOI 10.1007/s00167-002-0322-y
   TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thomas GP, 1996, CALCIFIED TISSUE INT, V58, P101, DOI 10.1007/BF02529731
   Van Griensven M, 2003, EXP TOXICOL PATHOL, V54, P335, DOI 10.1078/0940-2993-00268
   VICO L, 1988, AM J PHYSIOL, V255, pR243
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Walker LM, 2000, J CELL BIOCHEM, V79, P648, DOI 10.1002/1097-4644(20001215)79:4<648::AID-JCB130>3.0.CO;2-Q
   Wang HC, 1995, J BIOMECH, V28, P1543, DOI 10.1016/0021-9290(95)00101-8
   WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   Weyts FAA, 2003, CALCIFIED TISSUE INT, V72, P505, DOI 10.1007/s00223-002-2027-0
   Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731
   Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393
   Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P369
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   ZAMAN G, 1992, CALCIFIED TISSUE INT, V51, P132, DOI 10.1007/BF00298501
   Zeichen J, 2000, AM J SPORT MED, V28, P888, DOI 10.1177/03635465000280061901
   Zhao L, 2004, J MATER SCI-MATER M, V15, P625, DOI 10.1023/B:JMSM.0000026103.44687.d0
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 80
TC 15
Z9 15
U1 0
U2 6
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0724-6145
EI 1616-8542
BN 978-3-540-69356-7
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2009
VL 112
BP 95
EP 123
DI 10.1007/10_2008_14
D2 10.1007/978-3-540-69357-4
PG 29
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BJB97
UT WOS:000264638000005
PM 19290499
DA 2018-10-19
ER

PT J
AU Ferreira, M
   Mendonca, RJ
   Coutinho-Netto, J
   Mulato, M
AF Ferreira, Mariselma
   Mendonca, Ricardo Jose
   Coutinho-Netto, Joaquim
   Mulato, Marcelo
TI Angiogenic Properties of Natural Rubber Latex Biomembranes and The Serum
   Fraction of Hevea brasiliensis
SO BRAZILIAN JOURNAL OF PHYSICS
LA English
DT Article
DE Biomatherials; Hevea brasiliensis; Natural Latex; Rubber; Angiogenesis
ID GROWTH-FACTOR; VASCULAR PROSTHESIS; SPECTROSCOPY; MATRICES; TUBES
AB The angiogenic properties of natural rubber were evaluated in this work. We have used the chick chorioal-lantoic membrane assay (CAM) as a model to investigate the influence of the heating on biological activity in rubber membranes and in non rubber fraction as well. Results showed that natural rubber membranes can induce vascularization. It was observed that angiogenesis activity was maximum when membranes were heated in temperatures between 65 degrees C and 85 degrees C, considering a range from 55 degrees C to 105 degrees C. The same behavior was observed for non rubber fraction and it indicates that this serum fraction may be responsible for angiogenesis. When infrared spectroscopy was performed in the cast films of non rubber fraction samples, as a function of heating, no structural changes was observed. The results obtained shown that natural rubber latex films produced by casting induce the vessel growth in the CAM and it can be considered as a potential biomaterial.
C1 [Ferreira, Mariselma; Mulato, Marcelo] Univ Sao Paulo, Dept Fis & Matemat, FFCLRP, Sao Paulo, Brazil.
   [Mendonca, Ricardo Jose; Coutinho-Netto, Joaquim] Univ Sao Paulo, Dept Bioquim, FMRP, Sao Paulo, Brazil.
RP Ferreira, M (reprint author), Univ Sao Paulo, Dept Fis & Matemat, FFCLRP, Sao Paulo, Brazil.
EM mariselma.ferreira@ufabc.edu.br
RI Mendonca, Ricardo/B-8902-2013; Mulato, Marcelo/J-7756-2012; Ferreira,
   Mariselma/G-7234-2012
OI Mulato, Marcelo/0000-0002-2865-9507; 
FU FAPESP [03/02516-2]; CNPq [420198/2005-9, 478452/2004-7]; IFSC-USP
FX FAPESP (03/02516-2); CNPq (420198/2005-9) and (478452/2004-7); Prof.
   Osvaldo Novais de Oliveira Jr. Polymer Group of IFSC-USP; Prof. Carlos
   F. de O Graeff; and Prof. Marcos Bernardes, for the latex sample
   donation.
CR AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x
   Ferreira M, 2002, RUBBER CHEM TECHNOL, V75, P171, DOI 10.5254/1.3547668
   Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a
   Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5
   Frade MAC, 2001, INT J DERMATOL, V40, P238, DOI 10.1046/j.1365-4362.2001.00977-2.x
   GRAVE HH, 1993, ULLMANNS ENCY IND CH, P221
   Gupta MK, 2003, WORLD J GASTROENTERO, V9, P1144, DOI 10.3748/wjg.v9.i6.1144
   Hasma H., 1991, Journal of Natural Rubber Research, V6, P105
   HASMA H, 1993, J RUBBER RES, V12, P21
   HAVEL HA, 1989, ANAL CHEM, V61, P642, DOI 10.1021/ac00182a002
   Helmlinger G, 2000, NATURE, V405, P139, DOI 10.1038/35012132
   Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b
   MENDONCA RJ, 2004, CARACTERIZAC BIOL FR
   MRUE F, 2006, BIOMEMBRANE SUITABLE
   Mrue F., 2000, NEOFORMACAO TECIDUAL
   Neves WFP, 2006, J APPL POLYM SCI, V100, P702, DOI 10.1002/app.23416
   Neves-Junior WFP, 2006, BRAZ J PHYS, V36, P586, DOI 10.1590/S0103-97332006000400021
   PRESTRELSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P314, DOI 10.1016/0003-9861(92)90401-H
   Schultz GS, 2003, WOUND REPAIR REGEN, V11, pS1, DOI 10.1046/j.1524-475X.11.s2.1.x
   SHARP WV, 1964, T AM SOC ART INT ORG, V10, P223
   SHARP WV, 1963, AM J SURG, V105, P802, DOI 10.1016/0002-9610(63)90495-1
   SHARP WV, 1965, T AM SOC ART INT ORG, V11, P336
   Shen JT, 2003, J CUTAN MED SURG, V7, P217, DOI 10.1007/s10227-002-0106-5
   Wilting J, 1995, CELL MOL BIOL RES, V41, P219
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wittemann A, 2004, ANAL CHEM, V76, P2813, DOI 10.1021/ac0354692
   YIP E, 1994, J RUBBER RES, V9, P79
   Yip E., 2000, J RUBBER RES, V3, P129
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 33
TC 33
Z9 34
U1 1
U2 9
PU SOC BRASILEIRA FISICA
PI SAO PAULO
PA CAIXA POSTAL 66328, 05315-970 SAO PAULO, BRAZIL
SN 0103-9733
J9 BRAZ J PHYS
JI Braz. J. Phys.
PY 2009
VL 39
IS 3
BP 564
EP 569
DI 10.1590/S0103-97332009000500010
PG 6
WC Physics, Multidisciplinary
SC Physics
GA 510TS
UT WOS:000271115800010
OA Other Gold, Bronze
DA 2018-10-19
ER

PT J
AU Shi, ZD
   Liu, MW
   Qin, ZZ
   Wang, QM
   He, HY
   Guo, Y
   Yu, ZH
AF Shi, Zhi-Dong
   Liu, Ming-Wang
   Qin, Zhong-Zong
   Wang, Qin-Mei
   He, Hai-Yong
   Guo, Ying
   Yu, Zhong-He
TI A new modified dura mater implant: characteristics in recipient dogs
SO BRITISH JOURNAL OF NEUROSURGERY
LA English
DT Article
DE Xenogeneic dura mater; biomaterial; animal experiment
ID REPAIR
AB Duraplasty is critical to the maintenance of anatomical integrity and the protection of brain tissue. Allotransplantation of cadaveric dura mater was abandoned after it was found to transmit Creutzfeldt-Jakob disease (CJD). In this study, the usefulness of a xenogeneic dura mater for dural reconstruction was tested. Twelve dogs were randomly assigned to 4 groups. To simulate the condition of patients with brain surface injury, an area of approximately 2cm1.5cm of the dura mater was removed to create a defect. Xenogeneinc dura mater derived from porcine pericardium was trimmed to the shape and size of the defect and sutured to the endogenous dura mater. Muscles at the apex of the skull and scalp were also sutured. Three dogs were euthanized at 3, 6, 9, and 12 months after implantation and the xenogeneic dura mater and surrounding endogenous tissue were examined macroscopically and microscopically. Three months after implantation, the graft site had begun to heal. Macroscopically, at 6, 9, and 12 months after implantation, the graft had healed completely with the surrounding tissue. No boundary between the graft and surrounding tissue was distinguishable, and the two could not be separated. The graft was smoothly epithelialized and nonadherent to the brain surface. Microscopically, the inner surface of the implant was covered with epithelial cells, and internal capillaries, subepithelial fibrous tissue deposition, and fibroblast proliferation were observed. The xenogeneic dura mater progressively degraded over time. No cysts and no neutrophilic or lymphocytic inflammatory cell response developed between the implant and the recipient brain parenchyma. The modified xenogeneic dura mater is sufficiently biocompatible to allow epithelialization of its inner surface without adherence to brain tissue. No abnormalities develop in recipients, and the xenograft is gradually biodegraded and replaced by endogenous tissue identical to the endogenous dura mater.
C1 [Shi, Zhi-Dong; Liu, Ming-Wang; Qin, Zhong-Zong; He, Hai-Yong; Guo, Ying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurosurg, Guangzhou 510630, Guangdong, Peoples R China.
   [Wang, Qin-Mei] Sun Yat Sen Univ, Affiliated Hosp 1, Artificial Heart Lab, Guangzhou 510630, Guangdong, Peoples R China.
   [Yu, Zhong-He] Sun Yat Sen Univ, Affiliated Hosp 3, Anim Ctr, Guangzhou 510630, Guangdong, Peoples R China.
RP Shi, ZD (reprint author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurosurg, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China.
EM shizhidong2@163.com
FU Guangdong Province Science and Technology Department [2007B33801007];
   Guangzhou City Department of Science and Technology [2006C13G0091];
   State Food and Drug Administration [2006- 3460627]
FX This study was supported by scientific research grants from Guangdong
   Province Science and Technology Department (No. 2007B33801007) and
   Guangzhou City Department of Science and Technology (No. 2006C13G0091).
   The xenogeneic dura mater used in this study was registered with the
   State Food and Drug Administration (Registration No. Nat. Food & Drug
   Admin 2006- 3460627).
CR Chaplin JM, 1999, NEUROSURGERY, V45, P320, DOI 10.1097/00006123-199908000-00025
   Filippi R, 2001, NEUROSURG REV, V24, P103, DOI 10.1007/PL00012392
   HUANG Y, 2002, CHIN J CLIN NEUROSUR, V6, P9
   Liu Peng, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P1242
   Reddy M, 2002, ACTA NEUROCHIR, V144, P265, DOI 10.1007/s007010200034
   SHI ZD, 1999, CHIN J NERV MENT DIS, V25, P265
   SUN M, 2003, CHIN J MINIM INVASIV, V8, P382
   Tachibana E, 2002, J NEUROSURG, V96, P280, DOI 10.3171/jns.2002.96.2.0280
   Vinas FC, 1999, NEUROL RES, V21, P262, DOI 10.1080/01616412.1999.11740929
   YU SQ, 2003, CHIN J NEUROLOGICAL, V2, P354
NR 10
TC 3
Z9 3
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0268-8697
EI 1360-046X
J9 BRIT J NEUROSURG
JI Br. J. Neurosurg.
PY 2009
VL 23
IS 1
BP 71
EP 75
AR PII 908918720
DI 10.1080/02688690802582638
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 411II
UT WOS:000263642600012
PM 19234912
DA 2018-10-19
ER

PT S
AU Moldovan, C
   Dinescu, A
   Manea, E
   Iosub, R
   Brasoveanu, C
   Firtat, B
   Moldovan, C
   Ion, M
   Manolescu, A
AF Moldovan, Clara
   Dinescu, Adrian
   Manea, Elena
   Iosub, Rodica
   Brasoveanu, Costin
   Firtat, Bogdan
   Moldovan, Carmen
   Ion, Marian
   Manolescu, Anca
GP IEEE
TI TECHNOLOGY OF A NANOWIRE BIOFET DEVICE FOR BIOMOLECULES DETECTION
SO CAS: 2009 INTERNATIONAL SEMICONDUCTOR CONFERENCE, VOLS 1 AND 2,
   PROCEEDINGS
SE International Semiconductor Conference
LA English
DT Proceedings Paper
CT 32nd International Semiconductor Conference
CY OCT 12-14, 2009
CL Sinaia, ROMANIA
SP Natl Inst Res & Dev Microtechnol
ID FIELD-EFFECT TRANSISTORS
AB The paper is presenting the technology of a nanowire FET device to be used in biodetection. The nanosensor we are presenting is containing a PET device realized on top of a silicon wafer substrate with a long nanowire allowing the conduction between source and drain and hosting the specific biomaterial on top of it.(nanowire bioFET)
   The FET device that is presented comprises two gates, one on the back, and one on top. The FET with double gate was realized in a unique technological process flow that will be described.
   The masks and the layout will be presented. The technology of the device will be presented and the development of the nanowire technology as well.
C1 [Moldovan, Clara; Manolescu, Anca] Univ Politehn Bucuresti, Iuliu Maniu St 1-3,Sector6, Bucharest, Romania.
   [Dinescu, Adrian; Manea, Elena; Iosub, Rodica; Brasoveanu, Costin; Firtat, Bogdan; Moldovan, Carmen; Ion, Marian] Natl Inst R & D Microtechnol, Bucharest 077190, Romania.
RP Moldovan, C (reprint author), Univ Politehn Bucuresti, Iuliu Maniu St 1-3,Sector6, Bucharest, Romania.
EM clara_mol@yahoo.com
RI Dinescu, Adrian/H-9737-2014
FU IMUNOSENSE [51-083/2007]
FX This work was supported by the IMUNOSENSE project (PNII, No
   51-083/2007), using IMT technological infrastructure
CR Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711
   Cui Y, 2003, NANO LETT, V3, P149, DOI 10.1021/nl025875l
   Eggins B.R., 2002, CHEM SENSORS BIOSENS
   Errachid A, 2004, ELECTROANAL, V16, P1843, DOI 10.1002/elan.200403072
   Grieshaber D, 2008, SENSORS-BASEL, V8, P1400, DOI 10.3390/s8031400
   Koo SM, 2005, NANOTECHNOLOGY, V16, P1482, DOI 10.1088/0957-4484/16/9/011
   Schoning MJ, 2002, ANALYST, V127, P1137, DOI 10.1039/b204444g
   Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498
NR 8
TC 1
Z9 1
U1 1
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1545-827X
BN 978-1-4244-4413-7
J9 INT SEMICONDUCT CON
PY 2009
BP 549
EP +
PG 2
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BPO79
UT WOS:000279558600115
DA 2018-10-19
ER

PT J
AU Li, JH
   Olton, D
   Lee, D
   Kumta, PN
   Sfeir, C
AF Li, Jinhua
   Olton, Dana
   Lee, Donghyun
   Kumta, Prashant N.
   Sfeir, Charles
TI Cell Derived Hierarchical Assembly of a Novel Phosphophoryn-Based
   Biomaterial
SO CELLS TISSUES ORGANS
LA English
DT Article; Proceedings Paper
CT 9th International Conference on the Chemistry and Biology of Mineralized
   Tissues
CY NOV 04-08, 2007
CL Lakeland, TX
DE Phosphophoryn; SIBLING; Self-assembly; Phosphoproteins
ID DENTIN MATRIX PROTEIN-1; HYDROXYAPATITE FORMATION; IN-VITRO;
   PHOSPHOPROTEIN; BONE; SIALOPROTEIN
AB Phosphophoryn (PP) is an acidic phosphoprotein belonging to the small integrin-binding ligand N-linked glycoprotein (SIBLING) protein family. PP is highly phosphorylated with approximately 200 phosphates per molecule and has a high affinity for calcium. The aim of this manuscript is to demonstrate that PP has the ability to self-assemble when it is over-expressed in a mammalian cell in the presence of calcium. Our data show that when PP is overexpressed using an adenovirus, the self-assembly occurs in the endoplasmic reticulum (ER) which contains high calcium concentration. We hypothesize that the physicochemical properties of the highly phosphorylated state and acidic nature of PP are playing an important role in its assembly in the ER. It appears that when a critical concentration of PP is reached, the assembly is then favored and facilitated. This self-assembly could be due to several factors. (1) The ER provides an ideal environment for this phenomenon to occur, since the ER environment usually promotes aggregation [Stevens and Argon: Semin Cell Dev Biol 1999; 10: 443-454]. (2) In addition to PP's physicochemical properties, the unfolded protein response could also be playing a role in this self-assembly [Schroder and Kaufman: Mutat Res 2005; 569: 29-63]. Unfolded protein response could be activated by a broad spectrum of insults that result in protein misfolding and ultimately blocking of the protein synthesis progression to the Golgi apparatus resulting in an accumulation of the protein in the ER. In summary, our data show that PP has the ability to self-assemble in a hierarchical manner. Copyright (C) 2008 S. Karger AG, Basel
C1 [Li, Jinhua; Olton, Dana; Lee, Donghyun; Kumta, Prashant N.; Sfeir, Charles] Univ Pittsburgh, Ctr Craniofacial Regenerat, Sch Dent Med, Pittsburgh, PA 15261 USA.
   [Olton, Dana; Lee, Donghyun; Kumta, Prashant N.; Sfeir, Charles] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Olton, Dana; Lee, Donghyun; Kumta, Prashant N.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
   [Olton, Dana; Lee, Donghyun; Kumta, Prashant N.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15261 USA.
RP Sfeir, C (reprint author), Univ Pittsburgh, Ctr Craniofacial Regenerat, Sch Dent Med, 693A Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.
EM csfeir@pitt.edu
FU NIDCR NIH HHS [K02 DE016900, R01 DE016123, 5R01DE016123, 5K02DE016900]
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146
   He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   LINDE A, 1980, J BIOL CHEM, V255, P5931
   MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835
   Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198
   RICHARDSON WS, 1978, J BIOL CHEM, V253, P8042
   Shi ST, 1996, J BONE MINER RES, V11, P1139, DOI 10.1002/jbmr.5650110813
   Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x
   VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017
   VEIS A, 1993, J BONE MINER RES, V8, pS493
   Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200
   YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275
NR 14
TC 3
Z9 3
U1 0
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2009
VL 189
IS 1-4
BP 252
EP 255
DI 10.1159/000158571
PG 4
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 384VJ
UT WOS:000261772000044
PM 18815439
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Kim, M
   Lee, JY
   Shah, SS
   Tae, G
   Revzin, A
AF Kim, Mihye
   Lee, Ji Youn
   Shah, Sunny S.
   Tae, Giyoong
   Revzin, Alexander
TI On-cue detachment of hydrogels and cells from optically transparent
   electrodes
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; HEPARIN-BASED HYDROGEL; ELECTROCHEMICAL
   DESORPTION; RELEASE; MICROELECTRODES; ATTACHMENT; PROTEINS; SURFACE
AB The goal of the present communication was to develop a strategy for detachment of cells and biomaterial constructs from indium tin oxide (ITO) electrodes.
C1 [Kim, Mihye; Tae, Giyoong] Gwangju Inst Sci & Technol, Dept Nanobio Mat & Elect, Kwangju 500712, South Korea.
   [Kim, Mihye; Tae, Giyoong] Gwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangju 500712, South Korea.
   [Lee, Ji Youn; Shah, Sunny S.; Revzin, Alexander] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
RP Tae, G (reprint author), Gwangju Inst Sci & Technol, Dept Nanobio Mat & Elect, Kwangju 500712, South Korea.
EM gytae@gist.ac.kr; arevzin@ucdavis.edu
FU World Class University (WCU); Ministry of Education, Science and
   Technology (MEST) of Korea [R31-20008-000-10026-0]; Research Center for
   Biomolecular Nanotechnology; UC Davis; NIGMS-NIH [T32-GM08799]
FX This work was partially supported by the World Class University (WCU)
   program at GIST through a grant provided by the Ministry of Education,
   Science and Technology (MEST) of Korea (Project No.
   R31-20008-000-10026-0) and by the Research Center for Biomolecular
   Nanotechnology, GIST. This was also supported in part by UC Davis
   start-up funds. SSS acknowledges support from Grant Number T32-GM08799
   from NIGMS-NIH.
CR Balasubramanian S, 2006, ELECTROANAL, V18, P1885, DOI 10.1002/elan.200603627
   Chan EWL, 2008, ANGEW CHEM INT EDIT, V47, P6267, DOI 10.1002/anie.200800166
   Guillaume-Gentil O, 2008, ADV MATER, V20, P560, DOI 10.1002/adma.200700758
   Il Choi W, 2008, BIOMACROMOLECULES, V9, P1698, DOI [10.1021/bm701391b, 10.1021/bm701391]
   Inaba R, 2009, BIOMATERIALS, V30, P3573, DOI 10.1016/j.biomaterials.2009.03.045
   Jiang XY, 2003, J AM CHEM SOC, V125, P2366, DOI 10.1021/ja029485c
   Kim M, 2010, TISSUE ENG PART C-ME, V16, P1, DOI [10.1089/ten.tec.2008.0548, 10.1089/ten.TEC.2008.0548]
   Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933
   Li Y, 2007, ANGEW CHEM INT EDIT, V46, P1094, DOI 10.1002/anie.200603844
   McGonigle JS, 2008, J BIOMAT SCI-POLYM E, V19, P1021, DOI 10.1163/156856208784909381
   Shah SS, 2008, LANGMUIR, V24, P6837, DOI 10.1021/la800231e
   Tae G, 2007, BIOMACROMOLECULES, V8, P1979, DOI 10.1021/bm0701189
   WIDRIG CA, 1991, J ELECTROANAL CHEM, V310, P335, DOI 10.1016/0022-0728(91)85271-P
   Yeo WS, 2006, LANGMUIR, V22, P10816, DOI 10.1021/la061212y
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
   Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898
   Zhu H, 2008, COLLOID SURFACE B, V64, P260, DOI 10.1016/j.colsurfb.2008.02.010
NR 17
TC 16
Z9 17
U1 1
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
J9 CHEM COMMUN
JI Chem. Commun.
PY 2009
IS 39
BP 5865
EP 5867
DI 10.1039/b909169f
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 500GD
UT WOS:000270285900020
PM 19787123
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Petrovic, M
   Mitrakovic, D
   Bugarski, B
   Vonwil, D
   Martin, I
   Obradovic, B
AF Petrovic, Milos
   Mitrakovic, Dragan
   Bugarski, Branko
   Vonwil, Daniel
   Martin, Ivan
   Obradovic, Bojana
TI A NOVEL BIOREACTOR WITH MECHANICAL STIMULATION FOR SKELETAL TISSUE
   ENGINEERING
SO CHEMICAL INDUSTRY & CHEMICAL ENGINEERING QUARTERLY
LA English
DT Article
DE bioreactor; dynamic compression; perfusion; cartilage; bone; tissue
   engineering
ID MINERALIZED MATRIX DEPOSITION; HUMAN ARTICULAR CHONDROCYTES; 3D
   PERFUSION CULTURE; SEEDING DENSITY; CELL SUPPORT; CARTILAGE; CONSTRUCTS;
   INCREASES
AB The provision of mechanical stimulation is believed to be necessary for the functional assembly of skeletal tissues, which are normally exposed to. a variety of biomechanical signals In vivo In this paper, we present a development and validation of a novel bioreactor aimed for skeletal tissue engineering that provides dynamic compression and perfusion of cultivated tissues Dynamic compression can be applied at frequencies up to 67.5 Hz and displacements down to 5 pm thus suitable for the simulation of physiological conditions In a native cartilage tissue (0.1-1 Hz, 5- 10 % strain). The bioreactor also includes a load sensor that was calibrated so to measure average loads imposed on tissue samples. Regimes of the mechanical stimulation and acquisition of load sensor outputs are directed by an automatic control system using applications developed within the Lab View platform. In addition, perfusion of tissue samples at physiological velocities (10- 100 mu m/s) provides efficient mass transfer, as well as the possibilities to expose the cells to hydrodynamic shear and simulate the conditions in a native bone tissue. Thus, the novel bioreactor is suited for studies of the effects of different biomechanical signals on in vitro regeneration of skeletal tissues, as well as for the studies of newly formulated biomaterials and cell biomaterial interactions under in vivo-like settings.
C1 [Petrovic, Milos; Mitrakovic, Dragan; Bugarski, Branko; Obradovic, Bojana] Univ Belgrade, Fac Technol & Met, Belgrade 11120, Serbia.
   [Vonwil, Daniel; Martin, Ivan] Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Surg, CH-4031 Basel, Switzerland.
   [Vonwil, Daniel; Martin, Ivan] Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Res, CH-4031 Basel, Switzerland.
RP Obradovic, B (reprint author), Univ Belgrade, Fac Technol & Met, Karnegijeva 4, Belgrade 11120, Serbia.
EM bojana@tmf.bg.ac.rs
OI Obradovic, Bojana/0000-0002-7276-0442; Petrovic,
   Milos/0000-0002-2460-7793; Vonwil, Daniel/0000-0003-3314-445X
FU Swiss National Science Foundation [IB73B0-111016/1]; Ministry of Science
   and Technological Development of the Republic of Serbia [142075]
FX This work was supported by the Swiss National Science Foundation (SNSF,
   SCOPES grant IB73B0-111016/1) and the Ministry of Science and
   Technological Development of the Republic of Serbia (Grant 142075).
CR Ateshian GA, 2003, FUNCTIONAL TISSUE ENGINEERING, P46, DOI 10.1007/0-387-21547-6_4
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Barbero A, 2003, ARTHRITIS RHEUM, V48, P1315, DOI 10.1002/art.10950
   Braccini A, 2005, STEM CELLS, V23, P1066, DOI 10.1634/stemcells.2005-0002
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099
   Demarteau O, 2003, BIORHEOLOGY, V40, P331
   Freshney RI, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P155, DOI 10.1016/B978-012370615-7/50016-0
   GRAYSON WL, 2007, ORTHOPAEDIC RES SOC, V32
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Obradovic B, 2007, MATER SCI FORUM, V555, P417, DOI 10.4028/www.scientific.net/MSF.555.417
   Obradovic B, 2004, MATER SCI FORUM, V453-454, P549, DOI 10.4028/www.scientific.net/MSF.453-454.549
   Seidel JO, 2004, BIORHEOLOGY, V41, P445
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
NR 18
TC 15
Z9 15
U1 2
U2 12
PU ASSOC CHEMICAL ENG
PI BELGRADE
PA KNEZA MILOSO 9-I, BELGRADE, 11000, SERBIA
SN 1451-9372
J9 CHEM IND CHEM ENG Q
JI Chem. Ind. Chem. Eng. Q.
PD JAN-MAR
PY 2009
VL 15
IS 1
BP 41
EP 44
DI 10.2298/CICEQ0901041P
PG 4
WC Chemistry, Applied; Engineering, Chemical
SC Chemistry; Engineering
GA 413GE
UT WOS:000263780100011
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Saito, N
   Usui, Y
   Aoki, K
   Narita, N
   Shimizu, M
   Hara, K
   Ogiwara, N
   Nakamura, K
   Ishigaki, N
   Kato, H
   Taruta, S
   Endo, M
AF Saito, Naoto
   Usui, Yuki
   Aoki, Kaoru
   Narita, Nobuyo
   Shimizu, Masayuki
   Hara, Kazuo
   Ogiwara, Nobuhide
   Nakamura, Koichi
   Ishigaki, Norio
   Kato, Hiroyuki
   Taruta, Seiichi
   Endo, Morinobu
TI Carbon nanotubes: biomaterial applications
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID MAMMALIAN-CELLS; STEM-CELLS; IN-VITRO; BONE-FORMATION; DELIVERY;
   FUNCTIONALIZATION; SCAFFOLDS; DNA; BIOCOMPATIBILITY; PROLIFERATION
AB There is increasing interest in the unique biological and medical properties of carbon nanotubes (CNTs), and it is expected that biomaterials incorporating CNTs will be developed for clinical use. There has been a great deal of progress in improving the various properties of CNTs for use in biomaterials and for promotion of tissue regeneration as scaffold materials. The effects of CNTs on cells and tissues are extremely important for their use in biomaterials. This tutorial review clarifies the current state of knowledge in the interdisciplinary field of CNT-based nanobiotechnology to determine whether CNTs may be useful in biomaterials. Future perspectives in this rapidly developing field will also be discussed.
C1 [Saito, Naoto] Shinshu Univ, Sch Hlth Sci, Dept Appl Phys Therapy, Nagano 3908621, Japan.
   [Usui, Yuki; Aoki, Kaoru; Narita, Nobuyo; Shimizu, Masayuki; Hara, Kazuo; Ogiwara, Nobuhide; Nakamura, Koichi; Ishigaki, Norio; Kato, Hiroyuki] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Nagano 3908621, Japan.
   [Taruta, Seiichi; Endo, Morinobu] Shinshu Univ, Fac Engn, Nagano 3808553, Japan.
RP Saito, N (reprint author), Shinshu Univ, Sch Hlth Sci, Dept Appl Phys Therapy, 3-1-1 Asahi, Nagano 3908621, Japan.
EM saitoko@shinshu-u.ac.jp
FU Ministry of Education, Culture, Sports, Science, and Technology, Japan;
   Ministry of Education, Science, Sports, and Culture, Japan; New Energy
   and Industrial Technology Development Organization, Japan
FX This research was supported by the CLUSTER program of the Ministry of
   Education, Culture, Sports, Science, and Technology, Japan, by a
   Grant-in-Aid for Scientific Research from the Ministry of Education,
   Science, Sports, and Culture, Japan, and by the Research and Development
   of Nanodevices for Practical Utilization of Nanotechnology program of
   the New Energy and Industrial Technology Development Organization,
   Japan.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Armentano I, 2008, J MATER SCI-MATER M, V19, P2377, DOI 10.1007/s10856-007-3276-2
   Cai D, 2005, NAT METHODS, V2, P449, DOI 10.1038/NMETH761
   Cao Y, 2007, J NANOSCI NANOTECHNO, V7, P447, DOI 10.1166/jnn.2007.137
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   Chen X, 2006, J AM CHEM SOC, V128, P6292, DOI 10.1021/ja060276s
   Cheng W, 2008, ANAL CHEM, V80, P3867, DOI 10.1021/ac800199t
   Crouzier T, 2008, LANGMUIR, V24, P13173, DOI 10.1021/la801999n
   Dubin RA, 2008, IEEE T NANOBIOSCI, V7, P11, DOI 10.1109/TNB.2008.2000144
   Endo M, 2001, CARBON, V39, P1287, DOI 10.1016/S0008-6223(00)00295-5
   Hirano S, 2008, TOXICOL APPL PHARM, V232, P244, DOI 10.1016/j.taap.2008.06.016
   Holzinger M, 2003, J AM CHEM SOC, V125, P8566, DOI 10.1021/ja029931w
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kam NWS, 2005, J AM CHEM SOC, V127, P12492, DOI 10.1021/ja053962k
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   Krul LP, 2007, BIOMOL ENG, V24, P93, DOI 10.1016/j.bioeng.2006.05.021
   Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   McCullen SD, 2007, INT J NANOMED, V2, P253
   Meng J, 2005, J BIOMED MATER RES A, V74A, P208, DOI 10.1002/jbm.a.30315
   Meng J, 2005, NANOMED-NANOTECHNOL, V1, P136, DOI 10.1016/j.nano.2005.03.003
   Meng J, 2006, J BIOMED MATER RES A, V79A, P298, DOI 10.1002/jbm.a.30787
   Moulton SE, 2007, J AM CHEM SOC, V129, P9452, DOI 10.1021/ja072160h
   Murugesan S, 2006, LANGMUIR, V22, P3461, DOI 10.1021/la0534468
   Nepal D, 2005, BIOMACROMOLECULES, V6, P2919, DOI 10.1021/bm050380m
   Ni YC, 2005, J NANOSCI NANOTECHNO, V5, P1707, DOI 10.1166/jnn.2005.189
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   OBERLIN A, 1976, J CRYST GROWTH, V32, P335, DOI 10.1016/0022-0248(76)90115-9
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saito N, 2008, CURR MED CHEM, V15, P523, DOI 10.2174/092986708783503140
   SCHIPPER ML, 2008, NAT NANOTECHNOL, V3, P191
   Shen JW, 2008, BIOMATERIALS, V29, P3847, DOI 10.1016/j.biomaterials.2008.06.013
   Sorkin R, 2006, J NEURAL ENG, V3, P95, DOI 10.1088/1741-2560/3/2/003
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670
   Vakarelski IU, 2007, LANGMUIR, V23, P10893, DOI 10.1021/la701878n
   Venkatesan N, 2005, BIOMATERIALS, V26, P7154, DOI 10.1016/j.biiomaterials.2005.05.012
   Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zhang DH, 2006, J PHYS CHEM B, V110, P12910, DOI 10.1021/jp061628k
   Zhou XJ, 2007, NAT NANOTECHNOL, V2, P185, DOI 10.1038/nnano.2007.34
   Zhu L, 2007, NANO LETT, V7, P3592, DOI 10.1021/nl071303v
NR 47
TC 154
Z9 155
U1 4
U2 80
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2009
VL 38
IS 7
BP 1897
EP 1903
DI 10.1039/b804822n
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 461NA
UT WOS:000267272600006
PM 19551170
DA 2018-10-19
ER

PT J
AU Araujo, M
   Linder, E
   Lindhe, J
AF Araujo, M.
   Linder, E.
   Lindhe, J.
TI Effect of a xenograft on early bone formation in extraction sockets: an
   experimental study in dog
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; bone formation; extraction socket; grafting
ID TOOTH EXTRACTION; BIO-OSS; ALVEOLAR RIDGE; BIO-OSS(R); IMPLANTS;
   DEFECTS; TISSUE; AUGMENTATION; SUBSTITUTE; RESORPTION
AB The aim of this study was to study the effect on early bone formation resulting from the placement of a xenograft in the fresh extraction socket in dogs.
   Five beagle dogs were used. The distal roots of the third and fourth mandibular premolars were removed. In one quadrant, a graft consisting of Bio-Oss((R)) Collagen was placed in the fresh extraction wound, while the corresponding premolar sites in the contra-lateral jaw quadrant were left non-grafted. After 2 weeks of healing, the dogs were perfused with a fixative, the mandibles removed, the experimental sites dissected, demineralized, sectioned in the mesio-distal plane and stained in hematoxyline-eosine.
   The central portion of the non-grafted sockets was occupied by a provisional matrix comprised of densely packed connective tissue fibers and mesenchymal cells. Apical and lateral to the provisional matrix, newly formed woven bone was found to occupy most of the sockets. In the apical part of the grafted sockets, no particles of the xenograft could be observed but newly formed bone was present in this portion of the experimental site. In addition, limited numbers of woven bone trabeculae occurred along the lateral socket walls. The central and marginal segments of the grafted sockets, however, were occupied by a non-mineralized connective tissue that enclosed Bio-Oss((R)) particles that frequently were coated by multinucleated cells.
   The placement of Bio-Oss((R)) Collagen in the fresh extraction wound obviously delayed socket healing. Thus, after 2 weeks of tissue repair, only minute amounts of newly formed bone occurred in the apical and lateral borders of the grafted sockets, while large amounts of woven bone had formed in most parts of the non-grafted sites.
   To cite this article:Araujo M, Linder E, Lindhe J. Effect of a xenograft on early bone formation in extraction sockets: an experimental study in dog.Clin. Oral Impl. Res. 20, 2009; 1-6.doi: 10.1111/j.1600-0501.2008.01606.x.
C1 [Araujo, M.] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [Linder, E.; Lindhe, J.] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Gothenburg, Sweden.
RP Araujo, M (reprint author), Rua Silva Jardim 15,Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
CR Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BREDAN BF, 2007, ARTHRITIS RES THERAP, V9, P1
   Cardaropoli G, 2005, J CLIN PERIODONTOL, V32, P435, DOI 10.1111/j.1600-051X.2005.00692.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Chen ST, 2004, INT J ORAL MAX IMPL, V19, P12
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Houshmand B, 2007, J PERIODONTAL RES, V42, P119, DOI 10.1111/j.1600-0765.2006.00923.x
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Merkx MAW, 2000, CLIN ORAL IMPLAN RES, V11, P422, DOI 10.1034/j.1600-0501.2000.011005422.x
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Pietrokovski Jaime, 2007, J Prosthodont, V16, P141, DOI 10.1111/j.1532-849X.2007.00165.x
   Ratner B D, 2001, J Dent Educ, V65, P1340
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Simion M, 2007, CLIN ORAL IMPLAN RES, V18, P620, DOI 10.1111/j.1600-0501.2007.01389.x
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x
NR 28
TC 91
Z9 94
U1 0
U2 10
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JAN
PY 2009
VL 20
IS 1
BP 1
EP 6
DI 10.1111/j.1600-0501.2008.01606.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 389XQ
UT WOS:000262129300001
PM 19126101
DA 2018-10-19
ER

PT J
AU Klein, M
   Goetz, H
   Pazen, S
   Al-Nawas, B
   Wagner, W
   Duschner, H
AF Klein, Marcus
   Goetz, Hermann
   Pazen, Sabine
   Al-Nawas, Bilal
   Wagner, Wilfried
   Duschner, Heinz
TI Pore characteristics of bone substitute materials assessed by
   microcomputed tomography
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE bone substitute materials; microcomputed tomography; osteoconduction;
   porosity; scaffolds
ID HYDROXYAPATITE CERAMICS; POROUS HYDROXYAPATITE; IN-VITRO; CANCELLOUS
   BONE; DENTAL IMPLANTS; AUGMENTATION; POROSITY; BIOCERAMICS; VIVO;
   OSTEOINDUCTION
AB Pore configurations of alloplastic biomaterial scaffolds play a major role for new bone formation in vivo. Current studies on characteristics of pores in bone substitute materials focus on individual particles or single blocks. Thus, three-dimensional (3-D) architecture of particle aggregates, representing the clinical relevant in vivo situation is not adequately taken into account. The aim of this study was the visualization and quantification of pore properties, both of the scaffold structure of single particles as well as of the micro-morphology of complex 3-D aggregated particle-conglomerates.
   In model experiments, standardized plexiglass cylinders were stuffed with commercial bone substitute material particles with diverse chemical composition (HA, beta-TCP, HA-SiO(2), HA-beta-TCP, bioactive glass), origin (phycogenic, bovine, synthetic) and granulation (50 mu m-2000 mu m). Analogue to establish procedures for native (human) bone samples, non-fixed bone substitute materials were scanned by high-resolution microcomputed tomography. In addition to computer animated two-dimensional and 3-D reconstruction of the samples, median pore thickness and pore size distribution were determined. Materials representative for their chemical constitution were documented by SEM imaging.
   Investigated specimens significantly were different in micro-morophology and pore properties, ranging from highly porous to rather solid. The most voluminous pores were localized interparticularly. Within one product line, the determined pore properties showed a significant correlation with single particle grain sizes.
   The generation and interpretation of mu-CT based 3-D pore models can provide further insight into the expected osteoconduction dynamics and therefore might serve as a basis for further modifications of scaffold size and geometry as well as for further invasive studies on the biological behaviour of the scaffolds.
   To cite this article:Klein M, Goetz H, Pazen S, Al-Nawas B, Wagner W, Duschner H. Pore characteristics of bone substitute materials assessed by microcomputed tomography.Clin. Oral Impl. Res. 20, 2009; 67-74.doi: 10.1111/j.1600-0501.2008.01605.x.
C1 [Klein, Marcus; Pazen, Sabine; Al-Nawas, Bilal; Wagner, Wilfried] Univ Hosp Mainz, Dept Oral & Maxillofacial Surg, Mainz, Germany.
   [Goetz, Hermann; Duschner, Heinz] Johannes Gutenberg Univ Mainz, Appl Struct & Microanal Med Fac, Mainz, Germany.
RP Klein, M (reprint author), Augustuspl 2, D-55131 Mainz, Germany.
EM klein@mkg.klinik.uni-mainz.de
RI Al-Nawas, Bilal/C-8885-2013
OI Al-Nawas, Bilal/0000-0002-8665-5803
CR Artzi Z, 2003, INT J ORAL MAX IMPL, V18, P440
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Cooper D. M. L., 2003, Anatomical Record, V274B, P169, DOI 10.1002/ar.b.10024
   Cooper DML, 2004, CALCIFIED TISSUE INT, V74, P437, DOI 10.1007/s00223-003-0071-z
   Cyster LA, 2005, BIOMATERIALS, V26, P697, DOI 10.1016/j.biomaterials.2004.03.017
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   FABBRI M, 1995, BIOMATERIALS, V16, P225, DOI 10.1016/0142-9612(95)92121-L
   Froum SJ, 2006, INT J PERIODONT REST, V26, P543
   Galois Laurent, 2004, Acta Orthop Belg, V70, P598
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Hising P, 2001, INT J ORAL MAX IMPL, V16, P90
   Hollister S J, 2005, Orthod Craniofac Res, V8, P162, DOI 10.1111/j.1601-6343.2005.00329.x
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   Jones AC, 2004, J MATER SCI-MATER M, V15, P529, DOI 10.1023/B:JMSM.0000021133.48661.62
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keaveny T. M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P205
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   Knackstedt MA, 2006, BIOMATERIALS, V27, P2776, DOI 10.1016/j.biomaterials.2005.12.016
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Maiorana C, 2006, INT J ORAL MAX IMPL, V21, P426
   Mangano Carlo, 2006, J Oral Implantol, V32, P122, DOI 10.1563/796.1
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Muller B, 2002, BIOMOL ENG, V19, P73, DOI 10.1016/S1389-0344(02)00014-X
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Okamoto M, 2006, J MATER SCI-MATER M, V17, P327, DOI 10.1007/s10856-006-8232-z
   Rose FR, 2004, BIOMATERIALS, V25, P5507, DOI 10.1016/j.biomaterials.2004.01.012
   Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Tsay RC, 2005, J ORAL MAXIL SURG, V63, P521, DOI 10.1016/j.joms.2004.09.012
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Weibrich G, 2000, Mund Kiefer Gesichtschir, V4, P148, DOI 10.1007/s100060050187
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 40
TC 25
Z9 26
U1 0
U2 12
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JAN
PY 2009
VL 20
IS 1
BP 67
EP 74
DI 10.1111/j.1600-0501.2008.01605.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 389XQ
UT WOS:000262129300010
PM 19126109
DA 2018-10-19
ER

PT J
AU Chambrone, L
   Sukekava, F
   Araujo, MG
   Pustiglioni, FE
   Chambrone, LA
   Lima, LA
AF Chambrone, Leandro
   Sukekava, Flavia
   Araujo, Mauricio G.
   Pustiglioni, Francisco E.
   Chambrone, Luiz Armando
   Lima, Luiz A.
TI Root coverage procedures for the treatment of localised recession-type
   defects
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID CONNECTIVE-TISSUE GRAFT; CORONALLY POSITIONED FLAP; ACELLULAR DERMAL
   MATRIX; HUMAN GINGIVAL RECESSION; DRIED BONE ALLOGRAFT; DOUBLE PEDICLE
   GRAFT; QUALITY-OF-LIFE; MILLER CLASS-I; BIOABSORBABLE MEMBRANE;
   CLINICAL-EVALUATION
AB Background
   Gingival recession is defined as the oral exposure of the root surface due to a displacement of the gingival margin apical to the cemento-enamel junction and it is regularly linked to the deterioration of dental aesthetics. Successful treatment of recession-type defects is based on the use of predictable periodontal plastic surgery ( PPS) procedures.
   Objectives
   To evaluate the effectiveness of different root coverage procedures in the treatment of recession-type defects.
   Search strategy
   The Cochrane Oral Health Group's Trials Register, CENTRAL, MEDLINE and EMBASE were searched up to October 2008. The main international periodontal journals were handsearched. There were no restrictions with regard to publication status or language of publication.
   Selection criteria
   Only randomised controlled clinical trials (RCTs) of at least 6 months' duration evaluating recession areas (Miller's Class I or II > 3 mm) and that were treated by means of PPS procedures were included.
   Data collection and analysis
   Screening of eligible studies, assessment of the methodological quality of the trials and data extraction were conducted independently and in duplicate. Authors were contacted for any missing information. Results were expressed as random-effects models using mean differences for continuous outcomes and risk ratios for dichotomous outcomes with 95% confidence intervals.
   Main results
   Twenty-four RCTs provided data. Only one trial was considered to be at low risk of bias. The remaining trials were considered to be at high risk of bias.
   The results indicated a significant greater reduction in gingival recession and gain in keratinized tissue for subepithelial connective tissue grafts (SCTG) compared to guided tissue regeneration with resorbable membranes (GTR rm).
   A significant greater gain in the keratinized tissue was found for enamel matrix protein when compared to coronally advanced flap (0.40 mm) and for SCTG when compared to GTR rm plus bone substitutes.
   Limited data exist on aesthetic condition change related to patients' opinion and patients' preference for a specific procedure.
   Authors' conclusions
   Subepithelial connective tissue grafts, coronally advanced flap alone or associated with other biomaterial and guided tissue regeneration may be used as root coverage procedures for the treatment of localised recession-type defects. In cases where both root coverage and gain in the keratinized tissue are expected, the use of subepithelial connective tissue grafts seems to be more adequate.
   Randomised controlled clinical trials are necessary to identify possible factors associated with the prognosis of each PPS procedure.
   The potential impact of bias on these outcomes is unclear.
C1 [Chambrone, Leandro; Sukekava, Flavia; Pustiglioni, Francisco E.; Lima, Luiz A.] Univ Sao Paulo, Dept Periodontol, BR-05508000 Sao Paulo, Brazil.
   [Araujo, Mauricio G.] Univ Estadual Maringa, Dept Periodontol, Maringa, Parana, Brazil.
   [Chambrone, Luiz Armando] Methodist Univ Sao Paulo, Dept Periodontol, BR-05508000 Sao Paulo, Brazil.
RP Chambrone, L (reprint author), Univ Sao Paulo, Dept Periodontol, Av Prof Lineu Prestes,2227 Cidade Univ, BR-05508000 Sao Paulo, Brazil.
EM chambrone@usp.br
RI Chambrone, Leandro/D-8038-2011
FU University of Sao Paulo, Brazil.
FX University of Sao Paulo, Brazil.
CR Aichelmann-Reidy ME, 2001, J PERIODONTOL, V72, P998, DOI 10.1902/jop.2001.72.8.998
   Amarante ES, 2000, J PERIODONTOL, V71, P989, DOI 10.1902/jop.2000.71.6.989
   BAER PN, 1981, J PERIODONTOL, V52, P206, DOI 10.1902/jop.1981.52.4.206
   Baldi C, 1999, J PERIODONTOL, V70, P1077, DOI 10.1902/jop.1999.70.9.1077
   Barros Raquel R M, 2005, J Esthet Restor Dent, V17, P156, DOI 10.1111/j.1708-8240.2005.tb00105.x
   Barros RRM, 2004, J PERIODONTOL, V75, P1350, DOI 10.1902/jop.2004.75.10.1350
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Berlucchi I, 2005, J PERIODONTOL, V76, P899, DOI 10.1902/jop.2005.76.6.899
   Berlucchi I, 2002, INT J PERIODONT REST, V22, P583
   BERNIMOULIN J-P, 1975, Journal of Clinical Periodontology, V2, P1, DOI 10.1111/j.1600-051X.1975.tb01721.x
   Bittencourt S, 2006, J PERIODONTOL, V77, P174, DOI 10.1902/jop.2006.050114
   BJORN H, 1963, SVERIGES TANDLAKARFO, V22, P684
   Borghetti A, 1999, J PERIODONTOL, V70, P123, DOI 10.1902/jop.1999.70.2.123
   BORGHETTI A, 1994, J PERIODONTOL, V65, P1107, DOI 10.1902/jop.1994.65.12.1107
   Bouchard P, 1997, J PERIODONTOL, V68, P262, DOI 10.1902/jop.1997.68.3.262
   BOUCHARD P, 1994, J PERIODONTOL, V65, P929, DOI 10.1902/jop.1994.65.10.929
   Burkhardt R, 2005, J CLIN PERIODONTOL, V32, P287, DOI 10.1111/j.1600-051X.2005.00660.x
   Caffesse RG, 1995, PERIODONTOL 2000, V9, P7, DOI 10.1111/j.1600-0757.1995.tb00051.x
   Caffesse RG, 2000, J PERIODONTOL, V71, P568, DOI 10.1902/jop.2000.71.4.568
   Camargo PM, 2001, PERIODONTOL 2000, V27, P72, DOI 10.1034/j.1600-0757.2001.027001072.x
   Castellanos A, 2006, J PERIODONTOL, V77, P7, DOI 10.1902/jop.2006.77.1.7
   Cetiner D, 2003, J PERIODONTOL, V74, P1196, DOI 10.1902/jop.2003.74.8.1196
   Chambrone L, 2008, J DENT, V36, P659, DOI 10.1016/j.jdent.2008.05.007
   Chambrone Leandro, 2003, J Can Dent Assoc, V69, P505
   Chambrone L, 2009, J AM DENT ASSOC, V140, P294, DOI 10.14219/jada.archive.2009.0158
   Chambrone LA, 2006, J PERIODONTOL, V77, P909, DOI 10.1902/jop.2006.050249
   CHECCHI L, 1993, J PERIODONTOL, V64, P1238, DOI 10.1902/jop.1993.64.12.1238
   Cheung WS, 2004, J PERIODONTOL, V75, P1678, DOI 10.1902/jop.2004.75.12.1678
   COHEN DW, 1968, J PERIODONTOL, V39, P65, DOI 10.1902/jop.1968.39.2.65
   Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087
   Cordioli G, 2001, J PERIODONTOL, V72, P1470, DOI 10.1902/jop.2001.72.11.1470
   Cortes AD, 2004, J PERIODONTOL, V75, P1137
   da Silva RC, 2004, J PERIODONTOL, V75, P413, DOI 10.1902/jop.2004.75.3.413
   Daniel A, 1990, J Indian Dent Assoc, V61, P294
   Cortes AD, 2006, J CLIN PERIODONTOL, V33, P683, DOI 10.1111/j.1600-051X.2006.00969.x
   Del Pizzo M, 2005, J CLIN PERIODONTOL, V32, P1181, DOI 10.1111/j.1600-051X.2005.00831.x
   Dembowska E, 2007, ORAL SURG ORAL MED O, V104, pE1, DOI 10.1016/j.tripleo.2007.03.013
   Dodge JR, 2000, INT J PERIODONT REST, V20, P399
   Duval BT, 2000, J PERIODONTOL, V71, P1687, DOI 10.1902/jop.2000.71.11.1687
   Egger M, 1997, BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Erley KJ, 2006, J PERIODONTOL, V77, P1148, DOI 10.1902/jop.2006.050252
   Esposito M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub2
   Fardal O, 2002, J PERIODONTOL, V73, P1060, DOI 10.1902/jop.2002.73.9.1060
   Felipe MEMC, 2007, J PERIODONTOL, V78, P1209, DOI 10.1902/jop.2007.060356
   FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q
   Glickman I, 1958, J PERIODONTOL, V29, P50
   GRUPE HE, 1966, J PERIODONTOL, V37, P491, DOI 10.1902/jop.1966.37.6.491
   Grupe HE, 1956, J PERIODONTOL, V27, P92
   Gupta R, 2006, INT J PERIODONT REST, V26, P271
   Harris RJ, 2005, J PERIODONTOL, V76, P1758, DOI 10.1902/jop.2005.76.10.1758
   HARRIS RJ, 1992, J PERIODONTOL, V63, P477, DOI 10.1902/jop.1992.63.5.477
   Harris RJ, 2000, INT J PERIODONT REST, V20, P51
   Harris RJ, 2002, J PERIODONTOL, V73, P1054, DOI 10.1902/jop.2002.73.9.1054
   Harris RJ, 1997, J PERIODONTOL, V68, P779, DOI 10.1902/jop.1997.68.8.779
   Harvey P M, 1965, N Z Dent J, V61, P180
   Harvey P M, 1970, N Z Dent J, V66, P42
   Henderson RD, 2001, J PERIODONTOL, V72, P571, DOI 10.1902/jop.2001.72.5.571
   Higgins JPT, 2008, COCHRANE HDB SYSTEMA
   Hirsch A, 2005, J PERIODONTOL, V76, P1323, DOI 10.1902/jop.2005.76.8.1323
   Huang LH, 2005, J PERIODONTOL, V76, P1768, DOI 10.1902/jop.2005.76.10.1768
   Ito K, 2000, QUINTESSENCE INT, V31, P319
   JAHNKE PV, 1993, J PERIODONTOL, V64, P315, DOI 10.1902/jop.1993.64.4.315
   Jepsen K, 1998, J PERIODONTOL, V69, P383, DOI 10.1902/jop.1998.69.3.383
   Joly JC, 2007, J PERIODONTOL, V78, P1017, DOI 10.1902/jop.2007.060428
   Jornung J, 2007, J AM DENT ASSOC, V138, P1544, DOI 10.14219/jada.archive.2007.0103
   Karadottir H, 2002, J PERIODONTOL, V73, P536, DOI 10.1902/jop.2002.73.5.536
   Keceli HG, 2008, J CLIN PERIODONTOL, V35, P255, DOI 10.1111/j.1600-051X.2007.01181.x
   KENNEDY JE, 1985, J CLIN PERIODONTOL, V12, P667, DOI 10.1111/j.1600-051X.1985.tb00938.x
   KHOCHT A, 1993, J PERIODONTOL, V64, P900, DOI 10.1902/jop.1993.64.9.900
   Kimble KM, 2004, J PERIODONTOL, V75, P210, DOI 10.1902/jop.2004.75.2.210
   Lafzi A, 2007, CLIN ORAL INVEST, V11, P401, DOI 10.1007/s00784-007-0143-y
   LANEY JB, 1992, J PERIODONTOL, V63, P19, DOI 10.1902/jop.1992.63.1.19
   LANGER B, 1985, J PERIODONTOL, V56, P715, DOI 10.1902/jop.1985.56.12.715
   Leknes KN, 2005, J CLIN PERIODONTOL, V32, P518, DOI 10.1111/j.1600-051X.2005.00706.x
   Lins LHS, 2003, J PERIODONTOL, V74, P168, DOI 10.1902/jop.2003.74.2.168
   Mahajan A, 2007, J PERIODONTOL, V78, P2348, DOI 10.1902/jop.2007.070074
   Martins AG, 2004, J PERIODONTOL, V75, P586, DOI 10.1902/jop.2004.75.4.586
   Matarasso S, 1998, INT J PERIODONT REST, V18, P445
   MATTHEWS DC, 1993, J PERIODONTOL, V64, P990, DOI 10.1902/jop.1993.64.10.990
   McGuire MK, 2003, J PERIODONTOL, V74, P1110, DOI 10.1902/jop.2003.74.8.1110
   MCGUIRE MK, 1995, INT J PERIODONT REST, V15, P71
   Miller P D Jr, 1985, Int J Periodontics Restorative Dent, V5, P8
   Modica F, 2000, J PERIODONTOL, V71, P1693, DOI 10.1902/jop.2000.71.11.1693
   Moses O, 2006, J PERIODONTOL, V77, P195, DOI 10.1902/jop.2006.050008
   Muller HP, 1998, J CLIN PERIODONTOL, V25, P424, DOI 10.1111/j.1600-051X.1998.tb02466.x
   Muller HP, 1999, J PERIODONTOL, V70, P743, DOI 10.1902/jop.1999.70.7.743
   NABERS JM, 1966, PERIODONTICS, V4, P243
   Needleman I, 2005, PERIODONTOL 2000, V37, P12, DOI 10.1111/j.1600-0757.2004.37100.x
   Needleman I, 2005, PERIODONTOL 2000, V37, P106, DOI 10.1111/j.1600-0757.2004.37101.x
   Needleman IG, 2002, J CLIN PERIODONTOL, V29, P6, DOI 10.1034/j.1600-051X.29.s3.15.x
   Nemcovsky CE, 2004, J PERIODONTOL, V75, P600, DOI 10.1902/jop.2004.75.4.600
   Ng SKS, 2006, COMMUNITY DENT ORAL, V34, P114, DOI 10.1111/j.1600-0528.2006.00267.x
   Novaes AB, 2001, J PERIODONTOL, V72, P1477, DOI 10.1902/jop.2001.72.11.1477
   Oates Thomas W, 2003, Ann Periodontol, V8, P303, DOI 10.1902/annals.2003.8.1.303
   Ozcelik O, 2007, J CLIN PERIODONTOL, V34, P788, DOI 10.1111/j.1600-051X.2007.01120.x
   Paolantonio M, 1997, J CLIN PERIODONTOL, V24, P51, DOI 10.1111/j.1600-051X.1997.tb01184.x
   Paolantonio M, 2002, J PERIODONTOL, V73, P1299, DOI 10.1902/jop.2002.73.11.1299
   Paolantonio M, 2002, J PERIODONTOL, V73, P53, DOI 10.1902/jop.2002.73.1.53
   Pilloni A, 2006, J PERIODONTOL, V77, P2031, DOI 10.1902/jop.2006.050390
   Pini-Prato G, 1999, J PERIODONTOL, V70, P1064, DOI 10.1902/jop.1999.70.9.1064
   Prato GP, 1996, J PERIODONTOL, V67, P1216, DOI 10.1902/jop.1996.67.11.1216
   Prato GP, 2000, J PERIODONTOL, V71, P188, DOI 10.1902/jop.2000.71.2.188
   PRATO GP, 1992, J PERIODONTOL, V63, P919, DOI 10.1902/jop.1992.63.11.919
   Prato GPP, 2005, J PERIODONTOL, V76, P713, DOI 10.1902/jop.2005.76.5.713
   Rahmani M E, 2006, J Contemp Dent Pract, V7, P63
   Ricci G, 1996, J Esthet Dent, V8, P66, DOI 10.1111/j.1708-8240.1996.tb00887.x
   Ricci G, 1996, INT J PERIODONT REST, V16, P539
   Richmond S, 2007, COMMUNITY DENT ORAL, V35, P89, DOI 10.1111/j.1600-0528.2007.00296.x
   Roccuzzo M, 2002, J CLIN PERIODONTOL, V29, P178, DOI 10.1034/j.1600-051X.29.s3.11.x
   Roccuzzo M, 1996, J PERIODONTOL, V67, P7, DOI 10.1902/jop.1996.67.1.7
   Romagna-Genon C, 2001, J PERIODONTOL, V72, P1258, DOI 10.1902/jop.2000.72.9.1258
   Rosetti EP, 2000, J PERIODONTOL, V71, P1441, DOI 10.1902/jop.2000.71.9.1441
   Saletta D, 2001, J PERIODONTOL, V72, P760, DOI 10.1902/jop.2001.72.6.760
   Sallum EA, 2003, AM J DENT, V16, P287
   Sbordone L, 1988, Periodontal Case Rep, V10, P8
   Scabbia A, 1998, J CLIN PERIODONTOL, V25, P1041, DOI 10.1111/j.1600-051X.1998.tb02411.x
   Silva CO, 2007, J PERIODONTOL, V78, P1702, DOI 10.1902/jop.2007.070068
   Spahr A, 2005, J PERIODONTOL, V76, P1871, DOI 10.1902/jop.2005.76.11.1871
   SULLIVAN HC, 1968, PERIODONTICS, V6, P152
   SUMNER CF, 1969, J PERIODONTOL, V40, P119, DOI 10.1902/jop.1969.40.2.119
   Susin C, 2004, J PERIODONTOL, V75, P1377, DOI 10.1902/jop.2004.75.10.1377
   Tal H, 2002, J PERIODONTOL, V73, P1405, DOI 10.1902/jop.2002.73.12.1405
   TARNOW DP, 1992, J PERIODONTOL, V63, P995, DOI 10.1902/jop.1992.63.12.995
   Tatakis DN, 2000, J PERIODONTOL, V71, P299, DOI 10.1902/jop.2000.71.2.299
   Thomson WM, 2006, J PERIODONTOL, V77, P947, DOI 10.1902/jop.2006.050319
   Tozum TF, 2005, J PERIODONTOL, V76, P1842, DOI 10.1902/jop.2005.76.11.1842
   Trabulsi M, 2004, J PERIODONTOL, V75, P1446, DOI 10.1902/jop.2004.75.11.1446
   TROMBELLI L, 1995, J PERIODONTOL, V66, P313, DOI 10.1902/jop.1995.66.5.313
   Trombelli L, 2005, J CLIN PERIODONTOL, V32, P16, DOI 10.1111/j.1600-051X.2004.00625.x
   TROMBELLI L, 1995, J PERIODONTOL, V66, P14, DOI 10.1902/jop.1995.66.1.14
   Trombelli L, 1996, J CLIN PERIODONTOL, V23, P861, DOI 10.1111/j.1600-051X.1996.tb00624.x
   Trombelli L, 1997, INT J PERIODONT REST, V17, P449
   Trombelli L, 1998, J PERIODONTOL, V69, P1271, DOI 10.1902/jop.1998.69.11.1271
   Wang HL, 2001, J PERIODONTOL, V72, P1301, DOI 10.1902/jop.2001.72.10.1301
   Wennstrom JL, 1996, J CLIN PERIODONTOL, V23, P770, DOI 10.1111/j.1600-051X.1996.tb00608.x
   Wilson TG, 2005, J PERIODONTOL, V76, P881, DOI 10.1902/jop.2005.76.6.881
   Woodyard JG, 2004, J PERIODONTOL, V75, P44, DOI 10.1902/jop.2004.75.1.44
   YONEYAMA T, 1988, J CLIN PERIODONTOL, V15, P581, DOI 10.1111/j.1600-051X.1988.tb02133.x
   Zucchelli G, 2003, J CLIN PERIODONTOL, V30, P862, DOI 10.1034/j.1600-051X.2003.00397.x
   Zucchelli G, 1998, J PERIODONTOL, V69, P138, DOI 10.1902/jop.1998.69.2.138
   1996, ANN PERIODONTOL, V1, P702
NR 141
TC 44
Z9 45
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2009
IS 2
AR CD007161
DI 10.1002/14651858.CD007161.pub2
PG 81
WC Medicine, General & Internal
SC General & Internal Medicine
GA 469DK
UT WOS:000267875600017
PM 19370675
DA 2018-10-19
ER

PT J
AU Ericsson, EM
   Faxalv, L
   Weissenrieder, A
   Askendal, A
   Lindahl, TL
   Tengvall, P
AF Ericsson, Emma M.
   Faxalv, Lars
   Weissenrieder, Anna
   Askendal, Agneta
   Lindahl, Tomas L.
   Tengvall, Pentti
TI Glycerol monooleate-blood interactions
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Glycerol monooleate; Blood compatibility; Shear; Ellipsometry
ID DRUG-DELIVERY SYSTEMS; BEHAVIOR; SILICON; FILMS
AB In the present study the initial blood compatibility of glycerol monooleate (GMO)-coated surfaces was evaluated after deposition to surfaces and in bulk. The model surface was silica onto which multiple layers of fibrinogen or human serum albumin (HSA) was immobilized. The protein-coated surfaces were subsequently dip-coated in GMO in ethanol and used for blood plasma and whole blood experiments. The characterization methods included null ellipsometry, scanning electron microscopy, imaging of coagulation, hemolysis test and whole blood coagulation time by free oscillation rheometry.
   The results showed a GMO film thickness of approximately 350 angstrom (similar to 4 mu g/cm(2)) upon dip-coating in ethanolic solution. A major part of the deposited layer detached in aqueous solutions, especially during shear conditions. The coagulation time on GMO was significantly prolonged compared to that on HSA coated silica. Whole blood tests showed that GMO is a very weak hemolytic agent. Deposited GMO detached easily from surfaces upon rinsing or shearing, although a stable layer with undefined phase structure and a thickness of 50-70 angstrom remained on HSA and fibrinogen precoated surfaces. This indicates that GMO has stronger adhesive forces to its substrate compared to the cohesive forces acting within the bulk GMO. The ability of GMO to detach from itself and tentatively form micelles or lipid bilayers when subjected to flowing blood may be of use in extravascular applications. It is concluded that GMO results in weak blood activation, and the material may in spite of this be suitable in selected biomaterial applications, especially as a biosealant and in colloidal dispersions. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Ericsson, Emma M.; Askendal, Agneta; Tengvall, Pentti] Linkoping Univ, Dept Phys Chem & Biol, Appl Phys Lab, SE-58183 Linkoping, Sweden.
   [Faxalv, Lars; Lindahl, Tomas L.] Linkoping Univ, Dept Clin & Expt Med, Clin Chem Lab, SE-58183 Linkoping, Sweden.
   [Weissenrieder, Anna] St Jude Med Inc, St Paul, MN 55117 USA.
RP Ericsson, EM (reprint author), Linkoping Univ, Dept Phys Chem & Biol, Appl Phys Lab, SE-58183 Linkoping, Sweden.
EM emmer@ifm.liu.se
FU County Council of Ostergotland and Linkopings Universitet, Sweden
FX This investigation was supported by the local strategic research project
   Materials in Medicine funded by County Council of Ostergotland and
   Linkopings Universitet, Sweden.
CR Abe S, 2007, CHEM PHYS LIPIDS, V147, P59, DOI 10.1016/j.chemphyslip.2007.03.005
   Adams GL, 2008, J INVASIVE CARDIOL, V20, P29
   Burdock GA, 1997, ENCY FOOD COLOR ADDI
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Faxalv L, 2008, J BIOMED MATER RES A, V85A, P1129, DOI 10.1002/jbm.a.31529
   GRIFFIN WC, 1979, KIRKOTHMER ENCY CHEM, P117
   Jansson E, 2001, BIOMATERIALS, V22, P1803, DOI 10.1016/S0142-9612(00)00359-8
   Kumar KM, 2004, INT J PHARM, V272, P151, DOI 10.1016/j.ijpharm.2003.12.025
   MCCRACKIN FL, 1969, NBS TECHNICAL NOTE, V479
   Nielsen LS, 1998, EUR J PHARM SCI, V6, P231, DOI 10.1016/S0928-0987(97)10004-5
   NOSB TAP Review, 2001, NOSB TAP REV
   Plasma V., 2005, PLAST ADDIT COMPD, V7, P30
   Ranby M, 2003, SCAND J CLIN LAB INV, V63, P397, DOI 10.1080/00365510310002095
   Sadhale Y, 1998, Pharm Dev Technol, V3, P549, DOI 10.3109/10837459809028637
   Shah JC, 2001, ADV DRUG DELIVER REV, V47, P229, DOI 10.1016/S0169-409X(01)00108-9
   Sintov AC, 2003, J PHARM PHARMACOL, V55, P911, DOI 10.1211/0022357021486
   Tengvall P, 2003, COLLOID SURFACE B, V28, P261, DOI 10.1016/S0927-7765(02)00151-0
   1986, J AM COLL TOXICOL, P413
NR 18
TC 8
Z9 8
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2009
VL 68
IS 1
BP 20
EP 26
DI 10.1016/j.colsurfb.2008.09.016
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 387VW
UT WOS:000261980700004
PM 18996684
DA 2018-10-19
ER

PT J
AU Soerensen, MM
   Lundby, L
   Buntzen, S
   Laurberg, S
AF Soerensen, M. M.
   Lundby, L.
   Buntzen, S.
   Laurberg, S.
TI Intersphincteric injected silicone biomaterial implants: a treatment for
   faecal incontinence
SO COLORECTAL DISEASE
LA English
DT Article
DE Minimal invasive procedure; intersphincteric PTQ (TM) injections;
   intersphincteric bulking agents; faecal incontinence
ID AUTOLOGOUS FAT
AB The aim of this study was to evaluate the functional efficacy of intersphincteric injected silicone biomaterial (PTQ (TM)) in patients with faecal incontinence.
   Prospective study of 33 consecutively included patients (male-female ratio: 9:24); median age 53 years (range: 21-75 years) with faecal incontinence of varied aetiology. The PTQ (TM) was injected under general anaesthesia with antibiotic cover. All patients had anorectal manometry, endoanal ultrasonography and responded to faecal incontinence severity questionnaire (Wexner score) and SF-36 short-form health survey questionnaire before and 3 months postoperatively. At time of final follow-up, the continence status and quality of life questionnaire were reassessed.
   The mean follow-up was 12.9 months (range: 3-22 months). The Wexner Continence Score was significantly reduced short term from 12.7 to 11.0 (P = 0.03) and long term to 10.4 (P = 0.02). The long-term effect on liquid stool incontinence continued to improve significantly (P < 0.01). Six patients (18%) reported major improvement in Wexner Continence Score at the time of final follow-up. Anorectal manometry was not affected except for the maximum tolerable rectal volume, which was significantly reduced (P < 0.05). The SF-36 short-form questionnaire showed no significant improvement in quality of life after treatment with PTQ (TM).
   Treatment with intersphincteric injection of PTQ (TM) implants can provide an improvement in anal continence in patients with faecal incontinence of varied aetiology. However, the improvement is mainly limited to soiling and minor leakage. A majority of patients still have severe incontinence, both short- and long-term.
C1 [Soerensen, M. M.; Lundby, L.; Buntzen, S.; Laurberg, S.] Aarhus Univ Hosp, Dept Surg P, Surg Res Unit, DK-8000 Aarhus C, Denmark.
RP Lundby, L (reprint author), Aarhus Univ Hosp, Dept Surg P, Surg Res Unit, Tage Hansens Gade 2, DK-8000 Aarhus C, Denmark.
EM lilli@dadlnet.dk
CR Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   DAVIS K, 2003, ALIMENT PHARM THER, V15, P18
   Kumar D, 1998, BRIT J SURG, V85, P978
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Rao SSC, 2004, GASTROENTEROLOGY, V126, pS14, DOI 10.1053/j.gastro.2003.10.013
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
NR 13
TC 22
Z9 24
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1462-8910
J9 COLORECTAL DIS
JI Colorectal Dis.
PD JAN
PY 2009
VL 11
IS 1
BP 73
EP 76
DI 10.1111/j.1463-1318.2008.01544.x
PG 4
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 382VY
UT WOS:000261634700014
PM 18462216
DA 2018-10-19
ER

PT J
AU Pepper, IL
   Gerba, CP
   Newby, DT
   Rice, CW
AF Pepper, I. L.
   Gerba, C. P.
   Newby, D. T.
   Rice, C. W.
TI Soil: A Public Health Threat or Savior?
SO CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY
LA English
DT Review
DE soil; geoindigenous pathogens; antibiotics; natural products
ID ARBUSCULAR-MYCORRHIZAL-FUNGI; JAPONICUM KIRCHNER JORDAN; HORIZONTAL
   GENE-TRANSFER; MAX L. MERR.; ENDOPHYTIC FUNGUS; TRIPARTITE-SYMBIOSIS;
   CARBON SEQUESTRATION; BACILLUS-ANTHRACIS; NATURAL-PRODUCTS;
   CLIMATE-CHANGE
AB Soil is the most complicated biomaterial on the planet due to complex soil architecture and billions of soil microbes with extreme biotic diversity. Soil is potentially a source of human pathogens, which can be defined as geo-indigenous, geo-transportable, or geo-treatable. Such pathogens cumulatively can and do result in multiple human fatalities annually. A striking example is Helminths, with current infections worldwide estimated to be around two billion. However, soil can also be a source of antibiotics and other natural products that enhance human health. Soilborne antibiotics are used to treat human infections, but can also result in antibiotic-resistant bacteria. Natural products isolated from soil resulted in 60% of new cancer drugs between the period 1983-1994. Soils are also crucial to human health through their impact on human nutrition. Finally, from a global perspective, soils are vital to the future well-being of nations through their impact on climate change and global warming. A critical review of soil with respect to public health leads to the conclusion that overall soil is a public health savior. The value of soil using a systems approach is estimated to be $20 trillion, and is by far the most valuable ecosystem in the world.
C1 [Pepper, I. L.] Univ Arizona, Environm Res Lab, Tucson, AZ 85706 USA.
   [Gerba, C. P.] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85706 USA.
   [Newby, D. T.] Idaho Natl Lab, Idaho Falls, ID USA.
   [Rice, C. W.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.
RP Pepper, IL (reprint author), Univ Arizona, Environm Res Lab, Tucson, AZ 85706 USA.
EM ipepper@ag.arizona.edu
FU National Academies Committee; United States National Committee for Soil
   Science
FX We would like to thank members of the National Academies Committee,
   United States National Committee for Soil Science, for their initial
   discussions of soil and human health, which initiated this review
   article.
CR Abbaszadegan M, 2003, J AM WATER WORKS ASS, V95, P107
   Antunes PM, 2006, SOIL BIOL BIOCHEM, V38, P1234, DOI 10.1016/j.soilbio.2005.09.016
   Antunes PM, 2006, SOIL BIOL BIOCHEM, V38, P533, DOI 10.1016/j.soilbio.2005.06.008
   Bejat L, 2000, SOIL SCI SOC AM J, V64, P818, DOI 10.2136/sssaj2000.643818x
   Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038
   Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8
   Bouwman A., 2001, GLOBAL ESTIMATES GAS, P106
   Brewer S, 2000, ROY SOC CH, P59, DOI 10.1039/9781847550231-00059
   BROOKS JP, 2004, J RESIDUALS SCI TECH, V1, P15
   Cassadevall A., 2006, MICROBE, V1, P359
   Castillo UF, 2002, MICROBIOL-SGM, V148, P2675
   Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539
   D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800
   Daisy BH, 2002, MICROBIOL-SGM, V148, P3737, DOI 10.1099/00221287-148-11-3737
   de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002
   Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1
   Dominy NJ, 2004, J EXP BIOL, V207, P319, DOI 10.1242/jeb.00758
   Dragon DC, 2001, LETT APPL MICROBIOL, V33, P100, DOI 10.1046/j.1472-765x.2001.00966.x
   Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138
   Findlay JA, 1997, J NAT PROD, V60, P1214, DOI 10.1021/np970222j
   Fleming A, 1942, LANCET, V1, P732
   Fleming FM, 2006, TROP MED INT HEALTH, V11, P56, DOI 10.1111/j.1365-3156.2005.01541.x
   Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2
   GERBA CP, 2006, FALL M DEC 4 5 TEMP
   Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076
   GLENN EP, 2006, ENV POLLUTION SCI, P395
   Grabley S., 1999, DRUG DISCOVERY NATUR, P3
   Gunatilaka AAL, 2006, J NAT PROD, V69, P509, DOI 10.1021/np058128n
   Harper JK, 2003, TETRAHEDRON, V59, P2471, DOI 10.1016/S0040-4020(03)00255-2
   Hector RF, 2005, PLOS MED, V2, P15, DOI 10.1371/journal.pmed.0020002
   Hendriksen NB, 2002, CAN J MICROBIOL, V48, P256, DOI 10.1139/W02-009
   Hughes-Jones M, 1999, J APPL MICROBIOL, V87, P189, DOI 10.1046/j.1365-2672.1999.00867.x
   Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236
   KELLOGG CA, 2006, TRENDS ECOL EVOL, V21, P838
   Kieser T., 2000, PRACTICAL STREPTOMYC
   Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226
   Koide M, 1999, CLIN INFECT DIS, V29, P943, DOI 10.1086/520470
   Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396
   Lal R., 1999, Progress in Environmental Science, V1, P307
   LEE JC, 1995, J ORG CHEM, V60, P7076, DOI 10.1021/jo00127a001
   Loh J, 2002, CURR OPIN PLANT BIOL, V5, P285, DOI 10.1016/S1369-5266(02)00274-1
   Lokupitiya E, 2006, J ENVIRON QUAL, V35, P1413, DOI 10.2134/jeq2005.0157
   LONHART SW, 1994, APPL OCCUPAT ENV HYG, V9, P230
   Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599
   Metz B., 2007, CLIMATE CHANGE 2007
   NEILSON JW, 1994, APPL ENVIRON MICROB, V60, P4053
   Newby DT, 2000, APPL ENVIRON MICROB, V66, P290, DOI 10.1128/AEM.66.1.290-296.2000
   Pepper IL, 2002, ENVIRON HEALTH PERSP, V110, P943, DOI 10.1289/ehp.02110s6943
   Pepper IL, 2002, SOIL SCI, V167, P627, DOI 10.1097/01.ss.0000034856.98442.ab
   Pepper IL, 2006, ENV POLLUTION SCI
   POINTING SB, 2001, BIOEXPLOITATION FILA, P93
   Powlson D, 2005, NATURE, V433, P204, DOI 10.1038/433204a
   Rensing C, 2002, SOIL BIOL BIOCHEM, V34, P285, DOI 10.1016/S0038-0717(01)00183-3
   Rice CW, 2006, J ENVIRON QUAL, V35, P1338, DOI 10.2134/jeq2006.0001
   Schmitt H, 2005, SOIL BIOL BIOCHEM, V37, P1882, DOI 10.1016/j.soilbio.2005.02.022
   SCHMITT H, ENV SCI TECHNOL, V15, P1148
   SHATZ A, 1944, P SOC EXP BIOL MED, V55, P66
   Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008
   Stirzaker RJ, 1996, PLANT SOIL, V185, P151, DOI 10.1007/BF02257571
   Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003
   SUNDQUIST ET, 1993, SCIENCE, V259, P934, DOI 10.1126/science.259.5097.934
   Tomasz A, 2006, SCIENCE, V311, P342, DOI 10.1126/science.1123982
   TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782
   Tumbull P. C. B., 1998, J APPL MICROBIOL, V84, P667
   WAKSMAN SA, 1949, SCIENCE, V109, P305, DOI 10.1126/science.109.2830.305
   Walsh Thomas J., 1995, P749
   Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394
   Young P, 1997, ASM NEWS, V63, P417
   Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999
   Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974
   Zheng HM, 2006, J BACTERIOL, V188, P1943, DOI 10.1128/JB.188.5.1943-1949.2006
   Zhou L, 2003, J EUKARYOT MICROBIOL, V50, P522, DOI 10.1111/j.1550-7408.2003.tb00617.x
   2000, MMWR MORBIDITY MORTA, V49, P34
NR 73
TC 13
Z9 13
U1 4
U2 44
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1064-3389
J9 CRIT REV ENV SCI TEC
JI Crit. Rev. Environ. Sci. Technol.
PY 2009
VL 39
IS 5
BP 416
EP 432
AR PII 910740138
DI 10.1080/10643380701664748
PG 17
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 438RQ
UT WOS:000265573500002
DA 2018-10-19
ER

PT J
AU Kang, M
   Chen, P
   Jin, HJ
AF Kang, Minsung
   Chen, Peng
   Jin, Hyoung-Joon
TI Preparation of multiwalled carbon nanotubes incorporated silk fibroin
   nanofibers by electrospinning
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE Fibres, synthetic and natural; Biomolecules: proteins; Reinforced
   polymers and polymerbased composites
ID MEMBRANES; COMPOSITE; FIBERS
AB Nanocomposite fibers, including silk fibroin (Bombyx mori)and multiwalled carbon nanotube (MWCNT), were successfully prepared using electrospinning. Regenerated silk fibroins and MWCNTs were dissolved in formic acid, with the solution then electrospun into nanofibers. The morphology and microstructure of the electrospun nanofibers were characterized using field emission scanning electron microscopy (FESEM) and transmission electron microscopy (TEM). The FESEM and TEM images showed the MWCNTs to be well incorporated along the nanofibers. The tensile properties of the nanofibers were also enhanced by the incorporation of a small amount of MWCNTs. The electrospinning of silk/MWCNT composites could potentially Supply Useful options for the fabrication of biomaterial scaffolds, such as wound dressings. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Kang, Minsung; Chen, Peng; Jin, Hyoung-Joon] Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
RP Jin, HJ (reprint author), Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
EM hjjin@inha.ac.kr
RI Chen, Peng/E-9792-2011
FU Korea Research Foundation; Korean Government; MOEHRD, Basic Research
   Promotion Fund [KRF-2007-331-D00120]
FX This work was supported by the Korea Research Foundation Grant funded by
   the Korean Government (MOEHRD, Basic Research Promotion Fund)
   (KRF-2007-331-D00120).
CR Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Gao JB, 2005, J AM CHEM SOC, V127, P3847, DOI 10.1021/ja0446193
   HARTMAN AZ, 2004, PHYS REV LETT, V92
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kang M, 2006, POLYMER, V47, P3961, DOI 10.1016/j.polymer.2006.03.073
   Kim HS, 2006, MACROMOL RAPID COMM, V27, P146, DOI 10.1002/marc.200500617
   Sung JH, 2004, MACROMOLECULES, V37, P9899, DOI 10.1021/ma048355g
   Wang H, 2005, J MATER SCI, V40, P5359, DOI 10.1007/s10853-005-4332-2
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Yoon SH, 2006, BIOMACROMOLECULES, V7, P1280, DOI 10.1021/bm050597g
NR 10
TC 31
Z9 36
U1 7
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JAN
PY 2009
VL 9
SU 1
SI SI
BP S95
EP S97
DI 10.1016/j.cap.2008.08.014
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 395CS
UT WOS:000262500500028
DA 2018-10-19
ER

PT J
AU Kim, H
   Kim, Y
AF Kim, Hero
   Kim, Younghun
TI Preparation of nanoporous gold using PS bead, Ludox and nanoporous
   alumina as physical templates
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE Sol-gel; Porous gold; Template; PS bead; Dealloy
AB The binding system of specific proteins to gold nanoparticles in nano/bio-sensor was usually used to detect target molecules. Nanoporous materials have some unique properties; uniform pore system (1-10 nm) and large surface area (-1000 m(2)/g), and easily prepared by oxide elements like silica and alumina. When we prepare nanoporous gold structure, it will be useful to fabricate electrode for biomaterial friendly nano/bio-sensor. In this study, nanoporous gold was prepared by using PS bead, Ludox and nanoporous alumina as physical templates. PS bead prepared by emulsifier-free emulsion polymerization method showed 100 nm with 20 nm of textural pore. Ludox (silica) has 7-22 nm size with 4 min of textural pore, which was controlled by Stober method. PS bead template was deposited by filtering method, while Ludox template was fabricated by natural drying method. Inversed gold nanostructure was obtained after selective etching of templates. The nanoporous structure of porous gold was confirmed by SEM analysis. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Kim, Hero; Kim, Younghun] Kwangwoon Univ, Dept Chem Engn, Seoul 139701, South Korea.
RP Kim, Y (reprint author), Kwangwoon Univ, Dept Chem Engn, Seoul 139701, South Korea.
EM korea1@kw.ac.krr
FU Kwangwoon University
FX This research was conducted through the Research Grant of Kwangwoon
   University in 2008 and the Seoul R&BD Program of Seoul City.
CR Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529
   Kim Y, 2004, MATER RES BULL, V39, P2103, DOI 10.1016/j.materresbull.2004.07.002
   Moreau F, 2007, CATAL TODAY, V122, P215, DOI 10.1016/j.cattod.2006.12.001
   ROBERSON LJ, 2006, NNIN REU RES ACCOMPL, P82
NR 5
TC 14
Z9 14
U1 2
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JAN
PY 2009
VL 9
SU 1
SI SI
BP S88
EP S90
DI 10.1016/j.cap.2008.08.049
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 395CS
UT WOS:000262500500026
DA 2018-10-19
ER

PT J
AU Mundada, AS
   Avari, JG
AF Mundada, A. S.
   Avari, J. G.
TI Damar Batu as a novel matrix former for the transdermal drug delivery:
   in vitro evaluation
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
DE Diltiazem hydrochloride; in vitro permeation; in vitro release; matrix
   system; transdermal drug delivery
ID SKIN PERMEATION; DILTIAZEM HYDROCHLORIDE; POLYMERIC FILMS; THERAPEUTIC
   SYSTEM; CONTROLLED-RELEASE; NITROGLYCERIN; PENETRATION; PATCHES
AB Purpose: Damar Batu (DB) is a novel film-forming biomaterial obtained from Shorea species, evaluated in this study for its potential application in transdermal drug delivery system. Methods: DB was characterized initially in terms of acid value, softening point, molecular weight (M-w), polydispersity index (M-w/M-n), and glass transition temperature (T-g). Neat, plasticized films of DB were investigated for mechanical properties. The biomaterial was further investigated as a matrix-forming agent for transdermal drug delivery system. Developed matrix-type transdermal patches were evaluated for thickness and weight uniformity, folding endurance, drug content, in vitro drug release study, and skin permeation study. Results: On the basis of in vitro drug release and in vitro skin permeation performance, formulation containing DB/Eudragit RL100 (60 : 40) was found to be better than other formulations and was selected as the optimized formulation. IR analysis of physical mixture of drug and polymer and thin layer chromatography study exhibited compatibility between drug and polymer. Conclusion: From the outcome of this study, it can be concluded that applying suitable adhesive layer and backing membrane-developed DB/ERL100, transdermal patches can be of potential therapeutic use.
C1 [Mundada, A. S.; Avari, J. G.] RTM Nagpur Univ, Dept Pharmaceut Sci, Nagpur 440033, Maharashtra, India.
RP Mundada, AS (reprint author), RTM Nagpur Univ, Dept Pharmaceut Sci, Amravati Rd, Nagpur 440033, Maharashtra, India.
EM atishmundada@rediffmail.com
CR American Society for Testing and Materials, 1995, D88295A ASTM
   Aqil M, 2002, EUR J PHARM BIOPHARM, V54, P161, DOI 10.1016/S0939-6411(02)00059-0
   Aqil Mohamed, 2003, Acta Pharmaceutica (Zagreb), V53, P119
   BERNER B, 1989, J PHARM SCI, V78, P402, DOI 10.1002/jps.2600780512
   BODMEIER R, 1990, J PHARM SCI, V79, P32, DOI 10.1002/jps.2600790109
   Bohme K, 2002, CLIN RHEUMATOL, V21, pS13, DOI 10.1007/s100670200031
   BONINA FP, 1993, INT J PHARM, V100, P41, DOI 10.1016/0378-5173(93)90073-O
   CHIEN YW, 1983, J PHARM SCI, V72, P968, DOI 10.1002/jps.2600720837
   CHIEN YW, 1987, DRUG DEV IND PHARM, V13, P589, DOI 10.3109/03639048709105212
   CHIEN YW, 1984, DRUG DEV IND PHARM, V10, P575, DOI 10.3109/03639048409041408
   CORBO M, 1990, J PHARM SCI, V79, P584, DOI 10.1002/jps.2600790707
   Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
   Gupta R, 2003, DRUG DEV IND PHARM, V29, P1, DOI 10.1082/DDC-120016678
   Jain SK, 2003, DRUG DELIV, V10, P169, DOI 10.1080/10717540390215582
   Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306
   KERINS DM, 2001, GOODMAN GILMANS PHAR, P856
   LOFTSSON T, 1987, PHARMACEUT RES, V4, P436, DOI 10.1023/A:1016402900093
   Lopez CR, 1996, DRUG DEV IND PHARM, V22, P1201
   MAZZO DJ, 1994, ANAL PROF DRUG SUBST, V23, P53
   Mundada AS, 2006, DRUG DEV IND PHARM, V32, P443, DOI 10.1080/03639040500534101
   MUNDADA AS, 2009, DRUG DELIV IN PRESS
   Mutalik S, 2004, J PHARM SCI-US, V93, P1577, DOI 10.1002/jps.20058
   Rao PR, 2000, PHARM DEV TECHNOL, V5, P465, DOI 10.1081/PDT-100102030
   Rao PR, 1998, DRUG DEV IND PHARM, V24, P327, DOI 10.3109/03639049809085627
   RAYNOLDS JEF, 1996, MARTINDALE EXTRA PHA, P857
   Rowe RC, 2006, HDB PHARM EXCIPIENTS, P553
   SARPOTDAR PP, 1986, J PHARM SCI, V75, P26, DOI 10.1002/jps.2600750107
   SETH AK, 1985, INDIAN DRUGS, V23, P45
   Sood A, 1999, STP PHARMA SCI, V9, P157
   Ubaidulla U, 2007, AAPS PHARMSCITECH, V8
   *US PHARM CONV, 1995, US PHARM, V23, P1796
   Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025
   1959, PAINT OIL COLOUR J, V11, P215
   1973, 136 FPRI DEV COMM
NR 34
TC 5
Z9 5
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0363-9045
EI 1520-5762
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PY 2009
VL 35
IS 9
BP 1147
EP 1154
DI 10.1080/03639040902882249
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 495WW
UT WOS:000269927100015
PM 19555240
DA 2018-10-19
ER

PT J
AU Chevalier, E
   Viana, M
   Cazalbou, S
   Chulia, D
AF Chevalier, E.
   Viana, M.
   Cazalbou, S.
   Chulia, D.
TI Comparison of low-shear and high-shear granulation processes: effect on
   implantable calcium phosphate granule properties
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
DE Bioceramics; bone filling; calcium phosphate; dissolution; high-shear
   process; ibuprofen; low-shear process; physicochemical properties;
   porosity; wet granulation
ID PORE-SIZE DISTRIBUTION; WET GRANULATION; BONE-CEMENT; PHYSICOCHEMICAL
   PROPERTIES; HYDROXYAPATITE GRANULES; LIQUID DISTRIBUTION; DELIVERY
   SYSTEM; PLANETARY MIXER; RELEASE; CERAMICS
AB Background: Calcium phosphate porous ceramics present a great interest not only as complex bone defect fillers but also as drug delivery systems. Most of the methods described in the literature to fabricate pellets are based on compaction, casting into spherical molds, or on processes such as liquid immiscibility or foaming. Despite wet granulation is used in a wide range of applications in pharmaceuticals, food, detergents, fertilizers, and minerals, it is not applied in the biomaterial field to produce granules. Methods: In this study physicochemical and in vitro drug delivery properties of implantable calcium phosphate granules, produced by two wet agglomeration processes, were compared. Pellets obtained by high shear granulation ( granulation in a Mi-Pro apparatus) were shown to be more spherical and less friable than granules elaborated by low shear process ( granulation in a Kenwood apparatus). Although Mi-Pro pellets had a slightly lower porosity compared to Kenwood granules, ibuprofen loading efficiency and dissolution profiles were not statistically different and the release mechanism was mainly controlled by diffusion, in both cases. Conclusion: Mi-Pro pellets appeared to be better candidates as bone defect fillers and local drug delivery systems as far as they were more spherical and less friable than Kenwood agglomerates.
C1 [Chevalier, E.; Viana, M.; Chulia, D.] Univ Limoges, CNRS, SPCTS, Pharm Galen Lab,Fac Pharm,UMR 6638, F-87025 Limoges, France.
   [Cazalbou, S.] Pharm Galen Lab, Fac Pharmaceut Sci, CIRIMAT, UMR 5085, Toulouse, France.
RP Viana, M (reprint author), Univ Limoges, CNRS, SPCTS, Pharm Galen Lab,Fac Pharm,UMR 6638, 2 Rue Dr Marcland, F-87025 Limoges, France.
EM marylene.viana@unilim.fr
RI CAZALBOU, sophie/G-5683-2012
FU Region Limousin
FX The authors thank the Region Limousin for its financial support. They
   are grateful to Eric Champion and Mickael Palard for calcinations and
   Miguel Viana for SEM observations.
CR Albertini B, 2003, EUR J PHARM BIOPHARM, V56, P479, DOI 10.1016/S0939-6411(03)00114-0
   Ameye D, 2002, EUR J PHARM SCI, V17, P247, DOI 10.1016/S0928-0987(02)00218-X
   [Anonymous], 2008, EUR PHARM
   BADAWY SIF, 2004, AAPS PHARMSCITECH, V5, P1
   Bae CJ, 2006, J MATER SCI-MATER M, V17, P517, DOI 10.1007/s10856-006-8934-2
   Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   Benali M, 2009, POWDER TECHNOL, V190, P160, DOI 10.1016/j.powtec.2008.04.082
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Chevalier E, 2007, PHARM DEV TECHNOL, V12, P133, DOI 10.1080/10837450701212461
   CHEVALIER E, 2009, BIOCERAMICS PROPERTI, P27
   Chevalier E, 2007, J PHARM SCI, V97, P1135
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Flautre B, 2001, J MATER SCI-MATER M, V12, P679, DOI 10.1023/A:1011256107282
   Gabaude CMD, 2001, J MATER SCI, V36, P1763, DOI 10.1023/A:1017528809955
   Gautier H, 2001, BIOMATERIALS, V22, P2481, DOI 10.1016/S0142-9612(00)00436-1
   Ghorab MK, 2007, AAPS PHARMSCITECH, V8, P1
   GIBASSIER D, 1982, LAB PHARM PROB TECHN, V30, P250
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Hamdani J, 2002, INT J PHARM, V245, P167, DOI 10.1016/S0378-5173(02)00348-4
   Hapgood KP, 2003, AICHE J, V49, P350, DOI 10.1002/aic.690490207
   Hasegawa M, 2004, J BIOMED MATER RES B, V70B, P332, DOI 10.1002/jbm.b.30047
   Herath H M T U, 2005, J Appl Biomater Biomech, V3, P192
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hilbrig F, 2012, KEY ENG MATER, V1, p283 
   Hiseman MJP, 2002, CHEM ENG RES DES, V80, P432, DOI 10.1205/026387602320224012
   Hixson AW, 1931, IND ENG CHEM, V23, P923, DOI 10.1021/ie50260a018
   Hulbert SF, 1971, J BIOMED MATER RES, V5, P269
   Ioku K, 2006, J MATER SCI, V41, P1341, DOI 10.1007/s10853-006-7338-5
   Isobe T, 2006, J EUR CERAM SOC, V26, P2213, DOI 10.1016/j.jeuceramsoc.2005.04.014
   IVESON SM, 2001, POWDER TECHNOL, V11, P3
   Komath M, 2000, B MATER SCI, V23, P135, DOI 10.1007/BF02706555
   Komlev VS, 2002, J MATER SCI-MATER M, V13, P295, DOI 10.1023/A:1014015002331
   KOPCHA M, 1991, J PHARM PHARMACOL, V43, P382, DOI 10.1111/j.2042-7158.1991.tb03493.x
   Laurent BFC, 2005, CHEM ENG SCI, V60, P3805, DOI 10.1016/j.ces.2005.02.011
   Lee JS, 2003, CERAM INT, V29, P271, DOI 10.1016/S0272-8842(02)00115-3
   Litster JD, 2001, POWDER TECHNOL, V114, P32, DOI 10.1016/S0032-5910(00)00259-X
   Liu DM, 1996, BIOMATERIALS, V17, P1955, DOI 10.1016/0142-9612(95)00301-0
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Moore JW, 1996, PHARM TECH, V20, P64
   Mort P. R., 1999, KONA, V17, P64
   OTSUKA M, 1994, J PHARM SCI, V83, P255, DOI 10.1002/jps.2600830229
   Paul W, 1999, J MATER SCI-MATER M, V10, P383, DOI 10.1023/A:1008918412198
   PONTIER C, 2001, THESIS U PARIX 11 CH
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   RAYNAUD S, 1998, BIOCERAMICS, V11, P109
   Rivera-Munoz E, 2001, J MATER SCI-MATER M, V12, P305, DOI 10.1023/A:1011290919642
   Shah VP, 1998, PHARMACEUT RES, V15, P889, DOI 10.1023/A:1011976615750
   SHESKEY PJ, 1996, PHARM TECH, V20, P80
   Shiromani PK, 2000, DRUG DEV IND PHARM, V26, P357, DOI 10.1081/DDC-100100365
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   Sundar M, 2005, TRENDS BIOMATER ARTI, V18, P213
   Turchiuli C, 2005, POWDER TECHNOL, V157, P168, DOI 10.1016/j.powtec.2005.05.024
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Viana M, 2002, TALANTA, V57, P583, DOI 10.1016/S0039-9140(02)00058-9
   VISAVARUNGROJ N, 1991, INT J PHARM, V69, P43, DOI 10.1016/0378-5173(91)90085-3
   Vonk P, 1997, INT J PHARM, V157, P93, DOI 10.1016/S0378-5173(97)00232-9
   Wauters PAL, 2002, POWDER TECHNOL, V123, P166, DOI 10.1016/S0032-5910(01)00446-6
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Zoulgami M, 2001, BIOMATERIALS, V22, P1933, DOI 10.1016/S0142-9612(00)00384-7
NR 66
TC 9
Z9 9
U1 2
U2 15
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0363-9045
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PY 2009
VL 35
IS 10
BP 1255
EP 1263
DI 10.1080/03639040902882298
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 511SM
UT WOS:000271187400010
PM 19555242
DA 2018-10-19
ER

PT B
AU Nishida, M
   Yamaguchi, M
   Todo, M
   Takayama, T
   Haggblad, HA
   Jonsen, P
AF Nishida, M.
   Yamaguchi, M.
   Todo, M.
   Takayama, T.
   Haggblad, H. -A.
   Jonsen, P.
GP EDPS
TI Evaluation of dynamic compressive properties of PLA polymer blends using
   split Hopkinson pressure bar
SO DYMAT 2009: 9TH INTERNATIONAL CONFERENCE ON THE MECHANICAL AND PHYSICAL
   BEHAVIOUR OF MATERIALS UNDER DYNAMIC LOADING, VOL 1
LA English
DT Proceedings Paper
CT 9th International Conference on Mechanical and Physical Behaviour of
   Materials under Dynamic Loading
CY SEP 07-11, 2009
CL Royal Mil Acad, Brussels, BELGIUM
HO Royal Mil Acad
ID BEHAVIOR
AB Poly(lactic acid) (PLA) has been used as a biomaterial for bone fixation devices in oral and orthopedic surgery because of good biocompatibility and bioabsorbability. Because Poly(epsilon-Caprolactone) (PCL) is a ductile, bioabsorbable and biodegradable polymer, many types of PLA/PCL polymer blends have been developed to improve its material strength and impact resistance. The stress-strain curves of PLA and PLA/PCL polymer blends were measured using a split Hopkinson pressure bar (Kolsky bar) method and a universal testing machine. The effect of PCL content on Young's modulus and yield stress was examined. The values of constants in Cowper-Symonds equation with respect to yield stress were determined for PLA and PLA/PCL polymer blend specimens. PLA/PCL specimens were observed using a scanning electron microscope.
C1 [Nishida, M.; Yamaguchi, M.] Nagoya Inst Technol, Showa Ku, Gokiso Cho, Nagoya, Aichi, Japan.
   [Todo, M.; Takayama, T.; Haggblad, H. -A.; Jonsen, P.] Kyushu Univ, Fukuoka, Japan.
RP Nishida, M (reprint author), Nagoya Inst Technol, Showa Ku, Gokiso Cho, Nagoya, Aichi, Japan.
RI Kyushu, RIAM/F-4018-2015
OI Kyushu, RIAM/0000-0002-3518-444X
FU Research Institute for Applied Mechanics, Kyushu University
FX This work was supported in part by the Collaborative Research Program of
   the Research Institute for Applied Mechanics, Kyushu University. We
   thank Mr. Noriomi Ito, a master course student of Nagoya Institute of
   Technology, for generously assisting with the experiments.
CR BAUWENSCROWET C, 1969, J MAT SCI A, V2, P735
   Borvik T, 2008, ENG STRUCT, V30, P1605, DOI 10.1016/j.engstruct.2007.10.010
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Gray GT, 2000, ASM HDB, V8, P462
   HiljanenVainio M, 1996, MACROMOL CHEM PHYSIC, V197, P1503, DOI 10.1002/macp.1996.021970427
   Jones N., 1989, STRUCTURAL IMPACT, P348
   Nakai K, 2008, J SOLID MECH MAT ENG, V2, P557
   Todo M, 2007, ENG FRACT MECH, V74, P1872, DOI 10.1016/j.engfracmech.2006.05.021
   TODO M, 2007, INTERFACE ORAL HLTH, P95
   Tsuji H, 1996, J APPL POLYM SCI, V60, P2367, DOI 10.1002/(SICI)1097-4628(19960627)60:13<2367::AID-APP8>3.0.CO;2-C
NR 10
TC 3
Z9 3
U1 1
U2 5
PU E D P SCIENCES
PI CEDEX A
PA 17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A,
   FRANCE
BN 978-2-7598-0472-6
PY 2009
BP 909
EP +
DI 10.1051/dymat/2009127
PG 3
WC Materials Science, Multidisciplinary; Mechanics
SC Materials Science; Mechanics
GA BMO55
UT WOS:000273127300126
DA 2018-10-19
ER

PT S
AU Liao, JG
   Li, YB
   Zhang, L
   Zuo, Y
AF Liao Jianguo
   Li Yubao
   Zhang Li
   Zuo Yi
BE Kim, H
   Yang, JF
   Sekino, T
   Lee, SW
TI Study of Nano-hydroxyapatite/Polycarbonate Composite for Bone Repair
SO ECO-MATERIALS PROCESSING AND DESIGN X
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 10th International Symposium on Eco-Materials Processing and Design
CY JAN 13-15, 2009
CL Xian, PEOPLES R CHINA
SP Xian Jiaotong Univ, State Key Lab Mech BehavMat, SW Univ Sci & Technol, Xian Univ Technol, Japan Soc Symbol & Algebra Computat, Natl Nat Sci Fdn China, Korea Sci & Engn Fdn, JSPS-KOSEF Core Univ Program, Minist Educ, Xian Municipal Bureau Sci & Technol
DE Nano-hydroxyapatite; Polycarbonate; Bone substitute; Composite
ID BIOMATERIALS
AB Acicular nano-hydroxyapatite (n-HA) was used to make a new biomaterial composite with polycarbonate by a novel technique. The physical and chemical characteristics of the composites were tested. It was found that the synthesized n-HA crystals were similar to bone apatite in size, phase composition and crystal structure. The TEM results indicated the biomimetic n-HA crystals were uniformly distributed in the polymer matrix. Chemical inter-action between inorganic n-HA and polycarbonate was investigated and discussed. These results indicate that the composite fulfills the basic requirement of bone substitute material, and has the potential for clinical applications.
C1 [Liao Jianguo] Henan Polytech Univ, Sch Mat Sci & Engn, Jiaozuo 454000, Peoples R China.
   [Li Yubao; Zhang Li; Zuo Yi] Sichuan Univ, Analyt & Testing Ctr, Res Ctr Nano Biomat 2, Chengdu 610064, Peoples R China.
RP Liao, JG (reprint author), Henan Polytech Univ, Sch Mat Sci & Engn, Jiaozuo 454000, Peoples R China.
EM liaojianguo10@hpu.edu.cn
CR Abu Bakar MS, 2003, MAT SCI ENG A-STRUCT, V345, P55, DOI 10.1016/S0921-5093(02)00289-7
   Danilchenko SN, 2002, CRYST RES TECHNOL, V37, P1234, DOI 10.1002/1521-4079(200211)37:11<1234::AID-CRAT1234>3.0.CO;2-X
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KEMAL K, 2000, J BIOMATER SCI POLY, V11, P617
   Li Y. B., 1994, J MATER SCI-MATER M, V5, P252, DOI DOI 10.1007/BF00122393)
   Liu Q, 1998, BIOMATERIALS, V19, P1067, DOI 10.1016/S0142-9612(98)00033-7
   MEYER JL, 1982, INORG CHEM, V21, P3029, DOI 10.1021/ic00138a021
   MONTEL G, 1981, J CRYST GROWTH, V53, P74, DOI 10.1016/0022-0248(81)90057-9
   Park JB, 1992, BIOMATERIALS INTRO, P192
   Paschalis EP, 1997, CALCIFIED TISSUE INT, V61, P480, DOI 10.1007/s002239900371
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
NR 13
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2009
VL 620-622
BP 587
EP +
DI 10.4028/www.scientific.net/MSF.620-622.587
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BMQ10
UT WOS:000273336800145
DA 2018-10-19
ER

PT S
AU Branzoi, IV
   Iordoc, M
   Branzoi, F
AF Branzoi, Ioan-Viorel
   Iordoc, Mihai
   Branzoi, Florina
BE Ionita, D
TI Evaluation of Electrochemical Behaviour and Surface Properties for
   Oxinium-like Zr-Nb Biomedical Alloys
SO ELECTROCHEMISTRY AND PHYSICAL CHEMICAL METHODS IN SERVING MATERIALS FOR
   SUSTAINABLE DEVELOPMENT
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT Workshop on Electrochemistry and Physical Chemical Methods in Serving
   Materials for Sustainable Development
CY SEP 09-12, 2009
CL Sinaia, ROMANIA
DE Oxinium; biomaterial; EIS; electrochemical behaviour; micro-hardness
ID CORROSION
AB The aim of this study is to evaluate the influence of Nb amount on electrochemical behaviour and surface properties for Oxinium-like Zr-Nb biomedical alloys. Oxinium (heat treated Zr-2.5%Nb alloy) represents the newest metal-ceramic composite used in orthopaedic surgery for total hip and total knee replacement. We used potentiodynamic polarization measurements and electrochemical impedance spectroscopy (EIS) as electrochemical techniques and Vickers micro-hardness as surface properties evaluation technique.
C1 [Branzoi, Ioan-Viorel] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Appl Phys Chem & Electrochem, 132 Calea Grivitei, Bucharest 010737, Romania.
   [Iordoc, Mihai] Natl Inst Res & Dev Elect Engn, INCDIE ICPE Adv Res, Bucharest 030108, Romania.
   [Branzoi, Florina] Inst Phys Chem, Bucharest 030108, Romania.
RP Branzoi, IV (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Appl Phys Chem & Electrochem, 132 Calea Grivitei, Bucharest 010737, Romania.
EM mihai_iordoc@icpe-ca.ro
RI Branzoi, Florina/C-4586-2011
OI Branzoi, Florina/0000-0002-6892-0052; Iordoc, Mihai/0000-0002-9621-7727
CR Black J., 1992, BIOL PERFORMANCE MAT
   Choubey A, 2005, TRENDS BIOMATER ARTI, V18, P64
   DING YQ, 1994, CORROS SCI, V36, P259, DOI 10.1016/0010-938X(94)90157-0
   Hernigou P, 2007, EUR J ORTHOP SURG TR, V17, P243, DOI 10.1007/s00590-006-0180-2
   Jeong YH, 2002, J NUCL MATER, V302, P9, DOI 10.1016/S0022-3115(02)00703-1
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   SUN W, 2007, MATER SCI FORUM, V1525, P561
   TSUTSUMI Y, 2007, MATER SCI FORUM, V1489, P561
NR 8
TC 2
Z9 2
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2009
VL 415
BP 13
EP +
PG 2
WC Chemistry, Physical; Electrochemistry; Materials Science,
   Multidisciplinary
SC Chemistry; Electrochemistry; Materials Science
GA BPI35
UT WOS:000278916000004
DA 2018-10-19
ER

PT S
AU Wu, J
   Zeng, FQ
   Weisel, RD
   Li, RK
AF Wu, Jun
   Zeng, Faquan
   Weisel, Richard D.
   Li, Ren-Ke
BE Martin, U
TI Stem Cells for Cardiac Regeneration by Cell Therapy and Myocardial
   Tissue Engineering
SO ENGINEERING OF STEM CELLS
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE Cell therapy; Congestive heart failure; Myocardial infarction; Stem
   cells; Tissue engineering
ID BONE-MARROW-CELLS; SKELETAL MYOBLAST TRANSPLANTATION; IMPROVES HEART
   FUNCTION; INFARCTED RAT HEARTS; HUMAN ADIPOSE-TISSUE; PROGENITOR CELLS;
   SMOOTH-MUSCLE; ISCHEMIC-HEART; CARDIOMYOCYTE TRANSPLANTATION;
   VENTRICULAR-FUNCTION
AB Congestive heart failure, which often occurs progressively following a myocardial infarction, is characterized by impaired myocardial perfusion, ventricular dilatation, and cardiac dysfunction. Novel treatments are required to reverse these effects - especially in older patients whose endogenous regenerative responses to currently available therapies are limited by age. This review explores the current state of research for two related approaches to cardiac regeneration: cell therapy and tissue engineering. First, to evaluate cell therapy, we review the effectiveness of various cell types for their ability to limit ventricular dilatation and promote functional recovery following implantation into a damaged heart. Next, to assess tissue engineering, we discuss the characteristics of several biomaterials for their potential to physically support the infarcted myocardium and promote implanted cell survival following cardiac injury. Finally, looking ahead, we present recent findings suggesting that hybrid constructs combining a biomaterial with stem and supporting cells may be the most effective approaches to cardiac regeneration.
C1 [Wu, Jun; Zeng, Faquan; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada.
RP Li, RK (reprint author), Univ Toronto, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada.
EM renkeli@uhnres.utoronto.ca
OI Li, Ren-Ke/0000-0002-2584-060X
FU Canadian Institutes of Health Research [RMF82498, MOP14795]
CR Ali NN, 2004, BASIC RES CARDIOL, V99, P382, DOI 10.1007/s00395-004-0484-5
   Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069
   Amado LC, 2006, J AM COLL CARDIOL, V48, P2116, DOI 10.1016/j.jacc.2006.06.073
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460
   Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001
   BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0
   Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF
   Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONHA.105.588954
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Caspi O, 2006, EUR HEART J SUPPL, V8, pE43, DOI 10.1093/eurheartj/sul031
   Chekanov V, 2003, PACE, V26, P496, DOI 10.1046/j.1460-9592.2003.00080.x
   Cho SW, 2006, J VASC SURG, V44, P1329, DOI 10.1016/j.jvs.2006.07.032
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cohen S, 2004, SCI AM, V291, P44, DOI 10.1038/scientificamerican1104-44
   Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102
   Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0
   Dimmeler S, 2003, J AM COLL CARDIOL, V42, P2081, DOI 10.1016/j.jacc.2003.09.016
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Fazel S, 2005, ANN THORAC SURG, V79, pS2238, DOI 10.1016/j.athoracsur.2005-02-085
   Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019
   Fedak PWM, 2005, J THORAC CARDIOV SUR, V130, P1430, DOI 10.1016/j.jtcvs.2005.05.055
   Formigli L, 2007, J CELL MOL MED, V11, P1087, DOI 10.1111/j.1582-4934.2007.00111.x
   Gaustad KG, 2004, BIOCHEM BIOPH RES CO, V314, P420, DOI 10.1016/j.bbrc.2003.12.109
   Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003
   GUENET JMM, 1992, THERMOREVERSIBLE GEL
   Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3
   HIGGS PG, 1990, PHYS NETWORKS POLYM
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Kang WJ, 2006, J NUCL MED, V47, P1295
   Ke Qingen, 2005, Shengli Xuebao, V57, P673
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Kofidis T, 2005, EUR J CARDIO-THORAC, V28, P461, DOI 10.1016/j.ejcts.2005.03.049
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215
   Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3
   Leor J, 2004, CIRCULATION, V110, P279
   Leor J, 1996, CIRCULATION, V94, P332
   Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161
   Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   Li RK, 1999, J MOL CELL CARDIOL, V31, P513, DOI 10.1006/jmcc.1998.0882
   Li RK, 1996, ANN THORAC SURG, V62, P654
   Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561
   Liu TB, 2004, AM J PHYSIOL-HEART C, V287, pH2840, DOI 10.1152/ajpheart.00439.2004
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   McMurray J, 2002, CIRCULATION, V105, P2099, DOI 10.1161/01.CIR.0000014763.63528.9D
   Memon IA, 2005, J THORAC CARDIOV SUR, V130, P646, DOI 10.1016/j.jtcvs.2005.02.024
   Menard C, 2005, LANCET, V366, P1005, DOI 10.1016/S0140-6736(05)67380-1
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Min JY, 2002, J APPL PHYSIOL, V92, P288
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029
   MURRAY L, 1994, BLOOD CELLS, V20, P364
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Nakamura Y, 2006, AM J PHYSIOL-HEART C, V291, pH939, DOI 10.1152/ajpheart.00155.2006
   Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562
   Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Oh H, 2004, ANN NY ACAD SCI, V1015, P182, DOI 10.1196/annals.1302.015
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pouzet B, 2001, ANN THORAC SURG, V71, P844, DOI 10.1016/S0003-4975(00)01785-9
   Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X
   Roh JD, 2007, J PEDIATR SURG, V42, P198, DOI 10.1016/j.jpedsurg.2006.09.054
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Sakakibara Y, 2002, J THORAC CARDIOV SUR, V124, P50, DOI 10.1067/mtc.2002.121293
   Schuster MD, 2004, AM J PHYSIOL-HEART C, V287, pH525, DOI 10.1152/ajpheart.00058.2004
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Smith A, 2006, NATURE, V441, P1060, DOI 10.1038/nature04954
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Sutton MS, 1997, CIRCULATION, V96, P3294
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716
   Tomita S, 1999, CIRCULATION, V100, P247
   Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39
   Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11
   Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102
   van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505
   VAN VP, 2008, NETH HEART J, V16, P163
   Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442
   Wu JC, 2003, CIRCULATION, V108, P1302, DOI 10.1161/01.CIR.0000091252.20010.6E
   Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91
   Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894
   Yau TM, 2005, ANN THORAC SURG, V80, P1779, DOI 10.1016/j.athoracsur.2005.04.079
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang DZ, 2007, CHINESE MED J-PEKING, V120, P300
   Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005
   Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10
   Zimmermann WH, 2005, CARDIOVASC RES, V68, P344, DOI 10.1016/j.cardiores.2005.09.010
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zimmermann Wolfram-Hubertus, 2007, Trends Cardiovasc Med, V17, P134, DOI 10.1016/j.tcm.2007.02.007
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 134
TC 9
Z9 10
U1 1
U2 13
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0724-6145
EI 1616-8542
BN 978-3-540-88805-5
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2009
VL 114
BP 107
EP 128
DI 10.1007/10_2008_37
D2 10.1007/978-3-540-88806-2
PG 22
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA BLY26
UT WOS:000271413800004
PM 19543706
DA 2018-10-19
ER

PT J
AU Ahmady-Asbchin, S
   Andres, Y
   Gerente, C
   Le Cloirec, P
AF Ahmady-Asbchin, Salman
   Andres, Yves
   Gerente, Claire
   Le Cloirec, Pierre
TI Natural seaweed waste as sorbent for heavy metal removal from solution
SO ENVIRONMENTAL TECHNOLOGY
LA English
DT Article
DE low-cost biosorbent; brown alga; heavy metal; biosorption capacities;
   dynamic studies
ID BIOSORPTION; ADSORPTION; ALGAE; BIOSORBENT; BIOMASS; IONS;
   POLYSACCHARIDE; EQUILIBRIUM; MECHANISMS; COPPER
AB Biosorption is a suitable heavy metal remediation technique for the treatment of aqueous effluents of large volume and low pollutant concentration. However, today industrial applications need the selection of efficient low-cost biosorbents. The aim of this work is to investigate brown alga such as Fucus serratus (FS) as a low-cost biosorbent, for the fixation of metallic ions, namely Cu2+, Zn2+, Pb2+, Ni2+, Cd2+ and Ce3+, in a batch reactor. Biosorption kinetics and isotherms have been performed at pH 5.5. For all of the studied metallic ions, the equilibrium time is about 450 min and a tendency based on the initial sorption rate has been established: Ce3+ Zn2+ Ni2+ Cu2+ Cd2+ Pb2+. The adsorption equilibrium data are well described by the Langmuir equation. The sequence of the maximum adsorption capacity is Pb2+ Cu2+ >> Ce3+ Ni2+ Cd2+ Zn2+ and values are ranged between 1.78 and 0.71 mmol g-1. These results indicate that the FS biomass is a suitable biosorbent for the removal of heavy metals from wastewater and can be tested in a dynamic process. The selected pilot process involves a hybrid membrane process: a continuous stirred tank reactor is coupled with a microfiltration immersed membrane, in order to confine the FS particles. A mass balance model is used to describe the adsorption process and the breakthrough curves are correctly modelled. Based on these results, it is demonstrated that FS is an interesting biomaterial for the treatment of water contaminated heavy metals.
C1 [Ahmady-Asbchin, Salman; Andres, Yves; Gerente, Claire] CNRS, UMR 6144, GEPEA, Ecole Mines Nantes, F-44307 Nantes 3, France.
   [Le Cloirec, Pierre] CNRS, UMR 6226, Ecole Natl Super Chim Rennes, F-35708 Rennes, France.
   [Le Cloirec, Pierre] Univ Europeenne Bretagne, F-35000 Rennes, France.
RP Andres, Y (reprint author), CNRS, UMR 6144, GEPEA, Ecole Mines Nantes, 4 Rue Alfred Kastler,BP 20722, F-44307 Nantes 3, France.
EM yves.andres@emn.fr
OI Ahmady-Asbchin, Salman/0000-0001-6079-1842
FU Iranian Research Ministry; French Embassy in Tehran; Egide
FX The authors thank the Iranian Research Ministry, the French Embassy in
   Tehran, and Egide for the financial grant awarded to Salman AHMADY
   ASBCHIN, PhD student in 2004-2008.
CR Ahmady-Asbchin S, 2008, BIORESOURCE TECHNOL, V99, P6150, DOI 10.1016/j.biortech.2007.12.040
   Andres Y, 2003, ENVIRON TECHNOL, V24, P1367, DOI 10.1080/09593330309385681
   Boulinguiez B, 2008, LANGMUIR, V24, P6420, DOI 10.1021/la800725s
   Cochrane EL, 2006, J HAZARD MATER, V137, P198, DOI 10.1016/j.jhazmat.2006.01.054
   Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Fourest E, 1997, APPL BIOCHEM BIOTECH, V67, P33
   Gerente C, 2007, CRIT REV ENV SCI TEC, V37, P41, DOI 10.1080/10643380600729089
   Gerente C, 2004, ENVIRON TECHNOL, V25, P219, DOI 10.1080/09593330409355455
   Jalali R, 2002, J HAZARD MATER, V92, P253, DOI 10.1016/S0304-3894(02)00021-3
   Kaewsarn P, 2001, ENVIRON POLLUT, V112, P209, DOI 10.1016/S0269-7491(00)00114-7
   Kratochvil D, 1998, WATER RES, V32, P2760, DOI 10.1016/S0043-1354(98)00015-3
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   Ozer A, 2004, ADSORPTION, V10, P317
   Prasher SO, 2004, ENVIRON TECHNOL, V25, P1097, DOI 10.1080/09593332508618378
   Reddad Z, 2003, WATER RES, V37, P3983, DOI 10.1016/S0043-1354(03)00295-1
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Romera E, 2008, BIORESOURCE TECHNOL, V99, P4684, DOI 10.1016/j.biortech.2007.09.081
   Romera E, 2007, BIORESOURCE TECHNOL, V98, P3344, DOI 10.1016/j.biotech.2006.09.026
   Sanchez A, 1999, FEMS MICROBIOL REV, V23, P527, DOI 10.1016/S0168-6445(99)00019-4
   Texier AC, 1999, ENVIRON SCI TECHNOL, V33, P489, DOI 10.1021/es9807744
   Vilar VJP, 2005, PROCESS BIOCHEM, V40, P3267, DOI 10.1016/j.procbio.2005.03.023
   XIN SP, 2004, J COLLOID INTERF SCI, V275, P131
   Yang JB, 1999, PROCESS MET, V9, P483, DOI 10.1016/S1572-4409(99)80137-0
NR 24
TC 26
Z9 29
U1 0
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0959-3330
J9 ENVIRON TECHNOL
JI Environ. Technol.
PY 2009
VL 30
IS 7
BP 755
EP 762
AR PII 912176259
DI 10.1080/09593330902919401
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 454YK
UT WOS:000266720200013
PM 19705613
DA 2018-10-19
ER

PT J
AU Caleman, C
   Ortiz, C
   Marklund, E
   Bultmark, F
   Gabrysch, M
   Parak, FG
   Hajdu, J
   Klintenberg, M
   Timneanu, N
AF Caleman, C.
   Ortiz, C.
   Marklund, E.
   Bultmark, F.
   Gabrysch, M.
   Parak, F. G.
   Hajdu, J.
   Klintenberg, M.
   Timneanu, N.
TI Radiation damage in biological material: Electronic properties and
   electron impact ionization in urea
SO EPL
LA English
DT Article
ID MEAN FREE PATHS; LOW-ENERGY ELECTRONS; CHARGE-CARRIER RECOMBINATION;
   LIGHT-EMITTING-DIODES; X-RAY PULSES; CONDENSED MATTER; CRYSTALLINE UREA;
   CROSS-SECTIONS; DNA; DYNAMICS
AB Radiation damage is an unavoidable process when performing structural investigations of biological macromolecules with X-rays. In crystallography this process can be limited through damage distribution in a crystal, while for single molecular imaging it can be outrun by employing short intense pulses. Secondary electron generation is crucial during damage formation and we present a study of urea, as model for biomaterial. From first principles we calculate the band structure and energy loss function, and subsequently the inelastic electron cross-section in urea. Using Molecular Dynamics simulations, we quantify the damage and study the magnitude and spatial extent of the electron cloud coming from an incident electron, as well as the dependence with initial energy. Copyright (C) EPLA, 2009
C1 [Caleman, C.; Parak, F. G.] Tech Univ Munich, Phys Dept E17, D-85748 Garching, Germany.
   [Ortiz, C.; Bultmark, F.; Klintenberg, M.] Uppsala Univ, Dept Phys & Mat Sci, Angstromlab, SE-75121 Uppsala, Sweden.
   [Marklund, E.; Hajdu, J.; Timneanu, N.] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, SE-75124 Uppsala, Sweden.
   [Gabrysch, M.] Uppsala Univ, Dept Engn Sci, Angstromlab, SE-75121 Uppsala, Sweden.
RP Caleman, C (reprint author), Tech Univ Munich, Phys Dept E17, James Franck Str, D-85748 Garching, Germany.
EM nicusor@xray.bmc.uu.se
RI Marklund, Erik/G-7480-2012; Timneanu, Nicusor/C-7691-2012
OI Marklund, Erik/0000-0002-9804-5009; Timneanu,
   Nicusor/0000-0001-7328-0400
FU Swedish Research Foundation; Goran Gustafssons Stiftelse; DFG Cluster of
   Excellence; Munich-Centre for Advanced Photonics
FX The following organizations are acknowledged for their financial
   support: the Swedish Research Foundation (thanked by CO, EM, MG, FB, MK,
   JH, NT), Goran Gustafssons Stiftelse (thanked by CO and MK) and the DFG
   Cluster of Excellence: Munich-Centre for Advanced Photonics (thanked by
   CC, FGP and JH). Although not as cool as ice, or as shiny as diamond,
   the present work on urea has been endorsed by the following people, to
   whom we give thanks: M. BERGH, D. VAN DER SPOEL, R. LONDON and B. ZIAJA.
CR ALIG RC, 1980, PHYS REV B, V22, P5565, DOI 10.1103/PhysRevB.22.5565
   ASHLEY JC, 1991, J APPL PHYS, V69, P674, DOI 10.1063/1.347348
   ASHLEY JC, 1990, J ELECTRON SPECTROSC, V50, P323, DOI 10.1016/0368-2048(90)87075-Y
   ASHLEY JC, 1988, J ELECTRON SPECTROSC, V46, P199, DOI 10.1016/0368-2048(88)80019-7
   BARBIERI A, COMMUNICATION
   Bergh M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051904
   Bergh M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026404
   Bethe H, 1930, ANN PHYS-BERLIN, V5, P325
   Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658
   BRANSDEN BH, 1998, PHYS ATOMS MOL
   Breton SP, 2004, J CHEM PHYS, V121, P11240, DOI 10.1063/1.1814632
   BROOK E, 1978, J PHYS B-AT MOL OPT, V11, P3115, DOI 10.1088/0022-3700/11/17/021
   Chen JS, 2005, J PHYS D APPL PHYS, V38, P3366, DOI 10.1088/0022-3727/38/18/006
   Civalleri B, 2007, J PHYS CHEM B, V111, P26, DOI 10.1021/jp065757c
   DONALDSON WR, 1984, APPL PHYS LETT, V44, P25, DOI 10.1063/1.94590
   DOVESI R, 1990, J CHEM PHYS, V92, P7402, DOI 10.1063/1.458592
   FUNG AYC, 1994, RADIAT PROT DOSIM, V52, P111
   Gabrysch M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2890158
   Gonze X, 2002, COMP MATER SCI, V25, P478, DOI 10.1016/S0927-0256(02)00325-7
   GUNTER F, 2007, APPL PHYS B, V86, P431
   Hau-Riege SP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051906
   Huels MA, 1998, J CHEM PHYS, V108, P1309, DOI 10.1063/1.475503
   INAGAKI T, 1977, PHYS REV B, V15, P3243, DOI 10.1103/PhysRevB.15.3243
   Johnson MR, 2003, CHEM PHYS, V291, P53, DOI 10.1016/S0301-0104(03)00178-2
   Jurek Z, 2004, EUR PHYS J D, V29, P217, DOI 10.1140/epjd/e2004-00033-3
   Kalinowski J, 1998, APPL PHYS LETT, V72, P513, DOI 10.1063/1.120805
   KLEIN CA, 1968, J APPL PHYS, V39, P2029, DOI 10.1063/1.1656484
   LAVERNE JA, 1995, RADIAT RES, V141, P208, DOI 10.2307/3579049
   LENNON MA, 1988, J PHYS CHEM REF DATA, V17, P1285, DOI 10.1063/1.555809
   Lepage M, 2000, J CHEM PHYS, V113, P3602, DOI 10.1063/1.1287400
   Lin ZS, 2003, J CHEM PHYS, V118, P2349, DOI 10.1063/1.1533734
   LINDHARD J, 1954, K DAN VIDENSK SELSK, V18, P1
   MULLEN D, 1978, ACTA CRYSTALLOGR B, V34, P1624, DOI 10.1107/S0567740878006172
   Muroya Y, 2002, CAN J CHEM, V80, P1367, DOI 10.1139/V02-173
   Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099
   Ortiz C, 2009, COMP MATER SCI, V44, P1042, DOI 10.1016/j.commatsci.2008.07.016
   Ortiz C, 2007, J PHYS CHEM C, V111, P17442, DOI 10.1021/jp0736692
   PENN DR, 1987, PHYS REV B, V35, P482, DOI 10.1103/PhysRevB.35.482
   PENN DR, 1976, PHYS REV B, V13, P5248, DOI 10.1103/PhysRevB.13.5248
   PRYOR AW, 1970, ACTA CRYSTALL A-CRYS, VA 26, P543, DOI 10.1107/S0567739470001390
   SILVER M, 1967, J CHEM PHYS, V46, P692, DOI 10.1063/1.1840727
   Tan ZY, 2006, RADIAT ENVIRON BIOPH, V45, P135, DOI 10.1007/s00411-006-0049-0
   Tan ZY, 2004, RADIAT ENVIRON BIOPH, V43, P173, DOI 10.1007/s00411-004-0249-4
   TANUMA S, 1994, SURF INTERFACE ANAL, V21, P165, DOI 10.1002/sia.740210302
   TANUMA S, 1993, SURF INTERFACE ANAL, V20, P77, DOI 10.1002/sia.740200112
   TANUMA S, 1988, SURF INTERFACE ANAL, V11, P577, DOI 10.1002/sia.740111107
   Timneanu N, 2004, CHEM PHYS, V299, P277, DOI 10.1016/j.chemphys.2003.10.011
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206
   Ziaja B, 2006, EUR PHYS J D, V40, P465, DOI 10.1140/epjd/e2006-00240-x
   Ziaja B, 2005, J APPL PHYS, V97, DOI 10.1063/1.1853494
   Ziaja B, 2001, PHYS REV B, V64, DOI [10.1103/PhysRevB.64.214104, 10.1103/PhysRevLett.87.214104]
NR 52
TC 16
Z9 16
U1 1
U2 11
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 0295-5075
J9 EPL-EUROPHYS LETT
JI EPL
PD JAN
PY 2009
VL 85
IS 1
AR 18005
DI 10.1209/0295-5075/85/18005
PG 6
WC Physics, Multidisciplinary
SC Physics
GA 411ZH
UT WOS:000263692500037
DA 2018-10-19
ER

PT S
AU Bose, RK
   Nejati, S
   Lau, KKS
AF Bose, R. K.
   Nejati, S.
   Lau, K. K. S.
BE Swihart, MT
   Barreca, D
   Adomaitis, RA
   Worhoff, K
TI Initiated Chemical Vapor Deposition (iCVD) of Hydrogel Polymers
SO EUROCVD 17 / CVD 17
SE ECS Transactions
LA English
DT Proceedings Paper
CT Joint Conference on EuroCVD / 17th International Chemical Vapor
   Deposition Symposium (CVD) held jointly at the 216th Meeting of the
   Electrochemical-Society
CY OCT 04-09, 2009
CL Vienna, AUSTRIA
SP Electrochem Soc, Electrochem Soc, High Temp Mat Div, Electrochem Soc, Dielectr Sci & Technol Dic, Electrochem Soc, Elect & Photon Div
ID SOLAR-CELLS; POLY(2-HYDROXYETHYL METHACRYLATE); ELECTROLYTE; COPOLYMERS;
   ACRYLATES); CHARGE; FILM
AB Initiated chemical vapor deposition (iCVD) represents a novel CVD method for synthesizing polymer thin films in a single-step bottom-up polymerization-co-deposition process. Specifically, iCVD has been utilized to create poly(2-hydroxyethyl methacrylate) (PHEMA) hydrogels. FTIR and NMR evidenced the stoichiometric composition of PHEMA with full retention of chemical functionality. By controlling iCVD reaction kinetics, PHEMA deposition rate and molecular weight were successfully tuned, achieving rates as high as 1.5 mu m/min, yielding high molecular weight polymers as observed through DSC. Because PHEMA hydrogels are polymers capable of absorbing substantial amounts of water and other liquid media, iCVD PHEMA has been studied and is demonstrated as a potential biomaterial to support living cell growth and as a potential polymer electrolyte material for dye sensitized solar cells.
C1 [Bose, R. K.; Nejati, S.; Lau, K. K. S.] Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA.
RP Bose, RK (reprint author), Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA.
OI Bose, Ranjita/0000-0003-1928-5264
CR Arica MY, 2000, J APPL POLYM SCI, V75, P1685, DOI 10.1002/(SICI)1097-4628(20000401)75:14<1685::AID-APP1>3.0.CO;2-6
   Bose R. K., CHEM VAP DE IN PRESS
   Chan K, 2005, LANGMUIR, V21, P8930, DOI 10.1021/la051004q
   de Freitas JN, 2008, SOL ENERG MAT SOL C, V92, P1110, DOI 10.1016/j.solmat.2008.03.022
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Gratzel M, 2006, CR CHIM, V9, P578, DOI 10.1016/j.crci.2005.06.037
   Guan J. J., J BIOMATER SCI POLYM
   Han HW, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743381
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   Hsiue GH, 2001, BIOMATERIALS, V22, P1763, DOI 10.1016/S0142-9612(00)00336-7
   Lau KKS, 2007, MACROMOL BIOSCI, V7, P429, DOI 10.1002/mabi.200700017
   Lau KKS, 2006, ADV MATER, V18, P1972, DOI 10.1002/adma.200600896
   Lau KKS, 2006, THIN SOLID FILMS, V501, P211, DOI 10.1016/j.tsf.2005.07.208
   Lau KKS, 2006, MACROMOLECULES, V39, P3688, DOI 10.1021/ma0601619
   Lau KKS, 2006, MACROMOLECULES, V39, P3695, DOI 10.1021/ma0601621
   Lau KKS, 2003, NANO LETT, V3, P1701, DOI 10.1021/nl034704t
   Limb S. J., 1999, Plasmas and Polymers, V4, P21, DOI 10.1023/A:1021899414807
   Mossman T., 1989, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4
   NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063
   Nogueira AF, 2001, ADV MATER, V13, P826, DOI 10.1002/1521-4095(200106)13:11<826::AID-ADMA826>3.0.CO;2-L
   Prasitsilp M, 2003, J MATER SCI-MATER M, V14, P595, DOI 10.1023/A:1024066806347
   Tenhaeff WE, 2008, ADV FUNCT MATER, V18, P979, DOI 10.1002/adfm.200701479
   Wang P, 2003, NAT MATER, V2, P402, DOI 10.1038/nmat904
NR 23
TC 3
Z9 3
U1 0
U2 0
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 S MAIN ST, PENNINGTON, NJ 08534-2839 USA
SN 1938-5862
BN 978-1-60768-095-6; 978-1-56677-745-2
J9 ECS TRANSACTIONS
PY 2009
VL 25
IS 8
BP 1229
EP 1235
DI 10.1149/1.3207728
PG 7
WC Electrochemistry; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Materials Science, Coatings & Films
SC Electrochemistry; Science & Technology - Other Topics; Materials Science
GA BA8NH
UT WOS:000338305900159
DA 2018-10-19
ER

PT J
AU Kato, Y
   Matsumoto, I
   Tomita, S
   Watanabe, G
AF Kato, Yosuke
   Matsumoto, Isao
   Tomita, Shigeyuki
   Watanabe, Go
TI A novel technique to prevent intra-operative pneumothorax in awake
   coronary artery bypass grafting: biomaterial neo-pleura
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE Coronary artery bypass surgery; Less invasive surgery; Pleura;
   Pneumothorax; Thoracic general
ID SURGICAL-PROCEDURES; FIBRIN GLUE; ANESTHESIA; PATIENT;
   REVASCULARIZATION; SURGERY
AB Objective: Pneumothorax caused by damaged pleura represents the biggest obstacle in awake coronary artery bypass grafting. In order to safety perform this surgery, a new technique was developed to close the damaged pleura. Methods: A rub-and-spray method was employed using polyglycolic acid nonwoven fabric and fibrin glue. At first, some fibrinogen solution was rubbed on the edge of the pleural. defect and then the PGA fabric was placed and the fibrinogen and thrombin solutions were sprayed. Using a thorax model, the burst pressure caused by positive pressure and the influence of negative pressure, moisture, time, continuous respiratory movement and pleural. defect size were examined. In an animal experiment using pigs, the duration spent on repair was measured and any air leakage from the pleura was also identified. Results: In the thorax model, the burst pressure was 355.9 +/- 55.8 mmHg with positive pressure and no significant difference in negative pressure, moisture, time and respiratory moment was identified. However, there was a significant difference in the defect size. In the animal model, repair was easily achieved regardless of the defect size or location and air leakage was not seen after repair. The average duration of repair was 21.0 s. Conclusions: The present method achieved a strong closure with sufficient durability. Since the fabric is soft and flexible and suturing is not required; moving and fragile pleura can be easily repaired regardless of the defect location and size. Once established, the present method may be used in other forms of awake thoracic surgery or reconstruction of the thorax. (C) 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
C1 [Kato, Yosuke; Matsumoto, Isao; Tomita, Shigeyuki; Watanabe, Go] Kanazawa Univ, Dept Gen & Cardiothorac Surg, Kanazawa, Ishikawa 9208641, Japan.
RP Kato, Y (reprint author), Kanazawa Univ, Dept Gen & Cardiothorac Surg, Takaramachi 13-1, Kanazawa, Ishikawa 9208641, Japan.
EM yky43259949@hotmail.co.jp
CR Al-Abdullatief M, 2007, EUR J CARDIO-THORAC, V32, P346, DOI 10.1016/j.ejcts.2007.04.029
   Aybek T, 2003, J THORAC CARDIOV SUR, V125, P1394, DOI 10.1016/S0022-5223(02)73607-6
   DRESDALE A, 1985, ANN THORAC SURG, V40, P385, DOI 10.1016/S0003-4975(10)60074-4
   Hanks JB, 2003, EUR SURG RES, V35, P439, DOI 10.1159/000072229
   Karagoz HY, 2003, J THORAC CARDIOV SUR, V125, P1401, DOI 10.1016/S0022-5223(02)73268-6
   Karagoz HY, 2000, ANN THORAC SURG, V70, P91, DOI 10.1016/S0003-4975(00)01271-6
   Kawamura M, 2005, EUR J CARDIO-THORAC, V28, P39, DOI 10.1016/j.ejcts.2005.02.044
   Kirali K, 2004, ANN THORAC SURG, V78, P1598, DOI 10.1016/j.athoracsur.2004.05.049
   Meininger D, 2003, WORLD J SURG, V27, P534, DOI 10.1007/s00268-003-6725-1
   Minato Naoki, 2004, Jpn J Thorac Cardiovasc Surg, V52, P361
   Mineo TC, 2007, EUR J CARDIO-THORAC, V32, P13, DOI 10.1016/j.ejcts.2007.04.004
   Sugawara T, 2005, NEUROSURGERY, V57, P290, DOI 10.1227/01.NEU.0000176410.65750.C0
   Tateishi J, 2001, BIOLOGICALS, V29, P17, DOI 10.1006/biol.2001.0269
   TREHAN N, 2001, ANN THORAC SURG, V72, P1026
   Watanabe G, 1999, ANN THORAC SURG, V68, P131, DOI 10.1016/S0003-4975(99)00473-7
   Watanabe G, 1999, LANCET, V354, P2131, DOI 10.1016/S0140-6736(99)05262-9
NR 16
TC 16
Z9 16
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD JAN
PY 2009
VL 35
IS 1
BP 37
EP 41
DI 10.1016/j.ejcts.2008.07.067
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 405FP
UT WOS:000263208600007
PM 18824372
OA Bronze
DA 2018-10-19
ER

PT J
AU Wang, T
   Wu, DQ
   Jiang, XJ
   Zhang, XZ
   Li, XY
   Zhang, JF
   Zheng, ZB
   Zhuo, RX
   Jiang, H
   Huang, CX
AF Wang, Tao
   Wu, De-Qun
   Jiang, Xue-Jun
   Zhang, Xian-Zheng
   Li, Xiao-Yan
   Zhang, Jin-Feng
   Zheng, Zhao-Bin
   Zhuo, Renxi
   Jiang, Hong
   Huang, Congxin
TI Novel thermosensitive hydrogel injection inhibits post-infarct ventricle
   remodelling
SO EUROPEAN JOURNAL OF HEART FAILURE
LA English
DT Article
DE Myocardial infarction; Thermosensitive hydrogel; Remodelling;
   Extracellular matrix; Scar expansion; Paradoxical motion
ID ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; STEM-CELLS; RESTRAINT;
   SUPPORT; TISSUE
AB Aims Myocardial infarction (MI) remains the commonest cause of cardiac-related death throughout the world. Adverse cardiac remodelling and progressive heart failure after MI are associated with excessive and continuous damage of the extracellular matrix (ECM). In this study, we hypothesized that implantation of hydrogel into infarcted myocardium could replace the damaged ECM, thicken the infarcted wait, and inhibit cardiac remodelling.
   Methods and results MI was induced in rabbits by coronary artery ligation; 4 days later, 200 mu L Dex-PCL-HEMA/PNIPAAm get solution was injected into the infarcted myocardium. Injection of phosphate-buffered satine served as control. Thirty days after treatment, histological analysis indicated that injection of the biomaterial prevented scar expansion and wall thinning compared with controls. Echocardiography studies showed that injection of hydrogel increased left ventricular ejection fraction and attenuated left ventricular systolic and diastolic dilatation. Haemodynamic analysis demonstrated improved cardiac function following implantation of the hydrogel.
   Conclusion These results suggest that injection of thermosensitive Dex-PCL-HEMA/PNIPAAm hydrogel is an effective strategy that prevents adverse cardiac remodelling and dysfunction in MI rabbits.
C1 [Wang, Tao; Jiang, Xue-Jun; Li, Xiao-Yan; Zhang, Jin-Feng; Zheng, Zhao-Bin; Jiang, Hong; Huang, Congxin] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Peoples R China.
   [Wu, De-Qun; Zhang, Xian-Zheng; Zhuo, Renxi] Wuhan Univ, Dept Chem, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
RP Jiang, XJ (reprint author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Peoples R China.
EM xjjiang@whu.edu.cn
RI WANG, TAO/B-1888-2013
FU National Key Basic Research Program of China [2005CB623903]
FX This work was financially supported by National Key Basic Research
   Program of China (2005CB623903).
CR Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Kelly D, 2008, EUR J HEART FAIL, V10, P133, DOI 10.1016/j.ejheart.2007.12.009
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Mathur A, 2004, LANCET, V364, P183, DOI 10.1016/S0140-6736(04)16632-4
   Moainie SL, 2002, ANN THORAC SURG, V74, P444, DOI 10.1016/S0003-4975(02)03747-5
   NISHINA T, 2001, CIRCULATION S2, V104, P1241
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Park JS, 2004, MACROMOLECULES, V37, P6786, DOI 10.1021/ma049677n
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   ROBINSON KA, 2005, CIRCULATION, V112, P1135
   Saavedra WF, 2002, J AM COLL CARDIOL, V39, P2069, DOI 10.1016/S0735-1097(02)01890-9
   Sabbah HN, 2003, CIRC RES, V93, P1095, DOI 10.1161/01.RES.0000101932.70443.FE
   SAKAKIBARA Y, 2002, CIRCULATION S1, V106, P1193
   Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Takemura G, 1998, CIRC RES, V82, P1130, DOI 10.1161/01.RES.82.11.1130
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   *US NIH, 1996, NIH PUBL, V25, P34
NR 29
TC 69
Z9 72
U1 2
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1388-9842
J9 EUR J HEART FAIL
JI Eur. J. Heart Fail.
PD JAN
PY 2009
VL 11
IS 1
BP 14
EP 19
DI 10.1093/eurjhf/hfn009
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 442MM
UT WOS:000265845300004
PM 19147452
OA Bronze
DA 2018-10-19
ER

PT J
AU Stubinger, S
   Ghanaati, S
   Orth, C
   Hilbig, U
   Saldamli, B
   Biesterfeld, S
   Kirkpatrick, CJ
   Sader, RA
AF Stuebinger, S.
   Ghanaati, S.
   Orth, C.
   Hilbig, U.
   Saldamli, B.
   Biesterfeld, S.
   Kirkpatrick, C. J.
   Sader, R. A.
TI Maxillary Sinus Grafting with a Nano-Structured Biomaterial: Preliminary
   Clinical and Histological Results
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Article
DE Biomaterial; Bone graft; Histology; Degradation; Foreign body reaction;
   Osseoconduction; Dental implants
ID FLOOR AUGMENTATION; ENGINEERED BONE; HYDROXYAPATITE; OSTEOGENICITY;
   REGENERATION; SUBSTITUTES; IMPLANTS; MATRIX; GROWTH; MARROW
AB Background: In this study the potential of a new and entirely synthetic, nano-structured hydroxyapatite-based biomaterial for sinus floor augmentation is evaluated. Methods: 20 sinus floor elevations were carried out in a total of 20 patients. After a healing period of 6 months, in 10 cases cylinder-shaped bone biopsies were taken from the augmented maxillary region using trephine burs. Results: The healing period progressed without any complications. General and specific histological analysis of the bone biopsies showed a high osteoclast activity at the margin of the biomaterial which was well integrated into the newly formed bone. Conclusion: This study demonstrates that new trabecular bone is formed after grafting with the nanocrystalline bone substitute after 6 months. Ongoing histomorphological studies are necessary to quantify the biomaterial-bone ratio and the exact amount of newly built bone in the augmented cavity after 6 months. Copyright (C) 2009 S. Karger AG, Basel
C1 [Stuebinger, S.; Saldamli, B.; Sader, R. A.] Univ Frankfurt, Dept Oral Craniomaxillofacial & Facial Plast Surg, Med Ctr, DE-60596 Frankfurt, Germany.
   [Ghanaati, S.; Orth, C.; Hilbig, U.; Biesterfeld, S.; Kirkpatrick, C. J.] Johannes Gutenberg Univ Mainz, Inst Pathol, D-6500 Mainz, Germany.
   [Stuebinger, S.; Saldamli, B.; Sader, R. A.] Univ Basel, Hightech Res Ctr Craniomaxillofacial Surg, Basel, Switzerland.
RP Stubinger, S (reprint author), Univ Frankfurt, Dept Oral Craniomaxillofacial & Facial Plast Surg, Med Ctr, Theodor Stern Kai 7, DE-60596 Frankfurt, Germany.
EM sstuebinger@uhbs.ch
FU camlog foundation, Basel, Switzerland
FX This study was supported by a grant from the camlog foundation, Basel,
   Switzerland. The tested biomaterial was supplied free of charge by
   Artoss, Rostock, Germany.
CR Boeck-Neto R, 2002, J PERIODONTOL, V73, P266, DOI 10.1902/jop.2002.73.3.266
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Braccini A, 2007, J TISSUE ENG REGEN M, V1, P60, DOI 10.1002/term.11
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Carmagnola D, 2000, J CLIN PERIODONTOL, V27, P799, DOI 10.1034/j.1600-051x.2000.027011799.x
   Dietze S., 2006, Folia Morphologica, V65, P63
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Gruber RM, 2008, CLIN ORAL IMPLAN RES, V19, P522, DOI 10.1111/j.1600-0501.2007.01494.x
   Henkel K-O, 2004, Mund Kiefer Gesichtschir, V8, P277, DOI 10.1007/s10006-004-0561-9
   Hsiong SX, 2006, PERIODONTOL 2000, V41, P109, DOI 10.1111/j.1600-0757.2006.00158.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Kirmeier R, 2008, CLIN ORAL IMPLAN RES, V19, P366, DOI 10.1111/j.1600-0501.2007.01487.x
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Kruyt MC, 2004, TRANSPLANTATION, V77, P504, DOI 10.1097/01.TP.0000107283.19336.DA
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Piattelli A, 1996, BIOMATERIALS, V17, P1127, DOI 10.1016/0142-9612(96)85915-1
   ROMEIS B, 1989, ROMEIS MIKROSKOPISCH, P558
   Rumpel E., 2006, Folia Morphologica, V65, P43
   RUMPEL E, 2005, DEUT ZAHNAERZTL Z, V60, P33
   SCHENK RK, 1991, AKTUELLER STAND KNOC, P23
   Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tepper G, 2002, CLIN ORAL IMPLAN RES, V13, P657, DOI 10.1034/j.1600-0501.2002.130613.x
   Traianedes K, 2004, J BIOMED MATER RES B, V70B, P21, DOI 10.1002/jbm.b.30015
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 28
TC 19
Z9 22
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
J9 EUR SURG RES
JI Eur. Surg. Res.
PY 2009
VL 42
IS 3
BP 143
EP 149
DI 10.1159/000197215
PG 7
WC Surgery
SC Surgery
GA 432GY
UT WOS:000265122700002
PM 19176966
DA 2018-10-19
ER

PT J
AU Thanos, CG
   Elliott, RB
AF Thanos, C. G.
   Elliott, R. B.
TI Encapsulated porcine islet transplantation: an evolving therapy for the
   treatment of Type I diabetes
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE alginate; capsule; diabetes; encapsulation; islet; porcine;
   xenotransplantation
ID CILIARY NEUROTROPHIC FACTOR; ALGINATE-POLYORNITHINE MICROCAPSULES;
   BIOHYBRID ARTIFICIAL PANCREAS; BABOON CARDIAC TRANSPLANTS; HUMAN-FETAL
   PANCREAS; GENE-KNOCKOUT PIGS; ENDOGENOUS RETROVIRUS; XENOGRAFT SURVIVAL;
   CELL CLUSTERS; SEMIPERMEABLE MICROCAPSULES
AB Background: Allogeneic tissue-based therapies for Type I diabetes have demonstrated efficacy but are limited due to tissue-sourcing constraints, as the number of patients exceeds that of tissue donors. Porcine islets derived from designated pathogen-free sources could be an alternative, particularly if delivered in a way that evades the host immune system's rejection. Methods: This review focuses on approaches designed to protect xenogeneic islets from immune rejection by provision of perm-selective barriers. Results: Designated pathogen-free herds could provide a supply of wild-type porcine islets that are well tolerated when administered in a suitable protective delivery vehicle. Such barrier systems have enabled amelioration of diabetes in a variety of animal models and preliminary evidence suggests that similar results could be attained in humans. Conclusion: With advances in biomaterial design, source tissue selection, and the evolution of critical cell processing techniques, contemporary encapsulated porcine islet therapies offer a new level of clinical promise.
C1 [Thanos, C. G.] TSC Co, Providence, RI 02906 USA.
   [Thanos, C. G.; Elliott, R. B.] Living Cell Technol, Auckland, New Zealand.
   [Thanos, C. G.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.
RP Thanos, CG (reprint author), TSC Co, 4 Richmond Sq,Suite 500, Providence, RI 02906 USA.
EM cgthanos@gmail.com
CR AEBISCHER P, 1988, BRAIN RES, V448, P364, DOI 10.1016/0006-8993(88)91278-4
   Aebischer P, 1996, HUM GENE THER, V7, P851, DOI 10.1089/hum.1996.7.7-851
   AHGAWARA H, 1991, PANCREAS, V6, P625
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bartosch B, 2004, J VIROL, V78, P13880, DOI 10.1128/JVI.78.24.13880-13890.2004
   Beattie GM, 1999, J MOL MED-JMM, V77, P70, DOI 10.1007/s001090050304
   BERG D, 2007, MICROISLET HOLDS POS
   BERNE RM, 1998, PHYSIOLOGY
   Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Bottino R, 2007, XENOTRANSPLANTATION, V14, P74, DOI 10.1111/j.1399-3089.2006.00374.X
   Brandhorst H, 1999, J MOL MED-JMM, V77, P90, DOI 10.1007/s001090050309
   Brauker J, 1996, TRANSPLANTATION, V61, P1671, DOI 10.1097/00007890-199606270-00002
   BRUNDIN P, 1985, EXP BRAIN RES, V60, P204
   Calafiore R, 1999, ANN NY ACAD SCI, V875, P219, DOI 10.1111/j.1749-6632.1999.tb08506.x
   Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270
   Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   CHANG TMS, 1970, T AM SOC ART INT ORG, V16, P141
   CHAYA A, 1966, ARCH SURG-CHICAGO, V93, P598
   CHICK WL, 1975, ENDOCRINOLOGY, V96, P637, DOI 10.1210/endo-96-3-637
   CHICK WL, 1977, SCIENCE, V197, P780, DOI 10.1126/science.407649
   CHICK WL, 1975, T AM SOC ART INT ORG, V21, P8
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   Clemenceau B, 2001, DIABETOLOGIA, V44, P2044, DOI 10.1007/s001250100010
   Colton C. K., 2007, CELLULAR TRANSPLANTA, P85
   Cooper DKC, 2007, TRANSPLANTATION, V84, P1, DOI 10.1097/01.tp.0000260427.75804.f2
   CRUISE G, 1999, CELL TRANSPLANT, V8, P292
   Delaunay C, 1997, DIABETES METAB, V23, P219
   Denner J, 2008, TRANSPL P, V40, P587, DOI 10.1016/j.transproceed.2007.12.026
   Dionne KE, 1996, BIOMATERIALS, V17, P257, DOI 10.1016/0142-9612(96)85563-3
   Dor FJMF, 2004, XENOTRANSPLANTATION, V11, P101, DOI 10.1111/j.1399-3089.2004.00078.x
   Dufrane D, 2006, XENOTRANSPLANTATION, V13, P204, DOI 10.1111/j.1399-3089.2006.00275.x
   Dufrane D, 2006, BIOMATERIALS, V27, P3201, DOI 10.1016/j.biomaterials.2006.01.028
   Eisenbarth GS, 2007, J CLIN ENDOCR METAB, V92, P2403, DOI 10.1210/jc.2007-0339
   ELLIOTT R, 2008, LIVING CELL TECHNOLO
   Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038
   Elliott RB, 2005, TRANSPL P, V37, P466, DOI 10.1016/j.transproceed.2004.12.198
   Elliott RB, 2000, CELL TRANSPLANT, V9, P895, DOI 10.1177/096368970000900616
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   Erce C, 2002, TRANSPLANT P, V34, P193, DOI 10.1016/S0041-1345(01)02723-3
   Ezzell C., 1995, J NIH RES, V7, P47
   Frank A, 2004, ANN SURG, V240, P631, DOI 10.1097/01.sla.0000140754.26575.2a
   Friedman T, 1999, J IMMUNOL, V162, P5256
   GALLETTI PM, 1992, ARTIF ORGANS, V16, P55
   GALLETTI PM, 1994, CELL TRANSPLANT, V3, pS3
   Garkavenko O, 2008, TRANSPL P, V40, P590, DOI 10.1016/j.transproceed.2008.01.051
   Garkavenko O, 2004, J CLIN MICROBIOL, V42, P5353, DOI 10.1128/JCM.42.11.5353-5356.2004
   GERASIMIDIVAZEOU A, 1992, TRANSPLANT P, V24, P667
   Gouin E, 1997, DIABETES METAB, V23, P537
   GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   HARJUSALO W, 2008, LANCET, V371, P1777
   Hector RD, 2007, XENOTRANSPLANTATION, V14, P222, DOI 10.1111/j.1399-3089.2007.00394.x
   HEINE RJ, 1989, LANCET, V2, P946
   Hermansen K, 2002, DIABETES CARE, V25, P883, DOI 10.2337/diacare.25.5.883
   HERRING B, 2006, NAR MED, V12, P301
   HOEKSTRA JBL, 1982, DIABETES CARE, V5, P438, DOI 10.2337/diacare.5.4.438
   HOME PD, 1982, DIABETOLOGIA, V22, P41, DOI 10.1007/BF00253868
   Hortelano G, 1996, BLOOD, V87, P5095
   Kim JH, 2007, XENOTRANSPLANTATION, V14, P60, DOI 10.1111/j.1399-3089.2006.00364.x
   KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   Kobayashi T, 1997, TRANSPLANTATION, V64, P1255, DOI 10.1097/00007890-199711150-00005
   Kobayashi T, 2006, XENOTRANSPLANTATION, V13, P547, DOI 10.1111/j.1399-3089.2006.00349.x
   Komoda H, 2005, XENOTRANSPLANTATION, V12, P209, DOI 10.1111/j.1399-3089.2005.00206.x
   Korbutt GS, 2008, XENOTRANSPLANTATION, V15, P81, DOI 10.1111/j.1399-3089.2008.00455.x
   Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649
   Korsgren O, 2005, TRANSPLANTATION, V79, P1289, DOI 10.1097/01.TP.0000157273.60147.7C
   KORSGREN O, 1991, DIABETOLOGIA, V34, P379, DOI 10.1007/BF00403174
   Kulseng B, 1999, TRANSPLANTATION, V67, P978, DOI 10.1097/00007890-199904150-00008
   Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171
   LACY PE, 1991, SCIENCE, V254, P1782, DOI 10.1126/science.1763328
   Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228
   LAMB W, 2007, TYPE 1 DIABETES MELL
   LANZA RP, 1992, TRANSPLANT P, V24, P669
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lin SS, 1998, J CLIN INVEST, V101, P1745, DOI 10.1172/JCI2134
   Lozner EL, 1941, J CLIN INVEST, V20, P507, DOI 10.1172/JCI101243
   Mendez AJ, 2007, XENOTRANSPLANTATION, V14, P89, DOI 10.1111/j.1399-3089.2006.00372.X
   MONACO AP, 1991, ANN SURG, V214, P339, DOI 10.1097/00000658-199109000-00016
   Morisset J, 2008, PANCREAS, V37, P1, DOI 10.1097/MPA.0b013e318161b99a
   Nesbakken T, 2007, EMERG INFECT DIS, V13, P1860, DOI 10.3201/eid1312.070531
   *NIDDK, 2008, NAT DIAB STAT
   Nilsson B, 2008, XENOTRANSPLANTATION, V15, P96, DOI 10.1111/j.1399-3089.2008.00460.x
   Olack BJ, 1999, HUM IMMUNOL, V60, P1303, DOI 10.1016/S0198-8859(99)00118-4
   Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236
   Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942
   PLATT J, 2007, IMMUNOLOGY CELL TISS
   Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014
   RAHBAR S, 1969, BIOCHEM BIOPH RES CO, V36, P838, DOI 10.1016/0006-291X(69)90685-8
   Reach G, 1983, Life Support Syst, V1 Suppl 1, P49
   REMAKARAN R, 2008, LANCET, V371, P1790
   Sakuma Y, 2008, TRANSPL P, V40, P343, DOI 10.1016/j.transproceed.007.12.019
   SANDLER S, 1989, DIABETES, V38, P168, DOI 10.2337/diab.38.1.S168
   SCHARP DW, 1994, DIABETES, V43, P1167, DOI 10.2337/diabetes.43.9.1167
   Schroeder C, 2005, TRANSPLANT P, V37, P512, DOI 10.1016/j.transproceed.2004.12.133
   Scott WE, 2008, TRANSPL P, V40, P403, DOI 10.1016/j.transproceed.2008.01.042
   SELAWRY HP, 1988, AM J MED SCI, V295, P497, DOI 10.1097/00000441-198806000-00001
   SETCAVAGE TM, 1976, INFECT IMMUN, V13, P600
   Sherwin RS, 2008, DIABETES, V57, P2259, DOI 10.2337/db08-9023
   Siebers U, 1999, J MOL MED-JMM, V77, P215, DOI 10.1007/s001090050339
   Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103
   SIGRIST S, 2006, TRANSPL P, V37, P3516
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Sprangers B, 2008, KIDNEY INT, V74, P14, DOI 10.1038/ki.2008.135
   Storrs R, 2001, ANN NY ACAD SCI, V944, P252
   SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   SUTHERLAND DE, 1974, J SURG RES, V16, P102, DOI 10.1016/0022-4804(74)90017-1
   Sykes M, 2007, XENOTRANSPLANTATION, V14, P90, DOI 10.1111/j.1399-3089.2006.00373.x
   Tacke SJ, 2000, VIROLOGY, V268, P87, DOI 10.1006/viro.1999.0149
   Tacke SJ, 2001, XENOTRANSPLANTATION, V8, P125, DOI 10.1034/j.1399-3089.2001.00082.x
   TAO W, 2005, INVEST OPHTH VIS SCI, V46, pB471
   Taylor MJ, 2008, TRANSPL P, V40, P480, DOI 10.1016/j.transproceed.2008.01.004
   THANOS C, 2003, INVEST OPHTH VIS SCI, V44, pB118
   Thanos CG, 2007, J BIOMED MATER RES A, V83A, P216, DOI 10.1002/jbm.a.31472
   Thanos CG, 2007, J BIOMED MATER RES A, V81A, P1, DOI 10.1002/jbm.a.31033
   Thanos CG, 2006, BIOMATERIALS, V27, P3570, DOI 10.1016/j.biomaterials.2006.01.042
   Thanos CG, 2004, TISSUE ENG, V10, P1617, DOI 10.1089/ten.2004.10.1617
   Thanos CG, 2007, TISSUE ENG, V13, P747, DOI 10.1089/ten.2006.0294
   Tresco P A, 1992, ASAIO J, V38, P17, DOI 10.1097/00002480-199201000-00006
   Valdes-Gonzalez RA, 2005, EUR J ENDOCRINOL, V153, P419, DOI 10.1530/eje.1.01982
   Venstrom JM, 2003, JAMA-J AM MED ASSOC, V290, P2817, DOI 10.1001/jama.290.21.2817
   Weinzimer SA, 2008, CURR OPIN ENDOCRINOL, V15, P118, DOI 10.1097/MED.0b013e3282f7960b
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   YABUUCHI H, 1991, TRANSPLANT P, V23, P859
   Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172
   2007, MICROISLET HOLDS POS
NR 130
TC 20
Z9 21
U1 1
U2 15
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1471-2598
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PD JAN
PY 2009
VL 9
IS 1
BP 29
EP 44
DI 10.1517/14712590802630666
PG 16
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 393BX
UT WOS:000262347000004
PM 19063691
DA 2018-10-19
ER

PT J
AU Vayssade, M
   Nagel, MD
AF Vayssade, Muriel
   Nagel, Marie-Danielle
TI Stromal cells
SO FRONTIERS IN BIOSCIENCE
LA English
DT Review
DE Stromal Cells; Tissue Engineering; Biohybrid Systems; Bioreactors
ID MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; UMBILICAL-CORD BLOOD;
   FIBROBLAST-GROWTH-FACTOR; TITANIUM FIBER MESH; BETA-TRICALCIUM
   PHOSPHATE; EX-VIVO EXPANSION; IN-VITRO; OSTEOGENIC DIFFERENTIATION;
   CHONDROGENIC DIFFERENTIATION
AB Stromal cells, or mesenchymal stem cells, are adherent clonogenic cells that can form colonies. They are mainly isolated from bone marrow but can also be found in umbilical cord blood, adipose tissues and amniotic fluids. These stem cells are easy to culture in vitro, and can differentiate into osteoblasts, chondrocytes, or adipocytes when stimulated appropriately. When seeded on a natural (titanium, ceramics, collagen fibers, silk, etc.) or synthetic (PLLA, PLGA, etc.) biomaterial scaffold, they adhere and differentiate to form a new tissue. Many studies have also explored stromal cell differentiation in bioreactors to form a 3-dimensional culture. This review focuses on the biomaterials used for tissue engineering with stromal cells.
C1 [Vayssade, Muriel; Nagel, Marie-Danielle] Univ Technol Compiegne, UMR 6600, CNRS, F-60205 Compiegne, France.
RP Nagel, MD (reprint author), Univ Technol Compiegne, UMR 6600, CNRS, BP 20529, F-60205 Compiegne, France.
EM marie-danielle.nagel@utc.fr
CR Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Almeida-Porada G, 2000, BLOOD, V95, P3620
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman Greg, 2002, FASEB Journal, V16, P270
   Angelopoulou M, 2003, EXP HEMATOL, V31, P413, DOI 10.1016/S0301-472X(03)00042-0
   ANKER PS, 2003, BLOOD, V102, P1548
   Anker PSI, 2003, HAEMATOLOGICA, V88, P845
   Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337
   Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763
   AURADE F, 1994, DIFFERENTIATION, V55, P185, DOI 10.1046/j.1432-0436.1994.5530185.x
   Bai XW, 2004, BIOCHEM BIOPH RES CO, V325, P453, DOI 10.1016/j.bbrc.2004.10.055
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x
   Cancelas JA, 2000, BLOOD, V96, P498
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen LB, 2004, WORLD J GASTROENTERO, V10, P3016
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Cho SW, 2004, BIOMATERIALS, V25, P2979, DOI 10.1016/j.biomaterials.2003.09.068
   Chu Qian, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P259
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Dennis JE, 2002, CELLS TISSUES ORGANS, V170, P73, DOI 10.1159/000046182
   Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205
   Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034
   DORSHKIND K, 1993, BLOOD, V82, P38
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5
   Fernandez M, 1997, BONE MARROW TRANSPL, V20, P265, DOI 10.1038/sj.bmt.1700890
   Filshie RJA, 1998, LEUKEMIA, V12, P414, DOI 10.1038/sj.leu.2400922
   Fischer EM, 2003, TISSUE ENG, V9, P1179, DOI 10.1089/10763270360728080
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200
   Gang EJ, 2004, BIOCHEM BIOPH RES CO, V321, P102, DOI 10.1016/j.bbrc.2004.06.111
   Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617
   Ge ZG, 2004, BIOMATERIALS, V25, P1049, DOI 10.1016/S0142-9612(03)00612-4
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Green D, 2003, TISSUE ENG, V9, P1159, DOI 10.1089/10763270360728062
   Gronthos S, 1996, J Hematother, V5, P15, DOI 10.1089/scd.1.1996.5.15
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   GRONTHOS S, 1994, BLOOD, V84, P4164
   Gugala Z, 2004, BIOMATERIALS, V25, P2299, DOI 10.1016/j.biomaterials.2003.09.009
   Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Hori Y, 2004, TISSUE ENG, V10, P995, DOI 10.1089/1076327041887790
   Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313
   Huang WB, 2004, EXP CELL RES, V299, P325, DOI 10.1016/j.yexcr.2004.04.051
   Hung SC, 2004, GENE, V340, P141, DOI 10.1016/.j.gene.2004.06.028
   Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249
   Ikeda R, 2005, J BIOL CHEM, V280, P8523, DOI 10.1074/jbc.M409442200
   in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   Jeong JA, 2004, NEUROREPORT, V15, P1731, DOI 10.1097/01.wnr.0000134846.79002.5c
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Kha HT, 2004, J BONE MINER RES, V19, P830, DOI 10.1359/JBMR.040115
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim H, 2003, BIOMATERIALS, V24, P4671, DOI 10.1016/S0142-9612(03)00358-2
   Knabe C, 2002, BIOMATERIALS, V23, P3235, DOI 10.1016/S0142-9612(02)00078-9
   Kobayashi N, 2004, EXP HEMATOL, V32, P1238, DOI 10.1016/j.exphem.2004.08.011
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   LE BK, 2004, LANCET, V363, P1439
   Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7
   Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469
   Lee MW, 2004, BIOCHEM BIOPH RES CO, V320, P273, DOI 10.1016/j.bbrc.2004.04.206
   Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Li L, 2004, J PEDIATR ORTHOPED, V24, P205, DOI 10.1097/01241398-200403000-00014
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Lisignoli G, 2003, Chir Organi Mov, V88, P363
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   Lu LC, 2001, J BONE JOINT SURG AM, V83A, pS82
   Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   MAGRUFOV A, 2004, ACTA OTO-LARYNGOL, V551, P75
   Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400
   Majumdar MK, 2000, J CELL PHYSIOL, V185, P98
   Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710
   Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264
   Mante Mamle, 2003, J Oral Implantol, V29, P66, DOI 10.1563/1548-1336(2003)029<0066:AOHMSC>2.3.CO;2
   Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Noshi T, 2001, ARTIF ORGANS, V25, P201, DOI 10.1046/j.1525-1594.2001.025003201.x
   O'Connor KC, 2003, BIOTECHNOL LETT, V25, P1967, DOI 10.1023/B:BILE.0000004386.08923.ab
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024
   Park SA, 2004, BIOMATERIALS, V25, P527, DOI 10.1016/S0142-9612(03)00553-2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9
   Rosendaal M, 2003, BLOOD, V101, P2996, DOI 10.1182/blood-2002-07-2028
   Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Salim A, 2004, J BIOL CHEM, V279, P40007, DOI 10.1074/jbc.M403715200
   Sasaki T, 2002, CYTOTHERAPY, V4, P285, DOI 10.1080/146532402320219808
   Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Shimakura Y, 2003, J CRANIOFAC SURG, V14, P108, DOI 10.1097/00001665-200301000-00021
   Shimaoka H, 2004, J BIOMED MATER RES A, V68A, P168, DOI 10.1002/jbm.a.20059
   Short B, 2003, ARCH MED RES, V34, P565, DOI 10.1016/j.arcmed.2003.09.007
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   SIMMONS PJ, 1991, BLOOD, V78, P55
   Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tocci Angelo, 2003, Hematol J, V4, P92, DOI 10.1038/sj.thj.6200232
   Tominaga S, 2005, BIOCHEM BIOPH RES CO, V326, P499, DOI 10.1016/j.bbrc.2004.11.056
   Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   TORENSMA R, 2003, CLIN ORAL IMPLAN RES, V4, P569
   Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   Vehof JWM, 2001, TISSUE ENG, V7, P373, DOI 10.1089/10763270152436436
   Verfaillie CM, 1998, BLOOD, V92, P2609
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582
   Wang GF, 2002, J COMPUT-AIDED MATER, V8, P117
   Wang J, 2004, J DENT RES, V83, P296, DOI 10.1177/154405910408300405
   Wang JF, 2004, HAEMATOLOGICA, V89, P837
   Weimar IS, 1998, EXP HEMATOL, V26, P885
   Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.3.CO;2-3
   Wright N, 2003, BLOOD, V102, P1978, DOI 10.1182/blood-2002-10-3190
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yang IH, 2004, YONSEI MED J, V45, P891
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130
   Zweegman S, 2004, EXP CELL RES, V299, P383, DOI 10.1016/j.yexcr.2004.06.018
NR 142
TC 5
Z9 7
U1 0
U2 18
PU FRONTIERS IN BIOSCIENCE INC
PI MANHASSET
PA C/O NORTH SHORE UNIV HOSPITAL, BIOMEDICAL RESEARCH CENTER, 350 COMMUNITY
   DR, MANHASSET, NY 11030 USA
SN 1093-9946
J9 FRONT BIOSCI
JI Front. Biosci.
PD JAN 1
PY 2009
VL 14
BP 210
EP 224
DI 10.2741/3241
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 393DZ
UT WOS:000262352400014
PM 19273064
DA 2018-10-19
ER

EF